Citrus Sinensis ID: 046270
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 590 | 2.2.26 [Sep-21-2011] | |||||||
| O04086 | 625 | Probable receptor-like pr | yes | no | 0.954 | 0.900 | 0.5 | 1e-162 | |
| P93050 | 617 | Probable LRR receptor-lik | no | no | 0.9 | 0.860 | 0.373 | 3e-98 | |
| Q9ASQ6 | 1019 | Probable LRR receptor-lik | no | no | 0.557 | 0.322 | 0.405 | 7e-71 | |
| Q93ZS4 | 632 | Protein NSP-INTERACTING K | no | no | 0.535 | 0.5 | 0.428 | 4e-65 | |
| Q9LK03 | 717 | Proline-rich receptor-lik | no | no | 0.535 | 0.440 | 0.415 | 5e-65 | |
| Q1PEM5 | 513 | Proline-rich receptor-lik | no | no | 0.483 | 0.555 | 0.452 | 7e-65 | |
| Q9FFW5 | 681 | Proline-rich receptor-lik | no | no | 0.486 | 0.421 | 0.449 | 1e-64 | |
| C0LGH3 | 1033 | Probable LRR receptor-lik | no | no | 0.579 | 0.331 | 0.393 | 4e-64 | |
| C0LGE0 | 1014 | Probable LRR receptor-lik | no | no | 0.633 | 0.368 | 0.361 | 6e-64 | |
| Q9LV48 | 652 | Proline-rich receptor-lik | no | no | 0.542 | 0.490 | 0.420 | 6e-64 |
| >sp|O04086|Y1105_ARATH Probable receptor-like protein kinase At1g11050 OS=Arabidopsis thaliana GN=At1g11050 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 572 bits (1474), Expect = e-162, Method: Compositional matrix adjust.
Identities = 297/594 (50%), Positives = 407/594 (68%), Gaps = 31/594 (5%)
Query: 2 SSSCPVDLSYVQTYPWDRSSCLDPNGKF-----CCATLLSLIGMGLAAHLRETSLFQFPN 56
S +CP+D S+V T PW+ + C + CC +LL+LIG+ LA L++TS F+ PN
Sbjct: 24 SQTCPLDFSHVLTIPWNTTDCQKSDKSADSKNSCCQSLLTLIGIPLAHRLKQTSNFRLPN 83
Query: 57 ETASAFCLSELQGRLATLSINPSVVPTCFPNATQFASNTSFCAGIVTIEDWKKLVGPTSA 116
S CL+ LQ +L++LS++ ++ CF + QF N CAGI T +DW +GP++A
Sbjct: 84 LATSISCLNNLQTKLSSLSLSSNLTSLCF-DPNQFVINNETCAGIQTTQDWVSRLGPSTA 142
Query: 117 LDPACKN-FSGFSQCSSCVEAGYSVNAKLLSIQPNSTK---CFYFAVLYATGILND--PK 170
LD AC + + ++C +CV AG+ V +L+++ NS+ C++F V YA GI+N P+
Sbjct: 143 LDSACSSGLTDLTRCDACVAAGFRVQKQLITLDGNSSHGVYCYHFVVTYAAGIVNKKGPE 202
Query: 171 DEAAVACILRLPISSSKTKNSSSNNRTIKLVIGLLGALLGFLLASGLIILYRKWNKKRK- 229
+ A++C+ L + S NS T+ L +G+ GA+ G L+ +GLI LY ++ K K
Sbjct: 203 SDDALSCLFSLSLRSPL--NSKKKRHTVALALGITGAIFGALVIAGLICLYFRFGKAVKG 260
Query: 230 -QIALHEQFVSNLQASVLPNSGAKWFHVSELEQATNGFSQNNLIGQGASGIVYKGTLRHG 288
++ +Q + PN+G+ WF + ELE+ATN FSQ N IG+G G VYKG L G
Sbjct: 261 GEVGWEDQ---GSRPKWRPNTGSIWFKIEELEKATNNFSQKNFIGRGGFGFVYKGVLPDG 317
Query: 289 NLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFLVYDYMP 348
+++AVK++++ + +GD +F NEVEIIS ++HRNL+ LRGC + DDS +R+LVYDYM
Sbjct: 318 SVIAVKKVIESEFQGDAEFRNEVEIISNLKHRNLVPLRGCSMVDDDSE-SQRYLVYDYMS 376
Query: 349 NGTLSDNISISHK--RKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDS 406
NG L D++ + + L+WPQRK II+DVAKG+AYLHYG+KP IYHRDIK TNILLD
Sbjct: 377 NGNLDDHLFPRGETTKMPLSWPQRKSIILDVAKGLAYLHYGVKPAIYHRDIKGTNILLDV 436
Query: 407 ELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELM 466
++ A+VADFGLAKQS EG SHLTTRVAGT GYLAPEYALYGQLTEKSDVYSFG+VILE+M
Sbjct: 437 DMRARVADFGLAKQSREGESHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIM 496
Query: 467 SGRKVLDTSTSPFQ---LITDWAWVLAKSGKVDDIFDE-FIRAEGA-----RAVMERFVL 517
GRK LD STS LITDWAW L K+GK ++ ++ +R EG+ + +MERF+
Sbjct: 497 CGRKALDLSTSGSPNTFLITDWAWSLVKAGKTEEALEQSLLREEGSGLSNPKGIMERFLQ 556
Query: 518 VGILCAHVMVALRPTITDALKMLEGDIDIPKLPDRPLPLSHECLRSSPSRYSFS 571
VGILCAHV+VALRPTI DALKMLEGDI++P +PDRP+PL+H R + ++ S
Sbjct: 557 VGILCAHVLVALRPTILDALKMLEGDIEVPPIPDRPVPLAHPSYRMDGNGFTIS 610
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|P93050|RKF3_ARATH Probable LRR receptor-like serine/threonine-protein kinase RKF3 OS=Arabidopsis thaliana GN=RKF3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 359 bits (922), Expect = 3e-98, Method: Compositional matrix adjust.
Identities = 216/579 (37%), Positives = 327/579 (56%), Gaps = 48/579 (8%)
Query: 1 NSSSCPVDLSYVQTYPWDRSSCLDPNGKFCCATLLSLIGMGLAAHLRETSLFQFPNETAS 60
+S+CP+D S ++ P+ R P+G C LL + + + HLR+T F P E+A+
Sbjct: 21 QNSTCPLDFSVLE--PFRRPK---PDGATTCQYLLQGLRLLYSHHLRQTGSFLPPPESAA 75
Query: 61 AFCLSELQGRLATLSINPSVVPTCFPNATQFASNTSFCAGIVTIEDWKKLVGPTSALDPA 120
+ C + LQ +A V TC Q + C I T ++ L+ +S A
Sbjct: 76 S-CWAALQSSVAGFLPRFDVRSTC---GFQTPWISQGCMDITTRSQFESLIPNSSLATTA 131
Query: 121 CK---NFSGFSQCSSCVEAGYSVNAKLLSIQP--------NSTKCFYFAVLYATGILND- 168
+ + + C+SC ++ L + QP N + C F +YA N
Sbjct: 132 MRCNTSLESNTPCASCTQS-------LSAFQPYLSGPSLGNVSDCASFPSIYAAAFANSL 184
Query: 169 -PKDEAAVACILRLPISSSKTKNSSSNNRTIKLVIGLLGALLGFLLASGLIILYRKWNKK 227
P D+ C+ +L ++S +SS +K+++ LL +AS L+I W +
Sbjct: 185 GPTDKGTAKCLFQLDLASP----TSSGANKVKVLVSSFSVLL---VASVLVITAWFWYCR 237
Query: 228 RKQIALHEQFVSNLQA-------SVLPNSGAKWFHVSELEQATNGFSQNNLIGQGASGIV 280
RK+ L + ++L+A S+ ++ F E+++ATN FS++N+IG+G G V
Sbjct: 238 RKKSKLLKPRDTSLEAGTQSRLDSMSESTTLVKFSFDEIKKATNNFSRHNIIGRGGYGNV 297
Query: 281 YKGTLRHGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRR 340
+KG L G VA K+ + GD +F +EVE+I+ IRH NLL+LRG C + G +R
Sbjct: 298 FKGALPDGTQVAFKRFKNCSAGGDANFAHEVEVIASIRHVNLLALRGYCTATTPYEGHQR 357
Query: 341 FLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKST 400
+V D + NG+L D++ QL WP R++I + +A+G+AYLHYG +P I HRDIK++
Sbjct: 358 IIVCDLVSNGSLHDHL-FGDLEAQLAWPLRQRIALGMARGLAYLHYGAQPSIIHRDIKAS 416
Query: 401 NILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGI 460
NILLD AKVADFGLAK + EG +H++TRVAGT GY+APEYALYGQLTEKSDVYSFG+
Sbjct: 417 NILLDERFEAKVADFGLAKFNPEGMTHMSTRVAGTMGYVAPEYALYGQLTEKSDVYSFGV 476
Query: 461 VILELMSGRK--VLDTSTSPFQLITDWAWVLAKSGKVDDIFDEFIRAEGARAVMERFVLV 518
V+LEL+S RK V D P + DWAW L + G+ D+ ++ + +G V+E++VL+
Sbjct: 477 VLLELLSRRKAIVTDEEGQPVS-VADWAWSLVREGQTLDVVEDGMPEKGPPEVLEKYVLI 535
Query: 519 GILCAHVMVALRPTITDALKMLE-GDIDIPKLPDRPLPL 556
+LC+H + RPT+ +KMLE + + +P RP+PL
Sbjct: 536 AVLCSHPQLHARPTMDQVVKMLESNEFTVIAIPQRPIPL 574
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ASQ6|Y1972_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g29720 OS=Arabidopsis thaliana GN=RFK1 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 268 bits (686), Expect = 7e-71, Method: Compositional matrix adjust.
Identities = 138/340 (40%), Positives = 215/340 (63%), Gaps = 11/340 (3%)
Query: 254 FHVSELEQATNGFSQNNLIGQGASGIVYKGTLRHGNLVAVKQILDLDTKGDEDFTNEVEI 313
F +L+ ATN F Q N +G+G G V+KG L G ++AVKQ+ ++G+ +F NE+ +
Sbjct: 661 FSWRQLQTATNNFDQANKLGEGGFGSVFKGELSDGTIIAVKQLSSKSSQGNREFVNEIGM 720
Query: 314 ISKIRHRNLLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKI 373
IS + H NL+ L GCCV D + LVY+YM N +L+ + +L W R+KI
Sbjct: 721 ISGLNHPNLVKLYGCCVERD-----QLLLVYEYMENNSLALAL-FGQNSLKLDWAARQKI 774
Query: 374 IVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVA 433
V +A+G+ +LH G + HRDIK+TN+LLD++LNAK++DFGLA+ H+H++T+VA
Sbjct: 775 CVGIARGLEFLHDGSAMRMVHRDIKTTNVLLDTDLNAKISDFGLARLHEAEHTHISTKVA 834
Query: 434 GTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQL-ITDWAWVLAKS 492
GT GY+APEYAL+GQLTEK+DVYSFG+V +E++SG+ + + + +WA L ++
Sbjct: 835 GTIGYMAPEYALWGQLTEKADVYSFGVVAMEIVSGKSNTKQQGNADSVSLINWALTLQQT 894
Query: 493 GKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEGDIDIPKLPDR 552
G + +I D + E R+ R + V ++C + +LRPT+++A+KMLEG+I+I ++
Sbjct: 895 GDILEIVDRMLEGEFNRSEAVRMIKVALVCTNSSPSLRPTMSEAVKMLEGEIEITQVMSD 954
Query: 553 PLPLSHEC----LRSSPSRYSFSTSTDRSATSSSMTSTIS 588
P H+ LR + S STS T+++M S++S
Sbjct: 955 PGIYGHDWSISKLRDIDTHSSSSTSGVTDQTTTTMKSSVS 994
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q93ZS4|NIK3_ARATH Protein NSP-INTERACTING KINASE 3 OS=Arabidopsis thaliana GN=NIK3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 249 bits (636), Expect = 4e-65, Method: Compositional matrix adjust.
Identities = 144/336 (42%), Positives = 194/336 (57%), Gaps = 20/336 (5%)
Query: 215 SGLIILYRKWNKKRKQIALHEQFVSNLQASVLPNSGAKWFHVSELEQATNGFSQNNLIGQ 274
SG+ + +R K+ ++EQ+ + L K + EL ATN F+ N++G+
Sbjct: 255 SGMFLWWRYRRNKQIFFDVNEQYDPEVSLGHL-----KRYTFKELRSATNHFNSKNILGR 309
Query: 275 GASGIVYKGTLRHGNLVAVKQILDLDTKGDE-DFTNEVEIISKIRHRNLLSLRGCCVTSD 333
G GIVYKG L G LVAVK++ D + G E F EVE IS HRNLL LRG C
Sbjct: 310 GGYGIVYKGHLNDGTLVAVKRLKDCNIAGGEVQFQTEVETISLALHRNLLRLRGFC---- 365
Query: 334 DSSGKRRFLVYDYMPNGT----LSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLK 389
SS + R LVY YMPNG+ L DNI L W +RKKI V A+G+ YLH
Sbjct: 366 -SSNQERILVYPYMPNGSVASRLKDNI---RGEPALDWSRRKKIAVGTARGLVYLHEQCD 421
Query: 390 PGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALYGQL 449
P I HRD+K+ NILLD + A V DFGLAK SH+TT V GT G++APEY GQ
Sbjct: 422 PKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQS 481
Query: 450 TEKSDVYSFGIVILELMSGRKVLDTSTSPFQ--LITDWAWVLAKSGKVDDIFDEFIRAEG 507
+EK+DV+ FGI++LEL++G+K LD S Q ++ DW L + GK+ + D+ + +
Sbjct: 482 SEKTDVFGFGILLLELITGQKALDFGRSAHQKGVMLDWVKKLHQEGKLKQLIDKDLNDKF 541
Query: 508 ARAVMERFVLVGILCAHVMVALRPTITDALKMLEGD 543
R +E V V +LC + RP +++ +KMLEGD
Sbjct: 542 DRVELEEIVQVALLCTQFNPSHRPKMSEVMKMLEGD 577
|
Involved in defense response to geminivirus infection. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LK03|PERK2_ARATH Proline-rich receptor-like protein kinase PERK2 OS=Arabidopsis thaliana GN=PERK2 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 249 bits (635), Expect = 5e-65, Method: Compositional matrix adjust.
Identities = 136/327 (41%), Positives = 196/327 (59%), Gaps = 11/327 (3%)
Query: 254 FHVSELEQATNGFSQNNLIGQGASGIVYKGTLRHGNLVAVKQILDLDTKGDEDFTNEVEI 313
F+ EL +ATNGFS+ NL+GQG G V+KG LR+G VAVKQ+ + ++G+ +F EV I
Sbjct: 342 FNYEELSRATNGFSEANLLGQGGFGYVFKGMLRNGKEVAVKQLKEGSSQGEREFQAEVGI 401
Query: 314 ISKIRHRNLLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKI 373
IS++ HR+L++L G C+ +R LVY+++PN TL ++ R + W R KI
Sbjct: 402 ISRVHHRHLVALVGYCIAD-----AQRLLVYEFVPNNTLEFHLH-GKGRPTMEWSSRLKI 455
Query: 374 IVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVA 433
V AKG++YLH P I HRDIK++NIL+D + AKVADFGLAK + + ++H++TRV
Sbjct: 456 AVGSAKGLSYLHENCNPKIIHRDIKASNILIDFKFEAKVADFGLAKIASDTNTHVSTRVM 515
Query: 434 GTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLD-TSTSPFQLITDWAWVL--- 489
GTFGYLAPEYA G+LTEKSDV+SFG+V+LEL++GR+ +D + + DWA L
Sbjct: 516 GTFGYLAPEYASSGKLTEKSDVFSFGVVLLELITGRRPIDVNNVHADNSLVDWARPLLNQ 575
Query: 490 -AKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEGDIDIPK 548
++ G + + D+ + E + M R V C RP + ++LEG+I
Sbjct: 576 VSELGNFEVVVDKKLNNEYDKEEMARMVACAAACVRSTAPRRPRMDQVARVLEGNISPSD 635
Query: 549 LPDRPLPLSHECLRSSPSRYSFSTSTD 575
L P SS + +S D
Sbjct: 636 LNQGITPGHSNVYGSSGGSTDYDSSQD 662
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q1PEM5|PERK3_ARATH Proline-rich receptor-like protein kinase PERK3 OS=Arabidopsis thaliana GN=PERK3 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 248 bits (634), Expect = 7e-65, Method: Compositional matrix adjust.
Identities = 134/296 (45%), Positives = 185/296 (62%), Gaps = 11/296 (3%)
Query: 254 FHVSELEQATNGFSQNNLIGQGASGIVYKGTLRHGNLVAVKQILDLDTKGDEDFTNEVEI 313
F EL +ATN FS+ NL+G+G G VYKG L +GN VAVKQ+ +G+++F EV I
Sbjct: 171 FTYGELARATNKFSEANLLGEGGFGFVYKGILNNGNEVAVKQLKVGSAQGEKEFQAEVNI 230
Query: 314 ISKIRHRNLLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKI 373
IS+I HRNL+SL G C+ +G +R LVY+++PN TL ++ R + W R KI
Sbjct: 231 ISQIHHRNLVSLVGYCI-----AGAQRLLVYEFVPNNTLEFHLH-GKGRPTMEWSLRLKI 284
Query: 374 IVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVA 433
V +KG++YLH P I HRDIK+ NIL+D + AKVADFGLAK +L+ ++H++TRV
Sbjct: 285 AVSSSKGLSYLHENCNPKIIHRDIKAANILIDFKFEAKVADFGLAKIALDTNTHVSTRVM 344
Query: 434 GTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLD-TSTSPFQLITDWAWVL--- 489
GTFGYLAPEYA G+LTEKSDVYSFG+V+LEL++GR+ +D + + DWA L
Sbjct: 345 GTFGYLAPEYAASGKLTEKSDVYSFGVVLLELITGRRPVDANNVYADDSLVDWARPLLVQ 404
Query: 490 -AKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEGDI 544
+ + + D + E R M R V C RP + +++LEG+I
Sbjct: 405 ALEESNFEGLADIKLNNEYDREEMARMVACAAACVRYTARRRPRMDQVVRVLEGNI 460
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FFW5|PERK8_ARATH Proline-rich receptor-like protein kinase PERK8 OS=Arabidopsis thaliana GN=PERK8 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 248 bits (632), Expect = 1e-64, Method: Compositional matrix adjust.
Identities = 137/305 (44%), Positives = 188/305 (61%), Gaps = 18/305 (5%)
Query: 253 WFHVSELEQATNGFSQNNLIGQGASGIVYKGTLRHGNLVAVKQILDLDTKGDEDFTNEVE 312
WF EL Q T+GFS+ NL+G+G G VYKG L G VAVKQ+ ++G+ +F EVE
Sbjct: 326 WFSYDELSQVTSGFSEKNLLGEGGFGCVYKGVLSDGREVAVKQLKIGGSQGEREFKAEVE 385
Query: 313 IISKIRHRNLLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKK 372
IIS++ HR+L++L G C+ S + R LVYDY+PN TL ++ + R +TW R +
Sbjct: 386 IISRVHHRHLVTLVGYCI-----SEQHRLLVYDYVPNNTLHYHLH-APGRPVMTWETRVR 439
Query: 373 IIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAK--QSLEGHSHLTT 430
+ A+GIAYLH P I HRDIKS+NILLD+ A VADFGLAK Q L+ ++H++T
Sbjct: 440 VAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDNSFEALVADFGLAKIAQELDLNTHVST 499
Query: 431 RVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPF--QLITDWAWV 488
RV GTFGY+APEYA G+L+EK+DVYS+G+++LEL++GRK +DTS P + + +WA
Sbjct: 500 RVMGTFGYMAPEYATSGKLSEKADVYSYGVILLELITGRKPVDTS-QPLGDESLVEWARP 558
Query: 489 LAKSGKVDDIFDEFIRAEGAR----AVMERFVLVGILCAHVMVALRPTITD---ALKMLE 541
L ++ FDE + + M R V C A RP ++ AL LE
Sbjct: 559 LLGQAIENEEFDELVDPRLGKNFIPGEMFRMVEAAAACVRHSAAKRPKMSQVVRALDTLE 618
Query: 542 GDIDI 546
DI
Sbjct: 619 EATDI 623
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGH3|Y5614_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g56140 OS=Arabidopsis thaliana GN=At1g56140 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 246 bits (627), Expect = 4e-64, Method: Compositional matrix adjust.
Identities = 146/371 (39%), Positives = 213/371 (57%), Gaps = 29/371 (7%)
Query: 188 TKNSSSNNRTIKLVIGLLGALLGFLLASGLIILYRKWNKKRKQIALHEQFVSNLQASVLP 247
+K S + +++G+ LL + SG++I + K+RK+ E+ +S V P
Sbjct: 628 SKGKSMTGTIVGVIVGV--GLLSII--SGVVIFIIR--KRRKRYTDDEEILS---MDVKP 678
Query: 248 NSGAKWFHVSELEQATNGFSQNNLIGQGASGIVYKGTLRHGNLVAVKQILDLDTKGDEDF 307
+ F SEL+ AT F +N +G+G G VYKG L G VAVK + +G F
Sbjct: 679 YT----FTYSELKSATQDFDPSNKLGEGGFGPVYKGKLNDGREVAVKLLSVGSRQGKGQF 734
Query: 308 TNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTW 367
E+ IS ++HRNL+ L GCC G+ R LVY+Y+PNG+L D K L W
Sbjct: 735 VAEIVAISAVQHRNLVKLYGCCY-----EGEHRLLVYEYLPNGSL-DQALFGEKTLHLDW 788
Query: 368 PQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSH 427
R +I + VA+G+ YLH + I HRD+K++NILLDS+L KV+DFGLAK + +H
Sbjct: 789 STRYEICLGVARGLVYLHEEARLRIVHRDVKASNILLDSKLVPKVSDFGLAKLYDDKKTH 848
Query: 428 LTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTS-TSPFQLITDWA 486
++TRVAGT GYLAPEYA+ G LTEK+DVY+FG+V LEL+SGR D + + + +WA
Sbjct: 849 ISTRVAGTIGYLAPEYAMRGHLTEKTDVYAFGVVALELVSGRPNSDENLEDEKRYLLEWA 908
Query: 487 WVLAKSGK----VDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEG 542
W L + G+ +D EF EG +R + + +LC ALRP ++ + ML G
Sbjct: 909 WNLHEKGREVELIDHQLTEFNMEEG-----KRMIGIALLCTQTSHALRPPMSRVVAMLSG 963
Query: 543 DIDIPKLPDRP 553
D+++ + +P
Sbjct: 964 DVEVSDVTSKP 974
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGE0|Y1765_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g07650 OS=Arabidopsis thaliana GN=At1g07650 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 245 bits (626), Expect = 6e-64, Method: Compositional matrix adjust.
Identities = 146/404 (36%), Positives = 233/404 (57%), Gaps = 30/404 (7%)
Query: 194 NNRTIKLVIGLLGALLGFLLASGLIILYRKWNKKRKQIALHEQFVS-NLQASVLPNSGAK 252
+ + I L +G+ A LL II+ W K+R + + ++ +LQ
Sbjct: 616 DTKDIILKVGVPVAAATLLL---FIIVGVFWKKRRDKNDIDKELRGLDLQTGT------- 665
Query: 253 WFHVSELEQATNGFSQNNLIGQGASGIVYKGTLRHGNLVAVKQILDLDTKGDEDFTNEVE 312
F + +++ AT+ F IG+G G VYKG L G L+AVKQ+ +G+ +F NE+
Sbjct: 666 -FTLRQIKAATDNFDVTRKIGEGGFGSVYKGELSEGKLIAVKQLSAKSRQGNREFVNEIG 724
Query: 313 IISKIRHRNLLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNI--SISHKRKQLTWPQR 370
+IS ++H NL+ L GCCV G + LVY+Y+ N LS + R +L W R
Sbjct: 725 MISALQHPNLVKLYGCCV-----EGNQLILVYEYLENNCLSRALFGKDESSRLKLDWSTR 779
Query: 371 KKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTT 430
KKI + +AKG+ +LH + I HRDIK++N+LLD +LNAK++DFGLAK + +G++H++T
Sbjct: 780 KKIFLGIAKGLTFLHEESRIKIVHRDIKASNVLLDKDLNAKISDFGLAKLNDDGNTHIST 839
Query: 431 RVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLD-TSTSPFQLITDWAWVL 489
R+AGT GY+APEYA+ G LTEK+DVYSFG+V LE++SG+ + T F + DWA+VL
Sbjct: 840 RIAGTIGYMAPEYAMRGYLTEKADVYSFGVVALEIVSGKSNTNFRPTEDFVYLLDWAYVL 899
Query: 490 AKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEGDIDIPKL 549
+ G + ++ D + ++ + + V ++C + LRPT++ + ++EG + +L
Sbjct: 900 QERGSLLELVDPTLASDYSEEEAMLMLNVALMCTNASPTLRPTMSQVVSLIEGKTAMQEL 959
Query: 550 PDRP---------LPLSHECLRSSPSR-YSFSTSTDRSATSSSM 583
P L + ++ SR SFSTS R+A+++S+
Sbjct: 960 LSDPSFSTVNPKLKALRNHFWQNELSRSLSFSTSGPRTASANSL 1003
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LV48|PERK1_ARATH Proline-rich receptor-like protein kinase PERK1 OS=Arabidopsis thaliana GN=PERK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 245 bits (626), Expect = 6e-64, Method: Compositional matrix adjust.
Identities = 141/335 (42%), Positives = 200/335 (59%), Gaps = 15/335 (4%)
Query: 254 FHVSELEQATNGFSQNNLIGQGASGIVYKGTLRHGNLVAVKQILDLDTKGDEDFTNEVEI 313
F EL +ATNGFS+ NL+GQG G V+KG L G VAVKQ+ +G+ +F EVEI
Sbjct: 268 FTYEELSRATNGFSEANLLGQGGFGYVHKGILPSGKEVAVKQLKAGSGQGEREFQAEVEI 327
Query: 314 ISKIRHRNLLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKI 373
IS++ HR+L+SL G C+ +G +R LVY+++PN L ++ R + W R KI
Sbjct: 328 ISRVHHRHLVSLIGYCM-----AGVQRLLVYEFVPNNNLEFHLH-GKGRPTMEWSTRLKI 381
Query: 374 IVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVA 433
+ AKG++YLH P I HRDIK++NIL+D + AKVADFGLAK + + ++H++TRV
Sbjct: 382 ALGSAKGLSYLHEDCNPKIIHRDIKASNILIDFKFEAKVADFGLAKIASDTNTHVSTRVM 441
Query: 434 GTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPF-QLITDWAWVL--- 489
GTFGYLAPEYA G+LTEKSDV+SFG+V+LEL++GR+ +D + + DWA L
Sbjct: 442 GTFGYLAPEYAASGKLTEKSDVFSFGVVLLELITGRRPVDANNVYVDDSLVDWARPLLNR 501
Query: 490 -AKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEGDIDIPK 548
++ G + + D + E R M R V C RP ++ ++ LEG++ +
Sbjct: 502 ASEEGDFEGLADSKMGNEYDREEMARMVACAAACVRHSARRRPRMSQIVRALEGNVSLSD 561
Query: 549 LPDRPLPLSHECLRSSPSRYSFSTSTDRSATSSSM 583
L + P H + SS Y ST D S + M
Sbjct: 562 LNEGMRP-GHSNVYSS---YGGSTDYDTSQYNDDM 592
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 590 | ||||||
| 225459647 | 612 | PREDICTED: probable receptor-like protei | 0.984 | 0.949 | 0.672 | 0.0 | |
| 224082334 | 622 | predicted protein [Populus trichocarpa] | 0.950 | 0.901 | 0.697 | 0.0 | |
| 356547489 | 613 | PREDICTED: probable receptor-like protei | 0.944 | 0.908 | 0.653 | 0.0 | |
| 356551236 | 603 | PREDICTED: probable receptor-like protei | 0.950 | 0.930 | 0.581 | 0.0 | |
| 356528805 | 736 | PREDICTED: probable receptor-like protei | 0.937 | 0.751 | 0.513 | 1e-167 | |
| 225447949 | 658 | PREDICTED: probable receptor-like protei | 0.961 | 0.861 | 0.499 | 1e-167 | |
| 357445489 | 656 | Kinase-like protein [Medicago truncatula | 0.933 | 0.839 | 0.512 | 1e-166 | |
| 224065114 | 652 | predicted protein [Populus trichocarpa] | 0.955 | 0.865 | 0.503 | 1e-165 | |
| 224065122 | 652 | predicted protein [Populus trichocarpa] | 0.955 | 0.865 | 0.501 | 1e-165 | |
| 356558471 | 642 | PREDICTED: probable receptor-like protei | 0.938 | 0.862 | 0.505 | 1e-163 |
| >gi|225459647|ref|XP_002284588.1| PREDICTED: probable receptor-like protein kinase At1g11050 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 822 bits (2124), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 397/590 (67%), Positives = 473/590 (80%), Gaps = 9/590 (1%)
Query: 2 SSSCPVDLSYVQTYPWDRSSCLDPNGKFCCATLLSLIGMGLAAHLRETSLFQFPNETASA 61
SSSCP+DL YV+TYPWD SSC D + CC LLSL GMGLA HL+ETS+FQ P S+
Sbjct: 25 SSSCPIDLGYVETYPWDTSSCRDGDQDHCCMALLSLFGMGLAQHLKETSMFQLPTAAVSS 84
Query: 62 FCLSELQGRLATLSINPSVVPTCFPNATQFASNTSFCAGIVTIEDWKKLVGPTSALDPAC 121
CLSELQ RL+ ++ PS+V CF N+TQF +N+S CAGI+T EDW K VG +ALD +C
Sbjct: 85 SCLSELQTRLSAMAFQPSLVSLCFKNSTQFVANSSSCAGIITKEDWIKRVGEKTALDSSC 144
Query: 122 KNFSGFSQCSSCVEAGYSVNAKLLSIQPNSTKCFYFAVLYATGILND--PKDEAAVACIL 179
K+ +G QC SC++AG VN++L ++ PNSTKCFYF +LYA GI+N+ P+D ACIL
Sbjct: 145 KDLTGLVQCGSCLDAGMKVNSQLRALAPNSTKCFYFTILYAAGIVNELGPQDGTTAACIL 204
Query: 180 RLPISSSKTKNSS---SNNRTIKLVIGLLGALLGFLLASGLIILYRKWNKKRKQIALHEQ 236
LP+S+SKT +S S KL+ G LGA L L A G ++LYR W KK+K A HE+
Sbjct: 205 GLPLSNSKTGETSNHLSQETLFKLIFGFLGAFLVVLFALGSVVLYRIWQKKKKN-AFHEE 263
Query: 237 FVSNLQASVLPNSGAKWFHVSELEQATNGFSQNNLIGQGASGIVYKGTLRHGNLVAVKQI 296
FVS++QA VLPN+GAKW+H++E+E+AT+GFSQ N IGQGA G+V+KGTL G LVAVKQI
Sbjct: 264 FVSSMQARVLPNTGAKWYHIAEIERATDGFSQKNFIGQGAYGVVHKGTLSDGTLVAVKQI 323
Query: 297 LDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNI 356
LDLD++GDE+F+NEVEIISKIRHRNLLSLRGCCVTSDD GKRR+LV DYM NG LSD++
Sbjct: 324 LDLDSQGDEEFSNEVEIISKIRHRNLLSLRGCCVTSDDCKGKRRYLVCDYMLNGNLSDHL 383
Query: 357 -SISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADF 415
+ S+ RK+LTWPQRK II+DV KG+AYLH G+KP IYHRDIK+TNILLD E+ AKVADF
Sbjct: 384 FNSSNSRKELTWPQRKNIILDVGKGLAYLHDGIKPAIYHRDIKTTNILLDLEMKAKVADF 443
Query: 416 GLAKQSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTS 475
GLAKQS EG SHLTTRVAGT GYLAPEYALYGQLTEKSDVYSFGIVILE MSGRKVLDTS
Sbjct: 444 GLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGIVILETMSGRKVLDTS 503
Query: 476 TSPFQLITDWAWVLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITD 535
+S LITDWAW+L KSGKV+++FD FIR EG + VMERFVLVGILCAHVMVA RPTI +
Sbjct: 504 SSSMVLITDWAWMLVKSGKVEEVFDNFIRKEGPKGVMERFVLVGILCAHVMVAFRPTIAE 563
Query: 536 ALKMLEGDIDIPKLPDRPLPLSHECLRSSPSRYSFSTSTDRSATSSSMTS 585
ALKMLEGDIDIP+LPDRP PLSHE RSS + SF T+ +RS S+SM++
Sbjct: 564 ALKMLEGDIDIPRLPDRPWPLSHEAFRSSL-QCSFLTN-ERSRPSTSMST 611
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224082334|ref|XP_002306651.1| predicted protein [Populus trichocarpa] gi|222856100|gb|EEE93647.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 815 bits (2106), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 397/569 (69%), Positives = 472/569 (82%), Gaps = 8/569 (1%)
Query: 2 SSSCPVDLSYVQTYPWDRSSCLDPNG-KFCCATLLSLIGMGLAAHLRETSLFQFPNETAS 60
+SSCPVDLSYVQT PWD S C P+G + CC TLLSL GMGLA LRETS+FQFPN AS
Sbjct: 31 ASSCPVDLSYVQTVPWDTSLCRQPDGLEHCCQTLLSLFGMGLAQQLRETSMFQFPNLNAS 90
Query: 61 AFCLSELQGRLATLSINPSVVPTCFPNATQFASNTSFCAGIVTIEDWKKLVGPTSALDPA 120
+ CLS+ Q +LATLSI+PS+VP+CF N++QF S+TS C GIVT +DW + VGP + L+ A
Sbjct: 91 SACLSDFQAKLATLSIDPSLVPSCFKNSSQFVSSTSSCIGIVTTQDWIEKVGPMTPLNTA 150
Query: 121 CK-NFSGFSQCSSCVEAGYSVNAKLLSIQPNST---KCFYFAVLYATGILND--PKDEAA 174
C+ +FS ++CSSC++AG VN++L S+ PN+T KCFY+ LYA GI+++ P D
Sbjct: 151 CRGDFSELTRCSSCLDAGQKVNSQLTSLDPNATATSKCFYYTCLYAAGIVSELGPLDAKT 210
Query: 175 VACILRLPISSSKTKN-SSSNNRTIKLVIGLLGALLGFLLASGLIILYRKWNKKRKQIAL 233
AC L LP+++S TK + S ++ +KLV GLLG+L+G LLA GLI +YRKW++KRK A
Sbjct: 211 AACTLALPLANSGTKKPAKSKDKLLKLVFGLLGSLIGVLLAFGLITMYRKWDRKRKVSAS 270
Query: 234 HEQFVSNLQASVLPNSGAKWFHVSELEQATNGFSQNNLIGQGASGIVYKGTLRHGNLVAV 293
HE+FVS+ +AS+LPNSGAKWFH+SELE+AT GFSQ N IGQGA G VYKGTL G LVAV
Sbjct: 271 HERFVSSFKASMLPNSGAKWFHLSELERATQGFSQRNFIGQGAYGFVYKGTLADGTLVAV 330
Query: 294 KQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLS 353
KQ+ DLD++GDEDF+NEVEIISKIRHRNLLSLRGCCVTSD+S GKRR++VYD+M NG+L
Sbjct: 331 KQMHDLDSQGDEDFSNEVEIISKIRHRNLLSLRGCCVTSDNSKGKRRYIVYDFMSNGSLG 390
Query: 354 DNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVA 413
D++S H RKQLTWPQRK II+DVAKG+AYLHYG+KP IYHRDIK+TNILLD E+ AKVA
Sbjct: 391 DHLSNDHSRKQLTWPQRKNIILDVAKGLAYLHYGIKPAIYHRDIKATNILLDLEMKAKVA 450
Query: 414 DFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLD 473
DFGLAKQSL+G SHLTTRVAGT GYLAPEYALYGQLTEKSDVYSFGIVILE+MSGRKV+D
Sbjct: 451 DFGLAKQSLDGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGIVILEIMSGRKVID 510
Query: 474 TSTSPFQLITDWAWVLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTI 533
TS S F LITDWAW LAKSGK+ +I DE IR +G +AVMERFVLVGILCAHVMVA RPTI
Sbjct: 511 TSNSSFLLITDWAWTLAKSGKLQEILDESIRDQGPKAVMERFVLVGILCAHVMVAFRPTI 570
Query: 534 TDALKMLEGDIDIPKLPDRPLPLSHECLR 562
DAL+MLEGDIDIP+LP+RPLPL HE R
Sbjct: 571 ADALRMLEGDIDIPRLPERPLPLGHESFR 599
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356547489|ref|XP_003542144.1| PREDICTED: probable receptor-like protein kinase At1g11050-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 768 bits (1984), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 371/568 (65%), Positives = 452/568 (79%), Gaps = 11/568 (1%)
Query: 1 NSSSCPVDLSYVQTYPWDRSSCLDPNGK-FCCATLLSLIGMGLAAHLRETSLFQFPNETA 59
+SSSCP+DL+YV+T+PWD SSC DP K CC LLS+IG+GL+ HL++TSLFQ PNET
Sbjct: 25 SSSSCPMDLNYVETFPWDSSSCRDPVDKNHCCQVLLSVIGIGLSQHLKQTSLFQLPNETI 84
Query: 60 SAFCLSELQGRLATLSINPSVVPTCFPNATQFASNTSFCAGIVTIEDWKKLVGPTSALDP 119
S+ CLS Q +L LSI+PS+V +CFPN++QF +N+S CAGI+TI+DWK+ VG S LD
Sbjct: 85 SSNCLSNFQAKLTALSIDPSLVNSCFPNSSQFVTNSSTCAGIITIDDWKQKVGLISPLDT 144
Query: 120 ACK-NFSGFSQCSSCVEAGYSVNAKLLSIQPNSTKCFYFAVLYATGILND--PKDEAAVA 176
+C + S ++CS C +AG V + L S NST+CFYF +LYA I+N P + +
Sbjct: 145 SCNGDLSDQTRCSICSDAGLKVTSGLNS---NSTRCFYFTILYAAAIVNQFGPTNLGTAS 201
Query: 177 CILRLPISSSKTKNSSSNNRTIKLVIGLLGALLGFLLASGLIILYRKWNKKRKQIALHEQ 236
CIL +P+S K SS+ +KLVIGLLGA +G LLA LI++YRKW+K+RK+ H +
Sbjct: 202 CILGMPLS---VKGSSNRGLVLKLVIGLLGAFVGVLLAFVLIVVYRKWDKRRKEDMHHRE 258
Query: 237 FVSNLQASVLPNSGAKWFHVSELEQATNGFSQNNLIGQGASGIVYKGTLRHGNLVAVKQI 296
S ++ SVLPN+GAKWFH+SELE+AT+ FSQ N++GQG G+VYKGTL G +VAVK+I
Sbjct: 259 IESGVRNSVLPNTGAKWFHISELERATSKFSQRNMLGQGGDGVVYKGTLSDGTVVAVKEI 318
Query: 297 LDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNI 356
L+TKGDEDFT EVEIISKI+HRNLL+LRGCC++SD+ GKRRFLVYD+MPNG+LS +
Sbjct: 319 FGLETKGDEDFTYEVEIISKIKHRNLLALRGCCISSDNVKGKRRFLVYDFMPNGSLSHQL 378
Query: 357 SISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFG 416
SI+ + LTWPQRK II+DVAKG+AYLHY +KP IYHRDIK+TNILLDS++ AKV+DFG
Sbjct: 379 SIAGANR-LTWPQRKNIILDVAKGLAYLHYEIKPPIYHRDIKATNILLDSKMKAKVSDFG 437
Query: 417 LAKQSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTST 476
LAKQ EG SHLTTRVAGT+GYLAPEYALYGQLTEKSDVYSFGIVILE+MSGRKVLDT
Sbjct: 438 LAKQGNEGQSHLTTRVAGTYGYLAPEYALYGQLTEKSDVYSFGIVILEIMSGRKVLDTMN 497
Query: 477 SPFQLITDWAWVLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDA 536
S LITDWAW LAKSG ++DIFD+ IR EG VMERFVLVGILCAH MVALRPTI +A
Sbjct: 498 SSVVLITDWAWTLAKSGNMEDIFDQSIREEGPEKVMERFVLVGILCAHAMVALRPTIAEA 557
Query: 537 LKMLEGDIDIPKLPDRPLPLSHECLRSS 564
LKMLEGDIDIP+LPDRP+PL HE SS
Sbjct: 558 LKMLEGDIDIPQLPDRPVPLGHESFPSS 585
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356551236|ref|XP_003543983.1| PREDICTED: probable receptor-like protein kinase At1g11050-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 650 bits (1677), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 332/571 (58%), Positives = 414/571 (72%), Gaps = 10/571 (1%)
Query: 2 SSSCPVDLSYVQTYPWDRSSCLDPNGKF-CCATLLSLIGMGLAAHLRETSLFQFPNETAS 60
S SCP+DLSYV T PW+ S+C DP K CC LLS+ +GLA L++T F PNE+ S
Sbjct: 26 SFSCPIDLSYVDTIPWNTSTCKDPIDKEPCCDILLSVFAIGLAELLKDTKTFYLPNESTS 85
Query: 61 AFCLSELQGRLATLSINPSVVPTCFPNATQFASNTSFCAGIVTIEDWKKLVGPTSALDPA 120
+ CL + RL LSI P +VP CFPN+T+F N S CAGI T DW + VG S +D
Sbjct: 86 SSCLHDFNLRLQALSIPPKMVPLCFPNSTRFVFNASACAGIRTTLDWTQRVGMVSPVDTF 145
Query: 121 CK-NFSGFSQCSSCVEAGYSVNAKLLSIQPN--STKCFYFAVLYATGILND--PKDEAAV 175
C + ++C +C EA Y V ++L +I PN +TKCFY+ VLYA ++N D +
Sbjct: 146 CNGDLKDKTRCKTCTEAAYQVTSQLTTIDPNANTTKCFYYIVLYAAAVVNQFGTTDVSTT 205
Query: 176 ACIL--RLPISSSKTKNSSSNNRTIKLVIGLLGALLGFLLASGLIILYRKWNKKRKQIAL 233
+CIL R P S + SS+ +KL LLG ++G +LA I++Y+KW+K+RK+
Sbjct: 206 SCILGLRQPSSGVIEEGSSNTEEVLKLGFSLLGVIIGVVLALLTIVMYKKWDKRRKEHVY 265
Query: 234 HEQFVSNLQASVLPNSGAKWFHVSELEQATNGFSQNNLIGQGASGIVYKGTLRHGNLVAV 293
H + + ++A VLPN+GAKWF VSEL+ ATN FS N++GQG G+VYKG L G +VAV
Sbjct: 266 HREIENKVRAGVLPNAGAKWFDVSELKCATNKFSPRNVVGQGGDGVVYKGILSDGAVVAV 325
Query: 294 KQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLS 353
K+I DL+ KGDEDF EVEIISKI+HRNLL+LRGCCV SD+ +GKRRFLVYD+MPNG+LS
Sbjct: 326 KEIFDLEAKGDEDFCYEVEIISKIKHRNLLALRGCCVASDNLNGKRRFLVYDFMPNGSLS 385
Query: 354 DNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVA 413
D + + LTWPQRK II+ VA+G+AYLHY +KP IYHRDIK+TNILLDSE+NAK+A
Sbjct: 386 DQLCFDGANR-LTWPQRKNIILGVARGLAYLHYEIKPPIYHRDIKATNILLDSEMNAKLA 444
Query: 414 DFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLD 473
DFGLAKQ E SHLTT+VAGT+GY+APEYALYG+LTEKSDVYSFGIVILE+MSGRKVLD
Sbjct: 445 DFGLAKQGSEDQSHLTTKVAGTYGYVAPEYALYGKLTEKSDVYSFGIVILEIMSGRKVLD 504
Query: 474 TSTSPFQLITDWAWVLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTI 533
S ITDW W L +SGK +IF E IR EG VMERFVLVG+LCAH +V LRPTI
Sbjct: 505 ALNSSADSITDWVWTLVESGKKGEIFCESIR-EGPVKVMERFVLVGMLCAHGVVTLRPTI 563
Query: 534 TDALKMLEGDIDIPKLPDRPLPLSHECLRSS 564
+ALKMLEGDI+IP+LP+RP+PL H +SS
Sbjct: 564 VEALKMLEGDIEIPELPERPVPLGHVSFQSS 594
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356528805|ref|XP_003532988.1| PREDICTED: probable receptor-like protein kinase At1g11050-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 596 bits (1537), Expect = e-167, Method: Compositional matrix adjust.
Identities = 310/604 (51%), Positives = 410/604 (67%), Gaps = 51/604 (8%)
Query: 2 SSSCPVDLSYVQTYPWDRSSCLD-------PNG---KFCCATLLSLIGMGLAAHLRETSL 51
S++CP+DL+YV PW+ S+C + NG CC +LLSL G+GLA HL+ETS
Sbjct: 106 STTCPMDLNYVLRIPWNTSACHNFQQTLAAKNGTDANTCCISLLSLFGIGLANHLKETSQ 165
Query: 52 FQFPNETASAFCLSELQGRLATLSINPSVVPTCFPNATQFASNTSFCAGIVTIEDWKKLV 111
FQ N +S C+ + Q +L++LS+ ++V TCF + QF + + CAGI TI DW K V
Sbjct: 166 FQLQNLASSLSCIKDFQSKLSSLSLPNNLVDTCF-DPLQFVISPNICAGIQTIPDWTKKV 224
Query: 112 GPTSALDPACK-NFSGFSQCSSCVEAGYSVNAKLLSIQPN---STKCFYFAVLYATGILN 167
G ++ L+ AC+ + + S C C++AG V KL+SI N S CFYFA+LYA GI+N
Sbjct: 225 GQSTPLNTACRSDLTDISLCDVCLQAGLQVKQKLISIDGNASHSIDCFYFAILYAAGIVN 284
Query: 168 D--PKDEAAVACILRLPISSSKTKNSSSNNRTIKLVIGLLGALLGFLLASGLIILYRKWN 225
+ P+ AV+CI + + S + S R LV GL GA + L+ S + +Y ++
Sbjct: 285 EFGPESNGAVSCIFSISVYS---QGGSGGKRHQALVFGLTGAGVALLVMSSFLGMYSWYD 341
Query: 226 KK--RKQIALHEQF------VSNLQASVLPNSGAKWFHVSELEQATNGFSQNNLIGQGAS 277
+K RK++ QF + + PN+G+ WF + ELE+AT+ FS N IG+G
Sbjct: 342 RKHRRKKLETFNQFDFDPEEQGGSRPRLRPNTGSIWFKIEELEKATDNFSSKNFIGRGGF 401
Query: 278 GIVYKGTLRHGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSS- 336
G+V+KGTL G +VAVK+IL+ D +G+ +F NEVEIIS ++HRNL+ LRGCCV +D +
Sbjct: 402 GMVFKGTLSDGTVVAVKRILESDFQGNAEFCNEVEIISNLKHRNLVPLRGCCVAEEDENC 461
Query: 337 ----GKRRFLVYDYMPNGTLSDNISISH-------KRKQLTWPQRKKIIVDVAKGIAYLH 385
+R+LVYDYMPNG L D+I +S K LTWPQRK II+DVAKG+AYLH
Sbjct: 462 DERGSSQRYLVYDYMPNGNLEDHIFLSSTEDSQKSKGLSLTWPQRKSIILDVAKGLAYLH 521
Query: 386 YGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYAL 445
YG+KP I+HRDIK+TNILLDS++ A+VADFGLAKQS EG SHLTTRVAGT GYLAPEYAL
Sbjct: 522 YGVKPAIFHRDIKATNILLDSDMRARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYAL 581
Query: 446 YGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQ---LITDWAWVLAKSGKVDDIF--- 499
YGQLTEKSDVYSFG+V+LE+M GRK LD S+S LITDWAW L K+GK+++
Sbjct: 582 YGQLTEKSDVYSFGVVVLEIMCGRKALDLSSSGSPRAFLITDWAWSLVKAGKIEEALDGS 641
Query: 500 -----DEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEGDIDIPKLPDRPL 554
DE + +++MERF+LVGILC+HVMVALRPTI DALKMLEGDI++P++PDRP+
Sbjct: 642 LVKDKDESFPSSNPKSIMERFLLVGILCSHVMVALRPTIADALKMLEGDIEVPQIPDRPM 701
Query: 555 PLSH 558
PL H
Sbjct: 702 PLGH 705
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225447949|ref|XP_002269016.1| PREDICTED: probable receptor-like protein kinase At1g11050 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 594 bits (1532), Expect = e-167, Method: Compositional matrix adjust.
Identities = 307/615 (49%), Positives = 412/615 (66%), Gaps = 48/615 (7%)
Query: 1 NSSSCPVDLSYVQTYPWDRSSCLD--------PNGKF-CCATLLSLIGMGLAAHLRETSL 51
N+S+CP+D +YV W+ S+C + N K CC TLLSL + LA HL+ETSL
Sbjct: 33 NASACPMDFNYVLRISWNSSNCHNFVSQGNTSVNSKSSCCTTLLSLFAVSLAQHLKETSL 92
Query: 52 FQFPNETASAFCLSELQGRLATLSINPSVVPTCFPNATQFASNTSFCAGIVTIEDWKKLV 111
F P+ + S CL + Q +L +L + ++ +CF + QF CAG+ I DW +
Sbjct: 93 FNLPDVSTSQSCLHDFQSKLTSLPLANNLASSCF-DPQQFVIGPDICAGVQNISDWVAKL 151
Query: 112 GPTSALDPACK-NFSGFSQCSSCVEAGYSVNAKLLSIQPN---STKCFYFAVLYATGILN 167
GP++ALD +C+ + + + C +CV AG+ V +KL+ I N ST CFYF VLYA GI+N
Sbjct: 152 GPSTALDSSCRADLTDLTACDACVNAGFEVQSKLIEIDGNKSHSTDCFYFTVLYAAGIVN 211
Query: 168 D--PKDEAAVACILRLPISSSKTKNSSSNNRTIKLVIGLLGALLGFLLASGLIILY---- 221
+ P+ A++C+L +P++S + +S S++ L+ G GA + L+ S L+ LY
Sbjct: 212 EAGPESTGAMSCVLAVPLNSDEGSSSKSHS---ALIFGFTGAGVAVLVMSCLLGLYFWWE 268
Query: 222 RKWNKKRKQ-----IALHEQFVSNLQASVLPNSGAKWFHVSELEQATNGFSQNNLIGQGA 276
RKW KK K+ + + + + V PN+G+ WF + +LE+AT+ FSQ N IG+G
Sbjct: 269 RKWGKKSKRSGSGFFGVDLEDLGGSRPRVRPNTGSIWFKIPDLERATDNFSQKNFIGRGG 328
Query: 277 SGIVYKGTLRHGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSD--- 333
G+VYKGTL G+ VAVK+I++ D + D DF NE+EIIS ++HRNL+ LRGCCV
Sbjct: 329 FGLVYKGTLADGSTVAVKKIIESDIQVDADFCNEIEIISNLKHRNLVPLRGCCVVDGGEG 388
Query: 334 -DSSGKRRFLVYDYMPNGTLSDNI--------SISHKRKQLTWPQRKKIIVDVAKGIAYL 384
D R+LVYDYMPNG L D++ +K LTWPQRK II+DVAKG+AYL
Sbjct: 389 YDDRASPRYLVYDYMPNGNLDDHLFSKWENGNGNGMGKKPLTWPQRKSIILDVAKGLAYL 448
Query: 385 HYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYA 444
HYG+KP IYHRDIK+TNILLD+++ A+VADFGLAKQS EG SHLTTRVAGT GYLAPEYA
Sbjct: 449 HYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYA 508
Query: 445 LYGQLTEKSDVYSFGIVILELMSGRKVLD-TSTSPFQ-LITDWAWVLAKSGKVDDIFDEF 502
LYGQLTEKSDVYSFG+V+LE+M GRK LD +S SP LITDWAW + K+GK ++ D
Sbjct: 509 LYGQLTEKSDVYSFGVVVLEIMCGRKALDLSSRSPRAFLITDWAWSMVKAGKAEEALDAS 568
Query: 503 IRAEG------ARAVMERFVLVGILCAHVMVALRPTITDALKMLEGDIDIPKLPDRPLPL 556
+ +G +A+MERF+LVGILCAHVMVALRPTI+DALKMLEGD+++P +PDRP+PL
Sbjct: 569 LVKDGDSSNSNPKAIMERFLLVGILCAHVMVALRPTISDALKMLEGDVEVPAIPDRPVPL 628
Query: 557 SHECLRSSPSRYSFS 571
H + + +S S
Sbjct: 629 GHPSFLTDGNTFSIS 643
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357445489|ref|XP_003593022.1| Kinase-like protein [Medicago truncatula] gi|355482070|gb|AES63273.1| Kinase-like protein [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 590 bits (1522), Expect = e-166, Method: Compositional matrix adjust.
Identities = 303/591 (51%), Positives = 400/591 (67%), Gaps = 40/591 (6%)
Query: 4 SCPVDLSYVQTYPWDRSSCLDPNG------KFCCATLLSLIGMGLAAHLRETSLFQFPNE 57
+CP+DL+YV W+ S+C + N CCA++LSL G+G A HL+ETS F +
Sbjct: 11 TCPMDLNYVLRIHWNSSACQNFNSLSSKETSTCCASVLSLFGIGFAQHLKETSQFNLQDL 70
Query: 58 TASAFCLSELQGRLATLSINPSVVPTCFPNATQFASNTSFCAGIVTIEDWKKLVGPTSAL 117
S C+ + Q +L +LS+ ++V +CF + QF + + CAGI T+ DW + VG S+L
Sbjct: 71 QTSNSCMQDFQSKLNSLSLYNNLVNSCF-DPLQFVISRNICAGIETVHDWNEKVGQNSSL 129
Query: 118 DPACK-NFSGFSQCSSCVEAGYSVNAKLLSIQPNSTK---CFYFAVLYATGILND--PKD 171
+ ACK + + SQC +CV AG V KL+S+ N ++ CFYFA+LYA GI+N+ P+
Sbjct: 130 NTACKPDLTHLSQCDACVAAGLQVKQKLVSVSGNDSQSLSCFYFAILYAAGIVNEFGPES 189
Query: 172 EAAVACILRLPISSSKTKNSSSNNRTIKLVIGLLGALLGFLLASGLIILY----RKWNKK 227
AV C LP+ S S + LV GL GA + + L+ LY RK +K
Sbjct: 190 NGAVTCAFSLPVYSQVGSGSKGHQ---GLVFGLTGAGVALFVMCSLLGLYVWCDRKRMRK 246
Query: 228 RKQIALHEQFVSNLQAS---VLPNSGAKWFHVSELEQATNGFSQNNLIGQGASGIVYKGT 284
RK F Q S + PN+G+ W+ + ELE+AT+ FS N IG+G G+V+KGT
Sbjct: 247 RKLETFQFDFDPEEQGSRRRLRPNTGSIWYKIQELEKATDNFSSKNFIGRGGFGLVFKGT 306
Query: 285 LRHGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSS----GKRR 340
L G++VAVK++L+ D +GD +F NEVEIIS ++HRNLL LRGCCV ++ + G +R
Sbjct: 307 LADGSVVAVKRVLESDFQGDVEFCNEVEIISNLKHRNLLPLRGCCVVDENENYGDKGSQR 366
Query: 341 FLVYDYMPNGTLSDNISISHK----RKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRD 396
+LVYDYMPNG L D++ +S K L+WP RK II+DV KG+AYLHYG+KP IYHRD
Sbjct: 367 YLVYDYMPNGNLEDHLFVSKDPQKANKSLSWPLRKNIILDVGKGLAYLHYGVKPAIYHRD 426
Query: 397 IKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVY 456
IK+TNILLD ++ A+VADFGLAKQS EG SHLTTRVAGT GYLAPEYALYGQLTEKSDVY
Sbjct: 427 IKATNILLDEDMRARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVY 486
Query: 457 SFGIVILELMSGRKVLDTSTSPFQ---LITDWAWVLAKSGKVDDIFDEFIRAE------G 507
SFG+V+LE+M GRK LD S+S LITDWAW L KSGK+D+ D + +
Sbjct: 487 SFGVVVLEIMCGRKALDLSSSGSPRAFLITDWAWSLVKSGKIDEALDASLLKDDNTASAN 546
Query: 508 ARAVMERFVLVGILCAHVMVALRPTITDALKMLEGDIDIPKLPDRPLPLSH 558
+++MERF+LVGILC+HVMVALRPTI+DALKMLEGDI++P++PDRP+PL H
Sbjct: 547 PKSIMERFLLVGILCSHVMVALRPTISDALKMLEGDIEVPQIPDRPMPLGH 597
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224065114|ref|XP_002301677.1| predicted protein [Populus trichocarpa] gi|222843403|gb|EEE80950.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 589 bits (1519), Expect = e-165, Method: Compositional matrix adjust.
Identities = 308/612 (50%), Positives = 410/612 (66%), Gaps = 48/612 (7%)
Query: 2 SSSCPVDLSYVQTYPWDRSSCLDPN------------GKFCCATLLSLIGMGLAAHLRET 49
S+ CP+DL+YV PW+++ C + N CC T+LSL G+ L+ HL+ET
Sbjct: 32 SNICPMDLNYVLRIPWNQTLCRNFNPLAQNDNTNSTSKPPCCQTILSLFGVALSQHLKET 91
Query: 50 SLFQFPNETASAFCLSELQGRLATLSINPSVVPTCFPNATQFASNTSFCAGIVTIEDWKK 109
S FQ PN S+ CL + Q +L++ S++ +V CF N QF + + CA I T +DW
Sbjct: 92 SFFQLPNLATSSSCLQDYQSKLSSFSLSDDLVSHCF-NPLQFVTAPNICARIETSQDWVD 150
Query: 110 LVGPTSALDPACK-NFSGFSQCSSCVEAGYSVNAKLLSIQPNSTK---CFYFAVLYATGI 165
+G +++LD C+ + + + C SC+ AG V + LLS N T CFYFAVLYA G+
Sbjct: 151 QLGKSTSLDSDCRSDLTDLTACDSCLRAGNKVQSLLLSADGNQTHAQDCFYFAVLYAAGV 210
Query: 166 LND--PKDEAAVACILRLPISSSKTKNSSSNNRTIKLVIGLLGALLGFLLASGLIILY-- 221
+N+ P+ + V+CI L ++S + S++N LV GL GA + L+ S L+ LY
Sbjct: 211 VNEFGPESDGVVSCIFGLELNS---RVGSASNSHSALVFGLTGAGVAILVMSSLLGLYLW 267
Query: 222 --RKWNKKRK---QIALHEQFVSNLQASVLPNSGAKWFHVSELEQATNGFSQNNLIGQGA 276
+KW +K+ L EQ S + + PN+G+ WF + +LE+AT+ FSQ N IG+G
Sbjct: 268 YDKKWRRKKNLGFGFDLDEQQGS--RPKLRPNTGSIWFKIRDLEKATDNFSQKNFIGRGG 325
Query: 277 SGIVYKGTLRHGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDD-- 334
G VYKG L G +VA+K++++ D +GD +F NEVEIIS ++HRNL+ LRGCCV DD
Sbjct: 326 FGFVYKGVLSDGTVVAIKRVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVIDDDVN 385
Query: 335 --SSGKRRFLVYDYMPNGTLSDNISISH----KRKQLTWPQRKKIIVDVAKGIAYLHYGL 388
G +R+LVYDYM NG L D++ S +++ L+WPQRK II+DVAKG+AYLH+G+
Sbjct: 386 SDERGNQRYLVYDYMSNGNLDDHLFPSSDNQIQKQLLSWPQRKSIILDVAKGLAYLHHGV 445
Query: 389 KPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALYGQ 448
KPGIYHRDIK TNILLD+E+ A+VADFGLAKQS EG SHLTTRVAGT GYLAPEYALYGQ
Sbjct: 446 KPGIYHRDIKGTNILLDAEMRARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQ 505
Query: 449 LTEKSDVYSFGIVILELMSGRKVLDTSTSPFQ---LITDWAWVLAKSGKVDDIFDEFIRA 505
LTEKSDVYSFG+V+LE+MSGRK LD S+S LITDWAW L K+GKV+ D +
Sbjct: 506 LTEKSDVYSFGVVVLEIMSGRKALDLSSSGSPRALLITDWAWSLVKAGKVEQALDASLLR 565
Query: 506 EG------ARAVMERFVLVGILCAHVMVALRPTITDALKMLEGDIDIPKLPDRPLPLSHE 559
G + +MERFVLVGILCAH+MVALRPTI DALKMLEGDI++P++PDRP+PL H
Sbjct: 566 GGDSSNSNPKGIMERFVLVGILCAHIMVALRPTILDALKMLEGDIEVPQIPDRPVPLGHP 625
Query: 560 CLRSSPSRYSFS 571
+ + +S S
Sbjct: 626 SFHADGNSFSIS 637
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224065122|ref|XP_002301680.1| predicted protein [Populus trichocarpa] gi|222843406|gb|EEE80953.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 587 bits (1514), Expect = e-165, Method: Compositional matrix adjust.
Identities = 307/612 (50%), Positives = 410/612 (66%), Gaps = 48/612 (7%)
Query: 2 SSSCPVDLSYVQTYPWDRSSCLDPN------------GKFCCATLLSLIGMGLAAHLRET 49
S+ CP+DL+YV PW+++ C + N CC T+LSL G+ L+ HL+ET
Sbjct: 32 SNICPMDLNYVLRIPWNQTLCRNFNPLAQNDNTNSTSKPPCCQTILSLFGVALSQHLKET 91
Query: 50 SLFQFPNETASAFCLSELQGRLATLSINPSVVPTCFPNATQFASNTSFCAGIVTIEDWKK 109
S FQ PN S+ CL + Q +L + S++ ++V CF N QF + + CA I T +DW
Sbjct: 92 SFFQLPNLATSSSCLQDYQSKLISFSLSDNLVSHCF-NPLQFVTAPNICARIETSQDWVD 150
Query: 110 LVGPTSALDPACK-NFSGFSQCSSCVEAGYSVNAKLLSIQPNSTK---CFYFAVLYATGI 165
+G +++LD C+ + + + C SC+ AG V + LLS N T CFYFAVLYA G+
Sbjct: 151 QLGKSTSLDSDCRSDLTDLTACDSCLRAGNKVQSLLLSADGNQTHAQDCFYFAVLYAAGV 210
Query: 166 LND--PKDEAAVACILRLPISSSKTKNSSSNNRTIKLVIGLLGALLGFLLASGLIILY-- 221
+N+ P+ + V+CI L ++S + S++N LV GL GA + L+ S L+ LY
Sbjct: 211 VNEFGPESDGVVSCIFGLELNS---RVGSASNSHSALVFGLTGAGVAILVISSLLGLYLW 267
Query: 222 --RKWNKKRK---QIALHEQFVSNLQASVLPNSGAKWFHVSELEQATNGFSQNNLIGQGA 276
+KW +K+ L EQ S + + PN+G+ WF + +LE+AT+ FSQ N IG+G
Sbjct: 268 YDKKWRRKKNLGFGFDLDEQQGS--RPKLRPNTGSIWFKIRDLEKATDNFSQKNFIGRGG 325
Query: 277 SGIVYKGTLRHGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDD-- 334
G VYKG L G +VA+K++++ D +GD +F NEVEIIS ++HRNL+ LRGCCV DD
Sbjct: 326 FGFVYKGVLSDGTVVAIKRVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVIDDDVN 385
Query: 335 --SSGKRRFLVYDYMPNGTLSDNISISH----KRKQLTWPQRKKIIVDVAKGIAYLHYGL 388
G +R+LVYDYM NG L D++ S +++ L+WPQRK II+DVAKG+AYLH+G+
Sbjct: 386 SDERGNQRYLVYDYMSNGNLDDHLFPSSDNQIQKQLLSWPQRKSIILDVAKGLAYLHHGV 445
Query: 389 KPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALYGQ 448
KPGIYHRDIK TNILLD+E+ A+VADFGLAKQS EG SHLTTRVAGT GYLAPEYALYGQ
Sbjct: 446 KPGIYHRDIKGTNILLDAEMRARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQ 505
Query: 449 LTEKSDVYSFGIVILELMSGRKVLDTSTSPFQ---LITDWAWVLAKSGKVDDIFDEFIRA 505
LTEKSDVYSFG+V+LE+MSGRK LD S+S LITDWAW L K+ KV+ D +
Sbjct: 506 LTEKSDVYSFGVVVLEIMSGRKALDLSSSGSPRALLITDWAWSLVKAAKVEQALDASLLR 565
Query: 506 EG------ARAVMERFVLVGILCAHVMVALRPTITDALKMLEGDIDIPKLPDRPLPLSHE 559
G + +MERFVLVGILCAH+MVALRPTI DALKMLEGDI++P++PDRP+PL H
Sbjct: 566 GGDSSNSNPKGIMERFVLVGILCAHIMVALRPTILDALKMLEGDIEVPQIPDRPVPLGHP 625
Query: 560 CLRSSPSRYSFS 571
++ + +S S
Sbjct: 626 SFQADGNNFSIS 637
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356558471|ref|XP_003547530.1| PREDICTED: probable receptor-like protein kinase At1g11050-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 583 bits (1502), Expect = e-163, Method: Compositional matrix adjust.
Identities = 302/597 (50%), Positives = 405/597 (67%), Gaps = 43/597 (7%)
Query: 1 NSSSCPVDLSYVQTYPWDRSSCLD----------PNGKFCCATLLSLIGMGLAAHLRETS 50
N+++CP+DL+YV PW+ S+C + + CC +LLSL G+GLA HL+ETS
Sbjct: 18 NTTTCPMDLNYVLRIPWNTSACHNFQQTLAAKNGTDANTCCISLLSLFGIGLAQHLKETS 77
Query: 51 LFQFPNETASAFCLSELQGRLATLSINPSVVPTCFPNATQFASNTSFCAGIVTIEDWKKL 110
FQ PN S C+ + Q +L++LS+ ++ TCF + QF + + CAGI TI DW K
Sbjct: 78 QFQLPNLATSLSCIQDFQLKLSSLSLPSNLADTCF-DPLQFVISPNICAGIQTIPDWTKK 136
Query: 111 VGPTSALDPACK-NFSGFSQCSSCVEAGYSVNAKLLSIQPN---STKCFYFAVLYATGIL 166
+G ++ L+ ACK + + S C C++AG L+SI N S CFYFA+LYA G++
Sbjct: 137 LGQSTPLNTACKSDLTDISLCDVCLQAGLQAKQVLISIDGNASHSIDCFYFAILYAAGVV 196
Query: 167 ND--PKDEAAVACILRLPISSSKTKNSSSNNRTIKLVIGLLGALLGFLLASGLIILYRKW 224
N+ P+ AV+CI + + S + S LV GL GA + L+ S + +Y +
Sbjct: 197 NEFGPESNGAVSCIFSISVYS---QGGSGGKGHQALVFGLTGAGIALLVMSSFLGIYAWY 253
Query: 225 NKKRKQIALHE---QFVSNLQAS---VLPNSGAKWFHVSELEQATNGFSQNNLIGQGASG 278
++K ++ L F Q S + PN+G+ WF + ELE+AT+ FS N IG+G G
Sbjct: 254 DRKHRRKKLETFQFDFDPEEQGSRPRLRPNTGSIWFKIEELEKATDNFSSKNFIGRGGFG 313
Query: 279 IVYKGTLRHGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSD----D 334
+V+KGTL G +V VK+IL+ D +GD +F NEVEIIS ++HRNL+ LRGCCV + D
Sbjct: 314 MVFKGTLSDGTVVGVKRILESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVAEENENYD 373
Query: 335 SSGKRRFLVYDYMPNGTLSDNISISHKRKQ----LTWPQRKKIIVDVAKGIAYLHYGLKP 390
G +R+LVYDYMPNG L D++ +S ++ LTWPQRK II+DVAKG+AYLHYG+KP
Sbjct: 374 ERGSQRYLVYDYMPNGNLEDHLFLSTDSQKAKGSLTWPQRKSIILDVAKGLAYLHYGVKP 433
Query: 391 GIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALYGQLT 450
I+HRDIK+TNILLD+++ A+VADFGLAKQS EG SHLTTRVAGT GYLAPEYALYGQLT
Sbjct: 434 AIFHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLT 493
Query: 451 EKSDVYSFGIVILELMSGRKVLDTSTSPFQ---LITDWAWVLAKSGKVDDIFDEFIRAE- 506
EKSDVYSFG+V LE+M GRK LD S+S LITDWAW L K+GK+++ D F+ +
Sbjct: 494 EKSDVYSFGVVALEIMCGRKALDLSSSGSPRAFLITDWAWSLVKAGKIEEALDAFLVKDE 553
Query: 507 -----GARAVMERFVLVGILCAHVMVALRPTITDALKMLEGDIDIPKLPDRPLPLSH 558
+++MERF+LVGILC+HVMVALRPTI DALKMLEGDI++P++PDRP+PL H
Sbjct: 554 NFPSSNPKSIMERFLLVGILCSHVMVALRPTIADALKMLEGDIEVPQIPDRPMPLGH 610
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 590 | ||||||
| TAIR|locus:2197414 | 625 | AT1G11050 [Arabidopsis thalian | 0.930 | 0.878 | 0.491 | 1.1e-142 | |
| TAIR|locus:2066390 | 617 | RKF3 "receptor-like kinase in | 0.916 | 0.876 | 0.366 | 3.7e-87 | |
| TAIR|locus:2019317 | 969 | AT1G29730 [Arabidopsis thalian | 0.494 | 0.301 | 0.439 | 9.4e-62 | |
| TAIR|locus:2019367 | 1078 | AT1G29740 [Arabidopsis thalian | 0.494 | 0.270 | 0.437 | 4.1e-61 | |
| TAIR|locus:2203718 | 1035 | AT1G53440 [Arabidopsis thalian | 0.494 | 0.282 | 0.411 | 4.7e-61 | |
| TAIR|locus:2012325 | 466 | AT1G09440 [Arabidopsis thalian | 0.535 | 0.678 | 0.408 | 5.5e-61 | |
| TAIR|locus:2036636 | 632 | NIK3 "NSP-interacting kinase 3 | 0.525 | 0.490 | 0.431 | 1.5e-60 | |
| TAIR|locus:2139559 | 437 | AT4G34500 [Arabidopsis thalian | 0.501 | 0.677 | 0.420 | 1.9e-60 | |
| TAIR|locus:2159873 | 681 | PERK8 "proline-rich extensin-l | 0.477 | 0.414 | 0.447 | 6.4e-60 | |
| TAIR|locus:2077730 | 512 | AT3G59110 [Arabidopsis thalian | 0.484 | 0.558 | 0.416 | 1.3e-59 |
| TAIR|locus:2197414 AT1G11050 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1395 (496.1 bits), Expect = 1.1e-142, P = 1.1e-142
Identities = 286/582 (49%), Positives = 386/582 (66%)
Query: 2 SSSCPVDLSYVQTYPWDRSSCL--DPNG---KFCCATLLSLIGMGLAAHLRETSLFQFPN 56
S +CP+D S+V T PW+ + C D + CC +LL+LIG+ LA L++TS F+ PN
Sbjct: 24 SQTCPLDFSHVLTIPWNTTDCQKSDKSADSKNSCCQSLLTLIGIPLAHRLKQTSNFRLPN 83
Query: 57 ETASAFCLSELQGRLATLSINPSVVPTCF-PNATQFASNTSFCAGIVTIEDWKKLVGPTS 115
S CL+ LQ +L++LS++ ++ CF PN QF N CAGI T +DW +GP++
Sbjct: 84 LATSISCLNNLQTKLSSLSLSSNLTSLCFDPN--QFVINNETCAGIQTTQDWVSRLGPST 141
Query: 116 ALDPACKN-FSGFSQCSSCVEAGYSVNAKLLSIQPNSTK---CFYFAVLYATGILND--P 169
ALD AC + + ++C +CV AG+ V +L+++ NS+ C++F V YA GI+N P
Sbjct: 142 ALDSACSSGLTDLTRCDACVAAGFRVQKQLITLDGNSSHGVYCYHFVVTYAAGIVNKKGP 201
Query: 170 KDEAAVACILRLPIXXXXXXXXXXXXRTXXXXXXXXXXXXXXXXXXXXXXXYRKWNKKRK 229
+ + A++C+ L + T Y ++ K K
Sbjct: 202 ESDDALSCLFSLSLRSPLNSKKKR--HTVALALGITGAIFGALVIAGLICLYFRFGKAVK 259
Query: 230 --QIALHEQFVSNLQASVLPNSGAKWFHVSELEQATNGFSQNNLIGQGASGIVYKGTLRH 287
++ +Q + PN+G+ WF + ELE+ATN FSQ N IG+G G VYKG L
Sbjct: 260 GGEVGWEDQ---GSRPKWRPNTGSIWFKIEELEKATNNFSQKNFIGRGGFGFVYKGVLPD 316
Query: 288 GNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFLVYDYM 347
G+++AVK++++ + +GD +F NEVEIIS ++HRNL+ LRGC + DDS +R +LVYDYM
Sbjct: 317 GSVIAVKKVIESEFQGDAEFRNEVEIISNLKHRNLVPLRGCSMVDDDSESQR-YLVYDYM 375
Query: 348 PNGTLSDNISISHK--RKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLD 405
NG L D++ + + L+WPQRK II+DVAKG+AYLHYG+KP IYHRDIK TNILLD
Sbjct: 376 SNGNLDDHLFPRGETTKMPLSWPQRKSIILDVAKGLAYLHYGVKPAIYHRDIKGTNILLD 435
Query: 406 SELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILEL 465
++ A+VADFGLAKQS EG SHLTTRVAGT GYLAPEYALYGQLTEKSDVYSFG+VILE+
Sbjct: 436 VDMRARVADFGLAKQSREGESHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEI 495
Query: 466 MSGRKVLDTSTS--PFQ-LITDWAWVLAKSGKVDDIFDE-FIRAEGA-----RAVMERFV 516
M GRK LD STS P LITDWAW L K+GK ++ ++ +R EG+ + +MERF+
Sbjct: 496 MCGRKALDLSTSGSPNTFLITDWAWSLVKAGKTEEALEQSLLREEGSGLSNPKGIMERFL 555
Query: 517 LVGILCAHVMVALRPTITDALKMLEGDIDIPKLPDRPLPLSH 558
VGILCAHV+VALRPTI DALKMLEGDI++P +PDRP+PL+H
Sbjct: 556 QVGILCAHVLVALRPTILDALKMLEGDIEVPPIPDRPVPLAH 597
|
|
| TAIR|locus:2066390 RKF3 "receptor-like kinase in in flowers 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 871 (311.7 bits), Expect = 3.7e-87, P = 3.7e-87
Identities = 208/567 (36%), Positives = 307/567 (54%)
Query: 2 SSSCPVDLSYVQTYPWDRSSCLDPNGKFCCATLLSLIGMGLAAHLRETSLFQFPNETASA 61
+S+CP+D S ++ P+ R P+G C LL + + + HLR+T F P E+A++
Sbjct: 22 NSTCPLDFSVLE--PFRRPK---PDGATTCQYLLQGLRLLYSHHLRQTGSFLPPPESAAS 76
Query: 62 FCLSELQGRLATLSINPSVVPTCFPNATQFASNTSFCAGIVTIEDWKKLVGPTSALDPA- 120
C + LQ +A V TC T + S C I T ++ L+ P S+L
Sbjct: 77 -CWAALQSSVAGFLPRFDVRSTC-GFQTPWISQG--CMDITTRSQFESLI-PNSSLATTA 131
Query: 121 --CK-NFSGFSQCSSCVEAGYSVNAKLLSIQ-PNSTKCFYFAVLYATGILND--PKDEAA 174
C + + C+SC ++ + L N + C F +YA N P D+
Sbjct: 132 MRCNTSLESNTPCASCTQSLSAFQPYLSGPSLGNVSDCASFPSIYAAAFANSLGPTDKGT 191
Query: 175 VACILRLPIXXXXXXXXXXXXRTXXXXXXXXXXXXXXXXXXXXXXXYRKWNK--KRKQIA 232
C+ +L + + RK +K K + +
Sbjct: 192 AKCLFQLDLASPTSSGANKV-KVLVSSFSVLLVASVLVITAWFWYCRRKKSKLLKPRDTS 250
Query: 233 LHEQFVSNLQASVLPNSGAKWFHVSELEQATNGFSQNNLIGQGASGIVYKGTLRHGNLVA 292
L S L + + K F E+++ATN FS++N+IG+G G V+KG L G VA
Sbjct: 251 LEAGTQSRLDSMSESTTLVK-FSFDEIKKATNNFSRHNIIGRGGYGNVFKGALPDGTQVA 309
Query: 293 VKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFLVYDYMPNGTL 352
K+ + GD +F +EVE+I+ IRH NLL+LRG C + G +R +V D + NG+L
Sbjct: 310 FKRFKNCSAGGDANFAHEVEVIASIRHVNLLALRGYCTATTPYEGHQRIIVCDLVSNGSL 369
Query: 353 SDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKV 412
D++ QL WP R++I + +A+G+AYLHYG +P I HRDIK++NILLD AKV
Sbjct: 370 HDHL-FGDLEAQLAWPLRQRIALGMARGLAYLHYGAQPSIIHRDIKASNILLDERFEAKV 428
Query: 413 ADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRK-- 470
ADFGLAK + EG +H++TRVAGT GY+APEYALYGQLTEKSDVYSFG+V+LEL+S RK
Sbjct: 429 ADFGLAKFNPEGMTHMSTRVAGTMGYVAPEYALYGQLTEKSDVYSFGVVLLELLSRRKAI 488
Query: 471 VLDTSTSPFQLITDWAWVLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALR 530
V D P + DWAW L + G+ D+ ++ + +G V+E++VL+ +LC+H + R
Sbjct: 489 VTDEEGQPVS-VADWAWSLVREGQTLDVVEDGMPEKGPPEVLEKYVLIAVLCSHPQLHAR 547
Query: 531 PTITDALKMLEG-DIDIPKLPDRPLPL 556
PT+ +KMLE + + +P RP+PL
Sbjct: 548 PTMDQVVKMLESNEFTVIAIPQRPIPL 574
|
|
| TAIR|locus:2019317 AT1G29730 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 636 (228.9 bits), Expect = 9.4e-62, P = 9.4e-62
Identities = 134/305 (43%), Positives = 192/305 (62%)
Query: 254 FHVSELEQATNGFSQNNLIGQGASGIVYKGTLRHGNLVAVKQILDLDTKGDEDFTNEVEI 313
F + +L+ ATN F N IG+G G VYKG L G L+AVK++ +G+++F NE+ +
Sbjct: 628 FSLRQLKVATNDFDPLNKIGEGGFGSVYKGRLPDGTLIAVKKLSSKSHQGNKEFVNEIGM 687
Query: 314 ISKIRHRNLLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKI 373
I+ ++H NL+ L GCCV + + LVY+Y+ N LSD + +L W R KI
Sbjct: 688 IACLQHPNLVKLYGCCVEKN-----QLLLVYEYLENNCLSDALFAGRSCLKLEWGTRHKI 742
Query: 374 IVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVA 433
+ +A+G+A+LH I HRDIK TN+LLD +LN+K++DFGLA+ + SH+TTRVA
Sbjct: 743 CLGIARGLAFLHEDSAVKIIHRDIKGTNVLLDKDLNSKISDFGLARLHEDNQSHITTRVA 802
Query: 434 GTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGR---KVLDTSTSPFQLITDWAWVLA 490
GT GY+APEYA+ G LTEK+DVYSFG+V +E++SG+ K L+ DWA+VL
Sbjct: 803 GTIGYMAPEYAMRGHLTEKADVYSFGVVAMEIVSGKSNAKYTPDDECCVGLL-DWAFVLQ 861
Query: 491 KSGKVDDIFDEFIRAEGARAVME--RFVLVGILCAHVMVALRPTITDALKMLEGDIDIPK 548
K G + +I D R EG VME R + V +LCA+ LRP ++ +KMLEG+ +I +
Sbjct: 862 KKGDIAEILDP--RLEGMFDVMEAERMIKVSLLCANKSSTLRPNMSQVVKMLEGETEIEQ 919
Query: 549 LPDRP 553
+ P
Sbjct: 920 IISDP 924
|
|
| TAIR|locus:2019367 AT1G29740 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 633 (227.9 bits), Expect = 4.1e-61, P = 4.1e-61
Identities = 133/304 (43%), Positives = 196/304 (64%)
Query: 254 FHVSELEQATNGFSQNNLIGQGASGIVYKGTLRHGNLVAVKQILDLDTKGDEDFTNEVEI 313
F + +L+ AT+ F+ N IG+G G VYKG L +G L+AVK++ +G+++F NE+ I
Sbjct: 665 FSLRQLKVATDDFNPLNKIGEGGFGSVYKGRLPNGTLIAVKKLSSKSCQGNKEFINEIGI 724
Query: 314 ISKIRHRNLLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKI 373
I+ ++H NL+ L GCCV + LVY+Y+ N L+D + +L W R KI
Sbjct: 725 IACLQHPNLVKLYGCCVEKT-----QLLLVYEYLENNCLADAL-FGRSGLKLDWRTRHKI 778
Query: 374 IVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVA 433
+ +A+G+A+LH I HRDIK TNILLD +LN+K++DFGLA+ + SH+TTRVA
Sbjct: 779 CLGIARGLAFLHEDSAVKIIHRDIKGTNILLDKDLNSKISDFGLARLHEDDQSHITTRVA 838
Query: 434 GTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLD-TSTSPFQL-ITDWAWVLAK 491
GT GY+APEYA+ G LTEK+DVYSFG+V +E++SG+ + T + + + DWA+VL K
Sbjct: 839 GTIGYMAPEYAMRGHLTEKADVYSFGVVAMEIVSGKSNANYTPDNECCVGLLDWAFVLQK 898
Query: 492 SGKVDDIFDEFIRAEGARAVME--RFVLVGILCAHVMVALRPTITDALKMLEGDIDIPKL 549
G D+I D + EG VME R + V +LC+ LRPT+++ +KMLEG+ +I ++
Sbjct: 899 KGAFDEILDP--KLEGVFDVMEAERMIKVSLLCSSKSPTLRPTMSEVVKMLEGETEIEEI 956
Query: 550 PDRP 553
P
Sbjct: 957 ISDP 960
|
|
| TAIR|locus:2203718 AT1G53440 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 620 (223.3 bits), Expect = 4.7e-61, Sum P(2) = 4.7e-61
Identities = 125/304 (41%), Positives = 192/304 (63%)
Query: 254 FHVSELEQATNGFSQNNLIGQGASGIVYKGTLRHGNLVAVKQILDLDTKGDEDFTNEVEI 313
F + ++++ATN F N IG+G G VYKG L G +AVKQ+ +G+ +F E+ +
Sbjct: 655 FTLKQIKRATNNFDPENKIGEGGFGPVYKGVLADGMTIAVKQLSSKSKQGNREFVTEIGM 714
Query: 314 ISKIRHRNLLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRK-QLTWPQRKK 372
IS ++H NL+ L GCC+ GK LVY+Y+ N +L+ + + K++ L W R K
Sbjct: 715 ISALQHPNLVKLYGCCI-----EGKELLLVYEYLENNSLARALFGTEKQRLHLDWSTRNK 769
Query: 373 IIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRV 432
+ + +AKG+AYLH + I HRDIK+TN+LLD LNAK++DFGLAK E ++H++TR+
Sbjct: 770 VCIGIAKGLAYLHEESRLKIVHRDIKATNVLLDLSLNAKISDFGLAKLDEEENTHISTRI 829
Query: 433 AGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSP---FQLITDWAWVL 489
AGT GY+APEYA+ G LT+K+DVYSFG+V LE++SG+ +T+ P F + DWA+VL
Sbjct: 830 AGTIGYMAPEYAMRGYLTDKADVYSFGVVCLEIVSGKS--NTNYRPKEEFIYLLDWAYVL 887
Query: 490 AKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEGDIDI-PK 548
+ G + ++ D + ++ R + + +LC + LRP ++ + ML+G I + P
Sbjct: 888 QEQGSLLELVDPDLGTSFSKKEAMRMLNIALLCTNPSPTLRPPMSSVVSMLQGKIKVQPP 947
Query: 549 LPDR 552
L R
Sbjct: 948 LVKR 951
|
|
| TAIR|locus:2012325 AT1G09440 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 624 (224.7 bits), Expect = 5.5e-61, P = 5.5e-61
Identities = 134/328 (40%), Positives = 203/328 (61%)
Query: 228 RKQIALHEQFV-SNLQASVLPNS--G-AKWFHVSELEQATNGFSQNNLIGQGASGIVYKG 283
R +L+E S S LP S G WF + +LE ATN FS+ N+IG+G G+VY+G
Sbjct: 115 RSTSSLYEMATPSPSPLSGLPESHLGWGHWFTLRDLEIATNRFSKENVIGEGGYGVVYRG 174
Query: 284 TLRHGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFLV 343
L +G+LVAVK+IL+ + +++F EV+ I +RH+NL+ L G C+ G R LV
Sbjct: 175 ELVNGSLVAVKKILNHLGQAEKEFRVEVDAIGHVRHKNLVRLLGYCI-----EGTNRILV 229
Query: 344 YDYMPNGTLSDNISISHKRK-QLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNI 402
Y+YM NG L + + + K LTW R K++ +K +AYLH ++P + HRDIKS+NI
Sbjct: 230 YEYMNNGNLEEWLHGAMKHHGYLTWEARMKVLTGTSKALAYLHEAIEPKVVHRDIKSSNI 289
Query: 403 LLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVI 462
L+D NAK++DFGLAK +G SH+TTRV GTFGY+APEYA G L EKSDVYSFG+++
Sbjct: 290 LIDDRFNAKISDFGLAKLLGDGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLV 349
Query: 463 LELMSGRKVLDTSTSPFQL-ITDWAWVLAKSGKVDDIFDEFIRAEGARAVMERFVLVGIL 521
LE ++GR +D + ++ + +W ++ S +++++ D I A ++R +L +
Sbjct: 350 LEAITGRDPVDYARPANEVNLVEWLKMMVGSKRLEEVIDPNIAVRPATRALKRVLLTALR 409
Query: 522 CAHVMVALRPTITDALKMLEGD-IDIPK 548
C RP ++ ++MLE + +P+
Sbjct: 410 CIDPDSEKRPKMSQVVRMLESEEYPVPR 437
|
|
| TAIR|locus:2036636 NIK3 "NSP-interacting kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 620 (223.3 bits), Expect = 1.5e-60, P = 1.5e-60
Identities = 141/327 (43%), Positives = 194/327 (59%)
Query: 224 WNKKR-KQIA--LHEQFVSNLQASVLPNSGAKWFHVSELEQATNGFSQNNLIGQGASGIV 280
W +R KQI ++EQ+ + L K + EL ATN F+ N++G+G GIV
Sbjct: 261 WRYRRNKQIFFDVNEQYDPEVSLGHL-----KRYTFKELRSATNHFNSKNILGRGGYGIV 315
Query: 281 YKGTLRHGNLVAVKQILDLDTKGDE-DFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKR 339
YKG L G LVAVK++ D + G E F EVE IS HRNLL LRG C SS +
Sbjct: 316 YKGHLNDGTLVAVKRLKDCNIAGGEVQFQTEVETISLALHRNLLRLRGFC-----SSNQE 370
Query: 340 RFLVYDYMPNGTLSDNISISHKRKQ-LTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIK 398
R LVY YMPNG+++ + + + + L W +RKKI V A+G+ YLH P I HRD+K
Sbjct: 371 RILVYPYMPNGSVASRLKDNIRGEPALDWSRRKKIAVGTARGLVYLHEQCDPKIIHRDVK 430
Query: 399 STNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSF 458
+ NILLD + A V DFGLAK SH+TT V GT G++APEY GQ +EK+DV+ F
Sbjct: 431 AANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGF 490
Query: 459 GIVILELMSGRKVLDTSTSPFQ--LITDWAWVLAKSGKVDDIFDEFIRAEGARAVMERFV 516
GI++LEL++G+K LD S Q ++ DW L + GK+ + D+ + + R +E V
Sbjct: 491 GILLLELITGQKALDFGRSAHQKGVMLDWVKKLHQEGKLKQLIDKDLNDKFDRVELEEIV 550
Query: 517 LVGILCAHVMVALRPTITDALKMLEGD 543
V +LC + RP +++ +KMLEGD
Sbjct: 551 QVALLCTQFNPSHRPKMSEVMKMLEGD 577
|
|
| TAIR|locus:2139559 AT4G34500 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 619 (223.0 bits), Expect = 1.9e-60, P = 1.9e-60
Identities = 127/302 (42%), Positives = 190/302 (62%)
Query: 252 KWFHVSELEQATNGFSQNNLIGQGASGIVYKGTLRHGNLVAVKQILDLDTKGDEDFTNEV 311
KW+ + +LE AT GFS +N+IG+G G+VY+ G++ AVK +L+ + +++F EV
Sbjct: 131 KWYSLKDLEIATRGFSDDNMIGEGGYGVVYRADFSDGSVAAVKNLLNNKGQAEKEFKVEV 190
Query: 312 EIISKIRHRNLLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISIS-HKRKQLTWPQR 370
E I K+RH+NL+ L G C DS+ +R LVY+Y+ NG L + LTW R
Sbjct: 191 EAIGKVRHKNLVGLMGYCA---DSAQSQRMLVYEYIDNGNLEQWLHGDVGPVSPLTWDIR 247
Query: 371 KKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTT 430
KI + AKG+AYLH GL+P + HRD+KS+NILLD + NAKV+DFGLAK S++TT
Sbjct: 248 MKIAIGTAKGLAYLHEGLEPKVVHRDVKSSNILLDKKWNAKVSDFGLAKLLGSETSYVTT 307
Query: 431 RVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQL-ITDWAWVL 489
RV GTFGY++PEYA G L E SDVYSFG++++E+++GR +D S P ++ + DW +
Sbjct: 308 RVMGTFGYVSPEYASTGMLNECSDVYSFGVLLMEIITGRSPVDYSRPPGEMNLVDWFKGM 367
Query: 490 AKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEGDIDIPKL 549
S + +++ D I+ ++R +LV + C + + RP + + MLE + D P
Sbjct: 368 VASRRGEEVIDPKIKTSPPPRALKRALLVCLRCIDLDSSKRPKMGQIIHMLEAE-DFPFR 426
Query: 550 PD 551
P+
Sbjct: 427 PE 428
|
|
| TAIR|locus:2159873 PERK8 "proline-rich extensin-like receptor kinase 8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 614 (221.2 bits), Expect = 6.4e-60, P = 6.4e-60
Identities = 133/297 (44%), Positives = 187/297 (62%)
Query: 253 WFHVSELEQATNGFSQNNLIGQGASGIVYKGTLRHGNLVAVKQILDLDTKGDEDFTNEVE 312
WF EL Q T+GFS+ NL+G+G G VYKG L G VAVKQ+ ++G+ +F EVE
Sbjct: 326 WFSYDELSQVTSGFSEKNLLGEGGFGCVYKGVLSDGREVAVKQLKIGGSQGEREFKAEVE 385
Query: 313 IISKIRHRNLLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKK 372
IIS++ HR+L++L G C+ S + R LVYDY+PN TL ++ + R +TW R +
Sbjct: 386 IISRVHHRHLVTLVGYCI-----SEQHRLLVYDYVPNNTLHYHLH-APGRPVMTWETRVR 439
Query: 373 IIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAK--QSLEGHSHLTT 430
+ A+GIAYLH P I HRDIKS+NILLD+ A VADFGLAK Q L+ ++H++T
Sbjct: 440 VAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDNSFEALVADFGLAKIAQELDLNTHVST 499
Query: 431 RVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPF--QLITDWAWV 488
RV GTFGY+APEYA G+L+EK+DVYS+G+++LEL++GRK +DTS P + + +WA
Sbjct: 500 RVMGTFGYMAPEYATSGKLSEKADVYSYGVILLELITGRKPVDTS-QPLGDESLVEWARP 558
Query: 489 LAKSGKVDDIFDEFIRAE-GARAV---MERFVLVGILCAHVMVALRPTITDALKMLE 541
L ++ FDE + G + M R V C A RP ++ ++ L+
Sbjct: 559 LLGQAIENEEFDELVDPRLGKNFIPGEMFRMVEAAAACVRHSAAKRPKMSQVVRALD 615
|
|
| TAIR|locus:2077730 AT3G59110 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 611 (220.1 bits), Expect = 1.3e-59, P = 1.3e-59
Identities = 122/293 (41%), Positives = 186/293 (63%)
Query: 253 WFHVSELEQATNGFSQNNLIGQGASGIVYKGTLRHGNLVAVKQILDLDTKGDEDFTNEVE 312
WF + +L+ ATN F+ N+IG+G G+VYKG L +GN VAVK++L+ + +++F EVE
Sbjct: 177 WFTLRDLQLATNRFAAENVIGEGGYGVVYKGRLINGNDVAVKKLLNNLGQAEKEFRVEVE 236
Query: 313 IISKIRHRNLLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNI-SISHKRKQLTWPQRK 371
I +RH+NL+ L G C+ G R LVY+Y+ +G L + K+ LTW R
Sbjct: 237 AIGHVRHKNLVRLLGYCI-----EGVNRMLVYEYVNSGNLEQWLHGAMGKQSTLTWEARM 291
Query: 372 KIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTR 431
KI+V A+ +AYLH ++P + HRDIK++NIL+D + NAK++DFGLAK G SH+TTR
Sbjct: 292 KILVGTAQALAYLHEAIEPKVVHRDIKASNILIDDDFNAKLSDFGLAKLLDSGESHITTR 351
Query: 432 VAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQL-ITDWAWVLA 490
V GTFGY+APEYA G L EKSD+YSFG+++LE ++GR +D ++ + +W ++
Sbjct: 352 VMGTFGYVAPEYANTGLLNEKSDIYSFGVLLLETITGRDPVDYERPANEVNLVEWLKMMV 411
Query: 491 KSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEGD 543
+ + +++ D I A ++R +LV + C RP ++ ++MLE D
Sbjct: 412 GTRRAEEVVDSRIEPPPATRALKRALLVALRCVDPEAQKRPKMSQVVRMLESD 464
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| O04086 | Y1105_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.5 | 0.9542 | 0.9008 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 590 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-52 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 6e-51 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-50 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 6e-46 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-44 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-44 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-42 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-42 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-35 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-34 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 4e-32 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-31 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-31 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 7e-30 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-29 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 3e-29 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 4e-27 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 5e-27 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-26 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-26 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-26 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 3e-26 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 3e-26 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 8e-26 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 8e-26 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-25 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 4e-25 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 4e-25 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 6e-25 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 6e-25 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 5e-24 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 6e-24 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-23 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-23 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-23 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 5e-23 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 8e-23 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-22 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-22 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-22 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 3e-22 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 4e-22 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 4e-22 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 4e-22 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 6e-22 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 8e-22 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 9e-22 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 9e-22 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-21 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-21 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 4e-21 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 5e-21 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 5e-21 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 5e-21 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 7e-21 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 9e-21 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-20 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-20 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-20 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 3e-20 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 5e-20 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 5e-20 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 5e-20 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 6e-20 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 6e-20 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 8e-20 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-19 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 1e-19 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-19 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-19 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-19 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 3e-19 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 3e-19 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 3e-19 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 4e-19 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 4e-19 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-19 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 5e-19 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 8e-19 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 9e-19 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-18 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-18 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-18 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-18 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-18 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 3e-18 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 5e-18 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 7e-18 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 8e-18 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 8e-18 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 9e-18 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 9e-18 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-17 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-17 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-17 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-17 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-17 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-17 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-17 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 3e-17 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 3e-17 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 4e-17 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 4e-17 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 5e-17 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 5e-17 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 6e-17 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 6e-17 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 6e-17 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 7e-17 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-16 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-16 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-16 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-16 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-16 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-16 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-16 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-16 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 3e-16 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 3e-16 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 3e-16 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 3e-16 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 4e-16 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 4e-16 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 5e-16 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 5e-16 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 6e-16 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 8e-16 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-15 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-15 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-15 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-15 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-15 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-15 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-15 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-15 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-15 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-15 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-15 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-15 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-15 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 3e-15 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 3e-15 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 3e-15 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 4e-15 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 5e-15 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 5e-15 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 5e-15 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 5e-15 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 6e-15 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 7e-15 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 8e-15 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 8e-15 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-14 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-14 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-14 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-14 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-14 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 3e-14 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 4e-14 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 4e-14 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 4e-14 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 9e-14 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-13 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-13 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-13 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-13 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-13 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-13 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-13 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-13 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-13 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-13 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-13 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-13 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-13 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 3e-13 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 3e-13 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 3e-13 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 4e-13 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 4e-13 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 7e-13 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 7e-13 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 8e-13 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 8e-13 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 8e-13 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 9e-13 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 9e-13 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 9e-13 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-12 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-12 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-12 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-12 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-12 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 3e-12 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 3e-12 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 3e-12 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 3e-12 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 4e-12 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 4e-12 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 4e-12 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 5e-12 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 7e-12 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 8e-12 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-11 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-11 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-11 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-11 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-11 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-11 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-11 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-11 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 3e-11 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 3e-11 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 3e-11 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 3e-11 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 5e-11 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 5e-11 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 6e-11 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 6e-11 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 7e-11 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 7e-11 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 7e-11 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 7e-11 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 8e-11 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 9e-11 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 9e-11 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-10 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-10 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-10 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-10 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-10 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 3e-10 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 3e-10 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 3e-10 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 3e-10 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 4e-10 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 4e-10 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 6e-10 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 7e-10 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 7e-10 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 8e-10 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 8e-10 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 9e-10 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-09 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-09 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-09 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-09 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-09 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-09 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 2e-09 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-09 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 3e-09 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 3e-09 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 3e-09 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 3e-09 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 3e-09 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 3e-09 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 3e-09 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 4e-09 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 4e-09 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 8e-09 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-08 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-08 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 3e-08 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 3e-08 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 4e-08 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-07 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-07 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-07 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-07 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-07 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 3e-07 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 3e-07 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 4e-07 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 5e-07 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 7e-07 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 7e-07 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 7e-07 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 9e-07 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-06 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 1e-06 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-06 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 1e-06 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 4e-06 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 8e-06 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-05 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-05 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-05 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 2e-05 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-05 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-05 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 3e-05 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 4e-05 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 6e-05 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 7e-05 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-04 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-04 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-04 | |
| COG3642 | 204 | COG3642, COG3642, Mn2+-dependent serine/threonine | 3e-04 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 5e-04 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 5e-04 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 5e-04 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 7e-04 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 178 bits (454), Expect = 2e-52
Identities = 70/206 (33%), Positives = 108/206 (52%), Gaps = 15/206 (7%)
Query: 272 IGQGASGIVYKGTLRH-GNLVAVKQI-LDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCC 329
+G+G G VY + G VA+K I + + E+ E+EI+ K+ H N++ L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 330 VTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLK 389
+LV +Y G+L D + +L+ + +I++ + +G+ YLH
Sbjct: 61 ED-----ENHLYLVMEYCEGGSLKD--LLKENEGKLSEDEILRILLQILEGLEYLH---S 110
Query: 390 PGIYHRDIKSTNILLDS-ELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYAL-YG 447
GI HRD+K NILLDS K+ADFGL+K S L T V GT Y+APE L G
Sbjct: 111 NGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV-GTPAYMAPEVLLGKG 169
Query: 448 QLTEKSDVYSFGIVILELMSGRKVLD 473
+EKSD++S G+++ EL + ++
Sbjct: 170 YYSEKSDIWSLGVILYELPELKDLIR 195
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 175 bits (447), Expect = 6e-51
Identities = 77/272 (28%), Positives = 124/272 (45%), Gaps = 27/272 (9%)
Query: 270 NLIGQGASGIVYKGTLRH-GNLVAVKQI-LDLDTKGDEDFTNEVEIISKIRHRNLLSLRG 327
+G+G+ G VY + G LVA+K I K E E++I+ K++H N++ L
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64
Query: 328 CCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYG 387
D +LV +Y G L D + KR +L+ + + + + + YLH
Sbjct: 65 VFEDEDK-----LYLVMEYCEGGDLFDLL---KKRGRLSEDEARFYLRQILSALEYLH-- 114
Query: 388 LKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALYG 447
GI HRD+K NILLD + + K+ADFGLA+Q L+ LTT V GT Y+APE L
Sbjct: 115 -SKGIVHRDLKPENILLDEDGHVKLADFGLARQ-LDPGEKLTTFV-GTPEYMAPEVLLGK 171
Query: 448 QLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDEFIRAEG 507
+ D++S G+++ EL++G+ +L K E+ +
Sbjct: 172 GYGKAVDIWSLGVILYELLTGKPPFPGDDQLLELFK-----KIGKPKPPFPPPEWDISPE 226
Query: 508 ARAVMERFVLVGILCAHVMVALRPTITDALKM 539
A+ ++ + R T +AL+
Sbjct: 227 AKDLIRK-------LLVKDPEKRLTAEEALQH 251
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 174 bits (443), Expect = 2e-50
Identities = 86/274 (31%), Positives = 134/274 (48%), Gaps = 31/274 (11%)
Query: 272 IGQGASGIVYKGTLRH-GNLVAVKQI--LDLDTKGDEDFTNEVEIISKIRHRNLLSLRGC 328
+G G+ G VYK + G +VAVK + +K D+ E+ I+ ++ H N++ L
Sbjct: 7 LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDA 66
Query: 329 CVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGL 388
D +LV +Y G L D +S + L+ + KKI + + +G+ YLH
Sbjct: 67 FEDKD-----HLYLVMEYCEGGDLFDYLS---RGGPLSEDEAKKIALQILRGLEYLH--- 115
Query: 389 KPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALYGQ 448
GI HRD+K NILLD K+ADFGLAK+ L+ S LTT V GT Y+APE L G
Sbjct: 116 SNGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFV-GTPWYMAPEVLLGGN 174
Query: 449 L-TEKSDVYSFGIVILELMSGRKVL--DTSTSPFQLITDWAWVLAKSGKVD-DIFDEFIR 504
K DV+S G+++ EL++G+ + QLI ++ D
Sbjct: 175 GYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLI-----RRILGPPLEFDEPKWSSG 229
Query: 505 AEGARAVMERFVLVGILCAHVMVALRPTITDALK 538
+E A+ ++++ C + + RPT + L+
Sbjct: 230 SEEAKDLIKK-------CLNKDPSKRPTAEEILQ 256
|
Length = 260 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 162 bits (413), Expect = 6e-46
Identities = 60/214 (28%), Positives = 104/214 (48%), Gaps = 28/214 (13%)
Query: 270 NLIGQGASGIVYKGTLRHGN----LVAVKQILDLDTKGD-EDFTNEVEIISKIRHRNLLS 324
+G+GA G VYKG L+ + VAVK + + ++ + +DF E ++ K+ H N++
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 325 LRGCCVTSDDSSGKRRFLVYDYMPNGTL------SDNISISHKRKQLTWPQRKKIIVDVA 378
L G C + +LV +YM G L S + S ++ L+ + +A
Sbjct: 61 LLGVCTEEE-----PLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIA 115
Query: 379 KGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTR-----VA 433
KG+ YL HRD+ + N L+ +L K++DFGL++ + + +
Sbjct: 116 KGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR 172
Query: 434 GTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS 467
++APE G T KSDV+SFG+++ E+ +
Sbjct: 173 ----WMAPESLKDGIFTSKSDVWSFGVLLWEIFT 202
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 159 bits (404), Expect = 1e-44
Identities = 61/208 (29%), Positives = 101/208 (48%), Gaps = 22/208 (10%)
Query: 269 NNLIGQGASGIVYKGTLRHGN-----LVAVKQIL-DLDTKGDEDFTNEVEIISKIRHRNL 322
+G+GA G VYKG L+ VAVK + D + E+F E I+ K+ H N+
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63
Query: 323 LSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIA 382
+ L G C + + ++V +YM G L + R +L+ + +A+G+
Sbjct: 64 VKLLGVC-----TEEEPLYIVMEYMEGGDLLSYLRK--NRPKLSLSDLLSFALQIARGME 116
Query: 383 YLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGT---FGYL 439
YL HRD+ + N L+ L K++DFGL++ + + R G ++
Sbjct: 117 YLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSR---DLYDDDYYRKRGGKLPIRWM 170
Query: 440 APEYALYGQLTEKSDVYSFGIVILELMS 467
APE G+ T KSDV+SFG+++ E+ +
Sbjct: 171 APESLKEGKFTSKSDVWSFGVLLWEIFT 198
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 158 bits (402), Expect = 1e-44
Identities = 64/208 (30%), Positives = 106/208 (50%), Gaps = 21/208 (10%)
Query: 269 NNLIGQGASGIVYKGTLRHGN-----LVAVKQIL-DLDTKGDEDFTNEVEIISKIRHRNL 322
+G+GA G VYKGTL+ VAVK + D + E+F E I+ K+ H N+
Sbjct: 4 GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNI 63
Query: 323 LSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIA 382
+ L G C + + +V +YMP G L D + ++ K+L+ + +A+G+
Sbjct: 64 VKLLGVC-----TEEEPLMIVMEYMPGGDLLDYLR-KNRPKELSLSDLLSFALQIARGME 117
Query: 383 YLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGT---FGYL 439
YL HRD+ + N L+ L K++DFGL++ + + +V G ++
Sbjct: 118 YLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSR---DLYDDDYYKVKGGKLPIRWM 171
Query: 440 APEYALYGQLTEKSDVYSFGIVILELMS 467
APE G+ T KSDV+SFG+++ E+ +
Sbjct: 172 APESLKEGKFTSKSDVWSFGVLLWEIFT 199
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 152 bits (387), Expect = 3e-42
Identities = 74/278 (26%), Positives = 134/278 (48%), Gaps = 28/278 (10%)
Query: 266 FSQNNLIGQGASGIVYKGTLRH-GNLVAVKQIL--DLDTKGDEDFTNEVEIISKIRHRNL 322
+++ L+G+G+ G VY + G L+AVK + + E E+ I+S ++H N+
Sbjct: 2 WTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNI 61
Query: 323 LSLRGCCVTSDDSSGKRRFLVY-DYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGI 381
+ G + ++ ++ +Y+ G+LS S+ K +L P +K + +G+
Sbjct: 62 VRYYGSERDEEKNT----LNIFLEYVSGGSLS---SLLKKFGKLPEPVIRKYTRQILEGL 114
Query: 382 AYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTR-VAGTFGYLA 440
AYLH GI HRDIK NIL+DS+ K+ADFG AK+ + + T V GT ++A
Sbjct: 115 AYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMA 171
Query: 441 PEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFD 500
PE + +D++S G ++E+ +G+ +P + + + SG+ +I +
Sbjct: 172 PEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAAL----YKIGSSGEPPEIPE 227
Query: 501 EFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALK 538
+E A+ + + C RPT + L+
Sbjct: 228 HL--SEEAKDFLRK-------CLRRDPKKRPTADELLQ 256
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 152 bits (386), Expect = 3e-42
Identities = 66/206 (32%), Positives = 109/206 (52%), Gaps = 21/206 (10%)
Query: 272 IGQGASGIVYKGTLR-----HGNLVAVKQILDLDTKGD-EDFTNEVEIISKIRHRNLLSL 325
+G+GA G VYKGTL+ VAVK + + ++ + E+F E I+ K+ H N++ L
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66
Query: 326 RGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQ-LTWPQRKKIIVDVAKGIAYL 384
G C + G+ ++V +YMP G L D + K + LT ++ + +AKG+ YL
Sbjct: 67 LGVC-----TQGEPLYIVTEYMPGGDLLDFL---RKHGEKLTLKDLLQMALQIAKGMEYL 118
Query: 385 HYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTF--GYLAPE 442
HRD+ + N L+ L K++DFGL++ + + R G ++APE
Sbjct: 119 E---SKNFVHRDLAARNCLVTENLVVKISDFGLSRD-IYEDDYYRKRGGGKLPIKWMAPE 174
Query: 443 YALYGQLTEKSDVYSFGIVILELMSG 468
G+ T KSDV+SFG+++ E+ +
Sbjct: 175 SLKDGKFTSKSDVWSFGVLLWEIFTL 200
|
Length = 258 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 132 bits (335), Expect = 3e-35
Identities = 76/245 (31%), Positives = 117/245 (47%), Gaps = 34/245 (13%)
Query: 272 IGQGASGIVYKGT-LRHGNLVAVKQILDLDTKGD-EDFTNEVEIISKIRHRNLLSLRGCC 329
IG+G G VYK R G VA+K I L++K E NE++I+ K +H N++ G
Sbjct: 8 IGKGGFGEVYKARHKRTGKEVAIKVI-KLESKEKKEKIINEIQILKKCKHPNIVKYYGSY 66
Query: 330 VTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLK 389
+ D ++V ++ G+L D + +++ LT Q + ++ KG+ YLH
Sbjct: 67 LKKD-----ELWIVMEFCSGGSLKDLLKSTNQT--LTESQIAYVCKELLKGLEYLH---S 116
Query: 390 PGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALYGQL 449
GI HRDIK+ NILL S+ K+ DFGL+ Q L + + GT ++APE
Sbjct: 117 NGIIHRDIKAANILLTSDGEVKLIDFGLSAQ-LS-DTKARNTMVGTPYWMAPEVINGKPY 174
Query: 450 TEKSDVYSFGIVILELMSGR---------KVLD-TSTSPF-QLITDWAWVLAKSGKVDDI 498
K+D++S GI +EL G+ K L +T+ L W D
Sbjct: 175 DYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKW--------SDE 226
Query: 499 FDEFI 503
F +F+
Sbjct: 227 FKDFL 231
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 131 bits (333), Expect = 2e-34
Identities = 68/198 (34%), Positives = 105/198 (53%), Gaps = 13/198 (6%)
Query: 272 IGQGASGIVYKGTLRH-GNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCV 330
IG+GASG VYK T R G VA+K++ L + E NE+ I+ +H N++ +
Sbjct: 27 IGEGASGEVYKATDRATGKEVAIKKM-RLRKQNKELIINEILIMKDCKHPNIVDYYDSYL 85
Query: 331 TSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKP 390
D+ ++V +YM G+L+D I+ ++ PQ + +V +G+ YLH
Sbjct: 86 VGDE-----LWVVMEYMDGGSLTD--IITQNFVRMNEPQIAYVCREVLQGLEYLH---SQ 135
Query: 391 GIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALYGQLT 450
+ HRDIKS NILL + + K+ADFG A Q + S + V GT ++APE
Sbjct: 136 NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVV-GTPYWMAPEVIKRKDYG 194
Query: 451 EKSDVYSFGIVILELMSG 468
K D++S GI+ +E+ G
Sbjct: 195 PKVDIWSLGIMCIEMAEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 4e-32
Identities = 66/203 (32%), Positives = 104/203 (51%), Gaps = 15/203 (7%)
Query: 270 NLIGQGASGIVYKG-TLRHGNLVAVKQILDLDTKGDE--DFTNEVEIISKIRHRNLLSLR 326
+LIG+GA G+VYKG L G+ VA+KQI K + E++++ ++H N++
Sbjct: 6 DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYI 65
Query: 327 GCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHY 386
G TSD +++ +Y NG+L I + V +G+AYLH
Sbjct: 66 GSIETSDSL-----YIILEYAENGSLRQIIKKFGP---FPESLVAVYVYQVLQGLAYLH- 116
Query: 387 GLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALY 446
+ G+ HRDIK+ NIL + K+ADFG+A + L S V GT ++APE
Sbjct: 117 --EQGVIHRDIKAANILTTKDGVVKLADFGVATK-LNDVSKDDASVVGTPYWMAPEVIEM 173
Query: 447 GQLTEKSDVYSFGIVILELMSGR 469
+ SD++S G ++EL++G
Sbjct: 174 SGASTASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 123 bits (312), Expect = 1e-31
Identities = 72/222 (32%), Positives = 112/222 (50%), Gaps = 29/222 (13%)
Query: 272 IGQGASGIVYKG-TLRHGNLVAVKQILDLDTKGDE-DFT--NEVEIISKIRHRNLLSLRG 327
IG+G G VYK + G LVA+K+I ++ + + T E++++ K+RH N++ L+
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKI-RMENEKEGFPITAIREIKLLQKLRHPNIVRLK- 64
Query: 328 CCVTSDDSSGKRRFLVYDYMP---NGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYL 384
VTS ++V++YM G L + T Q K + + +G+ YL
Sbjct: 65 EIVTSKGKGSI--YMVFEYMDHDLTGLLD------SPEVKFTESQIKCYMKQLLEGLQYL 116
Query: 385 HYGLKPGIYHRDIKSTNILLDSELNAKVADFGLA-KQSLEGHSHLTTRVAGTFGYLAPEY 443
H GI HRDIK +NIL++++ K+ADFGLA + + T RV T Y PE
Sbjct: 117 HSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TLWYRPPEL 172
Query: 444 AL----YGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQL 481
L YG + D++S G ++ EL G+ + ST QL
Sbjct: 173 LLGATRYG---PEVDMWSVGCILAELFLGKPIFQGSTELEQL 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 3e-31
Identities = 71/200 (35%), Positives = 107/200 (53%), Gaps = 16/200 (8%)
Query: 271 LIGQGASGIVYKGTLRHGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCV 330
IG+G G V G R G VAVK + D D+ + F E +++ +RH NL+ L G +
Sbjct: 13 TIGKGEFGDVMLGDYR-GQKVAVKCLKD-DSTAAQAFLAEASVMTTLRHPNLVQLLGVVL 70
Query: 331 TSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKP 390
G ++V +YM G+L D + S R +T Q+ +DV +G+ YL +
Sbjct: 71 Q-----GNPLYIVTEYMAKGSLVDYLR-SRGRAVITLAQQLGFALDVCEGMEYLE---EK 121
Query: 391 GIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALYGQLT 450
HRD+ + N+L+ +L AKV+DFGLAK++ +G V T APE + +
Sbjct: 122 NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWT----APEALREKKFS 177
Query: 451 EKSDVYSFGIVILELMS-GR 469
KSDV+SFGI++ E+ S GR
Sbjct: 178 TKSDVWSFGILLWEIYSFGR 197
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 7e-30
Identities = 63/224 (28%), Positives = 105/224 (46%), Gaps = 45/224 (20%)
Query: 272 IGQGASGIVYKGTLRHG------NLVAVKQILDL-DTKGDEDFTNEVEIISKIRHRNLLS 324
+G+GA G V+ G H LVAVK + + +DF E E+++ +H N++
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 325 LRGCCVTSDDSSGKRRFLVYDYMPNGTLSD---------NISISHKRK--QLTWPQRKKI 373
G C D +V++YM +G L+ S +LT Q +I
Sbjct: 73 FYGVCTEGDPP-----IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQI 127
Query: 374 IVDVAKGIAYL---HYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQ-------SLE 423
V +A G+ YL H+ HRD+ + N L+ +L K+ DFG+++ +
Sbjct: 128 AVQIASGMVYLASQHF------VHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVG 181
Query: 424 GHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS 467
GH+ L R ++ PE +Y + T +SDV+SFG+V+ E+ +
Sbjct: 182 GHTMLPIR------WMPPESIMYRKFTTESDVWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 2e-29
Identities = 67/222 (30%), Positives = 98/222 (44%), Gaps = 34/222 (15%)
Query: 270 NLIGQGASGIVYKGT-LRHGNLVAVKQI--LDLDTKGDEDFTNEVEIISKIRHRNLLSLR 326
IG+G+ G VY G L +K+I ++ K ED NEV+I+ K+ H N++
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65
Query: 327 GCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRK--KIIVDVAKGIAYL 384
+ +V +Y G LS I K++ +P+ + V + + YL
Sbjct: 66 ESFEEKG-----KLCIVMEYADGGDLSQKIK-KQKKEGKPFPEEQILDWFVQLCLALKYL 119
Query: 385 HYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPE-- 442
H I HRDIK NI L S K+ DFG++K L L V GT YL+PE
Sbjct: 120 H---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKV-LSSTVDLAKTVVGTPYYLSPELC 175
Query: 443 ----YALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQ 480
Y KSD++S G V+ EL + + PF+
Sbjct: 176 QNKPY------NYKSDIWSLGCVLYELCTLKH-------PFE 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 3e-29
Identities = 77/214 (35%), Positives = 109/214 (50%), Gaps = 24/214 (11%)
Query: 272 IGQGASGIVYKGTLRHGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVT 331
+G G G V+ GT VAVK L T E F E +I+ K+RH L+ L C
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVK-TLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVC-- 70
Query: 332 SDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPG 391
S + ++V +YM G+L D + S + K+L PQ + +A+G+AYL
Sbjct: 71 ---SEEEPIYIVTEYMSKGSLLDFLK-SGEGKKLRLPQLVDMAAQIAEGMAYLE---SRN 123
Query: 392 IYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTF--GYLAPEYALYGQL 449
HRD+ + NIL+ L K+ADFGLA+ L T R F + APE A YG+
Sbjct: 124 YIHRDLAARNILVGENLVCKIADFGLAR--LIEDDEYTAREGAKFPIKWTAPEAANYGRF 181
Query: 450 TEKSDVYSFGIVILEL----------MSGRKVLD 473
T KSDV+SFGI++ E+ M+ R+VL+
Sbjct: 182 TIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLE 215
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 113 bits (282), Expect = 4e-27
Identities = 80/329 (24%), Positives = 129/329 (39%), Gaps = 37/329 (11%)
Query: 271 LIGQGASGIVYKGTLRHGNLVAVKQI---LDLDTKGDEDFTNEVEIISKIRH-RNLLSLR 326
+G+G+ G VY R LVA+K + L+ +K E F E++I++ + H N++ L
Sbjct: 7 KLGEGSFGEVYLARDRK--LVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64
Query: 327 GCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHY 386
+LV +Y+ G+L D + ++ L+ + I+ + + YLH
Sbjct: 65 DFFQDEGSL-----YLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH- 118
Query: 387 GLKPGIYHRDIKSTNILLDSELN-AKVADFGLAKQSLEGHSHLTTR-----VAGTFGYLA 440
GI HRDIK NILLD + K+ DFGLAK + S + GT GY+A
Sbjct: 119 --SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMA 176
Query: 441 PEYAL---YGQLTEKSDVYSFGIVILELMSGR--KVLDTSTSPFQLITDWAWVLAKS--- 492
PE L + SD++S GI + EL++G + ++S L
Sbjct: 177 PEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLA 236
Query: 493 --------GKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEGDI 544
+ + ++ A+ R L H ++A L L
Sbjct: 237 SPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLS-HDLLAHLKLKESDLSDLLKPD 295
Query: 545 DIPKLPDRPLPLSHECLRSSPSRYSFSTS 573
D L P + S S +
Sbjct: 296 DSAPLRLSLPPSLEALISSLNSLAISGSD 324
|
Length = 384 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 5e-27
Identities = 62/206 (30%), Positives = 101/206 (49%), Gaps = 16/206 (7%)
Query: 266 FSQNNLIGQGASGIVYKGTLRH-GNLVAVKQILDLDTKGD-EDFTNEVEIISKIRHRNLL 323
F +G+G+ G VYK + G +VA+K + + D ++ E+ I+ + ++
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVP---VEEDLQEIIKEISILKQCDSPYIV 61
Query: 324 SLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAY 383
G + D ++V +Y G++SD + I+ K LT + I+ KG+ Y
Sbjct: 62 KYYGSYFKNTDL-----WIVMEYCGAGSVSDIMKIT--NKTLTEEEIAAILYQTLKGLEY 114
Query: 384 LHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEY 443
LH HRDIK+ NILL+ E AK+ADFG++ Q L V GT ++APE
Sbjct: 115 LH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQ-LTDTMAKRNTVIGTPFWMAPEV 170
Query: 444 ALYGQLTEKSDVYSFGIVILELMSGR 469
K+D++S GI +E+ G+
Sbjct: 171 IQEIGYNNKADIWSLGITAIEMAEGK 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 68/227 (29%), Positives = 104/227 (45%), Gaps = 29/227 (12%)
Query: 270 NLIGQGASGIVYKGTL-----RHGNLVAVKQILDLDTKGDE----DFTNEVEIISKIRHR 320
+G+G G V G VAVK L+ G+E DF E+EI+ + H
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKS---LNHSGEEQHRSDFEREIEILRTLDHE 66
Query: 321 NLLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKG 380
N++ +G C + G+ L+ +Y+P+G+L D + R Q+ + + KG
Sbjct: 67 NIVKYKGVC---EKPGGRSLRLIMEYLPSGSLRD--YLQRHRDQINLKRLLLFSSQICKG 121
Query: 381 IAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAG---TFG 437
+ YL HRD+ + NIL++SE K++DFGLAK E + + G F
Sbjct: 122 MDYLG---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFW 178
Query: 438 YLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLDTSTSPFQLIT 483
Y APE + + SDV+SFG+ + EL + G S SP
Sbjct: 179 Y-APECLRTSKFSSASDVWSFGVTLYELFTYGDP----SQSPPAEFL 220
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 2e-26
Identities = 78/214 (36%), Positives = 110/214 (51%), Gaps = 25/214 (11%)
Query: 272 IGQGASGIVYKGTLRHGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVT 331
+GQG G V+ GT VA+K L T E F E +++ K+RH L+ L V
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKT-LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA--VV 70
Query: 332 SDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPG 391
S++ ++V +YM G+L D + K L PQ + +A G+AY+ +
Sbjct: 71 SEEPI----YIVTEYMSKGSLLDFLK-GEMGKYLRLPQLVDMAAQIASGMAYVE---RMN 122
Query: 392 IYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTF--GYLAPEYALYGQL 449
HRD+++ NIL+ L KVADFGLA+ L + T R F + APE ALYG+
Sbjct: 123 YVHRDLRAANILVGENLVCKVADFGLAR--LIEDNEYTARQGAKFPIKWTAPEAALYGRF 180
Query: 450 TEKSDVYSFGIVILEL----------MSGRKVLD 473
T KSDV+SFGI++ EL M R+VLD
Sbjct: 181 TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLD 214
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 61/208 (29%), Positives = 105/208 (50%), Gaps = 29/208 (13%)
Query: 272 IGQGASGIVYKGTLR-HGNLVAVKQI-LDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCC 329
+GQG+SG+VYK + G + A+K+I +D D + + E++ + ++ G
Sbjct: 9 LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYG-- 66
Query: 330 VTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQR--KKIIVDVAKGIAYLHYG 387
+ G +V +YM G+L+D + +K P+ I + KG+ YLH
Sbjct: 67 --AFYKEG-EISIVLEYMDGGSLADLL-----KKVGKIPEPVLAYIARQILKGLDYLHTK 118
Query: 388 LKPGIYHRDIKSTNILLDSELNAKVADFGLAK---QSLEGHSHLTTRVAGTFGYLAPEY- 443
I HRDIK +N+L++S+ K+ADFG++K +L+ + T V GT Y++PE
Sbjct: 119 RH--IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCN---TFV-GTVTYMSPERI 172
Query: 444 --ALYGQLTEKSDVYSFGIVILELMSGR 469
Y +D++S G+ +LE G+
Sbjct: 173 QGESYSY---AADIWSLGLTLLECALGK 197
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 3e-26
Identities = 70/217 (32%), Positives = 105/217 (48%), Gaps = 30/217 (13%)
Query: 272 IGQGASGIVYKGTLRHGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVT 331
+G G G V++G + VAVK L T +DF E +I+ K+RH L+ L C T
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKT-LKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVC-T 71
Query: 332 SDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYL---HYGL 388
++ ++V + M G+L + + + L PQ + VA G+AYL +Y
Sbjct: 72 LEEPI----YIVTELMKYGSLLEYLQ-GGAGRALKLPQLIDMAAQVASGMAYLEAQNY-- 124
Query: 389 KPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTF--GYLAPEYALY 446
HRD+ + N+L+ KVADFGLA+ E R F + APE ALY
Sbjct: 125 ----IHRDLAARNVLVGENNICKVADFGLARVIKE--DIYEAREGAKFPIKWTAPEAALY 178
Query: 447 GQLTEKSDVYSFGIVILEL----------MSGRKVLD 473
+ + KSDV+SFGI++ E+ M+ +VL
Sbjct: 179 NRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQ 215
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 3e-26
Identities = 63/216 (29%), Positives = 103/216 (47%), Gaps = 29/216 (13%)
Query: 272 IGQGASGIVY----KGTLRHGNLVAVKQI---LDLDTKGDEDFTNEVEIISKIRHRNLLS 324
+G+G+ G V K T G L A+K + + K E E I+S+I H ++
Sbjct: 1 LGKGSFGKVLLVRKKDT---GKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVK 57
Query: 325 LRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYL 384
L +++ +LV +Y P G L ++S K + + + + ++ + YL
Sbjct: 58 LH-YAFQTEEK----LYLVLEYAPGGELFSHLS---KEGRFSEERARFYAAEIVLALEYL 109
Query: 385 HYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYA 444
H GI +RD+K NILLD++ + K+ DFGLAK+ S T GT YLAPE
Sbjct: 110 H---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT-FCGTPEYLAPEVL 165
Query: 445 LYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQ 480
L + D +S G+++ E+++G+ PF
Sbjct: 166 LGKGYGKAVDWWSLGVLLYEMLTGK-------PPFY 194
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 8e-26
Identities = 73/226 (32%), Positives = 111/226 (49%), Gaps = 34/226 (15%)
Query: 272 IGQGASGIVYKGTLRH---GNLVAVKQI-LDLDTKGDEDFTNEVEIISKIRHRNLLSLRG 327
+G G SG+V K + H G ++AVK I L+++ + E++I+ K ++ G
Sbjct: 9 LGAGNSGVVSK--VLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYG 66
Query: 328 CCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQR--KKIIVDVAKGIAYLH 385
+ D S + +YM G+L D I K Q P+R KI V V KG+ YLH
Sbjct: 67 AFYNNGDIS-----ICMEYMDGGSL-DKI---LKEVQGRIPERILGKIAVAVLKGLTYLH 117
Query: 386 YGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTF----GYLAP 441
K I HRD+K +NIL++S K+ DFG++ Q L +A TF Y+AP
Sbjct: 118 EKHK--IIHRDVKPSNILVNSRGQIKLCDFGVSGQ-------LVNSLAKTFVGTSSYMAP 168
Query: 442 EYALYGQLTEKSDVYSFGIVILELMSGR----KVLDTSTSPFQLIT 483
E + KSD++S G+ ++EL +GR D F+L+
Sbjct: 169 ERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQ 214
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 8e-26
Identities = 75/202 (37%), Positives = 106/202 (52%), Gaps = 15/202 (7%)
Query: 272 IGQGASGIVYKGTLRHGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVT 331
+G G G V+ GT VAVK L T E F E +I+ K+RH L+ L V
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKT-LKPGTMSPESFLEEAQIMKKLRHDKLVQLYA--VV 70
Query: 332 SDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPG 391
S++ ++V +YM G+L D + R L P + VA G+AY+ +
Sbjct: 71 SEEPI----YIVTEYMSKGSLLDFLKDGEGR-ALKLPNLVDMAAQVAAGMAYIE---RMN 122
Query: 392 IYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTF--GYLAPEYALYGQL 449
HRD++S NIL+ L K+ADFGLA+ L + T R F + APE ALYG+
Sbjct: 123 YIHRDLRSANILVGDGLVCKIADFGLAR--LIEDNEYTARQGAKFPIKWTAPEAALYGRF 180
Query: 450 TEKSDVYSFGIVILELMSGRKV 471
T KSDV+SFGI++ EL++ +V
Sbjct: 181 TIKSDVWSFGILLTELVTKGRV 202
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 70/241 (29%), Positives = 109/241 (45%), Gaps = 32/241 (13%)
Query: 272 IGQGASGIVYKGTLRH---GNLVAVKQI--LDLDTKGDEDFTNEVEIISKIRHRNLLSLR 326
IG+G+ G V K +R G ++ K+I ++ K + +EV I+ +++H N++
Sbjct: 8 IGKGSFGTVRK--VRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYY 65
Query: 327 GCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHK-RKQLTWPQRKKIIVDVAKGIAYLH 385
+ D S + ++V +Y G L+ I K RK + +I+ + + H
Sbjct: 66 DRII---DRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECH 122
Query: 386 YGLKPG--IYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEY 443
PG + HRD+K NI LD+ N K+ DFGLAK L S GT Y++PE
Sbjct: 123 NRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAK-ILGHDSSFAKTYVGTPYYMSPEQ 181
Query: 444 ALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPF------QLITDWAWVLAKSGKVDD 497
+ EKSD++S G +I EL + PF QL + K GK
Sbjct: 182 LNHMSYDEKSDIWSLGCLIYELCALS-------PPFTARNQLQLAS-----KIKEGKFRR 229
Query: 498 I 498
I
Sbjct: 230 I 230
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 4e-25
Identities = 63/202 (31%), Positives = 111/202 (54%), Gaps = 10/202 (4%)
Query: 266 FSQNNLIGQGASGIVYKGTLRHGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSL 325
F+ +G G G V++G ++ VA+K + D +DF EV+ + ++RH++L+SL
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67
Query: 326 RGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLH 385
C S G+ +++ + M G+L + S + + L + VA+G+AYL
Sbjct: 68 FAVC-----SVGEPVYIITELMEKGSLLAFLR-SPEGQVLPVASLIDMACQVAEGMAYLE 121
Query: 386 YGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYAL 445
+ HRD+ + NIL+ +L KVADFGLA+ ++ +L++ + + APE A
Sbjct: 122 ---EQNSIHRDLAARNILVGEDLVCKVADFGLAR-LIKEDVYLSSDKKIPYKWTAPEAAS 177
Query: 446 YGQLTEKSDVYSFGIVILELMS 467
+G + KSDV+SFGI++ E+ +
Sbjct: 178 HGTFSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 4e-25
Identities = 67/232 (28%), Positives = 108/232 (46%), Gaps = 34/232 (14%)
Query: 268 QNNLIGQGASGIVYKG-TLRHGNLVAVKQI--LDLDTKGDEDFTNEVEIISKIRHRNLLS 324
+ N IG G G VY L G L+AVK+I D D K ++ +E++++ ++H NL+
Sbjct: 4 RGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVK 63
Query: 325 LRGCCVTSDDSSGKRRFLVYDYMP---NGTLSDNISISHKRKQLTWPQRKKIIVDVAKGI 381
G V + VY +M GTL + + + L + + + +G+
Sbjct: 64 YYGVEVHREK--------VYIFMEYCSGGTLEE---LLEHGRILDEHVIRVYTLQLLEGL 112
Query: 382 AYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFG---Y 438
AYLH GI HRDIK NI LD K+ DFG A + + + V G Y
Sbjct: 113 AYLH---SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAY 169
Query: 439 LAPEYALYGQLTEK---SDVYSFGIVILELMSGRKVLDTSTSPF-QLITDWA 486
+APE G+ +D++S G V+LE+ +G++ P+ +L ++
Sbjct: 170 MAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKR-------PWSELDNEFQ 214
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 6e-25
Identities = 73/202 (36%), Positives = 108/202 (53%), Gaps = 15/202 (7%)
Query: 272 IGQGASGIVYKGTLRHGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVT 331
+GQG G V+ GT VA+K L T E F E +I+ K+RH L+ L V
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKT-LKPGTMMPEAFLQEAQIMKKLRHDKLVPLYA--VV 70
Query: 332 SDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPG 391
S++ ++V ++M G+L D + K L PQ + +A G+AY+ +
Sbjct: 71 SEEPI----YIVTEFMGKGSLLDFLK-EGDGKYLKLPQLVDMAAQIADGMAYIE---RMN 122
Query: 392 IYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTF--GYLAPEYALYGQL 449
HRD+++ NIL+ L K+ADFGLA+ L + T R F + APE ALYG+
Sbjct: 123 YIHRDLRAANILVGDNLVCKIADFGLAR--LIEDNEYTARQGAKFPIKWTAPEAALYGRF 180
Query: 450 TEKSDVYSFGIVILELMSGRKV 471
T KSDV+SFGI++ EL++ +V
Sbjct: 181 TIKSDVWSFGILLTELVTKGRV 202
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 6e-25
Identities = 65/206 (31%), Positives = 103/206 (50%), Gaps = 18/206 (8%)
Query: 269 NNLIGQGASGIVYKGTLRHGN----LVAVKQILDLDTKGDE-DFTNEVEIISKIRHRNLL 323
+IG G G V +G L+ VA+K + + DF E I+ + H N++
Sbjct: 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNII 68
Query: 324 SLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAY 383
L G VT + ++ +YM NG+L D + + T Q ++ +A G+ Y
Sbjct: 69 RLEGV-VTK----SRPVMIITEYMENGSL-DKF-LRENDGKFTVGQLVGMLRGIASGMKY 121
Query: 384 LHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFG--YLAP 441
L + HRD+ + NIL++S L KV+DFGL+++ + + TT+ G + AP
Sbjct: 122 LS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTK-GGKIPIRWTAP 177
Query: 442 EYALYGQLTEKSDVYSFGIVILELMS 467
E Y + T SDV+SFGIV+ E+MS
Sbjct: 178 EAIAYRKFTSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 5e-24
Identities = 71/213 (33%), Positives = 113/213 (53%), Gaps = 27/213 (12%)
Query: 266 FSQNNLIGQGASGIVYKGT-LRHGNLVAVKQILDLDTKGDE--DFTNEVEIISKIRH--- 319
+ + LIG+GA G VY+G + G +VA+K I++LDT D+ D EV ++S++R
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALK-IINLDTPDDDVSDIQREVALLSQLRQSQP 61
Query: 320 RNLLSLRGCCVTSDDSSGKRRFLVYDYMPNG---TLSDNISISHKRKQLTWPQRKKIIVD 376
N+ G + G R +++ +Y G TL I+ K + II +
Sbjct: 62 PNITKYYGSYL-----KGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISV-------IIRE 109
Query: 377 VAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTF 436
V + Y+H K G+ HRDIK+ NIL+ + N K+ DFG+A + S +T V GT
Sbjct: 110 VLVALKYIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV-GTP 165
Query: 437 GYLAPEYALYGQLTE-KSDVYSFGIVILELMSG 468
++APE G+ + K+D++S GI I E+ +G
Sbjct: 166 YWMAPEVITEGKYYDTKADIWSLGITIYEMATG 198
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 6e-24
Identities = 60/211 (28%), Positives = 104/211 (49%), Gaps = 13/211 (6%)
Query: 266 FSQNNLIGQGASGIVYKGTLR-HGNLVAVKQI--LDLDTKGDEDFTNEVEIISKIRHRNL 322
F N IG+G+ G+V+K + + A+KQI ++ + E+ +E +++K+ +
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 323 LSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIA 382
+ + + +V +Y NG L + + R L Q + + + G+A
Sbjct: 62 IRYYESFL-----DKGKLNIVMEYAENGDLHKLLKMQRGRP-LPEDQVWRFFIQILLGLA 115
Query: 383 YLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPE 442
+LH I HRDIKS N+ LD+ N K+ D G+AK L +++ + GT YL+PE
Sbjct: 116 HLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAK-LLSDNTNFANTIVGTPYYLSPE 171
Query: 443 YALYGQLTEKSDVYSFGIVILELMSGRKVLD 473
EKSDV++ G+V+ E +G+ D
Sbjct: 172 LCEDKPYNEKSDVWALGVVLYECCTGKHPFD 202
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 1e-23
Identities = 64/218 (29%), Positives = 112/218 (51%), Gaps = 20/218 (9%)
Query: 272 IGQGASG--IVYKGTLRHGNLVAVKQI--LDLDTKGDEDFTNEVEIISKIRHRNLLSLRG 327
+G+GA G +Y+ T +LV K++ L K D NE+ I+S ++H N+++
Sbjct: 8 LGKGAFGEATLYRRT-EDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYN 66
Query: 328 CCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKI--IVDVAKGIAYLH 385
+ DD++ + +Y GTL D I ++K + + + + + ++Y+H
Sbjct: 67 HFM--DDNT---LLIEMEYANGGTLYDKIV---RQKGQLFEEEMVLWYLFQIVSAVSYIH 118
Query: 386 YGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYAL 445
K GI HRDIK+ NI L K+ DFG++K +S T V GT Y++PE
Sbjct: 119 ---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET-VVGTPYYMSPELCQ 174
Query: 446 YGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLIT 483
+ KSD+++ G V+ EL++ ++ D +T+P L+
Sbjct: 175 GVKYNFKSDIWALGCVLYELLTLKRTFD-ATNPLNLVV 211
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 99.8 bits (249), Expect = 1e-23
Identities = 63/204 (30%), Positives = 101/204 (49%), Gaps = 19/204 (9%)
Query: 272 IGQGASGIVYKGTLRHGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVT 331
+G G G+V+ G R VA+K I + ++DF E +++ K+ H NL+ L G C
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIRE-GAMSEDDFIEEAKVMMKLSHPNLVQLYGVCT- 69
Query: 332 SDDSSGKRR--FLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLK 389
K+R F+V +YM NG L + + + W + DV + + YL
Sbjct: 70 ------KQRPIFIVTEYMANGCLLNYLRERKGKLGTEW--LLDMCSDVCEAMEYLE---S 118
Query: 390 PGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTF--GYLAPEYALYG 447
G HRD+ + N L+ + KV+DFGLA+ L+ T+ F + PE Y
Sbjct: 119 NGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLD--DQYTSSQGTKFPVKWAPPEVFDYS 176
Query: 448 QLTEKSDVYSFGIVILELMSGRKV 471
+ + KSDV+SFG+++ E+ S K+
Sbjct: 177 RFSSKSDVWSFGVLMWEVFSEGKM 200
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 99.7 bits (249), Expect = 3e-23
Identities = 64/205 (31%), Positives = 100/205 (48%), Gaps = 21/205 (10%)
Query: 272 IGQGASGIVYKGTLRH-GNLVAVKQILDLDTKGDEDFTN----EVEIISKIRHRNLLSLR 326
IG+GA GIV+K R G VA+K++ + + N E++ + +H ++ L
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVAL--RRLEGGIPNQALREIKALQACQHPYVVKLL 65
Query: 327 GCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHY 386
V S LV +YMP LS+ + + + L Q K + + KG+AY+H
Sbjct: 66 D--VFPHGSG---FVLVMEYMP-SDLSE--VLRDEERPLPEAQVKSYMRMLLKGVAYMH- 116
Query: 387 GLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALY 446
GI HRD+K N+L+ ++ K+ADFGLA+ E L + T Y APE LY
Sbjct: 117 --ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPEL-LY 173
Query: 447 GQ--LTEKSDVYSFGIVILELMSGR 469
G D+++ G + EL++G
Sbjct: 174 GARKYDPGVDLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.8 bits (247), Expect = 5e-23
Identities = 68/206 (33%), Positives = 102/206 (49%), Gaps = 17/206 (8%)
Query: 266 FSQNNLIGQGASGIVYKGT-LRHGNLVAVKQILDLDTKGD--EDFTNEVEIISKIRHRNL 322
F+ IG+G+ G VYK R +VA+K I DL+ D ED E++ +S+ R +
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVI-DLEEAEDEIEDIQQEIQFLSQCRSPYI 61
Query: 323 LSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIA 382
G + S +++ +Y G+ D + K +L I+ +V G+
Sbjct: 62 TKYYGSFL--KGSK---LWIIMEYCGGGSCLDLL----KPGKLDETYIAFILREVLLGLE 112
Query: 383 YLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPE 442
YLH + G HRDIK+ NILL E + K+ADFG++ Q S T V GT ++APE
Sbjct: 113 YLH---EEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV-GTPFWMAPE 168
Query: 443 YALYGQLTEKSDVYSFGIVILELMSG 468
EK+D++S GI +EL G
Sbjct: 169 VIKQSGYDEKADIWSLGITAIELAKG 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.2 bits (245), Expect = 8e-23
Identities = 60/205 (29%), Positives = 101/205 (49%), Gaps = 22/205 (10%)
Query: 272 IGQGASGIVYKG-TLRHGNLVAVKQI-LDLDTKGDEDFT-NEVEIISKIRHRNLLSLRGC 328
IG+G G+VYK G +VA+K+I L +++G E++++ ++ H N++ L
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 329 CVTSDDSSGKRRFLVYDYMPNGTLSDNIS--ISHKRKQLTWPQRKKIIVDVAKGIAYLHY 386
D LV+++M ++ I +++ L K + + +G+A+ H
Sbjct: 67 FRHKGDLY-----LVFEFM-----DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH- 115
Query: 387 GLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALY 446
GI HRD+K N+L+++E K+ADFGLA+ T V T Y APE L
Sbjct: 116 --SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVV-TRWYRAPE-LLL 171
Query: 447 G--QLTEKSDVYSFGIVILELMSGR 469
G + D++S G + EL+S R
Sbjct: 172 GDKGYSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 1e-22
Identities = 67/200 (33%), Positives = 103/200 (51%), Gaps = 27/200 (13%)
Query: 288 GNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRF-LVYDY 346
G +VAVK++ + DF E+EI+ ++H N++ +G C S+G+R LV +Y
Sbjct: 33 GEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCY----SAGRRNLRLVMEY 88
Query: 347 MPNGTLSDNIS-----ISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTN 401
+P G+L D + + H++ L Q + KG+ YL G K + HRD+ + N
Sbjct: 89 LPYGSLRDYLQKHRERLDHRKLLLYASQ-------ICKGMEYL--GSKRYV-HRDLATRN 138
Query: 402 ILLDSELNAKVADFGLAKQSLEGHSHLTTRVAG---TFGYLAPEYALYGQLTEKSDVYSF 458
IL++SE K+ DFGL K + + R G F Y APE + + SDV+SF
Sbjct: 139 ILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWY-APESLTESKFSVASDVWSF 197
Query: 459 GIVILELMSGRKVLDTSTSP 478
G+V+ EL + D S SP
Sbjct: 198 GVVLYELFT---YSDKSCSP 214
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 97.5 bits (243), Expect = 1e-22
Identities = 62/214 (28%), Positives = 104/214 (48%), Gaps = 33/214 (15%)
Query: 272 IGQGASGIVYKGTLRHGN-----LVAVKQILD-LDTKGDEDFTNEVEIISKIRHRNLLSL 325
+G GA G VYKG VA+K + + K +++ +E +++ + H +++ L
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 326 RGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHK-----RKQLTWPQRKKIIVDVAKG 380
G C++S + L+ MP G L D + +HK + L W V +AKG
Sbjct: 75 LGICLSS------QVQLITQLMPLGCLLDYVR-NHKDNIGSQYLLNWC------VQIAKG 121
Query: 381 IAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAG---TFG 437
++YL + + HRD+ + N+L+ + + K+ DFGLAK G
Sbjct: 122 MSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEY--HAEGGKVPIK 176
Query: 438 YLAPEYALYGQLTEKSDVYSFGIVILELMS-GRK 470
++A E L+ T KSDV+S+G+ + ELM+ G K
Sbjct: 177 WMALESILHRIYTHKSDVWSYGVTVWELMTFGAK 210
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 97.5 bits (243), Expect = 2e-22
Identities = 63/222 (28%), Positives = 107/222 (48%), Gaps = 39/222 (17%)
Query: 272 IGQGASGIVYKGTL------RHGNLVAVKQILD-LDTKGDEDFTNEVEIISKIRHRNLLS 324
+G+GA G VYKG L VA+K + + + K ++F E E++S ++H N++
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 325 LRGCCVTSDDSSGKRRFLVYDYMPNGTL----------SDNISISHKR---KQLTWPQRK 371
L G C + ++++Y+ +G L SD + S L
Sbjct: 73 LLGVCTKEQPTC-----MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFL 127
Query: 372 KIIVDVAKGIAYL--HYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLT 429
I + +A G+ YL H+ HRD+ + N L+ L K++DFGL++ + +S
Sbjct: 128 HIAIQIAAGMEYLSSHH-----FVHRDLAARNCLVGEGLTVKISDFGLSR---DIYSADY 179
Query: 430 TRVAGT----FGYLAPEYALYGQLTEKSDVYSFGIVILELMS 467
RV ++ PE LYG+ T +SD++SFG+V+ E+ S
Sbjct: 180 YRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 3e-22
Identities = 65/206 (31%), Positives = 98/206 (47%), Gaps = 24/206 (11%)
Query: 271 LIGQGASGIVYKGTLRHGNLVAVKQILDLDTKGD-EDFTNEVEIISKIRHRNLLSLRGCC 329
IG+G G VYKG L+ VAVK F E EI+ + H N++ L G C
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 330 VTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRK---QLTWPQRKKIIVDVAKGIAYLHY 386
V ++V + +P G+L ++ RK +LT + ++ +D A G+ YL
Sbjct: 62 VQKQPI-----YIVMELVPGGSL-----LTFLRKKKNRLTVKKLLQMSLDAAAGMEYLES 111
Query: 387 GLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGT----FGYLAPE 442
K I HRD+ + N L+ K++DFG+ S E + T G + APE
Sbjct: 112 --KNCI-HRDLAARNCLVGENNVLKISDFGM---SREEEGGIYTVSDGLKQIPIKWTAPE 165
Query: 443 YALYGQLTEKSDVYSFGIVILELMSG 468
YG+ T +SDV+S+GI++ E S
Sbjct: 166 ALNYGRYTSESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.4 bits (241), Expect = 4e-22
Identities = 58/214 (27%), Positives = 104/214 (48%), Gaps = 28/214 (13%)
Query: 266 FSQNNLIGQGASGIVYKGT-LRHGNLVAVKQI-LDLDTKGDEDFT----NEVEIISKIRH 319
+ + +G+G G+VYK + G +VA+K+I LD +E E+ ++ +++H
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLD---NEEEGIPSTALREISLLKELKH 57
Query: 320 RNLLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNIS--ISHKRKQLTWPQRKKIIVDV 377
N++ L T ++ +LV++Y ++ + + L+ K I+ +
Sbjct: 58 PNIVKLLDVIHTE-----RKLYLVFEYCDM-----DLKKYLDKRPGPLSPNLIKSIMYQL 107
Query: 378 AKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFG 437
+G+AY H I HRD+K NIL++ + K+ADFGLA+ T V T
Sbjct: 108 LRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV-TLW 163
Query: 438 YLAPEYALYGQLTEKS--DVYSFGIVILELMSGR 469
Y APE L G + D++S G + E+++G+
Sbjct: 164 YRAPE-ILLGSKHYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 4e-22
Identities = 76/277 (27%), Positives = 126/277 (45%), Gaps = 38/277 (13%)
Query: 271 LIGQGASGIVYKG-TLRHGNLVAVKQ--ILDLDTKGDE---DFTNEVEIISKIRHRNLLS 324
L+G G+ G VY+G L G+ AVK+ + D G E E+ ++SK++H N++
Sbjct: 7 LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66
Query: 325 LRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYL 384
G T + FL + +P G+L+ + K P + + G+ YL
Sbjct: 67 YLG---TEREEDNLYIFL--ELVPGGSLA---KLLKKYGSFPEPVIRLYTRQILLGLEYL 118
Query: 385 HYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYA 444
H HRDIK NIL+D+ K+ADFG+AKQ +E G+ ++APE
Sbjct: 119 H---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVE--FSFAKSFKGSPYWMAPEVI 173
Query: 445 L-YGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWA--WVLAKSGKVDDIFDE 501
G +D++S G +LE+ +G+ P+ + A + + +S ++ I D
Sbjct: 174 AQQGGYGLAADIWSLGCTVLEMATGK-------PPWSQLEGVAAVFKIGRSKELPPIPDH 226
Query: 502 FIRAEGARAVMERFVLVGILCAHVMVALRPTITDALK 538
+ E + F+L C +LRPT + L+
Sbjct: 227 -LSDEA-----KDFIL---KCLQRDPSLRPTAAELLE 254
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 95.9 bits (239), Expect = 4e-22
Identities = 66/206 (32%), Positives = 102/206 (49%), Gaps = 18/206 (8%)
Query: 272 IGQGASGIVYKG-TLRHGNLVAVKQILDLDTKGD--EDFTNEVEIISKIRHRNLLSLRGC 328
IG GA+ +VY L + VA+K+I DL+ ++ EV+ +S+ H N++
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRI-DLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTS 67
Query: 329 CVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGL 388
V G +LV Y+ G+L D + S+ R L ++ +V KG+ YLH
Sbjct: 68 FVV-----GDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH--- 119
Query: 389 KPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEG----HSHLTTRVAGTFGYLAPEYA 444
G HRDIK+ NILL + + K+ADFG++ +G T GT ++APE
Sbjct: 120 SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKT-FVGTPCWMAPEVM 178
Query: 445 LYGQ-LTEKSDVYSFGIVILELMSGR 469
K+D++SFGI +EL +G
Sbjct: 179 EQVHGYDFKADIWSFGITAIELATGA 204
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 95.0 bits (236), Expect = 6e-22
Identities = 58/200 (29%), Positives = 99/200 (49%), Gaps = 11/200 (5%)
Query: 272 IGQGASGIVYKGTLRHGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVT 331
IG G G+V+ G VA+K I + +EDF E +++ K+ H L+ L G C
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIRE-GAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTE 70
Query: 332 SDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPG 391
LV+++M +G LSD + +R + + + +DV +G+AYL
Sbjct: 71 RSPI-----CLVFEFMEHGCLSD--YLRAQRGKFSQETLLGMCLDVCEGMAYLE---SSN 120
Query: 392 IYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALYGQLTE 451
+ HRD+ + N L+ KV+DFG+ + L+ +T + +PE + + +
Sbjct: 121 VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSS 180
Query: 452 KSDVYSFGIVILELMSGRKV 471
KSDV+SFG+++ E+ S K
Sbjct: 181 KSDVWSFGVLMWEVFSEGKT 200
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 94.7 bits (236), Expect = 8e-22
Identities = 61/213 (28%), Positives = 98/213 (46%), Gaps = 23/213 (10%)
Query: 265 GFSQNNLIGQGASGIVYKGTLRHGNLV-AVKQIL--DLDTKGD-EDFTNEVEIISKIRHR 320
F +IG+GA G V R + A+K + KG + NE I+ ++ H
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 321 NLLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKG 380
L++L ++ +LV D + G L ++S ++ + + Q K I ++
Sbjct: 61 FLVNLWYSFQDEENM-----YLVVDLLLGGDLRYHLS---QKVKFSEEQVKFWICEIVLA 112
Query: 381 IAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLA 440
+ YLH GI HRDIK NILLD + + + DF +A + + LTT +GT GY+A
Sbjct: 113 LEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATK-VTP-DTLTTSTSGTPGYMA 167
Query: 441 PE---YALYGQLTEKSDVYSFGIVILELMSGRK 470
PE Y D +S G+ E + G++
Sbjct: 168 PEVLCRQGYSVA---VDWWSLGVTAYECLRGKR 197
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 96.1 bits (240), Expect = 9e-22
Identities = 69/260 (26%), Positives = 115/260 (44%), Gaps = 33/260 (12%)
Query: 270 NLIGQGASGIVYKGT-LRHGNLVAVKQILDLDTKGDEDFTN------EVEIISKIRHRNL 322
IG GA G+V R G VA+K+I ++ +D + E++++ +RH N+
Sbjct: 6 KPIGSGAYGVVCSAVDKRTGRKVAIKKISNVF----DDLIDAKRILREIKLLRHLRHENI 61
Query: 323 LSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIA 382
+ L ++V + M +D + + LT + + + +G+
Sbjct: 62 IGLLDILRPPSPEDFNDVYIVTELME----TDLHKVIKSPQPLTDDHIQYFLYQILRGLK 117
Query: 383 YLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQ---SLEGHSHLTTRVAGTFGYL 439
YLH + HRD+K +NIL++S + K+ DFGLA+ + LT V T Y
Sbjct: 118 YLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVV-TRWYR 173
Query: 440 APEYAL-YGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPF---QLITDWAWVLAKSGKV 495
APE L + T+ D++S G + EL+ RK L LI + VL G
Sbjct: 174 APELLLSSSRYTKAIDIWSVGCIFAELL-TRKPLFPGRDYIDQLNLIVE---VL---GTP 226
Query: 496 DDIFDEFIRAEGARAVMERF 515
+ +FI +E AR ++
Sbjct: 227 SEEDLKFITSEKARNYLKSL 246
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 95.8 bits (239), Expect = 9e-22
Identities = 72/230 (31%), Positives = 112/230 (48%), Gaps = 29/230 (12%)
Query: 272 IGQGASGIVYKG-TLRHGNLVAVKQILDLDTKGDEDFT--NEVEIISKIRHRNLLSLRGC 328
+G+G G VYK ++ G +VA+K+IL + K T E++I+ K++H N++ L
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDM 75
Query: 329 CVTSDDSSGKRRFLVYDYMP------NGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIA 382
V D S ++R VY P +G L + +LT Q K ++ + +GI
Sbjct: 76 AVERPDKSKRKRGSVYMVTPYMDHDLSGLLENP------SVKLTESQIKCYMLQLLEGIN 129
Query: 383 YLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLA------KQSLEGHSHLTTR----V 432
YLH + I HRDIK+ NIL+D++ K+ADFGLA + +G TR +
Sbjct: 130 YLH---ENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNL 186
Query: 433 AGTFGYLAPEYAL-YGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQL 481
T Y PE L + T D++ G V E+ + R +L + QL
Sbjct: 187 VVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQL 236
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 95.3 bits (238), Expect = 1e-21
Identities = 61/211 (28%), Positives = 102/211 (48%), Gaps = 27/211 (12%)
Query: 270 NLIGQGASGIVYKGTLRH-GNLVAVKQILDLDTKGDEDFTN-----EVEIISKIRHRNLL 323
+G+G +VYK + G +VA+K+I + K +D N E++++ +++H N++
Sbjct: 6 KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNII 65
Query: 324 SLRGCCVTSDDSSGKRRF--LVYDYMPNGTLSD-NISISHKRKQLTWPQRKKIIVDVAKG 380
L D G + LV+++M +D I K LT K ++ +G
Sbjct: 66 GLL-------DVFGHKSNINLVFEFME----TDLEKVIKDKSIVLTPADIKSYMLMTLRG 114
Query: 381 IAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLA 440
+ YLH I HRD+K N+L+ S+ K+ADFGLA+ + +T +V T Y A
Sbjct: 115 LEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV-TRWYRA 170
Query: 441 PEYALYG--QLTEKSDVYSFGIVILELMSGR 469
PE L+G D++S G + EL+
Sbjct: 171 PEL-LFGARHYGVGVDMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 1e-21
Identities = 60/214 (28%), Positives = 106/214 (49%), Gaps = 25/214 (11%)
Query: 271 LIGQGASGIVYKG-TLRHGNLVAVKQILDLDTKGDED----------FTNEVEIISKIRH 319
LIG+G G VY + G ++AVKQ+ T +E+E + + H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 320 RNLLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAK 379
N++ G T + S + +Y+P G++ S + + V +
Sbjct: 68 LNIVQYLGFETTEEYLS-----IFLEYVPGGSIG---SCLRTYGRFEEQLVRFFTEQVLE 119
Query: 380 GIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHL-TTRVAGTFGY 438
G+AYLH GI HRD+K+ N+L+D++ K++DFG++K+S + + + + G+ +
Sbjct: 120 GLAYLH---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFW 176
Query: 439 LAPEY-ALYGQ-LTEKSDVYSFGIVILELMSGRK 470
+APE Y Q + K D++S G V+LE+ +GR+
Sbjct: 177 MAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 92.6 bits (230), Expect = 4e-21
Identities = 60/198 (30%), Positives = 102/198 (51%), Gaps = 15/198 (7%)
Query: 272 IGQGASGIVYKGTLRHGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVT 331
+G G G+V G R VA+K I + + +++F E +++ K+ H L+ L G C
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKE-GSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTK 70
Query: 332 SDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPG 391
+ ++V +YM NG L + + K+ Q ++ DV +G+AYL
Sbjct: 71 Q-----RPIYIVTEYMSNGCLLN--YLREHGKRFQPSQLLEMCKDVCEGMAYLE---SKQ 120
Query: 392 IYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTF--GYLAPEYALYGQL 449
HRD+ + N L+D + KV+DFGL++ L+ T+ V F + PE LY +
Sbjct: 121 FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLD--DEYTSSVGSKFPVRWSPPEVLLYSKF 178
Query: 450 TEKSDVYSFGIVILELMS 467
+ KSDV++FG+++ E+ S
Sbjct: 179 SSKSDVWAFGVLMWEVYS 196
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 5e-21
Identities = 69/216 (31%), Positives = 101/216 (46%), Gaps = 29/216 (13%)
Query: 270 NLIGQGASGIVYKGTLRHGNL------VAVKQILDLDTKGDE-DFTNEVEIISKIRHRNL 322
+G GA G VY+G R + VAVK + + ++ DE DF E I+SK H+N+
Sbjct: 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71
Query: 323 LSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRK----QLTWPQRKKIIVDVA 378
+ L G RF++ + M G L + + R LT DVA
Sbjct: 72 VRLIGVSFERLP-----RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVA 126
Query: 379 KGIAYLHYGLKPGIYHRDIKSTNILLDSE---LNAKVADFGLAKQSLEGHSHLTTRVAGT 435
KG YL + HRDI + N LL + AK+ADFG+A+ + S+ R G
Sbjct: 127 KGCKYLE---ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARD-IYRASYY--RKGGR 180
Query: 436 ----FGYLAPEYALYGQLTEKSDVYSFGIVILELMS 467
++ PE L G T K+DV+SFG+++ E+ S
Sbjct: 181 AMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 93.0 bits (232), Expect = 5e-21
Identities = 58/225 (25%), Positives = 97/225 (43%), Gaps = 39/225 (17%)
Query: 271 LIGQGASGIVYKGTLRHGNL-VAVKQILD---LDTKGDEDF-TNEVEIISKI-RHRNLLS 324
+IG+G+ V + N A+K ILD L + + E E+++++ H ++
Sbjct: 8 IIGEGSFSTVVLAKEKETNKEYAIK-ILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIK 66
Query: 325 LRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYL 384
L T D + V +Y PNG L I K L + ++ + YL
Sbjct: 67 LYY---TFQDEE--NLYFVLEYAPNGELLQYI---RKYGSLDEKCTRFYAAEILLALEYL 118
Query: 385 HYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAK--------------------QSLEG 424
H GI HRD+K NILLD +++ K+ DFG AK Q +
Sbjct: 119 H---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKN 175
Query: 425 HSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGR 469
+ V GT Y++PE + SD+++ G +I ++++G+
Sbjct: 176 RRRFASFV-GTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.2 bits (232), Expect = 5e-21
Identities = 63/211 (29%), Positives = 100/211 (47%), Gaps = 31/211 (14%)
Query: 271 LIGQGASGIVYKGTLRH---GNLVAVKQILDLDTKGDEDFTN----EVEIISKIRHRNLL 323
++G+GA G+V K R+ G +VA+K+ + + DED EV+++ ++RH N++
Sbjct: 8 VVGEGAYGVVLK--CRNKATGEIVAIKKFKESED--DEDVKKTALREVKVLRQLRHENIV 63
Query: 324 SLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAY 383
+L+ R +LV++Y+ L + L + I + + IAY
Sbjct: 64 NLKEAF-----RRKGRLYLVFEYVERTLLEL---LEASPGGLPPDAVRSYIWQLLQAIAY 115
Query: 384 LHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQ-SLEGHSHLTTRVAGTFGYLAPE 442
H I HRDIK NIL+ K+ DFG A+ S LT VA T Y APE
Sbjct: 116 CH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVA-TRWYRAPE 171
Query: 443 YAL----YGQLTEKSDVYSFGIVILELMSGR 469
+ YG+ DV++ G ++ EL+ G
Sbjct: 172 LLVGDTNYGK---PVDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 92.3 bits (229), Expect = 7e-21
Identities = 66/216 (30%), Positives = 111/216 (51%), Gaps = 24/216 (11%)
Query: 266 FSQNNLIGQGASGIVYKGTLRHGNLVAVKQILDLDT-------KGDEDFTNEVEIISKIR 318
+++ ++G+GA G VY G G L+AVKQ+ +LDT K E EV+++ ++
Sbjct: 2 WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQV-ELDTSNVLAAEKEYEKLQEEVDLLKSLK 60
Query: 319 HRNLLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVA 378
H N++ G C+ + S + +++P G++S SI ++ L P K +
Sbjct: 61 HVNIVQYLGTCLDDNTIS-----IFMEFVPGGSIS---SILNRFGPLPEPVFCKYTKQIL 112
Query: 379 KGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQ----SLEG-HSHLTTRVA 433
G+AYLH + HRDIK N++L K+ DFG A++ L G HS++ +
Sbjct: 113 DGVAYLH---NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMH 169
Query: 434 GTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGR 469
GT ++APE KSD++S G + E+ +G+
Sbjct: 170 GTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGK 205
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 92.3 bits (229), Expect = 9e-21
Identities = 61/195 (31%), Positives = 98/195 (50%), Gaps = 18/195 (9%)
Query: 288 GNLVAVKQI-LDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFLVYDY 346
G +VAVK + + + + E+ I+ + H N++ +GCC + GK L+ +Y
Sbjct: 33 GEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCC---SEQGGKGLQLIMEY 89
Query: 347 MPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDS 406
+P G+L D + + +L Q + +G+AYLH HRD+ + N+LLD+
Sbjct: 90 VPLGSLRDYLP----KHKLNLAQLLLFAQQICEGMAYLH---SQHYIHRDLAARNVLLDN 142
Query: 407 ELNAKVADFGLAKQSLEGHSHLTTRVAG---TFGYLAPEYALYGQLTEKSDVYSFGIVIL 463
+ K+ DFGLAK EGH + R G F Y A E + + SDV+SFG+ +
Sbjct: 143 DRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-AVECLKENKFSYASDVWSFGVTLY 201
Query: 464 ELMSGRKVLDTSTSP 478
EL++ D+ SP
Sbjct: 202 ELLTH---CDSKQSP 213
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 1e-20
Identities = 73/239 (30%), Positives = 119/239 (49%), Gaps = 32/239 (13%)
Query: 234 HEQFVSNLQASVLPNSGAKWFHVSELEQATNGFSQNNLIGQGASGIVYKGTLRH-GNLVA 292
HEQF + LQ V P N F + IG+G++GIV T + G VA
Sbjct: 1 HEQFRAALQLVVDPGD--------PRSYLDN-FVK---IGEGSTGIVCIATDKSTGRQVA 48
Query: 293 VKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFLVYDYMPNGTL 352
VK++ + E NEV I+ +H N++ + + D+ ++V +++ G L
Sbjct: 49 VKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDE-----LWVVMEFLEGGAL 103
Query: 353 SDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKV 412
+D ++H R + Q + + V K +++LH G+ HRDIKS +ILL S+ K+
Sbjct: 104 TD--IVTHTR--MNEEQIATVCLAVLKALSFLH---AQGVIHRDIKSDSILLTSDGRVKL 156
Query: 413 ADFGLAKQSLEGHSHLTTRVAGTFGYLAPEY---ALYGQLTEKSDVYSFGIVILELMSG 468
+DFG Q + + V GT ++APE YG TE D++S GI+++E++ G
Sbjct: 157 SDFGFCAQVSKEVPRRKSLV-GTPYWMAPEVISRLPYG--TE-VDIWSLGIMVIEMVDG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 1e-20
Identities = 65/215 (30%), Positives = 106/215 (49%), Gaps = 25/215 (11%)
Query: 264 NGFSQNNLIGQGASGIVYKG-TLRHGNLVAVKQI----LDLDTKGD-EDFTNEVEIISKI 317
+ + L+GQGA G VY + G +AVKQ+ +TK + E++++ +
Sbjct: 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL 61
Query: 318 RHRNLLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDV 377
+H ++ GC DD + + +YMP G++ D + LT +K +
Sbjct: 62 QHERIVQYYGC--LRDDET---LSIFMEYMPGGSVKDQLK---AYGALTETVTRKYTRQI 113
Query: 378 AKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLT--TRVAGT 435
+G+ YLH + I HRDIK NIL DS N K+ DFG +K+ S T V GT
Sbjct: 114 LEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGT 170
Query: 436 FGYLAPEYAL---YGQLTEKSDVYSFGIVILELMS 467
+++PE YG+ K+DV+S G ++E+++
Sbjct: 171 PYWMSPEVISGEGYGR---KADVWSVGCTVVEMLT 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 90.7 bits (225), Expect = 2e-20
Identities = 64/201 (31%), Positives = 103/201 (51%), Gaps = 16/201 (7%)
Query: 272 IGQGASGIVYKGTLRHGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVT 331
+G G G V+ G VA+K L + E F E ++ +++H L+ L VT
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKS-LKQGSMSPEAFLAEANLMKQLQHPRLVRLYAV-VT 71
Query: 332 SDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPG 391
+ +++ +YM NG+L D + K LT + + +A+G+A++ +
Sbjct: 72 QEPI-----YIITEYMENGSLVDFLKTPEGIK-LTINKLIDMAAQIAEGMAFIE---RKN 122
Query: 392 IYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTF--GYLAPEYALYGQL 449
HRD+++ NIL+ L K+ADFGLA+ L + T R F + APE YG
Sbjct: 123 YIHRDLRAANILVSETLCCKIADFGLAR--LIEDNEYTAREGAKFPIKWTAPEAINYGTF 180
Query: 450 TEKSDVYSFGIVILELMS-GR 469
T KSDV+SFGI++ E+++ GR
Sbjct: 181 TIKSDVWSFGILLTEIVTYGR 201
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 3e-20
Identities = 72/214 (33%), Positives = 104/214 (48%), Gaps = 33/214 (15%)
Query: 270 NLIGQGASGIVYKGTL-------RHGNLVAVKQILDL-DTKGDEDFTNEVEIISKIRHRN 321
+IG+G G VY GTL H AVK + + D + E F E I+ H N
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIH---CAVKSLNRITDLEEVEQFLKEGIIMKDFSHPN 57
Query: 322 LLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKII---VDVA 378
+LSL G C+ S+ S +V YM +G L + I R + P K +I + VA
Sbjct: 58 VLSLLGICLPSEGSP----LVVLPYMKHGDLRNFI-----RSETHNPTVKDLIGFGLQVA 108
Query: 379 KGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEG-----HSHLTTRVA 433
KG+ YL HRD+ + N +LD KVADFGLA+ + H+H ++
Sbjct: 109 KGMEYL---ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLP 165
Query: 434 GTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS 467
++A E + T KSDV+SFG+++ ELM+
Sbjct: 166 --VKWMALESLQTQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.0 bits (224), Expect = 5e-20
Identities = 68/222 (30%), Positives = 105/222 (47%), Gaps = 20/222 (9%)
Query: 259 LEQATNGFSQNNLIGQGASGIVYKGTLRH-GNLVAVKQILDLDTKGDEDFTNEVEIISKI 317
L T F +IG+G G VYK + G LVA+K I+D+ +E+ E I+ K
Sbjct: 1 LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIK-IMDIIEDEEEEIKEEYNILRKY 59
Query: 318 -RHRNLLSLRGCCVTSDDSS-GKRRFLVYDYMPNGTLSDNISISHKR-KQLTWPQRKKII 374
H N+ + G + + + +LV + G+++D + K+ K+L I+
Sbjct: 60 SNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYIL 119
Query: 375 VDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAG 434
+ +G+AYLH + + HRDIK NILL K+ DFG++ Q L+ G
Sbjct: 120 RETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQ-LDSTLGRRNTFIG 175
Query: 435 TFGYLAPEY--------ALYGQLTEKSDVYSFGIVILELMSG 468
T ++APE A Y +SDV+S GI +EL G
Sbjct: 176 TPYWMAPEVIACDEQPDASYDA---RSDVWSLGITAIELADG 214
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 5e-20
Identities = 62/230 (26%), Positives = 107/230 (46%), Gaps = 32/230 (13%)
Query: 289 NLVAVKQIL-DLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFLVYDYM 347
LVAVK + D+ DF E++I+S++++ N++ L G CV+ D ++ +YM
Sbjct: 45 VLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLC-----MITEYM 99
Query: 348 PNGTLSDNISISHKRKQLTWPQRKKII---------VDVAKGIAYLHYGLKPGIYHRDIK 398
NG L+ +S T + V +A G+ YL HRD+
Sbjct: 100 ENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLA 156
Query: 399 STNILLDSELNAKVADFGLAKQSLEG-HSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYS 457
+ N L+ + K+ADFG+++ G + + R ++A E L G+ T SDV++
Sbjct: 157 TRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWA 216
Query: 458 FGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDEFIRAEG 507
FG+ + E+ + K P+ L++D V+ +G EF R +G
Sbjct: 217 FGVTLWEMFTLCK-----EQPYSLLSD-EQVIENTG-------EFFRNQG 253
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 5e-20
Identities = 65/202 (32%), Positives = 103/202 (50%), Gaps = 24/202 (11%)
Query: 272 IGQGASGIVYKGTLRHGNLVAVKQILDLDTKGD---EDFTNEVEIISKIRHRNLLSLRGC 328
IG+G G V +G G VAVK I K D + F E +++K+ H+NL+ L G
Sbjct: 14 IGEGEFGAVLQGEYT-GQKVAVKNI-----KCDVTAQAFLEETAVMTKLHHKNLVRLLGV 67
Query: 329 CVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGL 388
+ + ++V + M G L N + R ++ Q + +DVA+G+ YL
Sbjct: 68 ILHNG------LYIVMELMSKGNLV-NFLRTRGRALVSVIQLLQFSLDVAEGMEYLE--- 117
Query: 389 KPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALYGQ 448
+ HRD+ + NIL+ + AKV+DFGLA+ G + V T APE + +
Sbjct: 118 SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVKWT----APEALKHKK 173
Query: 449 LTEKSDVYSFGIVILELMS-GR 469
+ KSDV+S+G+++ E+ S GR
Sbjct: 174 FSSKSDVWSYGVLLWEVFSYGR 195
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.7 bits (223), Expect = 6e-20
Identities = 69/208 (33%), Positives = 98/208 (47%), Gaps = 35/208 (16%)
Query: 272 IGQGASGIVYKGTLRH-GNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCV 330
IG G G VYK G LVA+K I E E+ ++ + RH N+++ G
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFG--- 67
Query: 331 TSDDSSGKRR---FLVYDYMPNGTLSDNISISHK-RKQLTWPQRKKIIVDVAKGIAYLHY 386
S RR ++V +Y G+L D I R L+ Q + + KG+AYLH
Sbjct: 68 -----SYLRRDKLWIVMEYCGGGSLQD---IYQVTRGPLSELQIAYVCRETLKGLAYLH- 118
Query: 387 GLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVA------GTFGYLA 440
+ G HRDIK NILL + + K+ADFG++ Q LT +A GT ++A
Sbjct: 119 --ETGKIHRDIKGANILLTEDGDVKLADFGVSAQ-------LTATIAKRKSFIGTPYWMA 169
Query: 441 PEYA---LYGQLTEKSDVYSFGIVILEL 465
PE A G K D+++ GI +EL
Sbjct: 170 PEVAAVERKGGYDGKCDIWALGITAIEL 197
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 6e-20
Identities = 67/216 (31%), Positives = 105/216 (48%), Gaps = 19/216 (8%)
Query: 260 EQATNGFSQNNLIGQGASGIVYKGTL----RHGNLVAVKQILDLDT-KGDEDFTNEVEII 314
E + ++ +IG G G V++G L R VA+K + T K +DF +E I+
Sbjct: 1 EIHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIM 60
Query: 315 SKIRHRNLLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKII 374
+ H N++ L G + K ++ +YM NG L + + + Q ++
Sbjct: 61 GQFSHHNIIRLEGVV-----TKFKPAMIITEYMENGALDK--YLRDHDGEFSSYQLVGML 113
Query: 375 VDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAG 434
+A G+ YL HRD+ + NIL++S L KV+DFGL++ LE T +G
Sbjct: 114 RGIAAGMKYLS---DMNYVHRDLAARNILVNSNLECKVSDFGLSR-VLEDDPEGTYTTSG 169
Query: 435 ---TFGYLAPEYALYGQLTEKSDVYSFGIVILELMS 467
+ APE Y + T SDV+SFGIV+ E+MS
Sbjct: 170 GKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMS 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 8e-20
Identities = 61/215 (28%), Positives = 110/215 (51%), Gaps = 28/215 (13%)
Query: 271 LIGQGASGIVYKG-TLRHGNLVAVKQIL--DLDTKGD-------EDFTNEVEIISKIRHR 320
LIG G+ G VY G G L+AVKQ+ + + E+ ++ +++H
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 321 NLLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKG 380
N++ G S D+ FL +Y+P G+++ ++ + + + + KG
Sbjct: 67 NIVQYLGS---SLDADHLNIFL--EYVPGGSVA---ALLNNYGAFEETLVRNFVRQILKG 118
Query: 381 IAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTR------VAG 434
+ YLH GI HRDIK NIL+D++ K++DFG++K+ LE +S T + G
Sbjct: 119 LNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISKK-LEANSLSTKTNGARPSLQG 174
Query: 435 TFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGR 469
+ ++APE T K+D++S G +++E+++G+
Sbjct: 175 SVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 1e-19
Identities = 65/199 (32%), Positives = 104/199 (52%), Gaps = 13/199 (6%)
Query: 271 LIGQGASGIVYKGTLRHGNLVAVKQIL-DLDTKGDEDFTNEVEIISKIRHRNLLSLRGCC 329
L+G+G G V+KGTL+ VAVK DL + F +E I+ + H N++ L G C
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 330 VTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRK-QLTWPQRKKIIVDVAKGIAYLHYGL 388
+ + ++V + +P G D +S K+K +L Q K +D A G+AYL
Sbjct: 62 -----TQRQPIYIVMELVPGG---DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLE--S 111
Query: 389 KPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALYGQ 448
K I HRD+ + N L+ K++DFG+++Q +G + + APE YG+
Sbjct: 112 KNCI-HRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGR 170
Query: 449 LTEKSDVYSFGIVILELMS 467
+ +SDV+S+GI++ E S
Sbjct: 171 YSSESDVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 90.1 bits (224), Expect = 1e-19
Identities = 68/222 (30%), Positives = 96/222 (43%), Gaps = 41/222 (18%)
Query: 272 IGQGASGIV----YKGTLRHGNLVAVKQILDLDTKGDEDFTNEVE----------IISKI 317
+G+G G V YK T G L A+K + KGD +EVE +
Sbjct: 7 LGRGHFGKVLLAEYKKT---GELYAIKAL----KKGDIIARDEVESLMCEKRIFETANSE 59
Query: 318 RHRNLLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDV 377
RH L++L C T D V +Y G L +I + P+ V
Sbjct: 60 RHPFLVNLFACFQTED-----HVCFVMEYAAGGDLMMHI----HTDVFSEPRAVFYAACV 110
Query: 378 AKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFG 437
G+ YLH + I +RD+K N+LLD+E K+ADFGL K+ + G T+ GT
Sbjct: 111 VLGLQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGM-GFGDRTSTFCGTPE 166
Query: 438 YLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPF 479
+LAPE T D + G++I E++ G SPF
Sbjct: 167 FLAPEVLTETSYTRAVDWWGLGVLIYEMLVGE-------SPF 201
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 2e-19
Identities = 69/201 (34%), Positives = 104/201 (51%), Gaps = 20/201 (9%)
Query: 272 IGQGASGIVYKGTLRHGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVT 331
IG+G G V G R GN VAVK I + T + F E +++++RH NL+ L G V
Sbjct: 14 IGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIV- 69
Query: 332 SDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPG 391
++ G ++V +YM G+L D + S R L K +DV + + YL
Sbjct: 70 -EEKGG--LYIVTEYMAKGSLVDYLR-SRGRSVLGGDCLLKFSLDVCEAMEYLEAN---N 122
Query: 392 IYHRDIKSTNILLDSELNAKVADFGLAKQ--SLEGHSHLTTRVAGTFGYLAPEYALYGQL 449
HRD+ + N+L+ + AKV+DFGL K+ S + L + + APE +
Sbjct: 123 FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK------WTAPEALREKKF 176
Query: 450 TEKSDVYSFGIVILELMS-GR 469
+ KSDV+SFGI++ E+ S GR
Sbjct: 177 STKSDVWSFGILLWEIYSFGR 197
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 88.8 bits (220), Expect = 2e-19
Identities = 58/198 (29%), Positives = 98/198 (49%), Gaps = 14/198 (7%)
Query: 272 IGQGASGIVYKGT-LRHGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCV 330
IGQGASG VY + G VA+KQ+ E NE+ ++ + +H N+++ +
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL 86
Query: 331 TSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKP 390
D+ ++V +Y+ G+L+D ++ + Q + + + + +LH
Sbjct: 87 VGDE-----LWVVMEYLAGGSLTDVVT----ETCMDEGQIAAVCRECLQALEFLH---SN 134
Query: 391 GIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALYGQLT 450
+ HRDIKS NILL + + K+ DFG Q S +T V GT ++APE
Sbjct: 135 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYG 193
Query: 451 EKSDVYSFGIVILELMSG 468
K D++S GI+ +E++ G
Sbjct: 194 PKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 88.6 bits (220), Expect = 2e-19
Identities = 60/216 (27%), Positives = 99/216 (45%), Gaps = 26/216 (12%)
Query: 264 NGFSQNNLIGQGASGIVYKGTLRHGNLVAVKQILDLDTKGD--EDFTNEVEIISKIRHRN 321
+ + +G+GA G V K L++ ++ + + D D + E+EI +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60
Query: 322 LLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVA--- 378
++ G + SS + +Y G+L SI K K+ +K++ +A
Sbjct: 61 IVKYYGAFLDESSSSIG---IAMEYCEGGSLD---SIYKKVKKRGGRIGEKVLGKIAESV 114
Query: 379 -KGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFG 437
KG++YLH I HRDIK +NILL + K+ DFG++ + L +AGTF
Sbjct: 115 LKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGE-------LVNSLAGTFT 164
Query: 438 ----YLAPEYALYGQLTEKSDVYSFGIVILELMSGR 469
Y+APE + SDV+S G+ +LE+ R
Sbjct: 165 GTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNR 200
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 3e-19
Identities = 57/202 (28%), Positives = 99/202 (49%), Gaps = 15/202 (7%)
Query: 267 SQNNLIGQGASGIVYKGTL-RHGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSL 325
+ + +G G G VY+G ++ VAVK L DT E+F E ++ +I+H NL+ L
Sbjct: 9 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKT-LKEDTMEVEEFLKEAAVMKEIKHPNLVQL 67
Query: 326 RGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLH 385
G C +++ ++M G L D + R+++ + ++ + YL
Sbjct: 68 LGVCTREPPF-----YIITEFMTYGNLLDYLR-ECNRQEVNAVVLLYMATQISSAMEYLE 121
Query: 386 YGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTF--GYLAPEY 443
K HRD+ + N L+ KVADFGL++ + G ++ T F + APE
Sbjct: 122 ---KKNFIHRDLAARNCLVGENHLVKVADFGLSRL-MTGDTY-TAHAGAKFPIKWTAPES 176
Query: 444 ALYGQLTEKSDVYSFGIVILEL 465
Y + + KSDV++FG+++ E+
Sbjct: 177 LAYNKFSIKSDVWAFGVLLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.1 bits (219), Expect = 3e-19
Identities = 61/204 (29%), Positives = 99/204 (48%), Gaps = 17/204 (8%)
Query: 270 NLIGQGASGIVYKGT-LRHGNLVAVKQIL-DLDTKGDEDFT-NEVEIISKIR---HRNLL 323
IG+GA G VYK L G VA+K++ L +G T E+ ++ ++ H N++
Sbjct: 5 AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIV 64
Query: 324 SLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAY 383
L C + LV++++ + L+ +S + L K ++ + +G+ +
Sbjct: 65 RLLDVCHGPRTDRELKLTLVFEHV-DQDLATYLS-KCPKPGLPPETIKDLMRQLLRGVDF 122
Query: 384 LHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEY 443
LH I HRD+K NIL+ S+ K+ADFGLA+ LT+ V T Y APE
Sbjct: 123 LHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR-IYSFEMALTSVVV-TLWYRAPEV 177
Query: 444 ALYGQLTEKS--DVYSFGIVILEL 465
L Q + + D++S G + EL
Sbjct: 178 LL--QSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 88.2 bits (219), Expect = 3e-19
Identities = 66/226 (29%), Positives = 112/226 (49%), Gaps = 26/226 (11%)
Query: 266 FSQNNLIGQGASGIVYKG-TLRHGNLVAVKQILDLDTKGDEDFTN--EVEIISKIRHRNL 322
F + N IG+G GIVY+ G +VA+K++ + + ++ E+ ++ +RH N+
Sbjct: 9 FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNI 68
Query: 323 LSLRGCCVTSDDSSGKRR---FLVYDYMPN--GTLSDNISISHKRKQLTWPQRKKIIVDV 377
+ L+ V GK FLV +Y +L DN+ + Q K +++ +
Sbjct: 69 VELKEVVV------GKHLDSIFLVMEYCEQDLASLLDNMP-----TPFSESQVKCLMLQL 117
Query: 378 AKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFG 437
+G+ YLH I HRD+K +N+LL + K+ADFGLA+ +T +V T
Sbjct: 118 LRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV-TLW 173
Query: 438 YLAPEYALYGQL--TEKSDVYSFGIVILELMSGRKVLDTSTSPFQL 481
Y APE L G T D+++ G ++ EL++ + +L + QL
Sbjct: 174 YRAPEL-LLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQL 218
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 4e-19
Identities = 56/212 (26%), Positives = 105/212 (49%), Gaps = 11/212 (5%)
Query: 272 IGQGASGIVYKGTLRHGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVT 331
+G G G+V+ G R VA+K I + +EDF E +++ K+ H L+ L G C
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAINE-GAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQ 70
Query: 332 SDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPG 391
K ++V ++M NG L + + ++ +L+ + DV +G+ YL +
Sbjct: 71 Q-----KPLYIVTEFMENGCLLN--YLRQRQGKLSKDMLLSMCQDVCEGMEYLE---RNS 120
Query: 392 IYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALYGQLTE 451
HRD+ + N L+ S KV+DFG+ + L+ ++ + PE + + +
Sbjct: 121 FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSS 180
Query: 452 KSDVYSFGIVILELMSGRKVLDTSTSPFQLIT 483
KSDV+SFG+++ E+ + K+ S ++++
Sbjct: 181 KSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVE 212
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 4e-19
Identities = 68/236 (28%), Positives = 117/236 (49%), Gaps = 26/236 (11%)
Query: 234 HEQFVSNLQASVLPNSGAKWFHVSELEQATNGFSQNNLIGQGASGIVYKGTLRH-GNLVA 292
HEQF + LQ V P + + + F + IG+G++GIV T +H G VA
Sbjct: 4 HEQFRAALQLVVSP---------GDPREYLDSFIK---IGEGSTGIVCIATEKHTGKQVA 51
Query: 293 VKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFLVYDYMPNGTL 352
VK++ + E NEV I+ H N++ + + D+ ++V +++ G L
Sbjct: 52 VKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDE-----LWVVMEFLEGGAL 106
Query: 353 SDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKV 412
+D ++H R + Q + + V + ++YLH G+ HRDIKS +ILL S+ K+
Sbjct: 107 TD--IVTHTR--MNEEQIATVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKL 159
Query: 413 ADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSG 468
+DFG Q + + GT ++APE + D++S GI+++E++ G
Sbjct: 160 SDFGFCAQ-VSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDG 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 91.1 bits (226), Expect = 5e-19
Identities = 88/346 (25%), Positives = 160/346 (46%), Gaps = 33/346 (9%)
Query: 201 VIGLLGALLGFLL-ASGLIILYRKWNKKRKQIALHEQFVSNLQASVLPNSGAKWFHVSEL 259
+ LGA L L A G + + + N + K++ +E LQ + +K ++++
Sbjct: 632 ITCTLGAFLVLALVAFGFVFIRGRNNLELKRVE-NEDGTWELQ--FFDSKVSKSITINDI 688
Query: 260 EQATNGFSQNNLIGQGASGIVYKG-TLRHGNLVAVKQILDLDTKGDEDFTNEVEIISKIR 318
+ + N+I +G G YKG ++++G VK+I D+++ +E+ + K++
Sbjct: 689 LSSLK---EENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPS----SEIADMGKLQ 741
Query: 319 HRNLLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVA 378
H N++ L G C S K +L+++Y+ LS+ + L+W +R+KI + +A
Sbjct: 742 HPNIVKLIGLC-----RSEKGAYLIHEYIEGKNLSEVLR------NLSWERRRKIAIGIA 790
Query: 379 KGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGY 438
K + +LH P + ++ I++D D + SL G T+ + Y
Sbjct: 791 KALRFLHCRCSPAVVVGNLSPEKIIID------GKDEPHLRLSLPGLLCTDTKCFISSAY 844
Query: 439 LAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDI 498
+APE +TEKSD+Y FG++++EL++G+ D I +WA +D
Sbjct: 845 VAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMW 904
Query: 499 FDEFIRAEGA---RAVMERFVLVGILCAHVMVALRPTITDALKMLE 541
D IR + + ++E L + C RP D LK LE
Sbjct: 905 IDPSIRGDVSVNQNEIVEVMNL-ALHCTATDPTARPCANDVLKTLE 949
|
Length = 968 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 5e-19
Identities = 61/222 (27%), Positives = 107/222 (48%), Gaps = 41/222 (18%)
Query: 272 IGQGASGIVYKGTLRH------GNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSL 325
+G+GA G V+ + LVAVK + + +DF E E+++ ++H++++
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 326 RGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRK-------------QLTWPQRKK 372
G C + G+ +V++YM +G L+ + SH QLT Q
Sbjct: 73 YGVC-----TEGRPLLMVFEYMRHGDLNRFLR-SHGPDAKILAGGEDVAPGQLTLGQMLA 126
Query: 373 IIVDVAKGIAYL---HYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLT 429
I +A G+ YL H+ HRD+ + N L+ L K+ DFG+++ + +S
Sbjct: 127 IASQIASGMVYLASLHF------VHRDLATRNCLVGQGLVVKIGDFGMSR---DIYSTDY 177
Query: 430 TRVAG----TFGYLAPEYALYGQLTEKSDVYSFGIVILELMS 467
RV G ++ PE LY + T +SD++SFG+V+ E+ +
Sbjct: 178 YRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 86.9 bits (216), Expect = 8e-19
Identities = 55/209 (26%), Positives = 109/209 (52%), Gaps = 24/209 (11%)
Query: 270 NLIGQGASGIVYKGT-LRHGNLVAVKQI-LDLDTKGDEDFT----NEVEIISKIRHRNLL 323
N I +G G+VY+ + G +VA+K++ ++ K E F E+ I+ K++H N++
Sbjct: 11 NRIEEGTYGVVYRARDKKTGEIVALKKLKME---KEKEGFPITSLREINILLKLQHPNIV 67
Query: 324 SLRGCCVTSDDSSGKRRFLVYDYMPNG--TLSDNISISHKRKQLTWPQRKKIIVDVAKGI 381
+++ V S+ + ++V +Y+ + +L + ++ + K +++ + G+
Sbjct: 68 TVKEVVVGSNL---DKIYMVMEYVEHDLKSL-----METMKQPFLQSEVKCLMLQLLSGV 119
Query: 382 AYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAP 441
A+LH I HRD+K++N+LL++ K+ DFGLA++ T V T Y AP
Sbjct: 120 AHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVV-TLWYRAP 175
Query: 442 EYAL-YGQLTEKSDVYSFGIVILELMSGR 469
E L + + D++S G + EL++ +
Sbjct: 176 ELLLGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 86.5 bits (214), Expect = 9e-19
Identities = 59/201 (29%), Positives = 102/201 (50%), Gaps = 18/201 (8%)
Query: 286 RHGNLVAVKQILDLDTKGDE--DFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFLV 343
G VAVK L ++ G+ D E+EI+ + H N++ +G C + K L+
Sbjct: 31 NTGEQVAVKS-LKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK---LI 86
Query: 344 YDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNIL 403
+++P+G+L + + + ++ Q+ K V + KG+ YL G + + HRD+ + N+L
Sbjct: 87 MEFLPSGSLKE--YLPRNKNKINLKQQLKYAVQICKGMDYL--GSRQYV-HRDLAARNVL 141
Query: 404 LDSELNAKVADFGLAKQSLEGHSHLTT---RVAGTFGYLAPEYALYGQLTEKSDVYSFGI 460
++SE K+ DFGL K + T + F Y APE + + SDV+SFG+
Sbjct: 142 VESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWY-APECLIQSKFYIASDVWSFGV 200
Query: 461 VILELMSGRKVLDTSTSPFQL 481
+ EL++ D+ +SP L
Sbjct: 201 TLYELLT---YCDSESSPMTL 218
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.9 bits (213), Expect = 1e-18
Identities = 59/206 (28%), Positives = 98/206 (47%), Gaps = 25/206 (12%)
Query: 272 IGQGASGIVYKGTLRHGNL----VAVKQILDLDTKGDED-FTNEVEIISKIRHRNLLSLR 326
+G G G V KG + VAVK + + F E +++++ H ++ L
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 327 GCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYL-- 384
G C G+ LV + P G L + KR+++ K++ VA G+AYL
Sbjct: 63 GVCK------GEPLMLVMELAPLGPLLKYLK---KRREIPVSDLKELAHQVAMGMAYLES 113
Query: 385 -HYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTF--GYLAP 441
H+ HRD+ + N+LL + AK++DFG+++ G + AG + + AP
Sbjct: 114 KHF------VHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAP 167
Query: 442 EYALYGQLTEKSDVYSFGIVILELMS 467
E YG+ + KSDV+S+G+ + E S
Sbjct: 168 ECINYGKFSSKSDVWSYGVTLWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 87.0 bits (216), Expect = 1e-18
Identities = 67/220 (30%), Positives = 107/220 (48%), Gaps = 36/220 (16%)
Query: 271 LIGQGASGIV----YKGTLRHGNLVAVKQ-----ILDLDTKGDEDFT-NEVEIISKI-RH 319
++G+G+ G V KGT L AVK IL D D + T E +++ +H
Sbjct: 2 VLGKGSFGKVLLAELKGT---DELYAVKVLKKDVILQDD---DVECTMTEKRVLALAGKH 55
Query: 320 RNLLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAK 379
L L C T D R F V +Y+ G L +I S + + P+ + ++
Sbjct: 56 PFLTQLHSCFQTKD-----RLFFVMEYVNGGDLMFHIQRSGRFDE---PRARFYAAEIVL 107
Query: 380 GIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYL 439
G+ +LH + GI +RD+K N+LLDSE + K+ADFG+ K+ + T+ GT Y+
Sbjct: 108 GLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGI-LGGVTTSTFCGTPDYI 163
Query: 440 APEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPF 479
APE Y D ++ G+++ E+++G+ SPF
Sbjct: 164 APEILSYQPYGPAVDWWALGVLLYEMLAGQ-------SPF 196
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 2e-18
Identities = 61/202 (30%), Positives = 106/202 (52%), Gaps = 14/202 (6%)
Query: 272 IGQGASGIVYKGTLRHGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVT 331
+G G G V+ G + VAVK L T + F E ++ ++H L+ L VT
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKT-LKPGTMSVQAFLEEANLMKTLQHDKLVRLYAV-VT 71
Query: 332 SDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPG 391
++ +++ +YM G+L D + S + ++ P+ +A+G+AY+ +
Sbjct: 72 KEEPI----YIITEYMAKGSLLDFLK-SDEGGKVLLPKLIDFSAQIAEGMAYIE---RKN 123
Query: 392 IYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTF--GYLAPEYALYGQL 449
HRD+++ N+L+ L K+ADFGLA+ +E + + T R F + APE +G
Sbjct: 124 YIHRDLRAANVLVSESLMCKIADFGLAR-VIEDNEY-TAREGAKFPIKWTAPEAINFGSF 181
Query: 450 TEKSDVYSFGIVILELMSGRKV 471
T KSDV+SFGI++ E+++ K+
Sbjct: 182 TIKSDVWSFGILLYEIVTYGKI 203
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 85.1 bits (211), Expect = 2e-18
Identities = 58/207 (28%), Positives = 87/207 (42%), Gaps = 23/207 (11%)
Query: 271 LIGQGASGIVYKGTLRHGNL----VAVKQILDLD--TKGDEDFTNEVEIISKIRHRNLLS 324
+G G+ G+V +G VAVK L D + +DF E I+ + H NL+
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVK-CLKSDKLSDIMDDFLKEAAIMHSLDHENLIR 60
Query: 325 LRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYL 384
L G V +V + P G+L D + V +A G+ YL
Sbjct: 61 LYG--VVLTHPL----MMVTELAPLGSLLDRLRKDALG-HFLISTLCDYAVQIANGMRYL 113
Query: 385 HYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTT----RVAGTFGYLA 440
K I HRD+ + NILL S+ K+ DFGL + + H +V F + A
Sbjct: 114 E--SKRFI-HRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVP--FAWCA 168
Query: 441 PEYALYGQLTEKSDVYSFGIVILELMS 467
PE + SDV+ FG+ + E+ +
Sbjct: 169 PESLRTRTFSHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 2e-18
Identities = 67/236 (28%), Positives = 116/236 (49%), Gaps = 26/236 (11%)
Query: 234 HEQFVSNLQASVLPNSGAKWFHVSELEQATNGFSQNNLIGQGASGIVYKGTLRH-GNLVA 292
HEQF + LQ V P + + F + IG+G++GIV T++ G LVA
Sbjct: 2 HEQFRAALQMVVDPGDPRTYL---------DNFIK---IGEGSTGIVCIATVKSSGKLVA 49
Query: 293 VKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFLVYDYMPNGTL 352
VK++ + E NEV I+ +H N++ + + D+ ++V +++ G L
Sbjct: 50 VKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDE-----LWVVMEFLEGGAL 104
Query: 353 SDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKV 412
+D ++H R + Q + + V K ++ LH G+ HRDIKS +ILL + K+
Sbjct: 105 TD--IVTHTR--MNEEQIAAVCLAVLKALSVLH---AQGVIHRDIKSDSILLTHDGRVKL 157
Query: 413 ADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSG 468
+DFG Q + + GT ++APE + D++S GI+++E++ G
Sbjct: 158 SDFGFCAQ-VSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.9 bits (211), Expect = 3e-18
Identities = 61/210 (29%), Positives = 99/210 (47%), Gaps = 32/210 (15%)
Query: 272 IGQGASGIVYKGTLRH-GNLVAVKQILDLDTKGD----EDFTN--EVEIISKI-RHRNLL 323
+G G G VY + G LVA+K++ K E+ N EV+ + K+ H N++
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKM-----KKKFYSWEECMNLREVKSLRKLNEHPNIV 61
Query: 324 SLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAY 383
L+ V ++ + V++YM G L + K K + + II + +G+A+
Sbjct: 62 KLKE--VFREN---DELYFVFEYM-EGNLYQLMK-DRKGKPFSESVIRSIIYQILQGLAH 114
Query: 384 LHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEY 443
+H K G +HRD+K N+L+ K+ADFGLA+ + T V T Y APE
Sbjct: 115 IH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAR-EIRSRPPYTDYV-STRWYRAPEI 169
Query: 444 AL----YGQLTEKSDVYSFGIVILELMSGR 469
L Y D+++ G ++ EL + R
Sbjct: 170 LLRSTSYSS---PVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 83.8 bits (208), Expect = 5e-18
Identities = 60/211 (28%), Positives = 93/211 (44%), Gaps = 28/211 (13%)
Query: 272 IGQGASGIVY----KGTLRHGNLVAVKQILDLDTKGDEDFTN---EVEIISKIRHRNLLS 324
I +GA G V+ K T G++ A+K I D E +I+S+ + ++
Sbjct: 1 ISKGAYGRVFLAKKKST---GDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVK 57
Query: 325 LRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYL 384
L K +LV +Y+P G L+ S+ L + I ++ + YL
Sbjct: 58 LY-YSFQGK----KNLYLVMEYLPGGDLA---SLLENVGSLDEDVARIYIAEIVLALEYL 109
Query: 385 HYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEG-------HSHLTTRVAGTFG 437
H GI HRD+K NIL+DS + K+ DFGL+K L R+ GT
Sbjct: 110 H---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPD 166
Query: 438 YLAPEYALYGQLTEKSDVYSFGIVILELMSG 468
Y+APE L ++ D +S G ++ E + G
Sbjct: 167 YIAPEVILGQGHSKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 83.8 bits (207), Expect = 7e-18
Identities = 64/206 (31%), Positives = 101/206 (49%), Gaps = 19/206 (9%)
Query: 271 LIGQGASGIVYKGTLRHG----NLVAVKQILDLDT-KGDEDFTNEVEIISKIRHRNLLSL 325
+IG G G V +G L+ VA+K + T K DF +E I+ + H N++ L
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 326 RGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLH 385
G S + ++ ++M NG L + Q T Q ++ +A G+ YL
Sbjct: 71 EGVVTKS-----RPVMIITEFMENGALDSFLRQ--NDGQFTVIQLVGMLRGIAAGMKYLS 123
Query: 386 YGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSH--LTTRVAGTFG--YLAP 441
+ HRD+ + NIL++S L KV+DFGL++ + S T+ + G + AP
Sbjct: 124 ---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAP 180
Query: 442 EYALYGQLTEKSDVYSFGIVILELMS 467
E Y + T SDV+S+GIV+ E+MS
Sbjct: 181 EAIAYRKFTSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 8e-18
Identities = 67/226 (29%), Positives = 107/226 (47%), Gaps = 46/226 (20%)
Query: 270 NLIGQGASGIVYKGTLR------HGNL-VAVKQILDLDTKGDED-----FTNEVEIISKI 317
N +G GA G VY+GT G + VAVK + KG D F E ++S
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTL----RKGATDQEKKEFLKEAHLMSNF 56
Query: 318 RHRNLLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQ----LTWPQRKKI 373
H N++ L G C+ ++ ++++ + M G L + + + LT + I
Sbjct: 57 NHPNIVKLLGVCLLNEP-----QYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDI 111
Query: 374 IVDVAKGIAYLHYGLKPGIYHRDIKSTNILL-----DSELNAKVADFGLAKQ-------S 421
+DVAKG YL + HRD+ + N L+ D++ K+ DFGLA+
Sbjct: 112 CLDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYR 168
Query: 422 LEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS 467
EG L R ++APE L G+ T +SDV+SFG+++ E+++
Sbjct: 169 KEGEGLLPVR------WMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 84.0 bits (207), Expect = 8e-18
Identities = 60/222 (27%), Positives = 105/222 (47%), Gaps = 43/222 (19%)
Query: 272 IGQGASGIVYKGTL------RHGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSL 325
+G+GA G V+ + LVAVK + D +DF E E+++ ++H +++
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 326 RGCCVTSDDSSGKRRFLVYDYMPNGTLS--------DNISISHKR--KQLTWPQRKKIIV 375
G CV D +V++YM +G L+ D + ++ +LT Q I
Sbjct: 73 YGVCVEGDP-----LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQ 127
Query: 376 DVAKGIAYL---HYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQ-------SLEGH 425
+A G+ YL H+ HRD+ + N L+ L K+ DFG+++ + GH
Sbjct: 128 QIAAGMVYLASQHF------VHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGH 181
Query: 426 SHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS 467
+ L R ++ PE +Y + T +SDV+S G+V+ E+ +
Sbjct: 182 TMLPIR------WMPPESIMYRKFTTESDVWSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 83.6 bits (206), Expect = 9e-18
Identities = 61/205 (29%), Positives = 99/205 (48%), Gaps = 15/205 (7%)
Query: 266 FSQNNLIGQGASGIVYKGTLRHGNLVAVKQILDLDTKGDE--DFTNEVEIISKIRHRNLL 323
F++ IG+G+ G VYKG V +I+DL+ DE D E+ ++S+ +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 324 SLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAY 383
G + G + +++ +Y+ G+ D + K L I+ ++ KG+ Y
Sbjct: 66 RYYGSYL-----KGTKLWIIMEYLGGGSALDLL----KPGPLEETYIATILREILKGLDY 116
Query: 384 LHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEY 443
LH K HRDIK+ N+LL + + K+ADFG+A Q + T V F ++APE
Sbjct: 117 LHSERK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPF-WMAPEV 172
Query: 444 ALYGQLTEKSDVYSFGIVILELMSG 468
K+D++S GI +EL G
Sbjct: 173 IKQSAYDFKADIWSLGITAIELAKG 197
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 84.0 bits (207), Expect = 9e-18
Identities = 57/204 (27%), Positives = 102/204 (50%), Gaps = 14/204 (6%)
Query: 266 FSQNNLIGQGASGIVYKGT-LRHGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLS 324
+++ IGQGASG V+ + G VA+KQI E NE+ ++ ++++ N+++
Sbjct: 21 YTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVN 80
Query: 325 LRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYL 384
+ D+ F+V +Y+ G+L+D ++ + Q + + + + +L
Sbjct: 81 FLDSFLVGDE-----LFVVMEYLAGGSLTDVVT----ETCMDEAQIAAVCRECLQALEFL 131
Query: 385 HYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYA 444
H + HRDIKS N+LL + + K+ DFG Q S +T V GT ++APE
Sbjct: 132 HAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVV 187
Query: 445 LYGQLTEKSDVYSFGIVILELMSG 468
K D++S GI+ +E++ G
Sbjct: 188 TRKAYGPKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 1e-17
Identities = 61/215 (28%), Positives = 103/215 (47%), Gaps = 27/215 (12%)
Query: 265 GFSQNNLIGQGASGIVYK-GTLRHGNLVAVKQ--ILDLDTKGDEDFTNEVEIISKIRHRN 321
F +G+G+ G VYK L A+K+ + + K ED NE+ I++ + H N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 322 LLSLRGCCVTSDDSS--GKRRFLVYDYMPNGTLSDNISISHKRK-----QLTWPQRKKII 374
++S + ++ G + +V +Y P G LS IS K++ Q W +I
Sbjct: 61 IISYK-------EAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIW----RIF 109
Query: 375 VDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAG 434
+ + +G+ LH + I HRD+KS NILL + K+ D G++K + + G
Sbjct: 110 IQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN---MAKTQIG 163
Query: 435 TFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGR 469
T Y+APE + KSD++S G ++ E+ +
Sbjct: 164 TPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFA 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 1e-17
Identities = 57/205 (27%), Positives = 103/205 (50%), Gaps = 19/205 (9%)
Query: 272 IGQGASGIVYKGTLRHGNLVAVKQILDLDTKGD-EDFTNEVEIISKIRHRNLLSLRGCCV 330
+G GA G VYK + L A +I+ ++++ + EDF E++I+S+ +H N++ L
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 331 TSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKP 390
+ +++ ++ G L D+I + + LT PQ + + + + + +LH
Sbjct: 73 YENK-----LWILIEFCDGGAL-DSI-MLELERGLTEPQIRYVCRQMLEALNFLHSHK-- 123
Query: 391 GIYHRDIKSTNILLDSELNAKVADFGL-AKQSLEGHSHLTTRVAGTFGYLAPEYALYGQL 449
+ HRD+K+ NILL + + K+ADFG+ AK T GT ++APE
Sbjct: 124 -VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT--FIGTPYWMAPEVVACETF 180
Query: 450 TE-----KSDVYSFGIVILELMSGR 469
+ K+D++S GI ++EL
Sbjct: 181 KDNPYDYKADIWSLGITLIELAQME 205
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 2e-17
Identities = 70/241 (29%), Positives = 114/241 (47%), Gaps = 35/241 (14%)
Query: 260 EQATNGFSQNNLIGQGASGIVYKGTLRH-GNLVAVKQI-LDLDTKGDEDF----TNEVEI 313
++ + F IG+G G VYK + G LVA+K++ LD + +G F E++I
Sbjct: 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEG---FPITAIREIKI 59
Query: 314 ISKIRHRNLLSLRGCCVTSDDSSGKRR-----FLVYDYMPN---GTL-SDNISISHKRKQ 364
+ ++ HRN+++L+ D+ ++ +LV++YM + G L S + S
Sbjct: 60 LRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSED--- 116
Query: 365 LTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEG 424
K + + +G+ Y H K HRDIK +NILL+++ K+ADFGLA+
Sbjct: 117 ----HIKSFMKQLLEGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSE 169
Query: 425 HSHLTTRVAGTFGYLAPEYAL----YGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQ 480
S T T Y PE L YG DV+S G ++ EL + + + + Q
Sbjct: 170 ESRPYTNKVITLWYRPPELLLGEERYGPAI---DVWSCGCILGELFTKKPIFQANQELAQ 226
Query: 481 L 481
L
Sbjct: 227 L 227
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 2e-17
Identities = 78/255 (30%), Positives = 118/255 (46%), Gaps = 71/255 (27%)
Query: 257 SELEQATNGFSQNNLIGQGASGIVYKGTLRH---GNLVAVKQILDLDTKGDED------F 307
SELE+ N IG GA G VYK + H G L A+K I G+ +
Sbjct: 74 SELERV-------NRIGSGAGGTVYK--VIHRPTGRLYALKVIY-----GNHEDTVRRQI 119
Query: 308 TNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTW 367
E+EI+ + H N++ C D +G+ + L+ ++M G+L + I+ ++
Sbjct: 120 CREIEILRDVNHPNVVK----CHDMFDHNGEIQVLL-EFMDGGSL-EGTHIADEQF---- 169
Query: 368 PQRKKIIVDVAK----GIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLE 423
+ DVA+ GIAYLH + I HRDIK +N+L++S N K+ADFG+++ +
Sbjct: 170 ------LADVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQ 220
Query: 424 GHSHLTTRVAGTFGYLAPE----------YALYGQLTEKSDVYSFGIVILELMSGRKVLD 473
+ V GT Y++PE Y Y D++S G+ ILE GR
Sbjct: 221 TMDPCNSSV-GTIAYMSPERINTDLNHGAYDGYA-----GDIWSLGVSILEFYLGR---- 270
Query: 474 TSTSPFQLIT--DWA 486
PF + DWA
Sbjct: 271 ---FPFGVGRQGDWA 282
|
Length = 353 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 2e-17
Identities = 62/210 (29%), Positives = 107/210 (50%), Gaps = 16/210 (7%)
Query: 272 IGQGASGIVYKGTLRHGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVT 331
+G G G V+ T VAVK + + E F E ++ ++H L+ L VT
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAVKT-MKPGSMSVEAFLAEANVMKTLQHDKLVKLHAV-VT 71
Query: 332 SDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPG 391
+ +++ ++M G+L D + KQ P+ +A+G+A++ +
Sbjct: 72 KEPI-----YIITEFMAKGSLLDFLKSDEGSKQ-PLPKLIDFSAQIAEGMAFIE---QRN 122
Query: 392 IYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTF--GYLAPEYALYGQL 449
HRD+++ NIL+ + L K+ADFGLA+ +E + + T R F + APE +G
Sbjct: 123 YIHRDLRAANILVSASLVCKIADFGLAR-VIEDNEY-TAREGAKFPIKWTAPEAINFGSF 180
Query: 450 TEKSDVYSFGIVILELMS-GRKVLDTSTSP 478
T KSDV+SFGI+++E+++ GR ++P
Sbjct: 181 TIKSDVWSFGILLMEIVTYGRIPYPGMSNP 210
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 2e-17
Identities = 67/201 (33%), Positives = 98/201 (48%), Gaps = 23/201 (11%)
Query: 272 IGQGASGIVYKGT-LRHGNLVAVKQILDLDTKGDE---DFTNEVEIISKIRHRNLLSLRG 327
IG G+ G VY +R +VA+K++ + +E D EV + ++RH N + +G
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKG 82
Query: 328 CCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYG 387
C + + +LV +Y G+ SD + + HK K L + I +G+AYLH
Sbjct: 83 CYLREHTA-----WLVMEYCL-GSASDILEV-HK-KPLQEVEIAAICHGALQGLAYLH-- 132
Query: 388 LKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALY- 446
HRDIK+ NILL K+ADFG A +S + GT ++APE L
Sbjct: 133 -SHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV-----GTPYWMAPEVILAM 186
Query: 447 --GQLTEKSDVYSFGIVILEL 465
GQ K DV+S GI +EL
Sbjct: 187 DEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 2e-17
Identities = 64/200 (32%), Positives = 97/200 (48%), Gaps = 20/200 (10%)
Query: 272 IGQGASGIVYKGT-LRHGNLVAVKQI-LDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCC 329
+G G G VYK L ++AVK I LD+ + + +E+EI+ K ++ G
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 330 VTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLK 389
+ R + ++M G+L I +I V V KG+ YL + LK
Sbjct: 69 FVEN-----RISICTEFMDGGSLDVYRKIPE-------HVLGRIAVAVVKGLTYL-WSLK 115
Query: 390 PGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALYGQL 449
I HRD+K +N+L+++ K+ DFG++ Q + +S T V GT Y+APE Q
Sbjct: 116 --ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLV--NSIAKTYV-GTNAYMAPERISGEQY 170
Query: 450 TEKSDVYSFGIVILELMSGR 469
SDV+S GI +EL GR
Sbjct: 171 GIHSDVWSLGISFMELALGR 190
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 3e-17
Identities = 61/228 (26%), Positives = 104/228 (45%), Gaps = 45/228 (19%)
Query: 272 IGQGASGIVYKGTL------RHGNLVAVKQILD---LDTKGDEDFTNEVEIISKIRHRNL 322
IGQGA G V++ +VAVK + + D + DF E ++++ H N+
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQ--ADFQREAALMAEFDHPNI 70
Query: 323 LSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNI---------SISHK----------RK 363
+ L G C GK L+++YM G L++ + S+SH
Sbjct: 71 VKLLGVCAV-----GKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPL 125
Query: 364 QLTWPQRKKIIVDVAKGIAYL---HYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQ 420
L+ ++ I VA G+AYL + HRD+ + N L+ + K+ADFGL++
Sbjct: 126 PLSCTEQLCIAKQVAAGMAYLSERKF------VHRDLATRNCLVGENMVVKIADFGLSRN 179
Query: 421 -SLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS 467
+ + A ++ PE Y + T +SDV+++G+V+ E+ S
Sbjct: 180 IYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 3e-17
Identities = 61/220 (27%), Positives = 107/220 (48%), Gaps = 21/220 (9%)
Query: 258 ELEQATNGFSQNNLIGQGASGIVYKG-TLRHGNLVAVKQILDLDTKGDEDFTNEVEIISK 316
E E + + ++G+G GIVY L +A+K+I + D++ + E+ + S
Sbjct: 2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSY 61
Query: 317 IRHRNLLSLRGCCVTSDDSSGKRRFLVY-DYMPNGTLSDNISIS---HKRKQLTWPQRKK 372
++HRN++ G + F ++ + +P G+LS + K + T K
Sbjct: 62 LKHRNIVQYLGSDSENG------FFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTK 115
Query: 373 IIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNA-KVADFGLAKQSLEGHSHLTTR 431
I++ G+ YLH I HRDIK N+L+++ K++DFG +K+ L G + T
Sbjct: 116 QILE---GLKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKR-LAGINPCTET 168
Query: 432 VAGTFGYLAPEYALYGQ--LTEKSDVYSFGIVILELMSGR 469
GT Y+APE G +D++S G I+E+ +G+
Sbjct: 169 FTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 82.6 bits (205), Expect = 4e-17
Identities = 68/220 (30%), Positives = 109/220 (49%), Gaps = 46/220 (20%)
Query: 272 IGQGASGIVYKGT-LRHGNLVAVKQILDLDTKGDEDFTN---------EVEIISKIR-HR 320
+G+GA GIV+K R +VA+K+I D F N E+ + ++ H
Sbjct: 15 LGKGAYGIVWKAIDRRTKEVVALKKIFDA-------FRNATDAQRTFREIMFLQELGDHP 67
Query: 321 NLLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSD-NISISHKRKQLTWPQRKK-IIVDVA 378
N++ L +D K +LV++YM +D + I R + K+ I+ +
Sbjct: 68 NIVKLLNVIKAEND---KDIYLVFEYME----TDLHAVI---RANILEDVHKRYIMYQLL 117
Query: 379 KGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAK---QSLEGHSH--LTTRVA 433
K + Y+H G + HRD+K +NILL+S+ K+ADFGLA+ + E + LT VA
Sbjct: 118 KALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVA 174
Query: 434 GTFGYLAPEYAL----YGQLTEKSDVYSFGIVILELMSGR 469
T Y APE L Y T+ D++S G ++ E++ G+
Sbjct: 175 -TRWYRAPEILLGSTRY---TKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 4e-17
Identities = 57/213 (26%), Positives = 100/213 (46%), Gaps = 14/213 (6%)
Query: 266 FSQNNLIGQGASGIVYKGTLRHGNL----VAVKQI-LDLDTKGD-EDFTNEVEIISKIRH 319
++G+G G V +G L + VAVK + LD+ T + E+F +E + H
Sbjct: 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDH 60
Query: 320 RNLLSLRGCCVTSDDSSG-KRRFLVYDYMPNGTLSDNI---SISHKRKQLTWPQRKKIIV 375
N++ L G C + + ++ +M +G L + + ++L K +V
Sbjct: 61 PNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMV 120
Query: 376 DVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGT 435
D+A G+ YL HRD+ + N +L ++ VADFGL+K+ G + R+A
Sbjct: 121 DIALGMEYLS---NRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKM 177
Query: 436 -FGYLAPEYALYGQLTEKSDVYSFGIVILELMS 467
++A E T KSDV++FG+ + E+ +
Sbjct: 178 PVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 210
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 5e-17
Identities = 57/225 (25%), Positives = 103/225 (45%), Gaps = 46/225 (20%)
Query: 272 IGQGASGIVYKGT------LRHGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSL 325
+G+GA G V+ + LVAVK + D +DF E E+++ ++H +++
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 326 RGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISIS-------------HKRKQLTWPQRKK 372
G C D +V++YM +G L+ + + +L Q
Sbjct: 73 YGVCGDGDP-----LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 127
Query: 373 IIVDVAKGIAYL---HYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQ-------SL 422
I +A G+ YL H+ HRD+ + N L+ + L K+ DFG+++ +
Sbjct: 128 IASQIASGMVYLASQHF------VHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRV 181
Query: 423 EGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS 467
GH+ L R ++ PE +Y + T +SDV+SFG+++ E+ +
Sbjct: 182 GGHTMLPIR------WMPPESIMYRKFTTESDVWSFGVILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 5e-17
Identities = 59/216 (27%), Positives = 101/216 (46%), Gaps = 37/216 (17%)
Query: 272 IGQGASGIVYKGTLR-----HGNL-VAVKQILDLDTKGDE-DFTNEVEIISKIRHRNLLS 324
+GQG+ G+VY+G + VA+K + + + + +F NE ++ + +++
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 325 LRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQ-----LTWPQRKKII---VD 376
L G S+G+ +V + M G L + S + + L P +K I +
Sbjct: 74 LLGVV-----STGQPTLVVMELMAKGDLKSYLR-SRRPEAENNPGLGPPTLQKFIQMAAE 127
Query: 377 VAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLE-------GHSHLT 429
+A G+AYL K HRD+ + N ++ +L K+ DFG+ + E G L
Sbjct: 128 IADGMAYLA-AKK--FVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLP 184
Query: 430 TRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILEL 465
R ++APE G T KSDV+SFG+V+ E+
Sbjct: 185 VR------WMAPESLKDGVFTTKSDVWSFGVVLWEM 214
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 81.7 bits (201), Expect = 6e-17
Identities = 68/212 (32%), Positives = 106/212 (50%), Gaps = 34/212 (16%)
Query: 271 LIGQGASGIVYKGT-LRHGNLVAVK---QILDLDT--KGDEDFTNEVEIISKIRHRNLLS 324
++G GA G VYKG + G V + +IL+ T K + +F +E I++ + H +L+
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73
Query: 325 LRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQ-------LTWPQRKKIIVDV 377
L G C++ LV MP+G L D + H+ K L W V +
Sbjct: 74 LLGVCLSPTIQ------LVTQLMPHGCLLDYV---HEHKDNIGSQLLLNW------CVQI 118
Query: 378 AKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTF- 436
AKG+ YL + + HRD+ + N+L+ S + K+ DFGLA+ LEG G
Sbjct: 119 AKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARL-LEGDEKEYNADGGKMP 174
Query: 437 -GYLAPEYALYGQLTEKSDVYSFGIVILELMS 467
++A E Y + T +SDV+S+G+ I ELM+
Sbjct: 175 IKWMALECIHYRKFTHQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 6e-17
Identities = 61/208 (29%), Positives = 101/208 (48%), Gaps = 17/208 (8%)
Query: 268 QNNLIGQGASGIVYKG-TLRHGNLVAVKQI-LDLDTKGDEDFTN----EVEIISKIRHRN 321
L+G+GA G VY G +AVKQ+ D D++ N E++++ +RH
Sbjct: 6 LGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDR 65
Query: 322 LLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGI 381
++ GC D K+ + +YMP G++ D + LT ++ + +G+
Sbjct: 66 IVQYYGCL---RDPEEKKLSIFVEYMPGGSIKDQLK---AYGALTENVTRRYTRQILQGV 119
Query: 382 AYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAK--QSLEGHSHLTTRVAGTFGYL 439
+YLH + I HRDIK NIL DS N K+ DFG +K Q++ V GT ++
Sbjct: 120 SYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWM 176
Query: 440 APEYALYGQLTEKSDVYSFGIVILELMS 467
+PE K+DV+S ++E+++
Sbjct: 177 SPEVISGEGYGRKADVWSVACTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 6e-17
Identities = 67/204 (32%), Positives = 98/204 (48%), Gaps = 17/204 (8%)
Query: 271 LIGQGASGIVYKGTLRHGN----LVAVKQI-LDLDTKGDEDFTNEVEIISKIRHRNLLSL 325
+IG G G V G L+ VA+K + K DF +E I+ + H N++ L
Sbjct: 11 VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 326 RGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLH 385
G + K +V +YM NG+L D H Q T Q ++ +A G+ YL
Sbjct: 71 EGVV-----TKSKPVMIVTEYMENGSL-DAFLRKHD-GQFTVIQLVGMLRGIASGMKYLS 123
Query: 386 YGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFG--YLAPEY 443
G HRD+ + NIL++S L KV+DFGL++ + T G + APE
Sbjct: 124 ---DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEA 180
Query: 444 ALYGQLTEKSDVYSFGIVILELMS 467
Y + T SDV+S+GIV+ E+MS
Sbjct: 181 IAYRKFTSASDVWSYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 7e-17
Identities = 63/210 (30%), Positives = 100/210 (47%), Gaps = 25/210 (11%)
Query: 271 LIGQGASGIVYK--GTLRHGNLVAVKQIL-----DLDTKGD-----EDFTNEVEIISK-I 317
+G GA G VYK NL+A+K+I K + D +EV II + +
Sbjct: 7 HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66
Query: 318 RHRNLLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRK--KIIV 375
RH N++ + +D R ++V D + L ++ + S K K+ + + + I V
Sbjct: 67 RHPNIVRYYKTFLEND-----RLYIVMDLIEGAPLGEHFN-SLKEKKQRFTEERIWNIFV 120
Query: 376 DVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGT 435
+ + YLH + I HRD+ NI+L + + DFGLAKQ S LT+ V GT
Sbjct: 121 QMVLALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAKQKQP-ESKLTS-VVGT 176
Query: 436 FGYLAPEYALYGQLTEKSDVYSFGIVILEL 465
Y PE EK+DV++FG ++ ++
Sbjct: 177 ILYSCPEIVKNEPYGEKADVWAFGCILYQM 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 1e-16
Identities = 70/201 (34%), Positives = 103/201 (51%), Gaps = 23/201 (11%)
Query: 272 IGQGASGIVYKGTLRHGN-LVAVKQILDLDTKGDE---DFTNEVEIISKIRHRNLLSLRG 327
IG G+ G VY T H N +VAVK++ + +E D EV+ + +++H N + +G
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 328 CCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYG 387
C + + +LV +Y G+ SD + + HK K L + I +G+AYLH
Sbjct: 89 CYLKEHTA-----WLVMEYCL-GSASDLLEV-HK-KPLQEVEIAAITHGALQGLAYLH-- 138
Query: 388 LKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALY- 446
+ HRDIK+ NILL K+ADFG A +S +S + GT ++APE L
Sbjct: 139 -SHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV-----GTPYWMAPEVILAM 192
Query: 447 --GQLTEKSDVYSFGIVILEL 465
GQ K DV+S GI +EL
Sbjct: 193 DEGQYDGKVDVWSLGITCIEL 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 1e-16
Identities = 61/212 (28%), Positives = 104/212 (49%), Gaps = 17/212 (8%)
Query: 266 FSQNNLIGQGASGIVYKG-TLRHGNLVAVKQI-LDLDT----KGDEDFTNEVEIISKIRH 319
+ + L+GQGA G VY + G +A KQ+ D ++ K E++++ ++H
Sbjct: 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQH 63
Query: 320 RNLLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAK 379
++ GC D + K + +YMP G++ D + LT +K + +
Sbjct: 64 ERIVQYYGCL---RDRAEKTLTIFMEYMPGGSVKDQLK---AYGALTESVTRKYTRQILE 117
Query: 380 GIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAK--QSLEGHSHLTTRVAGTFG 437
G++YLH + I HRDIK NIL DS N K+ DFG +K Q++ V GT
Sbjct: 118 GMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPY 174
Query: 438 YLAPEYALYGQLTEKSDVYSFGIVILELMSGR 469
+++PE K+DV+S G ++E+++ +
Sbjct: 175 WMSPEVISGEGYGRKADVWSLGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 2e-16
Identities = 63/218 (28%), Positives = 108/218 (49%), Gaps = 32/218 (14%)
Query: 270 NLIGQGASGIVYKGTLRHGNL---VAVKQILDLDTKGDE-DFTNEVEIISKI-RHRNLLS 324
++IG+G G V K ++ L A+K++ + +K D DF E+E++ K+ H N+++
Sbjct: 13 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 72
Query: 325 LRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNI------------SISHKRKQ-LTWPQRK 371
L G C + G +L +Y P+G L D + +I++ L+ Q
Sbjct: 73 LLGAC----EHRG-YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 127
Query: 372 KIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTR 431
DVA+G+ YL + HRD+ + NIL+ AK+ADFGL++ G +
Sbjct: 128 HFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVKK 180
Query: 432 VAGTFG--YLAPEYALYGQLTEKSDVYSFGIVILELMS 467
G ++A E Y T SDV+S+G+++ E++S
Sbjct: 181 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 2e-16
Identities = 72/245 (29%), Positives = 118/245 (48%), Gaps = 22/245 (8%)
Query: 272 IGQGASGIVYKGTLRHGN-LVAVKQILD-LDTKGDEDFT-NEVEIISKIRHRNLLSLRGC 328
IG+GA GIV N VA+K+I + D + D T E++++ + H N+++++
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDI 72
Query: 329 CVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGL 388
+ ++VY+ M +D I + L+ + + + +G+ Y+H
Sbjct: 73 MPPPHREAFNDVYIVYELMD----TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIH--- 125
Query: 389 KPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYAL-YG 447
+ HRD+K +N+LL++ + K+ DFGLA+ + E +T V T Y APE L
Sbjct: 126 SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVV-TRWYRAPELLLNCS 184
Query: 448 QLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQ---LITDWAWVLAKSGKVDDIFDEFIR 504
+ T DV+S G + EL+ GRK L LIT+ L S +D+ FIR
Sbjct: 185 EYTTAIDVWSVGCIFAELL-GRKPLFPGKDYVHQLKLITE----LLGSPSEEDL--GFIR 237
Query: 505 AEGAR 509
E AR
Sbjct: 238 NEKAR 242
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 80.1 bits (198), Expect = 2e-16
Identities = 67/238 (28%), Positives = 111/238 (46%), Gaps = 46/238 (19%)
Query: 272 IGQGASGIVYKGTLRH---GNLVAVKQILDLDTKGDEDFT----NEVEIISKIRHRNLLS 324
IGQG G V+K RH +VA+K++L + K E F E++I+ ++H N+++
Sbjct: 20 IGQGTFGEVFKA--RHKKTKQIVALKKVLMENEK--EGFPITALREIKILQLLKHENVVN 75
Query: 325 LRGCCVTSDDSSGKRR---FLVYDYMPN--GTLSDNISISHKRKQLTWPQRKKIIVDVAK 379
L C T + + +LV+++ + L N ++ + T + KK++ +
Sbjct: 76 LIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNV-----KFTLSEIKKVMKMLLN 130
Query: 380 GIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAK---QSLEGHSHL-TTRVAGT 435
G+ Y+H I HRD+K+ NIL+ + K+ADFGLA+ S + T RV T
Sbjct: 131 GLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVV-T 186
Query: 436 FGYLAPEYAL----YGQLTEKSDVYSFGIVILEL------MSGRKVLDTSTSPFQLIT 483
Y PE L YG D++ G ++ E+ M G +T LI+
Sbjct: 187 LWYRPPELLLGERDYGP---PIDMWGAGCIMAEMWTRSPIMQG----NTEQHQLTLIS 237
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 2e-16
Identities = 62/218 (28%), Positives = 106/218 (48%), Gaps = 32/218 (14%)
Query: 270 NLIGQGASGIVYKGTLRHGNL---VAVKQILDLDTKGDE-DFTNEVEIISKI-RHRNLLS 324
++IG+G G V + ++ L A+K + + ++ D DF E+E++ K+ H N+++
Sbjct: 8 DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIIN 67
Query: 325 LRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISH-------------KRKQLTWPQRK 371
L G C ++ G ++ +Y P G L D + S LT Q
Sbjct: 68 LLGAC----ENRG-YLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLL 122
Query: 372 KIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTR 431
+ DVA G+ YL + HRD+ + N+L+ L +K+ADFGL++ G +
Sbjct: 123 QFASDVATGMQYLS---EKQFIHRDLAARNVLVGENLASKIADFGLSR----GEEVYVKK 175
Query: 432 VAGTFG--YLAPEYALYGQLTEKSDVYSFGIVILELMS 467
G ++A E Y T KSDV+SFG+++ E++S
Sbjct: 176 TMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 2e-16
Identities = 57/199 (28%), Positives = 103/199 (51%), Gaps = 16/199 (8%)
Query: 272 IGQGASGIVYKGTLRH-GNLVAVKQILDLDTKGDEDFT-NEVEIISKIRHRNLLSLRGCC 329
IG+G++GIV +H G VAVK ++DL + + NEV I+ +H+N++ +
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVK-MMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87
Query: 330 VTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLK 389
+ G+ +++ +++ G L+D +S + +L Q + V + + YLH
Sbjct: 88 LV-----GEELWVLMEFLQGGALTDIVS----QTRLNEEQIATVCESVLQALCYLH---S 135
Query: 390 PGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALYGQL 449
G+ HRDIKS +ILL + K++DFG Q + + GT ++APE
Sbjct: 136 QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQ-ISKDVPKRKSLVGTPYWMAPEVISRTPY 194
Query: 450 TEKSDVYSFGIVILELMSG 468
+ D++S GI+++E++ G
Sbjct: 195 GTEVDIWSLGIMVIEMVDG 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 79.7 bits (197), Expect = 2e-16
Identities = 66/224 (29%), Positives = 112/224 (50%), Gaps = 27/224 (12%)
Query: 271 LIGQGASGIVYKGTLRH-GNLVAVKQILDLDTKGDED--FTNEVEIISKIRHR--NLLSL 325
IG G G VYK + G+++AVKQ+ K +E+ +++++ K H ++
Sbjct: 22 EIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK-EENKRILMDLDVVLK-SHDCPYIVKC 79
Query: 326 RGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQR--KKIIVDVAKGIAY 383
G +T D F+ + M T D + KR Q P+ K+ V + K + Y
Sbjct: 80 YGYFITDSDV-----FICMELM--STCLDKLL---KRIQGPIPEDILGKMTVAIVKALHY 129
Query: 384 LHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEY 443
L K G+ HRD+K +NILLD+ N K+ DFG++ + ++ + TR AG Y+APE
Sbjct: 130 LKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK--TRSAGCAAYMAPER 185
Query: 444 ----ALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLIT 483
+ ++DV+S GI ++EL +G+ + F+++T
Sbjct: 186 IDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLT 229
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 3e-16
Identities = 62/220 (28%), Positives = 107/220 (48%), Gaps = 13/220 (5%)
Query: 266 FSQNNLIGQGASGIVYKGTLRH-GNLVAVKQI-LDLDTKGDEDFTNEVEIISKIRHRNLL 323
F Q +G+G VYKG R G +VA+K+I LD + E+ ++ +++H N++
Sbjct: 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIV 61
Query: 324 SLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAY 383
L T + + LV++YM + L + R L K + KGIA+
Sbjct: 62 RLHDVIHTEN-----KLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAF 115
Query: 384 LHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEY 443
H + + HRD+K N+L++ K+ADFGLA+ + + V T Y AP+
Sbjct: 116 CH---ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV-TLWYRAPDV 171
Query: 444 ALYGQLTEKS-DVYSFGIVILELMSGRKVLDTSTSPFQLI 482
L + S D++S G ++ E+++GR + + + QL+
Sbjct: 172 LLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLL 211
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 3e-16
Identities = 53/166 (31%), Positives = 85/166 (51%), Gaps = 16/166 (9%)
Query: 322 LLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGI 381
L L C T D R + V +Y+ G L +I K K+ P ++A G+
Sbjct: 63 LTQLHSCFQTMD-----RLYFVMEYVNGGDLMYHIQQVGKFKE---PHAVFYAAEIAIGL 114
Query: 382 AYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRV-AGTFGYLA 440
+LH GI +RD+K N++LD+E + K+ADFG+ K+++ G TTR GT Y+A
Sbjct: 115 FFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK--TTRTFCGTPDYIA 169
Query: 441 PEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSP--FQLITD 484
PE Y + D ++FG+++ E+++G+ D FQ I +
Sbjct: 170 PEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIME 215
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 3e-16
Identities = 64/227 (28%), Positives = 108/227 (47%), Gaps = 31/227 (13%)
Query: 251 AKWFHVSELEQATNGFSQNNLIGQGASGIVYKGT-LRHGNL----VAVKQILDLDTKGDE 305
A+ +EL + L+G G G V+KG + G+ VA+K I D G +
Sbjct: 1 ARILKETELRKL-------KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQD--RSGRQ 51
Query: 306 DF---TNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKR 362
F T+ + + + H ++ L G C G LV P G+L D++ +
Sbjct: 52 TFQEITDHMLAMGSLDHAYIVRLLGIC------PGASLQLVTQLSPLGSLLDHV---RQH 102
Query: 363 KQLTWPQRK-KIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQS 421
+ PQR V +AKG+ YL + + HR++ + NILL S+ ++ADFG+A
Sbjct: 103 RDSLDPQRLLNWCVQIAKGMYYLE---EHRMVHRNLAARNILLKSDSIVQIADFGVADLL 159
Query: 422 L-EGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS 467
+ + + ++A E L+G+ T +SDV+S+G+ + E+MS
Sbjct: 160 YPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 3e-16
Identities = 57/210 (27%), Positives = 103/210 (49%), Gaps = 32/210 (15%)
Query: 271 LIGQGASGIVYKGTLRH---GNLVAVKQILDLDTKGDEDFTN-----EVEIISKIRHRNL 322
L+G+G+ G+V K +H G +VA+K+ L+ + D+ E+ ++ ++RH NL
Sbjct: 8 LVGEGSYGMVMK--CKHKETGQIVAIKKFLESE---DDKMVKKIAMREIRMLKQLRHENL 62
Query: 323 LSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIA 382
++L KR +LV++++ + L D + L + +K + + +GI
Sbjct: 63 VNLIEVF-----RRKKRLYLVFEFVDHTVLDD---LEKYPNGLDESRVRKYLFQILRGIE 114
Query: 383 YLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPE 442
+ H I HRDIK NIL+ K+ DFG A+ +L + T T Y APE
Sbjct: 115 FCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFAR-TLAAPGEVYTDYVATRWYRAPE 170
Query: 443 YAL----YGQLTEKSDVYSFGIVILELMSG 468
+ YG+ D+++ G ++ E+++G
Sbjct: 171 LLVGDTKYGRAV---DIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 78.9 bits (195), Expect = 4e-16
Identities = 57/216 (26%), Positives = 99/216 (45%), Gaps = 37/216 (17%)
Query: 286 RHGNLVAVKQIL-DLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFLVY 344
LVAVK + D EDF EV+I+S++ N+ L G C ++
Sbjct: 44 DAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPL-----CMIM 98
Query: 345 DYMPNGTLS--------DNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRD 396
+YM NG L+ + ++ K L++ + +A G+ YL HRD
Sbjct: 99 EYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRD 155
Query: 397 IKSTNILLDSELNAKVADFGLAKQ-------SLEGHSHLTTRVAGTFGYLAPEYALYGQL 449
+ + N L+ K+ADFG+++ ++G + L R ++A E L G+
Sbjct: 156 LATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIR------WMAWESVLLGKF 209
Query: 450 TEKSDVYSFGIVILELMS-GRKVLDTSTSPFQLITD 484
T KSDV++FG+ + E+++ R+ P++ +TD
Sbjct: 210 TTKSDVWAFGVTLWEILTLCRE------QPYEHLTD 239
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 4e-16
Identities = 69/274 (25%), Positives = 113/274 (41%), Gaps = 40/274 (14%)
Query: 272 IGQGASGIVYKGTLRHGNLVAVKQILDLDTKGD--EDFTNEVEIISKIRHRNLLSLRGCC 329
+G G G V K V K+++ + K + E++I+ + R ++S G
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72
Query: 330 VTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLK 389
+ ++ + ++M G+L I K + KI V V +G+ YL+ +
Sbjct: 73 LNENNIC-----MCMEFMDCGSLD---RIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHR 124
Query: 390 PGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTF----GYLAPEYAL 445
I HRDIK +NIL++S K+ DFG++ + L +A TF Y++PE
Sbjct: 125 --IMHRDIKPSNILVNSRGQIKLCDFGVSGE-------LINSIADTFVGTSTYMSPERIQ 175
Query: 446 YGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDEFIRA 505
G+ T KSDV+S GI I+EL G+ PF + D+ + ++
Sbjct: 176 GGKYTVKSDVWSLGISIIELALGK-------FPFAFSNIDDDGQDDPMGILDLLQQIVQE 228
Query: 506 EGAR-------AVMERFVLVGILCAHVMVALRPT 532
R + FV C RPT
Sbjct: 229 PPPRLPSSDFPEDLRDFV---DACLLKDPTERPT 259
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 5e-16
Identities = 66/205 (32%), Positives = 97/205 (47%), Gaps = 13/205 (6%)
Query: 272 IGQGASGIVYKGT-LRHGNLVAVKQILDLDTKGDEDFTNEVEIISKI-RHRNLLSLRGCC 329
IG+G G VYK T + G+L AVK ILD + DE+ E I+ + H N++ G
Sbjct: 30 IGKGTYGKVYKVTNKKDGSLAAVK-ILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMF 88
Query: 330 VTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQ-LTWPQRKKIIVDVAKGIAYLHYGL 388
+D G + +LV + G++++ + Q L I+ G+ +LH
Sbjct: 89 YKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLH--- 145
Query: 389 KPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALYGQ 448
I HRD+K NILL +E K+ DFG++ Q T V GT ++APE Q
Sbjct: 146 NNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GTPFWMAPEVIACEQ 204
Query: 449 LTEKS-----DVYSFGIVILELMSG 468
+ S DV+S GI +EL G
Sbjct: 205 QYDYSYDARCDVWSLGITAIELGDG 229
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 5e-16
Identities = 58/205 (28%), Positives = 99/205 (48%), Gaps = 15/205 (7%)
Query: 266 FSQNNLIGQGASGIVYKGTLRHGNLVAVKQILDLDTKGDE--DFTNEVEIISKIRHRNLL 323
F++ IG+G+ G V+KG V +I+DL+ DE D E+ ++S+ +
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 324 SLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAY 383
G + G + +++ +Y+ G+ D + + Q ++ ++ KG+ Y
Sbjct: 66 KYYGSYL-----KGTKLWIIMEYLGGGSALDLL----RAGPFDEFQIATMLKEILKGLDY 116
Query: 384 LHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEY 443
LH K HRDIK+ N+LL + + K+ADFG+A Q + T V F ++APE
Sbjct: 117 LHSEKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPF-WMAPEV 172
Query: 444 ALYGQLTEKSDVYSFGIVILELMSG 468
K+D++S GI +EL G
Sbjct: 173 IQQSAYDSKADIWSLGITAIELAKG 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 78.4 bits (194), Expect = 6e-16
Identities = 73/216 (33%), Positives = 105/216 (48%), Gaps = 49/216 (22%)
Query: 272 IGQGASGIV----YKGTLRHGNLVAVKQILD----LDTKGDEDFTNEVEIISKIRHRNLL 323
+G G+ G V +KG+ G A+K IL + K E NE I+ IRH L+
Sbjct: 9 LGTGSFGRVMLVRHKGS---GKYYALK-ILSKAKIVKLKQVEHVLNEKRILQSIRHPFLV 64
Query: 324 SLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAK---- 379
+L G DDS+ +LV +Y+P G L SH RK + VA+
Sbjct: 65 NLYGS--FQDDSN---LYLVMEYVPGGEL-----FSHLRK------SGRFPEPVARFYAA 108
Query: 380 ----GIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGT 435
+ YLH I +RD+K N+LLDS+ K+ DFG AK+ ++G T + GT
Sbjct: 109 QVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKR-VKGR---TYTLCGT 161
Query: 436 FGYLAPEYAL---YGQLTEKSDVYSFGIVILELMSG 468
YLAPE L YG+ D ++ GI+I E+++G
Sbjct: 162 PEYLAPEIILSKGYGKA---VDWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 8e-16
Identities = 69/227 (30%), Positives = 112/227 (49%), Gaps = 32/227 (14%)
Query: 272 IGQGASGIVYKGTLRH---GNLVAVKQI-LDLDTKGDEDFTNEVEIISKIRHRNLLSLR- 326
+G+GA G+V K +RH G ++AVK+I ++++ + +++I S+R
Sbjct: 9 LGRGAYGVVDK--MRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDI----------SMRS 56
Query: 327 GCCVTSDDSSGK--RRFLVYDYMP-NGTLSDNISISHKRKQLTWPQR--KKIIVDVAKGI 381
C + G R V+ M T D K LT P+ KI V + K +
Sbjct: 57 VDCPYTVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKAL 116
Query: 382 AYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAP 441
YLH L + HRD+K +N+L++ K+ DFG++ ++ S T AG Y+AP
Sbjct: 117 EYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD--SVAKTIDAGCKPYMAP 172
Query: 442 EYALYGQLTE-----KSDVYSFGIVILELMSGRKVLDTSTSPFQLIT 483
E + +L + KSDV+S GI ++EL +GR D+ +PFQ +
Sbjct: 173 E-RINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLK 218
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 1e-15
Identities = 66/244 (27%), Positives = 112/244 (45%), Gaps = 41/244 (16%)
Query: 290 LVAVKQIL--DLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFLVYDYM 347
LVAVK IL D + DF EV+I+S+++ N++ L G CV D ++ +YM
Sbjct: 48 LVAVK-ILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLC-----MITEYM 101
Query: 348 PNGTL----------------SDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPG 391
NG L +D + +H +++ + + +A G+ YL
Sbjct: 102 ENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS---SLN 158
Query: 392 IYHRDIKSTNILLDSELNAKVADFGLAKQSLEG-HSHLTTRVAGTFGYLAPEYALYGQLT 450
HRD+ + N L+ L K+ADFG+++ G + + R ++A E L G+ T
Sbjct: 159 FVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFT 218
Query: 451 EKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDEFIRAEGARA 510
SDV++FG+ + E++ K P+ +TD V+ +G EF R +G +
Sbjct: 219 TASDVWAFGVTLWEILMLCK-----EQPYGELTD-EQVIENAG-------EFFRDQGRQV 265
Query: 511 VMER 514
+ R
Sbjct: 266 YLFR 269
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 1e-15
Identities = 70/241 (29%), Positives = 107/241 (44%), Gaps = 43/241 (17%)
Query: 266 FSQNNL-----IGQGASGIVYKGTLRH---GNLVAVKQI-LDLDTKGDEDFTNEVEIISK 316
F+ +L IG+GA G V K + H G ++AVK+I +D K + +++++ +
Sbjct: 1 FTAEDLKDLGEIGRGAFGTVNK--MLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMR 58
Query: 317 -------IRHRNLLSLRG----CCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQL 365
++ L G C D S K VY+ + + + I
Sbjct: 59 SSDCPYIVKFYGALFREGDCWICMELMDISLDKFYKYVYEVL-KSVIPEEI--------- 108
Query: 366 TWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGH 425
KI V K + YL LK I HRD+K +NILLD N K+ DFG++ Q ++
Sbjct: 109 ----LGKIAVATVKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGISGQLVD-- 160
Query: 426 SHLTTRVAGTFGYLAPEYALYGQLTE---KSDVYSFGIVILELMSGRKVLDTSTSPFQLI 482
S TR AG Y+APE +SDV+S GI + E+ +G+ S F +
Sbjct: 161 SIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQL 220
Query: 483 T 483
T
Sbjct: 221 T 221
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 1e-15
Identities = 50/154 (32%), Positives = 84/154 (54%), Gaps = 16/154 (10%)
Query: 322 LLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGI 381
L L C T D R + V +Y+ G L +I K K+ PQ +++ G+
Sbjct: 63 LTQLHSCFQTVD-----RLYFVMEYVNGGDLMYHIQQVGKFKE---PQAVFYAAEISVGL 114
Query: 382 AYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSL-EGHSHLTTRV-AGTFGYL 439
+LH + GI +RD+K N++LDSE + K+ADFG+ K+ + +G +TTR GT Y+
Sbjct: 115 FFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG---VTTRTFCGTPDYI 168
Query: 440 APEYALYGQLTEKSDVYSFGIVILELMSGRKVLD 473
APE Y + D +++G+++ E+++G+ D
Sbjct: 169 APEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 1e-15
Identities = 59/218 (27%), Positives = 104/218 (47%), Gaps = 31/218 (14%)
Query: 266 FSQNNLIGQGASGIVYKGTLRH-GNLVAVKQILDLDTKGDEDFTN---------EVEIIS 315
+ + IG+GA G+V T + G VA+K+I F + E++I+
Sbjct: 7 YQNLSYIGEGAYGMVCSATHKPTGVKVAIKKI--------SPFEHQTFCQRTLREIKILR 58
Query: 316 KIRHRNLLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIV 375
+ +H N++ + S ++V + M L I K + L+ + +
Sbjct: 59 RFKHENIIGILDIIRPPSFESFNDVYIVQELMET-DLYKLI----KTQHLSNDHIQYFLY 113
Query: 376 DVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSH---LTTRV 432
+ +G+ Y+H + HRD+K +N+LL++ + K+ DFGLA+ + H H LT V
Sbjct: 114 QILRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYV 170
Query: 433 AGTFGYLAPEYALYGQLTEKS-DVYSFGIVILELMSGR 469
A T Y APE L + K+ D++S G ++ E++S R
Sbjct: 171 A-TRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 1e-15
Identities = 57/208 (27%), Positives = 105/208 (50%), Gaps = 22/208 (10%)
Query: 272 IGQGASGIVYKG-TLRHGNLVAVKQI-LDLDTKG-DEDFTNEVEIISKIRHRNLLSLRGC 328
IG+G G+VYK G +VA+K+I LD +T+G E+ ++ ++ H N++ L
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 67
Query: 329 CVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGL 388
T + +LV++++ + L + S + P K + + +G+A+ H
Sbjct: 68 IHTE-----NKLYLVFEFL-HQDLKKFMDASPL-SGIPLPLIKSYLFQLLQGLAFCH--- 117
Query: 389 KPGIYHRDIKSTNILLDSELNAKVADFGLAKQ---SLEGHSHLTTRVAGTFGYLAPEYAL 445
+ HRD+K N+L+++E K+ADFGLA+ + ++H T Y APE L
Sbjct: 118 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV----TLWYRAPEILL 173
Query: 446 YGQL-TEKSDVYSFGIVILELMSGRKVL 472
+ + D++S G + E+++ R+ L
Sbjct: 174 GCKYYSTAVDIWSLGCIFAEMVT-RRAL 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 1e-15
Identities = 56/212 (26%), Positives = 106/212 (50%), Gaps = 26/212 (12%)
Query: 271 LIGQGASGIVYKGT-LRHGNLVAVKQI-LDLDTKGDEDFT-----NEVEIISKIRHRNLL 323
+G GA Y+ ++ G L+AVKQ+ +T +++ E+ +++++ H +++
Sbjct: 7 QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66
Query: 324 SLRGCCVTSDDSSGKRRFLVY-DYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIA 382
+ G T +DS F ++ ++M G++S + K + +G++
Sbjct: 67 RMLG--ATCEDS----HFNLFVEWMAGGSVS---HLLSKYGAFKEAVIINYTEQLLRGLS 117
Query: 383 YLHYGLKPGIYHRDIKSTNILLDSE-LNAKVADFGLAKQ---SLEGHSHLTTRVAGTFGY 438
YLH + I HRD+K N+L+DS ++ADFG A + G ++ GT +
Sbjct: 118 YLH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAF 174
Query: 439 LAPEYALYGQLTEKS-DVYSFGIVILELMSGR 469
+APE L G+ +S DV+S G VI+E+ + +
Sbjct: 175 MAPE-VLRGEQYGRSCDVWSVGCVIIEMATAK 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 2e-15
Identities = 67/207 (32%), Positives = 100/207 (48%), Gaps = 23/207 (11%)
Query: 266 FSQNNLIGQGASGIVYKG-TLRHGNLVAVKQILDLDTKGDE---DFTNEVEIISKIRHRN 321
FS IG G+ G VY +R+ +VA+K++ + +E D EV + K+RH N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 322 LLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGI 381
+ RGC + + +LV +Y G+ SD + + HK K L + + +G+
Sbjct: 77 TIQYRGCYLREHTA-----WLVMEYCL-GSASDLLEV-HK-KPLQEVEIAAVTHGALQGL 128
Query: 382 AYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAP 441
AYLH + HRD+K+ NILL K+ DFG A + + GT ++AP
Sbjct: 129 AYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV-----GTPYWMAP 180
Query: 442 EYALY---GQLTEKSDVYSFGIVILEL 465
E L GQ K DV+S GI +EL
Sbjct: 181 EVILAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 2e-15
Identities = 65/237 (27%), Positives = 108/237 (45%), Gaps = 49/237 (20%)
Query: 269 NNLIGQGASGIVYKG-TLRHGNLVAVKQILDLDTKGDED------------FT--NEVEI 313
+G+G G V K G +VA+K++ ++ D FT E++I
Sbjct: 14 GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKI 73
Query: 314 ISKIRHRNLLSLRGCCVTSDDSSGKRRF--LVYDYMPNGTLSDNISISHKRKQLTWPQRK 371
+++I+H N++ L V D F LV D M SD + ++ +LT Q K
Sbjct: 74 MNEIKHENIMGLVDVYVEGD-------FINLVMDIMA----SDLKKVVDRKIRLTESQVK 122
Query: 372 KIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQ----------S 421
I++ + G+ LH K HRD+ NI ++S+ K+ADFGLA++ S
Sbjct: 123 CILLQILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLS 179
Query: 422 LEGHS----HLTTRVAGTFGYLAPEYALYG--QLTEKSDVYSFGIVILELMSGRKVL 472
+ +T++V T Y APE L G + D++S G + EL++G+ +
Sbjct: 180 KDETMQRREEMTSKVV-TLWYRAPEL-LMGAEKYHFAVDMWSVGCIFAELLTGKPLF 234
|
Length = 335 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 2e-15
Identities = 63/213 (29%), Positives = 101/213 (47%), Gaps = 17/213 (7%)
Query: 271 LIGQGASGIVY--KGTLRHGNLVAVKQILDLDTKGDEDFT--NEVEIISKIRHRNLLSLR 326
++G+GA GIV+ + LV +KQI DE NE +++ + H N++
Sbjct: 7 VVGRGAFGIVHLCRRKADQ-KLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYY 65
Query: 327 GCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHY 386
+ K +V +Y P GTL++ I KR + I+ + + LH+
Sbjct: 66 ENFLED-----KALMIVMEYAPGGTLAEYI---QKRCNSLLDE-DTILHFFVQILLALHH 116
Query: 387 GLKPGIYHRDIKSTNILLDSELNA-KVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYAL 445
I HRD+K+ NILLD K+ DFG++K L S T V GT Y++PE
Sbjct: 117 VHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKI-LSSKSKAYT-VVGTPCYISPELCE 174
Query: 446 YGQLTEKSDVYSFGIVILELMSGRKVLDTSTSP 478
+KSD+++ G V+ EL S ++ + + P
Sbjct: 175 GKPYNQKSDIWALGCVLYELASLKRAFEAANLP 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.3 bits (191), Expect = 2e-15
Identities = 64/246 (26%), Positives = 103/246 (41%), Gaps = 60/246 (24%)
Query: 272 IGQGASGIVYKG---TLRHGNLVAVKQILDLDTKGDEDFTN--------EVEIISKIRHR 320
IG+G G VYK + G A+K+ KGD++ E+ ++ +++H
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIKKF-----KGDKEQYTGISQSACREIALLRELKHE 62
Query: 321 NLLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISI-----SHKRKQLTWPQRKKIIV 375
N++SL + D K +L++DY + D I KR + K ++
Sbjct: 63 NVVSLVEVFLEHAD---KSVYLLFDYAEH----DLWQIIKFHRQAKRVSIPPSMVKSLLW 115
Query: 376 DVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNA----KVADFGLA-------KQSLEG 424
+ G+ YLH + HRD+K NIL+ E K+ D GLA K +
Sbjct: 116 QILNGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADL 172
Query: 425 HSHLTTRVAGTFGYLAPEYAL----YGQLTEKSDVYSFGIVILELMS------GRKVLDT 474
V T Y APE L Y T+ D+++ G + EL++ GR+
Sbjct: 173 D-----PVVVTIWYRAPELLLGARHY---TKAIDIWAIGCIFAELLTLEPIFKGREAKIK 224
Query: 475 STSPFQ 480
++PFQ
Sbjct: 225 KSNPFQ 230
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 2e-15
Identities = 60/216 (27%), Positives = 95/216 (43%), Gaps = 28/216 (12%)
Query: 272 IGQGASGIVYKGTLRH-GNLVAVKQILDLDTK------GDEDFTNEVEIISKIRHRNLLS 324
+G+G G V ++ G + A K+ LD K G++ NE +I+ K+ R ++S
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKK---LDKKRLKKRKGEQMALNEKKILEKVSSRFIVS 57
Query: 325 LRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYL 384
L T DD LV M G L +I + + + G+ +L
Sbjct: 58 LAYAFETKDDLC-----LVMTLMNGGDLKYHIY-NVGEPGFPEARAIFYAAQIICGLEHL 111
Query: 385 HYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYA 444
H + I +RD+K N+LLD N +++D GLA + G AGT GY+APE
Sbjct: 112 H---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK--IKGRAGTPGYMAPEVL 166
Query: 445 LYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQ 480
D ++ G + E+++GR SPF+
Sbjct: 167 QGEVYDFSVDWFALGCTLYEMIAGR-------SPFR 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 76.3 bits (187), Expect = 2e-15
Identities = 63/218 (28%), Positives = 105/218 (48%), Gaps = 32/218 (14%)
Query: 270 NLIGQGASGIVYKGTLRHGNL---VAVKQILDLDTKGD-EDFTNEVEIISKI-RHRNLLS 324
++IG+G G V K ++ L A+K++ + +K D DF E+E++ K+ H N+++
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 325 LRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISH-------------KRKQLTWPQRK 371
L G C + G +L +Y P+G L D + S L+ Q
Sbjct: 61 LLGAC----EHRG-YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 115
Query: 372 KIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTR 431
DVA+G+ YL + HRD+ + NIL+ AK+ADFGL++ G +
Sbjct: 116 HFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVKK 168
Query: 432 VAGTFG--YLAPEYALYGQLTEKSDVYSFGIVILELMS 467
G ++A E Y T SDV+S+G+++ E++S
Sbjct: 169 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 3e-15
Identities = 72/231 (31%), Positives = 111/231 (48%), Gaps = 37/231 (16%)
Query: 272 IGQGASGIVYKGT-LRHGNLVAVKQILDLDTKGDEDFTN---------EVEIISKIRHRN 321
IG GA G+V+ T R G VA+K++ ++ F N E++++ +H N
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMPNV-------FQNLVSCKRVFRELKMLCFFKHDN 60
Query: 322 LLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSD--NISISHKRKQLTWPQRKKIIVDVAK 379
+LS + ++V + M SD I +S + L+ K + + +
Sbjct: 61 VLSALDILQPPHIDPFEEIYVVTELMQ----SDLHKIIVSPQP--LSSDHVKVFLYQILR 114
Query: 380 GIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLA-KQSLEGHSHLTTRVAGTFGY 438
G+ YLH GI HRDIK N+L++S K+ DFGLA + + H+T V + Y
Sbjct: 115 GLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQY-Y 170
Query: 439 LAPEYALYG--QLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQ---LITD 484
APE L G T D++S G + EL+ GR++L + SP Q LITD
Sbjct: 171 RAPEI-LMGSRHYTSAVDIWSVGCIFAELL-GRRILFQAQSPIQQLDLITD 219
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 3e-15
Identities = 61/210 (29%), Positives = 101/210 (48%), Gaps = 20/210 (9%)
Query: 272 IGQGASGIVYKGT-LRHGNLVAVKQI---LDLDTKGDEDFTNEVEIISKIRHRNLLSLRG 327
IG GA G+V R G VA+K+I D+ T E++I+ +H N++++R
Sbjct: 13 IGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTL-RELKILRHFKHDNIIAIRD 71
Query: 328 CCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYG 387
+ + K ++V D M SD I H + LT + + + +G+ Y+H
Sbjct: 72 I-LRPPGADFKDVYVVMDLME----SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIH-- 124
Query: 388 LKPGIYHRDIKSTNILLDSELNAKVADFGLAK----QSLEGHSHLTTRVAGTFGYLAPEY 443
+ HRD+K +N+L++ + ++ DFG+A+ E +T VA T Y APE
Sbjct: 125 -SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVA-TRWYRAPEL 182
Query: 444 AL-YGQLTEKSDVYSFGIVILELMSGRKVL 472
L + T D++S G + E M GR+ L
Sbjct: 183 LLSLPEYTTAIDMWSVGCIFAE-MLGRRQL 211
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 76.7 bits (188), Expect = 3e-15
Identities = 68/207 (32%), Positives = 103/207 (49%), Gaps = 23/207 (11%)
Query: 266 FSQNNLIGQGASGIVY-KGTLRHGNLVAVKQILDLDTKGDE---DFTNEVEIISKIRHRN 321
F+ IG G+ G VY +R +VA+K++ + +E D EV+ + +I+H N
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 322 LLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGI 381
+ +GC + + +LV +Y G+ SD + + HK K L + I +G+
Sbjct: 87 SIEYKGCYLREHTA-----WLVMEYCL-GSASDLLEV-HK-KPLQEVEIAAITHGALQGL 138
Query: 382 AYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAP 441
AYLH + HRDIK+ NILL K+ADFG A + +S + GT ++AP
Sbjct: 139 AYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFV-----GTPYWMAP 190
Query: 442 EYALY---GQLTEKSDVYSFGIVILEL 465
E L GQ K DV+S GI +EL
Sbjct: 191 EVILAMDEGQYDGKVDVWSLGITCIEL 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 3e-15
Identities = 60/209 (28%), Positives = 101/209 (48%), Gaps = 21/209 (10%)
Query: 271 LIGQGASGIVYKG-TLRHGNLVAVKQI-LDLDTKGDEDFTN----EVEIISKIRHRNLLS 324
L+GQGA G VY G +AVKQ+ D ++ N E++++ + H ++
Sbjct: 9 LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68
Query: 325 LRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYL 384
GC D + + ++MP G++ D + LT +K + +G++YL
Sbjct: 69 YYGCL---RDPMERTLSIFMEHMPGGSIKDQLK---SYGALTENVTRKYTRQILEGVSYL 122
Query: 385 HYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQ----SLEGHSHLTTRVAGTFGYLA 440
H + I HRDIK NIL DS N K+ DFG +K+ L G + V GT +++
Sbjct: 123 HSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKS--VTGTPYWMS 177
Query: 441 PEYALYGQLTEKSDVYSFGIVILELMSGR 469
PE K+D++S G ++E+++ +
Sbjct: 178 PEVISGEGYGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 4e-15
Identities = 63/219 (28%), Positives = 103/219 (47%), Gaps = 30/219 (13%)
Query: 271 LIGQGASGIVYKGTLRHGN------LVAVKQILDLDTKGD-EDFTNEVEIISKI-RHRNL 322
+G+GA G V K + VAVK + D T+ D D +E+E++ I +H+N+
Sbjct: 19 PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 78
Query: 323 LSLRGCC--------VTSDDSSGK-RRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKI 373
++L G C V + G R FL P S + + LT
Sbjct: 79 INLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPP-EETLTQKDLVSF 137
Query: 374 IVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHS----HLT 429
VA+G+ +L HRD+ + N+L+ + K+ADFGLA+ + H T
Sbjct: 138 AYQVARGMEFLA---SKKCIHRDLAARNVLVTEDHVMKIADFGLAR---DIHHIDYYRKT 191
Query: 430 TRVAGTFGYLAPEYALYGQL-TEKSDVYSFGIVILELMS 467
T ++APE AL+ ++ T +SDV+SFG+++ E+ +
Sbjct: 192 TNGRLPVKWMAPE-ALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 5e-15
Identities = 61/203 (30%), Positives = 97/203 (47%), Gaps = 24/203 (11%)
Query: 272 IGQGASGIVYKGTLRHGNLVAVKQILDLD---TKGDEDFTNEVEIISKIRHRNLLSLRGC 328
IG+G+ G +Y + + V + +DL K E EV +++K++H N+++
Sbjct: 8 IGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTF--- 64
Query: 329 CVTSDDSSGKRRFLVYDYMPNGTLSDNISISH-----KRKQLTWPQRKKIIVDVAKGIAY 383
S +G R F+V +Y G L I+ + + L+W V ++ G+ +
Sbjct: 65 -FASFQENG-RLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSW------FVQISLGLKH 116
Query: 384 LHYGLKPGIYHRDIKSTNILLDSE-LNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPE 442
+H I HRDIKS NI L + AK+ DFG+A+Q L L GT YL+PE
Sbjct: 117 IH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQ-LNDSMELAYTCVGTPYYLSPE 172
Query: 443 YALYGQLTEKSDVYSFGIVILEL 465
K+D++S G V+ EL
Sbjct: 173 ICQNRPYNNKTDIWSLGCVLYEL 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 5e-15
Identities = 66/223 (29%), Positives = 110/223 (49%), Gaps = 33/223 (14%)
Query: 266 FSQNNLIGQGASGIVYKGT-LRHGN----LVAVKQILDLDT-KGDEDFTNEVEIISKIRH 319
F + ++G GA G VYKG + G VA+K++ + + K +++ +E +++ + +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 320 RNLLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHK-----RKQLTWPQRKKII 374
++ L G C+TS L+ MP G L D + HK + L W
Sbjct: 69 PHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVR-EHKDNIGSQYLLNW------C 115
Query: 375 VDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAG 434
V +AKG+ YL + + HRD+ + N+L+ + + K+ DFGLAK L G G
Sbjct: 116 VQIAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAK--LLGADEKEYHAEG 170
Query: 435 ---TFGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLD 473
++A E L+ T +SDV+S+G+ + ELM+ G K D
Sbjct: 171 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 5e-15
Identities = 59/205 (28%), Positives = 97/205 (47%), Gaps = 15/205 (7%)
Query: 266 FSQNNLIGQGASGIVYKGTLRHGNLVAVKQILDLDTKGDE--DFTNEVEIISKIRHRNLL 323
F++ IG+G+ G V+KG V +I+DL+ DE D E+ ++S+ +
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 324 SLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAY 383
G + + +++ +Y+ G+ D + + L Q I+ ++ KG+ Y
Sbjct: 66 KYYGSYLKD-----TKLWIIMEYLGGGSALDLL----EPGPLDETQIATILREILKGLDY 116
Query: 384 LHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEY 443
LH K HRDIK+ N+LL K+ADFG+A Q + T V F ++APE
Sbjct: 117 LHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPF-WMAPEV 172
Query: 444 ALYGQLTEKSDVYSFGIVILELMSG 468
K+D++S GI +EL G
Sbjct: 173 IKQSAYDSKADIWSLGITAIELAKG 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 5e-15
Identities = 60/206 (29%), Positives = 102/206 (49%), Gaps = 13/206 (6%)
Query: 272 IGQGASGIVYKGTLRHGNL---VAVKQI-LDLDTKGD-EDFTNEVEIISKIRHRNLLSLR 326
+G+G G V +G L + VAVK + + + T+ + EDF +E + + H N++ L
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 327 GCCVTSDDSSG-KRRFLVYDYMPNGTLSDNISISHKRKQ-LTWPQRK--KIIVDVAKGIA 382
G C+ + +S G ++ +M +G L + S P + K + D+A G+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 383 YLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGT-FGYLAP 441
YL HRD+ + N +L+ +N VADFGL+K+ G + R+A ++A
Sbjct: 127 YLS---SKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183
Query: 442 EYALYGQLTEKSDVYSFGIVILELMS 467
E T KSDV+SFG+ + E+ +
Sbjct: 184 ESLADRVYTTKSDVWSFGVTMWEIAT 209
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 6e-15
Identities = 57/198 (28%), Positives = 98/198 (49%), Gaps = 14/198 (7%)
Query: 272 IGQGASGIVYKG-TLRHGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCV 330
IGQGASG VY + G VA+KQ+ E NE+ ++ + ++ N+++ +
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 86
Query: 331 TSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKP 390
D+ ++V +Y+ G+L+D ++ + Q + + + + +LH
Sbjct: 87 VGDE-----LWVVMEYLAGGSLTDVVT----ETCMDEGQIAAVCRECLQALDFLHSN--- 134
Query: 391 GIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALYGQLT 450
+ HRDIKS NILL + + K+ DFG Q S +T V GT ++APE
Sbjct: 135 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYG 193
Query: 451 EKSDVYSFGIVILELMSG 468
K D++S GI+ +E++ G
Sbjct: 194 PKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 7e-15
Identities = 46/140 (32%), Positives = 74/140 (52%), Gaps = 14/140 (10%)
Query: 341 FLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKST 400
F V +Y+ G L +I HK P+ ++ G+ +LH GI +RD+K
Sbjct: 72 FFVMEYLNGGDLMFHIQSCHK---FDLPRATFYAAEIICGLQFLH---SKGIVYRDLKLD 125
Query: 401 NILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGI 460
NILLD++ + K+ADFG+ K+++ G + T GT Y+APE L + D +SFG+
Sbjct: 126 NILLDTDGHIKIADFGMCKENMLGDAK-TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGV 184
Query: 461 VILELMSGRKVLDTSTSPFQ 480
++ E++ G+ SPF
Sbjct: 185 LLYEMLIGQ-------SPFH 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 8e-15
Identities = 58/206 (28%), Positives = 101/206 (49%), Gaps = 18/206 (8%)
Query: 272 IGQGASGIVYKGTLRHGNL---VAVKQILDLDTKGDED-FTNEVEIISKIRHRNLLSLRG 327
+G G G V KG + VA+K + + + K D E EI+ ++ + ++ + G
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 328 CCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYG 387
C + LV + G L N +S K+ ++T +++ V+ G+ YL
Sbjct: 63 VC------EAEALMLVMEMASGGPL--NKFLSGKKDEITVSNVVELMHQVSMGMKYLE-- 112
Query: 388 LKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTF--GYLAPEYAL 445
HRD+ + N+LL ++ AK++DFGL+K S+ R AG + + APE
Sbjct: 113 -GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECIN 171
Query: 446 YGQLTEKSDVYSFGIVILELMS-GRK 470
+ + + +SDV+S+GI + E S G+K
Sbjct: 172 FRKFSSRSDVWSYGITMWEAFSYGQK 197
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 8e-15
Identities = 59/211 (27%), Positives = 104/211 (49%), Gaps = 14/211 (6%)
Query: 266 FSQNNLIGQGASGIVYKGT-LRHGNLVAVKQILDLDTKGDEDFTNEVEIISKI-RHRNLL 323
F L+G G G VYKG ++ G L A+K ++D+ +E+ E+ ++ K HRN+
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIK-VMDVTGDEEEEIKQEINMLKKYSHHRNIA 66
Query: 324 SLRGCCVTSDDSS-GKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIA 382
+ G + + + +LV ++ G+++D I + K L I ++ +G++
Sbjct: 67 TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIK-NTKGNTLKEEWIAYICREILRGLS 125
Query: 383 YLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPE 442
+LH + + HRDIK N+LL K+ DFG++ Q L+ GT ++APE
Sbjct: 126 HLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ-LDRTVGRRNTFIGTPYWMAPE 181
Query: 443 YALYGQLTE-----KSDVYSFGIVILELMSG 468
+ + KSD++S GI +E+ G
Sbjct: 182 VIACDENPDATYDFKSDLWSLGITAIEMAEG 212
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 1e-14
Identities = 53/200 (26%), Positives = 106/200 (53%), Gaps = 17/200 (8%)
Query: 272 IGQGASGIVYKGTLRHGNLVAVKQILDLDTKGD-EDFTNEVEIISKIRHRNLLSLRGCCV 330
+G GA G VYK + +A ++++ ++ + ED+ E+EI++ H ++ L G
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 331 TSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKP 390
+ +++ ++ P G + D I + R LT PQ + I + + + YLH
Sbjct: 80 WDG-----KLWIMIEFCPGGAV-DAIMLELDRG-LTEPQIQVICRQMLEALQYLH---SM 129
Query: 391 GIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALYGQLT 450
I HRD+K+ N+LL + + K+ADFG++ ++++ + + GT ++APE + +
Sbjct: 130 KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI-GTPYWMAPEVVMCETMK 188
Query: 451 E-----KSDVYSFGIVILEL 465
+ K+D++S GI ++E+
Sbjct: 189 DTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 1e-14
Identities = 67/238 (28%), Positives = 97/238 (40%), Gaps = 39/238 (16%)
Query: 272 IGQGASGIVYKGTLR-HGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCV 330
I +GA G VY R G+ A+K + K D N+V + K ++
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVL----KKSDMIAKNQVTNV-KAERAIMMIQGESPY 58
Query: 331 TSD----DSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHY 386
+ S +LV +Y+ G D S+ L K+ I +V G+ LH
Sbjct: 59 VAKLYYSFQSKDYLYLVMEYLNGG---DCASLIKTLGGLPEDWAKQYIAEVVLGVEDLH- 114
Query: 387 GLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALY 446
+ GI HRDIK N+L+D + K+ DFGL++ LE + GT YLAPE L
Sbjct: 115 --QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----NKKFVGTPDYLAPETILG 167
Query: 447 GQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDEFIR 504
+ SD +S G VI E + G PF + D +FD +
Sbjct: 168 VGDDKMSDWWSLGCVIFEFLFG-------YPPFH-----------AETPDAVFDNILS 207
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 2e-14
Identities = 50/189 (26%), Positives = 95/189 (50%), Gaps = 20/189 (10%)
Query: 290 LVAVKQIL-DLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFLVYDYMP 348
LVAVK + D + DF E++I+S+++ N++ L C+TSD ++ +YM
Sbjct: 48 LVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLC-----MITEYME 102
Query: 349 NGTLSDNISISHKRKQ---------LTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKS 399
NG L+ +S H+ ++ +++ + +A G+ YL HRD+ +
Sbjct: 103 NGDLNQFLS-RHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS---SLNFVHRDLAT 158
Query: 400 TNILLDSELNAKVADFGLAKQSLEG-HSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSF 458
N L+ K+ADFG+++ G + + R +++ E L G+ T SDV++F
Sbjct: 159 RNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAF 218
Query: 459 GIVILELMS 467
G+ + E+++
Sbjct: 219 GVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 2e-14
Identities = 60/239 (25%), Positives = 105/239 (43%), Gaps = 46/239 (19%)
Query: 264 NGFSQNNLIGQGASGIVYKGTLRHGN-LVAVKQILDLDTKGDEDFTN----EVEIISKIR 318
N F ++G+GA G+V K + +VA+K+ D ++ +E+ E++++ ++
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKD--SEENEEVKETTLRELKMLRTLK 58
Query: 319 HRNLLSLRGCCVTSDDSSGKRR---FLVYDY-----------MPNGTLSDNISISHKRKQ 364
N++ L+ + +RR +LV++Y MPNG + +
Sbjct: 59 QENIVELK--------EAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKV-------- 102
Query: 365 LTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEG 424
+ I + K I + H K I HRDIK N+L+ K+ DFG A+ EG
Sbjct: 103 ------RSYIYQLIKAIHWCH---KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEG 153
Query: 425 HSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLIT 483
+ T T Y +PE L + D++S G ++ EL G+ + + QL T
Sbjct: 154 SNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFT 212
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 2e-14
Identities = 57/225 (25%), Positives = 109/225 (48%), Gaps = 45/225 (20%)
Query: 272 IGQGASGIVYKGTL-----RHGNLVAVKQILDLDTKGD-EDFTNEVEIISKIRHRNLLSL 325
+G+ A G +YKG L H LVA+K + D++ +F E +++++ H N++ L
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72
Query: 326 RGCCVTSDDSSGKRRFLVYDYMPNGTLSD---------NISISHK-----RKQLTWPQRK 371
G VT + ++++Y+ G L + ++ S + L
Sbjct: 73 LGV-VTQEQPV----CMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFL 127
Query: 372 KIIVDVAKGIAYL--HYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQ-------SL 422
I + +A G+ YL H+ H+D+ + NIL+ +L+ K++D GL+++ +
Sbjct: 128 HIAIQIAAGMEYLSSHF-----FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRV 182
Query: 423 EGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS 467
+ S L R ++ PE +YG+ + SD++SFG+V+ E+ S
Sbjct: 183 QPKSLLPIR------WMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.1 bits (180), Expect = 3e-14
Identities = 62/208 (29%), Positives = 103/208 (49%), Gaps = 22/208 (10%)
Query: 272 IGQGASGIVYKG-TLRHGNLVAVKQI-LDLDTKGDEDFT-NEVEIISKIRHRNLLSLRGC 328
IG+G G+VYK G +VA+K+I L+ + +G E+ ++ ++ H N++ L
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66
Query: 329 CVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGL 388
V S+ + +LV++++ + L + S L P K + + +GIAY H
Sbjct: 67 -VHSE----NKLYLVFEFL-DLDLKKYMD-SSPLTGLDPPLIKSYLYQLLQGIAYCH--- 116
Query: 389 KPGIYHRDIKSTNILLDSELNAKVADFGLAKQ---SLEGHSHLTTRVAGTFGYLAPEYAL 445
+ HRD+K N+L+D E K+ADFGLA+ + ++H T Y APE L
Sbjct: 117 SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV----TLWYRAPEILL 172
Query: 446 YG-QLTEKSDVYSFGIVILELMSGRKVL 472
Q + D++S G + E M R+ L
Sbjct: 173 GSRQYSTPVDIWSIGCIFAE-MVNRRPL 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 4e-14
Identities = 60/227 (26%), Positives = 106/227 (46%), Gaps = 31/227 (13%)
Query: 263 TNGFSQNNLIGQGASGIVYKGT-LRHGNLVAVK--QILDL-DTKGDEDFTNEVEIISKIR 318
F IG+G +VYK L G +VA+K QI ++ D K +D E++++ ++
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 319 HRNLLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRK--KIIVD 376
H N++ + +++ + +V + G LS I K+K+L P+R K V
Sbjct: 61 HPNVIKYLASFIENNELN-----IVLELADAGDLSRMIKHFKKQKRLI-PERTIWKYFVQ 114
Query: 377 VAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAK----QSLEGHSHLTTRV 432
+ + ++H I HRDIK N+ + + K+ D GL + ++ HS +
Sbjct: 115 LCSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS-----L 166
Query: 433 AGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPF 479
GT Y++PE KSD++S G ++ E+ + + SPF
Sbjct: 167 VGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQ-------SPF 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 4e-14
Identities = 56/198 (28%), Positives = 98/198 (49%), Gaps = 14/198 (7%)
Query: 272 IGQGASGIVYKGT-LRHGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCV 330
IGQGASG VY + G VA++Q+ E NE+ ++ + ++ N+++ +
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 331 TSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKP 390
D+ ++V +Y+ G+L+D ++ + Q + + + + +LH
Sbjct: 88 VGDE-----LWVVMEYLAGGSLTDVVT----ETCMDEGQIAAVCRECLQALEFLHSN--- 135
Query: 391 GIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALYGQLT 450
+ HRDIKS NILL + + K+ DFG Q S +T V GT ++APE
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYG 194
Query: 451 EKSDVYSFGIVILELMSG 468
K D++S GI+ +E++ G
Sbjct: 195 PKVDIWSLGIMAIEMIEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 4e-14
Identities = 55/209 (26%), Positives = 96/209 (45%), Gaps = 21/209 (10%)
Query: 272 IGQGASGIVYKG-TLRHGNLVAVKQI-LDLDTKGDEDFT-NEVEIISKIRHRNLLSLRGC 328
IG+G G VYK G LVA+K+ L++D +G E+ ++ + +
Sbjct: 9 IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLD 68
Query: 329 CVTSDDSSGKRR-FLVYDYMPNGTLSDNISISHKRKQ---LTWPQRKKIIVDVAKGIAYL 384
++ +GK +LV++Y+ + L + S+ R L K + + KG+A+
Sbjct: 69 VEHVEEKNGKPSLYLVFEYL-DSDLKKFM-DSNGRGPGRPLPAKTIKSFMYQLLKGVAHC 126
Query: 385 HYGLKPGIYHRDIKSTNILLDSELNA-KVADFGLAKQ---SLEGHSHLTTRVAGTFGYLA 440
H K G+ HRD+K N+L+D + K+AD GL + ++ ++H T Y A
Sbjct: 127 H---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV----TLWYRA 179
Query: 441 PEYALYG-QLTEKSDVYSFGIVILELMSG 468
PE L + D++S G + E+
Sbjct: 180 PEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 9e-14
Identities = 53/215 (24%), Positives = 96/215 (44%), Gaps = 31/215 (14%)
Query: 271 LIGQGASGIVY----KGTLRHGN--LVAVKQILDLDTKGDE----DFTNEVEIISKIRHR 320
+G+G G V+ KG G LV VK L DE +F E+++ K+ H+
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKA---LQKTKDENLQSEFRRELDMFRKLSHK 68
Query: 321 NLLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKR------KQLTWPQRKKII 374
N++ L G C ++ +++ +Y G L + + + L+ Q+ +
Sbjct: 69 NVVRLLGLCREAEP-----HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALC 123
Query: 375 VDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQ--SLEGHSHLTTRV 432
+A G+ +L HRD+ + N L+ S+ KV+ L+K + E + +
Sbjct: 124 TQIALGMDHLS---NARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALI 180
Query: 433 AGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS 467
+LAPE + KSDV+SFG+++ E+ +
Sbjct: 181 P--LRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT 213
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 1e-13
Identities = 66/244 (27%), Positives = 113/244 (46%), Gaps = 41/244 (16%)
Query: 271 LIGQGASGIVYKGTLRH-GNLVAVKQILDLDTKGDED----FTNEVEIISKIRHRNLLSL 325
++G+G+ G V L+ G L AVK +L D +D E I+S R+ L+
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVK-VLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60
Query: 326 RGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLH 385
CC + D R F V +++ G L +I K ++ + + ++ + +LH
Sbjct: 61 LYCCFQTPD----RLFFVMEFVNGGDLMFHI---QKSRRFDEARARFYAAEITSALMFLH 113
Query: 386 YGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEY-- 443
GI +RD+K N+LLD E + K+ADFG+ K+ + + T+ GT Y+APE
Sbjct: 114 ---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIF-NGKTTSTFCGTPDYIAPEILQ 169
Query: 444 -ALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDEF 502
LYG D ++ G+++ E++ G +PF+ + DD+F+
Sbjct: 170 EMLYGPSV---DWWAMGVLLYEMLCGH-------APFEAENE-----------DDLFEAI 208
Query: 503 IRAE 506
+ E
Sbjct: 209 LNDE 212
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 1e-13
Identities = 50/165 (30%), Positives = 85/165 (51%), Gaps = 23/165 (13%)
Query: 322 LLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQR--KKIIVDVAK 379
L+ L C T+ R FLV +Y+ G L + H ++Q P+ + ++
Sbjct: 58 LVGLHSCFQTT-----SRLFLVIEYVNGGDL-----MFHMQRQRKLPEEHARFYAAEICI 107
Query: 380 GIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYL 439
+ +LH + GI +RD+K N+LLD++ + K+ D+G+ K+ L G T+ GT Y+
Sbjct: 108 ALNFLH---ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGL-GPGDTTSTFCGTPNYI 163
Query: 440 APEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITD 484
APE + D ++ G+++ E+M+GR SPF +ITD
Sbjct: 164 APEILRGEEYGFSVDWWALGVLMFEMMAGR-------SPFDIITD 201
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 1e-13
Identities = 64/205 (31%), Positives = 99/205 (48%), Gaps = 13/205 (6%)
Query: 272 IGQGASGIVYK-GTLRHGNLVAVKQILDLDTKGDEDFTNEVEIISKIR-HRNLLSLRGCC 329
IG+G G V+K ++G+ AVK ILD DE+ E I+ + H N++ G
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVK-ILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMY 84
Query: 330 VTSDDSSGKRRFLVYDYMPNGTLSDNISISHKR-KQLTWPQRKKIIVDVAKGIAYLHYGL 388
D +G + +LV + G+++D + KR +++ P I+ + G+ +LH
Sbjct: 85 YKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN- 143
Query: 389 KPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEY-ALYG 447
HRD+K NILL +E K+ DFG++ Q L GT ++APE A
Sbjct: 144 --KTIHRDVKGNNILLTTEGGVKLVDFGVSAQ-LTSTRLRRNTSVGTPFWMAPEVIACEQ 200
Query: 448 QL----TEKSDVYSFGIVILELMSG 468
QL + DV+S GI +EL G
Sbjct: 201 QLDSTYDARCDVWSLGITAIELGDG 225
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 1e-13
Identities = 47/140 (33%), Positives = 76/140 (54%), Gaps = 14/140 (10%)
Query: 341 FLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKST 400
+L+ D++ G L +S K T K + ++A + +LH L GI +RD+K
Sbjct: 74 YLILDFLRGGDLFTRLS---KEVMFTEEDVKFYLAELALALDHLH-SL--GIIYRDLKPE 127
Query: 401 NILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGI 460
NILLD E + K+ DFGL+K+S++ H GT Y+APE T+ +D +SFG+
Sbjct: 128 NILLDEEGHIKLTDFGLSKESID-HEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGV 186
Query: 461 VILELMSGRKVLDTSTSPFQ 480
++ E+++G + PFQ
Sbjct: 187 LMFEMLTG-------SLPFQ 199
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 1e-13
Identities = 66/207 (31%), Positives = 103/207 (49%), Gaps = 34/207 (16%)
Query: 272 IGQGASGIVYKG-TLRHGNLVAVKQILDLDTKGDEDFT---NEVEIISKIRHRNLLSLRG 327
+G G G VYK L G L AVK I+ L+ GD DF+ E+ ++ + +H N+++ G
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVK-IIKLE-PGD-DFSLIQQEIFMVKECKHCNIVAYFG 73
Query: 328 CCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYG 387
+ S ++ ++ +Y G+L D I H L+ Q + + +G+AYLH
Sbjct: 74 SYL-----SREKLWICMEYCGGGSLQD---IYHVTGPLSELQIAYVCRETLQGLAYLH-- 123
Query: 388 LKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVA------GTFGYLAP 441
G HRDIK NILL + K+ADFG+A + +T +A GT ++AP
Sbjct: 124 -SKGKMHRDIKGANILLTDNGDVKLADFGVAAK-------ITATIAKRKSFIGTPYWMAP 175
Query: 442 EYALY---GQLTEKSDVYSFGIVILEL 465
E A G + D+++ GI +EL
Sbjct: 176 EVAAVEKNGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 1e-13
Identities = 58/225 (25%), Positives = 104/225 (46%), Gaps = 24/225 (10%)
Query: 271 LIGQGASGIVYKGTLRHGNLVAVKQILDLDTKGDEDFTNEVEIISKI-----RHRNLLSL 325
+IG+G+ V L+ + +++ + D++ + V+ + H L+ L
Sbjct: 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61
Query: 326 RGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKII--VDVAKGIAY 383
C T R F V +Y+ G L + H ++Q P+ +++ + Y
Sbjct: 62 HSCFQTE-----SRLFFVIEYVNGGDL-----MFHMQRQRKLPEEHARFYSAEISLALNY 111
Query: 384 LHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEY 443
LH + GI +RD+K N+LLDSE + K+ D+G+ K+ L T+ GT Y+APE
Sbjct: 112 LH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP-GDTTSTFCGTPNYIAPEI 167
Query: 444 ALYGQLTEKSDVYSFGIVILELMSGRKVLD---TSTSPFQLITDW 485
D ++ G+++ E+M+GR D +S +P Q D+
Sbjct: 168 LRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDY 212
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 1e-13
Identities = 62/223 (27%), Positives = 106/223 (47%), Gaps = 18/223 (8%)
Query: 256 VSELEQATNGFSQNNLIGQGASGIVYKGTLRH---GNLVAVKQILDLDTKGDEDFTNEVE 312
+S L F ++G G G VYKG RH G L A+K ++D+ +E+ E+
Sbjct: 8 LSALRDPAGIFELVEVVGNGTYGQVYKG--RHVKTGQLAAIK-VMDVTEDEEEEIKLEIN 64
Query: 313 IISKI-RHRNLLSLRGCCVT-SDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQR 370
++ K HRN+ + G + S + +LV ++ G+++D + + K L
Sbjct: 65 MLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVK-NTKGNALKEDWI 123
Query: 371 KKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTT 430
I ++ +G+A+LH + HRDIK N+LL K+ DFG++ Q L+
Sbjct: 124 AYICREILRGLAHLH---AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ-LDRTVGRRN 179
Query: 431 RVAGTFGYLAPEYALYGQLTE-----KSDVYSFGIVILELMSG 468
GT ++APE + + +SD++S GI +E+ G
Sbjct: 180 TFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEG 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 2e-13
Identities = 53/202 (26%), Positives = 98/202 (48%), Gaps = 24/202 (11%)
Query: 288 GNLVAVKQILDLDTKGDED---FTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFLVY 344
G+ VA+K + + + F E + +++ H N+++L F V+
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPG----LLFAVF 58
Query: 345 DYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILL 404
+Y+P TL + ++ L + ++++ V +A H GI HRD+K NI++
Sbjct: 59 EYVPGRTLREVLA---ADGALPAGETGRLMLQVLDALACAH---NQGIVHRDLKPQNIMV 112
Query: 405 ---DSELNAKVADFGL------AKQSLEGHSHLTTRVAGTFGYLAPEYALYGQ-LTEKSD 454
+AKV DFG+ + + TT V GT Y APE L G+ +T SD
Sbjct: 113 SQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPE-QLRGEPVTPNSD 171
Query: 455 VYSFGIVILELMSGRKVLDTST 476
+Y++G++ LE ++G++V+ ++
Sbjct: 172 LYAWGLIFLECLTGQRVVQGAS 193
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 2e-13
Identities = 61/204 (29%), Positives = 100/204 (49%), Gaps = 17/204 (8%)
Query: 271 LIGQGASGIVYKGTLRHGNLVAVKQILDLDT---KGDEDFT-NEVEIISKIR-HRNLLSL 325
++G+G+ G V L+ + V ++L D D D T E I++ H L +L
Sbjct: 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTAL 61
Query: 326 RGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLH 385
C T D R F V +Y+ G L I S K + P+ + +V + +LH
Sbjct: 62 HCCFQTKD-----RLFFVMEYVNGGDLMFQIQRSRKFDE---PRSRFYAAEVTLALMFLH 113
Query: 386 YGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYAL 445
+ G+ +RD+K NILLD+E + K+ADFG+ K+ + TT GT Y+APE
Sbjct: 114 ---RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILN-GVTTTTFCGTPDYIAPEILQ 169
Query: 446 YGQLTEKSDVYSFGIVILELMSGR 469
+ D ++ G+++ E+M+G+
Sbjct: 170 ELEYGPSVDWWALGVLMYEMMAGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 2e-13
Identities = 62/210 (29%), Positives = 104/210 (49%), Gaps = 30/210 (14%)
Query: 272 IGQGASGIVYKGTLRHGN-LVAVKQI-LDLDTKG-DEDFTNEVEIISKIRHRNLLSLRGC 328
IG+G G+VYK R N +A+K+I L+ + +G E+ ++ +++H N++ L+
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDV 69
Query: 329 CVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWP-----QR--KKIIVDVAKGI 381
V S+ KR +LV++Y+ + K+ + P R K + + +GI
Sbjct: 70 -VHSE----KRLYLVFEYL---------DLDLKKHMDSSPDFAKNPRLIKTYLYQILRGI 115
Query: 382 AYLHYGLKPGIYHRDIKSTNILLDSELNA-KVADFGLAKQSLEGHSHLTTRVAGTFGYLA 440
AY H + HRD+K N+L+D NA K+ADFGLA+ T V T Y A
Sbjct: 116 AYCH---SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV-TLWYRA 171
Query: 441 PEYALYG-QLTEKSDVYSFGIVILELMSGR 469
PE L + D++S G + E+++ +
Sbjct: 172 PEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 2e-13
Identities = 48/150 (32%), Positives = 81/150 (54%), Gaps = 16/150 (10%)
Query: 322 LLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGI 381
L L C T D R + V +Y+ G L I + K+ P ++A G+
Sbjct: 63 LTQLHSCFQTMD-----RLYFVMEYVNGGDLMYQIQQVGRFKE---PHAVFYAAEIAIGL 114
Query: 382 AYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSL-EGHSHLTTRV-AGTFGYL 439
+LH GI +RD+K N++LDSE + K+ADFG+ K+++ +G +TT+ GT Y+
Sbjct: 115 FFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG---VTTKTFCGTPDYI 168
Query: 440 APEYALYGQLTEKSDVYSFGIVILELMSGR 469
APE Y + D ++FG+++ E+++G+
Sbjct: 169 APEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 2e-13
Identities = 62/211 (29%), Positives = 105/211 (49%), Gaps = 32/211 (15%)
Query: 271 LIGQGASGIVYKGT-LRHGNLVAVK---QILDLDT--KGDEDFTNEVEIISKIRHRNLLS 324
++G GA G VYKG + G V + ++L +T K +++ +E +++ + +
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73
Query: 325 LRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKR----KQLTWPQRKKIIVDVAKG 380
L G C+TS LV MP G L D + + R L W V +AKG
Sbjct: 74 LLGICLTSTVQ------LVTQLMPYGCLLDYVRENKDRIGSQDLLNW------CVQIAKG 121
Query: 381 IAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAK----QSLEGHSHLTTRVAGTF 436
++YL + + HRD+ + N+L+ S + K+ DFGLA+ E H+ +V
Sbjct: 122 MSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHAD-GGKVP--I 175
Query: 437 GYLAPEYALYGQLTEKSDVYSFGIVILELMS 467
++A E L+ + T +SDV+S+G+ + ELM+
Sbjct: 176 KWMALESILHRRFTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 2e-13
Identities = 61/215 (28%), Positives = 100/215 (46%), Gaps = 44/215 (20%)
Query: 272 IGQGASGIVYKGTLRH---GNLVAVKQILDLDTKGDEDFTN-------EVEIISKIRHRN 321
IG+G+ G+V+K R+ G +VA+K+ ++ ED E+ ++ +++H N
Sbjct: 9 IGEGSYGVVFK--CRNRETGQIVAIKKFVE-----SEDDPVIKKIALREIRMLKQLKHPN 61
Query: 322 LLSL-----RGCCVTSDDSSGKRRF-LVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIV 375
L++L R KR+ LV++Y + L++ + + + KKII
Sbjct: 62 LVNLIEVFRR-----------KRKLHLVFEYCDHTVLNE---LEKNPRGVPEHLIKKIIW 107
Query: 376 DVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGT 435
+ + + H K HRD+K NIL+ + K+ DFG A+ T VA T
Sbjct: 108 QTLQAVNFCH---KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVA-T 163
Query: 436 FGYLAPEYALYG--QLTEKSDVYSFGIVILELMSG 468
Y APE L G Q DV++ G V EL++G
Sbjct: 164 RWYRAPEL-LVGDTQYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 3e-13
Identities = 53/202 (26%), Positives = 90/202 (44%), Gaps = 15/202 (7%)
Query: 271 LIGQGASGIVYKGTL----RHGNLVAVKQILD-LDTKGDEDFTNEVEIISKIRHRNLLSL 325
++G G G + +G L + VA+ + K F E + + H N++ L
Sbjct: 12 ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRL 71
Query: 326 RGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLH 385
G G +V +YM NG L D+ H+ QL Q ++ +A G+ YL
Sbjct: 72 EGVITR-----GNTMMIVTEYMSNGAL-DSFLRKHE-GQLVAGQLMGMLPGLASGMKYLS 124
Query: 386 YGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYAL 445
+ G H+ + + +L++S+L K++ F ++ + T + APE
Sbjct: 125 ---EMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQ 181
Query: 446 YGQLTEKSDVYSFGIVILELMS 467
Y + SDV+SFGIV+ E+MS
Sbjct: 182 YHHFSSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 3e-13
Identities = 50/209 (23%), Positives = 83/209 (39%), Gaps = 26/209 (12%)
Query: 273 GQGASGIVYKGTLRHGNLVAVKQILDLDTKGDEDFT---NEVEIISKIRHRNLLSLRGCC 329
+ K LVAVK+I +LD+ ED E+ +++H N+L
Sbjct: 11 EDLMIVHLAKHK-PTNTLVAVKKI-NLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSF 68
Query: 330 VTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLK 389
+ ++V M G+ D + +H + L I+ DV + Y+H
Sbjct: 69 I-----VDSELYVVSPLMAYGSCEDLLK-THFPEGLPELAIAFILKDVLNALDYIH---S 119
Query: 390 PGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEG-------HSHLTTRVAGTFGYLAPE 442
G HR +K+++ILL + ++ + ++ H +L+PE
Sbjct: 120 KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDF-PKSSVKNLPWLSPE 178
Query: 443 YALYGQL---TEKSDVYSFGIVILELMSG 468
L L EKSD+YS GI EL +G
Sbjct: 179 -VLQQNLQGYNEKSDIYSVGITACELANG 206
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 3e-13
Identities = 58/219 (26%), Positives = 92/219 (42%), Gaps = 26/219 (11%)
Query: 269 NNLIGQGASGIVYKGTLRHGN----LVAVKQI-LDLDTKGDEDFTNEVEIISKIRHRNLL 323
IG+G G VY+G VAVK E F E I+ + H +++
Sbjct: 11 GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIV 70
Query: 324 SLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAY 383
L G +++ ++V + P G L + + L ++ +AY
Sbjct: 71 KLIGVI--TENPV----WIVMELAPLGELRS--YLQVNKYSLDLASLILYSYQLSTALAY 122
Query: 384 LHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLT-TRVAGTFGYLAPE 442
L HRDI + N+L+ S K+ DFGL++ LE S+ ++ ++APE
Sbjct: 123 LE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSR-YLEDESYYKASKGKLPIKWMAPE 178
Query: 443 YALYGQLTEKSDVYSFGIVILE-LMSGRKVLDTSTSPFQ 480
+ + T SDV+ FG+ + E LM G K PFQ
Sbjct: 179 SINFRRFTSASDVWMFGVCMWEILMLGVK-------PFQ 210
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 4e-13
Identities = 49/200 (24%), Positives = 98/200 (49%), Gaps = 15/200 (7%)
Query: 272 IGQGASGIVYKGTLRHGNLVAVKQILDLDTKG--DEDFTNEVEIISKIRHRNLLSLRGCC 329
+G G G+V K + L+ ++++ L+ K E++++ + ++ G
Sbjct: 13 LGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72
Query: 330 VTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLK 389
+ + S + ++M G+L + + K++ K+ + V +G+AYL K
Sbjct: 73 YSDGEIS-----ICMEHMDGGSLD---QVLKEAKRIPEEILGKVSIAVLRGLAYLRE--K 122
Query: 390 PGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALYGQL 449
I HRD+K +NIL++S K+ DFG++ Q ++ + GT Y++PE
Sbjct: 123 HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFVGTRSYMSPERLQGTHY 179
Query: 450 TEKSDVYSFGIVILELMSGR 469
+ +SD++S G+ ++EL GR
Sbjct: 180 SVQSDIWSMGLSLVELAIGR 199
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 4e-13
Identities = 63/221 (28%), Positives = 105/221 (47%), Gaps = 26/221 (11%)
Query: 266 FSQNNLIGQGASGIVYKGTLRH-GNLVAVKQILDL---DTKGDEDFTNEVEIISKIRHRN 321
F Q ++G+G G V +R G + A K++ KG+ NE +I+ K+ R
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 322 LLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKII--VDVAK 379
++SL T D LV M G L +I + + + + + + ++
Sbjct: 62 VVSLAYAYETKDALC-----LVLTLMNGGDLKFHI---YHMGEAGFEEGRAVFYAAEICC 113
Query: 380 GIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYL 439
G+ LH + I +RD+K NILLD + +++D GLA EG + + RV GT GY+
Sbjct: 114 GLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKGRV-GTVGYM 168
Query: 440 APEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQ 480
APE + T D ++ G ++ E+++G+ SPFQ
Sbjct: 169 APEVVKNERYTFSPDWWALGCLLYEMIAGQ-------SPFQ 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 7e-13
Identities = 62/230 (26%), Positives = 110/230 (47%), Gaps = 26/230 (11%)
Query: 263 TNGFSQNNLIGQGASGIV--YKGTLRHGNLVAVKQILD-LDTKGDEDFT-NEVEIISKIR 318
TN + +G GA G+V + L N VA+K+I+ T T E++++ +R
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQN-VAIKKIMKPFSTPVLAKRTYRELKLLKHLR 67
Query: 319 HRNLLSLRGCCVTSDDSSGKRRFLVYDYMPNGT-LSDNISISHKRKQLTWPQRKKIIVDV 377
H N++SL + S + + V + + GT L ++ KQ + + +
Sbjct: 68 HENIISLSDIFI----SPLEDIYFVTELL--GTDLHRLLTSRPLEKQFI----QYFLYQI 117
Query: 378 AKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFG 437
+G+ Y+H G+ HRD+K +NIL++ + K+ DFGLA+ +T V+ +
Sbjct: 118 LRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARIQ---DPQMTGYVSTRY- 170
Query: 438 YLAPEYALYGQ-LTEKSDVYSFGIVILELMSGRKVL--DTSTSPFQLITD 484
Y APE L Q + D++S G + E++ G+ + + F +ITD
Sbjct: 171 YRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITD 220
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 7e-13
Identities = 58/225 (25%), Positives = 106/225 (47%), Gaps = 45/225 (20%)
Query: 272 IGQGASGIVYKGTL------RHGNLVAVKQILD-LDTKGDEDFTNEVEIISKIRHRNLLS 324
+G+ G VYKG L VA+K + D + E+F +E + S+++H N++
Sbjct: 13 LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVC 72
Query: 325 LRGCCVTSDDSSGKRRFLVYDYMPNGTL----------SDNISISHKR---KQLTWPQRK 371
L G VT + +++ Y + L SD S + L
Sbjct: 73 LLGV-VTKEQPLS----MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFV 127
Query: 372 KIIVDVAKGIAYL--HYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQ-------SL 422
I+ +A G+ +L H+ + H+D+ + N+L+ +LN K++D GL ++ L
Sbjct: 128 HIVTQIAAGMEFLSSHH-----VVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKL 182
Query: 423 EGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS 467
G+S L R +++PE +YG+ + SD++S+G+V+ E+ S
Sbjct: 183 MGNSLLPIR------WMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 69.6 bits (171), Expect = 8e-13
Identities = 79/300 (26%), Positives = 126/300 (42%), Gaps = 57/300 (19%)
Query: 270 NLIGQGASGIVYKGTLRH-GNLVAVKQILDLDTKGDEDFTN---------EVEIISKIRH 319
+ +G GA G V G VA+K K F + E+ ++ + H
Sbjct: 21 SPVGSGAYGQVCSAFDTKTGRKVAIK-------KLSRPFQSAIHAKRTYRELRLLKHMDH 73
Query: 320 RNLLSLRGCCVTSDDSSGKRR--FLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDV 377
N++ L T S + +LV M G +NI K ++L+ + ++ +
Sbjct: 74 ENVIGLLDV-FTPASSLEDFQDVYLVTHLM--GADLNNIV---KCQKLSDDHIQFLVYQI 127
Query: 378 AKGIAYLHYGLKPGIYHRDIKSTNILL--DSELNAKVADFGLAKQSLEGHSHLTTRVAGT 435
+G+ Y+H GI HRD+K +NI + D EL K+ DFGLA+ + +T VA T
Sbjct: 128 LRGLKYIH---SAGIIHRDLKPSNIAVNEDCEL--KILDFGLARHT---DDEMTGYVA-T 178
Query: 436 FGYLAPEYAL-YGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGK 494
Y APE L + + D++S G ++ EL++G+ + S QL ++ G
Sbjct: 179 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKR----IMNLVGT 234
Query: 495 VDDIFDEFIRAEGARAVMER--------FVLVGILCAHVMVALRPTITDAL-KMLEGDID 545
D+ + I +E AR ++ F V P D L KML D D
Sbjct: 235 PDEELLQKISSESARNYIQSLPQMPKKDF-------KEVFSGANPLAIDLLEKMLVLDPD 287
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 68.4 bits (168), Expect = 8e-13
Identities = 59/205 (28%), Positives = 87/205 (42%), Gaps = 23/205 (11%)
Query: 272 IGQGASGIVYKGTL-RHGNLVAVKQILDL---DTKGDEDFTNEVEIISKIRHRNLLSLRG 327
+G G G V + A+K + +T E +E EI+ + H ++ L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 328 CCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYG 387
T D K +++ +Y G L + R + I V YLH
Sbjct: 61 ---TFKDK--KYIYMLMEYCLGGELWTIL---RDRGLFDEYTARFYIACVVLAFEYLH-- 110
Query: 388 LKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYAL-- 445
GI +RD+K N+LLDS K+ DFG AK+ L+ T GT Y+APE L
Sbjct: 111 -NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKK-LKSGQKTWTFC-GTPEYVAPEIILNK 167
Query: 446 -YGQLTEKSDVYSFGIVILELMSGR 469
Y D +S GI++ EL++GR
Sbjct: 168 GYDFS---VDYWSLGILLYELLTGR 189
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 8e-13
Identities = 48/141 (34%), Positives = 77/141 (54%), Gaps = 18/141 (12%)
Query: 341 FLVYDYMPNGTLSDNISISHKRKQLTWPQRKKII-VDVAKGIAYLHYGLKPGIYHRDIKS 399
F V +Y+ G L +I S + + R + ++ G+ +LH K GI +RD+K
Sbjct: 72 FFVMEYLNGGDLMFHIQSSGRFDE----ARARFYAAEIICGLQFLH---KKGIIYRDLKL 124
Query: 400 TNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALYGQL-TEKSDVYSF 458
N+LLD + + K+ADFG+ K+++ G +T GT Y+APE L GQ E D +SF
Sbjct: 125 DNVLLDKDGHIKIADFGMCKENMNGEGKAST-FCGTPDYIAPE-ILKGQKYNESVDWWSF 182
Query: 459 GIVILELMSGRKVLDTSTSPF 479
G+++ E++ G+ SPF
Sbjct: 183 GVLLYEMLIGQ-------SPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 9e-13
Identities = 48/167 (28%), Positives = 82/167 (49%), Gaps = 21/167 (12%)
Query: 319 HRNLLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVA 378
H L+ L C T R F V +++ G L + H ++Q P+
Sbjct: 55 HPFLVGLHSCFQTE-----SRLFFVIEFVSGGDL-----MFHMQRQRKLPEEHARFYSAE 104
Query: 379 KGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGY 438
+A L++ + GI +RD+K N+LLD+E + K+ D+G+ K+ + T+ GT Y
Sbjct: 105 ISLA-LNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGI-RPGDTTSTFCGTPNY 162
Query: 439 LAPEYALYGQLTEKS-DVYSFGIVILELMSGRKVLDTSTSPFQLITD 484
+APE L G+ S D ++ G+++ E+M+GR SPF ++
Sbjct: 163 IAPE-ILRGEDYGFSVDWWALGVLMFEMMAGR-------SPFDIVGM 201
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 9e-13
Identities = 55/223 (24%), Positives = 106/223 (47%), Gaps = 16/223 (7%)
Query: 271 LIGQGASGIVYKGTLRH-GNLVAVKQILDL-DTKGDED-FTNEVEIISKIRHRNLLSLRG 327
+IG+G+ G+V H G VA+K+I D+ + D E++++ +RH +++ ++
Sbjct: 7 VIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKH 66
Query: 328 CCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYG 387
+ K ++V++ M SD + LT + + + + + Y+H
Sbjct: 67 IMLPPSRREFKDIYVVFELME----SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIH-- 120
Query: 388 LKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLE--GHSHLTTRVAGTFGYLAPEY-- 443
++HRD+K NIL +++ K+ DFGLA+ + + T T Y APE
Sbjct: 121 -TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCG 179
Query: 444 ALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQL--ITD 484
+ + + T D++S G + E+++G+ + QL ITD
Sbjct: 180 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITD 222
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 9e-13
Identities = 57/202 (28%), Positives = 95/202 (47%), Gaps = 19/202 (9%)
Query: 272 IGQGASGIVYKGTLRHGN-LVAVKQILD-LDTKGDEDFTNEVEIISKIRHRNLLSLRGCC 329
IG+G G V+ G LR N VAVK + L F E I+ + H N++ L G C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 330 VTSDDSSGKRRFLVYDYMPNG---TLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHY 386
+ + ++V + + G T K K+L +++ + A G+ YL
Sbjct: 63 -----TQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELI-----QMVENAAAGMEYLE- 111
Query: 387 GLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGT-FGYLAPEYAL 445
HRD+ + N L+ + K++DFG++++ +G T + + APE
Sbjct: 112 --SKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALN 169
Query: 446 YGQLTEKSDVYSFGIVILELMS 467
YG+ + +SDV+SFGI++ E S
Sbjct: 170 YGRYSSESDVWSFGILLWEAFS 191
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 1e-12
Identities = 57/194 (29%), Positives = 96/194 (49%), Gaps = 26/194 (13%)
Query: 291 VAVKQILDLDTKGD-EDFTNEVEIISKI-RHRNLLSLRGCC---------VTSDDSSGKR 339
VAVK + D T D D +E+E++ I +H+N+++L G C V R
Sbjct: 47 VAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLR 106
Query: 340 RFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKS 399
FL P + +I+ + +QL++ VA+G+ YL HRD+ +
Sbjct: 107 EFLRARRPPGPDYTFDITKVPE-EQLSFKDLVSCAYQVARGMEYLE---SRRCIHRDLAA 162
Query: 400 TNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFG-----YLAPEYALYGQL-TEKS 453
N+L+ + K+ADFGLA+ G + + G ++APE AL+ ++ T +S
Sbjct: 163 RNVLVTEDNVMKIADFGLAR----GVHDIDYYKKTSNGRLPVKWMAPE-ALFDRVYTHQS 217
Query: 454 DVYSFGIVILELMS 467
DV+SFGI++ E+ +
Sbjct: 218 DVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 2e-12
Identities = 60/209 (28%), Positives = 101/209 (48%), Gaps = 29/209 (13%)
Query: 272 IGQGASGIV-YKGTLRHGNLVAVKQIL-----DLDTKGDEDFTNEVEIISKIRHRNLLSL 325
+G GA G V R G VA+K++ +L K E+ ++ ++H N++ L
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAK---RAYRELRLLKHMKHENVIGL 79
Query: 326 RGCCVTSDDSSGKRR--FLVYDYMPN--GTLSDNISISHKRKQLTWPQRKKIIVDVAKGI 381
T D S + +LV +M G L + +S R Q ++ + KG+
Sbjct: 80 LDV-FTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQF-------LVYQMLKGL 131
Query: 382 AYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAP 441
Y+H GI HRD+K N+ ++ + K+ DFGLA+Q+ S +T V T Y AP
Sbjct: 132 KYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQT---DSEMTGYVV-TRWYRAP 184
Query: 442 EYAL-YGQLTEKSDVYSFGIVILELMSGR 469
E L + T+ D++S G ++ E+++G+
Sbjct: 185 EVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 2e-12
Identities = 59/228 (25%), Positives = 101/228 (44%), Gaps = 30/228 (13%)
Query: 272 IGQGASGIVYKGTLRHGNLVA---VKQILDLDTKGDED-FTNEVEIISKIRHRNLLSLRG 327
IG G G V G G A VK++ T ++ F EV+ ++ H N+L G
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 328 CCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQR---KKIIVDVAKGIAYL 384
C+ S LV ++ P G L + + S++ Q+ +++ +VA G+ +L
Sbjct: 63 QCIESIP-----YLLVLEFCPLGDLKNYLR-SNRGMVAQMAQKDVLQRMACEVASGLLWL 116
Query: 385 HYGLKPGIYHRDIKSTNILLDSELNAKVADFGLA-KQSLEGHSHLTTRVAGTFGYLAPEY 443
H + H D+ N L ++L+ K+ D+GLA +Q E + A +LAPE
Sbjct: 117 H---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPEL 173
Query: 444 A-------LYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITD 484
L T+KS+++S G+ + EL + P+ ++D
Sbjct: 174 VEIRGQDLLPKDQTKKSNIWSLGVTMWEL------FTAADQPYPDLSD 215
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 51/214 (23%), Positives = 105/214 (49%), Gaps = 19/214 (8%)
Query: 260 EQATNGFSQNNLIGQGASGIVYKGTLRHGNLVAVKQILDLDTKG--DEDFTNEVEIISKI 317
E + F + + +G G G+V+K + + L+ ++++ L+ K E++++ +
Sbjct: 1 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC 60
Query: 318 RHRNLLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQR--KKIIV 375
++ G + + S + ++M G+L + +K P++ K+ +
Sbjct: 61 NSPYIVGFYGAFYSDGEIS-----ICMEHMDGGSLDQVL-----KKAGRIPEQILGKVSI 110
Query: 376 DVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGT 435
V KG+ YL K I HRD+K +NIL++S K+ DFG++ Q ++ + GT
Sbjct: 111 AVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFVGT 165
Query: 436 FGYLAPEYALYGQLTEKSDVYSFGIVILELMSGR 469
Y++PE + +SD++S G+ ++E+ GR
Sbjct: 166 RSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGR 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 2e-12
Identities = 59/201 (29%), Positives = 95/201 (47%), Gaps = 22/201 (10%)
Query: 272 IGQGASGIVYKG-TLRHGNLVAVKQILDLDTKGDEDFT---NEVEIISKIRHRNLLSLRG 327
IG G G VYK + G L A+K I + EDF E+ ++ +H N+++ G
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVI---KLEPGEDFAVVQQEIIMMKDCKHSNIVAYFG 73
Query: 328 CCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYG 387
+ D + ++ ++ G+L D I H L+ Q + + +G+ YLH
Sbjct: 74 SYLRRD-----KLWICMEFCGGGSLQD---IYHVTGPLSESQIAYVSRETLQGLYYLH-- 123
Query: 388 LKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALY- 446
G HRDIK NILL + K+ADFG++ Q + + + GT ++APE A
Sbjct: 124 -SKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFI-GTPYWMAPEVAAVE 181
Query: 447 --GQLTEKSDVYSFGIVILEL 465
G + D+++ GI +EL
Sbjct: 182 RKGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 3e-12
Identities = 51/159 (32%), Positives = 85/159 (53%), Gaps = 18/159 (11%)
Query: 313 IISKIRHRNLLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQ-RK 371
++ ++H L+ L T+D + + V DY+ G L H +++ ++P+ R
Sbjct: 49 LLKNVKHPFLVGLHYSFQTAD-----KLYFVLDYVNGGEL-----FFHLQRERSFPEPRA 98
Query: 372 KI-IVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTT 430
+ ++A + YLH L I +RD+K NILLDS+ + + DFGL K+ +E HS T+
Sbjct: 99 RFYAAEIASALGYLH-SLN--IIYRDLKPENILLDSQGHVVLTDFGLCKEGIE-HSKTTS 154
Query: 431 RVAGTFGYLAPEYALYGQLTEKS-DVYSFGIVILELMSG 468
GT YLAPE L Q +++ D + G V+ E++ G
Sbjct: 155 TFCGTPEYLAPE-VLRKQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 3e-12
Identities = 61/227 (26%), Positives = 95/227 (41%), Gaps = 32/227 (14%)
Query: 256 VSELEQATNGFSQNNLIGQGASGIVYKGTLRH---GNLVAVKQILDLDTKGDED---FTN 309
+++L F +IG+GA G V +RH + A+K + + D F
Sbjct: 35 ITKLRMKAEDFDVIKVIGRGAFGEVQ--LVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWE 92
Query: 310 EVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFLVYDYMPNG---TLSDNISISHKRKQLT 366
E +I++ ++ L DD K ++V +YMP G L N I K
Sbjct: 93 ERDIMAHANSEWIVQL--HYAFQDD---KYLYMVMEYMPGGDLVNLMSNYDIPEK----- 142
Query: 367 WPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLA-KQSLEGH 425
W + +V + +H G HRD+K N+LLD + K+ADFG K G
Sbjct: 143 WARF--YTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGM 197
Query: 426 SHLTTRVAGTFGYLAPEYAL----YGQLTEKSDVYSFGIVILELMSG 468
T V GT Y++PE G + D +S G+ + E++ G
Sbjct: 198 VRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 3e-12
Identities = 56/202 (27%), Positives = 97/202 (48%), Gaps = 19/202 (9%)
Query: 272 IGQGASG--IVYKGTLRHGNLVAVKQI--LDLDTKGDEDFTNEVEIISKIRHRNLLSLRG 327
IG+G+ G I+ K G +K+I + K E+ EV ++S ++H N++ +
Sbjct: 8 IGEGSFGKAILVKSK-EDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQ- 65
Query: 328 CCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKI--IVDVAKGIAYLH 385
S + +G ++V DY G L I+ ++ + +P+ + + V + + ++H
Sbjct: 66 ---ESFEENGNL-YIVMDYCEGGDLYKKIN---AQRGVLFPEDQILDWFVQICLALKHVH 118
Query: 386 YGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYAL 445
I HRDIKS NI L + K+ DFG+A+ L L GT YL+PE
Sbjct: 119 ---DRKILHRDIKSQNIFLTKDGTIKLGDFGIAR-VLNSTVELARTCIGTPYYLSPEICE 174
Query: 446 YGQLTEKSDVYSFGIVILELMS 467
KSD+++ G V+ E+ +
Sbjct: 175 NRPYNNKSDIWALGCVLYEMCT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 3e-12
Identities = 57/210 (27%), Positives = 109/210 (51%), Gaps = 30/210 (14%)
Query: 272 IGQGASGIVYKG-TLRHGNLVAVKQI-LDLDTKG-DEDFTNEVEIISKIRHRNLLSLRGC 328
IG+G G+VYKG + G +VA+K+I L+ + +G E+ ++ +++H N++ L+
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQD- 66
Query: 329 CVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGL 388
V +S R +L+++++ S+ K+ + P+ + + ++ K +YL+ L
Sbjct: 67 -VLMQES---RLYLIFEFL---------SMDLKKYLDSLPKGQYMDAELVK--SYLYQIL 111
Query: 389 KPGIY--------HRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLA 440
+ GI HRD+K N+L+D++ K+ADFGLA+ + + T T Y A
Sbjct: 112 Q-GILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLAR-AFGIPVRVYTHEVVTLWYRA 169
Query: 441 PEYALYGQL-TEKSDVYSFGIVILELMSGR 469
PE L + D++S G + E+ + +
Sbjct: 170 PEVLLGSPRYSTPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 4e-12
Identities = 50/200 (25%), Positives = 94/200 (47%), Gaps = 15/200 (7%)
Query: 272 IGQGASGIVYKGTLRHGNLVAVKQILDLDTKGD--EDFTNEVEIISKIRHRNLLSLRGCC 329
+G G G+V K R L+ ++++ L+ K E++++ + ++ G
Sbjct: 9 LGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAF 68
Query: 330 VTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLK 389
+ + S + ++M G+L + K ++ KI + V +G+ YL K
Sbjct: 69 YSDGEIS-----ICMEHMDGGSLD---QVLKKAGRIPENILGKISIAVLRGLTYLREKHK 120
Query: 390 PGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALYGQL 449
I HRD+K +NIL++S K+ DFG++ Q + GT Y++PE
Sbjct: 121 --IMHRDVKPSNILVNSRGEIKLCDFGVSGQL---IDSMANSFVGTRSYMSPERLQGTHY 175
Query: 450 TEKSDVYSFGIVILELMSGR 469
T +SD++S G+ ++E+ GR
Sbjct: 176 TVQSDIWSLGLSLVEMAIGR 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 4e-12
Identities = 51/200 (25%), Positives = 104/200 (52%), Gaps = 17/200 (8%)
Query: 272 IGQGASGIVYKGTLRHGNLVAVKQILDLDTKGD-EDFTNEVEIISKIRHRNLLSLRGCCV 330
+G GA G VYK + ++A +++D ++ + ED+ E++I++ H N++ L
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 331 TSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKP 390
++ +++ ++ G + D + + +R LT PQ + + + + YLH +
Sbjct: 73 YENN-----LWILIEFCAGGAV-DAVMLELERP-LTEPQIRVVCKQTLEALNYLH---EN 122
Query: 391 GIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALYGQLT 450
I HRD+K+ NIL + + K+ADFG++ ++ + + GT ++APE +
Sbjct: 123 KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPYWMAPEVVMCETSK 181
Query: 451 E-----KSDVYSFGIVILEL 465
+ K+DV+S GI ++E+
Sbjct: 182 DRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 4e-12
Identities = 47/142 (33%), Positives = 73/142 (51%), Gaps = 16/142 (11%)
Query: 342 LVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTN 401
L+ DY+ G + ++ ++R + + + ++ + +LH K GI +RDIK N
Sbjct: 82 LILDYVSGGEMFTHL---YQRDNFSEDEVRFYSGEIILALEHLH---KLGIVYRDIKLEN 135
Query: 402 ILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKS--DVYSFG 459
ILLDSE + + DFGL+K+ L T GT Y+APE + G+ D +S G
Sbjct: 136 ILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPE-IIRGKGGHGKAVDWWSLG 194
Query: 460 IVILELMSGRKVLDTSTSPFQL 481
I+I EL++G SPF L
Sbjct: 195 ILIFELLTG-------ASPFTL 209
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 5e-12
Identities = 63/220 (28%), Positives = 104/220 (47%), Gaps = 31/220 (14%)
Query: 266 FSQNNL-----IGQGASGIVYKGT---LRHGNL---VAVKQI---LDLDTKGDEDFTNEV 311
F +NNL +G GA G V + T L + VAVK + + E +E+
Sbjct: 32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSER--EALMSEL 89
Query: 312 EIISKI-RHRNLLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQR 370
+I+S + H N+++L G C + G ++ +Y G L + + + LT
Sbjct: 90 KIMSHLGNHENIVNLLGAC-----TIGGPILVITEYCCYGDLLNFLR-RKRESFLTLEDL 143
Query: 371 KKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHL-- 428
VAKG+A+L K I HRD+ + N+LL K+ DFGLA+ + +++
Sbjct: 144 LSFSYQVAKGMAFLAS--KNCI-HRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVK 200
Query: 429 -TTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS 467
R+ ++APE T +SDV+S+GI++ E+ S
Sbjct: 201 GNARLP--VKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 7e-12
Identities = 57/212 (26%), Positives = 99/212 (46%), Gaps = 24/212 (11%)
Query: 266 FSQNNLIGQGASGIVYKGT-LRHGNLVAVK--QILDL-DTKGDEDFTNEVEIISKIRHRN 321
F IG+G VY+ T L G VA+K QI DL D K D E++++ ++ H N
Sbjct: 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 63
Query: 322 LLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRK--KIIVDVAK 379
++ + ++ + +V + G LS I K+K+L P++ K V +
Sbjct: 64 VIKYYASFIEDNELN-----IVLELADAGDLSRMIKHFKKQKRLI-PEKTVWKYFVQLCS 117
Query: 380 GIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAK----QSLEGHSHLTTRVAGT 435
+ ++H + HRDIK N+ + + K+ D GL + ++ HS + GT
Sbjct: 118 ALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS-----LVGT 169
Query: 436 FGYLAPEYALYGQLTEKSDVYSFGIVILELMS 467
Y++PE KSD++S G ++ E+ +
Sbjct: 170 PYYMSPERIHENGYNFKSDIWSLGCLLYEMAA 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 8e-12
Identities = 60/227 (26%), Positives = 104/227 (45%), Gaps = 38/227 (16%)
Query: 266 FSQNNLIGQGASGIVYKGTLRH-GNLVAVKQILDL---DTKGDEDFTNEVEIISKIRHRN 321
F Q ++G+G G V +R G + A K++ KG+ NE +I+ K+ +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 322 LLSLRG--------CCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKI 373
+++L C V + + G +F +Y+ M N + ++ +
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIYN-MGNPGFEEERALFYA------------ 108
Query: 374 IVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVA 433
++ G+ LH + +RD+K NILLD + +++D GLA + EG S + RV
Sbjct: 109 -AEILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES-IRGRV- 162
Query: 434 GTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQ 480
GT GY+APE + T D + G +I E++ G+ SPF+
Sbjct: 163 GTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQ-------SPFR 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 57/204 (27%), Positives = 102/204 (50%), Gaps = 19/204 (9%)
Query: 271 LIGQGASGIVYKGTLRHGNLVAVKQILD----LDTKGDEDFTNEVEIISK-IRHRNLLSL 325
+IG+G+ G V + ++L L K ++ +E ++ K ++H L+ L
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61
Query: 326 RGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLH 385
T+D + + V DY+ G L ++ + + P+ + ++A + YLH
Sbjct: 62 HFSFQTAD-----KLYFVLDYINGGELFYHL---QRERCFLEPRARFYAAEIASALGYLH 113
Query: 386 YGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYAL 445
I +RD+K NILLDS+ + + DFGL K+++E H+ T+ GT YLAPE L
Sbjct: 114 ---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE-HNGTTSTFCGTPEYLAPE-VL 168
Query: 446 YGQLTEKS-DVYSFGIVILELMSG 468
+ Q +++ D + G V+ E++ G
Sbjct: 169 HKQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 61/233 (26%), Positives = 106/233 (45%), Gaps = 46/233 (19%)
Query: 272 IGQGASGIVYKGTLR-HGNLVAVKQILDLDTKGDEDFT--NEVEIISKIRHRNLLSLRGC 328
+G+G+ VYKG R +G LVA+K ++ + T+ FT E ++ ++H N++ L
Sbjct: 13 LGEGSYATVYKGISRINGQLVALK-VISMKTEEGVPFTAIREASLLKGLKHANIVLLHDI 71
Query: 329 CVTSDDSSGKRRFLVYDYM-----------PNGTLSDNISISHKRKQLTWPQRKKIIVDV 377
T + + V++YM P G N+ + + +
Sbjct: 72 IHTKETLT-----FVFEYMHTDLAQYMIQHPGGLHPYNVRL--------------FMFQL 112
Query: 378 AKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAK-QSLEGHSHLTTRVAGTF 436
+G+AY+H I HRD+K N+L+ K+ADFGLA+ +S+ ++ + V T
Sbjct: 113 LRGLAYIH---GQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TL 167
Query: 437 GYLAPEYALYGQLTEKS---DVYSFGIVILELMSGRKVL-DTSTSPFQLITDW 485
Y P+ L G T+ S D++ G + +E++ G+ S QL W
Sbjct: 168 WYRPPD-VLLGA-TDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIW 218
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 1e-11
Identities = 51/204 (25%), Positives = 90/204 (44%), Gaps = 23/204 (11%)
Query: 271 LIGQGASGIVYKGTLRHG------NLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLS 324
+G G G V+ R ++A+ +++ L K ++ NE ++ ++ H ++
Sbjct: 8 TVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRL--KQEQHVHNEKRVLKEVSHPFIIR 65
Query: 325 LRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYL 384
L D +++ +Y+P G L S + + ++ + YL
Sbjct: 66 LF--WTEHDQRF---LYMLMEYVPGGEL---FSYLRNSGRFSNSTGLFYASEIVCALEYL 117
Query: 385 HYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYA 444
H I +RD+K NILLD E + K+ DFG AK+ + T + GT YLAPE
Sbjct: 118 H---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR----TWTLCGTPEYLAPEVI 170
Query: 445 LYGQLTEKSDVYSFGIVILELMSG 468
+ D ++ GI+I E++ G
Sbjct: 171 QSKGHNKAVDWWALGILIYEMLVG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 62/220 (28%), Positives = 99/220 (45%), Gaps = 29/220 (13%)
Query: 271 LIGQGASGIVY--KGTLRH--GNLVAVKQILDLDT-----KGDEDFTNEVEIISKIRHRN 321
++G GA G V+ + H G L A+K +L T K E E +++ IR
Sbjct: 7 VLGTGAYGKVFLVRKVSGHDSGKLYAMK-VLKKATIVQKAKTTEHTRTERQVLEHIRQSP 65
Query: 322 LLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGI 381
L +D + L+ DY+ G L ++S +R++ + + ++ +
Sbjct: 66 FLVTLHYAFQTD----TKLHLILDYINGGELFTHLS---QRERFKEQEVQIYSGEIVLAL 118
Query: 382 AYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAP 441
+LH K GI +RDIK NILLDS + + DFGL+K+ E GT Y+AP
Sbjct: 119 EHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAP 175
Query: 442 EYALYGQLTEKS--DVYSFGIVILELMSGRKVLDTSTSPF 479
+ G D +S G+++ EL++G SPF
Sbjct: 176 DIVRGGDGGHDKAVDWWSMGVLMYELLTG-------ASPF 208
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 1e-11
Identities = 35/101 (34%), Positives = 59/101 (58%), Gaps = 11/101 (10%)
Query: 380 GIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYL 439
G+ +LH GI +RD+K N++LD + + K+ADFG+ K+++ G + +T GT Y+
Sbjct: 108 GLQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST-FCGTPDYI 163
Query: 440 APEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQ 480
APE + T D +SFG+++ E++ G+ SPF
Sbjct: 164 APEILQGLKYTFSVDWWSFGVLLYEMLIGQ-------SPFH 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 53/194 (27%), Positives = 95/194 (48%), Gaps = 26/194 (13%)
Query: 291 VAVKQILDLDTKGD-EDFTNEVEIISKI-RHRNLLSLRGCCVTSDDSSGKRRFLVYDYMP 348
VAVK + D T+ D D +E+E++ I +H+N+++L G C + +++ +Y
Sbjct: 50 VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC-----TQDGPLYVIVEYAS 104
Query: 349 NGTLSDNISISH-------------KRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHR 395
G L + + +Q+T+ VA+G+ YL HR
Sbjct: 105 KGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYL---ASQKCIHR 161
Query: 396 DIKSTNILLDSELNAKVADFGLAKQSLE-GHSHLTTRVAGTFGYLAPEYALYGQL-TEKS 453
D+ + N+L+ K+ADFGLA+ + TT ++APE AL+ ++ T +S
Sbjct: 162 DLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPE-ALFDRVYTHQS 220
Query: 454 DVYSFGIVILELMS 467
DV+SFG+++ E+ +
Sbjct: 221 DVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 2e-11
Identities = 45/142 (31%), Positives = 70/142 (49%), Gaps = 15/142 (10%)
Query: 342 LVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTN 401
L+ DY+ G L ++ +R+ T + + I ++ + +LH + GI +RDIK N
Sbjct: 82 LILDYVNGGELFTHLY---QREHFTESEVRVYIAEIVLALDHLH---QLGIIYRDIKLEN 135
Query: 402 ILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKS--DVYSFG 459
ILLDSE + + DFGL+K+ L GT Y+APE G D +S G
Sbjct: 136 ILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLG 195
Query: 460 IVILELMSGRKVLDTSTSPFQL 481
++ EL++G SPF +
Sbjct: 196 VLTFELLTG-------ASPFTV 210
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 57/205 (27%), Positives = 99/205 (48%), Gaps = 21/205 (10%)
Query: 271 LIGQGASG-IVYKGTLRHGNLVAVKQI---LDLDTKGDEDFTNEVEIISK-IRHRNLLSL 325
+IG+G+ G ++ G AVK + + L+ K + E ++ K ++H L+ L
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 326 RGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQ-RKKI-IVDVAKGIAY 383
T++ + + V D++ G L H +++ ++P+ R + ++A + Y
Sbjct: 62 HYSFQTTE-----KLYFVLDFVNGGEL-----FFHLQRERSFPEPRARFYAAEIASALGY 111
Query: 384 LHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEY 443
LH + I +RD+K NILLDS+ + + DFGL K+ + S TT GT YLAPE
Sbjct: 112 LH-SIN--IVYRDLKPENILLDSQGHVVLTDFGLCKEGI-AQSDTTTTFCGTPEYLAPEV 167
Query: 444 ALYGQLTEKSDVYSFGIVILELMSG 468
D + G V+ E++ G
Sbjct: 168 IRKQPYDNTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 3e-11
Identities = 51/213 (23%), Positives = 101/213 (47%), Gaps = 25/213 (11%)
Query: 270 NLIGQGASGIVYKGTLRHGNLVAVKQILDLDTKGDEDFTNEVEI---------ISKIRHR 320
+L+ +G G ++ G L +++ K +D +E+++ + + H+
Sbjct: 12 DLLQEGTFGRIFYGILIDEKPGKEEEVF---VKTVKDHASEIQVTLLLQESCLLYGLSHQ 68
Query: 321 NLLSLRGCCVTSDDSSGKRRFLVYDYMPNGTL-----SDNISISHKRKQLTWPQRKKIIV 375
N+L + C+ G+ F++Y YM G L + ++ + L+ Q + +
Sbjct: 69 NILPILHVCI----EDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAI 124
Query: 376 DVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSH-LTTRVAG 434
+A G++YLH K G+ H+DI + N ++D EL K+ D L++ H L
Sbjct: 125 QIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENR 181
Query: 435 TFGYLAPEYALYGQLTEKSDVYSFGIVILELMS 467
++A E + + + SDV+SFG+++ ELM+
Sbjct: 182 PVKWMALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 3e-11
Identities = 55/234 (23%), Positives = 104/234 (44%), Gaps = 41/234 (17%)
Query: 272 IGQGASGIVYKGTLRH------GNLVAVKQILDLDTKGDE-DFTNEVEIISKIRHRNLLS 324
+GQG+ G+VY+G + VA+K + + + + +F NE ++ + +++
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 325 LRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQ----LTWPQRKKIIV---DV 377
L G S G+ ++ + M G L + + P KK+I ++
Sbjct: 74 LLGVV-----SQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEI 128
Query: 378 AKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLE-------GHSHLTT 430
A G+AYL+ HRD+ + N ++ + K+ DFG+ + E G L
Sbjct: 129 ADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 185
Query: 431 RVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITD 484
R +++PE G T SDV+SFG+V+ E+ + + P+Q +++
Sbjct: 186 R------WMSPESLKDGVFTTYSDVWSFGVVLWEIAT------LAEQPYQGMSN 227
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 3e-11
Identities = 33/93 (35%), Positives = 53/93 (56%), Gaps = 5/93 (5%)
Query: 377 VAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTF 436
+ GI +LH I +RD+K N+LLD + N +++D GLA + +G + T+ AGT
Sbjct: 104 ITCGILHLH---SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT--ITQRAGTN 158
Query: 437 GYLAPEYALYGQLTEKSDVYSFGIVILELMSGR 469
GY+APE + D ++ G I E+++GR
Sbjct: 159 GYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 3e-11
Identities = 52/201 (25%), Positives = 94/201 (46%), Gaps = 17/201 (8%)
Query: 272 IGQGASGIVY----KGTLRHGNLVAVKQILDLDTKGDEDF--TNEVEIISKIRHRNLLSL 325
+G+G+ G VY K + L +K+I + +E E +++SK+ H ++
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKF 67
Query: 326 RGCCVTSDDSSGKRRFLVYDYMPNGTLSDNI-SISHKRKQLTWPQRKKIIVDVAKGIAYL 384
+ D ++ +Y L + + H K L+ Q + + + G+ Y+
Sbjct: 68 HASFLERDAFC-----IITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYM 122
Query: 385 HYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYA 444
H + I HRD+K+ NI L + L K+ DFG+++ L G L T GT Y++PE
Sbjct: 123 H---QRRILHRDLKAKNIFLKNNL-LKIGDFGVSR-LLMGSCDLATTFTGTPYYMSPEAL 177
Query: 445 LYGQLTEKSDVYSFGIVILEL 465
+ KSD++S G ++ E+
Sbjct: 178 KHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 5e-11
Identities = 48/161 (29%), Positives = 77/161 (47%), Gaps = 14/161 (8%)
Query: 310 EVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQ 369
E ++ RH L SL+ T D R V +Y+ G L ++S R+++
Sbjct: 45 ESRVLKNTRHPFLTSLKYSFQTKD-----RLCFVMEYVNGGELFFHLS----RERVFSED 95
Query: 370 RKKII-VDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHL 428
R + ++ + YLH G I +RD+K N++LD + + K+ DFGL K+ + + +
Sbjct: 96 RTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATM 152
Query: 429 TTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGR 469
T GT YLAPE D + G+V+ E+M GR
Sbjct: 153 KT-FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 63.4 bits (155), Expect = 5e-11
Identities = 57/209 (27%), Positives = 92/209 (44%), Gaps = 34/209 (16%)
Query: 272 IGQGASGIVYKG-TLRHGNLVAVKQILDLDTKGDEDFTNEVEIISKIR---HRNLLSLRG 327
IG+G V K + + G A+K + K E N EI + R H N+L L
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKK-HFKSLEQVNNLREIQALRRLSPHPNILRL-- 63
Query: 328 CCVTSDDSSGKRRFL-------VYDYMPNGTLSDNISISHKRKQLTWPQR-KKIIVDVAK 379
V D +G+ + +Y+ + RK+ +R K + + K
Sbjct: 64 IEVLFDRKTGRLALVFELMDMNLYELIKG------------RKRPLPEKRVKSYMYQLLK 111
Query: 380 GIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYL 439
+ ++H + GI+HRDIK NIL+ ++ K+ADFG + + T ++ T Y
Sbjct: 112 SLDHMH---RNGIFHRDIKPENILIKDDI-LKLADFGSCR-GIYSKPPYTEYIS-TRWYR 165
Query: 440 APEYALY-GQLTEKSDVYSFGIVILELMS 467
APE L G K D+++ G V E++S
Sbjct: 166 APECLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 6e-11
Identities = 54/195 (27%), Positives = 98/195 (50%), Gaps = 28/195 (14%)
Query: 291 VAVKQILDLDTKGD-EDFTNEVEIISKI-RHRNLLSLRGCCVTSDDSSGKRRFLVYDYMP 348
VAVK + D T D D +E+E++ I +H+N+++L G C + +++ +Y
Sbjct: 47 VAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGAC-----TQDGPLYVLVEYAS 101
Query: 349 NGTLSDNISISHK-------------RKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHR 395
G L + + +QLT+ VA+G+ YL HR
Sbjct: 102 KGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYL---ASQKCIHR 158
Query: 396 DIKSTNILLDSELNAKVADFGLAK--QSLEGHSHLTTRVAGTFGYLAPEYALYGQL-TEK 452
D+ + N+L+ + K+ADFGLA+ +++ + TT ++APE AL+ ++ T +
Sbjct: 159 DLAARNVLVTEDNVMKIADFGLARDVHNIDYYKK-TTNGRLPVKWMAPE-ALFDRVYTHQ 216
Query: 453 SDVYSFGIVILELMS 467
SDV+SFG+++ E+ +
Sbjct: 217 SDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 6e-11
Identities = 58/216 (26%), Positives = 101/216 (46%), Gaps = 20/216 (9%)
Query: 266 FSQNNLIGQGASGIVYKGTLRH----GNLVAVKQI-LDLDTKGD-EDFTNEVEIISKIRH 319
F+ ++G+G G V + L+ VAVK + D+ + D E+F E + + H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 320 RNLLSLRGCCVTSDDSSGKRRF----LVYDYMPNGTLSDNISISH-KRKQLTWPQRK--K 372
N++ L G S S K R ++ +M +G L + +S + T P + +
Sbjct: 61 PNVIKLIG---VSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVR 117
Query: 373 IIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRV 432
++D+A G+ YL HRD+ + N +L+ + VADFGL+K+ G +
Sbjct: 118 FMIDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCA 174
Query: 433 AG-TFGYLAPEYALYGQLTEKSDVYSFGIVILELMS 467
+ +LA E T SDV++FG+ + E+M+
Sbjct: 175 SKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMT 210
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 7e-11
Identities = 54/204 (26%), Positives = 97/204 (47%), Gaps = 24/204 (11%)
Query: 272 IGQGASGIVYKGT-LRHGNLVAVK--QILDL-DTKGDEDFTNEVEIISKIRHRNLLSLRG 327
IG+G VY+ T L VA+K QI ++ D K +D E++++ ++ H N++
Sbjct: 10 IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLD 69
Query: 328 CCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRK--KIIVDVAKGIAYLH 385
+ ++ + +V + G LS I K+K+L P+R K V + + ++H
Sbjct: 70 SFIEDNELN-----IVLELADAGDLSQMIKYFKKQKRLI-PERTVWKYFVQLCSAVEHMH 123
Query: 386 YGLKPGIYHRDIKSTNILLDSELNAKVADFGLAK----QSLEGHSHLTTRVAGTFGYLAP 441
+ HRDIK N+ + + K+ D GL + ++ HS + GT Y++P
Sbjct: 124 ---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS-----LVGTPYYMSP 175
Query: 442 EYALYGQLTEKSDVYSFGIVILEL 465
E KSD++S G ++ E+
Sbjct: 176 ERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 7e-11
Identities = 63/237 (26%), Positives = 109/237 (45%), Gaps = 24/237 (10%)
Query: 257 SELEQATN-GFSQNNLIGQGASGIVYKGT-LRHGNLVAVKQILDLDTKGDEDFTN-EVEI 313
+++ ++ N + N+IG G+ G+VY+ + VA+K++L D + N E+ I
Sbjct: 58 NDINRSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQ-----DPQYKNRELLI 112
Query: 314 ISKIRHRNLLSLRGCCVT-SDDSSGKRRFL--VYDYMPNGTLSDNISISHKRKQLTWPQR 370
+ + H N++ L+ T + K FL V +++P + L
Sbjct: 113 MKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLV 172
Query: 371 KKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNA-KVADFGLAKQSLEGH---S 426
K + + +AY+H I HRD+K N+L+D + K+ DFG AK L G S
Sbjct: 173 KLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVS 229
Query: 427 HLTTRVAGTFGYLAPEYALYG-QLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLI 482
++ +R Y APE L T D++S G +I E++ G + +S QL+
Sbjct: 230 YICSRF-----YRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLV 281
|
Length = 440 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 7e-11
Identities = 57/215 (26%), Positives = 97/215 (45%), Gaps = 35/215 (16%)
Query: 266 FSQNNLIGQGASGIV----YKGTLRHGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRN 321
F +G G+ G V +KGT + + +K+ L K + E I+ ++ H
Sbjct: 20 FEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPF 79
Query: 322 LLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAK-- 379
++++ C D+ R + + +++ G L +H RK +P DVAK
Sbjct: 80 IVNM--MCSFQDE---NRVYFLLEFVVGGEL-----FTHLRKAGRFPN------DVAKFY 123
Query: 380 ------GIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVA 433
YLH I +RD+K N+LLD++ + KV DFG AK+ + T +
Sbjct: 124 HAELVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD----RTFTLC 176
Query: 434 GTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSG 468
GT YLAPE + D ++ G+++ E ++G
Sbjct: 177 GTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 7e-11
Identities = 55/211 (26%), Positives = 99/211 (46%), Gaps = 21/211 (9%)
Query: 272 IGQGASGIVYKGTLR-HGNLVAVKQI-LDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCC 329
+G+G V+KG + NLVA+K+I L+ + EV ++ ++H N+++L
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIV 73
Query: 330 VTSDDSSGKRRFLVYDYMPNGT---LSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHY 386
T K LV++Y+ + D +I ++ K + + +G+AY H
Sbjct: 74 HTD-----KSLTLVFEYLDKDLKQYMDDCGNI------MSMHNVKIFLYQILRGLAYCH- 121
Query: 387 GLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYAL- 445
+ + HRD+K N+L++ K+ADFGLA+ + V T Y P+ L
Sbjct: 122 --RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLG 178
Query: 446 YGQLTEKSDVYSFGIVILELMSGRKVLDTST 476
+ + + D++ G + E+ SGR + ST
Sbjct: 179 SSEYSTQIDMWGVGCIFFEMASGRPLFPGST 209
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 8e-11
Identities = 65/225 (28%), Positives = 94/225 (41%), Gaps = 50/225 (22%)
Query: 272 IGQGASGIVYKGTLRH-GNLVAVKQI--------LDLDTKGDEDFTNEVEIISKIR---H 319
IG GA G VYK H G+ VA+K + L L T EV ++ ++ H
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLST------VREVALLKRLEAFDH 61
Query: 320 RNLLSLRGCCVTSDDSSGKRRFLVYDYM------------PNGTLSDNISISHKRKQLTW 367
N++ L C TS + LV++++ P G ++ I
Sbjct: 62 PNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETI----------- 110
Query: 368 PQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSH 427
K ++ +G+ +LH I HRD+K NIL+ S K+ADFGLA+ +
Sbjct: 111 ---KDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLAR--IYSCQM 162
Query: 428 LTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVL 472
T V T Y APE L D++S G + E M RK L
Sbjct: 163 ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAE-MFRRKPL 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 9e-11
Identities = 61/227 (26%), Positives = 101/227 (44%), Gaps = 38/227 (16%)
Query: 266 FSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDTK---GDEDFTNEVEIISKIRHRN 321
F ++G+G G V +R G + A K++ K G+ NE +I+ K+ R
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61
Query: 322 LLSLRG--------CCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKI 373
++SL C V + + G +F +Y+ G +R +
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPG-------FDEERAVFYAAE---- 110
Query: 374 IVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVA 433
+ G+ LH + I +RD+K NILLD + +++D GLA + EG + + RV
Sbjct: 111 ---ITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET-IRGRV- 162
Query: 434 GTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQ 480
GT GY+APE + T D + G +I E++ G+ SPF+
Sbjct: 163 GTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGK-------SPFR 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 9e-11
Identities = 45/131 (34%), Positives = 68/131 (51%), Gaps = 12/131 (9%)
Query: 341 FLVYDYMPNGTLSDNISISHKRKQLTWP-QRKKI-IVDVAKGIAYLHYGLKPGIYHRDIK 398
+LV DYM G L H +K+ + R K I ++ + +LH K I +RD+K
Sbjct: 72 YLVTDYMSGGEL-----FWHLQKEGRFSEDRAKFYIAELVLALEHLH---KYDIVYRDLK 123
Query: 399 STNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALYGQ-LTEKSDVYS 457
NILLD+ + + DFGL+K +L + T GT YLAPE L + T+ D +S
Sbjct: 124 PENILLDATGHIALCDFGLSKANLTDNK-TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWS 182
Query: 458 FGIVILELMSG 468
G+++ E+ G
Sbjct: 183 LGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.1 bits (154), Expect = 1e-10
Identities = 63/258 (24%), Positives = 103/258 (39%), Gaps = 63/258 (24%)
Query: 271 LIGQGASGIVYKGTLRH-GNLVAVKQIL--DLDTKGDEDFTN-EVEIISKIRHRNLLSLR 326
+IG+GA G V+ + G + A+K + D+ + E +I++ ++ L
Sbjct: 8 VIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLY 67
Query: 327 GCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVD------VAKG 380
D+ + +LV +YMP G L + RK + + +A+
Sbjct: 68 --YSFQDE---EHLYLVMEYMPGGDL------------MNLLIRKDVFPEETARFYIAEL 110
Query: 381 IAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQ-------------------- 420
+ L K G HRDIK NIL+D++ + K+ADFGL K+
Sbjct: 111 VLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFR 170
Query: 421 ---SLEGHSHLTTRV-----AGTFGYLAPEYAL---YGQLTEKSDVYSFGIVILELMSGR 469
+ H RV GT Y+APE YG D +S G+++ E++ G
Sbjct: 171 DNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLE---CDWWSLGVILYEMLYGF 227
Query: 470 KVL--DTSTSPFQLITDW 485
DT + I +W
Sbjct: 228 PPFYSDTLQETYNKIINW 245
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 58/203 (28%), Positives = 93/203 (45%), Gaps = 17/203 (8%)
Query: 271 LIGQGASGIVYKGTLR-HGNLVAVKQILD---LDTKGDEDFTNEVEIISK-IRHRNLLSL 325
+IG+G+ G V + G+ AVK + L K E ++ K ++H L+ L
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61
Query: 326 RGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLH 385
T++ + + V DY+ G L ++ + + P+ + +VA I YLH
Sbjct: 62 HYSFQTAE-----KLYFVLDYVNGGELFFHL---QRERCFLEPRARFYAAEVASAIGYLH 113
Query: 386 YGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYAL 445
I +RD+K NILLDS+ + + DFGL K+ +E T+ GT YLAPE
Sbjct: 114 ---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVE-PEETTSTFCGTPEYLAPEVLR 169
Query: 446 YGQLTEKSDVYSFGIVILELMSG 468
D + G V+ E++ G
Sbjct: 170 KEPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 1e-10
Identities = 56/208 (26%), Positives = 100/208 (48%), Gaps = 22/208 (10%)
Query: 272 IGQGASGIVYKG---TLRHGNLVAVKQIL---DLDTKGDEDFTNEVEIISKIRHRNLLSL 325
+G G G V KG + VAVK IL + D ++ E ++ ++ + ++ +
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVK-ILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 326 RGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLH 385
G C + LV + G L+ + K K +T +++ V+ G+ YL
Sbjct: 62 IGIC------EAESWMLVMELAELGPLNKFLQ---KNKHVTEKNITELVHQVSMGMKYLE 112
Query: 386 YGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTF--GYLAPEY 443
+ HRD+ + N+LL ++ AK++DFGL+K ++ + G + + APE
Sbjct: 113 ---ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPEC 169
Query: 444 ALYGQLTEKSDVYSFGIVILELMS-GRK 470
Y + + KSDV+SFG+++ E S G+K
Sbjct: 170 MNYYKFSSKSDVWSFGVLMWEAFSYGQK 197
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 2e-10
Identities = 60/219 (27%), Positives = 100/219 (45%), Gaps = 18/219 (8%)
Query: 272 IGQGASGIVYKG-TLRHGN-LVAVKQI-LDLDTKGDEDFT-NEVEIISKIR---HRNLLS 324
IG+GA G V+K L++G VA+K++ + +G T EV ++ + H N++
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 325 LRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQR--KKIIVDVAKGIA 382
L C S + LV++++ D + K + P K ++ + +G+
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHVDQ----DLTTYLDKVPEPGVPTETIKDMMFQLLRGLD 124
Query: 383 YLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPE 442
+LH + HRD+K NIL+ S K+ADFGLA+ + T V T Y APE
Sbjct: 125 FLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLAR--IYSFQMALTSVVVTLWYRAPE 179
Query: 443 YALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQL 481
L D++S G + E+ + + S+ QL
Sbjct: 180 VLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQL 218
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 2e-10
Identities = 78/314 (24%), Positives = 129/314 (41%), Gaps = 68/314 (21%)
Query: 272 IGQGASGIV---YKGTLRHGNLVAVKQI---LDLDTKGDEDFTNEVEIISKIRHRNLLSL 325
IG GA GIV Y L VA+K++ T + E+ ++ + H+N++SL
Sbjct: 25 IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAY-RELVLMKCVNHKNIISL 81
Query: 326 RGCCVTSDD-SSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYL 384
+ +LV + M + L I + +++++ ++ + GI +L
Sbjct: 82 LNVFTPQKSLEEFQDVYLVMELM-DANLCQVIQMELDHERMSY-----LLYQMLCGIKHL 135
Query: 385 HYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYA 444
H GI HRD+K +NI++ S+ K+ DFGLA+ + G S + T T Y APE
Sbjct: 136 H---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRYYRAPEVI 190
Query: 445 LYGQLTEKSDVYSFGIVILE------LMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDI 498
L E D++S G ++ E L GR +D W V+ +
Sbjct: 191 LGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID----------QWNKVIEQ------- 233
Query: 499 FDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLE--GDIDIPKL-PDRPLP 555
+G C M L+PT+ + ++ + PKL PD P
Sbjct: 234 -------------------LGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFP 274
Query: 556 L--SHECLRSSPSR 567
H L++S +R
Sbjct: 275 ADSEHNKLKASQAR 288
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 3e-10
Identities = 60/217 (27%), Positives = 93/217 (42%), Gaps = 32/217 (14%)
Query: 272 IGQGASGIV----YKGTLRHGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLS-LR 326
+GQGA GIV T VA+K+I ++ F+ ++ +R LL R
Sbjct: 8 LGQGAYGIVCSARNAET-SEEETVAIKKITNV-------FSKKILAKRALRELKLLRHFR 59
Query: 327 G-----CCVTSD--DSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAK 379
G C D +Y+ + L I + LT + I +
Sbjct: 60 GHKNITCLYDMDIVFPGNFNELYLYEELMEADLH---QIIRSGQPLTDAHFQSFIYQILC 116
Query: 380 GIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGH----SHLTTRVAGT 435
G+ Y+H + HRD+K N+L++++ K+ DFGLA+ E +T VA T
Sbjct: 117 GLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVA-T 172
Query: 436 FGYLAPEYALYGQLTEKS-DVYSFGIVILELMSGRKV 471
Y APE L Q K+ DV+S G ++ EL+ + V
Sbjct: 173 RWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPV 209
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 3e-10
Identities = 57/213 (26%), Positives = 95/213 (44%), Gaps = 32/213 (15%)
Query: 272 IGQGASGIVYKGTLRH---GNLVAVKQI-LDLDTKGDEDFTNEVEIISKIRHRNLLSLRG 327
+G+G G VYK + H G +A+K+I L+LD E++I+ K ++ G
Sbjct: 9 LGKGNYGSVYK--VLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYG 66
Query: 328 C-----CVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIA 382
V ++ +YM G+L + + + ++I V KG+
Sbjct: 67 AFFIEGAV----------YMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLK 116
Query: 383 YLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPE 442
+L I HRD+K TN+L++ K+ DFG++ + + L G Y+APE
Sbjct: 117 FLKEEHN--IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLV---ASLAKTNIGCQSYMAPE 171
Query: 443 YALYGQLTE------KSDVYSFGIVILELMSGR 469
G + +SDV+S G+ ILE+ GR
Sbjct: 172 RIKSGGPNQNPTYTVQSDVWSLGLSILEMALGR 204
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 3e-10
Identities = 55/206 (26%), Positives = 93/206 (45%), Gaps = 23/206 (11%)
Query: 266 FSQNNLIGQGASGIVYK-GTLRHGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLS 324
F + L+ + A+G Y LR ++A ++ T E ++ RH L +
Sbjct: 8 FGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVT--------ESRVLQNTRHPFLTA 59
Query: 325 LRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKII-VDVAKGIAY 383
L+ T D R V +Y G L ++S R+++ +R + ++ + Y
Sbjct: 60 LKYAFQTHD-----RLCFVMEYANGGELFFHLS----RERVFTEERARFYGAEIVSALEY 110
Query: 384 LHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEY 443
LH + +RDIK N++LD + + K+ DFGL K+ + + + T GT YLAPE
Sbjct: 111 LH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYLAPEV 166
Query: 444 ALYGQLTEKSDVYSFGIVILELMSGR 469
D + G+V+ E+M GR
Sbjct: 167 LEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 3e-10
Identities = 57/203 (28%), Positives = 96/203 (47%), Gaps = 14/203 (6%)
Query: 272 IGQGASGIVYKGTLRH-GNLVAVKQILDL---DTKGDEDFTNEVEIISKIRHRNLLSLRG 327
+G+G G V +R G L A K++ KG E E I++K+ R ++SL
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 328 CCVTSDDSSGKRRFLVYDYMPNGTLSDNI-SISHKRKQLTWPQRKKIIVDVAKGIAYLHY 386
T D LV M G L +I ++ + P+ + G+ +LH
Sbjct: 61 AFQTKTDLC-----LVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH- 114
Query: 387 GLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALY 446
+ I +RD+K N+LLD++ N +++D GLA + +G S T AGT G++APE
Sbjct: 115 --QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-TKGYAGTPGFMAPELLQG 171
Query: 447 GQLTEKSDVYSFGIVILELMSGR 469
+ D ++ G+ + E+++ R
Sbjct: 172 EEYDFSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 4e-10
Identities = 57/217 (26%), Positives = 101/217 (46%), Gaps = 23/217 (10%)
Query: 272 IGQGASGIVYKGTLR-HGNLVAVKQI-LDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCC 329
+G+G VYKG + NLVA+K+I L+ + EV ++ ++H N+++L
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 73
Query: 330 VTSDDSSGKRRFLVYDYMPNGT---LSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHY 386
T K LV++Y+ L D + + K + + +G+ Y H
Sbjct: 74 HTE-----KSLTLVFEYLDKDLKQYLDDCGNSINMHNV------KLFLFQLLRGLNYCH- 121
Query: 387 GLKPGIYHRDIKSTNILLDSELNAKVADFGLAK-QSLEGHSHLTTRVAGTFGYLAPEYAL 445
+ + HRD+K N+L++ K+ADFGLA+ +S+ ++ V T Y P+ L
Sbjct: 122 --RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV--TLWYRPPDILL 177
Query: 446 -YGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQL 481
+ + D++ G + E+ +GR + ST QL
Sbjct: 178 GSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQL 214
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 4e-10
Identities = 62/227 (27%), Positives = 102/227 (44%), Gaps = 38/227 (16%)
Query: 266 FSQNNLIGQGASGIVYKGTLRH-GNLVAVKQILDL---DTKGDEDFTNEVEIISKIRHRN 321
F ++G+G G V +R G + A K++ KG+ NE I+ K+ R
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61
Query: 322 LLSLRG--------CCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKI 373
++SL C V + + G +F +Y+ M N + +I +
Sbjct: 62 VVSLAYAYETKDALCLVLTIMNGGDLKFHIYN-MGNPGFDEQRAIFYA------------ 108
Query: 374 IVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVA 433
++ G+ L + I +RD+K NILLD + +++D GLA Q EG + + RV
Sbjct: 109 -AELCCGLEDLQ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET-VRGRV- 162
Query: 434 GTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQ 480
GT GY+APE + T D + G +I E++ G+ SPF+
Sbjct: 163 GTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQ-------SPFR 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 6e-10
Identities = 57/211 (27%), Positives = 105/211 (49%), Gaps = 21/211 (9%)
Query: 272 IGQGASGIVYKGTLR-HGNLVAVKQI-LDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCC 329
+G+G V+KG + NLVA+K+I L+ + EV ++ ++H N+++L
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72
Query: 330 VTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLK 389
T + LV++Y+ + + + ++ K + + +G++Y H K
Sbjct: 73 HTERCLT-----LVFEYLDSDLKQ---YLDNCGNLMSMHNVKIFMFQLLRGLSYCH---K 121
Query: 390 PGIYHRDIKSTNILLDSELNAKVADFGLAK-QSLEGHSHLTTRVAGTFGYLAPEYALYGQ 448
I HRD+K N+L++ + K+ADFGLA+ +S+ ++ V T Y P+ L G
Sbjct: 122 RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPD-VLLGS 178
Query: 449 LTEKS---DVYSFGIVILELMSGRKVLDTST 476
TE S D++ G ++ E+ +GR + ST
Sbjct: 179 -TEYSTPIDMWGVGCILYEMATGRPMFPGST 208
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 7e-10
Identities = 58/215 (26%), Positives = 103/215 (47%), Gaps = 45/215 (20%)
Query: 272 IGQGASGIVYKGTLR-HGNLVAVKQILDLDTKGDEDFT--NEVEIISKIRHRNLLSLRGC 328
+G+G+ VYKG + +G LVA+K ++ L + FT E ++ ++H N++ L
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALK-VIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDI 71
Query: 329 CVTSDDSSGKRRFLVYDYM-----------PNGTLSDNISISHKRKQLTWPQRKKIIVDV 377
T + + LV++Y+ P G +N+ K + +
Sbjct: 72 IHTKETLT-----LVFEYVHTDLCQYMDKHPGGLHPENV--------------KLFLFQL 112
Query: 378 AKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAK-QSLEGHSHLTTRVAGTF 436
+G++Y+H + I HRD+K N+L+ K+ADFGLA+ +S+ H++ V T
Sbjct: 113 LRGLSYIH---QRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV--TL 167
Query: 437 GYLAPEYALYGQLTEKS---DVYSFGIVILELMSG 468
Y P+ L G TE S D++ G + +E++ G
Sbjct: 168 WYRPPD-VLLGS-TEYSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 7e-10
Identities = 43/158 (27%), Positives = 76/158 (48%), Gaps = 9/158 (5%)
Query: 310 EVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQ 369
E +++S+++H N+++ R S + ++V + G L + K K L Q
Sbjct: 49 EAQLLSQLKHPNIVAYR----ESWEGEDGLLYIVMGFCEGGDLYHKLK-EQKGKLLPENQ 103
Query: 370 RKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLT 429
+ V +A + YLH + I HRD+K+ N+ L KV D G+A+ LE +
Sbjct: 104 VVEWFVQIAMALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIAR-VLENQCDMA 159
Query: 430 TRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS 467
+ + GT Y++PE KSDV++ G + E+ +
Sbjct: 160 STLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMAT 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 8e-10
Identities = 44/163 (26%), Positives = 74/163 (45%), Gaps = 18/163 (11%)
Query: 310 EVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQ 369
E ++ RH L +L+ T D R V +Y G L ++S + + + +
Sbjct: 45 ESRVLQNTRHPFLTALKYSFQTHD-----RLCFVMEYANGGELFFHLS---RERVFSEDR 96
Query: 370 RKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLT 429
+ ++ + YLH + +RD+K N++LD + + K+ DFGL K+ +
Sbjct: 97 ARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGIS-DGATM 152
Query: 430 TRVAGTFGYLAPEY---ALYGQLTEKSDVYSFGIVILELMSGR 469
GT YLAPE YG+ D + G+V+ E+M GR
Sbjct: 153 KTFCGTPEYLAPEVLEDNDYGRAV---DWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 8e-10
Identities = 50/225 (22%), Positives = 99/225 (44%), Gaps = 37/225 (16%)
Query: 272 IGQGASGIVYKGTLRH------GNLVAVKQILDLDTKGD-EDFTNEVEIISKIRHRNLLS 324
+G+G G V K T VAVK + + + + D +E ++ ++ H +++
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 325 LRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHK-------------RKQLTWPQRK 371
L G C S L+ +Y G+L + S K L P +
Sbjct: 68 LYGAC-----SQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDER 122
Query: 372 KIIV--------DVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLE 423
+ + +++G+ YL + + HRD+ + N+L+ K++DFGL++ E
Sbjct: 123 ALTMGDLISFAWQISRGMQYLA---EMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYE 179
Query: 424 GHSHLT-TRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS 467
S++ ++ ++A E T +SDV+SFG+++ E+++
Sbjct: 180 EDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 9e-10
Identities = 54/195 (27%), Positives = 88/195 (45%), Gaps = 28/195 (14%)
Query: 292 AVKQI-LDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFLVYDYMPNG 350
A+K+I L + ED E +++K++H N+++ + S ++ G ++V +Y G
Sbjct: 29 AMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFK----ESFEADG-HLYIVMEYCDGG 83
Query: 351 TLSDNISISHKR-----KQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLD 405
L I + + L W V + G+ ++H + + HRDIKS NI L
Sbjct: 84 DLMQKIKLQRGKLFPEDTILQW------FVQMCLGVQHIH---EKRVLHRDIKSKNIFLT 134
Query: 406 SELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILEL 465
K+ DFG A+ ++ T V GT Y+ PE KSD++S G ++ EL
Sbjct: 135 QNGKVKLGDFGSARLLTSPGAYACTYV-GTPYYVPPEIWENMPYNNKSDIWSLGCILYEL 193
Query: 466 MSGRKVLDTSTSPFQ 480
T PFQ
Sbjct: 194 C-------TLKHPFQ 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 1e-09
Identities = 57/198 (28%), Positives = 99/198 (50%), Gaps = 34/198 (17%)
Query: 291 VAVKQILDLDTKGD-EDFTNEVEIISKI-RHRNLLSLRGCCVTSDDSSGKRRFLVYDYMP 348
VAVK + T+ D D +E+E++ I +H+N+++L G C T D +++ +Y
Sbjct: 53 VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC-TQDGP----LYVIVEYAS 107
Query: 349 NGTLSDNISISHK-------------RKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHR 395
G L + + +QL++ VA+G+ YL K I HR
Sbjct: 108 KGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYL--ASKKCI-HR 164
Query: 396 DIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFG-----YLAPEYALYGQL- 449
D+ + N+L+ + K+ADFGLA+ H+ T G ++APE AL+ ++
Sbjct: 165 DLAARNVLVTEDNVMKIADFGLARDI----HHIDYYKKTTNGRLPVKWMAPE-ALFDRIY 219
Query: 450 TEKSDVYSFGIVILELMS 467
T +SDV+SFG+++ E+ +
Sbjct: 220 THQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 1e-09
Identities = 70/303 (23%), Positives = 131/303 (43%), Gaps = 54/303 (17%)
Query: 272 IGQGASGIVYKGTLR---HGNL---VAVKQILDLDTKGDE-DFTNEVEIISKIRHRNLLS 324
+GQG+ G+VY+G R G VAVK + + + + +F NE ++ +++
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 325 LRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNI----SISHKRKQLTWPQRKKII---VDV 377
L G S G+ +V + M +G L + + P +++I ++
Sbjct: 74 LLGVV-----SKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEI 128
Query: 378 AKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLE-------GHSHLTT 430
A G+AYL+ HRD+ + N ++ + K+ DFG+ + E G L
Sbjct: 129 ADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 185
Query: 431 RVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWV-- 488
R ++APE G T SD++SFG+V+ E+ S + P+Q +++ +
Sbjct: 186 R------WMAPESLKDGVFTTSSDMWSFGVVLWEITS------LAEQPYQGLSNEQVLKF 233
Query: 489 LAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEGDIDIPK 548
+ G +D + + ER + +C +RPT + + +L+ D+ P
Sbjct: 234 VMDGGYLD-------QPDNCP---ERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLH-PS 282
Query: 549 LPD 551
P+
Sbjct: 283 FPE 285
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 1e-09
Identities = 62/231 (26%), Positives = 104/231 (45%), Gaps = 31/231 (13%)
Query: 272 IGQGASGIVYKGTLRHGN---LVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGC 328
+G+G G VYK + G A+KQI T E+ ++ +++H N+++L+
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEG--TGISMSACREIALLRELKHPNVIALQKV 66
Query: 329 CVTSDDSSGKRRFLVYDYMPNG-----TLSDNISISHKRKQLTWPQRKKIIVDVAKGIAY 383
++ D ++ +L++DY + + K QL K ++ + GI Y
Sbjct: 67 FLSHSD---RKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHY 123
Query: 384 LHYGLKPGIYHRDIKSTNILLDSE----LNAKVADFGLAK---QSLEGHSHLTTRVAGTF 436
LH + HRD+K NIL+ E K+AD G A+ L+ + L V TF
Sbjct: 124 LHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV-TF 179
Query: 437 GYLAPEYALYGQ-LTEKSDVYSFGIVILELMSGRKVL-----DTSTS-PFQ 480
Y APE L + T+ D+++ G + EL++ + D TS PF
Sbjct: 180 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFH 230
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 1e-09
Identities = 60/241 (24%), Positives = 113/241 (46%), Gaps = 22/241 (9%)
Query: 310 EVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFLVYD--YMPNGTLSDNISISHKRKQLTW 367
E+ ++ ++H N++ L D + R ++ Y+ + +++ K ++LT
Sbjct: 66 ELRLLKHMKHENVIGLL------DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD 119
Query: 368 PQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSH 427
+ +I + +G+ Y+H I HRD+K +N+ ++ + K+ DFGLA+ + +
Sbjct: 120 DHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD---E 173
Query: 428 LTTRVAGTFGYLAPEYAL-YGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWA 486
+T VA T Y APE L + + D++S G ++ EL++GR + + QL
Sbjct: 174 MTGYVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQL----K 228
Query: 487 WVLAKSGKVDDIFDEFIRAEGARAVMERFVLVGIL-CAHVMVALRPTITDAL-KMLEGDI 544
+L G + I +E AR ++ + + A+V + P D L KML D
Sbjct: 229 LILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDS 288
Query: 545 D 545
D
Sbjct: 289 D 289
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 51/202 (25%), Positives = 92/202 (45%), Gaps = 15/202 (7%)
Query: 272 IGQGASGIV---YKGTL-RHGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRG 327
IG GA GIV Y L R+ + + + T + E+ ++ + H+N++ L
Sbjct: 32 IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVNHKNIIGLLN 90
Query: 328 CCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYG 387
+ + + + L I + +++++ ++ + GI +LH
Sbjct: 91 VFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSY-----LLYQMLCGIKHLH-- 143
Query: 388 LKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALYG 447
GI HRD+K +NI++ S+ K+ DFGLA+ + G S + T T Y APE L
Sbjct: 144 -SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRYYRAPEVILGM 200
Query: 448 QLTEKSDVYSFGIVILELMSGR 469
E D++S G ++ E++ G
Sbjct: 201 GYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 2e-09
Identities = 60/212 (28%), Positives = 98/212 (46%), Gaps = 35/212 (16%)
Query: 272 IGQGASGIV---YKGTLRHGNLVAVKQILDLDTKGDEDFTN---------EVEIISKIRH 319
IG GA GIV Y G VA+K K F N E+ ++ + H
Sbjct: 24 IGSGAQGIVCAAYDTVT--GQNVAIK-------KLSRPFQNVTHAKRAYRELVLMKLVNH 74
Query: 320 RNLLSLRGCCVTSDDSSGKRR--FLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDV 377
+N++ L T S + + +LV + M + L I + +++++ ++ +
Sbjct: 75 KNIIGLLNV-FTPQKSLEEFQDVYLVMELM-DANLCQVIQMDLDHERMSY-----LLYQM 127
Query: 378 AKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFG 437
GI +LH GI HRD+K +NI++ S+ K+ DFGLA+ + G S + T T
Sbjct: 128 LCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRY 182
Query: 438 YLAPEYALYGQLTEKSDVYSFGIVILELMSGR 469
Y APE L E D++S G ++ E++ G
Sbjct: 183 YRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 2e-09
Identities = 55/204 (26%), Positives = 98/204 (48%), Gaps = 39/204 (19%)
Query: 310 EVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQ 369
EV ++ +++H+N++ + + + ++ +++ ++ G LS NI +K +
Sbjct: 62 EVNVMRELKHKNIVRYIDRFL---NKANQKLYILMEFCDAGDLSRNIQKCYK---MFGKI 115
Query: 370 RKKIIVDVAK----GIAYLHYGLKPG-----IYHRDIKSTNILLDS-------------E 407
+ IVD+ + +AY H LK G + HRD+K NI L +
Sbjct: 116 EEHAIVDITRQLLHALAYCH-NLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANN 174
Query: 408 LN----AKVADFGLAKQ-SLEGHSHLTTRVAGTFGYLAPEYALY--GQLTEKSDVYSFGI 460
LN AK+ DFGL+K +E +H GT Y +PE L+ +KSD+++ G
Sbjct: 175 LNGRPIAKIGDFGLSKNIGIESMAH---SCVGTPYYWSPELLLHETKSYDDKSDMWALGC 231
Query: 461 VILELMSGRKVLDTSTSPFQLITD 484
+I EL SG+ + + QLI++
Sbjct: 232 IIYELCSGKTPFHKANNFSQLISE 255
|
Length = 1021 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 58/210 (27%), Positives = 99/210 (47%), Gaps = 21/210 (10%)
Query: 266 FSQNNLIGQGASGIV---YKGTLRHGNLVAVKQI---LDLDTKGDEDFTNEVEIISKIRH 319
+ Q IG GA GIV + L G VAVK++ T + E+ ++ + H
Sbjct: 23 YQQLKPIGSGAQGIVCAAFDTVL--GINVAVKKLSRPFQNQTHAKRAY-RELVLLKCVNH 79
Query: 320 RNLLSLRGCCVTSDD-SSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVA 378
+N++SL + +LV + M + L I + +++++ ++ +
Sbjct: 80 KNIISLLNVFTPQKSLEEFQDVYLVMELM-DANLCQVIHMELDHERMSY-----LLYQML 133
Query: 379 KGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGY 438
GI +LH GI HRD+K +NI++ S+ K+ DFGLA+ + + + T T Y
Sbjct: 134 CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACT--NFMMTPYVVTRYY 188
Query: 439 LAPEYALYGQLTEKSDVYSFGIVILELMSG 468
APE L E D++S G ++ EL+ G
Sbjct: 189 RAPEVILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 3e-09
Identities = 59/217 (27%), Positives = 102/217 (47%), Gaps = 25/217 (11%)
Query: 272 IGQGASGIVYKGTLRHGNL---VAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGC 328
+G+G G VYK + G A+KQI T E+ ++ +++H N++SL+
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEG--TGISMSACREIALLRELKHPNVISLQKV 66
Query: 329 CVTSDDSSGKRRFLVYDYMPNGTLS----DNISISHKRK-QLTWPQRKKIIVDVAKGIAY 383
++ D ++ +L++DY + S ++K+ QL K ++ + GI Y
Sbjct: 67 FLSHAD---RKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHY 123
Query: 384 LHYGLKPGIYHRDIKSTNILLDSE----LNAKVADFGLAK---QSLEGHSHLTTRVAGTF 436
LH + HRD+K NIL+ E K+AD G A+ L+ + L V TF
Sbjct: 124 LHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV-TF 179
Query: 437 GYLAPEYALYGQ-LTEKSDVYSFGIVILELMSGRKVL 472
Y APE L + T+ D+++ G + EL++ +
Sbjct: 180 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 216
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 3e-09
Identities = 46/164 (28%), Positives = 88/164 (53%), Gaps = 18/164 (10%)
Query: 310 EVEIISKIRHRNLLSLRGCCVTSDDSSGK---RRFLVYDYMPNGTLSDNISISHKRKQLT 366
E+ ++ ++H N++ L V + +S + +LV + M G +NI K ++L+
Sbjct: 64 ELRLLKHMKHENVIGLLD--VFTPATSIENFNEVYLVTNLM--GADLNNIV---KCQKLS 116
Query: 367 WPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHS 426
+ +I + +G+ Y+H GI HRD+K +N+ ++ + ++ DFGLA+Q+ +
Sbjct: 117 DEHVQFLIYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLARQADD--- 170
Query: 427 HLTTRVAGTFGYLAPEYAL-YGQLTEKSDVYSFGIVILELMSGR 469
+T VA T Y APE L + + D++S G ++ EL+ G+
Sbjct: 171 EMTGYVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 3e-09
Identities = 31/108 (28%), Positives = 55/108 (50%), Gaps = 7/108 (6%)
Query: 373 IIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRV 432
I + +G+ YLH + I HRD+K+ NI ++ + D G A+ + + L +
Sbjct: 162 IEKQILEGLRYLH-AQR--IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLG--L 216
Query: 433 AGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVL--DTSTSP 478
AGT APE + K+D++S GIV+ E+++ + D ++P
Sbjct: 217 AGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTP 264
|
Length = 357 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 3e-09
Identities = 30/88 (34%), Positives = 53/88 (60%), Gaps = 4/88 (4%)
Query: 381 IAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLA 440
+ +LH + GI +RD+K NILLD++ + K+ DFGL K+S+ + +T GT Y+A
Sbjct: 113 LEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT-VTHTFCGTIEYMA 168
Query: 441 PEYALYGQLTEKSDVYSFGIVILELMSG 468
PE + + D +S G ++ ++++G
Sbjct: 169 PEILMRSGHGKAVDWWSLGALMYDMLTG 196
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 3e-09
Identities = 59/254 (23%), Positives = 101/254 (39%), Gaps = 60/254 (23%)
Query: 271 LIGQGASGIVYKGTLRH----GNLVAVKQILDLDTKGDE----DFTNEVEIISKIRHRNL 322
LIG+G G VY L + VA+K+I + D + F E +I + + H +
Sbjct: 9 LIGKGGMGEVY---LAYDPVCSRRVALKKIRE-DLSENPLLKKRFLREAKIAADLIHPGI 64
Query: 323 LSLRGCCVTSDDSSGKRRFLVYDYMP---NGTLSDNISISHKRKQLTWPQRKK------- 372
+ + C D VY MP TL + +++ L+ +K
Sbjct: 65 VPVYSICSDGD--------PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFL 116
Query: 373 -IIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAK------------ 419
I + I Y+H G+ HRD+K NILL + D+G A
Sbjct: 117 SIFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDI 173
Query: 420 ---QSLEGHSHLTT--RVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS------- 467
+ +S +T ++ GT Y+APE L +E +D+Y+ G+++ ++++
Sbjct: 174 DVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRR 233
Query: 468 --GRKVLDTSTSPF 479
GRK+
Sbjct: 234 KKGRKISYRDVILS 247
|
Length = 932 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 3e-09
Identities = 60/225 (26%), Positives = 102/225 (45%), Gaps = 45/225 (20%)
Query: 272 IGQGASGIVYKGTLRH-GNLVAVKQILDLDTKGDEDFT--NEVEIISKIRHRNLLSLRGC 328
+G+G+ VYKG + G LVA+K+I L+ + FT E ++ ++H N+++L
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALKEI-RLEHEEGAPFTAIREASLLKDLKHANIVTLHDI 71
Query: 329 CVTSDDSSGKRRFLVYDYM-----------PNGTLSDNISISHKRKQLTWPQRKKIIVDV 377
T K LV++Y+ G N+ + + +
Sbjct: 72 IHTK-----KTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRL--------------FLFQL 112
Query: 378 AKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAK-QSLEGHSHLTTRVAGTF 436
+G+AY H + + HRD+K N+L+ K+ADFGLA+ +S+ ++ V T
Sbjct: 113 LRGLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVV--TL 167
Query: 437 GYLAPEYALYGQLTEKS---DVYSFGIVILELMSGRKVLDTSTSP 478
Y P+ L G TE S D++ G + E+ +GR + ST
Sbjct: 168 WYRPPD-VLLGS-TEYSTSLDMWGVGCIFYEMATGRPLFPGSTDV 210
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 3e-09
Identities = 37/102 (36%), Positives = 51/102 (50%), Gaps = 17/102 (16%)
Query: 381 IAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSL--------EGHSHLTTR- 431
+ YLH GI HRD+K N+L+ S + K+ DFGL+K L EGH TR
Sbjct: 114 LEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTRE 170
Query: 432 -----VAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSG 468
V GT Y+APE L + D ++ GI++ E + G
Sbjct: 171 FLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 4e-09
Identities = 56/215 (26%), Positives = 98/215 (45%), Gaps = 34/215 (15%)
Query: 272 IGQGASGIVYKGTLR--------HGNLVAVKQILDLDTKG-DEDFTNEVEIISKIRHRNL 322
+GQG ++KG R H V +K +LD + E F ++S++ H++L
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLK-VLDKSHRNYSESFFEAASMMSQLSHKHL 61
Query: 323 LSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIA 382
+ G CV D+S +V +Y+ G+L + + ++W ++VAK +A
Sbjct: 62 VLNYGVCVCGDES-----IMVQEYVKFGSLDTYLKKNKNLINISWK------LEVAKQLA 110
Query: 383 Y-LHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHS-------HLTTRVAG 434
+ LH+ G+ H ++ + N+LL E + K + K S G S L R+
Sbjct: 111 WALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIP- 169
Query: 435 TFGYLAPEYALYGQ-LTEKSDVYSFGIVILELMSG 468
++ PE Q L+ +D +SFG + E+ SG
Sbjct: 170 ---WVPPECIENPQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 4e-09
Identities = 45/161 (27%), Positives = 77/161 (47%), Gaps = 13/161 (8%)
Query: 310 EVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQ 369
E ++ RH L +L+ T D R V +Y G L ++S R+++
Sbjct: 45 ENRVLQNSRHPFLTALKYSFQTHD-----RLCFVMEYANGGELFFHLS----RERVFSED 95
Query: 370 RKKII-VDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHL 428
R + ++ + YLH + + +RD+K N++LD + + K+ DFGL K+ ++ + +
Sbjct: 96 RARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATM 153
Query: 429 TTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGR 469
T GT YLAPE D + G+V+ E+M GR
Sbjct: 154 KT-FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 8e-09
Identities = 55/214 (25%), Positives = 94/214 (43%), Gaps = 42/214 (19%)
Query: 272 IGQGASGIVYKGTLRH-GNLVAVKQI-LDLDTKGDEDFT-NEVEIISKIRHRNLLSLRGC 328
IG+G G V+K R +VA+K++ LD D +G E+ ++ +++H+N++ L
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67
Query: 329 CVTSDDSSGKRRFLVYDYMP----------NGTLSDNISISHKRKQLTWPQRKKIIVDVA 378
S K+ LV++Y NG + I K + +
Sbjct: 68 L-----HSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIV-------------KSFMFQLL 109
Query: 379 KGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQ---SLEGHSHLTTRVAGT 435
KG+A+ H + HRD+K N+L++ K+ADFGLA+ + +S T
Sbjct: 110 KGLAFCH---SHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV----T 162
Query: 436 FGYLAPEYALYGQLTEKS-DVYSFGIVILELMSG 468
Y P+ +L S D++S G + EL +
Sbjct: 163 LWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANA 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 2e-08
Identities = 51/208 (24%), Positives = 94/208 (45%), Gaps = 26/208 (12%)
Query: 271 LIGQGASGIVYKGT-LRHGNLVAVKQILDLDTKGDEDFTN----EVEIISKIRHRNLLSL 325
+G GA G V R G VA+K++ E F E+ ++ ++H N++ L
Sbjct: 22 QVGSGAYGSVCSAIDKRTGEKVAIKKLSR--PFQSEIFAKRAYRELTLLKHMQHENVIGL 79
Query: 326 RGCCVTSDDSSGKRRF-LVYDYMPNGTLSDNISISHKR-KQLTWPQRKKIIVDVAKGIAY 383
++ + F LV YM + L+ + + ++ + G+ Y
Sbjct: 80 LDVFTSAVSGDEFQDFYLVMPYM-------QTDLQKIMGHPLSEDKVQYLVYQMLCGLKY 132
Query: 384 LHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQS-LEGHSHLTTRVAGTFGYLAPE 442
+H GI HRD+K N+ ++ + K+ DFGLA+ + E ++ TR Y APE
Sbjct: 133 IH---SAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR-----WYRAPE 184
Query: 443 YAL-YGQLTEKSDVYSFGIVILELMSGR 469
L + + D++S G ++ E+++G+
Sbjct: 185 VILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 2e-08
Identities = 62/209 (29%), Positives = 98/209 (46%), Gaps = 38/209 (18%)
Query: 275 GASGIVYKGTLRHGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRG------- 327
G+ G V+ T +HG+ K I+ T G + E++I+ I HR +++L
Sbjct: 103 GSEGEVFVCT-KHGDEQRKKVIVKAVTGG-KTPGREIDILKTISHRAIINLIHAYRWKST 160
Query: 328 -CCVTSDDSSGKRRFLVYDYMP-NGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLH 385
C V K + ++ Y+ +G L +I+ +R+ L + +AYLH
Sbjct: 161 VCMVMP-----KYKCDLFTYVDRSGPLPLEQAITIQRRLL-------------EALAYLH 202
Query: 386 YGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYL---APE 442
GI HRD+K+ NI LD NA + DFG A + L+ H T + G G L +PE
Sbjct: 203 ---GRGIIHRDVKTENIFLDEPENAVLGDFGAACK-LDAHPD-TPQCYGWSGTLETNSPE 257
Query: 443 YALYGQLTEKSDVYSFGIVILELMSGRKV 471
K+D++S G+V+ E MS + V
Sbjct: 258 LLALDPYCAKTDIWSAGLVLFE-MSVKNV 285
|
Length = 392 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 3e-08
Identities = 47/206 (22%), Positives = 89/206 (43%), Gaps = 20/206 (9%)
Query: 271 LIGQGASGIVYKGTLRHGNLVAVKQILDLDTKGD----EDFTNEVEIISKIRHRNLLSLR 326
LI + +YKG + V ++ KG + NE++ + +I N+L +
Sbjct: 27 LIKENDQNSIYKGIF-NNKEVIIR-TFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIY 84
Query: 327 GCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLH- 385
G + D R L+ +Y G L + + K K L++ + + +D KG+ L+
Sbjct: 85 GFIIDIVDDL-PRLSLILEYCTRGYLREVLD---KEKDLSFKTKLDMAIDCCKGLYNLYK 140
Query: 386 YGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYAL 445
Y KP ++++ S + L+ K+ GL K S + Y + +
Sbjct: 141 YTNKP---YKNLTSVSFLVTENYKLKIICHGLEKIL----SSPPFKNVNFMVYFSYKMLN 193
Query: 446 --YGQLTEKSDVYSFGIVILELMSGR 469
+ + T K D+YS G+V+ E+ +G+
Sbjct: 194 DIFSEYTIKDDIYSLGVVLWEIFTGK 219
|
Length = 283 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 54.5 bits (132), Expect = 3e-08
Identities = 42/152 (27%), Positives = 69/152 (45%), Gaps = 19/152 (12%)
Query: 319 HRNLLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVA 378
+ N + L T L+ DY+ +G L D + K +L+ + KKII +
Sbjct: 68 NPNFIKLYYSVTTLKGH-----VLIMDYIKDGDLFDLL---KKEGKLSEAEVKKIIRQLV 119
Query: 379 KGIAYLHYGLKPGIYHRDIKSTNILLD-SELNAKVADFGLAKQSLEGHSHLTTRVAGTFG 437
+ + LH K I H DIK N+L D ++ + D+GL K + GT
Sbjct: 120 EALNDLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCK-----IIGTPSCYDGTLD 171
Query: 438 YLAPEYALYGQLTEKS-DVYSFGIVILELMSG 468
Y +PE + G + S D ++ G++ EL++G
Sbjct: 172 YFSPE-KIKGHNYDVSFDWWAVGVLTYELLTG 202
|
Length = 267 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 4e-08
Identities = 54/209 (25%), Positives = 99/209 (47%), Gaps = 35/209 (16%)
Query: 272 IGQGASGIVYKGTLRH-GNLVAVKQILDLDT--KGDE--DFTNEVEIISKIRHRNLLSLR 326
+GQG G V+ + G +VA+K + K +E E +I++ + L+ L
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALK-RMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKL- 66
Query: 327 GCCVTS--DDSSGKRRFLVYDYMPNG---TLSDNISISHKRKQLTWPQRKKIIVDVAKGI 381
+ + DD +L +Y+P G TL +N+ + + + + ++ + +
Sbjct: 67 ---LYAFQDDEY---LYLAMEYVPGGDFRTLLNNLGVLSED------HARFYMAEMFEAV 114
Query: 382 AYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLE-GHSHLTTRVAGTFGYLA 440
LH + G HRD+K N L+D+ + K+ DFGL+K + +S V G+ Y+A
Sbjct: 115 DALH---ELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANS-----VVGSPDYMA 166
Query: 441 PEYALYGQLTEKS-DVYSFGIVILELMSG 468
PE L G+ + + D +S G ++ E + G
Sbjct: 167 PE-VLRGKGYDFTVDYWSLGCMLYEFLCG 194
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 1e-07
Identities = 46/151 (30%), Positives = 68/151 (45%), Gaps = 28/151 (18%)
Query: 329 CVTSDDSSGKRRFLVYDYMPNGTLSD---NISISHKRKQLTWPQRKKIIVDVAKGIAYLH 385
C DD K ++V +YMP G L + N + K W K +V + +H
Sbjct: 110 CAFQDD---KYLYMVMEYMPGGDLVNLMSNYDVPEK-----WA--KFYTAEVVLALDAIH 159
Query: 386 YGLKPGIYHRDIKSTNILLDSELNAKVADFGLA-KQSLEGHSHLTTRVAGTFGYLAPEY- 443
G+ HRD+K N+LLD + K+ADFG K G T V GT Y++PE
Sbjct: 160 ---SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAV-GTPDYISPEVL 215
Query: 444 ------ALYGQLTEKSDVYSFGIVILELMSG 468
YG+ + D +S G+ + E++ G
Sbjct: 216 KSQGGDGYYGR---ECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 41/181 (22%), Positives = 75/181 (41%), Gaps = 42/181 (23%)
Query: 341 FLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKST 400
+L+ +++P G D +++ K+ LT + + I + I +H + G HRDIK
Sbjct: 77 YLIMEFLPGG---DMMTLLMKKDTLTEEETQFYIAETVLAIDSIH---QLGFIHRDIKPD 130
Query: 401 NILLDSELNAKVADFGLAKQSLEGH----------------------------------S 426
N+LLDS+ + K++DFGL + H
Sbjct: 131 NLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRR 190
Query: 427 HLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVL--DTSTSPFQLITD 484
L GT Y+APE + + D +S G+++ E++ G +T ++ + +
Sbjct: 191 QLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKVMN 250
Query: 485 W 485
W
Sbjct: 251 W 251
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 2e-07
Identities = 58/221 (26%), Positives = 100/221 (45%), Gaps = 35/221 (15%)
Query: 271 LIGQGASGIVYKGTLRH--GNLVAVKQILD---LDTKGDEDFT-NEVEIISKIRHRNLLS 324
+IG+G G VY G + G + A+K LD + K E NE ++S L+S
Sbjct: 1 IIGRGGFGEVY-GCRKADTGKMYAMK-CLDKKRIKMKQGETLALNERIMLS------LVS 52
Query: 325 LRGC----CVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKG 380
C C++ + + + D M G L ++S + + + + ++ G
Sbjct: 53 TGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS---QHGVFSEAEMRFYAAEIILG 109
Query: 381 IAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLA 440
+ ++H + +RD+K NILLD + +++D GLA + H + GT GY+A
Sbjct: 110 LEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMA 163
Query: 441 PEYALYGQLTEKS-DVYSFGIVILELMSGRKVLDTSTSPFQ 480
PE G + S D +S G ++ +L+ G SPF+
Sbjct: 164 PEVLQKGVAYDSSADWFSLGCMLFKLLRGH-------SPFR 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 2e-07
Identities = 31/81 (38%), Positives = 46/81 (56%), Gaps = 1/81 (1%)
Query: 394 HRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRV-AGTFGYLAPEYALYGQLTEK 452
HRDIKS NILL S K+ DFG +K S R GT Y+APE ++K
Sbjct: 166 HRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKK 225
Query: 453 SDVYSFGIVILELMSGRKVLD 473
+D++S G+++ EL++ ++ D
Sbjct: 226 ADMFSLGVLLYELLTLKRPFD 246
|
Length = 496 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 2e-07
Identities = 56/217 (25%), Positives = 99/217 (45%), Gaps = 27/217 (12%)
Query: 271 LIGQGASGIVYKGTLRH--GNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGC 328
+IG+G G VY G + G + A+K LD K + E +++ +L+S C
Sbjct: 1 IIGRGGFGEVY-GCRKADTGKMYAMKC---LDKKRIKMKQGETLALNERIMLSLVSTGDC 56
Query: 329 ----CVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYL 384
C+T + + + D M G L ++S + + + + ++ G+ ++
Sbjct: 57 PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLS---QHGVFSEKEMRFYATEIILGLEHM 113
Query: 385 HYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYA 444
H + +RD+K NILLD + +++D GLA + H + GT GY+APE
Sbjct: 114 HNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVL 167
Query: 445 LYGQLTEKS-DVYSFGIVILELMSGRKVLDTSTSPFQ 480
G + S D +S G ++ +L+ G SPF+
Sbjct: 168 QKGTAYDSSADWFSLGCMLFKLLRGH-------SPFR 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 3e-07
Identities = 33/98 (33%), Positives = 54/98 (55%), Gaps = 16/98 (16%)
Query: 377 VAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSL-------EGHSHLT 429
VA+G+ +L K I HRD+ + N+LL AK+ DFGLA+ + +G++ L
Sbjct: 221 VAQGMDFL--ASKNCI-HRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLP 277
Query: 430 TRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS 467
+ ++APE T +SDV+S+GI++ E+ S
Sbjct: 278 VK------WMAPESIFDCVYTVQSDVWSYGILLWEIFS 309
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 3e-07
Identities = 53/227 (23%), Positives = 97/227 (42%), Gaps = 29/227 (12%)
Query: 272 IGQGASGIVYKGTLRHGNLVA---VKQI-LDLDTKGDEDFTNEVEIISKIRHRNLLSLRG 327
IG G G V + VA VK++ + +K +F + + ++H N+L G
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 328 CCVTSDDSSGKRRFLVYDYMPNGTLSDNISISH-KRKQLTWPQRKKIIVDVAKGIAYLHY 386
CV + LV++Y G L +S R+ +++ ++A G+ ++H
Sbjct: 63 QCVEAIPY-----LLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH- 116
Query: 387 GLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTT--RVAGTFGYLAPEY- 443
K H D+ N L S+L KV D+G+ + ++ T +LAPE
Sbjct: 117 --KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYK-EDYIETEDDKCVPLRWLAPELV 173
Query: 444 -ALYGQL-----TEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITD 484
+G L T+ S+V++ G+ + EL + + P+ ++D
Sbjct: 174 GEFHGGLITAEQTKPSNVWALGVTLWEL------FENAAQPYSHLSD 214
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 4e-07
Identities = 28/75 (37%), Positives = 45/75 (60%), Gaps = 1/75 (1%)
Query: 394 HRDIKSTNILLDSELNAKVADFGLAKQSLEGHS-HLTTRVAGTFGYLAPEYALYGQLTEK 452
HRD+KS NI L K+ DFG +KQ + S + + GT YLAPE + ++K
Sbjct: 192 HRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKK 251
Query: 453 SDVYSFGIVILELMS 467
+D++S G+++ EL++
Sbjct: 252 ADMWSLGVILYELLT 266
|
Length = 478 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 5e-07
Identities = 59/238 (24%), Positives = 103/238 (43%), Gaps = 20/238 (8%)
Query: 236 QFVSNLQASVLPNSGAKWFHVSELEQATNGFSQNNLIGQGASGIVYKGTLRHGNL--VAV 293
QF+ NLQ +S + + + F+ +G G+ G V T ++ + VA+
Sbjct: 2 QFLKNLQLHKKKDSDSTKEPKRKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAI 61
Query: 294 KQILD---LDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFLVYDYMPNG 350
K+ + K + +E +I++ I H ++L G D+S +LV +++ G
Sbjct: 62 KRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGS--FKDESY---LYLVLEFVIGG 116
Query: 351 TLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNA 410
+ R+ +P A+ + Y I +RD+K N+LLD +
Sbjct: 117 EF-----FTFLRRNKRFPNDVGCFY-AAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFI 170
Query: 411 KVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSG 468
K+ DFG AK T + GT Y+APE L + +D ++ GI I E++ G
Sbjct: 171 KMTDFGFAKVV----DTRTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVG 224
|
Length = 340 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 7e-07
Identities = 54/208 (25%), Positives = 95/208 (45%), Gaps = 22/208 (10%)
Query: 272 IGQGASGIVYKGTLRHG---NLVAVKQILDLDTKGDE-DFTNEVEIISKIRHRNLLSLRG 327
IG G G V G + G V VK++ + ++ F E + ++H NLL G
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 328 CCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQR--KKIIVDVAKGIAYLH 385
C LV ++ P G L + K + +T +++ ++A G+ +LH
Sbjct: 63 QCTEVTPY-----LLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH 117
Query: 386 YGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTT-RVAGTFGYLAPEYA 444
K H D+ N LL ++L K+ D+GL+ + ++T ++ ++APE
Sbjct: 118 ---KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELV 174
Query: 445 --LYGQL-----TEKSDVYSFGIVILEL 465
++G L T++S+V+S G+ I EL
Sbjct: 175 DEVHGNLLVVDQTKESNVWSLGVTIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 7e-07
Identities = 46/213 (21%), Positives = 100/213 (46%), Gaps = 24/213 (11%)
Query: 272 IGQGASGIVYKGT-LRHGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCV 330
+G G++G+V+ VAVK+I+ D + + E++II ++ H N++ +
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72
Query: 331 TS--DDSSGKRR-------FLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGI 381
S D + ++V +YM +++ ++ L+ + + + +G+
Sbjct: 73 PSGSDLTEDVGSLTELNSVYIVQEYM-----ETDLANVLEQGPLSEEHARLFMYQLLRGL 127
Query: 382 AYLHYGLKPGIYHRDIKSTNILLDSE-LNAKVADFGLAK---QSLEGHSHLTTRVAGTFG 437
Y+H + HRD+K N+ +++E L K+ DFGLA+ +L+ + +
Sbjct: 128 KYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKW- 183
Query: 438 YLAPEYALY-GQLTEKSDVYSFGIVILELMSGR 469
Y +P L T+ D+++ G + E+++G+
Sbjct: 184 YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 7e-07
Identities = 43/150 (28%), Positives = 68/150 (45%), Gaps = 28/150 (18%)
Query: 341 FLVYDYMPNGTLSDNISI-SHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKS 399
+LV +Y P G L +S+ + Q + + ++ I +H + G HRDIK
Sbjct: 77 YLVMEYQPGGDL---LSLLNRYEDQFDEDMAQFYLAELVLAIHSVH---QMGYVHRDIKP 130
Query: 400 TNILLDSELNAKVADFG-LAKQSLEGHSHLTTRVAGTFGYLAPEY---------ALYGQL 449
N+L+D + K+ADFG A+ + + V GT Y+APE YG
Sbjct: 131 ENVLIDRTGHIKLADFGSAARLTANKMVNSKLPV-GTPDYIAPEVLTTMNGDGKGTYGV- 188
Query: 450 TEKSDVYSFGIVILELMSGRKVLDTSTSPF 479
+ D +S G++ E++ GR SPF
Sbjct: 189 --ECDWWSLGVIAYEMIYGR-------SPF 209
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 9e-07
Identities = 39/181 (21%), Positives = 74/181 (40%), Gaps = 42/181 (23%)
Query: 341 FLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKST 400
+L+ +++P G D +++ K+ L+ + I + I +H + G HRDIK
Sbjct: 77 YLIMEFLPGG---DMMTLLMKKDTLSEEATQFYIAETVLAIDAIH---QLGFIHRDIKPD 130
Query: 401 NILLDSELNAKVADFGLAKQSLEGH----------------------------------S 426
N+LLD++ + K++DFGL + H
Sbjct: 131 NLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRR 190
Query: 427 HLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVL--DTSTSPFQLITD 484
L GT Y+APE + + D +S G+++ E++ G +T ++ + +
Sbjct: 191 QLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYRKVMN 250
Query: 485 W 485
W
Sbjct: 251 W 251
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 1e-06
Identities = 50/154 (32%), Positives = 71/154 (46%), Gaps = 13/154 (8%)
Query: 272 IGQGASGIVYKGTLR-HGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCV 330
I +GA G VY G + + L AVK + K D N V + R LS V
Sbjct: 12 ISRGAFGKVYLGRKKNNSKLYAVKVV----KKADMINKNMVHQVQAERDALALSKSPFIV 67
Query: 331 TSDDS--SGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGL 388
S S +LV +Y+ G + S+ H K I +VA + YLH
Sbjct: 68 HLYYSLQSANNVYLVMEYLIGGDVK---SLLHIYGYFDEEMAVKYISEVALALDYLH--- 121
Query: 389 KPGIYHRDIKSTNILLDSELNAKVADFGLAKQSL 422
+ GI HRD+K N+L+ +E + K+ DFGL+K +L
Sbjct: 122 RHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVTL 155
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 1e-06
Identities = 39/168 (23%), Positives = 75/168 (44%), Gaps = 25/168 (14%)
Query: 309 NEVEIISKIRHRNLLSLRGCCVTSDDS---SGKRRFLVYDYMPNGTLSDNISISHKRKQL 365
NE+ + ++ H N+L + + ++ + K F +Y +M + K + L
Sbjct: 212 NEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFD------WKDRPL 265
Query: 366 TWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGH 425
Q + I+ + + Y+H + HRDIK NI L+ + + DFG A E
Sbjct: 266 LK-QTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFLNCDGKIVLGDFGTA-MPFE-- 318
Query: 426 SHLTTRVAGTFGYL------APEYALYGQLTEKSDVYSFGIVILELMS 467
R A +G++ +PE E +D++S G+++L+++S
Sbjct: 319 ---KEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 1e-06
Identities = 27/77 (35%), Positives = 45/77 (58%), Gaps = 1/77 (1%)
Query: 392 IYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALYGQLTE 451
+ +RD+K NILLD + + + DFGL K +++ T GT YLAPE L T+
Sbjct: 114 VIYRDLKPENILLDYQGHIALCDFGLCKLNMK-DDDKTNTFCGTPEYLAPELLLGHGYTK 172
Query: 452 KSDVYSFGIVILELMSG 468
D ++ G+++ E+++G
Sbjct: 173 AVDWWTLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 1e-06
Identities = 32/98 (32%), Positives = 52/98 (53%), Gaps = 16/98 (16%)
Query: 377 VAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQ-------SLEGHSHLT 429
VAKG+++L HRD+ + NILL K+ DFGLA+ ++G++ L
Sbjct: 223 VAKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLP 279
Query: 430 TRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS 467
+ ++APE T +SDV+S+GI++ E+ S
Sbjct: 280 VK------WMAPESIFNCVYTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 4e-06
Identities = 30/94 (31%), Positives = 50/94 (53%), Gaps = 8/94 (8%)
Query: 377 VAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTF 436
VA+G+ +L HRD+ + N+LL K+ DFGLA+ + ++++ TF
Sbjct: 246 VARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSK--GSTF 300
Query: 437 ---GYLAPEYALYGQLTEKSDVYSFGIVILELMS 467
++APE T SDV+S+GI++ E+ S
Sbjct: 301 LPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 8e-06
Identities = 42/139 (30%), Positives = 65/139 (46%), Gaps = 25/139 (17%)
Query: 341 FLVYDYMPNGTLSD---NISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDI 397
++V +YMP G L + N + K W + +V + +H G HRD+
Sbjct: 119 YMVMEYMPGGDLVNLMSNYDVPEK-----WA--RFYTAEVVLALDAIH---SMGFIHRDV 168
Query: 398 KSTNILLDSELNAKVADFGLA-KQSLEGHSHLTTRVAGTFGYLAPEY-------ALYGQL 449
K N+LLD + K+ADFG K + EG T V GT Y++PE YG+
Sbjct: 169 KPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGR- 226
Query: 450 TEKSDVYSFGIVILELMSG 468
+ D +S G+ + E++ G
Sbjct: 227 --ECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 1e-05
Identities = 30/92 (32%), Positives = 48/92 (52%), Gaps = 4/92 (4%)
Query: 377 VAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAG-T 435
VA+G+ +L HRD+ + NILL K+ DFGLA+ + ++ A
Sbjct: 183 VARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239
Query: 436 FGYLAPEYALYGQLTEKSDVYSFGIVILELMS 467
++APE T +SDV+SFG+++ E+ S
Sbjct: 240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 1e-05
Identities = 31/92 (33%), Positives = 48/92 (52%), Gaps = 4/92 (4%)
Query: 377 VAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAG-T 435
VAKG+ +L HRD+ + NILL K+ DFGLA+ + ++ A
Sbjct: 188 VAKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244
Query: 436 FGYLAPEYALYGQLTEKSDVYSFGIVILELMS 467
++APE T +SDV+SFG+++ E+ S
Sbjct: 245 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 1e-05
Identities = 51/209 (24%), Positives = 96/209 (45%), Gaps = 23/209 (11%)
Query: 271 LIGQGASGIVYKGTLRHGNLVAVKQILD----LDTKGDEDFTNEVEIISKIRHRNLLSLR 326
+IG+GA G V L++ + V +IL+ L F E +++ ++ + +L
Sbjct: 8 VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLH 67
Query: 327 GCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKR--KQLTWPQRKKIIVDVAKGIAYL 384
D+++ +LV DY G L +S R + + ++++ + + L
Sbjct: 68 --YAFQDENN---LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAI-DSVHQL 121
Query: 385 HYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYA 444
HY HRDIK NIL+D + ++ADFG + +E + ++ GT Y++PE
Sbjct: 122 HY------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEIL 175
Query: 445 LY-----GQLTEKSDVYSFGIVILELMSG 468
G+ + D +S G+ + E++ G
Sbjct: 176 QAMEDGKGKYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 29/94 (30%), Positives = 49/94 (52%), Gaps = 8/94 (8%)
Query: 377 VAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTF 436
VA G+ +L HRD+ + N+L+ K+ DFGLA+ + ++++ TF
Sbjct: 248 VANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISK--GSTF 302
Query: 437 ---GYLAPEYALYGQLTEKSDVYSFGIVILELMS 467
++APE T SDV+SFGI++ E+ +
Sbjct: 303 LPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 2e-05
Identities = 68/242 (28%), Positives = 94/242 (38%), Gaps = 69/242 (28%)
Query: 272 IGQGASGIVYKGTLRH---GNLVAVKQILDLDTKGDEDFT---NEVEIISKIRHRNLLSL 325
IG+G + RH G LV V+ I DL+ +E NEV + RH N+++
Sbjct: 6 IGRGFCNLTSVYLARHTPTGTLVTVR-ITDLENCTEEHLKALQNEVVLSHFFRHPNIMTS 64
Query: 326 RGCCVTSD--------DSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDV 377
T + G L+ Y P G I I+
Sbjct: 65 WTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALI--------------GNILFGA 110
Query: 378 AKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHL--------T 429
+G+ YLH + G HR+IK+++IL+ + GL SL G SHL
Sbjct: 111 LRGLNYLH---QNGYIHRNIKASHILISGD--------GLV--SLSGLSHLYSLVRNGQK 157
Query: 430 TRVAGTFG--------YLAPEYA---LYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSP 478
+V F +L+PE LYG KSD+YS GI EL +GR P
Sbjct: 158 AKVVYDFPQFSTSVLPWLSPELLRQDLYG-YNVKSDIYSVGITACELATGR-------VP 209
Query: 479 FQ 480
FQ
Sbjct: 210 FQ 211
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 2e-05
Identities = 42/184 (22%), Positives = 74/184 (40%), Gaps = 45/184 (24%)
Query: 341 FLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKST 400
+L+ +Y+P G D +++ K+ T + + I + I +H K G HRDIK
Sbjct: 77 YLIMEYLPGG---DMMTLLMKKDTFTEEETRFYIAETILAIDSIH---KLGYIHRDIKPD 130
Query: 401 NILLDSELNAKVADFGLAK---------------QSLEGHSHLTTR-------------- 431
N+LLD++ + K++DFGL +L +
Sbjct: 131 NLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKR 190
Query: 432 --------VAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRK--VLDTSTSPFQL 481
GT Y+APE L ++ D +S G+++ E++ G D ++
Sbjct: 191 NRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCSDNPQETYRK 250
Query: 482 ITDW 485
I +W
Sbjct: 251 IINW 254
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 2e-05
Identities = 30/96 (31%), Positives = 47/96 (48%), Gaps = 3/96 (3%)
Query: 377 VAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTF 436
V + I YLH + I HRDIK+ NI ++ + + DFG A ++ +++ AGT
Sbjct: 191 VLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTI 247
Query: 437 GYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVL 472
APE D++S GIV+ E+ + L
Sbjct: 248 ATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSL 283
|
Length = 391 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 3e-05
Identities = 31/92 (33%), Positives = 50/92 (54%), Gaps = 4/92 (4%)
Query: 377 VAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAG-T 435
VA+G+ +L + I HRD+ + NILL K+ DFGLA+ + ++ A
Sbjct: 182 VARGMEFL--ASRKCI-HRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 238
Query: 436 FGYLAPEYALYGQLTEKSDVYSFGIVILELMS 467
++APE T +SDV+SFG+++ E+ S
Sbjct: 239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 4e-05
Identities = 33/110 (30%), Positives = 50/110 (45%), Gaps = 8/110 (7%)
Query: 358 ISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFG- 416
+ + + L Q + + I Y+H GI HRDIK+ N+L++ + + DFG
Sbjct: 250 LGARLRPLGLAQVTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGA 306
Query: 417 --LAKQSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILE 464
A+ S H +AGT APE T D++S G+VI E
Sbjct: 307 ACFARGSWSTPFHYG--IAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 6e-05
Identities = 42/173 (24%), Positives = 69/173 (39%), Gaps = 52/173 (30%)
Query: 341 FLVYDYMPNGTLSDNISISHKRKQLTWPQR--KKIIVDVAKGIAYLHYGLKPGIYHRDIK 398
+ V DY+P G + +S + + + + I ++ I +H K G HRDIK
Sbjct: 77 YFVMDYIPGGDM-----MSLLIRLGIFEEDLARFYIAELTCAIESVH---KMGFIHRDIK 128
Query: 399 STNILLDSELNAKVADFGL---------AKQSLEGHSH---------------------- 427
NIL+D + + K+ DFGL +K +G H
Sbjct: 129 PDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPL 188
Query: 428 -----------LTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGR 469
L + GT Y+APE L T+ D +S G+++ E++ G+
Sbjct: 189 ERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQ 241
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 7e-05
Identities = 42/177 (23%), Positives = 70/177 (39%), Gaps = 56/177 (31%)
Query: 341 FLVYDYMPNGTLSDNISISHKRKQLTWPQR--KKIIVDVAKGIAYLHYGLKPGIYHRDIK 398
+ V DY+P G + +S + +P+ + I ++ I +H K G HRDIK
Sbjct: 77 YFVMDYIPGGDM-----MSLLIRMEVFPEVLARFYIAELTLAIESVH---KMGFIHRDIK 128
Query: 399 STNILLDSELNAKVADFGLAK--------------------------------------- 419
NIL+D + + K+ DFGL
Sbjct: 129 PDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDR 188
Query: 420 -QSLEGHSH------LTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGR 469
++LE + L + GT Y+APE L T+ D +S G+++ E++ G+
Sbjct: 189 LKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQ 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.2 bits (105), Expect = 1e-04
Identities = 62/243 (25%), Positives = 96/243 (39%), Gaps = 65/243 (26%)
Query: 271 LIGQGASGIVY----KGTLRHGNLVAVKQIL-DLDTKGDE--DFTNEVEIISKIRHRNLL 323
L+G+G G V+ KGT G L A+K + K ++ E EI++ + H L
Sbjct: 8 LLGKGDVGRVFLVRLKGT---GKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLP 64
Query: 324 SLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAK---- 379
+L T LV DY P G L ++Q K + +VA+
Sbjct: 65 TLYASFQTETYL-----CLVMDYCPGGELF-----RLLQRQ----PGKCLSEEVARFYAA 110
Query: 380 ----GIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQS-------------- 421
+ YLH GI +RD+K NILL + ++DF L+KQS
Sbjct: 111 EVLLALEYLHL---LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKG 167
Query: 422 ---LEGHSHLTTRVA-----------GTFGYLAPEY-ALYGQLTEKSDVYSFGIVILELM 466
+S + + GT Y+APE + G D ++ GI++ E++
Sbjct: 168 SRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGH-GSAVDWWTLGILLYEML 226
Query: 467 SGR 469
G
Sbjct: 227 YGT 229
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 28/93 (30%), Positives = 46/93 (49%), Gaps = 11/93 (11%)
Query: 381 IAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLA 440
I LHY HRDIK N+LLD + ++ADFG + + + ++ GT Y++
Sbjct: 118 IHQLHY------VHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYIS 171
Query: 441 PEYAL-----YGQLTEKSDVYSFGIVILELMSG 468
PE G+ + D +S G+ + E++ G
Sbjct: 172 PEILQAMEDGMGKYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 2e-04
Identities = 57/217 (26%), Positives = 93/217 (42%), Gaps = 37/217 (17%)
Query: 272 IGQGASGIVYKGTLR-------HGNLVAVKQIL-DLDTKG--DEDFTNEVEIISKIRHRN 321
+GQG +YKG LR G V +L L + F ++S++ H++
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 322 LLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGI 381
L+ L G CV ++ +V +Y+ G L + H+ K K +DVAK +
Sbjct: 63 LVKLYGVCVRDENI------MVEEYVKFGPLDVFL---HREKNNVSLHWK---LDVAKQL 110
Query: 382 AY-LHYGLKPGIYHRDIKSTNILLDSE-------LNAKVADFGLAKQSLEGHSHLTTRVA 433
A LHY + H ++ NIL+ K++D G+ ++ R+
Sbjct: 111 ASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI-TVLSREERVERIP 169
Query: 434 GTFGYLAPEYALYGQ--LTEKSDVYSFGIVILELMSG 468
++APE GQ LT +D +SFG +LE+ S
Sbjct: 170 ----WIAPECIRNGQASLTIAADKWSFGTTLLEICSN 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 41.9 bits (99), Expect = 3e-04
Identities = 44/163 (26%), Positives = 64/163 (39%), Gaps = 36/163 (22%)
Query: 271 LIGQGASGIVYKGTLRHGNLVAVKQ-------ILDLDTKGDEDFT-NEVEIISKIRHRNL 322
LI QGA I+Y G VK+ +LD K + T E I++K R
Sbjct: 3 LIKQGAEAIIYLTDF-LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAR---- 57
Query: 323 LSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKR----KQLTWPQRKKIIVDVA 378
G V +VYD P+ L I + + K R ++ +V
Sbjct: 58 --EAGVPVP----------IVYDVDPDNGL---IVMEYIEGELLKDALEEARPDLLREVG 102
Query: 379 KGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQS 421
+ + LH K GI H D+ ++NI+L DFGL + S
Sbjct: 103 RLVGKLH---KAGIVHGDLTTSNIILSGG-RIYFIDFGLGEFS 141
|
Length = 204 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 5e-04
Identities = 29/148 (19%), Positives = 59/148 (39%), Gaps = 16/148 (10%)
Query: 271 LIGQGASGIVYKGTLRHGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCV 330
L+ G + VY + + V +K + D EV I+ + + L + V
Sbjct: 5 LLKGGLTNRVYLLGTKDEDYV-LKINPS--REKGADREREVAILQLLARKGLPVPK---V 58
Query: 331 TSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKP 390
+ S +L+ +++ TL +++ +++ I +A+ +A LH
Sbjct: 59 LASGESDGWSYLLMEWIEGETLD----------EVSEEEKEDIAEQLAELLAKLHQLPLL 108
Query: 391 GIYHRDIKSTNILLDSELNAKVADFGLA 418
+ H D+ NIL+D + D+ A
Sbjct: 109 VLCHGDLHPGNILVDDGKILGIIDWEYA 136
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 5e-04
Identities = 37/142 (26%), Positives = 60/142 (42%), Gaps = 14/142 (9%)
Query: 341 FLVYDYMPNGTLSDNISISHKRKQLTWPQR--KKIIVDVAKGIAYLHYGLKPGIYHRDIK 398
FLV + G L SH K L P+ K+ ++ + LH + GI RD+
Sbjct: 61 FLVLQHAEGGKL-----WSHISKFLNIPEECVKRWAAEMVVALDALH---REGIVCRDLN 112
Query: 399 STNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSF 458
NILLD + ++ F + + A Y APE + TE D +S
Sbjct: 113 PNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVENMYCAPEVGGISEETEACDWWSL 168
Query: 459 GIVILELMSGRKVLDTSTSPFQ 480
G ++ EL++G+ +++ S
Sbjct: 169 GAILFELLTGKTLVECHPSGIN 190
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 5e-04
Identities = 29/94 (30%), Positives = 47/94 (50%), Gaps = 12/94 (12%)
Query: 391 GIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEY--AL--- 445
G HRDIK N+LLD + ++ADFG + L + + GT Y++PE A+
Sbjct: 122 GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDG 181
Query: 446 YGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPF 479
G+ + D +S G+ + E++ G +PF
Sbjct: 182 KGRYGPECDWWSLGVCMYEMLYG-------ETPF 208
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 7e-04
Identities = 40/175 (22%), Positives = 67/175 (38%), Gaps = 52/175 (29%)
Query: 341 FLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKST 400
+ V DY+P G D +S+ + + I ++ + +H K G HRDIK
Sbjct: 77 YFVMDYIPGG---DMMSLLIRMGIFPEDLARFYIAELTCAVESVH---KMGFIHRDIKPD 130
Query: 401 NILLDSELNAKVADFGLA------------------------------------------ 418
NIL+D + + K+ DFGL
Sbjct: 131 NILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLK 190
Query: 419 ---KQSLEGHSH-LTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGR 469
+++ H L + GT Y+APE L T+ D +S G+++ E++ G+
Sbjct: 191 PLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQ 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 590 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.98 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.98 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.97 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.96 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.96 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.96 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.96 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.95 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.95 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.94 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.93 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.93 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.93 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.93 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.93 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.93 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.92 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.91 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.9 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.88 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.86 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.84 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.84 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.82 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.81 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.81 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.8 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.8 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.79 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.79 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.78 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.76 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.75 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.74 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.74 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.73 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.72 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.72 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.69 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.67 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.66 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.65 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.62 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.6 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.56 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.49 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.39 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.34 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.33 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.27 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.22 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.17 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.09 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.03 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.0 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.0 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.95 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.9 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.9 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.83 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.63 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.62 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.58 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.57 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.57 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.5 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.31 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.27 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.27 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.26 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.26 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.22 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.19 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.96 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.94 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.94 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.89 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.82 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.74 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.65 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.62 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.6 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.53 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.5 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.4 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.32 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.31 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.2 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.0 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.99 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.75 | |
| PLN02236 | 344 | choline kinase | 96.49 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.47 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.32 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 96.3 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 96.26 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 95.88 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 95.74 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 95.72 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 95.67 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 95.57 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 95.56 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 95.47 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 95.4 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 95.35 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 95.25 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 95.11 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 94.91 | |
| PF08693 | 40 | SKG6: Transmembrane alpha-helix domain; InterPro: | 94.76 | |
| PTZ00384 | 383 | choline kinase; Provisional | 94.53 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 94.42 | |
| PF04655 | 253 | APH_6_hur: Aminoglycoside/hydroxyurea antibiotic r | 93.86 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-62 Score=513.53 Aligned_cols=288 Identities=47% Similarity=0.772 Sum_probs=253.6
Q ss_pred CCccccHHHHHHHhcCCCccceecccCcEEEEEEEEcCCcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCccccceeE
Q 046270 250 GAKWFHVSELEQATNGFSQNNLIGQGASGIVYKGTLRHGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCC 329 (590)
Q Consensus 250 ~~~~f~~~el~~at~~f~~~~~LG~G~fG~Vykg~~~~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~ 329 (590)
..+.|++.|+..||++|+..++||+||||.||+|.+++|..||||++.....+...+|.+|++++.+++|||||+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 56789999999999999999999999999999999999999999988765443255699999999999999999999999
Q ss_pred EeccCCCCceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCc
Q 046270 330 VTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELN 409 (590)
Q Consensus 330 ~~~~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~ 409 (590)
.+.+. +++||||||+||+|.++|+..... .|+|.+|++|+.++|+||+|||+.+.+.||||||||+|||||++++
T Consensus 141 ~e~~~----~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~ 215 (361)
T KOG1187|consen 141 LEGGE----HRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFN 215 (361)
T ss_pred ecCCc----eEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCC
Confidence 84321 599999999999999999854433 8999999999999999999999999899999999999999999999
Q ss_pred EEEEeeCCcccccC-CCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC-chhhhhHHHH
Q 046270 410 AKVADFGLAKQSLE-GHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTS-PFQLITDWAW 487 (590)
Q Consensus 410 ~kL~DFGla~~~~~-~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~-~~~~l~~~~~ 487 (590)
+||+|||+|+..+. ........ .||.+|+||||+..+..+.|+|||||||+|+||+||+++.+.... ....+.+|++
T Consensus 216 aKlsDFGLa~~~~~~~~~~~~~~-~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~ 294 (361)
T KOG1187|consen 216 AKLSDFGLAKLGPEGDTSVSTTV-MGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAK 294 (361)
T ss_pred EEccCccCcccCCccccceeeec-CCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHH
Confidence 99999999976654 22222211 899999999999999999999999999999999999999986542 2335888999
Q ss_pred HHHhcCCchhhhhHHHh-hhhHH-HHHHHHHHHHHhchhcCCCCCCCHHHHHHHhccC
Q 046270 488 VLAKSGKVDDIFDEFIR-AEGAR-AVMERFVLVGILCAHVMVALRPTITDALKMLEGD 543 (590)
Q Consensus 488 ~~~~~~~~~~~~d~~l~-~~~~~-~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~~ 543 (590)
..+.++.+.+++|+.+. ..... +.+.++..+++.|++.+|.+||+|.||+++|+..
T Consensus 295 ~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~ 352 (361)
T KOG1187|consen 295 PLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGI 352 (361)
T ss_pred HHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhh
Confidence 99999999999999987 44443 6778999999999999999999999999999654
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-47 Score=401.94 Aligned_cols=252 Identities=35% Similarity=0.567 Sum_probs=204.3
Q ss_pred cceecccCcEEEEEEEEcCCcEEEEEEeecCCCCC--hHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEEEEEee
Q 046270 269 NNLIGQGASGIVYKGTLRHGNLVAVKQILDLDTKG--DEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFLVYDY 346 (590)
Q Consensus 269 ~~~LG~G~fG~Vykg~~~~g~~vAvK~l~~~~~~~--~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~LV~E~ 346 (590)
.+.||+|+||+||+|.+.....||||++....... .++|.+|+.+|.+++|||||+++|+|..... ..++||||
T Consensus 46 ~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~----~~~iVtEy 121 (362)
T KOG0192|consen 46 EEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPG----SLCIVTEY 121 (362)
T ss_pred hhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC----ceEEEEEe
Confidence 34599999999999999954559999997643332 4589999999999999999999999985331 48999999
Q ss_pred CCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCC-eEecCCCCCceEECCCC-cEEEEeeCCcccccCC
Q 046270 347 MPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPG-IYHRDIKSTNILLDSEL-NAKVADFGLAKQSLEG 424 (590)
Q Consensus 347 ~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~-ivHrDIKp~NILLd~~~-~~kL~DFGla~~~~~~ 424 (590)
|++|+|.++|+.. ....++|..+++|+.+||+||.||| +.+ ||||||||+||||+.++ ++||+|||+++.....
T Consensus 122 ~~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH---~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~ 197 (362)
T KOG0192|consen 122 MPGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLH---SEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVIS 197 (362)
T ss_pred CCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHh---cCCCeeecccChhhEEEcCCCCEEEECCCccceeeccc
Confidence 9999999999753 3568999999999999999999999 777 99999999999999997 9999999999865432
Q ss_pred CcccccccccCCCccCccccc--cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhhhHH
Q 046270 425 HSHLTTRVAGTFGYLAPEYAL--YGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDEF 502 (590)
Q Consensus 425 ~~~~~~~~~gt~~Y~APE~~~--~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 502 (590)
. ...+...||+.|||||.+. ...|+.|+|||||||+||||+||+.||..... .. +. ......+...+
T Consensus 198 ~-~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-~~-~~---~~v~~~~~Rp~----- 266 (362)
T KOG0192|consen 198 K-TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-VQ-VA---SAVVVGGLRPP----- 266 (362)
T ss_pred c-ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-HH-HH---HHHHhcCCCCC-----
Confidence 2 2334478999999999999 56999999999999999999999999976544 11 11 11112222111
Q ss_pred HhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhccC
Q 046270 503 IRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEGD 543 (590)
Q Consensus 503 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~~ 543 (590)
.+......+..++..||+.||..||++.+++.+|+..
T Consensus 267 ----~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~ 303 (362)
T KOG0192|consen 267 ----IPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESI 303 (362)
T ss_pred ----CCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHH
Confidence 1112345777788889999999999999999999864
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-46 Score=390.54 Aligned_cols=251 Identities=30% Similarity=0.460 Sum_probs=209.3
Q ss_pred ccceecccCcEEEEEEEEcCCcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEEEEEeeC
Q 046270 268 QNNLIGQGASGIVYKGTLRHGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFLVYDYM 347 (590)
Q Consensus 268 ~~~~LG~G~fG~Vykg~~~~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~LV~E~~ 347 (590)
..+.||+|.||+||.|.++....||+|.++... ...++|.+|+++|++|+|+|||+|+|+|...+ ..+||||||
T Consensus 210 l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~-----piyIVtE~m 283 (468)
T KOG0197|consen 210 LIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQE-----PIYIVTEYM 283 (468)
T ss_pred HHHHhcCCccceEEEEEEcCCCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecCC-----ceEEEEEec
Confidence 457899999999999999987799999997753 44678999999999999999999999998533 489999999
Q ss_pred CCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccccCCCcc
Q 046270 348 PNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSH 427 (590)
Q Consensus 348 ~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~~~~~~~ 427 (590)
++|+|.++|.. ..+..+...+.+.++.|||+||+||+ ++++|||||.++||||+++..+||+||||||...++...
T Consensus 284 ~~GsLl~yLr~-~~~~~l~~~~Ll~~a~qIaeGM~YLe---s~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~ 359 (468)
T KOG0197|consen 284 PKGSLLDYLRT-REGGLLNLPQLLDFAAQIAEGMAYLE---SKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYT 359 (468)
T ss_pred ccCcHHHHhhh-cCCCccchHHHHHHHHHHHHHHHHHH---hCCccchhhhhhheeeccCceEEEcccccccccCCCcee
Confidence 99999999965 34567999999999999999999999 999999999999999999999999999999965555444
Q ss_pred cccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhhHHHHHHHhcCCchhhhhHHHhhh
Q 046270 428 LTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDEFIRAE 506 (590)
Q Consensus 428 ~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 506 (590)
......-...|.|||.+..++++.|||||||||+||||+| |+.|+....... +.+.++...+-.
T Consensus 360 ~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~e---------------v~~~le~GyRlp 424 (468)
T KOG0197|consen 360 ASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEE---------------VLELLERGYRLP 424 (468)
T ss_pred ecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHH---------------HHHHHhccCcCC
Confidence 4444445678999999999999999999999999999999 777765433211 112233322222
Q ss_pred hHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhccC
Q 046270 507 GARAVMERFVLVGILCAHVMVALRPTITDALKMLEGD 543 (590)
Q Consensus 507 ~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~~ 543 (590)
.+...+..+.+|+..||+.+|++|||++.+...|+..
T Consensus 425 ~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~ 461 (468)
T KOG0197|consen 425 RPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDF 461 (468)
T ss_pred CCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHh
Confidence 3444566888999999999999999999998888753
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=366.23 Aligned_cols=254 Identities=26% Similarity=0.437 Sum_probs=207.6
Q ss_pred ccHHHHHHHhcCCCccceecccCcEEEEEEEEcC-CcEEEEEEeec-CCCCChHHHHHHHHHHHhcCCCCccccceeEEe
Q 046270 254 FHVSELEQATNGFSQNNLIGQGASGIVYKGTLRH-GNLVAVKQILD-LDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVT 331 (590)
Q Consensus 254 f~~~el~~at~~f~~~~~LG~G~fG~Vykg~~~~-g~~vAvK~l~~-~~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~ 331 (590)
++..||+ ..+.||+|..|+|||++++. +..+|+|.+.. .+....+++.+|++++++.+||+||.++|.|..
T Consensus 76 i~~~dle-------~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~ 148 (364)
T KOG0581|consen 76 ISLSDLE-------RLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYS 148 (364)
T ss_pred cCHHHhh-------hhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEe
Confidence 4555555 45789999999999999985 67899999843 333446789999999999999999999999985
Q ss_pred ccCCCCceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEE
Q 046270 332 SDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAK 411 (590)
Q Consensus 332 ~~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~k 411 (590)
.. .+..++||||.+|||++++. ..+.+++...-+|+.+|++||.|||+ +++||||||||+|||++..|++|
T Consensus 149 ~~----~~isI~mEYMDgGSLd~~~k---~~g~i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVK 219 (364)
T KOG0581|consen 149 NG----EEISICMEYMDGGSLDDILK---RVGRIPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVK 219 (364)
T ss_pred CC----ceEEeehhhcCCCCHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEE
Confidence 43 25999999999999999985 33679999999999999999999994 38999999999999999999999
Q ss_pred EEeeCCcccccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHh
Q 046270 412 VADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAK 491 (590)
Q Consensus 412 L~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~ 491 (590)
|+|||.++..... ......||..|||||.+.+..|+.++||||||+.++|+.+|+.|+.........
T Consensus 220 icDFGVS~~lvnS---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~---------- 286 (364)
T KOG0581|consen 220 ICDFGVSGILVNS---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLD---------- 286 (364)
T ss_pred eccccccHHhhhh---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCC----------
Confidence 9999999876544 456678999999999999999999999999999999999999998764222211
Q ss_pred cCCchhhhhHHHhhh---hHH-HHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 492 SGKVDDIFDEFIRAE---GAR-AVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 492 ~~~~~~~~d~~l~~~---~~~-~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
..++++..+.+. .+. ....++..++-.|++.||.+||+..|++++
T Consensus 287 ---~~~Ll~~Iv~~ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 287 ---IFELLCAIVDEPPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred ---HHHHHHHHhcCCCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 112222222211 111 245678899999999999999999998763
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-43 Score=357.78 Aligned_cols=202 Identities=31% Similarity=0.545 Sum_probs=178.8
Q ss_pred hcCCCccceecccCcEEEEEEEEcC-CcEEEEEEeecC--CCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCce
Q 046270 263 TNGFSQNNLIGQGASGIVYKGTLRH-GNLVAVKQILDL--DTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKR 339 (590)
Q Consensus 263 t~~f~~~~~LG~G~fG~Vykg~~~~-g~~vAvK~l~~~--~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~ 339 (590)
.++|...+.||+|.||+||+|++++ +..||||.+... ..+..+.+..|+++|+.++|||||+|++++.. +..
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~-----~~~ 83 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIED-----DDF 83 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEec-----CCe
Confidence 3568888889999999999999874 789999999654 44456678899999999999999999999985 446
Q ss_pred EEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCC------CcEEEE
Q 046270 340 RFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSE------LNAKVA 413 (590)
Q Consensus 340 ~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~------~~~kL~ 413 (590)
.+||||||.+|+|.+|++ +++.+++...+.++.|||.||++|| +++||||||||.||||+.. -.+||+
T Consensus 84 i~lVMEyC~gGDLs~yi~---~~~~l~e~t~r~Fm~QLA~alq~L~---~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIA 157 (429)
T KOG0595|consen 84 IYLVMEYCNGGDLSDYIR---RRGRLPEATARHFMQQLASALQFLH---ENNIIHRDLKPQNILLSTTARNDTSPVLKIA 157 (429)
T ss_pred EEEEEEeCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCcceEEeccCCCCCCCceEEec
Confidence 999999999999999995 5568999999999999999999999 9999999999999999765 458999
Q ss_pred eeCCcccccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 046270 414 DFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTS 477 (590)
Q Consensus 414 DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~ 477 (590)
|||+||....+ ......+|++-|||||+++..+|+.|+|+||.|++|||+++|+.||+....
T Consensus 158 DFGfAR~L~~~--~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~ 219 (429)
T KOG0595|consen 158 DFGFARFLQPG--SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETP 219 (429)
T ss_pred ccchhhhCCch--hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCH
Confidence 99999987643 345568899999999999999999999999999999999999999985443
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-44 Score=391.13 Aligned_cols=259 Identities=25% Similarity=0.422 Sum_probs=213.5
Q ss_pred cCCCccceecccCcEEEEEEEEcC------CcEEEEEEeecCCCC-ChHHHHHHHHHHHhcCCCCccccceeEEeccCCC
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLRH------GNLVAVKQILDLDTK-GDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSS 336 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~~------g~~vAvK~l~~~~~~-~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~ 336 (590)
.+....+.||+|.||+||+|...+ ...||||.+++.... ...+|++|+++++.++|||||+|+|.|..
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~----- 560 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCRE----- 560 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEcc-----
Confidence 344456789999999999998643 457999999887665 67899999999999999999999999994
Q ss_pred CceEEEEEeeCCCCCcchhhhhhcc-----------cccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEC
Q 046270 337 GKRRFLVYDYMPNGTLSDNISISHK-----------RKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLD 405 (590)
Q Consensus 337 ~~~~~LV~E~~~~gsL~~~L~~~~~-----------~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd 405 (590)
+...+||+|||..|+|.+||..... ..+|+..+.+.|+.|||.||+||- +..+|||||..+|+|+.
T Consensus 561 ~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs---~~~FVHRDLATRNCLVg 637 (774)
T KOG1026|consen 561 GDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLS---SHHFVHRDLATRNCLVG 637 (774)
T ss_pred CCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCcccccchhhhhceec
Confidence 5559999999999999999964321 234889999999999999999999 89999999999999999
Q ss_pred CCCcEEEEeeCCcccccCCCccccc-ccccCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhh
Q 046270 406 SELNAKVADFGLAKQSLEGHSHLTT-RVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLDTSTSPFQLIT 483 (590)
Q Consensus 406 ~~~~~kL~DFGla~~~~~~~~~~~~-~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELlt-G~~p~~~~~~~~~~l~ 483 (590)
+++.+||+||||+|.....+.+... +-.-..+||+||.+++++||.+||||||||+|||++| |+.|+.....++
T Consensus 638 e~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E---- 713 (774)
T KOG1026|consen 638 ENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE---- 713 (774)
T ss_pred cceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHH----
Confidence 9999999999999976555444322 3334679999999999999999999999999999999 988987544432
Q ss_pred HHHHHHHhcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhccCCC
Q 046270 484 DWAWVLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEGDID 545 (590)
Q Consensus 484 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~~~~ 545 (590)
+-...+.|++.+ .++..+.++..|++.||+.+|.+||+++||-..|+....
T Consensus 714 --VIe~i~~g~lL~---------~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~ 764 (774)
T KOG1026|consen 714 --VIECIRAGQLLS---------CPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQ 764 (774)
T ss_pred --HHHHHHcCCccc---------CCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHh
Confidence 222344454422 233455688999999999999999999999999987543
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=367.94 Aligned_cols=245 Identities=26% Similarity=0.428 Sum_probs=204.6
Q ss_pred cCCCccceecccCcEEEEEEEE-cCCcEEEEEEeecC---CCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCce
Q 046270 264 NGFSQNNLIGQGASGIVYKGTL-RHGNLVAVKQILDL---DTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKR 339 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~-~~g~~vAvK~l~~~---~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~ 339 (590)
..|...+.||+|||..+|+++. ..|..||+|++.+. .....+.+.+|+++.++|+|||||++++|+++. +.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs-----~n 92 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDS-----NN 92 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecC-----Cc
Confidence 4588889999999999999998 67999999998652 233356789999999999999999999999854 45
Q ss_pred EEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcc
Q 046270 340 RFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAK 419 (590)
Q Consensus 340 ~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~ 419 (590)
.|+|.|+|++++|..++. .++.+++.+.+.++.||+.||.||| +.+|+|||||..|+||++++++||+|||||.
T Consensus 93 VYivLELC~~~sL~el~K---rrk~ltEpEary~l~QIv~GlkYLH---~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt 166 (592)
T KOG0575|consen 93 VYIVLELCHRGSLMELLK---RRKPLTEPEARYFLRQIVEGLKYLH---SLGIIHRDLKLGNLFLNENMNVKIGDFGLAT 166 (592)
T ss_pred eEEEEEecCCccHHHHHH---hcCCCCcHHHHHHHHHHHHHHHHHH---hcCceecccchhheeecCcCcEEecccceee
Confidence 999999999999999885 5678999999999999999999999 9999999999999999999999999999998
Q ss_pred cccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhh
Q 046270 420 QSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIF 499 (590)
Q Consensus 420 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 499 (590)
....+. +.....+||+.|+|||++.....+..+||||+||+||-|+.|++||+...-. +..
T Consensus 167 ~le~~~-Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vk------------------ety 227 (592)
T KOG0575|consen 167 QLEYDG-ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVK------------------ETY 227 (592)
T ss_pred eecCcc-cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHH------------------HHH
Confidence 775432 3345578999999999999989999999999999999999999999753211 111
Q ss_pred hHHHhhh--hHHHHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 046270 500 DEFIRAE--GARAVMERFVLVGILCAHVMVALRPTITDALK 538 (590)
Q Consensus 500 d~~l~~~--~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~ 538 (590)
+.....+ .+........+++..+++.||.+|||+++|+.
T Consensus 228 ~~Ik~~~Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 228 NKIKLNEYSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred HHHHhcCcccccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 1111111 11223335567788899999999999999986
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-42 Score=405.70 Aligned_cols=267 Identities=26% Similarity=0.487 Sum_probs=216.8
Q ss_pred ccHHHHHHHhcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCccccceeEEec
Q 046270 254 FHVSELEQATNGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTS 332 (590)
Q Consensus 254 f~~~el~~at~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~ 332 (590)
++++++. ..|...+.||+|+||.||+|++. +|..||||++...... ..+|++++++++|||||+++|+|...
T Consensus 683 ~~~~~~~---~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~ 755 (968)
T PLN00113 683 ITINDIL---SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSE 755 (968)
T ss_pred hhHHHHH---hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcC
Confidence 4444443 45778899999999999999984 6889999998653322 23568999999999999999999743
Q ss_pred cCCCCceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEE
Q 046270 333 DDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKV 412 (590)
Q Consensus 333 ~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL 412 (590)
...++||||+++|+|.+++. .++|.++.+|+.|||+||+|||+.++++|+||||||+||++++++.+++
T Consensus 756 -----~~~~lv~Ey~~~g~L~~~l~------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~ 824 (968)
T PLN00113 756 -----KGAYLIHEYIEGKNLSEVLR------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL 824 (968)
T ss_pred -----CCCEEEEeCCCCCcHHHHHh------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEE
Confidence 45899999999999999984 4899999999999999999999877889999999999999999999888
Q ss_pred EeeCCcccccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhc
Q 046270 413 ADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKS 492 (590)
Q Consensus 413 ~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~ 492 (590)
. ||........ ....||.+|+|||++.++.++.|+|||||||++|||+||+.|++........+.+|++.....
T Consensus 825 ~-~~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 898 (968)
T PLN00113 825 R-LSLPGLLCTD-----TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSD 898 (968)
T ss_pred E-eccccccccC-----CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCc
Confidence 6 6665432211 223678999999999999999999999999999999999999975544444667787766655
Q ss_pred CCchhhhhHHHhhh--hHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhccCC
Q 046270 493 GKVDDIFDEFIRAE--GARAVMERFVLVGILCAHVMVALRPTITDALKMLEGDI 544 (590)
Q Consensus 493 ~~~~~~~d~~l~~~--~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~~~ 544 (590)
....+.+|+.+... ...+.+.++.+++..|++.+|++||||+||+++|+...
T Consensus 899 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~ 952 (968)
T PLN00113 899 CHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESAS 952 (968)
T ss_pred cchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhh
Confidence 55666667665432 23344567889999999999999999999999998753
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-44 Score=385.33 Aligned_cols=272 Identities=28% Similarity=0.400 Sum_probs=222.5
Q ss_pred ccccHHHHHHHhcCCC---------ccceecccCcEEEEEEEEcC----CcEEEEEEeecCCC-CChHHHHHHHHHHHhc
Q 046270 252 KWFHVSELEQATNGFS---------QNNLIGQGASGIVYKGTLRH----GNLVAVKQILDLDT-KGDEDFTNEVEIISKI 317 (590)
Q Consensus 252 ~~f~~~el~~at~~f~---------~~~~LG~G~fG~Vykg~~~~----g~~vAvK~l~~~~~-~~~~~f~~Ev~il~~l 317 (590)
..++|++-..|...|. +.++||.|.||+||+|+++- ...||||.++.... +...+|..|+.||.++
T Consensus 608 DP~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQF 687 (996)
T KOG0196|consen 608 DPHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQF 687 (996)
T ss_pred CCccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccC
Confidence 4567777666666554 46789999999999999873 34799999987544 3467899999999999
Q ss_pred CCCCccccceeEEeccCCCCceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCC
Q 046270 318 RHRNLLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDI 397 (590)
Q Consensus 318 ~H~nlv~l~g~~~~~~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDI 397 (590)
.||||++|.|.... .+..++|.|||+||+|+.||.. +.++++|.+...++++||.||.||- ..++|||||
T Consensus 688 dHPNIIrLEGVVTk-----s~PvMIiTEyMENGsLDsFLR~--~DGqftviQLVgMLrGIAsGMkYLs---dm~YVHRDL 757 (996)
T KOG0196|consen 688 DHPNIIRLEGVVTK-----SKPVMIITEYMENGSLDSFLRQ--NDGQFTVIQLVGMLRGIASGMKYLS---DMNYVHRDL 757 (996)
T ss_pred CCCcEEEEEEEEec-----CceeEEEhhhhhCCcHHHHHhh--cCCceEeehHHHHHHHHHHHhHHHh---hcCchhhhh
Confidence 99999999999874 4458999999999999999974 3467999999999999999999999 999999999
Q ss_pred CCCceEECCCCcEEEEeeCCcccccCCCccccccccc--CCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 046270 398 KSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAG--TFGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLDT 474 (590)
Q Consensus 398 Kp~NILLd~~~~~kL~DFGla~~~~~~~~~~~~~~~g--t~~Y~APE~~~~~~~t~ksDVySfGvvLlELlt-G~~p~~~ 474 (590)
.++|||++.+...||+|||++|...++.....+...| ..+|.|||.+...++|.+||||||||||||.++ |.+|+-.
T Consensus 758 AARNILVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWd 837 (996)
T KOG0196|consen 758 AARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWD 837 (996)
T ss_pred hhhheeeccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccc
Confidence 9999999999999999999999765554333333333 468999999999999999999999999999998 9999754
Q ss_pred CCCchhhhhHHHHHHHhcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhccCCCCCC
Q 046270 475 STSPFQLITDWAWVLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEGDIDIPK 548 (590)
Q Consensus 475 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~~~~~~~ 548 (590)
..... +...+++..+-..+-+.+..+.++++.|||.|-..||.+.+++.+|+..+..|.
T Consensus 838 mSNQd---------------VIkaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~ 896 (996)
T KOG0196|consen 838 MSNQD---------------VIKAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPN 896 (996)
T ss_pred cchHH---------------HHHHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCch
Confidence 33211 122233333333445667789999999999999999999999999998765553
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=357.38 Aligned_cols=261 Identities=23% Similarity=0.357 Sum_probs=203.4
Q ss_pred HhcCCCccceecccCcEEEEEEEEc------CCcEEEEEEeecCCCC-ChHHHHHHHHHHHhc-CCCCccccceeEEecc
Q 046270 262 ATNGFSQNNLIGQGASGIVYKGTLR------HGNLVAVKQILDLDTK-GDEDFTNEVEIISKI-RHRNLLSLRGCCVTSD 333 (590)
Q Consensus 262 at~~f~~~~~LG~G~fG~Vykg~~~------~g~~vAvK~l~~~~~~-~~~~f~~Ev~il~~l-~H~nlv~l~g~~~~~~ 333 (590)
..++|...++||+|+||.||+|.+. .+..||||++...... ....+.+|++++.++ +||||++++++|...
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~- 83 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKP- 83 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCC-
Confidence 3467888899999999999999752 2467999998654322 245689999999999 899999999988642
Q ss_pred CCCCceEEEEEeeCCCCCcchhhhhhcc----------------------------------------------------
Q 046270 334 DSSGKRRFLVYDYMPNGTLSDNISISHK---------------------------------------------------- 361 (590)
Q Consensus 334 ~~~~~~~~LV~E~~~~gsL~~~L~~~~~---------------------------------------------------- 361 (590)
+...++||||+++|+|.+++.....
T Consensus 84 ---~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (338)
T cd05102 84 ---NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPP 160 (338)
T ss_pred ---CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccc
Confidence 3358999999999999998863211
Q ss_pred -------cccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccccCCCccc-ccccc
Q 046270 362 -------RKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHL-TTRVA 433 (590)
Q Consensus 362 -------~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~~~~~~~~-~~~~~ 433 (590)
...+++..++.++.||++||+||| +.+|+||||||+|||++.++.+||+|||+++......... .....
T Consensus 161 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~ 237 (338)
T cd05102 161 QETDDLWKSPLTMEDLICYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSAR 237 (338)
T ss_pred hhccccccCCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCC
Confidence 134888999999999999999999 8999999999999999999999999999998654332221 22344
Q ss_pred cCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhhHHHHHHHhcCCchhhhhHHHhhhhHHHHH
Q 046270 434 GTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDEFIRAEGARAVM 512 (590)
Q Consensus 434 gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 512 (590)
++..|+|||++.+..++.++||||||+++|||++ |+.||......... . .....+.... .+....
T Consensus 238 ~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~----~-~~~~~~~~~~---------~~~~~~ 303 (338)
T cd05102 238 LPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEF----C-QRLKDGTRMR---------APENAT 303 (338)
T ss_pred CCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHH----H-HHHhcCCCCC---------CCCCCC
Confidence 6788999999999999999999999999999997 99998654332211 1 1112221111 011223
Q ss_pred HHHHHHHHhchhcCCCCCCCHHHHHHHhccC
Q 046270 513 ERFVLVGILCAHVMVALRPTITDALKMLEGD 543 (590)
Q Consensus 513 ~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~~ 543 (590)
..+..++..|++.||++|||+.|++++|+..
T Consensus 304 ~~l~~li~~cl~~dp~~RPs~~el~~~l~~~ 334 (338)
T cd05102 304 PEIYRIMLACWQGDPKERPTFSALVEILGDL 334 (338)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 4678899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=349.76 Aligned_cols=252 Identities=28% Similarity=0.391 Sum_probs=200.2
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCCC-------ChHHHHHHHHHHHhcCCCCccccceeEEeccCC
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDTK-------GDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDS 335 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~~-------~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~ 335 (590)
+.|...+.||+|+||.|-+|..+ .|+.||||++...... ......+|+++|++|+|||||++++++...+
T Consensus 172 d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d-- 249 (475)
T KOG0615|consen 172 DYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD-- 249 (475)
T ss_pred ceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC--
Confidence 45667789999999999999876 5899999999643211 1234579999999999999999999998544
Q ss_pred CCceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCC---CcEEE
Q 046270 336 SGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSE---LNAKV 412 (590)
Q Consensus 336 ~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~---~~~kL 412 (590)
..|||||||++|.|.+.+- ..+.+.+..-..+++|++.|+.||| +.||+||||||+|||+..+ ..+||
T Consensus 250 ---s~YmVlE~v~GGeLfd~vv---~nk~l~ed~~K~~f~Qll~avkYLH---~~GI~HRDiKPeNILl~~~~e~~llKI 320 (475)
T KOG0615|consen 250 ---SSYMVLEYVEGGELFDKVV---ANKYLREDLGKLLFKQLLTAVKYLH---SQGIIHRDIKPENILLSNDAEDCLLKI 320 (475)
T ss_pred ---ceEEEEEEecCccHHHHHH---hccccccchhHHHHHHHHHHHHHHH---HcCcccccCCcceEEeccCCcceEEEe
Confidence 4799999999999999885 3456778888899999999999999 9999999999999999665 77999
Q ss_pred EeeCCcccccCCCcccccccccCCCccCccccccCCC---CcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHH
Q 046270 413 ADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALYGQL---TEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVL 489 (590)
Q Consensus 413 ~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~---t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~ 489 (590)
+|||+|+...+ .......+||+.|.|||++.++.. ..|.|+||+||+||-+++|-.||.....+..+..+
T Consensus 321 tDFGlAK~~g~--~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQ----- 393 (475)
T KOG0615|consen 321 TDFGLAKVSGE--GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQ----- 393 (475)
T ss_pred cccchhhcccc--ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHH-----
Confidence 99999997653 345667899999999999986543 34889999999999999999999765543322211
Q ss_pred HhcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 490 AKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 490 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
...|+.... ...-.++.++..+++-+++..||++|||+.|+++.
T Consensus 394 I~~G~y~f~------p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 394 ILKGRYAFG------PLQWDRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred HhcCccccc------ChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 122321110 01123455688889999999999999999999863
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=339.71 Aligned_cols=260 Identities=19% Similarity=0.282 Sum_probs=202.8
Q ss_pred ccccHHHHHHHhcCCCccceecccCcEEEEEEEEcCCcEEEEEEeecCCCCC---hHHHHHHHHHHHhcCCCCcccccee
Q 046270 252 KWFHVSELEQATNGFSQNNLIGQGASGIVYKGTLRHGNLVAVKQILDLDTKG---DEDFTNEVEIISKIRHRNLLSLRGC 328 (590)
Q Consensus 252 ~~f~~~el~~at~~f~~~~~LG~G~fG~Vykg~~~~g~~vAvK~l~~~~~~~---~~~f~~Ev~il~~l~H~nlv~l~g~ 328 (590)
+.++.++++ +.....||+|++|.||+|+++ |+.||||++....... .+.|.+|+++|.+++||||++++|+
T Consensus 13 ~~i~~~~i~-----~~~~~~i~~g~~~~v~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~ 86 (283)
T PHA02988 13 KCIESDDID-----KYTSVLIKENDQNSIYKGIFN-NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGF 86 (283)
T ss_pred eecCHHHcC-----CCCCeEEeeCCceEEEEEEEC-CEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeee
Confidence 344555552 333368999999999999985 8899999987654333 3568899999999999999999999
Q ss_pred EEeccCCCCceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCC-CCeEecCCCCCceEECCC
Q 046270 329 CVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLK-PGIYHRDIKSTNILLDSE 407 (590)
Q Consensus 329 ~~~~~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~-~~ivHrDIKp~NILLd~~ 407 (590)
+..... .....++||||+++|+|.+++. +.+.++|...++++.+++.||.||| . .+++||||||+|||++++
T Consensus 87 ~~~~~~-~~~~~~lv~Ey~~~g~L~~~l~---~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~Hrdlkp~nill~~~ 159 (283)
T PHA02988 87 IIDIVD-DLPRLSLILEYCTRGYLREVLD---KEKDLSFKTKLDMAIDCCKGLYNLY---KYTNKPYKNLTSVSFLVTEN 159 (283)
T ss_pred EEeccc-CCCceEEEEEeCCCCcHHHHHh---hCCCCChhHHHHHHHHHHHHHHHHH---hcCCCCCCcCChhhEEECCC
Confidence 875322 2356899999999999999985 3457999999999999999999999 5 478899999999999999
Q ss_pred CcEEEEeeCCcccccCCCcccccccccCCCccCcccccc--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHH
Q 046270 408 LNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALY--GQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDW 485 (590)
Q Consensus 408 ~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~--~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~ 485 (590)
+.+||+|||+++...... ....|+..|+|||++.+ ..++.++|||||||++|||++|+.||...... . +
T Consensus 160 ~~~kl~dfg~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~-~----~ 230 (283)
T PHA02988 160 YKLKIICHGLEKILSSPP----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK-E----I 230 (283)
T ss_pred CcEEEcccchHhhhcccc----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH-H----H
Confidence 999999999998643221 23457889999999875 68999999999999999999999999754321 1 1
Q ss_pred HHHHHhcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhcc
Q 046270 486 AWVLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEG 542 (590)
Q Consensus 486 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~ 542 (590)
.......+.... + +......+.+++..||+.||++|||+.|+++.|+.
T Consensus 231 ~~~i~~~~~~~~-~--------~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~ 278 (283)
T PHA02988 231 YDLIINKNNSLK-L--------PLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSL 278 (283)
T ss_pred HHHHHhcCCCCC-C--------CCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHH
Confidence 111111111000 1 11123467788999999999999999999999874
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=331.02 Aligned_cols=261 Identities=23% Similarity=0.329 Sum_probs=205.4
Q ss_pred CCCccceecccCcEEEEEEEE-cCCcEEEEEEeec--CCCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEE
Q 046270 265 GFSQNNLIGQGASGIVYKGTL-RHGNLVAVKQILD--LDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRF 341 (590)
Q Consensus 265 ~f~~~~~LG~G~fG~Vykg~~-~~g~~vAvK~l~~--~~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~ 341 (590)
+|.+.+.||+|.||+|||+.. .+|..||.|.+.- .+.+...+...|+.+|++|+|||||+++++-...+ ..-++
T Consensus 20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~---~evln 96 (375)
T KOG0591|consen 20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIED---NEVLN 96 (375)
T ss_pred HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhcc---chhhH
Confidence 355667899999999999975 4789999999863 23344567899999999999999999998544322 23389
Q ss_pred EEEeeCCCCCcchhhhhhc-ccccCChhhHHHHHHHHHHHHHHHHhcCCC-CeEecCCCCCceEECCCCcEEEEeeCCcc
Q 046270 342 LVYDYMPNGTLSDNISISH-KRKQLTWPQRKKIIVDVAKGIAYLHYGLKP-GIYHRDIKSTNILLDSELNAKVADFGLAK 419 (590)
Q Consensus 342 LV~E~~~~gsL~~~L~~~~-~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~-~ivHrDIKp~NILLd~~~~~kL~DFGla~ 419 (590)
+||||+..|+|...+...+ .++.+++..+++++.|+++||...|+...+ .|+||||||.||+|+.+|.+||+|||+++
T Consensus 97 ivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r 176 (375)
T KOG0591|consen 97 IVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGR 176 (375)
T ss_pred HHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHh
Confidence 9999999999999886433 345699999999999999999999953322 38899999999999999999999999999
Q ss_pred cccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhh
Q 046270 420 QSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIF 499 (590)
Q Consensus 420 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 499 (590)
.+.... .......||+.||+||.+....|+.||||||+||+++||..-+.||.... +.... .....++...+.
T Consensus 177 ~l~s~~-tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n-----~~~L~-~KI~qgd~~~~p 249 (375)
T KOG0591|consen 177 FLSSKT-TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDN-----LLSLC-KKIEQGDYPPLP 249 (375)
T ss_pred Hhcchh-HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccccc-----HHHHH-HHHHcCCCCCCc
Confidence 775443 34456789999999999999999999999999999999999999997541 11111 122344433333
Q ss_pred hHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhccC
Q 046270 500 DEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEGD 543 (590)
Q Consensus 500 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~~ 543 (590)
|. -....+..++..|+.+||+.||+.-..+..+.+.
T Consensus 250 ~~--------~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~~ 285 (375)
T KOG0591|consen 250 DE--------HYSTDLRELINMCIAVDPEQRPDTVPYVQDIQSE 285 (375)
T ss_pred HH--------HhhhHHHHHHHHHccCCcccCCCcchHHHHHHHH
Confidence 22 2345777888899999999999966666655543
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-40 Score=339.63 Aligned_cols=263 Identities=25% Similarity=0.385 Sum_probs=198.9
Q ss_pred cCCCccceecccCcEEEEEEEEcC-----------------CcEEEEEEeecCCCC-ChHHHHHHHHHHHhcCCCCcccc
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLRH-----------------GNLVAVKQILDLDTK-GDEDFTNEVEIISKIRHRNLLSL 325 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~~-----------------g~~vAvK~l~~~~~~-~~~~f~~Ev~il~~l~H~nlv~l 325 (590)
++|...++||+|+||.||++.+++ +..||+|.+...... ...+|.+|++++.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 467788899999999999998643 236999998654322 34579999999999999999999
Q ss_pred ceeEEeccCCCCceEEEEEeeCCCCCcchhhhhhc----------------ccccCChhhHHHHHHHHHHHHHHHHhcCC
Q 046270 326 RGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISH----------------KRKQLTWPQRKKIIVDVAKGIAYLHYGLK 389 (590)
Q Consensus 326 ~g~~~~~~~~~~~~~~LV~E~~~~gsL~~~L~~~~----------------~~~~l~~~~r~~I~~~ia~gL~yLH~~~~ 389 (590)
++++... ...++||||+++|+|.+++.... ....++|..+++|+.||+.||.||| +
T Consensus 85 ~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~ 156 (304)
T cd05096 85 LGVCVDE-----DPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS---S 156 (304)
T ss_pred EEEEecC-----CceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH---H
Confidence 9999743 35899999999999999885321 1135789999999999999999999 8
Q ss_pred CCeEecCCCCCceEECCCCcEEEEeeCCcccccCCCcc-cccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhC
Q 046270 390 PGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSH-LTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSG 468 (590)
Q Consensus 390 ~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG 468 (590)
.+|+||||||+|||++.++.+||+|||+++........ ......++..|+|||++..+.++.++||||||+++|||+++
T Consensus 157 ~~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~ 236 (304)
T cd05096 157 LNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILML 236 (304)
T ss_pred CCccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHc
Confidence 89999999999999999999999999999865433221 22334567899999999989999999999999999999974
Q ss_pred --CCCCCCCCCchhhhhHHHHHHHhcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhcc
Q 046270 469 --RKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEG 542 (590)
Q Consensus 469 --~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~ 542 (590)
..|+...... ..+ ................ ..+......+.+++..|++.+|++||||.+|.++|+.
T Consensus 237 ~~~~p~~~~~~~-~~~-~~~~~~~~~~~~~~~~------~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 237 CKEQPYGELTDE-QVI-ENAGEFFRDQGRQVYL------FRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred cCCCCCCcCCHH-HHH-HHHHHHhhhccccccc------cCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 4565533221 111 1121111111000000 0011123467889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=341.01 Aligned_cols=258 Identities=29% Similarity=0.449 Sum_probs=201.7
Q ss_pred cCCCccceecccCcEEEEEEEEcC-CcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEEE
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLRH-GNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFL 342 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~L 342 (590)
.++...+.||+|.||.||++...+ |...|||.+...+....+.+.+|+.+|.+++|||||+.+|.....+. ...++
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~---~~~~i 93 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSREN---DEYNI 93 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccC---eeeEe
Confidence 346667899999999999999876 88999999865533336678999999999999999999997554321 46899
Q ss_pred EEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECC-CCcEEEEeeCCcccc
Q 046270 343 VYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDS-ELNAKVADFGLAKQS 421 (590)
Q Consensus 343 V~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~-~~~~kL~DFGla~~~ 421 (590)
.|||+++|+|.+++.... ..|++..+..+..||++||+||| +++|+||||||+||||+. ++.+||+|||+++..
T Consensus 94 ~mEy~~~GsL~~~~~~~g--~~l~E~~v~~ytr~iL~GL~ylH---s~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~ 168 (313)
T KOG0198|consen 94 FMEYAPGGSLSDLIKRYG--GKLPEPLVRRYTRQILEGLAYLH---SKGIVHCDIKPANILLDPSNGDVKLADFGLAKKL 168 (313)
T ss_pred eeeccCCCcHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCcccceEEEeCCCCeEEeccCcccccc
Confidence 999999999999996332 26999999999999999999999 999999999999999999 799999999999876
Q ss_pred cC--CCcccccccccCCCccCccccccCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhh
Q 046270 422 LE--GHSHLTTRVAGTFGYLAPEYALYGQL-TEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDI 498 (590)
Q Consensus 422 ~~--~~~~~~~~~~gt~~Y~APE~~~~~~~-t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 498 (590)
.. ..........||+.|||||++..+.. ..++|||||||+++||+||++||....... ++.-.....+...
T Consensus 169 ~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~----~~~~~ig~~~~~P-- 242 (313)
T KOG0198|consen 169 ESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEA----EALLLIGREDSLP-- 242 (313)
T ss_pred ccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchH----HHHHHHhccCCCC--
Confidence 53 12223445789999999999996533 359999999999999999999987531111 1111111111111
Q ss_pred hhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhcc
Q 046270 499 FDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEG 542 (590)
Q Consensus 499 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~ 542 (590)
..+........+++..|++.+|+.|||++++++..-.
T Consensus 243 -------~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~ 279 (313)
T KOG0198|consen 243 -------EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFL 279 (313)
T ss_pred -------CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhh
Confidence 1112233456678889999999999999999986543
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=333.26 Aligned_cols=242 Identities=25% Similarity=0.358 Sum_probs=197.2
Q ss_pred hcCCCccceecccCcEEEEEEEEcC-CcEEEEEEeecCCC---CChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCc
Q 046270 263 TNGFSQNNLIGQGASGIVYKGTLRH-GNLVAVKQILDLDT---KGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGK 338 (590)
Q Consensus 263 t~~f~~~~~LG~G~fG~Vykg~~~~-g~~vAvK~l~~~~~---~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~ 338 (590)
-++|...+.||+|+||.||.++.++ ++.+|+|++++..- ...+...+|..+|.+++||.||.+.-.+. .+.
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQ-----t~~ 98 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQ-----TEE 98 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecc-----cCC
Confidence 4578999999999999999998876 78899999965322 33566889999999999999999987776 455
Q ss_pred eEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCc
Q 046270 339 RRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLA 418 (590)
Q Consensus 339 ~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla 418 (590)
.+|||+||+.||.|..+|. +.+.+++....-++..|+.||.||| +.+||||||||+|||||++|.++|+|||++
T Consensus 99 kLylVld~~~GGeLf~hL~---~eg~F~E~~arfYlaEi~lAL~~LH---~~gIiyRDlKPENILLd~~GHi~LtDFgL~ 172 (357)
T KOG0598|consen 99 KLYLVLDYLNGGELFYHLQ---REGRFSEDRARFYLAEIVLALGYLH---SKGIIYRDLKPENILLDEQGHIKLTDFGLC 172 (357)
T ss_pred eEEEEEeccCCccHHHHHH---hcCCcchhHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHeeecCCCcEEEeccccc
Confidence 7999999999999999994 5567999999999999999999999 999999999999999999999999999999
Q ss_pred ccccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhh
Q 046270 419 KQSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDI 498 (590)
Q Consensus 419 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 498 (590)
+...... ..+...+||+.|||||++....|+..+|.||+||++|||++|.+||...+. ..+.....+..
T Consensus 173 k~~~~~~-~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~-----~~~~~~I~~~k----- 241 (357)
T KOG0598|consen 173 KEDLKDG-DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDV-----KKMYDKILKGK----- 241 (357)
T ss_pred hhcccCC-CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccH-----HHHHHHHhcCc-----
Confidence 9654432 344558999999999999999999999999999999999999999975432 22332222221
Q ss_pred hhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCC
Q 046270 499 FDEFIRAEGARAVMERFVLVGILCAHVMVALRP 531 (590)
Q Consensus 499 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RP 531 (590)
+ ...+.-...+..+++...++.||++|-
T Consensus 242 ----~-~~~p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 242 ----L-PLPPGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred ----C-CCCCccCCHHHHHHHHHHhccCHHHhc
Confidence 0 001111223556677788899999994
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=326.43 Aligned_cols=263 Identities=21% Similarity=0.291 Sum_probs=201.0
Q ss_pred cCCCccceecccCcEEEEEEEEcC-CcEEEEEEeecCCCC--ChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceE
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLRH-GNLVAVKQILDLDTK--GDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRR 340 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~vAvK~l~~~~~~--~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~ 340 (590)
+.|+...++|+|+||+|||.++++ |+.||||++...... -.+-..+|+++|++++|+|+|.|+..|. .....
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFr-----rkrkl 76 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFR-----RKRKL 76 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHH-----hccee
Confidence 356777899999999999999986 899999999764332 1334579999999999999999999997 45679
Q ss_pred EEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCccc
Q 046270 341 FLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQ 420 (590)
Q Consensus 341 ~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~ 420 (590)
+||+||++..-|.+.- +....++.+...+++.|+++|+.|+| +.++|||||||+||||..++.+||+|||+||.
T Consensus 77 hLVFE~~dhTvL~eLe---~~p~G~~~~~vk~~l~Q~l~ai~~cH---k~n~IHRDIKPENILit~~gvvKLCDFGFAR~ 150 (396)
T KOG0593|consen 77 HLVFEYCDHTVLHELE---RYPNGVPSELVKKYLYQLLKAIHFCH---KNNCIHRDIKPENILITQNGVVKLCDFGFART 150 (396)
T ss_pred EEEeeecchHHHHHHH---hccCCCCHHHHHHHHHHHHHHhhhhh---hcCeecccCChhheEEecCCcEEeccchhhHh
Confidence 9999999876565433 24557999999999999999999999 99999999999999999999999999999998
Q ss_pred ccCCCcccccccccCCCccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhh--hh--------HHHHHH
Q 046270 421 SLEGHSHLTTRVAGTFGYLAPEYALY-GQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQL--IT--------DWAWVL 489 (590)
Q Consensus 421 ~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~--l~--------~~~~~~ 489 (590)
... .....+....|.+|.|||.+.+ .+|....|||+.||++.||++|.+.|...++-..+ +. +.....
T Consensus 151 L~~-pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF 229 (396)
T KOG0593|consen 151 LSA-PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIF 229 (396)
T ss_pred hcC-CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHh
Confidence 764 3344566778999999999887 68999999999999999999999888655443221 11 000000
Q ss_pred HhcCCchhhhhHHH-----hhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 046270 490 AKSGKVDDIFDEFI-----RAEGARAVMERFVLVGILCAHVMVALRPTITDALK 538 (590)
Q Consensus 490 ~~~~~~~~~~d~~l-----~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~ 538 (590)
..++-...+.-|.. .+..-.....-+++++..|++.||++|++-++++.
T Consensus 230 ~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 230 SSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred ccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 11111111111100 01111123346788999999999999999998764
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=333.95 Aligned_cols=254 Identities=23% Similarity=0.349 Sum_probs=200.0
Q ss_pred cCCCccceecccCcEEEEEEEEc----CCcEEEEEEeecCCC-CChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCc
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLR----HGNLVAVKQILDLDT-KGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGK 338 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~----~g~~vAvK~l~~~~~-~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~ 338 (590)
++|...+.||+|+||.||+|+++ .+..||+|.+..... .....|.+|+.++.+++||||++++|++.. +.
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~ 79 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITR-----GN 79 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEec-----CC
Confidence 46778899999999999999874 356899999875432 224578999999999999999999999873 44
Q ss_pred eEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCc
Q 046270 339 RRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLA 418 (590)
Q Consensus 339 ~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla 418 (590)
..++||||+++|+|.+++.. ....++|.+++.++.||+.||+||| +.+++||||||+|||++.++.+|++|||.+
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~--~~~~l~~~~~~~~~~~i~~al~~lH---~~~iiH~dikp~nili~~~~~~~l~dfg~~ 154 (266)
T cd05064 80 TMMIVTEYMSNGALDSFLRK--HEGQLVAGQLMGMLPGLASGMKYLS---EMGYVHKGLAAHKVLVNSDLVCKISGFRRL 154 (266)
T ss_pred CcEEEEEeCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeeccccHhhEEEcCCCcEEECCCccc
Confidence 68999999999999998853 2346899999999999999999999 899999999999999999999999999987
Q ss_pred ccccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhhHHHHHHHhcCCchh
Q 046270 419 KQSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLDTSTSPFQLITDWAWVLAKSGKVDD 497 (590)
Q Consensus 419 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 497 (590)
...............++..|+|||.+.++.++.++||||||+++||+++ |+.||....... .+ .. ...+....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~-~~----~~-~~~~~~~~ 228 (266)
T cd05064 155 QEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD-VI----KA-VEDGFRLP 228 (266)
T ss_pred ccccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH-HH----HH-HHCCCCCC
Confidence 6543222111222345678999999999999999999999999999875 999986543211 11 11 11111110
Q ss_pred hhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhcc
Q 046270 498 IFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEG 542 (590)
Q Consensus 498 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~ 542 (590)
.+......+.+++..|++.+|.+||++.++.+.|+.
T Consensus 229 ---------~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~ 264 (266)
T cd05064 229 ---------APRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSK 264 (266)
T ss_pred ---------CCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHh
Confidence 112233467788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=327.93 Aligned_cols=251 Identities=25% Similarity=0.420 Sum_probs=200.0
Q ss_pred CCCccceecccCcEEEEEEEEcCCcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEEEEE
Q 046270 265 GFSQNNLIGQGASGIVYKGTLRHGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFLVY 344 (590)
Q Consensus 265 ~f~~~~~LG~G~fG~Vykg~~~~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~LV~ 344 (590)
+|...+.||+|+||.||++.++++..+|+|.+... ....++|.+|++++++++||||+++++++.. ....++||
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~iv~ 78 (256)
T cd05114 5 ELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQ-----QKPLYIVT 78 (256)
T ss_pred HcEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEcc-----CCCEEEEE
Confidence 46777899999999999999988889999987543 3345689999999999999999999999874 34589999
Q ss_pred eeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccccCC
Q 046270 345 DYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEG 424 (590)
Q Consensus 345 E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~~~~ 424 (590)
||+++|+|.+++... ...++|..+..++.+++.||.||| +.+|+||||||+||++++++.+||+|||+++.....
T Consensus 79 e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~ 153 (256)
T cd05114 79 EFMENGCLLNYLRQR--QGKLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDD 153 (256)
T ss_pred EcCCCCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcceEEEcCCCeEEECCCCCccccCCC
Confidence 999999999988532 346899999999999999999999 899999999999999999999999999999865433
Q ss_pred CcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhhHHHHHHHhcCCchhhhhHHH
Q 046270 425 HSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDEFI 503 (590)
Q Consensus 425 ~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 503 (590)
.........++..|+|||++....++.++||||||+++|||++ |+.||....... .+. . . ..+... ..+
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~-~~~-~---i-~~~~~~--~~~-- 223 (256)
T cd05114 154 EYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYE-VVE-M---I-SRGFRL--YRP-- 223 (256)
T ss_pred ceeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHH-HHH-H---H-HCCCCC--CCC--
Confidence 3222223345678999999988899999999999999999999 888886433211 111 1 1 111100 001
Q ss_pred hhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhc
Q 046270 504 RAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLE 541 (590)
Q Consensus 504 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~ 541 (590)
......+..++..|++.+|++||+|.+++++|.
T Consensus 224 -----~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 224 -----KLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred -----CCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 112246788999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=328.52 Aligned_cols=256 Identities=28% Similarity=0.396 Sum_probs=204.0
Q ss_pred HhcCCCccceecccCcEEEEEEEEcCCcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEE
Q 046270 262 ATNGFSQNNLIGQGASGIVYKGTLRHGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRF 341 (590)
Q Consensus 262 at~~f~~~~~LG~G~fG~Vykg~~~~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~ 341 (590)
..++|...+.||+|+||.||+|.+.++..||+|.+.... ...+++.+|++++++++|+|++++++++.. +...+
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~ 77 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTL-----EEPIY 77 (261)
T ss_pred chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEec-----CCCee
Confidence 345688889999999999999998888899999986533 346779999999999999999999998874 34589
Q ss_pred EEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccc
Q 046270 342 LVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQS 421 (590)
Q Consensus 342 LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~ 421 (590)
+||||+++++|.+++.... ...++|..+..++.+++.||.||| +.+|+||||||+||++++++.+||+|||+++..
T Consensus 78 lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~ 153 (261)
T cd05068 78 IVTELMKYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLE---AQNYIHRDLAARNVLVGENNICKVADFGLARVI 153 (261)
T ss_pred eeeecccCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCcceEEEcCCCCEEECCcceEEEc
Confidence 9999999999999985322 346899999999999999999999 899999999999999999999999999999876
Q ss_pred cCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhhHHHHHHHhcCCchhhhh
Q 046270 422 LEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFD 500 (590)
Q Consensus 422 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 500 (590)
............++..|+|||++....++.++||||||++++||+| |+.|+...... ..+. ....+...
T Consensus 154 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-~~~~-----~~~~~~~~---- 223 (261)
T cd05068 154 KEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA-EVLQ-----QVDQGYRM---- 223 (261)
T ss_pred cCCcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH-HHHH-----HHHcCCCC----
Confidence 5332222222233468999999998899999999999999999999 88888643221 1111 11111100
Q ss_pred HHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhcc
Q 046270 501 EFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEG 542 (590)
Q Consensus 501 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~ 542 (590)
..+....+.+.+++.+|++.+|++||++.+++++|+.
T Consensus 224 -----~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 224 -----PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred -----CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 0011223577889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-40 Score=349.68 Aligned_cols=258 Identities=24% Similarity=0.336 Sum_probs=200.0
Q ss_pred hcCCCccceecccCcEEEEEEEEc------CCcEEEEEEeecCC-CCChHHHHHHHHHHHhc-CCCCccccceeEEeccC
Q 046270 263 TNGFSQNNLIGQGASGIVYKGTLR------HGNLVAVKQILDLD-TKGDEDFTNEVEIISKI-RHRNLLSLRGCCVTSDD 334 (590)
Q Consensus 263 t~~f~~~~~LG~G~fG~Vykg~~~------~g~~vAvK~l~~~~-~~~~~~f~~Ev~il~~l-~H~nlv~l~g~~~~~~~ 334 (590)
.++|...+.||+|+||.||+|++. .+..||||+++... ....+.+.+|++++..+ +||||++++++|..
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~--- 110 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTV--- 110 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeecc---
Confidence 346788899999999999999742 35589999986433 22345788999999999 89999999999974
Q ss_pred CCCceEEEEEeeCCCCCcchhhhhhcc-----------------------------------------------------
Q 046270 335 SSGKRRFLVYDYMPNGTLSDNISISHK----------------------------------------------------- 361 (590)
Q Consensus 335 ~~~~~~~LV~E~~~~gsL~~~L~~~~~----------------------------------------------------- 361 (590)
+...++||||+++|+|.+++.....
T Consensus 111 --~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 188 (375)
T cd05104 111 --GGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRS 188 (375)
T ss_pred --CCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccc
Confidence 4458999999999999988853210
Q ss_pred -------------------cccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCccccc
Q 046270 362 -------------------RKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSL 422 (590)
Q Consensus 362 -------------------~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~~ 422 (590)
...++|..+++|+.||++||+||| +.+|+||||||+|||++.++.+||+|||+++...
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~ 265 (375)
T cd05104 189 VRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIR 265 (375)
T ss_pred cccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCchhhEEEECCCcEEEecCccceecc
Confidence 125889999999999999999999 8999999999999999999999999999998654
Q ss_pred CCCcc-cccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhhHHHHHHHhcCCchhhhh
Q 046270 423 EGHSH-LTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFD 500 (590)
Q Consensus 423 ~~~~~-~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 500 (590)
..... ......++..|+|||.+....++.++||||||+++|||++ |..||........ +..+ ...+....
T Consensus 266 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~-~~~~----~~~~~~~~--- 337 (375)
T cd05104 266 NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSK-FYKM----IKEGYRML--- 337 (375)
T ss_pred CcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHH-HHHH----HHhCccCC---
Confidence 33221 1222345678999999999999999999999999999998 8888764332221 1111 11111000
Q ss_pred HHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhcc
Q 046270 501 EFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEG 542 (590)
Q Consensus 501 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~ 542 (590)
.+......+.+++..|++.||++||||.||+++|+.
T Consensus 338 ------~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 338 ------SPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred ------CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 001112467889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=341.20 Aligned_cols=266 Identities=27% Similarity=0.346 Sum_probs=203.4
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCC--CChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceE
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDT--KGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRR 340 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~--~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~ 340 (590)
+.|+...+||+|.||.||||+.. .|..||+|+++-... ....-..+||.||++|+||||++|.+...+. .....
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~---~~~si 193 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSK---LSGSI 193 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEec---CCceE
Confidence 44666778999999999999875 588999999975442 2244567999999999999999999998765 24569
Q ss_pred EEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCccc
Q 046270 341 FLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQ 420 (590)
Q Consensus 341 ~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~ 420 (590)
|||+|||+. +|.-++. ...-.++..++..++.|++.||+|+| .++|+|||||.+|||||.+|.+||+|||||+.
T Consensus 194 YlVFeYMdh-DL~GLl~--~p~vkft~~qIKc~mkQLl~Gl~~cH---~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~ 267 (560)
T KOG0600|consen 194 YLVFEYMDH-DLSGLLS--SPGVKFTEPQIKCYMKQLLEGLEYCH---SRGVLHRDIKGSNILIDNNGVLKIADFGLARF 267 (560)
T ss_pred EEEEecccc-hhhhhhc--CCCcccChHHHHHHHHHHHHHHHHHh---hcCeeeccccccceEEcCCCCEEeccccceee
Confidence 999999976 6766664 23446999999999999999999999 99999999999999999999999999999998
Q ss_pred ccCCCcccccccccCCCccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhh--HHH----HHHHhcC
Q 046270 421 SLEGHSHLTTRVAGTFGYLAPEYALY-GQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLIT--DWA----WVLAKSG 493 (590)
Q Consensus 421 ~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~--~~~----~~~~~~~ 493 (590)
.........+...-|.+|.|||.+.+ ..|+.+.|+||.||||.||++|++.+....+-.++-. ... ...|...
T Consensus 268 y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~ 347 (560)
T KOG0600|consen 268 YTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVS 347 (560)
T ss_pred ccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccc
Confidence 77666555555566999999999885 4799999999999999999999998876554322111 000 0001111
Q ss_pred Cch--hh------hhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 494 KVD--DI------FDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 494 ~~~--~~------~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
++. .. ....+.+. -.......+.++..++..||.+|.|+.++++.
T Consensus 348 kLP~~~~~kp~~~y~r~l~E~-~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 348 KLPHATIFKPQQPYKRRLRET-FKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred cCCcccccCCCCcccchHHHH-hccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 111 11 11222221 22334466778888999999999999998863
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=328.09 Aligned_cols=254 Identities=23% Similarity=0.389 Sum_probs=203.8
Q ss_pred cCCCccceecccCcEEEEEEEEcCCcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEEEE
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLRHGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFLV 343 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~LV 343 (590)
++|...++||+|+||.||+|...++..||+|.+.... ...+.+.+|+.++++++|+||+++++++.. +...++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv 79 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTK-----EEPIYII 79 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcC-----CCCcEEE
Confidence 5678889999999999999998888899999876432 345689999999999999999999988763 4458999
Q ss_pred EeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccccC
Q 046270 344 YDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLE 423 (590)
Q Consensus 344 ~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~~~ 423 (590)
|||+++|+|.+++... ....+++..++.++.|++.||+||| +.+++||||||+||+++.++.+||+|||+++....
T Consensus 80 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 155 (261)
T cd05072 80 TEYMAKGSLLDFLKSD-EGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIED 155 (261)
T ss_pred EecCCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEecCCCcEEECCCccceecCC
Confidence 9999999999988532 3456899999999999999999999 89999999999999999999999999999987644
Q ss_pred CCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhhHHHHHHHhcCCchhhhhHH
Q 046270 424 GHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDEF 502 (590)
Q Consensus 424 ~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 502 (590)
..........++..|+|||++..+.++.++||||||+++|||+| |+.||...... .... +. ..+....
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~-~~~~-~~----~~~~~~~----- 224 (261)
T cd05072 156 NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS-DVMS-AL----QRGYRMP----- 224 (261)
T ss_pred CceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH-HHHH-HH----HcCCCCC-----
Confidence 33222233445778999999998999999999999999999999 88888643221 1111 11 1111100
Q ss_pred HhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhcc
Q 046270 503 IRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEG 542 (590)
Q Consensus 503 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~ 542 (590)
........+.+++..|++.+|++||+++++.++|+.
T Consensus 225 ----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 225 ----RMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred ----CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 001123467789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=329.52 Aligned_cols=264 Identities=21% Similarity=0.289 Sum_probs=200.4
Q ss_pred cCCCccceecccCcEEEEEEEEcC-CcEEEEEEeecCC--CCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceE
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLRH-GNLVAVKQILDLD--TKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRR 340 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~vAvK~l~~~~--~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~ 340 (590)
++|...+.||+|+||.||+++++. ++.||+|++.... ....+.+.+|++++++++|+||+++++++.. ....
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~ 75 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRR-----RGKL 75 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEec-----CCEE
Confidence 468889999999999999999874 7789999986532 2234568899999999999999999999873 4568
Q ss_pred EEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCccc
Q 046270 341 FLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQ 420 (590)
Q Consensus 341 ~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~ 420 (590)
++||||++++.+..+.. ....+++..++.++.||+.||.||| +.+|+||||||+||+++.++.+||+|||+++.
T Consensus 76 ~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~ 149 (287)
T cd07848 76 YLVFEYVEKNMLELLEE---MPNGVPPEKVRSYIYQLIKAIHWCH---KNDIVHRDIKPENLLISHNDVLKLCDFGFARN 149 (287)
T ss_pred EEEEecCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccCccc
Confidence 99999999887765432 2356999999999999999999999 89999999999999999999999999999987
Q ss_pred ccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhh--h--------HHHHHHH
Q 046270 421 SLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLI--T--------DWAWVLA 490 (590)
Q Consensus 421 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l--~--------~~~~~~~ 490 (590)
.............|+..|+|||++.+..++.++|||||||++|||++|+.||.......... . .+.....
T Consensus 150 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (287)
T cd07848 150 LSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFY 229 (287)
T ss_pred ccccccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhh
Confidence 64433333344678999999999998899999999999999999999999997543322110 0 0000000
Q ss_pred hcCCchhhhhHHH------hhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 046270 491 KSGKVDDIFDEFI------RAEGARAVMERFVLVGILCAHVMVALRPTITDALK 538 (590)
Q Consensus 491 ~~~~~~~~~d~~l------~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~ 538 (590)
..........+.. ...........+.+++..|++.||++|||++|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 230 SNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred ccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0000000000000 00011123346889999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=333.75 Aligned_cols=266 Identities=21% Similarity=0.341 Sum_probs=198.6
Q ss_pred CCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCC--CCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEE
Q 046270 265 GFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLD--TKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRF 341 (590)
Q Consensus 265 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~--~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~ 341 (590)
+|...+.||+|+||.||+|+.. +|..||||++.... ......+.+|++++++++||||+++++++...+.......+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4677889999999999999976 58899999986432 22345688999999999999999999998765433345689
Q ss_pred EEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccc
Q 046270 342 LVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQS 421 (590)
Q Consensus 342 LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~ 421 (590)
+||||+. ++|.+++. ....+++..+..++.||++||.||| +.+|+||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~~-~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~ 153 (338)
T cd07859 81 VVFELME-SDLHQVIK---ANDDLTPEHHQFFLYQLLRALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVA 153 (338)
T ss_pred EEEecCC-CCHHHHHH---hcccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEccCcccccc
Confidence 9999995 68888774 3446999999999999999999999 899999999999999999999999999999864
Q ss_pred cCCCc--ccccccccCCCccCcccccc--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHH-------
Q 046270 422 LEGHS--HLTTRVAGTFGYLAPEYALY--GQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLA------- 490 (590)
Q Consensus 422 ~~~~~--~~~~~~~gt~~Y~APE~~~~--~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~------- 490 (590)
..... .......||..|+|||++.. ..++.++|||||||++|||+||+.||........ +. +.....
T Consensus 154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~-~~-~~~~~~~~~~~~~ 231 (338)
T cd07859 154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQ-LD-LITDLLGTPSPET 231 (338)
T ss_pred ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHH-HH-HHHHHhCCCCHHH
Confidence 33221 12234568999999999865 6789999999999999999999999865432111 10 111000
Q ss_pred ----hcCCchhhhhHHHhhh---hH---HHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 491 ----KSGKVDDIFDEFIRAE---GA---RAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 491 ----~~~~~~~~~d~~l~~~---~~---~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
......+.+....... .. ......+.+++..|++.||++|||++|+++.
T Consensus 232 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 232 ISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 0011111111100000 00 0122356789999999999999999999864
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=374.26 Aligned_cols=256 Identities=29% Similarity=0.460 Sum_probs=205.5
Q ss_pred CCCccceecccCcEEEEEEEEcC--Cc----EEEEEEeecCC-CCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCC
Q 046270 265 GFSQNNLIGQGASGIVYKGTLRH--GN----LVAVKQILDLD-TKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSG 337 (590)
Q Consensus 265 ~f~~~~~LG~G~fG~Vykg~~~~--g~----~vAvK~l~~~~-~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~ 337 (590)
+....+.||+|.||.||+|...+ |. .||||.+.... .+...+|.+|..+|++++|||||+++|.|...
T Consensus 693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~----- 767 (1025)
T KOG1095|consen 693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDS----- 767 (1025)
T ss_pred heEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCC-----
Confidence 34556789999999999998764 43 49999987654 44567899999999999999999999999963
Q ss_pred ceEEEEEeeCCCCCcchhhhhhc----ccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEE
Q 046270 338 KRRFLVYDYMPNGTLSDNISISH----KRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVA 413 (590)
Q Consensus 338 ~~~~LV~E~~~~gsL~~~L~~~~----~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~ 413 (590)
...++++|||++|+|..||...+ ....|+..+.+.|+.|||+|+.||+ ++++|||||.++|+||++...+||+
T Consensus 768 ~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe---~~~fvHRDLAaRNCLL~~~r~VKIa 844 (1025)
T KOG1095|consen 768 GPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLE---SKHFVHRDLAARNCLLDERRVVKIA 844 (1025)
T ss_pred CCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHH---hCCCcCcchhhhheeecccCcEEEc
Confidence 34899999999999999997543 1356999999999999999999999 9999999999999999999999999
Q ss_pred eeCCcccccCCCccccc-ccccCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhhHHHHHHHh
Q 046270 414 DFGLAKQSLEGHSHLTT-RVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLDTSTSPFQLITDWAWVLAK 491 (590)
Q Consensus 414 DFGla~~~~~~~~~~~~-~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELlt-G~~p~~~~~~~~~~l~~~~~~~~~ 491 (590)
||||||.....+..... +..-...|||||.+..+.+|.|+|||||||+|||++| |..|+..... ...+..| .+
T Consensus 845 DFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n-~~v~~~~----~~ 919 (1025)
T KOG1095|consen 845 DFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSN-FEVLLDV----LE 919 (1025)
T ss_pred ccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcch-HHHHHHH----Hh
Confidence 99999955443332221 2122458999999999999999999999999999999 7778764333 2222111 12
Q ss_pred cCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhccC
Q 046270 492 SGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEGD 543 (590)
Q Consensus 492 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~~ 543 (590)
.|+ -..+...++.+.+|+..||+.+|++||++..+++.+...
T Consensus 920 ggR----------L~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i 961 (1025)
T KOG1095|consen 920 GGR----------LDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAI 961 (1025)
T ss_pred CCc----------cCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhh
Confidence 221 112344566888999999999999999999999987654
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=330.44 Aligned_cols=266 Identities=24% Similarity=0.418 Sum_probs=201.2
Q ss_pred CccceecccCcEEEEEEEE-----cCCcEEEEEEeecCCC-CChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceE
Q 046270 267 SQNNLIGQGASGIVYKGTL-----RHGNLVAVKQILDLDT-KGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRR 340 (590)
Q Consensus 267 ~~~~~LG~G~fG~Vykg~~-----~~g~~vAvK~l~~~~~-~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~ 340 (590)
...+.||+|+||.||++.. .++..||+|.+..... ...+.|.+|++++++++||||+++++++... .....
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~~~~ 83 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQ---GGKGL 83 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC---CCceE
Confidence 6778999999999988653 3477899999865432 3456788999999999999999999988643 23458
Q ss_pred EEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCccc
Q 046270 341 FLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQ 420 (590)
Q Consensus 341 ~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~ 420 (590)
++||||+++++|.+++. ...++|.+++.++.|++.||.||| +.+|+||||||+|||+++++.+||+|||+++.
T Consensus 84 ~lv~e~~~~~~l~~~~~----~~~l~~~~~~~i~~~l~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~ 156 (283)
T cd05080 84 QLIMEYVPLGSLRDYLP----KHKLNLAQLLLFAQQICEGMAYLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKA 156 (283)
T ss_pred EEEecCCCCCCHHHHHH----HcCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccChheEEEcCCCcEEEeecccccc
Confidence 99999999999999884 235999999999999999999999 89999999999999999999999999999986
Q ss_pred ccCCCcc--cccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhh
Q 046270 421 SLEGHSH--LTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDI 498 (590)
Q Consensus 421 ~~~~~~~--~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 498 (590)
....... ......++..|+|||.+..+.++.++||||||++++||+||+.|+............+...........+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd05080 157 VPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIEL 236 (283)
T ss_pred cCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhh
Confidence 6443221 11223456679999999888999999999999999999999999765432221111111100000111111
Q ss_pred hhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhcc
Q 046270 499 FDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEG 542 (590)
Q Consensus 499 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~ 542 (590)
++.......+......+.+++..|++.+|++|||+++++++|+.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~ 280 (283)
T cd05080 237 LERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKE 280 (283)
T ss_pred hhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHH
Confidence 21111111122234578889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-39 Score=327.98 Aligned_cols=251 Identities=24% Similarity=0.289 Sum_probs=197.4
Q ss_pred CCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCC---CCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceE
Q 046270 265 GFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLD---TKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRR 340 (590)
Q Consensus 265 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~---~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~ 340 (590)
.|...+.||+|+||.||++.+. +|+.||+|.+.... ......+.+|++++.+++|+|++++.+++.. +...
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~-----~~~~ 75 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYET-----KDAL 75 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEcc-----CCeE
Confidence 3677889999999999999875 58899999986432 2223467899999999999999999998873 4468
Q ss_pred EEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCccc
Q 046270 341 FLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQ 420 (590)
Q Consensus 341 ~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~ 420 (590)
++||||+++|+|.+++... ....+++..+..++.|++.||+||| +.+|+||||||+|||+++++.+||+|||++..
T Consensus 76 ~lv~e~~~~g~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~ 151 (285)
T cd05631 76 CLVLTIMNGGDLKFHIYNM-GNPGFDEQRAIFYAAELCCGLEDLQ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQ 151 (285)
T ss_pred EEEEEecCCCcHHHHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeCCCcEE
Confidence 9999999999998877532 2346899999999999999999999 89999999999999999999999999999986
Q ss_pred ccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhhh
Q 046270 421 SLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFD 500 (590)
Q Consensus 421 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 500 (590)
..... ......||..|+|||++.+..++.++|||||||++|||++|+.||........ ...... ......
T Consensus 152 ~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~-~~~~~~-~~~~~~------ 221 (285)
T cd05631 152 IPEGE--TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK-REEVDR-RVKEDQ------ 221 (285)
T ss_pred cCCCC--eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchh-HHHHHH-Hhhccc------
Confidence 53322 22345689999999999999999999999999999999999999975433211 110100 000000
Q ss_pred HHHhhhhHHHHHHHHHHHHHhchhcCCCCCCC-----HHHHHH
Q 046270 501 EFIRAEGARAVMERFVLVGILCAHVMVALRPT-----ITDALK 538 (590)
Q Consensus 501 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt-----m~eVl~ 538 (590)
..........+..++..|++.||.+||+ ++++++
T Consensus 222 ----~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 222 ----EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred ----ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 0111223346778899999999999997 777775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=329.63 Aligned_cols=261 Identities=26% Similarity=0.383 Sum_probs=205.7
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCCCC-hHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEE
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDTKG-DEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRF 341 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~~~-~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~ 341 (590)
+.|.....||.|.-++||+|+.. .+..||||++.-..... .+++.+|+..++.++||||++++-.|.. +..++
T Consensus 26 ~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv-----~~~LW 100 (516)
T KOG0582|consen 26 KDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVV-----DSELW 100 (516)
T ss_pred cceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEe-----cceeE
Confidence 46778889999999999999864 57899999986443333 5789999999999999999999988884 44699
Q ss_pred EEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccc
Q 046270 342 LVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQS 421 (590)
Q Consensus 342 LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~ 421 (590)
+||.||.+||+.+.++.... ..+++..+..|++++++||.||| +.|.||||||+.|||||++|.+||+|||..-.+
T Consensus 101 vVmpfMa~GS~ldIik~~~~-~Gl~E~~Ia~iLre~LkaL~YLH---~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l 176 (516)
T KOG0582|consen 101 VVMPFMAGGSLLDIIKTYYP-DGLEEASIATILREVLKALDYLH---QNGHIHRDVKAGNILIDSDGTVKLADFGVSASL 176 (516)
T ss_pred EeehhhcCCcHHHHHHHHcc-ccccHHHHHHHHHHHHHHHHHHH---hcCceecccccccEEEcCCCcEEEcCceeeeee
Confidence 99999999999999865443 45999999999999999999999 999999999999999999999999999987654
Q ss_pred cCCCccc--c-cccccCCCccCcccccc--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCch
Q 046270 422 LEGHSHL--T-TRVAGTFGYLAPEYALY--GQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVD 496 (590)
Q Consensus 422 ~~~~~~~--~-~~~~gt~~Y~APE~~~~--~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 496 (590)
....... . ....||+.|||||+++. ..|+.|+|||||||+.+||.+|..||........++.. -.+...
T Consensus 177 ~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~t------Lqn~pp 250 (516)
T KOG0582|consen 177 FDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLT------LQNDPP 250 (516)
T ss_pred cccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHH------hcCCCC
Confidence 4332211 1 45689999999999653 46999999999999999999999999765554433321 122222
Q ss_pred hhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 497 DIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 497 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
...-..+..+........+.+++-.|++.||.+|||++++++.
T Consensus 251 ~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 251 TLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred CcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 1111111122222333477888899999999999999998764
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-39 Score=330.84 Aligned_cols=268 Identities=29% Similarity=0.410 Sum_probs=201.9
Q ss_pred CccceecccCcEEEEEEEEcCCcEEEEEEeecCCCCChHHHHHHHHHHHhc--CCCCccccceeEEeccCCCCceEEEEE
Q 046270 267 SQNNLIGQGASGIVYKGTLRHGNLVAVKQILDLDTKGDEDFTNEVEIISKI--RHRNLLSLRGCCVTSDDSSGKRRFLVY 344 (590)
Q Consensus 267 ~~~~~LG~G~fG~Vykg~~~~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l--~H~nlv~l~g~~~~~~~~~~~~~~LV~ 344 (590)
....+||+|+||.||||.+. ++.||||++.. +..+.|.+|-+|.+.. +|+||+++++.-..... ...+.+||+
T Consensus 213 ~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~-~~~eywLVt 287 (534)
T KOG3653|consen 213 QLLELIGRGRFGCVWKAQLD-NRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTA-DRMEYWLVT 287 (534)
T ss_pred hhHHHhhcCccceeehhhcc-CceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCc-cccceeEEe
Confidence 34467999999999999998 48999999854 4566788998887754 89999999998664443 356799999
Q ss_pred eeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcC------CCCeEecCCCCCceEECCCCcEEEEeeCCc
Q 046270 345 DYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGL------KPGIYHRDIKSTNILLDSELNAKVADFGLA 418 (590)
Q Consensus 345 E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~------~~~ivHrDIKp~NILLd~~~~~kL~DFGla 418 (590)
||.++|+|.++|. ...++|....+|+..+++||+|||++. +++|+|||||++||||.+|++..|+|||+|
T Consensus 288 ~fh~kGsL~dyL~----~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLA 363 (534)
T KOG3653|consen 288 EFHPKGSLCDYLK----ANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLA 363 (534)
T ss_pred eeccCCcHHHHHH----hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecccee
Confidence 9999999999994 457999999999999999999999765 678999999999999999999999999999
Q ss_pred ccccCCCcc-cccccccCCCccCccccccC-CCC-----cchhHHHHHHHHHHHHhCCCCCCCC-CCchh----------
Q 046270 419 KQSLEGHSH-LTTRVAGTFGYLAPEYALYG-QLT-----EKSDVYSFGIVILELMSGRKVLDTS-TSPFQ---------- 480 (590)
Q Consensus 419 ~~~~~~~~~-~~~~~~gt~~Y~APE~~~~~-~~t-----~ksDVySfGvvLlELltG~~p~~~~-~~~~~---------- 480 (590)
..+..+... ......||.+|||||++.+. .+. .+.||||+|.|||||+++-..++.. ..+++
T Consensus 364 l~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~h 443 (534)
T KOG3653|consen 364 LRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNH 443 (534)
T ss_pred EEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCC
Confidence 988765443 34457899999999988753 222 3689999999999999988766421 11111
Q ss_pred -hhhHHHHHHHhcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhccCCCCC
Q 046270 481 -LITDWAWVLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEGDIDIP 547 (590)
Q Consensus 481 -~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~~~~~~ 547 (590)
.+.+.....+.+.....+.|..... ..+..+.+.+..||..||+.|-|+.=|-+++.......
T Consensus 444 Pt~e~mq~~VV~kK~RP~~p~~W~~h----~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~ 507 (534)
T KOG3653|consen 444 PTLEEMQELVVRKKQRPKIPDAWRKH----AGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLW 507 (534)
T ss_pred CCHHHHHHHHHhhccCCCChhhhhcC----ccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccC
Confidence 1111111111111111111221111 23446677888999999999999998888877654443
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=347.13 Aligned_cols=258 Identities=23% Similarity=0.363 Sum_probs=199.5
Q ss_pred hcCCCccceecccCcEEEEEEEEc------CCcEEEEEEeecCCCC-ChHHHHHHHHHHHhc-CCCCccccceeEEeccC
Q 046270 263 TNGFSQNNLIGQGASGIVYKGTLR------HGNLVAVKQILDLDTK-GDEDFTNEVEIISKI-RHRNLLSLRGCCVTSDD 334 (590)
Q Consensus 263 t~~f~~~~~LG~G~fG~Vykg~~~------~g~~vAvK~l~~~~~~-~~~~f~~Ev~il~~l-~H~nlv~l~g~~~~~~~ 334 (590)
.++|...+.||+|+||.||+|+.. ++..||+|++...... ..+.+.+|+++++++ +|+||++++++|..
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~--- 113 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTH--- 113 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecC---
Confidence 346888899999999999999853 2357999998654322 245688999999999 89999999999874
Q ss_pred CCCceEEEEEeeCCCCCcchhhhhhcc-----------------------------------------------------
Q 046270 335 SSGKRRFLVYDYMPNGTLSDNISISHK----------------------------------------------------- 361 (590)
Q Consensus 335 ~~~~~~~LV~E~~~~gsL~~~L~~~~~----------------------------------------------------- 361 (590)
+...++||||+++|+|.+++.....
T Consensus 114 --~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (374)
T cd05106 114 --GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSS 191 (374)
T ss_pred --CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccc
Confidence 4458999999999999998853210
Q ss_pred --------------cccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccccCCCcc
Q 046270 362 --------------RKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSH 427 (590)
Q Consensus 362 --------------~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~~~~~~~ 427 (590)
...++|.++++|+.||++||.||| +.+|+||||||+|||+++++.+||+|||+++........
T Consensus 192 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~ 268 (374)
T cd05106 192 SQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLA---SKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNY 268 (374)
T ss_pred cccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcce
Confidence 124788999999999999999999 899999999999999999999999999999865433221
Q ss_pred -cccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhhHHHHHHHhcCCchhhhhHHHhh
Q 046270 428 -LTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDEFIRA 505 (590)
Q Consensus 428 -~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 505 (590)
......++..|+|||++..+.++.++|||||||++|||++ |+.||........ +. .....+....
T Consensus 269 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~----~~-~~~~~~~~~~-------- 335 (374)
T cd05106 269 VVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK----FY-KMVKRGYQMS-------- 335 (374)
T ss_pred eeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH----HH-HHHHcccCcc--------
Confidence 1222345678999999998999999999999999999997 9999865332211 11 1111110000
Q ss_pred hhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhcc
Q 046270 506 EGARAVMERFVLVGILCAHVMVALRPTITDALKMLEG 542 (590)
Q Consensus 506 ~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~ 542 (590)
.+......+.+++..|++.||++|||+.+|+++|+.
T Consensus 336 -~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~ 371 (374)
T cd05106 336 -RPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQR 371 (374)
T ss_pred -CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 001112467788899999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=331.97 Aligned_cols=249 Identities=31% Similarity=0.513 Sum_probs=190.1
Q ss_pred ccceecccCcEEEEEEEEc-----CCcEEEEEEeecCCCC-ChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEE
Q 046270 268 QNNLIGQGASGIVYKGTLR-----HGNLVAVKQILDLDTK-GDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRF 341 (590)
Q Consensus 268 ~~~~LG~G~fG~Vykg~~~-----~g~~vAvK~l~~~~~~-~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~ 341 (590)
..+.||.|.||.||+|.+. .+..|+||.+...... ..++|.+|++.+++++||||++++|+|.. ....+
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~-----~~~~~ 77 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIE-----NEPLF 77 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEES-----SSSEE
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccc-----ccccc
Confidence 3468999999999999988 2558999999653332 36789999999999999999999999993 33489
Q ss_pred EEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccc
Q 046270 342 LVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQS 421 (590)
Q Consensus 342 LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~ 421 (590)
+||||+++|+|.++|... ....+++.++..|+.||++||.||| +.+++|+||+++|||+++++.+||+|||+++..
T Consensus 78 lv~e~~~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh---~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~ 153 (259)
T PF07714_consen 78 LVMEYCPGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLH---SNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPI 153 (259)
T ss_dssp EEEE--TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHH---HTTEEEST-SGGGEEEETTTEEEEESTTTGEET
T ss_pred cccccccccccccccccc-ccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc
Confidence 999999999999999643 2457999999999999999999999 789999999999999999999999999999876
Q ss_pred cCCCc-ccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhhHHHHHHHhcCCchhhh
Q 046270 422 LEGHS-HLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLDTSTSPFQLITDWAWVLAKSGKVDDIF 499 (590)
Q Consensus 422 ~~~~~-~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 499 (590)
..... .......+...|+|||.+....++.++||||||+++|||++ |+.|+..... .. +...+ ..+.....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~-~~----~~~~~-~~~~~~~~- 226 (259)
T PF07714_consen 154 SEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN-EE----IIEKL-KQGQRLPI- 226 (259)
T ss_dssp TTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH-HH----HHHHH-HTTEETTS-
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-cc----ccccc-ccccccee-
Confidence 32222 22233446778999999999999999999999999999999 6777754321 11 11122 22221111
Q ss_pred hHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHh
Q 046270 500 DEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKML 540 (590)
Q Consensus 500 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L 540 (590)
+......+..++..||+.+|++||||.++++.|
T Consensus 227 --------~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 227 --------PDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp --------BTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred --------ccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 111234677899999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=332.42 Aligned_cols=252 Identities=23% Similarity=0.272 Sum_probs=195.3
Q ss_pred CCCccceecccCcEEEEEEEEc----CCcEEEEEEeecCC----CCChHHHHHHHHHHHhc-CCCCccccceeEEeccCC
Q 046270 265 GFSQNNLIGQGASGIVYKGTLR----HGNLVAVKQILDLD----TKGDEDFTNEVEIISKI-RHRNLLSLRGCCVTSDDS 335 (590)
Q Consensus 265 ~f~~~~~LG~G~fG~Vykg~~~----~g~~vAvK~l~~~~----~~~~~~f~~Ev~il~~l-~H~nlv~l~g~~~~~~~~ 335 (590)
+|...+.||+|+||.||+++.. .+..||+|++.... ....+.+.+|++++.++ +|+||+++++++.
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~----- 75 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQ----- 75 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEe-----
Confidence 4778899999999999999763 47899999986421 22245678999999999 5999999998876
Q ss_pred CCceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEee
Q 046270 336 SGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADF 415 (590)
Q Consensus 336 ~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DF 415 (590)
.....++||||+++|+|.+++. .+..+++.++..++.||+.||.||| +.+|+||||||+|||++.++.+||+||
T Consensus 76 ~~~~~~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nili~~~~~~kl~Df 149 (332)
T cd05614 76 TEAKLHLILDYVSGGEMFTHLY---QRDNFSEDEVRFYSGEIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDF 149 (332)
T ss_pred cCCEEEEEEeCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHeEECCCCCEEEeeC
Confidence 3456899999999999999885 3456999999999999999999999 899999999999999999999999999
Q ss_pred CCcccccCCCcccccccccCCCccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCC
Q 046270 416 GLAKQSLEGHSHLTTRVAGTFGYLAPEYALYG-QLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGK 494 (590)
Q Consensus 416 Gla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~ 494 (590)
|+++..............||..|+|||.+.+. .++.++|||||||++|||+||+.||........ .......... ..
T Consensus 150 G~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~-~~~~~~~~~~-~~ 227 (332)
T cd05614 150 GLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNT-QSEVSRRILK-CD 227 (332)
T ss_pred cCCccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCC-HHHHHHHHhc-CC
Confidence 99986544433334456799999999998764 478999999999999999999999964332211 1111111111 00
Q ss_pred chhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCC-----CHHHHHHH
Q 046270 495 VDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRP-----TITDALKM 539 (590)
Q Consensus 495 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-----tm~eVl~~ 539 (590)
+. .+......+.+++..|++.||++|| ++.++++.
T Consensus 228 ------~~----~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 228 ------PP----FPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred ------CC----CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 00 0111223567788899999999999 67777654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=328.69 Aligned_cols=255 Identities=26% Similarity=0.472 Sum_probs=201.9
Q ss_pred CCCccceecccCcEEEEEEEEcCC------cEEEEEEeecCCC-CChHHHHHHHHHHHhcCCCCccccceeEEeccCCCC
Q 046270 265 GFSQNNLIGQGASGIVYKGTLRHG------NLVAVKQILDLDT-KGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSG 337 (590)
Q Consensus 265 ~f~~~~~LG~G~fG~Vykg~~~~g------~~vAvK~l~~~~~-~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~ 337 (590)
+|...+.||+|+||.||+|.+... ..||+|.+..... ....+|.+|++++.+++||||+++++++.. .
T Consensus 6 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~-----~ 80 (283)
T cd05048 6 AVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTK-----E 80 (283)
T ss_pred HcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcC-----C
Confidence 577788999999999999987532 4799998864332 224568999999999999999999999873 3
Q ss_pred ceEEEEEeeCCCCCcchhhhhhcc-------------cccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEE
Q 046270 338 KRRFLVYDYMPNGTLSDNISISHK-------------RKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILL 404 (590)
Q Consensus 338 ~~~~LV~E~~~~gsL~~~L~~~~~-------------~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILL 404 (590)
...+++|||+++|+|.+++..... ...+++..++.++.|++.||.||| ..+++||||||+||++
T Consensus 81 ~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nil~ 157 (283)
T cd05048 81 QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS---SHHFVHRDLAARNCLV 157 (283)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccccceEEE
Confidence 458999999999999999854211 145899999999999999999999 8999999999999999
Q ss_pred CCCCcEEEEeeCCcccccCCCc-ccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhh
Q 046270 405 DSELNAKVADFGLAKQSLEGHS-HLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLDTSTSPFQLI 482 (590)
Q Consensus 405 d~~~~~kL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELlt-G~~p~~~~~~~~~~l 482 (590)
++++.+||+|||+++....... .......++..|+|||++..+.++.++|||||||++|||++ |+.||....... +
T Consensus 158 ~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~--~ 235 (283)
T cd05048 158 GEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE--V 235 (283)
T ss_pred cCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH--H
Confidence 9999999999999986543322 22334456788999999998999999999999999999998 999986533211 1
Q ss_pred hHHHHHHHhcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhcc
Q 046270 483 TDWAWVLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEG 542 (590)
Q Consensus 483 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~ 542 (590)
.. ....+.... .+......+.+++..|++.+|++||++.||+++|++
T Consensus 236 ~~----~i~~~~~~~---------~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 236 IE----MIRSRQLLP---------CPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred HH----HHHcCCcCC---------CcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 11 111221111 112334578889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=325.47 Aligned_cols=254 Identities=23% Similarity=0.370 Sum_probs=201.3
Q ss_pred cCCCccceecccCcEEEEEEEEcC-CcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEEE
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLRH-GNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFL 342 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~L 342 (590)
.+|...+.||+|+||.||+|.+++ +..||+|.+... ....+++.+|++++++++|+|++++++++.. ....++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~l 79 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR-----EPPFYI 79 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcC-----CCCcEE
Confidence 347778899999999999999864 778999987643 3345679999999999999999999999874 345899
Q ss_pred EEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCccccc
Q 046270 343 VYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSL 422 (590)
Q Consensus 343 V~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~~ 422 (590)
||||+++++|.+++... ....+++..++.++.|+++||+||| +.+++||||||+||++++++.+||+|||+++...
T Consensus 80 v~e~~~~~~L~~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~ 155 (263)
T cd05052 80 ITEFMTYGNLLDYLREC-NRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT 155 (263)
T ss_pred EEEeCCCCcHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCcEEeCCCccccccc
Confidence 99999999999988532 2346899999999999999999999 8999999999999999999999999999998654
Q ss_pred CCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhhHHHHHHHhcCCchhhhhH
Q 046270 423 EGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDE 501 (590)
Q Consensus 423 ~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 501 (590)
...........++..|+|||++.+..++.++||||||+++|||++ |..|+...... ++... ...+..
T Consensus 156 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~-----~~~~~-~~~~~~------ 223 (263)
T cd05052 156 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-----QVYEL-LEKGYR------ 223 (263)
T ss_pred cceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-----HHHHH-HHCCCC------
Confidence 433222222334668999999998999999999999999999998 88887643221 11111 111100
Q ss_pred HHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhcc
Q 046270 502 FIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEG 542 (590)
Q Consensus 502 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~ 542 (590)
...+......+.+++..|++.+|++||++.+++++|+.
T Consensus 224 ---~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~ 261 (263)
T cd05052 224 ---MERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFET 261 (263)
T ss_pred ---CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHh
Confidence 01111223467789999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=326.01 Aligned_cols=257 Identities=26% Similarity=0.427 Sum_probs=207.5
Q ss_pred HHhcCCCccceecccCcEEEEEEEEcCCcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceE
Q 046270 261 QATNGFSQNNLIGQGASGIVYKGTLRHGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRR 340 (590)
Q Consensus 261 ~at~~f~~~~~LG~G~fG~Vykg~~~~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~ 340 (590)
++..+|...++||+|+||.||+|.+.++..+|+|.+.........++.+|++++++++|+|++++++++.. +...
T Consensus 3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~ 77 (261)
T cd05148 3 RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSV-----GEPV 77 (261)
T ss_pred CcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEec-----CCCe
Confidence 34556888899999999999999998889999999876655556789999999999999999999999874 4458
Q ss_pred EEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCccc
Q 046270 341 FLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQ 420 (590)
Q Consensus 341 ~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~ 420 (590)
++||||+++++|.+++... ....+++.+++.++.+|+.||.||| +.+|+||||||+||++++++.+||+|||++..
T Consensus 78 ~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~ 153 (261)
T cd05148 78 YIITELMEKGSLLAFLRSP-EGQVLPVASLIDMACQVAEGMAYLE---EQNSIHRDLAARNILVGEDLVCKVADFGLARL 153 (261)
T ss_pred EEEEeecccCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccCcceEEEcCCceEEEccccchhh
Confidence 9999999999999998643 2346899999999999999999999 89999999999999999999999999999976
Q ss_pred ccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhhHHHHHHHhcCCchhhh
Q 046270 421 SLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLDTSTSPFQLITDWAWVLAKSGKVDDIF 499 (590)
Q Consensus 421 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 499 (590)
...... ......++..|+|||.+..+.++.++||||||++++||++ |+.|+...... ..+. .. . .+...
T Consensus 154 ~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~-~~~~-~~---~-~~~~~--- 223 (261)
T cd05148 154 IKEDVY-LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH-EVYD-QI---T-AGYRM--- 223 (261)
T ss_pred cCCccc-cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH-HHHH-HH---H-hCCcC---
Confidence 543221 2223345678999999998899999999999999999999 88888643321 1111 11 1 11000
Q ss_pred hHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhcc
Q 046270 500 DEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEG 542 (590)
Q Consensus 500 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~ 542 (590)
..+....+.+.+++..|++.+|.+|||+.++++.|++
T Consensus 224 ------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 224 ------PCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred ------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 0111223467789999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=335.41 Aligned_cols=245 Identities=22% Similarity=0.321 Sum_probs=197.0
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCC---CCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCce
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLD---TKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKR 339 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~---~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~ 339 (590)
++|...+.||+|+||.||+|++. +|+.||+|.+.... ....+.+.+|++++.+++||||+++++++.. +..
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~~~ 92 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQD-----ENR 92 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEc-----CCE
Confidence 46788899999999999999986 47899999986432 2334568899999999999999999998873 456
Q ss_pred EEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcc
Q 046270 340 RFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAK 419 (590)
Q Consensus 340 ~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~ 419 (590)
.++||||+++|+|.+++. ....+++.....++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++
T Consensus 93 ~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~ 166 (329)
T PTZ00263 93 VYFLLEFVVGGELFTHLR---KAGRFPNDVAKFYHAELVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAK 166 (329)
T ss_pred EEEEEcCCCCChHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEECCCCCEEEeeccCce
Confidence 999999999999999885 3456899999999999999999999 8999999999999999999999999999998
Q ss_pred cccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhh
Q 046270 420 QSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIF 499 (590)
Q Consensus 420 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 499 (590)
..... .....||+.|+|||.+.+..++.++|||||||++|||++|+.||..... .... . ....+... +
T Consensus 167 ~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~-~~~~----~-~i~~~~~~--~ 234 (329)
T PTZ00263 167 KVPDR----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP-FRIY----E-KILAGRLK--F 234 (329)
T ss_pred EcCCC----cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH-HHHH----H-HHhcCCcC--C
Confidence 65432 2235689999999999998999999999999999999999999864322 1111 1 11112110 0
Q ss_pred hHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCC-----HHHHHHH
Q 046270 500 DEFIRAEGARAVMERFVLVGILCAHVMVALRPT-----ITDALKM 539 (590)
Q Consensus 500 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt-----m~eVl~~ 539 (590)
+.....++.+++..|++.||.+||+ +++++..
T Consensus 235 --------p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 235 --------PNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred --------CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 0112235677889999999999997 6777654
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-39 Score=333.91 Aligned_cols=242 Identities=21% Similarity=0.288 Sum_probs=192.6
Q ss_pred ceecccCcEEEEEEEEc-CCcEEEEEEeecCC---CCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEEEEEe
Q 046270 270 NLIGQGASGIVYKGTLR-HGNLVAVKQILDLD---TKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFLVYD 345 (590)
Q Consensus 270 ~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~---~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~LV~E 345 (590)
+.||+|+||.||+++.+ +|+.||+|++.... ......+.+|++++++++||||+++++++.. +...++|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~-----~~~~~lv~e 75 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQT-----HDRLCFVME 75 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEc-----CCEEEEEEe
Confidence 36999999999999876 58899999986532 2223567889999999999999999998873 456999999
Q ss_pred eCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccccCCC
Q 046270 346 YMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGH 425 (590)
Q Consensus 346 ~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~~~~~ 425 (590)
|+++|+|.+++. ....+++.++..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 76 ~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~- 148 (323)
T cd05571 76 YANGGELFFHLS---RERVFSEDRARFYGAEIVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISD- 148 (323)
T ss_pred CCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccC-
Confidence 999999998885 3457899999999999999999999 899999999999999999999999999998753221
Q ss_pred cccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhhhHHHhh
Q 046270 426 SHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDEFIRA 505 (590)
Q Consensus 426 ~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 505 (590)
........||+.|+|||.+.+..++.++|||||||++|||++|+.||...... .+... . ..+..
T Consensus 149 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~--~~~~~---~-~~~~~---------- 212 (323)
T cd05571 149 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--KLFEL---I-LMEEI---------- 212 (323)
T ss_pred CCcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHH--HHHHH---H-HcCCC----------
Confidence 12233456899999999999889999999999999999999999999643221 11111 0 11110
Q ss_pred hhHHHHHHHHHHHHHhchhcCCCCCC-----CHHHHHHH
Q 046270 506 EGARAVMERFVLVGILCAHVMVALRP-----TITDALKM 539 (590)
Q Consensus 506 ~~~~~~~~~l~~l~~~Cl~~dp~~RP-----tm~eVl~~ 539 (590)
..+......+.+++..|++.||++|| ++.++++.
T Consensus 213 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 213 RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred CCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 01112234667788899999999999 78888753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-39 Score=327.29 Aligned_cols=267 Identities=23% Similarity=0.279 Sum_probs=197.8
Q ss_pred cCCCccceecccCcEEEEEEEEc--CCcEEEEEEeecCCCC--ChHHHHHHHHHHHhc---CCCCccccceeEEeccCCC
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLR--HGNLVAVKQILDLDTK--GDEDFTNEVEIISKI---RHRNLLSLRGCCVTSDDSS 336 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~--~g~~vAvK~l~~~~~~--~~~~f~~Ev~il~~l---~H~nlv~l~g~~~~~~~~~ 336 (590)
++|...+.||+|+||.||+|+.. +|..||+|++...... ....+.+|+++++++ +||||++++++|.......
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 36788899999999999999873 3678999998643322 234567788887776 6999999999987544334
Q ss_pred CceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeC
Q 046270 337 GKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFG 416 (590)
Q Consensus 337 ~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFG 416 (590)
....++||||++ ++|.+++... ....+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH---~~~iiH~dlkp~Nil~~~~~~~kl~Dfg 155 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFG 155 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEcCCCCEEEcccc
Confidence 556899999996 6888888532 2345899999999999999999999 8999999999999999999999999999
Q ss_pred CcccccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhc--CC
Q 046270 417 LAKQSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKS--GK 494 (590)
Q Consensus 417 la~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~--~~ 494 (590)
+++..... .......||..|+|||.+....++.++|||||||++|||++|+.||....... .+.......... ..
T Consensus 156 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~-~~~~i~~~~~~~~~~~ 232 (290)
T cd07862 156 LARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD-QLGKILDVIGLPGEED 232 (290)
T ss_pred ceEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHH-HHHHHHHHhCCCChhh
Confidence 99765432 23344568999999999988899999999999999999999999997644322 111111100000 00
Q ss_pred c-------hhhhhHHH---hhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 046270 495 V-------DDIFDEFI---RAEGARAVMERFVLVGILCAHVMVALRPTITDALK 538 (590)
Q Consensus 495 ~-------~~~~d~~l---~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~ 538 (590)
. ...+.+.- ......+..+.+.+++..|++.||++|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 233 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred chhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 0 00000000 00001123345678999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=324.38 Aligned_cols=251 Identities=27% Similarity=0.432 Sum_probs=199.7
Q ss_pred CCCccceecccCcEEEEEEEEcCCcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEEEEE
Q 046270 265 GFSQNNLIGQGASGIVYKGTLRHGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFLVY 344 (590)
Q Consensus 265 ~f~~~~~LG~G~fG~Vykg~~~~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~LV~ 344 (590)
+|...+.||+|+||.||+|.+.++..+|+|.+.... ...++|.+|+.++.+++||||+++++++.. ....++||
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv~ 78 (256)
T cd05113 5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTK-----QRPIYIVT 78 (256)
T ss_pred HeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEcc-----CCCcEEEE
Confidence 466778999999999999998877789999886432 345679999999999999999999999864 33479999
Q ss_pred eeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccccCC
Q 046270 345 DYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEG 424 (590)
Q Consensus 345 E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~~~~ 424 (590)
||+++|+|.+++... ...++|.+++.++.||+.||+||| +.+++|+||||+||++++++.+||+|||+++.....
T Consensus 79 e~~~~~~l~~~i~~~--~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~ 153 (256)
T cd05113 79 EYMSNGCLLNYLREH--GKRFQPSQLLEMCKDVCEGMAYLE---SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDD 153 (256)
T ss_pred EcCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCCEEECCCccceecCCC
Confidence 999999999988532 236899999999999999999999 899999999999999999999999999998865443
Q ss_pred CcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhhHHHHHHHhcCCchhhhhHHH
Q 046270 425 HSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDEFI 503 (590)
Q Consensus 425 ~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 503 (590)
.........++..|+|||++..+.++.++||||||+++|||++ |+.|+....... +.+ . ...+....
T Consensus 154 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~--~~~---~-~~~~~~~~------ 221 (256)
T cd05113 154 EYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE--TVE---K-VSQGLRLY------ 221 (256)
T ss_pred ceeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH--HHH---H-HhcCCCCC------
Confidence 2222223345678999999998899999999999999999999 988886433211 111 1 11111100
Q ss_pred hhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhc
Q 046270 504 RAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLE 541 (590)
Q Consensus 504 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~ 541 (590)
........+.+++..|++.+|.+||++.++++.|+
T Consensus 222 ---~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 222 ---RPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred ---CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 00112347788999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=322.91 Aligned_cols=251 Identities=26% Similarity=0.417 Sum_probs=198.9
Q ss_pred CCCccceecccCcEEEEEEEEcCCcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEEEEE
Q 046270 265 GFSQNNLIGQGASGIVYKGTLRHGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFLVY 344 (590)
Q Consensus 265 ~f~~~~~LG~G~fG~Vykg~~~~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~LV~ 344 (590)
+|+..+.||+|+||.||+|.++.+..+|+|.+.... ....+|.+|++++++++|+||+++++++.. ....++||
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~lv~ 78 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTK-----QRPIFIVT 78 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcC-----CCceEEEE
Confidence 467778999999999999998877789999875432 335678999999999999999999998863 34589999
Q ss_pred eeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccccCC
Q 046270 345 DYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEG 424 (590)
Q Consensus 345 E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~~~~ 424 (590)
||+++++|.+++... ...++|..++.|+.|++.||+||| +.+|+||||||+||++++++.+||+|||+++.....
T Consensus 79 e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~ 153 (256)
T cd05059 79 EYMANGCLLNYLRER--KGKLGTEWLLDMCSDVCEAMEYLE---SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDD 153 (256)
T ss_pred ecCCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHhhEEECCCCcEEECCcccceecccc
Confidence 999999999988532 346899999999999999999999 899999999999999999999999999999865433
Q ss_pred CcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhhHHHHHHHhcCCchhhhhHHH
Q 046270 425 HSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDEFI 503 (590)
Q Consensus 425 ~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 503 (590)
.........++..|+|||++....++.++||||||+++|||++ |+.||+..... ... .. ...+..
T Consensus 154 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-~~~----~~-~~~~~~-------- 219 (256)
T cd05059 154 QYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS-EVV----ES-VSAGYR-------- 219 (256)
T ss_pred cccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH-HHH----HH-HHcCCc--------
Confidence 2222222234568999999998999999999999999999999 78888643321 111 11 111100
Q ss_pred hhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhc
Q 046270 504 RAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLE 541 (590)
Q Consensus 504 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~ 541 (590)
...+......+.+++..|++.+|++||||.|++++|.
T Consensus 220 -~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~ 256 (256)
T cd05059 220 -LYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT 256 (256)
T ss_pred -CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence 0001113447888999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=328.48 Aligned_cols=255 Identities=26% Similarity=0.400 Sum_probs=198.2
Q ss_pred cCCCccceecccCcEEEEEEEEcC-Cc----EEEEEEeecCCC-CChHHHHHHHHHHHhcCCCCccccceeEEeccCCCC
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLRH-GN----LVAVKQILDLDT-KGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSG 337 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~~-g~----~vAvK~l~~~~~-~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~ 337 (590)
++|...+.||+|+||.||+|++.. |+ .+++|.+..... ....++..|+.++++++||||++++|++. +
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~------~ 80 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP------G 80 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC------C
Confidence 356777899999999999999753 44 477887754322 22356888999999999999999999874 2
Q ss_pred ceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCC
Q 046270 338 KRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGL 417 (590)
Q Consensus 338 ~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGl 417 (590)
...++++||+++|+|.+++.. ....++|..++.|+.||+.||.||| +.+++||||||+|||+++++.+||+|||+
T Consensus 81 ~~~~~i~e~~~~gsL~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~kl~Dfg~ 155 (279)
T cd05111 81 ASLQLVTQLSPLGSLLDHVRQ--HRDSLDPQRLLNWCVQIAKGMYYLE---EHRMVHRNLAARNILLKSDSIVQIADFGV 155 (279)
T ss_pred CccEEEEEeCCCCcHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEEcCCcc
Confidence 347899999999999999853 3356999999999999999999999 89999999999999999999999999999
Q ss_pred cccccCCCcc-cccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhhHHHHHHHhcCCc
Q 046270 418 AKQSLEGHSH-LTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLDTSTSPFQLITDWAWVLAKSGKV 495 (590)
Q Consensus 418 a~~~~~~~~~-~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~ 495 (590)
++........ ......++..|+|||++.++.++.++||||||+++|||++ |+.|+...... .+.++ ...+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~--~~~~~----~~~~~~ 229 (279)
T cd05111 156 ADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH--EVPDL----LEKGER 229 (279)
T ss_pred ceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHH----HHCCCc
Confidence 9866443322 2334567789999999999999999999999999999998 99888643221 11111 122211
Q ss_pred hhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhccCC
Q 046270 496 DDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEGDI 544 (590)
Q Consensus 496 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~~~ 544 (590)
.. .+. .....+..++..|++.+|++|||+.|++++|....
T Consensus 230 ~~--~~~-------~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~ 269 (279)
T cd05111 230 LA--QPQ-------ICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMA 269 (279)
T ss_pred CC--CCC-------CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 11 000 01224566888999999999999999999988743
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=339.47 Aligned_cols=249 Identities=27% Similarity=0.413 Sum_probs=206.5
Q ss_pred CCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEEEE
Q 046270 265 GFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFLV 343 (590)
Q Consensus 265 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~LV 343 (590)
.|....+||+|.-|.||.+.-. .++.||||++........+-+.+|+.+|+..+|+|||.++.-|.. +.++++|
T Consensus 274 ~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv-----~deLWVV 348 (550)
T KOG0578|consen 274 KYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLV-----GDELWVV 348 (550)
T ss_pred hhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcc-----cceeEEE
Confidence 4566678999999999999754 588999999977666667778999999999999999999998884 3569999
Q ss_pred EeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccccC
Q 046270 344 YDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLE 423 (590)
Q Consensus 344 ~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~~~ 423 (590)
||||++|+|.|.+. ...+++.++..|.++++.||+||| ..+|+|||||.+||||+.++.+||+|||++.....
T Consensus 349 MEym~ggsLTDvVt----~~~~~E~qIA~Icre~l~aL~fLH---~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~ 421 (550)
T KOG0578|consen 349 MEYMEGGSLTDVVT----KTRMTEGQIAAICREILQGLKFLH---ARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISE 421 (550)
T ss_pred EeecCCCchhhhhh----cccccHHHHHHHHHHHHHHHHHHH---hcceeeeccccceeEeccCCcEEEeeeeeeecccc
Confidence 99999999999884 345999999999999999999999 99999999999999999999999999999988766
Q ss_pred CCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhhhHHH
Q 046270 424 GHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDEFI 503 (590)
Q Consensus 424 ~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 503 (590)
... ......||+.|||||++....|.+|.||||||++++||+-|.+||-.... +.. .+....+|...- -
T Consensus 422 ~~~-KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~P---lrA--lyLIa~ng~P~l-k---- 490 (550)
T KOG0578|consen 422 EQS-KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENP---LRA--LYLIATNGTPKL-K---- 490 (550)
T ss_pred ccC-ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCCh---HHH--HHHHhhcCCCCc-C----
Confidence 554 44557899999999999999999999999999999999999999854221 222 122223333211 1
Q ss_pred hhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 504 RAEGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 504 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
.++.+...+.++..+|++.|+++||++.|+|+.
T Consensus 491 ---~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 491 ---NPEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred ---CccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 122233467778889999999999999999863
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-39 Score=324.01 Aligned_cols=254 Identities=27% Similarity=0.395 Sum_probs=201.0
Q ss_pred cCCCccceecccCcEEEEEEEEcC----CcEEEEEEeecCCC-CChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCc
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLRH----GNLVAVKQILDLDT-KGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGK 338 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~~----g~~vAvK~l~~~~~-~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~ 338 (590)
++|+..+.||+|+||.||+|.+.. ...||||.+..... ....+|.+|+.++++++|+||+++++++.. +.
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~ 78 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTK-----SR 78 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEec-----CC
Confidence 568888999999999999999853 34799998864332 234578999999999999999999998863 34
Q ss_pred eEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCc
Q 046270 339 RRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLA 418 (590)
Q Consensus 339 ~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla 418 (590)
..++||||+++++|.+++.. ....++|.++++++.|++.||+||| +.+|+||||||+|||+++++.+||+|||++
T Consensus 79 ~~~iv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~di~p~nili~~~~~~~l~dfg~~ 153 (266)
T cd05033 79 PVMIITEYMENGSLDKFLRE--NDGKFTVGQLVGMLRGIASGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLS 153 (266)
T ss_pred ceEEEEEcCCCCCHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCCEEECccchh
Confidence 58999999999999999853 2347899999999999999999999 899999999999999999999999999999
Q ss_pred ccccCCCcc-cccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhhHHHHHHHhcCCch
Q 046270 419 KQSLEGHSH-LTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLDTSTSPFQLITDWAWVLAKSGKVD 496 (590)
Q Consensus 419 ~~~~~~~~~-~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 496 (590)
+........ ......++..|+|||.+.+..++.++||||||++++||++ |..|+...... .+.+. ...+...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~--~~~~~----~~~~~~~ 227 (266)
T cd05033 154 RRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ--DVIKA----VEDGYRL 227 (266)
T ss_pred hcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH--HHHHH----HHcCCCC
Confidence 876422221 1222344678999999998999999999999999999998 98888543221 11111 1111100
Q ss_pred hhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhcc
Q 046270 497 DIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEG 542 (590)
Q Consensus 497 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~ 542 (590)
. .+....+.+.+++..|++.+|++||++.||+++|+.
T Consensus 228 ~---------~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~ 264 (266)
T cd05033 228 P---------PPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDK 264 (266)
T ss_pred C---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 0 011223467889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=343.54 Aligned_cols=265 Identities=28% Similarity=0.400 Sum_probs=205.2
Q ss_pred HHHHHHhcCCCccceecccCcEEEEEEEEcCCcEEEEEEeecCCCC--ChHHHHHHHHHHHhcCCCCccccceeEEeccC
Q 046270 257 SELEQATNGFSQNNLIGQGASGIVYKGTLRHGNLVAVKQILDLDTK--GDEDFTNEVEIISKIRHRNLLSLRGCCVTSDD 334 (590)
Q Consensus 257 ~el~~at~~f~~~~~LG~G~fG~Vykg~~~~g~~vAvK~l~~~~~~--~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~ 334 (590)
++.+..-+.+.....||+|.||+||+|.|- ..||||++...... ..++|++|+.++++-||.||+-+.|||...
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p-- 460 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNP-- 460 (678)
T ss_pred cccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCC--
Confidence 444555555667789999999999999986 35999998654433 356899999999999999999999999743
Q ss_pred CCCceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEe
Q 046270 335 SSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVAD 414 (590)
Q Consensus 335 ~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~D 414 (590)
. ..+|..++++-+|..||+.. +..++..+.+.|+.|||+|+.||| .++|||||||..||+|.+++.+||+|
T Consensus 461 ---~-~AIiTqwCeGsSLY~hlHv~--etkfdm~~~idIAqQiaqGM~YLH---AK~IIHrDLKSnNIFl~~~~kVkIgD 531 (678)
T KOG0193|consen 461 ---P-LAIITQWCEGSSLYTHLHVQ--ETKFDMNTTIDIAQQIAQGMDYLH---AKNIIHRDLKSNNIFLHEDLKVKIGD 531 (678)
T ss_pred ---c-eeeeehhccCchhhhhccch--hhhhhHHHHHHHHHHHHHhhhhhh---hhhhhhhhccccceEEccCCcEEEec
Confidence 2 49999999999999999854 356899999999999999999999 99999999999999999999999999
Q ss_pred eCCcccccC-CCcccccccccCCCccCcccccc---CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHH
Q 046270 415 FGLAKQSLE-GHSHLTTRVAGTFGYLAPEYALY---GQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLA 490 (590)
Q Consensus 415 FGla~~~~~-~~~~~~~~~~gt~~Y~APE~~~~---~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~ 490 (590)
||++..... ..........|...|||||+++. .+|+..+||||||+|+|||+||..|+.....+ ..| |
T Consensus 532 FGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~d-qIi-------f 603 (678)
T KOG0193|consen 532 FGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRD-QII-------F 603 (678)
T ss_pred ccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChh-heE-------E
Confidence 999864321 11112223456788999999874 46899999999999999999999999832222 211 1
Q ss_pred hcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhccCCC
Q 046270 491 KSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEGDID 545 (590)
Q Consensus 491 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~~~~ 545 (590)
.-|+-.-..|.... ..+..+.+.++...||..++++||.+.+++.+|+....
T Consensus 604 mVGrG~l~pd~s~~---~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 604 MVGRGYLMPDLSKI---RSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred EecccccCccchhh---hccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 11221111121111 11233467778899999999999999999998887543
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=335.18 Aligned_cols=254 Identities=25% Similarity=0.401 Sum_probs=198.9
Q ss_pred cCCCccceecccCcEEEEEEEEcC-Cc----EEEEEEeecCCC-CChHHHHHHHHHHHhcCCCCccccceeEEeccCCCC
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLRH-GN----LVAVKQILDLDT-KGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSG 337 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~~-g~----~vAvK~l~~~~~-~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~ 337 (590)
.+|+..+.||+|+||.||+|++.. |. .||+|.+..... ...+++.+|+.+++.++|+||++++|+|...
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~----- 81 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS----- 81 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-----
Confidence 458889999999999999998753 33 389999865432 3356789999999999999999999999742
Q ss_pred ceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCC
Q 046270 338 KRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGL 417 (590)
Q Consensus 338 ~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGl 417 (590)
..++|+||+++|+|.+++.. ....+++..++.++.||+.||+||| +.+|+||||||+|||+++++.+||+|||+
T Consensus 82 -~~~~v~e~~~~g~l~~~l~~--~~~~~~~~~~~~~~~qi~~~L~~LH---~~~iiH~dlkp~Nill~~~~~~kl~DfG~ 155 (316)
T cd05108 82 -TVQLITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGL 155 (316)
T ss_pred -CceeeeecCCCCCHHHHHHh--ccccCCHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEecCCCcEEEccccc
Confidence 36899999999999998853 2346899999999999999999999 89999999999999999999999999999
Q ss_pred cccccCCCccc-ccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhhHHHHHHHhcCCc
Q 046270 418 AKQSLEGHSHL-TTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLDTSTSPFQLITDWAWVLAKSGKV 495 (590)
Q Consensus 418 a~~~~~~~~~~-~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~ 495 (590)
++......... .....++..|+|||++....++.++||||||+++|||++ |+.|++..... .+..+ ...+..
T Consensus 156 a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~--~~~~~----~~~~~~ 229 (316)
T cd05108 156 AKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--EISSI----LEKGER 229 (316)
T ss_pred cccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH--HHHHH----HhCCCC
Confidence 98765433222 122334678999999999999999999999999999998 99998643221 11111 111110
Q ss_pred hhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhccC
Q 046270 496 DDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEGD 543 (590)
Q Consensus 496 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~~ 543 (590)
... +......+..++..|++.+|++||++.+++..|...
T Consensus 230 ~~~---------~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~ 268 (316)
T cd05108 230 LPQ---------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 268 (316)
T ss_pred CCC---------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 000 001123567889999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=326.63 Aligned_cols=255 Identities=25% Similarity=0.462 Sum_probs=202.5
Q ss_pred cCCCccceecccCcEEEEEEEEcC------CcEEEEEEeecCCCC-ChHHHHHHHHHHHhcCCCCccccceeEEeccCCC
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLRH------GNLVAVKQILDLDTK-GDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSS 336 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~~------g~~vAvK~l~~~~~~-~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~ 336 (590)
++|...+.||+|+||.||+|++.+ +..||||.+...... ..+.+.+|++++++++|+|++++++++..
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----- 79 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTE----- 79 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEec-----
Confidence 457777899999999999998753 468999998655443 35689999999999999999999999874
Q ss_pred CceEEEEEeeCCCCCcchhhhhhc-----------ccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEC
Q 046270 337 GKRRFLVYDYMPNGTLSDNISISH-----------KRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLD 405 (590)
Q Consensus 337 ~~~~~LV~E~~~~gsL~~~L~~~~-----------~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd 405 (590)
+...++||||+++++|.+++.... ....+++.++..++.|++.||.||| ..+++||||||+||+++
T Consensus 80 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~h~dlkp~nili~ 156 (280)
T cd05049 80 GDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLA---SQHFVHRDLATRNCLVG 156 (280)
T ss_pred CCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeeccccccceEEEc
Confidence 346899999999999999986421 2345899999999999999999999 89999999999999999
Q ss_pred CCCcEEEEeeCCcccccCCCc-ccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhh
Q 046270 406 SELNAKVADFGLAKQSLEGHS-HLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLDTSTSPFQLIT 483 (590)
Q Consensus 406 ~~~~~kL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELlt-G~~p~~~~~~~~~~l~ 483 (590)
.++.+||+|||+++....... .......++..|+|||++..+.++.++||||||+++|||++ |+.||....... ..
T Consensus 157 ~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~--~~ 234 (280)
T cd05049 157 YDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE--VI 234 (280)
T ss_pred CCCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH--HH
Confidence 999999999999975433221 11233445788999999999999999999999999999999 999986433211 11
Q ss_pred HHHHHHHhcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhc
Q 046270 484 DWAWVLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLE 541 (590)
Q Consensus 484 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~ 541 (590)
+. ...+..... +......+.+++..|++.+|++||++.||+++|+
T Consensus 235 ~~----~~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 235 EC----ITQGRLLQR---------PRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred HH----HHcCCcCCC---------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 11 112221111 1122346788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=337.21 Aligned_cols=251 Identities=21% Similarity=0.280 Sum_probs=200.4
Q ss_pred cCCCccceecccCcEEEEEEEEcC-CcEEEEEEeecCC---CCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCce
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLRH-GNLVAVKQILDLD---TKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKR 339 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~vAvK~l~~~~---~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~ 339 (590)
++|...+.||+|+||.||+|++.+ ++.||||++.... ......+.+|++++.+++||||+++++++. .+..
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~-----~~~~ 75 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQ-----DDEY 75 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEE-----cCCE
Confidence 368888999999999999999874 7899999986532 223456889999999999999999999887 3456
Q ss_pred EEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcc
Q 046270 340 RFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAK 419 (590)
Q Consensus 340 ~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~ 419 (590)
.++||||+++|+|.+++. ....+++.++..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++
T Consensus 76 ~~lv~e~~~g~~L~~~l~---~~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~ 149 (333)
T cd05600 76 LYLAMEYVPGGDFRTLLN---NLGVLSEDHARFYMAEMFEAVDALH---ELGYIHRDLKPENFLIDASGHIKLTDFGLSK 149 (333)
T ss_pred EEEEEeCCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEEEeCcCCc
Confidence 999999999999999985 3456899999999999999999999 8999999999999999999999999999998
Q ss_pred cccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchh--hhhHHHHHHHhcCCchh
Q 046270 420 QSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQ--LITDWAWVLAKSGKVDD 497 (590)
Q Consensus 420 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~--~l~~~~~~~~~~~~~~~ 497 (590)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||........ .+..|.... ....
T Consensus 150 ~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~----~~~~ 221 (333)
T cd05600 150 GIVT----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETL----QRPV 221 (333)
T ss_pred cccc----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccc----cCCC
Confidence 6533 23345689999999999988999999999999999999999999975432211 111110000 0000
Q ss_pred hhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 498 IFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 498 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
..++ .......+..++..|++.+|.+||++.+++++
T Consensus 222 ~~~~------~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 222 YDDP------RFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred CCcc------ccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 0000 01223466778889999999999999999875
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=336.11 Aligned_cols=261 Identities=25% Similarity=0.335 Sum_probs=202.0
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCCCChHH--HHHHHHHHHhcC-CCCccccceeEEeccCCCCc
Q 046270 263 TNGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDTKGDED--FTNEVEIISKIR-HRNLLSLRGCCVTSDDSSGK 338 (590)
Q Consensus 263 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~~~~~~--f~~Ev~il~~l~-H~nlv~l~g~~~~~~~~~~~ 338 (590)
.++|...++||.|.||.||+|+-. .|..||||+++..-.. .++ =.+|++.|++|+ |||||+|...+.+.+ .
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~----~ 83 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDND----R 83 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccC----c
Confidence 456777889999999999999865 4889999999764333 333 358999999998 999999999988543 2
Q ss_pred eEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCc
Q 046270 339 RRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLA 418 (590)
Q Consensus 339 ~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla 418 (590)
.+++|||||+ .+|.+++.. +++.+++..++.|+.||.+||+|+| ++|++|||+||+|||+..+..+||+|||+|
T Consensus 84 ~L~fVfE~Md-~NLYqLmK~--R~r~fse~~irnim~QilqGL~hiH---k~GfFHRDlKPENiLi~~~~~iKiaDFGLA 157 (538)
T KOG0661|consen 84 ILYFVFEFMD-CNLYQLMKD--RNRLFSESDIRNIMYQILQGLAHIH---KHGFFHRDLKPENILISGNDVIKIADFGLA 157 (538)
T ss_pred eEeeeHHhhh-hhHHHHHhh--cCCcCCHHHHHHHHHHHHHHHHHHH---hcCcccccCChhheEecccceeEecccccc
Confidence 6999999996 589888763 3678999999999999999999999 999999999999999999999999999999
Q ss_pred ccccCCCcccccccccCCCccCccccc-cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCC---
Q 046270 419 KQSLEGHSHLTTRVAGTFGYLAPEYAL-YGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGK--- 494 (590)
Q Consensus 419 ~~~~~~~~~~~~~~~gt~~Y~APE~~~-~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~--- 494 (590)
|..... ...+....|.+|+|||++. .+-|+.+.|+|++|||++||.+-++.|-+..+-.+ +-.....+ ....
T Consensus 158 Rev~Sk--pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dq-i~KIc~VL-GtP~~~~ 233 (538)
T KOG0661|consen 158 REVRSK--PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQ-IYKICEVL-GTPDKDS 233 (538)
T ss_pred cccccC--CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHH-HHHHHHHh-CCCcccc
Confidence 976543 3456678899999999865 67899999999999999999999988865443222 11111111 0000
Q ss_pred chh--hhhHHH------------hhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 495 VDD--IFDEFI------------RAEGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 495 ~~~--~~d~~l------------~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
+.+ .+-..+ ..-.+ ....++++++..|+.+||.+|||+.+++++
T Consensus 234 ~~eg~~La~~mnf~~P~~~~~~l~~L~p-~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 234 WPEGYNLASAMNFRFPQVKPSPLKDLLP-NASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred chhHHHHHHHhccCCCcCCCCChHHhCc-ccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 000 000000 00011 134578889999999999999999999986
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=328.14 Aligned_cols=264 Identities=24% Similarity=0.387 Sum_probs=201.4
Q ss_pred cCCCccceecccCcEEEEEEEEc-----CCcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCc
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLR-----HGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGK 338 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~-----~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~ 338 (590)
.+|...+.||+|+||.||++..+ ++..||+|++........+.|.+|++++++++||||+++++++...+ ..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~---~~ 80 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG---RR 80 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCC---CC
Confidence 46777889999999999999853 47799999987655555668999999999999999999999876432 34
Q ss_pred eEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCc
Q 046270 339 RRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLA 418 (590)
Q Consensus 339 ~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla 418 (590)
..++||||+++|+|.+++.. ....++|..+..++.|+++||+||| ..+|+||||||+||++++++.+||+|||++
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~--~~~~l~~~~~~~~~~~l~~aL~~LH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~ 155 (284)
T cd05081 81 NLRLVMEYLPYGSLRDYLQK--HRERLDHRKLLLYASQICKGMEYLG---SKRYVHRDLATRNILVESENRVKIGDFGLT 155 (284)
T ss_pred ceEEEEEecCCCCHHHHHHh--cCcCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHhhEEECCCCeEEECCCccc
Confidence 58999999999999999853 2346899999999999999999999 899999999999999999999999999999
Q ss_pred ccccCCCccc--ccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCc-
Q 046270 419 KQSLEGHSHL--TTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKV- 495 (590)
Q Consensus 419 ~~~~~~~~~~--~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~- 495 (590)
+......... .....++..|+|||++.++.++.++||||||++++||++|..++...... |... ......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~------~~~~-~~~~~~~ 228 (284)
T cd05081 156 KVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE------FMRM-MGNDKQG 228 (284)
T ss_pred ccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh------hhhh-ccccccc
Confidence 8664432211 11222345699999999889999999999999999999998765322111 1100 000000
Q ss_pred hhhhh---HHHhh----hhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhcc
Q 046270 496 DDIFD---EFIRA----EGARAVMERFVLVGILCAHVMVALRPTITDALKMLEG 542 (590)
Q Consensus 496 ~~~~d---~~l~~----~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~ 542 (590)
..... ..+.. .........+.+++..|++.+|++||||.||+++|+.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~ 282 (284)
T cd05081 229 QMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEA 282 (284)
T ss_pred ccchHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHh
Confidence 00000 00100 0111234578889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=350.64 Aligned_cols=260 Identities=25% Similarity=0.361 Sum_probs=200.2
Q ss_pred CCCccceecccCcEEEEEEEEcCC----cE-EEEEEeecC---CCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCC
Q 046270 265 GFSQNNLIGQGASGIVYKGTLRHG----NL-VAVKQILDL---DTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSS 336 (590)
Q Consensus 265 ~f~~~~~LG~G~fG~Vykg~~~~g----~~-vAvK~l~~~---~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~ 336 (590)
+-...++||+|.||+||+|++..+ .. ||||..+.. ......+|.+|++++++++|||||+++|++....
T Consensus 158 ~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~--- 234 (474)
T KOG0194|consen 158 DIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEE--- 234 (474)
T ss_pred CccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCC---
Confidence 334458999999999999998642 23 899998752 2344678999999999999999999999998544
Q ss_pred CceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeC
Q 046270 337 GKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFG 416 (590)
Q Consensus 337 ~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFG 416 (590)
..++|||+|+||+|.++|... ...++..++++++.+.|+||+||| ++++|||||.++|+|++.++.+||+|||
T Consensus 235 --Pl~ivmEl~~gGsL~~~L~k~--~~~v~~~ek~~~~~~AA~Gl~YLh---~k~~IHRDIAARNcL~~~~~~vKISDFG 307 (474)
T KOG0194|consen 235 --PLMLVMELCNGGSLDDYLKKN--KKSLPTLEKLRFCYDAARGLEYLH---SKNCIHRDIAARNCLYSKKGVVKISDFG 307 (474)
T ss_pred --ccEEEEEecCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHhHHHHHH---HCCCcchhHhHHHheecCCCeEEeCccc
Confidence 489999999999999999632 236999999999999999999999 9999999999999999999999999999
Q ss_pred CcccccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhhHHHHHHHhcCCc
Q 046270 417 LAKQSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLDTSTSPFQLITDWAWVLAKSGKV 495 (590)
Q Consensus 417 la~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~ 495 (590)
+++....-... .....-...|+|||.+..+.|+.++|||||||++||+++ |..|+...... .+..++ ..++-.
T Consensus 308 Ls~~~~~~~~~-~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~--~v~~kI---~~~~~r 381 (474)
T KOG0194|consen 308 LSRAGSQYVMK-KFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY--EVKAKI---VKNGYR 381 (474)
T ss_pred cccCCcceeec-cccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH--HHHHHH---HhcCcc
Confidence 98854311111 101123578999999999999999999999999999999 78887643321 111111 111211
Q ss_pred hhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhccCCCCCCC
Q 046270 496 DDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEGDIDIPKL 549 (590)
Q Consensus 496 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~~~~~~~~ 549 (590)
... +...+..+..+...|+..+|++||+|.++.+.|+........
T Consensus 382 ~~~---------~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 382 MPI---------PSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred CCC---------CCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 111 112233556677799999999999999999999875544433
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-39 Score=329.19 Aligned_cols=245 Identities=22% Similarity=0.269 Sum_probs=196.7
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCC---CCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCce
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLD---TKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKR 339 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~---~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~ 339 (590)
++|...+.||+|+||.||++... +|+.||+|++.... .+..+.+.+|++++++++||||+++++++. ++..
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~~ 75 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEH-----DQRF 75 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhc-----cCCe
Confidence 36888899999999999999987 58899999986432 123456889999999999999999998876 3456
Q ss_pred EEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcc
Q 046270 340 RFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAK 419 (590)
Q Consensus 340 ~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~ 419 (590)
.++||||+++|+|.+++. ..+.+++.....++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++
T Consensus 76 ~~lv~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~ 149 (291)
T cd05612 76 LYMLMEYVPGGELFSYLR---NSGRFSNSTGLFYASEIVCALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAK 149 (291)
T ss_pred EEEEEeCCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEEecCcch
Confidence 999999999999999885 3457999999999999999999999 8999999999999999999999999999998
Q ss_pred cccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhh
Q 046270 420 QSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIF 499 (590)
Q Consensus 420 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 499 (590)
..... .....||+.|+|||.+.+..++.++|||||||++|||++|+.||...... ... ... ..+...
T Consensus 150 ~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~-~~~----~~i-~~~~~~--- 216 (291)
T cd05612 150 KLRDR----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPF-GIY----EKI-LAGKLE--- 216 (291)
T ss_pred hccCC----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHH----HHH-HhCCcC---
Confidence 65332 22356899999999999888999999999999999999999998653321 111 111 111110
Q ss_pred hHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCC-----HHHHHHH
Q 046270 500 DEFIRAEGARAVMERFVLVGILCAHVMVALRPT-----ITDALKM 539 (590)
Q Consensus 500 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt-----m~eVl~~ 539 (590)
.+......+.+++..|++.||.+||+ +.++++.
T Consensus 217 -------~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 217 -------FPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred -------CCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 01111235677889999999999995 7787754
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=330.86 Aligned_cols=262 Identities=21% Similarity=0.320 Sum_probs=201.0
Q ss_pred hcCCCccceecccCcEEEEEEEEcC-CcEEEEEEeecCCC-CChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceE
Q 046270 263 TNGFSQNNLIGQGASGIVYKGTLRH-GNLVAVKQILDLDT-KGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRR 340 (590)
Q Consensus 263 t~~f~~~~~LG~G~fG~Vykg~~~~-g~~vAvK~l~~~~~-~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~ 340 (590)
.++|+..+.||+|+||.||+++... |..+|+|.+..... ...+.+.+|++++++++||||+++++++.. +...
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~ 78 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-----DGEI 78 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE-----CCEE
Confidence 3678889999999999999999874 77899998864322 234579999999999999999999999874 3468
Q ss_pred EEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCC-CeEecCCCCCceEECCCCcEEEEeeCCcc
Q 046270 341 FLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKP-GIYHRDIKSTNILLDSELNAKVADFGLAK 419 (590)
Q Consensus 341 ~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~-~ivHrDIKp~NILLd~~~~~kL~DFGla~ 419 (590)
++||||+++|+|.+++. ....+++..+..++.|++.||.||| +. +|+||||||+|||++.++.+||+|||+++
T Consensus 79 ~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~~i~~~l~~lH---~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 152 (331)
T cd06649 79 SICMEHMDGGSLDQVLK---EAKRIPEEILGKVSIAVLRGLAYLR---EKHQIMHRDVKPSNILVNSRGEIKLCDFGVSG 152 (331)
T ss_pred EEEeecCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHh---hcCCEEcCCCChhhEEEcCCCcEEEccCcccc
Confidence 99999999999999885 3346899999999999999999999 54 69999999999999999999999999987
Q ss_pred cccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcC------
Q 046270 420 QSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSG------ 493 (590)
Q Consensus 420 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~------ 493 (590)
..... ......|+..|+|||++.+..++.++|||||||++|||++|+.||....... +..........+
T Consensus 153 ~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~ 227 (331)
T cd06649 153 QLIDS---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE--LEAIFGRPVVDGEEGEPH 227 (331)
T ss_pred ccccc---ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHhcccccccccCCcc
Confidence 65332 2234568999999999998899999999999999999999999996432211 110000000000
Q ss_pred ------------------------CchhhhhHHHhhh----hHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHh
Q 046270 494 ------------------------KVDDIFDEFIRAE----GARAVMERFVLVGILCAHVMVALRPTITDALKML 540 (590)
Q Consensus 494 ------------------------~~~~~~d~~l~~~----~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L 540 (590)
...+.++...... ........+.+++.+|++.||++|||+.|+++.-
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~ 302 (331)
T cd06649 228 SISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT 302 (331)
T ss_pred ccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 0011111111110 0112345788899999999999999999998753
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=326.23 Aligned_cols=258 Identities=20% Similarity=0.391 Sum_probs=200.3
Q ss_pred HhcCCCccceecccCcEEEEEEEEc------CCcEEEEEEeecCCC-CChHHHHHHHHHHHhcCCCCccccceeEEeccC
Q 046270 262 ATNGFSQNNLIGQGASGIVYKGTLR------HGNLVAVKQILDLDT-KGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDD 334 (590)
Q Consensus 262 at~~f~~~~~LG~G~fG~Vykg~~~------~g~~vAvK~l~~~~~-~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~ 334 (590)
++++|+..+.||+|+||.||+|.+. .+..||+|++..... ....+|.+|+.++++++|+||+++++++.
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~---- 79 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS---- 79 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc----
Confidence 5677999999999999999999864 245799998854322 23456889999999999999999999986
Q ss_pred CCCceEEEEEeeCCCCCcchhhhhhcc-------cccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCC
Q 046270 335 SSGKRRFLVYDYMPNGTLSDNISISHK-------RKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSE 407 (590)
Q Consensus 335 ~~~~~~~LV~E~~~~gsL~~~L~~~~~-------~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~ 407 (590)
.+...++||||+++|+|.+++..... ...++|..++.++.|++.||.||| +.+++||||||+||+++++
T Consensus 80 -~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~vH~dlkp~Nil~~~~ 155 (277)
T cd05062 80 -QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAED 155 (277)
T ss_pred -CCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCcchheEEEcCC
Confidence 34568999999999999998853221 234688999999999999999999 8999999999999999999
Q ss_pred CcEEEEeeCCcccccCCCcc-cccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhhHH
Q 046270 408 LNAKVADFGLAKQSLEGHSH-LTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLDTSTSPFQLITDW 485 (590)
Q Consensus 408 ~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELlt-G~~p~~~~~~~~~~l~~~ 485 (590)
+.+||+|||+++........ ......++..|+|||++..+.++.++||||||+++|||++ |..|+...... ..+.
T Consensus 156 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~-~~~~-- 232 (277)
T cd05062 156 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE-QVLR-- 232 (277)
T ss_pred CCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-HHHH--
Confidence 99999999998755433221 1122345778999999998899999999999999999999 67887543221 1111
Q ss_pred HHHHHhcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhcc
Q 046270 486 AWVLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEG 542 (590)
Q Consensus 486 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~ 542 (590)
....+..... +......+.+++..|++.+|++|||+.|++++|++
T Consensus 233 ---~~~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 233 ---FVMEGGLLDK---------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred ---HHHcCCcCCC---------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 1111111110 11123467889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=337.53 Aligned_cols=260 Identities=24% Similarity=0.361 Sum_probs=202.2
Q ss_pred hcCCCccceecccCcEEEEEEEEcC------CcEEEEEEeecCCCC-ChHHHHHHHHHHHhc-CCCCccccceeEEeccC
Q 046270 263 TNGFSQNNLIGQGASGIVYKGTLRH------GNLVAVKQILDLDTK-GDEDFTNEVEIISKI-RHRNLLSLRGCCVTSDD 334 (590)
Q Consensus 263 t~~f~~~~~LG~G~fG~Vykg~~~~------g~~vAvK~l~~~~~~-~~~~f~~Ev~il~~l-~H~nlv~l~g~~~~~~~ 334 (590)
.++|...+.||+|+||.||+|+..+ ++.||+|++...... ..+.+.+|++++.++ +|+||++++++|...
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~-- 83 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKP-- 83 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecC--
Confidence 3468888999999999999997532 468999998643222 234678899999999 899999999988743
Q ss_pred CCCceEEEEEeeCCCCCcchhhhhhcc-----------------------------------------------------
Q 046270 335 SSGKRRFLVYDYMPNGTLSDNISISHK----------------------------------------------------- 361 (590)
Q Consensus 335 ~~~~~~~LV~E~~~~gsL~~~L~~~~~----------------------------------------------------- 361 (590)
+...+++|||+++++|.+++.....
T Consensus 84 --~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (337)
T cd05054 84 --GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEE 161 (337)
T ss_pred --CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchh
Confidence 3458999999999999988853211
Q ss_pred -----cccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccccCCCccc-ccccccC
Q 046270 362 -----RKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHL-TTRVAGT 435 (590)
Q Consensus 362 -----~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~~~~~~~~-~~~~~gt 435 (590)
...++|..+.+++.||+.||+||| ..+|+||||||+|||+++++.+||+|||+++......... .....++
T Consensus 162 ~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~ 238 (337)
T cd05054 162 GDELYKEPLTLEDLISYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 238 (337)
T ss_pred hhHHhhcCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCC
Confidence 136899999999999999999999 8999999999999999999999999999998764433222 2234557
Q ss_pred CCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhhHHHHHHHhcCCchhhhhHHHhhhhHHHHHHH
Q 046270 436 FGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDEFIRAEGARAVMER 514 (590)
Q Consensus 436 ~~Y~APE~~~~~~~t~ksDVySfGvvLlELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~ 514 (590)
..|+|||++.+..++.++|||||||+++||++ |+.||........ + +.....+.... .+......
T Consensus 239 ~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~-~----~~~~~~~~~~~---------~~~~~~~~ 304 (337)
T cd05054 239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE-F----CRRLKEGTRMR---------APEYATPE 304 (337)
T ss_pred ccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH-H----HHHHhccCCCC---------CCccCCHH
Confidence 78999999999999999999999999999998 9988864322111 1 11111111110 01122347
Q ss_pred HHHHHHhchhcCCCCCCCHHHHHHHhccC
Q 046270 515 FVLVGILCAHVMVALRPTITDALKMLEGD 543 (590)
Q Consensus 515 l~~l~~~Cl~~dp~~RPtm~eVl~~L~~~ 543 (590)
+.+++..|++.+|++||++.|++++|+..
T Consensus 305 ~~~l~~~cl~~~p~~RPs~~ell~~l~~~ 333 (337)
T cd05054 305 IYSIMLDCWHNNPEDRPTFSELVEILGDL 333 (337)
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 78899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=337.78 Aligned_cols=263 Identities=26% Similarity=0.386 Sum_probs=208.9
Q ss_pred cCCCccceecccCcEEEEEEEEcCCcEEEEEEeecCCCCCh-HHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEEE
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLRHGNLVAVKQILDLDTKGD-EDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFL 342 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~~g~~vAvK~l~~~~~~~~-~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~L 342 (590)
......++||+|.||+|.......+..||||.++....... .+|.+|+++|.+|+|||||+|+|.|...++ .++
T Consensus 538 s~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DeP-----icm 612 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDP-----LCM 612 (807)
T ss_pred hheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCc-----hHH
Confidence 34456788999999999999999889999999988766554 789999999999999999999999996554 899
Q ss_pred EEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCccccc
Q 046270 343 VYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSL 422 (590)
Q Consensus 343 V~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~~ 422 (590)
|+|||++|+|.+||..+.. ..+.-+.-.+|+.|||.||+||. +.++|||||.++|+|+|+++++||+|||++|-..
T Consensus 613 I~EYmEnGDLnqFl~ahea-pt~~t~~~vsi~tqiasgmaYLe---s~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~ly 688 (807)
T KOG1094|consen 613 ITEYMENGDLNQFLSAHEL-PTAETAPGVSICTQIASGMAYLE---SLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLY 688 (807)
T ss_pred HHHHHhcCcHHHHHHhccC-cccccchhHHHHHHHHHHHHHHH---hhchhhccccccceeecCcccEEecCcccccccc
Confidence 9999999999999965432 22456677789999999999999 8999999999999999999999999999999776
Q ss_pred CCCccc-ccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHh--CCCCCCCCCCchhhhhHHHHHHHhcCCchhhh
Q 046270 423 EGHSHL-TTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS--GRKVLDTSTSPFQLITDWAWVLAKSGKVDDIF 499 (590)
Q Consensus 423 ~~~~~~-~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELlt--G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 499 (590)
.++.+. ..+..-..+|||||.+..+++|.+||||+||++|||+++ ..+|+....+++ +.+-...+...+....++
T Consensus 689 sg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~--vven~~~~~~~~~~~~~l 766 (807)
T KOG1094|consen 689 SGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQ--VVENAGEFFRDQGRQVVL 766 (807)
T ss_pred cCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHH--HHHhhhhhcCCCCcceec
Confidence 655543 334445689999999999999999999999999999886 567775443322 111111122211111111
Q ss_pred hHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhccC
Q 046270 500 DEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEGD 543 (590)
Q Consensus 500 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~~ 543 (590)
..+.-....+.++++.|+..+-.+||+++++...|..+
T Consensus 767 ------~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 767 ------SRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred ------cCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 11223345778999999999999999999999988764
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=337.95 Aligned_cols=252 Identities=22% Similarity=0.310 Sum_probs=193.6
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCC---CCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCce
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLD---TKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKR 339 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~---~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~ 339 (590)
++|...+.||+|+||.||+++.. .|+.||||++.... ......+.+|++++..++|+||+++++++.. +..
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~-----~~~ 75 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQD-----ENY 75 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEc-----CCe
Confidence 46888999999999999999986 48899999986432 2234567899999999999999999999873 456
Q ss_pred EEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcc
Q 046270 340 RFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAK 419 (590)
Q Consensus 340 ~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~ 419 (590)
.++||||+++|+|.+++. ....+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++
T Consensus 76 ~~lv~E~~~~g~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~ 149 (364)
T cd05599 76 LYLIMEYLPGGDMMTLLM---KKDTFTEEETRFYIAETILAIDSIH---KLGYIHRDIKPDNLLLDAKGHIKLSDFGLCT 149 (364)
T ss_pred EEEEECCCCCcHHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEeecccce
Confidence 999999999999999885 3456999999999999999999999 8999999999999999999999999999987
Q ss_pred cccCCCcc-------------------------------------cccccccCCCccCccccccCCCCcchhHHHHHHHH
Q 046270 420 QSLEGHSH-------------------------------------LTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVI 462 (590)
Q Consensus 420 ~~~~~~~~-------------------------------------~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvL 462 (590)
........ ......||+.|+|||++....++.++|||||||++
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il 229 (364)
T cd05599 150 GLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIM 229 (364)
T ss_pred eccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHH
Confidence 54321100 01124589999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCC---HHHHHHH
Q 046270 463 LELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPT---ITDALKM 539 (590)
Q Consensus 463 lELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt---m~eVl~~ 539 (590)
+||++|+.||....... ... ............+. ....+.+.+++..|+. +|.+|++ +.|+++.
T Consensus 230 ~el~~G~~Pf~~~~~~~-~~~----~i~~~~~~~~~~~~-------~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 230 YEMLVGYPPFCSDNPQE-TYR----KIINWKETLQFPDE-------VPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred HHhhcCCCCCCCCCHHH-HHH----HHHcCCCccCCCCC-------CCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 99999999997543211 111 00000000000000 0112244556666775 8999998 8888764
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=320.22 Aligned_cols=253 Identities=29% Similarity=0.438 Sum_probs=201.1
Q ss_pred cCCCccceecccCcEEEEEEEEcCCcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEEEE
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLRHGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFLV 343 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~LV 343 (590)
++|...++||+|+||.||+|..+++..+|+|.+..... ..+.+.+|+.++++++|+|++++++++.. ...+++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~------~~~~lv 78 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVSE------EPIYIV 78 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEECC------CCcEEE
Confidence 45777889999999999999988888999999865433 35679999999999999999999988742 237899
Q ss_pred EeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccccC
Q 046270 344 YDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLE 423 (590)
Q Consensus 344 ~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~~~ 423 (590)
|||+++++|.+++... ....+++.++..++.+++.||.||| +.+|+||||||+||++++++.+||+|||++.....
T Consensus 79 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05070 79 TEYMSKGSLLDFLKDG-EGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDLRSANILVGDGLVCKIADFGLARLIED 154 (260)
T ss_pred EEecCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEEeCCceEEeCCceeeeeccC
Confidence 9999999999988532 2345899999999999999999999 89999999999999999999999999999986543
Q ss_pred CCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhhHHHHHHHhcCCchhhhhHH
Q 046270 424 GHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDEF 502 (590)
Q Consensus 424 ~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 502 (590)
..........++..|+|||++....++.++||||||++++||++ |+.||..... ..... ........
T Consensus 155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~-~~~~~----~~~~~~~~------- 222 (260)
T cd05070 155 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN-REVLE----QVERGYRM------- 222 (260)
T ss_pred cccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH-HHHHH----HHHcCCCC-------
Confidence 32222222345678999999988899999999999999999999 8888864322 11111 11111010
Q ss_pred HhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhcc
Q 046270 503 IRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEG 542 (590)
Q Consensus 503 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~ 542 (590)
..+.+....+.+++..|++.+|++|||+.++.+.|+.
T Consensus 223 ---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 223 ---PCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred ---CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 0111223467889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-39 Score=328.69 Aligned_cols=258 Identities=24% Similarity=0.419 Sum_probs=204.3
Q ss_pred cCCCccceecccCcEEEEEEEEc------CCcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCC
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLR------HGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSG 337 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~------~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~ 337 (590)
++|...+.||+|+||.||+|+.. ++..+++|.+........+.+.+|++++++++|+||+++++++.. +
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~ 79 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGD-----G 79 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEcc-----C
Confidence 35677789999999999999853 245689998866554445679999999999999999999999873 4
Q ss_pred ceEEEEEeeCCCCCcchhhhhhc-------------ccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEE
Q 046270 338 KRRFLVYDYMPNGTLSDNISISH-------------KRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILL 404 (590)
Q Consensus 338 ~~~~LV~E~~~~gsL~~~L~~~~-------------~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILL 404 (590)
...++||||+++++|.+++.... ....++|..+++++.||+.||+||| ..+|+||||||+|||+
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nil~ 156 (291)
T cd05094 80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA---SQHFVHRDLATRNCLV 156 (291)
T ss_pred CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEE
Confidence 45899999999999999985321 1235899999999999999999999 8999999999999999
Q ss_pred CCCCcEEEEeeCCcccccCCCc-ccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhh
Q 046270 405 DSELNAKVADFGLAKQSLEGHS-HLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLDTSTSPFQLI 482 (590)
Q Consensus 405 d~~~~~kL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELlt-G~~p~~~~~~~~~~l 482 (590)
+.++.+||+|||+++....... .......++..|+|||++....++.++||||||+++|||+| |+.|+....... .+
T Consensus 157 ~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-~~ 235 (291)
T cd05094 157 GANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE-VI 235 (291)
T ss_pred ccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-HH
Confidence 9999999999999976543322 12234456788999999999999999999999999999999 999886433211 11
Q ss_pred hHHHHHHHhcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhccCC
Q 046270 483 TDWAWVLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEGDI 544 (590)
Q Consensus 483 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~~~ 544 (590)
.....+...+.. ......+.+++..|++.+|.+|||+.+|+++|+...
T Consensus 236 -----~~~~~~~~~~~~---------~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~ 283 (291)
T cd05094 236 -----ECITQGRVLERP---------RVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALG 283 (291)
T ss_pred -----HHHhCCCCCCCC---------ccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHH
Confidence 112222222111 112346788999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=325.33 Aligned_cols=256 Identities=22% Similarity=0.430 Sum_probs=199.0
Q ss_pred cCCCccceecccCcEEEEEEEEc-----CCcEEEEEEeecCCC-CChHHHHHHHHHHHhcCCCCccccceeEEeccCCCC
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLR-----HGNLVAVKQILDLDT-KGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSG 337 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~-----~g~~vAvK~l~~~~~-~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~ 337 (590)
++|+..+.||+|+||.||+|++. .+..||+|.+..... ....++.+|++++++++|+||+++++++.. +
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~ 79 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQ-----E 79 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEec-----C
Confidence 35677789999999999999852 457899999865332 233578999999999999999999999874 3
Q ss_pred ceEEEEEeeCCCCCcchhhhhhc--------------ccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceE
Q 046270 338 KRRFLVYDYMPNGTLSDNISISH--------------KRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNIL 403 (590)
Q Consensus 338 ~~~~LV~E~~~~gsL~~~L~~~~--------------~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NIL 403 (590)
...++||||+++++|.+++.... ....+++.+.+.++.+++.||.||| +.+|+||||||+|||
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~nil 156 (283)
T cd05090 80 QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLS---SHFFVHKDLAARNIL 156 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hcCeehhccccceEE
Confidence 45899999999999999885321 1235889999999999999999999 899999999999999
Q ss_pred ECCCCcEEEEeeCCcccccCCCc-ccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhh
Q 046270 404 LDSELNAKVADFGLAKQSLEGHS-HLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLDTSTSPFQL 481 (590)
Q Consensus 404 Ld~~~~~kL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELlt-G~~p~~~~~~~~~~ 481 (590)
+++++.+||+|||+++....... .......++..|+|||++.++.++.++||||||++++||++ |..||..... . .
T Consensus 157 i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~-~-~ 234 (283)
T cd05090 157 IGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN-Q-E 234 (283)
T ss_pred EcCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH-H-H
Confidence 99999999999999986543321 22233445678999999988899999999999999999999 8888854322 1 1
Q ss_pred hhHHHHHHHhcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhcc
Q 046270 482 ITDWAWVLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEG 542 (590)
Q Consensus 482 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~ 542 (590)
+.+. ...+.... .+.....++.+++..|++.+|++||++.++.++|..
T Consensus 235 ~~~~----~~~~~~~~---------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 235 VIEM----VRKRQLLP---------CSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHHH----HHcCCcCC---------CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 1111 11111111 111223467788899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=330.20 Aligned_cols=242 Identities=22% Similarity=0.277 Sum_probs=192.4
Q ss_pred ceecccCcEEEEEEEEc-CCcEEEEEEeecCC---CCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEEEEEe
Q 046270 270 NLIGQGASGIVYKGTLR-HGNLVAVKQILDLD---TKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFLVYD 345 (590)
Q Consensus 270 ~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~---~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~LV~E 345 (590)
+.||+|+||.||++... +|+.||+|++.... ......+.+|++++++++||||+++.+++.. ....++|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~~~~~lv~E 75 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQT-----KDRLCFVME 75 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEc-----CCEEEEEEe
Confidence 36999999999999876 48899999986532 2234568899999999999999999988873 456899999
Q ss_pred eCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccccCCC
Q 046270 346 YMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGH 425 (590)
Q Consensus 346 ~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~~~~~ 425 (590)
|+++|+|.+++. ....+++.++..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++......
T Consensus 76 y~~~g~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~ 149 (328)
T cd05593 76 YVNGGELFFHLS---RERVFSEDRTRFYGAEIVSALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA 149 (328)
T ss_pred CCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcc
Confidence 999999988874 3456999999999999999999999 8999999999999999999999999999987543221
Q ss_pred cccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhhhHHHhh
Q 046270 426 SHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDEFIRA 505 (590)
Q Consensus 426 ~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 505 (590)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||....... . ...... +.. .
T Consensus 150 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~-~----~~~~~~-~~~------~--- 213 (328)
T cd05593 150 -ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK-L----FELILM-EDI------K--- 213 (328)
T ss_pred -cccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHH-H----HHHhcc-CCc------c---
Confidence 22334578999999999998899999999999999999999999996432211 1 111110 100 0
Q ss_pred hhHHHHHHHHHHHHHhchhcCCCCCC-----CHHHHHHH
Q 046270 506 EGARAVMERFVLVGILCAHVMVALRP-----TITDALKM 539 (590)
Q Consensus 506 ~~~~~~~~~l~~l~~~Cl~~dp~~RP-----tm~eVl~~ 539 (590)
.+......+.+++..|++.||++|| ++.++++.
T Consensus 214 -~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 214 -FPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred -CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 0111234667788899999999997 88988764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=320.60 Aligned_cols=254 Identities=30% Similarity=0.422 Sum_probs=202.1
Q ss_pred cCCCccceecccCcEEEEEEEEcCCcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEEEE
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLRHGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFLV 343 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~LV 343 (590)
++|...++||+|+||.||+|+++++..||+|++.... ...+.|.+|++++++++|+||+++++++.. ...++|
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~------~~~~lv 78 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EPIYIV 78 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEECC------CCcEEE
Confidence 4588889999999999999998877789999986532 345679999999999999999999987632 347999
Q ss_pred EeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccccC
Q 046270 344 YDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLE 423 (590)
Q Consensus 344 ~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~~~ 423 (590)
|||+++|+|.+++... ....++|..+..++.|+++||+||| +.+|+||||||+||++++++.+||+|||.++....
T Consensus 79 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~ 154 (262)
T cd05071 79 TEYMSKGSLLDFLKGE-MGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIED 154 (262)
T ss_pred EEcCCCCcHHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcccEEEcCCCcEEeccCCceeeccc
Confidence 9999999999998532 2346899999999999999999999 89999999999999999999999999999976544
Q ss_pred CCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhhHHHHHHHhcCCchhhhhHH
Q 046270 424 GHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDEF 502 (590)
Q Consensus 424 ~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 502 (590)
..........++..|+|||+...+.++.++||||||++++||+| |+.||...... .... .. ..+...
T Consensus 155 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~-~~~~----~~-~~~~~~------ 222 (262)
T cd05071 155 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-EVLD----QV-ERGYRM------ 222 (262)
T ss_pred cccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH-HHHH----HH-hcCCCC------
Confidence 33222223446778999999988999999999999999999999 77787643321 1111 11 111000
Q ss_pred HhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhccC
Q 046270 503 IRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEGD 543 (590)
Q Consensus 503 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~~ 543 (590)
....+.+..+.+++..|++.+|++||++.+++++|+..
T Consensus 223 ---~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 223 ---PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred ---CCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 01123345778899999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=331.93 Aligned_cols=240 Identities=20% Similarity=0.273 Sum_probs=189.7
Q ss_pred ecccCcEEEEEEEEcC-CcEEEEEEeecC---CCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEEEEEeeC
Q 046270 272 IGQGASGIVYKGTLRH-GNLVAVKQILDL---DTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFLVYDYM 347 (590)
Q Consensus 272 LG~G~fG~Vykg~~~~-g~~vAvK~l~~~---~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~LV~E~~ 347 (590)
||+|+||.||+++..+ +..||+|++... .......+.+|++++.+++||||+++++++.. ....++||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv~e~~ 75 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQS-----PEKLYLVLAFI 75 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEec-----CCeEEEEEcCC
Confidence 6999999999999874 778999998643 22334568899999999999999999998873 45689999999
Q ss_pred CCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccccCCCcc
Q 046270 348 PNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSH 427 (590)
Q Consensus 348 ~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~~~~~~~ 427 (590)
++|+|.+++. ....+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++...... .
T Consensus 76 ~~g~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~ 148 (312)
T cd05585 76 NGGELFHHLQ---REGRFDLSRARFYTAELLCALENLH---KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-D 148 (312)
T ss_pred CCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCC-C
Confidence 9999999885 3456999999999999999999999 8999999999999999999999999999998543222 2
Q ss_pred cccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhhhHHHhhhh
Q 046270 428 LTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDEFIRAEG 507 (590)
Q Consensus 428 ~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 507 (590)
......||+.|+|||.+.+..++.++|||||||++|||++|+.||...... +....... +.. ..
T Consensus 149 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~-----~~~~~~~~-~~~----------~~ 212 (312)
T cd05585 149 KTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVN-----EMYRKILQ-EPL----------RF 212 (312)
T ss_pred ccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHH-----HHHHHHHc-CCC----------CC
Confidence 234467899999999999989999999999999999999999999643221 11111111 110 01
Q ss_pred HHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 508 ARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 508 ~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
+......+.+++..|++.||.+||+..++.+.
T Consensus 213 ~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~ 244 (312)
T cd05585 213 PDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEI 244 (312)
T ss_pred CCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHH
Confidence 11223466778899999999999865433333
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=341.70 Aligned_cols=260 Identities=23% Similarity=0.346 Sum_probs=202.3
Q ss_pred HhcCCCccceecccCcEEEEEEEEcC------CcEEEEEEeecCCCC-ChHHHHHHHHHHHhcC-CCCccccceeEEecc
Q 046270 262 ATNGFSQNNLIGQGASGIVYKGTLRH------GNLVAVKQILDLDTK-GDEDFTNEVEIISKIR-HRNLLSLRGCCVTSD 333 (590)
Q Consensus 262 at~~f~~~~~LG~G~fG~Vykg~~~~------g~~vAvK~l~~~~~~-~~~~f~~Ev~il~~l~-H~nlv~l~g~~~~~~ 333 (590)
..++|...++||+|+||.||+|++.. +..||||++...... ..+.+.+|+++++++. ||||++++++|..
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~-- 112 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTK-- 112 (400)
T ss_pred cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEcc--
Confidence 35678888999999999999998632 346999998654332 2457899999999996 9999999999974
Q ss_pred CCCCceEEEEEeeCCCCCcchhhhhhcc----------------------------------------------------
Q 046270 334 DSSGKRRFLVYDYMPNGTLSDNISISHK---------------------------------------------------- 361 (590)
Q Consensus 334 ~~~~~~~~LV~E~~~~gsL~~~L~~~~~---------------------------------------------------- 361 (590)
+...+|||||+++|+|.++|.....
T Consensus 113 ---~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (400)
T cd05105 113 ---SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYV 189 (400)
T ss_pred ---CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccc
Confidence 4458999999999999998854210
Q ss_pred -----------------------------------------cccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCC
Q 046270 362 -----------------------------------------RKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKST 400 (590)
Q Consensus 362 -----------------------------------------~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~ 400 (590)
...++|.+++.++.||++||.||| ..+|+||||||+
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dikp~ 266 (400)
T cd05105 190 PMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLA---SKNCVHRDLAAR 266 (400)
T ss_pred hhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChH
Confidence 124889999999999999999999 899999999999
Q ss_pred ceEECCCCcEEEEeeCCcccccCCCcc-cccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCc
Q 046270 401 NILLDSELNAKVADFGLAKQSLEGHSH-LTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLDTSTSP 478 (590)
Q Consensus 401 NILLd~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELlt-G~~p~~~~~~~ 478 (590)
|||+++++.+||+|||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |+.|+......
T Consensus 267 Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~ 346 (400)
T cd05105 267 NVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD 346 (400)
T ss_pred hEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchh
Confidence 999999999999999999865433222 1223456788999999998899999999999999999997 88888643222
Q ss_pred hhhhhHHHHHHHhcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhccC
Q 046270 479 FQLITDWAWVLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEGD 543 (590)
Q Consensus 479 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~~ 543 (590)
... ......+.... .+......+.+++..|++.+|++||++.+|+++|+..
T Consensus 347 ~~~-----~~~~~~~~~~~---------~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l 397 (400)
T cd05105 347 STF-----YNKIKSGYRMA---------KPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESL 397 (400)
T ss_pred HHH-----HHHHhcCCCCC---------CCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHH
Confidence 111 11111111000 1112334678899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=329.40 Aligned_cols=241 Identities=23% Similarity=0.298 Sum_probs=191.2
Q ss_pred ceecccCcEEEEEEEEc-CCcEEEEEEeecCC---CCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEEEEEe
Q 046270 270 NLIGQGASGIVYKGTLR-HGNLVAVKQILDLD---TKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFLVYD 345 (590)
Q Consensus 270 ~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~---~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~LV~E 345 (590)
+.||+|+||.||+++.. +|..||+|++.... ......+.+|++++++++||||+++++++.. ....++|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~-----~~~~~lv~E 75 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT-----HDRLCFVME 75 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEec-----CCEEEEEEe
Confidence 36999999999999976 58899999986532 2234567789999999999999999998873 446899999
Q ss_pred eCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccccCCC
Q 046270 346 YMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGH 425 (590)
Q Consensus 346 ~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~~~~~ 425 (590)
|+++|+|.+++. ....+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++......
T Consensus 76 ~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~ 149 (323)
T cd05595 76 YANGGELFFHLS---RERVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 149 (323)
T ss_pred CCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCC
Confidence 999999988874 3456999999999999999999999 8999999999999999999999999999987532221
Q ss_pred cccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhhhHHHhh
Q 046270 426 SHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDEFIRA 505 (590)
Q Consensus 426 ~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 505 (590)
.......||..|+|||++.++.++.++|||||||++|||++|+.||....... ..... .......
T Consensus 150 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~-~~~~~---~~~~~~~---------- 214 (323)
T cd05595 150 -ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER-LFELI---LMEEIRF---------- 214 (323)
T ss_pred -CccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHH-HHHHH---hcCCCCC----------
Confidence 12234568999999999999999999999999999999999999986433211 11100 0000011
Q ss_pred hhHHHHHHHHHHHHHhchhcCCCCCC-----CHHHHHH
Q 046270 506 EGARAVMERFVLVGILCAHVMVALRP-----TITDALK 538 (590)
Q Consensus 506 ~~~~~~~~~l~~l~~~Cl~~dp~~RP-----tm~eVl~ 538 (590)
+......+.+++..|++.||.+|| ++.++++
T Consensus 215 --p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 215 --PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred --CCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 111234567788899999999998 7888865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=315.65 Aligned_cols=246 Identities=27% Similarity=0.394 Sum_probs=195.5
Q ss_pred eecccCcEEEEEEEEcCCcEEEEEEeecCCCC-ChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEEEEEeeCCC
Q 046270 271 LIGQGASGIVYKGTLRHGNLVAVKQILDLDTK-GDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFLVYDYMPN 349 (590)
Q Consensus 271 ~LG~G~fG~Vykg~~~~g~~vAvK~l~~~~~~-~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~LV~E~~~~ 349 (590)
+||+|+||.||+|.+.++..+|+|.+...... ....+.+|++++++++|+||+++++++.. ....++||||+++
T Consensus 2 ~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~ 76 (250)
T cd05085 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQ-----RQPIYIVMELVPG 76 (250)
T ss_pred ccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEec-----CCccEEEEECCCC
Confidence 68999999999999888899999988654322 23468899999999999999999999874 3458999999999
Q ss_pred CCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccccCCCcccc
Q 046270 350 GTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLT 429 (590)
Q Consensus 350 gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~~~~~~~~~ 429 (590)
++|.+++.. ....++|..++.++.+++.||.||| ..+++||||||+||+++.++.+||+|||++...........
T Consensus 77 ~~L~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~ 151 (250)
T cd05085 77 GDFLSFLRK--KKDELKTKQLVKFALDAAAGMAYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSS 151 (250)
T ss_pred CcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccChheEEEcCCCeEEECCCccceeccccccccC
Confidence 999998853 2346899999999999999999999 89999999999999999999999999999875433322222
Q ss_pred cccccCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhhHHHHHHHhcCCchhhhhHHHhhhhH
Q 046270 430 TRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDEFIRAEGA 508 (590)
Q Consensus 430 ~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 508 (590)
....++..|+|||++..+.++.++||||||+++||+++ |..||....... .. .....+.... .+
T Consensus 152 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~--~~----~~~~~~~~~~---------~~ 216 (250)
T cd05085 152 GLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ--AR----EQVEKGYRMS---------CP 216 (250)
T ss_pred CCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH--HH----HHHHcCCCCC---------CC
Confidence 22344678999999999999999999999999999999 888886432211 11 1111111100 01
Q ss_pred HHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhc
Q 046270 509 RAVMERFVLVGILCAHVMVALRPTITDALKMLE 541 (590)
Q Consensus 509 ~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~ 541 (590)
......+.+++..|++.+|++||++.|++++|.
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 217 QKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 122357888999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=334.61 Aligned_cols=257 Identities=21% Similarity=0.231 Sum_probs=194.2
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEEE
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFL 342 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~L 342 (590)
++|...+.||+|+||.||++... .++.||+|+.. ...+.+|++++++++||||+++++++.. +...++
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~-----~~~~~l 160 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTY-----NKFTCL 160 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEE-----CCeeEE
Confidence 56889999999999999999986 47889999642 2357899999999999999999999874 345899
Q ss_pred EEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCccccc
Q 046270 343 VYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSL 422 (590)
Q Consensus 343 V~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~~ 422 (590)
|+|++. ++|..++. ....+++..++.|+.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++...
T Consensus 161 v~e~~~-~~L~~~l~---~~~~l~~~~~~~i~~qi~~aL~ylH---~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~ 233 (391)
T PHA03212 161 ILPRYK-TDLYCYLA---AKRNIAICDILAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPV 233 (391)
T ss_pred EEecCC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHhEEEcCCCCEEEEeCCcccccc
Confidence 999995 68877774 3356899999999999999999999 8899999999999999999999999999997543
Q ss_pred CCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc------hhhhhHHHHHHHhcC---
Q 046270 423 EGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSP------FQLITDWAWVLAKSG--- 493 (590)
Q Consensus 423 ~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~------~~~l~~~~~~~~~~~--- 493 (590)
...........||+.|+|||++.+..++.++|||||||++|||++|+.|+...... ...+...........
T Consensus 234 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~ 313 (391)
T PHA03212 234 DINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEF 313 (391)
T ss_pred cccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhc
Confidence 33223334567999999999999999999999999999999999999876432110 011111111000000
Q ss_pred --CchhhhhHHH----hh-----------hhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 046270 494 --KVDDIFDEFI----RA-----------EGARAVMERFVLVGILCAHVMVALRPTITDALK 538 (590)
Q Consensus 494 --~~~~~~d~~l----~~-----------~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~ 538 (590)
.....++... .. ....+....+..++..|++.||++|||++|+++
T Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 314 PIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred CcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000011000 00 001123456788999999999999999999986
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=336.96 Aligned_cols=247 Identities=28% Similarity=0.361 Sum_probs=205.9
Q ss_pred cCCCccceecccCcEEEEEEEEcC-CcEEEEEEeecCCC--CChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceE
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLRH-GNLVAVKQILDLDT--KGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRR 340 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~vAvK~l~~~~~--~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~ 340 (590)
++|...+.||+|.||.||||+.+. .+.||+|.+.+... +..+.+.+|++++++++|||||.++.+|.. ..+.
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt-----~~~~ 76 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFET-----SAHL 76 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcc-----cceE
Confidence 467777899999999999999875 67899998865433 234568899999999999999999999984 4569
Q ss_pred EEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCccc
Q 046270 341 FLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQ 420 (590)
Q Consensus 341 ~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~ 420 (590)
++|.||+.+ +|..+|. ..+.|+++.++.|+.++..||.||| +.+|+|||+||.||||+..+.+|++|||+||.
T Consensus 77 ~vVte~a~g-~L~~il~---~d~~lpEe~v~~~a~~LVsaL~yLh---s~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~ 149 (808)
T KOG0597|consen 77 WVVTEYAVG-DLFTILE---QDGKLPEEQVRAIAYDLVSALYYLH---SNRILHRDMKPQNILLEKGGTLKLCDFGLARA 149 (808)
T ss_pred EEEehhhhh-hHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHH---hcCcccccCCcceeeecCCCceeechhhhhhh
Confidence 999999976 9999995 4568999999999999999999999 99999999999999999999999999999997
Q ss_pred ccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhhh
Q 046270 421 SLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFD 500 (590)
Q Consensus 421 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 500 (590)
... .+...+.+.||+-|||||.+.++.|+..+|.||+||++||+++|++||... .+.+.+.....+..
T Consensus 150 m~~-~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~-----si~~Lv~~I~~d~v------ 217 (808)
T KOG0597|consen 150 MST-NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR-----SITQLVKSILKDPV------ 217 (808)
T ss_pred ccc-CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH-----HHHHHHHHHhcCCC------
Confidence 655 345667889999999999999999999999999999999999999999532 22223332222211
Q ss_pred HHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 501 EFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 501 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
..+......++.+....++.||..|-|-.+++..
T Consensus 218 -----~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 218 -----KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred -----CCcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 1222445578888899999999999999888653
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=323.47 Aligned_cols=263 Identities=21% Similarity=0.302 Sum_probs=196.2
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCC-CChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceE
Q 046270 263 TNGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDT-KGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRR 340 (590)
Q Consensus 263 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~-~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~ 340 (590)
.++|...+.||+|+||.||+|+.. +++.||||++..... .....+.+|++++++++||||+++++++.. +...
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~~~~ 78 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHT-----KETL 78 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEec-----CCeE
Confidence 467889999999999999999987 588999999864432 223467899999999999999999999873 4468
Q ss_pred EEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCccc
Q 046270 341 FLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQ 420 (590)
Q Consensus 341 ~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~ 420 (590)
++||||++ ++|.+++.. ....+++..+..++.||+.||+||| +.+|+||||||+|||+++++.+||+|||+++.
T Consensus 79 ~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 152 (303)
T cd07869 79 TLVFEYVH-TDLCQYMDK--HPGGLHPENVKLFLFQLLRGLSYIH---QRYILHRDLKPQNLLISDTGELKLADFGLARA 152 (303)
T ss_pred EEEEECCC-cCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECCCCccee
Confidence 99999996 677777642 3356899999999999999999999 89999999999999999999999999999875
Q ss_pred ccCCCcccccccccCCCccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCc----
Q 046270 421 SLEGHSHLTTRVAGTFGYLAPEYALY-GQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKV---- 495 (590)
Q Consensus 421 ~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~---- 495 (590)
.... ........||..|+|||.+.+ ..++.++|||||||++|||++|+.||.........+....... .....
T Consensus 153 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~ 230 (303)
T cd07869 153 KSVP-SHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVL-GTPNEDTWP 230 (303)
T ss_pred ccCC-CccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHh-CCCChhhcc
Confidence 4322 122234567899999998765 4588999999999999999999999976544322222111110 00000
Q ss_pred -----hhh--------hhHHHhhhhH-HHHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 046270 496 -----DDI--------FDEFIRAEGA-RAVMERFVLVGILCAHVMVALRPTITDALK 538 (590)
Q Consensus 496 -----~~~--------~d~~l~~~~~-~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~ 538 (590)
... ....+..... ......+.+++..|++.||.+|||+.|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 231 GVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred chhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 000 0000000000 011235667889999999999999999985
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=325.50 Aligned_cols=257 Identities=25% Similarity=0.437 Sum_probs=202.5
Q ss_pred cCCCccceecccCcEEEEEEEEc------CCcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCC
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLR------HGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSG 337 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~------~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~ 337 (590)
++|...+.||+|+||.||++... ++..+|+|.+........+.+.+|++++++++|+||+++++++.. +
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~ 79 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVE-----G 79 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-----C
Confidence 56788899999999999999852 245689998876554556679999999999999999999999873 4
Q ss_pred ceEEEEEeeCCCCCcchhhhhhc----------ccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCC
Q 046270 338 KRRFLVYDYMPNGTLSDNISISH----------KRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSE 407 (590)
Q Consensus 338 ~~~~LV~E~~~~gsL~~~L~~~~----------~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~ 407 (590)
...++||||+++++|.+++.... ....++|.+++.++.|++.||+||| +.+++||||||+|||++++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH---~~~i~H~dlkp~Nili~~~ 156 (288)
T cd05093 80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGEN 156 (288)
T ss_pred CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccC
Confidence 56899999999999999885321 1235999999999999999999999 8999999999999999999
Q ss_pred CcEEEEeeCCcccccCCCcc-cccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhhHH
Q 046270 408 LNAKVADFGLAKQSLEGHSH-LTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLDTSTSPFQLITDW 485 (590)
Q Consensus 408 ~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELlt-G~~p~~~~~~~~~~l~~~ 485 (590)
+.+||+|||+++........ ......++..|+|||++.+..++.++||||||++++||++ |+.||....... .+.
T Consensus 157 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~-~~~-- 233 (288)
T cd05093 157 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE-VIE-- 233 (288)
T ss_pred CcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-HHH--
Confidence 99999999999865433221 1223345778999999998899999999999999999999 888885433211 111
Q ss_pred HHHHHhcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhccC
Q 046270 486 AWVLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEGD 543 (590)
Q Consensus 486 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~~ 543 (590)
....+..... .......+.+++..|++.+|.+|||+.||++.|+..
T Consensus 234 ---~i~~~~~~~~---------~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~ 279 (288)
T cd05093 234 ---CITQGRVLQR---------PRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNL 279 (288)
T ss_pred ---HHHcCCcCCC---------CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence 1112221110 011224678899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=332.94 Aligned_cols=249 Identities=28% Similarity=0.405 Sum_probs=202.4
Q ss_pred HHhcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecC----CC-CChHHHHHHHHHHHhcC-CCCccccceeEEecc
Q 046270 261 QATNGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDL----DT-KGDEDFTNEVEIISKIR-HRNLLSLRGCCVTSD 333 (590)
Q Consensus 261 ~at~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~----~~-~~~~~f~~Ev~il~~l~-H~nlv~l~g~~~~~~ 333 (590)
...++|...+.||+|+||.|+.|.+. .|..||+|.+... .. ...+.+.+|+.++++++ ||||++++.++...
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~- 92 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATP- 92 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecC-
Confidence 44568889999999999999999875 4789999966442 11 23456778999999998 99999999999853
Q ss_pred CCCCceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCC-CcEEE
Q 046270 334 DSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSE-LNAKV 412 (590)
Q Consensus 334 ~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~-~~~kL 412 (590)
...++||||+.+|+|.+++. ..+.+.+.+..+++.|++.|++|+| +.+|+||||||+|||+|.+ +++||
T Consensus 93 ----~~~~ivmEy~~gGdL~~~i~---~~g~l~E~~ar~~F~Qlisav~y~H---~~gi~HRDLK~ENilld~~~~~~Kl 162 (370)
T KOG0583|consen 93 ----TKIYIVMEYCSGGDLFDYIV---NKGRLKEDEARKYFRQLISAVAYCH---SRGIVHRDLKPENILLDGNEGNLKL 162 (370)
T ss_pred ----CeEEEEEEecCCccHHHHHH---HcCCCChHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEecCCCCCEEE
Confidence 34999999999999999995 3567999999999999999999999 9999999999999999999 99999
Q ss_pred EeeCCcccccCCCcccccccccCCCccCccccccCC-CC-cchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHH
Q 046270 413 ADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALYGQ-LT-EKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLA 490 (590)
Q Consensus 413 ~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~-~t-~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~ 490 (590)
+|||++.... ..........||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||+....... . +. .
T Consensus 163 ~DFG~s~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l-~----~k-i 235 (370)
T KOG0583|consen 163 SDFGLSAISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNL-Y----RK-I 235 (370)
T ss_pred eccccccccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHH-H----HH-H
Confidence 9999999774 2233456678999999999999876 76 789999999999999999999987332111 1 11 1
Q ss_pred hcCC--chhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 046270 491 KSGK--VDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALK 538 (590)
Q Consensus 491 ~~~~--~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~ 538 (590)
..+. +...++ ...+..++..|+..+|..|+|+.++++
T Consensus 236 ~~~~~~~p~~~~-----------S~~~~~Li~~mL~~~P~~R~t~~~i~~ 274 (370)
T KOG0583|consen 236 RKGEFKIPSYLL-----------SPEARSLIEKMLVPDPSTRITLLEILE 274 (370)
T ss_pred hcCCccCCCCcC-----------CHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence 1111 111111 346778889999999999999999984
|
|
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=316.96 Aligned_cols=254 Identities=27% Similarity=0.412 Sum_probs=203.6
Q ss_pred hcCCCccceecccCcEEEEEEEEcCCcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEEE
Q 046270 263 TNGFSQNNLIGQGASGIVYKGTLRHGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFL 342 (590)
Q Consensus 263 t~~f~~~~~LG~G~fG~Vykg~~~~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~L 342 (590)
.++|...++||+|+||.||+|..++++.||+|.+.... ...+++.+|++++++++|+|++++++++. ....++
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~------~~~~~~ 77 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT------QEPIYI 77 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc------cCCcEE
Confidence 45678889999999999999999889999999986543 34568999999999999999999998763 234899
Q ss_pred EEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCccccc
Q 046270 343 VYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSL 422 (590)
Q Consensus 343 V~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~~ 422 (590)
+|||+++++|.+++... ....+++.+++.++.|++.||+||| +.+++||||||+||++++++.++|+|||++....
T Consensus 78 v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 153 (260)
T cd05067 78 ITEYMENGSLVDFLKTP-EGIKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDLRAANILVSETLCCKIADFGLARLIE 153 (260)
T ss_pred EEEcCCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHHhEEEcCCCCEEEccCcceeecC
Confidence 99999999999988533 2356899999999999999999999 8999999999999999999999999999997654
Q ss_pred CCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhhHHHHHHHhcCCchhhhhH
Q 046270 423 EGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDE 501 (590)
Q Consensus 423 ~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 501 (590)
...........++..|+|||++..+.++.++||||||++++||++ |+.||....... ... .+ ..+....
T Consensus 154 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-~~~----~~-~~~~~~~---- 223 (260)
T cd05067 154 DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE-VIQ----NL-ERGYRMP---- 223 (260)
T ss_pred CCCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHH-HHH----HH-HcCCCCC----
Confidence 333222233445678999999998899999999999999999999 999986443211 111 11 1111101
Q ss_pred HHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhcc
Q 046270 502 FIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEG 542 (590)
Q Consensus 502 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~ 542 (590)
........+.+++..|++.+|++||++++++++|+.
T Consensus 224 -----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 224 -----RPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred -----CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 011123468889999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=331.51 Aligned_cols=244 Identities=27% Similarity=0.398 Sum_probs=188.7
Q ss_pred CCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCCC-ChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEEEE
Q 046270 266 FSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDTK-GDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFLV 343 (590)
Q Consensus 266 f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~~-~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~LV 343 (590)
|...++||+|+||.||+|++. +|+.||||++...... ....+.+|++++++++|+||+++++++.. +...++|
T Consensus 76 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv 150 (353)
T PLN00034 76 LERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDH-----NGEIQVL 150 (353)
T ss_pred HhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEecc-----CCeEEEE
Confidence 445678999999999999976 5889999998654322 24578999999999999999999999863 4568999
Q ss_pred EeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccccC
Q 046270 344 YDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLE 423 (590)
Q Consensus 344 ~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~~~ 423 (590)
|||+++|+|.+.. .+++..+..|+.||+.||.||| +.+|+||||||+|||+++++.+||+|||+++....
T Consensus 151 ~e~~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~ 220 (353)
T PLN00034 151 LEFMDGGSLEGTH-------IADEQFLADVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQ 220 (353)
T ss_pred EecCCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEcccccceeccc
Confidence 9999999997533 3567788899999999999999 89999999999999999999999999999986543
Q ss_pred CCcccccccccCCCccCcccccc-----CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHh--cCCch
Q 046270 424 GHSHLTTRVAGTFGYLAPEYALY-----GQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAK--SGKVD 496 (590)
Q Consensus 424 ~~~~~~~~~~gt~~Y~APE~~~~-----~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~--~~~~~ 496 (590)
.. .......||..|+|||++.. ...+.++|||||||++|||++|+.||...... +|...... .+..
T Consensus 221 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~-----~~~~~~~~~~~~~~- 293 (353)
T PLN00034 221 TM-DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQG-----DWASLMCAICMSQP- 293 (353)
T ss_pred cc-ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc-----cHHHHHHHHhccCC-
Confidence 22 12234568999999998743 22456899999999999999999999733221 12111100 0000
Q ss_pred hhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 497 DIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 497 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
..........+.+++..|++.||++|||+.|+++.
T Consensus 294 --------~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 294 --------PEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred --------CCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00111223467888999999999999999999974
|
|
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=320.06 Aligned_cols=258 Identities=25% Similarity=0.347 Sum_probs=198.1
Q ss_pred CccceecccCcEEEEEEEEcCCc---EEEEEEeecCC--CCChHHHHHHHHHHHhcCCCCccccceeEEeccCC-CCceE
Q 046270 267 SQNNLIGQGASGIVYKGTLRHGN---LVAVKQILDLD--TKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDS-SGKRR 340 (590)
Q Consensus 267 ~~~~~LG~G~fG~Vykg~~~~g~---~vAvK~l~~~~--~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~-~~~~~ 340 (590)
...+.||+|+||.||+|++.+.. .+|+|.++... ....+.+.+|++++++++|+||+++++++...... .....
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 45678999999999999987533 58999876432 22346788999999999999999999988654321 22357
Q ss_pred EEEEeeCCCCCcchhhhhhc---ccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCC
Q 046270 341 FLVYDYMPNGTLSDNISISH---KRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGL 417 (590)
Q Consensus 341 ~LV~E~~~~gsL~~~L~~~~---~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGl 417 (590)
+++|||+++|+|.+++.... ....++|.....++.|++.||+||| +.+|+||||||+|||+++++.+||+|||+
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 158 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLS---SKSFIHRDLAARNCMLNENMNVCVADFGL 158 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhheEEcCCCCEEECCCCc
Confidence 99999999999998874322 2345899999999999999999999 89999999999999999999999999999
Q ss_pred cccccCCCccc-ccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhhHHHHHHHhcCCc
Q 046270 418 AKQSLEGHSHL-TTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLDTSTSPFQLITDWAWVLAKSGKV 495 (590)
Q Consensus 418 a~~~~~~~~~~-~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~ 495 (590)
++......... .....++..|++||++....++.++||||||+++|||++ |+.||..... . .+ ......+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-~-~~----~~~~~~~~~ 232 (272)
T cd05075 159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN-S-EI----YDYLRQGNR 232 (272)
T ss_pred ccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH-H-HH----HHHHHcCCC
Confidence 98654332211 122345678999999999999999999999999999999 7888754322 1 11 111222221
Q ss_pred hhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhcc
Q 046270 496 DDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEG 542 (590)
Q Consensus 496 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~ 542 (590)
... .......+.+++..|++.+|++|||+.++++.|+.
T Consensus 233 ~~~---------~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~ 270 (272)
T cd05075 233 LKQ---------PPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEK 270 (272)
T ss_pred CCC---------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 110 11123467789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=327.18 Aligned_cols=242 Identities=21% Similarity=0.336 Sum_probs=191.6
Q ss_pred ceecccCcEEEEEEEEc----CCcEEEEEEeecC----CCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEE
Q 046270 270 NLIGQGASGIVYKGTLR----HGNLVAVKQILDL----DTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRF 341 (590)
Q Consensus 270 ~~LG~G~fG~Vykg~~~----~g~~vAvK~l~~~----~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~ 341 (590)
+.||+|+||.||+++.. .++.||+|.+... .......+.+|++++++++||||+++++++.. +...+
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~-----~~~~~ 76 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQT-----GGKLY 76 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEec-----CCeEE
Confidence 57999999999999863 4778999998642 12234567899999999999999999998874 44689
Q ss_pred EEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccc
Q 046270 342 LVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQS 421 (590)
Q Consensus 342 LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~ 421 (590)
+||||+++|+|.+++. ..+.+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++..
T Consensus 77 lv~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 150 (323)
T cd05584 77 LILEYLSGGELFMHLE---REGIFMEDTACFYLSEISLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKES 150 (323)
T ss_pred EEEeCCCCchHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEeeCcCCeec
Confidence 9999999999998884 3456888999999999999999999 899999999999999999999999999998754
Q ss_pred cCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhhhH
Q 046270 422 LEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDE 501 (590)
Q Consensus 422 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 501 (590)
.... .......||..|+|||++.+..++.++|||||||++|||++|+.||....... ...... .+... +
T Consensus 151 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~-----~~~~~~-~~~~~--~-- 219 (323)
T cd05584 151 IHEG-TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKK-----TIDKIL-KGKLN--L-- 219 (323)
T ss_pred ccCC-CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHH-----HHHHHH-cCCCC--C--
Confidence 3322 22334578999999999998889999999999999999999999996533211 111111 11110 0
Q ss_pred HHhhhhHHHHHHHHHHHHHhchhcCCCCCC-----CHHHHHHH
Q 046270 502 FIRAEGARAVMERFVLVGILCAHVMVALRP-----TITDALKM 539 (590)
Q Consensus 502 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-----tm~eVl~~ 539 (590)
+......+.+++..|++.+|++|| ++.++++.
T Consensus 220 ------~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 220 ------PPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred ------CCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 111224667888999999999999 78887663
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=325.64 Aligned_cols=244 Identities=26% Similarity=0.348 Sum_probs=190.2
Q ss_pred CCccceecccCcEEEEEEEEc-CCcEEEEEEeecCC---CCChHHHHHHHHHH---HhcCCCCccccceeEEeccCCCCc
Q 046270 266 FSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLD---TKGDEDFTNEVEII---SKIRHRNLLSLRGCCVTSDDSSGK 338 (590)
Q Consensus 266 f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~---~~~~~~f~~Ev~il---~~l~H~nlv~l~g~~~~~~~~~~~ 338 (590)
|...+.||+|+||.||+|.+. .|+.||||++.... ....+.+.+|++++ .+++||||+++++++. .+.
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~-----~~~ 75 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQ-----TED 75 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEE-----cCC
Confidence 556789999999999999876 47899999986432 22334566776665 5668999999999987 345
Q ss_pred eEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCc
Q 046270 339 RRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLA 418 (590)
Q Consensus 339 ~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla 418 (590)
..++||||+++|+|..++. ...+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||++
T Consensus 76 ~~~lv~E~~~~~~L~~~~~----~~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~ 148 (324)
T cd05589 76 HVCFVMEYAAGGDLMMHIH----TDVFSEPRAVFYAACVVLGLQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLC 148 (324)
T ss_pred EEEEEEcCCCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCcEEeCcccCC
Confidence 6999999999999988773 346999999999999999999999 899999999999999999999999999998
Q ss_pred ccccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhh
Q 046270 419 KQSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDI 498 (590)
Q Consensus 419 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 498 (590)
+...... .......|++.|+|||.+.+..++.++|||||||++|||++|+.||...... ..+. .... +...
T Consensus 149 ~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~-~~~~----~i~~-~~~~-- 219 (324)
T cd05589 149 KEGMGFG-DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE-EVFD----SIVN-DEVR-- 219 (324)
T ss_pred ccCCCCC-CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH-HHHH----HHHh-CCCC--
Confidence 7533221 2233467899999999999989999999999999999999999999653321 1111 1111 1100
Q ss_pred hhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCC-----CHHHHHH
Q 046270 499 FDEFIRAEGARAVMERFVLVGILCAHVMVALRP-----TITDALK 538 (590)
Q Consensus 499 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-----tm~eVl~ 538 (590)
.+......+.+++..|++.||.+|| ++.++++
T Consensus 220 --------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 220 --------YPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred --------CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 1111234567788999999999999 4666655
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=332.86 Aligned_cols=251 Identities=22% Similarity=0.284 Sum_probs=199.4
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCC---CCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCce
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLD---TKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKR 339 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~---~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~ 339 (590)
++|...+.||+|+||.||+++.. +|+.||||++.... ......+.+|++++..++|+||+++++++. .+..
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~ 75 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQ-----DEEH 75 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhhee-----cCCe
Confidence 46888899999999999999987 58899999986432 233557889999999999999999999887 3456
Q ss_pred EEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcc
Q 046270 340 RFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAK 419 (590)
Q Consensus 340 ~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~ 419 (590)
.++||||+++|+|.+++.. ...+++..+..++.||+.||+||| ..+|+||||||+|||++.++.+||+|||+++
T Consensus 76 ~~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH---~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~ 149 (350)
T cd05573 76 LYLVMEYMPGGDLMNLLIR---KDVFPEETARFYIAELVLALDSVH---KLGFIHRDIKPDNILIDADGHIKLADFGLCK 149 (350)
T ss_pred EEEEEcCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEeecCCCCc
Confidence 9999999999999998853 357999999999999999999999 8999999999999999999999999999998
Q ss_pred cccCCC----------------------------cccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCC
Q 046270 420 QSLEGH----------------------------SHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKV 471 (590)
Q Consensus 420 ~~~~~~----------------------------~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p 471 (590)
...... ........||..|+|||.+.+..++.++|||||||++|||++|+.|
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~P 229 (350)
T cd05573 150 KMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPP 229 (350)
T ss_pred cCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCC
Confidence 654332 1122345689999999999999999999999999999999999999
Q ss_pred CCCCCCchhhhhHHHHHHHhc-CCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCC-HHHHHHH
Q 046270 472 LDTSTSPFQLITDWAWVLAKS-GKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPT-ITDALKM 539 (590)
Q Consensus 472 ~~~~~~~~~~l~~~~~~~~~~-~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt-m~eVl~~ 539 (590)
|........ + ...... .... +.. .......+..++..|++ +|.+||+ +.++++.
T Consensus 230 f~~~~~~~~----~-~~i~~~~~~~~------~p~--~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 230 FYSDTLQET----Y-NKIINWKESLR------FPP--DPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred CCCCCHHHH----H-HHHhccCCccc------CCC--CCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 975442111 1 111110 0000 000 00023466677788997 9999999 9999875
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=335.63 Aligned_cols=252 Identities=23% Similarity=0.295 Sum_probs=191.4
Q ss_pred CCCccceecccCcEEEEEEEEcC-CcEEEEEEeecCC---CCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceE
Q 046270 265 GFSQNNLIGQGASGIVYKGTLRH-GNLVAVKQILDLD---TKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRR 340 (590)
Q Consensus 265 ~f~~~~~LG~G~fG~Vykg~~~~-g~~vAvK~l~~~~---~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~ 340 (590)
.|...+.||+|+||.||+|+..+ +..||||++.... ......+.+|++++++++|+||+++++++.+ +...
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~-----~~~~ 76 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQD-----KDNL 76 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEec-----CCEE
Confidence 57788999999999999998764 7899999986532 2234568899999999999999999999873 4569
Q ss_pred EEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCccc
Q 046270 341 FLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQ 420 (590)
Q Consensus 341 ~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~ 420 (590)
++||||+++|+|.+++. ....+++.....++.||+.||.||| ..+|+||||||+|||++.++.+||+|||+++.
T Consensus 77 ~lv~E~~~gg~L~~~l~---~~~~~~e~~~~~~~~qi~~aL~~LH---~~givHrDlKp~Nili~~~~~~kL~DFGl~~~ 150 (381)
T cd05626 77 YFVMDYIPGGDMMSLLI---RMEVFPEVLARFYIAELTLAIESVH---KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTG 150 (381)
T ss_pred EEEEecCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCcHHHEEECCCCCEEEeeCcCCcc
Confidence 99999999999999885 3456899999999999999999999 89999999999999999999999999999764
Q ss_pred ccCCCc----------------------------------------------ccccccccCCCccCccccccCCCCcchh
Q 046270 421 SLEGHS----------------------------------------------HLTTRVAGTFGYLAPEYALYGQLTEKSD 454 (590)
Q Consensus 421 ~~~~~~----------------------------------------------~~~~~~~gt~~Y~APE~~~~~~~t~ksD 454 (590)
...... .......||..|+|||.+.+..++.++|
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~D 230 (381)
T cd05626 151 FRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCD 230 (381)
T ss_pred cccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccc
Confidence 311000 0012356999999999999888999999
Q ss_pred HHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhhhHHHhhhhHHHHHHHHHHHHH--hchhcCCCCCCC
Q 046270 455 VYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDEFIRAEGARAVMERFVLVGI--LCAHVMVALRPT 532 (590)
Q Consensus 455 VySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~--~Cl~~dp~~RPt 532 (590)
||||||++|||++|+.||........... ......... +... ......+.+++. .|...++..||+
T Consensus 231 iwSlG~il~elltG~~Pf~~~~~~~~~~~----i~~~~~~~~--~~~~------~~~s~~~~dli~~ll~~~~~~~~R~~ 298 (381)
T cd05626 231 WWSVGVILFEMLVGQPPFLAPTPTETQLK----VINWENTLH--IPPQ------VKLSPEAVDLITKLCCSAEERLGRNG 298 (381)
T ss_pred eeehhhHHHHHHhCCCCCcCCCHHHHHHH----HHccccccC--CCCC------CCCCHHHHHHHHHHccCcccccCCCC
Confidence 99999999999999999975443221110 000000000 0000 001123333443 377778888999
Q ss_pred HHHHHHH
Q 046270 533 ITDALKM 539 (590)
Q Consensus 533 m~eVl~~ 539 (590)
+.+++..
T Consensus 299 ~~~~l~h 305 (381)
T cd05626 299 ADDIKAH 305 (381)
T ss_pred HHHHhcC
Confidence 9999875
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=324.21 Aligned_cols=240 Identities=24% Similarity=0.342 Sum_probs=187.1
Q ss_pred ceecccCcEEEEEEEEcC-CcEEEEEEeecCC---CCChHHHHHHHHHHHhc-CCCCccccceeEEeccCCCCceEEEEE
Q 046270 270 NLIGQGASGIVYKGTLRH-GNLVAVKQILDLD---TKGDEDFTNEVEIISKI-RHRNLLSLRGCCVTSDDSSGKRRFLVY 344 (590)
Q Consensus 270 ~~LG~G~fG~Vykg~~~~-g~~vAvK~l~~~~---~~~~~~f~~Ev~il~~l-~H~nlv~l~g~~~~~~~~~~~~~~LV~ 344 (590)
+.||+|+||.||+|+..+ ++.||+|.+.... ....+.+..|.+++..+ +||||+++++++.. +...++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~-----~~~~~lv~ 75 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQT-----KEHLFFVM 75 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEc-----CCEEEEEE
Confidence 369999999999999864 7789999986432 22344566777777755 89999999998863 45699999
Q ss_pred eeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccccCC
Q 046270 345 DYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEG 424 (590)
Q Consensus 345 E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~~~~ 424 (590)
||+++|+|.+++. ....+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 76 e~~~gg~L~~~~~---~~~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~ 149 (316)
T cd05592 76 EYLNGGDLMFHIQ---SSGRFDEARARFYAAEIICGLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNG 149 (316)
T ss_pred cCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCC
Confidence 9999999998885 3446899999999999999999999 899999999999999999999999999999864332
Q ss_pred CcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhhhHHHh
Q 046270 425 HSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDEFIR 504 (590)
Q Consensus 425 ~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 504 (590)
. .......||..|+|||.+.+..++.++|||||||++|||++|+.||...... ..+ +.... ... .+
T Consensus 150 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~-~~~----~~i~~-~~~--~~----- 215 (316)
T cd05592 150 E-GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDED-ELF----DSILN-DRP--HF----- 215 (316)
T ss_pred C-CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHH-HHH----HHHHc-CCC--CC-----
Confidence 2 2234467899999999999889999999999999999999999999753321 111 11111 100 00
Q ss_pred hhhHHHHHHHHHHHHHhchhcCCCCCCCHH-HHH
Q 046270 505 AEGARAVMERFVLVGILCAHVMVALRPTIT-DAL 537 (590)
Q Consensus 505 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~-eVl 537 (590)
+......+.+++..|++.+|.+||++. +++
T Consensus 216 ---~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05592 216 ---PRWISKEAKDCLSKLFERDPTKRLGVDGDIR 246 (316)
T ss_pred ---CCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 111223566788899999999999976 453
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=339.61 Aligned_cols=240 Identities=28% Similarity=0.475 Sum_probs=197.8
Q ss_pred cceecccCcEEEEEEEEcCCcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEEEEEeeCC
Q 046270 269 NNLIGQGASGIVYKGTLRHGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFLVYDYMP 348 (590)
Q Consensus 269 ~~~LG~G~fG~Vykg~~~~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~LV~E~~~ 348 (590)
.+-||.|..|.||.|++. ++.||||+++... ..+++-|++|+|+||+.+.|+|... .-+++||||++
T Consensus 129 LeWlGSGaQGAVF~Grl~-netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqs-----PcyCIiMEfCa 195 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRLH-NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQS-----PCYCIIMEFCA 195 (904)
T ss_pred hhhhccCcccceeeeecc-CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCC-----ceeEEeeeccc
Confidence 356999999999999998 6889999875432 3578889999999999999999854 45899999999
Q ss_pred CCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccccCCCccc
Q 046270 349 NGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHL 428 (590)
Q Consensus 349 ~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~~~~~~~~ 428 (590)
.|-|...|. .+..++......+..+||.||.||| .+.|||||||.-||||..+..+||+|||-++...+. ..
T Consensus 196 ~GqL~~VLk---a~~~itp~llv~Wsk~IA~GM~YLH---~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~--ST 267 (904)
T KOG4721|consen 196 QGQLYEVLK---AGRPITPSLLVDWSKGIAGGMNYLH---LHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK--ST 267 (904)
T ss_pred cccHHHHHh---ccCccCHHHHHHHHHHhhhhhHHHH---HhhHhhhccCCCceEeeccceEEeccccchHhhhhh--hh
Confidence 999999995 4567888999999999999999999 999999999999999999999999999999865443 22
Q ss_pred ccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhhhHHHhhhhH
Q 046270 429 TTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDEFIRAEGA 508 (590)
Q Consensus 429 ~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 508 (590)
...++||..|||||++...+.++|.||||||||||||+||..|+...+... + .| .-|. ..|.-..+
T Consensus 268 kMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA--I---Iw---GVGs------NsL~LpvP 333 (904)
T KOG4721|consen 268 KMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA--I---IW---GVGS------NSLHLPVP 333 (904)
T ss_pred hhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe--e---EE---eccC------CcccccCc
Confidence 345789999999999999999999999999999999999999986543321 1 11 1111 01111123
Q ss_pred HHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhccC
Q 046270 509 RAVMERFVLVGILCAHVMVALRPTITDALKMLEGD 543 (590)
Q Consensus 509 ~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~~ 543 (590)
...++-|..++..||+..|..||++++++..|+-.
T Consensus 334 stcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa 368 (904)
T KOG4721|consen 334 STCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIA 368 (904)
T ss_pred ccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence 34455777888999999999999999999999753
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=301.50 Aligned_cols=264 Identities=24% Similarity=0.277 Sum_probs=200.7
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCCCC--hHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceE
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDTKG--DEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRR 340 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~~~--~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~ 340 (590)
++|...++||+|.||.||+|+.. .|+.||||+++.....+ .....+|++.|+.++|+||+.|++++...+ ..
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~-----~l 76 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKS-----NL 76 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCC-----ce
Confidence 35667789999999999999975 48899999997543332 345789999999999999999999998544 48
Q ss_pred EEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCccc
Q 046270 341 FLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQ 420 (590)
Q Consensus 341 ~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~ 420 (590)
.||+|||+ .+|...+.+ +...++..++..++.++.+||+|+| .+.|+||||||.|+|+++++.+||+|||+++.
T Consensus 77 ~lVfEfm~-tdLe~vIkd--~~i~l~pa~iK~y~~m~LkGl~y~H---~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~ 150 (318)
T KOG0659|consen 77 SLVFEFMP-TDLEVVIKD--KNIILSPADIKSYMLMTLKGLAYCH---SKWILHRDLKPNNLLISSDGQLKIADFGLARF 150 (318)
T ss_pred EEEEEecc-ccHHHHhcc--cccccCHHHHHHHHHHHHHHHHHHH---hhhhhcccCCccceEEcCCCcEEeecccchhc
Confidence 99999996 488888863 4457999999999999999999999 99999999999999999999999999999998
Q ss_pred ccCCCcccccccccCCCccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcC------
Q 046270 421 SLEGHSHLTTRVAGTFGYLAPEYALY-GQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSG------ 493 (590)
Q Consensus 421 ~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~------ 493 (590)
+.......+.. .-|..|.|||.+.+ .+|+...|+||.||++.||+-|.+-|...++-+ ++......+ ...
T Consensus 151 f~~p~~~~~~~-V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDid-QL~~If~~L-GTP~~~~WP 227 (318)
T KOG0659|consen 151 FGSPNRIQTHQ-VVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDID-QLSKIFRAL-GTPTPDQWP 227 (318)
T ss_pred cCCCCcccccc-eeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHH-HHHHHHHHc-CCCCcccCc
Confidence 76544433333 56899999998875 579999999999999999999987765544322 222111111 000
Q ss_pred CchhhhhHHHh--------hhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhc
Q 046270 494 KVDDIFDEFIR--------AEGARAVMERFVLVGILCAHVMVALRPTITDALKMLE 541 (590)
Q Consensus 494 ~~~~~~d~~l~--------~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~ 541 (590)
.+.++-|-.-. ...-.......+++...++..||.+|.|+.|++++=-
T Consensus 228 ~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~y 283 (318)
T KOG0659|consen 228 EMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPY 283 (318)
T ss_pred cccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchh
Confidence 01111111100 0001122345688889999999999999999998644
|
|
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=317.35 Aligned_cols=245 Identities=25% Similarity=0.376 Sum_probs=193.7
Q ss_pred eecccCcEEEEEEEEc---CCcEEEEEEeecCCC--CChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEEEEEe
Q 046270 271 LIGQGASGIVYKGTLR---HGNLVAVKQILDLDT--KGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFLVYD 345 (590)
Q Consensus 271 ~LG~G~fG~Vykg~~~---~g~~vAvK~l~~~~~--~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~LV~E 345 (590)
.||+|+||.||+|.++ ++..+|+|++..... ...+++.+|+.++++++|+||+++++++. +...++|||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~------~~~~~lv~e 75 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE------AESWMLVME 75 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc------CCCcEEEEe
Confidence 5899999999999764 467899998864332 23467899999999999999999999874 234789999
Q ss_pred eCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccccCCC
Q 046270 346 YMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGH 425 (590)
Q Consensus 346 ~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~~~~~ 425 (590)
|+++|+|.+++. ....+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++......
T Consensus 76 ~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~ 149 (257)
T cd05116 76 LAELGPLNKFLQ---KNKHVTEKNITELVHQVSMGMKYLE---ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADE 149 (257)
T ss_pred cCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchhhEEEcCCCeEEECCCccccccCCCC
Confidence 999999999885 3346899999999999999999999 8999999999999999999999999999998654433
Q ss_pred ccc--ccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhhHHHHHHHhcCCchhhhhHH
Q 046270 426 SHL--TTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDEF 502 (590)
Q Consensus 426 ~~~--~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 502 (590)
... .....++..|+|||.+..+.++.++||||||+++|||++ |+.||..... .. +.... ..+...+.
T Consensus 150 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-~~----~~~~i-~~~~~~~~---- 219 (257)
T cd05116 150 NYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG-NE----VTQMI-ESGERMEC---- 219 (257)
T ss_pred CeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH-HH----HHHHH-HCCCCCCC----
Confidence 221 122334578999999988889999999999999999998 9999865322 11 11111 12211110
Q ss_pred HhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhcc
Q 046270 503 IRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEG 542 (590)
Q Consensus 503 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~ 542 (590)
+......+.+++..|++.||++||++.+|.++|++
T Consensus 220 -----~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 220 -----PQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred -----CCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 11123467789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=316.32 Aligned_cols=253 Identities=30% Similarity=0.436 Sum_probs=200.3
Q ss_pred cCCCccceecccCcEEEEEEEEcCCcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEEEE
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLRHGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFLV 343 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~LV 343 (590)
++|.....||+|+||.||++.++.+..+|+|++.... ...+.+.+|++++++++|+|++++++++. ....++|
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~------~~~~~~v 78 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS------EEPIYIV 78 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc------CCCcEEE
Confidence 4577778999999999999998877789999875433 33567899999999999999999998874 2347899
Q ss_pred EeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccccC
Q 046270 344 YDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLE 423 (590)
Q Consensus 344 ~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~~~ 423 (590)
|||+++|+|.+++... ....++|..+..++.+++.||.||| +.+++|+||||+||++++++.+||+|||+++....
T Consensus 79 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05069 79 TEFMGKGSLLDFLKEG-DGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLIED 154 (260)
T ss_pred EEcCCCCCHHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCeEEECCCccceEccC
Confidence 9999999999988532 2345899999999999999999999 89999999999999999999999999999976543
Q ss_pred CCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhhHHHHHHHhcCCchhhhhHH
Q 046270 424 GHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDEF 502 (590)
Q Consensus 424 ~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 502 (590)
..........++..|+|||+...+.++.++||||||+++|||+| |+.|+...... .... + ...+...
T Consensus 155 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-~~~~-~----~~~~~~~------ 222 (260)
T cd05069 155 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR-EVLE-Q----VERGYRM------ 222 (260)
T ss_pred CcccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH-HHHH-H----HHcCCCC------
Confidence 32222223345678999999998999999999999999999999 88888643321 1111 1 1111000
Q ss_pred HhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhcc
Q 046270 503 IRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEG 542 (590)
Q Consensus 503 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~ 542 (590)
..+.+....+..++..|++.+|++||++.+|++.|+.
T Consensus 223 ---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 223 ---PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred ---CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 0111234567788899999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=315.80 Aligned_cols=247 Identities=23% Similarity=0.355 Sum_probs=192.5
Q ss_pred ceecccCcEEEEEEEEc-CCcEEEEEEeecCC-CCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEEEEEeeC
Q 046270 270 NLIGQGASGIVYKGTLR-HGNLVAVKQILDLD-TKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFLVYDYM 347 (590)
Q Consensus 270 ~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~-~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~LV~E~~ 347 (590)
+.||+|+||.||+|++. +++.+|+|.+.... ......+.+|++++++++|+||+++++++.. ....++||||+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~ 75 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ-----KQPIYIVMELV 75 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-----CCCeEEEEeec
Confidence 36999999999999986 58899999875432 2234679999999999999999999999874 34589999999
Q ss_pred CCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccccCCCcc
Q 046270 348 PNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSH 427 (590)
Q Consensus 348 ~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~~~~~~~ 427 (590)
++++|.+++.. ....++|..++.++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++........
T Consensus 76 ~~~~L~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~ 150 (252)
T cd05084 76 QGGDFLTFLRT--EGPRLKVKELIQMVENAAAGMEYLE---SKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYA 150 (252)
T ss_pred cCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEEcCCCcEEECccccCccccccccc
Confidence 99999998852 2346899999999999999999999 899999999999999999999999999998754332111
Q ss_pred c-ccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhhHHHHHHHhcCCchhhhhHHHhh
Q 046270 428 L-TTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDEFIRA 505 (590)
Q Consensus 428 ~-~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 505 (590)
. .....++..|+|||.+..+.++.++||||||+++|||++ |..|+....... .. .....+...
T Consensus 151 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~--~~----~~~~~~~~~--------- 215 (252)
T cd05084 151 STGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ--TR----EAIEQGVRL--------- 215 (252)
T ss_pred ccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH--HH----HHHHcCCCC---------
Confidence 1 111123457999999999999999999999999999998 888775432211 10 111111000
Q ss_pred hhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhc
Q 046270 506 EGARAVMERFVLVGILCAHVMVALRPTITDALKMLE 541 (590)
Q Consensus 506 ~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~ 541 (590)
..+......+.+++..|++.+|++|||+.+|.++|.
T Consensus 216 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 216 PCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 111122346788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=327.22 Aligned_cols=262 Identities=21% Similarity=0.321 Sum_probs=198.9
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCC-CChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceE
Q 046270 263 TNGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDT-KGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRR 340 (590)
Q Consensus 263 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~-~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~ 340 (590)
.++|+..++||+|+||.||++.+. .+..+|+|.+..... ...+.+.+|++++++++|+||+++++++.. +...
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~ 78 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-----DGEI 78 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEE-----CCEE
Confidence 467889999999999999999987 477889988764322 234578999999999999999999999984 3469
Q ss_pred EEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCccc
Q 046270 341 FLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQ 420 (590)
Q Consensus 341 ~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~ 420 (590)
++||||+++|+|.+++. ....+++.....++.+++.||.|||+ ..+|+||||||+|||++.++.+||+|||++..
T Consensus 79 ~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~~l~~~l~~lH~--~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~ 153 (333)
T cd06650 79 SICMEHMDGGSLDQVLK---KAGRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQ 153 (333)
T ss_pred EEEEecCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCChhhEEEcCCCCEEEeeCCcchh
Confidence 99999999999999985 34468999999999999999999993 24799999999999999999999999999875
Q ss_pred ccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHh---------
Q 046270 421 SLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAK--------- 491 (590)
Q Consensus 421 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~--------- 491 (590)
.... ......|+..|+|||++.+..++.++|||||||++|||++|+.||....... +.........
T Consensus 154 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 228 (333)
T cd06650 154 LIDS---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKE--LELMFGCPVEGDPAESETS 228 (333)
T ss_pred hhhh---ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhH--HHHHhcCcccCCccccccC
Confidence 4322 1233468999999999998889999999999999999999999986432211 1000000000
Q ss_pred ---------------cC----CchhhhhHHHhhhh----HHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 492 ---------------SG----KVDDIFDEFIRAEG----ARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 492 ---------------~~----~~~~~~d~~l~~~~----~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
.. ......+....... .......+.+++.+|++.||++|||+.|+++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h 299 (333)
T cd06650 229 PRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVH 299 (333)
T ss_pred cccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhC
Confidence 00 00011111111000 00123467889999999999999999999763
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=313.51 Aligned_cols=259 Identities=19% Similarity=0.281 Sum_probs=204.1
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCC---CChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCce
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDT---KGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKR 339 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~---~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~ 339 (590)
++|...+.||+|+||.||+|+.. ++..||||.+..... .....+.+|++++++++|||++++++++.. ...
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~ 76 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIE-----DNE 76 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEE-----CCe
Confidence 47888899999999999999976 588999998754322 223568899999999999999999999874 346
Q ss_pred EEEEEeeCCCCCcchhhhhhc-ccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCc
Q 046270 340 RFLVYDYMPNGTLSDNISISH-KRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLA 418 (590)
Q Consensus 340 ~~LV~E~~~~gsL~~~L~~~~-~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla 418 (590)
.++|+||+++|+|.+++.... ....+++..+..++.|+++||.||| +.+++|+||||+||+++.++.++|+|||++
T Consensus 77 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~nil~~~~~~~~l~d~g~~ 153 (267)
T cd08228 77 LNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLG 153 (267)
T ss_pred EEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCCHHHEEEcCCCCEEECccccc
Confidence 899999999999998875322 2345899999999999999999999 899999999999999999999999999998
Q ss_pred ccccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhh
Q 046270 419 KQSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDI 498 (590)
Q Consensus 419 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 498 (590)
........ ......|+..|+|||.+.+..++.++||||||+++|||++|+.|+........ .+...... .....
T Consensus 154 ~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~---~~~~~~~~-~~~~~- 227 (267)
T cd08228 154 RFFSSKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLF---SLCQKIEQ-CDYPP- 227 (267)
T ss_pred eeccchhH-HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHH---HHHHHHhc-CCCCC-
Confidence 86543221 12234578899999999888899999999999999999999999864332211 12211111 11111
Q ss_pred hhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhccC
Q 046270 499 FDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEGD 543 (590)
Q Consensus 499 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~~ 543 (590)
.........+.+++..|++.+|++||++.+|++.|+..
T Consensus 228 -------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 228 -------LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred -------CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 01122334677888999999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=321.08 Aligned_cols=262 Identities=22% Similarity=0.294 Sum_probs=195.2
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCC-CChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEE
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDT-KGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRF 341 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~-~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~ 341 (590)
++|...+.||+|+||.||+|+.+ ++..||+|++..... .....+.+|++++++++||||+++++++.. +...+
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~~~~~ 79 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHT-----ERCLT 79 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcC-----CCeEE
Confidence 46888899999999999999886 478999999864332 234567899999999999999999998863 34689
Q ss_pred EEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccc
Q 046270 342 LVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQS 421 (590)
Q Consensus 342 LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~ 421 (590)
+||||+++ +|.+++.. ....+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++..
T Consensus 80 lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~ 153 (288)
T cd07871 80 LVFEYLDS-DLKQYLDN--CGNLMSMHNVKIFMFQLLRGLSYCH---KRKILHRDLKPQNLLINEKGELKLADFGLARAK 153 (288)
T ss_pred EEEeCCCc-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEECcCcceeec
Confidence 99999974 88887742 2345889999999999999999999 899999999999999999999999999999754
Q ss_pred cCCCcccccccccCCCccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHH-------HHhcC
Q 046270 422 LEGHSHLTTRVAGTFGYLAPEYALY-GQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWV-------LAKSG 493 (590)
Q Consensus 422 ~~~~~~~~~~~~gt~~Y~APE~~~~-~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~-------~~~~~ 493 (590)
.... .......|+..|+|||.+.+ ..++.++||||+||++|||+||+.||........ +...... .|..-
T Consensus 154 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 231 (288)
T cd07871 154 SVPT-KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEE-LHLIFRLLGTPTEETWPGI 231 (288)
T ss_pred cCCC-ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCChHHhhcc
Confidence 3222 12233467899999998865 5689999999999999999999999965433221 1111000 00000
Q ss_pred ----CchhhhhHHHhhh----hHHHHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 046270 494 ----KVDDIFDEFIRAE----GARAVMERFVLVGILCAHVMVALRPTITDALK 538 (590)
Q Consensus 494 ----~~~~~~d~~l~~~----~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~ 538 (590)
.....+.+..... ........+.+++..|++.||.+|||++|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 232 TSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred ccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 0000000000000 00012346778999999999999999999985
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=323.95 Aligned_cols=257 Identities=24% Similarity=0.364 Sum_probs=199.3
Q ss_pred CCCccceecccCcEEEEEEEEcC------CcEEEEEEeecCCC-CChHHHHHHHHHHHhcCCCCccccceeEEeccCCCC
Q 046270 265 GFSQNNLIGQGASGIVYKGTLRH------GNLVAVKQILDLDT-KGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSG 337 (590)
Q Consensus 265 ~f~~~~~LG~G~fG~Vykg~~~~------g~~vAvK~l~~~~~-~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~ 337 (590)
+|...+.||+|+||.||+|+... ...+++|.+..... ....++.+|++++++++||||+++++.+.. .
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~ 75 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQ-----D 75 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEec-----C
Confidence 46778899999999999998642 34688888764332 234578899999999999999999999874 3
Q ss_pred ceEEEEEeeCCCCCcchhhhhhc---------------------ccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecC
Q 046270 338 KRRFLVYDYMPNGTLSDNISISH---------------------KRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRD 396 (590)
Q Consensus 338 ~~~~LV~E~~~~gsL~~~L~~~~---------------------~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrD 396 (590)
...++|+||+++|+|.+++.... ....++|..++.++.|++.||.||| +.+|+|||
T Consensus 76 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~ivH~d 152 (290)
T cd05045 76 GPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA---EMKLVHRD 152 (290)
T ss_pred CCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHH---HCCeehhh
Confidence 45899999999999999875321 1235889999999999999999999 89999999
Q ss_pred CCCCceEECCCCcEEEEeeCCcccccCCCcc-cccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 046270 397 IKSTNILLDSELNAKVADFGLAKQSLEGHSH-LTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLDT 474 (590)
Q Consensus 397 IKp~NILLd~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELlt-G~~p~~~ 474 (590)
|||+|||+++++.+||+|||+++........ ......++..|+|||++.+..++.++||||||++++||++ |+.|+..
T Consensus 153 ikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~ 232 (290)
T cd05045 153 LAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG 232 (290)
T ss_pred hhhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCC
Confidence 9999999999999999999999865433222 1223345678999999988889999999999999999999 9888854
Q ss_pred CCCchhhhhHHHHHHHhcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhccCC
Q 046270 475 STSPFQLITDWAWVLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEGDI 544 (590)
Q Consensus 475 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~~~ 544 (590)
... . .+ +.....+... ..+......+.+++..|++.+|++||++.|++++|+...
T Consensus 233 ~~~-~-~~----~~~~~~~~~~---------~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~ 287 (290)
T cd05045 233 IAP-E-RL----FNLLKTGYRM---------ERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMM 287 (290)
T ss_pred CCH-H-HH----HHHHhCCCCC---------CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHH
Confidence 321 1 11 1111211100 011122346788999999999999999999999998643
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=318.11 Aligned_cols=259 Identities=25% Similarity=0.368 Sum_probs=200.4
Q ss_pred CCccceecccCcEEEEEEEEcC----CcEEEEEEeecCCC--CChHHHHHHHHHHHhcCCCCccccceeEEeccC-CCCc
Q 046270 266 FSQNNLIGQGASGIVYKGTLRH----GNLVAVKQILDLDT--KGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDD-SSGK 338 (590)
Q Consensus 266 f~~~~~LG~G~fG~Vykg~~~~----g~~vAvK~l~~~~~--~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~-~~~~ 338 (590)
|...+.||+|+||.||+|++.. +..||+|++..... .....+.+|++.+++++|+|++++++++...+. ....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 4567889999999999998753 35799999864322 224578999999999999999999998875432 1234
Q ss_pred eEEEEEeeCCCCCcchhhhhhc---ccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEee
Q 046270 339 RRFLVYDYMPNGTLSDNISISH---KRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADF 415 (590)
Q Consensus 339 ~~~LV~E~~~~gsL~~~L~~~~---~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DF 415 (590)
..++|+||+++|+|..++.... ....+++..+..++.|++.||.||| +.+|+||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLS---NRNFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchheEEECCCCeEEECCc
Confidence 5799999999999999885432 2346899999999999999999999 899999999999999999999999999
Q ss_pred CCcccccCCCccc-ccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhhHHHHHHHhcC
Q 046270 416 GLAKQSLEGHSHL-TTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLDTSTSPFQLITDWAWVLAKSG 493 (590)
Q Consensus 416 Gla~~~~~~~~~~-~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~ 493 (590)
|+++......... .....++..|+|||++....++.++||||||+++|||++ |..|+...... .+.++. . .+
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~--~~~~~~---~-~~ 231 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH--EIYDYL---R-HG 231 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHH---H-cC
Confidence 9998654433221 122334678999999988889999999999999999999 88887543221 111111 1 11
Q ss_pred CchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhcc
Q 046270 494 KVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEG 542 (590)
Q Consensus 494 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~ 542 (590)
.... .+......+.+++..|++.||++|||+.|+++.|+.
T Consensus 232 ~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~ 271 (273)
T cd05035 232 NRLK---------QPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLEN 271 (273)
T ss_pred CCCC---------CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 1111 111234477888999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=345.10 Aligned_cols=251 Identities=21% Similarity=0.267 Sum_probs=198.7
Q ss_pred CCCccceecccCcEEEEEEEEcC--CcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEEE
Q 046270 265 GFSQNNLIGQGASGIVYKGTLRH--GNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFL 342 (590)
Q Consensus 265 ~f~~~~~LG~G~fG~Vykg~~~~--g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~L 342 (590)
.|...+.||+|+||.||++.... +..||+|++..........+.+|++++++++|||||++++++.. +...+|
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~-----~~~~~l 142 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKS-----DDKLLL 142 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEE-----CCEEEE
Confidence 37788999999999999998653 56788887654444444567889999999999999999999874 456999
Q ss_pred EEeeCCCCCcchhhhhhc-ccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccc
Q 046270 343 VYDYMPNGTLSDNISISH-KRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQS 421 (590)
Q Consensus 343 V~E~~~~gsL~~~L~~~~-~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~ 421 (590)
||||+++|+|.+++.... ....+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++..
T Consensus 143 v~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~ 219 (478)
T PTZ00267 143 IMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVH---SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQY 219 (478)
T ss_pred EEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCcCHHhEEECCCCcEEEEeCcCceec
Confidence 999999999999885422 3446899999999999999999999 899999999999999999999999999999865
Q ss_pred cCCCc-ccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhhh
Q 046270 422 LEGHS-HLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFD 500 (590)
Q Consensus 422 ~~~~~-~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 500 (590)
..... .......||++|+|||++.+..++.++|||||||++|||++|+.||...... . ...... .+....
T Consensus 220 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~-~----~~~~~~-~~~~~~--- 290 (478)
T PTZ00267 220 SDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQR-E----IMQQVL-YGKYDP--- 290 (478)
T ss_pred CCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH-H----HHHHHH-hCCCCC---
Confidence 43322 1234567999999999999999999999999999999999999998643221 1 111111 111110
Q ss_pred HHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 046270 501 EFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALK 538 (590)
Q Consensus 501 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~ 538 (590)
.+......+.+++..|++.+|++||++.+++.
T Consensus 291 ------~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 291 ------FPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred ------CCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 01112346778889999999999999999864
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=330.76 Aligned_cols=253 Identities=22% Similarity=0.250 Sum_probs=197.7
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCC---CCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCce
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLD---TKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKR 339 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~---~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~ 339 (590)
++|...+.||+|+||.||+++.. +|+.||+|++.... ....+.+.+|+++++.++|+||+++++++.. ...
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~-----~~~ 75 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQD-----KDN 75 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEec-----CCe
Confidence 46888899999999999999886 58899999987532 2234568899999999999999999998873 456
Q ss_pred EEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcc
Q 046270 340 RFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAK 419 (590)
Q Consensus 340 ~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~ 419 (590)
.++||||+++|+|.+++.. ....+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++
T Consensus 76 ~~lv~e~~~~~~L~~~l~~--~~~~l~~~~~~~~~~qi~~aL~~lH---~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~ 150 (330)
T cd05601 76 LYLVMEYQPGGDLLSLLNR--YEDQFDEDMAQFYLAELVLAIHSVH---QMGYVHRDIKPENVLIDRTGHIKLADFGSAA 150 (330)
T ss_pred EEEEECCCCCCCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEcccCchHheEECCCCCEEeccCCCCe
Confidence 8999999999999998853 2357999999999999999999999 8999999999999999999999999999998
Q ss_pred cccCCCcccccccccCCCccCccccc------cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcC
Q 046270 420 QSLEGHSHLTTRVAGTFGYLAPEYAL------YGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSG 493 (590)
Q Consensus 420 ~~~~~~~~~~~~~~gt~~Y~APE~~~------~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~ 493 (590)
..............||+.|+|||++. ...++.++|||||||++|||++|+.||........ ........
T Consensus 151 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~-----~~~i~~~~ 225 (330)
T cd05601 151 RLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKT-----YNNIMNFQ 225 (330)
T ss_pred ECCCCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHH-----HHHHHcCC
Confidence 76544333334457899999999986 45678999999999999999999999965433111 11111111
Q ss_pred CchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 494 KVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 494 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
.....-+ .......+..++..|++ +|.+|||+.+++..
T Consensus 226 ~~~~~~~-------~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 226 RFLKFPE-------DPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred CccCCCC-------CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 1110000 00122356667778887 99999999998863
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=318.78 Aligned_cols=255 Identities=27% Similarity=0.427 Sum_probs=200.1
Q ss_pred hcCCCccceecccCcEEEEEEEEcC-Cc---EEEEEEeecCC-CCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCC
Q 046270 263 TNGFSQNNLIGQGASGIVYKGTLRH-GN---LVAVKQILDLD-TKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSG 337 (590)
Q Consensus 263 t~~f~~~~~LG~G~fG~Vykg~~~~-g~---~vAvK~l~~~~-~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~ 337 (590)
.++|+..+.||+|+||.||+|++.. +. .+|+|++.... ....+++.+|++++++++|+|++++++++...
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----- 78 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKF----- 78 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccC-----
Confidence 3567888999999999999999863 32 79999886542 22346789999999999999999999998743
Q ss_pred ceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCC
Q 046270 338 KRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGL 417 (590)
Q Consensus 338 ~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGl 417 (590)
...++||||+++++|.+++.. ....++|.++..++.|++.||+||| +.+++||||||+||++++++.+||+|||+
T Consensus 79 ~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~ 153 (268)
T cd05063 79 KPAMIITEYMENGALDKYLRD--HDGEFSSYQLVGMLRGIAAGMKYLS---DMNYVHRDLAARNILVNSNLECKVSDFGL 153 (268)
T ss_pred CCcEEEEEcCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEEcCCCcEEECCCcc
Confidence 458999999999999998853 2356999999999999999999999 88999999999999999999999999999
Q ss_pred cccccCCCcccc--cccccCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhhHHHHHHHhcCC
Q 046270 418 AKQSLEGHSHLT--TRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLDTSTSPFQLITDWAWVLAKSGK 494 (590)
Q Consensus 418 a~~~~~~~~~~~--~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~ 494 (590)
+........... .....+..|+|||++..+.++.++||||||+++|||++ |+.|+...... . +.........
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~-~----~~~~i~~~~~ 228 (268)
T cd05063 154 SRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH-E----VMKAINDGFR 228 (268)
T ss_pred ceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH-H----HHHHHhcCCC
Confidence 986543322211 11223457999999998899999999999999999998 99998643321 1 1111111111
Q ss_pred chhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhcc
Q 046270 495 VDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEG 542 (590)
Q Consensus 495 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~ 542 (590)
.. ...+....+.+++..|++.+|++||+|.+|++.|+.
T Consensus 229 ~~----------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~ 266 (268)
T cd05063 229 LP----------APMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDK 266 (268)
T ss_pred CC----------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 10 011223467889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=312.08 Aligned_cols=250 Identities=26% Similarity=0.386 Sum_probs=201.4
Q ss_pred CCCccceecccCcEEEEEEEEc-CCcEEEEEEeecC--CCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEE
Q 046270 265 GFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDL--DTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRF 341 (590)
Q Consensus 265 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~--~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~ 341 (590)
+|+..+.||+|+||.||+|+.+ ++..|++|.+... ......++.+|++++++++|||++++++++.. +...+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~ 75 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLD-----KGKLN 75 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeecc-----CCEEE
Confidence 4677889999999999999986 4789999988643 23345678999999999999999999999873 45699
Q ss_pred EEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccc
Q 046270 342 LVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQS 421 (590)
Q Consensus 342 LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~ 421 (590)
+||||+++++|.+++... ....+++..+..++.+++.||.||| ..+++|+||||+||++++++.+||+|||+++..
T Consensus 76 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~~l~~al~~lH---~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~ 151 (256)
T cd08529 76 IVMEYAENGDLHKLLKMQ-RGRPLPEDQVWRFFIQILLGLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLL 151 (256)
T ss_pred EEEEeCCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEeCCCCEEEcccccceec
Confidence 999999999999998643 2357999999999999999999999 899999999999999999999999999998865
Q ss_pred cCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhhhH
Q 046270 422 LEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDE 501 (590)
Q Consensus 422 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 501 (590)
..... ......|+..|+|||+..++.++.++||||||++++||++|+.||..... .... .. ...+....
T Consensus 152 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-~~~~----~~-~~~~~~~~---- 220 (256)
T cd08529 152 SDNTN-FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ-GALI----LK-IIRGVFPP---- 220 (256)
T ss_pred cCccc-hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH-HHHH----HH-HHcCCCCC----
Confidence 44322 22345678999999999999999999999999999999999999865432 1111 11 11111111
Q ss_pred HHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 502 FIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 502 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
........+.+++..|++.+|++||++.++++.
T Consensus 221 -----~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 221 -----VSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred -----CccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 111233467889999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=315.47 Aligned_cols=258 Identities=24% Similarity=0.320 Sum_probs=201.7
Q ss_pred HHHHHhcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCC
Q 046270 258 ELEQATNGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSS 336 (590)
Q Consensus 258 el~~at~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~ 336 (590)
|++.+++++.....||+|+||.||+|++. ++..||+|.+........+.+.+|++++++++|+||+++++++..
T Consensus 2 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----- 76 (268)
T cd06624 2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSE----- 76 (268)
T ss_pred CcccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeecc-----
Confidence 45677888888899999999999999976 467899998876555556789999999999999999999999873
Q ss_pred CceEEEEEeeCCCCCcchhhhhhcccccC--ChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECC-CCcEEEE
Q 046270 337 GKRRFLVYDYMPNGTLSDNISISHKRKQL--TWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDS-ELNAKVA 413 (590)
Q Consensus 337 ~~~~~LV~E~~~~gsL~~~L~~~~~~~~l--~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~-~~~~kL~ 413 (590)
+...++|+||+++++|.+++... ...+ ++..+..++.||+.||+||| +.+|+||||||+||+++. ++.+||+
T Consensus 77 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~h~dl~p~nil~~~~~~~~~l~ 151 (268)
T cd06624 77 NGFFKIFMEQVPGGSLSALLRSK--WGPLKDNEQTIIFYTKQILEGLKYLH---DNQIVHRDIKGDNVLVNTYSGVVKIS 151 (268)
T ss_pred CCEEEEEEecCCCCCHHHHHHHh--cccCCCcHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCeEEEe
Confidence 45689999999999999988632 2334 88889999999999999999 899999999999999986 6799999
Q ss_pred eeCCcccccCCCcccccccccCCCccCccccccCC--CCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHh
Q 046270 414 DFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALYGQ--LTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAK 491 (590)
Q Consensus 414 DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~--~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~ 491 (590)
|||++........ ......|+..|+|||++..+. ++.++||||||+++|||++|+.|+......... .|......
T Consensus 152 dfg~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~--~~~~~~~~ 228 (268)
T cd06624 152 DFGTSKRLAGINP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAA--MFKVGMFK 228 (268)
T ss_pred cchhheecccCCC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhh--Hhhhhhhc
Confidence 9999876533221 223345789999999987654 789999999999999999999998643321111 11100000
Q ss_pred cCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 492 SGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 492 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
. . ...+....+.+..++.+|++.+|++|||+.|+++.
T Consensus 229 ~---~--------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 229 I---H--------PEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred c---C--------CCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 0 0 00111233467788899999999999999999863
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=321.38 Aligned_cols=260 Identities=24% Similarity=0.390 Sum_probs=205.4
Q ss_pred HhcCCCccceecccCcEEEEEEEEcC-----CcEEEEEEeecCCC-CChHHHHHHHHHHHhcCCCCccccceeEEeccCC
Q 046270 262 ATNGFSQNNLIGQGASGIVYKGTLRH-----GNLVAVKQILDLDT-KGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDS 335 (590)
Q Consensus 262 at~~f~~~~~LG~G~fG~Vykg~~~~-----g~~vAvK~l~~~~~-~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~ 335 (590)
..++|...+.||+|+||.||+|.+.+ +..|++|++..... ...+.+.+|+.++++++|+|++++++++...
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~--- 80 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIED--- 80 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC---
Confidence 34678888999999999999999876 67899998865422 2345688999999999999999999998753
Q ss_pred CCceEEEEEeeCCCCCcchhhhhhccc-----ccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcE
Q 046270 336 SGKRRFLVYDYMPNGTLSDNISISHKR-----KQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNA 410 (590)
Q Consensus 336 ~~~~~~LV~E~~~~gsL~~~L~~~~~~-----~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~ 410 (590)
+...++++||+++|+|.+++...... ..+++.+++.++.|++.||+||| +.+++||||||+||++++++.+
T Consensus 81 -~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~i~H~di~p~nil~~~~~~~ 156 (280)
T cd05043 81 -GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQV 156 (280)
T ss_pred -CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCHhhEEEcCCCcE
Confidence 34589999999999999998643222 46999999999999999999999 8999999999999999999999
Q ss_pred EEEeeCCcccccCCCcc-cccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhhHHHHH
Q 046270 411 KVADFGLAKQSLEGHSH-LTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLDTSTSPFQLITDWAWV 488 (590)
Q Consensus 411 kL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELlt-G~~p~~~~~~~~~~l~~~~~~ 488 (590)
||+|||+++........ ......++..|+|||++....++.++||||||+++||+++ |+.||..... . .+..+
T Consensus 157 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-~-~~~~~--- 231 (280)
T cd05043 157 KITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP-F-EMAAY--- 231 (280)
T ss_pred EECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH-H-HHHHH---
Confidence 99999999866443322 2233456778999999988889999999999999999999 9999865322 1 11111
Q ss_pred HHhcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhccC
Q 046270 489 LAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEGD 543 (590)
Q Consensus 489 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~~ 543 (590)
...+.... ........+.+++..|++.+|++|||+.+++++|+..
T Consensus 232 -~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~ 276 (280)
T cd05043 232 -LKDGYRLA---------QPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDF 276 (280)
T ss_pred -HHcCCCCC---------CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 11111000 0011234678899999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=310.06 Aligned_cols=258 Identities=21% Similarity=0.310 Sum_probs=205.3
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCC---CCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCce
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLD---TKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKR 339 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~---~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~ 339 (590)
++|+..+.||+|+||.||+|... +|+.||+|.++... ....+.+.+|++++++++|+|++++++++.. +..
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~-----~~~ 76 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIE-----NNE 76 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeec-----CCe
Confidence 57888999999999999999987 68899999885322 2235678999999999999999999999874 346
Q ss_pred EEEEEeeCCCCCcchhhhhhc-ccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCc
Q 046270 340 RFLVYDYMPNGTLSDNISISH-KRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLA 418 (590)
Q Consensus 340 ~~LV~E~~~~gsL~~~L~~~~-~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla 418 (590)
.++||||+++|+|.+++.... ....+++.+++.++.+++.||.||| +.+|+||||||+||+++.++.++|+|||++
T Consensus 77 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~nil~~~~~~~~l~d~~~~ 153 (267)
T cd08224 77 LNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLG 153 (267)
T ss_pred EEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecCCcChhhEEECCCCcEEEecccee
Confidence 899999999999999885432 2346899999999999999999999 899999999999999999999999999998
Q ss_pred ccccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhh
Q 046270 419 KQSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDI 498 (590)
Q Consensus 419 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 498 (590)
+....... ......++..|+|||++.+..++.++||||||+++|||++|+.|+...... +.++... ...+.....
T Consensus 154 ~~~~~~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~~~-~~~~~~~~~ 228 (267)
T cd08224 154 RFFSSKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN---LYSLCKK-IEKCDYPPL 228 (267)
T ss_pred eeccCCCc-ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc---HHHHHhh-hhcCCCCCC
Confidence 76533221 223346788999999999888999999999999999999999998643321 1111111 111111111
Q ss_pred hhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhcc
Q 046270 499 FDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEG 542 (590)
Q Consensus 499 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~ 542 (590)
........+.+++..|++.+|++|||+.+++++|+.
T Consensus 229 --------~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~ 264 (267)
T cd08224 229 --------PADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKE 264 (267)
T ss_pred --------ChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHH
Confidence 111233467788999999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=320.77 Aligned_cols=257 Identities=28% Similarity=0.397 Sum_probs=198.3
Q ss_pred HhcCCCccceecccCcEEEEEEEEcC------CcEEEEEEeecCCC-CChHHHHHHHHHHHhcCCCCccccceeEEeccC
Q 046270 262 ATNGFSQNNLIGQGASGIVYKGTLRH------GNLVAVKQILDLDT-KGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDD 334 (590)
Q Consensus 262 at~~f~~~~~LG~G~fG~Vykg~~~~------g~~vAvK~l~~~~~-~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~ 334 (590)
.+++|...+.||+|+||.||+|.+.+ +..||+|.+..... .....|.+|+.++++++|+||+++++++...
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-- 81 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFER-- 81 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC--
Confidence 35678889999999999999999864 45789998754332 2345699999999999999999999988743
Q ss_pred CCCceEEEEEeeCCCCCcchhhhhhcc----cccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCC--
Q 046270 335 SSGKRRFLVYDYMPNGTLSDNISISHK----RKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSEL-- 408 (590)
Q Consensus 335 ~~~~~~~LV~E~~~~gsL~~~L~~~~~----~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~-- 408 (590)
...++||||+++++|.+++..... ...++|..+++++.||+.||+||| +.+++||||||+||+++.++
T Consensus 82 ---~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~nil~~~~~~~ 155 (277)
T cd05036 82 ---LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE---ENHFIHRDIAARNCLLTCKGPG 155 (277)
T ss_pred ---CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchheEEEeccCCC
Confidence 347999999999999998864321 135899999999999999999999 88999999999999998754
Q ss_pred -cEEEEeeCCcccccCCCcc-cccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhhHH
Q 046270 409 -NAKVADFGLAKQSLEGHSH-LTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLDTSTSPFQLITDW 485 (590)
Q Consensus 409 -~~kL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELlt-G~~p~~~~~~~~~~l~~~ 485 (590)
.+||+|||+++........ .......+..|+|||++.++.++.++|||||||++|||++ |+.||....... +
T Consensus 156 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~--~--- 230 (277)
T cd05036 156 RVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE--V--- 230 (277)
T ss_pred cceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH--H---
Confidence 5899999999865322211 1122233568999999999999999999999999999997 888886433211 1
Q ss_pred HHHHHhcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhc
Q 046270 486 AWVLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLE 541 (590)
Q Consensus 486 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~ 541 (590)
.......... ..+......+.+++..|++.+|++||++.+|++.|+
T Consensus 231 ~~~~~~~~~~----------~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 231 MEFVTGGGRL----------DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred HHHHHcCCcC----------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 1111111111 011122346788999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=323.68 Aligned_cols=241 Identities=25% Similarity=0.374 Sum_probs=189.4
Q ss_pred CCCccceecccCcEEEEEEEEcC-CcEEEEEEeecC---CCCChHHHHHHHHHHHhcCCC-CccccceeEEeccCCCCce
Q 046270 265 GFSQNNLIGQGASGIVYKGTLRH-GNLVAVKQILDL---DTKGDEDFTNEVEIISKIRHR-NLLSLRGCCVTSDDSSGKR 339 (590)
Q Consensus 265 ~f~~~~~LG~G~fG~Vykg~~~~-g~~vAvK~l~~~---~~~~~~~f~~Ev~il~~l~H~-nlv~l~g~~~~~~~~~~~~ 339 (590)
+|...+.||+|+||.||+|+..+ ++.||||++... .....+.+..|++++..++|+ +|+++++++.. ...
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~-----~~~ 75 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT-----MDR 75 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEc-----CCE
Confidence 47788999999999999999875 678999998643 223345688899999999765 57788877763 446
Q ss_pred EEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcc
Q 046270 340 RFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAK 419 (590)
Q Consensus 340 ~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~ 419 (590)
.++||||+++|+|.+++. ....+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++
T Consensus 76 ~~lv~E~~~~g~L~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~ 149 (324)
T cd05587 76 LYFVMEYVNGGDLMYHIQ---QVGKFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCK 149 (324)
T ss_pred EEEEEcCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEEcCCCCEEEeecCcce
Confidence 899999999999998884 3456899999999999999999999 8999999999999999999999999999987
Q ss_pred cccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhh
Q 046270 420 QSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIF 499 (590)
Q Consensus 420 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 499 (590)
...... .......||..|+|||++.+..++.++|||||||++|||+||+.||...... ..+. ... ....
T Consensus 150 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~-~~~~----~i~-~~~~---- 218 (324)
T cd05587 150 ENIFGG-KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED-ELFQ----SIM-EHNV---- 218 (324)
T ss_pred ecCCCC-CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH-HHHH----HHH-cCCC----
Confidence 532211 1223456899999999999999999999999999999999999999754321 1111 111 1110
Q ss_pred hHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCH
Q 046270 500 DEFIRAEGARAVMERFVLVGILCAHVMVALRPTI 533 (590)
Q Consensus 500 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm 533 (590)
..+......+.+++..|++.+|.+||+.
T Consensus 219 ------~~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 219 ------SYPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred ------CCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 0111223466788899999999999976
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=324.52 Aligned_cols=237 Identities=24% Similarity=0.343 Sum_probs=184.9
Q ss_pred ceecccCcEEEEEEEEc-CCcEEEEEEeecCC---CCChHHHHHHHH-HHHhcCCCCccccceeEEeccCCCCceEEEEE
Q 046270 270 NLIGQGASGIVYKGTLR-HGNLVAVKQILDLD---TKGDEDFTNEVE-IISKIRHRNLLSLRGCCVTSDDSSGKRRFLVY 344 (590)
Q Consensus 270 ~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~---~~~~~~f~~Ev~-il~~l~H~nlv~l~g~~~~~~~~~~~~~~LV~ 344 (590)
+.||+|+||.||+|+.. +|+.||+|++.... .....++..|.. +++.++||||+++++.+.. ....++||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~-----~~~~~lv~ 75 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQT-----ADKLYFVL 75 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEe-----CCEEEEEE
Confidence 36999999999999986 58899999986432 122334555554 5678999999999998873 45689999
Q ss_pred eeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccccCC
Q 046270 345 DYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEG 424 (590)
Q Consensus 345 E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~~~~ 424 (590)
||+++|+|.+++. ....+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 76 e~~~~g~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH---~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~ 149 (323)
T cd05575 76 DYVNGGELFFHLQ---RERSFPEPRARFYAAEIASALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH 149 (323)
T ss_pred cCCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccC
Confidence 9999999998885 3457899999999999999999999 899999999999999999999999999998753222
Q ss_pred CcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhhhHHHh
Q 046270 425 HSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDEFIR 504 (590)
Q Consensus 425 ~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 504 (590)
........||+.|+|||++.+..++.++|||||||++|||++|+.||...... . ....... +... +
T Consensus 150 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~-~----~~~~i~~-~~~~------~- 215 (323)
T cd05575 150 -SKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTA-E----MYDNILN-KPLR------L- 215 (323)
T ss_pred -CCccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHH-H----HHHHHHc-CCCC------C-
Confidence 22234567899999999999999999999999999999999999998643221 1 1111111 1100 0
Q ss_pred hhhHHHHHHHHHHHHHhchhcCCCCCCCHH
Q 046270 505 AEGARAVMERFVLVGILCAHVMVALRPTIT 534 (590)
Q Consensus 505 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~ 534 (590)
.......+.+++..|++.||.+||++.
T Consensus 216 ---~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 216 ---KPNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred ---CCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 011234677888999999999999984
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=324.68 Aligned_cols=261 Identities=26% Similarity=0.377 Sum_probs=202.5
Q ss_pred HHHhcCCCccceecccCcEEEEEEEEcC------CcEEEEEEeecCC-CCChHHHHHHHHHHHhc-CCCCccccceeEEe
Q 046270 260 EQATNGFSQNNLIGQGASGIVYKGTLRH------GNLVAVKQILDLD-TKGDEDFTNEVEIISKI-RHRNLLSLRGCCVT 331 (590)
Q Consensus 260 ~~at~~f~~~~~LG~G~fG~Vykg~~~~------g~~vAvK~l~~~~-~~~~~~f~~Ev~il~~l-~H~nlv~l~g~~~~ 331 (590)
+...++|...+.||+|+||.||++.+.+ ...+|+|.+.... .+...++.+|++++.++ +|+||+++++++..
T Consensus 8 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 87 (293)
T cd05053 8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ 87 (293)
T ss_pred ccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC
Confidence 3344568888999999999999998753 3579999886532 22345688999999999 89999999999873
Q ss_pred ccCCCCceEEEEEeeCCCCCcchhhhhh-------------cccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCC
Q 046270 332 SDDSSGKRRFLVYDYMPNGTLSDNISIS-------------HKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIK 398 (590)
Q Consensus 332 ~~~~~~~~~~LV~E~~~~gsL~~~L~~~-------------~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIK 398 (590)
+...+++|||+++|+|.+++... .....++|..+++++.|++.||.||| +.+|+|||||
T Consensus 88 -----~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~dlk 159 (293)
T cd05053 88 -----EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA---SKKCIHRDLA 159 (293)
T ss_pred -----CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCccccccc
Confidence 34589999999999999988532 12356999999999999999999999 8999999999
Q ss_pred CCceEECCCCcEEEEeeCCcccccCCCcc-cccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 046270 399 STNILLDSELNAKVADFGLAKQSLEGHSH-LTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLDTST 476 (590)
Q Consensus 399 p~NILLd~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELlt-G~~p~~~~~ 476 (590)
|+|||+++++.+||+|||+++........ ......++..|+|||++....++.++|||||||++|||++ |..|+....
T Consensus 160 p~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~ 239 (293)
T cd05053 160 ARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP 239 (293)
T ss_pred eeeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCC
Confidence 99999999999999999999865443221 1222345678999999988899999999999999999998 888875432
Q ss_pred CchhhhhHHHHHHHhcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhccC
Q 046270 477 SPFQLITDWAWVLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEGD 543 (590)
Q Consensus 477 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~~ 543 (590)
.... . .....+... ..+......+.+++..|++.+|++|||+.|+++.|+..
T Consensus 240 ~~~~-~-----~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~ 291 (293)
T cd05053 240 VEEL-F-----KLLKEGYRM---------EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291 (293)
T ss_pred HHHH-H-----HHHHcCCcC---------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence 2111 0 111111100 01112234678899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=312.39 Aligned_cols=258 Identities=20% Similarity=0.293 Sum_probs=203.3
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCC---CChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCce
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDT---KGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKR 339 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~---~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~ 339 (590)
++|...+.||+|+||.||++... ++..+|||.+..... ....++.+|+++++.++|+||+++++++.. +..
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~~ 76 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE-----DNE 76 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEe-----CCe
Confidence 46777889999999999999974 688999998764322 224578899999999999999999999874 446
Q ss_pred EEEEEeeCCCCCcchhhhhhc-ccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCc
Q 046270 340 RFLVYDYMPNGTLSDNISISH-KRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLA 418 (590)
Q Consensus 340 ~~LV~E~~~~gsL~~~L~~~~-~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla 418 (590)
.+++|||+++++|.+++.... ....++|..++.++.+|+.||.||| +.+++|+||||+||+++.++.++|+|||++
T Consensus 77 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~ 153 (267)
T cd08229 77 LNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLG 153 (267)
T ss_pred EEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEECcchhh
Confidence 899999999999999885322 2456899999999999999999999 899999999999999999999999999998
Q ss_pred ccccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhh
Q 046270 419 KQSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDI 498 (590)
Q Consensus 419 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 498 (590)
........ ......|+..|+|||++.+..++.++||||||+++|||++|..|+........ .+..... ....
T Consensus 154 ~~~~~~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~---~~~~~~~-~~~~--- 225 (267)
T cd08229 154 RFFSSKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY---SLCKKIE-QCDY--- 225 (267)
T ss_pred hccccCCc-ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHH---HHhhhhh-cCCC---
Confidence 76543221 22335688999999999988899999999999999999999999864322111 1111111 0000
Q ss_pred hhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhcc
Q 046270 499 FDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEG 542 (590)
Q Consensus 499 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~ 542 (590)
+ ........+.+.+++..|++.+|++||||.+|+++++.
T Consensus 226 --~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~ 264 (267)
T cd08229 226 --P---PLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKR 264 (267)
T ss_pred --C---CCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhh
Confidence 0 00112234567788899999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=331.24 Aligned_cols=266 Identities=24% Similarity=0.287 Sum_probs=198.6
Q ss_pred CCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCC--CCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEE
Q 046270 265 GFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLD--TKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRF 341 (590)
Q Consensus 265 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~--~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~ 341 (590)
+|+..+.||+|+||.||++... +|+.||||++.... ....+.+.+|+++++.++|+||+++++++...+.......+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4778899999999999999975 58899999985432 22345788999999999999999999998754422223689
Q ss_pred EEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccc
Q 046270 342 LVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQS 421 (590)
Q Consensus 342 LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~ 421 (590)
+|+||+. ++|.+.+. ....+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~~-~~l~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~ 153 (372)
T cd07853 81 VVTELMQ-SDLHKIIV---SPQPLSSDHVKVFLYQILRGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVE 153 (372)
T ss_pred EEeeccc-cCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHHEEECCCCCEEeccccceeec
Confidence 9999996 57777663 3457999999999999999999999 899999999999999999999999999999865
Q ss_pred cCCCcccccccccCCCccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhh-
Q 046270 422 LEGHSHLTTRVAGTFGYLAPEYALYG-QLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIF- 499 (590)
Q Consensus 422 ~~~~~~~~~~~~gt~~Y~APE~~~~~-~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~- 499 (590)
............++..|+|||.+.+. .++.++|||||||+++||++|+.||....... .+.... .........++.
T Consensus 154 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~i~-~~~g~~~~~~~~~ 231 (372)
T cd07853 154 EPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQ-QLDLIT-DLLGTPSLEAMRS 231 (372)
T ss_pred ccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHH-HHHHHH-HHcCCCCHHHHHH
Confidence 44333333445678999999998764 57999999999999999999999997543321 111110 000111110000
Q ss_pred -----hHHHhh------------hhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 500 -----DEFIRA------------EGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 500 -----d~~l~~------------~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
...+.. .......+.+.+++..|++.||++|||+.|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 232 ACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred hhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 000000 0001123467889999999999999999999874
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=313.76 Aligned_cols=256 Identities=29% Similarity=0.446 Sum_probs=204.3
Q ss_pred HhcCCCccceecccCcEEEEEEEEcCCcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEE
Q 046270 262 ATNGFSQNNLIGQGASGIVYKGTLRHGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRF 341 (590)
Q Consensus 262 at~~f~~~~~LG~G~fG~Vykg~~~~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~ 341 (590)
..++|...+.||+|+||.||+|.++++..+|||.+.... ...+++.+|++++++++|+|++++++++.. +...+
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~ 77 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSE-----EEPIY 77 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeec-----CCceE
Confidence 356788899999999999999999888899999886533 346789999999999999999999998763 34589
Q ss_pred EEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccc
Q 046270 342 LVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQS 421 (590)
Q Consensus 342 LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~ 421 (590)
+||||+++++|.+++... ....+++..+..++.+++.||.||| +.+++|+||||+||++++++.+||+|||+++..
T Consensus 78 ~v~e~~~~~~L~~~i~~~-~~~~~~~~~~~~~~~~i~~al~~lh---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~ 153 (261)
T cd05034 78 IVTEYMSKGSLLDFLKSG-EGKKLRLPQLVDMAAQIAEGMAYLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLI 153 (261)
T ss_pred EEEeccCCCCHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcchheEEEcCCCCEEECccccceec
Confidence 999999999999998542 2346899999999999999999999 889999999999999999999999999999866
Q ss_pred cCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhhHHHHHHHhcCCchhhhh
Q 046270 422 LEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFD 500 (590)
Q Consensus 422 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 500 (590)
............++..|+|||.+.+..++.++||||||++++||++ |+.||..... ...+... ......
T Consensus 154 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~-~~~~~~~----~~~~~~----- 223 (261)
T cd05034 154 EDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN-REVLEQV----ERGYRM----- 223 (261)
T ss_pred cchhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH-HHHHHHH----HcCCCC-----
Confidence 4432222223335678999999998899999999999999999999 8988854322 1111111 110000
Q ss_pred HHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhcc
Q 046270 501 EFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEG 542 (590)
Q Consensus 501 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~ 542 (590)
..+.+....+.+++..|++.+|++||++.++.+.|+.
T Consensus 224 -----~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 224 -----PRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred -----CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 0011123467889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=323.34 Aligned_cols=256 Identities=27% Similarity=0.389 Sum_probs=196.7
Q ss_pred cCCCccceecccCcEEEEEEEEcC-Cc--EEEEEEeecCC-CCChHHHHHHHHHHHhc-CCCCccccceeEEeccCCCCc
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLRH-GN--LVAVKQILDLD-TKGDEDFTNEVEIISKI-RHRNLLSLRGCCVTSDDSSGK 338 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~~-g~--~vAvK~l~~~~-~~~~~~f~~Ev~il~~l-~H~nlv~l~g~~~~~~~~~~~ 338 (590)
++|+..+.||+|+||.||+|++++ +. .+++|.++... ....+.+.+|++++.++ +||||+++++++.. ..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~-----~~ 76 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACEN-----RG 76 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEcc-----CC
Confidence 467888999999999999999864 32 47888876432 23345789999999999 79999999998864 34
Q ss_pred eEEEEEeeCCCCCcchhhhhhc-------------ccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEC
Q 046270 339 RRFLVYDYMPNGTLSDNISISH-------------KRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLD 405 (590)
Q Consensus 339 ~~~LV~E~~~~gsL~~~L~~~~-------------~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd 405 (590)
..++|+||+++|+|.+++.... ....+++..++.|+.|++.||+||| +.+|+||||||+|||++
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nill~ 153 (297)
T cd05089 77 YLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLS---EKQFIHRDLAARNVLVG 153 (297)
T ss_pred cceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCcCCcceEEEC
Confidence 5899999999999999985321 1135899999999999999999999 89999999999999999
Q ss_pred CCCcEEEEeeCCcccccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhhH
Q 046270 406 SELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLDTSTSPFQLITD 484 (590)
Q Consensus 406 ~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELlt-G~~p~~~~~~~~~~l~~ 484 (590)
+++.+||+|||++...... ........+..|+|||++....++.++|||||||+++||++ |+.||....... ..
T Consensus 154 ~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~-~~-- 228 (297)
T cd05089 154 ENLASKIADFGLSRGEEVY--VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE-LY-- 228 (297)
T ss_pred CCCeEEECCcCCCccccce--eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH-HH--
Confidence 9999999999998643211 11111223567999999998899999999999999999998 999986432211 11
Q ss_pred HHHHHHhcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhccCC
Q 046270 485 WAWVLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEGDI 544 (590)
Q Consensus 485 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~~~ 544 (590)
.. ...+... ..+......+.+++..|++.+|.+||++.+++++|+...
T Consensus 229 --~~-~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~ 276 (297)
T cd05089 229 --EK-LPQGYRM---------EKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRML 276 (297)
T ss_pred --HH-HhcCCCC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 11 1111000 011112346778999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-38 Score=325.41 Aligned_cols=238 Identities=25% Similarity=0.352 Sum_probs=188.6
Q ss_pred ceecccCcEEEEEEEE----cCCcEEEEEEeecCCC--CChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEEEE
Q 046270 270 NLIGQGASGIVYKGTL----RHGNLVAVKQILDLDT--KGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFLV 343 (590)
Q Consensus 270 ~~LG~G~fG~Vykg~~----~~g~~vAvK~l~~~~~--~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~LV 343 (590)
+.||+|+||.||+++. ..|+.+|+|++..... .....+.+|++++++++||||+++++++.. +...++|
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~~~~~lv 76 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQT-----EGKLYLI 76 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEc-----CCEEEEE
Confidence 5799999999999875 2478999999865322 234457789999999999999999998873 4568999
Q ss_pred EeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccccC
Q 046270 344 YDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLE 423 (590)
Q Consensus 344 ~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~~~ 423 (590)
|||+++|+|.+++. +...+++..+..++.||+.||.||| +.+|+||||||+|||+++++.+||+|||+++....
T Consensus 77 ~e~~~~~~L~~~l~---~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 150 (318)
T cd05582 77 LDFLRGGDLFTRLS---KEVMFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESID 150 (318)
T ss_pred EcCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHeEECCCCcEEEeeccCCcccCC
Confidence 99999999999884 3456999999999999999999999 89999999999999999999999999999986533
Q ss_pred CCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhhhHHH
Q 046270 424 GHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDEFI 503 (590)
Q Consensus 424 ~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 503 (590)
.. .......||..|+|||.+....++.++||||||+++|||++|+.||...... ..+ ..... ....
T Consensus 151 ~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~-~~~----~~i~~-~~~~------- 216 (318)
T cd05582 151 HE-KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK-ETM----TMILK-AKLG------- 216 (318)
T ss_pred CC-CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHH-HHH----HHHHc-CCCC-------
Confidence 22 2233467899999999999888999999999999999999999999653321 111 11111 1110
Q ss_pred hhhhHHHHHHHHHHHHHhchhcCCCCCCCHHH
Q 046270 504 RAEGARAVMERFVLVGILCAHVMVALRPTITD 535 (590)
Q Consensus 504 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~e 535 (590)
.+......+..++..|++.||++||++.+
T Consensus 217 ---~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 217 ---MPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred ---CCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 01112235667888999999999999544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=324.02 Aligned_cols=237 Identities=24% Similarity=0.332 Sum_probs=183.5
Q ss_pred ceecccCcEEEEEEEEc-CCcEEEEEEeecCC---CCChHHHHHHHH-HHHhcCCCCccccceeEEeccCCCCceEEEEE
Q 046270 270 NLIGQGASGIVYKGTLR-HGNLVAVKQILDLD---TKGDEDFTNEVE-IISKIRHRNLLSLRGCCVTSDDSSGKRRFLVY 344 (590)
Q Consensus 270 ~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~---~~~~~~f~~Ev~-il~~l~H~nlv~l~g~~~~~~~~~~~~~~LV~ 344 (590)
++||+|+||.||+++.. +|..||+|.+.... ......+..|.. +++.++||||+++++++.. ....++||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~-----~~~~~lv~ 75 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQT-----AEKLYFVL 75 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEc-----CCEEEEEE
Confidence 36999999999999986 47899999986432 122334555554 6788999999999988863 45699999
Q ss_pred eeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccccCC
Q 046270 345 DYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEG 424 (590)
Q Consensus 345 E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~~~~ 424 (590)
||+++|+|..++. ....+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 76 e~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 149 (321)
T cd05603 76 DYVNGGELFFHLQ---RERCFLEPRARFYAAEVASAIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP 149 (321)
T ss_pred cCCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCC
Confidence 9999999988774 3456889999999999999999999 899999999999999999999999999998753222
Q ss_pred CcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhhhHHHh
Q 046270 425 HSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDEFIR 504 (590)
Q Consensus 425 ~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 504 (590)
. .......||+.|+|||.+....++.++|||||||++|||++|+.||...... +....... +.. .
T Consensus 150 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-----~~~~~i~~-~~~-~------- 214 (321)
T cd05603 150 E-ETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVS-----QMYDNILH-KPL-Q------- 214 (321)
T ss_pred C-CccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHH-----HHHHHHhc-CCC-C-------
Confidence 2 2234457899999999999889999999999999999999999999653221 11111111 110 0
Q ss_pred hhhHHHHHHHHHHHHHhchhcCCCCCCCHH
Q 046270 505 AEGARAVMERFVLVGILCAHVMVALRPTIT 534 (590)
Q Consensus 505 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~ 534 (590)
.+......+.+++..|++.+|.+||+..
T Consensus 215 --~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 215 --LPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred --CCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 0111223567888999999999999753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=330.92 Aligned_cols=245 Identities=22% Similarity=0.250 Sum_probs=196.5
Q ss_pred cCCCccceecccCcEEEEEEEEcC--CcEEEEEEeecC---CCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCc
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLRH--GNLVAVKQILDL---DTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGK 338 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~~--g~~vAvK~l~~~---~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~ 338 (590)
++|...+.||+|+||.||+|++++ +..||+|++... .....+.+.+|+++++.++||||+++++++.. +.
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~-----~~ 104 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKD-----ES 104 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEe-----CC
Confidence 468888999999999999998754 358999998643 22334578899999999999999999999873 45
Q ss_pred eEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCc
Q 046270 339 RRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLA 418 (590)
Q Consensus 339 ~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla 418 (590)
..++||||+++|+|.+++. ....+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++
T Consensus 105 ~~~lv~Ey~~~g~L~~~i~---~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~ikL~DFG~a 178 (340)
T PTZ00426 105 YLYLVLEFVIGGEFFTFLR---RNKRFPNDVGCFYAAQIVLIFEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFA 178 (340)
T ss_pred EEEEEEeCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEecCCCC
Confidence 6999999999999999885 3456999999999999999999999 899999999999999999999999999999
Q ss_pred ccccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhh
Q 046270 419 KQSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDI 498 (590)
Q Consensus 419 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 498 (590)
+..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ... .....+...
T Consensus 179 ~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~-~~~-----~~i~~~~~~-- 246 (340)
T PTZ00426 179 KVVDTR----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL-LIY-----QKILEGIIY-- 246 (340)
T ss_pred eecCCC----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH-HHH-----HHHhcCCCC--
Confidence 865322 23457899999999999888999999999999999999999999753321 111 111111110
Q ss_pred hhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCC-----CHHHHHHH
Q 046270 499 FDEFIRAEGARAVMERFVLVGILCAHVMVALRP-----TITDALKM 539 (590)
Q Consensus 499 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-----tm~eVl~~ 539 (590)
+ +......+.+++..|++.+|++|+ +++++++.
T Consensus 247 ~--------p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 247 F--------PKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred C--------CCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 0 111223566788899999999995 88888765
|
|
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=318.79 Aligned_cols=263 Identities=23% Similarity=0.357 Sum_probs=201.5
Q ss_pred hcCCCccceecccCcEEEEEEEEcC-----------------CcEEEEEEeecCCC-CChHHHHHHHHHHHhcCCCCccc
Q 046270 263 TNGFSQNNLIGQGASGIVYKGTLRH-----------------GNLVAVKQILDLDT-KGDEDFTNEVEIISKIRHRNLLS 324 (590)
Q Consensus 263 t~~f~~~~~LG~G~fG~Vykg~~~~-----------------g~~vAvK~l~~~~~-~~~~~f~~Ev~il~~l~H~nlv~ 324 (590)
..+|...+.||+|+||.||++++.+ +..||+|++..... ...+++.+|++++++++|+|+++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 3568888999999999999998753 23589998865432 23567899999999999999999
Q ss_pred cceeEEeccCCCCceEEEEEeeCCCCCcchhhhhhc--------ccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecC
Q 046270 325 LRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISH--------KRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRD 396 (590)
Q Consensus 325 l~g~~~~~~~~~~~~~~LV~E~~~~gsL~~~L~~~~--------~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrD 396 (590)
+++++.. +...++||||+++++|.+++.... ....+++..++.++.|++.||+||| +.+|+|||
T Consensus 84 ~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH---~~~i~H~d 155 (296)
T cd05051 84 LLGVCTV-----DPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRD 155 (296)
T ss_pred EEEEEec-----CCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHH---HcCccccc
Confidence 9999874 345899999999999999986432 1126899999999999999999999 89999999
Q ss_pred CCCCceEECCCCcEEEEeeCCcccccCCCc-ccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHh--CCCCCC
Q 046270 397 IKSTNILLDSELNAKVADFGLAKQSLEGHS-HLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS--GRKVLD 473 (590)
Q Consensus 397 IKp~NILLd~~~~~kL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELlt--G~~p~~ 473 (590)
|||+||++++++.+||+|||+++....... .......++..|+|||++..+.++.++||||||+++|||++ |..|+.
T Consensus 156 lkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~ 235 (296)
T cd05051 156 LATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYE 235 (296)
T ss_pred cchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCC
Confidence 999999999999999999999986543322 12334456789999999998899999999999999999998 556665
Q ss_pred CCCCchhhhhHHHHHHHhcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhc
Q 046270 474 TSTSPFQLITDWAWVLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLE 541 (590)
Q Consensus 474 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~ 541 (590)
..... .+.......++......... .+......+.+++..|++.+|++|||+.|+++.|+
T Consensus 236 ~~~~~--~~~~~~~~~~~~~~~~~~~~------~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 236 HLTDQ--QVIENAGHFFRDDGRQIYLP------RPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred CcChH--HHHHHHHhccccccccccCC------CccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 33221 11112221111111111110 01112347889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=316.87 Aligned_cols=247 Identities=23% Similarity=0.279 Sum_probs=192.3
Q ss_pred ecccCcEEEEEEEEc-CCcEEEEEEeecCCC---CChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEEEEEeeC
Q 046270 272 IGQGASGIVYKGTLR-HGNLVAVKQILDLDT---KGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFLVYDYM 347 (590)
Q Consensus 272 LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~---~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~LV~E~~ 347 (590)
||+|+||+||++... +|+.+|+|++..... ...+.+..|++++++++|+||+++.+++.. +...++||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~-----~~~~~lv~e~~ 75 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQT-----KTDLCLVMTIM 75 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcC-----CCeEEEEEeCC
Confidence 699999999999876 578999999864322 223567889999999999999999988763 45689999999
Q ss_pred CCCCcchhhhhhc-ccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccccCCCc
Q 046270 348 PNGTLSDNISISH-KRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHS 426 (590)
Q Consensus 348 ~~gsL~~~L~~~~-~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~~~~~~ 426 (590)
++|+|.+++.... ....+++..+..++.||+.||.||| +.+|+||||||+||+++.++.+||+|||+++.......
T Consensus 76 ~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~ 152 (280)
T cd05608 76 NGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS 152 (280)
T ss_pred CCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc
Confidence 9999988774322 3356999999999999999999999 89999999999999999999999999999976544322
Q ss_pred ccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhhhHHHhhh
Q 046270 427 HLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDEFIRAE 506 (590)
Q Consensus 427 ~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 506 (590)
......||..|+|||.+.++.++.++||||||+++|||++|+.||......... ......... +.. .
T Consensus 153 -~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~-~~~~~~~~~-~~~----------~ 219 (280)
T cd05608 153 -KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN-KELKQRILN-DSV----------T 219 (280)
T ss_pred -cccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhH-HHHHHhhcc-cCC----------C
Confidence 233457899999999999999999999999999999999999999754332110 000000000 000 0
Q ss_pred hHHHHHHHHHHHHHhchhcCCCCCC-----CHHHHHHH
Q 046270 507 GARAVMERFVLVGILCAHVMVALRP-----TITDALKM 539 (590)
Q Consensus 507 ~~~~~~~~l~~l~~~Cl~~dp~~RP-----tm~eVl~~ 539 (590)
.+......+.+++..|++.||++|| ++++++++
T Consensus 220 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 220 YPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred CcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 1112334677888999999999999 67777753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=321.11 Aligned_cols=254 Identities=22% Similarity=0.376 Sum_probs=197.6
Q ss_pred CCccceecccCcEEEEEEEEcC------CcEEEEEEeecCCCCC-hHHHHHHHHHHHhcCCCCccccceeEEeccCCCCc
Q 046270 266 FSQNNLIGQGASGIVYKGTLRH------GNLVAVKQILDLDTKG-DEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGK 338 (590)
Q Consensus 266 f~~~~~LG~G~fG~Vykg~~~~------g~~vAvK~l~~~~~~~-~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~ 338 (590)
|...+.||+|+||.||+|++.+ +..||+|++....... .+.+.+|++++.+++||||+++++++.. ..
T Consensus 7 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~-----~~ 81 (283)
T cd05091 7 VRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTK-----EQ 81 (283)
T ss_pred HHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-----CC
Confidence 5566789999999999998743 4689999986543222 3568899999999999999999999874 34
Q ss_pred eEEEEEeeCCCCCcchhhhhhc-------------ccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEC
Q 046270 339 RRFLVYDYMPNGTLSDNISISH-------------KRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLD 405 (590)
Q Consensus 339 ~~~LV~E~~~~gsL~~~L~~~~-------------~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd 405 (590)
..++++||+++++|.+++.... .+..+++..+++++.|++.||.||| +.+|+||||||+||+++
T Consensus 82 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH---~~gi~H~dlkp~Nil~~ 158 (283)
T cd05091 82 PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS---SHHVVHKDLATRNVLVF 158 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HcCccccccchhheEec
Confidence 5899999999999999884211 1235899999999999999999999 89999999999999999
Q ss_pred CCCcEEEEeeCCcccccCCCc-ccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhh
Q 046270 406 SELNAKVADFGLAKQSLEGHS-HLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLDTSTSPFQLIT 483 (590)
Q Consensus 406 ~~~~~kL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELlt-G~~p~~~~~~~~~~l~ 483 (590)
+++.+||+|||+++....... .......+++.|+|||.+.++.++.++||||||+++|||++ |..|+......
T Consensus 159 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~----- 233 (283)
T cd05091 159 DKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ----- 233 (283)
T ss_pred CCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH-----
Confidence 999999999999886543322 12233445779999999998999999999999999999998 77777543221
Q ss_pred HHHHHHHhcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhcc
Q 046270 484 DWAWVLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEG 542 (590)
Q Consensus 484 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~ 542 (590)
++... ...+.... .+.+....+..++..|++.+|.+||++.+++..|+.
T Consensus 234 ~~~~~-i~~~~~~~---------~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 234 DVIEM-IRNRQVLP---------CPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHHHH-HHcCCcCC---------CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 11111 11121111 111233467789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=313.35 Aligned_cols=251 Identities=25% Similarity=0.430 Sum_probs=198.9
Q ss_pred CCCccceecccCcEEEEEEEEcCCcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEEEEE
Q 046270 265 GFSQNNLIGQGASGIVYKGTLRHGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFLVY 344 (590)
Q Consensus 265 ~f~~~~~LG~G~fG~Vykg~~~~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~LV~ 344 (590)
+|+..+.||+|+||.||+|.+.++..+|+|.+.... ....+|.+|++++++++|||++++++++.. ....++||
T Consensus 5 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~~v~ 78 (256)
T cd05112 5 ELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTE-----RSPICLVF 78 (256)
T ss_pred HeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEcc-----CCceEEEE
Confidence 566778999999999999998878899999876432 335679999999999999999999998863 34589999
Q ss_pred eeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccccCC
Q 046270 345 DYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEG 424 (590)
Q Consensus 345 E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~~~~ 424 (590)
||+++++|.+++.. ....++|+.+..++.+++.||+||| +.+++||||||+||+++.++.+||+|||+++.....
T Consensus 79 e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~ 153 (256)
T cd05112 79 EFMEHGCLSDYLRA--QRGKFSQETLLGMCLDVCEGMAYLE---SSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDD 153 (256)
T ss_pred EcCCCCcHHHHHHh--CccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccccceEEEcCCCeEEECCCcceeecccC
Confidence 99999999998853 2346899999999999999999999 889999999999999999999999999998765432
Q ss_pred CcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhhHHHHHHHhcCCchhhhhHHH
Q 046270 425 HSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDEFI 503 (590)
Q Consensus 425 ~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 503 (590)
.........++.+|+|||++.++.++.++||||||+++|||++ |+.|+...... ........... ...+.
T Consensus 154 ~~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~-----~~~~~~~~~~~---~~~~~- 224 (256)
T cd05112 154 QYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS-----EVVETINAGFR---LYKPR- 224 (256)
T ss_pred cccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH-----HHHHHHhCCCC---CCCCC-
Confidence 2211222334678999999998999999999999999999998 88888643221 11111111101 01111
Q ss_pred hhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhc
Q 046270 504 RAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLE 541 (590)
Q Consensus 504 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~ 541 (590)
...+.+.+++.+|++.+|++|||+.||+++|.
T Consensus 225 ------~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 225 ------LASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred ------CCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 11347888999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-38 Score=344.96 Aligned_cols=265 Identities=22% Similarity=0.265 Sum_probs=206.2
Q ss_pred HHHHHHhcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCC--CCChHHHHHHHHHHHhcCCCCccccceeEEecc
Q 046270 257 SELEQATNGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLD--TKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSD 333 (590)
Q Consensus 257 ~el~~at~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~--~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~ 333 (590)
.+.+...++|...+.||+|+||.||+++.. +|+.||||++.... ......+.+|+.++..++|+|++++...+...+
T Consensus 25 ~~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~ 104 (496)
T PTZ00283 25 ATAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKD 104 (496)
T ss_pred ccccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceeccc
Confidence 344555678999999999999999999875 58899999986432 233456889999999999999999888765443
Q ss_pred CC---CCceEEEEEeeCCCCCcchhhhhhc-ccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCc
Q 046270 334 DS---SGKRRFLVYDYMPNGTLSDNISISH-KRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELN 409 (590)
Q Consensus 334 ~~---~~~~~~LV~E~~~~gsL~~~L~~~~-~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~ 409 (590)
.. .....++||||+++|+|.+++.... ....+++..+..|+.|++.||+||| +.+|+||||||+|||++.++.
T Consensus 105 ~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH---~~~IiHrDLKP~NILl~~~~~ 181 (496)
T PTZ00283 105 PRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVH---SKHMIHRDIKSANILLCSNGL 181 (496)
T ss_pred ccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEeCCCC
Confidence 21 1224789999999999999886432 2346899999999999999999999 899999999999999999999
Q ss_pred EEEEeeCCcccccCCCc-ccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHH
Q 046270 410 AKVADFGLAKQSLEGHS-HLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWV 488 (590)
Q Consensus 410 ~kL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~ 488 (590)
+||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .++...
T Consensus 182 vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~-----~~~~~~ 256 (496)
T PTZ00283 182 VKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENM-----EEVMHK 256 (496)
T ss_pred EEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH-----HHHHHH
Confidence 99999999986543222 223456799999999999999999999999999999999999999964321 111111
Q ss_pred HHhcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 489 LAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 489 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
. ..+.... .+......+..++..|++.+|.+||++.+++++
T Consensus 257 ~-~~~~~~~---------~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 257 T-LAGRYDP---------LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred H-hcCCCCC---------CCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 1 1111111 111223467788999999999999999999864
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=323.48 Aligned_cols=247 Identities=24% Similarity=0.350 Sum_probs=192.1
Q ss_pred ceecccCcEEEEEEEEcC-CcEEEEEEeecCC---CCChHHHHHHHHHHHhc-CCCCccccceeEEeccCCCCceEEEEE
Q 046270 270 NLIGQGASGIVYKGTLRH-GNLVAVKQILDLD---TKGDEDFTNEVEIISKI-RHRNLLSLRGCCVTSDDSSGKRRFLVY 344 (590)
Q Consensus 270 ~~LG~G~fG~Vykg~~~~-g~~vAvK~l~~~~---~~~~~~f~~Ev~il~~l-~H~nlv~l~g~~~~~~~~~~~~~~LV~ 344 (590)
+.||+|+||.||+++.+. ++.+|+|.+.... ......+.+|+.++.++ +||||+++++++.. +...++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~-----~~~~~lv~ 75 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT-----ESRLFFVI 75 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEe-----CCEEEEEE
Confidence 469999999999999864 7789999987532 22334577899998887 89999999999874 45699999
Q ss_pred eeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccccCC
Q 046270 345 DYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEG 424 (590)
Q Consensus 345 E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~~~~ 424 (590)
||+++|+|..++. ....+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 76 E~~~~~~L~~~~~---~~~~l~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~ 149 (329)
T cd05618 76 EYVNGGDLMFHMQ---RQRKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 149 (329)
T ss_pred eCCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCC
Confidence 9999999988774 3457999999999999999999999 899999999999999999999999999998753222
Q ss_pred CcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc---hhhhhHHHHHHHhcCCchhhhhH
Q 046270 425 HSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSP---FQLITDWAWVLAKSGKVDDIFDE 501 (590)
Q Consensus 425 ~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~---~~~l~~~~~~~~~~~~~~~~~d~ 501 (590)
. .......||..|+|||++.+..++.++||||||+++|||++|+.||...... ......+.......+...
T Consensus 150 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~----- 223 (329)
T cd05618 150 G-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR----- 223 (329)
T ss_pred C-CccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCC-----
Confidence 1 1233467899999999999999999999999999999999999999632211 112222332222222110
Q ss_pred HHhhhhHHHHHHHHHHHHHhchhcCCCCCCC------HHHHHH
Q 046270 502 FIRAEGARAVMERFVLVGILCAHVMVALRPT------ITDALK 538 (590)
Q Consensus 502 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt------m~eVl~ 538 (590)
.+......+..++..|++.||.+||+ +.++++
T Consensus 224 -----~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05618 224 -----IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 261 (329)
T ss_pred -----CCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhc
Confidence 11122346678889999999999998 567654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=314.43 Aligned_cols=246 Identities=24% Similarity=0.370 Sum_probs=192.7
Q ss_pred eecccCcEEEEEEEEc---CCcEEEEEEeecCCCC-ChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEEEEEee
Q 046270 271 LIGQGASGIVYKGTLR---HGNLVAVKQILDLDTK-GDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFLVYDY 346 (590)
Q Consensus 271 ~LG~G~fG~Vykg~~~---~g~~vAvK~l~~~~~~-~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~LV~E~ 346 (590)
.||+|+||.||+|++. .+..||+|.+...... ..+.|.+|++++++++|+||+++++++.. ...++||||
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~------~~~~lv~e~ 75 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA------EALMLVMEM 75 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC------CCeEEEEEe
Confidence 3899999999999875 3457999988654332 24568999999999999999999998742 347999999
Q ss_pred CCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccccCCCc
Q 046270 347 MPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHS 426 (590)
Q Consensus 347 ~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~~~~~~ 426 (590)
+++|+|.+++.. ....+++..+++++.|++.||.||| ..+++||||||+|||++.++.+||+|||+++.......
T Consensus 76 ~~~~~L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~ 150 (257)
T cd05115 76 ASGGPLNKFLSG--KKDEITVSNVVELMHQVSMGMKYLE---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDS 150 (257)
T ss_pred CCCCCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHH---hcCeeecccchheEEEcCCCcEEeccCCccccccCCcc
Confidence 999999998852 2457999999999999999999999 88999999999999999999999999999986543332
Q ss_pred ccc--cccccCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhhHHHHHHHhcCCchhhhhHHH
Q 046270 427 HLT--TRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDEFI 503 (590)
Q Consensus 427 ~~~--~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 503 (590)
... ....++..|+|||.+....++.++||||||+++|||++ |+.||....... +. .....+...+
T Consensus 151 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-----~~-~~~~~~~~~~------ 218 (257)
T cd05115 151 YYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE-----VM-SFIEQGKRLD------ 218 (257)
T ss_pred ceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH-----HH-HHHHCCCCCC------
Confidence 211 12223578999999988889999999999999999997 999986543211 11 1111221111
Q ss_pred hhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhcc
Q 046270 504 RAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEG 542 (590)
Q Consensus 504 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~ 542 (590)
.+....+.+.+++..|++.+|++||++.+|.+.|+.
T Consensus 219 ---~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~ 254 (257)
T cd05115 219 ---CPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRT 254 (257)
T ss_pred ---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhh
Confidence 011123467789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=312.36 Aligned_cols=249 Identities=31% Similarity=0.451 Sum_probs=200.8
Q ss_pred cCCCccceecccCcEEEEEEEEcCCcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEEEE
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLRHGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFLV 343 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~LV 343 (590)
++|...+.||+|+||.||+|... |+.||+|.+..... ..+++.+|+.++++++|+|++++++++.. +...++|
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~~v 78 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQ-----GNPLYIV 78 (256)
T ss_pred hhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcC-----CCCeEEE
Confidence 46778899999999999999876 78999999876543 46679999999999999999999999874 3458999
Q ss_pred EeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccccC
Q 046270 344 YDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLE 423 (590)
Q Consensus 344 ~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~~~ 423 (590)
|||+++++|.+++... ....++|..+..++.|++.||.||| ..+++||||||+||++++++.+||+|||+++....
T Consensus 79 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~ 154 (256)
T cd05039 79 TEYMAKGSLVDYLRSR-GRAVITLAQQLGFALDVCEGMEYLE---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQ 154 (256)
T ss_pred EEecCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHH---hCCccchhcccceEEEeCCCCEEEccccccccccc
Confidence 9999999999988532 2236999999999999999999999 89999999999999999999999999999986633
Q ss_pred CCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhhHHHHHHHhcCCchhhhhHH
Q 046270 424 GHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDEF 502 (590)
Q Consensus 424 ~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 502 (590)
... ...++..|+|||++..+.++.++||||||++++||++ |+.|+...... .+.. ....+...+
T Consensus 155 ~~~----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~~----~~~~~~~~~----- 219 (256)
T cd05039 155 GQD----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--DVVP----HVEKGYRME----- 219 (256)
T ss_pred ccc----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH--HHHH----HHhcCCCCC-----
Confidence 221 2334678999999998899999999999999999998 98888543211 1111 111111000
Q ss_pred HhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhcc
Q 046270 503 IRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEG 542 (590)
Q Consensus 503 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~ 542 (590)
.+...+..+.+++..|+..+|++|||++|++++|+.
T Consensus 220 ----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 220 ----APEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred ----CccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 111223577889999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=319.80 Aligned_cols=262 Identities=23% Similarity=0.367 Sum_probs=197.1
Q ss_pred cCCCccceecccCcEEEEEEEEcC---------------CcEEEEEEeecCCC-CChHHHHHHHHHHHhcCCCCccccce
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLRH---------------GNLVAVKQILDLDT-KGDEDFTNEVEIISKIRHRNLLSLRG 327 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~~---------------g~~vAvK~l~~~~~-~~~~~f~~Ev~il~~l~H~nlv~l~g 327 (590)
++|...+.||+|+||.||+++..+ ...||+|.+..... .....|.+|++++++++|+|++++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 468888999999999999987643 12589998865322 23457999999999999999999999
Q ss_pred eEEeccCCCCceEEEEEeeCCCCCcchhhhhhcc---------cccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCC
Q 046270 328 CCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHK---------RKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIK 398 (590)
Q Consensus 328 ~~~~~~~~~~~~~~LV~E~~~~gsL~~~L~~~~~---------~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIK 398 (590)
++.. ....++||||+++++|.+++..... ...++|..++.++.|+++||+||| +.+++|||||
T Consensus 85 ~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlk 156 (295)
T cd05097 85 VCVS-----DDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLA---SLNFVHRDLA 156 (295)
T ss_pred EEcC-----CCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHH---hcCeeccccC
Confidence 9874 3458999999999999998853211 124789999999999999999999 8999999999
Q ss_pred CCceEECCCCcEEEEeeCCcccccCCCcc-cccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHh--CCCCCCCC
Q 046270 399 STNILLDSELNAKVADFGLAKQSLEGHSH-LTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS--GRKVLDTS 475 (590)
Q Consensus 399 p~NILLd~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELlt--G~~p~~~~ 475 (590)
|+||++++++.+||+|||+++........ ......++..|+|||++..+.++.++||||||++++||++ |..||...
T Consensus 157 p~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~ 236 (295)
T cd05097 157 TRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLL 236 (295)
T ss_pred hhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCccc
Confidence 99999999999999999999765433221 1223345778999999999999999999999999999998 44565533
Q ss_pred CCchhhhhHHHHHHHhcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhc
Q 046270 476 TSPFQLITDWAWVLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLE 541 (590)
Q Consensus 476 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~ 541 (590)
... ..+..... .+......... .........+.+++..|++.+|++||+|++|+++|+
T Consensus 237 ~~~-~~~~~~~~-~~~~~~~~~~~------~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 237 SDE-QVIENTGE-FFRNQGRQIYL------SQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred ChH-HHHHHHHH-hhhhccccccC------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 221 11111111 11110000000 001112347889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=335.80 Aligned_cols=255 Identities=24% Similarity=0.397 Sum_probs=209.2
Q ss_pred hcCCCccceecccCcEEEEEEEEcC-CcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEE
Q 046270 263 TNGFSQNNLIGQGASGIVYKGTLRH-GNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRF 341 (590)
Q Consensus 263 t~~f~~~~~LG~G~fG~Vykg~~~~-g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~ 341 (590)
..+....++||-|.||.||.|+|+. .-.||||.++.. ....++|.+|..+|+.++|||+|+|+|.|.... ..|
T Consensus 266 RtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~Ep-----PFY 339 (1157)
T KOG4278|consen 266 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEP-----PFY 339 (1157)
T ss_pred chheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCC-----CeE
Confidence 3445566899999999999999986 568999998764 345789999999999999999999999998544 489
Q ss_pred EEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccc
Q 046270 342 LVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQS 421 (590)
Q Consensus 342 LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~ 421 (590)
+|.|||.+|+|.+||.... +..++--..+.++.||+.||+||. .+++|||||.++|.|+.++..+||+||||+|.+
T Consensus 340 IiTEfM~yGNLLdYLRecn-r~ev~avvLlyMAtQIsSaMeYLE---kknFIHRDLAARNCLVgEnhiVKvADFGLsRlM 415 (1157)
T KOG4278|consen 340 IITEFMCYGNLLDYLRECN-RSEVPAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHIVKVADFGLSRLM 415 (1157)
T ss_pred EEEecccCccHHHHHHHhc-hhhcchhHHHHHHHHHHHHHHHHH---HhhhhhhhhhhhhccccccceEEeeccchhhhh
Confidence 9999999999999997543 446777888999999999999999 999999999999999999999999999999987
Q ss_pred cCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhhHHHHHHHhcCCchhhhh
Q 046270 422 LEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFD 500 (590)
Q Consensus 422 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 500 (590)
..+.........-...|.|||-+....++.|+|||+|||+||||.| |..|+-..+ +. .+-+++.
T Consensus 416 tgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid-----lS----------qVY~LLE 480 (1157)
T KOG4278|consen 416 TGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID-----LS----------QVYGLLE 480 (1157)
T ss_pred cCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc-----HH----------HHHHHHh
Confidence 6654433333334678999999999999999999999999999999 666654321 11 1123334
Q ss_pred HHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhcc
Q 046270 501 EFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEG 542 (590)
Q Consensus 501 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~ 542 (590)
+..+-+.++..+..+.++++.||+++|.+||++.|+-+.+|.
T Consensus 481 kgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEt 522 (1157)
T KOG4278|consen 481 KGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFET 522 (1157)
T ss_pred ccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHH
Confidence 444444556667789999999999999999999988776654
|
|
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-38 Score=319.46 Aligned_cols=255 Identities=25% Similarity=0.427 Sum_probs=198.9
Q ss_pred cCCCccceecccCcEEEEEEEEc------CCcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCC
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLR------HGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSG 337 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~------~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~ 337 (590)
.+|....+||+|+||.||++... ++..+|+|.+..........|.+|++++++++|+||+++++++.. +
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~ 79 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTE-----G 79 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEec-----C
Confidence 35666789999999999999743 355799998876555556789999999999999999999998874 3
Q ss_pred ceEEEEEeeCCCCCcchhhhhhcc------------cccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEC
Q 046270 338 KRRFLVYDYMPNGTLSDNISISHK------------RKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLD 405 (590)
Q Consensus 338 ~~~~LV~E~~~~gsL~~~L~~~~~------------~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd 405 (590)
...++||||+++|+|.+++..... ...++|..++.++.|++.||+||| +.+++||||||+|||++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~nil~~ 156 (280)
T cd05092 80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA---SLHFVHRDLATRNCLVG 156 (280)
T ss_pred CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHH---HCCeecccccHhhEEEc
Confidence 458999999999999998853221 135899999999999999999999 89999999999999999
Q ss_pred CCCcEEEEeeCCcccccCCCc-ccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhh
Q 046270 406 SELNAKVADFGLAKQSLEGHS-HLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLDTSTSPFQLIT 483 (590)
Q Consensus 406 ~~~~~kL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELlt-G~~p~~~~~~~~~~l~ 483 (590)
+++.+||+|||+++....... .......++..|+|||++....++.++|||||||++|||++ |+.||........ +
T Consensus 157 ~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~-~- 234 (280)
T cd05092 157 QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEA-I- 234 (280)
T ss_pred CCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHH-H-
Confidence 999999999999975543221 11223345678999999998999999999999999999999 8888754322111 1
Q ss_pred HHHHHHHhcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhc
Q 046270 484 DWAWVLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLE 541 (590)
Q Consensus 484 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~ 541 (590)
... ..+...+ .+......+.+++..|++.||++||++.||++.|+
T Consensus 235 ---~~~-~~~~~~~---------~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 235 ---ECI-TQGRELE---------RPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred ---HHH-HcCccCC---------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 000 1111000 01112245678889999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=316.48 Aligned_cols=269 Identities=23% Similarity=0.322 Sum_probs=208.6
Q ss_pred ccHHHHHHHhcCCCccceecccCcEEEEEEEEcC-CcEEEEEEeecCCCCChHHHHHHHHHHHhc-CCCCccccceeEEe
Q 046270 254 FHVSELEQATNGFSQNNLIGQGASGIVYKGTLRH-GNLVAVKQILDLDTKGDEDFTNEVEIISKI-RHRNLLSLRGCCVT 331 (590)
Q Consensus 254 f~~~el~~at~~f~~~~~LG~G~fG~Vykg~~~~-g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l-~H~nlv~l~g~~~~ 331 (590)
+.++.+..+.++|...+.||+|+||.||+++... ++.+|+|.+.... ....++.+|+.++.++ +|+|++++++++..
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 4556777889999999999999999999998864 7889999875432 2346788999999999 69999999999876
Q ss_pred ccCCCCceEEEEEeeCCCCCcchhhhhhc-ccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcE
Q 046270 332 SDDSSGKRRFLVYDYMPNGTLSDNISISH-KRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNA 410 (590)
Q Consensus 332 ~~~~~~~~~~LV~E~~~~gsL~~~L~~~~-~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~ 410 (590)
.+...+...++||||+++++|.+++.... ....+++..+..++.|+++||.||| +.+|+||||||+||++++++.+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~ 163 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH---VNKTIHRDVKGNNILLTTEGGV 163 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHH---hCCccccCCCHHhEEECCCCCE
Confidence 54445667999999999999998875322 3356899999999999999999999 8999999999999999999999
Q ss_pred EEEeeCCcccccCCCcccccccccCCCccCcccccc-----CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHH
Q 046270 411 KVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALY-----GQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDW 485 (590)
Q Consensus 411 kL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~-----~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~ 485 (590)
||+|||+++....... ......|+..|+|||++.. ..++.++|||||||++|||++|+.|+....... .+..+
T Consensus 164 kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~-~~~~~ 241 (286)
T cd06638 164 KLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR-ALFKI 241 (286)
T ss_pred EEccCCceeecccCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH-HHhhc
Confidence 9999999876543221 2233468999999998753 457889999999999999999999986533211 11110
Q ss_pred HHHHHhcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHh
Q 046270 486 AWVLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKML 540 (590)
Q Consensus 486 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L 540 (590)
..+......++. .....+..++..|++.+|++|||+.|+++.+
T Consensus 242 -----~~~~~~~~~~~~-------~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 242 -----PRNPPPTLHQPE-------LWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred -----cccCCCcccCCC-------CcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 011111111111 1123577889999999999999999998753
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=327.05 Aligned_cols=260 Identities=25% Similarity=0.348 Sum_probs=199.6
Q ss_pred hcCCCccceecccCcEEEEEEEE------cCCcEEEEEEeecCCC-CChHHHHHHHHHHHhc-CCCCccccceeEEeccC
Q 046270 263 TNGFSQNNLIGQGASGIVYKGTL------RHGNLVAVKQILDLDT-KGDEDFTNEVEIISKI-RHRNLLSLRGCCVTSDD 334 (590)
Q Consensus 263 t~~f~~~~~LG~G~fG~Vykg~~------~~g~~vAvK~l~~~~~-~~~~~f~~Ev~il~~l-~H~nlv~l~g~~~~~~~ 334 (590)
.++|...+.||+|+||.||+|++ ..++.||||++..... .....+.+|++++.++ +|+||+++++++...
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~-- 83 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP-- 83 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecC--
Confidence 35688889999999999999974 2467899999865332 2245688999999999 789999999988643
Q ss_pred CCCceEEEEEeeCCCCCcchhhhhhcc-----------------------------------------------------
Q 046270 335 SSGKRRFLVYDYMPNGTLSDNISISHK----------------------------------------------------- 361 (590)
Q Consensus 335 ~~~~~~~LV~E~~~~gsL~~~L~~~~~----------------------------------------------------- 361 (590)
+...++||||+++|+|.+++.....
T Consensus 84 --~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (343)
T cd05103 84 --GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDV 161 (343)
T ss_pred --CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccc
Confidence 3458999999999999998853210
Q ss_pred -----------cccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccccCCCcc-cc
Q 046270 362 -----------RKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSH-LT 429 (590)
Q Consensus 362 -----------~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~~~~~~~-~~ 429 (590)
...++|.++..++.||++||+||| +.+|+||||||+|||+++++.+||+|||+++........ ..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 238 (343)
T cd05103 162 EEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRK 238 (343)
T ss_pred hhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhc
Confidence 124789999999999999999999 899999999999999999999999999999865332221 12
Q ss_pred cccccCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhhHHHHHHHhcCCchhhhhHHHhhhhH
Q 046270 430 TRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDEFIRAEGA 508 (590)
Q Consensus 430 ~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 508 (590)
....++..|+|||.+....++.++||||||+++|||++ |..|+......... . .....+..... +
T Consensus 239 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~----~-~~~~~~~~~~~---------~ 304 (343)
T cd05103 239 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF----C-RRLKEGTRMRA---------P 304 (343)
T ss_pred CCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHH----H-HHHhccCCCCC---------C
Confidence 22345678999999988899999999999999999997 88887643222111 1 11112211110 0
Q ss_pred HHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhccC
Q 046270 509 RAVMERFVLVGILCAHVMVALRPTITDALKMLEGD 543 (590)
Q Consensus 509 ~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~~ 543 (590)
......+.+++..|++.+|++|||+.|+++.|+..
T Consensus 305 ~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~ 339 (343)
T cd05103 305 DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 339 (343)
T ss_pred CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 01123677888999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=311.60 Aligned_cols=251 Identities=26% Similarity=0.326 Sum_probs=198.5
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCCC-----ChHHHHHHHHHHHhcCCCCccccceeEEeccCCCC
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDTK-----GDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSG 337 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~~-----~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~ 337 (590)
++|...+.||+|+||.||++... .++.+|+|.+...... ....+.+|++++++++||||+++++++.. +
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~ 76 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRD-----D 76 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEcc-----C
Confidence 57888999999999999999875 4889999988643211 23468899999999999999999999874 3
Q ss_pred ceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCC
Q 046270 338 KRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGL 417 (590)
Q Consensus 338 ~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGl 417 (590)
...++|+||+++++|.+++. ....+++..+..++.+++.||.||| +.+|+||||||+||++++++++||+|||+
T Consensus 77 ~~~~~v~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nilv~~~~~~~l~dfg~ 150 (263)
T cd06625 77 ETLSIFMEYMPGGSVKDQLK---AYGALTETVTRKYTRQILEGVEYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGA 150 (263)
T ss_pred CeEEEEEEECCCCcHHHHHH---HhCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeeccc
Confidence 46999999999999999885 3356899999999999999999999 89999999999999999999999999999
Q ss_pred cccccCCCcccc--cccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCc
Q 046270 418 AKQSLEGHSHLT--TRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKV 495 (590)
Q Consensus 418 a~~~~~~~~~~~--~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~ 495 (590)
++.......... ....|+..|+|||.+.+..++.++||||||+++|||++|+.||....... ... + .......
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~~---~-~~~~~~~ 225 (263)
T cd06625 151 SKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMA-AIF---K-IATQPTN 225 (263)
T ss_pred ceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHH-HHH---H-HhccCCC
Confidence 976543222111 33557889999999998889999999999999999999999986432211 110 0 1111110
Q ss_pred hhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 496 DDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 496 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
. ..+......+..++..|++.+|.+|||+.+++++
T Consensus 226 ~---------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 226 P---------QLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred C---------CCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 0 0111223466778899999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=330.02 Aligned_cols=254 Identities=19% Similarity=0.251 Sum_probs=197.1
Q ss_pred HhcCCCccceecccCcEEEEEEEEcC-CcEEEEEEeecC---CCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCC
Q 046270 262 ATNGFSQNNLIGQGASGIVYKGTLRH-GNLVAVKQILDL---DTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSG 337 (590)
Q Consensus 262 at~~f~~~~~LG~G~fG~Vykg~~~~-g~~vAvK~l~~~---~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~ 337 (590)
..++|...++||+|+||.||+++... +..||+|++... .....+.+.+|+++++.++||||+++++++. .+
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~-----~~ 115 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQ-----DD 115 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEe-----cC
Confidence 45678889999999999999999864 789999998642 2223445789999999999999999998887 34
Q ss_pred ceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCC
Q 046270 338 KRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGL 417 (590)
Q Consensus 338 ~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGl 417 (590)
...++||||+++|+|.+++. ...+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+
T Consensus 116 ~~~~lv~Ey~~gg~L~~~l~----~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~kL~DfG~ 188 (370)
T cd05596 116 KYLYMVMEYMPGGDLVNLMS----NYDIPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGT 188 (370)
T ss_pred CEEEEEEcCCCCCcHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEcCCCCEEEEeccc
Confidence 56999999999999999884 235888889999999999999999 89999999999999999999999999999
Q ss_pred cccccCCCcccccccccCCCccCccccccC----CCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcC
Q 046270 418 AKQSLEGHSHLTTRVAGTFGYLAPEYALYG----QLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSG 493 (590)
Q Consensus 418 a~~~~~~~~~~~~~~~gt~~Y~APE~~~~~----~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~ 493 (590)
++..............||+.|+|||.+... .++.++|||||||++|||++|+.||....... . +.. .....
T Consensus 189 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~-~---~~~-i~~~~ 263 (370)
T cd05596 189 CMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG-T---YSK-IMDHK 263 (370)
T ss_pred eeeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHH-H---HHH-HHcCC
Confidence 986543322223445799999999988643 47899999999999999999999997543211 1 111 11110
Q ss_pred CchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCC--CCCHHHHHHH
Q 046270 494 KVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVAL--RPTITDALKM 539 (590)
Q Consensus 494 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~--RPtm~eVl~~ 539 (590)
.... +.. .......+.+++..|++.+|.+ ||++.|+++.
T Consensus 264 ~~~~-~~~------~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 264 NSLT-FPD------DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred CcCC-CCC------cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 0000 000 0012346677888899988987 9999999764
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=320.60 Aligned_cols=260 Identities=24% Similarity=0.387 Sum_probs=200.0
Q ss_pred CCCccceecccCcEEEEEEEEc-----CCcEEEEEEeecCC-CCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCc
Q 046270 265 GFSQNNLIGQGASGIVYKGTLR-----HGNLVAVKQILDLD-TKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGK 338 (590)
Q Consensus 265 ~f~~~~~LG~G~fG~Vykg~~~-----~g~~vAvK~l~~~~-~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~ 338 (590)
.|...+.||+|+||.||++++. .+..||+|.+.... ......+.+|++++++++|+|++++.+++...+ +.
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---~~ 81 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDG---GN 81 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCC---CC
Confidence 4677889999999999999853 46789999986543 233467999999999999999999999887532 34
Q ss_pred eEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCc
Q 046270 339 RRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLA 418 (590)
Q Consensus 339 ~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla 418 (590)
..++||||+++++|.+++.. ....++|..+..++.|++.||+||| +.+++||||||+||++++++.+||+|||++
T Consensus 82 ~~~lv~e~~~g~~L~~~l~~--~~~~~~~~~~~~i~~~i~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~ 156 (284)
T cd05079 82 GIKLIMEFLPSGSLKEYLPR--NKNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLT 156 (284)
T ss_pred ceEEEEEccCCCCHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccchheEEEcCCCCEEECCCccc
Confidence 58999999999999998852 2346899999999999999999999 899999999999999999999999999999
Q ss_pred ccccCCCcc--cccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCch----------hhhhHHH
Q 046270 419 KQSLEGHSH--LTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPF----------QLITDWA 486 (590)
Q Consensus 419 ~~~~~~~~~--~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~----------~~l~~~~ 486 (590)
+........ ......++..|+|||++.+..++.++||||||+++|||+|++.|........ .....+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05079 157 KAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLV 236 (284)
T ss_pred cccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHH
Confidence 865433221 1223456778999999988899999999999999999999886643211100 0011111
Q ss_pred HHHHhcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhcc
Q 046270 487 WVLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEG 542 (590)
Q Consensus 487 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~ 542 (590)
.....+... .........+.+++..|++.+|++|||+.++++.|+.
T Consensus 237 -~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~ 282 (284)
T cd05079 237 -RVLEEGKRL---------PRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEA 282 (284)
T ss_pred -HHHHcCccC---------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHh
Confidence 111111100 0111234578899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=317.59 Aligned_cols=255 Identities=25% Similarity=0.401 Sum_probs=198.7
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCc----EEEEEEeecCCC-CChHHHHHHHHHHHhcCCCCccccceeEEeccCCCC
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLR-HGN----LVAVKQILDLDT-KGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSG 337 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~-~g~----~vAvK~l~~~~~-~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~ 337 (590)
++|...+.||+|+||.||+|++. +|. .||+|.+..... ...+++.+|+.++..++|+|++++++++...
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~----- 81 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS----- 81 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-----
Confidence 45778899999999999999864 344 489998865332 2356788999999999999999999998632
Q ss_pred ceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCC
Q 046270 338 KRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGL 417 (590)
Q Consensus 338 ~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGl 417 (590)
..++++||+++|+|.+++.. ....+++..++.++.||+.||+||| +.+|+||||||+|||+++++.+||+|||+
T Consensus 82 -~~~l~~~~~~~g~l~~~l~~--~~~~~~~~~~~~~~~qi~~~L~~lH---~~~iiH~dlkp~Nil~~~~~~~kL~dfG~ 155 (279)
T cd05109 82 -TVQLVTQLMPYGCLLDYVRE--NKDRIGSQDLLNWCVQIAKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGL 155 (279)
T ss_pred -CcEEEEEcCCCCCHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEcCCCcEEECCCCc
Confidence 36899999999999998853 2346999999999999999999999 89999999999999999999999999999
Q ss_pred cccccCCCccc-ccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhhHHHHHHHhcCCc
Q 046270 418 AKQSLEGHSHL-TTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLDTSTSPFQLITDWAWVLAKSGKV 495 (590)
Q Consensus 418 a~~~~~~~~~~-~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~ 495 (590)
++......... .....++..|+|||...+..++.++||||||+++|||++ |..|++.... ..+..+. ..+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--~~~~~~~----~~~~~ 229 (279)
T cd05109 156 ARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA--REIPDLL----EKGER 229 (279)
T ss_pred eeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHH----HCCCc
Confidence 98664332211 122334678999999998899999999999999999998 8888864322 1122111 11111
Q ss_pred hhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhccCC
Q 046270 496 DDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEGDI 544 (590)
Q Consensus 496 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~~~ 544 (590)
... .......+..++..|++.||++||++.++++.|+...
T Consensus 230 ~~~---------~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~ 269 (279)
T cd05109 230 LPQ---------PPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMA 269 (279)
T ss_pred CCC---------CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 110 0112236678889999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=331.25 Aligned_cols=201 Identities=27% Similarity=0.380 Sum_probs=170.2
Q ss_pred CCCccceecccCcEEEEEEEEcC-CcEEEEEEeecCC---CCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceE
Q 046270 265 GFSQNNLIGQGASGIVYKGTLRH-GNLVAVKQILDLD---TKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRR 340 (590)
Q Consensus 265 ~f~~~~~LG~G~fG~Vykg~~~~-g~~vAvK~l~~~~---~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~ 340 (590)
+|...+.||+|+||.||+++... ++.||||.+.... ......+.+|++++++++|+||+++++.+. .+...
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~-----~~~~~ 76 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQ-----DKDNL 76 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEE-----cCCEE
Confidence 68889999999999999999764 7899999985422 223456889999999999999999999887 34579
Q ss_pred EEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCccc
Q 046270 341 FLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQ 420 (590)
Q Consensus 341 ~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~ 420 (590)
++||||+++|+|.+++. +.+.+++.....++.||+.||+||| +.+|+||||||+|||++.++.+||+|||++..
T Consensus 77 ~lv~E~~~~g~L~~~i~---~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~ 150 (376)
T cd05598 77 YFVMDYIPGGDMMSLLI---RLGIFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTG 150 (376)
T ss_pred EEEEeCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHEEECCCCCEEEEeCCCCcc
Confidence 99999999999999985 3456889999999999999999999 89999999999999999999999999999753
Q ss_pred ccCCC------------------------------------------cccccccccCCCccCccccccCCCCcchhHHHH
Q 046270 421 SLEGH------------------------------------------SHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSF 458 (590)
Q Consensus 421 ~~~~~------------------------------------------~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySf 458 (590)
..... ........||+.|+|||++.+..++.++|||||
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 230 (376)
T cd05598 151 FRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV 230 (376)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeec
Confidence 21000 000123469999999999998899999999999
Q ss_pred HHHHHHHHhCCCCCCCCC
Q 046270 459 GIVILELMSGRKVLDTST 476 (590)
Q Consensus 459 GvvLlELltG~~p~~~~~ 476 (590)
||++|||++|+.||....
T Consensus 231 Gvilyell~G~~Pf~~~~ 248 (376)
T cd05598 231 GVILYEMLVGQPPFLADT 248 (376)
T ss_pred cceeeehhhCCCCCCCCC
Confidence 999999999999997544
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=316.61 Aligned_cols=269 Identities=25% Similarity=0.340 Sum_probs=210.3
Q ss_pred cccHHHHHHHhcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCCCChHHHHHHHHHHHhc-CCCCccccceeEE
Q 046270 253 WFHVSELEQATNGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDTKGDEDFTNEVEIISKI-RHRNLLSLRGCCV 330 (590)
Q Consensus 253 ~f~~~el~~at~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l-~H~nlv~l~g~~~ 330 (590)
.+...++..++++|...+.||+|+||.||++... +++.+|+|.+.... ....++.+|+.++.++ +|+|++++++++.
T Consensus 11 ~~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~ 89 (291)
T cd06639 11 MLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFY 89 (291)
T ss_pred hhhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEE
Confidence 3566777888999999999999999999999985 57899999885432 2356788999999999 8999999999998
Q ss_pred eccCCCCceEEEEEeeCCCCCcchhhhhhc-ccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCc
Q 046270 331 TSDDSSGKRRFLVYDYMPNGTLSDNISISH-KRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELN 409 (590)
Q Consensus 331 ~~~~~~~~~~~LV~E~~~~gsL~~~L~~~~-~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~ 409 (590)
..+...+...++||||+++|+|.+++.... ....++|..++.++.|++.||+||| +.+++||||||+||+++.++.
T Consensus 90 ~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~nili~~~~~ 166 (291)
T cd06639 90 KADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLH---NNRIIHRDVKGNNILLTTEGG 166 (291)
T ss_pred eccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCC
Confidence 665444567999999999999999885322 3356899999999999999999999 889999999999999999999
Q ss_pred EEEEeeCCcccccCCCcccccccccCCCccCccccccCC-----CCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhH
Q 046270 410 AKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALYGQ-----LTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITD 484 (590)
Q Consensus 410 ~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~-----~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~ 484 (590)
+||+|||+++....... ......|+..|+|||.+..+. ++.++|||||||++|||++|+.|+....... .+..
T Consensus 167 ~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~-~~~~ 244 (291)
T cd06639 167 VKLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVK-TLFK 244 (291)
T ss_pred EEEeecccchhcccccc-cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHH-HHHH
Confidence 99999999886543221 122346788999999876443 6899999999999999999999986533211 1111
Q ss_pred HHHHHHhcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 485 WAWVLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 485 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
+ ..+....+.+ ..+....+.+++..|++.+|++||++.|+++.
T Consensus 245 ~-----~~~~~~~~~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 245 I-----PRNPPPTLLH-------PEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred H-----hcCCCCCCCc-------ccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 1 1111111111 11223467889999999999999999999863
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=313.06 Aligned_cols=254 Identities=24% Similarity=0.398 Sum_probs=202.7
Q ss_pred hcCCCccceecccCcEEEEEEEEcCCcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEEE
Q 046270 263 TNGFSQNNLIGQGASGIVYKGTLRHGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFL 342 (590)
Q Consensus 263 t~~f~~~~~LG~G~fG~Vykg~~~~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~L 342 (590)
.++|...++||+|+||.||+|.+.++..+|+|.+.... ...+.+.+|++++++++|+|++++.+++.. ...++
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------~~~~~ 77 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK------EPIYI 77 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC------CCeEE
Confidence 35688889999999999999998888889999876432 235678999999999999999999998763 34799
Q ss_pred EEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCccccc
Q 046270 343 VYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSL 422 (590)
Q Consensus 343 V~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~~ 422 (590)
+|||+++++|.+++... ....++|..++.++.+++.||.||| +.+++||||||+||+++.++.+||+|||++....
T Consensus 78 v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 153 (260)
T cd05073 78 ITEFMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIE 153 (260)
T ss_pred EEEeCCCCcHHHHHHhC-CccccCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCCcceeecc
Confidence 99999999999998532 2346899999999999999999999 8899999999999999999999999999997654
Q ss_pred CCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhhHHHHHHHhcCCchhhhhH
Q 046270 423 EGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDE 501 (590)
Q Consensus 423 ~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 501 (590)
...........++..|+|||++..+.++.++||||||++++|++| |+.||....... +..+ ...+...+
T Consensus 154 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~--~~~~----~~~~~~~~---- 223 (260)
T cd05073 154 DNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE--VIRA----LERGYRMP---- 223 (260)
T ss_pred CCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHH--HHHH----HhCCCCCC----
Confidence 433222333445678999999998899999999999999999999 888886433211 1111 11111111
Q ss_pred HHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhcc
Q 046270 502 FIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEG 542 (590)
Q Consensus 502 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~ 542 (590)
........+.+++..|++.+|++||++.++.++|+.
T Consensus 224 -----~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 224 -----RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred -----CcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 011223467788899999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=327.26 Aligned_cols=258 Identities=26% Similarity=0.400 Sum_probs=199.3
Q ss_pred cCCCccceecccCcEEEEEEEEcC--------CcEEEEEEeecCC-CCChHHHHHHHHHHHhc-CCCCccccceeEEecc
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLRH--------GNLVAVKQILDLD-TKGDEDFTNEVEIISKI-RHRNLLSLRGCCVTSD 333 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~~--------g~~vAvK~l~~~~-~~~~~~f~~Ev~il~~l-~H~nlv~l~g~~~~~~ 333 (590)
.+|...+.||+|+||.||++.... +..||+|.+.... ....+++.+|++++.++ +|+||+++++++..
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-- 89 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ-- 89 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEcc--
Confidence 457788999999999999997531 2368999876432 22356789999999999 89999999999874
Q ss_pred CCCCceEEEEEeeCCCCCcchhhhhhc-------------ccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCC
Q 046270 334 DSSGKRRFLVYDYMPNGTLSDNISISH-------------KRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKST 400 (590)
Q Consensus 334 ~~~~~~~~LV~E~~~~gsL~~~L~~~~-------------~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~ 400 (590)
+...+++|||+++|+|.+++.... ....++|.+++.++.|++.||.||| +.+|+||||||+
T Consensus 90 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~ 163 (334)
T cd05100 90 ---DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLA---SQKCIHRDLAAR 163 (334)
T ss_pred ---CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccc
Confidence 345899999999999999986421 1235899999999999999999999 899999999999
Q ss_pred ceEECCCCcEEEEeeCCcccccCCCcc-cccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCc
Q 046270 401 NILLDSELNAKVADFGLAKQSLEGHSH-LTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLDTSTSP 478 (590)
Q Consensus 401 NILLd~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELlt-G~~p~~~~~~~ 478 (590)
|||+++++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |+.|+.....
T Consensus 164 Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~- 242 (334)
T cd05100 164 NVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV- 242 (334)
T ss_pred eEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH-
Confidence 999999999999999999865432211 1222334568999999999999999999999999999999 7788754321
Q ss_pred hhhhhHHHHHHHhcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhccCC
Q 046270 479 FQLITDWAWVLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEGDI 544 (590)
Q Consensus 479 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~~~ 544 (590)
.++.... ..+...+. +......+.+++..|++.+|++||||.|+++.|+...
T Consensus 243 ----~~~~~~~-~~~~~~~~---------~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~ 294 (334)
T cd05100 243 ----EELFKLL-KEGHRMDK---------PANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVL 294 (334)
T ss_pred ----HHHHHHH-HcCCCCCC---------CCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHh
Confidence 1111111 11111111 1122346778999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=317.12 Aligned_cols=257 Identities=23% Similarity=0.398 Sum_probs=201.5
Q ss_pred hcCCCccceecccCcEEEEEEEEcC------CcEEEEEEeecCCC-CChHHHHHHHHHHHhcCCCCccccceeEEeccCC
Q 046270 263 TNGFSQNNLIGQGASGIVYKGTLRH------GNLVAVKQILDLDT-KGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDS 335 (590)
Q Consensus 263 t~~f~~~~~LG~G~fG~Vykg~~~~------g~~vAvK~l~~~~~-~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~ 335 (590)
.++|...+.||+|+||.||+|...+ +..||+|.+..... .....+.+|+.++..++|+|++++++++..
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~---- 80 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVST---- 80 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcC----
Confidence 3568888999999999999998753 35799999754332 234578899999999999999999999874
Q ss_pred CCceEEEEEeeCCCCCcchhhhhhcc-------cccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCC
Q 046270 336 SGKRRFLVYDYMPNGTLSDNISISHK-------RKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSEL 408 (590)
Q Consensus 336 ~~~~~~LV~E~~~~gsL~~~L~~~~~-------~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~ 408 (590)
+...++||||+++|+|.+++..... ...++|..++.++.|++.||.||| +.+|+||||||+||+++.++
T Consensus 81 -~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~di~p~nill~~~~ 156 (277)
T cd05032 81 -GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA---AKKFVHRDLAARNCMVAEDL 156 (277)
T ss_pred -CCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccChheEEEcCCC
Confidence 3568999999999999999854221 234789999999999999999999 89999999999999999999
Q ss_pred cEEEEeeCCcccccCCCc-ccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhhHHH
Q 046270 409 NAKVADFGLAKQSLEGHS-HLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLDTSTSPFQLITDWA 486 (590)
Q Consensus 409 ~~kL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELlt-G~~p~~~~~~~~~~l~~~~ 486 (590)
.+||+|||+++....... .......++..|+|||.+..+.++.++||||||+++|||+| |+.|+..... .. +..+
T Consensus 157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~-~~-~~~~- 233 (277)
T cd05032 157 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN-EE-VLKF- 233 (277)
T ss_pred CEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCH-HH-HHHH-
Confidence 999999999986543322 12233456789999999998899999999999999999998 8888854322 11 1111
Q ss_pred HHHHhcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhcc
Q 046270 487 WVLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEG 542 (590)
Q Consensus 487 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~ 542 (590)
...+...... ......+..++..|++.+|++|||+.++++.|+.
T Consensus 234 ---~~~~~~~~~~---------~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 234 ---VIDGGHLDLP---------ENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred ---HhcCCCCCCC---------CCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 1112111111 1123477889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=341.00 Aligned_cols=255 Identities=29% Similarity=0.437 Sum_probs=203.7
Q ss_pred CccceecccCcEEEEEEEE-cCCc----EEEEEEeecCC-CCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceE
Q 046270 267 SQNNLIGQGASGIVYKGTL-RHGN----LVAVKQILDLD-TKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRR 340 (590)
Q Consensus 267 ~~~~~LG~G~fG~Vykg~~-~~g~----~vAvK~l~~~~-~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~ 340 (590)
...++||+|.||+||||.+ .+|. +||+|++.... .+...++.+|+-+|.+++||||++|+|+|..+. .
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~------~ 772 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST------L 772 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch------H
Confidence 3457899999999999986 3443 79999987654 345678999999999999999999999997543 7
Q ss_pred EEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCccc
Q 046270 341 FLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQ 420 (590)
Q Consensus 341 ~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~ 420 (590)
.||.+|||.|+|.+|++. .+..+--+..+.|..|||+||.||| +..++||||.++|||+..-..+||.|||+++.
T Consensus 773 qlvtq~mP~G~LlDyvr~--hr~~igsq~lLnw~~QIAkgM~YLe---~qrlVHrdLaaRNVLVksP~hvkitdfgla~l 847 (1177)
T KOG1025|consen 773 QLVTQLMPLGCLLDYVRE--HRDNIGSQDLLNWCYQIAKGMKYLE---EQRLVHRDLAARNVLVKSPNHVKITDFGLAKL 847 (1177)
T ss_pred HHHHHhcccchHHHHHHH--hhccccHHHHHHHHHHHHHHHHHHH---hcchhhhhhhhhheeecCCCeEEEEecchhhc
Confidence 899999999999999974 4557888999999999999999999 89999999999999999999999999999998
Q ss_pred ccCCCccccc-ccccCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhhHHHHHHHhcCCchhh
Q 046270 421 SLEGHSHLTT-RVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLDTSTSPFQLITDWAWVLAKSGKVDDI 498 (590)
Q Consensus 421 ~~~~~~~~~~-~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 498 (590)
...+...... ...-.+.|||=|.+....|+.++|||||||++||++| |.+|++...... +. .+.+.|.
T Consensus 848 l~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~e--I~----dlle~ge---- 917 (1177)
T KOG1025|consen 848 LAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEE--IP----DLLEKGE---- 917 (1177)
T ss_pred cCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHH--hh----HHHhccc----
Confidence 7665544332 2233568999999999999999999999999999999 889987543211 11 1112221
Q ss_pred hhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhccCCCCC
Q 046270 499 FDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEGDIDIP 547 (590)
Q Consensus 499 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~~~~~~ 547 (590)
+-..+.-....+..+++.||..|+..||+++++.....+....|
T Consensus 918 -----RLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardp 961 (1177)
T KOG1025|consen 918 -----RLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDP 961 (1177)
T ss_pred -----cCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCc
Confidence 11122223346778899999999999999999988776654444
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-39 Score=327.95 Aligned_cols=248 Identities=27% Similarity=0.369 Sum_probs=202.2
Q ss_pred CCCccceecccCcEEEEEEEEcC-CcEEEEEEeecCC-CCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEEE
Q 046270 265 GFSQNNLIGQGASGIVYKGTLRH-GNLVAVKQILDLD-TKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFL 342 (590)
Q Consensus 265 ~f~~~~~LG~G~fG~Vykg~~~~-g~~vAvK~l~~~~-~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~L 342 (590)
.|+....||+|.||.||||.... ++.||+|.+.-.. ....+++..|+.+|..++++||.+++|.+. .+..+++
T Consensus 14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl-----~g~~Lwi 88 (467)
T KOG0201|consen 14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYL-----KGTKLWI 88 (467)
T ss_pred ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhhee-----ecccHHH
Confidence 46666789999999999999875 7789999985433 334678999999999999999999999998 5667999
Q ss_pred EEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCccccc
Q 046270 343 VYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSL 422 (590)
Q Consensus 343 V~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~~ 422 (590)
+|||+.+|++.+.|. ....+++..+.-|++++..||.||| ..+.+|||||+.|||+..+|.+||+|||++-+..
T Consensus 89 iMey~~gGsv~~lL~---~~~~~~E~~i~~ilre~l~~l~ylH---~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~ 162 (467)
T KOG0201|consen 89 IMEYCGGGSVLDLLK---SGNILDEFEIAVILREVLKGLDYLH---SEKKIHRDIKAANILLSESGDVKLADFGVAGQLT 162 (467)
T ss_pred HHHHhcCcchhhhhc---cCCCCccceeeeehHHHHHHhhhhh---hcceecccccccceeEeccCcEEEEecceeeeee
Confidence 999999999999984 3445588888999999999999999 8999999999999999999999999999998765
Q ss_pred CCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhhhHH
Q 046270 423 EGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDEF 502 (590)
Q Consensus 423 ~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 502 (590)
..... .....||+.|||||++....|+.|+||||||++.+||.+|.+|+........+.. .... .-|.
T Consensus 163 ~~~~r-r~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlfl------Ipk~-----~PP~ 230 (467)
T KOG0201|consen 163 NTVKR-RKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFL------IPKS-----APPR 230 (467)
T ss_pred chhhc-cccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEe------ccCC-----CCCc
Confidence 54433 3668899999999999988999999999999999999999999875544322110 0000 0111
Q ss_pred HhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 503 IRAEGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 503 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
+.+ .....+.+++..|+..||+.||++.++++.
T Consensus 231 L~~----~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 231 LDG----DFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred ccc----ccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 111 223356778889999999999999998764
|
|
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=311.81 Aligned_cols=247 Identities=27% Similarity=0.430 Sum_probs=195.5
Q ss_pred ceecccCcEEEEEEEEcC----CcEEEEEEeecCCCC-ChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEEEEE
Q 046270 270 NLIGQGASGIVYKGTLRH----GNLVAVKQILDLDTK-GDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFLVY 344 (590)
Q Consensus 270 ~~LG~G~fG~Vykg~~~~----g~~vAvK~l~~~~~~-~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~LV~ 344 (590)
++||+|+||.||+|++.. +..+|+|.+...... ..+++.+|+++++++.|+|++++++++. +...++||
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~------~~~~~~v~ 74 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK------GEPLMLVM 74 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc------CCceEEEE
Confidence 469999999999998643 258999998654432 3567899999999999999999999874 33479999
Q ss_pred eeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccccCC
Q 046270 345 DYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEG 424 (590)
Q Consensus 345 E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~~~~ 424 (590)
||+++|+|.+++.. ...++|..+..++.|++.||+||| ..+++||||||+|||++.++.+||+|||+++.....
T Consensus 75 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~ 148 (257)
T cd05060 75 ELAPLGPLLKYLKK---RREIPVSDLKELAHQVAMGMAYLE---SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAG 148 (257)
T ss_pred EeCCCCcHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHh---hcCeeccCcccceEEEcCCCcEEeccccccceeecC
Confidence 99999999999853 336999999999999999999999 889999999999999999999999999999866443
Q ss_pred Ccccc--cccccCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhhHHHHHHHhcCCchhhhhH
Q 046270 425 HSHLT--TRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDE 501 (590)
Q Consensus 425 ~~~~~--~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 501 (590)
..... ....++..|+|||.+..+.++.++||||||+++|||++ |+.||...... .+..+. ..+....
T Consensus 149 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~--~~~~~~----~~~~~~~---- 218 (257)
T cd05060 149 SDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA--EVIAML----ESGERLP---- 218 (257)
T ss_pred CcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHH--HHHHHH----HcCCcCC----
Confidence 33221 12223568999999998999999999999999999998 99998654321 111111 1111111
Q ss_pred HHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhccC
Q 046270 502 FIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEGD 543 (590)
Q Consensus 502 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~~ 543 (590)
.+......+.+++..|++.+|.+||++.++++.|+..
T Consensus 219 -----~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 219 -----RPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred -----CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 1111234677899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=328.08 Aligned_cols=201 Identities=25% Similarity=0.406 Sum_probs=172.0
Q ss_pred cCCCccceecccCcEEEEEEEEcC-CcEEEEEEeecCC---CCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCce
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLRH-GNLVAVKQILDLD---TKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKR 339 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~vAvK~l~~~~---~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~ 339 (590)
++|+..+.||+|+||.||++.... ++.||+|++.... ......+.+|++++.+++|+||+++++.+.+ +..
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~-----~~~ 75 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQD-----KLN 75 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEec-----CCe
Confidence 468889999999999999998764 7899999986432 2223568899999999999999999998873 456
Q ss_pred EEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcc
Q 046270 340 RFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAK 419 (590)
Q Consensus 340 ~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~ 419 (590)
.++||||+++|+|.+++. +.+.+++.....++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++
T Consensus 76 ~~lv~E~~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~lH---~~givHrDlKp~NILi~~~~~vkL~DFGla~ 149 (363)
T cd05628 76 LYLIMEFLPGGDMMTLLM---KKDTLTEEETQFYIAETVLAIDSIH---QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCT 149 (363)
T ss_pred EEEEEcCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCCEEEeeccCcc
Confidence 899999999999999885 3457999999999999999999999 8999999999999999999999999999987
Q ss_pred cccCCCc----------------------------------ccccccccCCCccCccccccCCCCcchhHHHHHHHHHHH
Q 046270 420 QSLEGHS----------------------------------HLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILEL 465 (590)
Q Consensus 420 ~~~~~~~----------------------------------~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlEL 465 (590)
....... .......||+.|+|||++.+..++.++|||||||++|||
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~el 229 (363)
T cd05628 150 GLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEM 229 (363)
T ss_pred cccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHH
Confidence 5432110 011235799999999999999999999999999999999
Q ss_pred HhCCCCCCCC
Q 046270 466 MSGRKVLDTS 475 (590)
Q Consensus 466 ltG~~p~~~~ 475 (590)
++|+.||...
T Consensus 230 l~G~~Pf~~~ 239 (363)
T cd05628 230 LIGYPPFCSE 239 (363)
T ss_pred HhCCCCCCCC
Confidence 9999999754
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=342.55 Aligned_cols=262 Identities=23% Similarity=0.296 Sum_probs=206.5
Q ss_pred HhcCCCccceecccCcEEEEEEEEcCC-cEEEEEEeecCCCCChHHHHHHHHHHHhcC-CCCccccce-eEEeccCCC-C
Q 046270 262 ATNGFSQNNLIGQGASGIVYKGTLRHG-NLVAVKQILDLDTKGDEDFTNEVEIISKIR-HRNLLSLRG-CCVTSDDSS-G 337 (590)
Q Consensus 262 at~~f~~~~~LG~G~fG~Vykg~~~~g-~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~-H~nlv~l~g-~~~~~~~~~-~ 337 (590)
...+.++.+.|.+|||+.||.+.+..+ ..+|+|++.-.+....+.+.+|+++|++|+ |+|||.+++ ......... .
T Consensus 35 g~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~ 114 (738)
T KOG1989|consen 35 GSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV 114 (738)
T ss_pred CCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence 345567789999999999999998876 999999998877788889999999999996 999999999 443332223 4
Q ss_pred ceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCC
Q 046270 338 KRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGL 417 (590)
Q Consensus 338 ~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGl 417 (590)
.+.+|.||||++|+|-|++...... .|++.++++|+.++++|+++||. ++++|||||||.+||||+.+++.||||||.
T Consensus 115 ~EvllLmEyC~gg~Lvd~mn~Rlq~-~lte~eVLkIf~dv~~AVa~mH~-~~pPiIHRDLKiENvLls~~g~~KLCDFGS 192 (738)
T KOG1989|consen 115 WEVLLLMEYCKGGSLVDFMNTRLQT-RLTEDEVLKIFYDVCEAVAAMHY-LKPPIIHRDLKIENVLLSADGNYKLCDFGS 192 (738)
T ss_pred eEEEeehhhccCCcHHHHHHHHHhc-cCChHHHHHHHHHHHHHHHHHhc-CCCccchhhhhhhheEEcCCCCEEeCcccc
Confidence 6899999999999999999644333 49999999999999999999994 468899999999999999999999999999
Q ss_pred cccccCCCccc--------ccccccCCCccCccccc---cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHH
Q 046270 418 AKQSLEGHSHL--------TTRVAGTFGYLAPEYAL---YGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWA 486 (590)
Q Consensus 418 a~~~~~~~~~~--------~~~~~gt~~Y~APE~~~---~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~ 486 (590)
+.......... .-...-|+-|+|||.+. +..+++|+|||++||+||-|.....||+....-.
T Consensus 193 att~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~la------- 265 (738)
T KOG1989|consen 193 ATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLA------- 265 (738)
T ss_pred cccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCccee-------
Confidence 86432222100 00123489999999764 6679999999999999999999999998643211
Q ss_pred HHHHhcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhccC
Q 046270 487 WVLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEGD 543 (590)
Q Consensus 487 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~~ 543 (590)
+++....--.......+|..|+..||++||.+||++.+|++.+-..
T Consensus 266 -----------Ilng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l 311 (738)
T KOG1989|consen 266 -----------ILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFEL 311 (738)
T ss_pred -----------EEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHH
Confidence 0111100000123445888999999999999999999998876554
|
|
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=313.19 Aligned_cols=254 Identities=24% Similarity=0.312 Sum_probs=198.4
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEEE
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFL 342 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~L 342 (590)
++|...+.||+|+||.||+|+.. +++.||+|++..........+.+|+.++.+++|+||+++++++.. +...++
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~-----~~~~~i 83 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLS-----REKLWI 83 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEe-----CCEEEE
Confidence 46888899999999999999975 578899999875544455678899999999999999999999874 446899
Q ss_pred EEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCccccc
Q 046270 343 VYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSL 422 (590)
Q Consensus 343 V~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~~ 422 (590)
||||+++++|.+++. ....+++..+..++.|++.||.||| ..+|+||||||+||+++.++.+||+|||+++...
T Consensus 84 v~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~ 157 (267)
T cd06646 84 CMEYCGGGSLQDIYH---VTGPLSELQIAYVCRETLQGLAYLH---SKGKMHRDIKGANILLTDNGDVKLADFGVAAKIT 157 (267)
T ss_pred EEeCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEECcCccceeec
Confidence 999999999999885 3456899999999999999999999 8999999999999999999999999999998653
Q ss_pred CCCcccccccccCCCccCccccc---cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhh
Q 046270 423 EGHSHLTTRVAGTFGYLAPEYAL---YGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIF 499 (590)
Q Consensus 423 ~~~~~~~~~~~gt~~Y~APE~~~---~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 499 (590)
.... ......|+..|+|||.+. ...++.++||||||++++||++|+.|+.......... .+ ......
T Consensus 158 ~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~-~~-----~~~~~~--- 227 (267)
T cd06646 158 ATIA-KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF-LM-----SKSNFQ--- 227 (267)
T ss_pred cccc-ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe-ee-----ecCCCC---
Confidence 2211 123346788999999874 4557889999999999999999999985332211100 00 000000
Q ss_pred hHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHh
Q 046270 500 DEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKML 540 (590)
Q Consensus 500 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L 540 (590)
.+... ........+.+++..|++.+|++|||++++++.|
T Consensus 228 ~~~~~--~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 228 PPKLK--DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred CCCCc--cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 00000 0112234677889999999999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=317.91 Aligned_cols=240 Identities=22% Similarity=0.314 Sum_probs=188.1
Q ss_pred ceecccCcEEEEEEEEcC-CcEEEEEEeecCC---CCChHHHHHHHHHHHhc-CCCCccccceeEEeccCCCCceEEEEE
Q 046270 270 NLIGQGASGIVYKGTLRH-GNLVAVKQILDLD---TKGDEDFTNEVEIISKI-RHRNLLSLRGCCVTSDDSSGKRRFLVY 344 (590)
Q Consensus 270 ~~LG~G~fG~Vykg~~~~-g~~vAvK~l~~~~---~~~~~~f~~Ev~il~~l-~H~nlv~l~g~~~~~~~~~~~~~~LV~ 344 (590)
+.||+|+||.||+|+++. |..||+|.+.... ......+..|.+++..+ +|+||+++++++.. ....++||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~-----~~~~~lv~ 75 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQT-----KEHLFFVM 75 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEe-----CCEEEEEE
Confidence 469999999999999874 7899999986532 22345567788888765 89999999999873 45699999
Q ss_pred eeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccccCC
Q 046270 345 DYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEG 424 (590)
Q Consensus 345 E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~~~~ 424 (590)
||+++|+|.+++. ....+++.+...++.||++||+||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 76 E~~~~g~L~~~i~---~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 149 (316)
T cd05620 76 EFLNGGDLMFHIQ---DKGRFDLYRATFYAAEIVCGLQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG 149 (316)
T ss_pred CCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEeCccCCCeecccC
Confidence 9999999998884 3456899999999999999999999 899999999999999999999999999998753222
Q ss_pred CcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhhhHHHh
Q 046270 425 HSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDEFIR 504 (590)
Q Consensus 425 ~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 504 (590)
. .......||..|+|||++.+..++.++|||||||++|||++|+.||...... .... .. ..+.. .
T Consensus 150 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~-~~~~----~~-~~~~~------~-- 214 (316)
T cd05620 150 D-NRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED-ELFE----SI-RVDTP------H-- 214 (316)
T ss_pred C-CceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH-HHHH----HH-HhCCC------C--
Confidence 2 2234467899999999999999999999999999999999999999643321 1111 11 11100 0
Q ss_pred hhhHHHHHHHHHHHHHhchhcCCCCCCCHH-HHH
Q 046270 505 AEGARAVMERFVLVGILCAHVMVALRPTIT-DAL 537 (590)
Q Consensus 505 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~-eVl 537 (590)
.+......+.+++..|++.||.+||++. ++.
T Consensus 215 --~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 215 --YPRWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred --CCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 0011223566788899999999999985 555
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=319.32 Aligned_cols=261 Identities=23% Similarity=0.408 Sum_probs=200.9
Q ss_pred HHhcCCCccceecccCcEEEEEEEEcC------CcEEEEEEeecCCC-CChHHHHHHHHHHHhcCCCCccccceeEEecc
Q 046270 261 QATNGFSQNNLIGQGASGIVYKGTLRH------GNLVAVKQILDLDT-KGDEDFTNEVEIISKIRHRNLLSLRGCCVTSD 333 (590)
Q Consensus 261 ~at~~f~~~~~LG~G~fG~Vykg~~~~------g~~vAvK~l~~~~~-~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~ 333 (590)
...++|...+.||+|+||.||+|..++ +..||+|.+..... .....+.+|+.++++++|+|++++++++..
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-- 80 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSK-- 80 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC--
Confidence 346778899999999999999997642 44799998754332 223468899999999999999999998863
Q ss_pred CCCCceEEEEEeeCCCCCcchhhhhhcc-------cccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECC
Q 046270 334 DSSGKRRFLVYDYMPNGTLSDNISISHK-------RKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDS 406 (590)
Q Consensus 334 ~~~~~~~~LV~E~~~~gsL~~~L~~~~~-------~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~ 406 (590)
+...++||||+++|+|.+++..... ...+++..+.+++.|++.||.||| +++|+||||||+|||+++
T Consensus 81 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dikp~nili~~ 154 (288)
T cd05061 81 ---GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAH 154 (288)
T ss_pred ---CCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCCChheEEEcC
Confidence 3458999999999999999854221 234677889999999999999999 899999999999999999
Q ss_pred CCcEEEEeeCCcccccCCCcc-cccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhhH
Q 046270 407 ELNAKVADFGLAKQSLEGHSH-LTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLDTSTSPFQLITD 484 (590)
Q Consensus 407 ~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELlt-G~~p~~~~~~~~~~l~~ 484 (590)
++.+||+|||+++........ ......++..|+|||.+.++.++.++||||||++++||++ |+.|+...... +
T Consensus 155 ~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~-----~ 229 (288)
T cd05061 155 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE-----Q 229 (288)
T ss_pred CCcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH-----H
Confidence 999999999999865332211 1222345678999999999999999999999999999999 67777542221 1
Q ss_pred HHHHHHhcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhccCC
Q 046270 485 WAWVLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEGDI 544 (590)
Q Consensus 485 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~~~ 544 (590)
+.......+.. . .+......+.+++..|++.+|++|||+.++++.|+...
T Consensus 230 ~~~~~~~~~~~-~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 230 VLKFVMDGGYL-D---------QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred HHHHHHcCCCC-C---------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 11111111111 0 01112347888999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=317.52 Aligned_cols=260 Identities=27% Similarity=0.418 Sum_probs=201.6
Q ss_pred CCCccceecccCcEEEEEEEEc-----CCcEEEEEEeecCCCC-ChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCc
Q 046270 265 GFSQNNLIGQGASGIVYKGTLR-----HGNLVAVKQILDLDTK-GDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGK 338 (590)
Q Consensus 265 ~f~~~~~LG~G~fG~Vykg~~~-----~g~~vAvK~l~~~~~~-~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~ 338 (590)
.|...+.||+|+||.||+|++. .+..+|||.+...... ..++|.+|++++++++|+||+++++++... .+.
T Consensus 5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~---~~~ 81 (284)
T cd05038 5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKP---GGR 81 (284)
T ss_pred hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecC---CCC
Confidence 4566689999999999999865 2578999998754433 466899999999999999999999988643 245
Q ss_pred eEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCc
Q 046270 339 RRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLA 418 (590)
Q Consensus 339 ~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla 418 (590)
..++||||+++++|.+++... ...++|..+..++.|++.||+||| ..+|+||||||+||+++.++.+||+|||++
T Consensus 82 ~~~lv~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~ 156 (284)
T cd05038 82 SLRLIMEYLPSGSLRDYLQRH--RDQINLKRLLLFSSQICKGMDYLG---SQRYIHRDLAARNILVESEDLVKISDFGLA 156 (284)
T ss_pred ceEEEEecCCCCCHHHHHHhC--ccccCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccccc
Confidence 689999999999999998532 335999999999999999999999 899999999999999999999999999999
Q ss_pred ccccCCCcc--cccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhh----------hhHHH
Q 046270 419 KQSLEGHSH--LTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQL----------ITDWA 486 (590)
Q Consensus 419 ~~~~~~~~~--~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~----------l~~~~ 486 (590)
......... ......++..|++||.+....++.++||||||++++||+||+.|+......... ...+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05038 157 KVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLL 236 (284)
T ss_pred cccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHH
Confidence 876533221 112234456799999999889999999999999999999999887543221110 11111
Q ss_pred HHHHhcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhcc
Q 046270 487 WVLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEG 542 (590)
Q Consensus 487 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~ 542 (590)
..+ ..+ .....+......+.+++.+|++.+|++||||.||+++|+.
T Consensus 237 ~~~-~~~---------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~ 282 (284)
T cd05038 237 ELL-KEG---------ERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDR 282 (284)
T ss_pred HHH-HcC---------CcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhh
Confidence 100 000 0000111223578889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=312.55 Aligned_cols=252 Identities=24% Similarity=0.295 Sum_probs=197.4
Q ss_pred CCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCC---CChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceE
Q 046270 265 GFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDT---KGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRR 340 (590)
Q Consensus 265 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~---~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~ 340 (590)
+|+..++||+|+||.||++... ++..||+|++..... .....+.+|++++++++|+||+++++++.. +...
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~ 75 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYET-----KDAL 75 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecC-----CCeE
Confidence 4777899999999999999976 588999999864322 223457889999999999999999998863 4469
Q ss_pred EEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCccc
Q 046270 341 FLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQ 420 (590)
Q Consensus 341 ~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~ 420 (590)
++||||+++|+|.+++... ....+++..+..++.|++.||.||| +.+|+||||||+||++++++.++|+|||+++.
T Consensus 76 ~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~ 151 (285)
T cd05605 76 CLVLTLMNGGDLKFHIYNM-GNPGFDEERAVFYAAEITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVE 151 (285)
T ss_pred EEEEeccCCCcHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHEEECCCCCEEEeeCCCcee
Confidence 9999999999999887532 2346999999999999999999999 89999999999999999999999999999986
Q ss_pred ccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhhh
Q 046270 421 SLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFD 500 (590)
Q Consensus 421 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 500 (590)
...... .....|+..|+|||++.+..++.++||||||+++|||++|+.||....... ...++... ...+.
T Consensus 152 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~-~~~~~~~~-~~~~~------ 221 (285)
T cd05605 152 IPEGET--IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV-KREEVERR-VKEDQ------ 221 (285)
T ss_pred cCCCCc--cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhh-HHHHHHHH-hhhcc------
Confidence 533221 223468999999999998899999999999999999999999997533211 11111110 00000
Q ss_pred HHHhhhhHHHHHHHHHHHHHhchhcCCCCCC-----CHHHHHHH
Q 046270 501 EFIRAEGARAVMERFVLVGILCAHVMVALRP-----TITDALKM 539 (590)
Q Consensus 501 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-----tm~eVl~~ 539 (590)
...+......+..++..|++.||.+|| +++++++.
T Consensus 222 ----~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 222 ----EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred ----cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 011122344677889999999999999 78888553
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=315.44 Aligned_cols=266 Identities=23% Similarity=0.277 Sum_probs=196.4
Q ss_pred CCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCCC--ChHHHHHHHHHHHhc---CCCCccccceeEEeccCCCCc
Q 046270 265 GFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDTK--GDEDFTNEVEIISKI---RHRNLLSLRGCCVTSDDSSGK 338 (590)
Q Consensus 265 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~~--~~~~f~~Ev~il~~l---~H~nlv~l~g~~~~~~~~~~~ 338 (590)
+|...+.||+|+||.||+|+.. .|+.||+|.+...... ....+.+|+++++++ +||||+++++++.......+.
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4777889999999999999987 4789999988643222 234567788887776 699999999998765443456
Q ss_pred eEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCc
Q 046270 339 RRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLA 418 (590)
Q Consensus 339 ~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla 418 (590)
..++||||++ ++|.+++... ....+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||++
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~kl~dfg~~ 155 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKV-PPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGQVKLADFGLA 155 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccCcc
Confidence 7899999997 4888877532 2345899999999999999999999 899999999999999999999999999999
Q ss_pred ccccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHH-------Hh
Q 046270 419 KQSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVL-------AK 491 (590)
Q Consensus 419 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~-------~~ 491 (590)
+...... ......||..|+|||.+.+..++.++|||||||+++||++|+.||........ +....... +.
T Consensus 156 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~-~~~~~~~~~~~~~~~~~ 232 (288)
T cd07863 156 RIYSCQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ-LGKIFDLIGLPPEDDWP 232 (288)
T ss_pred ccccCcc--cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHH-HHHHHHHhCCCChhhCc
Confidence 8654321 22345678999999999988999999999999999999999999865433211 11111000 00
Q ss_pred cC-Cc-hhhhhHHHh---hhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 046270 492 SG-KV-DDIFDEFIR---AEGARAVMERFVLVGILCAHVMVALRPTITDALK 538 (590)
Q Consensus 492 ~~-~~-~~~~d~~l~---~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~ 538 (590)
.. .. ...+.+... .....+..+.+.+++..|++.||++|||+.|++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 233 RDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred ccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 00 00 000000000 0011123456778999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=323.88 Aligned_cols=247 Identities=23% Similarity=0.333 Sum_probs=193.2
Q ss_pred ceecccCcEEEEEEEEc-CCcEEEEEEeecCC---CCChHHHHHHHHHHHhc-CCCCccccceeEEeccCCCCceEEEEE
Q 046270 270 NLIGQGASGIVYKGTLR-HGNLVAVKQILDLD---TKGDEDFTNEVEIISKI-RHRNLLSLRGCCVTSDDSSGKRRFLVY 344 (590)
Q Consensus 270 ~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~---~~~~~~f~~Ev~il~~l-~H~nlv~l~g~~~~~~~~~~~~~~LV~ 344 (590)
+.||+|+||.||+++.. ++..||+|.+.... ....+.+..|..++.++ +||||+++++++.. ....++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~-----~~~~~lv~ 75 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQT-----ESRLFFVI 75 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEc-----CCEEEEEE
Confidence 36999999999999986 47899999987532 22345578999999999 79999999998873 45689999
Q ss_pred eeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccccCC
Q 046270 345 DYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEG 424 (590)
Q Consensus 345 E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~~~~ 424 (590)
||+++|+|.+++. ..+.+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 76 e~~~~g~L~~~~~---~~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~ 149 (329)
T cd05588 76 EFVSGGDLMFHMQ---RQRKLPEEHARFYSAEISLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP 149 (329)
T ss_pred eCCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEECcCccccccccC
Confidence 9999999988874 3457999999999999999999999 899999999999999999999999999998753221
Q ss_pred CcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc---hhhhhHHHHHHHhcCCchhhhhH
Q 046270 425 HSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSP---FQLITDWAWVLAKSGKVDDIFDE 501 (590)
Q Consensus 425 ~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~---~~~l~~~~~~~~~~~~~~~~~d~ 501 (590)
........||..|+|||++.+..++.++|||||||++|||++|+.||+..... .....++.......+...
T Consensus 150 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 223 (329)
T cd05588 150 -GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIR----- 223 (329)
T ss_pred -CCccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCC-----
Confidence 12233467899999999999999999999999999999999999999643221 112222322222222110
Q ss_pred HHhhhhHHHHHHHHHHHHHhchhcCCCCCCC------HHHHHH
Q 046270 502 FIRAEGARAVMERFVLVGILCAHVMVALRPT------ITDALK 538 (590)
Q Consensus 502 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt------m~eVl~ 538 (590)
.+......+..++..|++.||.+||+ ++++++
T Consensus 224 -----~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 224 -----IPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred -----CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 01112346778889999999999997 677764
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=313.59 Aligned_cols=254 Identities=28% Similarity=0.389 Sum_probs=198.7
Q ss_pred cCCCccceecccCcEEEEEEEEcC----CcEEEEEEeecCC-CCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCc
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLRH----GNLVAVKQILDLD-TKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGK 338 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~~----g~~vAvK~l~~~~-~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~ 338 (590)
++|...+.||+|+||.||+|.+.. +..+|+|.+.... ....+.|.+|+.++++++||||+++++++.. +.
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~ 78 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTK-----SK 78 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-----CC
Confidence 467778999999999999998742 3379999886432 2234578999999999999999999999863 34
Q ss_pred eEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCc
Q 046270 339 RRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLA 418 (590)
Q Consensus 339 ~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla 418 (590)
..++||||+++++|.+++.. ....+++.+++.|+.|++.||.||| +.+++||||||+|||++.++.+||+|||++
T Consensus 79 ~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~~l~dfg~~ 153 (267)
T cd05066 79 PVMIVTEYMENGSLDAFLRK--HDGQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILVNSNLVCKVSDFGLS 153 (267)
T ss_pred ccEEEEEcCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeehhhchhcEEECCCCeEEeCCCCcc
Confidence 58999999999999998853 2346899999999999999999999 899999999999999999999999999999
Q ss_pred ccccCCCcccc--cccccCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhhHHHHHHHhcCCc
Q 046270 419 KQSLEGHSHLT--TRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLDTSTSPFQLITDWAWVLAKSGKV 495 (590)
Q Consensus 419 ~~~~~~~~~~~--~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~ 495 (590)
+.......... ....++..|+|||++.++.++.++||||||++++|+++ |+.||....... .. .+ ..++..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~-~~-~~----~~~~~~ 227 (267)
T cd05066 154 RVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD-VI-KA----IEEGYR 227 (267)
T ss_pred cccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH-HH-HH----HhCCCc
Confidence 87654332221 12223568999999998899999999999999999887 999986433211 11 11 111100
Q ss_pred hhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhcc
Q 046270 496 DDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEG 542 (590)
Q Consensus 496 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~ 542 (590)
. ......+..+.+++..|++.+|.+||+|.++++.|+.
T Consensus 228 ~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 265 (267)
T cd05066 228 L---------PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDK 265 (267)
T ss_pred C---------CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHh
Confidence 0 0011223467789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=334.75 Aligned_cols=261 Identities=22% Similarity=0.354 Sum_probs=201.0
Q ss_pred HHhcCCCccceecccCcEEEEEEEEcC------CcEEEEEEeecCCCCC-hHHHHHHHHHHHhcC-CCCccccceeEEec
Q 046270 261 QATNGFSQNNLIGQGASGIVYKGTLRH------GNLVAVKQILDLDTKG-DEDFTNEVEIISKIR-HRNLLSLRGCCVTS 332 (590)
Q Consensus 261 ~at~~f~~~~~LG~G~fG~Vykg~~~~------g~~vAvK~l~~~~~~~-~~~f~~Ev~il~~l~-H~nlv~l~g~~~~~ 332 (590)
...++|...++||+|+||.||+|++.+ +..||+|++....... .+.+.+|++++.++. ||||++++|+|..
T Consensus 34 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~- 112 (401)
T cd05107 34 MPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTK- 112 (401)
T ss_pred ecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc-
Confidence 344467778899999999999998642 4579999997543222 346889999999997 9999999999974
Q ss_pred cCCCCceEEEEEeeCCCCCcchhhhhhc----------------------------------------------------
Q 046270 333 DDSSGKRRFLVYDYMPNGTLSDNISISH---------------------------------------------------- 360 (590)
Q Consensus 333 ~~~~~~~~~LV~E~~~~gsL~~~L~~~~---------------------------------------------------- 360 (590)
....++||||+++|+|.++++...
T Consensus 113 ----~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (401)
T cd05107 113 ----GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESAD 188 (401)
T ss_pred ----CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccC
Confidence 345899999999999999986421
Q ss_pred -------------------------------------------ccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCC
Q 046270 361 -------------------------------------------KRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDI 397 (590)
Q Consensus 361 -------------------------------------------~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDI 397 (590)
....++|..+++|+.||+.||.||| ..+|+||||
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrdl 265 (401)
T cd05107 189 YVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA---SKNCVHRDL 265 (401)
T ss_pred ccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCcCcccC
Confidence 1124788889999999999999999 899999999
Q ss_pred CCCceEECCCCcEEEEeeCCcccccCCCcc-cccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 046270 398 KSTNILLDSELNAKVADFGLAKQSLEGHSH-LTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLDTS 475 (590)
Q Consensus 398 Kp~NILLd~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELlt-G~~p~~~~ 475 (590)
||+|||+++++.+||+|||+++........ ......++..|+|||.+....++.++||||||+++|||++ |+.|+...
T Consensus 266 kp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~ 345 (401)
T cd05107 266 AARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPEL 345 (401)
T ss_pred CcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCC
Confidence 999999999999999999999865332221 1223456788999999998899999999999999999998 88888643
Q ss_pred CCchhhhhHHHHHHHhcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhccC
Q 046270 476 TSPFQLITDWAWVLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEGD 543 (590)
Q Consensus 476 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~~ 543 (590)
..... + ......+... ..+......+.+++..|++.+|.+||+++|+++.|+..
T Consensus 346 ~~~~~-~----~~~~~~~~~~---------~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~ 399 (401)
T cd05107 346 PMNEQ-F----YNAIKRGYRM---------AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL 399 (401)
T ss_pred CchHH-H----HHHHHcCCCC---------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 32111 1 1111111100 00111234677888899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=323.64 Aligned_cols=242 Identities=24% Similarity=0.355 Sum_probs=191.3
Q ss_pred ceecccCcEEEEEEEEcC-CcEEEEEEeecCC---CCChHHHHHHHHHHHhc-CCCCccccceeEEeccCCCCceEEEEE
Q 046270 270 NLIGQGASGIVYKGTLRH-GNLVAVKQILDLD---TKGDEDFTNEVEIISKI-RHRNLLSLRGCCVTSDDSSGKRRFLVY 344 (590)
Q Consensus 270 ~~LG~G~fG~Vykg~~~~-g~~vAvK~l~~~~---~~~~~~f~~Ev~il~~l-~H~nlv~l~g~~~~~~~~~~~~~~LV~ 344 (590)
++||+|+||.||+|+..+ ++.||+|++.... ....+.+..|.+++..+ +||||+++++++.. +...++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~-----~~~~~lv~ 75 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQT-----KDRLFFVM 75 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEc-----CCeEEEEE
Confidence 369999999999999875 7799999986532 23345677899999876 89999999999873 45689999
Q ss_pred eeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccccCC
Q 046270 345 DYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEG 424 (590)
Q Consensus 345 E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~~~~ 424 (590)
||+++|+|.+++. ....+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 76 E~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~ 149 (321)
T cd05591 76 EYVNGGDLMFQIQ---RSRKFDEPRSRFYAAEVTLALMFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILN 149 (321)
T ss_pred eCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeecccceecccC
Confidence 9999999998874 3456999999999999999999999 899999999999999999999999999998754322
Q ss_pred CcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhhhHHHh
Q 046270 425 HSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDEFIR 504 (590)
Q Consensus 425 ~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 504 (590)
. .......||..|+|||++.+..++.++|||||||++|||++|+.||...... ..+. .... +.. .
T Consensus 150 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~-~~~~----~i~~-~~~---~----- 214 (321)
T cd05591 150 G-VTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED-DLFE----SILH-DDV---L----- 214 (321)
T ss_pred C-ccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHH-HHHH----HHHc-CCC---C-----
Confidence 2 2233456899999999999889999999999999999999999999754321 1111 1111 110 0
Q ss_pred hhhHHHHHHHHHHHHHhchhcCCCCCC-------CHHHHHHH
Q 046270 505 AEGARAVMERFVLVGILCAHVMVALRP-------TITDALKM 539 (590)
Q Consensus 505 ~~~~~~~~~~l~~l~~~Cl~~dp~~RP-------tm~eVl~~ 539 (590)
.+......+.+++..|++.||++|| ++.++++.
T Consensus 215 --~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 215 --YPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred --CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 0011123667788899999999999 78888754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=315.13 Aligned_cols=253 Identities=27% Similarity=0.423 Sum_probs=196.8
Q ss_pred CCCccceecccCcEEEEEEEEcC-C---cEEEEEEeecC-CCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCce
Q 046270 265 GFSQNNLIGQGASGIVYKGTLRH-G---NLVAVKQILDL-DTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKR 339 (590)
Q Consensus 265 ~f~~~~~LG~G~fG~Vykg~~~~-g---~~vAvK~l~~~-~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~ 339 (590)
.|...+.||+|+||.||+|.+.. + ..||||.+... ......+|.+|++++++++||||+++++++.. +..
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~-----~~~ 79 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTK-----SRP 79 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECC-----CCc
Confidence 36677899999999999999864 3 36999998653 22335679999999999999999999998863 445
Q ss_pred EEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcc
Q 046270 340 RFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAK 419 (590)
Q Consensus 340 ~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~ 419 (590)
.++||||+++|+|.+++.. ..+.+++.+++.++.|++.||.||| +.+++||||||+||+++.++.+||+|||+++
T Consensus 80 ~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~~l~~al~~lH---~~g~~H~dl~p~nili~~~~~~kl~dfg~~~ 154 (269)
T cd05065 80 VMIITEFMENGALDSFLRQ--NDGQFTVIQLVGMLRGIAAGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSR 154 (269)
T ss_pred eEEEEecCCCCcHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccChheEEEcCCCcEEECCCcccc
Confidence 8999999999999998853 2456899999999999999999999 8999999999999999999999999999987
Q ss_pred cccCCCccc--cccccc--CCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhhHHHHHHHhcCC
Q 046270 420 QSLEGHSHL--TTRVAG--TFGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLDTSTSPFQLITDWAWVLAKSGK 494 (590)
Q Consensus 420 ~~~~~~~~~--~~~~~g--t~~Y~APE~~~~~~~t~ksDVySfGvvLlELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~ 494 (590)
......... .....+ +..|+|||++..+.++.++||||||+++||+++ |..||...... ....+.. ....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~--~~~~~i~---~~~~ 229 (269)
T cd05065 155 FLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ--DVINAIE---QDYR 229 (269)
T ss_pred ccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH--HHHHHHH---cCCc
Confidence 654322211 111112 357999999999999999999999999999987 99998643321 1111111 0000
Q ss_pred chhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhcc
Q 046270 495 VDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEG 542 (590)
Q Consensus 495 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~ 542 (590)
.. ...+.+..+.+++..|++.+|++||+|.+++.+|+.
T Consensus 230 ~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 267 (269)
T cd05065 230 LP----------PPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDK 267 (269)
T ss_pred CC----------CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 00 011223456788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=311.71 Aligned_cols=259 Identities=25% Similarity=0.382 Sum_probs=201.7
Q ss_pred HHHhcCCCccceecccCcEEEEEEEEcC-CcEEEEEEeecCCCCChHHHHHHHHHHHhc-CCCCccccceeEEeccCC-C
Q 046270 260 EQATNGFSQNNLIGQGASGIVYKGTLRH-GNLVAVKQILDLDTKGDEDFTNEVEIISKI-RHRNLLSLRGCCVTSDDS-S 336 (590)
Q Consensus 260 ~~at~~f~~~~~LG~G~fG~Vykg~~~~-g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l-~H~nlv~l~g~~~~~~~~-~ 336 (590)
+.+++.|+..+.||+|+||.||+|...+ ++.||+|++... .....++..|+.++.++ +|+|++++++++...+.. .
T Consensus 2 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (272)
T cd06637 2 RDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM 80 (272)
T ss_pred CChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcC-CccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCC
Confidence 3467788889999999999999998864 778999988643 34456789999999999 799999999998765432 1
Q ss_pred CceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeC
Q 046270 337 GKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFG 416 (590)
Q Consensus 337 ~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFG 416 (590)
....++||||+++|+|.+++... ....++|..+..++.|++.||+||| ..+|+||||||+||++++++.+||+|||
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~LH---~~~ivh~dl~~~nili~~~~~~~l~Dfg 156 (272)
T cd06637 81 DDQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFG 156 (272)
T ss_pred CcEEEEEEEcCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHEEECCCCCEEEccCC
Confidence 34689999999999999988632 2346899999999999999999999 8899999999999999999999999999
Q ss_pred CcccccCCCcccccccccCCCccCccccc-----cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHh
Q 046270 417 LAKQSLEGHSHLTTRVAGTFGYLAPEYAL-----YGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAK 491 (590)
Q Consensus 417 la~~~~~~~~~~~~~~~gt~~Y~APE~~~-----~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~ 491 (590)
+++...... .......|+..|+|||++. ...++.++|||||||++|||++|+.|+.......... ....
T Consensus 157 ~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~-----~~~~ 230 (272)
T cd06637 157 VSAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF-----LIPR 230 (272)
T ss_pred Cceeccccc-ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHH-----HHhc
Confidence 997653322 1233456889999999986 3458889999999999999999999986432211111 0011
Q ss_pred cCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 046270 492 SGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALK 538 (590)
Q Consensus 492 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~ 538 (590)
. ......+ ......+.+++..|++.+|.+|||+.++++
T Consensus 231 ~-~~~~~~~--------~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 231 N-PAPRLKS--------KKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred C-CCCCCCC--------CCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 1 1111111 112246778889999999999999999975
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=320.85 Aligned_cols=258 Identities=25% Similarity=0.396 Sum_probs=200.2
Q ss_pred hcCCCccceecccCcEEEEEEEEc--------CCcEEEEEEeecCC-CCChHHHHHHHHHHHhc-CCCCccccceeEEec
Q 046270 263 TNGFSQNNLIGQGASGIVYKGTLR--------HGNLVAVKQILDLD-TKGDEDFTNEVEIISKI-RHRNLLSLRGCCVTS 332 (590)
Q Consensus 263 t~~f~~~~~LG~G~fG~Vykg~~~--------~g~~vAvK~l~~~~-~~~~~~f~~Ev~il~~l-~H~nlv~l~g~~~~~ 332 (590)
.++|...+.||+|+||.||+++.. ++..||+|.+.... .....++.+|+.++..+ +|+||+++++++..
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~- 92 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ- 92 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec-
Confidence 456778899999999999999742 24479999886432 23356789999999999 89999999999874
Q ss_pred cCCCCceEEEEEeeCCCCCcchhhhhhc-------------ccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCC
Q 046270 333 DDSSGKRRFLVYDYMPNGTLSDNISISH-------------KRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKS 399 (590)
Q Consensus 333 ~~~~~~~~~LV~E~~~~gsL~~~L~~~~-------------~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp 399 (590)
....++||||+++|+|.+++.... ....++|.+++.++.||++||.||| +.+|+||||||
T Consensus 93 ----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~givH~dlkp 165 (304)
T cd05101 93 ----DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA---SQKCIHRDLAA 165 (304)
T ss_pred ----CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHH---HCCeeeccccc
Confidence 345899999999999999986432 1235889999999999999999999 89999999999
Q ss_pred CceEECCCCcEEEEeeCCcccccCCCcc-cccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCC
Q 046270 400 TNILLDSELNAKVADFGLAKQSLEGHSH-LTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLDTSTS 477 (590)
Q Consensus 400 ~NILLd~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELlt-G~~p~~~~~~ 477 (590)
+||++++++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..|+.....
T Consensus 166 ~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~ 245 (304)
T cd05101 166 RNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 245 (304)
T ss_pred ceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH
Confidence 9999999999999999999866433222 1223345678999999988889999999999999999999 7777753221
Q ss_pred chhhhhHHHHHHHhcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhccC
Q 046270 478 PFQLITDWAWVLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEGD 543 (590)
Q Consensus 478 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~~ 543 (590)
.++.... ..+.... .+......+..++..|++.+|++||||.|+++.|+..
T Consensus 246 -----~~~~~~~-~~~~~~~---------~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~ 296 (304)
T cd05101 246 -----EELFKLL-KEGHRMD---------KPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRI 296 (304)
T ss_pred -----HHHHHHH-HcCCcCC---------CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHH
Confidence 1111111 1111110 0112334677889999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=319.22 Aligned_cols=201 Identities=25% Similarity=0.379 Sum_probs=171.0
Q ss_pred cCCCccceecccCcEEEEEEEEcC-CcEEEEEEeecC---CCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCce
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLRH-GNLVAVKQILDL---DTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKR 339 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~vAvK~l~~~---~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~ 339 (590)
++|...+.||+|+||.||+++... ++.||+|.+... .....+.+.+|+.++..++|+||+++++++.. +..
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~ 75 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQD-----ENN 75 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEec-----CCe
Confidence 468888999999999999999864 889999998642 22234568899999999999999999998873 456
Q ss_pred EEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcc
Q 046270 340 RFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAK 419 (590)
Q Consensus 340 ~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~ 419 (590)
.++||||+++|+|.+++.. ....+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++
T Consensus 76 ~~lv~e~~~g~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 150 (331)
T cd05597 76 LYLVMDYYVGGDLLTLLSK--FEDRLPEDMARFYLAEMVLAIDSVH---QLGYVHRDIKPDNVLLDKNGHIRLADFGSCL 150 (331)
T ss_pred EEEEEecCCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEECCCCHHHEEECCCCCEEEEECCcee
Confidence 9999999999999998852 2346899999999999999999999 8999999999999999999999999999987
Q ss_pred cccCCCcccccccccCCCccCcccccc-----CCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 046270 420 QSLEGHSHLTTRVAGTFGYLAPEYALY-----GQLTEKSDVYSFGIVILELMSGRKVLDT 474 (590)
Q Consensus 420 ~~~~~~~~~~~~~~gt~~Y~APE~~~~-----~~~t~ksDVySfGvvLlELltG~~p~~~ 474 (590)
..............||+.|+|||++.. +.++.++|||||||++|||++|+.||..
T Consensus 151 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~ 210 (331)
T cd05597 151 RLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYA 210 (331)
T ss_pred ecCCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCC
Confidence 654433333334568999999999863 4578899999999999999999999864
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=315.78 Aligned_cols=240 Identities=25% Similarity=0.374 Sum_probs=188.3
Q ss_pred ceecccCcEEEEEEEEcC-CcEEEEEEeecCC---CCChHHHHHHHHHHHhc-CCCCccccceeEEeccCCCCceEEEEE
Q 046270 270 NLIGQGASGIVYKGTLRH-GNLVAVKQILDLD---TKGDEDFTNEVEIISKI-RHRNLLSLRGCCVTSDDSSGKRRFLVY 344 (590)
Q Consensus 270 ~~LG~G~fG~Vykg~~~~-g~~vAvK~l~~~~---~~~~~~f~~Ev~il~~l-~H~nlv~l~g~~~~~~~~~~~~~~LV~ 344 (590)
+.||+|+||.||+|.+.+ +..||||.+.... ......+..|..++..+ +||||+++++++.. ....++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~-----~~~~~lv~ 75 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQT-----KENLFFVM 75 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEe-----CCEEEEEE
Confidence 369999999999999875 6789999986532 23345567788888765 99999999999874 34689999
Q ss_pred eeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccccCC
Q 046270 345 DYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEG 424 (590)
Q Consensus 345 E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~~~~ 424 (590)
||+++|+|.+++. ....+++.++..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 76 ey~~~g~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 149 (316)
T cd05619 76 EYLNGGDLMFHIQ---SCHKFDLPRATFYAAEIICGLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLG 149 (316)
T ss_pred eCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCC
Confidence 9999999999884 3356899999999999999999999 899999999999999999999999999998754322
Q ss_pred CcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhhhHHHh
Q 046270 425 HSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDEFIR 504 (590)
Q Consensus 425 ~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 504 (590)
. .......||..|+|||++.+..++.++|||||||++|||++|+.||...... .... .. ..+.. .+
T Consensus 150 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~-~~~~----~i-~~~~~--~~----- 215 (316)
T cd05619 150 D-AKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE-ELFQ----SI-RMDNP--CY----- 215 (316)
T ss_pred C-CceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH-HHHH----HH-HhCCC--CC-----
Confidence 2 1233456899999999999889999999999999999999999999653321 1111 11 11110 00
Q ss_pred hhhHHHHHHHHHHHHHhchhcCCCCCCCHH-HHH
Q 046270 505 AEGARAVMERFVLVGILCAHVMVALRPTIT-DAL 537 (590)
Q Consensus 505 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~-eVl 537 (590)
+......+.+++..|++.+|++||++. ++.
T Consensus 216 ---~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 216 ---PRWLTREAKDILVKLFVREPERRLGVKGDIR 246 (316)
T ss_pred ---CccCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence 111223567788899999999999997 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=324.09 Aligned_cols=242 Identities=21% Similarity=0.274 Sum_probs=191.0
Q ss_pred ceecccCcEEEEEEEEc-CCcEEEEEEeecCC---CCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEEEEEe
Q 046270 270 NLIGQGASGIVYKGTLR-HGNLVAVKQILDLD---TKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFLVYD 345 (590)
Q Consensus 270 ~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~---~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~LV~E 345 (590)
+.||+|+||.||++... .|..||+|.+.... ......+.+|++++.+++||||+++.+++.. ....++|||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~-----~~~~~lv~E 75 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQT-----HDRLCFVME 75 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEc-----CCEEEEEEe
Confidence 36999999999999875 58899999986532 2234567889999999999999999988873 456999999
Q ss_pred eCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCC-CCeEecCCCCCceEECCCCcEEEEeeCCcccccCC
Q 046270 346 YMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLK-PGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEG 424 (590)
Q Consensus 346 ~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~-~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~~~~ 424 (590)
|+++|+|.+++. ....+++..+..++.||+.||.||| + .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 76 ~~~~~~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~lH---~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~ 149 (325)
T cd05594 76 YANGGELFFHLS---RERVFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD 149 (325)
T ss_pred CCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHH---hcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCC
Confidence 999999988874 3456999999999999999999999 6 79999999999999999999999999998754322
Q ss_pred CcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhhhHHHh
Q 046270 425 HSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDEFIR 504 (590)
Q Consensus 425 ~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 504 (590)
. .......||..|+|||++.++.++.++|||||||++|||++|+.||....... +. .... .+.. .
T Consensus 150 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~--~~---~~i~-~~~~------~-- 214 (325)
T cd05594 150 G-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK--LF---ELIL-MEEI------R-- 214 (325)
T ss_pred C-cccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHH--HH---HHHh-cCCC------C--
Confidence 2 12234568999999999999999999999999999999999999996433211 11 0000 0100 0
Q ss_pred hhhHHHHHHHHHHHHHhchhcCCCCCC-----CHHHHHHH
Q 046270 505 AEGARAVMERFVLVGILCAHVMVALRP-----TITDALKM 539 (590)
Q Consensus 505 ~~~~~~~~~~l~~l~~~Cl~~dp~~RP-----tm~eVl~~ 539 (590)
.+......+.+++..|++.||++|+ ++.++++.
T Consensus 215 --~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 215 --FPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred --CCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 0111223567788899999999996 89998764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=330.02 Aligned_cols=257 Identities=19% Similarity=0.237 Sum_probs=194.7
Q ss_pred HHHHhcCCCccceecccCcEEEEEEEEcC-CcEEEEEEeecC---CCCChHHHHHHHHHHHhcCCCCccccceeEEeccC
Q 046270 259 LEQATNGFSQNNLIGQGASGIVYKGTLRH-GNLVAVKQILDL---DTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDD 334 (590)
Q Consensus 259 l~~at~~f~~~~~LG~G~fG~Vykg~~~~-g~~vAvK~l~~~---~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~ 334 (590)
+....++|...+.||+|+||.||+++... ++.+|+|.+... .......+.+|+++++.++||||+++++++.
T Consensus 38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~---- 113 (370)
T cd05621 38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQ---- 113 (370)
T ss_pred cCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEE----
Confidence 33445678999999999999999999874 778999998642 2223456889999999999999999999887
Q ss_pred CCCceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEe
Q 046270 335 SSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVAD 414 (590)
Q Consensus 335 ~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~D 414 (590)
.+...++||||+++|+|.+++. ...+++..+..++.||+.||+||| +.+|+||||||+|||+++++.+||+|
T Consensus 114 -~~~~~~lv~Ey~~gg~L~~~l~----~~~~~~~~~~~~~~qil~aL~~LH---~~~IvHrDLKp~NILl~~~~~~kL~D 185 (370)
T cd05621 114 -DDKYLYMVMEYMPGGDLVNLMS----NYDVPEKWAKFYTAEVVLALDAIH---SMGLIHRDVKPDNMLLDKHGHLKLAD 185 (370)
T ss_pred -cCCEEEEEEcCCCCCcHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEEe
Confidence 3456999999999999999884 235889999999999999999999 89999999999999999999999999
Q ss_pred eCCcccccCCCcccccccccCCCccCccccccC----CCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHH
Q 046270 415 FGLAKQSLEGHSHLTTRVAGTFGYLAPEYALYG----QLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLA 490 (590)
Q Consensus 415 FGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~----~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~ 490 (590)
||+++..............||+.|+|||.+... .++.++|||||||++|||++|+.||....... ... ...
T Consensus 186 FG~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~-~~~----~i~ 260 (370)
T cd05621 186 FGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVG-TYS----KIM 260 (370)
T ss_pred cccceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHH-HHH----HHH
Confidence 999986543322223456799999999998753 37899999999999999999999997543211 111 111
Q ss_pred hcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCC--CCCCHHHHHHH
Q 046270 491 KSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVA--LRPTITDALKM 539 (590)
Q Consensus 491 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~--~RPtm~eVl~~ 539 (590)
........-+ .......+..++..|++.++. .||++.|++++
T Consensus 261 ~~~~~~~~p~-------~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 261 DHKNSLNFPE-------DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred hCCcccCCCC-------cccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 1111000000 011223445556667764443 38899999886
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=323.26 Aligned_cols=239 Identities=23% Similarity=0.326 Sum_probs=185.4
Q ss_pred ceecccCcEEEEEEEEc-CCcEEEEEEeecCC---CCChHHHHHHHH-HHHhcCCCCccccceeEEeccCCCCceEEEEE
Q 046270 270 NLIGQGASGIVYKGTLR-HGNLVAVKQILDLD---TKGDEDFTNEVE-IISKIRHRNLLSLRGCCVTSDDSSGKRRFLVY 344 (590)
Q Consensus 270 ~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~---~~~~~~f~~Ev~-il~~l~H~nlv~l~g~~~~~~~~~~~~~~LV~ 344 (590)
+.||+|+||.||+++.. +|+.+|+|++.... ......+..|.. +++.++||||+++++.+.. ....++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~-----~~~~~lv~ 75 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQT-----TEKLYFVL 75 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEec-----CCEEEEEE
Confidence 36999999999999876 58899999986431 222345556655 4677899999999988874 44689999
Q ss_pred eeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccccCC
Q 046270 345 DYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEG 424 (590)
Q Consensus 345 E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~~~~ 424 (590)
||+++|+|..++. +...+++..+..++.||++||+||| +.+|+||||||+|||+++++.+||+|||+++.....
T Consensus 76 e~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~lH---~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~ 149 (325)
T cd05604 76 DFVNGGELFFHLQ---RERSFPEPRARFYAAEIASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ 149 (325)
T ss_pred cCCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCC
Confidence 9999999988874 3457999999999999999999999 899999999999999999999999999998753222
Q ss_pred CcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhhhHHHh
Q 046270 425 HSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDEFIR 504 (590)
Q Consensus 425 ~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 504 (590)
........||..|+|||.+.+..++.++|||||||++|||++|+.||...... ... ..... +.. .+.
T Consensus 150 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~-~~~----~~~~~-~~~--~~~---- 216 (325)
T cd05604 150 -SDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA-EMY----DNILH-KPL--VLR---- 216 (325)
T ss_pred -CCCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHH-HHH----HHHHc-CCc--cCC----
Confidence 12234467899999999999999999999999999999999999999653221 111 11111 110 000
Q ss_pred hhhHHHHHHHHHHHHHhchhcCCCCCCCHHHH
Q 046270 505 AEGARAVMERFVLVGILCAHVMVALRPTITDA 536 (590)
Q Consensus 505 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eV 536 (590)
......+..++..|++.+|.+||++++.
T Consensus 217 ----~~~~~~~~~ll~~ll~~~p~~R~~~~~~ 244 (325)
T cd05604 217 ----PGASLTAWSILEELLEKDRQRRLGAKED 244 (325)
T ss_pred ----CCCCHHHHHHHHHHhccCHHhcCCCCCC
Confidence 0122356678889999999999988643
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=322.70 Aligned_cols=236 Identities=25% Similarity=0.349 Sum_probs=187.6
Q ss_pred ceecccCcEEEEEEEEcC-CcEEEEEEeecC---CCCChHHHHHHHHHHHhc-CCCCccccceeEEeccCCCCceEEEEE
Q 046270 270 NLIGQGASGIVYKGTLRH-GNLVAVKQILDL---DTKGDEDFTNEVEIISKI-RHRNLLSLRGCCVTSDDSSGKRRFLVY 344 (590)
Q Consensus 270 ~~LG~G~fG~Vykg~~~~-g~~vAvK~l~~~---~~~~~~~f~~Ev~il~~l-~H~nlv~l~g~~~~~~~~~~~~~~LV~ 344 (590)
+.||+|+||.||+++.+. ++.||+|++... .....+.+..|.+++..+ +||||+++++++.. ....++||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~-----~~~~~iv~ 75 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQT-----PDRLFFVM 75 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEc-----CCEEEEEE
Confidence 369999999999999864 789999998643 223345677899999877 69999999998873 45689999
Q ss_pred eeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccccCC
Q 046270 345 DYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEG 424 (590)
Q Consensus 345 E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~~~~ 424 (590)
||+++|+|.+++. ....+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 76 Ey~~~g~L~~~i~---~~~~l~~~~~~~~~~ql~~~L~~lH---~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~ 149 (320)
T cd05590 76 EFVNGGDLMFHIQ---KSRRFDEARARFYAAEITSALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN 149 (320)
T ss_pred cCCCCchHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC
Confidence 9999999998885 3456999999999999999999999 899999999999999999999999999998754322
Q ss_pred CcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhhhHHHh
Q 046270 425 HSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDEFIR 504 (590)
Q Consensus 425 ~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 504 (590)
. .......||+.|+|||.+.+..++.++|||||||++|||++|+.||....... .. ... ..+...
T Consensus 150 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~-~~----~~i-~~~~~~-------- 214 (320)
T cd05590 150 G-KTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDD-LF----EAI-LNDEVV-------- 214 (320)
T ss_pred C-CcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH-HH----HHH-hcCCCC--------
Confidence 1 22334578999999999998899999999999999999999999997543211 11 111 111110
Q ss_pred hhhHHHHHHHHHHHHHhchhcCCCCCCCH
Q 046270 505 AEGARAVMERFVLVGILCAHVMVALRPTI 533 (590)
Q Consensus 505 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm 533 (590)
.+......+.+++..|++.||.+||++
T Consensus 215 --~~~~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 215 --YPTWLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred --CCCCCCHHHHHHHHHHcccCHHHCCCC
Confidence 011123466778899999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=307.66 Aligned_cols=249 Identities=28% Similarity=0.457 Sum_probs=199.9
Q ss_pred ceecccCcEEEEEEEEcC----CcEEEEEEeecCCCCC-hHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEEEEE
Q 046270 270 NLIGQGASGIVYKGTLRH----GNLVAVKQILDLDTKG-DEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFLVY 344 (590)
Q Consensus 270 ~~LG~G~fG~Vykg~~~~----g~~vAvK~l~~~~~~~-~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~LV~ 344 (590)
+.||+|+||.||++...+ +..+++|.+....... .+.+.+|++++.+++|+|++++++++.. +...++||
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~~lv~ 75 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTE-----EEPLYLVL 75 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecC-----CCceEEEE
Confidence 469999999999999874 7789999986654333 5789999999999999999999999874 45689999
Q ss_pred eeCCCCCcchhhhhhcc------cccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCc
Q 046270 345 DYMPNGTLSDNISISHK------RKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLA 418 (590)
Q Consensus 345 E~~~~gsL~~~L~~~~~------~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla 418 (590)
||+++++|.+++..... ...+++.++..++.|++.||+||| +.+++||||||+||++++++.+||+|||.+
T Consensus 76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~nili~~~~~~~l~dfg~~ 152 (262)
T cd00192 76 EYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLS 152 (262)
T ss_pred EeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHH---cCCcccCccCcceEEECCCCcEEEcccccc
Confidence 99999999999864311 367999999999999999999999 899999999999999999999999999999
Q ss_pred ccccCCCc-ccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhhHHHHHHHhcCCch
Q 046270 419 KQSLEGHS-HLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLDTSTSPFQLITDWAWVLAKSGKVD 496 (590)
Q Consensus 419 ~~~~~~~~-~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 496 (590)
+....... .......++..|+|||.+....++.++||||||++++||++ |+.|+...... .+ ... ...+...
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~---~~~-~~~~~~~ 226 (262)
T cd00192 153 RDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE--EV---LEY-LRKGYRL 226 (262)
T ss_pred cccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHH--HH---HHH-HHcCCCC
Confidence 87654321 22334557889999999988899999999999999999999 58888654221 11 111 1111110
Q ss_pred hhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhc
Q 046270 497 DIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLE 541 (590)
Q Consensus 497 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~ 541 (590)
..+......+..++..|++.+|.+|||+.+++++|+
T Consensus 227 ---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 227 ---------PKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred ---------CCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 011122357788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=320.30 Aligned_cols=257 Identities=25% Similarity=0.349 Sum_probs=200.8
Q ss_pred hcCCCccceecccCcEEEEEEEEc------CCcEEEEEEeecCCC-CChHHHHHHHHHHHhc-CCCCccccceeEEeccC
Q 046270 263 TNGFSQNNLIGQGASGIVYKGTLR------HGNLVAVKQILDLDT-KGDEDFTNEVEIISKI-RHRNLLSLRGCCVTSDD 334 (590)
Q Consensus 263 t~~f~~~~~LG~G~fG~Vykg~~~------~g~~vAvK~l~~~~~-~~~~~f~~Ev~il~~l-~H~nlv~l~g~~~~~~~ 334 (590)
.++|...+.||+|+||.||++... .+..||||+++.... ...+.+.+|+++++++ +|+||+++++++..
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~--- 110 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTI--- 110 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEec---
Confidence 356888999999999999999752 245799998865432 2345789999999999 79999999999874
Q ss_pred CCCceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEe
Q 046270 335 SSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVAD 414 (590)
Q Consensus 335 ~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~D 414 (590)
....++||||+++|+|.+++.... ...+++.++..++.+++.||.||| +.+|+|+||||+|||++.++.+||+|
T Consensus 111 --~~~~~lv~e~~~~~~L~~~i~~~~-~~~l~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~d 184 (302)
T cd05055 111 --GGPILVITEYCCYGDLLNFLRRKR-ESFLTLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNVLLTHGKIVKICD 184 (302)
T ss_pred --CCceEEEEEcCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeehhhhccceEEEcCCCeEEECC
Confidence 345899999999999999885322 234899999999999999999999 89999999999999999999999999
Q ss_pred eCCcccccCCCcc-cccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhhHHHHHHHhc
Q 046270 415 FGLAKQSLEGHSH-LTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLDTSTSPFQLITDWAWVLAKS 492 (590)
Q Consensus 415 FGla~~~~~~~~~-~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELlt-G~~p~~~~~~~~~~l~~~~~~~~~~ 492 (590)
||+++........ ......++..|+|||.+..+.++.++|||||||++|||++ |+.|+........ .... ...
T Consensus 185 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~-~~~~----~~~ 259 (302)
T cd05055 185 FGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK-FYKL----IKE 259 (302)
T ss_pred CcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH-HHHH----HHc
Confidence 9999865433221 1222345778999999999999999999999999999998 9988865433211 1111 111
Q ss_pred CCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhcc
Q 046270 493 GKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEG 542 (590)
Q Consensus 493 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~ 542 (590)
+.... ........+.+++..|++.+|++|||+.|+++.|+.
T Consensus 260 ~~~~~---------~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~ 300 (302)
T cd05055 260 GYRMA---------QPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGK 300 (302)
T ss_pred CCcCC---------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHh
Confidence 11000 011123477889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=334.48 Aligned_cols=266 Identities=23% Similarity=0.306 Sum_probs=195.0
Q ss_pred HhcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCccccceeEEeccC---CCC
Q 046270 262 ATNGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDD---SSG 337 (590)
Q Consensus 262 at~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~---~~~ 337 (590)
..++|...+.||+|+||.||+|+.. .++.||||++... .....+|+.++++++|+||+++++++..... ...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~----~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQD----PQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecC----cchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 3457889999999999999999986 4789999988542 2234579999999999999999998754321 122
Q ss_pred ceEEEEEeeCCCCCcchhhhhh-cccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCC-cEEEEee
Q 046270 338 KRRFLVYDYMPNGTLSDNISIS-HKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSEL-NAKVADF 415 (590)
Q Consensus 338 ~~~~LV~E~~~~gsL~~~L~~~-~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~-~~kL~DF 415 (590)
...++||||+++ +|.+++... .....+++..++.++.||+.||+||| +.+|+||||||+|||++.++ .+||+||
T Consensus 140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH---~~~IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCcCHHHEEEcCCCCceeeecc
Confidence 356799999985 676665422 23457999999999999999999999 89999999999999999664 7999999
Q ss_pred CCcccccCCCcccccccccCCCccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCC
Q 046270 416 GLAKQSLEGHSHLTTRVAGTFGYLAPEYALYG-QLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGK 494 (590)
Q Consensus 416 Gla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~ 494 (590)
|+++....... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||........ +......+ ....
T Consensus 216 Gla~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~-~~~i~~~~-~~p~ 291 (440)
T PTZ00036 216 GSAKNLLAGQR--SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQ-LVRIIQVL-GTPT 291 (440)
T ss_pred ccchhccCCCC--cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHh-CCCC
Confidence 99986644322 2335679999999988754 689999999999999999999999975433221 11111110 0000
Q ss_pred ch---------------hhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 495 VD---------------DIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 495 ~~---------------~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
.. ......+....+......+.+++..|++.||.+|||+.|+++.
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 292 EDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred HHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 00 0000111111111223467889999999999999999999864
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=310.44 Aligned_cols=250 Identities=31% Similarity=0.432 Sum_probs=191.0
Q ss_pred ceecccCcEEEEEEEEcC----CcEEEEEEeecCC-CCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEEEEE
Q 046270 270 NLIGQGASGIVYKGTLRH----GNLVAVKQILDLD-TKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFLVY 344 (590)
Q Consensus 270 ~~LG~G~fG~Vykg~~~~----g~~vAvK~l~~~~-~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~LV~ 344 (590)
+.||+|+||.||+|++.+ +..||+|++.... ....+.+.+|+.+++.++|||++++++++... +...++|+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~----~~~~~lv~ 76 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPS----EGSPLVVL 76 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecC----CCCcEEEE
Confidence 468999999999998642 3479999875432 23356788999999999999999999987643 23478999
Q ss_pred eeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccccCC
Q 046270 345 DYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEG 424 (590)
Q Consensus 345 E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~~~~ 424 (590)
||+++|+|.+++.. ....+++..++.++.||+.||+||| +.+++||||||+|||+++++.+||+|||+++.....
T Consensus 77 e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~ 151 (262)
T cd05058 77 PYMKHGDLRNFIRS--ETHNPTVKDLIGFGLQVAKGMEYLA---SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDK 151 (262)
T ss_pred ecCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCccccccccCC
Confidence 99999999999853 2345788889999999999999999 899999999999999999999999999999754332
Q ss_pred Cc---ccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCC-CCCCCCCchhhhhHHHHHHHhcCCchhhhh
Q 046270 425 HS---HLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRK-VLDTSTSPFQLITDWAWVLAKSGKVDDIFD 500 (590)
Q Consensus 425 ~~---~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~-p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 500 (590)
.. .......++..|+|||++....++.++||||||+++|||++|+. |+... .... +. ..... +....
T Consensus 152 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~-~~~~-~~---~~~~~-~~~~~--- 222 (262)
T cd05058 152 EYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV-DSFD-IT---VYLLQ-GRRLL--- 222 (262)
T ss_pred cceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCC-CHHH-HH---HHHhc-CCCCC---
Confidence 11 11123456778999999988899999999999999999999654 44322 2111 11 11111 11000
Q ss_pred HHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhccC
Q 046270 501 EFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEGD 543 (590)
Q Consensus 501 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~~ 543 (590)
.+...+..+.+++..|++.+|++||++.+++++|+..
T Consensus 223 ------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~ 259 (262)
T cd05058 223 ------QPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQI 259 (262)
T ss_pred ------CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 0111234677899999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=309.78 Aligned_cols=249 Identities=30% Similarity=0.399 Sum_probs=197.2
Q ss_pred cCCCccceecccCcEEEEEEEEcCCcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEEEE
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLRHGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFLV 343 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~LV 343 (590)
++|...+.||+|+||.||++..+ |..+|+|.+... ...+.+.+|+.++++++|+|++++++++... +...++|
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----~~~~~lv 78 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEE----KGGLYIV 78 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcC----CCceEEE
Confidence 36777889999999999999876 788999987543 2356799999999999999999999987542 3458999
Q ss_pred EeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccccC
Q 046270 344 YDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLE 423 (590)
Q Consensus 344 ~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~~~ 423 (590)
|||+++++|.+++... ....++|..++.++.+++.||+||| ..+++||||||+||++++++.+||+|||+++....
T Consensus 79 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 154 (256)
T cd05082 79 TEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLE---ANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 154 (256)
T ss_pred EECCCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccccchheEEEcCCCcEEecCCccceeccc
Confidence 9999999999988532 2335899999999999999999999 89999999999999999999999999999875433
Q ss_pred CCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhhHHHHHHHhcCCchhhhhHH
Q 046270 424 GHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDEF 502 (590)
Q Consensus 424 ~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 502 (590)
.. ....++..|+|||++....++.++||||||+++|||++ |+.|+..... .+..... ..+...+.
T Consensus 155 ~~----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~-----~~~~~~~-~~~~~~~~---- 220 (256)
T cd05082 155 TQ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-----KDVVPRV-EKGYKMDA---- 220 (256)
T ss_pred cC----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH-----HHHHHHH-hcCCCCCC----
Confidence 22 22334568999999998899999999999999999998 8888753221 1111111 11111110
Q ss_pred HhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhcc
Q 046270 503 IRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEG 542 (590)
Q Consensus 503 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~ 542 (590)
.......+..++..|++.+|++|||+.+++++|+.
T Consensus 221 -----~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 221 -----PDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred -----CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 11123467788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=321.26 Aligned_cols=254 Identities=27% Similarity=0.390 Sum_probs=195.4
Q ss_pred cCCCccceecccCcEEEEEEEEcC-Cc--EEEEEEeecCC-CCChHHHHHHHHHHHhc-CCCCccccceeEEeccCCCCc
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLRH-GN--LVAVKQILDLD-TKGDEDFTNEVEIISKI-RHRNLLSLRGCCVTSDDSSGK 338 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~~-g~--~vAvK~l~~~~-~~~~~~f~~Ev~il~~l-~H~nlv~l~g~~~~~~~~~~~ 338 (590)
++|+..+.||+|+||.||+|.+++ +. .+|+|++.... ......+.+|++++.++ +|+||+++++++.. +.
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~-----~~ 81 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH-----RG 81 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECC-----CC
Confidence 467788899999999999999754 44 46888775432 23345788999999999 89999999999864 34
Q ss_pred eEEEEEeeCCCCCcchhhhhhc-------------ccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEC
Q 046270 339 RRFLVYDYMPNGTLSDNISISH-------------KRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLD 405 (590)
Q Consensus 339 ~~~LV~E~~~~gsL~~~L~~~~-------------~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd 405 (590)
..++||||+++|+|.+++.... ....+++.+++.++.|++.||+||| +.+|+||||||+|||++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dlkp~Nili~ 158 (303)
T cd05088 82 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVG 158 (303)
T ss_pred CceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEec
Confidence 5899999999999999986432 1235899999999999999999999 89999999999999999
Q ss_pred CCCcEEEEeeCCcccccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhhH
Q 046270 406 SELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLDTSTSPFQLITD 484 (590)
Q Consensus 406 ~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELlt-G~~p~~~~~~~~~~l~~ 484 (590)
.++.+||+|||+++..... .......++..|+|||++....++.++||||||++++||+| |..||.......
T Consensus 159 ~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~----- 231 (303)
T cd05088 159 ENYVAKIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE----- 231 (303)
T ss_pred CCCcEEeCccccCcccchh--hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH-----
Confidence 9999999999998642211 11112234568999999988889999999999999999998 999885432211
Q ss_pred HHHHHHhcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhcc
Q 046270 485 WAWVLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEG 542 (590)
Q Consensus 485 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~ 542 (590)
..... ..+...+ .+......+.+++..|++.+|++||++.+++++|+.
T Consensus 232 ~~~~~-~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~ 279 (303)
T cd05088 232 LYEKL-PQGYRLE---------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR 279 (303)
T ss_pred HHHHH-hcCCcCC---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 11111 1110000 011123466788999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=315.95 Aligned_cols=250 Identities=24% Similarity=0.384 Sum_probs=200.7
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEEE
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFL 342 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~L 342 (590)
.+|...+.||+|+||.||+|+.. +++.||+|.+........+.+.+|+++++.++|+|++++++++.. +.+.++
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~-----~~~~~l 94 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV-----GDELWV 94 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEe-----CCEEEE
Confidence 46778889999999999999875 578999999876555556778999999999999999999999874 456999
Q ss_pred EEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCccccc
Q 046270 343 VYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSL 422 (590)
Q Consensus 343 V~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~~ 422 (590)
||||+++++|.+++. ...+++.++..++.|++.||+||| ..+|+||||||+||+++.++.+||+|||+++...
T Consensus 95 v~e~~~~~~L~~~~~----~~~~~~~~~~~i~~ql~~aL~~LH---~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~ 167 (296)
T cd06654 95 VMEYLAGGSLTDVVT----ETCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 167 (296)
T ss_pred eecccCCCCHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEECccccchhcc
Confidence 999999999999884 235899999999999999999999 8999999999999999999999999999987643
Q ss_pred CCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhhhHH
Q 046270 423 EGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDEF 502 (590)
Q Consensus 423 ~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 502 (590)
.... ......|+..|+|||++....++.++|||||||++|||++|+.||........ +. .....+.. ..
T Consensus 168 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~----~~-~~~~~~~~-~~---- 236 (296)
T cd06654 168 PEQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA----LY-LIATNGTP-EL---- 236 (296)
T ss_pred cccc-ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh----HH-HHhcCCCC-CC----
Confidence 3221 12334678899999999988899999999999999999999999965432111 11 11111110 00
Q ss_pred HhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 503 IRAEGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 503 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
..+......+.+++..|+..+|++|||+.|+++.
T Consensus 237 ---~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 237 ---QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred ---CCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 0111233467778899999999999999999973
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=320.85 Aligned_cols=258 Identities=25% Similarity=0.385 Sum_probs=199.2
Q ss_pred hcCCCccceecccCcEEEEEEEEcC--------CcEEEEEEeecCC-CCChHHHHHHHHHHHhc-CCCCccccceeEEec
Q 046270 263 TNGFSQNNLIGQGASGIVYKGTLRH--------GNLVAVKQILDLD-TKGDEDFTNEVEIISKI-RHRNLLSLRGCCVTS 332 (590)
Q Consensus 263 t~~f~~~~~LG~G~fG~Vykg~~~~--------g~~vAvK~l~~~~-~~~~~~f~~Ev~il~~l-~H~nlv~l~g~~~~~ 332 (590)
.++|...+.||+|+||.||++...+ +..+|+|.+.... .....++.+|++++.++ +|+||+++++++..
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~- 95 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ- 95 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec-
Confidence 3568888999999999999998632 3469999986532 23345688999999999 89999999999874
Q ss_pred cCCCCceEEEEEeeCCCCCcchhhhhhcc-------------cccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCC
Q 046270 333 DDSSGKRRFLVYDYMPNGTLSDNISISHK-------------RKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKS 399 (590)
Q Consensus 333 ~~~~~~~~~LV~E~~~~gsL~~~L~~~~~-------------~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp 399 (590)
+...++||||+++|+|.+++..... ...++|.++++++.|++.||+||| +.+++||||||
T Consensus 96 ----~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp 168 (307)
T cd05098 96 ----DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLA---SKKCIHRDLAA 168 (307)
T ss_pred ----CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCcccccccH
Confidence 3458999999999999999864321 235899999999999999999999 89999999999
Q ss_pred CceEECCCCcEEEEeeCCcccccCCCcc-cccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCC
Q 046270 400 TNILLDSELNAKVADFGLAKQSLEGHSH-LTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLDTSTS 477 (590)
Q Consensus 400 ~NILLd~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELlt-G~~p~~~~~~ 477 (590)
+||+++.++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |+.|+.....
T Consensus 169 ~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~ 248 (307)
T cd05098 169 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 248 (307)
T ss_pred HheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH
Confidence 9999999999999999998765432211 1222234568999999998889999999999999999998 7788753221
Q ss_pred chhhhhHHHHHHHhcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhccC
Q 046270 478 PFQLITDWAWVLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEGD 543 (590)
Q Consensus 478 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~~ 543 (590)
.+..... ..+...+ .+......+.+++..|++.+|++||||.+|++.|+..
T Consensus 249 -----~~~~~~~-~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~ 299 (307)
T cd05098 249 -----EELFKLL-KEGHRMD---------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 299 (307)
T ss_pred -----HHHHHHH-HcCCCCC---------CCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence 1111111 1111111 1112234677889999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=307.91 Aligned_cols=247 Identities=28% Similarity=0.433 Sum_probs=195.1
Q ss_pred ceecccCcEEEEEEEEcCCcEEEEEEeecCCCC-ChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEEEEEeeCC
Q 046270 270 NLIGQGASGIVYKGTLRHGNLVAVKQILDLDTK-GDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFLVYDYMP 348 (590)
Q Consensus 270 ~~LG~G~fG~Vykg~~~~g~~vAvK~l~~~~~~-~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~LV~E~~~ 348 (590)
++||+|+||.||++.+.+++.||+|++...... ....+.+|++++++++|+||+++++++.. ....++||||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~~v~e~~~ 75 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQ-----KQPIYIVMELVP 75 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEec-----CCCeEEEEEcCC
Confidence 369999999999999888999999988654433 45679999999999999999999999874 345899999999
Q ss_pred CCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccccCCCccc
Q 046270 349 NGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHL 428 (590)
Q Consensus 349 ~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~~~~~~~~ 428 (590)
+++|.+++.. ....+++..++.++.+++.||.||| +.+++||||||+||+++.++.+||+|||+++.........
T Consensus 76 ~~~l~~~l~~--~~~~~~~~~~~~~~~~~~~~l~~lH---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~ 150 (251)
T cd05041 76 GGSLLTFLRK--KKNRLTVKKLLQMSLDAAAGMEYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTV 150 (251)
T ss_pred CCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHH---hCCEehhhcCcceEEEcCCCcEEEeeccccccccCCccee
Confidence 9999998853 2346899999999999999999999 8999999999999999999999999999998654322111
Q ss_pred c-cccccCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhhHHHHHHHhcCCchhhhhHHHhhh
Q 046270 429 T-TRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDEFIRAE 506 (590)
Q Consensus 429 ~-~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 506 (590)
. ....++..|+|||.+.++.++.++||||||++++||+| |..|+....... .... ...+. ...
T Consensus 151 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~--~~~~----~~~~~---------~~~ 215 (251)
T cd05041 151 SDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ--TRER----IESGY---------RMP 215 (251)
T ss_pred ccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH--HHHH----HhcCC---------CCC
Confidence 1 12233567999999998899999999999999999999 777775432211 1111 11110 000
Q ss_pred hHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhc
Q 046270 507 GARAVMERFVLVGILCAHVMVALRPTITDALKMLE 541 (590)
Q Consensus 507 ~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~ 541 (590)
.+......+.+++..|++.+|++|||+.|+++.|+
T Consensus 216 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 216 APQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred CCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 11122346788999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=312.43 Aligned_cols=254 Identities=22% Similarity=0.317 Sum_probs=199.7
Q ss_pred cCCCccceecccCcEEEEEEEEcCC----cEEEEEEeecCC-CCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCc
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLRHG----NLVAVKQILDLD-TKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGK 338 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~~g----~~vAvK~l~~~~-~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~ 338 (590)
++|...+.||+|+||.||+|++.+. ..||||...... ....+.+.+|+.++++++|+|++++++++.. .
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~------~ 79 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE------N 79 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC------C
Confidence 4577788999999999999987542 368999876543 2345679999999999999999999998863 2
Q ss_pred eEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCc
Q 046270 339 RRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLA 418 (590)
Q Consensus 339 ~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla 418 (590)
..++||||+++|+|.+++.. ....+++..++.++.+++.||.||| +.+++||||||+||+++.++.+||+|||++
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~ 154 (270)
T cd05056 80 PVWIVMELAPLGELRSYLQV--NKYSLDLASLILYSYQLSTALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLS 154 (270)
T ss_pred CcEEEEEcCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccChheEEEecCCCeEEccCcee
Confidence 36899999999999999853 2345899999999999999999999 899999999999999999999999999999
Q ss_pred ccccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhhHHHHHHHhcCCchh
Q 046270 419 KQSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLDTSTSPFQLITDWAWVLAKSGKVDD 497 (590)
Q Consensus 419 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 497 (590)
+..............++..|+|||.+....++.++||||||++++|+++ |+.||....... ... + ...+....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~-~~~-~----~~~~~~~~ 228 (270)
T cd05056 155 RYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNND-VIG-R----IENGERLP 228 (270)
T ss_pred eecccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHH-HHH-H----HHcCCcCC
Confidence 8654433222233344568999999988889999999999999999996 999986543321 111 1 11111110
Q ss_pred hhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhccC
Q 046270 498 IFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEGD 543 (590)
Q Consensus 498 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~~ 543 (590)
.+......+..++..|+..+|++|||+.++++.|+..
T Consensus 229 ---------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~ 265 (270)
T cd05056 229 ---------MPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDI 265 (270)
T ss_pred ---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 0112234677888999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=322.00 Aligned_cols=241 Identities=24% Similarity=0.357 Sum_probs=190.2
Q ss_pred CCCccceecccCcEEEEEEEEcC-CcEEEEEEeecCC---CCChHHHHHHHHHHHhc-CCCCccccceeEEeccCCCCce
Q 046270 265 GFSQNNLIGQGASGIVYKGTLRH-GNLVAVKQILDLD---TKGDEDFTNEVEIISKI-RHRNLLSLRGCCVTSDDSSGKR 339 (590)
Q Consensus 265 ~f~~~~~LG~G~fG~Vykg~~~~-g~~vAvK~l~~~~---~~~~~~f~~Ev~il~~l-~H~nlv~l~g~~~~~~~~~~~~ 339 (590)
+|...+.||+|+||.||+|+... +..||+|.+.... ....+.+..|.+++..+ +|++|+++++++.. ...
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~-----~~~ 75 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQT-----MDR 75 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEec-----CCE
Confidence 47788999999999999999874 6799999986532 22234567788888887 58899999988863 446
Q ss_pred EEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcc
Q 046270 340 RFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAK 419 (590)
Q Consensus 340 ~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~ 419 (590)
.++||||+++|+|.+++. ....+++.++..++.||+.||+||| +.+|+||||||+|||+++++.+||+|||+++
T Consensus 76 ~~lv~E~~~~g~L~~~~~---~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~ 149 (323)
T cd05616 76 LYFVMEYVNGGDLMYQIQ---QVGRFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK 149 (323)
T ss_pred EEEEEcCCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHH---HCCEEecCCCHHHeEECCCCcEEEccCCCce
Confidence 899999999999998874 3456899999999999999999999 8999999999999999999999999999997
Q ss_pred cccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhh
Q 046270 420 QSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIF 499 (590)
Q Consensus 420 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 499 (590)
...... .......||+.|+|||++.+..++.++|||||||++|||+||+.||...... .... ... ....
T Consensus 150 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~-~~~~----~i~-~~~~---- 218 (323)
T cd05616 150 ENMWDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED-ELFQ----SIM-EHNV---- 218 (323)
T ss_pred ecCCCC-CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH-HHHH----HHH-hCCC----
Confidence 543221 1233467899999999999999999999999999999999999999753321 1111 111 1110
Q ss_pred hHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCH
Q 046270 500 DEFIRAEGARAVMERFVLVGILCAHVMVALRPTI 533 (590)
Q Consensus 500 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm 533 (590)
..+......+..++..|++.+|.+|++.
T Consensus 219 ------~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 219 ------AYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred ------CCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 0111223467788899999999999984
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=313.51 Aligned_cols=249 Identities=27% Similarity=0.389 Sum_probs=191.1
Q ss_pred ceecccCcEEEEEEEEcC-Cc--EEEEEEeecCC-CCChHHHHHHHHHHHhc-CCCCccccceeEEeccCCCCceEEEEE
Q 046270 270 NLIGQGASGIVYKGTLRH-GN--LVAVKQILDLD-TKGDEDFTNEVEIISKI-RHRNLLSLRGCCVTSDDSSGKRRFLVY 344 (590)
Q Consensus 270 ~~LG~G~fG~Vykg~~~~-g~--~vAvK~l~~~~-~~~~~~f~~Ev~il~~l-~H~nlv~l~g~~~~~~~~~~~~~~LV~ 344 (590)
+.||+|+||.||+|++++ +. .+++|.+.... ....+.+.+|++++.++ +|||++++++++.. ....++||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-----~~~~~lv~ 75 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH-----RGYLYLAI 75 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEec-----CCCceEEE
Confidence 368999999999999865 33 47888876433 23346788999999999 89999999999874 34589999
Q ss_pred eeCCCCCcchhhhhhc-------------ccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEE
Q 046270 345 DYMPNGTLSDNISISH-------------KRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAK 411 (590)
Q Consensus 345 E~~~~gsL~~~L~~~~-------------~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~k 411 (590)
||+++|+|.+++.... ....+++.+++.++.|++.||+||| +.+++||||||+|||+++++.+|
T Consensus 76 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nili~~~~~~k 152 (270)
T cd05047 76 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAK 152 (270)
T ss_pred EeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccccceEEEcCCCeEE
Confidence 9999999999885322 1235899999999999999999999 89999999999999999999999
Q ss_pred EEeeCCcccccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhhHHHHHHH
Q 046270 412 VADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLDTSTSPFQLITDWAWVLA 490 (590)
Q Consensus 412 L~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELlt-G~~p~~~~~~~~~~l~~~~~~~~ 490 (590)
|+|||+++..... ........+..|+|||++....++.++||||||++++||++ |+.||....... . ... .
T Consensus 153 l~dfgl~~~~~~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~-~----~~~-~ 224 (270)
T cd05047 153 IADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-L----YEK-L 224 (270)
T ss_pred ECCCCCccccchh--hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHH-H----HHH-H
Confidence 9999998632211 11111223567999999988899999999999999999997 999985432211 1 111 1
Q ss_pred hcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhccC
Q 046270 491 KSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEGD 543 (590)
Q Consensus 491 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~~ 543 (590)
..+...+ ........+.+++..|++.+|.+|||+.+++.+|+..
T Consensus 225 ~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~ 268 (270)
T cd05047 225 PQGYRLE---------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 268 (270)
T ss_pred hCCCCCC---------CCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence 1111000 0111234677899999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=300.89 Aligned_cols=266 Identities=24% Similarity=0.276 Sum_probs=209.9
Q ss_pred hcCCCccceecccCcEEEEEEEE-cCCcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEE
Q 046270 263 TNGFSQNNLIGQGASGIVYKGTL-RHGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRF 341 (590)
Q Consensus 263 t~~f~~~~~LG~G~fG~Vykg~~-~~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~ 341 (590)
.++|.+.++||+|||.-||.++. .++..+|+|++.-...++.+...+|++..++++|||+++++.++.........+.|
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y 99 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY 99 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence 45788899999999999999984 45789999999876667778899999999999999999999998876544456799
Q ss_pred EEEeeCCCCCcchhhhhhc-ccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCccc
Q 046270 342 LVYDYMPNGTLSDNISISH-KRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQ 420 (590)
Q Consensus 342 LV~E~~~~gsL~~~L~~~~-~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~ 420 (590)
|+++|...|+|.+++.... ++..+++.+.+.|+.+|.+||++||+. .+++.||||||.|||+.+++.++|.|||.+..
T Consensus 100 ll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~ 178 (302)
T KOG2345|consen 100 LLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSATQ 178 (302)
T ss_pred EEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCccc
Confidence 9999999999999986544 334799999999999999999999933 34599999999999999999999999999876
Q ss_pred ccCCCc---c-----cccccccCCCccCccccc---cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHH
Q 046270 421 SLEGHS---H-----LTTRVAGTFGYLAPEYAL---YGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVL 489 (590)
Q Consensus 421 ~~~~~~---~-----~~~~~~gt~~Y~APE~~~---~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~ 489 (590)
..-... . .-.....|..|.|||.+. +...++++|||||||+||+|+.|..||+...+.+..+.
T Consensus 179 a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSla------ 252 (302)
T KOG2345|consen 179 APIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLA------ 252 (302)
T ss_pred cceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEE------
Confidence 432111 0 111234689999999886 44678999999999999999999999975333221111
Q ss_pred HhcCCchhhhhHHH--hhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhccC
Q 046270 490 AKSGKVDDIFDEFI--RAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEGD 543 (590)
Q Consensus 490 ~~~~~~~~~~d~~l--~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~~ 543 (590)
..+....+ .+..+ ..+.+.+++.+|++.||.+||++.+++..++..
T Consensus 253 ------LAv~n~q~s~P~~~~--yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 253 ------LAVQNAQISIPNSSR--YSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred ------EeeeccccccCCCCC--ccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 00011111 11111 456788899999999999999999999988754
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=320.47 Aligned_cols=263 Identities=25% Similarity=0.345 Sum_probs=197.7
Q ss_pred HhcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecC--CCCChHHHHHHHHHHHhcCCCCccccceeEEeccCC-CC
Q 046270 262 ATNGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDL--DTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDS-SG 337 (590)
Q Consensus 262 at~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~--~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~-~~ 337 (590)
..++|...+.||+|+||.||+++.. .|..||+|++... .......+.+|+.+++.++||||+++++++...... ..
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 3478999999999999999999876 4789999998643 223355688999999999999999999988654321 23
Q ss_pred ceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCC
Q 046270 338 KRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGL 417 (590)
Q Consensus 338 ~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGl 417 (590)
...++||||+++ +|.+.+. ..+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH---~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~ 169 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIH-----MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGL 169 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHh-----ccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEecCCC
Confidence 457999999975 5555542 35889999999999999999999 89999999999999999999999999999
Q ss_pred cccccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCc-h
Q 046270 418 AKQSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKV-D 496 (590)
Q Consensus 418 a~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~-~ 496 (590)
++..... .......||..|+|||.+.+..++.++|||||||++|||++|+.||...... ..|......-+.. .
T Consensus 170 a~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~----~~~~~~~~~~~~~~~ 243 (359)
T cd07876 170 ARTACTN--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHI----DQWNKVIEQLGTPSA 243 (359)
T ss_pred ccccccC--ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHHhcCCCcH
Confidence 9754322 2233456899999999999999999999999999999999999999754321 1121111111110 0
Q ss_pred hhhhH--------------------------HHhh---hhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 497 DIFDE--------------------------FIRA---EGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 497 ~~~d~--------------------------~l~~---~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
+..+. .... .........+.+++..|++.||++|||+.|+++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 244 EFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00000 0000 0000112457789999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=320.93 Aligned_cols=250 Identities=23% Similarity=0.318 Sum_probs=199.9
Q ss_pred hcCCCccceecccCcEEEEEEEEcC-CcEEEEEEeecC---CCCChHHHHHHHHHHHhc-CCCCccccceeEEeccCCCC
Q 046270 263 TNGFSQNNLIGQGASGIVYKGTLRH-GNLVAVKQILDL---DTKGDEDFTNEVEIISKI-RHRNLLSLRGCCVTSDDSSG 337 (590)
Q Consensus 263 t~~f~~~~~LG~G~fG~Vykg~~~~-g~~vAvK~l~~~---~~~~~~~f~~Ev~il~~l-~H~nlv~l~g~~~~~~~~~~ 337 (590)
-++|...+.||+|+|++||+++..+ ++++|||++.+. ..+..+-+..|-++|.+| .||.|++|+-.+.+ .
T Consensus 72 ~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD-----~ 146 (604)
T KOG0592|consen 72 PNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQD-----E 146 (604)
T ss_pred hhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeec-----c
Confidence 4567788899999999999998765 789999998542 222344577899999999 89999999988874 3
Q ss_pred ceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCC
Q 046270 338 KRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGL 417 (590)
Q Consensus 338 ~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGl 417 (590)
..+|+|+||++||+|.++|. +.+.|++...+.++.+|+.||+||| ..|||||||||+|||||+||++||.|||.
T Consensus 147 ~sLYFvLe~A~nGdll~~i~---K~Gsfde~caR~YAAeIldAleylH---~~GIIHRDlKPENILLd~dmhikITDFGs 220 (604)
T KOG0592|consen 147 ESLYFVLEYAPNGDLLDLIK---KYGSFDETCARFYAAEILDALEYLH---SNGIIHRDLKPENILLDKDGHIKITDFGS 220 (604)
T ss_pred cceEEEEEecCCCcHHHHHH---HhCcchHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeEcCCCcEEEeeccc
Confidence 45999999999999999995 5578999999999999999999999 99999999999999999999999999999
Q ss_pred cccccCCCcc---------cc---cccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHH
Q 046270 418 AKQSLEGHSH---------LT---TRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDW 485 (590)
Q Consensus 418 a~~~~~~~~~---------~~---~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~ 485 (590)
|+.+.+.... .. ..+.||..|.+||.+..+..+..+|+|+|||+||+|+.|++||....+ ... +
T Consensus 221 AK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne-yli---F 296 (604)
T KOG0592|consen 221 AKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANE-YLI---F 296 (604)
T ss_pred cccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccH-HHH---H
Confidence 9977543221 11 337899999999999999999999999999999999999999975443 111 1
Q ss_pred HHHHHhcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 486 AWVLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 486 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
...+.. |- ..+....+...+++...+-.||.+|+|..++-++
T Consensus 297 qkI~~l--------~y----~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 297 QKIQAL--------DY----EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred HHHHHh--------cc----cCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 111100 11 1112222355566677888999999999998765
|
|
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=314.99 Aligned_cols=257 Identities=26% Similarity=0.430 Sum_probs=199.8
Q ss_pred hcCCCccceecccCcEEEEEEEEc------CCcEEEEEEeecCCC-CChHHHHHHHHHHHhcCCCCccccceeEEeccCC
Q 046270 263 TNGFSQNNLIGQGASGIVYKGTLR------HGNLVAVKQILDLDT-KGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDS 335 (590)
Q Consensus 263 t~~f~~~~~LG~G~fG~Vykg~~~------~g~~vAvK~l~~~~~-~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~ 335 (590)
.++|...+.||+|+||.||++..+ .+..||+|.+..... ....+|.+|++++++++|||++++++++..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~---- 79 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAV---- 79 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcC----
Confidence 467888999999999999999864 356899998864322 234679999999999999999999998874
Q ss_pred CCceEEEEEeeCCCCCcchhhhhhc-------------------ccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecC
Q 046270 336 SGKRRFLVYDYMPNGTLSDNISISH-------------------KRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRD 396 (590)
Q Consensus 336 ~~~~~~LV~E~~~~gsL~~~L~~~~-------------------~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrD 396 (590)
+...++||||+++|+|.+++.... ....+++.+++.++.|++.||.||| ..+++|||
T Consensus 80 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH---~~~i~H~d 155 (288)
T cd05050 80 -GKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLS---ERKFVHRD 155 (288)
T ss_pred -CCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCeeccc
Confidence 345899999999999999985321 1135789999999999999999999 89999999
Q ss_pred CCCCceEECCCCcEEEEeeCCcccccCCCcc-cccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 046270 397 IKSTNILLDSELNAKVADFGLAKQSLEGHSH-LTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLDT 474 (590)
Q Consensus 397 IKp~NILLd~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELlt-G~~p~~~ 474 (590)
|||+||++++++.+||+|||+++........ .......+..|+|||.+.++.++.++|||||||++|||++ |..|+..
T Consensus 156 l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~ 235 (288)
T cd05050 156 LATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYG 235 (288)
T ss_pred ccHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999998754332211 1222334668999999998999999999999999999998 8777753
Q ss_pred CCCchhhhhHHHHHHHhcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhcc
Q 046270 475 STSPFQLITDWAWVLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEG 542 (590)
Q Consensus 475 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~ 542 (590)
.... ++... ...+..... +......+.+++.+|++.+|++|||+.|+++.|+.
T Consensus 236 ~~~~-----~~~~~-~~~~~~~~~---------~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 236 MAHE-----EVIYY-VRDGNVLSC---------PDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred CCHH-----HHHHH-HhcCCCCCC---------CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 2211 11111 112221110 11223477889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=310.28 Aligned_cols=248 Identities=25% Similarity=0.339 Sum_probs=194.0
Q ss_pred CCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCC-CCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEEE
Q 046270 265 GFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLD-TKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFL 342 (590)
Q Consensus 265 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~-~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~L 342 (590)
+|...+.||+|+||.||+|++. .++.||+|.+.... .....++.+|++++++++|||++++++++.. ....++
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~l 76 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFV-----ENRISI 76 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEE-----CCEEEE
Confidence 5677789999999999999875 57899999886432 2334578999999999999999999999984 345899
Q ss_pred EEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCccccc
Q 046270 343 VYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSL 422 (590)
Q Consensus 343 V~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~~ 422 (590)
||||+++++|..+. .+++..+..++.|++.||.||| +.+|+|+||||+|||++.++.+||+|||++....
T Consensus 77 v~e~~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~ 146 (279)
T cd06619 77 CTEFMDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLW---SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLV 146 (279)
T ss_pred EEecCCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCCHHHEEECCCCCEEEeeCCcceecc
Confidence 99999999996542 4788899999999999999999 8999999999999999999999999999997653
Q ss_pred CCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhh--hhHHHHHHHhcCCchhhhh
Q 046270 423 EGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQL--ITDWAWVLAKSGKVDDIFD 500 (590)
Q Consensus 423 ~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~--l~~~~~~~~~~~~~~~~~d 500 (590)
.. ......|+..|+|||++....++.++||||||+++|||++|+.||......... ...+..... ......
T Consensus 147 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~--- 219 (279)
T cd06619 147 NS---IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIV-DEDPPV--- 219 (279)
T ss_pred cc---cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHh-ccCCCC---
Confidence 32 223356889999999999889999999999999999999999998643221111 011111100 000000
Q ss_pred HHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 501 EFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 501 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
+ ........+.+++..|++.+|++||+++|+++.
T Consensus 220 --~---~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 220 --L---PVGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred --C---CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 0 011123467788999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=308.31 Aligned_cols=248 Identities=26% Similarity=0.415 Sum_probs=197.0
Q ss_pred ceecccCcEEEEEEEEcC--Cc--EEEEEEeecCCC-CChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEEEEE
Q 046270 270 NLIGQGASGIVYKGTLRH--GN--LVAVKQILDLDT-KGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFLVY 344 (590)
Q Consensus 270 ~~LG~G~fG~Vykg~~~~--g~--~vAvK~l~~~~~-~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~LV~ 344 (590)
++||+|++|.||+|.+.+ +. .||+|.+..... ...+.+.+|++++++++|+||+++++++.. ...++||
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~~~~v~ 74 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT------HPLMMVT 74 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC------CeEEEEE
Confidence 368999999999998754 32 699999876555 446689999999999999999999999863 4589999
Q ss_pred eeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccccCC
Q 046270 345 DYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEG 424 (590)
Q Consensus 345 E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~~~~ 424 (590)
||+++|+|.+++..... ..++|...+.++.|++.||+||| ..+++||||||+||+++.++.+||+|||+++.....
T Consensus 75 e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~ 150 (257)
T cd05040 75 ELAPLGSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLE---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQN 150 (257)
T ss_pred EecCCCcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHH---hCCccccccCcccEEEecCCEEEecccccccccccc
Confidence 99999999999864322 46899999999999999999999 899999999999999999999999999999876443
Q ss_pred Ccc--cccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhhHHHHHHHhcCCchhhhhH
Q 046270 425 HSH--LTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDE 501 (590)
Q Consensus 425 ~~~--~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 501 (590)
... ......++.+|+|||++....++.++||||||++++||++ |+.|+....... ... .....+....
T Consensus 151 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-~~~----~~~~~~~~~~---- 221 (257)
T cd05040 151 EDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ-ILK----KIDKEGERLE---- 221 (257)
T ss_pred ccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH-HHH----HHHhcCCcCC----
Confidence 222 1223456789999999998899999999999999999999 999986432211 111 1111111000
Q ss_pred HHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhc
Q 046270 502 FIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLE 541 (590)
Q Consensus 502 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~ 541 (590)
.+......+.+++..|++.+|++||++.++++.|.
T Consensus 222 -----~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 222 -----RPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred -----CCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 01122346778999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=312.29 Aligned_cols=247 Identities=23% Similarity=0.268 Sum_probs=191.0
Q ss_pred ecccCcEEEEEEEEc-CCcEEEEEEeecCCC---CChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEEEEEeeC
Q 046270 272 IGQGASGIVYKGTLR-HGNLVAVKQILDLDT---KGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFLVYDYM 347 (590)
Q Consensus 272 LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~---~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~LV~E~~ 347 (590)
||+|+||.||+++.+ +|+.+|+|++..... .....+..|++++++++||||+++.+++. .+...++||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~-----~~~~~~lv~e~~ 75 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFE-----SKTHLCLVMSLM 75 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEe-----cCCeEEEEEecC
Confidence 699999999999876 488999999854221 12344567999999999999999998886 345689999999
Q ss_pred CCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccccCCCcc
Q 046270 348 PNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSH 427 (590)
Q Consensus 348 ~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~~~~~~~ 427 (590)
++++|.+++... ....+++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||++.......
T Consensus 76 ~g~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~-- 149 (277)
T cd05607 76 NGGDLKYHIYNV-GERGLEMERVIHYSAQITCGILHLH---SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK-- 149 (277)
T ss_pred CCCCHHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHH---HCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--
Confidence 999999887532 2345899999999999999999999 8999999999999999999999999999987654322
Q ss_pred cccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhhhHHHhhhh
Q 046270 428 LTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDEFIRAEG 507 (590)
Q Consensus 428 ~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 507 (590)
......|+..|+|||++.++.++.++|||||||++|||++|+.||........ ..+....... +.... .
T Consensus 150 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~-~~~~~~~~~~-~~~~~---------~ 218 (277)
T cd05607 150 TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA-KEELKRRTLE-DEVKF---------E 218 (277)
T ss_pred eeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh-HHHHHHHhhc-ccccc---------c
Confidence 22345689999999999988999999999999999999999999865332211 1111111111 01000 0
Q ss_pred HHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHh
Q 046270 508 ARAVMERFVLVGILCAHVMVALRPTITDALKML 540 (590)
Q Consensus 508 ~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L 540 (590)
.......+.+++..|++.||++||+++|+++.+
T Consensus 219 ~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~ 251 (277)
T cd05607 219 HQNFTEESKDICRLFLAKKPEDRLGSREKNDDP 251 (277)
T ss_pred cccCCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence 011234677889999999999999997766433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=306.29 Aligned_cols=249 Identities=26% Similarity=0.369 Sum_probs=200.4
Q ss_pred cCCCccceecccCcEEEEEEEEcC-CcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEEE
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLRH-GNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFL 342 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~L 342 (590)
++|+..+.||+|+||.||+|++.+ +..+++|.+..... .+++.+|++++++++|+|++++++++.. +...++
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~~~l 75 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFK-----NTDLWI 75 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeec-----CCcEEE
Confidence 578888999999999999999876 78999999865432 6789999999999999999999999874 356899
Q ss_pred EEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCccccc
Q 046270 343 VYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSL 422 (590)
Q Consensus 343 V~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~~ 422 (590)
++||+++++|.+++.. ....++|..+..++.|++.||.||| ..+++||||+|+||++++++.+||+|||++....
T Consensus 76 ~~e~~~~~~L~~~l~~--~~~~l~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~ 150 (256)
T cd06612 76 VMEYCGAGSVSDIMKI--TNKTLTEEEIAAILYQTLKGLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLT 150 (256)
T ss_pred EEecCCCCcHHHHHHh--CccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEECCCCcEEEcccccchhcc
Confidence 9999999999998853 2457899999999999999999999 8899999999999999999999999999988654
Q ss_pred CCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhhhHH
Q 046270 423 EGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDEF 502 (590)
Q Consensus 423 ~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 502 (590)
.... ......|+..|+|||++.+..++.++||||||+++|||++|+.|+........... ........ +
T Consensus 151 ~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~------~~~~~~~~-~--- 219 (256)
T cd06612 151 DTMA-KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFM------IPNKPPPT-L--- 219 (256)
T ss_pred cCcc-ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhh------hccCCCCC-C---
Confidence 3321 22334578899999999888999999999999999999999999875332211110 00000000 0
Q ss_pred HhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 046270 503 IRAEGARAVMERFVLVGILCAHVMVALRPTITDALK 538 (590)
Q Consensus 503 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~ 538 (590)
..+......+.+++..|++.+|++|||+.||++
T Consensus 220 ---~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 220 ---SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred ---CchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 011122346778889999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=318.88 Aligned_cols=263 Identities=22% Similarity=0.308 Sum_probs=197.7
Q ss_pred HhcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCC--CCChHHHHHHHHHHHhcCCCCccccceeEEeccC-CCC
Q 046270 262 ATNGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLD--TKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDD-SSG 337 (590)
Q Consensus 262 at~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~--~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~-~~~ 337 (590)
..++|...+.||+|+||.||++... .++.||||++.... ......+.+|+.+++.++||||+++++++...+. ...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 3568999999999999999999876 47889999986432 2334568899999999999999999998764332 123
Q ss_pred ceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCC
Q 046270 338 KRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGL 417 (590)
Q Consensus 338 ~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGl 417 (590)
...++||||+++ +|.+.+. ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~ 172 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGL 172 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHH-----hcCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEECCCCcEEEEeCCC
Confidence 458999999975 6666552 35889999999999999999999 89999999999999999999999999999
Q ss_pred cccccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCc-h
Q 046270 418 AKQSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKV-D 496 (590)
Q Consensus 418 a~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~-~ 496 (590)
++..... .......||..|+|||++.+..++.++|||||||++|||++|+.||....... .|......-+.. .
T Consensus 173 a~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~----~~~~~~~~~~~~~~ 246 (364)
T cd07875 173 ARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHID----QWNKVIEQLGTPCP 246 (364)
T ss_pred ccccCCC--CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHH----HHHHHHHhcCCCCH
Confidence 9865332 22234568999999999999999999999999999999999999996543211 111111111110 0
Q ss_pred hh---hhHHH-------------------h-------hhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 497 DI---FDEFI-------------------R-------AEGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 497 ~~---~d~~l-------------------~-------~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
+. +.+.+ . ..........+.+++..|++.||.+|||+.|++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 247 EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00 00000 0 00000112357789999999999999999999875
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=305.80 Aligned_cols=238 Identities=23% Similarity=0.331 Sum_probs=186.9
Q ss_pred ceecccCcEEEEEEEEcCCc-----------EEEEEEeecCCCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCc
Q 046270 270 NLIGQGASGIVYKGTLRHGN-----------LVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGK 338 (590)
Q Consensus 270 ~~LG~G~fG~Vykg~~~~g~-----------~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~ 338 (590)
+.||+|+||.||+|.+.+.. .+++|.+...... ...|.+|+.++++++|+|+++++|++.. .
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~ 73 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR------D 73 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec------C
Confidence 36999999999999987533 5788876544333 6789999999999999999999999875 2
Q ss_pred eEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCC-------cEE
Q 046270 339 RRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSEL-------NAK 411 (590)
Q Consensus 339 ~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~-------~~k 411 (590)
..++||||+++|+|.+++... ...+++..++.++.||+.||.||| +.+|+||||||+|||++.++ .+|
T Consensus 74 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dlkp~Nill~~~~~~~~~~~~~k 148 (259)
T cd05037 74 ENIMVEEYVKFGPLDVFLHRE--KNNVSLHWKLDVAKQLASALHYLE---DKKLVHGNVCGKNILVARYGLNEGYVPFIK 148 (259)
T ss_pred CcEEEEEcCCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHh---hCCeecccCccceEEEecCccccCCceeEE
Confidence 369999999999999988532 226899999999999999999999 89999999999999999887 799
Q ss_pred EEeeCCcccccCCCcccccccccCCCccCccccccC--CCCcchhHHHHHHHHHHHHhC-CCCCCCCCCchhhhhHHHHH
Q 046270 412 VADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALYG--QLTEKSDVYSFGIVILELMSG-RKVLDTSTSPFQLITDWAWV 488 (590)
Q Consensus 412 L~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~--~~t~ksDVySfGvvLlELltG-~~p~~~~~~~~~~l~~~~~~ 488 (590)
|+|||+++.... .....++..|+|||++... .++.++||||||+++|||++| ..|+..... ..... +
T Consensus 149 l~Dfg~a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~-~~~~~-~--- 218 (259)
T cd05037 149 LSDPGIPITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSS-SEKER-F--- 218 (259)
T ss_pred eCCCCccccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCc-hhHHH-H---
Confidence 999999986543 1223466789999998876 789999999999999999994 666644321 11111 1
Q ss_pred HHhcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhc
Q 046270 489 LAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLE 541 (590)
Q Consensus 489 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~ 541 (590)
+......... ....+.+++..|++.+|.+|||+.++++.|+
T Consensus 219 -~~~~~~~~~~-----------~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 219 -YQDQHRLPMP-----------DCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred -HhcCCCCCCC-----------CchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0111100000 0146778999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=319.62 Aligned_cols=242 Identities=26% Similarity=0.387 Sum_probs=191.9
Q ss_pred ceecccCcEEEEEEEEcC-CcEEEEEEeecC---CCCChHHHHHHHHHHHhc-CCCCccccceeEEeccCCCCceEEEEE
Q 046270 270 NLIGQGASGIVYKGTLRH-GNLVAVKQILDL---DTKGDEDFTNEVEIISKI-RHRNLLSLRGCCVTSDDSSGKRRFLVY 344 (590)
Q Consensus 270 ~~LG~G~fG~Vykg~~~~-g~~vAvK~l~~~---~~~~~~~f~~Ev~il~~l-~H~nlv~l~g~~~~~~~~~~~~~~LV~ 344 (590)
+.||+|+||.||++++.. +..||||.+... .......+..|.+++..+ +||||+++++++.. ....++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~-----~~~~~lv~ 75 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQT-----KDRLFFVM 75 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEc-----CCEEEEEE
Confidence 469999999999999874 779999998753 223345677899999888 79999999998873 45699999
Q ss_pred eeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccccCC
Q 046270 345 DYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEG 424 (590)
Q Consensus 345 E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~~~~ 424 (590)
||+++|+|.+++. ....+++.++..++.||+.||.||| +.+|+||||||+|||+++++.+||+|||+++.....
T Consensus 76 e~~~~~~L~~~~~---~~~~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 149 (318)
T cd05570 76 EYVNGGDLMFHIQ---RSGRFDEPRARFYAAEIVLGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILG 149 (318)
T ss_pred cCCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEccCCCHHHeEECCCCcEEecccCCCeecCcC
Confidence 9999999998874 3347999999999999999999999 899999999999999999999999999998753222
Q ss_pred CcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhhhHHHh
Q 046270 425 HSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDEFIR 504 (590)
Q Consensus 425 ~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 504 (590)
. .......|+..|+|||++.+..++.++|||||||++|||++|+.||...... ... ... ..+...
T Consensus 150 ~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~-~~~----~~i-~~~~~~-------- 214 (318)
T cd05570 150 G-VTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED-ELF----QSI-LEDEVR-------- 214 (318)
T ss_pred C-CcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH-HHH----HHH-HcCCCC--------
Confidence 2 1233456899999999999999999999999999999999999999643321 111 111 111110
Q ss_pred hhhHHHHHHHHHHHHHhchhcCCCCCCCH-----HHHHHH
Q 046270 505 AEGARAVMERFVLVGILCAHVMVALRPTI-----TDALKM 539 (590)
Q Consensus 505 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm-----~eVl~~ 539 (590)
.+......+.+++..|++.||.+||++ .++++.
T Consensus 215 --~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 215 --YPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred --CCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 011123467788899999999999999 887653
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=320.07 Aligned_cols=263 Identities=23% Similarity=0.303 Sum_probs=197.8
Q ss_pred HhcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCC--CCChHHHHHHHHHHHhcCCCCccccceeEEeccC-CCC
Q 046270 262 ATNGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLD--TKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDD-SSG 337 (590)
Q Consensus 262 at~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~--~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~-~~~ 337 (590)
..++|...+.||+|+||.||++... .++.||||++.... ......+.+|+.+++.++|+||+++++++..... ...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 4578999999999999999999876 47899999986432 2234567899999999999999999998865432 123
Q ss_pred ceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCC
Q 046270 338 KRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGL 417 (590)
Q Consensus 338 ~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGl 417 (590)
...++||||+++ +|.+.+. ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH---~~givHrDikp~Nill~~~~~~kl~Dfg~ 165 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHh-----hcCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEECCCCCEEEeeCcc
Confidence 458999999975 5655552 35889999999999999999999 89999999999999999999999999999
Q ss_pred cccccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCC-ch
Q 046270 418 AKQSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGK-VD 496 (590)
Q Consensus 418 a~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~-~~ 496 (590)
++..... .......||..|+|||++.+..++.++|||||||++|||++|+.||...... ..|......-+. ..
T Consensus 166 ~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~----~~~~~~~~~~~~~~~ 239 (355)
T cd07874 166 ARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI----DQWNKVIEQLGTPCP 239 (355)
T ss_pred cccCCCc--cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHHHhCCCCH
Confidence 9864332 2233456899999999999889999999999999999999999999653321 111111111010 00
Q ss_pred hhhh---------------------H-----HHh---hhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 497 DIFD---------------------E-----FIR---AEGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 497 ~~~d---------------------~-----~l~---~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
+... + .+. ..........+.+++..|++.||++|||+.|+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 240 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 0000 0 000 00011123467789999999999999999999975
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=316.91 Aligned_cols=242 Identities=23% Similarity=0.326 Sum_probs=188.9
Q ss_pred ceecccCcEEEEEEEEcC-CcEEEEEEeecCCC---CChHHHHHHHHHHHhc-CCCCccccceeEEeccCCCCceEEEEE
Q 046270 270 NLIGQGASGIVYKGTLRH-GNLVAVKQILDLDT---KGDEDFTNEVEIISKI-RHRNLLSLRGCCVTSDDSSGKRRFLVY 344 (590)
Q Consensus 270 ~~LG~G~fG~Vykg~~~~-g~~vAvK~l~~~~~---~~~~~f~~Ev~il~~l-~H~nlv~l~g~~~~~~~~~~~~~~LV~ 344 (590)
++||+|+||.||+++... ++.+|+|++..... ...+.+.+|+.++.++ +|+||+++++++.. ....++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~-----~~~~~lv~ 75 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQT-----TSRLFLVI 75 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEe-----CCEEEEEE
Confidence 469999999999999864 67899999875322 2344578999999998 69999999998873 45699999
Q ss_pred eeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccccCC
Q 046270 345 DYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEG 424 (590)
Q Consensus 345 E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~~~~ 424 (590)
||+++|+|.+++. ..+.+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 76 e~~~~~~L~~~~~---~~~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 149 (327)
T cd05617 76 EYVNGGDLMFHMQ---RQRKLPEEHARFYAAEICIALNFLH---ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP 149 (327)
T ss_pred eCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEeCCCCEEEeccccceeccCC
Confidence 9999999988874 3356999999999999999999999 899999999999999999999999999998753221
Q ss_pred CcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCch-hhhhHHHHHHHhcCCchhhhhHHH
Q 046270 425 HSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPF-QLITDWAWVLAKSGKVDDIFDEFI 503 (590)
Q Consensus 425 ~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~-~~l~~~~~~~~~~~~~~~~~d~~l 503 (590)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||+...... ....++...........
T Consensus 150 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~------- 221 (327)
T cd05617 150 G-DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIR------- 221 (327)
T ss_pred C-CceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCC-------
Confidence 1 22334678999999999999999999999999999999999999996433211 11222222222211110
Q ss_pred hhhhHHHHHHHHHHHHHhchhcCCCCCCCH
Q 046270 504 RAEGARAVMERFVLVGILCAHVMVALRPTI 533 (590)
Q Consensus 504 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm 533 (590)
.+......+.+++..|++.||.+||++
T Consensus 222 ---~p~~~~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 222 ---IPRFLSVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred ---CCCCCCHHHHHHHHHHhccCHHHcCCC
Confidence 011122356778889999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=312.26 Aligned_cols=198 Identities=27% Similarity=0.422 Sum_probs=160.9
Q ss_pred cceecccCcEEEEEEEEc---CCcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEEEEEe
Q 046270 269 NNLIGQGASGIVYKGTLR---HGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFLVYD 345 (590)
Q Consensus 269 ~~~LG~G~fG~Vykg~~~---~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~LV~E 345 (590)
.++||+|+||.||+|+.. .+..+|+|.+.... ....+.+|++++++++||||+++++++... .+...++|||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~---~~~~~~lv~e 80 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSH---ADRKVWLLFD 80 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecC---CCcEEEEEEe
Confidence 358999999999999875 35689999885432 245678999999999999999999988643 2356899999
Q ss_pred eCCCCCcchhhhhhc------ccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEE----CCCCcEEEEee
Q 046270 346 YMPNGTLSDNISISH------KRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILL----DSELNAKVADF 415 (590)
Q Consensus 346 ~~~~gsL~~~L~~~~------~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILL----d~~~~~kL~DF 415 (590)
|+. ++|.+++.... ....+++..+..|+.||+.||.||| +.+|+||||||+|||+ +.++.+||+||
T Consensus 81 ~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivHrDlkp~Nil~~~~~~~~~~~kl~Df 156 (317)
T cd07868 81 YAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADM 156 (317)
T ss_pred ccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEecCCCCcCcEEEeec
Confidence 986 47777664221 1235899999999999999999999 8999999999999999 45678999999
Q ss_pred CCcccccCCCcc--cccccccCCCccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 046270 416 GLAKQSLEGHSH--LTTRVAGTFGYLAPEYALY-GQLTEKSDVYSFGIVILELMSGRKVLDTS 475 (590)
Q Consensus 416 Gla~~~~~~~~~--~~~~~~gt~~Y~APE~~~~-~~~t~ksDVySfGvvLlELltG~~p~~~~ 475 (590)
|+++........ ......||+.|+|||++.+ ..++.++||||+||+++||++|+.||...
T Consensus 157 G~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 157 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred CceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 999865433221 2334678999999999876 45899999999999999999999999643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-37 Score=308.92 Aligned_cols=254 Identities=26% Similarity=0.378 Sum_probs=198.2
Q ss_pred CCCccceecccCcEEEEEEEEcC--CcEEEEEEeecCC----------CCChHHHHHHHHHHHh-cCCCCccccceeEEe
Q 046270 265 GFSQNNLIGQGASGIVYKGTLRH--GNLVAVKQILDLD----------TKGDEDFTNEVEIISK-IRHRNLLSLRGCCVT 331 (590)
Q Consensus 265 ~f~~~~~LG~G~fG~Vykg~~~~--g~~vAvK~l~~~~----------~~~~~~f~~Ev~il~~-l~H~nlv~l~g~~~~ 331 (590)
+|+..+.||+|+||.||+|.++. +..+|+|.+.... .....++..|+.++.+ ++|+|++++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47778899999999999999875 6789999875321 1123457789988875 799999999999873
Q ss_pred ccCCCCceEEEEEeeCCCCCcchhhhhh-cccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcE
Q 046270 332 SDDSSGKRRFLVYDYMPNGTLSDNISIS-HKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNA 410 (590)
Q Consensus 332 ~~~~~~~~~~LV~E~~~~gsL~~~L~~~-~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~ 410 (590)
+...++||||+++++|.+++... .....+++..+++++.|++.||.|||+ ..+++|+||||+||+++.++.+
T Consensus 81 -----~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~--~~~i~H~dl~~~nil~~~~~~~ 153 (269)
T cd08528 81 -----NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKV 153 (269)
T ss_pred -----CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhcc--CCceeecCCCHHHEEECCCCcE
Confidence 45699999999999999887532 234568999999999999999999992 2679999999999999999999
Q ss_pred EEEeeCCcccccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHH
Q 046270 411 KVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLA 490 (590)
Q Consensus 411 kL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~ 490 (590)
||+|||++....... ......|+..|+|||.+.++.++.++||||||+++|||++|+.|+....... .....
T Consensus 154 ~l~dfg~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~-----~~~~~- 225 (269)
T cd08528 154 TITDFGLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLS-----LATKI- 225 (269)
T ss_pred EEecccceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHH-----HHHHH-
Confidence 999999998654432 3344568899999999998899999999999999999999999986432211 11111
Q ss_pred hcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhc
Q 046270 491 KSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLE 541 (590)
Q Consensus 491 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~ 541 (590)
..+...... .......+.+++.+|++.||++||++.||.++|+
T Consensus 226 ~~~~~~~~~--------~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 226 VEAVYEPLP--------EGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred hhccCCcCC--------cccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 111111100 0112346778888999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=311.34 Aligned_cols=239 Identities=21% Similarity=0.336 Sum_probs=184.4
Q ss_pred eecccCcEEEEEEEEcC-------------------------CcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCcccc
Q 046270 271 LIGQGASGIVYKGTLRH-------------------------GNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSL 325 (590)
Q Consensus 271 ~LG~G~fG~Vykg~~~~-------------------------g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv~l 325 (590)
+||+|+||.||+|++.. ...|++|.+.........+|.+|++++++++|+||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999998531 12588998865444445678899999999999999999
Q ss_pred ceeEEeccCCCCceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEC
Q 046270 326 RGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLD 405 (590)
Q Consensus 326 ~g~~~~~~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd 405 (590)
+++|.. +...++||||+++|+|..++.. ..+.+++..++.++.||++||+||| +.+|+||||||+|||++
T Consensus 82 ~~~~~~-----~~~~~lv~ey~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~Nill~ 151 (274)
T cd05076 82 HGVCVR-----GSENIMVEEFVEHGPLDVCLRK--EKGRVPVAWKITVAQQLASALSYLE---DKNLVHGNVCAKNILLA 151 (274)
T ss_pred EEEEEe-----CCceEEEEecCCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHH---cCCccCCCCCcccEEEe
Confidence 999984 3458999999999999988852 2456899999999999999999999 89999999999999997
Q ss_pred CCC-------cEEEEeeCCcccccCCCcccccccccCCCccCcccccc-CCCCcchhHHHHHHHHHHHH-hCCCCCCCCC
Q 046270 406 SEL-------NAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALY-GQLTEKSDVYSFGIVILELM-SGRKVLDTST 476 (590)
Q Consensus 406 ~~~-------~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~t~ksDVySfGvvLlELl-tG~~p~~~~~ 476 (590)
..+ .+|++|||++...... ....++..|+|||.+.. ..++.++||||||+++|||+ +|+.|+....
T Consensus 152 ~~~~~~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~ 226 (274)
T cd05076 152 RLGLAEGTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERT 226 (274)
T ss_pred ccCcccCccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccC
Confidence 643 3799999988643222 12346788999998875 56899999999999999995 6888886433
Q ss_pred CchhhhhHHHHHHHhcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhc
Q 046270 477 SPFQLITDWAWVLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLE 541 (590)
Q Consensus 477 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~ 541 (590)
... ...+.. ...... ......+.+++..|++.+|++|||+.++++.|+
T Consensus 227 ~~~--~~~~~~---~~~~~~------------~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 227 PSE--KERFYE---KKHRLP------------EPSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred hHH--HHHHHH---hccCCC------------CCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 211 111100 000000 011235778889999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=328.00 Aligned_cols=241 Identities=26% Similarity=0.418 Sum_probs=204.1
Q ss_pred HhcCCCccceecccCcEEEEEEEEcC-CcEEEEEEeecCCC---CChHHHHHHHHHHHhc-CCCCccccceeEEeccCCC
Q 046270 262 ATNGFSQNNLIGQGASGIVYKGTLRH-GNLVAVKQILDLDT---KGDEDFTNEVEIISKI-RHRNLLSLRGCCVTSDDSS 336 (590)
Q Consensus 262 at~~f~~~~~LG~G~fG~Vykg~~~~-g~~vAvK~l~~~~~---~~~~~f~~Ev~il~~l-~H~nlv~l~g~~~~~~~~~ 336 (590)
.-++|....+||+|.||.|+++.++. ++.+|||.+++... ...+..+.|.+|+... +||.|++|+.++.+
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT----- 440 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQT----- 440 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeeccccccc-----
Confidence 34679999999999999999999875 77899999977533 3455678899988888 59999999999885
Q ss_pred CceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeC
Q 046270 337 GKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFG 416 (590)
Q Consensus 337 ~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFG 416 (590)
..++|+||||..||++..+. ..+.+++....-++..|+-||.||| +++||+||||.+|||||.+|.+||+|||
T Consensus 441 ~~~l~fvmey~~Ggdm~~~~----~~~~F~e~rarfyaAev~l~L~fLH---~~~IIYRDlKLdNiLLD~eGh~kiADFG 513 (694)
T KOG0694|consen 441 KEHLFFVMEYVAGGDLMHHI----HTDVFSEPRARFYAAEVVLGLQFLH---ENGIIYRDLKLDNLLLDTEGHVKIADFG 513 (694)
T ss_pred CCeEEEEEEecCCCcEEEEE----ecccccHHHHHHHHHHHHHHHHHHH---hcCceeeecchhheEEcccCcEEecccc
Confidence 44699999999999965443 4467999999999999999999999 9999999999999999999999999999
Q ss_pred CcccccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCch
Q 046270 417 LAKQSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVD 496 (590)
Q Consensus 417 la~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 496 (590)
|++.... ....++...||+.|||||++.+..|+...|.|+|||+||||+.|..||...++ +
T Consensus 514 lcKe~m~-~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddE------------------e 574 (694)
T KOG0694|consen 514 LCKEGMG-QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDE------------------E 574 (694)
T ss_pred cccccCC-CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCH------------------H
Confidence 9996542 23367789999999999999999999999999999999999999999975433 3
Q ss_pred hhhhHHHhhh--hHHHHHHHHHHHHHhchhcCCCCCCCH
Q 046270 497 DIFDEFIRAE--GARAVMERFVLVGILCAHVMVALRPTI 533 (590)
Q Consensus 497 ~~~d~~l~~~--~~~~~~~~l~~l~~~Cl~~dp~~RPtm 533 (590)
+++|..+.++ ++.....+.+.|+...+..+|++|--+
T Consensus 575 e~FdsI~~d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 575 EVFDSIVNDEVRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred HHHHHHhcCCCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 4455555433 455566688889999999999999876
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=321.38 Aligned_cols=202 Identities=24% Similarity=0.343 Sum_probs=171.8
Q ss_pred cCCCccceecccCcEEEEEEEEcC-CcEEEEEEeecC---CCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCce
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLRH-GNLVAVKQILDL---DTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKR 339 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~vAvK~l~~~---~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~ 339 (590)
++|...+.||+|+||.||+++... ++.||+|.+... .......+.+|+.++..++|+||+++++++. .+..
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~-----~~~~ 75 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQ-----DENY 75 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-----cCCE
Confidence 468888999999999999999874 778999998642 1222345888999999999999999999887 3456
Q ss_pred EEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcc
Q 046270 340 RFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAK 419 (590)
Q Consensus 340 ~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~ 419 (590)
.++||||+++|+|.+++.. ....+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++
T Consensus 76 ~~lv~Ey~~gg~L~~~l~~--~~~~l~~~~~~~~~~qi~~~L~~lH---~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~ 150 (331)
T cd05624 76 LYLVMDYYVGGDLLTLLSK--FEDRLPEDMARFYIAEMVLAIHSIH---QLHYVHRDIKPDNVLLDMNGHIRLADFGSCL 150 (331)
T ss_pred EEEEEeCCCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCchHHEEEcCCCCEEEEecccee
Confidence 9999999999999999853 2346899999999999999999999 8999999999999999999999999999998
Q ss_pred cccCCCcccccccccCCCccCcccccc-----CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 046270 420 QSLEGHSHLTTRVAGTFGYLAPEYALY-----GQLTEKSDVYSFGIVILELMSGRKVLDTS 475 (590)
Q Consensus 420 ~~~~~~~~~~~~~~gt~~Y~APE~~~~-----~~~t~ksDVySfGvvLlELltG~~p~~~~ 475 (590)
..............||++|+|||++.. +.++.++|||||||++|||++|+.||...
T Consensus 151 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~ 211 (331)
T cd05624 151 KMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAE 211 (331)
T ss_pred eccCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCC
Confidence 654433333334569999999998875 56889999999999999999999999643
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=308.12 Aligned_cols=252 Identities=23% Similarity=0.354 Sum_probs=188.0
Q ss_pred eecccCcEEEEEEEEcC---CcEEEEEEeecCCC-CChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEEEEEee
Q 046270 271 LIGQGASGIVYKGTLRH---GNLVAVKQILDLDT-KGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFLVYDY 346 (590)
Q Consensus 271 ~LG~G~fG~Vykg~~~~---g~~vAvK~l~~~~~-~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~LV~E~ 346 (590)
.||+|+||.||+|++.+ +..+|+|++..... .....+.+|+.++++++|||++++++++.. ....++||||
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv~e~ 76 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTE-----VTPYLLVMEF 76 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC-----CCCcEEEEEC
Confidence 68999999999998754 34799998865432 233578899999999999999999998874 3358999999
Q ss_pred CCCCCcchhhhhhcc--cccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccccCC
Q 046270 347 MPNGTLSDNISISHK--RKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEG 424 (590)
Q Consensus 347 ~~~gsL~~~L~~~~~--~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~~~~ 424 (590)
+++|+|.+++..... ...+++..+..++.|+++||+||| +.+++||||||+||+++.++++||+|||+++.....
T Consensus 77 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~ 153 (269)
T cd05087 77 CPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH---KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKE 153 (269)
T ss_pred CCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEECCccccccccCc
Confidence 999999999864322 234678888899999999999999 899999999999999999999999999999754332
Q ss_pred Cccc-ccccccCCCccCccccccC-------CCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhhHHHHHHHhcCCc
Q 046270 425 HSHL-TTRVAGTFGYLAPEYALYG-------QLTEKSDVYSFGIVILELMS-GRKVLDTSTSPFQLITDWAWVLAKSGKV 495 (590)
Q Consensus 425 ~~~~-~~~~~gt~~Y~APE~~~~~-------~~t~ksDVySfGvvLlELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~ 495 (590)
.... .....++..|+|||++... .++.++||||||+++|||++ |+.||........ .. +. .. +..
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~-~~-~~---~~-~~~ 227 (269)
T cd05087 154 DYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV-LT-YT---VR-EQQ 227 (269)
T ss_pred ceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH-HH-HH---hh-ccc
Confidence 2211 2234577899999988632 35789999999999999996 9999865433211 11 11 11 111
Q ss_pred hhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhc
Q 046270 496 DDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLE 541 (590)
Q Consensus 496 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~ 541 (590)
....++.+.. ...+.+.+++..|+ .+|++|||++||+..|+
T Consensus 228 ~~~~~~~~~~----~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 228 LKLPKPRLKL----PLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCCCCccCC----CCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 1111111111 11234566777888 68999999999999886
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=310.51 Aligned_cols=263 Identities=22% Similarity=0.308 Sum_probs=195.2
Q ss_pred CCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCC--CCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEE
Q 046270 265 GFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLD--TKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRF 341 (590)
Q Consensus 265 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~--~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~ 341 (590)
+|+..+.||+|+||.||+|+.. ++..||+|++.... ....+.+.+|+.++.+++|+|++++++++.. +...+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~ 75 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQ-----ESRLY 75 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEee-----CCeEE
Confidence 4677889999999999999986 58899999985432 2234678899999999999999999999874 44689
Q ss_pred EEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccc
Q 046270 342 LVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQS 421 (590)
Q Consensus 342 LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~ 421 (590)
+||||++ ++|.+++........+++..+..++.||+.||.||| ..+|+||||||+||+++.++.+||+|||+++..
T Consensus 76 ~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 151 (285)
T cd07861 76 LIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAF 151 (285)
T ss_pred EEEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEEcCCCcEEECcccceeec
Confidence 9999997 688887754333457999999999999999999999 899999999999999999999999999998754
Q ss_pred cCCCcccccccccCCCccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHH-------HHhcC
Q 046270 422 LEGHSHLTTRVAGTFGYLAPEYALYG-QLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWV-------LAKSG 493 (590)
Q Consensus 422 ~~~~~~~~~~~~gt~~Y~APE~~~~~-~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~-------~~~~~ 493 (590)
.... .......++..|+|||.+.+. .++.++||||||++++||+||+.||........... .... .|...
T Consensus 152 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 229 (285)
T cd07861 152 GIPV-RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFR-IFRILGTPTEDVWPGV 229 (285)
T ss_pred CCCc-ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHH-HHHHhCCCChhhhhcc
Confidence 3221 122234568899999987654 578999999999999999999999875433211110 0000 00000
Q ss_pred CchhhhhHHHh-------hhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 046270 494 KVDDIFDEFIR-------AEGARAVMERFVLVGILCAHVMVALRPTITDALK 538 (590)
Q Consensus 494 ~~~~~~d~~l~-------~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~ 538 (590)
........... .........++.+++..|++.||++|||+.+|++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 230 TSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred hhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 00000000000 0001112346678999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=313.20 Aligned_cols=262 Identities=21% Similarity=0.357 Sum_probs=197.0
Q ss_pred cCCCccceecccCcEEEEEEEEcC-----------------CcEEEEEEeecCCC-CChHHHHHHHHHHHhcCCCCcccc
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLRH-----------------GNLVAVKQILDLDT-KGDEDFTNEVEIISKIRHRNLLSL 325 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~~-----------------g~~vAvK~l~~~~~-~~~~~f~~Ev~il~~l~H~nlv~l 325 (590)
++|+..+.||+|+||.||++...+ +..+|+|++..... ....+|.+|++++++++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 568888999999999999986432 34689999865422 234679999999999999999999
Q ss_pred ceeEEeccCCCCceEEEEEeeCCCCCcchhhhhhc--------ccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCC
Q 046270 326 RGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISH--------KRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDI 397 (590)
Q Consensus 326 ~g~~~~~~~~~~~~~~LV~E~~~~gsL~~~L~~~~--------~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDI 397 (590)
++++.. +...++||||+++|+|.+++.... ....+++.+++.++.|++.||+||| +.+|+||||
T Consensus 85 ~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dl 156 (296)
T cd05095 85 LAVCIT-----SDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS---SLNFVHRDL 156 (296)
T ss_pred EEEEec-----CCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCeecccC
Confidence 999874 345899999999999999885422 1134788999999999999999999 889999999
Q ss_pred CCCceEECCCCcEEEEeeCCcccccCCCcc-cccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHh--CCCCCCC
Q 046270 398 KSTNILLDSELNAKVADFGLAKQSLEGHSH-LTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS--GRKVLDT 474 (590)
Q Consensus 398 Kp~NILLd~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELlt--G~~p~~~ 474 (590)
||+|||++.++.+||+|||+++........ ......++..|++||....+.++.++|||||||++|||++ |..|+..
T Consensus 157 kp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~ 236 (296)
T cd05095 157 ATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQ 236 (296)
T ss_pred ChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccc
Confidence 999999999999999999999865433221 1223344678999999888899999999999999999998 6667653
Q ss_pred CCCchhhhhHHHHHHHhcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhc
Q 046270 475 STSPFQLITDWAWVLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLE 541 (590)
Q Consensus 475 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~ 541 (590)
..... .+. ..............+ + .+......+.+++.+|++.||.+||+|.||++.|+
T Consensus 237 ~~~~~-~~~-~~~~~~~~~~~~~~~-~-----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 237 LSDEQ-VIE-NTGEFFRDQGRQVYL-P-----KPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred cChHH-HHH-HHHHHHhhccccccC-C-----CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 32211 111 111111111000000 0 01112347788999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=330.29 Aligned_cols=260 Identities=21% Similarity=0.259 Sum_probs=192.9
Q ss_pred hcCCCccceecccCcEEEEEEEEcC-CcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEE
Q 046270 263 TNGFSQNNLIGQGASGIVYKGTLRH-GNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRF 341 (590)
Q Consensus 263 t~~f~~~~~LG~G~fG~Vykg~~~~-g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~ 341 (590)
..+|...+.||+|+||.||++++.+ ++.||||... ...+.+|+++|++++|+|||++++++.. +...+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~-----~~~~~ 236 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVV-----GGLTC 236 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEE-----CCEEE
Confidence 3468889999999999999999875 7789999632 2346789999999999999999999874 44689
Q ss_pred EEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccc
Q 046270 342 LVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQS 421 (590)
Q Consensus 342 LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~ 421 (590)
+|||++. ++|.+++.. ....++|.+++.|+.||++||.||| ..+|+||||||+|||++.++.+||+|||+++..
T Consensus 237 lv~e~~~-~~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~ 310 (461)
T PHA03211 237 LVLPKYR-SDLYTYLGA--RLRPLGLAQVTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFA 310 (461)
T ss_pred EEEEccC-CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHH---HCCEEECcCCHHHEEECCCCCEEEcccCCceec
Confidence 9999995 788887742 2346999999999999999999999 899999999999999999999999999999865
Q ss_pred cCCCcc-cccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC-Cch-----hhhhHHHHHHHh-cC
Q 046270 422 LEGHSH-LTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTST-SPF-----QLITDWAWVLAK-SG 493 (590)
Q Consensus 422 ~~~~~~-~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~-~~~-----~~l~~~~~~~~~-~~ 493 (590)
...... ......||..|+|||++.+..++.++|||||||+||||++|..++-... .+. ..+......... ..
T Consensus 311 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~ 390 (461)
T PHA03211 311 RGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVD 390 (461)
T ss_pred ccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccc
Confidence 432221 2234679999999999999999999999999999999999886653221 111 111111111000 00
Q ss_pred Cch-----hhhhHHHhhh------------hH--HHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 494 KVD-----DIFDEFIRAE------------GA--RAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 494 ~~~-----~~~d~~l~~~------------~~--~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
... .+........ .. ......+.+++..|++.||.+|||+.|+++.
T Consensus 391 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 391 EFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred cCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 000 0000000000 00 0112256678899999999999999999974
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=328.50 Aligned_cols=202 Identities=25% Similarity=0.394 Sum_probs=170.7
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCC---CCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCce
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLD---TKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKR 339 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~---~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~ 339 (590)
++|...+.||+|+||.||+++.. +|+.||||++.... ....+.+.+|++++++++||||+++++++.. +..
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~-----~~~ 75 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQD-----AQY 75 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEc-----CCe
Confidence 46888899999999999999876 58899999986432 2234568899999999999999999999873 456
Q ss_pred EEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcc
Q 046270 340 RFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAK 419 (590)
Q Consensus 340 ~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~ 419 (590)
.++||||+++|+|.+++. ....+++.....++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++
T Consensus 76 ~~lv~E~~~gg~L~~~l~---~~~~~~~~~~~~~~~ql~~aL~~LH---~~givHrDlkp~NIll~~~~~~kl~DfGla~ 149 (377)
T cd05629 76 LYLIMEFLPGGDLMTMLI---KYDTFSEDVTRFYMAECVLAIEAVH---KLGFIHRDIKPDNILIDRGGHIKLSDFGLST 149 (377)
T ss_pred eEEEEeCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEEeeccccc
Confidence 999999999999999885 3456899999999999999999999 8999999999999999999999999999996
Q ss_pred cccCCCcc----------------------------------------------cccccccCCCccCccccccCCCCcch
Q 046270 420 QSLEGHSH----------------------------------------------LTTRVAGTFGYLAPEYALYGQLTEKS 453 (590)
Q Consensus 420 ~~~~~~~~----------------------------------------------~~~~~~gt~~Y~APE~~~~~~~t~ks 453 (590)
........ ......||+.|+|||++.+..++.++
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 229 (377)
T cd05629 150 GFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQEC 229 (377)
T ss_pred ccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCce
Confidence 43211000 00124689999999999988999999
Q ss_pred hHHHHHHHHHHHHhCCCCCCCCC
Q 046270 454 DVYSFGIVILELMSGRKVLDTST 476 (590)
Q Consensus 454 DVySfGvvLlELltG~~p~~~~~ 476 (590)
|||||||++|||++|+.||....
T Consensus 230 DiwSlGvil~elltG~~Pf~~~~ 252 (377)
T cd05629 230 DWWSLGAIMFECLIGWPPFCSEN 252 (377)
T ss_pred eeEecchhhhhhhcCCCCCCCCC
Confidence 99999999999999999996543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=312.13 Aligned_cols=246 Identities=26% Similarity=0.385 Sum_probs=195.3
Q ss_pred CCccceecccCcEEEEEEEEcC-CcEEEEEEeecCC-CCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEEEE
Q 046270 266 FSQNNLIGQGASGIVYKGTLRH-GNLVAVKQILDLD-TKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFLV 343 (590)
Q Consensus 266 f~~~~~LG~G~fG~Vykg~~~~-g~~vAvK~l~~~~-~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~LV 343 (590)
|+..+.||+|+||.||+|.+.. +..||+|.+.... ....+.+.+|++++++++|+||+++++++.. +...++|
T Consensus 6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv 80 (277)
T cd06642 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLK-----GTKLWII 80 (277)
T ss_pred HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhccccc-----CCceEEE
Confidence 4556789999999999998764 7789999876433 2334578999999999999999999999873 4568999
Q ss_pred EeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccccC
Q 046270 344 YDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLE 423 (590)
Q Consensus 344 ~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~~~ 423 (590)
|||+++++|.+++. ...+++..+..++.|+++||.||| +.+++|+||+|+||++++++.+||+|||++.....
T Consensus 81 ~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH---~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06642 81 MEYLGGGSALDLLK----PGPLEETYIATILREILKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD 153 (277)
T ss_pred EEccCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHh---cCCeeccCCChheEEEeCCCCEEEccccccccccC
Confidence 99999999998874 346899999999999999999999 89999999999999999999999999999976543
Q ss_pred CCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhhhHHH
Q 046270 424 GHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDEFI 503 (590)
Q Consensus 424 ~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 503 (590)
.. .......|+..|+|||++.+..++.++||||||++++||++|+.|+....... .. .. ...+.. +.+
T Consensus 154 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~-~~----~~-~~~~~~-----~~~ 221 (277)
T cd06642 154 TQ-IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR-VL----FL-IPKNSP-----PTL 221 (277)
T ss_pred cc-hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh-HH----hh-hhcCCC-----CCC
Confidence 22 12223457889999999998899999999999999999999999986432211 11 10 111110 001
Q ss_pred hhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 504 RAEGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 504 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
.......+.+++..|++.+|++||+|.+++++
T Consensus 222 ----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 222 ----EGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred ----CcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 11223467788899999999999999999974
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=307.05 Aligned_cols=248 Identities=25% Similarity=0.418 Sum_probs=195.7
Q ss_pred CCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCCCC---------hHHHHHHHHHHHhcCCCCccccceeEEeccC
Q 046270 265 GFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDTKG---------DEDFTNEVEIISKIRHRNLLSLRGCCVTSDD 334 (590)
Q Consensus 265 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~~~---------~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~ 334 (590)
+|.....||+|+||.||+|... +++.+|+|.+....... .+.+.+|++++++++|+||+++++++..
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--- 77 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLD--- 77 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEe---
Confidence 3666789999999999999875 47899999886433221 2468899999999999999999999874
Q ss_pred CCCceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEe
Q 046270 335 SSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVAD 414 (590)
Q Consensus 335 ~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~D 414 (590)
....++||||+++++|.+++. ....+++..+..++.|++.||.||| +.+++||||||+||++++++.+||+|
T Consensus 78 --~~~~~lv~e~~~~~~L~~~l~---~~~~l~~~~~~~~~~~l~~~l~~lH---~~~ivH~di~p~nil~~~~~~~~l~d 149 (267)
T cd06628 78 --ADHLNIFLEYVPGGSVAALLN---NYGAFEETLVRNFVRQILKGLNYLH---NRGIIHRDIKGANILVDNKGGIKISD 149 (267)
T ss_pred --CCccEEEEEecCCCCHHHHHH---hccCccHHHHHHHHHHHHHHHHHHH---hcCcccccCCHHHEEEcCCCCEEecc
Confidence 346899999999999999884 3356899999999999999999999 89999999999999999999999999
Q ss_pred eCCcccccCCCcc-----cccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHH
Q 046270 415 FGLAKQSLEGHSH-----LTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVL 489 (590)
Q Consensus 415 FGla~~~~~~~~~-----~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~ 489 (590)
||+++........ ......|+..|+|||.+..+.++.++||||||+++|||++|+.||........ +. .
T Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~----~- 223 (267)
T cd06628 150 FGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQA-IF----K- 223 (267)
T ss_pred cCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHH-HH----H-
Confidence 9999866432111 11224578899999999988999999999999999999999999975332111 10 0
Q ss_pred HhcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 046270 490 AKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALK 538 (590)
Q Consensus 490 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~ 538 (590)
...... ...+....+.+..++..|++.+|.+||++.|+++
T Consensus 224 ~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 224 IGENAS---------PEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred HhccCC---------CcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 000100 0111123346778889999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=333.20 Aligned_cols=266 Identities=23% Similarity=0.300 Sum_probs=194.7
Q ss_pred HHHHHHhcCCCccceecccCcEEEEEEEEcC-CcEEEEEEeecCCCCChHHHHHHHHHHHhcCCC------CccccceeE
Q 046270 257 SELEQATNGFSQNNLIGQGASGIVYKGTLRH-GNLVAVKQILDLDTKGDEDFTNEVEIISKIRHR------NLLSLRGCC 329 (590)
Q Consensus 257 ~el~~at~~f~~~~~LG~G~fG~Vykg~~~~-g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~------nlv~l~g~~ 329 (590)
+++...+++|...++||+|+||.||+|++.. ++.||||+++... ....++..|++++.+++|. +++++++++
T Consensus 122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~ 200 (467)
T PTZ00284 122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF 200 (467)
T ss_pred CccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence 3455567899999999999999999999864 7789999986432 2344567788888888655 477888877
Q ss_pred EeccCCCCceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCC-CCeEecCCCCCceEECCCC
Q 046270 330 VTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLK-PGIYHRDIKSTNILLDSEL 408 (590)
Q Consensus 330 ~~~~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~-~~ivHrDIKp~NILLd~~~ 408 (590)
.. +..+.++|||++ +++|.+++. +.+.+++..+..|+.||+.||.||| . .+|+||||||+|||++.++
T Consensus 201 ~~----~~~~~~iv~~~~-g~~l~~~l~---~~~~l~~~~~~~i~~qi~~aL~yLH---~~~gIiHrDlKP~NILl~~~~ 269 (467)
T PTZ00284 201 QN----ETGHMCIVMPKY-GPCLLDWIM---KHGPFSHRHLAQIIFQTGVALDYFH---TELHLMHTDLKPENILMETSD 269 (467)
T ss_pred Ec----CCceEEEEEecc-CCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHH---hcCCeecCCCCHHHEEEecCC
Confidence 63 234689999988 678888774 3457999999999999999999999 6 5999999999999998765
Q ss_pred ----------------cEEEEeeCCcccccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCC
Q 046270 409 ----------------NAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVL 472 (590)
Q Consensus 409 ----------------~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~ 472 (590)
.+||+|||++.... .......||..|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 270 ~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf 345 (467)
T PTZ00284 270 TVVDPVTNRALPPDPCRVRICDLGGCCDER----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLY 345 (467)
T ss_pred cccccccccccCCCCceEEECCCCccccCc----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence 49999999876422 2234567899999999999999999999999999999999999999
Q ss_pred CCCCCchh--hhh--------HHHHH--------HHh-cCCchhhhhHH-H----hhhhH--HHHHHHHHHHHHhchhcC
Q 046270 473 DTSTSPFQ--LIT--------DWAWV--------LAK-SGKVDDIFDEF-I----RAEGA--RAVMERFVLVGILCAHVM 526 (590)
Q Consensus 473 ~~~~~~~~--~l~--------~~~~~--------~~~-~~~~~~~~d~~-l----~~~~~--~~~~~~l~~l~~~Cl~~d 526 (590)
+....... .+. .|... ++. .+.+....++. + ..... ......+.+++..|++.|
T Consensus 346 ~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~d 425 (467)
T PTZ00284 346 DTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYD 425 (467)
T ss_pred CCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcC
Confidence 75443211 110 11100 000 00000000000 0 00000 001235678999999999
Q ss_pred CCCCCCHHHHHH
Q 046270 527 VALRPTITDALK 538 (590)
Q Consensus 527 p~~RPtm~eVl~ 538 (590)
|.+|||++|+++
T Consensus 426 P~~R~ta~e~L~ 437 (467)
T PTZ00284 426 RQKRLNARQMTT 437 (467)
T ss_pred hhhCCCHHHHhc
Confidence 999999999987
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=316.15 Aligned_cols=261 Identities=22% Similarity=0.337 Sum_probs=197.8
Q ss_pred cCCCccceecccCcEEEEEEEEcC-CcEEEEEEeecCCC-CChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEE
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLRH-GNLVAVKQILDLDT-KGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRF 341 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~vAvK~l~~~~~-~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~ 341 (590)
++|...+.||+|+||.||++.+.. +..+|+|.+..... ....++.+|++++.+++||||+++++++.. +...+
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~ 75 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYS-----DGEIS 75 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee-----CCEEE
Confidence 468889999999999999999764 67888888754322 223568899999999999999999999974 45699
Q ss_pred EEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccc
Q 046270 342 LVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQS 421 (590)
Q Consensus 342 LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~ 421 (590)
+||||+++++|.+++. +...+++..+..++.|+++||.|||+ ..+++||||||+|||++.++.+||+|||++...
T Consensus 76 lv~ey~~~~~L~~~l~---~~~~~~~~~~~~~~~~i~~~l~~lH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 150 (308)
T cd06615 76 ICMEHMDGGSLDQVLK---KAGRIPENILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL 150 (308)
T ss_pred EEeeccCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHh--hCCEEECCCChHHEEEecCCcEEEccCCCcccc
Confidence 9999999999999985 33568999999999999999999993 258999999999999999999999999998754
Q ss_pred cCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcC--------
Q 046270 422 LEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSG-------- 493 (590)
Q Consensus 422 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~-------- 493 (590)
... ......|+..|+|||.+.+..++.++||||||++++||++|+.|+...... . +..+........
T Consensus 151 ~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~-~-~~~~~~~~~~~~~~~~~~~~ 225 (308)
T cd06615 151 IDS---MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAK-E-LEAMFGRPVSEGEAKESHRP 225 (308)
T ss_pred ccc---ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchh-h-HHHhhcCccccccccCCccc
Confidence 332 123356889999999988888999999999999999999999998643211 1 111110000000
Q ss_pred ------------CchhhhhHHHhhh----hHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 494 ------------KVDDIFDEFIRAE----GARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 494 ------------~~~~~~d~~l~~~----~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
...+..+...... ........+.+++.+|++.+|++|||+.+|++.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 226 VSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred ccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0001111111100 001123467889999999999999999999875
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=312.13 Aligned_cols=262 Identities=22% Similarity=0.312 Sum_probs=194.4
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCC-CChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEE
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDT-KGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRF 341 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~-~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~ 341 (590)
++|...+.||+|+||.||+|+.+ .+..||+|++..... .....+.+|++++++++|+||+++++++.. +...+
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~ 80 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHT-----DKSLT 80 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEee-----CCeEE
Confidence 46888899999999999999986 477899999864432 234467899999999999999999999874 34589
Q ss_pred EEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccc
Q 046270 342 LVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQS 421 (590)
Q Consensus 342 LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~ 421 (590)
+||||+++ +|.+++.. ....+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 154 (309)
T cd07872 81 LVFEYLDK-DLKQYMDD--CGNIMSMHNVKIFLYQILRGLAYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAK 154 (309)
T ss_pred EEEeCCCC-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECccccceec
Confidence 99999975 77777642 2345899999999999999999999 899999999999999999999999999999754
Q ss_pred cCCCcccccccccCCCccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHH-------HhcC
Q 046270 422 LEGHSHLTTRVAGTFGYLAPEYALY-GQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVL-------AKSG 493 (590)
Q Consensus 422 ~~~~~~~~~~~~gt~~Y~APE~~~~-~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~-------~~~~ 493 (590)
..... ......++..|+|||.+.+ ..++.++||||||+++|||+||+.||........ +....... |..-
T Consensus 155 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 232 (309)
T cd07872 155 SVPTK-TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDE-LHLIFRLLGTPTEETWPGI 232 (309)
T ss_pred CCCcc-ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCCHHHHhhh
Confidence 32221 2233457899999998864 4689999999999999999999999965433211 11000000 0000
Q ss_pred -CchhhhhHHHhh-------hhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 046270 494 -KVDDIFDEFIRA-------EGARAVMERFVLVGILCAHVMVALRPTITDALK 538 (590)
Q Consensus 494 -~~~~~~d~~l~~-------~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~ 538 (590)
...+..+..... .........+.+++..|++.||.+|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 233 SSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred cchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 000000000000 000112346678999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=309.07 Aligned_cols=259 Identities=23% Similarity=0.392 Sum_probs=197.1
Q ss_pred cCCCccceecccCcEEEEEEEEcC-CcEEEEEEeecCCCC--ChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceE
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLRH-GNLVAVKQILDLDTK--GDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRR 340 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~vAvK~l~~~~~~--~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~ 340 (590)
++|+..+.||+|+||.||+|.+++ ++.||+|++...... ..+.+.+|++++++++|+||+++++++. .+...
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~ 75 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFR-----RKKRL 75 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcc-----cCCeE
Confidence 467888999999999999999874 789999987543222 3457889999999999999999999986 34569
Q ss_pred EEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCccc
Q 046270 341 FLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQ 420 (590)
Q Consensus 341 ~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~ 420 (590)
++||||+++++|.++.. ....++|.+++.++.||+.||+||| +.+|+||||+|+||++++++.+||+|||++..
T Consensus 76 ~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~ 149 (286)
T cd07846 76 YLVFEFVDHTVLDDLEK---YPNGLDESRVRKYLFQILRGIEFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFART 149 (286)
T ss_pred EEEEecCCccHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCcEEEEeeeeeee
Confidence 99999999999887653 2345899999999999999999999 88999999999999999999999999999886
Q ss_pred ccCCCcccccccccCCCccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchh--
Q 046270 421 SLEGHSHLTTRVAGTFGYLAPEYALY-GQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDD-- 497 (590)
Q Consensus 421 ~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~-- 497 (590)
..... .......++..|+|||++.+ ..++.++||||||++++||++|+.|+........ +.......+...+
T Consensus 150 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~----~~~~~~~~~~~~~~~ 224 (286)
T cd07846 150 LAAPG-EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQ----LYHIIKCLGNLIPRH 224 (286)
T ss_pred ccCCc-cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHH----HHHHHHHhCCCchhh
Confidence 54332 22334557889999999875 4578899999999999999999988864332111 1110000011000
Q ss_pred --hhhH----------HHh-----hhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 046270 498 --IFDE----------FIR-----AEGARAVMERFVLVGILCAHVMVALRPTITDALK 538 (590)
Q Consensus 498 --~~d~----------~l~-----~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~ 538 (590)
..+. ... ..........+.+++..|++.+|++||++.++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 225 QEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred HHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 0000 000 0001123456888999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=308.47 Aligned_cols=256 Identities=21% Similarity=0.373 Sum_probs=199.5
Q ss_pred cCCCccceecccCcEEEEEEEEcC------CcEEEEEEeecCCCC-ChHHHHHHHHHHHhcCCCCccccceeEEeccCCC
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLRH------GNLVAVKQILDLDTK-GDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSS 336 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~~------g~~vAvK~l~~~~~~-~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~ 336 (590)
.+|.....||+|+||.||+|+.+. ...|++|.+...... ..+++.+|++++++++|+||+++++++..
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----- 79 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCRE----- 79 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECC-----
Confidence 467888999999999999999752 457999987554333 34679999999999999999999998864
Q ss_pred CceEEEEEeeCCCCCcchhhhhhccc------ccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcE
Q 046270 337 GKRRFLVYDYMPNGTLSDNISISHKR------KQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNA 410 (590)
Q Consensus 337 ~~~~~LV~E~~~~gsL~~~L~~~~~~------~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~ 410 (590)
....++||||+++|+|.+++...... ..++|..+..++.|++.||+||| +.+|+||||||+||+++.++.+
T Consensus 80 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~ 156 (275)
T cd05046 80 AEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS---NARFVHRDLAARNCLVSSQREV 156 (275)
T ss_pred CCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhh---hcCcccCcCccceEEEeCCCcE
Confidence 34589999999999999998643311 26899999999999999999999 8899999999999999999999
Q ss_pred EEEeeCCcccccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhhHHHHHH
Q 046270 411 KVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLDTSTSPFQLITDWAWVL 489 (590)
Q Consensus 411 kL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELlt-G~~p~~~~~~~~~~l~~~~~~~ 489 (590)
||+|||+++..............++..|+|||.+..+..+.++||||||++++||++ |..||....... .+. .
T Consensus 157 ~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~-~~~-----~ 230 (275)
T cd05046 157 KVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE-VLN-----R 230 (275)
T ss_pred EEcccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH-HHH-----H
Confidence 999999987543332222333456778999999988889999999999999999999 777875322211 111 1
Q ss_pred HhcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhc
Q 046270 490 AKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLE 541 (590)
Q Consensus 490 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~ 541 (590)
...+...... .......+..++..|++.+|++||++.|++.+|.
T Consensus 231 ~~~~~~~~~~--------~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 231 LQAGKLELPV--------PEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred HHcCCcCCCC--------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 1111111100 1112347788999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=329.10 Aligned_cols=201 Identities=26% Similarity=0.373 Sum_probs=169.5
Q ss_pred CCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCC---CCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceE
Q 046270 265 GFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLD---TKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRR 340 (590)
Q Consensus 265 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~---~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~ 340 (590)
.|...++||+|+||.||+|+.. .++.+|+|++.... ......+.+|++++++++|+||+++++.+.. +...
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~-----~~~~ 76 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQD-----KDNL 76 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEe-----CCEE
Confidence 5788899999999999999976 47789999986432 1224568899999999999999999999874 4569
Q ss_pred EEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCccc
Q 046270 341 FLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQ 420 (590)
Q Consensus 341 ~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~ 420 (590)
++||||+++|+|.+++. +.+.+++.....++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++.
T Consensus 77 ~lv~E~~~gg~L~~~l~---~~~~~~e~~~~~~~~qi~~al~~lH---~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~ 150 (382)
T cd05625 77 YFVMDYIPGGDMMSLLI---RMGIFPEDLARFYIAELTCAVESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTG 150 (382)
T ss_pred EEEEeCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEeECCCCcc
Confidence 99999999999999885 3346889999999999999999999 89999999999999999999999999999753
Q ss_pred ccCCC----------------------------------------------cccccccccCCCccCccccccCCCCcchh
Q 046270 421 SLEGH----------------------------------------------SHLTTRVAGTFGYLAPEYALYGQLTEKSD 454 (590)
Q Consensus 421 ~~~~~----------------------------------------------~~~~~~~~gt~~Y~APE~~~~~~~t~ksD 454 (590)
..... ........||+.|+|||++.+..++.++|
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~D 230 (382)
T cd05625 151 FRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCD 230 (382)
T ss_pred ccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeee
Confidence 21000 00012346899999999999889999999
Q ss_pred HHHHHHHHHHHHhCCCCCCCCC
Q 046270 455 VYSFGIVILELMSGRKVLDTST 476 (590)
Q Consensus 455 VySfGvvLlELltG~~p~~~~~ 476 (590)
||||||++|||++|+.||....
T Consensus 231 iwSlGvil~elltG~~Pf~~~~ 252 (382)
T cd05625 231 WWSVGVILYEMLVGQPPFLAQT 252 (382)
T ss_pred EEechHHHHHHHhCCCCCCCCC
Confidence 9999999999999999997543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=307.19 Aligned_cols=252 Identities=23% Similarity=0.346 Sum_probs=184.9
Q ss_pred eecccCcEEEEEEEEcC---CcEEEEEEeecCCC-CChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEEEEEee
Q 046270 271 LIGQGASGIVYKGTLRH---GNLVAVKQILDLDT-KGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFLVYDY 346 (590)
Q Consensus 271 ~LG~G~fG~Vykg~~~~---g~~vAvK~l~~~~~-~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~LV~E~ 346 (590)
.||+|+||.||+|...+ ...+++|.+..... .....|.+|+++++.++|+||+++++.+.. +...++||||
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~-----~~~~~lv~e~ 76 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIE-----SIPYLLVLEF 76 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECC-----CCceEEEEEe
Confidence 58999999999997654 34688887754332 224568899999999999999999999874 3458999999
Q ss_pred CCCCCcchhhhhhcc--cccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccccCC
Q 046270 347 MPNGTLSDNISISHK--RKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEG 424 (590)
Q Consensus 347 ~~~gsL~~~L~~~~~--~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~~~~ 424 (590)
+++|+|.+++..... ....++...+.++.||+.||+||| +.+|+||||||+|||+++++.+||+|||+++.....
T Consensus 77 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~ 153 (269)
T cd05042 77 CPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPE 153 (269)
T ss_pred CCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHH---hcCEecccccHhheEecCCCcEEEeccccccccccc
Confidence 999999999864322 234578888999999999999999 899999999999999999999999999998754332
Q ss_pred Ccc-cccccccCCCccCcccccc-------CCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhhHHHHHHHhcCCc
Q 046270 425 HSH-LTTRVAGTFGYLAPEYALY-------GQLTEKSDVYSFGIVILELMS-GRKVLDTSTSPFQLITDWAWVLAKSGKV 495 (590)
Q Consensus 425 ~~~-~~~~~~gt~~Y~APE~~~~-------~~~t~ksDVySfGvvLlELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~ 495 (590)
... ......++..|+|||++.. ..++.++||||||+++|||++ |+.|+....... .+. .....+.
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-~~~----~~~~~~~- 227 (269)
T cd05042 154 DYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ-VLK----QVVREQD- 227 (269)
T ss_pred hheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH-HHH----HHhhccC-
Confidence 211 1223345678999998753 356889999999999999999 677775432211 111 1111111
Q ss_pred hhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhc
Q 046270 496 DDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLE 541 (590)
Q Consensus 496 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~ 541 (590)
....++.+. ......+.++...|+ .||++|||+++|+++|.
T Consensus 228 ~~~~~~~~~----~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 228 IKLPKPQLD----LKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred ccCCCCccc----ccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 111111111 112235556667777 59999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=321.69 Aligned_cols=192 Identities=23% Similarity=0.349 Sum_probs=162.8
Q ss_pred HhcCCCccceecccCcEEEEEEEEcC-CcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceE
Q 046270 262 ATNGFSQNNLIGQGASGIVYKGTLRH-GNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRR 340 (590)
Q Consensus 262 at~~f~~~~~LG~G~fG~Vykg~~~~-g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~ 340 (590)
...+|...+.||+|+||.||+|+... +..||+|.... .....|+.++++++|+||+++++++.. +...
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~ 132 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK------GTTLIEAMLLQNVNHPSVIRMKDTLVS-----GAIT 132 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCc------cccHHHHHHHHhCCCCCCcChhheEEe-----CCee
Confidence 34679999999999999999999874 67899997432 224579999999999999999999874 4468
Q ss_pred EEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCccc
Q 046270 341 FLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQ 420 (590)
Q Consensus 341 ~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~ 420 (590)
++|+||+. ++|.+++.. ....++|..++.|+.||+.||.||| ..+|+||||||+|||++.++.+||+|||+++.
T Consensus 133 ~lv~e~~~-~~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~ 206 (357)
T PHA03209 133 CMVLPHYS-SDLYTYLTK--RSRPLPIDQALIIEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQF 206 (357)
T ss_pred EEEEEccC-CcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEecCccccc
Confidence 99999995 688887752 3456999999999999999999999 89999999999999999999999999999975
Q ss_pred ccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCC
Q 046270 421 SLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVL 472 (590)
Q Consensus 421 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~ 472 (590)
.... .......||..|+|||++.+..++.++|||||||++|||+++..++
T Consensus 207 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 207 PVVA--PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred cccC--cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 3322 1223456899999999999999999999999999999999976554
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=307.69 Aligned_cols=250 Identities=22% Similarity=0.282 Sum_probs=194.5
Q ss_pred CCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCC---CChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEE
Q 046270 266 FSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDT---KGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRF 341 (590)
Q Consensus 266 f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~---~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~ 341 (590)
|+..+.||+|+||+||+|++. +++.+|+|.+..... .....+.+|++++++++|+|++++.+++.. +...+
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~-----~~~~~ 76 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYET-----KDALC 76 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEec-----CCEEE
Confidence 666789999999999999886 578999999864322 223457889999999999999999988863 45689
Q ss_pred EEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccc
Q 046270 342 LVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQS 421 (590)
Q Consensus 342 LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~ 421 (590)
+||||+++++|.+++... ....+++..+..++.|++.||.||| +.+|+||||||+||++++++.+||+|||++...
T Consensus 77 lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~ql~~~l~~lH---~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~ 152 (285)
T cd05632 77 LVLTIMNGGDLKFHIYNM-GNPGFEEERALFYAAEILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKI 152 (285)
T ss_pred EEEEeccCccHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEECCCCCEEEecCCcceec
Confidence 999999999999887532 2346999999999999999999999 899999999999999999999999999998764
Q ss_pred cCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhhhH
Q 046270 422 LEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDE 501 (590)
Q Consensus 422 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 501 (590)
.... ......|+..|+|||++.+..++.++||||||+++|||++|+.||........ ...+... ...+. ..
T Consensus 153 ~~~~--~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~-~~~~~~~-~~~~~--~~--- 223 (285)
T cd05632 153 PEGE--SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK-REEVDRR-VLETE--EV--- 223 (285)
T ss_pred CCCC--cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHh-hhccc--cc---
Confidence 3322 12345689999999999988999999999999999999999999975432211 1111111 11110 00
Q ss_pred HHhhhhHHHHHHHHHHHHHhchhcCCCCCCC-----HHHHHH
Q 046270 502 FIRAEGARAVMERFVLVGILCAHVMVALRPT-----ITDALK 538 (590)
Q Consensus 502 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt-----m~eVl~ 538 (590)
........+.+++..|++.+|++||+ +.+++.
T Consensus 224 -----~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 224 -----YSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred -----cCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 11122345677888999999999999 556654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=303.35 Aligned_cols=251 Identities=21% Similarity=0.326 Sum_probs=199.0
Q ss_pred CCCccceecccCcEEEEEEEEcC-CcEEEEEEeecCC--CCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEE
Q 046270 265 GFSQNNLIGQGASGIVYKGTLRH-GNLVAVKQILDLD--TKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRF 341 (590)
Q Consensus 265 ~f~~~~~LG~G~fG~Vykg~~~~-g~~vAvK~l~~~~--~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~ 341 (590)
+|...+.||+|++|.||+++.+. ++.+|+|++.... ....+.+.+|++++++++|+|++++++.+.. .....+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~~~ 76 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEG----EDGLLY 76 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecC----CCCEEE
Confidence 47788999999999999999764 6789999986432 2334578899999999999999999887643 233579
Q ss_pred EEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccc
Q 046270 342 LVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQS 421 (590)
Q Consensus 342 LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~ 421 (590)
+||||+++++|.+++... ....+++.++..++.+++.||+||| +.+|+||||||+||+++.++.++|+|||++...
T Consensus 77 lv~e~~~~~~l~~~l~~~-~~~~l~~~~~~~~~~~l~~~l~~lH---~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~ 152 (257)
T cd08223 77 IVMGFCEGGDLYHKLKEQ-KGKLLPENQVVEWFVQIAMALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVL 152 (257)
T ss_pred EEecccCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCchhEEEecCCcEEEecccceEEe
Confidence 999999999999988632 2346899999999999999999999 899999999999999999999999999999865
Q ss_pred cCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhhhH
Q 046270 422 LEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDE 501 (590)
Q Consensus 422 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 501 (590)
.... .......|+..|+|||++.+..++.++||||||++++||++|+.||...... .+..... .+....
T Consensus 153 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~-----~~~~~~~-~~~~~~---- 221 (257)
T cd08223 153 ENQC-DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMN-----SLVYRII-EGKLPP---- 221 (257)
T ss_pred cccC-CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH-----HHHHHHH-hcCCCC----
Confidence 3322 2233456789999999999999999999999999999999999998643211 1111111 121111
Q ss_pred HHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 502 FIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 502 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
.+......+.+++..|++.+|++|||+.++++.
T Consensus 222 -----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 222 -----MPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred -----CccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 111233467789999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=308.68 Aligned_cols=249 Identities=27% Similarity=0.395 Sum_probs=199.1
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCC-CCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEE
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLD-TKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRF 341 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~-~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~ 341 (590)
++|...+.||.|+||.||+|+.. +++.||+|.+.... ......+.+|++++++++|+|++++++++.. +...+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~ 75 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLK-----GSKLW 75 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEE-----CCeEE
Confidence 35777889999999999999986 47899999986543 3334678999999999999999999998874 35699
Q ss_pred EEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccc
Q 046270 342 LVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQS 421 (590)
Q Consensus 342 LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~ 421 (590)
+|+||+++++|.+++.. ..+++..+..++.|++.||.||| +.+++||||+|+||++++++.++|+|||+++..
T Consensus 76 ~v~e~~~~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~ 148 (274)
T cd06609 76 IIMEYCGGGSCLDLLKP----GKLDETYIAFILREVLLGLEYLH---EEGKIHRDIKAANILLSEEGDVKLADFGVSGQL 148 (274)
T ss_pred EEEEeeCCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEcccccceee
Confidence 99999999999998842 27999999999999999999999 899999999999999999999999999999876
Q ss_pred cCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhhhH
Q 046270 422 LEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDE 501 (590)
Q Consensus 422 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 501 (590)
.... .......|+..|+|||++.+..++.++||||||+++|||+||+.|+...... ..+ .. ...+....+.+
T Consensus 149 ~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~-~~~----~~-~~~~~~~~~~~- 220 (274)
T cd06609 149 TSTM-SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPM-RVL----FL-IPKNNPPSLEG- 220 (274)
T ss_pred cccc-cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchH-HHH----HH-hhhcCCCCCcc-
Confidence 4332 2223456788999999999888999999999999999999999998653321 111 11 11111111111
Q ss_pred HHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 502 FIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 502 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
. .....+.+++..|++.+|++|||++++++.
T Consensus 221 ----~---~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 221 ----N---KFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred ----c---ccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 0 023457778899999999999999999863
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=310.58 Aligned_cols=250 Identities=24% Similarity=0.311 Sum_probs=195.6
Q ss_pred CCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCCC---ChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEE
Q 046270 266 FSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDTK---GDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRF 341 (590)
Q Consensus 266 f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~~---~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~ 341 (590)
|+..+.||+|+||.||++... .++.+|+|.+...... ..+.+.+|+.++++++|+|++++++.+.. +...+
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~-----~~~~~ 76 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYET-----KDALC 76 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEec-----CCEEE
Confidence 667789999999999999886 4789999998643222 23457789999999999999999998874 34689
Q ss_pred EEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccc
Q 046270 342 LVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQS 421 (590)
Q Consensus 342 LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~ 421 (590)
+||||+++++|.+++... ....+++..+..++.|++.||.||| +.+|+||||||+||++++++.++|+|||++...
T Consensus 77 lv~e~~~g~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~ 152 (285)
T cd05630 77 LVLTLMNGGDLKFHIYHM-GEAGFEEGRAVFYAAEICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHV 152 (285)
T ss_pred EEEEecCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeccceeec
Confidence 999999999999988532 2345999999999999999999999 899999999999999999999999999998765
Q ss_pred cCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhhhH
Q 046270 422 LEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDE 501 (590)
Q Consensus 422 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 501 (590)
..... .....|+..|+|||.+.+..++.++||||||+++|||++|+.||........ ...+ ......
T Consensus 153 ~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~-~~~~-~~~~~~--------- 219 (285)
T cd05630 153 PEGQT--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK-REEV-ERLVKE--------- 219 (285)
T ss_pred CCCcc--ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccch-HHHH-Hhhhhh---------
Confidence 43322 1234689999999999999999999999999999999999999975432211 0000 000000
Q ss_pred HHhhhhHHHHHHHHHHHHHhchhcCCCCCCC-----HHHHHH
Q 046270 502 FIRAEGARAVMERFVLVGILCAHVMVALRPT-----ITDALK 538 (590)
Q Consensus 502 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt-----m~eVl~ 538 (590)
............+.+++..|++.||++||| +.|+++
T Consensus 220 -~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 220 -VQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred -hhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 000111122345678889999999999999 778776
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=312.09 Aligned_cols=249 Identities=25% Similarity=0.407 Sum_probs=200.4
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEEE
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFL 342 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~L 342 (590)
.+|+..+.||.|+||.||+|+.. +|+.|++|.+........+.+.+|+++++.++|+|++++++++.. +...++
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~~l 93 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLV-----GDELFV 93 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEec-----CceEEE
Confidence 35788899999999999999874 588999999876555556788999999999999999999999873 456999
Q ss_pred EEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCccccc
Q 046270 343 VYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSL 422 (590)
Q Consensus 343 V~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~~ 422 (590)
|+||+++++|.+++. ...++|.++..++.+++.||+||| +.+++||||||+||+++.++.+||+|||++....
T Consensus 94 v~e~~~~~~L~~~~~----~~~l~~~~~~~i~~~l~~al~~LH---~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~ 166 (296)
T cd06655 94 VMEYLAGGSLTDVVT----ETCMDEAQIAAVCRECLQALEFLH---ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQIT 166 (296)
T ss_pred EEEecCCCcHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccchhcc
Confidence 999999999999874 335899999999999999999999 8999999999999999999999999999988654
Q ss_pred CCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhhhHH
Q 046270 423 EGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDEF 502 (590)
Q Consensus 423 ~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 502 (590)
.... ......|+..|+|||.+.+..++.++|||||||++|||++|+.||........... ....+. ...
T Consensus 167 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~-----~~~~~~-~~~---- 235 (296)
T cd06655 167 PEQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL-----IATNGT-PEL---- 235 (296)
T ss_pred cccc-cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-----HHhcCC-ccc----
Confidence 3322 22334678899999999988899999999999999999999999865433211110 111110 000
Q ss_pred HhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 046270 503 IRAEGARAVMERFVLVGILCAHVMVALRPTITDALK 538 (590)
Q Consensus 503 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~ 538 (590)
..+......+.+++..|++.+|++||++.+++.
T Consensus 236 ---~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 236 ---QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred ---CCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 011122335677889999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=302.21 Aligned_cols=261 Identities=24% Similarity=0.310 Sum_probs=197.8
Q ss_pred CCCccceecccCcEEEEEEEEcC-CcEEEEEEeecCCCCC--hHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEE
Q 046270 265 GFSQNNLIGQGASGIVYKGTLRH-GNLVAVKQILDLDTKG--DEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRF 341 (590)
Q Consensus 265 ~f~~~~~LG~G~fG~Vykg~~~~-g~~vAvK~l~~~~~~~--~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~ 341 (590)
+|...++|++|.||.||+|+++. +..||+|+++-..... .-.-.+|+.+|.+++|||||.+....+..+ -...|
T Consensus 77 efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~---~d~iy 153 (419)
T KOG0663|consen 77 EFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSN---MDKIY 153 (419)
T ss_pred HHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccc---cceee
Confidence 46677899999999999999874 7789999997543222 123578999999999999999998877553 34599
Q ss_pred EEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccc
Q 046270 342 LVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQS 421 (590)
Q Consensus 342 LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~ 421 (590)
+|||||+. +|...+... .+.+...+..-++.|+++|++||| ...|+|||||++|+|+...|.+||+|||+||..
T Consensus 154 ~VMe~~Eh-DLksl~d~m--~q~F~~~evK~L~~QlL~glk~lH---~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~y 227 (419)
T KOG0663|consen 154 IVMEYVEH-DLKSLMETM--KQPFLPGEVKTLMLQLLRGLKHLH---DNWILHRDLKTSNLLLSHKGILKIADFGLAREY 227 (419)
T ss_pred eeHHHHHh-hHHHHHHhc--cCCCchHHHHHHHHHHHHHHHHHh---hceeEecccchhheeeccCCcEEecccchhhhh
Confidence 99999975 788877532 357999999999999999999999 899999999999999999999999999999987
Q ss_pred cCCCcccccccccCCCccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhhh
Q 046270 422 LEGHSHLTTRVAGTFGYLAPEYALY-GQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFD 500 (590)
Q Consensus 422 ~~~~~~~~~~~~gt~~Y~APE~~~~-~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 500 (590)
..... ..+...-|.+|.|||.+.+ ..|++..|+||+|||+.||+++++.|.......+ +...... -|...+.+-
T Consensus 228 gsp~k-~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQ-l~~If~l---lGtPte~iw 302 (419)
T KOG0663|consen 228 GSPLK-PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQ-LDKIFKL---LGTPSEAIW 302 (419)
T ss_pred cCCcc-cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHH-HHHHHHH---hCCCccccC
Confidence 65433 3445556999999999885 4699999999999999999999988865544322 2211111 111111111
Q ss_pred -------------------HHHhhhhHHH-HHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 501 -------------------EFIRAEGARA-VMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 501 -------------------~~l~~~~~~~-~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
..++...... ..+.-.++.-..+..||.+|-|++|.++.
T Consensus 303 pg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 303 PGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred CCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 1111111111 22445667778899999999999998864
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=306.99 Aligned_cols=240 Identities=21% Similarity=0.324 Sum_probs=184.7
Q ss_pred ceecccCcEEEEEEEEcC-------------CcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCC
Q 046270 270 NLIGQGASGIVYKGTLRH-------------GNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSS 336 (590)
Q Consensus 270 ~~LG~G~fG~Vykg~~~~-------------g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~ 336 (590)
+.||+|+||.||+|++.. ...|++|.+..........|.+|+.++..++||||+++++++...
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~---- 76 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRD---- 76 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecC----
Confidence 368999999999998642 125888987655444456788999999999999999999998743
Q ss_pred CceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCc-------
Q 046270 337 GKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELN------- 409 (590)
Q Consensus 337 ~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~------- 409 (590)
...++||||+++|+|..++.. ....+++..+++|+.||++||+||| +.+|+||||||+|||++.++.
T Consensus 77 -~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~~~~~~~ 150 (262)
T cd05077 77 -VENIMVEEFVEFGPLDLFMHR--KSDVLTTPWKFKVAKQLASALSYLE---DKDLVHGNVCTKNILLAREGIDGECGPF 150 (262)
T ss_pred -CCCEEEEecccCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHhh---hCCeECCCCCcccEEEecCCccCCCCce
Confidence 357999999999999888742 3356999999999999999999999 899999999999999987654
Q ss_pred EEEEeeCCcccccCCCcccccccccCCCccCccccc-cCCCCcchhHHHHHHHHHHHH-hCCCCCCCCCCchhhhhHHHH
Q 046270 410 AKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYAL-YGQLTEKSDVYSFGIVILELM-SGRKVLDTSTSPFQLITDWAW 487 (590)
Q Consensus 410 ~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~-~~~~t~ksDVySfGvvLlELl-tG~~p~~~~~~~~~~l~~~~~ 487 (590)
+|++|||++...... ....++..|+|||++. ...++.++|||||||++|||+ +|+.|+....... ..
T Consensus 151 ~~l~d~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~--~~---- 219 (262)
T cd05077 151 IKLSDPGIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE--KE---- 219 (262)
T ss_pred eEeCCCCCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH--HH----
Confidence 899999998754322 2235678999999887 466899999999999999998 5777765322111 00
Q ss_pred HHHhcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhc
Q 046270 488 VLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLE 541 (590)
Q Consensus 488 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~ 541 (590)
.... +.. .... .....+..++..|++.||.+||++.++++.|+
T Consensus 220 ~~~~-~~~-~~~~---------~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 220 RFYE-GQC-MLVT---------PSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred HHHh-cCc-cCCC---------CChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 0011 110 0000 01235678899999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=317.50 Aligned_cols=241 Identities=24% Similarity=0.358 Sum_probs=188.8
Q ss_pred CCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCC---CCChHHHHHHHHHHHhcC-CCCccccceeEEeccCCCCce
Q 046270 265 GFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLD---TKGDEDFTNEVEIISKIR-HRNLLSLRGCCVTSDDSSGKR 339 (590)
Q Consensus 265 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~---~~~~~~f~~Ev~il~~l~-H~nlv~l~g~~~~~~~~~~~~ 339 (590)
+|...+.||+|+||.||++... +|+.||+|++.... ....+.+..|.+++..+. |++|+++.+++.. ...
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~-----~~~ 75 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQT-----VDR 75 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEec-----CCE
Confidence 4677889999999999999876 47899999986432 223456788999999885 5677788887763 346
Q ss_pred EEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcc
Q 046270 340 RFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAK 419 (590)
Q Consensus 340 ~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~ 419 (590)
.++||||+++|+|.+++. ....+++.+++.|+.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++
T Consensus 76 ~~lv~Ey~~~g~L~~~i~---~~~~l~~~~~~~i~~qi~~al~~lH---~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~ 149 (323)
T cd05615 76 LYFVMEYVNGGDLMYHIQ---QVGKFKEPQAVFYAAEISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCK 149 (323)
T ss_pred EEEEEcCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEecccccc
Confidence 899999999999998884 3456999999999999999999999 8999999999999999999999999999987
Q ss_pred cccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhh
Q 046270 420 QSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIF 499 (590)
Q Consensus 420 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 499 (590)
...... .......||..|+|||++.++.++.++|||||||++|||++|+.||...... ... ..... ...
T Consensus 150 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~-~~~----~~i~~-~~~---- 218 (323)
T cd05615 150 EHMVDG-VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED-ELF----QSIME-HNV---- 218 (323)
T ss_pred ccCCCC-ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH-HHH----HHHHh-CCC----
Confidence 543221 1233456899999999999889999999999999999999999999754321 111 11111 110
Q ss_pred hHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCH
Q 046270 500 DEFIRAEGARAVMERFVLVGILCAHVMVALRPTI 533 (590)
Q Consensus 500 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm 533 (590)
..+......+.+++..|++.+|.+|++.
T Consensus 219 ------~~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 219 ------SYPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred ------CCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 0111223466778899999999999984
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=308.07 Aligned_cols=263 Identities=22% Similarity=0.285 Sum_probs=197.8
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCC--CChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceE
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDT--KGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRR 340 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~--~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~ 340 (590)
++|+....||+|+||.||+|+++ +|+.||+|++..... ...+.+.+|++++++++|+|++++++++.. +...
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~~~ 75 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRR-----KRKL 75 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEee-----CCEE
Confidence 46788899999999999999987 488999999864322 234568899999999999999999999874 4568
Q ss_pred EEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCccc
Q 046270 341 FLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQ 420 (590)
Q Consensus 341 ~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~ 420 (590)
++||||+++++|..++. ....++|..++.++.|++.||.||| +.+++||||||+||+++.++.+||+|||++..
T Consensus 76 ~~v~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~ql~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 149 (286)
T cd07847 76 HLVFEYCDHTVLNELEK---NPRGVPEHLIKKIIWQTLQAVNFCH---KHNCIHRDVKPENILITKQGQIKLCDFGFARI 149 (286)
T ss_pred EEEEeccCccHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCChhhEEEcCCCcEEECcccccee
Confidence 99999999988887663 3346999999999999999999999 89999999999999999999999999999986
Q ss_pred ccCCCcccccccccCCCccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHH----------
Q 046270 421 SLEGHSHLTTRVAGTFGYLAPEYALY-GQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVL---------- 489 (590)
Q Consensus 421 ~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~---------- 489 (590)
...... ......++..|+|||++.+ ..++.++||||||+++|||++|+.||........ +..+....
T Consensus 150 ~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 227 (286)
T cd07847 150 LTGPGD-DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQ-LYLIRKTLGDLIPRHQQI 227 (286)
T ss_pred cCCCcc-cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCChHHhhh
Confidence 544321 2233457889999999875 5688999999999999999999999975443221 11111000
Q ss_pred HhcCCc-hhhhhHHHh-----hhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 490 AKSGKV-DDIFDEFIR-----AEGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 490 ~~~~~~-~~~~d~~l~-----~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
+..... .....+... ..........+.+++..|++.+|++||++.|++.+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 228 FSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred cccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 000000 000000000 00011224567889999999999999999998853
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=308.18 Aligned_cols=249 Identities=26% Similarity=0.425 Sum_probs=193.7
Q ss_pred ceecccCcEEEEEEEEcC-------CcEEEEEEeecCC-CCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEE
Q 046270 270 NLIGQGASGIVYKGTLRH-------GNLVAVKQILDLD-TKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRF 341 (590)
Q Consensus 270 ~~LG~G~fG~Vykg~~~~-------g~~vAvK~l~~~~-~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~ 341 (590)
+.||+|+||.||+|+..+ +..+|+|.+.... .....++.+|++++++++||||+++++++.. ....+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~ 75 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLL-----NEPQY 75 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecC-----CCCeE
Confidence 369999999999998753 2479999875433 2345678999999999999999999999874 34589
Q ss_pred EEEeeCCCCCcchhhhhhc----ccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCC-----cEEE
Q 046270 342 LVYDYMPNGTLSDNISISH----KRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSEL-----NAKV 412 (590)
Q Consensus 342 LV~E~~~~gsL~~~L~~~~----~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~-----~~kL 412 (590)
+||||+++++|.+++.... ....++|.+++.++.|++.||.||| +.+++|+||||+||+++.+. .+||
T Consensus 76 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~~~~~l 152 (269)
T cd05044 76 IIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKI 152 (269)
T ss_pred EEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHH---hCCcccCCCChheEEEecCCCCCCcceEE
Confidence 9999999999999986432 1234899999999999999999999 89999999999999999877 8999
Q ss_pred EeeCCcccccCCCcc-cccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhhHHHHHHH
Q 046270 413 ADFGLAKQSLEGHSH-LTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLDTSTSPFQLITDWAWVLA 490 (590)
Q Consensus 413 ~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELlt-G~~p~~~~~~~~~~l~~~~~~~~ 490 (590)
+|||+++........ ......++..|+|||++..+.++.++||||||+++|||+| |+.|+...... ....+ .
T Consensus 153 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~--~~~~~---~- 226 (269)
T cd05044 153 GDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ--EVLQH---V- 226 (269)
T ss_pred CCcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH--HHHHH---H-
Confidence 999999765432211 1222345678999999999999999999999999999998 99888643221 11111 1
Q ss_pred hcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhc
Q 046270 491 KSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLE 541 (590)
Q Consensus 491 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~ 541 (590)
..+... .........+.+++..|++.+|++||++.+++++|+
T Consensus 227 ~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 227 TAGGRL---------QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred hcCCcc---------CCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 111100 011123346778999999999999999999999986
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=302.61 Aligned_cols=253 Identities=27% Similarity=0.345 Sum_probs=201.3
Q ss_pred cCCCccceecccCcEEEEEEEEcC-CcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEEE
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLRH-GNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFL 342 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~L 342 (590)
++|...+.||+|+||.||+|.... +..+++|.+........+.+.+|++++++++|+|++++++++.. +...++
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~~~~l 77 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLR-----RDKLWI 77 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEe-----CCEEEE
Confidence 578888999999999999999864 67899999876555566789999999999999999999998873 456999
Q ss_pred EEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCccccc
Q 046270 343 VYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSL 422 (590)
Q Consensus 343 V~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~~ 422 (590)
+|||+++++|.+++.. ....+++.++..++.|++.||.||| +.+|+|+||||+||++++++.+||+|||++....
T Consensus 78 ~~e~~~~~~l~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~ 152 (262)
T cd06613 78 VMEYCGGGSLQDIYQV--TRGPLSELQIAYVCRETLKGLAYLH---ETGKIHRDIKGANILLTEDGDVKLADFGVSAQLT 152 (262)
T ss_pred EEeCCCCCcHHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHH---hCCceecCCChhhEEECCCCCEEECccccchhhh
Confidence 9999999999998753 2257999999999999999999999 8999999999999999999999999999987654
Q ss_pred CCCcccccccccCCCccCccccccC---CCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhh
Q 046270 423 EGHSHLTTRVAGTFGYLAPEYALYG---QLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIF 499 (590)
Q Consensus 423 ~~~~~~~~~~~gt~~Y~APE~~~~~---~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 499 (590)
... .......++..|+|||.+... .++.++||||||+++|||+||+.|+........ .... .. ....
T Consensus 153 ~~~-~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~-~~~~----~~-~~~~--- 222 (262)
T cd06613 153 ATI-AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRA-LFLI----SK-SNFP--- 222 (262)
T ss_pred hhh-hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH-HHHH----Hh-ccCC---
Confidence 321 122335678899999998776 889999999999999999999999865432211 1100 01 1000
Q ss_pred hHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 046270 500 DEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALK 538 (590)
Q Consensus 500 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~ 538 (590)
...+. ........+.+++.+|++.+|.+|||+.+|+.
T Consensus 223 ~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 223 PPKLK--DKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred Ccccc--chhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00000 11223456888999999999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=312.97 Aligned_cols=249 Identities=25% Similarity=0.384 Sum_probs=200.6
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEEE
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFL 342 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~L 342 (590)
.+|...+.||+|+||.||+|+.. +++.||+|.+........+.+.+|+.+++.++|+|++++++++.. +...++
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~~~~l 93 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV-----GDELWV 93 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEec-----CCEEEE
Confidence 56888899999999999999974 688999999876555556778999999999999999999999873 456999
Q ss_pred EEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCccccc
Q 046270 343 VYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSL 422 (590)
Q Consensus 343 V~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~~ 422 (590)
||||+++++|.+++. ...+++.++..++.+++.||.||| +.+|+||||||+|||++.++.+||+|||++....
T Consensus 94 v~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~l~~~L~~LH---~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~ 166 (297)
T cd06656 94 VMEYLAGGSLTDVVT----ETCMDEGQIAAVCRECLQALDFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 166 (297)
T ss_pred eecccCCCCHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEECcCccceEcc
Confidence 999999999999874 345899999999999999999999 8999999999999999999999999999987654
Q ss_pred CCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhhhHH
Q 046270 423 EGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDEF 502 (590)
Q Consensus 423 ~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 502 (590)
.... ......++..|+|||.+.+..++.++||||||+++|||++|+.||........... ....+.. ...
T Consensus 167 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~-----~~~~~~~-~~~--- 236 (297)
T cd06656 167 PEQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL-----IATNGTP-ELQ--- 236 (297)
T ss_pred CCcc-CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee-----eccCCCC-CCC---
Confidence 3322 22334678899999999988899999999999999999999999965433211111 0111110 000
Q ss_pred HhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 046270 503 IRAEGARAVMERFVLVGILCAHVMVALRPTITDALK 538 (590)
Q Consensus 503 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~ 538 (590)
.+......+.+++..|++.+|++||++.++++
T Consensus 237 ----~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 237 ----NPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred ----CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 01122335667888999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=305.06 Aligned_cols=250 Identities=30% Similarity=0.443 Sum_probs=196.3
Q ss_pred CCccceecccCcEEEEEEEEcC-CcEEEEEEeecCCCCChH--HHHHHHHHHHhcCCCCccccceeEEeccCCCCceEEE
Q 046270 266 FSQNNLIGQGASGIVYKGTLRH-GNLVAVKQILDLDTKGDE--DFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFL 342 (590)
Q Consensus 266 f~~~~~LG~G~fG~Vykg~~~~-g~~vAvK~l~~~~~~~~~--~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~L 342 (590)
|+..+.||+|+||.||+++... ++.+|+|.+......... ...+|+.++++++|+||+++++++.. ....++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~~~~ 75 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQD-----DNYLYI 75 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEE-----SSEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccc-----cccccc
Confidence 4566899999999999999876 558999998765433322 23569999999999999999999985 456899
Q ss_pred EEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCccccc
Q 046270 343 VYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSL 422 (590)
Q Consensus 343 V~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~~ 422 (590)
||||+++++|.+++. ....+++..+..++.|+++||.||| +.+|+|+||||+||+++++++++|+|||.+....
T Consensus 76 v~~~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~Lh---~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~ 149 (260)
T PF00069_consen 76 VMEYCPGGSLQDYLQ---KNKPLSEEEILKIAYQILEALAYLH---SKGIVHRDIKPENILLDENGEVKLIDFGSSVKLS 149 (260)
T ss_dssp EEEEETTEBHHHHHH---HHSSBBHHHHHHHHHHHHHHHHHHH---HTTEEESSBSGGGEEESTTSEEEESSGTTTEEST
T ss_pred ccccccccccccccc---ccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc
Confidence 999999999999995 4567999999999999999999999 8899999999999999999999999999987541
Q ss_pred CCCcccccccccCCCccCccccc-cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhhhH
Q 046270 423 EGHSHLTTRVAGTFGYLAPEYAL-YGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDE 501 (590)
Q Consensus 423 ~~~~~~~~~~~gt~~Y~APE~~~-~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 501 (590)
..........++..|+|||.+. ...++.++||||+|+++++|++|+.|+........ ...... ....
T Consensus 150 -~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~-~~~~~~----------~~~~ 217 (260)
T PF00069_consen 150 -ENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQ-LEIIEK----------ILKR 217 (260)
T ss_dssp -STTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHH-HHHHHH----------HHHT
T ss_pred -ccccccccccccccccccccccccccccccccccccccccccccccccccccccchhh-hhhhhh----------cccc
Confidence 2222344566889999999998 88899999999999999999999999875411111 100000 0000
Q ss_pred HHhhh--hHHHHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 046270 502 FIRAE--GARAVMERFVLVGILCAHVMVALRPTITDALK 538 (590)
Q Consensus 502 ~l~~~--~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~ 538 (590)
.+... ........+.+++..|++.||++||++.++++
T Consensus 218 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 218 PLPSSSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp HHHHHTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred cccccccccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000 00011257888999999999999999999985
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=311.09 Aligned_cols=255 Identities=25% Similarity=0.308 Sum_probs=200.0
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCC-CCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEE
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLD-TKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRF 341 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~-~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~ 341 (590)
++|+..+.||+|+||+||++... +|..+|+|++.... ....+.+.+|+++++.++|+||+++++++.. ....+
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~~ 79 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLN-----ENNIC 79 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEec-----CCEEE
Confidence 45667789999999999999876 47889999876543 2335679999999999999999999999874 35699
Q ss_pred EEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccc
Q 046270 342 LVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQS 421 (590)
Q Consensus 342 LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~ 421 (590)
+||||+++++|.+++. +.+.+++..+..++.+++.||.|||+ ..+++||||||+||++++++.++|+|||++...
T Consensus 80 lv~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~ 154 (284)
T cd06620 80 MCMEFMDCGSLDRIYK---KGGPIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGEL 154 (284)
T ss_pred EEEecCCCCCHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHH--hcCeeccCCCHHHEEECCCCcEEEccCCcccch
Confidence 9999999999998874 34568999999999999999999993 258999999999999999999999999998654
Q ss_pred cCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchh------hhhHHHHHHHhcCCc
Q 046270 422 LEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQ------LITDWAWVLAKSGKV 495 (590)
Q Consensus 422 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~------~l~~~~~~~~~~~~~ 495 (590)
... ......|+..|+|||++.++.++.++|||||||+++||+||+.||........ .+.++..........
T Consensus 155 ~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd06620 155 INS---IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPP 231 (284)
T ss_pred hhh---ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCC
Confidence 222 12245689999999999888999999999999999999999999975433211 111122111111100
Q ss_pred hhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHh
Q 046270 496 DDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKML 540 (590)
Q Consensus 496 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L 540 (590)
.....+....+.+++..|++.||++|||+.|++++.
T Consensus 232 ---------~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 232 ---------RLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred ---------CCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 000112334677888999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=306.83 Aligned_cols=251 Identities=26% Similarity=0.378 Sum_probs=192.3
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCC-----CChHHHHHHHHHHHhcCCCCccccceeEEeccCCCC
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDT-----KGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSG 337 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~-----~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~ 337 (590)
.+|...+.||+|+||.||+|... .+..||+|++..... +....+.+|++++++++|+||+++++++... .+
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~ 78 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDR---AE 78 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcC---CC
Confidence 47888999999999999999876 488999998854321 1234688999999999999999999987643 23
Q ss_pred ceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCC
Q 046270 338 KRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGL 417 (590)
Q Consensus 338 ~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGl 417 (590)
...++++||+++++|.+++. ....+++..++.++.|++.||+||| ..+|+||||||+||+++.++.+||+|||+
T Consensus 79 ~~~~l~~e~~~~~~L~~~l~---~~~~l~~~~~~~~~~qi~~~l~~LH---~~~i~H~~l~p~nil~~~~~~~~l~dfg~ 152 (266)
T cd06651 79 KTLTIFMEYMPGGSVKDQLK---AYGALTESVTRKYTRQILEGMSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGA 152 (266)
T ss_pred CEEEEEEeCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCCC
Confidence 56899999999999999885 3346899999999999999999999 89999999999999999999999999999
Q ss_pred cccccCCCc--ccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCc
Q 046270 418 AKQSLEGHS--HLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKV 495 (590)
Q Consensus 418 a~~~~~~~~--~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~ 495 (590)
++....... .......++.+|+|||++.+..++.++||||||+++|||++|+.||........ +. .......
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~-~~----~~~~~~~- 226 (266)
T cd06651 153 SKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAA-IF----KIATQPT- 226 (266)
T ss_pred ccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHH-HH----HHhcCCC-
Confidence 876532211 112234578899999999988899999999999999999999999864322111 10 0111110
Q ss_pred hhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 046270 496 DDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALK 538 (590)
Q Consensus 496 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~ 538 (590)
.+.+ +....+.+..+ +.|+..+|++||+|+||++
T Consensus 227 ----~~~~----~~~~~~~~~~l-i~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 227 ----NPQL----PSHISEHARDF-LGCIFVEARHRPSAEELLR 260 (266)
T ss_pred ----CCCC----chhcCHHHHHH-HHHhcCChhhCcCHHHHhc
Confidence 0000 11112223333 3688899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=317.36 Aligned_cols=241 Identities=23% Similarity=0.326 Sum_probs=185.2
Q ss_pred ceecccCcEEEEEEEEcC-CcEEEEEEeecCC---CCChHHHHHHHH-HHHhcCCCCccccceeEEeccCCCCceEEEEE
Q 046270 270 NLIGQGASGIVYKGTLRH-GNLVAVKQILDLD---TKGDEDFTNEVE-IISKIRHRNLLSLRGCCVTSDDSSGKRRFLVY 344 (590)
Q Consensus 270 ~~LG~G~fG~Vykg~~~~-g~~vAvK~l~~~~---~~~~~~f~~Ev~-il~~l~H~nlv~l~g~~~~~~~~~~~~~~LV~ 344 (590)
+.||+|+||.||+++... ++.||+|++.... ......+..|.. +++.++|+||+++++++.. +...++||
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~-----~~~~~lv~ 75 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQT-----ADKLYFVL 75 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEc-----CCeEEEEE
Confidence 369999999999999874 6789999986432 122334444444 5678899999999998873 45689999
Q ss_pred eeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccccCC
Q 046270 345 DYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEG 424 (590)
Q Consensus 345 E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~~~~ 424 (590)
||+++|+|.+++. ....+++.....++.||++||.||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 76 e~~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH---~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~ 149 (325)
T cd05602 76 DYINGGELFYHLQ---RERCFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH 149 (325)
T ss_pred eCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEEccCCCCcccccC
Confidence 9999999999885 3456888889999999999999999 899999999999999999999999999999754322
Q ss_pred CcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhhhHHHh
Q 046270 425 HSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDEFIR 504 (590)
Q Consensus 425 ~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 504 (590)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ....... .... +
T Consensus 150 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-----~~~~i~~-~~~~--~----- 215 (325)
T cd05602 150 N-GTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE-----MYDNILN-KPLQ--L----- 215 (325)
T ss_pred C-CCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHH-----HHHHHHh-CCcC--C-----
Confidence 1 22345679999999999999999999999999999999999999996432211 1111111 1000 0
Q ss_pred hhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 046270 505 AEGARAVMERFVLVGILCAHVMVALRPTITDALK 538 (590)
Q Consensus 505 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~ 538 (590)
.......+.+++..|++.+|.+||++.+.+.
T Consensus 216 ---~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~ 246 (325)
T cd05602 216 ---KPNITNSARHLLEGLLQKDRTKRLGAKDDFM 246 (325)
T ss_pred ---CCCCCHHHHHHHHHHcccCHHHCCCCCCCHH
Confidence 1122346677888999999999998875433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=308.78 Aligned_cols=250 Identities=24% Similarity=0.345 Sum_probs=195.0
Q ss_pred CCccceecccCcEEEEEEEEcC-CcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEEEEE
Q 046270 266 FSQNNLIGQGASGIVYKGTLRH-GNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFLVY 344 (590)
Q Consensus 266 f~~~~~LG~G~fG~Vykg~~~~-g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~LV~ 344 (590)
|+..+.||+|+||.||+|.... +..+++|.+........+.+.+|++++++++|+|++++++++.. +...++||
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~-----~~~~~~v~ 81 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYY-----ENNLWILI 81 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEee-----CCEEEEEE
Confidence 4456789999999999999875 67888988865544456678999999999999999999999874 45689999
Q ss_pred eeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccccCC
Q 046270 345 DYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEG 424 (590)
Q Consensus 345 E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~~~~ 424 (590)
||+++++|..++.. ....++|..+..++.|++.||.||| +.+++||||||+||+++.++.+||+|||+++.....
T Consensus 82 e~~~~~~l~~~~~~--~~~~l~~~~~~~~~~qi~~~L~~LH---~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~ 156 (282)
T cd06643 82 EFCAGGAVDAVMLE--LERPLTEPQIRVVCKQTLEALNYLH---ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT 156 (282)
T ss_pred EecCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEccCCCEEEcccccccccccc
Confidence 99999999887752 2356999999999999999999999 899999999999999999999999999998764332
Q ss_pred CcccccccccCCCccCccccc-----cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhh
Q 046270 425 HSHLTTRVAGTFGYLAPEYAL-----YGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIF 499 (590)
Q Consensus 425 ~~~~~~~~~gt~~Y~APE~~~-----~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 499 (590)
. .......++..|+|||++. ...++.++|||||||++|||++|+.|+..... ........ . +......
T Consensus 157 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~-~~~~~~~~----~-~~~~~~~ 229 (282)
T cd06643 157 I-QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNP-MRVLLKIA----K-SEPPTLA 229 (282)
T ss_pred c-cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCH-HHHHHHHh----h-cCCCCCC
Confidence 2 1223356889999999874 34578899999999999999999999865332 11111111 1 1100100
Q ss_pred hHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 500 DEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 500 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
. +......+.+++..|++.+|.+||++.++++.
T Consensus 230 ~-------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 230 Q-------PSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred C-------ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 11123467788899999999999999998754
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=315.59 Aligned_cols=263 Identities=20% Similarity=0.291 Sum_probs=195.9
Q ss_pred HhcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCC--CCChHHHHHHHHHHHhcCCCCccccceeEEeccC-CCC
Q 046270 262 ATNGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLD--TKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDD-SSG 337 (590)
Q Consensus 262 at~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~--~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~-~~~ 337 (590)
..++|...+.||+|+||.||+|... .+..||||++.... ......+.+|++++++++|+||+++++++..... ...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 4567888899999999999999875 47799999986432 1234567899999999999999999998764321 123
Q ss_pred ceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCC
Q 046270 338 KRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGL 417 (590)
Q Consensus 338 ~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGl 417 (590)
...++++|++ +++|.+++. ...+++..+..++.||+.||.||| +.+|+||||||+|||+++++.+||+|||+
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~ 164 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVK----CQKLSDEHVQFLIYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGL 164 (343)
T ss_pred CcEEEEeecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecccCChhhEEECCCCCEEEcCCcc
Confidence 4578999988 778887763 346999999999999999999999 89999999999999999999999999999
Q ss_pred cccccCCCcccccccccCCCccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCch
Q 046270 418 AKQSLEGHSHLTTRVAGTFGYLAPEYALY-GQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVD 496 (590)
Q Consensus 418 a~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 496 (590)
++..... .....||..|+|||.+.+ ..++.++|||||||+++||++|+.||....... .+..+... ......
T Consensus 165 ~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~--~~~~~~ 237 (343)
T cd07878 165 ARQADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYID-QLKRIMEV--VGTPSP 237 (343)
T ss_pred ceecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH-HHHHHHHH--hCCCCH
Confidence 9865332 233468999999999876 578999999999999999999999986533211 11111100 000111
Q ss_pred hhhhHH-----------HhhhhH-------HHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 497 DIFDEF-----------IRAEGA-------RAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 497 ~~~d~~-----------l~~~~~-------~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
+.+... +..... ......+.+++..|++.||.+|||+.|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 238 EVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred HHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 111100 000000 0012246788999999999999999999864
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=304.96 Aligned_cols=250 Identities=25% Similarity=0.415 Sum_probs=197.0
Q ss_pred CCCccceecccCcEEEEEEEEcCCcEEEEEEeecCCCC------ChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCc
Q 046270 265 GFSQNNLIGQGASGIVYKGTLRHGNLVAVKQILDLDTK------GDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGK 338 (590)
Q Consensus 265 ~f~~~~~LG~G~fG~Vykg~~~~g~~vAvK~l~~~~~~------~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~ 338 (590)
+|...+.||+|+||.||+|...+|+.+|+|.+...... ....+.+|++++++++|+||+++++++.. ..
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~ 75 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLD-----DN 75 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeec-----CC
Confidence 36677899999999999999888999999988643211 12458899999999999999999999874 45
Q ss_pred eEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCc
Q 046270 339 RRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLA 418 (590)
Q Consensus 339 ~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla 418 (590)
..++||||+++++|.+++. +...+++..+..++.|++.||+||| ..+|+|+||||+||++++++.+||+|||++
T Consensus 76 ~~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~ 149 (265)
T cd06631 76 TISIFMEFVPGGSISSILN---RFGPLPEPVFCKYTKQILDGVAYLH---NNCVVHRDIKGNNVMLMPNGIIKLIDFGCA 149 (265)
T ss_pred eEEEEEecCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHhEEECCCCeEEeccchhh
Confidence 6999999999999999985 3346899999999999999999999 889999999999999999999999999998
Q ss_pred ccccCCC-----cccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcC
Q 046270 419 KQSLEGH-----SHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSG 493 (590)
Q Consensus 419 ~~~~~~~-----~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~ 493 (590)
+...... ........|+..|+|||++.+..++.++||||||++++||++|+.||........ . .......+
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~-~---~~~~~~~~ 225 (265)
T cd06631 150 RRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAA-M---FYIGAHRG 225 (265)
T ss_pred HhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHH-H---HHhhhccC
Confidence 7543211 1122345688999999999988899999999999999999999999964332111 1 00000001
Q ss_pred CchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 046270 494 KVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALK 538 (590)
Q Consensus 494 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~ 538 (590)
...+ + +....+.+..++..|++.+|++||++.++++
T Consensus 226 ~~~~-----~----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 226 LMPR-----L----PDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred CCCC-----C----CCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 1111 1 1122346778889999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=324.74 Aligned_cols=261 Identities=19% Similarity=0.243 Sum_probs=198.5
Q ss_pred HHHHHHHhcCCCccceecccCcEEEEEEEEcC-CcEEEEEEeecCC---CCChHHHHHHHHHHHhcCCCCccccceeEEe
Q 046270 256 VSELEQATNGFSQNNLIGQGASGIVYKGTLRH-GNLVAVKQILDLD---TKGDEDFTNEVEIISKIRHRNLLSLRGCCVT 331 (590)
Q Consensus 256 ~~el~~at~~f~~~~~LG~G~fG~Vykg~~~~-g~~vAvK~l~~~~---~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~ 331 (590)
+.++....++|...+.||+|+||.||+++.+. ++.+|+|.+.... ......+.+|+++++.++||||+++++.+.
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~- 113 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQ- 113 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEE-
Confidence 44555566899999999999999999999874 7789999985421 223445789999999999999999999887
Q ss_pred ccCCCCceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEE
Q 046270 332 SDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAK 411 (590)
Q Consensus 332 ~~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~k 411 (590)
.+...++||||+++|+|.+++. ...++...+..++.||+.||.||| +.+|+||||||+|||++.++.+|
T Consensus 114 ----~~~~~~lv~Ey~~gg~L~~~~~----~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NIll~~~~~ik 182 (371)
T cd05622 114 ----DDRYLYMVMEYMPGGDLVNLMS----NYDVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLK 182 (371)
T ss_pred ----cCCEEEEEEcCCCCCcHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHEEECCCCCEE
Confidence 3457999999999999999884 235888899999999999999999 89999999999999999999999
Q ss_pred EEeeCCcccccCCCcccccccccCCCccCccccccC----CCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHH
Q 046270 412 VADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALYG----QLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAW 487 (590)
Q Consensus 412 L~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~----~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~ 487 (590)
|+|||+++..............||+.|+|||++... .++.++|||||||++|||++|+.||....... . + .
T Consensus 183 L~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~-~---~-~ 257 (371)
T cd05622 183 LADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG-T---Y-S 257 (371)
T ss_pred EEeCCceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHH-H---H-H
Confidence 999999986543332233456799999999998743 37899999999999999999999997533211 1 1 1
Q ss_pred HHHhcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCC--CCCHHHHHHHh
Q 046270 488 VLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVAL--RPTITDALKML 540 (590)
Q Consensus 488 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~--RPtm~eVl~~L 540 (590)
............+ .......+..++..|+...+.+ ||++.|++++.
T Consensus 258 ~i~~~~~~~~~~~-------~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 258 KIMNHKNSLTFPD-------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred HHHcCCCcccCCC-------cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 1111111111111 0112335566777888743332 78999998864
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=316.11 Aligned_cols=254 Identities=27% Similarity=0.423 Sum_probs=196.3
Q ss_pred cCCCccceecccCcEEEEEEEEcC-Cc----EEEEEEeecCCCC-ChHHHHHHHHHHHhcCCCCccccceeEEeccCCCC
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLRH-GN----LVAVKQILDLDTK-GDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSG 337 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~~-g~----~vAvK~l~~~~~~-~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~ 337 (590)
++|...+.||+|+||.||+|++.. |. .||+|.+...... ...++.+|+.++++++|+||++++|+|...
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~----- 81 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP----- 81 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-----
Confidence 456777899999999999998753 43 4788887653322 234688999999999999999999998632
Q ss_pred ceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCC
Q 046270 338 KRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGL 417 (590)
Q Consensus 338 ~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGl 417 (590)
..++++||+++|+|.+++.. ....+++..++.++.|++.||.||| +.+|+||||||+||++++++.+||+|||+
T Consensus 82 -~~~~v~e~~~~g~l~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dikp~Nill~~~~~~kL~Dfg~ 155 (303)
T cd05110 82 -TIQLVTQLMPHGCLLDYVHE--HKDNIGSQLLLNWCVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGL 155 (303)
T ss_pred -CceeeehhcCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHh---hcCeeccccccceeeecCCCceEEccccc
Confidence 36799999999999998852 2346899999999999999999999 89999999999999999999999999999
Q ss_pred cccccCCCccc-ccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhhHHHHHHHhcCCc
Q 046270 418 AKQSLEGHSHL-TTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLDTSTSPFQLITDWAWVLAKSGKV 495 (590)
Q Consensus 418 a~~~~~~~~~~-~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~ 495 (590)
++......... .....++..|+|||++.+..++.++||||||+++|||++ |+.|+..... ..+.++ ...+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~--~~~~~~----~~~~~~ 229 (303)
T cd05110 156 ARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT--REIPDL----LEKGER 229 (303)
T ss_pred cccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHH----HHCCCC
Confidence 98654332221 223345678999999998899999999999999999998 8888854321 111111 111111
Q ss_pred hhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhccC
Q 046270 496 DDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEGD 543 (590)
Q Consensus 496 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~~ 543 (590)
... .......+..++..|+..+|++||+|++++++|+..
T Consensus 230 ~~~---------~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~ 268 (303)
T cd05110 230 LPQ---------PPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRM 268 (303)
T ss_pred CCC---------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 000 001123567788999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=344.24 Aligned_cols=259 Identities=21% Similarity=0.295 Sum_probs=199.6
Q ss_pred cCCCccceecccCcEEEEEEEEcC-CcEEEEEEeecCCCC---ChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCce
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLRH-GNLVAVKQILDLDTK---GDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKR 339 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~vAvK~l~~~~~~---~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~ 339 (590)
++|...++||+|+||.||+|+... |+.||+|++...... ..+.|.+|++++++++||||+++++++.. +..
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d-----~~~ 76 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSD-----GDP 76 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEee-----CCE
Confidence 578889999999999999999864 889999998653222 24568999999999999999999999874 446
Q ss_pred EEEEEeeCCCCCcchhhhhhc--------ccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEE
Q 046270 340 RFLVYDYMPNGTLSDNISISH--------KRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAK 411 (590)
Q Consensus 340 ~~LV~E~~~~gsL~~~L~~~~--------~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~k 411 (590)
.++||||+++|+|.+++.... ....+++..+++|+.||++||+||| +.+|+||||||+|||++.++.+|
T Consensus 77 lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLH---s~GIIHRDLKPeNILLd~dg~vK 153 (932)
T PRK13184 77 VYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVV 153 (932)
T ss_pred EEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHH---HCCccccCCchheEEEcCCCCEE
Confidence 899999999999999885321 1234678889999999999999999 89999999999999999999999
Q ss_pred EEeeCCcccccCCCc-----------------ccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 046270 412 VADFGLAKQSLEGHS-----------------HLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDT 474 (590)
Q Consensus 412 L~DFGla~~~~~~~~-----------------~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~ 474 (590)
|+|||+++....... .......||+.|+|||++.+..++.++|||||||+++||+||+.||..
T Consensus 154 LiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~ 233 (932)
T PRK13184 154 ILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRR 233 (932)
T ss_pred EEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence 999999986521110 011235689999999999999999999999999999999999999865
Q ss_pred CCCchhhhhHHHHHHHhcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCC-CHHHHHHHhccC
Q 046270 475 STSPFQLITDWAWVLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRP-TITDALKMLEGD 543 (590)
Q Consensus 475 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-tm~eVl~~L~~~ 543 (590)
..... +. +. .... ...+. ....+....+.+++..|++.||++|| +++++.+.|+..
T Consensus 234 ~~~~k--i~-~~-~~i~--~P~~~-------~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~ 290 (932)
T PRK13184 234 KKGRK--IS-YR-DVIL--SPIEV-------APYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPH 290 (932)
T ss_pred cchhh--hh-hh-hhcc--Chhhc-------cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 32211 10 00 0000 00000 00112334677888999999999996 677777777654
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=305.95 Aligned_cols=268 Identities=24% Similarity=0.356 Sum_probs=204.0
Q ss_pred HHhcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeec--CCCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCC
Q 046270 261 QATNGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILD--LDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSG 337 (590)
Q Consensus 261 ~at~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~--~~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~ 337 (590)
.....|...+.||+|.||.|.+++.+ .|..||||++.+ ......+.-.+|+++|+.++|+||+.+..........+-
T Consensus 19 ~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f 98 (359)
T KOG0660|consen 19 EIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKF 98 (359)
T ss_pred eccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccc
Confidence 34455666789999999999999986 488999999963 233345667899999999999999999998876443456
Q ss_pred ceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCC
Q 046270 338 KRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGL 417 (590)
Q Consensus 338 ~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGl 417 (590)
+..|+|+|+| ..+|...+. .++.|+.....-++.||++||.|+| +.+|+||||||+|+|++.+...||+|||+
T Consensus 99 ~DvYiV~elM-etDL~~iik---~~~~L~d~H~q~f~YQiLrgLKyiH---SAnViHRDLKPsNll~n~~c~lKI~DFGL 171 (359)
T KOG0660|consen 99 NDVYLVFELM-ETDLHQIIK---SQQDLTDDHAQYFLYQILRGLKYIH---SANVIHRDLKPSNLLLNADCDLKICDFGL 171 (359)
T ss_pred ceeEEehhHH-hhHHHHHHH---cCccccHHHHHHHHHHHHHhcchhh---cccccccccchhheeeccCCCEEeccccc
Confidence 7799999999 568888884 3445999999999999999999999 99999999999999999999999999999
Q ss_pred cccccCC-CcccccccccCCCccCccccc-cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCc
Q 046270 418 AKQSLEG-HSHLTTRVAGTFGYLAPEYAL-YGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKV 495 (590)
Q Consensus 418 a~~~~~~-~~~~~~~~~gt~~Y~APE~~~-~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~ 495 (590)
||..... .....+....|.+|.|||.+. ...||...||||.||++.||++|+..|.+.+.-.+ +.. .+.--|..
T Consensus 172 AR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Q-l~l---I~~~lGtP 247 (359)
T KOG0660|consen 172 ARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQ-LQL---ILELLGTP 247 (359)
T ss_pred eeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHH-HHH---HHHhcCCC
Confidence 9987543 122235566799999999876 46899999999999999999999998865443222 110 01111222
Q ss_pred hhhhhHHHhhhhHH-------------------HHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 496 DDIFDEFIRAEGAR-------------------AVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 496 ~~~~d~~l~~~~~~-------------------~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
.+..-..+..+... ......+++...++..||.+|+|++|+++.
T Consensus 248 ~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 248 SEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred CHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 22111111110000 112256778889999999999999999874
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=310.53 Aligned_cols=264 Identities=24% Similarity=0.313 Sum_probs=201.5
Q ss_pred cCCCccceecccCcEEEEEEEEcC-CcEEEEEEeecC--CCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceE
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLRH-GNLVAVKQILDL--DTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRR 340 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~vAvK~l~~~--~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~ 340 (590)
++|+..+.||+|+||.||+|.+++ ++.||+|++... .....+.+.+|++++++++|+||+++++++.. +...
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~ 75 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRR-----KGRL 75 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEE-----CCEE
Confidence 368888999999999999999874 779999988543 22335678999999999999999999999974 4468
Q ss_pred EEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCccc
Q 046270 341 FLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQ 420 (590)
Q Consensus 341 ~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~ 420 (590)
++||||++++.+..+.. +...+++.++..++.+|+.||.||| +.+++|+||+|+||++++++.+||+|||++..
T Consensus 76 ~iv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~ 149 (288)
T cd07833 76 YLVFEYVERTLLELLEA---SPGGLPPDAVRSYIWQLLQAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARA 149 (288)
T ss_pred EEEEecCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEEeeecccc
Confidence 99999999877765542 3456899999999999999999999 89999999999999999999999999999987
Q ss_pred ccCCCcccccccccCCCccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHH----------
Q 046270 421 SLEGHSHLTTRVAGTFGYLAPEYALYG-QLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVL---------- 489 (590)
Q Consensus 421 ~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~---------- 489 (590)
.............++..|+|||++... .++.++||||||+++|||++|+.|+........... .....
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 228 (288)
T cd07833 150 LRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYL-IQKCLGPLPPSHQEL 228 (288)
T ss_pred cCCCccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHHHhCCCCHHHhhh
Confidence 655443333446678999999999888 889999999999999999999998865433211110 00000
Q ss_pred H-hcCC-----chhhhhHH-HhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 490 A-KSGK-----VDDIFDEF-IRAEGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 490 ~-~~~~-----~~~~~d~~-l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
+ ..+. ..+..++. +....+......+.+++..|++.+|++|||+++++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 229 FSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred cccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 0 0000 00011110 1111122235678899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=316.96 Aligned_cols=257 Identities=25% Similarity=0.406 Sum_probs=197.9
Q ss_pred cCCCccceecccCcEEEEEEEEc--------CCcEEEEEEeecCCC-CChHHHHHHHHHHHhc-CCCCccccceeEEecc
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLR--------HGNLVAVKQILDLDT-KGDEDFTNEVEIISKI-RHRNLLSLRGCCVTSD 333 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~--------~g~~vAvK~l~~~~~-~~~~~f~~Ev~il~~l-~H~nlv~l~g~~~~~~ 333 (590)
++|...+.||+|+||.||+++.. .+..+|+|.+..... ....++.+|++++.++ +|+||+++++++..
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-- 89 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQ-- 89 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc--
Confidence 56778899999999999999752 244699998764322 2345688999999999 69999999999873
Q ss_pred CCCCceEEEEEeeCCCCCcchhhhhhc-------------ccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCC
Q 046270 334 DSSGKRRFLVYDYMPNGTLSDNISISH-------------KRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKST 400 (590)
Q Consensus 334 ~~~~~~~~LV~E~~~~gsL~~~L~~~~-------------~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~ 400 (590)
....++||||+++|+|.+++.... ....++|.++++++.||+.||.||| +.+|+||||||+
T Consensus 90 ---~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~ 163 (314)
T cd05099 90 ---EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE---SRRCIHRDLAAR 163 (314)
T ss_pred ---CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeeccccce
Confidence 345899999999999999985422 1245899999999999999999999 899999999999
Q ss_pred ceEECCCCcEEEEeeCCcccccCCCcc-cccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCc
Q 046270 401 NILLDSELNAKVADFGLAKQSLEGHSH-LTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLDTSTSP 478 (590)
Q Consensus 401 NILLd~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELlt-G~~p~~~~~~~ 478 (590)
|||+++++.+||+|||+++........ ......++..|+|||.+..+.++.++||||||+++|||++ |+.||.....
T Consensus 164 Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~- 242 (314)
T cd05099 164 NVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV- 242 (314)
T ss_pred eEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH-
Confidence 999999999999999999865432221 1122234567999999998899999999999999999999 8888754321
Q ss_pred hhhhhHHHHHHHhcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhccC
Q 046270 479 FQLITDWAWVLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEGD 543 (590)
Q Consensus 479 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~~ 543 (590)
.. +.. ....+...+. +......+.+++..|++.+|++|||+.|+++.|+..
T Consensus 243 ~~-~~~----~~~~~~~~~~---------~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~ 293 (314)
T cd05099 243 EE-LFK----LLREGHRMDK---------PSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKV 293 (314)
T ss_pred HH-HHH----HHHcCCCCCC---------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 11 111 1111111110 111233677889999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=300.97 Aligned_cols=247 Identities=25% Similarity=0.435 Sum_probs=197.0
Q ss_pred CCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCC-----CChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCc
Q 046270 265 GFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDT-----KGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGK 338 (590)
Q Consensus 265 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~-----~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~ 338 (590)
+|...+.||+|+||.||+|+.. ++..|++|.+..... +..+.+.+|++++++++|+|++++++++. .+.
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~ 75 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTER-----EED 75 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEe-----cCC
Confidence 3667789999999999999987 688999999865332 23457899999999999999999999887 345
Q ss_pred eEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCc
Q 046270 339 RRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLA 418 (590)
Q Consensus 339 ~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla 418 (590)
..++||||+++++|.+++. +...+++..+..++.|++.||+||| +.+|+|+||+|+||+++.++.+||+|||++
T Consensus 76 ~~~lv~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~ 149 (258)
T cd06632 76 NLYIFLELVPGGSLAKLLK---KYGSFPEPVIRLYTRQILLGLEYLH---DRNTVHRDIKGANILVDTNGVVKLADFGMA 149 (258)
T ss_pred eEEEEEEecCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccc
Confidence 6899999999999999885 3346899999999999999999999 899999999999999999999999999998
Q ss_pred ccccCCCcccccccccCCCccCccccccCC-CCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchh
Q 046270 419 KQSLEGHSHLTTRVAGTFGYLAPEYALYGQ-LTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDD 497 (590)
Q Consensus 419 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~-~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 497 (590)
....... ......|+..|++||.+.... ++.++|+||||++++||++|+.||..... ...+ +..........
T Consensus 150 ~~~~~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~-~~~~----~~~~~~~~~~~ 222 (258)
T cd06632 150 KQVVEFS--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG-VAAV----FKIGRSKELPP 222 (258)
T ss_pred eeccccc--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH-HHHH----HHHHhcccCCC
Confidence 7653322 233456888999999988776 89999999999999999999999865432 1111 11111111111
Q ss_pred hhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 046270 498 IFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALK 538 (590)
Q Consensus 498 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~ 538 (590)
+ +......+.+++.+|++.+|++||++.++++
T Consensus 223 -~--------~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 223 -I--------PDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred -c--------CCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 1 1112346677888999999999999999985
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=308.63 Aligned_cols=251 Identities=23% Similarity=0.335 Sum_probs=197.0
Q ss_pred cCCCccceecccCcEEEEEEEEcC-CcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEEE
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLRH-GNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFL 342 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~L 342 (590)
++|...++||+|+||.||+|+... +..+++|.+........+.+.+|++++++++|+|++++++++.. +...++
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~l 86 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYW-----DGKLWI 86 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEe-----CCeEEE
Confidence 457788899999999999999875 78999999876555556778999999999999999999998874 346899
Q ss_pred EEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCccccc
Q 046270 343 VYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSL 422 (590)
Q Consensus 343 V~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~~ 422 (590)
||||+++++|..++.. ....+++..+..++.|++.||.||| ..+++||||||+||+++.++.+||+|||++....
T Consensus 87 v~e~~~~~~l~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 161 (292)
T cd06644 87 MIEFCPGGAVDAIMLE--LDRGLTEPQIQVICRQMLEALQYLH---SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNV 161 (292)
T ss_pred EEecCCCCcHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHh---cCCeeecCCCcceEEEcCCCCEEEccCccceecc
Confidence 9999999999887742 2346999999999999999999999 8999999999999999999999999999987543
Q ss_pred CCCcccccccccCCCccCccccc-----cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchh
Q 046270 423 EGHSHLTTRVAGTFGYLAPEYAL-----YGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDD 497 (590)
Q Consensus 423 ~~~~~~~~~~~gt~~Y~APE~~~-----~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 497 (590)
... .......++..|+|||++. ...++.++|||||||++|||++|+.|+...... .....+ .......
T Consensus 162 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-~~~~~~-----~~~~~~~ 234 (292)
T cd06644 162 KTL-QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM-RVLLKI-----AKSEPPT 234 (292)
T ss_pred ccc-cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH-HHHHHH-----hcCCCcc
Confidence 221 1223456788999999885 345788999999999999999999998643321 111111 1111111
Q ss_pred hhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 046270 498 IFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALK 538 (590)
Q Consensus 498 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~ 538 (590)
.. .+......+.+++..|++.+|++||++.++++
T Consensus 235 ~~-------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 235 LS-------QPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred CC-------CCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 00 01122346778889999999999999999986
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=302.31 Aligned_cols=251 Identities=27% Similarity=0.456 Sum_probs=198.2
Q ss_pred CCccceecccCcEEEEEEEEcC-----CcEEEEEEeecCCCC-ChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCce
Q 046270 266 FSQNNLIGQGASGIVYKGTLRH-----GNLVAVKQILDLDTK-GDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKR 339 (590)
Q Consensus 266 f~~~~~LG~G~fG~Vykg~~~~-----g~~vAvK~l~~~~~~-~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~ 339 (590)
|...+.||+|+||.||++++.+ +..||+|.+...... ..+.+.+|++++.+++|+|++++++++.. ...
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~ 75 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTE-----EEP 75 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcC-----CCe
Confidence 3456789999999999999875 378999998655433 46689999999999999999999999874 346
Q ss_pred EEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcc
Q 046270 340 RFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAK 419 (590)
Q Consensus 340 ~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~ 419 (590)
.+++|||+++++|.+++.... ...+++.++..++.|++.||+||| +.+++||||||+||++++++.++|+|||+++
T Consensus 76 ~~~i~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lh---~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~ 151 (258)
T smart00219 76 LMIVMEYMEGGDLLDYLRKNR-PKELSLSDLLSFALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSR 151 (258)
T ss_pred eEEEEeccCCCCHHHHHHhhh-hccCCHHHHHHHHHHHHHHHHHHh---cCCeeecccccceEEEccCCeEEEcccCCce
Confidence 899999999999999985322 112999999999999999999999 8999999999999999999999999999998
Q ss_pred cccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhhHHHHHHHhcCCchhh
Q 046270 420 QSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLDTSTSPFQLITDWAWVLAKSGKVDDI 498 (590)
Q Consensus 420 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 498 (590)
..............++..|+|||.+....++.++||||+|++++||++ |+.|+..... ..+.+. ...+.....
T Consensus 152 ~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~--~~~~~~----~~~~~~~~~ 225 (258)
T smart00219 152 DLYDDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN--EEVLEY----LKKGYRLPK 225 (258)
T ss_pred ecccccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHH----HhcCCCCCC
Confidence 765543322222346789999999988889999999999999999999 7777754221 111111 111111110
Q ss_pred hhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHh
Q 046270 499 FDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKML 540 (590)
Q Consensus 499 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L 540 (590)
.......+.+++..|+..+|++|||+.+++++|
T Consensus 226 ---------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 226 ---------PENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred ---------CCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 111334678899999999999999999999875
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=303.41 Aligned_cols=254 Identities=26% Similarity=0.367 Sum_probs=200.6
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCC-CChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEE
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDT-KGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRF 341 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~-~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~ 341 (590)
++|+..+.||+|+||.||++.++ +++.+|+|++..... ...+++.+|++++++++|+||+++++++.. +...+
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~~ 75 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYN-----NGDIS 75 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeec-----CCEEE
Confidence 35677789999999999999987 488999999865432 345678999999999999999999999874 45699
Q ss_pred EEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCC-CCeEecCCCCCceEECCCCcEEEEeeCCccc
Q 046270 342 LVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLK-PGIYHRDIKSTNILLDSELNAKVADFGLAKQ 420 (590)
Q Consensus 342 LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~-~~ivHrDIKp~NILLd~~~~~kL~DFGla~~ 420 (590)
+|+||+++++|.+++... ...+++..+..++.|++.||+||| . .+++|+||||+||++++++.+||+|||.+..
T Consensus 76 lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH---~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~ 150 (265)
T cd06605 76 ICMEYMDGGSLDKILKEV--QGRIPERILGKIAVAVLKGLTYLH---EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQ 150 (265)
T ss_pred EEEEecCCCcHHHHHHHc--cCCCCHHHHHHHHHHHHHHHHHHc---CCCCeecCCCCHHHEEECCCCCEEEeecccchh
Confidence 999999999999988532 257899999999999999999999 7 8999999999999999999999999999875
Q ss_pred ccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhhh
Q 046270 421 SLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFD 500 (590)
Q Consensus 421 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 500 (590)
...... ....++..|+|||++.+..++.++||||||++++||++|+.|+...........+.......... ..+
T Consensus 151 ~~~~~~---~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~-- 224 (265)
T cd06605 151 LVNSLA---KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPP-PRL-- 224 (265)
T ss_pred hHHHHh---hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCC-CCC--
Confidence 532211 12668889999999998899999999999999999999999986543222212112211111110 000
Q ss_pred HHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 501 EFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 501 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
........+.+++..|++.+|.+|||+.+++..
T Consensus 225 ------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 225 ------PSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred ------ChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 011133467788899999999999999999853
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=303.34 Aligned_cols=250 Identities=21% Similarity=0.279 Sum_probs=198.6
Q ss_pred CCCccceecccCcEEEEEEEEc-CCcEEEEEEeecC-CCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEEE
Q 046270 265 GFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDL-DTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFL 342 (590)
Q Consensus 265 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~-~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~L 342 (590)
+|...+.||+|+||.||++... .+..+|+|.+... .....+.+.+|++++++++|+|++++++.+.. +...++
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~l 75 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEA-----DGHLYI 75 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEE-----CCEEEE
Confidence 4677889999999999999986 4788999988543 23345678899999999999999999998873 456999
Q ss_pred EEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCccccc
Q 046270 343 VYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSL 422 (590)
Q Consensus 343 V~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~~ 422 (590)
||||+++|+|.+++... ....+++...+.++.+++.||.||| +.+|+|+||||+||++++++.++|+|||+++...
T Consensus 76 v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~ 151 (255)
T cd08219 76 VMEYCDGGDLMQKIKLQ-RGKLFPEDTILQWFVQMCLGVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLT 151 (255)
T ss_pred EEeeCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEECCCCcEEEcccCcceeec
Confidence 99999999999887532 3345899999999999999999999 8999999999999999999999999999987654
Q ss_pred CCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhhhHH
Q 046270 423 EGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDEF 502 (590)
Q Consensus 423 ~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 502 (590)
... .......|+..|+|||.+.+..++.++||||||+++++|++|+.||....... ..... ..+....+
T Consensus 152 ~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~-----~~~~~-~~~~~~~~---- 220 (255)
T cd08219 152 SPG-AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKN-----LILKV-CQGSYKPL---- 220 (255)
T ss_pred ccc-cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHH-----HHHHH-hcCCCCCC----
Confidence 322 12234568899999999998889999999999999999999999996432211 11111 11221111
Q ss_pred HhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 503 IRAEGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 503 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
+......+.+++..|++.||++||++.|++..
T Consensus 221 -----~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 221 -----PSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred -----CcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 11122356778889999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=316.35 Aligned_cols=202 Identities=24% Similarity=0.355 Sum_probs=171.1
Q ss_pred cCCCccceecccCcEEEEEEEEcC-CcEEEEEEeecC---CCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCce
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLRH-GNLVAVKQILDL---DTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKR 339 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~vAvK~l~~~---~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~ 339 (590)
++|...++||+|+||.||+++++. ++.+|+|.+... .......+.+|+.++..++|+||+++++++.. ...
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~ 75 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQD-----ENN 75 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEec-----CCE
Confidence 468888999999999999999875 678999998542 12223458899999999999999999998873 456
Q ss_pred EEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcc
Q 046270 340 RFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAK 419 (590)
Q Consensus 340 ~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~ 419 (590)
.++||||+++|+|.+++.. ....+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++
T Consensus 76 ~~lv~ey~~~g~L~~~l~~--~~~~l~~~~~~~~~~qi~~al~~lH---~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~ 150 (332)
T cd05623 76 LYLVMDYYVGGDLLTLLSK--FEDRLPEDMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCL 150 (332)
T ss_pred EEEEEeccCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEeecchhe
Confidence 9999999999999999853 2346899999999999999999999 8999999999999999999999999999997
Q ss_pred cccCCCcccccccccCCCccCccccc-----cCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 046270 420 QSLEGHSHLTTRVAGTFGYLAPEYAL-----YGQLTEKSDVYSFGIVILELMSGRKVLDTS 475 (590)
Q Consensus 420 ~~~~~~~~~~~~~~gt~~Y~APE~~~-----~~~~t~ksDVySfGvvLlELltG~~p~~~~ 475 (590)
..............||+.|+|||++. .+.++.++|||||||++|||++|+.||...
T Consensus 151 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~ 211 (332)
T cd05623 151 KLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAE 211 (332)
T ss_pred ecccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCC
Confidence 65443333334457999999999986 346889999999999999999999999653
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=305.70 Aligned_cols=246 Identities=27% Similarity=0.410 Sum_probs=195.7
Q ss_pred CCCccceecccCcEEEEEEEEcCCcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEEEEE
Q 046270 265 GFSQNNLIGQGASGIVYKGTLRHGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFLVY 344 (590)
Q Consensus 265 ~f~~~~~LG~G~fG~Vykg~~~~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~LV~ 344 (590)
+|...+.||+|+||.||+|.. .+..+|+|.+... ...+.+.+|+.++.+++|+|++++++++.. ...++||
T Consensus 7 ~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~------~~~~~v~ 77 (254)
T cd05083 7 KLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCD--VTAQAFLEETAVMTKLHHKNLVRLLGVILH------NGLYIVM 77 (254)
T ss_pred HceeeeeeccCCCCceEeccc-CCCceEEEeecCc--chHHHHHHHHHHHHhCCCCCcCeEEEEEcC------CCcEEEE
Confidence 477789999999999999986 4778999987543 235678999999999999999999998753 2269999
Q ss_pred eeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccccCC
Q 046270 345 DYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEG 424 (590)
Q Consensus 345 E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~~~~ 424 (590)
||+++++|.+++... ....+++..++.++.|++.||.||| +.+++||||||+||+++.++.+||+|||+++.....
T Consensus 78 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~al~~lH---~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~ 153 (254)
T cd05083 78 ELMSKGNLVNFLRTR-GRALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG 153 (254)
T ss_pred ECCCCCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCcEEECCCccceecccc
Confidence 999999999998532 2345899999999999999999999 899999999999999999999999999998754322
Q ss_pred CcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhhHHHHHHHhcCCchhhhhHHH
Q 046270 425 HSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDEFI 503 (590)
Q Consensus 425 ~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 503 (590)
. .....+..|+|||++.++.++.++||||||++++||++ |+.||...... ++.... ..+...+
T Consensus 154 ~----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~-----~~~~~~-~~~~~~~------ 217 (254)
T cd05083 154 V----DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK-----EVKECV-EKGYRME------ 217 (254)
T ss_pred C----CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHH-----HHHHHH-hCCCCCC------
Confidence 1 12234568999999998999999999999999999998 88888643221 111111 1111111
Q ss_pred hhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhcc
Q 046270 504 RAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEG 542 (590)
Q Consensus 504 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~ 542 (590)
........+..++..|++.+|++||++.++++.|+.
T Consensus 218 ---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 218 ---PPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred ---CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 111233467789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=308.79 Aligned_cols=239 Identities=21% Similarity=0.348 Sum_probs=184.9
Q ss_pred eecccCcEEEEEEEEcC--------CcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEEE
Q 046270 271 LIGQGASGIVYKGTLRH--------GNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFL 342 (590)
Q Consensus 271 ~LG~G~fG~Vykg~~~~--------g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~L 342 (590)
.||+|+||.||+|.... ...+++|.+........+.+.+|+.++++++|||++++++++.. +...++
T Consensus 2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~-----~~~~~l 76 (258)
T cd05078 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVC-----GDESIM 76 (258)
T ss_pred CCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEe-----CCCcEE
Confidence 69999999999998753 22488888755444445678999999999999999999999874 345799
Q ss_pred EEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCc--------EEEEe
Q 046270 343 VYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELN--------AKVAD 414 (590)
Q Consensus 343 V~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~--------~kL~D 414 (590)
||||+++|+|.+++... ...++|..+++++.||+.||+||| +.+|+||||||+||+++.++. +|++|
T Consensus 77 v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d 151 (258)
T cd05078 77 VQEYVKFGSLDTYLKKN--KNLINISWKLEVAKQLAWALHFLE---DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSD 151 (258)
T ss_pred EEecCCCCcHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEEecccccccCCCceEEecc
Confidence 99999999999998532 336899999999999999999999 899999999999999987765 59999
Q ss_pred eCCcccccCCCcccccccccCCCccCccccccC-CCCcchhHHHHHHHHHHHHhCC-CCCCCCCCchhhhhHHHHHHHhc
Q 046270 415 FGLAKQSLEGHSHLTTRVAGTFGYLAPEYALYG-QLTEKSDVYSFGIVILELMSGR-KVLDTSTSPFQLITDWAWVLAKS 492 (590)
Q Consensus 415 FGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~t~ksDVySfGvvLlELltG~-~p~~~~~~~~~~l~~~~~~~~~~ 492 (590)
||++..... .....++..|+|||++.+. .++.++||||||+++|||++|. .|+... ....... .....
T Consensus 152 ~g~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~-~~~~~~~----~~~~~ 221 (258)
T cd05078 152 PGISITVLP-----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSAL-DSQKKLQ----FYEDR 221 (258)
T ss_pred cccccccCC-----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhc-cHHHHHH----HHHcc
Confidence 998865432 2234578899999998864 5799999999999999999995 444322 1111110 00000
Q ss_pred CCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhc
Q 046270 493 GKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLE 541 (590)
Q Consensus 493 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~ 541 (590)
.. .+......+.+++..|++.+|++|||++++++.|+
T Consensus 222 ~~------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 222 HQ------------LPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred cc------------CCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 00 01111235778889999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=306.36 Aligned_cols=253 Identities=24% Similarity=0.310 Sum_probs=197.2
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEEE
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFL 342 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~L 342 (590)
++|...+.||+|+||.||+|+.. ++..||+|.+..........+.+|+.+++.++||||+++++.+.. +...++
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~-----~~~~~l 83 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLR-----RDKLWI 83 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEe-----CCEEEE
Confidence 45677788999999999999876 478999999876544455678899999999999999999998874 456899
Q ss_pred EEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCccccc
Q 046270 343 VYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSL 422 (590)
Q Consensus 343 V~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~~ 422 (590)
||||+++++|.+++. ..+.+++.+.+.++.|++.||.||| ..+|+|+||||+||+++.++.+||+|||++....
T Consensus 84 v~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd06645 84 CMEFCGGGSLQDIYH---VTGPLSESQIAYVSRETLQGLYYLH---SKGKMHRDIKGANILLTDNGHVKLADFGVSAQIT 157 (267)
T ss_pred EEeccCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECcceeeeEcc
Confidence 999999999999884 3457999999999999999999999 8899999999999999999999999999987653
Q ss_pred CCCcccccccccCCCccCccccc---cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhh
Q 046270 423 EGHSHLTTRVAGTFGYLAPEYAL---YGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIF 499 (590)
Q Consensus 423 ~~~~~~~~~~~gt~~Y~APE~~~---~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 499 (590)
... .......|+..|+|||++. .+.++.++|||||||++|||++|+.|+........ +. ............
T Consensus 158 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~-~~----~~~~~~~~~~~~ 231 (267)
T cd06645 158 ATI-AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA-LF----LMTKSNFQPPKL 231 (267)
T ss_pred Ccc-cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh-HH----hhhccCCCCCcc
Confidence 321 2223456899999999874 45688999999999999999999999854332111 10 001111000000
Q ss_pred hHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 500 DEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 500 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
.. .....+.+.+++..|++.+|++||++++++++
T Consensus 232 ~~------~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 232 KD------KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred cc------cCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 00 00122356788999999999999999998863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=296.64 Aligned_cols=199 Identities=27% Similarity=0.436 Sum_probs=177.2
Q ss_pred cCCCccceecccCcEEEEEEEEcC-CcEEEEEEeecCCCC---ChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCce
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLRH-GNLVAVKQILDLDTK---GDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKR 339 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~vAvK~l~~~~~~---~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~ 339 (590)
++|.....||.|+||.|...+.+. |..+|+|++...... ..+...+|..+|+.+.||.+++|.+.+. +...
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~-----d~~~ 118 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFK-----DNSN 118 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeec-----cCCe
Confidence 357778899999999999999874 789999998654322 2445779999999999999999999887 4556
Q ss_pred EEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcc
Q 046270 340 RFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAK 419 (590)
Q Consensus 340 ~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~ 419 (590)
.+|||||+++|.|..+|. +.+.+++...+-++.+|+.||+||| ...|++|||||+|||||.+|.+||.|||+|+
T Consensus 119 lymvmeyv~GGElFS~Lr---k~~rF~e~~arFYAAeivlAleylH---~~~iiYRDLKPENiLlD~~G~iKitDFGFAK 192 (355)
T KOG0616|consen 119 LYMVMEYVPGGELFSYLR---KSGRFSEPHARFYAAEIVLALEYLH---SLDIIYRDLKPENLLLDQNGHIKITDFGFAK 192 (355)
T ss_pred EEEEEeccCCccHHHHHH---hcCCCCchhHHHHHHHHHHHHHHHH---hcCeeeccCChHHeeeccCCcEEEEeccceE
Confidence 999999999999999995 5668999999999999999999999 9999999999999999999999999999999
Q ss_pred cccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 046270 420 QSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTS 477 (590)
Q Consensus 420 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~ 477 (590)
..... +...+||+.|+|||.+....+...+|.|+|||++|||+.|..||.....
T Consensus 193 ~v~~r----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~ 246 (355)
T KOG0616|consen 193 RVSGR----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP 246 (355)
T ss_pred EecCc----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh
Confidence 76442 5668899999999999999999999999999999999999999976544
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=310.97 Aligned_cols=264 Identities=27% Similarity=0.369 Sum_probs=199.9
Q ss_pred CCCccceecccCcEEEEEEEEcC-CcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEEEE
Q 046270 265 GFSQNNLIGQGASGIVYKGTLRH-GNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFLV 343 (590)
Q Consensus 265 ~f~~~~~LG~G~fG~Vykg~~~~-g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~LV 343 (590)
.|...+++|.|.||.||+|++.. +..||||+......- -.+|+++|+++.|||||+|+-++....+.+.-...||
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 45667899999999999999875 689999998654332 2369999999999999999999887765333456689
Q ss_pred EeeCCCCCcchhhhhh-cccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCC-CcEEEEeeCCcccc
Q 046270 344 YDYMPNGTLSDNISIS-HKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSE-LNAKVADFGLAKQS 421 (590)
Q Consensus 344 ~E~~~~gsL~~~L~~~-~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~-~~~kL~DFGla~~~ 421 (590)
|||||. +|.+.+... ..+..++...+.-+..||.+||+||| ..+|+||||||.|+|+|.+ +.+||+|||.|+..
T Consensus 101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh---~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLH---SHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHH---hcCcccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 999986 787777531 23567888889999999999999999 8999999999999999987 99999999999988
Q ss_pred cCCCcccccccccCCCccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhc--------
Q 046270 422 LEGHSHLTTRVAGTFGYLAPEYALY-GQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKS-------- 492 (590)
Q Consensus 422 ~~~~~~~~~~~~gt~~Y~APE~~~~-~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~-------- 492 (590)
..+..... ..-|..|+|||.+.+ ..|+.+.||||.|||+.||+-|+..|...+. ...+.+....+-..
T Consensus 177 ~~~epniS--YicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~-~dQL~eIik~lG~Pt~e~I~~m 253 (364)
T KOG0658|consen 177 VKGEPNIS--YICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSS-VDQLVEIIKVLGTPTREDIKSM 253 (364)
T ss_pred ccCCCcee--EEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCH-HHHHHHHHHHhCCCCHHHHhhc
Confidence 77665432 334778999999875 5799999999999999999999988876433 33344333322110
Q ss_pred -CCchhhhhHHHhhh-----hHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 493 -GKVDDIFDEFIRAE-----GARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 493 -~~~~~~~d~~l~~~-----~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
....+.-.+.+... .......+.+++...+++.+|.+|.+..|++.+
T Consensus 254 n~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 254 NPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred CcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 00011111111111 112234477889999999999999999998764
|
|
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=306.11 Aligned_cols=247 Identities=25% Similarity=0.368 Sum_probs=198.0
Q ss_pred CCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCC-CCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEEE
Q 046270 265 GFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLD-TKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFL 342 (590)
Q Consensus 265 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~-~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~L 342 (590)
.|+..+.||+|+||.||+|++. .+..||+|.+.... ......+.+|++++++++|+|++++++++.. +...++
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~l 79 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK-----GTKLWI 79 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE-----CCEEEE
Confidence 4666788999999999999986 47899999886432 2335678999999999999999999999874 456999
Q ss_pred EEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCccccc
Q 046270 343 VYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSL 422 (590)
Q Consensus 343 V~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~~ 422 (590)
||||+++|+|.+++. ...+++.+...++.+++.||.||| +.+++|+||+|+||+++.++.++|+|||++....
T Consensus 80 v~e~~~~~~L~~~i~----~~~l~~~~~~~~~~~l~~~l~~lh---~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~ 152 (277)
T cd06640 80 IMEYLGGGSALDLLR----AGPFDEFQIATMLKEILKGLDYLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLT 152 (277)
T ss_pred EEecCCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---hCCccCcCCChhhEEEcCCCCEEEcccccceecc
Confidence 999999999999884 246899999999999999999999 8999999999999999999999999999997654
Q ss_pred CCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhhhHH
Q 046270 423 EGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDEF 502 (590)
Q Consensus 423 ~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 502 (590)
... .......++..|+|||++.+..++.++||||||+++|||++|+.|+........ . .. ...+..
T Consensus 153 ~~~-~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~-~----~~-~~~~~~------- 218 (277)
T cd06640 153 DTQ-IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRV-L----FL-IPKNNP------- 218 (277)
T ss_pred CCc-cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhH-h----hh-hhcCCC-------
Confidence 332 222334678899999999888899999999999999999999999864332111 0 00 011111
Q ss_pred HhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 503 IRAEGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 503 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
..........+.+++..|++.+|++||++.+++..
T Consensus 219 --~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 219 --PTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred --CCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 11112234567789999999999999999999764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=302.41 Aligned_cols=256 Identities=25% Similarity=0.328 Sum_probs=202.5
Q ss_pred CCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCC--CCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEE
Q 046270 265 GFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLD--TKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRF 341 (590)
Q Consensus 265 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~--~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~ 341 (590)
+|...+.||.|+||.||++... +|..+|+|.+.... ....+.+.+|++++++++|+|++++++++... .+...+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---~~~~~~ 77 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDR---SNQTLY 77 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecC---CCCEEE
Confidence 4677789999999999999875 47889999886432 22345688999999999999999999987643 245689
Q ss_pred EEEeeCCCCCcchhhhhhc-ccccCChhhHHHHHHHHHHHHHHHHhcC--CCCeEecCCCCCceEECCCCcEEEEeeCCc
Q 046270 342 LVYDYMPNGTLSDNISISH-KRKQLTWPQRKKIIVDVAKGIAYLHYGL--KPGIYHRDIKSTNILLDSELNAKVADFGLA 418 (590)
Q Consensus 342 LV~E~~~~gsL~~~L~~~~-~~~~l~~~~r~~I~~~ia~gL~yLH~~~--~~~ivHrDIKp~NILLd~~~~~kL~DFGla 418 (590)
++|||+++++|.+++.... ....+++..++.++.+|+.||.|||... ..+++|+||||+||++++++.+||+|||++
T Consensus 78 ~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~ 157 (265)
T cd08217 78 IVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLA 157 (265)
T ss_pred EEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccc
Confidence 9999999999999985432 2457999999999999999999999543 678999999999999999999999999999
Q ss_pred ccccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhh
Q 046270 419 KQSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDI 498 (590)
Q Consensus 419 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 498 (590)
........ ......|+..|+|||.+....++.++||||||+++++|++|+.|+..... ..+.+. ...+....
T Consensus 158 ~~~~~~~~-~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~~~~~~----~~~~~~~~- 229 (265)
T cd08217 158 KILGHDSS-FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ--LQLASK----IKEGKFRR- 229 (265)
T ss_pred ccccCCcc-cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH--HHHHHH----HhcCCCCC-
Confidence 87644332 12335688999999999988999999999999999999999999875431 111111 11121111
Q ss_pred hhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 499 FDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 499 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
.+......+.+++..|++.+|++||++.+|+++
T Consensus 230 --------~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 230 --------IPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred --------CccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 111233577889999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=323.07 Aligned_cols=260 Identities=21% Similarity=0.263 Sum_probs=194.6
Q ss_pred hcCCCccceecccCcEEEEEEEEcC---CcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCce
Q 046270 263 TNGFSQNNLIGQGASGIVYKGTLRH---GNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKR 339 (590)
Q Consensus 263 t~~f~~~~~LG~G~fG~Vykg~~~~---g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~ 339 (590)
..+|...+.||+|+||.||++...+ +..||+|.+... ..+.+|++++++++|+||+++++++.. ...
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~-----~~~ 160 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRW-----KST 160 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEee-----CCE
Confidence 3578899999999999999997643 567999987542 345689999999999999999998863 446
Q ss_pred EEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcc
Q 046270 340 RFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAK 419 (590)
Q Consensus 340 ~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~ 419 (590)
.++|||++. ++|.+++. ....++|.+++.|+.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++
T Consensus 161 ~~lv~e~~~-~~l~~~l~---~~~~l~~~~~~~i~~ql~~aL~~LH---~~givHrDlkp~Nill~~~~~~~l~DfG~a~ 233 (392)
T PHA03207 161 VCMVMPKYK-CDLFTYVD---RSGPLPLEQAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAAC 233 (392)
T ss_pred EEEEehhcC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEccCcccc
Confidence 899999995 67877773 3457999999999999999999999 8999999999999999999999999999997
Q ss_pred cccCCCcc-cccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCch--hhhhHHHHHHHhc----
Q 046270 420 QSLEGHSH-LTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPF--QLITDWAWVLAKS---- 492 (590)
Q Consensus 420 ~~~~~~~~-~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~--~~l~~~~~~~~~~---- 492 (590)
........ ......||..|+|||++....++.++|||||||++|||++|+.||....... ..+......+-..
T Consensus 234 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~ 313 (392)
T PHA03207 234 KLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEF 313 (392)
T ss_pred ccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCcccc
Confidence 65443222 2335679999999999999999999999999999999999999986543221 1111111110000
Q ss_pred --CCchhh---hhHH---Hhhhh-------HHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 493 --GKVDDI---FDEF---IRAEG-------ARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 493 --~~~~~~---~d~~---l~~~~-------~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
.....+ +... .+... .......+..++..|++.||++|||+.|++.+
T Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 314 PQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred CCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000000 0000 00000 00112356678889999999999999999875
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=311.59 Aligned_cols=279 Identities=23% Similarity=0.307 Sum_probs=205.1
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCC-CChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceE
Q 046270 263 TNGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDT-KGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRR 340 (590)
Q Consensus 263 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~-~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~ 340 (590)
+++|...++||+|+||.||+|+.. +|+.||+|++..... .....+.+|+.++++++|+||+++++++...........
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 468999999999999999999875 588999999864322 234568899999999999999999998876544344568
Q ss_pred EEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCccc
Q 046270 341 FLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQ 420 (590)
Q Consensus 341 ~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~ 420 (590)
++|+||+++ +|.+++. ...+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++.
T Consensus 84 ~lv~e~~~~-~l~~~~~----~~~l~~~~~~~i~~ql~~aL~~LH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~ 155 (336)
T cd07849 84 YIVQELMET-DLYKLIK----TQHLSNDHIQYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARI 155 (336)
T ss_pred EEEehhccc-CHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEECcccceee
Confidence 999999974 7766663 346999999999999999999999 89999999999999999999999999999986
Q ss_pred ccCCCcc--cccccccCCCccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCc--
Q 046270 421 SLEGHSH--LTTRVAGTFGYLAPEYALY-GQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKV-- 495 (590)
Q Consensus 421 ~~~~~~~--~~~~~~gt~~Y~APE~~~~-~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~-- 495 (590)
....... ......|+..|+|||.+.+ ..++.++|||||||+++||++|+.||....... .+..+ .........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~-~~~~~-~~~~~~~~~~~ 233 (336)
T cd07849 156 ADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLH-QLNLI-LGVLGTPSQED 233 (336)
T ss_pred ccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHH-HHHcCCCCHHH
Confidence 5432221 1233568899999998754 568999999999999999999999986432211 11111 111111100
Q ss_pred -hhhhhHHHh--------------hhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH--hccCCCCCCCCC
Q 046270 496 -DDIFDEFIR--------------AEGARAVMERFVLVGILCAHVMVALRPTITDALKM--LEGDIDIPKLPD 551 (590)
Q Consensus 496 -~~~~d~~l~--------------~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~--L~~~~~~~~~p~ 551 (590)
....+.... ..........+.+++..|++.+|++|||+.|+++. ++........|.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~~~~~~ 306 (336)
T cd07849 234 LNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDPSDEPV 306 (336)
T ss_pred HHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCCCCccc
Confidence 000000000 00001123467889999999999999999999986 655544433333
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=301.20 Aligned_cols=251 Identities=24% Similarity=0.333 Sum_probs=201.0
Q ss_pred CCCccceecccCcEEEEEEEEc-CCcEEEEEEeecC--CCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEE
Q 046270 265 GFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDL--DTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRF 341 (590)
Q Consensus 265 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~--~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~ 341 (590)
+|+..+.||+|+||.||.++.. ++..+++|++... ......++.+|++++++++|+||+++++++.. ....+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~~~~ 75 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMD-----DNTLL 75 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEec-----CCeEE
Confidence 4778899999999999999875 4788999987543 33445678999999999999999999999974 45689
Q ss_pred EEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccc
Q 046270 342 LVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQS 421 (590)
Q Consensus 342 LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~ 421 (590)
++|||+++|+|.+++... ....+++.++..++.|+++||.||| +.+++||||||+||++++++.+||+|||+++..
T Consensus 76 ~~~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~ 151 (256)
T cd08221 76 IEMEYANGGTLYDKIVRQ-KGQLFEEEMVLWYLFQIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKIL 151 (256)
T ss_pred EEEEecCCCcHHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChHhEEEeCCCCEEECcCcceEEc
Confidence 999999999999988532 2346899999999999999999999 889999999999999999999999999999865
Q ss_pred cCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhhhH
Q 046270 422 LEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDE 501 (590)
Q Consensus 422 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 501 (590)
..... ......|+..|+|||++.+..++.++||||||++++||++|+.|+...... +..... ..+......
T Consensus 152 ~~~~~-~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~-----~~~~~~-~~~~~~~~~-- 222 (256)
T cd08221 152 GSEYS-MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL-----NLVVKI-VQGNYTPVV-- 222 (256)
T ss_pred ccccc-cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHH-----HHHHHH-HcCCCCCCc--
Confidence 44332 233456889999999998888999999999999999999999998643221 111111 112211111
Q ss_pred HHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHh
Q 046270 502 FIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKML 540 (590)
Q Consensus 502 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L 540 (590)
......+..++..|++.+|.+||++.++++.+
T Consensus 223 -------~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 223 -------SVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred -------cccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 12234677888999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=314.45 Aligned_cols=252 Identities=23% Similarity=0.311 Sum_probs=198.8
Q ss_pred HHhcCCCccceecccCcEEEEEEEEcC-CcEEEEEEeecCCC---CChHHHHHHHHHHHhcCCCCccccceeEEeccCCC
Q 046270 261 QATNGFSQNNLIGQGASGIVYKGTLRH-GNLVAVKQILDLDT---KGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSS 336 (590)
Q Consensus 261 ~at~~f~~~~~LG~G~fG~Vykg~~~~-g~~vAvK~l~~~~~---~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~ 336 (590)
...++|.....||+|+||+||.++-++ |..+|+|++++... ...+.++.|-.+|....+++||+|+-.+. +
T Consensus 138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQ-----D 212 (550)
T KOG0605|consen 138 LSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQ-----D 212 (550)
T ss_pred CCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEec-----C
Confidence 355789999999999999999998775 88999999976433 23456889999999999999999998887 4
Q ss_pred CceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeC
Q 046270 337 GKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFG 416 (590)
Q Consensus 337 ~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFG 416 (590)
...+||||||+|||++..+|. +.+.|++.....++.+++-||.-|| +.|+|||||||+|+|||..|.+||+|||
T Consensus 213 ~~~LYLiMEylPGGD~mTLL~---~~~~L~e~~arfYiaE~vlAI~~iH---~~gyIHRDIKPdNlLiD~~GHiKLSDFG 286 (550)
T KOG0605|consen 213 KEYLYLIMEYLPGGDMMTLLM---RKDTLTEDWARFYIAETVLAIESIH---QLGYIHRDIKPDNLLIDAKGHIKLSDFG 286 (550)
T ss_pred CCeeEEEEEecCCccHHHHHH---hcCcCchHHHHHHHHHHHHHHHHHH---HcCcccccCChhheeecCCCCEeecccc
Confidence 557999999999999999985 5568999999999999999999999 9999999999999999999999999999
Q ss_pred CcccccCC----------------------Ccc-----cc-------------------cccccCCCccCccccccCCCC
Q 046270 417 LAKQSLEG----------------------HSH-----LT-------------------TRVAGTFGYLAPEYALYGQLT 450 (590)
Q Consensus 417 la~~~~~~----------------------~~~-----~~-------------------~~~~gt~~Y~APE~~~~~~~t 450 (590)
|+...... ... .. ....||+.|||||++.+..|+
T Consensus 287 Ls~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~ 366 (550)
T KOG0605|consen 287 LSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYG 366 (550)
T ss_pred ccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCC
Confidence 98532110 000 00 014699999999999999999
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCCchh--hhhHHHHHHHhcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCC
Q 046270 451 EKSDVYSFGIVILELMSGRKVLDTSTSPFQ--LITDWAWVLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVA 528 (590)
Q Consensus 451 ~ksDVySfGvvLlELltG~~p~~~~~~~~~--~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~ 528 (590)
..+|.||+|||+|||+.|-+||........ .+..|...+....... ...+..+++..|+. ||+
T Consensus 367 ~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~--------------~s~eA~DLI~rll~-d~~ 431 (550)
T KOG0605|consen 367 KECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVD--------------LSDEAKDLITRLLC-DPE 431 (550)
T ss_pred ccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCc--------------ccHHHHHHHHHHhc-CHH
Confidence 999999999999999999999987655433 4555543332211110 01244555666666 999
Q ss_pred CCCC---HHHHHH
Q 046270 529 LRPT---ITDALK 538 (590)
Q Consensus 529 ~RPt---m~eVl~ 538 (590)
+|-- +.||-+
T Consensus 432 ~RLG~~G~~EIK~ 444 (550)
T KOG0605|consen 432 NRLGSKGAEEIKK 444 (550)
T ss_pred HhcCcccHHHHhc
Confidence 9975 555543
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=304.45 Aligned_cols=252 Identities=22% Similarity=0.354 Sum_probs=185.2
Q ss_pred eecccCcEEEEEEEEcCCc---EEEEEEeecCC-CCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEEEEEee
Q 046270 271 LIGQGASGIVYKGTLRHGN---LVAVKQILDLD-TKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFLVYDY 346 (590)
Q Consensus 271 ~LG~G~fG~Vykg~~~~g~---~vAvK~l~~~~-~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~LV~E~ 346 (590)
.||+|+||.||+|...++. .+++|.+.... ....+.|.+|+++++.++||||+++++++.. ....++||||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~-----~~~~~lv~e~ 76 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVE-----AIPYLLVFEY 76 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecC-----CCccEEEEec
Confidence 5999999999999865433 46677665433 2345679999999999999999999999874 3458999999
Q ss_pred CCCCCcchhhhhhcc-cccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccccCCC
Q 046270 347 MPNGTLSDNISISHK-RKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGH 425 (590)
Q Consensus 347 ~~~gsL~~~L~~~~~-~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~~~~~ 425 (590)
+++|+|.+++..... ...+++..+..++.||++||+||| +.+++||||||+|||++.++.+||+|||++.......
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~ 153 (268)
T cd05086 77 CELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKED 153 (268)
T ss_pred CCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCeeccCCccceEEEcCCccEEecccccccccCcch
Confidence 999999999864322 234677788899999999999999 8999999999999999999999999999986432211
Q ss_pred -cccccccccCCCccCcccccc-------CCCCcchhHHHHHHHHHHHHhC-CCCCCCCCCchhhhhHHHHHHHhcCCch
Q 046270 426 -SHLTTRVAGTFGYLAPEYALY-------GQLTEKSDVYSFGIVILELMSG-RKVLDTSTSPFQLITDWAWVLAKSGKVD 496 (590)
Q Consensus 426 -~~~~~~~~gt~~Y~APE~~~~-------~~~t~ksDVySfGvvLlELltG-~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 496 (590)
........++..|+|||++.. ..++.++||||||+++|||+++ ..|+..... ...+ ...... ...
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~-~~~~----~~~~~~-~~~ 227 (268)
T cd05086 154 YIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD-REVL----NHVIKD-QQV 227 (268)
T ss_pred hhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH-HHHH----HHHHhh-ccc
Confidence 112234567889999998753 2457899999999999999975 566653322 1111 111111 112
Q ss_pred hhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhc
Q 046270 497 DIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLE 541 (590)
Q Consensus 497 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~ 541 (590)
.+.++.+... ...++.+++..|+ .+|++||++.+|+++|.
T Consensus 228 ~~~~~~~~~~----~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 228 KLFKPQLELP----YSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred ccCCCccCCC----CcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 2223222211 2235666777888 67999999999999885
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=309.74 Aligned_cols=197 Identities=27% Similarity=0.433 Sum_probs=160.0
Q ss_pred ceecccCcEEEEEEEEcC---CcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEEEEEee
Q 046270 270 NLIGQGASGIVYKGTLRH---GNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFLVYDY 346 (590)
Q Consensus 270 ~~LG~G~fG~Vykg~~~~---g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~LV~E~ 346 (590)
.+||+|+||.||+|+..+ +..||+|.+.... ....+.+|++++++++||||+++++++... .+...++||||
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~---~~~~~~lv~e~ 81 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSH---SDRKVWLLFDY 81 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEecc---CCCeEEEEEee
Confidence 589999999999999764 4689999886432 234688999999999999999999988653 23568999999
Q ss_pred CCCCCcchhhhhhc------ccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEE----CCCCcEEEEeeC
Q 046270 347 MPNGTLSDNISISH------KRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILL----DSELNAKVADFG 416 (590)
Q Consensus 347 ~~~gsL~~~L~~~~------~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILL----d~~~~~kL~DFG 416 (590)
+++ +|.+++.... ....+++..+..|+.||+.||.||| +.+|+||||||+|||+ +.++.+||+|||
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG 157 (317)
T cd07867 82 AEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMG 157 (317)
T ss_pred eCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEccCCCCCCcEEEeecc
Confidence 875 6766663211 2235889999999999999999999 8999999999999999 556789999999
Q ss_pred CcccccCCCcc--cccccccCCCccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 046270 417 LAKQSLEGHSH--LTTRVAGTFGYLAPEYALY-GQLTEKSDVYSFGIVILELMSGRKVLDTS 475 (590)
Q Consensus 417 la~~~~~~~~~--~~~~~~gt~~Y~APE~~~~-~~~t~ksDVySfGvvLlELltG~~p~~~~ 475 (590)
+++........ ......||..|+|||.+.+ ..++.++|||||||++|||+||+.||...
T Consensus 158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred ceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 99865433221 1234568999999999876 45899999999999999999999998643
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=324.11 Aligned_cols=245 Identities=26% Similarity=0.403 Sum_probs=202.6
Q ss_pred ceecccCcEEEEEEEEcCCc-EEEEEEeecCCCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEEEEEeeCC
Q 046270 270 NLIGQGASGIVYKGTLRHGN-LVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFLVYDYMP 348 (590)
Q Consensus 270 ~~LG~G~fG~Vykg~~~~g~-~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~LV~E~~~ 348 (590)
-+||+|.||+||-|++.+.+ .+|||.+...+.+....+..|+.+-++|+|+|||+++|.+. +++..-+.||.+|
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~s-----enGf~kIFMEqVP 655 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVS-----ENGFFKIFMEQVP 655 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccC-----CCCeEEEEeecCC
Confidence 36999999999999988755 69999998777777778999999999999999999999976 4567889999999
Q ss_pred CCCcchhhhhhcccccC--ChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEC-CCCcEEEEeeCCcccccCCC
Q 046270 349 NGTLSDNISISHKRKQL--TWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLD-SELNAKVADFGLAKQSLEGH 425 (590)
Q Consensus 349 ~gsL~~~L~~~~~~~~l--~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd-~~~~~kL~DFGla~~~~~~~ 425 (590)
||+|.++|. .+-++| .+...-.+.+||++||.||| +..|||||||-.|||++ -.|.+||+|||-+++.- +.
T Consensus 656 GGSLSsLLr--skWGPlKDNEstm~fYtkQILeGLkYLH---en~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLA-gi 729 (1226)
T KOG4279|consen 656 GGSLSSLLR--SKWGPLKDNESTMNFYTKQILEGLKYLH---ENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLA-GI 729 (1226)
T ss_pred CCcHHHHHH--hccCCCccchhHHHHHHHHHHHHhhhhh---hcceeeccccCCcEEEeeccceEEecccccchhhc-cC
Confidence 999999985 234566 67778888999999999999 89999999999999996 46899999999998753 34
Q ss_pred cccccccccCCCccCccccccCC--CCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhhhHHH
Q 046270 426 SHLTTRVAGTFGYLAPEYALYGQ--LTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDEFI 503 (590)
Q Consensus 426 ~~~~~~~~gt~~Y~APE~~~~~~--~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 503 (590)
...+..+.||..|||||++..|+ |...+|||||||++.||.|||+||....+++... ++-|- + ..
T Consensus 730 nP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAM-------FkVGm----y--Kv 796 (1226)
T KOG4279|consen 730 NPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAM-------FKVGM----Y--KV 796 (1226)
T ss_pred CccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhh-------hhhcc----e--ec
Confidence 55667788999999999998774 8889999999999999999999997655544311 11110 0 01
Q ss_pred hhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 046270 504 RAEGARAVMERFVLVGILCAHVMVALRPTITDALK 538 (590)
Q Consensus 504 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~ 538 (590)
....+++...+...+++.|..++|.+||++.++++
T Consensus 797 HP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 797 HPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred CCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 12234556668888999999999999999999886
|
|
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=304.48 Aligned_cols=253 Identities=25% Similarity=0.340 Sum_probs=195.6
Q ss_pred CCCccceecccCcEEEEEEEEc-CCcEEEEEEeecC-CCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEEE
Q 046270 265 GFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDL-DTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFL 342 (590)
Q Consensus 265 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~-~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~L 342 (590)
+|+..+.||+|+||.||++..+ .|..+|+|.+... .......+.+|++++.+++|+||+++++++.. ....++
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~~l 76 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFI-----EGAVYM 76 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheec-----CCeEEE
Confidence 5677889999999999999987 5889999988643 22234578899999999999999999998874 456899
Q ss_pred EEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCccccc
Q 046270 343 VYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSL 422 (590)
Q Consensus 343 V~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~~ 422 (590)
||||+++++|..++........+++..+..++.+++.||.|||+ +.+|+||||||+||+++.++.+||+|||++....
T Consensus 77 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 154 (286)
T cd06622 77 CMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLV 154 (286)
T ss_pred EEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh--cCCEeeCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 99999999998888543223479999999999999999999993 3589999999999999999999999999987553
Q ss_pred CCCcccccccccCCCccCccccccCC------CCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCch
Q 046270 423 EGHSHLTTRVAGTFGYLAPEYALYGQ------LTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVD 496 (590)
Q Consensus 423 ~~~~~~~~~~~gt~~Y~APE~~~~~~------~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 496 (590)
.. ......++..|+|||.+.... ++.++|||||||++|||++|+.||....... ..... . ....+...
T Consensus 155 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~~-~-~~~~~~~~ 228 (286)
T cd06622 155 AS---LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN-IFAQL-S-AIVDGDPP 228 (286)
T ss_pred CC---ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh-HHHHH-H-HHhhcCCC
Confidence 22 223345788999999886443 5889999999999999999999986432211 11100 0 00111111
Q ss_pred hhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 497 DIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 497 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
. .+.+....+..++..|++.+|++||++.+++..
T Consensus 229 ~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 229 T---------LPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred C---------CCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 1 111234467788899999999999999999863
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=301.51 Aligned_cols=257 Identities=27% Similarity=0.396 Sum_probs=201.9
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCC-CCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEE
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLD-TKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRF 341 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~-~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~ 341 (590)
++|+..+.||.|+||.||+|... ++..+++|++.... ......+.+|+++++.++|+|++++++.+.. +...+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~ 75 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVV-----GDELW 75 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEee-----CCEEE
Confidence 46888899999999999999975 47789999985432 2345679999999999999999999998863 45689
Q ss_pred EEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccc
Q 046270 342 LVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQS 421 (590)
Q Consensus 342 LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~ 421 (590)
+|+||+++++|.+++........+++.....++.|++.||+||| +.+|+||||||+||++++++.+||+|||++...
T Consensus 76 iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh---~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~ 152 (267)
T cd06610 76 LVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH---SNGQIHRDIKAGNILLGEDGSVKIADFGVSASL 152 (267)
T ss_pred EEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccchHHHh
Confidence 99999999999999864333356899999999999999999999 899999999999999999999999999998766
Q ss_pred cCCCcc---cccccccCCCccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchh
Q 046270 422 LEGHSH---LTTRVAGTFGYLAPEYALYG-QLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDD 497 (590)
Q Consensus 422 ~~~~~~---~~~~~~gt~~Y~APE~~~~~-~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 497 (590)
...... ......|+..|+|||++... .++.++||||||++++||++|+.|+....... ....+. .... .
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~-~~~~~~----~~~~-~- 225 (267)
T cd06610 153 ADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK-VLMLTL----QNDP-P- 225 (267)
T ss_pred ccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh-hHHHHh----cCCC-C-
Confidence 543222 22345688999999998877 78999999999999999999999986543321 111111 1100 0
Q ss_pred hhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 046270 498 IFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALK 538 (590)
Q Consensus 498 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~ 538 (590)
.+... .........+.+++..|++.||++||++.++++
T Consensus 226 ~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 226 SLETG---ADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred CcCCc---cccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 00000 001123456788999999999999999999986
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=308.02 Aligned_cols=254 Identities=26% Similarity=0.415 Sum_probs=198.5
Q ss_pred cCCCccceecccCcEEEEEEEEcC-Cc----EEEEEEeecCCC-CChHHHHHHHHHHHhcCCCCccccceeEEeccCCCC
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLRH-GN----LVAVKQILDLDT-KGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSG 337 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~~-g~----~vAvK~l~~~~~-~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~ 337 (590)
++|...+.||+|+||.||+|.+++ |. .+|+|.+..... ....++.+|++++++++|+|++++++++..
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------ 80 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS------ 80 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec------
Confidence 456777899999999999998753 33 589998765433 234678899999999999999999999874
Q ss_pred ceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCC
Q 046270 338 KRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGL 417 (590)
Q Consensus 338 ~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGl 417 (590)
...++||||+++|+|.+++.. ....+++..++.++.||+.||+||| +.+|+||||||+||++++++.+||+|||+
T Consensus 81 ~~~~~v~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kL~dfg~ 155 (279)
T cd05057 81 SQVQLITQLMPLGCLLDYVRN--HKDNIGSQYLLNWCVQIAKGMSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGL 155 (279)
T ss_pred CceEEEEecCCCCcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecccCcceEEEcCCCeEEECCCcc
Confidence 358999999999999999853 2345999999999999999999999 89999999999999999999999999999
Q ss_pred cccccCCCccc-ccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhhHHHHHHHhcCCc
Q 046270 418 AKQSLEGHSHL-TTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLDTSTSPFQLITDWAWVLAKSGKV 495 (590)
Q Consensus 418 a~~~~~~~~~~-~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~ 495 (590)
++......... .....++..|+|||.+..+.++.++||||||++++||++ |+.|++..... .+.+. . ..+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~~---~-~~~~~ 229 (279)
T cd05057 156 AKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV--EIPDL---L-EKGER 229 (279)
T ss_pred cccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH--HHHHH---H-hCCCC
Confidence 98765333221 112223568999999988899999999999999999999 99998653221 11111 1 11110
Q ss_pred hhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhccC
Q 046270 496 DDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEGD 543 (590)
Q Consensus 496 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~~ 543 (590)
.. .+......+..++..|+..+|++||++.++++.|+..
T Consensus 230 ~~---------~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~ 268 (279)
T cd05057 230 LP---------QPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKM 268 (279)
T ss_pred CC---------CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 00 0001123567788899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=302.73 Aligned_cols=261 Identities=24% Similarity=0.314 Sum_probs=198.2
Q ss_pred CCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCC--CCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEE
Q 046270 265 GFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLD--TKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRF 341 (590)
Q Consensus 265 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~--~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~ 341 (590)
+|...+.||+|+||.||+|++. +|..||+|++.... ....+.+.+|++++++++|+|++++++++.. +...+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~~ 75 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPH-----GSGFV 75 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEec-----CCeeE
Confidence 4677889999999999999986 58899999986543 2235679999999999999999999999874 45689
Q ss_pred EEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccc
Q 046270 342 LVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQS 421 (590)
Q Consensus 342 LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~ 421 (590)
+||||+ +++|.+++... ...+++.+++.++.||++||+||| +.+++|+||||+||+++.++.++|+|||++...
T Consensus 76 ~v~e~~-~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~ 149 (286)
T cd07832 76 LVMEYM-PSDLSEVLRDE--ERPLPEAQVKSYMRMLLKGVAYMH---ANGIMHRDLKPANLLISADGVLKIADFGLARLF 149 (286)
T ss_pred EEeccc-CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCHHHEEEcCCCcEEEeeeeecccc
Confidence 999999 99999988532 356999999999999999999999 899999999999999999999999999999866
Q ss_pred cCCCcccccccccCCCccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCC------
Q 046270 422 LEGHSHLTTRVAGTFGYLAPEYALYG-QLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGK------ 494 (590)
Q Consensus 422 ~~~~~~~~~~~~gt~~Y~APE~~~~~-~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~------ 494 (590)
............|+..|+|||.+... .++.++||||+|++++||++|+.++...... ..+. +.........
T Consensus 150 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~-~~~~-~~~~~~~~~~~~~~~~ 227 (286)
T cd07832 150 SEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDI-EQLA-IVFRTLGTPNEETWPG 227 (286)
T ss_pred cCCCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHH-HHHH-HHHHHcCCCChHHHhh
Confidence 54332223345688999999988654 4689999999999999999997777543321 1111 1111000000
Q ss_pred chhhhh--H---------HHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 495 VDDIFD--E---------FIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 495 ~~~~~d--~---------~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
..++.+ . .+. ....+....+.+++..|++.+|++|||+++++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 228 LTSLPDYNKITFPESKPIPLE-EIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred ccCcchhhcccCCCCCcchHH-HhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000000 0 000 0001223577889999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=308.60 Aligned_cols=261 Identities=25% Similarity=0.355 Sum_probs=202.1
Q ss_pred ceecccCcEEEEEEEEc-CCcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEEEEEeeCC
Q 046270 270 NLIGQGASGIVYKGTLR-HGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFLVYDYMP 348 (590)
Q Consensus 270 ~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~LV~E~~~ 348 (590)
..||+|+||.||++... +++.||+|.+........+.+.+|+.++..++|||++++++++.. +...++||||++
T Consensus 27 ~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~-----~~~~~iv~e~~~ 101 (297)
T cd06659 27 IKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLV-----GEELWVLMEFLQ 101 (297)
T ss_pred hhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheee-----CCeEEEEEecCC
Confidence 47999999999999876 588999999865555556778999999999999999999999874 456899999999
Q ss_pred CCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccccCCCccc
Q 046270 349 NGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHL 428 (590)
Q Consensus 349 ~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~~~~~~~~ 428 (590)
+++|.+++. ...+++..++.++.|++.||+||| +.+++||||||+||+++.++.+||+|||++....... ..
T Consensus 102 ~~~L~~~~~----~~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~-~~ 173 (297)
T cd06659 102 GGALTDIVS----QTRLNEEQIATVCESVLQALCYLH---SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-PK 173 (297)
T ss_pred CCCHHHHHh----hcCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHeEEccCCcEEEeechhHhhccccc-cc
Confidence 999998763 346899999999999999999999 8999999999999999999999999999987543322 12
Q ss_pred ccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhhhHHHhhhhH
Q 046270 429 TTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDEFIRAEGA 508 (590)
Q Consensus 429 ~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 508 (590)
.....|+..|+|||++.+..++.++||||||++++||++|+.||..... ...+. .. ..... .... ..
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~-~~~~~----~~-~~~~~-~~~~------~~ 240 (297)
T cd06659 174 RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSP-VQAMK----RL-RDSPP-PKLK------NA 240 (297)
T ss_pred ccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHH----HH-hccCC-CCcc------cc
Confidence 2335688999999999988999999999999999999999999864322 11111 11 11100 0000 00
Q ss_pred HHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhccCCCCCCCCCCCCCCcc
Q 046270 509 RAVMERFVLVGILCAHVMVALRPTITDALKMLEGDIDIPKLPDRPLPLSH 558 (590)
Q Consensus 509 ~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~~~~~~~~p~~p~~~~~ 558 (590)
......+.+++..|++.+|++||++.++++.- .......|+.+.++..
T Consensus 241 ~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~--~~~~~~~~~~~~~~~~ 288 (297)
T cd06659 241 HKISPVLRDFLERMLTREPQERATAQELLDHP--FLLQTGLPECLVPLIQ 288 (297)
T ss_pred CCCCHHHHHHHHHHhcCCcccCcCHHHHhhCh--hhccCCCcccccchHH
Confidence 11223567788899999999999999999842 1223445565555543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=308.30 Aligned_cols=245 Identities=25% Similarity=0.377 Sum_probs=194.0
Q ss_pred cceecccCcEEEEEEEEc-CCcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEEEEEeeC
Q 046270 269 NNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFLVYDYM 347 (590)
Q Consensus 269 ~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~LV~E~~ 347 (590)
...||+|+||.||++... ++..||||++........+.+.+|+.++++++|+|++++++.+. .+...++||||+
T Consensus 27 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~-----~~~~~~lv~e~~ 101 (292)
T cd06658 27 FIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL-----VGDELWVVMEFL 101 (292)
T ss_pred hhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHhee-----cCCeEEEEEeCC
Confidence 357999999999999876 47899999986555455667899999999999999999999987 345689999999
Q ss_pred CCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccccCCCcc
Q 046270 348 PNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSH 427 (590)
Q Consensus 348 ~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~~~~~~~ 427 (590)
++++|.+++. ...+++.++..++.+|+.||.||| ..+|+||||||+||++++++.+||+|||++........
T Consensus 102 ~~~~L~~~~~----~~~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~- 173 (292)
T cd06658 102 EGGALTDIVT----HTRMNEEQIATVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP- 173 (292)
T ss_pred CCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc-
Confidence 9999998873 345899999999999999999999 88999999999999999999999999999875433222
Q ss_pred cccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhhhHHHhhhh
Q 046270 428 LTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDEFIRAEG 507 (590)
Q Consensus 428 ~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 507 (590)
......|+..|+|||.+....++.++||||||++++||++|+.||...... ..+.. .... +.+.+..
T Consensus 174 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~-~~~~~-----~~~~-----~~~~~~~-- 240 (292)
T cd06658 174 KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL-QAMRR-----IRDN-----LPPRVKD-- 240 (292)
T ss_pred cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHH-----HHhc-----CCCcccc--
Confidence 223356889999999998889999999999999999999999998643221 11110 0000 0111100
Q ss_pred HHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 508 ARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 508 ~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
.......+..++..|++.+|++|||+.++++.
T Consensus 241 ~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 241 SHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 01122356677888999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=303.34 Aligned_cols=262 Identities=24% Similarity=0.295 Sum_probs=201.4
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCC-CChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEE
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDT-KGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRF 341 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~-~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~ 341 (590)
++|...+.||.|++|.||++.+. .++.+|+|.+..... .....+.+|++++++++|+||+++++++...+ +...+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~---~~~~~ 77 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDES---SSSIG 77 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccC---CCeEE
Confidence 46788899999999999999986 478899998864332 33567999999999999999999999986532 34689
Q ss_pred EEEeeCCCCCcchhhhhhc-ccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCccc
Q 046270 342 LVYDYMPNGTLSDNISISH-KRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQ 420 (590)
Q Consensus 342 LV~E~~~~gsL~~~L~~~~-~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~ 420 (590)
+||||+++++|.+++.... ....+++..+..|+.||+.||.||| ..+++|+||+|+||++++++.++|+|||++..
T Consensus 78 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~ 154 (287)
T cd06621 78 IAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGE 154 (287)
T ss_pred EEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecCCeEEEeecccccc
Confidence 9999999999998875322 3456899999999999999999999 89999999999999999999999999999875
Q ss_pred ccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhhh
Q 046270 421 SLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFD 500 (590)
Q Consensus 421 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 500 (590)
..... .....++..|+|||.+.+..++.++||||||+++|||++|+.|++....+.....++..... ...... +.
T Consensus 155 ~~~~~---~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~-~~ 229 (287)
T cd06621 155 LVNSL---AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIV-NMPNPE-LK 229 (287)
T ss_pred ccccc---cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHh-cCCchh-hc
Confidence 43221 12345788999999999899999999999999999999999999755321111111111111 111111 10
Q ss_pred HHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 046270 501 EFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALK 538 (590)
Q Consensus 501 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~ 538 (590)
.... ......+.+.+++..|++.+|.+|||+.|+++
T Consensus 230 ~~~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 230 DEPG--NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred cCCC--CCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 0000 00123457788999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=305.71 Aligned_cols=262 Identities=23% Similarity=0.254 Sum_probs=195.7
Q ss_pred CCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCCC-----ChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCc
Q 046270 265 GFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDTK-----GDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGK 338 (590)
Q Consensus 265 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~~-----~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~ 338 (590)
+|...+.||+|+||.||+|... +|+.||||++...... ....+.+|++++++++|+||+++++++.. +.
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~ 75 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGH-----KS 75 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeec-----CC
Confidence 4677789999999999999976 5889999998654322 23457789999999999999999999974 45
Q ss_pred eEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCc
Q 046270 339 RRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLA 418 (590)
Q Consensus 339 ~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla 418 (590)
..++||||+ +|+|.+++... ...+++..++.++.||++||.||| ..+|+||||||+||+++.++.+||+|||++
T Consensus 76 ~~~lv~e~~-~~~L~~~i~~~--~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~ 149 (298)
T cd07841 76 NINLVFEFM-ETDLEKVIKDK--SIVLTPADIKSYMLMTLRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLA 149 (298)
T ss_pred EEEEEEccc-CCCHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCChhhEEEcCCCCEEEccceee
Confidence 689999999 99999988532 236999999999999999999999 899999999999999999999999999999
Q ss_pred ccccCCCcccccccccCCCccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHH-------H
Q 046270 419 KQSLEGHSHLTTRVAGTFGYLAPEYALY-GQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVL-------A 490 (590)
Q Consensus 419 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~-------~ 490 (590)
+....... ......++..|+|||.+.+ ..++.++||||||++++||++|..++...... ..+....... +
T Consensus 150 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 227 (298)
T cd07841 150 RSFGSPNR-KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDI-DQLGKIFEALGTPTEENW 227 (298)
T ss_pred eeccCCCc-cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccH-HHHHHHHHHcCCCchhhh
Confidence 86543321 2233356788999998864 46789999999999999999997776543321 1111110000 0
Q ss_pred h-cCCchhhhhHHHh-----hhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 491 K-SGKVDDIFDEFIR-----AEGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 491 ~-~~~~~~~~d~~l~-----~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
. ............. ..........+.+++..|++.+|.+|||+.|++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 228 PGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred hhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 0 0000000000000 00011223577889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=321.70 Aligned_cols=202 Identities=25% Similarity=0.416 Sum_probs=172.3
Q ss_pred cCCCccceecccCcEEEEEEEEcC-CcEEEEEEeecCC---CCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCce
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLRH-GNLVAVKQILDLD---TKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKR 339 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~vAvK~l~~~~---~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~ 339 (590)
++|+..+.||+|+||.||+++..+ ++.||+|++.... ......+.+|++++.+++|+||+++++.+. .+..
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~-----~~~~ 75 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQ-----DKRN 75 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEE-----cCCE
Confidence 468888999999999999999864 7899999986432 223456889999999999999999999887 3456
Q ss_pred EEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcc
Q 046270 340 RFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAK 419 (590)
Q Consensus 340 ~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~ 419 (590)
.++||||+++|+|.+++. +...+++.....++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++
T Consensus 76 ~~lv~E~~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~~L~~lH---~~givHrDLkp~NIli~~~~~vkL~DfG~~~ 149 (360)
T cd05627 76 LYLIMEFLPGGDMMTLLM---KKDTLSEEATQFYIAETVLAIDAIH---QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCT 149 (360)
T ss_pred EEEEEeCCCCccHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEeeccCCc
Confidence 999999999999999885 3456999999999999999999999 8999999999999999999999999999987
Q ss_pred cccCCCc----------------------------------ccccccccCCCccCccccccCCCCcchhHHHHHHHHHHH
Q 046270 420 QSLEGHS----------------------------------HLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILEL 465 (590)
Q Consensus 420 ~~~~~~~----------------------------------~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlEL 465 (590)
....... .......||+.|+|||++.+..++.++|||||||++|||
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel 229 (360)
T cd05627 150 GLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEM 229 (360)
T ss_pred ccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeec
Confidence 5432110 011235689999999999999999999999999999999
Q ss_pred HhCCCCCCCCC
Q 046270 466 MSGRKVLDTST 476 (590)
Q Consensus 466 ltG~~p~~~~~ 476 (590)
++|+.||....
T Consensus 230 ~tG~~Pf~~~~ 240 (360)
T cd05627 230 LIGYPPFCSET 240 (360)
T ss_pred ccCCCCCCCCC
Confidence 99999997543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=312.93 Aligned_cols=255 Identities=20% Similarity=0.282 Sum_probs=189.8
Q ss_pred cceeccc--CcEEEEEEEEc-CCcEEEEEEeecCCC--CChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEEEE
Q 046270 269 NNLIGQG--ASGIVYKGTLR-HGNLVAVKQILDLDT--KGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFLV 343 (590)
Q Consensus 269 ~~~LG~G--~fG~Vykg~~~-~g~~vAvK~l~~~~~--~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~LV 343 (590)
.++||+| +||+||+++.+ +|+.||+|++..... ...+.+.+|+++++.++||||+++++++.. +...++|
T Consensus 3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~-----~~~~~lv 77 (327)
T cd08227 3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIA-----DNELWVV 77 (327)
T ss_pred hhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEE-----CCEEEEE
Confidence 4689999 78999999886 588999999864322 223467789999999999999999999974 3468999
Q ss_pred EeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccccC
Q 046270 344 YDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLE 423 (590)
Q Consensus 344 ~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~~~ 423 (590)
|||+++|+|.+++... ....+++..++.++.|++.||.||| +.+|+||||||+|||++.++.+++.||+.......
T Consensus 78 ~e~~~~~~l~~~~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~ 153 (327)
T cd08227 78 TSFMAYGSAKDLICTH-FMDGMSELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMIN 153 (327)
T ss_pred EeccCCCcHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCChhhEEEecCCcEEEcccchhhcccc
Confidence 9999999999988532 2345899999999999999999999 89999999999999999999999999986543321
Q ss_pred CCcc------cccccccCCCccCcccccc--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCc
Q 046270 424 GHSH------LTTRVAGTFGYLAPEYALY--GQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKV 495 (590)
Q Consensus 424 ~~~~------~~~~~~gt~~Y~APE~~~~--~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~ 495 (590)
.... ......++..|+|||++.. ..++.++|||||||++|||++|+.||............ ..+..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~------~~~~~ 227 (327)
T cd08227 154 HGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEK------LNGTV 227 (327)
T ss_pred ccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHH------hcCCc
Confidence 1100 0112346778999999875 45899999999999999999999999753332211110 00111
Q ss_pred hhhhhHH-------------------H-----------------hhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 046270 496 DDIFDEF-------------------I-----------------RAEGARAVMERFVLVGILCAHVMVALRPTITDALK 538 (590)
Q Consensus 496 ~~~~d~~-------------------l-----------------~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~ 538 (590)
...++.. + ...........+.+++..|++.||++|||+.|+++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 228 PCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred cccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence 1000000 0 00011123346788999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=301.42 Aligned_cols=260 Identities=26% Similarity=0.382 Sum_probs=203.7
Q ss_pred HHhcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCCCChHHHHHHHHHHHhc-CCCCccccceeEEeccC-CCC
Q 046270 261 QATNGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDTKGDEDFTNEVEIISKI-RHRNLLSLRGCCVTSDD-SSG 337 (590)
Q Consensus 261 ~at~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l-~H~nlv~l~g~~~~~~~-~~~ 337 (590)
.++++|...+.||+|+||.||+|..+ +++.+++|.+.... ...+++.+|+++++++ +|+|++++++++..... ..+
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE-DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc-hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 46789999999999999999999986 47789999876543 3456799999999999 79999999999986543 245
Q ss_pred ceEEEEEeeCCCCCcchhhhhhc-ccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeC
Q 046270 338 KRRFLVYDYMPNGTLSDNISISH-KRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFG 416 (590)
Q Consensus 338 ~~~~LV~E~~~~gsL~~~L~~~~-~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFG 416 (590)
...++||||+++++|.+++.... ....+++..+..++.|++.||.||| +.+++|+||+|+||++++++.+||+|||
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~~l~p~ni~~~~~~~~~l~d~~ 158 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFG 158 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEEccCCeEEECCCc
Confidence 67899999999999999885432 2457999999999999999999999 8999999999999999999999999999
Q ss_pred CcccccCCCcccccccccCCCccCcccccc-----CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHh
Q 046270 417 LAKQSLEGHSHLTTRVAGTFGYLAPEYALY-----GQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAK 491 (590)
Q Consensus 417 la~~~~~~~~~~~~~~~gt~~Y~APE~~~~-----~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~ 491 (590)
++....... .......|+..|+|||++.. ..++.++||||||++++||++|+.||....... .+... .
T Consensus 159 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~-----~ 231 (275)
T cd06608 159 VSAQLDSTL-GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR-ALFKI-----P 231 (275)
T ss_pred cceecccch-hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH-HHHHh-----h
Confidence 987543322 12233458899999998753 346789999999999999999999986432211 11111 1
Q ss_pred cCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 046270 492 SGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALK 538 (590)
Q Consensus 492 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~ 538 (590)
.+...... ......+.+.+++..|+..||++|||+.++++
T Consensus 232 ~~~~~~~~-------~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 232 RNPPPTLK-------SPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred ccCCCCCC-------chhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 11111111 11123457788999999999999999999986
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=303.49 Aligned_cols=254 Identities=24% Similarity=0.383 Sum_probs=194.9
Q ss_pred CCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCC---C-------ChHHHHHHHHHHHhcCCCCccccceeEEecc
Q 046270 265 GFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDT---K-------GDEDFTNEVEIISKIRHRNLLSLRGCCVTSD 333 (590)
Q Consensus 265 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~---~-------~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~ 333 (590)
+|...+.||+|+||.||+|... +|+.+|+|.+..... . ..+.+.+|++++++++|+|++++++++..
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-- 79 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETT-- 79 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEecc--
Confidence 3566789999999999999875 588999998753211 1 12357889999999999999999999873
Q ss_pred CCCCceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEE
Q 046270 334 DSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVA 413 (590)
Q Consensus 334 ~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~ 413 (590)
+...++||||+++++|.+++.. ...+++..+..++.||+.||.||| +.+++||||||+||+++.++.+||+
T Consensus 80 ---~~~~~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~~~nil~~~~~~~~l~ 150 (272)
T cd06629 80 ---EEYLSIFLEYVPGGSIGSCLRT---YGRFEEQLVRFFTEQVLEGLAYLH---SKGILHRDLKADNLLVDADGICKIS 150 (272)
T ss_pred ---CCceEEEEecCCCCcHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHh---hCCeeecCCChhhEEEcCCCeEEEe
Confidence 4568999999999999998853 357999999999999999999999 8899999999999999999999999
Q ss_pred eeCCcccccCCCcc-cccccccCCCccCccccccCC--CCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHH
Q 046270 414 DFGLAKQSLEGHSH-LTTRVAGTFGYLAPEYALYGQ--LTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLA 490 (590)
Q Consensus 414 DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~~~~~~--~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~ 490 (590)
|||+++........ ......|+..|+|||.+.... ++.++||||||+++||+++|+.|+........ + ....
T Consensus 151 d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~----~-~~~~ 225 (272)
T cd06629 151 DFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAA----M-FKLG 225 (272)
T ss_pred eccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHH----H-HHhh
Confidence 99999865432211 123456789999999987654 88999999999999999999999854322111 1 1111
Q ss_pred hcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 491 KSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 491 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
.. .....+++.. ..+....+.+++..|++.+|++|||+.+|++.
T Consensus 226 ~~-~~~~~~~~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 226 NK-RSAPPIPPDV----SMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred cc-ccCCcCCccc----cccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 11 1111111111 11233567778899999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=308.89 Aligned_cols=261 Identities=22% Similarity=0.320 Sum_probs=194.1
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCC-CCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEE
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLD-TKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRF 341 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~-~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~ 341 (590)
++|...+.||+|+||.||+|+.+ .+..||+|.+.... ......+.+|++++++++|+||+++++++.. ....+
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~-----~~~~~ 80 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHT-----EKSLT 80 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEec-----CCeEE
Confidence 46788899999999999999886 47889999986433 2334567899999999999999999999873 45689
Q ss_pred EEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccc
Q 046270 342 LVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQS 421 (590)
Q Consensus 342 LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~ 421 (590)
+||||++ ++|.+++.. ....+++..+..++.||+.||.||| +.+|+||||||+||++++++.+||+|||+++..
T Consensus 81 lv~e~~~-~~l~~~l~~--~~~~~~~~~~~~~~~qi~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~ 154 (301)
T cd07873 81 LVFEYLD-KDLKQYLDD--CGNSINMHNVKLFLFQLLRGLNYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAK 154 (301)
T ss_pred EEEeccc-cCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHHHEEECCCCcEEECcCcchhcc
Confidence 9999997 588887753 2346899999999999999999999 899999999999999999999999999999754
Q ss_pred cCCCcccccccccCCCccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHH----------HHHHH
Q 046270 422 LEGHSHLTTRVAGTFGYLAPEYALY-GQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDW----------AWVLA 490 (590)
Q Consensus 422 ~~~~~~~~~~~~gt~~Y~APE~~~~-~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~----------~~~~~ 490 (590)
..... ......++..|+|||.+.+ ..++.++||||||+++|||+||+.||........ +... .|...
T Consensus 155 ~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 232 (301)
T cd07873 155 SIPTK-TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQ-LHFIFRILGTPTEETWPGI 232 (301)
T ss_pred CCCCC-cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHcCCCChhhchhh
Confidence 32221 1223456889999998765 4578899999999999999999999865432211 1000 00000
Q ss_pred hcC-Cc-----hhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 046270 491 KSG-KV-----DDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALK 538 (590)
Q Consensus 491 ~~~-~~-----~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~ 538 (590)
... .. .......+. .........+.+++..|++.||.+|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 233 LSNEEFKSYNYPKYRADCLH-NHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred hccccccccccCccccccHH-hhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 000 00 000000000 000112345678999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=297.63 Aligned_cols=251 Identities=27% Similarity=0.448 Sum_probs=197.9
Q ss_pred CCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCCC--ChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEE
Q 046270 265 GFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDTK--GDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRF 341 (590)
Q Consensus 265 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~~--~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~ 341 (590)
+|...+.||+|+||.||+|+.. +++.|++|.+...... ..+.+.+|++++++++|+||+++++++. .....+
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~-----~~~~~~ 75 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEV-----HREKVY 75 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEe-----cCCEEE
Confidence 4677889999999999999876 5789999998755443 4567999999999999999999999876 345689
Q ss_pred EEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccc
Q 046270 342 LVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQS 421 (590)
Q Consensus 342 LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~ 421 (590)
+|+||+++++|.+++. ....+++..+..|+.++++||.||| +.+|+|+||+|+||++++++.+||+|||++...
T Consensus 76 lv~e~~~~~~L~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~ 149 (264)
T cd06626 76 IFMEYCSGGTLEELLE---HGRILDEHVIRVYTLQLLEGLAYLH---SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKL 149 (264)
T ss_pred EEEecCCCCcHHHHHh---hcCCCChHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccccccccc
Confidence 9999999999999885 3345899999999999999999999 899999999999999999999999999998876
Q ss_pred cCCCcccc---cccccCCCccCccccccCC---CCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCc
Q 046270 422 LEGHSHLT---TRVAGTFGYLAPEYALYGQ---LTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKV 495 (590)
Q Consensus 422 ~~~~~~~~---~~~~gt~~Y~APE~~~~~~---~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~ 495 (590)
........ ....++..|+|||++.... ++.++||||||++++|+++|+.||.......... ... ..+..
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~----~~~-~~~~~ 224 (264)
T cd06626 150 KNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIM----FHV-GAGHK 224 (264)
T ss_pred CCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHH----HHH-hcCCC
Confidence 44332221 1356788999999998766 8899999999999999999999996543221111 000 00110
Q ss_pred hhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 046270 496 DDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALK 538 (590)
Q Consensus 496 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~ 538 (590)
.. +.. .......+.+++..|++.+|.+|||+.+++.
T Consensus 225 ~~-~~~------~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 225 PP-IPD------SLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred CC-CCc------ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00 100 0112345677889999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=307.47 Aligned_cols=255 Identities=22% Similarity=0.278 Sum_probs=198.5
Q ss_pred cCCCccceecccCcEEEEEEEEcC-CcEEEEEEeecCCC---CChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCce
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLRH-GNLVAVKQILDLDT---KGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKR 339 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~vAvK~l~~~~~---~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~ 339 (590)
++|...+.||+|+||.||++.... ++.|++|.+..... .....+.+|+++++.++|+||+++++.+. .+..
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~ 75 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFE-----TKRH 75 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEe-----cCCE
Confidence 468888999999999999999874 67899998865432 22456889999999999999999999886 3456
Q ss_pred EEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcc
Q 046270 340 RFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAK 419 (590)
Q Consensus 340 ~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~ 419 (590)
.++||||+++++|.+++. ....+++..+..++.+++.||.||| +.+++||||||+||+++.++.+||+|||+++
T Consensus 76 ~~lv~e~~~g~~L~~~l~---~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~ 149 (305)
T cd05609 76 LCMVMEYVEGGDCATLLK---NIGALPVDMARMYFAETVLALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSK 149 (305)
T ss_pred EEEEEecCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHEEECCCCCEEEeeCCCcc
Confidence 899999999999999985 3356899999999999999999999 8999999999999999999999999999987
Q ss_pred cccCCC--------------cccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHH
Q 046270 420 QSLEGH--------------SHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDW 485 (590)
Q Consensus 420 ~~~~~~--------------~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~ 485 (590)
...... ........|+..|+|||++....++.++||||||+++|||++|+.||..... ...+.
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~-~~~~~-- 226 (305)
T cd05609 150 IGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP-EELFG-- 226 (305)
T ss_pred ccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHH--
Confidence 421110 0111234578899999999988999999999999999999999999864321 11111
Q ss_pred HHHHHhcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhcc
Q 046270 486 AWVLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEG 542 (590)
Q Consensus 486 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~ 542 (590)
.... +... .+. ........+..++..|++.+|++||++.++.++|+.
T Consensus 227 --~~~~-~~~~---~~~----~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 227 --QVIS-DDIE---WPE----GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred --HHHh-cccC---CCC----ccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 1111 1000 000 000123467789999999999999998877777765
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=304.26 Aligned_cols=262 Identities=19% Similarity=0.250 Sum_probs=192.8
Q ss_pred CCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCC--CCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEE
Q 046270 265 GFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLD--TKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRF 341 (590)
Q Consensus 265 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~--~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~ 341 (590)
+|...+.||+|+||.||+|+.. .|..+|+|++.... ......+.+|++++++++|+|++++++++.. ....+
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~-----~~~~~ 75 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHS-----DKKLT 75 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhcc-----CCceE
Confidence 4677889999999999999986 58899999986432 2223567889999999999999999999873 45689
Q ss_pred EEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccc
Q 046270 342 LVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQS 421 (590)
Q Consensus 342 LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~ 421 (590)
+|+||++ ++|.+++.. ....+++..++.++.||++||.||| ..+|+||||||+||+++.++++||+|||+++..
T Consensus 76 lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~ 149 (284)
T cd07839 76 LVFEYCD-QDLKKYFDS--CNGDIDPEIVKSFMFQLLKGLAFCH---SHNVLHRDLKPQNLLINKNGELKLADFGLARAF 149 (284)
T ss_pred EEEecCC-CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEcCCCcEEECccchhhcc
Confidence 9999997 577776642 2356999999999999999999999 899999999999999999999999999999865
Q ss_pred cCCCcccccccccCCCccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHH----------HHHHH
Q 046270 422 LEGHSHLTTRVAGTFGYLAPEYALYG-QLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDW----------AWVLA 490 (590)
Q Consensus 422 ~~~~~~~~~~~~gt~~Y~APE~~~~~-~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~----------~~~~~ 490 (590)
..... ......++..|+|||.+.+. .++.++||||||+++|||+||+.|+.........+... .|...
T Consensus 150 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (284)
T cd07839 150 GIPVR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGV 228 (284)
T ss_pred CCCCC-CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHh
Confidence 33221 12334568899999988764 47899999999999999999998865433322211100 00000
Q ss_pred hc-CCc--hhhhhHHHh-hhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 046270 491 KS-GKV--DDIFDEFIR-AEGARAVMERFVLVGILCAHVMVALRPTITDALK 538 (590)
Q Consensus 491 ~~-~~~--~~~~d~~l~-~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~ 538 (590)
.. ... ......... ..........+.+++..|++.||.+|||+.++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 229 SKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred hhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 00 000 000000000 0001123346778999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=298.93 Aligned_cols=250 Identities=22% Similarity=0.311 Sum_probs=198.5
Q ss_pred CCCccceecccCcEEEEEEEEc-CCcEEEEEEeecC--CCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEE
Q 046270 265 GFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDL--DTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRF 341 (590)
Q Consensus 265 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~--~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~ 341 (590)
+|+..++||+|+||.||+++.. +|+.+|+|++... .....+++.+|++++++++|+||+++++++. .....+
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~ 75 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFE-----ENGNLY 75 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeec-----CCCeEE
Confidence 4778899999999999999876 5789999998643 2233457899999999999999999999886 345799
Q ss_pred EEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccc
Q 046270 342 LVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQS 421 (590)
Q Consensus 342 LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~ 421 (590)
+||||+++++|.+++... ....+++.+++.++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++...
T Consensus 76 lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~ 151 (256)
T cd08218 76 IVMDYCEGGDLYKKINAQ-RGVLFPEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVL 151 (256)
T ss_pred EEEecCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEEeeccceeec
Confidence 999999999999988532 2235899999999999999999999 899999999999999999999999999999765
Q ss_pred cCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhhhH
Q 046270 422 LEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDE 501 (590)
Q Consensus 422 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 501 (590)
..... ......|+..|+|||++.++.++.++||||||++++||++|+.|+...... +...... .+....
T Consensus 152 ~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~-----~~~~~~~-~~~~~~---- 220 (256)
T cd08218 152 NSTVE-LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMK-----NLVLKII-RGSYPP---- 220 (256)
T ss_pred Ccchh-hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHH-----HHHHHHh-cCCCCC----
Confidence 43221 223345788999999999889999999999999999999999998643211 1111111 111111
Q ss_pred HHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 502 FIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 502 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
.+......+.+++..|++.+|.+||+|.+|++.
T Consensus 221 -----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 221 -----VSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred -----CcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 111223467788899999999999999999873
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=302.13 Aligned_cols=252 Identities=25% Similarity=0.322 Sum_probs=193.1
Q ss_pred cCCCccceecccCcEEEEEEEEcC-CcEEEEEEeecCCC-----CChHHHHHHHHHHHhcCCCCccccceeEEeccCCCC
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLRH-GNLVAVKQILDLDT-----KGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSG 337 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~vAvK~l~~~~~-----~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~ 337 (590)
.+|...+.||+|+||.||+|...+ |..||+|.+..... ...+.+.+|++++++++|+||+++++++.+.. .
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~---~ 78 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPM---E 78 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCC---C
Confidence 468888999999999999999864 88999998753221 12346888999999999999999999875432 3
Q ss_pred ceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCC
Q 046270 338 KRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGL 417 (590)
Q Consensus 338 ~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGl 417 (590)
...++||||+++++|.+++. ....+++...++++.+++.||.||| +.+|+|+||||+||+++.++.+||+|||+
T Consensus 79 ~~~~~v~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~Dfg~ 152 (265)
T cd06652 79 RTLSIFMEHMPGGSIKDQLK---SYGALTENVTRKYTRQILEGVSYLH---SNMIVHRDIKGANILRDSVGNVKLGDFGA 152 (265)
T ss_pred ceEEEEEEecCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEecCCCCEEECcCcc
Confidence 45889999999999999885 3346889999999999999999999 88999999999999999999999999999
Q ss_pred cccccCCCc--ccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCc
Q 046270 418 AKQSLEGHS--HLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKV 495 (590)
Q Consensus 418 a~~~~~~~~--~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~ 495 (590)
++....... .......|+..|+|||.+.+..++.++||||||+++|||++|+.||........ +. . ......
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~-~~---~-~~~~~~- 226 (265)
T cd06652 153 SKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAA-IF---K-IATQPT- 226 (265)
T ss_pred ccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHH-HH---H-HhcCCC-
Confidence 875432111 112335688999999999888899999999999999999999999864322111 11 0 111110
Q ss_pred hhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 496 DDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 496 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
.. ..+......+..++..|+ .+|++||+++|+++.
T Consensus 227 ~~--------~~~~~~~~~~~~~i~~~l-~~p~~Rp~~~~il~~ 261 (265)
T cd06652 227 NP--------VLPPHVSDHCRDFLKRIF-VEAKLRPSADELLRH 261 (265)
T ss_pred CC--------CCchhhCHHHHHHHHHHh-cChhhCCCHHHHhcC
Confidence 00 011222335556666777 489999999999863
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=302.71 Aligned_cols=260 Identities=23% Similarity=0.318 Sum_probs=194.6
Q ss_pred CCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCC--CCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEE
Q 046270 265 GFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLD--TKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRF 341 (590)
Q Consensus 265 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~--~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~ 341 (590)
+|+..+.||+|+||.||+|+.. +|..||||++.... ......+.+|++++++++||||+++++++.. +...+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~~ 75 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT-----ENKLY 75 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhccc-----CCcEE
Confidence 5788899999999999999886 58899999885432 2223578899999999999999999999863 45689
Q ss_pred EEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccc
Q 046270 342 LVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQS 421 (590)
Q Consensus 342 LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~ 421 (590)
+||||+. ++|.+++... ....+++..+..++.|++.||+||| ..+++||||+|+||++++++.+||+|||+++..
T Consensus 76 ~v~e~~~-~~l~~~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lh---~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~ 150 (284)
T cd07860 76 LVFEFLH-QDLKKFMDAS-PLSGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAF 150 (284)
T ss_pred EEeeccc-cCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEeeccchhhc
Confidence 9999995 6888877532 2356899999999999999999999 899999999999999999999999999998765
Q ss_pred cCCCcccccccccCCCccCccccccCC-CCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhhh
Q 046270 422 LEGHSHLTTRVAGTFGYLAPEYALYGQ-LTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFD 500 (590)
Q Consensus 422 ~~~~~~~~~~~~gt~~Y~APE~~~~~~-~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 500 (590)
..... ......++..|+|||.+.+.. ++.++||||||+++|||+||+.||........ +..... ..+...+.+.
T Consensus 151 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~-~~~~~~---~~~~~~~~~~ 225 (284)
T cd07860 151 GVPVR-TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ-LFRIFR---TLGTPDEVVW 225 (284)
T ss_pred ccCcc-ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH-HHHHHH---HhCCCChhhh
Confidence 33221 122334678999999887644 68899999999999999999999865433221 111111 0011111110
Q ss_pred HHHh-----------------hhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 501 EFIR-----------------AEGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 501 ~~l~-----------------~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
+... ..........+.+++..|++.||.+|||++++++.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 226 PGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred hhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 0000 00001122456788999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=297.78 Aligned_cols=249 Identities=25% Similarity=0.367 Sum_probs=196.9
Q ss_pred CCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCC--CCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEE
Q 046270 265 GFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLD--TKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRF 341 (590)
Q Consensus 265 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~--~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~ 341 (590)
+|...+.||+|+||.||++... .++.+|+|.+.... ......+.+|++++++++|+|++++++.+. .+...+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~~ 75 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFL-----EDKALM 75 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEe-----cCCEEE
Confidence 4778899999999999999875 47789999986432 233567899999999999999999999876 345689
Q ss_pred EEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCC-CcEEEEeeCCccc
Q 046270 342 LVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSE-LNAKVADFGLAKQ 420 (590)
Q Consensus 342 LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~-~~~kL~DFGla~~ 420 (590)
+||||+++++|.+++... ....+++..+.+++.++++||.||| +.+++|+||||+||+++++ +.+||+|||++..
T Consensus 76 lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~ 151 (256)
T cd08220 76 IVMEYAPGGTLAEYIQKR-CNSLLDEDTILHFFVQILLALHHVH---TKLILHRDLKTQNILLDKHKMVVKIGDFGISKI 151 (256)
T ss_pred EEEecCCCCCHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccCCCcee
Confidence 999999999999998532 2345899999999999999999999 8999999999999999865 4689999999986
Q ss_pred ccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhhh
Q 046270 421 SLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFD 500 (590)
Q Consensus 421 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 500 (590)
..... ......|+..|+|||.+....++.++||||||+++|||++|+.|+....... . ..... .+......
T Consensus 152 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~-~----~~~~~-~~~~~~~~- 222 (256)
T cd08220 152 LSSKS--KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA-L----VLKIM-SGTFAPIS- 222 (256)
T ss_pred cCCCc--cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHH-H----HHHHH-hcCCCCCC-
Confidence 54322 2233567889999999998889999999999999999999999986543211 1 11111 11111111
Q ss_pred HHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 501 EFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 501 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
......+..++..|++.+|++|||+.|++..
T Consensus 223 --------~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 223 --------DRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred --------CCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 1123467788999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=308.73 Aligned_cols=254 Identities=25% Similarity=0.342 Sum_probs=198.6
Q ss_pred HhcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCC--------------CChHHHHHHHHHHHhcCCCCccccc
Q 046270 262 ATNGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDT--------------KGDEDFTNEVEIISKIRHRNLLSLR 326 (590)
Q Consensus 262 at~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~--------------~~~~~f~~Ev~il~~l~H~nlv~l~ 326 (590)
.-+.|.....||+|.||.|-+|... +++.||||++.+... ...+...+|+.+|++++|+|||+|+
T Consensus 95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li 174 (576)
T KOG0585|consen 95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI 174 (576)
T ss_pred ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence 3467888899999999999999876 588999999843211 1134688999999999999999999
Q ss_pred eeEEeccCCCCceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECC
Q 046270 327 GCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDS 406 (590)
Q Consensus 327 g~~~~~~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~ 406 (590)
.+..+. +....|||+||+..|.+...= .....|+..+.++++.++..||+||| ..+||||||||+|+||++
T Consensus 175 EvLDDP---~s~~~YlVley~s~G~v~w~p---~d~~els~~~Ar~ylrDvv~GLEYLH---~QgiiHRDIKPsNLLl~~ 245 (576)
T KOG0585|consen 175 EVLDDP---ESDKLYLVLEYCSKGEVKWCP---PDKPELSEQQARKYLRDVVLGLEYLH---YQGIIHRDIKPSNLLLSS 245 (576)
T ss_pred EeecCc---ccCceEEEEEeccCCccccCC---CCcccccHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEEcC
Confidence 876543 456799999999998875432 12233999999999999999999999 899999999999999999
Q ss_pred CCcEEEEeeCCcccccCCC----cccccccccCCCccCccccccCC----CCcchhHHHHHHHHHHHHhCCCCCCCCCCc
Q 046270 407 ELNAKVADFGLAKQSLEGH----SHLTTRVAGTFGYLAPEYALYGQ----LTEKSDVYSFGIVILELMSGRKVLDTSTSP 478 (590)
Q Consensus 407 ~~~~kL~DFGla~~~~~~~----~~~~~~~~gt~~Y~APE~~~~~~----~t~ksDVySfGvvLlELltG~~p~~~~~~~ 478 (590)
++.+||+|||.+.....+. .....+..||+.|+|||....+. .+.+.||||+||+||-|+.|+-||-....
T Consensus 246 ~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~- 324 (576)
T KOG0585|consen 246 DGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE- 324 (576)
T ss_pred CCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH-
Confidence 9999999999998663321 12234578999999999988643 34688999999999999999999854221
Q ss_pred hhhhhHHHHHHHhcCCchhhhhHHHhhh----hHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhcc
Q 046270 479 FQLITDWAWVLAKSGKVDDIFDEFIRAE----GARAVMERFVLVGILCAHVMVALRPTITDALKMLEG 542 (590)
Q Consensus 479 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~----~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~ 542 (590)
.+++|+.+... ...++-+++.+++..+++.||+.|-+..+|....--
T Consensus 325 -----------------~~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwv 375 (576)
T KOG0585|consen 325 -----------------LELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWV 375 (576)
T ss_pred -----------------HHHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheeccee
Confidence 12222222110 111345677889999999999999999999887643
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=300.71 Aligned_cols=263 Identities=26% Similarity=0.340 Sum_probs=197.6
Q ss_pred CCccceecccCcEEEEEEEEcC-CcEEEEEEeecCC--CCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEEE
Q 046270 266 FSQNNLIGQGASGIVYKGTLRH-GNLVAVKQILDLD--TKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFL 342 (590)
Q Consensus 266 f~~~~~LG~G~fG~Vykg~~~~-g~~vAvK~l~~~~--~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~L 342 (590)
|...+.||+|+||.||+|+..+ |..+|+|++.... ......+.+|++++++++|+|++++++++...+ +...++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---~~~~~l 77 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKG---KGSIYM 77 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCC---CCcEEE
Confidence 4567889999999999999874 7899999997653 233457889999999999999999999987531 356999
Q ss_pred EEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCccccc
Q 046270 343 VYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSL 422 (590)
Q Consensus 343 V~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~~ 422 (590)
||||+++ +|.+++.. ....+++..++.++.||++||+||| ..+++|+||||+||++++++.+||+|||++....
T Consensus 78 v~e~~~~-~l~~~~~~--~~~~~~~~~~~~i~~~i~~al~~LH---~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~ 151 (287)
T cd07840 78 VFEYMDH-DLTGLLDS--PEVKFTESQIKCYMKQLLEGLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYT 151 (287)
T ss_pred Eeccccc-cHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEEcCCCCEEEccccceeecc
Confidence 9999975 88877742 2247999999999999999999999 8899999999999999999999999999998665
Q ss_pred CCCcccccccccCCCccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHH------------
Q 046270 423 EGHSHLTTRVAGTFGYLAPEYALY-GQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVL------------ 489 (590)
Q Consensus 423 ~~~~~~~~~~~gt~~Y~APE~~~~-~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~------------ 489 (590)
.......+...++..|+|||.+.+ ..++.++||||||+++|||++|+.|+........ +.......
T Consensus 152 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 230 (287)
T cd07840 152 KRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQ-LEKIFELCGSPTDENWPGVS 230 (287)
T ss_pred CCCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCchhhccccc
Confidence 443222334456789999998764 4679999999999999999999999875443221 11000000
Q ss_pred ----HhcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 046270 490 ----AKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALK 538 (590)
Q Consensus 490 ----~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~ 538 (590)
+............+.+.........+.+++..|++.+|.+||+++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 231 KLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred cchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 0000001111111111111112457889999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=322.77 Aligned_cols=246 Identities=26% Similarity=0.409 Sum_probs=203.2
Q ss_pred CCCccceecccCcEEEEEEEEcC-CcEEEEEEeecC---CCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceE
Q 046270 265 GFSQNNLIGQGASGIVYKGTLRH-GNLVAVKQILDL---DTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRR 340 (590)
Q Consensus 265 ~f~~~~~LG~G~fG~Vykg~~~~-g~~vAvK~l~~~---~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~ 340 (590)
-|...+.||.|+-|.|-.|++.. |+.+|||.+... .......+.+|+-+|+-+.|||+++|++.+. +..++
T Consensus 13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe-----~~~~l 87 (786)
T KOG0588|consen 13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWE-----NKQHL 87 (786)
T ss_pred ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeec-----cCceE
Confidence 35667889999999999999864 999999998654 2222456889999999999999999999987 56679
Q ss_pred EEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCccc
Q 046270 341 FLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQ 420 (590)
Q Consensus 341 ~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~ 420 (590)
|||.||+++|-|.++|- .++.|++.+..+++.||..|+.|.| ..+|+|||+||+|+|||.++++||+|||+|..
T Consensus 88 ylvlEyv~gGELFdylv---~kG~l~e~eaa~ff~QIi~gv~yCH---~~~icHRDLKpENlLLd~~~nIKIADFGMAsL 161 (786)
T KOG0588|consen 88 YLVLEYVPGGELFDYLV---RKGPLPEREAAHFFRQILDGVSYCH---AFNICHRDLKPENLLLDVKNNIKIADFGMASL 161 (786)
T ss_pred EEEEEecCCchhHHHHH---hhCCCCCHHHHHHHHHHHHHHHHHh---hhcceeccCCchhhhhhcccCEeeeccceeec
Confidence 99999999999999984 5678999999999999999999999 89999999999999999999999999999986
Q ss_pred ccCCCcccccccccCCCccCccccccCCCC-cchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhh
Q 046270 421 SLEGHSHLTTRVAGTFGYLAPEYALYGQLT-EKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIF 499 (590)
Q Consensus 421 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t-~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 499 (590)
-.++. ....-+|.+.|.+||++++.+|. .++||||.||||+.|+||+.||++..-.. ++. .++.|..+
T Consensus 162 e~~gk--lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~-LLl-----KV~~G~f~--- 230 (786)
T KOG0588|consen 162 EVPGK--LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRV-LLL-----KVQRGVFE--- 230 (786)
T ss_pred ccCCc--cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHH-HHH-----HHHcCccc---
Confidence 54433 44556899999999999998884 69999999999999999999998432211 111 12223211
Q ss_pred hHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 500 DEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 500 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
.+..+..+..+++..|+..||+.|-|++||+++
T Consensus 231 -------MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 231 -------MPSNISSEAQDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred -------CCCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence 122334467778889999999999999999985
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=303.92 Aligned_cols=259 Identities=24% Similarity=0.356 Sum_probs=198.1
Q ss_pred CCccceecccCcEEEEEEEEc----CCcEEEEEEeecCC--CCChHHHHHHHHHHHhcCCCCccccceeEEeccCC-CCc
Q 046270 266 FSQNNLIGQGASGIVYKGTLR----HGNLVAVKQILDLD--TKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDS-SGK 338 (590)
Q Consensus 266 f~~~~~LG~G~fG~Vykg~~~----~g~~vAvK~l~~~~--~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~-~~~ 338 (590)
|...+.||+|+||.||+|.+. .+..||||++.... ....+++.+|++++++++|||++++++++...... ...
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 456678999999999999864 25789999886432 22355788999999999999999999988754321 112
Q ss_pred eEEEEEeeCCCCCcchhhhhhc---ccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEee
Q 046270 339 RRFLVYDYMPNGTLSDNISISH---KRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADF 415 (590)
Q Consensus 339 ~~~LV~E~~~~gsL~~~L~~~~---~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DF 415 (590)
..++++||+++|+|.+++.... ....+++...++++.||+.||+||| +.+|+||||||+||++++++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccchhhEEEcCCCCEEECcc
Confidence 3578999999999998875332 1235889999999999999999999 889999999999999999999999999
Q ss_pred CCcccccCCCcc-cccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhhHHHHHHHhcC
Q 046270 416 GLAKQSLEGHSH-LTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLDTSTSPFQLITDWAWVLAKSG 493 (590)
Q Consensus 416 Gla~~~~~~~~~-~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~ 493 (590)
|+++........ ......++..|++||.+..+.++.++||||||+++|||++ |+.|+..... ..+..+.. ...
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~--~~~~~~~~---~~~ 232 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN--SEIYNYLI---KGN 232 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH--HHHHHHHH---cCC
Confidence 999865433221 1223345678999999988889999999999999999999 8888754322 11111111 111
Q ss_pred CchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhcc
Q 046270 494 KVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEG 542 (590)
Q Consensus 494 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~ 542 (590)
.... .......+.+++..|++.+|++||++.++++.|++
T Consensus 233 ~~~~----------~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~ 271 (273)
T cd05074 233 RLKQ----------PPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLEL 271 (273)
T ss_pred cCCC----------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 1100 01123478889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=298.78 Aligned_cols=251 Identities=24% Similarity=0.367 Sum_probs=203.3
Q ss_pred cCCCccceecccCcEEEEEEEEcC-CcEEEEEEeecCCC-CChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEE
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLRH-GNLVAVKQILDLDT-KGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRF 341 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~vAvK~l~~~~~-~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~ 341 (590)
++|...+.||+|++|.||+++..+ ++.|++|++..... ....++.+|++.+.+++|+|++++++++.. +...+
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~ 75 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYK-----EGEIS 75 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcc-----CCeEE
Confidence 367888999999999999999875 88999999866543 345689999999999999999999999874 45699
Q ss_pred EEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCC-CCeEecCCCCCceEECCCCcEEEEeeCCccc
Q 046270 342 LVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLK-PGIYHRDIKSTNILLDSELNAKVADFGLAKQ 420 (590)
Q Consensus 342 LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~-~~ivHrDIKp~NILLd~~~~~kL~DFGla~~ 420 (590)
+||||+++++|.+++.. ...+++..++.++.|+++||.||| . .+++||||+|+||+++.++.++|+|||++..
T Consensus 76 lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~~l~~~l~~lh---~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~ 149 (264)
T cd06623 76 IVLEYMDGGSLADLLKK---VGKIPEPVLAYIARQILKGLDYLH---TKRHIIHRDIKPSNLLINSKGEVKIADFGISKV 149 (264)
T ss_pred EEEEecCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHh---ccCCCccCCCCHHHEEECCCCCEEEccCcccee
Confidence 99999999999999853 357999999999999999999999 8 9999999999999999999999999999986
Q ss_pred ccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC-chhhhhHHHHHHHhcCCchhhh
Q 046270 421 SLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTS-PFQLITDWAWVLAKSGKVDDIF 499 (590)
Q Consensus 421 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~-~~~~l~~~~~~~~~~~~~~~~~ 499 (590)
....... .....++..|+|||.+..+.++.++||||||+++|||+||+.|+..... ....+..+. .. .... .+
T Consensus 150 ~~~~~~~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~---~~-~~~~-~~ 223 (264)
T cd06623 150 LENTLDQ-CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAI---CD-GPPP-SL 223 (264)
T ss_pred cccCCCc-ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHH---hc-CCCC-CC
Confidence 6443322 2345678899999999988999999999999999999999999875542 111111111 11 1110 01
Q ss_pred hHHHhhhhHHH-HHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 500 DEFIRAEGARA-VMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 500 d~~l~~~~~~~-~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
... ..+.+.+++..|++.+|++||++.+++++
T Consensus 224 --------~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 224 --------PAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred --------CcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 111 34578889999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=304.51 Aligned_cols=253 Identities=24% Similarity=0.318 Sum_probs=198.5
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEE
Q 046270 263 TNGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRF 341 (590)
Q Consensus 263 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~ 341 (590)
.++|...+.||+|+||.||+|.+. ++..+|+|.+........+.|.+|++++++++|+|++++++.+.. +...+
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~ 78 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFY-----ENKLW 78 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEec-----CCeEE
Confidence 356788889999999999999986 478999999876554556679999999999999999999999873 44689
Q ss_pred EEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccc
Q 046270 342 LVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQS 421 (590)
Q Consensus 342 LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~ 421 (590)
+||||+++++|.+++.. ....+++..+..++.|++.||.||| +.+|+|+||||+||+++.++.+||+|||++...
T Consensus 79 lv~e~~~~~~L~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~ 153 (280)
T cd06611 79 ILIEFCDGGALDSIMLE--LERGLTEPQIRYVCRQMLEALNFLH---SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKN 153 (280)
T ss_pred EEeeccCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEECCCCCEEEccCccchhh
Confidence 99999999999998853 2346999999999999999999999 899999999999999999999999999998754
Q ss_pred cCCCcccccccccCCCccCccccc-----cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCch
Q 046270 422 LEGHSHLTTRVAGTFGYLAPEYAL-----YGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVD 496 (590)
Q Consensus 422 ~~~~~~~~~~~~gt~~Y~APE~~~-----~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 496 (590)
..... ......|+..|+|||.+. ...++.++||||||+++|||++|+.|+....... .+..+ ..+...
T Consensus 154 ~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~-~~~~~-----~~~~~~ 226 (280)
T cd06611 154 KSTLQ-KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR-VLLKI-----LKSEPP 226 (280)
T ss_pred ccccc-ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH-HHHHH-----hcCCCC
Confidence 33221 223356889999999875 3446789999999999999999999986533211 11111 111110
Q ss_pred hhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 497 DIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 497 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
... .+......+.+++..|++.+|.+||++.++++.
T Consensus 227 ~~~-------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 227 TLD-------QPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred CcC-------CcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 000 011122356778889999999999999999764
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=305.09 Aligned_cols=265 Identities=25% Similarity=0.379 Sum_probs=204.9
Q ss_pred ccHHHHHHHhcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCCCChHHHHHHHHHHHhc-CCCCccccceeEEe
Q 046270 254 FHVSELEQATNGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDTKGDEDFTNEVEIISKI-RHRNLLSLRGCCVT 331 (590)
Q Consensus 254 f~~~el~~at~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l-~H~nlv~l~g~~~~ 331 (590)
.++.++..+.+.|+..+.||+|+||.||+|++. .++.+|+|.+.... ....++..|+.++.++ +|+|++++++++..
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 84 (282)
T cd06636 6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIK 84 (282)
T ss_pred hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence 356677778889999999999999999999985 47889999875432 3346788999999999 79999999999865
Q ss_pred ccC-CCCceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcE
Q 046270 332 SDD-SSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNA 410 (590)
Q Consensus 332 ~~~-~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~ 410 (590)
... ..+...+++|||+++|+|.+++... ....+++..+..++.||+.||.||| ..+|+|+||||+||++++++.+
T Consensus 85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dl~~~nili~~~~~~ 160 (282)
T cd06636 85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNT-KGNALKEDWIAYICREILRGLAHLH---AHKVIHRDIKGQNVLLTENAEV 160 (282)
T ss_pred ccccCCCCEEEEEEEeCCCCcHHHHHHHc-cCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCE
Confidence 432 1356789999999999999988532 2345889999999999999999999 8999999999999999999999
Q ss_pred EEEeeCCcccccCCCcccccccccCCCccCccccc-----cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHH
Q 046270 411 KVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYAL-----YGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDW 485 (590)
Q Consensus 411 kL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~-----~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~ 485 (590)
+|+|||++........ ......|+..|+|||.+. ...++.++||||||+++|||++|+.||...........
T Consensus 161 ~l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~-- 237 (282)
T cd06636 161 KLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFL-- 237 (282)
T ss_pred EEeeCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhh--
Confidence 9999999875432211 123356889999999876 34678899999999999999999999864332111100
Q ss_pred HHHHHhcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 046270 486 AWVLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALK 538 (590)
Q Consensus 486 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~ 538 (590)
... ..... + ........+.+++..|++.||.+|||+.|+++
T Consensus 238 ---~~~-~~~~~-----~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 238 ---IPR-NPPPK-----L---KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred ---Hhh-CCCCC-----C---cccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 000 00000 0 01123347788999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=300.97 Aligned_cols=264 Identities=22% Similarity=0.328 Sum_probs=194.7
Q ss_pred HhcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCCC-ChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCce
Q 046270 262 ATNGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDTK-GDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKR 339 (590)
Q Consensus 262 at~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~~-~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~ 339 (590)
++++|...+.||+|+||.||+|... +|..||+|++...... ....+.+|++++++++|+||+++.+++.. +..
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~-----~~~ 77 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHT-----KET 77 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEec-----CCe
Confidence 4578999999999999999999875 5889999998654322 23467899999999999999999999873 446
Q ss_pred EEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcc
Q 046270 340 RFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAK 419 (590)
Q Consensus 340 ~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~ 419 (590)
.++||||+. ++|.+++.. ....+++..+..++.||+.||.||| ..+|+|+||||+|||++.++++||+|||+++
T Consensus 78 ~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~ 151 (291)
T cd07870 78 LTFVFEYMH-TDLAQYMIQ--HPGGLHPYNVRLFMFQLLRGLAYIH---GQHILHRDLKPQNLLISYLGELKLADFGLAR 151 (291)
T ss_pred EEEEEeccc-CCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEEcCCCcEEEecccccc
Confidence 899999996 677666542 2346889999999999999999999 8899999999999999999999999999987
Q ss_pred cccCCCcccccccccCCCccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCC----
Q 046270 420 QSLEGHSHLTTRVAGTFGYLAPEYALYG-QLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGK---- 494 (590)
Q Consensus 420 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~---- 494 (590)
...... .......++..|+|||++.+. .++.++||||||+++|||++|+.||+........+.. .|.......
T Consensus 152 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~-~~~~~~~~~~~~~ 229 (291)
T cd07870 152 AKSIPS-QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEK-IWTVLGVPTEDTW 229 (291)
T ss_pred ccCCCC-CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHH-HHHHcCCCChhhh
Confidence 543221 112234568899999998754 5789999999999999999999999755443222221 111110000
Q ss_pred -----chhhhhHH--------Hhhh-hHHHHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 046270 495 -----VDDIFDEF--------IRAE-GARAVMERFVLVGILCAHVMVALRPTITDALK 538 (590)
Q Consensus 495 -----~~~~~d~~--------l~~~-~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~ 538 (590)
........ +... ........+.+++..|++.||.+|||+.|++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 230 PGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred hhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 00000000 0000 00001235667889999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=297.39 Aligned_cols=252 Identities=23% Similarity=0.383 Sum_probs=196.6
Q ss_pred CCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCCC------ChHHHHHHHHHHHhcCCCCccccceeEEeccCCCC
Q 046270 265 GFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDTK------GDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSG 337 (590)
Q Consensus 265 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~~------~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~ 337 (590)
+|+..+.||+|+||.||+|... +++.+|+|.+...... ..+.+.+|++++++++|+||+++++++. .+
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~ 75 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATC-----ED 75 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceec-----cC
Confidence 4777889999999999999874 5889999998643211 2457889999999999999999999987 34
Q ss_pred ceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCC-cEEEEeeC
Q 046270 338 KRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSEL-NAKVADFG 416 (590)
Q Consensus 338 ~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~-~~kL~DFG 416 (590)
...++||||+++++|.+++. ....+++..+..++.|++.||.||| +.+++|+||||+||+++.++ .+||+|||
T Consensus 76 ~~~~~v~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~ql~~al~~LH---~~~i~H~~i~~~nil~~~~~~~~~l~dfg 149 (268)
T cd06630 76 SHFNLFVEWMAGGSVSHLLS---KYGAFKEAVIINYTEQLLRGLSYLH---ENQIIHRDVKGANLLIDSTGQRLRIADFG 149 (268)
T ss_pred CeEEEEEeccCCCcHHHHHH---HhCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEcccc
Confidence 56899999999999999885 3346899999999999999999999 89999999999999998775 59999999
Q ss_pred CcccccCCCc---ccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcC
Q 046270 417 LAKQSLEGHS---HLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSG 493 (590)
Q Consensus 417 la~~~~~~~~---~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~ 493 (590)
++........ .......|+..|+|||.+....++.++||||+|++++||++|+.|+........ .. .........
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-~~-~~~~~~~~~ 227 (268)
T cd06630 150 AAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNH-LA-LIFKIASAT 227 (268)
T ss_pred cccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcch-HH-HHHHHhccC
Confidence 9876543211 112335678999999999888899999999999999999999999864332111 11 111110100
Q ss_pred CchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 046270 494 KVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALK 538 (590)
Q Consensus 494 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~ 538 (590)
.. ...+......+.+++..|++.+|++||++.++++
T Consensus 228 ~~---------~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 228 TA---------PSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred CC---------CCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 00 0111223346778999999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=292.46 Aligned_cols=250 Identities=29% Similarity=0.419 Sum_probs=201.5
Q ss_pred CCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEEEE
Q 046270 265 GFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFLV 343 (590)
Q Consensus 265 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~LV 343 (590)
.|+..+.||+|++|.||++... ++..+++|++..........+.+|++++++++|+|++++++++.. ....+++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~l~ 75 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLK-----KDELWIV 75 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEec-----CCeEEEE
Confidence 3677789999999999999986 588999999876555556789999999999999999999999874 3468999
Q ss_pred EeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccccC
Q 046270 344 YDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLE 423 (590)
Q Consensus 344 ~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~~~ 423 (590)
+||+++++|.+++... ...+++..+..++.+++.||.||| ..+++||||+|+||++++++.++|+|||.+.....
T Consensus 76 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 150 (253)
T cd05122 76 MEFCSGGSLKDLLKST--NQTLTESQIAYVCKELLKGLEYLH---SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSD 150 (253)
T ss_pred EecCCCCcHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHhh---cCCEecCCCCHHHEEEccCCeEEEeeccccccccc
Confidence 9999999999988532 257999999999999999999999 89999999999999999999999999999886654
Q ss_pred CCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhhhHHH
Q 046270 424 GHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDEFI 503 (590)
Q Consensus 424 ~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 503 (590)
... .....++..|++||++....++.++||||||++++||++|+.|+........... ... .......+.
T Consensus 151 ~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~-----~~~-~~~~~~~~~-- 220 (253)
T cd05122 151 TKA--RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFK-----IAT-NGPPGLRNP-- 220 (253)
T ss_pred ccc--ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHH-----HHh-cCCCCcCcc--
Confidence 332 3445688999999999988899999999999999999999999865432111110 000 111111111
Q ss_pred hhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 504 RAEGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 504 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
......+.+++..|++.||++|||+.++++.
T Consensus 221 -----~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 221 -----EKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred -----cccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1113467888999999999999999999863
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=301.89 Aligned_cols=251 Identities=24% Similarity=0.353 Sum_probs=191.9
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCC-CCChHHHHHHHHH-HHhcCCCCccccceeEEeccCCCCceE
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLD-TKGDEDFTNEVEI-ISKIRHRNLLSLRGCCVTSDDSSGKRR 340 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~-~~~~~~f~~Ev~i-l~~l~H~nlv~l~g~~~~~~~~~~~~~ 340 (590)
++|+..+.||+|+||.||+++.. +|..||+|++.... .....++..|+.. ++.++|+|++++++++.. +...
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~-----~~~~ 75 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFR-----EGDV 75 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEec-----CCcE
Confidence 46888899999999999999986 48899999986532 2234456667775 556689999999999873 3458
Q ss_pred EEEEeeCCCCCcchhhhhh-cccccCChhhHHHHHHHHHHHHHHHHhcCCC-CeEecCCCCCceEECCCCcEEEEeeCCc
Q 046270 341 FLVYDYMPNGTLSDNISIS-HKRKQLTWPQRKKIIVDVAKGIAYLHYGLKP-GIYHRDIKSTNILLDSELNAKVADFGLA 418 (590)
Q Consensus 341 ~LV~E~~~~gsL~~~L~~~-~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~-~ivHrDIKp~NILLd~~~~~kL~DFGla 418 (590)
++||||++ |+|.+++... .....+++..++.++.||+.||+||| +. +++||||||+||+++.++.+||+|||++
T Consensus 76 ~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~ 151 (283)
T cd06617 76 WICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLH---SKLSVIHRDVKPSNVLINRNGQVKLCDFGIS 151 (283)
T ss_pred EEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeecccc
Confidence 99999996 6888777532 23356899999999999999999999 65 8999999999999999999999999999
Q ss_pred ccccCCCcccccccccCCCccCcccccc----CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCC
Q 046270 419 KQSLEGHSHLTTRVAGTFGYLAPEYALY----GQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGK 494 (590)
Q Consensus 419 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~----~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~ 494 (590)
+...... ..+...|+..|+|||.+.. ..++.++|+||||+++|||++|+.|+.........+... .. +.
T Consensus 152 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~----~~-~~ 224 (283)
T cd06617 152 GYLVDSV--AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQV----VE-EP 224 (283)
T ss_pred ccccccc--ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHH----Hh-cC
Confidence 8653321 2233567889999998764 456889999999999999999999986433322222111 11 11
Q ss_pred chhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 046270 495 VDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALK 538 (590)
Q Consensus 495 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~ 538 (590)
..... .....+.+..++..|++.+|++||++.++++
T Consensus 225 ~~~~~--------~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 225 SPQLP--------AEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred CCCCC--------ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11100 1112346788999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=300.91 Aligned_cols=262 Identities=21% Similarity=0.320 Sum_probs=194.1
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCCC-ChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEE
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDTK-GDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRF 341 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~~-~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~ 341 (590)
++|...+.||+|+||.||+|+.+ +++.||+|.+...... ....+.+|++++++++|+||+++++++.. +...+
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~~ 79 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHT-----KKTLT 79 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEec-----CCeEE
Confidence 56888899999999999999986 5789999998653322 23457789999999999999999999873 45689
Q ss_pred EEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccc
Q 046270 342 LVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQS 421 (590)
Q Consensus 342 LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~ 421 (590)
+||||+++ +|.+++... ...+++.....++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++..
T Consensus 80 lv~e~~~~-~L~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 153 (291)
T cd07844 80 LVFEYLDT-DLKQYMDDC--GGGLSMHNVRLFLFQLLRGLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLARAK 153 (291)
T ss_pred EEEecCCC-CHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCHHHEEEcCCCCEEECcccccccc
Confidence 99999984 898877532 346899999999999999999999 899999999999999999999999999998754
Q ss_pred cCCCcccccccccCCCccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchh---
Q 046270 422 LEGHSHLTTRVAGTFGYLAPEYALY-GQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDD--- 497 (590)
Q Consensus 422 ~~~~~~~~~~~~gt~~Y~APE~~~~-~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~--- 497 (590)
.... .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||.........+... +..........
T Consensus 154 ~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 231 (291)
T cd07844 154 SVPS-KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKI-FRVLGTPTEETWPG 231 (291)
T ss_pred CCCC-ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHH-HHhcCCCChhhhhh
Confidence 3211 11122346789999998875 458999999999999999999999986544222211111 11111000000
Q ss_pred --------------hhhHHHhhhh-HHHHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 046270 498 --------------IFDEFIRAEG-ARAVMERFVLVGILCAHVMVALRPTITDALK 538 (590)
Q Consensus 498 --------------~~d~~l~~~~-~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~ 538 (590)
.....+.... .......+.+++..|++.+|++|||+.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 232 VSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred hhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 0000000000 0011146678999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=301.53 Aligned_cols=246 Identities=25% Similarity=0.387 Sum_probs=195.9
Q ss_pred CCccceecccCcEEEEEEEEc-CCcEEEEEEeecCC-CCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEEEE
Q 046270 266 FSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLD-TKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFLV 343 (590)
Q Consensus 266 f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~-~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~LV 343 (590)
|...+.||+|+||.||+|... ++..+|+|.+.... ......+.+|++++.+++|+||+++++++.. +...++|
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv 80 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK-----DTKLWII 80 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEe-----CCeEEEE
Confidence 566788999999999999875 57899999875432 2234578899999999999999999999874 4568999
Q ss_pred EeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccccC
Q 046270 344 YDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLE 423 (590)
Q Consensus 344 ~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~~~ 423 (590)
|||+++++|.+++. ...+++..+..++.+++.|+.||| +.+++|+||||+||+++.++.++|+|||+++....
T Consensus 81 ~e~~~~~~l~~~i~----~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06641 81 MEYLGGGSALDLLE----PGPLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD 153 (277)
T ss_pred EEeCCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHc---cCCeecCCCCHHhEEECCCCCEEEeecccceeccc
Confidence 99999999998884 346899999999999999999999 89999999999999999999999999999876533
Q ss_pred CCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhhhHHH
Q 046270 424 GHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDEFI 503 (590)
Q Consensus 424 ~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 503 (590)
.. .......|+..|+|||++.+..++.++||||||++++||++|+.|+..... .. +.... ..+... .++
T Consensus 154 ~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~-~~----~~~~~-~~~~~~-~~~--- 222 (277)
T cd06641 154 TQ-IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHP-MK----VLFLI-PKNNPP-TLE--- 222 (277)
T ss_pred ch-hhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccch-HH----HHHHH-hcCCCC-CCC---
Confidence 22 122334678899999999888899999999999999999999999864321 11 11111 111111 011
Q ss_pred hhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 504 RAEGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 504 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
......+.+++..|++.+|.+||++.+++++
T Consensus 223 -----~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 223 -----GNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred -----cccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 1223467788899999999999999999984
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=317.44 Aligned_cols=252 Identities=23% Similarity=0.307 Sum_probs=206.1
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecC--CCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceE
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDL--DTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRR 340 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~--~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~ 340 (590)
++|...+.+|+|.||.++..+++ ++..+++|++.-. .....+...+|+.++++++|||||.+.+.++. ++...
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~----~~~~l 79 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEE----DGQLL 79 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhc----CCceE
Confidence 46777889999999999999877 4678999998543 23334467899999999999999999998875 34459
Q ss_pred EEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCccc
Q 046270 341 FLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQ 420 (590)
Q Consensus 341 ~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~ 420 (590)
++||+|++||+|.+.+... +...++++++.+++.|++.|+.||| +..|+|||||+.||+++.+..+||+|||+|+.
T Consensus 80 ~Ivm~Y~eGg~l~~~i~~~-k~~~f~E~~i~~~~~Q~~~av~ylH---~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~ 155 (426)
T KOG0589|consen 80 CIVMEYCEGGDLAQLIKEQ-KGVLFPEERILKWFVQILLAVNYLH---ENRVLHRDLKCANIFLTKDKKVKLGDFGLAKI 155 (426)
T ss_pred EEEEeecCCCCHHHHHHHH-hhccccHHHHHHHHHHHHHHHHHHH---hhhhhcccchhhhhhccccCceeecchhhhhh
Confidence 9999999999999998643 3467899999999999999999999 89999999999999999999999999999998
Q ss_pred ccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhhh
Q 046270 421 SLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFD 500 (590)
Q Consensus 421 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 500 (590)
..... .....+.||+.||.||.+.+.+|..|+|||||||++|||.+-+++|...+... ++... .+
T Consensus 156 l~~~~-~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~-Li~ki----~~--------- 220 (426)
T KOG0589|consen 156 LNPED-SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSE-LILKI----NR--------- 220 (426)
T ss_pred cCCch-hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHH-HHHHH----hh---------
Confidence 76654 24556889999999999999999999999999999999999999997544321 11110 00
Q ss_pred HHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 501 EFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 501 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
......+......+..++..|++.+|+.||++.+++.+
T Consensus 221 -~~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 221 -GLYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred -ccCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 00011122334477778889999999999999999875
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=288.79 Aligned_cols=248 Identities=25% Similarity=0.372 Sum_probs=203.5
Q ss_pred cCCCccceecccCcEEEEEEEEcC-CcEEEEEEeecCC---CCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCce
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLRH-GNLVAVKQILDLD---TKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKR 339 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~vAvK~l~~~~---~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~ 339 (590)
++|+..+.||+|.||.||.|+.+. +-.||+|++.+.. .+-..++.+|+++-..|+||||++++|++.+ ...
T Consensus 22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd-----~~r 96 (281)
T KOG0580|consen 22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHD-----SKR 96 (281)
T ss_pred hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheec-----cce
Confidence 568889999999999999999874 6689999986532 2335679999999999999999999999984 456
Q ss_pred EEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcc
Q 046270 340 RFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAK 419 (590)
Q Consensus 340 ~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~ 419 (590)
.||++||.++|+|...|... ....+++.....++.|+|.||.|+| .+++|||||||+|+|++.++..||+|||-+.
T Consensus 97 iyLilEya~~gel~k~L~~~-~~~~f~e~~~a~Yi~q~A~Al~y~h---~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV 172 (281)
T KOG0580|consen 97 IYLILEYAPRGELYKDLQEG-RMKRFDEQRAATYIKQLANALLYCH---LKRVIHRDIKPENLLLGSAGELKIADFGWSV 172 (281)
T ss_pred eEEEEEecCCchHHHHHHhc-ccccccccchhHHHHHHHHHHHHhc---cCCcccCCCCHHHhccCCCCCeeccCCCcee
Confidence 99999999999999999633 3456888999999999999999999 9999999999999999999999999999987
Q ss_pred cccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhh
Q 046270 420 QSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIF 499 (590)
Q Consensus 420 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 499 (590)
..+ ........||..|++||...+..++.+.|+|++||+.+|++.|.+||+..... ....... + .+..
T Consensus 173 ~~p---~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~-etYkrI~----k----~~~~ 240 (281)
T KOG0580|consen 173 HAP---SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHS-ETYKRIR----K----VDLK 240 (281)
T ss_pred ecC---CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhH-HHHHHHH----H----cccc
Confidence 544 23345678999999999999999999999999999999999999999865421 1111110 0 1111
Q ss_pred hHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 500 DEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 500 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
++ ..+.....+++..|+..+|.+|.+..||+..
T Consensus 241 ~p-------~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 241 FP-------STISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred CC-------cccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 11 2233466678889999999999999999864
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=307.16 Aligned_cols=252 Identities=25% Similarity=0.281 Sum_probs=197.2
Q ss_pred cCCCccceecccCcEEEEEEEEcC-CcEEEEEEeecCCCC---ChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCce
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLRH-GNLVAVKQILDLDTK---GDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKR 339 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~vAvK~l~~~~~~---~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~ 339 (590)
++|...+.||+|+||.||++...+ +..+|+|.+...... ..+.+.+|++++.+++|+||+++++.+. .+..
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~ 75 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQ-----TETY 75 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeee-----cCCE
Confidence 367888999999999999999875 889999998654322 3456889999999999999999999886 3456
Q ss_pred EEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcc
Q 046270 340 RFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAK 419 (590)
Q Consensus 340 ~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~ 419 (590)
.++||||+++++|.+++... ....+++..+..++.|++.||+||| ..+++||||||+||+++.++.++|+|||++.
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~ 151 (316)
T cd05574 76 LCLVMDYCPGGELFRLLQRQ-PGKCLSEEVARFYAAEVLLALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSK 151 (316)
T ss_pred EEEEEEecCCCCHHHHHHhC-CCCccCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChHHeEEcCCCCEEEeecchhh
Confidence 89999999999999988532 2356999999999999999999999 8999999999999999999999999999987
Q ss_pred cccCCCcc----------------------------cccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCC
Q 046270 420 QSLEGHSH----------------------------LTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKV 471 (590)
Q Consensus 420 ~~~~~~~~----------------------------~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p 471 (590)
........ ......|+..|+|||++.+..++.++||||||+++|||++|+.|
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~p 231 (316)
T cd05574 152 QSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTP 231 (316)
T ss_pred cccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCC
Confidence 54322110 11134578899999999988899999999999999999999999
Q ss_pred CCCCCCchhhhhHHHHHHHhcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCC----HHHHHH
Q 046270 472 LDTSTSPFQLITDWAWVLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPT----ITDALK 538 (590)
Q Consensus 472 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt----m~eVl~ 538 (590)
|........ +........... ........+.+++..|++.+|++||| +.|++.
T Consensus 232 f~~~~~~~~----~~~~~~~~~~~~----------~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 232 FKGSNRDET----FSNILKKEVTFP----------GSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred CCCCchHHH----HHHHhcCCccCC----------CccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 864433211 111110000000 00113457888999999999999999 555554
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=304.76 Aligned_cols=250 Identities=26% Similarity=0.393 Sum_probs=200.3
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEEE
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFL 342 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~L 342 (590)
++|...+.||+|+||.||+|... ++..||+|.+........+.+.+|+.++++++|||++++++++.. +...++
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~-----~~~~~l 93 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLV-----GDELWV 93 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeee-----CCcEEE
Confidence 57888899999999999999875 578899999865555556778999999999999999999999874 345899
Q ss_pred EEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCccccc
Q 046270 343 VYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSL 422 (590)
Q Consensus 343 V~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~~ 422 (590)
|+||+++++|.+++. ...+++.++..++.+++.||.||| +.+++||||||+||+++.++.+||+|||++....
T Consensus 94 v~e~~~~~~L~~~~~----~~~l~~~~~~~i~~~l~~al~~LH---~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~ 166 (293)
T cd06647 94 VMEYLAGGSLTDVVT----ETCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 166 (293)
T ss_pred EEecCCCCcHHHHHh----hcCCCHHHHHHHHHHHHHHHHHHH---hCCEeeccCCHHHEEEcCCCCEEEccCcceeccc
Confidence 999999999999884 235899999999999999999999 8999999999999999999999999999887554
Q ss_pred CCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhhhHH
Q 046270 423 EGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDEF 502 (590)
Q Consensus 423 ~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 502 (590)
.... ......|+..|+|||.+..+.++.++||||||+++||+++|+.||........... ....+... +
T Consensus 167 ~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~-----~~~~~~~~--~--- 235 (293)
T cd06647 167 PEQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL-----IATNGTPE--L--- 235 (293)
T ss_pred cccc-ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheee-----hhcCCCCC--C---
Confidence 3322 22334678899999999888899999999999999999999999965433211110 01111100 0
Q ss_pred HhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 503 IRAEGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 503 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
.........+.+++..|++.+|++||++++++.+
T Consensus 236 ---~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 236 ---QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred ---CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0111223356778899999999999999999976
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=301.01 Aligned_cols=267 Identities=21% Similarity=0.263 Sum_probs=196.6
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCC--CChHHHHHHHHHHHhcC-CCCccccceeEEeccCCCCce
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDT--KGDEDFTNEVEIISKIR-HRNLLSLRGCCVTSDDSSGKR 339 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~--~~~~~f~~Ev~il~~l~-H~nlv~l~g~~~~~~~~~~~~ 339 (590)
++|+..+.||+|+||.||+|.+. +|+.||+|++..... .....+.+|++++++++ |+|++++++++...+......
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46888899999999999999986 588999998754322 22457889999999995 699999999987654323445
Q ss_pred EEEEEeeCCCCCcchhhhhhcc--cccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECC-CCcEEEEeeC
Q 046270 340 RFLVYDYMPNGTLSDNISISHK--RKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDS-ELNAKVADFG 416 (590)
Q Consensus 340 ~~LV~E~~~~gsL~~~L~~~~~--~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~-~~~~kL~DFG 416 (590)
.++||||+++ +|.+++..... ...+++..++.++.||+.||.||| ..+|+||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEecCCCeEEEeecc
Confidence 8999999985 78887754322 346899999999999999999999 899999999999999998 8899999999
Q ss_pred CcccccCCCcccccccccCCCccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCc
Q 046270 417 LAKQSLEGHSHLTTRVAGTFGYLAPEYALY-GQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKV 495 (590)
Q Consensus 417 la~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~ 495 (590)
+++....... ......+++.|+|||++.+ ..++.++||||||+++|||++|..||........... ... ....+.
T Consensus 157 ~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~-~~~-~~~~~~- 232 (295)
T cd07837 157 LGRAFSIPVK-SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLH-IFK-LLGTPT- 232 (295)
T ss_pred cceecCCCcc-ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHH-HHH-HhCCCC-
Confidence 9875432211 1222346788999998865 4579999999999999999999999865433221111 100 000000
Q ss_pred hhhh-------h--------HHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 046270 496 DDIF-------D--------EFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALK 538 (590)
Q Consensus 496 ~~~~-------d--------~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~ 538 (590)
.+.. + +.............+.+++..|++.+|.+||++.|++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 233 EQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred hhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 0000 0 00000011123456788999999999999999999885
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=300.48 Aligned_cols=259 Identities=25% Similarity=0.301 Sum_probs=194.0
Q ss_pred CCccceecccCcEEEEEEEEc-CCcEEEEEEeecCC--CCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEEE
Q 046270 266 FSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLD--TKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFL 342 (590)
Q Consensus 266 f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~--~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~L 342 (590)
|+..+.||+|++|.||+|... +|..||+|++.... ....+.+.+|++++++++|+|++++++++.. +...++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~-----~~~~~i 75 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHS-----ENKLYL 75 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheecc-----CCeEEE
Confidence 556789999999999999876 58899999986432 2234578899999999999999999999873 456999
Q ss_pred EEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCccccc
Q 046270 343 VYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSL 422 (590)
Q Consensus 343 V~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~~ 422 (590)
||||++ ++|.+++... ....+++..+++++.|+++||.||| +.+++||||+|+||+++.++.+||+|||+++...
T Consensus 76 v~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~~L~~lH---~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~ 150 (283)
T cd07835 76 VFEFLD-LDLKKYMDSS-PLTGLDPPLIKSYLYQLLQGIAYCH---SHRVLHRDLKPQNLLIDREGALKLADFGLARAFG 150 (283)
T ss_pred EEeccC-cCHHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCcEEEeecccccccC
Confidence 999995 6898887532 2236899999999999999999999 8899999999999999999999999999997543
Q ss_pred CCCcccccccccCCCccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhhhH
Q 046270 423 EGHSHLTTRVAGTFGYLAPEYALYG-QLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDE 501 (590)
Q Consensus 423 ~~~~~~~~~~~gt~~Y~APE~~~~~-~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 501 (590)
.... ......++..|+|||++..+ .++.++||||||+++|||++|+.||........ +...... .+...+...+
T Consensus 151 ~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-~~~~~~~---~~~~~~~~~~ 225 (283)
T cd07835 151 VPVR-TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQ-LFRIFRT---LGTPDEDVWP 225 (283)
T ss_pred CCcc-ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHH---hCCCChHHhh
Confidence 3221 12223468899999987654 578999999999999999999999865433211 1111110 0110000000
Q ss_pred H----------H-------hhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 502 F----------I-------RAEGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 502 ~----------l-------~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
. . ...........+.+++..|++.+|++|||++|+++.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 226 GVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0 0 000011223567889999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=301.09 Aligned_cols=248 Identities=26% Similarity=0.380 Sum_probs=195.8
Q ss_pred CCCccceecccCcEEEEEEEEc-CCcEEEEEEeecC-CCCChHHHHHHHHHHHhcC---CCCccccceeEEeccCCCCce
Q 046270 265 GFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDL-DTKGDEDFTNEVEIISKIR---HRNLLSLRGCCVTSDDSSGKR 339 (590)
Q Consensus 265 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~-~~~~~~~f~~Ev~il~~l~---H~nlv~l~g~~~~~~~~~~~~ 339 (590)
.|+..+.||+|+||.||+|++. ++..+|+|.+... .....+++.+|++++++++ |+|++++++++.. +..
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~-----~~~ 76 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLK-----GPR 76 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeee-----CCE
Confidence 4667789999999999999975 5889999988643 2334567889999999997 9999999998873 456
Q ss_pred EEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcc
Q 046270 340 RFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAK 419 (590)
Q Consensus 340 ~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~ 419 (590)
.++||||+++++|.+++. ...+++...+.++.+++.||.||| +.+|+||||+|+||++++++.++|+|||++.
T Consensus 77 ~~lv~e~~~~~~L~~~~~----~~~l~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~ 149 (277)
T cd06917 77 LWIIMEYAEGGSVRTLMK----AGPIAEKYISVIIREVLVALKYIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAA 149 (277)
T ss_pred EEEEEecCCCCcHHHHHH----ccCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHHEEEcCCCCEEEccCCcee
Confidence 899999999999999874 237999999999999999999999 8999999999999999999999999999998
Q ss_pred cccCCCcccccccccCCCccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhh
Q 046270 420 QSLEGHSHLTTRVAGTFGYLAPEYALYG-QLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDI 498 (590)
Q Consensus 420 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 498 (590)
...... .......|+..|+|||++..+ .++.++||||||+++|||++|+.||........ ... .......
T Consensus 150 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~-----~~~-~~~~~~~-- 220 (277)
T cd06917 150 LLNQNS-SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRA-----MML-IPKSKPP-- 220 (277)
T ss_pred ecCCCc-cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhh-----hhc-cccCCCC--
Confidence 665433 223345688999999998765 468999999999999999999999965332111 100 0001011
Q ss_pred hhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 499 FDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 499 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
.+.. ......+.+++..|++.+|++||++.+++++
T Consensus 221 ---~~~~---~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 221 ---RLED---NGYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred ---CCCc---ccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 1111 0123467788899999999999999999863
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=302.48 Aligned_cols=268 Identities=22% Similarity=0.298 Sum_probs=196.3
Q ss_pred CCCccceecccCcEEEEEEEEcC---CcEEEEEEeecCC---CCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCc
Q 046270 265 GFSQNNLIGQGASGIVYKGTLRH---GNLVAVKQILDLD---TKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGK 338 (590)
Q Consensus 265 ~f~~~~~LG~G~fG~Vykg~~~~---g~~vAvK~l~~~~---~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~ 338 (590)
+|...+.||+|+||.||+|+... +..||+|.+.... ....+.+.+|++++.+++||||+++++++... ++.
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~ 77 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEH---ADK 77 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCC---CCc
Confidence 47778899999999999999864 6899999987632 33346788999999999999999999999753 235
Q ss_pred eEEEEEeeCCCCCcchhhhhhcc--cccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECC----CCcEEE
Q 046270 339 RRFLVYDYMPNGTLSDNISISHK--RKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDS----ELNAKV 412 (590)
Q Consensus 339 ~~~LV~E~~~~gsL~~~L~~~~~--~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~----~~~~kL 412 (590)
..++||||+++ +|.+++..... ...+++..++.|+.||+.||.||| +.+|+||||||+||+++. ++.+||
T Consensus 78 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~h~dlkp~Nil~~~~~~~~~~~kl 153 (316)
T cd07842 78 SVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKI 153 (316)
T ss_pred eEEEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEEcCCCCccceEEE
Confidence 79999999975 66666543221 236889999999999999999999 899999999999999999 899999
Q ss_pred EeeCCcccccCCCc--ccccccccCCCccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCchh--------h
Q 046270 413 ADFGLAKQSLEGHS--HLTTRVAGTFGYLAPEYALYG-QLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQ--------L 481 (590)
Q Consensus 413 ~DFGla~~~~~~~~--~~~~~~~gt~~Y~APE~~~~~-~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~--------~ 481 (590)
+|||+++....... .......++..|+|||.+.+. .++.++||||||++++||++|+.||........ .
T Consensus 154 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 233 (316)
T cd07842 154 GDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQ 233 (316)
T ss_pred CCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHH
Confidence 99999986543222 122345678899999987764 578999999999999999999999975433220 1
Q ss_pred hhHHHHHHH-----------hcCCchhhhh---------HHHhhhhHH--HHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 482 ITDWAWVLA-----------KSGKVDDIFD---------EFIRAEGAR--AVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 482 l~~~~~~~~-----------~~~~~~~~~d---------~~l~~~~~~--~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
+..+...+. .........+ ..+...... ....++.+++..|++.||++|||+.|++++
T Consensus 234 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 234 LERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred HHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 111111000 0000000000 000000000 223468889999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=304.76 Aligned_cols=266 Identities=26% Similarity=0.355 Sum_probs=197.6
Q ss_pred HhcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecC--CCCChHHHHHHHHHHHhc-CCCCccccceeEEeccCCCC
Q 046270 262 ATNGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDL--DTKGDEDFTNEVEIISKI-RHRNLLSLRGCCVTSDDSSG 337 (590)
Q Consensus 262 at~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~--~~~~~~~f~~Ev~il~~l-~H~nlv~l~g~~~~~~~~~~ 337 (590)
..++|...+.||+|+||.||+|.+. .|..+|+|++... .......+.+|+.+++++ +|+||+++++++... ++
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~---~~ 81 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAE---ND 81 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccC---CC
Confidence 3467888899999999999999986 4788999988542 223345678899999999 999999999988643 24
Q ss_pred ceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCC
Q 046270 338 KRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGL 417 (590)
Q Consensus 338 ~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGl 417 (590)
...++||||++ ++|.+++. ...++|..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+
T Consensus 82 ~~~~lv~e~~~-~~L~~~~~----~~~~~~~~~~~i~~qi~~~L~~LH---~~~i~H~dl~p~nill~~~~~~kl~d~g~ 153 (337)
T cd07852 82 KDIYLVFEYME-TDLHAVIR----ANILEDVHKRYIMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGL 153 (337)
T ss_pred ceEEEEecccc-cCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccc
Confidence 46899999997 58888774 227899999999999999999999 89999999999999999999999999999
Q ss_pred cccccCCCc----ccccccccCCCccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHH---
Q 046270 418 AKQSLEGHS----HLTTRVAGTFGYLAPEYALY-GQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVL--- 489 (590)
Q Consensus 418 a~~~~~~~~----~~~~~~~gt~~Y~APE~~~~-~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~--- 489 (590)
++....... .......|+..|+|||++.. ..++.++||||||+++|||++|+.||........ ........
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~-~~~~~~~~~~~ 232 (337)
T cd07852 154 ARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQ-LEKIIEVIGPP 232 (337)
T ss_pred hhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCC
Confidence 986544322 12334568899999998764 5678999999999999999999999864332211 11000000
Q ss_pred -------HhcCCchhhhhHHHhh------hhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 490 -------AKSGKVDDIFDEFIRA------EGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 490 -------~~~~~~~~~~d~~l~~------~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
+......++++..... .........+.+++..|++.+|++|||+.++++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 233 SAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred CHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 0000001111100000 0000123467889999999999999999999875
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=318.84 Aligned_cols=250 Identities=26% Similarity=0.393 Sum_probs=204.3
Q ss_pred CCccceecccCcEEEEEEEEcC---Cc--EEEEEEeecC-CCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCce
Q 046270 266 FSQNNLIGQGASGIVYKGTLRH---GN--LVAVKQILDL-DTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKR 339 (590)
Q Consensus 266 f~~~~~LG~G~fG~Vykg~~~~---g~--~vAvK~l~~~-~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~ 339 (590)
....++||+|-||.||+|+..+ |. .||||..+.. .....+.|..|..++++++|||||+|+|.|.+. .
T Consensus 391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~------P 464 (974)
T KOG4257|consen 391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ------P 464 (974)
T ss_pred ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc------c
Confidence 3456789999999999998753 33 5999998763 444567899999999999999999999999743 3
Q ss_pred EEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcc
Q 046270 340 RFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAK 419 (590)
Q Consensus 340 ~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~ 419 (590)
.++|||.++-|.|..||.. +...|+......+..||..+|+||| +..+|||||.++|||+...--+||+|||++|
T Consensus 465 ~WivmEL~~~GELr~yLq~--nk~sL~l~tL~ly~~Qi~talaYLe---SkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR 539 (974)
T KOG4257|consen 465 MWIVMELAPLGELREYLQQ--NKDSLPLRTLTLYCYQICTALAYLE---SKRFVHRDIAARNILVSSPQCVKLADFGLSR 539 (974)
T ss_pred eeEEEecccchhHHHHHHh--ccccchHHHHHHHHHHHHHHHHHHH---hhchhhhhhhhhheeecCcceeeecccchhh
Confidence 8999999999999999963 3456888899999999999999999 9999999999999999999999999999999
Q ss_pred cccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhhHHHHHHHhcCCchhh
Q 046270 420 QSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLDTSTSPFQLITDWAWVLAKSGKVDDI 498 (590)
Q Consensus 420 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 498 (590)
....+.....++..-...|||||.+...++|.+||||.|||.+||+++ |.+||..-....... ..+.|....
T Consensus 540 ~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~------~iEnGeRlP- 612 (974)
T KOG4257|consen 540 YLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIG------HIENGERLP- 612 (974)
T ss_pred hccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEE------EecCCCCCC-
Confidence 887776666666566779999999999999999999999999999998 999997533322100 011222111
Q ss_pred hhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhc
Q 046270 499 FDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLE 541 (590)
Q Consensus 499 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~ 541 (590)
.+...+..+..++..||..+|.+||.+.|+...|+
T Consensus 613 --------~P~nCPp~LYslmskcWayeP~kRPrftei~~~ls 647 (974)
T KOG4257|consen 613 --------CPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILS 647 (974)
T ss_pred --------CCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHH
Confidence 22334457888999999999999999988876553
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=340.49 Aligned_cols=260 Identities=22% Similarity=0.305 Sum_probs=198.1
Q ss_pred HHHHhcCCCccceecccCcEEEEEEEEcC-CcEEEEEEeecCC--CCChHHHHHHHHHHHhcCCCCccccceeEEeccCC
Q 046270 259 LEQATNGFSQNNLIGQGASGIVYKGTLRH-GNLVAVKQILDLD--TKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDS 335 (590)
Q Consensus 259 l~~at~~f~~~~~LG~G~fG~Vykg~~~~-g~~vAvK~l~~~~--~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~ 335 (590)
.+...++|...+.||+|+||.||++++.. +..+|+|.+.... ......|..|+.++.+|+|||||++++++....
T Consensus 8 ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~-- 85 (1021)
T PTZ00266 8 GESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKA-- 85 (1021)
T ss_pred CccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecC--
Confidence 34455789999999999999999999875 6688999875432 223457899999999999999999999886532
Q ss_pred CCceEEEEEeeCCCCCcchhhhhhc-ccccCChhhHHHHHHHHHHHHHHHHhcC----CCCeEecCCCCCceEECCC---
Q 046270 336 SGKRRFLVYDYMPNGTLSDNISISH-KRKQLTWPQRKKIIVDVAKGIAYLHYGL----KPGIYHRDIKSTNILLDSE--- 407 (590)
Q Consensus 336 ~~~~~~LV~E~~~~gsL~~~L~~~~-~~~~l~~~~r~~I~~~ia~gL~yLH~~~----~~~ivHrDIKp~NILLd~~--- 407 (590)
....+|||||+++|+|.++|.... ....+++..++.|+.||+.||.|||... ..+||||||||+||||+.+
T Consensus 86 -~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~ 164 (1021)
T PTZ00266 86 -NQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRH 164 (1021)
T ss_pred -CCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccc
Confidence 346899999999999999886422 2356999999999999999999999421 1459999999999999642
Q ss_pred --------------CcEEEEeeCCcccccCCCcccccccccCCCccCcccccc--CCCCcchhHHHHHHHHHHHHhCCCC
Q 046270 408 --------------LNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALY--GQLTEKSDVYSFGIVILELMSGRKV 471 (590)
Q Consensus 408 --------------~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~--~~~t~ksDVySfGvvLlELltG~~p 471 (590)
..+||+|||+++...... ......||+.|+|||++.. ..++.++|||||||+||||+||+.|
T Consensus 165 lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~P 242 (1021)
T PTZ00266 165 IGKITAQANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTP 242 (1021)
T ss_pred cccccccccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCC
Confidence 348999999998653321 2334578999999999864 4589999999999999999999999
Q ss_pred CCCCCCchhhhhHHHHHHHhcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 046270 472 LDTSTSPFQLITDWAWVLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALK 538 (590)
Q Consensus 472 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~ 538 (590)
|........ +...+ ..+.... .......+..++..||+.+|.+||++.+++.
T Consensus 243 F~~~~~~~q----li~~l-k~~p~lp----------i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 243 FHKANNFSQ----LISEL-KRGPDLP----------IKGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred CCcCCcHHH----HHHHH-hcCCCCC----------cCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 965433211 11111 1111000 0011236778889999999999999999984
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=305.48 Aligned_cols=259 Identities=27% Similarity=0.379 Sum_probs=199.6
Q ss_pred cCCCccceecccCcEEEEEEEEcCCcEEEEEEeecCCCCChHHHHHHHHHHHhc--CCCCccccceeEEeccCCCCceEE
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLRHGNLVAVKQILDLDTKGDEDFTNEVEIISKI--RHRNLLSLRGCCVTSDDSSGKRRF 341 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l--~H~nlv~l~g~~~~~~~~~~~~~~ 341 (590)
+.....+.||+|.||+||+|.|. |..||||++.. .+.+.+.+|.++.+.+ +|+||+.+++.-..... .-.+++
T Consensus 211 rqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~s---rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~g-s~TQLw 285 (513)
T KOG2052|consen 211 RQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSS---RDERSWFRETEIYQTVMLRHENILGFIAADNKDNG-SWTQLW 285 (513)
T ss_pred heeEEEEEecCccccceeecccc-CCceEEEEecc---cchhhhhhHHHHHHHHHhccchhhhhhhccccCCC-ceEEEE
Confidence 45667789999999999999998 88999999854 3456788999999865 99999999887554443 456799
Q ss_pred EEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcC-----CCCeEecCCCCCceEECCCCcEEEEeeC
Q 046270 342 LVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGL-----KPGIYHRDIKSTNILLDSELNAKVADFG 416 (590)
Q Consensus 342 LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~-----~~~ivHrDIKp~NILLd~~~~~kL~DFG 416 (590)
||.||.++|||.|||. +..++-+..++++..+|.||++||.+. ++.|.|||||+.|||+..++..-|+|+|
T Consensus 286 LvTdYHe~GSL~DyL~----r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLG 361 (513)
T KOG2052|consen 286 LVTDYHEHGSLYDYLN----RNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 361 (513)
T ss_pred EeeecccCCcHHHHHh----hccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeece
Confidence 9999999999999994 468999999999999999999999654 6889999999999999999999999999
Q ss_pred CcccccCCCcc---cccccccCCCccCccccccCC----C--CcchhHHHHHHHHHHHHhCC----------CCCCCCCC
Q 046270 417 LAKQSLEGHSH---LTTRVAGTFGYLAPEYALYGQ----L--TEKSDVYSFGIVILELMSGR----------KVLDTSTS 477 (590)
Q Consensus 417 la~~~~~~~~~---~~~~~~gt~~Y~APE~~~~~~----~--t~ksDVySfGvvLlELltG~----------~p~~~~~~ 477 (590)
||......... ......||.+|||||++...- + -..+||||||.|+||+..+- .||.....
T Consensus 362 LAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp 441 (513)
T KOG2052|consen 362 LAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVP 441 (513)
T ss_pred eeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCC
Confidence 99876554322 234467999999999886432 1 13689999999999998542 23322111
Q ss_pred chhhhhHHHHHHHhcCCchhhhh----HHHh----hh-hHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhccCC
Q 046270 478 PFQLITDWAWVLAKSGKVDDIFD----EFIR----AE-GARAVMERFVLVGILCAHVMVALRPTITDALKMLEGDI 544 (590)
Q Consensus 478 ~~~~l~~~~~~~~~~~~~~~~~d----~~l~----~~-~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~~~ 544 (590)
.++..+++.+ +.++ .. .+.+.+..+.+++..||..+|..|-|+--+-+.|....
T Consensus 442 -------------~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~ 504 (513)
T KOG2052|consen 442 -------------SDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLS 504 (513)
T ss_pred -------------CCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHh
Confidence 1222222221 1111 11 23356778889999999999999999988887776543
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=309.21 Aligned_cols=269 Identities=22% Similarity=0.310 Sum_probs=201.4
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecC--CCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCce
Q 046270 263 TNGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDL--DTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKR 339 (590)
Q Consensus 263 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~--~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~ 339 (590)
.++|...+.||+|+||.||+|+.. .+..||||++... .......+.+|+.++++++|+||+++++++..........
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 457888999999999999999876 4789999998643 2233456788999999999999999999887544323356
Q ss_pred EEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcc
Q 046270 340 RFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAK 419 (590)
Q Consensus 340 ~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~ 419 (590)
.++||||+. ++|.+++. ....+++..+..++.|++.||.||| +.+++||||||+||+++.++.+||+|||+++
T Consensus 84 ~~lv~e~~~-~~L~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 156 (337)
T cd07858 84 VYIVYELMD-TDLHQIIR---SSQTLSDDHCQYFLYQLLRGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLAR 156 (337)
T ss_pred EEEEEeCCC-CCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECcCcccc
Confidence 899999996 68887774 3456999999999999999999999 8999999999999999999999999999998
Q ss_pred cccCCCcccccccccCCCccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHh-------
Q 046270 420 QSLEGHSHLTTRVAGTFGYLAPEYALY-GQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAK------- 491 (590)
Q Consensus 420 ~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~------- 491 (590)
...... .......++..|+|||.+.. ..++.++||||||++++||++|+.||....... .+. .......
T Consensus 157 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~-~~~~~~~~~~~~~~ 233 (337)
T cd07858 157 TTSEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVH-QLK-LITELLGSPSEEDL 233 (337)
T ss_pred ccCCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHH-HHH-HHHHHhCCCChHHh
Confidence 654322 12233457889999998865 468999999999999999999999986533211 111 0000000
Q ss_pred ----cCCchhhhhH-------HHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH--hcc
Q 046270 492 ----SGKVDDIFDE-------FIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKM--LEG 542 (590)
Q Consensus 492 ----~~~~~~~~d~-------~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~--L~~ 542 (590)
.+...+.++. ... .........+.+++..|++.+|++|||++++++. ++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~ 296 (337)
T cd07858 234 GFIRNEKARRYIRSLPYTPRQSFA-RLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLAS 296 (337)
T ss_pred hhcCchhhhHHHHhcCcccccCHH-HHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhh
Confidence 0001111100 000 0011234577899999999999999999999886 544
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=296.63 Aligned_cols=262 Identities=24% Similarity=0.333 Sum_probs=196.5
Q ss_pred CCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCCC-ChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEEE
Q 046270 265 GFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDTK-GDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFL 342 (590)
Q Consensus 265 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~~-~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~L 342 (590)
+|+..+.||+|++|.||+|+.. +|..||||++...... ..+.+.+|++++++++|+|++++++++... ...++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~l 75 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTE-----NKLML 75 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeC-----CcEEE
Confidence 5778899999999999999986 4889999998654332 345678999999999999999999999843 45899
Q ss_pred EEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCccccc
Q 046270 343 VYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSL 422 (590)
Q Consensus 343 V~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~~ 422 (590)
||||+++ +|.+++........+++..+..++.|++.||.||| ..+++||||||+||++++++.+||+|||+++...
T Consensus 76 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~ 151 (284)
T cd07836 76 VFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH---ENRVLHRDLKPQNLLINKRGELKLADFGLARAFG 151 (284)
T ss_pred EEecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCcEEEeecchhhhhc
Confidence 9999985 88887754333456999999999999999999999 8899999999999999999999999999997543
Q ss_pred CCCcccccccccCCCccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHH----------HHHHh
Q 046270 423 EGHSHLTTRVAGTFGYLAPEYALYG-QLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWA----------WVLAK 491 (590)
Q Consensus 423 ~~~~~~~~~~~gt~~Y~APE~~~~~-~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~----------~~~~~ 491 (590)
.... ......++..|++||.+.+. .++.++||||||+++|||++|+.||........ ..... |..+.
T Consensus 152 ~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 229 (284)
T cd07836 152 IPVN-TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQ-LLKIFRIMGTPTESTWPGIS 229 (284)
T ss_pred CCcc-ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHH-HHHHHHHhCCCChhhHHHHh
Confidence 3211 12234568899999988654 578999999999999999999999875443221 11000 00000
Q ss_pred c-CCc----hhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 046270 492 S-GKV----DDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALK 538 (590)
Q Consensus 492 ~-~~~----~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~ 538 (590)
. ... ....+... ..........+.+++..|++.+|.+||++.++++
T Consensus 230 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 230 QLPEYKPTFPRYPPQDL-QQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred cCchhcccccCCChHHH-HHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0 000 00000000 0111123456778999999999999999999985
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=295.58 Aligned_cols=250 Identities=26% Similarity=0.369 Sum_probs=197.1
Q ss_pred CCCccceecccCcEEEEEEEEcC-CcEEEEEEeecCC--CCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEE
Q 046270 265 GFSQNNLIGQGASGIVYKGTLRH-GNLVAVKQILDLD--TKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRF 341 (590)
Q Consensus 265 ~f~~~~~LG~G~fG~Vykg~~~~-g~~vAvK~l~~~~--~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~ 341 (590)
+|...+.||+|+||.||+|..+. |..+|+|.+.... ....+.+.+|++++++++|+|++++++.+.. +...+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~-----~~~~~ 75 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQE-----NGRLF 75 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheecc-----CCeEE
Confidence 47788999999999999999874 7889999985432 2345678899999999999999999998863 45689
Q ss_pred EEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCC-cEEEEeeCCccc
Q 046270 342 LVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSEL-NAKVADFGLAKQ 420 (590)
Q Consensus 342 LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~-~~kL~DFGla~~ 420 (590)
+|+||+++++|.+++... ....++|..+..++.|++.||.||| ..+++|+||||+||++++++ .+||+|||.+..
T Consensus 76 lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~ 151 (257)
T cd08225 76 IVMEYCDGGDLMKRINRQ-RGVLFSEDQILSWFVQISLGLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQ 151 (257)
T ss_pred EEEecCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEcCCCCeEEecccccchh
Confidence 999999999999988532 2335899999999999999999999 88999999999999999885 569999999876
Q ss_pred ccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhhh
Q 046270 421 SLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFD 500 (590)
Q Consensus 421 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 500 (590)
..... .......|+..|+|||+.....++.++||||||++++||++|+.|+..... .++...... +..... .
T Consensus 152 ~~~~~-~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~-~~~~~~-~ 223 (257)
T cd08225 152 LNDSM-ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL-----HQLVLKICQ-GYFAPI-S 223 (257)
T ss_pred ccCCc-ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccH-----HHHHHHHhc-ccCCCC-C
Confidence 54322 222334688999999999888899999999999999999999999864322 112221111 111111 0
Q ss_pred HHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 501 EFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 501 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
......+.+++.+|++.+|++|||+.|+++.
T Consensus 224 --------~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 224 --------PNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred --------CCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 1122467778899999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=299.21 Aligned_cols=254 Identities=28% Similarity=0.398 Sum_probs=202.0
Q ss_pred HHhcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCce
Q 046270 261 QATNGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKR 339 (590)
Q Consensus 261 ~at~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~ 339 (590)
..+++|...+.||+|+||.||+|.++ ++..+++|++..... ..+.+.+|++++++++|+|++++++++.. +..
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~ 89 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLV-----GDE 89 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEE-----CCE
Confidence 35567888889999999999999987 588999999865443 56678999999999999999999999874 356
Q ss_pred EEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcc
Q 046270 340 RFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAK 419 (590)
Q Consensus 340 ~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~ 419 (590)
.++|+||+++++|.+++.... ..+++..+..++.+++.||.||| +.+|+|+||||+||+++.++.+||+|||++.
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH---~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~ 164 (286)
T cd06614 90 LWVVMEYMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAA 164 (286)
T ss_pred EEEEEeccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCChhhEEEcCCCCEEECccchhh
Confidence 899999999999999985321 37999999999999999999999 8999999999999999999999999999886
Q ss_pred cccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhh
Q 046270 420 QSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIF 499 (590)
Q Consensus 420 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 499 (590)
....... ......++..|++||++....++.++||||||+++|||++|+.|+....... ....+ .........
T Consensus 165 ~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~-~~~~~-----~~~~~~~~~ 237 (286)
T cd06614 165 QLTKEKS-KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLR-ALFLI-----TTKGIPPLK 237 (286)
T ss_pred hhccchh-hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHH-HHHHH-----HhcCCCCCc
Confidence 5433221 2233457889999999988889999999999999999999999986432211 11111 111111101
Q ss_pred hHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 500 DEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 500 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
+ .......+.+++..|++.+|.+||++.++++.
T Consensus 238 ~-------~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 238 N-------PEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred c-------hhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 1 11123467788999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=314.76 Aligned_cols=240 Identities=25% Similarity=0.309 Sum_probs=183.2
Q ss_pred ecccCcEEEEEEEEcC-CcEEEEEEeecCCC---CChHHHHHHHHHHHhc---CCCCccccceeEEeccCCCCceEEEEE
Q 046270 272 IGQGASGIVYKGTLRH-GNLVAVKQILDLDT---KGDEDFTNEVEIISKI---RHRNLLSLRGCCVTSDDSSGKRRFLVY 344 (590)
Q Consensus 272 LG~G~fG~Vykg~~~~-g~~vAvK~l~~~~~---~~~~~f~~Ev~il~~l---~H~nlv~l~g~~~~~~~~~~~~~~LV~ 344 (590)
||+|+||.||+|+... |..||||++..... .....+..|..++.++ +||||+++++.+.. ....++||
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~-----~~~~~lv~ 75 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQT-----DSDLYLVT 75 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEec-----CCeEEEEE
Confidence 7999999999999864 88999999854221 1223455677777766 69999999988874 45689999
Q ss_pred eeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccccCC
Q 046270 345 DYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEG 424 (590)
Q Consensus 345 E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~~~~ 424 (590)
||+++|+|.+++. ....+++..+..++.||++||+||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 76 e~~~~g~L~~~l~---~~~~~~~~~~~~~~~qil~al~~LH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~ 149 (330)
T cd05586 76 DYMSGGELFWHLQ---KEGRFSEDRAKFYIAELVLALEHLH---KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTD 149 (330)
T ss_pred cCCCCChHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCC
Confidence 9999999998884 3456999999999999999999999 899999999999999999999999999998754332
Q ss_pred CcccccccccCCCccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhhhHHH
Q 046270 425 HSHLTTRVAGTFGYLAPEYALYG-QLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDEFI 503 (590)
Q Consensus 425 ~~~~~~~~~gt~~Y~APE~~~~~-~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 503 (590)
. .......||..|+|||.+.+. .++.++|||||||++|||++|+.||....... .... ...+... +..
T Consensus 150 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~-----~~~~-i~~~~~~-~~~--- 218 (330)
T cd05586 150 N-KTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQ-----MYRN-IAFGKVR-FPK--- 218 (330)
T ss_pred C-CCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHH-----HHHH-HHcCCCC-CCC---
Confidence 2 123345789999999998754 48999999999999999999999986533211 1111 1111110 000
Q ss_pred hhhhHHHHHHHHHHHHHhchhcCCCCCC----CHHHHHH
Q 046270 504 RAEGARAVMERFVLVGILCAHVMVALRP----TITDALK 538 (590)
Q Consensus 504 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RP----tm~eVl~ 538 (590)
......+.+++..|++.||.+|| ++.++++
T Consensus 219 -----~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 219 -----NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred -----ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 01223566788899999999998 4666655
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=298.66 Aligned_cols=244 Identities=28% Similarity=0.359 Sum_probs=196.3
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCC---CCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCce
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLD---TKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKR 339 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~---~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~ 339 (590)
++|...+.||+|+||.||++... +++.+|+|.+.... ....+.+.+|++++++++||||+++++++. .+..
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~ 75 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQ-----DDSN 75 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEE-----cCCe
Confidence 46788899999999999999986 47899999986432 223456889999999999999999999987 3456
Q ss_pred EEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcc
Q 046270 340 RFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAK 419 (590)
Q Consensus 340 ~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~ 419 (590)
.++||||+++++|.+++. ....+++..+..++.|++.||.||| +.+|+||||+|+||++++++.+||+|||+++
T Consensus 76 ~~~v~e~~~~~~L~~~~~---~~~~l~~~~~~~~~~qil~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~dfg~~~ 149 (290)
T cd05580 76 LYLVMEYVPGGELFSHLR---KSGRFPEPVARFYAAQVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAK 149 (290)
T ss_pred EEEEEecCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEeeCCCcc
Confidence 899999999999999885 3357999999999999999999999 8999999999999999999999999999998
Q ss_pred cccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhh
Q 046270 420 QSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIF 499 (590)
Q Consensus 420 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 499 (590)
..... .....|+..|+|||.+.+...+.++||||||++++||++|+.||...... .... ....+...
T Consensus 150 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~-----~~~~~~~~--- 216 (290)
T cd05580 150 RVKGR----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI-QIYE-----KILEGKVR--- 216 (290)
T ss_pred ccCCC----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH-HHHH-----HHhcCCcc---
Confidence 65443 23456889999999998888999999999999999999999998653311 1110 11111110
Q ss_pred hHHHhhhhHHHHHHHHHHHHHhchhcCCCCCC-----CHHHHHH
Q 046270 500 DEFIRAEGARAVMERFVLVGILCAHVMVALRP-----TITDALK 538 (590)
Q Consensus 500 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-----tm~eVl~ 538 (590)
.+......+.+++..|++.+|.+|| +++|+++
T Consensus 217 -------~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 217 -------FPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred -------CCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 0111234677888999999999999 6666654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=322.26 Aligned_cols=246 Identities=26% Similarity=0.378 Sum_probs=202.7
Q ss_pred ccceecccCcEEEEEEEEcC--Cc--EEEEEEeecCCCC-ChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEEE
Q 046270 268 QNNLIGQGASGIVYKGTLRH--GN--LVAVKQILDLDTK-GDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFL 342 (590)
Q Consensus 268 ~~~~LG~G~fG~Vykg~~~~--g~--~vAvK~l~~~~~~-~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~L 342 (590)
..++||+|.||.|++|.|+. |+ .||||.++..... ...+|.+|+.+|.+|+|+|+++|+|...+ ....|
T Consensus 114 l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~------qp~mM 187 (1039)
T KOG0199|consen 114 LYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD------QPAMM 187 (1039)
T ss_pred HHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc------chhhH
Confidence 34689999999999999874 44 6999999765544 56789999999999999999999999873 34789
Q ss_pred EEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCccccc
Q 046270 343 VYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSL 422 (590)
Q Consensus 343 V~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~~ 422 (590)
|+|+++.|+|.+.|+. ..+..|-....-.++.|||.||.||. .+++|||||.++|+||-..-.+||+||||.|.+.
T Consensus 188 V~ELaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLe---skrlvHRDLAARNlllasprtVKI~DFGLmRaLg 263 (1039)
T KOG0199|consen 188 VFELAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLE---SKRLVHRDLAARNLLLASPRTVKICDFGLMRALG 263 (1039)
T ss_pred HhhhcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhhhheecccceeeeecccceeccC
Confidence 9999999999999976 34567888888899999999999999 9999999999999999999999999999999887
Q ss_pred CCCcccc--cccccCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhhHHHHHHHhcCCchhhh
Q 046270 423 EGHSHLT--TRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLDTSTSPFQLITDWAWVLAKSGKVDDIF 499 (590)
Q Consensus 423 ~~~~~~~--~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 499 (590)
.++.+.. ....-...|.|||.+.+.+++.+||||+|||+||||+| |..||-....- + +.+.+
T Consensus 264 ~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~--q-------------IL~~i 328 (1039)
T KOG0199|consen 264 ENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGI--Q-------------ILKNI 328 (1039)
T ss_pred CCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHH--H-------------HHHhc
Confidence 6554432 12223568999999999999999999999999999999 66777543221 1 22234
Q ss_pred hHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 046270 500 DEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALK 538 (590)
Q Consensus 500 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~ 538 (590)
|+.-+-..++...+++.+++..||..+|++|||+..+.+
T Consensus 329 D~~erLpRPk~csedIY~imk~cWah~paDRptFsair~ 367 (1039)
T KOG0199|consen 329 DAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRE 367 (1039)
T ss_pred cccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHH
Confidence 432222345566789999999999999999999999974
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=298.76 Aligned_cols=247 Identities=26% Similarity=0.356 Sum_probs=196.4
Q ss_pred CCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEEEEE
Q 046270 266 FSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFLVY 344 (590)
Q Consensus 266 f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~LV~ 344 (590)
|...+.||+|++|.||++... +++.+++|++........+.+.+|+.++++++|+|++++++++.. +.+.++|+
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~-----~~~~~~v~ 95 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLV-----GDELWVVM 95 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEc-----CCeEEEEE
Confidence 444579999999999999875 578999999865544556678999999999999999999998873 45689999
Q ss_pred eeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccccCC
Q 046270 345 DYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEG 424 (590)
Q Consensus 345 E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~~~~ 424 (590)
||+++++|.+++.. ..+++..+..++.+++.||+||| +.+|+||||||+||+++.++.+||+|||++......
T Consensus 96 e~~~~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~ 168 (285)
T cd06648 96 EFLEGGALTDIVTH----TRMNEEQIATVCLAVLKALSFLH---AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE 168 (285)
T ss_pred eccCCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChhhEEEcCCCcEEEcccccchhhccC
Confidence 99999999998852 46899999999999999999999 899999999999999999999999999988754332
Q ss_pred CcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhhhHHHh
Q 046270 425 HSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDEFIR 504 (590)
Q Consensus 425 ~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 504 (590)
.. ......|+..|+|||.+....++.++||||||++++||++|+.|+..... .. ....... +.. +.+.
T Consensus 169 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~-~~----~~~~~~~-~~~-----~~~~ 236 (285)
T cd06648 169 VP-RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP-LQ----AMKRIRD-NLP-----PKLK 236 (285)
T ss_pred Cc-ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH-HH----HHHHHHh-cCC-----CCCc
Confidence 21 22334688999999999888899999999999999999999999864321 11 1111111 110 0000
Q ss_pred hhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 046270 505 AEGARAVMERFVLVGILCAHVMVALRPTITDALK 538 (590)
Q Consensus 505 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~ 538 (590)
........+.+++..|++.+|++||++.++++
T Consensus 237 --~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 237 --NLHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred --ccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 01112346788999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=303.41 Aligned_cols=246 Identities=28% Similarity=0.398 Sum_probs=192.5
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCCC---ChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCce
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDTK---GDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKR 339 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~~---~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~ 339 (590)
..|...+.||+|+||.||+|+.. +|+.||+|++...... ...++.+|++++++++|||++++.+++.. +..
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~-----~~~ 89 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLR-----EHT 89 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEe-----CCe
Confidence 44777889999999999999986 5889999998643322 23468899999999999999999999984 345
Q ss_pred EEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcc
Q 046270 340 RFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAK 419 (590)
Q Consensus 340 ~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~ 419 (590)
.++||||++ |+|.+++.. ....+++..+..++.|++.||.||| ..+|+||||+|+||++++++.+||+|||++.
T Consensus 90 ~~lv~e~~~-g~l~~~~~~--~~~~l~~~~~~~~~~ql~~~L~~LH---~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~ 163 (307)
T cd06607 90 AWLVMEYCL-GSASDILEV--HKKPLQEVEIAAICHGALQGLAYLH---SHERIHRDIKAGNILLTEPGTVKLADFGSAS 163 (307)
T ss_pred EEEEHHhhC-CCHHHHHHH--cccCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEECCCCCEEEeecCcce
Confidence 899999997 577666642 2346999999999999999999999 8999999999999999999999999999987
Q ss_pred cccCCCcccccccccCCCccCccccc---cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCch
Q 046270 420 QSLEGHSHLTTRVAGTFGYLAPEYAL---YGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVD 496 (590)
Q Consensus 420 ~~~~~~~~~~~~~~gt~~Y~APE~~~---~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 496 (590)
..... ....++..|+|||.+. .+.++.++||||||+++|||+||+.|+....... .+. .. ..+...
T Consensus 164 ~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~-~~~----~~-~~~~~~ 232 (307)
T cd06607 164 LVSPA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-ALY----HI-AQNDSP 232 (307)
T ss_pred ecCCC-----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHH-HHH----HH-hcCCCC
Confidence 54322 2345788999999874 4568899999999999999999999986432211 110 00 001100
Q ss_pred hhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 497 DIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 497 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
.. ........+..++..|++.+|++||+|.+++.+
T Consensus 233 ~~--------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 233 TL--------SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred CC--------CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00 011233467888999999999999999999875
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=298.17 Aligned_cols=258 Identities=20% Similarity=0.222 Sum_probs=184.1
Q ss_pred cCCCccceecccCcEEEEEEEEcCC----cEEEEEEeecCCCCChH-----------HHHHHHHHHHhcCCCCcccccee
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLRHG----NLVAVKQILDLDTKGDE-----------DFTNEVEIISKIRHRNLLSLRGC 328 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~~g----~~vAvK~l~~~~~~~~~-----------~f~~Ev~il~~l~H~nlv~l~g~ 328 (590)
++|...++||+|+||.||+|.+.++ ..+|+|........... ....+...+..+.|+|+++++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 5788889999999999999998654 34556543221111110 12233344556789999999997
Q ss_pred EEeccCCCCceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCC
Q 046270 329 CVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSEL 408 (590)
Q Consensus 329 ~~~~~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~ 408 (590)
+..... .....++++|+... ++.+.+. .....++..+..|+.|+++||+||| +.+|+||||||+|||++.++
T Consensus 92 ~~~~~~-~~~~~~~~~~~~~~-~~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiHrDiKp~Nill~~~~ 163 (294)
T PHA02882 92 GSFKRC-RMYYRFILLEKLVE-NTKEIFK---RIKCKNKKLIKNIMKDMLTTLEYIH---EHGISHGDIKPENIMVDGNN 163 (294)
T ss_pred eeEecC-CceEEEEEEehhcc-CHHHHHH---hhccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCC
Confidence 765432 22345778887643 5555543 2234678889999999999999999 89999999999999999999
Q ss_pred cEEEEeeCCcccccCCCcc------cccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhh
Q 046270 409 NAKVADFGLAKQSLEGHSH------LTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLI 482 (590)
Q Consensus 409 ~~kL~DFGla~~~~~~~~~------~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l 482 (590)
.+||+|||+++........ ......||+.|+|||...+..++.++|||||||+++||++|+.||.........+
T Consensus 164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~ 243 (294)
T PHA02882 164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLI 243 (294)
T ss_pred cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHH
Confidence 9999999999865432211 1223468999999999999999999999999999999999999997653322211
Q ss_pred h----HHHHHHHhcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhc
Q 046270 483 T----DWAWVLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLE 541 (590)
Q Consensus 483 ~----~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~ 541 (590)
. ++...+. .+ .+. .......+.+++..|++.+|++||++.++.+.|+
T Consensus 244 ~~~~~~~~~~~~-~~--------~~~---~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 244 HAAKCDFIKRLH-EG--------KIK---IKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HHhHHHHHHHhh-hh--------hhc---cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 1 1111110 00 000 1112346788899999999999999999998774
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=300.09 Aligned_cols=265 Identities=24% Similarity=0.321 Sum_probs=196.1
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCCC--ChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceE
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDTK--GDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRR 340 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~~--~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~ 340 (590)
++|...+.||+|+||.||+|..+ +++.+|+|.++..... ....+.+|++++++++||||+++++++...+ ....
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~---~~~~ 81 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSN---LDKI 81 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecC---CCcE
Confidence 46788889999999999999987 4789999998643322 2345778999999999999999999987542 2569
Q ss_pred EEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCccc
Q 046270 341 FLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQ 420 (590)
Q Consensus 341 ~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~ 420 (590)
++||||++ ++|.+++... ...+++..++.++.||+.||+||| ..+++|+||||+||+++.++.+||+|||+++.
T Consensus 82 ~lv~e~~~-~~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~ 155 (293)
T cd07843 82 YMVMEYVE-HDLKSLMETM--KQPFLQSEVKCLMLQLLSGVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLARE 155 (293)
T ss_pred EEEehhcC-cCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCcEEEeecCceee
Confidence 99999997 5888877532 236999999999999999999999 88999999999999999999999999999986
Q ss_pred ccCCCcccccccccCCCccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhh--hhHH-------HHHHH
Q 046270 421 SLEGHSHLTTRVAGTFGYLAPEYALYG-QLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQL--ITDW-------AWVLA 490 (590)
Q Consensus 421 ~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~--l~~~-------~~~~~ 490 (590)
...... ......++..|+|||.+.+. .++.++|+||||++++||++|+.||......... +... .|..+
T Consensus 156 ~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (293)
T cd07843 156 YGSPLK-PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGF 234 (293)
T ss_pred ccCCcc-ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHh
Confidence 544321 22334568899999988754 4689999999999999999999998754332110 0000 00000
Q ss_pred hc------CCchhhhhHHHhhhhHHH-HHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 046270 491 KS------GKVDDIFDEFIRAEGARA-VMERFVLVGILCAHVMVALRPTITDALK 538 (590)
Q Consensus 491 ~~------~~~~~~~d~~l~~~~~~~-~~~~l~~l~~~Cl~~dp~~RPtm~eVl~ 538 (590)
.. ..........+....+.. ..+.+.+++..|++.+|++|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 235 SELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred hccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 00 000001111111111111 2446778899999999999999999985
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=298.04 Aligned_cols=269 Identities=23% Similarity=0.308 Sum_probs=199.9
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCC-CC-hHHHHHHHHHHHhcCCCC-ccccceeEEeccC-CCCc
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDT-KG-DEDFTNEVEIISKIRHRN-LLSLRGCCVTSDD-SSGK 338 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~-~~-~~~f~~Ev~il~~l~H~n-lv~l~g~~~~~~~-~~~~ 338 (590)
..|...++||+|.||+||+|+.+ .|+.||+|+++-... ++ .....+|+.+|++|+|+| ||+|.+++...+. ....
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 34555678999999999999976 488999999975443 22 345679999999999999 9999999986542 2234
Q ss_pred eEEEEEeeCCCCCcchhhhhhccc-ccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCC
Q 046270 339 RRFLVYDYMPNGTLSDNISISHKR-KQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGL 417 (590)
Q Consensus 339 ~~~LV~E~~~~gsL~~~L~~~~~~-~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGl 417 (590)
..+||+||+. -+|..++...... ..++...+..++.||++||+||| +++|+||||||.|||+++++.+||+|||+
T Consensus 91 ~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H---~~~IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 91 KLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLH---SHGILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred eEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCcceEEECCCCcEeeeccch
Confidence 6889999995 5888888643321 35777889999999999999999 99999999999999999999999999999
Q ss_pred cccccCCCcccccccccCCCccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcC---
Q 046270 418 AKQSLEGHSHLTTRVAGTFGYLAPEYALYG-QLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSG--- 493 (590)
Q Consensus 418 a~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~--- 493 (590)
|+...... ...+...+|..|.|||.+.+. .|+...||||+||++.||++++..|....+.. ++..... .....
T Consensus 167 Ara~~ip~-~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~-ql~~If~-~lGtP~e~ 243 (323)
T KOG0594|consen 167 ARAFSIPM-RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEID-QLFRIFR-LLGTPNEK 243 (323)
T ss_pred HHHhcCCc-ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHH-HHHHHHH-HcCCCCcc
Confidence 99654322 224566789999999998866 79999999999999999999988886654422 2211111 11100
Q ss_pred Cchhh-----hhHHHhhhh-H-------HHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 494 KVDDI-----FDEFIRAEG-A-------RAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 494 ~~~~~-----~d~~l~~~~-~-------~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
.+..+ .+.....-. . ........+++..|++.+|.+|.|++.++++
T Consensus 244 ~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 244 DWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 00000 000000000 0 0111367788999999999999999999986
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=298.64 Aligned_cols=270 Identities=26% Similarity=0.334 Sum_probs=199.8
Q ss_pred HHHhcCCCccceecccCcEEEEEEEEcC-CcEEEEEEeecCCC--CChHHHHHHHHHHHhcCCCCccccceeEEeccC--
Q 046270 260 EQATNGFSQNNLIGQGASGIVYKGTLRH-GNLVAVKQILDLDT--KGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDD-- 334 (590)
Q Consensus 260 ~~at~~f~~~~~LG~G~fG~Vykg~~~~-g~~vAvK~l~~~~~--~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~-- 334 (590)
+.+.++|+..+.||+|+||.||+|+++. |+.||+|++..... .....+.+|++++++++|||++++++++...++
T Consensus 3 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~ 82 (302)
T cd07864 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDAL 82 (302)
T ss_pred hhhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhh
Confidence 3456789999999999999999999874 78999999865332 234567899999999999999999999875431
Q ss_pred ---CCCceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEE
Q 046270 335 ---SSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAK 411 (590)
Q Consensus 335 ---~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~k 411 (590)
..+...++|+||+++ +|.+.+.. ....+++.+++.|+.||+.||+||| +.+|+||||||+||++++++.+|
T Consensus 83 ~~~~~~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~k 156 (302)
T cd07864 83 DFKKDKGAFYLVFEYMDH-DLMGLLES--GLVHFSEDHIKSFMKQLLEGLNYCH---KKNFLHRDIKCSNILLNNKGQIK 156 (302)
T ss_pred hccccCCcEEEEEcccCc-cHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCcEE
Confidence 123378999999986 66666542 2346999999999999999999999 89999999999999999999999
Q ss_pred EEeeCCcccccCCCcccccccccCCCccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHH
Q 046270 412 VADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALY-GQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLA 490 (590)
Q Consensus 412 L~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~ 490 (590)
|+|||++...............++..|+|||.+.. ..++.++|||||||+++||++|+.||........ +.... ...
T Consensus 157 l~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~-~~~~~-~~~ 234 (302)
T cd07864 157 LADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQ-LELIS-RLC 234 (302)
T ss_pred eCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHH-HHh
Confidence 99999998664433222333456788999998764 3578999999999999999999999875433221 11111 110
Q ss_pred hcCCc---hhh--------hh------HHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 046270 491 KSGKV---DDI--------FD------EFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALK 538 (590)
Q Consensus 491 ~~~~~---~~~--------~d------~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~ 538 (590)
..... .++ .+ ..+... .......+.+++..|++.+|.+||++.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 235 GSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREE-FSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred CCCChhhcccccccccccccccccccccchhhh-cCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 00000 000 00 000000 0112346788999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=316.78 Aligned_cols=244 Identities=30% Similarity=0.410 Sum_probs=196.9
Q ss_pred CCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCCCC---hHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEE
Q 046270 266 FSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDTKG---DEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRF 341 (590)
Q Consensus 266 f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~~~---~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~ 341 (590)
|...+.||.|+||.||.++.. +...||||++.....+. ..++.+|+..|.+++|||.+.+.|||.. ....+
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLr-----e~TaW 102 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLR-----EHTAW 102 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeec-----cchHH
Confidence 555667999999999999976 46789999997655444 4578899999999999999999999984 44589
Q ss_pred EEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccc
Q 046270 342 LVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQS 421 (590)
Q Consensus 342 LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~ 421 (590)
|||||| -||-.|+|... +++|.+.++..|..|.+.||+||| +.+.||||||+.||||.+.+.+||+|||.|...
T Consensus 103 LVMEYC-lGSAsDlleVh--kKplqEvEIAAi~~gaL~gLaYLH---S~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~ 176 (948)
T KOG0577|consen 103 LVMEYC-LGSASDLLEVH--KKPLQEVEIAAITHGALQGLAYLH---SHNRIHRDIKAGNILLSEPGLVKLADFGSASIM 176 (948)
T ss_pred HHHHHH-hccHHHHHHHH--hccchHHHHHHHHHHHHHHHHHHH---HhhHHhhhccccceEecCCCeeeeccccchhhc
Confidence 999999 57888888543 457999999999999999999999 999999999999999999999999999999765
Q ss_pred cCCCcccccccccCCCccCccccc---cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhh
Q 046270 422 LEGHSHLTTRVAGTFGYLAPEYAL---YGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDI 498 (590)
Q Consensus 422 ~~~~~~~~~~~~gt~~Y~APE~~~---~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 498 (590)
.+ ...+.||+.|||||++. .|+|+-|+||||+||+-.||.-.++|+-..+.... +-..+ .+.
T Consensus 177 ~P-----AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSA-LYHIA-----QNe---- 241 (948)
T KOG0577|consen 177 AP-----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-LYHIA-----QNE---- 241 (948)
T ss_pred Cc-----hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHH-HHHHH-----hcC----
Confidence 44 34478999999999876 68999999999999999999999998754332111 11011 111
Q ss_pred hhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 499 FDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 499 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
.|.+ ...+....|..++-.|++.-|++|||.+++++.
T Consensus 242 -sPtL---qs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 242 -SPTL---QSNEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred -CCCC---CCchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 0111 123455678889999999999999998887654
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=288.13 Aligned_cols=252 Identities=28% Similarity=0.412 Sum_probs=201.7
Q ss_pred CCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCC--CChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEE
Q 046270 265 GFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDT--KGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRF 341 (590)
Q Consensus 265 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~--~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~ 341 (590)
+|...+.||+|++|.||+|+.. ++..|++|++..... ...+.+.+|++++++++|+||+++++++.... ....+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---~~~~~ 77 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEE---KNTLN 77 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCC---CCeEE
Confidence 4677889999999999999987 588999999865432 34667999999999999999999999987431 25689
Q ss_pred EEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccc
Q 046270 342 LVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQS 421 (590)
Q Consensus 342 LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~ 421 (590)
+|+||+++++|.+++.. ...++|..+..++.++++||+||| +.+++|+||+|+||+++.++.+||+|||.+...
T Consensus 78 lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh---~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~ 151 (260)
T cd06606 78 IFLEYVSGGSLSSLLKK---FGKLPEPVIRKYTRQILEGLAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRL 151 (260)
T ss_pred EEEEecCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEcccccEEec
Confidence 99999999999998853 337999999999999999999999 899999999999999999999999999999876
Q ss_pred cCCCcc-cccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhhh
Q 046270 422 LEGHSH-LTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFD 500 (590)
Q Consensus 422 ~~~~~~-~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 500 (590)
...... ......++..|+|||.+.....+.++||||||++++||++|+.|+.......... +.....+....
T Consensus 152 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~----~~~~~~~~~~~--- 224 (260)
T cd06606 152 GDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAAL----YKIGSSGEPPE--- 224 (260)
T ss_pred ccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHH----HhccccCCCcC---
Confidence 544321 1234567889999999988889999999999999999999999997654211111 11111011111
Q ss_pred HHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 046270 501 EFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALK 538 (590)
Q Consensus 501 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~ 538 (590)
.+......+.+++.+|++.+|++||++.+++.
T Consensus 225 ------~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 225 ------IPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred ------CCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 11112347788889999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=292.64 Aligned_cols=247 Identities=25% Similarity=0.295 Sum_probs=198.0
Q ss_pred CCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCC---CChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceE
Q 046270 265 GFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDT---KGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRR 340 (590)
Q Consensus 265 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~---~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~ 340 (590)
+|...+.||+|+||.||++..+ .+..+|+|.+..... ...+.+.+|++++++++||||+++++++. .+...
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~ 75 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQ-----DEENM 75 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhc-----CCCeE
Confidence 4778899999999999999987 488999999865322 33567999999999999999999999886 45569
Q ss_pred EEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCccc
Q 046270 341 FLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQ 420 (590)
Q Consensus 341 ~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~ 420 (590)
++|+||+++++|.+++.. ...+++..+..|+.|+++||.||| ..+++|+||||+||++++++.++|+|||++..
T Consensus 76 ~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~ 149 (258)
T cd05578 76 YLVVDLLLGGDLRYHLSQ---KVKFSEEQVKFWICEIVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATK 149 (258)
T ss_pred EEEEeCCCCCCHHHHHHh---cCCcCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEEcCCCCEEEeecccccc
Confidence 999999999999998852 357999999999999999999999 88999999999999999999999999999886
Q ss_pred ccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhhh
Q 046270 421 SLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFD 500 (590)
Q Consensus 421 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 500 (590)
..... ......|+..|+|||.+....++.++||||||+++++|++|+.|+....... . ++....... ...
T Consensus 150 ~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--~-~~~~~~~~~--~~~--- 219 (258)
T cd05578 150 VTPDT--LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI--R-DQIRAKQET--ADV--- 219 (258)
T ss_pred cCCCc--cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccH--H-HHHHHHhcc--ccc---
Confidence 54332 2234567889999999998889999999999999999999999987554321 1 111111110 000
Q ss_pred HHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCH--HHHH
Q 046270 501 EFIRAEGARAVMERFVLVGILCAHVMVALRPTI--TDAL 537 (590)
Q Consensus 501 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm--~eVl 537 (590)
..+......+.+++..|++.+|.+||++ .|++
T Consensus 220 -----~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 220 -----LYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred -----cCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 1111223577788999999999999999 6654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=304.44 Aligned_cols=263 Identities=23% Similarity=0.345 Sum_probs=198.3
Q ss_pred HhcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecC--CCCChHHHHHHHHHHHhcCCCCccccceeEEeccC-CCC
Q 046270 262 ATNGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDL--DTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDD-SSG 337 (590)
Q Consensus 262 at~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~--~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~-~~~ 337 (590)
..++|...+.||+|+||.||+++.. .|..||+|++... .......+.+|++++++++|+||+++++++..... .+.
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 4577999999999999999999976 5889999998542 22234567889999999999999999998864432 123
Q ss_pred ceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCC
Q 046270 338 KRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGL 417 (590)
Q Consensus 338 ~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGl 417 (590)
...++||||+. ++|.+.+. ..+++..+..++.|++.||+||| ..+|+||||||+||+++.++.+||+|||+
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~-----~~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~ 164 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQ-----MDLDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGL 164 (353)
T ss_pred CcEEEEEeccC-CCHHHHHh-----hcCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCcc
Confidence 45799999996 57777663 13899999999999999999999 88999999999999999999999999999
Q ss_pred cccccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCc--
Q 046270 418 AKQSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKV-- 495 (590)
Q Consensus 418 a~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~-- 495 (590)
++...... ......++..|+|||.+.+..++.++||||||+++++|++|+.||...... ..|......-+..
T Consensus 165 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~----~~~~~~~~~~~~~~~ 238 (353)
T cd07850 165 ARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHI----DQWNKIIEQLGTPSD 238 (353)
T ss_pred ceeCCCCC--CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHH----HHHHHHHHhcCCCCH
Confidence 98654322 123345788999999999999999999999999999999999998654321 1111111100100
Q ss_pred -------------------------hhhhhHHHh----hhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 496 -------------------------DDIFDEFIR----AEGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 496 -------------------------~~~~d~~l~----~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
.+.+...+. ..........+.+++..|++.||++|||+.|+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 239 EFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred HHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000000000 00011234467889999999999999999999864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=302.90 Aligned_cols=247 Identities=29% Similarity=0.406 Sum_probs=192.5
Q ss_pred CCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCCC---ChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEE
Q 046270 266 FSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDTK---GDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRF 341 (590)
Q Consensus 266 f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~~---~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~ 341 (590)
|...+.||+|+||.||+|+.. ++..+|+|++...... ...++.+|++++++++|+|++++++++.. +...+
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~~ 101 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLR-----EHTAW 101 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-----CCeEE
Confidence 566788999999999999975 5789999998643222 23468899999999999999999999874 34589
Q ss_pred EEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccc
Q 046270 342 LVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQS 421 (590)
Q Consensus 342 LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~ 421 (590)
+||||++ |+|.+.+.. ....++|.++..++.+++.||.||| ..+|+||||+|+||+++.++.+||+|||++...
T Consensus 102 lv~e~~~-g~l~~~~~~--~~~~l~~~~~~~i~~~i~~~l~~lH---~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~ 175 (317)
T cd06635 102 LVMEYCL-GSASDLLEV--HKKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASIA 175 (317)
T ss_pred EEEeCCC-CCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcccEEECCCCCEEEecCCCcccc
Confidence 9999997 577776642 2456999999999999999999999 899999999999999999999999999998754
Q ss_pred cCCCcccccccccCCCccCccccc---cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhh
Q 046270 422 LEGHSHLTTRVAGTFGYLAPEYAL---YGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDI 498 (590)
Q Consensus 422 ~~~~~~~~~~~~gt~~Y~APE~~~---~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 498 (590)
.. .....|+..|+|||++. .+.++.++||||||+++|||++|+.|+...... ..+..+. ..+.. .
T Consensus 176 ~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~-~~~~~~~----~~~~~-~- 243 (317)
T cd06635 176 SP-----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-SALYHIA----QNESP-T- 243 (317)
T ss_pred CC-----cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH-HHHHHHH----hccCC-C-
Confidence 32 22346788999999974 467899999999999999999999998643211 1111111 11110 0
Q ss_pred hhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhcc
Q 046270 499 FDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEG 542 (590)
Q Consensus 499 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~ 542 (590)
.........+.+++..|++.+|.+||++.++++.+.-
T Consensus 244 -------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~ 280 (317)
T cd06635 244 -------LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFV 280 (317)
T ss_pred -------CCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhh
Confidence 0011223457788889999999999999999986644
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=292.53 Aligned_cols=259 Identities=24% Similarity=0.300 Sum_probs=196.2
Q ss_pred CCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCCC--ChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEEE
Q 046270 266 FSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDTK--GDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFL 342 (590)
Q Consensus 266 f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~~--~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~L 342 (590)
|...+.||+|++|.||++... +|+.+++|++...... ....+.+|++++++++|+|++++++++.. +...++
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~~ 75 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRH-----KGDLYL 75 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhcc-----CCCEEE
Confidence 456678999999999999986 5888999998654322 35678899999999999999999999874 356899
Q ss_pred EEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCccccc
Q 046270 343 VYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSL 422 (590)
Q Consensus 343 V~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~~ 422 (590)
|+||+++ +|.+++.. ....+++..+..++.+++.||.||| +.+|+|+||||+||+++.++.+||+|||.+....
T Consensus 76 v~e~~~~-~l~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~ 149 (283)
T cd05118 76 VFEFMDT-DLYKLIKD--RQRGLPESLIKSYLYQLLQGLAFCH---SHGILHRDLKPENLLINTEGVLKLADFGLARSFG 149 (283)
T ss_pred EEeccCC-CHHHHHHh--hcccCCHHHHHHHHHHHHHHHHHHH---HCCeeecCcCHHHEEECCCCcEEEeeeeeeEecC
Confidence 9999975 88777753 2357999999999999999999999 8999999999999999999999999999998665
Q ss_pred CCCcccccccccCCCccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcC------Cc
Q 046270 423 EGHSHLTTRVAGTFGYLAPEYALYG-QLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSG------KV 495 (590)
Q Consensus 423 ~~~~~~~~~~~gt~~Y~APE~~~~~-~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~------~~ 495 (590)
... .......++..|+|||.+.+. .++.++||||||+++++|+||+.||........ +..... ..... ..
T Consensus 150 ~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~-~~~~~~-~~~~~~~~~~~~~ 226 (283)
T cd05118 150 SPV-RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQ-LFKIFR-TLGTPDPEVWPKF 226 (283)
T ss_pred CCc-ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHH-HcCCCchHhcccc
Confidence 433 122334578899999998876 789999999999999999999998865433111 100000 00000 00
Q ss_pred hhhhhH---HH-------hhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 046270 496 DDIFDE---FI-------RAEGARAVMERFVLVGILCAHVMVALRPTITDALK 538 (590)
Q Consensus 496 ~~~~d~---~l-------~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~ 538 (590)
.+.... .. ...........+.+++..|++.||.+||++.+++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 227 TSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 000000 00 00111234567889999999999999999999986
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=303.63 Aligned_cols=268 Identities=22% Similarity=0.316 Sum_probs=200.5
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCC--CCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCce
Q 046270 263 TNGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLD--TKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKR 339 (590)
Q Consensus 263 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~--~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~ 339 (590)
.++|...+.||+|+||.||+|+.. .|..||+|++.... ......+.+|+.++.+++|+||+++++++..... .+..
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~~~ 82 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGA-DFKD 82 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCC-CCce
Confidence 367888899999999999999976 48899999986532 2334567889999999999999999998765442 4567
Q ss_pred EEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcc
Q 046270 340 RFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAK 419 (590)
Q Consensus 340 ~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~ 419 (590)
.++||||+. ++|.+++. ....+++..+..++.||+.||.||| ..+|+||||||+||++++++.+||+|||+++
T Consensus 83 ~~lv~e~~~-~~l~~~~~---~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~ 155 (334)
T cd07855 83 VYVVMDLME-SDLHHIIH---SDQPLTEEHIRYFLYQLLRGLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMAR 155 (334)
T ss_pred EEEEEehhh-hhHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEecccccce
Confidence 899999995 68888774 3446999999999999999999999 8999999999999999999999999999997
Q ss_pred cccCCCc---ccccccccCCCccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHH------
Q 046270 420 QSLEGHS---HLTTRVAGTFGYLAPEYALY-GQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVL------ 489 (590)
Q Consensus 420 ~~~~~~~---~~~~~~~gt~~Y~APE~~~~-~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~------ 489 (590)
....... .......|+..|+|||.+.. ..++.++||||||+++|||++|+.||........ +.......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~-~~~~~~~~g~~~~~ 234 (334)
T cd07855 156 GLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQ-LKLILSVLGSPSEE 234 (334)
T ss_pred eecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHH-HHHHHHHhCCChhH
Confidence 6533221 11234568899999998765 4689999999999999999999999965432211 11000000
Q ss_pred ----HhcCCchhhhhHHHh------hhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 490 ----AKSGKVDDIFDEFIR------AEGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 490 ----~~~~~~~~~~d~~l~------~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
.......+.++..-. ..........+..++..|++.+|++||++.+++..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 235 VLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred hhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 000000011110000 00001234578899999999999999999999874
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=292.35 Aligned_cols=257 Identities=24% Similarity=0.251 Sum_probs=190.9
Q ss_pred CCccceecccCcEEEEEEEEc-CCcEEEEEEeecCC-CCChHHHHHHHHHHHhcC-CCCccccceeEEeccCCCCceEEE
Q 046270 266 FSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLD-TKGDEDFTNEVEIISKIR-HRNLLSLRGCCVTSDDSSGKRRFL 342 (590)
Q Consensus 266 f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~-~~~~~~f~~Ev~il~~l~-H~nlv~l~g~~~~~~~~~~~~~~L 342 (590)
|...+.||+|+||.||+|+.. ++..+|+|++.... ........+|+.++.++. |+|++++++++... .....++
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~---~~~~~~l 77 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDR---KTGRLAL 77 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecC---CCCcEEE
Confidence 456788999999999999976 57899999986532 222334567999999995 99999999998753 2246899
Q ss_pred EEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCccccc
Q 046270 343 VYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSL 422 (590)
Q Consensus 343 V~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~~ 422 (590)
||||++ |+|.+++.. ....++|.++..++.|++.||+||| ..+++||||||+||+++. +.+||+|||+++...
T Consensus 78 v~e~~~-~~l~~~l~~--~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~ 150 (282)
T cd07831 78 VFELMD-MNLYELIKG--RKRPLPEKRVKSYMYQLLKSLDHMH---RNGIFHRDIKPENILIKD-DILKLADFGSCRGIY 150 (282)
T ss_pred EEecCC-ccHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEcC-CCeEEEecccccccc
Confidence 999997 577777642 2346899999999999999999999 899999999999999999 999999999998654
Q ss_pred CCCcccccccccCCCccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhhhH
Q 046270 423 EGHSHLTTRVAGTFGYLAPEYALY-GQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDE 501 (590)
Q Consensus 423 ~~~~~~~~~~~gt~~Y~APE~~~~-~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 501 (590)
.... .....++..|+|||++.. +.++.++|||||||++|||++|+.||....... .+. +.... .+...+.+..
T Consensus 151 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~-~~~-~~~~~--~~~~~~~~~~ 224 (282)
T cd07831 151 SKPP--YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD-QIA-KIHDV--LGTPDAEVLK 224 (282)
T ss_pred cCCC--cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH-HHH-HHHHH--cCCCCHHHHH
Confidence 3222 223457889999997654 567899999999999999999999996543211 111 11100 0111110000
Q ss_pred HHh-----------------hhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 046270 502 FIR-----------------AEGARAVMERFVLVGILCAHVMVALRPTITDALK 538 (590)
Q Consensus 502 ~l~-----------------~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~ 538 (590)
... ..........+.+++..|++.+|++||++.++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 225 KFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred hhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 000 0001123467889999999999999999999986
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=292.23 Aligned_cols=246 Identities=25% Similarity=0.350 Sum_probs=194.3
Q ss_pred ecccCcEEEEEEEEcC-CcEEEEEEeecCCC---CChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEEEEEeeC
Q 046270 272 IGQGASGIVYKGTLRH-GNLVAVKQILDLDT---KGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFLVYDYM 347 (590)
Q Consensus 272 LG~G~fG~Vykg~~~~-g~~vAvK~l~~~~~---~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~LV~E~~ 347 (590)
||+|+||.||+++..+ |+.+++|.+..... ...+.+.+|++++.+++|+|++++++.+. .+...++||||+
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~~~~lv~e~~ 75 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQ-----GKKNLYLVMEYL 75 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHhee-----cCcEEEEEEecC
Confidence 6899999999999875 88999999865433 34567889999999999999999998876 355689999999
Q ss_pred CCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccccCCCc-
Q 046270 348 PNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHS- 426 (590)
Q Consensus 348 ~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~~~~~~- 426 (590)
++++|.+++.. ...+++..+..++.||+.||+||| +.+++||||+|+||++++++.+||+|||++........
T Consensus 76 ~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~ 149 (265)
T cd05579 76 PGGDLASLLEN---VGSLDEDVARIYIAEIVLALEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQI 149 (265)
T ss_pred CCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccc
Confidence 99999998853 347999999999999999999999 89999999999999999999999999999876543311
Q ss_pred ------ccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhhh
Q 046270 427 ------HLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFD 500 (590)
Q Consensus 427 ------~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 500 (590)
.......++..|++||.......+.++||||||++++||++|+.|+...... . +...... +.... .
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~-~----~~~~~~~-~~~~~--~ 221 (265)
T cd05579 150 NLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE-E----IFQNILN-GKIEW--P 221 (265)
T ss_pred ccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH-H----HHHHHhc-CCcCC--C
Confidence 1223455788999999998888999999999999999999999998643321 1 1111111 11100 0
Q ss_pred HHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhcc
Q 046270 501 EFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEG 542 (590)
Q Consensus 501 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~ 542 (590)
........+..++..|++.+|.+|||+.++.+.|+.
T Consensus 222 ------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~ 257 (265)
T cd05579 222 ------EDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNH 257 (265)
T ss_pred ------ccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcC
Confidence 000023467888999999999999999777776653
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=304.51 Aligned_cols=263 Identities=22% Similarity=0.326 Sum_probs=194.9
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCC--CCChHHHHHHHHHHHhcCCCCccccceeEEeccC-CCCce
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLD--TKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDD-SSGKR 339 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~--~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~-~~~~~ 339 (590)
++|...+.||+|+||.||+|+.. +|+.||||++.... ......+.+|++++++++|+||+++++++..... .....
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 94 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQD 94 (342)
T ss_pred cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCce
Confidence 78888999999999999999975 58899999986432 2224568899999999999999999999875432 12345
Q ss_pred EEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcc
Q 046270 340 RFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAK 419 (590)
Q Consensus 340 ~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~ 419 (590)
.++|+||+.. +|..++ ...+++..+..++.|+++||+||| +.+|+||||||+||+++.++.+||+|||+++
T Consensus 95 ~~lv~e~~~~-~l~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~ 165 (342)
T cd07879 95 FYLVMPYMQT-DLQKIM-----GHPLSEDKVQYLVYQMLCGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLAR 165 (342)
T ss_pred EEEEeccccc-CHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCCCCc
Confidence 7999999964 565543 236899999999999999999999 8999999999999999999999999999987
Q ss_pred cccCCCcccccccccCCCccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCC-chh
Q 046270 420 QSLEGHSHLTTRVAGTFGYLAPEYALY-GQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGK-VDD 497 (590)
Q Consensus 420 ~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~-~~~ 497 (590)
..... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||........ +. ......+. ..+
T Consensus 166 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~-~~---~~~~~~~~~~~~ 237 (342)
T cd07879 166 HADAE----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ-LT---QILKVTGVPGPE 237 (342)
T ss_pred CCCCC----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HH---HHHHhcCCCCHH
Confidence 64322 223456889999999876 4689999999999999999999999975332111 11 10110010 000
Q ss_pred hhhHH-----------H----hhhh---HHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH--hccC
Q 046270 498 IFDEF-----------I----RAEG---ARAVMERFVLVGILCAHVMVALRPTITDALKM--LEGD 543 (590)
Q Consensus 498 ~~d~~-----------l----~~~~---~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~--L~~~ 543 (590)
+.+.. + .... .......+.+++..|++.||++||++.+++.. ++..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~ 303 (342)
T cd07879 238 FVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF 303 (342)
T ss_pred HHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhc
Confidence 00000 0 0000 00123467789999999999999999999864 5543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=286.50 Aligned_cols=247 Identities=27% Similarity=0.452 Sum_probs=198.7
Q ss_pred CCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCC--CChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEE
Q 046270 265 GFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDT--KGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRF 341 (590)
Q Consensus 265 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~--~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~ 341 (590)
+|+..+.||+|++|.||+++.. +++.+++|.+..... ...+.+.+|++++++++|+|++++++++.. +...+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~ 75 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIET-----SDSLY 75 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEe-----CCEEE
Confidence 4677889999999999999876 477999999876543 345679999999999999999999999873 45689
Q ss_pred EEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccc
Q 046270 342 LVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQS 421 (590)
Q Consensus 342 LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~ 421 (590)
+||||+++++|.+++.. ...+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++...
T Consensus 76 ~v~e~~~~~~L~~~~~~---~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~ 149 (254)
T cd06627 76 IILEYAENGSLRQIIKK---FGPFPESLVAVYVYQVLQGLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKL 149 (254)
T ss_pred EEEecCCCCcHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEECCCCCEEEeccccceec
Confidence 99999999999998852 357999999999999999999999 899999999999999999999999999999866
Q ss_pred cCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhhhH
Q 046270 422 LEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDE 501 (590)
Q Consensus 422 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 501 (590)
...... .....++..|+|||......++.++|||+||++++||++|+.|+..... .... |. ... ..... +
T Consensus 150 ~~~~~~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~-~~~~--~~--~~~-~~~~~-~-- 219 (254)
T cd06627 150 NDVSKD-DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP-MAAL--FR--IVQ-DDHPP-L-- 219 (254)
T ss_pred CCCccc-ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH-HHHH--HH--Hhc-cCCCC-C--
Confidence 543321 2345678899999999888889999999999999999999999864331 1111 11 111 11100 1
Q ss_pred HHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 046270 502 FIRAEGARAVMERFVLVGILCAHVMVALRPTITDALK 538 (590)
Q Consensus 502 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~ 538 (590)
+....+.+..++..|++.+|++|||+.+++.
T Consensus 220 ------~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 220 ------PEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred ------CCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 1122346778889999999999999999984
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=298.34 Aligned_cols=247 Identities=24% Similarity=0.340 Sum_probs=201.3
Q ss_pred cCCCccceecccCcEEEEEEEE-cCCcEEEEEEeecCCCCCh---HHHHHHHHHHHhcCCCCccccceeEEeccCCCCce
Q 046270 264 NGFSQNNLIGQGASGIVYKGTL-RHGNLVAVKQILDLDTKGD---EDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKR 339 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~-~~g~~vAvK~l~~~~~~~~---~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~ 339 (590)
.+|...+.||+|.||.|-++.. ..|+.||||.+++..-+.. -.+.+|+++|..|+||||+.++..+.. ...
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFEN-----kdK 127 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFEN-----KDK 127 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcC-----Cce
Confidence 3566667899999999999986 5699999999976544433 357899999999999999999999974 445
Q ss_pred EEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcc
Q 046270 340 RFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAK 419 (590)
Q Consensus 340 ~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~ 419 (590)
..+||||..+|.|.||+. .++.|++.+.+.+++||..|+.|.| +.+++|||||.+|||||.|+++||+|||++-
T Consensus 128 IvivMEYaS~GeLYDYiS---er~~LsErEaRhfFRQIvSAVhYCH---knrVvHRDLKLENILLD~N~NiKIADFGLSN 201 (668)
T KOG0611|consen 128 IVIVMEYASGGELYDYIS---ERGSLSEREARHFFRQIVSAVHYCH---KNRVVHRDLKLENILLDQNNNIKIADFGLSN 201 (668)
T ss_pred EEEEEEecCCccHHHHHH---HhccccHHHHHHHHHHHHHHHHHHh---hccceecccchhheeecCCCCeeeeccchhh
Confidence 899999999999999995 5678999999999999999999999 9999999999999999999999999999997
Q ss_pred cccCCCcccccccccCCCccCccccccCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhh
Q 046270 420 QSLEGHSHLTTRVAGTFGYLAPEYALYGQL-TEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDI 498 (590)
Q Consensus 420 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~-t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 498 (590)
.+..+ ...+.++|++-|.+||.+.+..| .+..|-||+||+||-|+.|..||+..+... ++. ....|...+-
T Consensus 202 ly~~~--kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~-lvr-----QIs~GaYrEP 273 (668)
T KOG0611|consen 202 LYADK--KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKR-LVR-----QISRGAYREP 273 (668)
T ss_pred hhccc--cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHH-HHH-----HhhcccccCC
Confidence 66433 34567899999999999998887 478999999999999999999998643211 111 1122222111
Q ss_pred hhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHh
Q 046270 499 FDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKML 540 (590)
Q Consensus 499 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L 540 (590)
- . +....-++.|++-.+|+.|.|+.+|...-
T Consensus 274 ~-------~----PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 274 E-------T----PSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred C-------C----CchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 1 1 11333467899999999999999998763
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=294.76 Aligned_cols=255 Identities=24% Similarity=0.308 Sum_probs=197.1
Q ss_pred CCCccceecccCcEEEEEEEEc----CCcEEEEEEeecCC----CCChHHHHHHHHHHHhc-CCCCccccceeEEeccCC
Q 046270 265 GFSQNNLIGQGASGIVYKGTLR----HGNLVAVKQILDLD----TKGDEDFTNEVEIISKI-RHRNLLSLRGCCVTSDDS 335 (590)
Q Consensus 265 ~f~~~~~LG~G~fG~Vykg~~~----~g~~vAvK~l~~~~----~~~~~~f~~Ev~il~~l-~H~nlv~l~g~~~~~~~~ 335 (590)
+|...+.||+|+||.||+++.. ++..||||.+.... ....+.+.+|++++.++ +|+|++++++.+.
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~----- 75 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQ----- 75 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeee-----
Confidence 3667789999999999999853 46789999986432 22345688999999999 6999999998876
Q ss_pred CCceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEee
Q 046270 336 SGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADF 415 (590)
Q Consensus 336 ~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DF 415 (590)
.+...++||||+++|+|.+++. ....+++..+..++.|+++||.||| ..+++||||||+||+++.++.++|+||
T Consensus 76 ~~~~~~lv~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~ql~~~l~~lH---~~~~~H~dl~p~nil~~~~~~~~l~df 149 (288)
T cd05583 76 TDTKLHLILDYVNGGELFTHLY---QREHFTESEVRVYIAEIVLALDHLH---QLGIIYRDIKLENILLDSEGHVVLTDF 149 (288)
T ss_pred cCCEEEEEEecCCCCcHHHHHh---hcCCcCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEEEC
Confidence 3456899999999999998885 3346899999999999999999999 899999999999999999999999999
Q ss_pred CCcccccCCCcccccccccCCCccCccccccCC--CCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcC
Q 046270 416 GLAKQSLEGHSHLTTRVAGTFGYLAPEYALYGQ--LTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSG 493 (590)
Q Consensus 416 Gla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~--~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~ 493 (590)
|+++..............|+..|+|||.+.+.. .+.++||||||++++||++|+.|+....... ...++........
T Consensus 150 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~ 228 (288)
T cd05583 150 GLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN-SQSEISRRILKSK 228 (288)
T ss_pred ccccccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc-hHHHHHHHHHccC
Confidence 998875544333333456889999999987655 7889999999999999999999985432211 1111111111110
Q ss_pred CchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhcc
Q 046270 494 KVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEG 542 (590)
Q Consensus 494 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~ 542 (590)
. ..+......+.+++..|++.+|++|||+.+|.+.|+-
T Consensus 229 ~-----------~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 229 P-----------PFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred C-----------CCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 0 0111122356678889999999999999999888764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=294.41 Aligned_cols=251 Identities=24% Similarity=0.302 Sum_probs=193.3
Q ss_pred CCCccceecccCcEEEEEEEEc----CCcEEEEEEeecCC----CCChHHHHHHHHHHHhc-CCCCccccceeEEeccCC
Q 046270 265 GFSQNNLIGQGASGIVYKGTLR----HGNLVAVKQILDLD----TKGDEDFTNEVEIISKI-RHRNLLSLRGCCVTSDDS 335 (590)
Q Consensus 265 ~f~~~~~LG~G~fG~Vykg~~~----~g~~vAvK~l~~~~----~~~~~~f~~Ev~il~~l-~H~nlv~l~g~~~~~~~~ 335 (590)
+|+..+.||+|+||.||++... +|..||+|++.... ....+.+.+|++++.++ +|+||+++++++..
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~---- 76 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT---- 76 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeec----
Confidence 4677889999999999999863 58899999986532 22346688999999999 69999999988763
Q ss_pred CCceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEee
Q 046270 336 SGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADF 415 (590)
Q Consensus 336 ~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DF 415 (590)
+...++||||+++++|.+++. ....+++.....++.|+++||.||| +.+++||||||+|||+++++.+||+||
T Consensus 77 -~~~~~lv~e~~~~~~L~~~l~---~~~~l~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~df 149 (290)
T cd05613 77 -DTKLHLILDYINGGELFTHLS---QRERFKEQEVQIYSGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDF 149 (290)
T ss_pred -CCeEEEEEecCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEECCCCCEEEeeC
Confidence 446899999999999999885 3356889999999999999999999 899999999999999999999999999
Q ss_pred CCcccccCCCcccccccccCCCccCccccccC--CCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcC
Q 046270 416 GLAKQSLEGHSHLTTRVAGTFGYLAPEYALYG--QLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSG 493 (590)
Q Consensus 416 Gla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~--~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~ 493 (590)
|+++..............|+..|+|||++..+ .++.++||||||+++|||++|+.|+....... ...++........
T Consensus 150 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~-~~~~~~~~~~~~~ 228 (290)
T cd05613 150 GLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKN-SQAEISRRILKSE 228 (290)
T ss_pred ccceecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccc-cHHHHHHHhhccC
Confidence 99986544333333345688999999998753 46889999999999999999999986432211 1122222221111
Q ss_pred CchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCC-----CHHHHHH
Q 046270 494 KVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRP-----TITDALK 538 (590)
Q Consensus 494 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-----tm~eVl~ 538 (590)
. ..+......+..++..|++.+|++|| ++.+++.
T Consensus 229 ~-----------~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 229 P-----------PYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred C-----------CCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 1 01112234667788999999999997 5555544
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=289.96 Aligned_cols=249 Identities=27% Similarity=0.396 Sum_probs=199.7
Q ss_pred CCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCC--CCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEE
Q 046270 265 GFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLD--TKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRF 341 (590)
Q Consensus 265 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~--~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~ 341 (590)
+|+..+.||+|+||.||+++.. ++..+++|.+.... .....++.+|++++++++|+||+++++++.. +...+
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~ 75 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLD-----GNKLC 75 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhcc-----CCEEE
Confidence 4777889999999999999876 57889999986432 2234568899999999999999999998873 45699
Q ss_pred EEEeeCCCCCcchhhhhhc-ccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCccc
Q 046270 342 LVYDYMPNGTLSDNISISH-KRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQ 420 (590)
Q Consensus 342 LV~E~~~~gsL~~~L~~~~-~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~ 420 (590)
+||||+++++|.+++.... ....+++..+..++.+++.||.||| ..+++|+||+|+||++++++.+||+|||+++.
T Consensus 76 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh---~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~ 152 (256)
T cd08530 76 IVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKV 152 (256)
T ss_pred EEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEEecCCcEEEeeccchhh
Confidence 9999999999999885422 2356899999999999999999999 89999999999999999999999999999987
Q ss_pred ccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhhh
Q 046270 421 SLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFD 500 (590)
Q Consensus 421 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 500 (590)
.... ......++..|++||++.+..++.++|+||||++++||++|+.|+...... . +. . ....+....+
T Consensus 153 ~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~-~-~~---~-~~~~~~~~~~-- 221 (256)
T cd08530 153 LKKN---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ-D-LR---Y-KVQRGKYPPI-- 221 (256)
T ss_pred hccC---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-H-HH---H-HHhcCCCCCC--
Confidence 6543 222345788999999999889999999999999999999999998654321 1 11 0 1111221111
Q ss_pred HHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 501 EFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 501 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
.......+..++..|++.+|++||++.++++.
T Consensus 222 -------~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 222 -------PPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred -------chhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 11233568889999999999999999999863
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=295.80 Aligned_cols=267 Identities=23% Similarity=0.314 Sum_probs=194.2
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCC--CChHHHHHHHHHHHhcCCCCccccceeEEeccCC---CC
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDT--KGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDS---SG 337 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~--~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~---~~ 337 (590)
++|...+.||+|+||.||+|+.. +++.||||++..... .....+.+|++++++++||||+++++++...+.. ..
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 91 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK 91 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence 46888999999999999999986 488999998864322 2234567899999999999999999998764321 23
Q ss_pred ceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCC
Q 046270 338 KRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGL 417 (590)
Q Consensus 338 ~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGl 417 (590)
...++||||+.+ +|.+.+.. ....+++.+++.++.||+.||+||| +.+++|+||||+||+++.++.+||+|||+
T Consensus 92 ~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~ 165 (310)
T cd07865 92 GSFYLVFEFCEH-DLAGLLSN--KNVKFTLSEIKKVMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGL 165 (310)
T ss_pred ceEEEEEcCCCc-CHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEECCCCcEEECcCCC
Confidence 457999999964 77776642 2346899999999999999999999 88999999999999999999999999999
Q ss_pred cccccCCCcc---cccccccCCCccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHh--
Q 046270 418 AKQSLEGHSH---LTTRVAGTFGYLAPEYALYG-QLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAK-- 491 (590)
Q Consensus 418 a~~~~~~~~~---~~~~~~gt~~Y~APE~~~~~-~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~-- 491 (590)
+......... ......++..|+|||.+.+. .++.++||||||++++||++|+.|+........ +. ....+..
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~-~~-~~~~~~~~~ 243 (310)
T cd07865 166 ARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQ-LT-LISQLCGSI 243 (310)
T ss_pred cccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH-HH-HHHHHhCCC
Confidence 9765432211 12334578899999988654 478899999999999999999999865433211 11 1111110
Q ss_pred ------cCCchhhhhHH---------Hhhh-hHHHHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 046270 492 ------SGKVDDIFDEF---------IRAE-GARAVMERFVLVGILCAHVMVALRPTITDALK 538 (590)
Q Consensus 492 ------~~~~~~~~d~~---------l~~~-~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~ 538 (590)
.....+..+.. +... ........+.+++..|++.||++|||++|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 244 TPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred ChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 00000000000 0000 00001235568999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=296.63 Aligned_cols=251 Identities=25% Similarity=0.417 Sum_probs=191.6
Q ss_pred cCCCccceecccCcEEEEEEEEcC-CcEEEEEEeecCCC-CChHHHHHHHHHHHhcC-CCCccccceeEEeccCCCCceE
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLRH-GNLVAVKQILDLDT-KGDEDFTNEVEIISKIR-HRNLLSLRGCCVTSDDSSGKRR 340 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~vAvK~l~~~~~-~~~~~f~~Ev~il~~l~-H~nlv~l~g~~~~~~~~~~~~~ 340 (590)
++|...+.||+|+||.||+|++++ ++.||||++..... ....++..|++++.+.. |+||+++++++.. +...
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~-----~~~~ 89 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFIT-----DSDV 89 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeec-----CCeE
Confidence 567788999999999999999976 88999999865432 23455777888777775 9999999999974 4569
Q ss_pred EEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCC-CCeEecCCCCCceEECCCCcEEEEeeCCcc
Q 046270 341 FLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLK-PGIYHRDIKSTNILLDSELNAKVADFGLAK 419 (590)
Q Consensus 341 ~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~-~~ivHrDIKp~NILLd~~~~~kL~DFGla~ 419 (590)
++||||++ ++|.+++.. ....+++..+..|+.+|++||+||| . .+|+||||+|+||++++++.+||+|||++.
T Consensus 90 ~~v~e~~~-~~l~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~lH---~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~ 163 (296)
T cd06618 90 FICMELMS-TCLDKLLKR--IQGPIPEDILGKMTVAIVKALHYLK---EKHGVIHRDVKPSNILLDASGNVKLCDFGISG 163 (296)
T ss_pred EEEeeccC-cCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHH---hhCCEecCCCcHHHEEEcCCCCEEECccccch
Confidence 99999985 467666532 2347999999999999999999999 5 589999999999999999999999999987
Q ss_pred cccCCCcccccccccCCCccCccccccC----CCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCc
Q 046270 420 QSLEGHSHLTTRVAGTFGYLAPEYALYG----QLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKV 495 (590)
Q Consensus 420 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~----~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~ 495 (590)
....... .....++..|+|||++... .++.++||||||+++|||++|+.||.........+. .......
T Consensus 164 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~----~~~~~~~- 236 (296)
T cd06618 164 RLVDSKA--KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLT----KILQEEP- 236 (296)
T ss_pred hccCCCc--ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHH----HHhcCCC-
Confidence 6543222 2234578899999998754 388999999999999999999999865332222111 1111110
Q ss_pred hhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 496 DDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 496 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
...-. .....+.+.+++..|++.+|++||++.+++++
T Consensus 237 ~~~~~-------~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 237 PSLPP-------NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred CCCCC-------CCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00000 00123467888999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=298.18 Aligned_cols=255 Identities=26% Similarity=0.350 Sum_probs=190.3
Q ss_pred CCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCC-CChHHHHHHHHHHHhcC-CCCccccceeEEeccCCCCceEE
Q 046270 265 GFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDT-KGDEDFTNEVEIISKIR-HRNLLSLRGCCVTSDDSSGKRRF 341 (590)
Q Consensus 265 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~-~~~~~f~~Ev~il~~l~-H~nlv~l~g~~~~~~~~~~~~~~ 341 (590)
+|...+.||+|+||.||+++.. .|+.+|+|++..... .....+.+|+.++.++. |+||+++++++.. ....+
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~-----~~~~~ 79 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFR-----EGDCW 79 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEec-----CCcEE
Confidence 3445678999999999999986 478999999864332 33457889999999996 9999999998874 34589
Q ss_pred EEEeeCCCCCcchhhhh--hcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcc
Q 046270 342 LVYDYMPNGTLSDNISI--SHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAK 419 (590)
Q Consensus 342 LV~E~~~~gsL~~~L~~--~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~ 419 (590)
++|||+. ++|.++... ......+++.....++.+++.||+|||+ ..+|+||||||+||+++.++.+||+|||+++
T Consensus 80 ~~~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~ 156 (288)
T cd06616 80 ICMELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISG 156 (288)
T ss_pred EEEeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh--cCCeeccCCCHHHEEEccCCcEEEeecchhH
Confidence 9999986 455543321 1123569999999999999999999993 2589999999999999999999999999997
Q ss_pred cccCCCcccccccccCCCccCccccccC---CCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCch
Q 046270 420 QSLEGHSHLTTRVAGTFGYLAPEYALYG---QLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVD 496 (590)
Q Consensus 420 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~---~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 496 (590)
...... ......|+..|+|||.+... .++.++||||||+++|||++|+.||.........+. ... .+..
T Consensus 157 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~----~~~-~~~~- 228 (288)
T cd06616 157 QLVDSI--AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLT----QVV-KGDP- 228 (288)
T ss_pred HhccCC--ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHh----hhc-CCCC-
Confidence 654322 12334578899999998766 689999999999999999999999864332111111 100 0111
Q ss_pred hhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 497 DIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 497 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
+.+...........+.+++..|++.+|++|||+.+|++.
T Consensus 229 ----~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 229 ----PILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred ----CcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 011111111234577889999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=289.29 Aligned_cols=242 Identities=25% Similarity=0.265 Sum_probs=191.3
Q ss_pred ecccCcEEEEEEEEcC-CcEEEEEEeecCCC---CChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEEEEEeeC
Q 046270 272 IGQGASGIVYKGTLRH-GNLVAVKQILDLDT---KGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFLVYDYM 347 (590)
Q Consensus 272 LG~G~fG~Vykg~~~~-g~~vAvK~l~~~~~---~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~LV~E~~ 347 (590)
||.|+||.||+++... ++.+|+|.+..... ...+.+.+|++++++++|+||+++++++. .+...++|+||+
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv~e~~ 75 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFK-----DKKYIYMLMEYC 75 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEE-----cCCccEEEEecC
Confidence 6999999999999875 78999999865332 23467999999999999999999999886 345689999999
Q ss_pred CCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccccCCCcc
Q 046270 348 PNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSH 427 (590)
Q Consensus 348 ~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~~~~~~~ 427 (590)
++++|.+++. +...+++..+..++.||+.||+||| +.+++|+||||+||+++.++.+||+|||+++......
T Consensus 76 ~~~~L~~~l~---~~~~l~~~~~~~~~~~i~~~l~~lH---~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~-- 147 (262)
T cd05572 76 LGGELWTILR---DRGLFDEYTARFYIACVVLAFEYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-- 147 (262)
T ss_pred CCCcHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--
Confidence 9999999985 3346899999999999999999999 8999999999999999999999999999998664432
Q ss_pred cccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhhhHHHhhhh
Q 046270 428 LTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDEFIRAEG 507 (590)
Q Consensus 428 ~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 507 (590)
......|+..|++||.+....++.++|+||||+++|||++|+.|+.....+... ........... ...
T Consensus 148 ~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---~~~~~~~~~~~---------~~~ 215 (262)
T cd05572 148 KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPME---IYNDILKGNGK---------LEF 215 (262)
T ss_pred ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHH---HHHHHhccCCC---------CCC
Confidence 223346788999999998888999999999999999999999999754421111 11111100000 001
Q ss_pred HHHHHHHHHHHHHhchhcCCCCCCC-----HHHHHH
Q 046270 508 ARAVMERFVLVGILCAHVMVALRPT-----ITDALK 538 (590)
Q Consensus 508 ~~~~~~~l~~l~~~Cl~~dp~~RPt-----m~eVl~ 538 (590)
+......+..++..|++.+|++||+ +.|+++
T Consensus 216 ~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 216 PNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred CcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 1112347788999999999999999 555554
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=295.84 Aligned_cols=261 Identities=23% Similarity=0.305 Sum_probs=192.2
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCC--CChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceE
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDT--KGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRR 340 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~--~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~ 340 (590)
++|...+.||+|++|.||+|+.+ +|+.||+|++..... ...+.+.+|++++++++|+|++++++++.. +...
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~ 76 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHS-----EKRL 76 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEec-----CCeE
Confidence 46888899999999999999986 588999998854322 234578899999999999999999999873 4569
Q ss_pred EEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECC-CCcEEEEeeCCcc
Q 046270 341 FLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDS-ELNAKVADFGLAK 419 (590)
Q Consensus 341 ~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~-~~~~kL~DFGla~ 419 (590)
++||||++ ++|.+++... ....+++.....++.||+.||+||| +.+++||||||+||+++. ++.+||+|||++.
T Consensus 77 ~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~ 151 (294)
T PLN00009 77 YLVFEYLD-LDLKKHMDSS-PDFAKNPRLIKTYLYQILRGIAYCH---SHRVLHRDLKPQNLLIDRRTNALKLADFGLAR 151 (294)
T ss_pred EEEEeccc-ccHHHHHHhC-CCCCcCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCcceEEEECCCCEEEEccccccc
Confidence 99999996 5777776422 2234678888899999999999999 889999999999999985 4679999999997
Q ss_pred cccCCCcccccccccCCCccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcC-----
Q 046270 420 QSLEGHSHLTTRVAGTFGYLAPEYALYG-QLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSG----- 493 (590)
Q Consensus 420 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~----- 493 (590)
...... .......++..|+|||++.+. .++.++||||||+++|||+||+.||........... ... ....+
T Consensus 152 ~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~-~~~-~~~~~~~~~~ 228 (294)
T PLN00009 152 AFGIPV-RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFK-IFR-ILGTPNEETW 228 (294)
T ss_pred ccCCCc-cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHH-HhCCCChhhc
Confidence 543321 122334568899999988654 578999999999999999999999875433221111 000 00000
Q ss_pred ----Cchhhhh-------HHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 046270 494 ----KVDDIFD-------EFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALK 538 (590)
Q Consensus 494 ----~~~~~~d-------~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~ 538 (590)
.+.+... ..+ ..........+.+++..|++.+|++||++.++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 229 PGVTSLPDYKSAFPKWPPKDL-ATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred cccccchhhhhhcccCCCCCH-HHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000000 000 0001123346788999999999999999999986
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=295.88 Aligned_cols=244 Identities=25% Similarity=0.362 Sum_probs=192.8
Q ss_pred ceecccCcEEEEEEEEc-CCcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEEEEEeeCC
Q 046270 270 NLIGQGASGIVYKGTLR-HGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFLVYDYMP 348 (590)
Q Consensus 270 ~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~LV~E~~~ 348 (590)
.+||+|+||.||++..+ +|..||||++..........+.+|+.++++++|+|++++++++.. +...++||||++
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv~e~~~ 100 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLV-----GDELWVVMEFLE 100 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEe-----CCEEEEEEecCC
Confidence 57999999999999885 588999999865444456678999999999999999999999874 456999999999
Q ss_pred CCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccccCCCccc
Q 046270 349 NGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHL 428 (590)
Q Consensus 349 ~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~~~~~~~~ 428 (590)
+++|.+++. ...+++.....++.|++.||+||| +.+++||||||+||+++.++.++|+|||++....... ..
T Consensus 101 ~~~L~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH---~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~-~~ 172 (292)
T cd06657 101 GGALTDIVT----HTRMNEEQIAAVCLAVLKALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PR 172 (292)
T ss_pred CCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEcccccceeccccc-cc
Confidence 999998773 335899999999999999999999 8899999999999999999999999999987554322 12
Q ss_pred ccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhhhHHHhhhhH
Q 046270 429 TTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDEFIRAEGA 508 (590)
Q Consensus 429 ~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 508 (590)
.....|+.+|+|||++....++.++||||||++++||++|+.|+...... ..+.. ...+. ...+.. .
T Consensus 173 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~-~~~~~-----~~~~~-----~~~~~~--~ 239 (292)
T cd06657 173 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL-KAMKM-----IRDNL-----PPKLKN--L 239 (292)
T ss_pred ccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHH-----HHhhC-----CcccCC--c
Confidence 23356789999999998888999999999999999999999998643221 11110 00000 000000 0
Q ss_pred HHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 509 RAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 509 ~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
......+..++..|++.+|.+||++.++++.
T Consensus 240 ~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 240 HKVSPSLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred ccCCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 1122356677889999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=320.51 Aligned_cols=266 Identities=19% Similarity=0.251 Sum_probs=185.4
Q ss_pred HhcCCCccceecccCcEEEEEEEEcC--CcEEEEEE--------------ee---cCCCCChHHHHHHHHHHHhcCCCCc
Q 046270 262 ATNGFSQNNLIGQGASGIVYKGTLRH--GNLVAVKQ--------------IL---DLDTKGDEDFTNEVEIISKIRHRNL 322 (590)
Q Consensus 262 at~~f~~~~~LG~G~fG~Vykg~~~~--g~~vAvK~--------------l~---~~~~~~~~~f~~Ev~il~~l~H~nl 322 (590)
..++|...+.||+|+||.||++.++. +...++|. +. .........+.+|+++|++++|+||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 45689999999999999999987643 22222221 10 1111223468899999999999999
Q ss_pred cccceeEEeccCCCCceEEEEEeeCCCCCcchhhhhhc--ccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCC
Q 046270 323 LSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISH--KRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKST 400 (590)
Q Consensus 323 v~l~g~~~~~~~~~~~~~~LV~E~~~~gsL~~~L~~~~--~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~ 400 (590)
+++++++... ...++|+|++. ++|.+++.... ........+...|+.||+.||.||| +.+|+||||||+
T Consensus 226 v~l~~~~~~~-----~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH---~~gIiHrDLKP~ 296 (501)
T PHA03210 226 LKIEEILRSE-----ANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH---DKKLIHRDIKLE 296 (501)
T ss_pred CcEeEEEEEC-----CeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHH
Confidence 9999998743 35899999985 56666664221 1122345667789999999999999 899999999999
Q ss_pred ceEECCCCcEEEEeeCCcccccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCC-CCCCCC-c
Q 046270 401 NILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKV-LDTSTS-P 478 (590)
Q Consensus 401 NILLd~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p-~~~~~~-~ 478 (590)
|||++.++.+||+|||+++..............||..|+|||++.+..++.++|||||||++|||++|+.+ +..... +
T Consensus 297 NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~ 376 (501)
T PHA03210 297 NIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKP 376 (501)
T ss_pred HEEECCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCH
Confidence 99999999999999999987654433334456799999999999999999999999999999999998754 432221 1
Q ss_pred hhhhhHHHHHHHh-cCCc-------hhhh------------hHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 046270 479 FQLITDWAWVLAK-SGKV-------DDIF------------DEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALK 538 (590)
Q Consensus 479 ~~~l~~~~~~~~~-~~~~-------~~~~------------d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~ 538 (590)
...+.+....+.. .... .+.+ .+.+.. ......+..++..|++.||.+|||+.|++.
T Consensus 377 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~---~~~~~~~~~li~kmL~~DP~~Rpsa~elL~ 453 (501)
T PHA03210 377 GKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRN---LGLPADFEYPLVKMLTFDWHLRPGAAELLA 453 (501)
T ss_pred HHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHh---cCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence 1122111111000 0000 0000 011110 011234566788999999999999999987
Q ss_pred H
Q 046270 539 M 539 (590)
Q Consensus 539 ~ 539 (590)
+
T Consensus 454 h 454 (501)
T PHA03210 454 L 454 (501)
T ss_pred C
Confidence 4
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=289.02 Aligned_cols=251 Identities=25% Similarity=0.339 Sum_probs=194.7
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCC-----CCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCC
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLD-----TKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSG 337 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~-----~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~ 337 (590)
.+|...+.||+|+||.||+|.+. ++..||+|.+.... .+....+.+|++++++++|+||+++++++... .+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~---~~ 78 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDP---EE 78 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcC---CC
Confidence 46888899999999999999976 48899999874321 12235788999999999999999999987643 23
Q ss_pred ceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCC
Q 046270 338 KRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGL 417 (590)
Q Consensus 338 ~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGl 417 (590)
...++|+||+++++|.+++. ....+++.....++.+++.||.||| +.+++|+||||+||+++.++.++|+|||+
T Consensus 79 ~~~~~v~e~~~~~~L~~~~~---~~~~l~~~~~~~~~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~ 152 (264)
T cd06653 79 KKLSIFVEYMPGGSIKDQLK---AYGALTENVTRRYTRQILQGVSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGA 152 (264)
T ss_pred CEEEEEEEeCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECcccc
Confidence 56889999999999999885 3345899999999999999999999 89999999999999999999999999999
Q ss_pred cccccCCC--cccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCc
Q 046270 418 AKQSLEGH--SHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKV 495 (590)
Q Consensus 418 a~~~~~~~--~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~ 495 (590)
++...... ........|+..|+|||++.+..++.++||||||++++||++|+.||....... .+.+ ....+ .
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~----~~~~~-~ 226 (264)
T cd06653 153 SKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMA-AIFK----IATQP-T 226 (264)
T ss_pred ccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHH-HHHH----HHcCC-C
Confidence 98653211 111234568899999999988889999999999999999999999986432211 1111 01111 1
Q ss_pred hhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 046270 496 DDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALK 538 (590)
Q Consensus 496 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~ 538 (590)
...+ +....+.+.+++..|++ +|..||+..+++.
T Consensus 227 ~~~~--------p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 227 KPML--------PDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred CCCC--------CcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 1111 12233466778888998 5799999998775
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=296.29 Aligned_cols=265 Identities=24% Similarity=0.284 Sum_probs=194.9
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCCC--ChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCce
Q 046270 263 TNGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDTK--GDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKR 339 (590)
Q Consensus 263 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~~--~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~ 339 (590)
.++|...+.||+|+||.||+|+.. .|..||+|++...... ....+.+|++++++++|+|++++++++.... ...
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~---~~~ 82 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKH---LDS 82 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCC---CCe
Confidence 457888999999999999999986 4889999998643222 2335678999999999999999999986432 245
Q ss_pred EEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcc
Q 046270 340 RFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAK 419 (590)
Q Consensus 340 ~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~ 419 (590)
.++||||+. ++|.+++... ...+++.++..++.||++||+||| +.+++||||||+||++++++.+||+|||+++
T Consensus 83 ~~lv~e~~~-~~l~~~l~~~--~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~ 156 (309)
T cd07845 83 IFLVMEYCE-QDLASLLDNM--PTPFSESQVKCLMLQLLRGLQYLH---ENFIIHRDLKVSNLLLTDKGCLKIADFGLAR 156 (309)
T ss_pred EEEEEecCC-CCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccceee
Confidence 899999996 4788777532 356999999999999999999999 8999999999999999999999999999998
Q ss_pred cccCCCcccccccccCCCccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHH----------H
Q 046270 420 QSLEGHSHLTTRVAGTFGYLAPEYALY-GQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAW----------V 488 (590)
Q Consensus 420 ~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~----------~ 488 (590)
....... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||....... .+..... .
T Consensus 157 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~-~~~~~~~~~~~~~~~~~~ 234 (309)
T cd07845 157 TYGLPAK-PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIE-QLDLIIQLLGTPNESIWP 234 (309)
T ss_pred ecCCccC-CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCChhhch
Confidence 6543321 1222345788999998865 457899999999999999999999987543321 1111100 0
Q ss_pred HHhcCCchhhh--h----HHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 489 LAKSGKVDDIF--D----EFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 489 ~~~~~~~~~~~--d----~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
..........+ . ..+.. ........+.+++..|++.||++|||+.++++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 235 GFSDLPLVGKFTLPKQPYNNLKH-KFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred hhhcccccccccccCCCCCchHH-hccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00000000000 0 00000 000123456778999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=288.43 Aligned_cols=265 Identities=23% Similarity=0.311 Sum_probs=196.1
Q ss_pred CCccceecccCcEEEEEEEEcC-CcEEEEEEeecCCCC--ChHHHHHHHHHHHhc---CCCCccccceeEEeccCCCCce
Q 046270 266 FSQNNLIGQGASGIVYKGTLRH-GNLVAVKQILDLDTK--GDEDFTNEVEIISKI---RHRNLLSLRGCCVTSDDSSGKR 339 (590)
Q Consensus 266 f~~~~~LG~G~fG~Vykg~~~~-g~~vAvK~l~~~~~~--~~~~f~~Ev~il~~l---~H~nlv~l~g~~~~~~~~~~~~ 339 (590)
|+..+.||+|+||.||+|+++. +..+|+|++...... ....+.+|++++.++ +|+|++++++++...+......
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 5667899999999999999875 889999998643221 234577888887776 5999999999998665433445
Q ss_pred EEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcc
Q 046270 340 RFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAK 419 (590)
Q Consensus 340 ~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~ 419 (590)
.+++|||++ ++|.+++... ....++|..++.++.|++.||.||| +.+++|+||+|+||+++.++.+||+|||++.
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~-~~~~l~~~~~~~~~~~i~~al~~LH---~~~i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKC-PKPGLPPETIKDLMRQLLRGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred eEEEehhcc-cCHHHHHHHc-cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhEEEccCCCEEEeccCcce
Confidence 899999997 4788877532 2235999999999999999999999 8999999999999999999999999999997
Q ss_pred cccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCc----
Q 046270 420 QSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKV---- 495 (590)
Q Consensus 420 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~---- 495 (590)
....... .....++..|+|||++....++.++||||||++++||++|+.|+...... ..+..+.......+..
T Consensus 156 ~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07838 156 IYSFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEA-DQLDKIFDVIGLPSEEEWPR 232 (287)
T ss_pred eccCCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChH-HHHHHHHHHcCCCChHhcCC
Confidence 6543321 22334788999999999999999999999999999999999888654332 1121111110000000
Q ss_pred -----hhhhhHHHh---hhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 046270 496 -----DDIFDEFIR---AEGARAVMERFVLVGILCAHVMVALRPTITDALK 538 (590)
Q Consensus 496 -----~~~~d~~l~---~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~ 538 (590)
...+..... .....+....+.+++..|++.||.+||++.+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 233 NVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred CcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 000000000 1111233457788999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-34 Score=287.89 Aligned_cols=248 Identities=23% Similarity=0.232 Sum_probs=188.0
Q ss_pred HHHHHhcCCCcccee--cccCcEEEEEEEEc-CCcEEEEEEeecCCCCChHHHHHHHHHHHhc-CCCCccccceeEEecc
Q 046270 258 ELEQATNGFSQNNLI--GQGASGIVYKGTLR-HGNLVAVKQILDLDTKGDEDFTNEVEIISKI-RHRNLLSLRGCCVTSD 333 (590)
Q Consensus 258 el~~at~~f~~~~~L--G~G~fG~Vykg~~~-~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l-~H~nlv~l~g~~~~~~ 333 (590)
+.....++|...+.+ |+|+||.||+++.+ ++..+|+|.+........ |+.....+ +|+|++++++.+..
T Consensus 8 ~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~-- 80 (267)
T PHA03390 8 ELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTT-- 80 (267)
T ss_pred HHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEec--
Confidence 344445666666666 99999999999876 477899998754322111 23222222 79999999999874
Q ss_pred CCCCceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCC-cEEE
Q 046270 334 DSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSEL-NAKV 412 (590)
Q Consensus 334 ~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~-~~kL 412 (590)
....++||||+++++|.+++. ....++|.++..++.||++||.||| +.+++||||||+||+++.++ .++|
T Consensus 81 ---~~~~~iv~e~~~~~~L~~~l~---~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~l 151 (267)
T PHA03390 81 ---LKGHVLIMDYIKDGDLFDLLK---KEGKLSEAEVKKIIRQLVEALNDLH---KHNIIHNDIKLENVLYDRAKDRIYL 151 (267)
T ss_pred ---CCeeEEEEEcCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEeCCCCeEEE
Confidence 346999999999999999885 2337999999999999999999999 89999999999999999998 9999
Q ss_pred EeeCCcccccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhc
Q 046270 413 ADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKS 492 (590)
Q Consensus 413 ~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~ 492 (590)
+|||+++..... ....|+..|+|||++....++.++||||||++++||++|+.||.........+..|....
T Consensus 152 ~dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--- 223 (267)
T PHA03390 152 CDYGLCKIIGTP-----SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ--- 223 (267)
T ss_pred ecCccceecCCC-----ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh---
Confidence 999998754322 224578999999999988999999999999999999999999974433222223332221
Q ss_pred CCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCC-HHHHHH
Q 046270 493 GKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPT-ITDALK 538 (590)
Q Consensus 493 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt-m~eVl~ 538 (590)
....... ......+.+++..|++.+|.+||+ ++|+++
T Consensus 224 ~~~~~~~---------~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 224 QKKLPFI---------KNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred cccCCcc---------cccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 1000111 123346778888999999999996 688874
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=293.41 Aligned_cols=242 Identities=20% Similarity=0.242 Sum_probs=183.2
Q ss_pred eecccCcEEEEEEEEc-CCcEEEEEEeecCCC---CChHHHHHHHHHHHh---cCCCCccccceeEEeccCCCCceEEEE
Q 046270 271 LIGQGASGIVYKGTLR-HGNLVAVKQILDLDT---KGDEDFTNEVEIISK---IRHRNLLSLRGCCVTSDDSSGKRRFLV 343 (590)
Q Consensus 271 ~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~---~~~~~f~~Ev~il~~---l~H~nlv~l~g~~~~~~~~~~~~~~LV 343 (590)
.||+|+||.||++... +++.+|+|.+..... .....+.+|..++.. .+|+|++.+.+++.. +...++|
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~-----~~~~~lv 75 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHT-----PDKLCFI 75 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEec-----CCeEEEE
Confidence 4899999999999986 478999998865322 112334455544443 479999999888873 3468999
Q ss_pred EeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccccC
Q 046270 344 YDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLE 423 (590)
Q Consensus 344 ~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~~~ 423 (590)
|||+++|+|.+++. ..+.++|..+..|+.|++.||.||| ..+|+||||||+|||+++++.+||+|||++.....
T Consensus 76 ~e~~~~~~L~~~i~---~~~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~ 149 (279)
T cd05633 76 LDLMNGGDLHYHLS---QHGVFSEKEMRFYATEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK 149 (279)
T ss_pred EecCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHH---HCCcCCCCCCHHHEEECCCCCEEEccCCcceeccc
Confidence 99999999998885 3456999999999999999999999 89999999999999999999999999999875432
Q ss_pred CCcccccccccCCCccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhhhHH
Q 046270 424 GHSHLTTRVAGTFGYLAPEYALY-GQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDEF 502 (590)
Q Consensus 424 ~~~~~~~~~~gt~~Y~APE~~~~-~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 502 (590)
.. .....|+..|+|||.+.. ..++.++||||||++++||++|+.||......... ........ ...
T Consensus 150 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~---~~~~~~~~------~~~- 216 (279)
T cd05633 150 KK---PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH---EIDRMTLT------VNV- 216 (279)
T ss_pred cC---ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH---HHHHHhhc------CCc-
Confidence 21 223468999999998864 45899999999999999999999999654332111 01110000 000
Q ss_pred HhhhhHHHHHHHHHHHHHhchhcCCCCCC-----CHHHHHHH
Q 046270 503 IRAEGARAVMERFVLVGILCAHVMVALRP-----TITDALKM 539 (590)
Q Consensus 503 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-----tm~eVl~~ 539 (590)
..+......+..++..|++.||++|| |+.|++++
T Consensus 217 ---~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 217 ---ELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred ---CCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 01112334677888999999999999 59998875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=287.58 Aligned_cols=251 Identities=28% Similarity=0.367 Sum_probs=201.3
Q ss_pred CCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCC--CChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEE
Q 046270 265 GFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDT--KGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRF 341 (590)
Q Consensus 265 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~--~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~ 341 (590)
+|...+.||+|+||.||++... ++..+++|++..... .....+.+|++++++++|+|++++++.+.. +...+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~-----~~~~~ 75 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEE-----KGKLC 75 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEec-----CCEEE
Confidence 4777889999999999999986 478999999865433 345678999999999999999999998873 45689
Q ss_pred EEEeeCCCCCcchhhhhhc-ccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCccc
Q 046270 342 LVYDYMPNGTLSDNISISH-KRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQ 420 (590)
Q Consensus 342 LV~E~~~~gsL~~~L~~~~-~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~ 420 (590)
+|+||+++++|.+++.... ....+++..+..++.+++.||.||| +.+++|+||+|+||++++++.++|+|||++..
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~ 152 (258)
T cd08215 76 IVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKV 152 (258)
T ss_pred EEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHHeEEcCCCcEEECCccceee
Confidence 9999999999999886432 1367999999999999999999999 88999999999999999999999999999986
Q ss_pred ccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhhh
Q 046270 421 SLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFD 500 (590)
Q Consensus 421 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 500 (590)
..... .......|+..|+|||......++.++||||||+++++|++|+.|+...... +....... .....+
T Consensus 153 ~~~~~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~-----~~~~~~~~-~~~~~~-- 223 (258)
T cd08215 153 LSSTV-DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLL-----ELALKILK-GQYPPI-- 223 (258)
T ss_pred cccCc-ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHH-----HHHHHHhc-CCCCCC--
Confidence 54432 2233456788999999998888999999999999999999999998643321 11111111 111111
Q ss_pred HHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 501 EFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 501 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
+......+..++..|++.+|++|||+.|+++.
T Consensus 224 -------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 224 -------PSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred -------CCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 11223467788999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=304.11 Aligned_cols=251 Identities=27% Similarity=0.358 Sum_probs=205.7
Q ss_pred hcCCCccceecccCcEEEEEEEEcC-CcEEEEEEeecCCCCC---hHHHHHHHHHHHhcC-CCCccccceeEEeccCCCC
Q 046270 263 TNGFSQNNLIGQGASGIVYKGTLRH-GNLVAVKQILDLDTKG---DEDFTNEVEIISKIR-HRNLLSLRGCCVTSDDSSG 337 (590)
Q Consensus 263 t~~f~~~~~LG~G~fG~Vykg~~~~-g~~vAvK~l~~~~~~~---~~~f~~Ev~il~~l~-H~nlv~l~g~~~~~~~~~~ 337 (590)
...|...+.||+|.||.||+++.+. |+.+|+|.+.+....+ .+.+.+|+.+|+++. |||+|.+.+.+...+
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~---- 109 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPD---- 109 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCC----
Confidence 3457777899999999999999886 8999999997654433 458999999999998 999999999998543
Q ss_pred ceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCC----CcEEEE
Q 046270 338 KRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSE----LNAKVA 413 (590)
Q Consensus 338 ~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~----~~~kL~ 413 (590)
..++|||++.+|.|.+.+... .+++.....++.||+.++.||| ..+|+||||||+|+|+... +.+|++
T Consensus 110 -~~~lvmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH---~~gvvHrDlKpEN~L~~~~~~~~~~ik~~ 181 (382)
T KOG0032|consen 110 -SVYLVMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLH---SLGVVHRDLKPENLLLASKDEGSGRIKLI 181 (382)
T ss_pred -eEEEEEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHH---hCCceeccCCHHHeeeccccCCCCcEEEe
Confidence 599999999999999988533 3999999999999999999999 8999999999999999543 479999
Q ss_pred eeCCcccccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcC
Q 046270 414 DFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSG 493 (590)
Q Consensus 414 DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~ 493 (590)
|||++..... ........||+.|+|||.+....|+...||||.||++|.|++|..||.......... ....+
T Consensus 182 DFGla~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~------~i~~~ 253 (382)
T KOG0032|consen 182 DFGLAKFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL------AILRG 253 (382)
T ss_pred eCCCceEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH------HHHcC
Confidence 9999998765 445667899999999999999999999999999999999999999998655433222 11222
Q ss_pred CchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 494 KVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 494 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
+. ++- ...-..+.+..-+++..++..||..|+|+.++++.
T Consensus 254 ~~-~f~-----~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 254 DF-DFT-----SEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred CC-CCC-----CCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 22 111 11112233456677889999999999999999984
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=296.30 Aligned_cols=268 Identities=27% Similarity=0.312 Sum_probs=196.4
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCCC--ChHHHHHHHHHHHhcCCCCccccceeEEeccC---CC
Q 046270 263 TNGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDTK--GDEDFTNEVEIISKIRHRNLLSLRGCCVTSDD---SS 336 (590)
Q Consensus 263 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~~--~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~---~~ 336 (590)
.++|...+.||+|+||.||+|+.. +++.+|+|++...... ....+.+|++++++++|+||+++++++..... ..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 478999999999999999999976 4789999998643322 23467899999999999999999998765432 13
Q ss_pred CceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeC
Q 046270 337 GKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFG 416 (590)
Q Consensus 337 ~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFG 416 (590)
....++|+||+.. +|...+.. ....+++..+..++.|+++||.||| ..+|+||||||+||++++++.+||+|||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~--~~~~~~~~~~~~i~~~l~~al~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg 160 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLEN--PSVKLTESQIKCYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFG 160 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECcCc
Confidence 4568999999975 56665542 2346999999999999999999999 8999999999999999999999999999
Q ss_pred CcccccCCCc----------ccccccccCCCccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHH
Q 046270 417 LAKQSLEGHS----------HLTTRVAGTFGYLAPEYALYG-QLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDW 485 (590)
Q Consensus 417 la~~~~~~~~----------~~~~~~~gt~~Y~APE~~~~~-~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~ 485 (590)
+++....... ...+...++..|+|||.+.+. .++.++||||||++++||++|+.||........ ....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~-~~~~ 239 (311)
T cd07866 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQ-LHLI 239 (311)
T ss_pred cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHH-HHHH
Confidence 9976533221 112334568889999987654 589999999999999999999999865433211 1110
Q ss_pred H----------HHHHhcCC------chhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 046270 486 A----------WVLAKSGK------VDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALK 538 (590)
Q Consensus 486 ~----------~~~~~~~~------~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~ 538 (590)
. +..+.... ......+.+... .....+.+.+++..|++.+|.+|||+.|++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 240 FKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEER-FGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHHhCCCChhhchhhhhcccccccccCCCCCccHHHH-cccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 0 00000000 000000111110 0112246788999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=291.01 Aligned_cols=244 Identities=23% Similarity=0.272 Sum_probs=187.6
Q ss_pred ecccCcEEEEEEEEc-CCcEEEEEEeecCC---CCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEEEEEeeC
Q 046270 272 IGQGASGIVYKGTLR-HGNLVAVKQILDLD---TKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFLVYDYM 347 (590)
Q Consensus 272 LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~---~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~LV~E~~ 347 (590)
||+|+||+||++..+ +|+.+|+|.+.... ......+.+|++++++++|||++++++.+.. ....++||||+
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~lv~e~~ 75 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFET-----KDDLCLVMTLM 75 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEec-----CCeEEEEEecC
Confidence 699999999999876 58899999986432 2234457789999999999999999988863 44689999999
Q ss_pred CCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccccCCCcc
Q 046270 348 PNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSH 427 (590)
Q Consensus 348 ~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~~~~~~~ 427 (590)
++++|.+++.... ...+++..++.++.|++.||.||| ..+++||||+|+||++++++.+||+|||++.......
T Consensus 76 ~~~~L~~~l~~~~-~~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~-- 149 (277)
T cd05577 76 NGGDLKYHIYNVG-EPGFPEARAIFYAAQIICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK-- 149 (277)
T ss_pred CCCcHHHHHHHcC-cCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCC--
Confidence 9999999886332 236899999999999999999999 8999999999999999999999999999987654321
Q ss_pred cccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhhhHHHhhhh
Q 046270 428 LTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDEFIRAEG 507 (590)
Q Consensus 428 ~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 507 (590)
......++..|+|||++.++.++.++||||||++++||++|+.||........ ..... ...... ....
T Consensus 150 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~-----~~~~~~------~~~~ 217 (277)
T cd05577 150 KIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVE-KEELK-----RRTLEM------AVEY 217 (277)
T ss_pred ccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccccc-HHHHH-----hccccc------cccC
Confidence 22334578899999999888899999999999999999999999865433111 00000 000000 0001
Q ss_pred HHHHHHHHHHHHHhchhcCCCCCC-----CHHHHHH
Q 046270 508 ARAVMERFVLVGILCAHVMVALRP-----TITDALK 538 (590)
Q Consensus 508 ~~~~~~~l~~l~~~Cl~~dp~~RP-----tm~eVl~ 538 (590)
+......+.+++..|++.+|.+|| +..+++.
T Consensus 218 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 218 PDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred CccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 111234667888999999999999 5555653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=291.12 Aligned_cols=262 Identities=26% Similarity=0.352 Sum_probs=194.2
Q ss_pred CCccceecccCcEEEEEEEEcC-CcEEEEEEeecCCC-CChHHHHHHHHHHHhcC-CCCccccceeEEeccCCCCceEEE
Q 046270 266 FSQNNLIGQGASGIVYKGTLRH-GNLVAVKQILDLDT-KGDEDFTNEVEIISKIR-HRNLLSLRGCCVTSDDSSGKRRFL 342 (590)
Q Consensus 266 f~~~~~LG~G~fG~Vykg~~~~-g~~vAvK~l~~~~~-~~~~~f~~Ev~il~~l~-H~nlv~l~g~~~~~~~~~~~~~~L 342 (590)
|...+.||+|+||.||+|+..+ ++.|+||++..... .......+|+..+++++ |+|++++++++.. +...++
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~-----~~~~~l 75 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRE-----NDELYF 75 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhc-----CCcEEE
Confidence 4567889999999999999874 77899999865432 22334567999999999 9999999999874 456899
Q ss_pred EEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCccccc
Q 046270 343 VYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSL 422 (590)
Q Consensus 343 V~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~~ 422 (590)
||||+ +|+|.+++.... ...++|.++..++.|++.+|.||| +.+++|+||+|+||++++++.++|+|||++....
T Consensus 76 v~e~~-~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~ 150 (283)
T cd07830 76 VFEYM-EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIR 150 (283)
T ss_pred EEecC-CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCCEEEeecccceecc
Confidence 99999 889988875322 246899999999999999999999 8999999999999999999999999999998654
Q ss_pred CCCcccccccccCCCccCccccc-cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhh-----------hhHHHHHHH
Q 046270 423 EGHSHLTTRVAGTFGYLAPEYAL-YGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQL-----------ITDWAWVLA 490 (590)
Q Consensus 423 ~~~~~~~~~~~gt~~Y~APE~~~-~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~-----------l~~~~~~~~ 490 (590)
.... .....++..|+|||.+. ...++.++||||||++++||++|+.||......... -..|.....
T Consensus 151 ~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (283)
T cd07830 151 SRPP--YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYK 228 (283)
T ss_pred CCCC--cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhh
Confidence 3222 23345788999999875 446799999999999999999999888654332110 001111111
Q ss_pred hcCCchhhhhHHHh---hhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 491 KSGKVDDIFDEFIR---AEGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 491 ~~~~~~~~~d~~l~---~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
........+..... ..........+.+++..|++.+|++|||++|++.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 229 LASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred hhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 11111111100000 00000113578899999999999999999999863
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=297.91 Aligned_cols=268 Identities=23% Similarity=0.314 Sum_probs=201.4
Q ss_pred CCCccceecccCcEEEEEEEEcC-CcEEEEEEeecCC--CCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEE
Q 046270 265 GFSQNNLIGQGASGIVYKGTLRH-GNLVAVKQILDLD--TKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRF 341 (590)
Q Consensus 265 ~f~~~~~LG~G~fG~Vykg~~~~-g~~vAvK~l~~~~--~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~ 341 (590)
+|...+.||+|+||.||+|+..+ +..+|||++.... ....+.+.+|++++++++|+||+++++++...+.......+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 47778899999999999999864 8899999986543 33456789999999999999999999998765432345689
Q ss_pred EEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccc
Q 046270 342 LVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQS 421 (590)
Q Consensus 342 LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~ 421 (590)
+||||++ ++|.+++. ....+++..+..++.+++.||+||| ..+|+||||||+|||++.++.++|+|||++...
T Consensus 81 lv~e~~~-~~l~~~l~---~~~~l~~~~~~~i~~~l~~~l~~LH---~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~ 153 (330)
T cd07834 81 IVTELME-TDLHKVIK---SPQPLTDDHIQYFLYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGV 153 (330)
T ss_pred EEecchh-hhHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence 9999998 47888774 3347999999999999999999999 899999999999999999999999999999876
Q ss_pred cCCCc--ccccccccCCCccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCchh--hhhHHH-------HHH
Q 046270 422 LEGHS--HLTTRVAGTFGYLAPEYALYG-QLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQ--LITDWA-------WVL 489 (590)
Q Consensus 422 ~~~~~--~~~~~~~gt~~Y~APE~~~~~-~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~--~l~~~~-------~~~ 489 (590)
..... .......++..|+|||.+.+. .++.++||||||+++++|++|+.||........ .+.... +..
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 233 (330)
T cd07834 154 DPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKF 233 (330)
T ss_pred cccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhh
Confidence 44321 123344578899999999877 889999999999999999999999865443211 000000 000
Q ss_pred HhcCCchhhhhHHHh------hhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 490 AKSGKVDDIFDEFIR------AEGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 490 ~~~~~~~~~~d~~l~------~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
.......+.+...-. ..........+.+++..|++.+|.+|||+.+++..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 289 (330)
T cd07834 234 ITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289 (330)
T ss_pred ccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 000001111110000 00001123467889999999999999999999874
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=301.82 Aligned_cols=266 Identities=21% Similarity=0.316 Sum_probs=195.1
Q ss_pred cCCCccceecccCcEEEEEEEEcC-CcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCccccceeEEeccCC-------
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLRH-GNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDS------- 335 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~------- 335 (590)
.+|...+.||+|+||.||+|.... |..||+|++........+.+.+|++++++++|+||+++++++......
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 678889999999999999999864 789999998766656667899999999999999999999877643211
Q ss_pred --CCceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECC-CCcEEE
Q 046270 336 --SGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDS-ELNAKV 412 (590)
Q Consensus 336 --~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~-~~~~kL 412 (590)
+....++||||++ ++|.+++. ...+++.....++.||+.||.||| +.+|+||||||+||+++. ++.+||
T Consensus 85 ~~~~~~~~lv~e~~~-~~L~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH---~~givH~dikp~Nili~~~~~~~kl 156 (342)
T cd07854 85 LTELNSVYIVQEYME-TDLANVLE----QGPLSEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANVFINTEDLVLKI 156 (342)
T ss_pred ccccceEEEEeeccc-ccHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCceEEE
Confidence 1235799999997 58877763 346899999999999999999999 899999999999999974 567899
Q ss_pred EeeCCcccccCCCcc--cccccccCCCccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHH
Q 046270 413 ADFGLAKQSLEGHSH--LTTRVAGTFGYLAPEYALY-GQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVL 489 (590)
Q Consensus 413 ~DFGla~~~~~~~~~--~~~~~~gt~~Y~APE~~~~-~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~ 489 (590)
+|||+++........ ......++..|+|||.+.. ..++.++|||||||++|||++|+.||........ .....+..
T Consensus 157 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~-~~~~~~~~ 235 (342)
T cd07854 157 GDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQ-MQLILESV 235 (342)
T ss_pred CCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhc
Confidence 999999765332211 1223457889999998754 4678899999999999999999999965433111 11010000
Q ss_pred Hhc-----CCchhhhhHHHh------h----hhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 046270 490 AKS-----GKVDDIFDEFIR------A----EGARAVMERFVLVGILCAHVMVALRPTITDALK 538 (590)
Q Consensus 490 ~~~-----~~~~~~~d~~l~------~----~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~ 538 (590)
... ......+...+. . .........+.+++..|++.||.+|||+.|++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 236 PVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred CCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 000 000000000000 0 000112346778999999999999999999985
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=285.70 Aligned_cols=253 Identities=27% Similarity=0.404 Sum_probs=199.4
Q ss_pred HhcCCCccceecccCcEEEEEEEEcC-CcEEEEEEeecCCC----CC----hHHHHHHHHHHHhc-CCCCccccceeEEe
Q 046270 262 ATNGFSQNNLIGQGASGIVYKGTLRH-GNLVAVKQILDLDT----KG----DEDFTNEVEIISKI-RHRNLLSLRGCCVT 331 (590)
Q Consensus 262 at~~f~~~~~LG~G~fG~Vykg~~~~-g~~vAvK~l~~~~~----~~----~~~f~~Ev~il~~l-~H~nlv~l~g~~~~ 331 (590)
.-++|...+.||+|+.++|.+..++. |...|+|++..... .. .++-..|+.+|+++ .||+|+.+.++|..
T Consensus 15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes 94 (411)
T KOG0599|consen 15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES 94 (411)
T ss_pred HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence 34567788899999999999988764 77899999854322 11 23456899999999 79999999999974
Q ss_pred ccCCCCceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEE
Q 046270 332 SDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAK 411 (590)
Q Consensus 332 ~~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~k 411 (590)
. ...++|+|.|+.|.|.|+|. ..-.++++.-++|+.|+.+|+.||| ..+||||||||+|||+|+++++|
T Consensus 95 ~-----sF~FlVFdl~prGELFDyLt---s~VtlSEK~tR~iMrqlfegVeylH---a~~IVHRDLKpENILlddn~~i~ 163 (411)
T KOG0599|consen 95 D-----AFVFLVFDLMPRGELFDYLT---SKVTLSEKETRRIMRQLFEGVEYLH---ARNIVHRDLKPENILLDDNMNIK 163 (411)
T ss_pred c-----chhhhhhhhcccchHHHHhh---hheeecHHHHHHHHHHHHHHHHHHH---HhhhhhcccChhheeeccccceE
Confidence 3 45899999999999999995 4567999999999999999999999 89999999999999999999999
Q ss_pred EEeeCCcccccCCCcccccccccCCCccCcccccc------CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHH
Q 046270 412 VADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALY------GQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDW 485 (590)
Q Consensus 412 L~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~------~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~ 485 (590)
|+|||++....++. .....+||+||+|||.+.. ..|+...|.|+.||++|.|+.|..||-.... + .
T Consensus 164 isDFGFa~~l~~Ge--kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQ----m--l 235 (411)
T KOG0599|consen 164 ISDFGFACQLEPGE--KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQ----M--L 235 (411)
T ss_pred EeccceeeccCCch--hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHH----H--H
Confidence 99999999887654 4567899999999998863 3578899999999999999999999842110 0 0
Q ss_pred HHHHHhcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 486 AWVLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 486 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
.-++..+|+..= ....-.+......+++..|++.||.+|-|.+|++..
T Consensus 236 MLR~ImeGkyqF------~speWadis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 236 MLRMIMEGKYQF------RSPEWADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred HHHHHHhccccc------CCcchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 111222232110 000112334456678889999999999999998763
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-34 Score=294.79 Aligned_cols=260 Identities=20% Similarity=0.228 Sum_probs=189.4
Q ss_pred ceecccCcEEEEEEEEcCCcEEEEEEeecC--CCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEEEEEeeC
Q 046270 270 NLIGQGASGIVYKGTLRHGNLVAVKQILDL--DTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFLVYDYM 347 (590)
Q Consensus 270 ~~LG~G~fG~Vykg~~~~g~~vAvK~l~~~--~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~LV~E~~ 347 (590)
+.+|.|+++.||+++. ++..||||++... .....+.+.+|++++++++|+||+++++++.. ....+++|||+
T Consensus 8 ~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~-----~~~~~~~~e~~ 81 (314)
T cd08216 8 KCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIV-----DSELYVVSPLM 81 (314)
T ss_pred HhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeec-----CCeEEEEEecc
Confidence 3445556666666655 5889999998654 33345679999999999999999999998874 44689999999
Q ss_pred CCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccccCCCc-
Q 046270 348 PNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHS- 426 (590)
Q Consensus 348 ~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~~~~~~- 426 (590)
++|+|.+++... ....+++.....++.|++.||+||| +.+|+||||||+||+++.++.+||+|||.+........
T Consensus 82 ~~~~l~~~l~~~-~~~~~~~~~~~~~~~~l~~~L~~LH---~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~ 157 (314)
T cd08216 82 AYGSCEDLLKTH-FPEGLPELAIAFILKDVLNALDYIH---SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKR 157 (314)
T ss_pred CCCCHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCcceEEEecCCceEEecCccceeecccccc
Confidence 999999988643 2345899999999999999999999 89999999999999999999999999998875432211
Q ss_pred -----ccccccccCCCccCcccccc--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHH---HH------
Q 046270 427 -----HLTTRVAGTFGYLAPEYALY--GQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWV---LA------ 490 (590)
Q Consensus 427 -----~~~~~~~gt~~Y~APE~~~~--~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~---~~------ 490 (590)
.......++..|+|||++.. ..++.++|||||||++|||++|+.||.........+...... ..
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (314)
T cd08216 158 QRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYP 237 (314)
T ss_pred ccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchh
Confidence 11223456789999999875 358899999999999999999999997543322211110000 00
Q ss_pred -hcCCchh----hhhHHH----hhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 491 -KSGKVDD----IFDEFI----RAEGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 491 -~~~~~~~----~~d~~l----~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
....... ..+... ...........+.+++..|++.||++|||+.+++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 238 LYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred hhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 0000000 000000 011122334577889999999999999999999874
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-34 Score=286.24 Aligned_cols=244 Identities=27% Similarity=0.327 Sum_probs=186.6
Q ss_pred ceecccCcEEEEEEEEc-CCcEEEEEEeecCCCC---ChHHHHHHHHHH-HhcCCCCccccceeEEeccCCCCceEEEEE
Q 046270 270 NLIGQGASGIVYKGTLR-HGNLVAVKQILDLDTK---GDEDFTNEVEII-SKIRHRNLLSLRGCCVTSDDSSGKRRFLVY 344 (590)
Q Consensus 270 ~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~~---~~~~f~~Ev~il-~~l~H~nlv~l~g~~~~~~~~~~~~~~LV~ 344 (590)
+.||+|+||.||+|... +|+.||+|.+...... ....+..|..++ ...+|+|++++++++.. +...++|+
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~-----~~~~~lv~ 76 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQS-----KDYLYLVM 76 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEc-----CCeEEEEE
Confidence 46899999999999885 4789999998643221 123345555554 44589999999999873 45699999
Q ss_pred eeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccccCC
Q 046270 345 DYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEG 424 (590)
Q Consensus 345 E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~~~~ 424 (590)
||+++++|.+++. ....+++..+..++.|++.||.||| ..+++||||+|+||++++++.+||+|||+++....
T Consensus 77 e~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~- 149 (260)
T cd05611 77 EYLNGGDCASLIK---TLGGLPEDWAKQYIAEVVLGVEDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE- 149 (260)
T ss_pred eccCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEeecccceeccc-
Confidence 9999999999885 3346899999999999999999999 88999999999999999999999999999875432
Q ss_pred CcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhhhHHHh
Q 046270 425 HSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDEFIR 504 (590)
Q Consensus 425 ~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 504 (590)
.....|+..|+|||.+.+..++.++||||||++++||++|+.||...... ..... ...+... ...
T Consensus 150 ----~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~-----~~~~~~~--~~~--- 214 (260)
T cd05611 150 ----NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD-AVFDN-----ILSRRIN--WPE--- 214 (260)
T ss_pred ----cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHH-HHHHH-----HHhcccC--CCC---
Confidence 22345788999999998888999999999999999999999998643321 11111 1111110 000
Q ss_pred hhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhc
Q 046270 505 AEGARAVMERFVLVGILCAHVMVALRPTITDALKMLE 541 (590)
Q Consensus 505 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~ 541 (590)
.........+..++..|++.+|++||++.++.+.|.
T Consensus 215 -~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~ 250 (260)
T cd05611 215 -EVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKS 250 (260)
T ss_pred -cccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence 001122346788999999999999998877766654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=294.89 Aligned_cols=264 Identities=22% Similarity=0.314 Sum_probs=196.9
Q ss_pred HHHHhcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCC--CCChHHHHHHHHHHHhcCCCCccccceeEEeccCC
Q 046270 259 LEQATNGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLD--TKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDS 335 (590)
Q Consensus 259 l~~at~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~--~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~ 335 (590)
+....++|...+.||+|+||.||++... +|..||||++.... ......+.+|++++++++|+||+++++++......
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07880 10 IWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL 89 (343)
T ss_pred hhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence 3445678999999999999999999865 58899999985422 12235688999999999999999999988654321
Q ss_pred -CCceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEe
Q 046270 336 -SGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVAD 414 (590)
Q Consensus 336 -~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~D 414 (590)
.....++||||+ +++|.+++. ...+++..++.++.||++||+||| +.+|+||||||+||+++.++.+||+|
T Consensus 90 ~~~~~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~al~~LH---~~gi~H~dlkp~Nill~~~~~~kl~d 161 (343)
T cd07880 90 DRFHDFYLVMPFM-GTDLGKLMK----HEKLSEDRIQFLVYQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILD 161 (343)
T ss_pred cccceEEEEEecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEee
Confidence 123578999999 678887763 346999999999999999999999 89999999999999999999999999
Q ss_pred eCCcccccCCCcccccccccCCCccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcC
Q 046270 415 FGLAKQSLEGHSHLTTRVAGTFGYLAPEYALY-GQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSG 493 (590)
Q Consensus 415 FGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~ 493 (590)
||+++..... .....++..|+|||.+.+ ..++.++||||||+++++|++|+.||........ ... .....+
T Consensus 162 fg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~-~~~---~~~~~~ 233 (343)
T cd07880 162 FGLARQTDSE----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQ-LME---IMKVTG 233 (343)
T ss_pred cccccccccC----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHH---HHHhcC
Confidence 9999865332 223456889999998875 4688999999999999999999999875432111 100 000001
Q ss_pred CchhhhhHHHh-------------------hhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 046270 494 KVDDIFDEFIR-------------------AEGARAVMERFVLVGILCAHVMVALRPTITDALK 538 (590)
Q Consensus 494 ~~~~~~d~~l~-------------------~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~ 538 (590)
.....+...+. ..........+.+++..|++.||++|||+.+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 234 TPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred CCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 10000000000 0000112335778999999999999999999985
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=299.25 Aligned_cols=270 Identities=20% Similarity=0.265 Sum_probs=200.3
Q ss_pred cHHHHHHHhcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCC--CCChHHHHHHHHHHHhcCCCCccccceeEEe
Q 046270 255 HVSELEQATNGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLD--TKGDEDFTNEVEIISKIRHRNLLSLRGCCVT 331 (590)
Q Consensus 255 ~~~el~~at~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~--~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~ 331 (590)
...++...+++|...+.||+|+||.||+|... +|..||+|++.... ....+.+.+|++++.+++|+||+++++++..
T Consensus 8 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~ 87 (345)
T cd07877 8 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 87 (345)
T ss_pred HHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeee
Confidence 34567778899999999999999999999865 58899999986432 2234568899999999999999999998864
Q ss_pred ccCC-CCceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcE
Q 046270 332 SDDS-SGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNA 410 (590)
Q Consensus 332 ~~~~-~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~ 410 (590)
.... .....+++++++ +++|.+++. ...+++..+..++.|+++||+||| +.+|+||||||+||++++++.+
T Consensus 88 ~~~~~~~~~~~lv~~~~-~~~L~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~ 159 (345)
T cd07877 88 ARSLEEFNDVYLVTHLM-GADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCEL 159 (345)
T ss_pred cccccccccEEEEehhc-ccCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEcCCCCE
Confidence 3321 223467888887 788887763 346999999999999999999999 8999999999999999999999
Q ss_pred EEEeeCCcccccCCCcccccccccCCCccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHH
Q 046270 411 KVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALY-GQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVL 489 (590)
Q Consensus 411 kL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~ 489 (590)
||+|||+++..... .....++..|+|||.+.+ ..++.++||||||++++||++|+.||....... .+.......
T Consensus 160 kl~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~~ 234 (345)
T cd07877 160 KILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID-QLKLILRLV 234 (345)
T ss_pred EEeccccccccccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHh
Confidence 99999998764322 233467889999998765 568899999999999999999999986433211 111111100
Q ss_pred HhcCCchhhhh-----------HHHhh---hhH----HHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 490 AKSGKVDDIFD-----------EFIRA---EGA----RAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 490 ~~~~~~~~~~d-----------~~l~~---~~~----~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
.....+... ..+.. ... ......+.+++..|++.+|.+||++.++++.
T Consensus 235 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 235 --GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred --CCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 000001100 00000 000 0112357789999999999999999998864
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-34 Score=297.24 Aligned_cols=261 Identities=21% Similarity=0.301 Sum_probs=189.0
Q ss_pred ceeccc--CcEEEEEEEEc-CCcEEEEEEeecCCC--CChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEEEEE
Q 046270 270 NLIGQG--ASGIVYKGTLR-HGNLVAVKQILDLDT--KGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFLVY 344 (590)
Q Consensus 270 ~~LG~G--~fG~Vykg~~~-~g~~vAvK~l~~~~~--~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~LV~ 344 (590)
..||+| +||+||++++. .|+.||+|.+..... ...+.+.+|+.+++.++||||+++++++.. +...++|+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~-----~~~~~~v~ 78 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTT-----GSWLWVIS 78 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEec-----CCceEEEE
Confidence 356666 99999999985 589999999864322 224578899999999999999999999974 44589999
Q ss_pred eeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccccCC
Q 046270 345 DYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEG 424 (590)
Q Consensus 345 E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~~~~ 424 (590)
||+++++|.+++.... ...+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+|++||+.+......
T Consensus 79 e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~ 154 (328)
T cd08226 79 PFMAYGSANSLLKTYF-PEGMSEALIGNILFGALRGLNYLH---QNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRN 154 (328)
T ss_pred ecccCCCHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhcc
Confidence 9999999999885432 235899999999999999999999 899999999999999999999999999865432211
Q ss_pred Cccc------ccccccCCCccCccccccC--CCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHH---------
Q 046270 425 HSHL------TTRVAGTFGYLAPEYALYG--QLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAW--------- 487 (590)
Q Consensus 425 ~~~~------~~~~~gt~~Y~APE~~~~~--~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~--------- 487 (590)
.... .....++..|+|||++.++ .++.++||||||++++||++|+.||...............
T Consensus 155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (328)
T cd08226 155 GQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDIT 234 (328)
T ss_pred CccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCcccc
Confidence 1100 1112345679999998763 4789999999999999999999998654332211110000
Q ss_pred ------HHHhc----------------CCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 488 ------VLAKS----------------GKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 488 ------~~~~~----------------~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
..+.. +....+.+..+...........+.+++..|++.||++|||+.|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~ 308 (328)
T cd08226 235 TFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH 308 (328)
T ss_pred ccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 00000 00001111111111223345578899999999999999999999863
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=294.72 Aligned_cols=248 Identities=25% Similarity=0.347 Sum_probs=202.8
Q ss_pred CCccceecccCcEEEEEEEEcC-CcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEEEEE
Q 046270 266 FSQNNLIGQGASGIVYKGTLRH-GNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFLVY 344 (590)
Q Consensus 266 f~~~~~LG~G~fG~Vykg~~~~-g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~LV~ 344 (590)
|....+||+|+||.|||+.++. |+.+|||++.- .....++.+|+.++++.+.|++|+++|.|.. ...+++||
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV--~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK-----~sDLWIVM 107 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV--DTDLQEIIKEISIMQQCKSKYVVKYYGSYFK-----HSDLWIVM 107 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc--cchHHHHHHHHHHHHHcCCchhhhhhhhhcc-----CCceEeeh
Confidence 6667899999999999999875 89999998743 2456789999999999999999999998874 44599999
Q ss_pred eeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccccCC
Q 046270 345 DYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEG 424 (590)
Q Consensus 345 E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~~~~ 424 (590)
|||--|+..+.+.. ++++|++.++..|+...++||+||| ...-||||||+.||||+.+|.+||+|||.|-++.+.
T Consensus 108 EYCGAGSiSDI~R~--R~K~L~E~EIs~iL~~TLKGL~YLH---~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT 182 (502)
T KOG0574|consen 108 EYCGAGSISDIMRA--RRKPLSEQEISAVLRDTLKGLQYLH---DLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT 182 (502)
T ss_pred hhcCCCcHHHHHHH--hcCCccHHHHHHHHHHHHhHHHHHH---HHHHHHhhcccccEEEcccchhhhhhccccchhhhh
Confidence 99999999998863 4568999999999999999999999 788899999999999999999999999999876443
Q ss_pred CcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhhhHHHh
Q 046270 425 HSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDEFIR 504 (590)
Q Consensus 425 ~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 504 (590)
. .....+.||+.|||||++..-.|..++||||+|+...||..|++|+.......... +........+-
T Consensus 183 M-AKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIF------MIPT~PPPTF~----- 250 (502)
T KOG0574|consen 183 M-AKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIF------MIPTKPPPTFK----- 250 (502)
T ss_pred H-HhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeE------eccCCCCCCCC-----
Confidence 2 23456889999999999999999999999999999999999999986543321100 00001111111
Q ss_pred hhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 505 AEGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 505 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
.++.....+.+++..|+-..|++|-|+.++++.
T Consensus 251 --KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 251 --KPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred --ChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 233445678889999999999999998887764
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=295.63 Aligned_cols=262 Identities=24% Similarity=0.302 Sum_probs=192.5
Q ss_pred cCCCc-cceecccCcEEEEEEEEc-CCcEEEEEEeecCCCCC--------------hHHHHHHHHHHHhcCCCCccccce
Q 046270 264 NGFSQ-NNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDTKG--------------DEDFTNEVEIISKIRHRNLLSLRG 327 (590)
Q Consensus 264 ~~f~~-~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~~~--------------~~~f~~Ev~il~~l~H~nlv~l~g 327 (590)
++|.. .+.||+|+||.||+|+.. .++.||||++....... ...+.+|++++.+++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 34543 467999999999999976 58899999986432221 124779999999999999999999
Q ss_pred eEEeccCCCCceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCC
Q 046270 328 CCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSE 407 (590)
Q Consensus 328 ~~~~~~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~ 407 (590)
++.. +...++||||++ |+|.+++. ....+++.....++.|++.||.||| +.+|+||||||+||+++.+
T Consensus 88 ~~~~-----~~~~~lv~e~~~-~~l~~~l~---~~~~~~~~~~~~~~~ql~~aL~~LH---~~~i~H~dl~~~nill~~~ 155 (335)
T PTZ00024 88 VYVE-----GDFINLVMDIMA-SDLKKVVD---RKIRLTESQVKCILLQILNGLNVLH---KWYFMHRDLSPANIFINSK 155 (335)
T ss_pred EEec-----CCcEEEEEeccc-cCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHeEECCC
Confidence 9873 456899999997 68888874 3456899999999999999999999 8999999999999999999
Q ss_pred CcEEEEeeCCcccccCCC-------------cccccccccCCCccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCC
Q 046270 408 LNAKVADFGLAKQSLEGH-------------SHLTTRVAGTFGYLAPEYALYG-QLTEKSDVYSFGIVILELMSGRKVLD 473 (590)
Q Consensus 408 ~~~kL~DFGla~~~~~~~-------------~~~~~~~~gt~~Y~APE~~~~~-~~t~ksDVySfGvvLlELltG~~p~~ 473 (590)
+.+||+|||+++...... ........++..|+|||++.+. .++.++||||||++++||++|+.||.
T Consensus 156 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~ 235 (335)
T PTZ00024 156 GICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFP 235 (335)
T ss_pred CCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 999999999997654110 1111223467889999998764 46899999999999999999999987
Q ss_pred CCCCchhhhhHHHHHHHhcCCch---h------------hhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 046270 474 TSTSPFQLITDWAWVLAKSGKVD---D------------IFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALK 538 (590)
Q Consensus 474 ~~~~~~~~l~~~~~~~~~~~~~~---~------------~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~ 538 (590)
....... +. ............ . ...+..... .......+.+++..|++.+|++|||++|++.
T Consensus 236 ~~~~~~~-~~-~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 236 GENEIDQ-LG-RIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTI-FPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred CCCHHHH-HH-HHHHHhCCCchhhCcchhhcccccccCcCCcccHHHh-CcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 5443221 11 111111110000 0 000000000 0112346778999999999999999999997
Q ss_pred Hh
Q 046270 539 ML 540 (590)
Q Consensus 539 ~L 540 (590)
.-
T Consensus 313 ~~ 314 (335)
T PTZ00024 313 HE 314 (335)
T ss_pred Cc
Confidence 43
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=288.60 Aligned_cols=248 Identities=22% Similarity=0.291 Sum_probs=197.9
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCC---CCChHHHHHHHHHHHhcC-CCCccccceeEEeccCCCCc
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLD---TKGDEDFTNEVEIISKIR-HRNLLSLRGCCVTSDDSSGK 338 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~---~~~~~~f~~Ev~il~~l~-H~nlv~l~g~~~~~~~~~~~ 338 (590)
++|...+.||+|+||.||+|+.. +|+.||+|.+.... ....+.+.+|++++.+++ |+||+++++++.. +.
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~-----~~ 75 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQD-----EE 75 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcC-----Cc
Confidence 36788899999999999999986 58899999885421 223467889999999998 9999999998863 45
Q ss_pred eEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCc
Q 046270 339 RRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLA 418 (590)
Q Consensus 339 ~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla 418 (590)
..++||||+++++|.+++. +...+++..+..|+.|++.||.||| ..+++|+||||+||+++.++.++|+|||++
T Consensus 76 ~~~lv~e~~~~~~L~~~l~---~~~~l~~~~~~~i~~ql~~~l~~Lh---~~~~~H~dl~~~ni~i~~~~~~~l~df~~~ 149 (280)
T cd05581 76 NLYFVLEYAPNGELLQYIR---KYGSLDEKCTRFYAAEILLALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTA 149 (280)
T ss_pred eEEEEEcCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEecCCccc
Confidence 6899999999999999885 3347999999999999999999999 899999999999999999999999999998
Q ss_pred ccccCCCc-------------------ccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCch
Q 046270 419 KQSLEGHS-------------------HLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPF 479 (590)
Q Consensus 419 ~~~~~~~~-------------------~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~ 479 (590)
........ .......|+..|+|||.+....++.++||||||++++|+++|+.|+......
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~- 228 (280)
T cd05581 150 KVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEY- 228 (280)
T ss_pred cccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHH-
Confidence 86543221 1122345788999999998888999999999999999999999998754321
Q ss_pred hhhhHHHHHHHhcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCH----HHHHH
Q 046270 480 QLITDWAWVLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTI----TDALK 538 (590)
Q Consensus 480 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm----~eVl~ 538 (590)
.... .... .. ...+....+.+..++..|++.+|.+||++ ++++.
T Consensus 229 ~~~~----~~~~-~~----------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 229 LTFQ----KILK-LE----------YSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred HHHH----HHHh-cC----------CCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 1111 0000 00 01111224577889999999999999999 77764
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=325.93 Aligned_cols=257 Identities=28% Similarity=0.402 Sum_probs=191.7
Q ss_pred HHHhcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecC-CCCChHHHHHHHHHHHhcCCCCccccceeEEeccC---
Q 046270 260 EQATNGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDL-DTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDD--- 334 (590)
Q Consensus 260 ~~at~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~-~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~--- 334 (590)
.+-..+|.+..+||+||||.|||++.+ ||+.+|||++.-. +.+....+.+|+++|++|+|||+|+++..+.+...
T Consensus 475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence 345567888899999999999999987 7999999998544 23335568899999999999999999775443321
Q ss_pred --------------------------------------------------------------------------------
Q 046270 335 -------------------------------------------------------------------------------- 334 (590)
Q Consensus 335 -------------------------------------------------------------------------------- 334 (590)
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence
Q ss_pred ------------------------CC-------CceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHH
Q 046270 335 ------------------------SS-------GKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAY 383 (590)
Q Consensus 335 ------------------------~~-------~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~y 383 (590)
.+ ...+|+-||||+..+|.+++....... .-...++++.+|++||+|
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLaY 712 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLAY 712 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHHH
Confidence 00 034788999999988888875332111 356778999999999999
Q ss_pred HHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCccccc------C----------C-CcccccccccCCCccCcccccc
Q 046270 384 LHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSL------E----------G-HSHLTTRVAGTFGYLAPEYALY 446 (590)
Q Consensus 384 LH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~~------~----------~-~~~~~~~~~gt~~Y~APE~~~~ 446 (590)
+| +.+||||||||.||+||++..+||+|||+|.... . + .....+...||.-|+|||.+..
T Consensus 713 IH---~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~ 789 (1351)
T KOG1035|consen 713 IH---DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSD 789 (1351)
T ss_pred HH---hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcc
Confidence 99 8999999999999999999999999999998621 0 0 1113455679999999999875
Q ss_pred C---CCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhh---hhHHHhhhhHHHHHHHHHHHHH
Q 046270 447 G---QLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDI---FDEFIRAEGARAVMERFVLVGI 520 (590)
Q Consensus 447 ~---~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~---~d~~l~~~~~~~~~~~l~~l~~ 520 (590)
. +|+.|+|+||+|||++||+- ||...-+....+.. .+.|.+..- .++.. ..=..++.
T Consensus 790 ~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~-----LR~g~iP~~~~f~~~~~---------~~e~slI~ 852 (1351)
T KOG1035|consen 790 TSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTN-----LRKGSIPEPADFFDPEH---------PEEASLIR 852 (1351)
T ss_pred cccccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHh-----cccCCCCCCcccccccc---------hHHHHHHH
Confidence 4 59999999999999999994 55432221112221 234443332 33222 23355778
Q ss_pred hchhcCCCCCCCHHHHHH
Q 046270 521 LCAHVMVALRPTITDALK 538 (590)
Q Consensus 521 ~Cl~~dp~~RPtm~eVl~ 538 (590)
++++.||.+|||+.|++.
T Consensus 853 ~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 853 WLLSHDPSKRPTATELLN 870 (1351)
T ss_pred HHhcCCCccCCCHHHHhh
Confidence 999999999999999874
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=292.79 Aligned_cols=245 Identities=29% Similarity=0.402 Sum_probs=190.2
Q ss_pred CCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCC---CChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEE
Q 046270 266 FSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDT---KGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRF 341 (590)
Q Consensus 266 f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~---~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~ 341 (590)
|...+.||+|+||.||+|+.. ++..+|+|.+..... ....++.+|++++++++|+|++++++++.. ....+
T Consensus 17 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~ 91 (308)
T cd06634 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-----EHTAW 91 (308)
T ss_pred HHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEc-----CCeeE
Confidence 556678999999999999986 477899998864322 223468899999999999999999999874 34689
Q ss_pred EEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccc
Q 046270 342 LVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQS 421 (590)
Q Consensus 342 LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~ 421 (590)
+||||+. |+|.+.+.. ....+++.++..++.+++.||.||| ..+++||||||+||+++.++.+||+|||++...
T Consensus 92 lv~e~~~-~~l~~~~~~--~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 165 (308)
T cd06634 92 LVMEYCL-GSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM 165 (308)
T ss_pred EEEEccC-CCHHHHHHH--cCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHhEEECCCCcEEECCcccceee
Confidence 9999996 678776642 2346899999999999999999999 889999999999999999999999999998754
Q ss_pred cCCCcccccccccCCCccCccccc---cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhh
Q 046270 422 LEGHSHLTTRVAGTFGYLAPEYAL---YGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDI 498 (590)
Q Consensus 422 ~~~~~~~~~~~~gt~~Y~APE~~~---~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 498 (590)
... ....|+..|+|||++. .+.++.++|||||||++|||++|+.|+...... ..+..+ ..+.....
T Consensus 166 ~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-~~~~~~-----~~~~~~~~ 234 (308)
T cd06634 166 APA-----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-SALYHI-----AQNESPAL 234 (308)
T ss_pred cCc-----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH-HHHHHH-----hhcCCCCc
Confidence 332 2345788999999874 456889999999999999999999997543221 111111 11111110
Q ss_pred hhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHh
Q 046270 499 FDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKML 540 (590)
Q Consensus 499 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L 540 (590)
........+.+++..|++.+|++||++.++++..
T Consensus 235 --------~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~ 268 (308)
T cd06634 235 --------QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 268 (308)
T ss_pred --------CcccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence 0112234567888999999999999999999764
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=293.93 Aligned_cols=265 Identities=22% Similarity=0.318 Sum_probs=197.4
Q ss_pred HHHHHhcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecC--CCCChHHHHHHHHHHHhcCCCCccccceeEEeccC
Q 046270 258 ELEQATNGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDL--DTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDD 334 (590)
Q Consensus 258 el~~at~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~--~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~ 334 (590)
++...+++|...+.||+|+||.||++... +|..||+|++... .....+.+.+|++++.+++|||++++++++...
T Consensus 4 ~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-- 81 (328)
T cd07856 4 TVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISP-- 81 (328)
T ss_pred ceeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecC--
Confidence 34457889999999999999999999876 5889999987542 223356788999999999999999999988642
Q ss_pred CCCceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEe
Q 046270 335 SSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVAD 414 (590)
Q Consensus 335 ~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~D 414 (590)
+...++|+||+ +++|.+++. ...+++.....++.|++.||.||| +.+|+||||||+||++++++.+||+|
T Consensus 82 --~~~~~lv~e~~-~~~L~~~~~----~~~~~~~~~~~~~~ql~~aL~~LH---~~~iiH~dl~p~Nili~~~~~~~l~d 151 (328)
T cd07856 82 --LEDIYFVTELL-GTDLHRLLT----SRPLEKQFIQYFLYQILRGLKYVH---SAGVVHRDLKPSNILINENCDLKICD 151 (328)
T ss_pred --CCcEEEEeehh-ccCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEeECCCCCEEeCc
Confidence 34589999998 568887763 346889999999999999999999 89999999999999999999999999
Q ss_pred eCCcccccCCCcccccccccCCCccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchh--hhhH-------
Q 046270 415 FGLAKQSLEGHSHLTTRVAGTFGYLAPEYALY-GQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQ--LITD------- 484 (590)
Q Consensus 415 FGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~--~l~~------- 484 (590)
||++...... .....++..|+|||++.+ ..++.++||||||++++||++|+.||........ .+.+
T Consensus 152 fg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~ 227 (328)
T cd07856 152 FGLARIQDPQ----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPD 227 (328)
T ss_pred cccccccCCC----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence 9998754221 123456789999998765 5689999999999999999999999864332111 1111
Q ss_pred -HHHHHHhcCCchhhhhHHHh-hh-hH----HHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 485 -WAWVLAKSGKVDDIFDEFIR-AE-GA----RAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 485 -~~~~~~~~~~~~~~~d~~l~-~~-~~----~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
|.... ..+...+++..... .. .. ......+.+++..|++.+|++|||+.+++..
T Consensus 228 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 228 DVINTI-CSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred HHHHhc-cchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 10000 00111111110000 00 00 1123577889999999999999999999764
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=297.90 Aligned_cols=262 Identities=22% Similarity=0.314 Sum_probs=196.8
Q ss_pred HhcCCCccceecccCcEEEEEEEEcC-CcEEEEEEeecC--CCCChHHHHHHHHHHHhcCCCCccccceeEEeccC-CCC
Q 046270 262 ATNGFSQNNLIGQGASGIVYKGTLRH-GNLVAVKQILDL--DTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDD-SSG 337 (590)
Q Consensus 262 at~~f~~~~~LG~G~fG~Vykg~~~~-g~~vAvK~l~~~--~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~-~~~ 337 (590)
..++|...+.||+|+||.||+|+... +..||+|++... .....+.+.+|+.++++++|+|++++++++...+. ...
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 46788899999999999999999864 789999987542 22234567889999999999999999987764332 233
Q ss_pred ceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCC
Q 046270 338 KRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGL 417 (590)
Q Consensus 338 ~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGl 417 (590)
...++|+||+ +++|.+++. ...+++..+..++.|+++||.||| ..+|+||||||+||++++++.+||+|||+
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~----~~~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nill~~~~~~kL~dfg~ 164 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVK----CQKLSDDHIQFLVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGL 164 (343)
T ss_pred ccEEEEEecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEccccc
Confidence 4589999998 568988774 346999999999999999999999 89999999999999999999999999999
Q ss_pred cccccCCCcccccccccCCCccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCch
Q 046270 418 AKQSLEGHSHLTTRVAGTFGYLAPEYALY-GQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVD 496 (590)
Q Consensus 418 a~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 496 (590)
+...... .....++..|+|||.+.. ..++.++||||||++++||++|+.||........ +..... ..+...
T Consensus 165 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~-~~~i~~---~~~~~~ 236 (343)
T cd07851 165 ARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQ-LKRIMN---LVGTPD 236 (343)
T ss_pred ccccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHH---hcCCCC
Confidence 9865432 233457889999998865 3678999999999999999999999865432211 110000 001100
Q ss_pred hhhhHHHhh-------------------hhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 497 DIFDEFIRA-------------------EGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 497 ~~~d~~l~~-------------------~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
+.+...+.. .........+.+++..|++.+|++|||+.||++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 237 EELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred HHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 000000000 0001124578899999999999999999999763
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=288.23 Aligned_cols=241 Identities=20% Similarity=0.252 Sum_probs=182.8
Q ss_pred eecccCcEEEEEEEEcC-CcEEEEEEeecCCCC---ChHHHHHHHHHH---HhcCCCCccccceeEEeccCCCCceEEEE
Q 046270 271 LIGQGASGIVYKGTLRH-GNLVAVKQILDLDTK---GDEDFTNEVEII---SKIRHRNLLSLRGCCVTSDDSSGKRRFLV 343 (590)
Q Consensus 271 ~LG~G~fG~Vykg~~~~-g~~vAvK~l~~~~~~---~~~~f~~Ev~il---~~l~H~nlv~l~g~~~~~~~~~~~~~~LV 343 (590)
.||+|+||.||++...+ ++.||+|.+...... ....+.+|..++ ....|+|++.+++++.. ....++|
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~-----~~~~~~v 75 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT-----PDKLSFI 75 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeec-----CCEEEEE
Confidence 48999999999998764 789999998653221 222344554444 44579999999988873 4468999
Q ss_pred EeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccccC
Q 046270 344 YDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLE 423 (590)
Q Consensus 344 ~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~~~ 423 (590)
|||+++|+|.+++. ....++|..+..|+.|+++||.||| +.+|+||||||+||+++.++.+||+|||+++....
T Consensus 76 ~e~~~g~~L~~~l~---~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~ 149 (278)
T cd05606 76 LDLMNGGDLHYHLS---QHGVFSEAEMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK 149 (278)
T ss_pred EecCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCCCCHHHEEECCCCCEEEccCcCccccCc
Confidence 99999999998874 3457999999999999999999999 89999999999999999999999999999875432
Q ss_pred CCcccccccccCCCccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhhhHH
Q 046270 424 GHSHLTTRVAGTFGYLAPEYALYG-QLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDEF 502 (590)
Q Consensus 424 ~~~~~~~~~~gt~~Y~APE~~~~~-~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 502 (590)
.. .....|+..|+|||.+..+ .++.++||||||++++||++|+.||.......... ......... ..
T Consensus 150 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~---~~~~~~~~~------~~ 217 (278)
T cd05606 150 KK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE---IDRMTLTMA------VE 217 (278)
T ss_pred cC---CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHH---HHHHhhccC------CC
Confidence 22 2234689999999998755 68999999999999999999999997543221100 000000000 00
Q ss_pred HhhhhHHHHHHHHHHHHHhchhcCCCCCC-----CHHHHHH
Q 046270 503 IRAEGARAVMERFVLVGILCAHVMVALRP-----TITDALK 538 (590)
Q Consensus 503 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-----tm~eVl~ 538 (590)
+ +......+.+++..|++.+|.+|| ++.++++
T Consensus 218 ~----~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 218 L----PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred C----CCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 1 111234677788899999999999 9999985
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=290.09 Aligned_cols=244 Identities=30% Similarity=0.441 Sum_probs=188.9
Q ss_pred CCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCCC---ChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEE
Q 046270 266 FSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDTK---GDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRF 341 (590)
Q Consensus 266 f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~~---~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~ 341 (590)
|...+.||+|+||.||+|+.. .|..|++|++...... ....+.+|++++++++|+|++++++++.. +...+
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~ 97 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLK-----EHTAW 97 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEe-----CCEEE
Confidence 455678999999999999975 4789999998643322 23468899999999999999999999874 45689
Q ss_pred EEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccc
Q 046270 342 LVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQS 421 (590)
Q Consensus 342 LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~ 421 (590)
+||||+. |+|.+++.. ....++|.++..++.||+.||.||| ..+++||||||+||+++.++.+||+|||++...
T Consensus 98 lv~e~~~-~~l~~~l~~--~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~ 171 (313)
T cd06633 98 LVMEYCL-GSASDLLEV--HKKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASKS 171 (313)
T ss_pred EEEecCC-CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChhhEEECCCCCEEEeecCCCccc
Confidence 9999996 577776642 2356999999999999999999999 889999999999999999999999999998643
Q ss_pred cCCCcccccccccCCCccCccccc---cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhh
Q 046270 422 LEGHSHLTTRVAGTFGYLAPEYAL---YGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDI 498 (590)
Q Consensus 422 ~~~~~~~~~~~~gt~~Y~APE~~~---~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 498 (590)
.. .....|+..|+|||++. .+.++.++||||||+++|||++|+.|+....... .+ ...... .....
T Consensus 172 ~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~-~~----~~~~~~-~~~~~ 240 (313)
T cd06633 172 SP-----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-AL----YHIAQN-DSPTL 240 (313)
T ss_pred CC-----CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH-HH----HHHHhc-CCCCC
Confidence 22 22456888999999974 4678899999999999999999999986432211 11 111111 11111
Q ss_pred hhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 499 FDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 499 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
.. ......+.+++..|++.+|.+||++.+++..
T Consensus 241 ~~--------~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 241 QS--------NEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred Cc--------cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11 1122356778889999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=320.48 Aligned_cols=263 Identities=25% Similarity=0.395 Sum_probs=206.0
Q ss_pred HHHHhcCCCccceecccCcEEEEEEEEcC--------CcEEEEEEeecCCCC-ChHHHHHHHHHHHhc-CCCCcccccee
Q 046270 259 LEQATNGFSQNNLIGQGASGIVYKGTLRH--------GNLVAVKQILDLDTK-GDEDFTNEVEIISKI-RHRNLLSLRGC 328 (590)
Q Consensus 259 l~~at~~f~~~~~LG~G~fG~Vykg~~~~--------g~~vAvK~l~~~~~~-~~~~f~~Ev~il~~l-~H~nlv~l~g~ 328 (590)
++...++....+.||+|.||.|++|.... ...||||.++..... ..+.+..|+++|..+ +|+|++.++|+
T Consensus 291 ~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~ 370 (609)
T KOG0200|consen 291 WEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGA 370 (609)
T ss_pred eeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheee
Confidence 34444555556699999999999998641 347999998765443 456899999999999 69999999999
Q ss_pred EEeccCCCCceEEEEEeeCCCCCcchhhhhhc-----cc--------ccCChhhHHHHHHHHHHHHHHHHhcCCCCeEec
Q 046270 329 CVTSDDSSGKRRFLVYDYMPNGTLSDNISISH-----KR--------KQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHR 395 (590)
Q Consensus 329 ~~~~~~~~~~~~~LV~E~~~~gsL~~~L~~~~-----~~--------~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHr 395 (590)
|.. ....++|+||++.|+|.++|...+ .. ..++..+.+.++.|||.|++||+ +.++|||
T Consensus 371 ~t~-----~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~---~~~~vHR 442 (609)
T KOG0200|consen 371 CTQ-----DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLA---SVPCVHR 442 (609)
T ss_pred ecc-----CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHh---hCCccch
Confidence 985 345899999999999999997543 00 23899999999999999999999 8999999
Q ss_pred CCCCCceEECCCCcEEEEeeCCcccccCCCccccccccc--CCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCC
Q 046270 396 DIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAG--TFGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVL 472 (590)
Q Consensus 396 DIKp~NILLd~~~~~kL~DFGla~~~~~~~~~~~~~~~g--t~~Y~APE~~~~~~~t~ksDVySfGvvLlELlt-G~~p~ 472 (590)
||.++|||+..+..+||+|||++|............-.| ...|||||.+....|+.|+|||||||+||||+| |..|+
T Consensus 443 DLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PY 522 (609)
T KOG0200|consen 443 DLAARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPY 522 (609)
T ss_pred hhhhhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCC
Confidence 999999999999999999999999655444333222223 346999999999999999999999999999999 77777
Q ss_pred CCCCCchhhhhHHHHHHHhcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhccC
Q 046270 473 DTSTSPFQLITDWAWVLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEGD 543 (590)
Q Consensus 473 ~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~~ 543 (590)
......... ....++|...+ .+.....++..++..||+.+|++||++.++++.++..
T Consensus 523 p~~~~~~~l-----~~~l~~G~r~~---------~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 523 PGIPPTEEL-----LEFLKEGNRME---------QPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred CCCCcHHHH-----HHHHhcCCCCC---------CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 542211111 22334443222 1222345778899999999999999999999999873
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=286.49 Aligned_cols=261 Identities=25% Similarity=0.341 Sum_probs=195.1
Q ss_pred CCccceecccCcEEEEEEEEcC-CcEEEEEEeecCC--CCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEEE
Q 046270 266 FSQNNLIGQGASGIVYKGTLRH-GNLVAVKQILDLD--TKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFL 342 (590)
Q Consensus 266 f~~~~~LG~G~fG~Vykg~~~~-g~~vAvK~l~~~~--~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~L 342 (590)
|+..+.||+|+||.||+|+..+ ++.+|+|.+.... ....+.+.+|++++++++|+|++++++++.. ....++
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~~~ 75 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHT-----ERKLYL 75 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhc-----CCceEE
Confidence 4556789999999999999875 8899999987543 2334678899999999999999999999874 356899
Q ss_pred EEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCccccc
Q 046270 343 VYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSL 422 (590)
Q Consensus 343 V~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~~ 422 (590)
||||++ ++|.+++... ...+++..++.++.++++||.||| ..+|+||||+|+||++++++.+||+|||+++...
T Consensus 76 v~e~~~-~~l~~~i~~~--~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~ 149 (282)
T cd07829 76 VFEYCD-MDLKKYLDKR--PGPLSPNLIKSIMYQLLRGLAYCH---SHRILHRDLKPQNILINRDGVLKLADFGLARAFG 149 (282)
T ss_pred EecCcC-cCHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChheEEEcCCCCEEEecCCcccccC
Confidence 999998 5899988532 146999999999999999999999 8899999999999999999999999999998654
Q ss_pred CCCcccccccccCCCccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhh---------HHHHHHHhc
Q 046270 423 EGHSHLTTRVAGTFGYLAPEYALYG-QLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLIT---------DWAWVLAKS 492 (590)
Q Consensus 423 ~~~~~~~~~~~gt~~Y~APE~~~~~-~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~---------~~~~~~~~~ 492 (590)
.... ......++..|+|||.+... .++.++||||||++++||++|+.||........... ...|..+..
T Consensus 150 ~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (282)
T cd07829 150 IPLR-TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTK 228 (282)
T ss_pred CCcc-ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcc
Confidence 3322 22233457789999998776 889999999999999999999998865432211000 000100000
Q ss_pred CC-chhhhhHHHh---hhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 046270 493 GK-VDDIFDEFIR---AEGARAVMERFVLVGILCAHVMVALRPTITDALK 538 (590)
Q Consensus 493 ~~-~~~~~d~~l~---~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~ 538 (590)
-. ....+..... ..........+.+++..|++.+|++||++.+++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 229 LPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred cccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 00 0000000000 0000112357889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-33 Score=290.25 Aligned_cols=263 Identities=22% Similarity=0.284 Sum_probs=192.4
Q ss_pred CCCccceecccCcEEEEEEEEcC---CcEEEEEEeecCCC--CChHHHHHHHHHHHhc-CCCCccccceeEEeccCCCCc
Q 046270 265 GFSQNNLIGQGASGIVYKGTLRH---GNLVAVKQILDLDT--KGDEDFTNEVEIISKI-RHRNLLSLRGCCVTSDDSSGK 338 (590)
Q Consensus 265 ~f~~~~~LG~G~fG~Vykg~~~~---g~~vAvK~l~~~~~--~~~~~f~~Ev~il~~l-~H~nlv~l~g~~~~~~~~~~~ 338 (590)
+|...+.||+|+||.||+++... +..||+|++..... ...+.+.+|+++++++ +|+||+++++++..... ...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~-~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPG-NFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccc-cCC
Confidence 46778899999999999999863 67899999864322 2245688999999999 59999999997654321 234
Q ss_pred eEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCc
Q 046270 339 RRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLA 418 (590)
Q Consensus 339 ~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla 418 (590)
..++++||+. ++|.+++. ....+++..+..++.||+.||.||| ..+|+||||||+||+++.++.+||+|||++
T Consensus 80 ~~~~~~e~~~-~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH---~~givH~dlkp~Nili~~~~~~kl~Dfg~a 152 (332)
T cd07857 80 ELYLYEELME-ADLHQIIR---SGQPLTDAHFQSFIYQILCGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLA 152 (332)
T ss_pred cEEEEEeccc-CCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHeEEcCCCCEEeCcCCCc
Confidence 5788999986 68888774 3457999999999999999999999 899999999999999999999999999999
Q ss_pred ccccCCCcc---cccccccCCCccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCC
Q 046270 419 KQSLEGHSH---LTTRVAGTFGYLAPEYALY-GQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGK 494 (590)
Q Consensus 419 ~~~~~~~~~---~~~~~~gt~~Y~APE~~~~-~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~ 494 (590)
+........ ......|+..|+|||++.+ ..++.++||||||++++||++|+.||....... .+......+- ..
T Consensus 153 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~-~~~~~~~~~~--~~ 229 (332)
T cd07857 153 RGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVD-QLNQILQVLG--TP 229 (332)
T ss_pred eecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHH-HHHHHHHHhC--CC
Confidence 865432221 1234568999999998765 468999999999999999999999986543211 1111000000 00
Q ss_pred chhhhhHH-----------Hh-------hhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 046270 495 VDDIFDEF-----------IR-------AEGARAVMERFVLVGILCAHVMVALRPTITDALK 538 (590)
Q Consensus 495 ~~~~~d~~-----------l~-------~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~ 538 (590)
..+.+... +. ..........+.+++..|++.+|.+|||+.++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 230 DEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred CHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00000000 00 0000011246778999999999999999999874
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=302.78 Aligned_cols=196 Identities=23% Similarity=0.344 Sum_probs=165.8
Q ss_pred CCCccceecccCcEEEEEEEEcC-CcEEEEEEeecCCCCChHHHHHHHHHHHhcC-C-----CCccccceeEEeccCCCC
Q 046270 265 GFSQNNLIGQGASGIVYKGTLRH-GNLVAVKQILDLDTKGDEDFTNEVEIISKIR-H-----RNLLSLRGCCVTSDDSSG 337 (590)
Q Consensus 265 ~f~~~~~LG~G~fG~Vykg~~~~-g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~-H-----~nlv~l~g~~~~~~~~~~ 337 (590)
+|...+.||+|.||.|-|+.... ++.||||++++... -..+-..|+.+|..|+ | -|+|++++|+.. .
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~-f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~f-----r 260 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKR-FLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYF-----R 260 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChH-HHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccc-----c
Confidence 67889999999999999998765 88999999876432 2445678999999997 4 389999999984 5
Q ss_pred ceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCC--CcEEEEee
Q 046270 338 KRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSE--LNAKVADF 415 (590)
Q Consensus 338 ~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~--~~~kL~DF 415 (590)
++.+||+|.+. .+|.++|...+. ..++...++.|+.||+.||.+|| +.+|||+||||+||||.+- ..+||+||
T Consensus 261 ~HlciVfELL~-~NLYellK~n~f-~Glsl~~ir~~~~Qil~~L~~L~---~l~IIHcDLKPENILL~~~~r~~vKVIDF 335 (586)
T KOG0667|consen 261 NHLCIVFELLS-TNLYELLKNNKF-RGLSLPLVRKFAQQILTALLFLH---ELGIIHCDLKPENILLKDPKRSRIKVIDF 335 (586)
T ss_pred cceeeeehhhh-hhHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCChhheeeccCCcCceeEEec
Confidence 57999999994 699999976544 45999999999999999999999 9999999999999999654 47999999
Q ss_pred CCcccccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 046270 416 GLAKQSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTS 475 (590)
Q Consensus 416 Gla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~ 475 (590)
|.+....... ....-+..|.|||++.+.+|+.+.|+||||||+.||++|.+.|...
T Consensus 336 GSSc~~~q~v----ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ 391 (586)
T KOG0667|consen 336 GSSCFESQRV----YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGD 391 (586)
T ss_pred ccccccCCcc----eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCC
Confidence 9998643322 1345578899999999999999999999999999999997666443
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=282.97 Aligned_cols=249 Identities=20% Similarity=0.319 Sum_probs=190.2
Q ss_pred CCCccceecccCcEEEEEEEEcC-CcEEEEEEeecC-----CCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCc
Q 046270 265 GFSQNNLIGQGASGIVYKGTLRH-GNLVAVKQILDL-----DTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGK 338 (590)
Q Consensus 265 ~f~~~~~LG~G~fG~Vykg~~~~-g~~vAvK~l~~~-----~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~ 338 (590)
+|...+.||+|+||.||+++... +..+++|.++.. ......++..|+.++++++|||++++++++.. ..
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~ 75 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLE-----RD 75 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhc-----CC
Confidence 46777899999999999998764 344555555432 12223457789999999999999999998863 34
Q ss_pred eEEEEEeeCCCCCcchhhhhh-cccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCC
Q 046270 339 RRFLVYDYMPNGTLSDNISIS-HKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGL 417 (590)
Q Consensus 339 ~~~LV~E~~~~gsL~~~L~~~-~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGl 417 (590)
..++||||+++++|.+++... .....+++.+++.++.|++.||.||| +.+++|+||||+||++++ +.+||+|||+
T Consensus 76 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~~l~~~nili~~-~~~~l~d~g~ 151 (260)
T cd08222 76 AFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH---QRRILHRDLKAKNIFLKN-NLLKIGDFGV 151 (260)
T ss_pred ceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHH---HcCccccCCChhheEeec-CCEeecccCc
Confidence 589999999999999888542 23457999999999999999999999 899999999999999976 4699999999
Q ss_pred cccccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchh
Q 046270 418 AKQSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDD 497 (590)
Q Consensus 418 a~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 497 (590)
++...... .......|+..|+|||++....++.++|+||||+++|+|++|+.|+..... .. ..... ..+....
T Consensus 152 ~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~-~~----~~~~~-~~~~~~~ 224 (260)
T cd08222 152 SRLLMGSC-DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF-LS----VVLRI-VEGPTPS 224 (260)
T ss_pred eeecCCCc-ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH-HH----HHHHH-HcCCCCC
Confidence 87654322 223345678899999999888889999999999999999999999854221 11 11111 1111111
Q ss_pred hhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 046270 498 IFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALK 538 (590)
Q Consensus 498 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~ 538 (590)
.+......+.+++..|++.+|++||++.|+++
T Consensus 225 ---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 225 ---------LPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred ---------CcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 11123346778889999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=307.83 Aligned_cols=208 Identities=29% Similarity=0.434 Sum_probs=177.5
Q ss_pred CCccceecccCcEEEEEEEEc-CCcEEEEEEeecCC-CCChHHHHHHHHHHHhcCCCCccccceeEEecc-CCCCceEEE
Q 046270 266 FSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLD-TKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSD-DSSGKRRFL 342 (590)
Q Consensus 266 f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~-~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~-~~~~~~~~L 342 (590)
+...+.||+|+||.||+|+++ .|+.||||.+.... ....+.+.+|+++|++++|+|||++++.-.+.. ........+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 344568999999999999976 49999999987644 344667889999999999999999998654332 112456899
Q ss_pred EEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEC--CCC--cEEEEeeCCc
Q 046270 343 VYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLD--SEL--NAKVADFGLA 418 (590)
Q Consensus 343 V~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd--~~~--~~kL~DFGla 418 (590)
||||+.+|||...|....+...|++.+.+.++.++..||.||| +.+|+||||||.||++- +++ .-||+|||.|
T Consensus 95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~Lr---En~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLR---ENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHH---HcCceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 9999999999999988888888999999999999999999999 99999999999999982 333 4699999999
Q ss_pred ccccCCCcccccccccCCCccCccccc-cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc
Q 046270 419 KQSLEGHSHLTTRVAGTFGYLAPEYAL-YGQLTEKSDVYSFGIVILELMSGRKVLDTSTSP 478 (590)
Q Consensus 419 ~~~~~~~~~~~~~~~gt~~Y~APE~~~-~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~ 478 (590)
|...++. ..+.+.||..|++||.+. .+.|+...|.|||||++||.+||..||.....+
T Consensus 172 rel~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~p 230 (732)
T KOG4250|consen 172 RELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGP 230 (732)
T ss_pred ccCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCc
Confidence 9876544 566788999999999998 488999999999999999999999999765554
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=291.88 Aligned_cols=273 Identities=24% Similarity=0.297 Sum_probs=211.9
Q ss_pred cCCCccceecccCcEEEEEEEEcC-CcEEEEEEeecC---CCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCce
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLRH-GNLVAVKQILDL---DTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKR 339 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~vAvK~l~~~---~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~ 339 (590)
+.|+.-++||+||||+||-.+.++ |..+|.|++.+. ..++..--.+|-.+|.+++.+.||.|--.+.+.+ .
T Consensus 185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd-----~ 259 (591)
T KOG0986|consen 185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKD-----A 259 (591)
T ss_pred cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCC-----c
Confidence 568888999999999999988764 888999987432 2334455679999999999999999877776544 4
Q ss_pred EEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcc
Q 046270 340 RFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAK 419 (590)
Q Consensus 340 ~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~ 419 (590)
++||+..|.||+|.-||.... ...++++..+-++.+|+-||++|| +..||.||+||+|||||+.|+++|+|+|||.
T Consensus 260 LClVLtlMNGGDLkfHiyn~g-~~gF~e~ra~FYAAEi~cGLehlH---~~~iVYRDLKPeNILLDd~GhvRISDLGLAv 335 (591)
T KOG0986|consen 260 LCLVLTLMNGGDLKFHIYNHG-NPGFDEQRARFYAAEIICGLEHLH---RRRIVYRDLKPENILLDDHGHVRISDLGLAV 335 (591)
T ss_pred eEEEEEeecCCceeEEeeccC-CCCCchHHHHHHHHHHHhhHHHHH---hcceeeccCChhheeeccCCCeEeeccceEE
Confidence 899999999999999997543 357999999999999999999999 9999999999999999999999999999999
Q ss_pred cccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhh
Q 046270 420 QSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIF 499 (590)
Q Consensus 420 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 499 (590)
...++..... ..||.||||||++.++.|+...|.||+||+||||+.|+.||....... -.+-+
T Consensus 336 ei~~g~~~~~--rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKv---------------k~eEv 398 (591)
T KOG0986|consen 336 EIPEGKPIRG--RVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKV---------------KREEV 398 (591)
T ss_pred ecCCCCcccc--ccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhh---------------hHHHH
Confidence 8877665432 379999999999999999999999999999999999999996433211 11223
Q ss_pred hHHHh---hhhHHHHHHHHHHHHHhchhcCCCCCCC-----HHHH----------HHHhccCCCCC-CCCCCCCCCcccc
Q 046270 500 DEFIR---AEGARAVMERFVLVGILCAHVMVALRPT-----ITDA----------LKMLEGDIDIP-KLPDRPLPLSHEC 560 (590)
Q Consensus 500 d~~l~---~~~~~~~~~~l~~l~~~Cl~~dp~~RPt-----m~eV----------l~~L~~~~~~~-~~p~~p~~~~~~~ 560 (590)
|.++. .++++...+....+....++.||.+|-- ..+| .++|+-..-.| -+|++-.....+.
T Consensus 399 drr~~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~rleagml~PPfiPdp~aVyakDv 478 (591)
T KOG0986|consen 399 DRRTLEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWRRLEAGMLEPPFIPDPGAVYAKDV 478 (591)
T ss_pred HHHHhcchhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHhHHhccCCCCCCCCCccccchhhh
Confidence 33332 1233444556667777888999998854 3344 34566554444 4666655444443
Q ss_pred cc
Q 046270 561 LR 562 (590)
Q Consensus 561 ~~ 562 (590)
++
T Consensus 479 ~D 480 (591)
T KOG0986|consen 479 LD 480 (591)
T ss_pred hh
Confidence 33
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=274.00 Aligned_cols=236 Identities=25% Similarity=0.328 Sum_probs=188.8
Q ss_pred ecccCcEEEEEEEEcC-CcEEEEEEeecCCCC---ChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEEEEEeeC
Q 046270 272 IGQGASGIVYKGTLRH-GNLVAVKQILDLDTK---GDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFLVYDYM 347 (590)
Q Consensus 272 LG~G~fG~Vykg~~~~-g~~vAvK~l~~~~~~---~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~LV~E~~ 347 (590)
||+|+||.||+++..+ ++.+|+|.+...... ....+.+|++++++++|+|++++++.+. .+...++||||+
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~~v~e~~ 75 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQ-----TEEKLYLVLEYA 75 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHee-----cCCeeEEEEecC
Confidence 6999999999999874 889999998654322 3457899999999999999999998886 345699999999
Q ss_pred CCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccccCCCcc
Q 046270 348 PNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSH 427 (590)
Q Consensus 348 ~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~~~~~~~ 427 (590)
++++|.+++. ....+++..+..++.|++.||.||| ..+++|+||||+||+++.++.++|+|||++....... .
T Consensus 76 ~~~~L~~~l~---~~~~l~~~~~~~~~~qi~~~l~~lh---~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~ 148 (250)
T cd05123 76 PGGELFSHLS---KEGRFSEERARFYAAEIVLALEYLH---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-S 148 (250)
T ss_pred CCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcceEEEcCCCcEEEeecCcceecccCC-C
Confidence 9999999985 2346899999999999999999999 8999999999999999999999999999997654332 2
Q ss_pred cccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhhhHHHhhhh
Q 046270 428 LTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDEFIRAEG 507 (590)
Q Consensus 428 ~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 507 (590)
......++..|++||...+...+.++|+||||+++|||++|+.||..... ..+ ...... +.. ..
T Consensus 149 ~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~--~~~---~~~~~~-~~~----------~~ 212 (250)
T cd05123 149 RTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR--KEI---YEKILK-DPL----------RF 212 (250)
T ss_pred cccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--HHH---HHHHhc-CCC----------CC
Confidence 23445678899999999888899999999999999999999999864332 111 111111 110 01
Q ss_pred HHHHHHHHHHHHHhchhcCCCCCCCHHH
Q 046270 508 ARAVMERFVLVGILCAHVMVALRPTITD 535 (590)
Q Consensus 508 ~~~~~~~l~~l~~~Cl~~dp~~RPtm~e 535 (590)
+......+.+++..|+..||++||++.+
T Consensus 213 ~~~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 213 PEFLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CCCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 1111346778899999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=301.42 Aligned_cols=244 Identities=27% Similarity=0.413 Sum_probs=194.3
Q ss_pred ceecccCcEEEEEEEEcC-CcEEEEEEe--ecC--CCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEEEEE
Q 046270 270 NLIGQGASGIVYKGTLRH-GNLVAVKQI--LDL--DTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFLVY 344 (590)
Q Consensus 270 ~~LG~G~fG~Vykg~~~~-g~~vAvK~l--~~~--~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~LV~ 344 (590)
..||+|.|-+||||.+.. |-.||=-.+ .+. +....+.|..|+.+|+.|+|+||++++.++.+... ...-+|.
T Consensus 46 evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n---~~in~iT 122 (632)
T KOG0584|consen 46 EVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDN---KTINFIT 122 (632)
T ss_pred hhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCC---ceeeeee
Confidence 469999999999999864 656663322 222 22334789999999999999999999999886543 5688999
Q ss_pred eeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCC-CcEEEEeeCCcccccC
Q 046270 345 DYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSE-LNAKVADFGLAKQSLE 423 (590)
Q Consensus 345 E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~-~~~kL~DFGla~~~~~ 423 (590)
|.|..|+|..|+. +.+.++...+.+|++||++||.|||.. .++|||||||-.||+|+++ |.+||+|+|||.....
T Consensus 123 EL~TSGtLr~Y~k---k~~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~ 198 (632)
T KOG0584|consen 123 ELFTSGTLREYRK---KHRRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK 198 (632)
T ss_pred ecccCCcHHHHHH---HhccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhc
Confidence 9999999999985 445788999999999999999999964 6899999999999999887 8999999999987644
Q ss_pred CCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhhhHHH
Q 046270 424 GHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDEFI 503 (590)
Q Consensus 424 ~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 503 (590)
.+ . ..+.||+.|||||.+. ..|++..||||||+.++||+|+..|+.....+... -+.+..|.....+.+.-
T Consensus 199 s~--a-ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQI-----YKKV~SGiKP~sl~kV~ 269 (632)
T KOG0584|consen 199 SH--A-KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQI-----YKKVTSGIKPAALSKVK 269 (632)
T ss_pred cc--c-ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHH-----HHHHHcCCCHHHhhccC
Confidence 32 2 2388999999999766 78999999999999999999999998765554321 12234454444333221
Q ss_pred hhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 046270 504 RAEGARAVMERFVLVGILCAHVMVALRPTITDALK 538 (590)
Q Consensus 504 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~ 538 (590)
...+.+++..|+.. ..+|||+.|++.
T Consensus 270 --------dPevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 270 --------DPEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred --------CHHHHHHHHHHhcC-chhccCHHHHhh
Confidence 12566788899999 999999999987
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=276.02 Aligned_cols=247 Identities=24% Similarity=0.382 Sum_probs=195.5
Q ss_pred cceecccCcEEEEEEEEcC-CcEEEEEEeecCCC-CChHHHHHHHHHHHhcC-CCCccccceeEEeccCCCCceEEEEEe
Q 046270 269 NNLIGQGASGIVYKGTLRH-GNLVAVKQILDLDT-KGDEDFTNEVEIISKIR-HRNLLSLRGCCVTSDDSSGKRRFLVYD 345 (590)
Q Consensus 269 ~~~LG~G~fG~Vykg~~~~-g~~vAvK~l~~~~~-~~~~~f~~Ev~il~~l~-H~nlv~l~g~~~~~~~~~~~~~~LV~E 345 (590)
...||.|..|.|+|.++.. |..+|||.+..... ...+.+...++++.+-+ .|.||+-+||+.... ..++.||
T Consensus 97 l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~-----dV~IcMe 171 (391)
T KOG0983|consen 97 LGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNT-----DVFICME 171 (391)
T ss_pred HHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCc-----hHHHHHH
Confidence 3469999999999999875 78999999976543 33456777787777765 899999999998644 3788999
Q ss_pred eCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccccCCC
Q 046270 346 YMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGH 425 (590)
Q Consensus 346 ~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~~~~~ 425 (590)
.|. ..++.+|.. -.+++++...-++...+.+||.||.+ +++|+|||+||+|||+|+.|++|++|||++-++.+..
T Consensus 172 lMs-~C~ekLlkr--ik~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk 246 (391)
T KOG0983|consen 172 LMS-TCAEKLLKR--IKGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK 246 (391)
T ss_pred HHH-HHHHHHHHH--hcCCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceeeccc
Confidence 984 355555542 34568888888999999999999996 6799999999999999999999999999998775544
Q ss_pred cccccccccCCCccCccccc---cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhhhHH
Q 046270 426 SHLTTRVAGTFGYLAPEYAL---YGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDEF 502 (590)
Q Consensus 426 ~~~~~~~~gt~~Y~APE~~~---~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 502 (590)
..++.+|-+.|||||.+. ...|+.++|||||||.|+||.||+.|+.....++..++..+. .+ . +.
T Consensus 247 --AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln---~e---P----P~ 314 (391)
T KOG0983|consen 247 --AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLN---EE---P----PL 314 (391)
T ss_pred --ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHh---cC---C----CC
Confidence 346678999999999987 346889999999999999999999999987777775553221 11 1 22
Q ss_pred HhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 503 IRAEGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 503 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
+.+. ......+.++...|++.|+.+||...++++.
T Consensus 315 L~~~--~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 315 LPGH--MGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred CCcc--cCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 2211 1134578889999999999999999998863
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=302.29 Aligned_cols=250 Identities=22% Similarity=0.315 Sum_probs=196.7
Q ss_pred CCccceecccCcEEEEEEEEcCCc-EEEEEEeecCCCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEEEEE
Q 046270 266 FSQNNLIGQGASGIVYKGTLRHGN-LVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFLVY 344 (590)
Q Consensus 266 f~~~~~LG~G~fG~Vykg~~~~g~-~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~LV~ 344 (590)
|.++..||.|.||.|||++.++.. ..|.|.+.-.+....++|.-|++||+...||+||+|++.|+. .+.+++..
T Consensus 34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~-----enkLwili 108 (1187)
T KOG0579|consen 34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYF-----ENKLWILI 108 (1187)
T ss_pred HHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhc-----cCceEEEE
Confidence 344567999999999999988744 456677665666667889999999999999999999998874 34589999
Q ss_pred eeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccccCC
Q 046270 345 DYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEG 424 (590)
Q Consensus 345 E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~~~~ 424 (590)
|||.||-.+..+-. -...|++.++.-+.++++.||.||| +.+|||||||+.|||++-+|.++|+|||.+-....
T Consensus 109 EFC~GGAVDaimlE--L~r~LtE~QIqvvc~q~ldALn~LH---s~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~- 182 (1187)
T KOG0579|consen 109 EFCGGGAVDAIMLE--LGRVLTEDQIQVVCYQVLDALNWLH---SQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS- 182 (1187)
T ss_pred eecCCchHhHHHHH--hccccchHHHHHHHHHHHHHHHHHh---hcchhhhhccccceEEEecCcEeeecccccccchh-
Confidence 99999999887642 3457999999999999999999999 99999999999999999999999999998754321
Q ss_pred CcccccccccCCCccCcccccc-----CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhh
Q 046270 425 HSHLTTRVAGTFGYLAPEYALY-----GQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIF 499 (590)
Q Consensus 425 ~~~~~~~~~gt~~Y~APE~~~~-----~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 499 (590)
.......+.||+.|||||+++. .+|+.++|||||||+|.||.-+.+|.........++. ........++
T Consensus 183 t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllK------iaKSePPTLl 256 (1187)
T KOG0579|consen 183 TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLK------IAKSEPPTLL 256 (1187)
T ss_pred HHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHH------HhhcCCCccc
Confidence 1223445789999999998873 5789999999999999999999988754333222221 1111222222
Q ss_pred hHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 500 DEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 500 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
.+ ......+-++...|+..||..||++.++++.
T Consensus 257 qP-------S~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 257 QP-------SHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred Cc-------chhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 22 2234567788889999999999999987754
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=277.34 Aligned_cols=251 Identities=26% Similarity=0.377 Sum_probs=195.3
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEee--cCCCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCce
Q 046270 263 TNGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQIL--DLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKR 339 (590)
Q Consensus 263 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~--~~~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~ 339 (590)
+++|+..+.||+|.|+.||+..+. .|+.+|+|.+. .....+.+++.+|+++-+.|+|||||+|...+. +...
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~-----~~~~ 84 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ-----EESF 84 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhc-----ccce
Confidence 356677788999999999998765 48888888763 344457788999999999999999999998775 4567
Q ss_pred EEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCC---CcEEEEeeC
Q 046270 340 RFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSE---LNAKVADFG 416 (590)
Q Consensus 340 ~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~---~~~kL~DFG 416 (590)
.|||+|+|.+++|..-+- .+..+++...-..+.||+++|.|.| .++|||||+||.|+||-.. --+||+|||
T Consensus 85 ~ylvFe~m~G~dl~~eIV---~R~~ySEa~aSH~~rQiLeal~yCH---~n~IvHRDvkP~nllLASK~~~A~vKL~~FG 158 (355)
T KOG0033|consen 85 HYLVFDLVTGGELFEDIV---AREFYSEADASHCIQQILEALAYCH---SNGIVHRDLKPENLLLASKAKGAAVKLADFG 158 (355)
T ss_pred eEEEEecccchHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeeeeccCCCceeecccc
Confidence 999999999999975442 3356788888899999999999999 9999999999999999543 347999999
Q ss_pred CcccccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCch
Q 046270 417 LAKQSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVD 496 (590)
Q Consensus 417 la~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 496 (590)
+|.... .........||++|||||++...+|+..+|||+-||+|+-|+.|..||....... +..+ ...|...
T Consensus 159 vAi~l~--~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~r-lye~-----I~~g~yd 230 (355)
T KOG0033|consen 159 LAIEVN--DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR-LYEQ-----IKAGAYD 230 (355)
T ss_pred eEEEeC--CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHH-HHHH-----HhccccC
Confidence 999876 3334456789999999999999999999999999999999999999997532211 1111 1111110
Q ss_pred hhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 046270 497 DIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALK 538 (590)
Q Consensus 497 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~ 538 (590)
++ ...-..+.+....++.+|+..||.+|-|+.|.+.
T Consensus 231 --~~----~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 231 --YP----SPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred --CC----CcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 00 0011122345566778899999999999998765
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=292.62 Aligned_cols=251 Identities=23% Similarity=0.337 Sum_probs=194.0
Q ss_pred cCCCccceecccCcEEEEEEEEcCCcEEEEEEeecC--CCCChHHHHHHHHHHHhc-CCCCccccceeEEeccCCCCceE
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLRHGNLVAVKQILDL--DTKGDEDFTNEVEIISKI-RHRNLLSLRGCCVTSDDSSGKRR 340 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~~g~~vAvK~l~~~--~~~~~~~f~~Ev~il~~l-~H~nlv~l~g~~~~~~~~~~~~~ 340 (590)
..|+..++||+||.+.|||+...+.+.+|+|++... +.+...-|.+|+++|.+| .|.+||+|++|-.. ...+
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~-----d~~l 435 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVT-----DGYL 435 (677)
T ss_pred chhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeecc-----CceE
Confidence 357778899999999999999988889999987543 334456799999999999 59999999999774 4579
Q ss_pred EEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCccc
Q 046270 341 FLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQ 420 (590)
Q Consensus 341 ~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~ 420 (590)
||||||- ..+|..+|... ......| .++.+..|++.++.++| +.+|||.||||.|+|+-. |.+||+|||+|..
T Consensus 436 YmvmE~G-d~DL~kiL~k~-~~~~~~~-~lk~ywkqML~aV~~IH---~~gIVHSDLKPANFLlVk-G~LKLIDFGIA~a 508 (677)
T KOG0596|consen 436 YMVMECG-DIDLNKILKKK-KSIDPDW-FLKFYWKQMLLAVKTIH---QHGIVHSDLKPANFLLVK-GRLKLIDFGIANA 508 (677)
T ss_pred EEEeecc-cccHHHHHHhc-cCCCchH-HHHHHHHHHHHHHHHHH---HhceeecCCCcccEEEEe-eeEEeeeechhcc
Confidence 9999997 46888888532 2223445 78889999999999999 999999999999999854 5899999999998
Q ss_pred ccCCCccc-ccccccCCCccCccccccC-----------CCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHH
Q 046270 421 SLEGHSHL-TTRVAGTFGYLAPEYALYG-----------QLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWV 488 (590)
Q Consensus 421 ~~~~~~~~-~~~~~gt~~Y~APE~~~~~-----------~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~ 488 (590)
...+.+.. .....||..||+||.+... +.+.++||||+||+||+|+-|+.||.. ....|++.
T Consensus 509 I~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~------~~n~~aKl 582 (677)
T KOG0596|consen 509 IQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQ------IINQIAKL 582 (677)
T ss_pred cCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHH------HHHHHHHH
Confidence 87766554 3456899999999988632 256799999999999999999999863 22234433
Q ss_pred HHhcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 046270 489 LAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALK 538 (590)
Q Consensus 489 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~ 538 (590)
......-.++--+.+ ... ..+++++..|++.||.+||++.|+++
T Consensus 583 ~aI~~P~~~Iefp~~---~~~---~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 583 HAITDPNHEIEFPDI---PEN---DELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred HhhcCCCccccccCC---CCc---hHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 222111111111111 111 13889999999999999999999986
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=282.24 Aligned_cols=265 Identities=23% Similarity=0.335 Sum_probs=213.4
Q ss_pred HHHHHHHhcCCCccceecccCcEEEEEEEEcC------CcEEEEEEeecCCCC-ChHHHHHHHHHHHhcCCCCcccccee
Q 046270 256 VSELEQATNGFSQNNLIGQGASGIVYKGTLRH------GNLVAVKQILDLDTK-GDEDFTNEVEIISKIRHRNLLSLRGC 328 (590)
Q Consensus 256 ~~el~~at~~f~~~~~LG~G~fG~Vykg~~~~------g~~vAvK~l~~~~~~-~~~~f~~Ev~il~~l~H~nlv~l~g~ 328 (590)
.+++.....+|+...++-+|.||.||.|.|.+ .+.|-+|.+++...+ ....+..|.-++..+.|||+.++.|.
T Consensus 276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V 355 (563)
T KOG1024|consen 276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV 355 (563)
T ss_pred HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence 45666667788888899999999999997753 345778877654333 24567889999999999999999999
Q ss_pred EEeccCCCCceEEEEEeeCCCCCcchhhh-----hhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceE
Q 046270 329 CVTSDDSSGKRRFLVYDYMPNGTLSDNIS-----ISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNIL 403 (590)
Q Consensus 329 ~~~~~~~~~~~~~LV~E~~~~gsL~~~L~-----~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NIL 403 (590)
+.+ ++...+++|.++.-|+|..+|. +....+.++-.+...++.|++.|++||| +.++||.||.++|.+
T Consensus 356 ~ie----~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh---~~~ViHkDiAaRNCv 428 (563)
T KOG1024|consen 356 SIE----DYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLH---NHGVIHKDIAARNCV 428 (563)
T ss_pred Eee----ccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHH---hcCcccchhhhhcce
Confidence 986 4456899999999999999997 3334456888899999999999999999 999999999999999
Q ss_pred ECCCCcEEEEeeCCcccccCCCccc-ccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhh
Q 046270 404 LDSELNAKVADFGLAKQSLEGHSHL-TTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLDTSTSPFQL 481 (590)
Q Consensus 404 Ld~~~~~kL~DFGla~~~~~~~~~~-~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELlt-G~~p~~~~~~~~~~ 481 (590)
+|+..++||+|=.++|...+.+.+. .........||+||.+.+..|+..+|||||||+||||+| |+.|+...+ +++
T Consensus 429 Idd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeID-PfE- 506 (563)
T KOG1024|consen 429 IDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEID-PFE- 506 (563)
T ss_pred ehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccC-HHH-
Confidence 9999999999999999887777664 344556779999999999999999999999999999999 888875432 222
Q ss_pred hhHHHHHHHhcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhcc
Q 046270 482 ITDWAWVLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEG 542 (590)
Q Consensus 482 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~ 542 (590)
...+.++| .+-..+...+.+++.++.-||..+|++||+.++++.-|..
T Consensus 507 ----m~~ylkdG---------yRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLse 554 (563)
T KOG1024|consen 507 ----MEHYLKDG---------YRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSE 554 (563)
T ss_pred ----HHHHHhcc---------ceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence 11112222 1112233456688999999999999999999999988754
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=278.74 Aligned_cols=251 Identities=24% Similarity=0.264 Sum_probs=196.7
Q ss_pred CCCccceecccCcEEEEEEEEcC-CcEEEEEEeecCCC---CChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceE
Q 046270 265 GFSQNNLIGQGASGIVYKGTLRH-GNLVAVKQILDLDT---KGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRR 340 (590)
Q Consensus 265 ~f~~~~~LG~G~fG~Vykg~~~~-g~~vAvK~l~~~~~---~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~ 340 (590)
.|...++||.|.-|+||.+.+.+ +..+|+|++.+..- +.......|-+||+.+.||.+..|++.+.. .+..
T Consensus 78 ~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet-----~~~~ 152 (459)
T KOG0610|consen 78 HFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFET-----DKYS 152 (459)
T ss_pred HHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeec-----ccee
Confidence 34556789999999999999986 47899999965432 233456789999999999999999999974 4568
Q ss_pred EEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCccc
Q 046270 341 FLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQ 420 (590)
Q Consensus 341 ~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~ 420 (590)
+||||||+||+|...++ .+..+.+++...+-++.+|+-||+||| -.|||.|||||+||||.++|.+.|+||.|+..
T Consensus 153 cl~meyCpGGdL~~Lrq-kQp~~~fse~~aRFYaAEvl~ALEYLH---mlGivYRDLKPENILvredGHIMLsDFDLS~~ 228 (459)
T KOG0610|consen 153 CLVMEYCPGGDLHSLRQ-KQPGKRFSESAARFYAAEVLLALEYLH---MLGIVYRDLKPENILVREDGHIMLSDFDLSLR 228 (459)
T ss_pred EEEEecCCCccHHHHHh-hCCCCccchhhHHHHHHHHHHHHHHHH---hhceeeccCCcceeEEecCCcEEeeecccccc
Confidence 99999999999988764 345567999999999999999999999 89999999999999999999999999998753
Q ss_pred ccC---------------------------------CCc----------------------ccccccccCCCccCccccc
Q 046270 421 SLE---------------------------------GHS----------------------HLTTRVAGTFGYLAPEYAL 445 (590)
Q Consensus 421 ~~~---------------------------------~~~----------------------~~~~~~~gt~~Y~APE~~~ 445 (590)
... ... ....-..||..|+|||++.
T Consensus 229 ~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~ 308 (459)
T KOG0610|consen 229 CPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIR 308 (459)
T ss_pred CCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeee
Confidence 210 000 0011246899999999999
Q ss_pred cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhc
Q 046270 446 YGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHV 525 (590)
Q Consensus 446 ~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~ 525 (590)
+...+.+.|.|.|||+||||+.|+.||........+. ..+.+.-+..+ ...++..+.+++...+-.
T Consensus 309 G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~----NIv~~~l~Fp~----------~~~vs~~akDLIr~LLvK 374 (459)
T KOG0610|consen 309 GEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLR----NIVGQPLKFPE----------EPEVSSAAKDLIRKLLVK 374 (459)
T ss_pred cCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHH----HHhcCCCcCCC----------CCcchhHHHHHHHHHhcc
Confidence 9999999999999999999999999998765543311 11111111111 113345677788899999
Q ss_pred CCCCCCC----HHHHHH
Q 046270 526 MVALRPT----ITDALK 538 (590)
Q Consensus 526 dp~~RPt----m~eVl~ 538 (590)
||.+|-. +.||-+
T Consensus 375 dP~kRlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 375 DPSKRLGSKRGAAEIKR 391 (459)
T ss_pred ChhhhhccccchHHhhc
Confidence 9999987 677654
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-32 Score=302.98 Aligned_cols=265 Identities=19% Similarity=0.227 Sum_probs=172.1
Q ss_pred HhcCCCccceecccCcEEEEEEEEcC-----CcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCccccceeEEe-ccCC
Q 046270 262 ATNGFSQNNLIGQGASGIVYKGTLRH-----GNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVT-SDDS 335 (590)
Q Consensus 262 at~~f~~~~~LG~G~fG~Vykg~~~~-----g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~-~~~~ 335 (590)
..++|...++||+|+||.||+|++.+ +..||||++..... .+.+.+| .+.+..+.+++.+...+.. ....
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 56789999999999999999999864 57899998754321 1112221 1222233334333322211 1112
Q ss_pred CCceEEEEEeeCCCCCcchhhhhhcc-----------------cccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCC
Q 046270 336 SGKRRFLVYDYMPNGTLSDNISISHK-----------------RKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIK 398 (590)
Q Consensus 336 ~~~~~~LV~E~~~~gsL~~~L~~~~~-----------------~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIK 398 (590)
.+...++||||+++++|.+++..... .....+..+..|+.||+.||+||| +.+|+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH---~~gIiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLH---STGIVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHH---HCCEEeCcCC
Confidence 45679999999999999988853210 001123345679999999999999 8999999999
Q ss_pred CCceEECC-CCcEEEEeeCCcccccCCCcccccccccCCCccCccccccC----------------------CCCcchhH
Q 046270 399 STNILLDS-ELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALYG----------------------QLTEKSDV 455 (590)
Q Consensus 399 p~NILLd~-~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~----------------------~~t~ksDV 455 (590)
|+|||+++ ++.+||+|||+++....+.........++++|+|||.+... .++.++||
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV 362 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 362 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence 99999986 57999999999987655444445567789999999965422 23456799
Q ss_pred HHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhhhHHHhhhhHHH----------HHHHHHHHHHhchhc
Q 046270 456 YSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDEFIRAEGARA----------VMERFVLVGILCAHV 525 (590)
Q Consensus 456 ySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~----------~~~~l~~l~~~Cl~~ 525 (590)
|||||+||||+++..+.+.. +..+...+...+.....+...+......+ ......+++..|++.
T Consensus 363 wSlGviL~el~~~~~~~~~~------~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~ 436 (566)
T PLN03225 363 YSAGLIFLQMAFPNLRSDSN------LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRF 436 (566)
T ss_pred HHHHHHHHHHHhCcCCCchH------HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccC
Confidence 99999999999977654321 11111111111110000000000000000 012345788999999
Q ss_pred CCCCCCCHHHHHHH
Q 046270 526 MVALRPTITDALKM 539 (590)
Q Consensus 526 dp~~RPtm~eVl~~ 539 (590)
||++|||+.++++.
T Consensus 437 dP~kR~ta~e~L~H 450 (566)
T PLN03225 437 KGRQRISAKAALAH 450 (566)
T ss_pred CcccCCCHHHHhCC
Confidence 99999999999974
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-32 Score=307.41 Aligned_cols=145 Identities=28% Similarity=0.409 Sum_probs=127.5
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCCC---ChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCce
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDTK---GDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKR 339 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~~---~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~ 339 (590)
++|...++||+|+||.||+|++. .++.||||++...... ....+..|+.++..++|+||+++++++.. +..
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~-----~~~ 78 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQS-----ANN 78 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEE-----CCE
Confidence 57888899999999999999987 5889999998653322 23568899999999999999999988763 446
Q ss_pred EEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcc
Q 046270 340 RFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAK 419 (590)
Q Consensus 340 ~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~ 419 (590)
.+|||||+++++|.+++. ..+.+++...+.|+.||+.||.||| ..+|+||||||+||||+.++.+||+|||+++
T Consensus 79 ~~lVmEy~~g~~L~~li~---~~~~l~~~~~~~i~~qil~aL~yLH---~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 79 VYLVMEYLIGGDVKSLLH---IYGYFDEEMAVKYISEVALALDYLH---RHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EEEEEeCCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999999999999885 2346899999999999999999999 8899999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=322.22 Aligned_cols=257 Identities=27% Similarity=0.372 Sum_probs=199.4
Q ss_pred HHHhcCCCccceecccCcEEEEEEEEcC-CcEEEEEEeecC--CCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCC
Q 046270 260 EQATNGFSQNNLIGQGASGIVYKGTLRH-GNLVAVKQILDL--DTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSS 336 (590)
Q Consensus 260 ~~at~~f~~~~~LG~G~fG~Vykg~~~~-g~~vAvK~l~~~--~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~ 336 (590)
...+-++...+.||.|.||.||-++..+ |...|+|.++-. .....+.+.+|+.++..|+|||+|+++|.-.+.+
T Consensus 1231 snV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRe--- 1307 (1509)
T KOG4645|consen 1231 SNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHRE--- 1307 (1509)
T ss_pred ccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHH---
Confidence 3445577788999999999999998764 788999987533 2344567899999999999999999999887544
Q ss_pred CceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeC
Q 046270 337 GKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFG 416 (590)
Q Consensus 337 ~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFG 416 (590)
..++.||||++|+|.+.+. ..+..++.....+..|++.|++||| +.+||||||||.||+||.+|.+|++|||
T Consensus 1308 --kv~IFMEyC~~GsLa~ll~---~gri~dE~vt~vyt~qll~gla~LH---~~gIVHRDIK~aNI~Ld~~g~iK~~DFG 1379 (1509)
T KOG4645|consen 1308 --KVYIFMEYCEGGSLASLLE---HGRIEDEMVTRVYTKQLLEGLAYLH---EHGIVHRDIKPANILLDFNGLIKYGDFG 1379 (1509)
T ss_pred --HHHHHHHHhccCcHHHHHH---hcchhhhhHHHHHHHHHHHHHHHHH---hcCceecCCCccceeeecCCcEEeeccc
Confidence 4899999999999999884 3345666677778899999999999 9999999999999999999999999999
Q ss_pred CcccccCCCc---ccccccccCCCccCccccccC---CCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHH-
Q 046270 417 LAKQSLEGHS---HLTTRVAGTFGYLAPEYALYG---QLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVL- 489 (590)
Q Consensus 417 la~~~~~~~~---~~~~~~~gt~~Y~APE~~~~~---~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~- 489 (590)
.|........ .......||+.|||||.+.+. ....+.||||+|||++||+||++||...+.. |+-.+
T Consensus 1380 sa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne------~aIMy~ 1453 (1509)
T KOG4645|consen 1380 SAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE------WAIMYH 1453 (1509)
T ss_pred ceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch------hHHHhH
Confidence 9987654321 123456799999999999753 3456899999999999999999999765543 33222
Q ss_pred HhcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhcc
Q 046270 490 AKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEG 542 (590)
Q Consensus 490 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~ 542 (590)
+..|....+ ++.+...=.+++..|++.||.+|.++.|+++.=-+
T Consensus 1454 V~~gh~Pq~---------P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~ 1497 (1509)
T KOG4645|consen 1454 VAAGHKPQI---------PERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFG 1497 (1509)
T ss_pred HhccCCCCC---------chhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhcc
Confidence 222221111 11122233456678999999999999888876443
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=284.77 Aligned_cols=247 Identities=21% Similarity=0.287 Sum_probs=202.8
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCC--CCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceE
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLD--TKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRR 340 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~--~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~ 340 (590)
+-|...+.||+|.|..|-.+++- .|..||||++.+.. ......+..|++.|+.++|||||+|+.... ....+
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViD-----TQTKl 92 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVID-----TQTKL 92 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhc-----ccceE
Confidence 34666678999999999999764 58999999986533 333456889999999999999999998765 35569
Q ss_pred EEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCC-CcEEEEeeCCcc
Q 046270 341 FLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSE-LNAKVADFGLAK 419 (590)
Q Consensus 341 ~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~-~~~kL~DFGla~ 419 (590)
|||+|+-.+|+|.+|+... ...+.+....+++.||.+||.|.| +..+|||||||+||.+-+. |-+||.|||++-
T Consensus 93 yLiLELGD~GDl~DyImKH--e~Gl~E~La~kYF~QI~~AI~YCH---qLHVVHRDLKPENVVFFEKlGlVKLTDFGFSN 167 (864)
T KOG4717|consen 93 YLILELGDGGDLFDYIMKH--EEGLNEDLAKKYFAQIVHAISYCH---QLHVVHRDLKPENVVFFEKLGLVKLTDFGFSN 167 (864)
T ss_pred EEEEEecCCchHHHHHHhh--hccccHHHHHHHHHHHHHHHHHHh---hhhhhcccCCcceeEEeeecCceEeeeccccc
Confidence 9999999999999999643 356999999999999999999999 9999999999999988655 789999999998
Q ss_pred cccCCCcccccccccCCCccCccccccCCCC-cchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhh
Q 046270 420 QSLEGHSHLTTRVAGTFGYLAPEYALYGQLT-EKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDI 498 (590)
Q Consensus 420 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t-~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 498 (590)
.+.++. ..+..+|...|-|||++.+..|+ ++.||||+||+||-|++|+.||+...+... +..+
T Consensus 168 kf~PG~--kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSET--------------LTmI 231 (864)
T KOG4717|consen 168 KFQPGK--KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSET--------------LTMI 231 (864)
T ss_pred cCCCcc--hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhh--------------hhhh
Confidence 776654 34567899999999999998886 588999999999999999999976544322 1222
Q ss_pred hhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 046270 499 FDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALK 538 (590)
Q Consensus 499 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~ 538 (590)
+|... ..+..+..+|.+++..|+..||.+|.+.+|++.
T Consensus 232 mDCKY--tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 232 MDCKY--TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred hcccc--cCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 23211 234445668899999999999999999999875
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.7e-32 Score=295.08 Aligned_cols=264 Identities=21% Similarity=0.270 Sum_probs=182.3
Q ss_pred HhcCCCccceecccCcEEEEEEEE-----------------cCCcEEEEEEeecCCCCChHHH--------------HHH
Q 046270 262 ATNGFSQNNLIGQGASGIVYKGTL-----------------RHGNLVAVKQILDLDTKGDEDF--------------TNE 310 (590)
Q Consensus 262 at~~f~~~~~LG~G~fG~Vykg~~-----------------~~g~~vAvK~l~~~~~~~~~~f--------------~~E 310 (590)
..++|...++||+|+||.||+|.+ .+++.||||++........++| ..|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 467899999999999999999975 2356899999865433222333 347
Q ss_pred HHHHHhcCCCCc-----cccceeEEeccC---CCCceEEEEEeeCCCCCcchhhhhhc---------------------c
Q 046270 311 VEIISKIRHRNL-----LSLRGCCVTSDD---SSGKRRFLVYDYMPNGTLSDNISISH---------------------K 361 (590)
Q Consensus 311 v~il~~l~H~nl-----v~l~g~~~~~~~---~~~~~~~LV~E~~~~gsL~~~L~~~~---------------------~ 361 (590)
+.++.+++|.++ ++++++|..... ......+|||||+++|+|.++++... .
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777888877655 678888865321 12346899999999999999886321 1
Q ss_pred cccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccccCCCcccccccccCCCccCc
Q 046270 362 RKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAP 441 (590)
Q Consensus 362 ~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~AP 441 (590)
...++|..++.|+.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++....+.........+|+.|+||
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH---~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLH---RIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP 379 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence 123578889999999999999999 88999999999999999999999999999976543322222223347899999
Q ss_pred cccccCCC----------------------CcchhHHHHHHHHHHHHhCCC-CCCCCCCchh-------hhhHHHHHHHh
Q 046270 442 EYALYGQL----------------------TEKSDVYSFGIVILELMSGRK-VLDTSTSPFQ-------LITDWAWVLAK 491 (590)
Q Consensus 442 E~~~~~~~----------------------t~ksDVySfGvvLlELltG~~-p~~~~~~~~~-------~l~~~~~~~~~ 491 (590)
|.+..... ..+.||||+||+++||++|.. |+.....-.. .+.. |..+.
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~--~r~~~ 457 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNR--WRMYK 457 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHH--HHhhc
Confidence 98764321 235799999999999999874 5542111000 1111 22222
Q ss_pred cCCch-hhhhHHHhhhhHHHHHHHHHHHHHhchhcCC---CCCCCHHHHHHH
Q 046270 492 SGKVD-DIFDEFIRAEGARAVMERFVLVGILCAHVMV---ALRPTITDALKM 539 (590)
Q Consensus 492 ~~~~~-~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp---~~RPtm~eVl~~ 539 (590)
..... ..+| ...+...+++..++..+| .+|+|+.|++++
T Consensus 458 ~~~~~~~~~d---------~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 458 GQKYDFSLLD---------RNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred ccCCCccccc---------ccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 22211 0111 112345566667777655 789999999863
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-31 Score=264.82 Aligned_cols=238 Identities=29% Similarity=0.380 Sum_probs=191.1
Q ss_pred CcEEEEEEEEcC-CcEEEEEEeecCCCCC-hHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEEEEEeeCCCCCcc
Q 046270 276 ASGIVYKGTLRH-GNLVAVKQILDLDTKG-DEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLS 353 (590)
Q Consensus 276 ~fG~Vykg~~~~-g~~vAvK~l~~~~~~~-~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~LV~E~~~~gsL~ 353 (590)
+||.||+|+..+ |..+++|++....... .+.+.+|++.+++++|+|++++++++.. ....++++||+++++|.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~~~l~~e~~~~~~L~ 75 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFED-----EDKLYLVMEYCDGGDLF 75 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheee-----CCEEEEEEeCCCCCCHH
Confidence 689999999975 8899999987655444 6789999999999999999999999974 35689999999999999
Q ss_pred hhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccccCCCcccccccc
Q 046270 354 DNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVA 433 (590)
Q Consensus 354 ~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~~~~~~~~~~~~~ 433 (590)
+++.. ...+++..++.++.+++++|.||| +.+++|+||+|+||++++++.++|+|||.+....... ......
T Consensus 76 ~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~ 147 (244)
T smart00220 76 DLLKK---RGRLSEDEARFYARQILSALEYLH---SNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFV 147 (244)
T ss_pred HHHHh---ccCCCHHHHHHHHHHHHHHHHHHH---HcCeecCCcCHHHeEECCCCcEEEccccceeeecccc--cccccc
Confidence 98853 223899999999999999999999 8899999999999999999999999999998765432 233456
Q ss_pred cCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhhhHHHhhhhHHHHHH
Q 046270 434 GTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDEFIRAEGARAVME 513 (590)
Q Consensus 434 gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 513 (590)
++..|++||.+....++.++|||+||++++||++|+.|+........ +.++. ..+.... .. .......
T Consensus 148 ~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~-~~~~~----~~~~~~~-~~------~~~~~~~ 215 (244)
T smart00220 148 GTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLE-LFKKI----GKPKPPF-PP------PEWKISP 215 (244)
T ss_pred CCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHH-HHHHH----hccCCCC-cc------ccccCCH
Confidence 78899999999988899999999999999999999999865322211 11111 1111100 00 0000334
Q ss_pred HHHHHHHhchhcCCCCCCCHHHHHH
Q 046270 514 RFVLVGILCAHVMVALRPTITDALK 538 (590)
Q Consensus 514 ~l~~l~~~Cl~~dp~~RPtm~eVl~ 538 (590)
.+.+++.+|+..+|++||++.++++
T Consensus 216 ~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 216 EAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHHHHccCCchhccCHHHHhh
Confidence 7888999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.2e-32 Score=268.72 Aligned_cols=220 Identities=21% Similarity=0.212 Sum_probs=173.1
Q ss_pred cCcEEEEEEEEc-CCcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEEEEEeeCCCCCcc
Q 046270 275 GASGIVYKGTLR-HGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLS 353 (590)
Q Consensus 275 G~fG~Vykg~~~-~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~LV~E~~~~gsL~ 353 (590)
|.||.||+++.. +++.+|+|++.... .+..|...+....|||++++++++.. +...++||||+++|+|.
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~ 73 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVS-----EDSVFLVLQHAEGGKLW 73 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheec-----CCeEEEEEecCCCCCHH
Confidence 899999999986 47899999986532 34456666667789999999999873 45689999999999999
Q ss_pred hhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccccCCCcccccccc
Q 046270 354 DNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVA 433 (590)
Q Consensus 354 ~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~~~~~~~~~~~~~ 433 (590)
+++. +...+++..+..++.|++.||.||| +.+|+||||||+||+++.++.++++|||.+...... .....
T Consensus 74 ~~l~---~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~ 143 (237)
T cd05576 74 SHIS---KFLNIPEECVKRWAAEMVVALDALH---REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEA 143 (237)
T ss_pred HHHH---HhcCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCC
Confidence 9885 2346999999999999999999999 899999999999999999999999999987654322 12334
Q ss_pred cCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhhhHHHhhhhHHHHHH
Q 046270 434 GTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDEFIRAEGARAVME 513 (590)
Q Consensus 434 gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 513 (590)
++..|+|||....+.++.++||||+|++++||++|+.++......... .... .+ +.....
T Consensus 144 ~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~~----------~~~~------~~----~~~~~~ 203 (237)
T cd05576 144 VENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGINT----------HTTL------NI----PEWVSE 203 (237)
T ss_pred cCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhccc----------cccc------CC----cccCCH
Confidence 567899999998888999999999999999999999876532211000 0000 00 111224
Q ss_pred HHHHHHHhchhcCCCCCCCHH
Q 046270 514 RFVLVGILCAHVMVALRPTIT 534 (590)
Q Consensus 514 ~l~~l~~~Cl~~dp~~RPtm~ 534 (590)
.+..++..|++.||++||++.
T Consensus 204 ~~~~li~~~l~~dp~~R~~~~ 224 (237)
T cd05576 204 EARSLLQQLLQFNPTERLGAG 224 (237)
T ss_pred HHHHHHHHHccCCHHHhcCCC
Confidence 567788899999999999974
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-32 Score=288.51 Aligned_cols=247 Identities=23% Similarity=0.289 Sum_probs=198.5
Q ss_pred HhcCCCccceecccCcEEEEEEEEcC-CcEEEEEEeecCCCC--ChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCc
Q 046270 262 ATNGFSQNNLIGQGASGIVYKGTLRH-GNLVAVKQILDLDTK--GDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGK 338 (590)
Q Consensus 262 at~~f~~~~~LG~G~fG~Vykg~~~~-g~~vAvK~l~~~~~~--~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~ 338 (590)
-.+.|.....||+|.|+.|..|++.. |..||||.+.+.... ....+.+|+++|..|+|||||+|+.+.... .
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~-----~ 128 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETE-----A 128 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeec-----c
Confidence 45678888999999999999999864 889999988654322 234588999999999999999999998754 4
Q ss_pred eEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCc
Q 046270 339 RRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLA 418 (590)
Q Consensus 339 ~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla 418 (590)
.+|+||||..+|.+.++|. +.+.+.......++.|+.++++|+| ++.|+|||||++||||+.++++||+|||++
T Consensus 129 ~lylV~eya~~ge~~~yl~---~~gr~~e~~ar~~F~q~vsaveYcH---~k~ivHrdLk~eNilL~~~mnikIaDfgfS 202 (596)
T KOG0586|consen 129 TLYLVMEYASGGELFDYLV---KHGRMKEKEARAKFRQIVSAVEYCH---SKNIVHRDLKAENILLDENMNIKIADFGFS 202 (596)
T ss_pred eeEEEEEeccCchhHHHHH---hcccchhhhhhhhhHHHHHHHHHHh---hcceeccccchhhcccccccceeeeccccc
Confidence 5999999999999999995 4455666888899999999999999 999999999999999999999999999999
Q ss_pred ccccCCCcccccccccCCCccCccccccCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchh
Q 046270 419 KQSLEGHSHLTTRVAGTFGYLAPEYALYGQL-TEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDD 497 (590)
Q Consensus 419 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~-t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 497 (590)
..+.. ........|++.|.|||++.+.+| .++.|+||+|++||-|+.|..||+...-..
T Consensus 203 ~~~~~--~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~------------------ 262 (596)
T KOG0586|consen 203 TFFDY--GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKE------------------ 262 (596)
T ss_pred eeecc--cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccc------------------
Confidence 87653 334566789999999999987766 579999999999999999999998533211
Q ss_pred hhhHHHhhhh--HHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 498 IFDEFIRAEG--ARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 498 ~~d~~l~~~~--~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
+-+..+.... +.-+...|-+++...+-.+|.+|++++++.+.
T Consensus 263 Lr~rvl~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 263 LRPRVLRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred ccchheeeeecccceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence 1111111110 11112355667777888999999999988653
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9e-32 Score=265.30 Aligned_cols=202 Identities=28% Similarity=0.432 Sum_probs=166.0
Q ss_pred CCCccceecccCcEEEEEEEEcC-----CcEEEEEEeecCCCC-C-hHHHHHHHHHHHhcCCCCccccceeEEeccCCCC
Q 046270 265 GFSQNNLIGQGASGIVYKGTLRH-----GNLVAVKQILDLDTK-G-DEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSG 337 (590)
Q Consensus 265 ~f~~~~~LG~G~fG~Vykg~~~~-----g~~vAvK~l~~~~~~-~-~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~ 337 (590)
.|.....||+|.||.|||++-++ ...+|||+++..... + .....+|+.+++.++|+|++.|...+... .
T Consensus 25 ~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~----d 100 (438)
T KOG0666|consen 25 EYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSH----D 100 (438)
T ss_pred HhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhcc----C
Confidence 57778899999999999997553 236999998654221 2 34567899999999999999999988753 3
Q ss_pred ceEEEEEeeCCCCCcchhhhhhc--ccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCC----CcEE
Q 046270 338 KRRFLVYDYMPNGTLSDNISISH--KRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSE----LNAK 411 (590)
Q Consensus 338 ~~~~LV~E~~~~gsL~~~L~~~~--~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~----~~~k 411 (590)
...+|++||.+. +|...++..+ +.+.++......|+.||+.|+.||| +.-|+||||||.|||+..+ |.+|
T Consensus 101 ~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH---~NWvlHRDLKPaNIlvmgdgperG~VK 176 (438)
T KOG0666|consen 101 KKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLH---SNWVLHRDLKPANILVMGDGPERGRVK 176 (438)
T ss_pred ceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHh---hhheeeccCCcceEEEeccCCccCeeE
Confidence 569999999976 6777775433 3457999999999999999999999 8889999999999999887 8999
Q ss_pred EEeeCCcccccCCCcc--cccccccCCCccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCC
Q 046270 412 VADFGLAKQSLEGHSH--LTTRVAGTFGYLAPEYALYG-QLTEKSDVYSFGIVILELMSGRKVLDT 474 (590)
Q Consensus 412 L~DFGla~~~~~~~~~--~~~~~~gt~~Y~APE~~~~~-~~t~ksDVySfGvvLlELltG~~p~~~ 474 (590)
|+|||++|.+...-.. ....+.-|..|.|||.+.+. .||.+.|||+.||+..||+|-++.|..
T Consensus 177 IaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g 242 (438)
T KOG0666|consen 177 IADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKG 242 (438)
T ss_pred eecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccc
Confidence 9999999987543322 23456678999999998864 699999999999999999999887753
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-33 Score=272.16 Aligned_cols=252 Identities=25% Similarity=0.288 Sum_probs=193.0
Q ss_pred cceecccCcEEEEEEEEcC-CcEEEEEEeecCCC-CChHHHHHHHHHHHhc-CCCCccccceeEEeccCCCCceEEEEEe
Q 046270 269 NNLIGQGASGIVYKGTLRH-GNLVAVKQILDLDT-KGDEDFTNEVEIISKI-RHRNLLSLRGCCVTSDDSSGKRRFLVYD 345 (590)
Q Consensus 269 ~~~LG~G~fG~Vykg~~~~-g~~vAvK~l~~~~~-~~~~~f~~Ev~il~~l-~H~nlv~l~g~~~~~~~~~~~~~~LV~E 345 (590)
...||.|.||+|+|-.++. |+..|||+++.... ....++..|.+...+- +.||||+++|.+.. ++..++.||
T Consensus 69 lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~-----EGdcWiCME 143 (361)
T KOG1006|consen 69 LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFS-----EGDCWICME 143 (361)
T ss_pred HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhc-----CCceeeeHH
Confidence 3569999999999999874 89999999976544 4566788999887776 78999999999884 344899999
Q ss_pred eCCCCCcchhhhhh--cccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccccC
Q 046270 346 YMPNGTLSDNISIS--HKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLE 423 (590)
Q Consensus 346 ~~~~gsL~~~L~~~--~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~~~ 423 (590)
.|. .||+.+...- .+...+++...-+|..-+.+||.||.+ ...||||||||+|||||..|.+||+|||++-.+.+
T Consensus 144 LMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~ 220 (361)
T KOG1006|consen 144 LMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD 220 (361)
T ss_pred HHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCEeeecccchHhHHH
Confidence 994 5776554321 134568888889999999999999996 57899999999999999999999999999876543
Q ss_pred CCcccccccccCCCccCcccccc--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhhhH
Q 046270 424 GHSHLTTRVAGTFGYLAPEYALY--GQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDE 501 (590)
Q Consensus 424 ~~~~~~~~~~gt~~Y~APE~~~~--~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 501 (590)
. ...+.-+|-..|||||.+.. ..|+.+|||||+|++|+|+.||+.|+..-.+.++++.+ +-.|....++.+
T Consensus 221 S--iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~-----Vv~gdpp~l~~~ 293 (361)
T KOG1006|consen 221 S--IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQ-----VVIGDPPILLFD 293 (361)
T ss_pred H--HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHH-----HHcCCCCeecCc
Confidence 2 23455678899999999863 34899999999999999999999998754433322221 112322222111
Q ss_pred HHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 502 FIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 502 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
. ..-+....+..++-.|+-.|-.+||...++.++
T Consensus 294 ~----~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 294 K----ECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred c----cccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 1 111233467888889999999999999998764
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.7e-31 Score=287.84 Aligned_cols=266 Identities=25% Similarity=0.386 Sum_probs=216.0
Q ss_pred ccHHHHHHHhcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCCCChHHHHHHHHHHHhc-CCCCccccceeEEe
Q 046270 254 FHVSELEQATNGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDTKGDEDFTNEVEIISKI-RHRNLLSLRGCCVT 331 (590)
Q Consensus 254 f~~~el~~at~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l-~H~nlv~l~g~~~~ 331 (590)
..++.+...++.|.+...||+|.+|.|||++.. +|+.+|+|++.. ....++++..|.++|+.+ .|||++.++|++..
T Consensus 9 ~~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~-~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k 87 (953)
T KOG0587|consen 9 IDLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDP-TEDEEEEIELEYNMLKKYSHHPNVATFYGAFIK 87 (953)
T ss_pred cchhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecC-CccccHHHHHHHHHHHhccCCCCcceEEEEEEE
Confidence 344555556778899999999999999999875 478888887654 445577889999999998 79999999999998
Q ss_pred ccCCCCceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEE
Q 046270 332 SDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAK 411 (590)
Q Consensus 332 ~~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~k 411 (590)
.+...+.+++||||||.+||.-|++.... ...+.|+.+.-|++.+++||.+|| ...++|||||-.||||+.++.+|
T Consensus 88 ~~~~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH---~nkviHRDikG~NiLLT~e~~VK 163 (953)
T KOG0587|consen 88 KDPGNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLH---NNKVIHRDIKGQNVLLTENAEVK 163 (953)
T ss_pred ecCCCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHh---hcceeeecccCceEEEeccCcEE
Confidence 88778889999999999999999997655 678999999999999999999999 99999999999999999999999
Q ss_pred EEeeCCcccccCCCcccccccccCCCccCccccccC-----CCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHH
Q 046270 412 VADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALYG-----QLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWA 486 (590)
Q Consensus 412 L~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-----~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~ 486 (590)
|.|||++.+..... .......||+.|||||++... .|+..+|+||+|++.+||--|.+|+.+......++.
T Consensus 164 LvDFGvSaQldsT~-grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~--- 239 (953)
T KOG0587|consen 164 LVDFGVSAQLDSTV-GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFL--- 239 (953)
T ss_pred Eeeeeeeeeeeccc-ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhcc---
Confidence 99999998764432 233456799999999998754 377799999999999999999999865443221111
Q ss_pred HHHHhcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 046270 487 WVLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALK 538 (590)
Q Consensus 487 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~ 538 (590)
..++ .. +.+ ..++...+++.+++..|+..|-++||++.++++
T Consensus 240 --IpRN-PP-----PkL--krp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 240 --IPRN-PP-----PKL--KRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred --CCCC-CC-----ccc--cchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 0011 11 111 123445678999999999999999999998775
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=297.06 Aligned_cols=208 Identities=26% Similarity=0.352 Sum_probs=181.5
Q ss_pred HHHHHHHhcCCCccceecccCcEEEEEEEEcC-CcEEEEEEeecC---CCCChHHHHHHHHHHHhcCCCCccccceeEEe
Q 046270 256 VSELEQATNGFSQNNLIGQGASGIVYKGTLRH-GNLVAVKQILDL---DTKGDEDFTNEVEIISKIRHRNLLSLRGCCVT 331 (590)
Q Consensus 256 ~~el~~at~~f~~~~~LG~G~fG~Vykg~~~~-g~~vAvK~l~~~---~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~ 331 (590)
..++.-..++|.+.++||+|+||.|..++++. ++.+|.|++.+. ......-|..|-.+|..-+.+-|++|+-.+.
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQ- 145 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQ- 145 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhc-
Confidence 45666667889999999999999999999975 778999998763 3344556899999999999999999987776
Q ss_pred ccCCCCceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEE
Q 046270 332 SDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAK 411 (590)
Q Consensus 332 ~~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~k 411 (590)
+..++|||||||+||+|-.++.. ...+++...+.++..|.-||.-|| +.|+|||||||.|||||..|.+|
T Consensus 146 ----D~~~LYlVMdY~pGGDlltLlSk---~~~~pE~~ArFY~aEiVlAldslH---~mgyVHRDiKPDNvLld~~GHik 215 (1317)
T KOG0612|consen 146 ----DERYLYLVMDYMPGGDLLTLLSK---FDRLPEDWARFYTAEIVLALDSLH---SMGYVHRDIKPDNVLLDKSGHIK 215 (1317)
T ss_pred ----CccceEEEEecccCchHHHHHhh---cCCChHHHHHHHHHHHHHHHHHHH---hccceeccCCcceeEecccCcEe
Confidence 45679999999999999998853 336999999999999999999999 99999999999999999999999
Q ss_pred EEeeCCcccccCCCcccccccccCCCccCccccc----c-CCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 046270 412 VADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYAL----Y-GQLTEKSDVYSFGIVILELMSGRKVLDT 474 (590)
Q Consensus 412 L~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~----~-~~~t~ksDVySfGvvLlELltG~~p~~~ 474 (590)
|+|||.+-.+..+..-......|||.|++||++. + +.|.+..|.||+||++|||+.|..||..
T Consensus 216 LADFGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa 283 (1317)
T KOG0612|consen 216 LADFGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA 283 (1317)
T ss_pred eccchhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH
Confidence 9999998877665555566678999999999986 3 6799999999999999999999999964
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=256.15 Aligned_cols=260 Identities=23% Similarity=0.309 Sum_probs=196.0
Q ss_pred cHHHHHHHhcCCCccceecccCcEEEEEEE-EcCCcEEEEEEeecCCCCChHHHHHHHHHHHhc-CCCCccccceeEEec
Q 046270 255 HVSELEQATNGFSQNNLIGQGASGIVYKGT-LRHGNLVAVKQILDLDTKGDEDFTNEVEIISKI-RHRNLLSLRGCCVTS 332 (590)
Q Consensus 255 ~~~el~~at~~f~~~~~LG~G~fG~Vykg~-~~~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l-~H~nlv~l~g~~~~~ 332 (590)
+++++-+.|+ ++||+|.|+.|--.+ +..|.++|||++.+........+.+|++++... .|+||++|+.|+.+
T Consensus 74 ~F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEd- 147 (463)
T KOG0607|consen 74 KFEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFED- 147 (463)
T ss_pred hHHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcc-
Confidence 4667777766 689999999999886 456899999999887777778899999999999 59999999999984
Q ss_pred cCCCCceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCc---
Q 046270 333 DDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELN--- 409 (590)
Q Consensus 333 ~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~--- 409 (590)
....|||||-|.+|+|..++. ++.-+++.+..+++.+||.||.||| .++|.|||+||+|||-..-..
T Consensus 148 ----d~~FYLVfEKm~GGplLshI~---~~~~F~E~EAs~vvkdia~aLdFlH---~kgIAHRDlKPENiLC~~pn~vsP 217 (463)
T KOG0607|consen 148 ----DTRFYLVFEKMRGGPLLSHIQ---KRKHFNEREASRVVKDIASALDFLH---TKGIAHRDLKPENILCESPNKVSP 217 (463)
T ss_pred ----cceEEEEEecccCchHHHHHH---HhhhccHHHHHHHHHHHHHHHHHHh---hcCcccccCCccceeecCCCCcCc
Confidence 456999999999999999985 5667999999999999999999999 999999999999999865443
Q ss_pred EEEEeeCCcccccCCC------cccccccccCCCccCccccc-----cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc
Q 046270 410 AKVADFGLAKQSLEGH------SHLTTRVAGTFGYLAPEYAL-----YGQLTEKSDVYSFGIVILELMSGRKVLDTSTSP 478 (590)
Q Consensus 410 ~kL~DFGla~~~~~~~------~~~~~~~~gt~~Y~APE~~~-----~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~ 478 (590)
+||+||.+........ +.......|+..|||||+.. ...|+.+.|.||+|||||-|++|-.||...-..
T Consensus 218 vKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~ 297 (463)
T KOG0607|consen 218 VKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGA 297 (463)
T ss_pred eeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCC
Confidence 7999999876532211 12233457888999999864 235888999999999999999999999754432
Q ss_pred hhhhhHHHHHHHhcCCc----hhhhhHHHhhh---hH-H---HHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 046270 479 FQLITDWAWVLAKSGKV----DDIFDEFIRAE---GA-R---AVMERFVLVGILCAHVMVALRPTITDALK 538 (590)
Q Consensus 479 ~~~l~~~~~~~~~~~~~----~~~~d~~l~~~---~~-~---~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~ 538 (590)
.-- |..|.. .+.+-..+.+. .+ + .+....-+++...+-.++.+|-++.+|+.
T Consensus 298 dCG--------WdrGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 298 DCG--------WDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred cCC--------ccCCCccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 110 122221 11111122110 11 1 12233344555666689999988888765
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.8e-31 Score=280.27 Aligned_cols=240 Identities=23% Similarity=0.333 Sum_probs=190.3
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCCCChHHHHHHHHHHHhc-CCCCccccceeEEeccCCCCceE
Q 046270 263 TNGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDTKGDEDFTNEVEIISKI-RHRNLLSLRGCCVTSDDSSGKRR 340 (590)
Q Consensus 263 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l-~H~nlv~l~g~~~~~~~~~~~~~ 340 (590)
++.|.....+|.|+|+.|-++.+. .++..+||++.+. ..+-.+|+.++.+. +|+|++++.+.+. ++.+.
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~----~~~~~~e~~~~~~~~~h~niv~~~~v~~-----~~~~~ 391 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR----ADDNQDEIPISLLVRDHPNIVKSHDVYE-----DGKEI 391 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheecccc----ccccccccchhhhhcCCCcceeecceec-----CCcee
Confidence 455666777999999999999876 4778999998654 22345678777776 7999999999987 56789
Q ss_pred EEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEE-CCCCcEEEEeeCCcc
Q 046270 341 FLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILL-DSELNAKVADFGLAK 419 (590)
Q Consensus 341 ~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILL-d~~~~~kL~DFGla~ 419 (590)
++|||++.++-|.+.+. ..+... .++..|+.+|+.++.||| ..++|||||||+|||+ ++.++++|+|||.++
T Consensus 392 ~~v~e~l~g~ell~ri~---~~~~~~-~e~~~w~~~lv~Av~~LH---~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~ 464 (612)
T KOG0603|consen 392 YLVMELLDGGELLRRIR---SKPEFC-SEASQWAAELVSAVDYLH---EQGVVHRDLKPGNILLDGSAGHLRLTYFGFWS 464 (612)
T ss_pred eeeehhccccHHHHHHH---hcchhH-HHHHHHHHHHHHHHHHHH---hcCeeecCCChhheeecCCCCcEEEEEechhh
Confidence 99999999988877664 222333 778889999999999999 8999999999999999 588999999999999
Q ss_pred cccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhh
Q 046270 420 QSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIF 499 (590)
Q Consensus 420 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 499 (590)
..... ....+-|..|.|||.+....|++++|+||||++||||++|+.|+.....+..... ....++..
T Consensus 465 ~~~~~----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~-----~i~~~~~s--- 532 (612)
T KOG0603|consen 465 ELERS----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHT-----RIQMPKFS--- 532 (612)
T ss_pred hCchh----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHH-----hhcCCccc---
Confidence 76554 2223457899999999988999999999999999999999999987655422111 11222222
Q ss_pred hHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 500 DEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 500 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
..+.+...+++..|+|.||.+||+|.++...
T Consensus 533 ---------~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 533 ---------ECVSDEAKDLLQQLLQVDPALRLGADEIGAH 563 (612)
T ss_pred ---------cccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence 2334456678889999999999999999763
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=263.66 Aligned_cols=239 Identities=25% Similarity=0.355 Sum_probs=188.6
Q ss_pred CCCccceecccCcEEEEEEEEcC-CcEEEEEEeecCCCCC---hHHHHHHHHHHHhc-CCCCccccceeEEeccCCCCce
Q 046270 265 GFSQNNLIGQGASGIVYKGTLRH-GNLVAVKQILDLDTKG---DEDFTNEVEIISKI-RHRNLLSLRGCCVTSDDSSGKR 339 (590)
Q Consensus 265 ~f~~~~~LG~G~fG~Vykg~~~~-g~~vAvK~l~~~~~~~---~~~f~~Ev~il~~l-~H~nlv~l~g~~~~~~~~~~~~ 339 (590)
+|.....||+|+||.|..+..+. ...+|||++++.-... .+--..|-++|+.. +-|.+++|..++...+ +
T Consensus 350 DFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmD-----R 424 (683)
T KOG0696|consen 350 DFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMD-----R 424 (683)
T ss_pred ccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhh-----h
Confidence 58888999999999999998774 4579999987542221 22235688888877 6789999999988655 4
Q ss_pred EEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcc
Q 046270 340 RFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAK 419 (590)
Q Consensus 340 ~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~ 419 (590)
+|+||||+.+|+|-.++. +-+.+.+....-++..||-||-+|| +++||.||||..|||||.+|.+||+|||+++
T Consensus 425 LyFVMEyvnGGDLMyhiQ---Q~GkFKEp~AvFYAaEiaigLFFLh---~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcK 498 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQ---QVGKFKEPVAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK 498 (683)
T ss_pred eeeEEEEecCchhhhHHH---HhcccCCchhhhhhHHHHHHhhhhh---cCCeeeeeccccceEeccCCceEeeeccccc
Confidence 899999999999988884 4567888999999999999999999 9999999999999999999999999999998
Q ss_pred cccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhh
Q 046270 420 QSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIF 499 (590)
Q Consensus 420 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 499 (590)
....+. ..+....||+.|+|||.+.+.+|....|.|||||+||||+.|+.||+..+++. +.... .
T Consensus 499 Eni~~~-~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~e-lF~aI-------------~ 563 (683)
T KOG0696|consen 499 ENIFDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE-LFQAI-------------M 563 (683)
T ss_pred ccccCC-cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHH-HHHHH-------------H
Confidence 654322 23556899999999999999999999999999999999999999998654432 11100 0
Q ss_pred hHHHhhhhHHHHHHHHHHHHHhchhcCCCCCC
Q 046270 500 DEFIRAEGARAVMERFVLVGILCAHVMVALRP 531 (590)
Q Consensus 500 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RP 531 (590)
+.. -.++.....+.+.+...-+...|.+|-
T Consensus 564 ehn--vsyPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 564 EHN--VSYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred Hcc--CcCcccccHHHHHHHHHHhhcCCcccc
Confidence 111 113344444556666677778888873
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-31 Score=273.37 Aligned_cols=197 Identities=30% Similarity=0.462 Sum_probs=167.9
Q ss_pred cceecccCcEEEEEEEEc-CCcEEEEEEeec--CCCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEEEEEe
Q 046270 269 NNLIGQGASGIVYKGTLR-HGNLVAVKQILD--LDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFLVYD 345 (590)
Q Consensus 269 ~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~--~~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~LV~E 345 (590)
.+.||.|.||+||-|+++ .|+.||||.+.+ ...+...++.+|+.+|++++||.||.|.-.|... ...++|||
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~-----ervFVVME 643 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETP-----ERVFVVME 643 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCC-----ceEEEEeh
Confidence 468999999999999986 599999999854 3455567899999999999999999998888754 35899999
Q ss_pred eCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCC---CcEEEEeeCCccccc
Q 046270 346 YMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSE---LNAKVADFGLAKQSL 422 (590)
Q Consensus 346 ~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~---~~~kL~DFGla~~~~ 422 (590)
-+.+.-|.-.|. ...+.|++..-..++.||+.||.||| -++|+|+||||+||||.+. -++||+|||+||...
T Consensus 644 Kl~GDMLEMILS--sEkgRL~er~TkFlvtQIL~ALr~LH---~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIg 718 (888)
T KOG4236|consen 644 KLHGDMLEMILS--SEKGRLPERITKFLVTQILVALRYLH---FKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIG 718 (888)
T ss_pred hhcchHHHHHHH--hhcccchHHHHHHHHHHHHHHHHHhh---hcceeeccCCchheeeccCCCCCceeeccccceeecc
Confidence 996544444443 34567998888899999999999999 8999999999999999654 478999999999876
Q ss_pred CCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 046270 423 EGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTS 477 (590)
Q Consensus 423 ~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~ 477 (590)
+. .....+.||+.|+|||++.++.|...-|+||.||++|--++|..||....+
T Consensus 719 Ek--sFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd 771 (888)
T KOG4236|consen 719 EK--SFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED 771 (888)
T ss_pred hh--hhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccc
Confidence 53 334568899999999999999999999999999999999999999975444
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-31 Score=257.95 Aligned_cols=270 Identities=22% Similarity=0.343 Sum_probs=194.2
Q ss_pred CCccceecccCcEEEEEEEEcC-CcEEEEEEeecCCC-CC-hHHHHHHHHHHHhcCCCCccccceeEEeccCC---CCce
Q 046270 266 FSQNNLIGQGASGIVYKGTLRH-GNLVAVKQILDLDT-KG-DEDFTNEVEIISKIRHRNLLSLRGCCVTSDDS---SGKR 339 (590)
Q Consensus 266 f~~~~~LG~G~fG~Vykg~~~~-g~~vAvK~l~~~~~-~~-~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~---~~~~ 339 (590)
|....+||+|.||+|||++.++ |+.||+|++.-..+ .+ ...-.+|+++|..|+|+|++.++..|...... ....
T Consensus 19 yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t 98 (376)
T KOG0669|consen 19 YEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRAT 98 (376)
T ss_pred HHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccce
Confidence 4455789999999999999875 67789987643222 22 34567899999999999999999999765432 2345
Q ss_pred EEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcc
Q 046270 340 RFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAK 419 (590)
Q Consensus 340 ~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~ 419 (590)
.||||++++. +|...|.. ....++..++.+++.++..||.|+| +..|+|||+||.|+|++.++.+||+|||+++
T Consensus 99 ~ylVf~~ceh-DLaGlLsn--~~vr~sls~Ikk~Mk~Lm~GL~~iH---r~kilHRDmKaaNvLIt~dgilklADFGlar 172 (376)
T KOG0669|consen 99 FYLVFDFCEH-DLAGLLSN--RKVRFSLSEIKKVMKGLMNGLYYIH---RNKILHRDMKAANVLITKDGILKLADFGLAR 172 (376)
T ss_pred eeeeHHHhhh-hHHHHhcC--ccccccHHHHHHHHHHHHHHHHHHH---HhhHHhhcccHhhEEEcCCceEEeecccccc
Confidence 8999999975 67777742 2356899999999999999999999 9999999999999999999999999999998
Q ss_pred cccCCCcc---cccccccCCCccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchh--hhhHHHHHH----
Q 046270 420 QSLEGHSH---LTTRVAGTFGYLAPEYALY-GQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQ--LITDWAWVL---- 489 (590)
Q Consensus 420 ~~~~~~~~---~~~~~~gt~~Y~APE~~~~-~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~--~l~~~~~~~---- 489 (590)
.+...... ..+...-|..|.+||.+.+ ..|+++.|||.-||++.||.||.+.+..+...+. .+.......
T Consensus 173 ~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkev 252 (376)
T KOG0669|consen 173 AFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEV 252 (376)
T ss_pred ceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCccc
Confidence 66433222 1233445899999999875 5799999999999999999999988876655433 222211100
Q ss_pred HhcCCchhhhhHH----Hh-hhh--HHHHH------HHHHHHHHhchhcCCCCCCCHHHHHHHhc
Q 046270 490 AKSGKVDDIFDEF----IR-AEG--ARAVM------ERFVLVGILCAHVMVALRPTITDALKMLE 541 (590)
Q Consensus 490 ~~~~~~~~~~d~~----l~-~~~--~~~~~------~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~ 541 (590)
|.+=.-.++.... +. +.. -++.+ ....+++..++..||.+|++.++++..--
T Consensus 253 WP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~ 317 (376)
T KOG0669|consen 253 WPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDF 317 (376)
T ss_pred CCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhh
Confidence 1000000111100 00 000 01111 14456777889999999999999886543
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-30 Score=254.50 Aligned_cols=202 Identities=27% Similarity=0.391 Sum_probs=173.2
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCCCCh---HHHHHHHHHHHhcCCCCccccceeEEeccCCCCc
Q 046270 263 TNGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDTKGD---EDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGK 338 (590)
Q Consensus 263 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~~~~---~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~ 338 (590)
.++|...++||+|.||.|-..+-+ .|+.+|+|++++.-.... ..-..|-++|...+||.+..|.-.+.. ..
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt-----~d 241 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQT-----QD 241 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhcc-----Cc
Confidence 367889999999999999999876 488999999876433333 334578999999999999988766653 34
Q ss_pred eEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCc
Q 046270 339 RRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLA 418 (590)
Q Consensus 339 ~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla 418 (590)
++++||||..+|.|.-||. ..+.+++...+-+...|..||.||| +.+||.||||.+|.|||.+|.+||+|||++
T Consensus 242 rlCFVMeyanGGeLf~HLs---rer~FsE~RtRFYGaEIvsAL~YLH---s~~ivYRDlKLENLlLDkDGHIKitDFGLC 315 (516)
T KOG0690|consen 242 RLCFVMEYANGGELFFHLS---RERVFSEDRTRFYGAEIVSALGYLH---SRNIVYRDLKLENLLLDKDGHIKITDFGLC 315 (516)
T ss_pred eEEEEEEEccCceEeeehh---hhhcccchhhhhhhHHHHHHhhhhh---hCCeeeeechhhhheeccCCceEeeecccc
Confidence 6999999999999999985 3457899888899999999999999 899999999999999999999999999999
Q ss_pred ccccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 046270 419 KQSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTST 476 (590)
Q Consensus 419 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~ 476 (590)
+.... ....+...+||+.|+|||++....|....|.|.+|||+|||++||.||...+
T Consensus 316 KE~I~-~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~d 372 (516)
T KOG0690|consen 316 KEEIK-YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKD 372 (516)
T ss_pred hhccc-ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccc
Confidence 85432 2234567899999999999999999999999999999999999999997543
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-30 Score=243.68 Aligned_cols=217 Identities=25% Similarity=0.374 Sum_probs=175.5
Q ss_pred HHHHHhcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecC-CCCChHHHHHHHHHHHhc-CCCCccccceeEEeccC
Q 046270 258 ELEQATNGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDL-DTKGDEDFTNEVEIISKI-RHRNLLSLRGCCVTSDD 334 (590)
Q Consensus 258 el~~at~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~-~~~~~~~f~~Ev~il~~l-~H~nlv~l~g~~~~~~~ 334 (590)
.++...+.......||+|++|.|-|-++. +|...|+|++... ..+..+...+|+.+..+- ..|.+|+++|.+..
T Consensus 40 ~~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~r--- 116 (282)
T KOG0984|consen 40 NFEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFR--- 116 (282)
T ss_pred ccccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhc---
Confidence 34555556666778999999999988875 5899999998643 344566788899887776 79999999997763
Q ss_pred CCCceEEEEEeeCCCCCcchhhhhh-cccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEE
Q 046270 335 SSGKRRFLVYDYMPNGTLSDNISIS-HKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVA 413 (590)
Q Consensus 335 ~~~~~~~LV~E~~~~gsL~~~L~~~-~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~ 413 (590)
....++.||.|. .||+.+...- .+.+.+++..+-+|+..|.+||.|||+ +..+||||+||+|||++.+|++|++
T Consensus 117 --egdvwIcME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiC 191 (282)
T KOG0984|consen 117 --EGDVWICMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKIC 191 (282)
T ss_pred --cccEEEeHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEc
Confidence 345899999995 5777655322 245678999999999999999999996 6799999999999999999999999
Q ss_pred eeCCcccccCCCcccccccccCCCccCccccc----cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhH
Q 046270 414 DFGLAKQSLEGHSHLTTRVAGTFGYLAPEYAL----YGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITD 484 (590)
Q Consensus 414 DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~----~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~ 484 (590)
|||++-.+.+.. ..+...|-..|||||.+. ...|+.|+||||+|+.+.||.+++.|++....+++++.+
T Consensus 192 DFGIsG~L~dSi--Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkq 264 (282)
T KOG0984|consen 192 DFGISGYLVDSI--AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQ 264 (282)
T ss_pred ccccceeehhhh--HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHH
Confidence 999987664432 233356778999999876 336899999999999999999999999988777776653
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-30 Score=264.61 Aligned_cols=258 Identities=24% Similarity=0.321 Sum_probs=192.1
Q ss_pred HhcCCCccceecccCcEEEEEEEE-cCCcEEEEEEeecCC---CCC----hHHHHHHHHHHHhcCCCCccccceeEEecc
Q 046270 262 ATNGFSQNNLIGQGASGIVYKGTL-RHGNLVAVKQILDLD---TKG----DEDFTNEVEIISKIRHRNLLSLRGCCVTSD 333 (590)
Q Consensus 262 at~~f~~~~~LG~G~fG~Vykg~~-~~g~~vAvK~l~~~~---~~~----~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~ 333 (590)
..++|-..++||+|||++|||+.+ ...+.||||+-.-.. ... .+...+|.++-+.|.||.||++++|+.-..
T Consensus 461 Ln~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDt 540 (775)
T KOG1151|consen 461 LNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDT 540 (775)
T ss_pred hHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecc
Confidence 344666788999999999999975 457789999752211 111 123568999999999999999999987543
Q ss_pred CCCCceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECC---CCcE
Q 046270 334 DSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDS---ELNA 410 (590)
Q Consensus 334 ~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~---~~~~ 410 (590)
+ ..+-|+||+++.+|+-+|. ..+.+++++.+.|+.||+.||.||.+ .+++|||-||||.||||-+ .|.+
T Consensus 541 d----sFCTVLEYceGNDLDFYLK---QhklmSEKEARSIiMQiVnAL~YLNE-ikpPIIHYDLKPgNILLv~GtacGeI 612 (775)
T KOG1151|consen 541 D----SFCTVLEYCEGNDLDFYLK---QHKLMSEKEARSIIMQIVNALKYLNE-IKPPIIHYDLKPGNILLVNGTACGEI 612 (775)
T ss_pred c----cceeeeeecCCCchhHHHH---hhhhhhHHHHHHHHHHHHHHHHHHhc-cCCCeeeeccCCccEEEecCccccee
Confidence 3 4899999999999999995 45679999999999999999999984 4789999999999999943 4889
Q ss_pred EEEeeCCcccccCCCc------ccccccccCCCccCccccccC----CCCcchhHHHHHHHHHHHHhCCCCCCCCCCchh
Q 046270 411 KVADFGLAKQSLEGHS------HLTTRVAGTFGYLAPEYALYG----QLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQ 480 (590)
Q Consensus 411 kL~DFGla~~~~~~~~------~~~~~~~gt~~Y~APE~~~~~----~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~ 480 (590)
||.|||+++.+..+.. ..+...+||.+|++||.+.-+ +++.|.||||.||++|+.+-|++||+.....+.
T Consensus 613 KITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQd 692 (775)
T KOG1151|consen 613 KITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQD 692 (775)
T ss_pred EeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHH
Confidence 9999999998754322 245667899999999988744 578899999999999999999999987655443
Q ss_pred hhhHHHHHHHhcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHH
Q 046270 481 LITDWAWVLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDAL 537 (590)
Q Consensus 481 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl 537 (590)
.+. .- ...+ ..++--+. ...+......++.+|++.--++|-...++.
T Consensus 693 ILq-eN-TIlk---AtEVqFP~-----KPvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 693 ILQ-EN-TILK---ATEVQFPP-----KPVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred HHh-hh-chhc---ceeccCCC-----CCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 332 10 0011 01111000 001122445577789999888886655543
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.5e-30 Score=251.23 Aligned_cols=257 Identities=23% Similarity=0.271 Sum_probs=195.9
Q ss_pred hcCCCcc-ceecccCcEEEEEEEEcC-CcEEEEEEeecCCCCChHHHHHHHHHHHhc-CCCCccccceeEEeccCCCCce
Q 046270 263 TNGFSQN-NLIGQGASGIVYKGTLRH-GNLVAVKQILDLDTKGDEDFTNEVEIISKI-RHRNLLSLRGCCVTSDDSSGKR 339 (590)
Q Consensus 263 t~~f~~~-~~LG~G~fG~Vykg~~~~-g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l-~H~nlv~l~g~~~~~~~~~~~~ 339 (590)
|++|++. .+||-|-.|.|-....+. |+.+|+|++.+. ...++|+++--+. .|+|||.+++.|..... ....
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~-~rkc 133 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQ-GRKC 133 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhcc-Ccee
Confidence 4444443 579999999999998874 778999998552 3456888886666 69999999999987654 4566
Q ss_pred EEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCC---CcEEEEeeC
Q 046270 340 RFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSE---LNAKVADFG 416 (590)
Q Consensus 340 ~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~---~~~kL~DFG 416 (590)
+++|||.|+||.|...+... ....+++.+.-.|+.||+.|+.||| ..+|.||||||+|+|.... -.+||+|||
T Consensus 134 LLiVmE~meGGeLfsriq~~-g~~afTErea~eI~~qI~~Av~~lH---~~nIAHRDlKpENLLyt~t~~na~lKLtDfG 209 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDR-GDQAFTEREASEIMKQIGLAVRYLH---SMNIAHRDLKPENLLYTTTSPNAPLKLTDFG 209 (400)
T ss_pred eEeeeecccchHHHHHHHHc-ccccchHHHHHHHHHHHHHHHHHHH---hcchhhccCChhheeeecCCCCcceEecccc
Confidence 88999999999999888543 3456999999999999999999999 9999999999999999643 468999999
Q ss_pred CcccccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCch
Q 046270 417 LAKQSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVD 496 (590)
Q Consensus 417 la~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 496 (590)
+|+...+. .......-|+.|.|||++...+|+...|+||+||++|-|+.|-+||...... . +.-=.+...+.|..
T Consensus 210 FAK~t~~~--~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~-a-ispgMk~rI~~gqy- 284 (400)
T KOG0604|consen 210 FAKETQEP--GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL-A-ISPGMKRRIRTGQY- 284 (400)
T ss_pred cccccCCC--ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCc-c-CChhHHhHhhccCc-
Confidence 99976542 2334456799999999999999999999999999999999999999765441 1 11111111122211
Q ss_pred hhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 497 DIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 497 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
++-++ .-..+.+...+++...+..+|.+|-|+.+++..
T Consensus 285 ~FP~p-----EWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 285 EFPEP-----EWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred cCCCh-----hHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 01111 112344556678888899999999999999864
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-28 Score=235.20 Aligned_cols=211 Identities=34% Similarity=0.533 Sum_probs=180.3
Q ss_pred ecccCcEEEEEEEEcC-CcEEEEEEeecCCCC-ChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEEEEEeeCCC
Q 046270 272 IGQGASGIVYKGTLRH-GNLVAVKQILDLDTK-GDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFLVYDYMPN 349 (590)
Q Consensus 272 LG~G~fG~Vykg~~~~-g~~vAvK~l~~~~~~-~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~LV~E~~~~ 349 (590)
||+|++|.||++...+ ++.+++|++...... ..+.+.+|++.+++++|++++++++++... ...++++||+++
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-----~~~~~~~e~~~~ 75 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDE-----NHLYLVMEYCEG 75 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecC-----CeEEEEEecCCC
Confidence 6899999999999875 889999998654332 246799999999999999999999998743 468999999999
Q ss_pred CCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECC-CCcEEEEeeCCcccccCCCccc
Q 046270 350 GTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDS-ELNAKVADFGLAKQSLEGHSHL 428 (590)
Q Consensus 350 gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~-~~~~kL~DFGla~~~~~~~~~~ 428 (590)
++|.+++.... ..+++..+..++.+++++|.||| ..+++|+||+|.||+++. ++.++|+|||.+........ .
T Consensus 76 ~~l~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh---~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~ 149 (215)
T cd00180 76 GSLKDLLKENE--GKLSEDEILRILLQILEGLEYLH---SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-L 149 (215)
T ss_pred CcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-h
Confidence 99999885321 46899999999999999999999 889999999999999999 89999999999986544321 2
Q ss_pred ccccccCCCccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhhhHHHhhhh
Q 046270 429 TTRVAGTFGYLAPEYALYG-QLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDEFIRAEG 507 (590)
Q Consensus 429 ~~~~~gt~~Y~APE~~~~~-~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 507 (590)
.....+...|++||..... ..+.+.|+|++|+++++|
T Consensus 150 ~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------ 187 (215)
T cd00180 150 LKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------ 187 (215)
T ss_pred hhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH------------------------------------------
Confidence 2334577899999998877 888999999999999998
Q ss_pred HHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHh
Q 046270 508 ARAVMERFVLVGILCAHVMVALRPTITDALKML 540 (590)
Q Consensus 508 ~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L 540 (590)
..+.+++..|++.+|++||++.++++.|
T Consensus 188 -----~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 -----PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred -----HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 3677788899999999999999998753
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.8e-29 Score=229.72 Aligned_cols=201 Identities=23% Similarity=0.382 Sum_probs=163.0
Q ss_pred CCCccceecccCcEEEEEEEEcC-CcEEEEEEeecCCC-CC-hHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEE
Q 046270 265 GFSQNNLIGQGASGIVYKGTLRH-GNLVAVKQILDLDT-KG-DEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRF 341 (590)
Q Consensus 265 ~f~~~~~LG~G~fG~Vykg~~~~-g~~vAvK~l~~~~~-~~-~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~ 341 (590)
+|...++||+|.||+||||+..+ ++.||+|+++-.+. ++ .....+|+-+|+.++|+|||++++... ..+..-
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlh-----sdkklt 77 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLH-----SDKKLT 77 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhc-----cCceeE
Confidence 45556789999999999999775 67899999864332 22 345789999999999999999998775 345689
Q ss_pred EEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccc
Q 046270 342 LVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQS 421 (590)
Q Consensus 342 LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~ 421 (590)
||+||+. .+|..+.. .-.+.++.+..+.++.|+++||.+.| ++++.|||+||.|.|++.+|+.|++|||+++.+
T Consensus 78 lvfe~cd-qdlkkyfd--slng~~d~~~~rsfmlqllrgl~fch---shnvlhrdlkpqnllin~ngelkladfglaraf 151 (292)
T KOG0662|consen 78 LVFEFCD-QDLKKYFD--SLNGDLDPEIVRSFMLQLLRGLGFCH---SHNVLHRDLKPQNLLINRNGELKLADFGLARAF 151 (292)
T ss_pred EeHHHhh-HHHHHHHH--hcCCcCCHHHHHHHHHHHHhhhhhhh---hhhhhhccCCcceEEeccCCcEEecccchhhhc
Confidence 9999995 46766653 23467999999999999999999999 899999999999999999999999999999976
Q ss_pred cCCCcccccccccCCCccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 046270 422 LEGHSHLTTRVAGTFGYLAPEYALYG-QLTEKSDVYSFGIVILELMSGRKVLDTSTS 477 (590)
Q Consensus 422 ~~~~~~~~~~~~gt~~Y~APE~~~~~-~~t~ksDVySfGvvLlELltG~~p~~~~~~ 477 (590)
.-... ......-|..|.+|.++.+. -|+...|+||-||++.||....+|.-...+
T Consensus 152 gipvr-cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~d 207 (292)
T KOG0662|consen 152 GIPVR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND 207 (292)
T ss_pred CCceE-eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCc
Confidence 54322 22334458999999998865 578999999999999999985555543333
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-29 Score=262.57 Aligned_cols=246 Identities=24% Similarity=0.276 Sum_probs=196.8
Q ss_pred CCccceecccCcEEEEEEEEcCCc-EEEEEEeecC---CCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEE
Q 046270 266 FSQNNLIGQGASGIVYKGTLRHGN-LVAVKQILDL---DTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRF 341 (590)
Q Consensus 266 f~~~~~LG~G~fG~Vykg~~~~g~-~vAvK~l~~~---~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~ 341 (590)
+..+..||-||||.|=....+... .+|+|.+++. +.+..+.+..|-.+|...+.|.||+|+-.+. +.++.|
T Consensus 422 l~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfr-----d~kyvY 496 (732)
T KOG0614|consen 422 LKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFR-----DSKYVY 496 (732)
T ss_pred hhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhc-----cchhhh
Confidence 344556999999999999887543 3888887653 3344567889999999999999999998887 566799
Q ss_pred EEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccc
Q 046270 342 LVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQS 421 (590)
Q Consensus 342 LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~ 421 (590)
+.||-|-+|.|+..|. .++.++......++..+.+|++||| +++||.|||||+|.+||.+|-+||.|||+|+..
T Consensus 497 mLmEaClGGElWTiLr---dRg~Fdd~tarF~~acv~EAfeYLH---~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki 570 (732)
T KOG0614|consen 497 MLMEACLGGELWTILR---DRGSFDDYTARFYVACVLEAFEYLH---RKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKI 570 (732)
T ss_pred hhHHhhcCchhhhhhh---hcCCcccchhhhhHHHHHHHHHHHH---hcCceeccCChhheeeccCCceEEeehhhHHHh
Confidence 9999999999999984 6678999999999999999999999 999999999999999999999999999999977
Q ss_pred cCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhhhH
Q 046270 422 LEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDE 501 (590)
Q Consensus 422 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 501 (590)
..+ ..+-.++||+.|.|||.+.+...+...|.|++||+++||++|++||...+.... |-. . ..-+|.
T Consensus 571 ~~g--~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmkt----Yn~--I-----LkGid~ 637 (732)
T KOG0614|consen 571 GSG--RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKT----YNL--I-----LKGIDK 637 (732)
T ss_pred ccC--CceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHH----HHH--H-----Hhhhhh
Confidence 544 356678999999999999999999999999999999999999999976544222 100 0 001111
Q ss_pred HHhhhhHHHHHHHHHHHHHhchhcCCCCCCC-----HHHHHH
Q 046270 502 FIRAEGARAVMERFVLVGILCAHVMVALRPT-----ITDALK 538 (590)
Q Consensus 502 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt-----m~eVl~ 538 (590)
. ..+..+.....+++...+..+|.+|-- +.++-+
T Consensus 638 i---~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkk 676 (732)
T KOG0614|consen 638 I---EFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKK 676 (732)
T ss_pred h---hcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHh
Confidence 1 122333445566777778889999875 556644
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.3e-28 Score=237.14 Aligned_cols=198 Identities=33% Similarity=0.497 Sum_probs=170.0
Q ss_pred CCccceecccCcEEEEEEEEcC-CcEEEEEEeecCCCC-ChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEEEE
Q 046270 266 FSQNNLIGQGASGIVYKGTLRH-GNLVAVKQILDLDTK-GDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFLV 343 (590)
Q Consensus 266 f~~~~~LG~G~fG~Vykg~~~~-g~~vAvK~l~~~~~~-~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~LV 343 (590)
|...+.||+|++|.||++...+ +..+++|.+...... ..+.+.+|++.+++++|+|++++++++.. ....+++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~-----~~~~~~v 75 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFED-----PEPLYLV 75 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeec-----CCceEEE
Confidence 4566889999999999999986 789999998765444 56789999999999999999999999874 3458999
Q ss_pred EeeCCCCCcchhhhhhccccc-CChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCccccc
Q 046270 344 YDYMPNGTLSDNISISHKRKQ-LTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSL 422 (590)
Q Consensus 344 ~E~~~~gsL~~~L~~~~~~~~-l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~~ 422 (590)
+||+++++|.+++... .. +++..+..++.+++++|.||| ..+++|+||+|+||+++.++.++|+|||.+....
T Consensus 76 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~ 149 (225)
T smart00221 76 MEYCEGGDLFDYLRKK---GGKLSEEEARFYLRQILEALEYLH---SLGIVHRDLKPENILLGMDGLVKLADFGLARFIH 149 (225)
T ss_pred EeccCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeeCceeeEec
Confidence 9999999999988532 23 899999999999999999999 8899999999999999999999999999998765
Q ss_pred CCCcccccccccCCCccCcccc-ccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 046270 423 EGHSHLTTRVAGTFGYLAPEYA-LYGQLTEKSDVYSFGIVILELMSGRKVLDT 474 (590)
Q Consensus 423 ~~~~~~~~~~~gt~~Y~APE~~-~~~~~t~ksDVySfGvvLlELltG~~p~~~ 474 (590)
...........++..|++||.+ ....++.++|||+||++++||++|+.||..
T Consensus 150 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 150 RDLAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred CcccccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 4431122345677899999998 666788899999999999999999999954
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-29 Score=254.59 Aligned_cols=261 Identities=23% Similarity=0.292 Sum_probs=196.3
Q ss_pred HhcCCCccceecccCcEEEEEEEEcC-CcEEEEEEeecCCCCChHHHHHHHHHHHhcC-C-C----CccccceeEEeccC
Q 046270 262 ATNGFSQNNLIGQGASGIVYKGTLRH-GNLVAVKQILDLDTKGDEDFTNEVEIISKIR-H-R----NLLSLRGCCVTSDD 334 (590)
Q Consensus 262 at~~f~~~~~LG~G~fG~Vykg~~~~-g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~-H-~----nlv~l~g~~~~~~~ 334 (590)
.+++|....++|+|.||.|-+..... +..||||+++....- .++-.-|+++|.++. + | -+|.+.+|+.
T Consensus 87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kY-reAa~iEi~vLqki~~~DP~g~~rcv~m~~wFd---- 161 (415)
T KOG0671|consen 87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKY-REAALIEIEVLQKINESDPNGKFRCVQMRDWFD---- 161 (415)
T ss_pred cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHH-hhHHHHHHHHHHHHHhcCCCCceEEEeeehhhh----
Confidence 37889999999999999999998765 678999998765432 445667999999993 2 2 3667777765
Q ss_pred CCCceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECC--------
Q 046270 335 SSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDS-------- 406 (590)
Q Consensus 335 ~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~-------- 406 (590)
-.++.++|+|.+ +-|+.++|... +-.+++..+++.|+.|++++++||| ..+++|-||||+|||+-+
T Consensus 162 -yrghiCivfell-G~S~~dFlk~N-~y~~fpi~~ir~m~~QL~~sv~fLh---~~kl~HTDLKPENILfvss~~~~~~~ 235 (415)
T KOG0671|consen 162 -YRGHICIVFELL-GLSTFDFLKEN-NYIPFPIDHIRHMGYQLLESVAFLH---DLKLTHTDLKPENILFVSSEYFKTYN 235 (415)
T ss_pred -ccCceEEEEecc-ChhHHHHhccC-CccccchHHHHHHHHHHHHHHHHHH---hcceeecCCChheEEEeccceEEEec
Confidence 345689999998 66899999643 3456899999999999999999999 999999999999999832
Q ss_pred ------------CCcEEEEeeCCcccccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 046270 407 ------------ELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDT 474 (590)
Q Consensus 407 ------------~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~ 474 (590)
+..+||+|||.|....+.+ +.+..|..|.|||++.+-.++..+||||+||||.||.||...|..
T Consensus 236 ~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqt 311 (415)
T KOG0671|consen 236 PKKKVCFIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQT 311 (415)
T ss_pred cCCccceeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceeccc
Confidence 2348999999998655444 446678999999999999999999999999999999999999987
Q ss_pred CCCchhhhhHH----------------HHHHHhcCCch-----------hhhhHH--Hh--hhhHHHHHHHHHHHHHhch
Q 046270 475 STSPFQLITDW----------------AWVLAKSGKVD-----------DIFDEF--IR--AEGARAVMERFVLVGILCA 523 (590)
Q Consensus 475 ~~~~~~~l~~~----------------~~~~~~~~~~~-----------~~~d~~--l~--~~~~~~~~~~l~~l~~~Cl 523 (590)
+++... +.-. +......++++ .++++. +. .........++++++..++
T Consensus 312 Hen~EH-LaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL 390 (415)
T KOG0671|consen 312 HENLEH-LAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRML 390 (415)
T ss_pred CCcHHH-HHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHH
Confidence 664321 1100 11111111111 011100 00 0011223447999999999
Q ss_pred hcCCCCCCCHHHHHH
Q 046270 524 HVMVALRPTITDALK 538 (590)
Q Consensus 524 ~~dp~~RPtm~eVl~ 538 (590)
..||.+|+|++|++.
T Consensus 391 ~fDP~~RiTl~EAL~ 405 (415)
T KOG0671|consen 391 EFDPARRITLREALS 405 (415)
T ss_pred ccCccccccHHHHhc
Confidence 999999999999985
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-29 Score=277.48 Aligned_cols=245 Identities=26% Similarity=0.367 Sum_probs=184.2
Q ss_pred CCccceecccCcE-EEEEEEEcCCcEEEEEEeecCCCCChHHHHHHHHHHHhc-CCCCccccceeEEeccCCCCceEEEE
Q 046270 266 FSQNNLIGQGASG-IVYKGTLRHGNLVAVKQILDLDTKGDEDFTNEVEIISKI-RHRNLLSLRGCCVTSDDSSGKRRFLV 343 (590)
Q Consensus 266 f~~~~~LG~G~fG-~Vykg~~~~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l-~H~nlv~l~g~~~~~~~~~~~~~~LV 343 (590)
|...+++|.|.-| .||+|..+ |+.||||++... ...-..+|+..|+.- +|||||++++.- . +....|+.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E--~---d~qF~YIa 581 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSE--Q---DRQFLYIA 581 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC-CceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeec--c---CCceEEEE
Confidence 5556789999887 68999997 789999998542 223456899999988 799999987543 3 34579999
Q ss_pred EeeCCCCCcchhhhhh-cccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECC---C--CcEEEEeeCC
Q 046270 344 YDYMPNGTLSDNISIS-HKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDS---E--LNAKVADFGL 417 (590)
Q Consensus 344 ~E~~~~gsL~~~L~~~-~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~---~--~~~kL~DFGl 417 (590)
.|.|. -+|.+++... .......-...+.+..|++.||++|| ..+||||||||.||||+. + ..++|+|||+
T Consensus 582 lELC~-~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLH---sl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfgl 657 (903)
T KOG1027|consen 582 LELCA-CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLH---SLKIVHRDLKPQNILISVPSADGTLRAKISDFGL 657 (903)
T ss_pred ehHhh-hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHH---hcccccccCCCceEEEEccCCCcceeEEeccccc
Confidence 99995 5999999653 11111121455788999999999999 899999999999999965 3 5789999999
Q ss_pred cccccCCCccc--ccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhC-CCCCCCCCCchhhhhHHHHHHHhcCC
Q 046270 418 AKQSLEGHSHL--TTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSG-RKVLDTSTSPFQLITDWAWVLAKSGK 494 (590)
Q Consensus 418 a~~~~~~~~~~--~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG-~~p~~~~~~~~~~l~~~~~~~~~~~~ 494 (590)
++....+.... .....||.||+|||.+....-+...||||+|||+|+.++| .+||+.....+.++.. .+..
T Consensus 658 sKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~------~~~~ 731 (903)
T KOG1027|consen 658 SKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILT------GNYT 731 (903)
T ss_pred ccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhc------Cccc
Confidence 99887766543 3467899999999999988888899999999999999996 8999865443332220 1001
Q ss_pred chhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 046270 495 VDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALK 538 (590)
Q Consensus 495 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~ 538 (590)
+.. +. ...+ . ...+++..|++++|..||++.+|+.
T Consensus 732 L~~-L~----~~~d--~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 732 LVH-LE----PLPD--C--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred eee-ec----cCch--H--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 100 00 0000 0 4456778899999999999999974
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.4e-30 Score=250.00 Aligned_cols=264 Identities=25% Similarity=0.314 Sum_probs=193.0
Q ss_pred CccceecccCcEEEEEEEEc-CCcEEEEEEeecCCC--CChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEEEE
Q 046270 267 SQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDT--KGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFLV 343 (590)
Q Consensus 267 ~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~--~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~LV 343 (590)
...+.||-|.||.||..++. +|+.||+|++.+.-. ...+.+.+|+++|..++|.|++..++........-=.+.|++
T Consensus 56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~ 135 (449)
T KOG0664|consen 56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL 135 (449)
T ss_pred CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence 34578999999999999886 699999999865422 234578899999999999999999887654332222347888
Q ss_pred EeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccccC
Q 046270 344 YDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLE 423 (590)
Q Consensus 344 ~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~~~ 423 (590)
.|.|. .+|...+- ..+.|+-..+.-+++||++||.||| ..+|.||||||.|.|++.|-..||+|||++|.-..
T Consensus 136 TELmQ-SDLHKIIV---SPQ~Ls~DHvKVFlYQILRGLKYLH---sA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~ 208 (449)
T KOG0664|consen 136 TELMQ-SDLHKIIV---SPQALTPDHVKVFVYQILRGLKYLH---TANILHRDIKPGNLLVNSNCILKICDFGLARTWDQ 208 (449)
T ss_pred HHHHH-hhhhheec---cCCCCCcchhhhhHHHHHhhhHHHh---hcchhhccCCCccEEeccCceEEecccccccccch
Confidence 99984 47777663 4567899999999999999999999 89999999999999999999999999999997655
Q ss_pred CCcccccccccCCCccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCchh--hhhHHHHHHHhcCCchhhhh
Q 046270 424 GHSHLTTRVAGTFGYLAPEYALYG-QLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQ--LITDWAWVLAKSGKVDDIFD 500 (590)
Q Consensus 424 ~~~~~~~~~~gt~~Y~APE~~~~~-~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~--~l~~~~~~~~~~~~~~~~~d 500 (590)
++....+...-|..|.|||.+++. .|+...||||.||++.||+.+|..|.....-+. ++.+. ......+.+-.
T Consensus 209 d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdL----LGTPs~EaMr~ 284 (449)
T KOG0664|consen 209 RDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDL----LGTPSQEAMKY 284 (449)
T ss_pred hhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHH----hCCCcHHHHHH
Confidence 544444455568899999999864 689999999999999999988877764333222 22222 11111111100
Q ss_pred -------HHHhh-------------hhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhc
Q 046270 501 -------EFIRA-------------EGARAVMERFVLVGILCAHVMVALRPTITDALKMLE 541 (590)
Q Consensus 501 -------~~l~~-------------~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~ 541 (590)
..++. ..+...-..-+++...++..||.+|-+..+.+..+.
T Consensus 285 ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 285 ACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY 345 (449)
T ss_pred HhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence 00000 000111124455667788999999999988877653
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.8e-28 Score=239.05 Aligned_cols=201 Identities=25% Similarity=0.433 Sum_probs=172.6
Q ss_pred hcCCCccceecccCcEEEEEEEEcC-CcEEEEEEeecCCC---CChHHHHHHHHHHHhc-CCCCccccceeEEeccCCCC
Q 046270 263 TNGFSQNNLIGQGASGIVYKGTLRH-GNLVAVKQILDLDT---KGDEDFTNEVEIISKI-RHRNLLSLRGCCVTSDDSSG 337 (590)
Q Consensus 263 t~~f~~~~~LG~G~fG~Vykg~~~~-g~~vAvK~l~~~~~---~~~~~f~~Ev~il~~l-~H~nlv~l~g~~~~~~~~~~ 337 (590)
-++|.....||+|+|..|..++++. .+.+|+|++++.-- +..+-.+.|-.+..+. +||.+|-|..++.. .
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqt-----e 323 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQT-----E 323 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcc-----c
Confidence 3578899999999999999999875 56789998865322 2233356777777776 79999999998874 4
Q ss_pred ceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCC
Q 046270 338 KRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGL 417 (590)
Q Consensus 338 ~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGl 417 (590)
.++++|.||+++|+|--++. +++.|+++..+.+...|.-||.||| +++||.||||..|||||.++.+||.|||+
T Consensus 324 srlffvieyv~ggdlmfhmq---rqrklpeeharfys~ei~lal~flh---~rgiiyrdlkldnvlldaeghikltdygm 397 (593)
T KOG0695|consen 324 SRLFFVIEYVNGGDLMFHMQ---RQRKLPEEHARFYSAEICLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGM 397 (593)
T ss_pred ceEEEEEEEecCcceeeehh---hhhcCcHHHhhhhhHHHHHHHHHHh---hcCeeeeeccccceEEccCCceeecccch
Confidence 56999999999999977663 5567999999999999999999999 99999999999999999999999999999
Q ss_pred cccccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 046270 418 AKQSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTS 475 (590)
Q Consensus 418 a~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~ 475 (590)
++.... ....+....||+.|.|||.+.+..|....|.|++||+++||+.|+.||+..
T Consensus 398 cke~l~-~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdiv 454 (593)
T KOG0695|consen 398 CKEGLG-PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIV 454 (593)
T ss_pred hhcCCC-CCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCccee
Confidence 986533 233567789999999999999999999999999999999999999999743
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-27 Score=253.29 Aligned_cols=212 Identities=27% Similarity=0.384 Sum_probs=173.3
Q ss_pred cHHHHHHHh---cCCCccceecccCcEEEEEEEEcC-CcEEEEEEeecCCC---CChHHHHHHHHHHHhcCCCCccccce
Q 046270 255 HVSELEQAT---NGFSQNNLIGQGASGIVYKGTLRH-GNLVAVKQILDLDT---KGDEDFTNEVEIISKIRHRNLLSLRG 327 (590)
Q Consensus 255 ~~~el~~at---~~f~~~~~LG~G~fG~Vykg~~~~-g~~vAvK~l~~~~~---~~~~~f~~Ev~il~~l~H~nlv~l~g 327 (590)
.|-.|++|. .-|..++.||-|.||+|.++.--| ...+|.|.+++.+. ......+.|-.||+....+-||+|+-
T Consensus 617 nYiRLkRaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyy 696 (1034)
T KOG0608|consen 617 NYIRLKRAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYY 696 (1034)
T ss_pred hHHHHHHhhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEE
Confidence 444555554 357888999999999999997655 45789998865432 23445788999999999999999998
Q ss_pred eEEeccCCCCceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCC
Q 046270 328 CCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSE 407 (590)
Q Consensus 328 ~~~~~~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~ 407 (590)
.+.+.+ .+|+||||+++|++-.+|. +-+.+.+...+.++.++..|+++.| ..|+|||||||.|||||.+
T Consensus 697 SFQDkd-----nLYFVMdYIPGGDmMSLLI---rmgIFeE~LARFYIAEltcAiesVH---kmGFIHRDiKPDNILIDrd 765 (1034)
T KOG0608|consen 697 SFQDKD-----NLYFVMDYIPGGDMMSLLI---RMGIFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRD 765 (1034)
T ss_pred EeccCC-----ceEEEEeccCCccHHHHHH---HhccCHHHHHHHHHHHHHHHHHHHH---hccceecccCccceEEccC
Confidence 777544 4999999999999998885 4467888888999999999999999 9999999999999999999
Q ss_pred CcEEEEeeCCccccc---------CCCc--------------------------------ccccccccCCCccCcccccc
Q 046270 408 LNAKVADFGLAKQSL---------EGHS--------------------------------HLTTRVAGTFGYLAPEYALY 446 (590)
Q Consensus 408 ~~~kL~DFGla~~~~---------~~~~--------------------------------~~~~~~~gt~~Y~APE~~~~ 446 (590)
|.+||.||||+.-+. ++.. ....-..||..|+|||++..
T Consensus 766 GHIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r 845 (1034)
T KOG0608|consen 766 GHIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLAR 845 (1034)
T ss_pred CceeeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcc
Confidence 999999999985321 1100 00011468999999999999
Q ss_pred CCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 046270 447 GQLTEKSDVYSFGIVILELMSGRKVLDTSTS 477 (590)
Q Consensus 447 ~~~t~ksDVySfGvvLlELltG~~p~~~~~~ 477 (590)
..++.-.|.||.||||+||+.|+.||-....
T Consensus 846 ~g~~q~cdwws~gvil~em~~g~~pf~~~tp 876 (1034)
T KOG0608|consen 846 TGYTQLCDWWSVGVILYEMLVGQPPFLADTP 876 (1034)
T ss_pred cCccccchhhHhhHHHHHHhhCCCCccCCCC
Confidence 9999999999999999999999999965544
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.4e-26 Score=237.55 Aligned_cols=136 Identities=24% Similarity=0.361 Sum_probs=114.3
Q ss_pred hcCCCccceecccCcEEEEEEEEcC-CcEEEEEEeecCCCCChHHHHHHHHHHHhcC-----C---CCccccceeEEecc
Q 046270 263 TNGFSQNNLIGQGASGIVYKGTLRH-GNLVAVKQILDLDTKGDEDFTNEVEIISKIR-----H---RNLLSLRGCCVTSD 333 (590)
Q Consensus 263 t~~f~~~~~LG~G~fG~Vykg~~~~-g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~-----H---~nlv~l~g~~~~~~ 333 (590)
.++|...++||.|.|++||++.+.. .+.||+|+.+.. ..-.+.-..|+++|++++ | ..||+|+++|....
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG 155 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG 155 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence 3578889999999999999999764 668999987542 223455778999999994 3 37999999999887
Q ss_pred CCCCceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEE
Q 046270 334 DSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILL 404 (590)
Q Consensus 334 ~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILL 404 (590)
. +|.+.+||+|++ +.+|..+|.... .+.++...+.+|++||+.||.|||. +.+|||-||||+||||
T Consensus 156 p-NG~HVCMVfEvL-GdnLLklI~~s~-YrGlpl~~VK~I~~qvL~GLdYLH~--ecgIIHTDlKPENvLl 221 (590)
T KOG1290|consen 156 P-NGQHVCMVFEVL-GDNLLKLIKYSN-YRGLPLSCVKEICRQVLTGLDYLHR--ECGIIHTDLKPENVLL 221 (590)
T ss_pred C-CCcEEEEEehhh-hhHHHHHHHHhC-CCCCcHHHHHHHHHHHHHHHHHHHH--hcCccccCCCcceeee
Confidence 6 899999999999 668888776543 4569999999999999999999997 4599999999999998
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.9e-27 Score=223.97 Aligned_cols=259 Identities=19% Similarity=0.271 Sum_probs=195.4
Q ss_pred hcCCCccceecccCcEEEEEEEE-cCCcEEEEEEeecCCCCChHHHHHHHHHHHhcC-CCCccccceeEEeccCCCCceE
Q 046270 263 TNGFSQNNLIGQGASGIVYKGTL-RHGNLVAVKQILDLDTKGDEDFTNEVEIISKIR-HRNLLSLRGCCVTSDDSSGKRR 340 (590)
Q Consensus 263 t~~f~~~~~LG~G~fG~Vykg~~-~~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~-H~nlv~l~g~~~~~~~~~~~~~ 340 (590)
.++|+..+++|+|.+++||.|.. .+...++||.+++. ..+.+.+|+++|..|+ ||||++|++...+. .....
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp---~Sktp 110 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDP---ESKTP 110 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCc---cccCc
Confidence 35788889999999999999984 45778999998764 3567899999999996 99999999987754 34568
Q ss_pred EEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCC-CcEEEEeeCCcc
Q 046270 341 FLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSE-LNAKVADFGLAK 419 (590)
Q Consensus 341 ~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~-~~~kL~DFGla~ 419 (590)
.||+||+.|.+..... +.|+...+...+.++++||.|.| +.||.|||+||.||++|.. -..+|+|+|+|.
T Consensus 111 aLiFE~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCH---S~GImHRDVKPhNvmIdh~~rkLrlIDWGLAE 181 (338)
T KOG0668|consen 111 SLIFEYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCH---SMGIMHRDVKPHNVMIDHELRKLRLIDWGLAE 181 (338)
T ss_pred hhHhhhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHH---hcCcccccCCcceeeechhhceeeeeecchHh
Confidence 8999999998776544 46888889999999999999999 9999999999999999976 568999999998
Q ss_pred cccCCCcccccccccCCCccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcC-----
Q 046270 420 QSLEGHSHLTTRVAGTFGYLAPEYALY-GQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSG----- 493 (590)
Q Consensus 420 ~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~----- 493 (590)
...++.... -...+..|.-||.+.. ..|+..-|+|||||+|..|+..+.||-...+...++...+..+-.+.
T Consensus 182 FYHp~~eYn--VRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl 259 (338)
T KOG0668|consen 182 FYHPGKEYN--VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYL 259 (338)
T ss_pred hcCCCceee--eeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHH
Confidence 776554321 1234567889998764 56888999999999999999999999766555555544443321110
Q ss_pred -CchhhhhHHHhh----------------hhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 046270 494 -KVDDIFDEFIRA----------------EGARAVMERFVLVGILCAHVMVALRPTITDALK 538 (590)
Q Consensus 494 -~~~~~~d~~l~~----------------~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~ 538 (590)
+..-.+|+...+ +...-...+.+++.-..+..|-++|||+.|.+.
T Consensus 260 ~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 260 NKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred HHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 000001221111 000011235677788889999999999999874
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2e-26 Score=228.90 Aligned_cols=259 Identities=25% Similarity=0.328 Sum_probs=194.8
Q ss_pred CCCccceecccCcEEEEEEEEc-CCcEEEEEEeecC--CCCChHHHHHHHHHHHhcCCCCccccceeEEeccC-CCCceE
Q 046270 265 GFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDL--DTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDD-SSGKRR 340 (590)
Q Consensus 265 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~--~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~-~~~~~~ 340 (590)
+|.....+|.|.- .|-.+.+. .+++||+|++... .....+.-.+|..++..++|+|+++++.++.-... .+-.+.
T Consensus 18 Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~ 96 (369)
T KOG0665|consen 18 RYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEV 96 (369)
T ss_pred eeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhH
Confidence 4555667888877 55555433 4789999987432 23345567889999999999999999998864432 133458
Q ss_pred EEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCccc
Q 046270 341 FLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQ 420 (590)
Q Consensus 341 ~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~ 420 (590)
|+|||+|. .+|...+. -.++-+....|..|+..|+.||| +.+|+||||||+||++..+..+||.|||+++.
T Consensus 97 y~v~e~m~-~nl~~vi~-----~elDH~tis~i~yq~~~~ik~lh---s~~IihRdLkPsnivv~~~~~lKi~dfg~ar~ 167 (369)
T KOG0665|consen 97 YLVMELMD-ANLCQVIL-----MELDHETISYILYQMLCGIKHLH---SAGIIHRDLKPSNIVVNSDCTLKILDFGLART 167 (369)
T ss_pred HHHHHhhh-hHHHHHHH-----HhcchHHHHHHHHHHHHHHHHHH---hcceeecccCcccceecchhheeeccchhhcc
Confidence 99999994 68887774 34777788899999999999999 99999999999999999999999999999985
Q ss_pred ccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhhh
Q 046270 421 SLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFD 500 (590)
Q Consensus 421 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 500 (590)
.... ...+....|..|.|||.+.+..+.+..||||.||++.||++|+-.|.. ...+.+|.+..-..|...+-+-
T Consensus 168 e~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g----~d~idQ~~ki~~~lgtpd~~F~ 241 (369)
T KOG0665|consen 168 EDTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPG----KDHIDQWNKIIEQLGTPDPSFM 241 (369)
T ss_pred cCcc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecC----chHHHHHHHHHHHhcCCCHHHH
Confidence 4433 345667788999999999988899999999999999999999987752 3356666555444444332222
Q ss_pred HHHhhhh------------------------------HHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 501 EFIRAEG------------------------------ARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 501 ~~l~~~~------------------------------~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
..+.... +.-.......++..++-.+|++|-+.+++++.
T Consensus 242 ~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 242 KQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred HHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 2111110 00011234567889999999999999999986
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.3e-25 Score=211.45 Aligned_cols=166 Identities=19% Similarity=0.194 Sum_probs=125.1
Q ss_pred CCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccccCCCcccc
Q 046270 350 GTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLT 429 (590)
Q Consensus 350 gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~~~~~~~~~ 429 (590)
|+|.+++.. ....++|.+++.|+.||++||.||| +.+ ||+|||++.++.+|+ ||+++......
T Consensus 1 GsL~~~l~~--~~~~l~~~~~~~i~~qi~~~L~~lH---~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~---- 63 (176)
T smart00750 1 VSLADILEV--RGRPLNEEEIWAVCLQCLRALRELH---RQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ---- 63 (176)
T ss_pred CcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHH---hcC------CcccEeEcCccceee--ccceEeecccc----
Confidence 688888852 2446999999999999999999999 555 999999999999999 99998654322
Q ss_pred cccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhhhHHHhhhhHH
Q 046270 430 TRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDEFIRAEGAR 509 (590)
Q Consensus 430 ~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 509 (590)
..||..|||||++.+..++.++|||||||++|||+||+.|+.........+..+........ .. + .....
T Consensus 64 --~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-~~---~----~~~~~ 133 (176)
T smart00750 64 --SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADD-PR---D----RSNLE 133 (176)
T ss_pred --CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCC-cc---c----cccHH
Confidence 25789999999999999999999999999999999999998654332222222221111100 00 0 00111
Q ss_pred HHHH--HHHHHHHhchhcCCCCCCCHHHHHHHhcc
Q 046270 510 AVME--RFVLVGILCAHVMVALRPTITDALKMLEG 542 (590)
Q Consensus 510 ~~~~--~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~ 542 (590)
.... .+.+++..|++.+|.+||++.|+++.+..
T Consensus 134 ~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~ 168 (176)
T smart00750 134 SVSAARSFADFMRVCASRLPQRREAANHYLAHCRA 168 (176)
T ss_pred HHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHH
Confidence 2222 68889999999999999999999998754
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.7e-26 Score=267.65 Aligned_cols=201 Identities=13% Similarity=0.162 Sum_probs=139.4
Q ss_pred hcCC-CCccccceeEEecc--CCCCceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCe
Q 046270 316 KIRH-RNLLSLRGCCVTSD--DSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGI 392 (590)
Q Consensus 316 ~l~H-~nlv~l~g~~~~~~--~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~i 392 (590)
.++| +||+++++++.... .......++++||+ +++|.++|.. ....+++.+++.|+.||++||.||| +.+|
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH---~~gI 101 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN--PDRSVDAFECFHVFRQIVEIVNAAH---SQGI 101 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc--ccccccHHHHHHHHHHHHHHHHHHH---hCCe
Confidence 4556 68888888873322 11223467888987 5699999852 2346999999999999999999999 8999
Q ss_pred EecCCCCCceEECC-------------------CCcEEEEeeCCcccccCCC--------c-------ccccccccCCCc
Q 046270 393 YHRDIKSTNILLDS-------------------ELNAKVADFGLAKQSLEGH--------S-------HLTTRVAGTFGY 438 (590)
Q Consensus 393 vHrDIKp~NILLd~-------------------~~~~kL~DFGla~~~~~~~--------~-------~~~~~~~gt~~Y 438 (590)
+||||||+||||+. ++.+||+|||+++...... . .......||+.|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 99999999999954 3456666666665321100 0 001123578899
Q ss_pred cCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhhhHHHhhhhHHHHHHHHHHH
Q 046270 439 LAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDEFIRAEGARAVMERFVLV 518 (590)
Q Consensus 439 ~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l 518 (590)
||||++.+..++.++|||||||+||||++|..|+.... ..+..+.. . .+.+... . ...+...+
T Consensus 182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~---~~~~~~~~-----~----~~~~~~~----~-~~~~~~~~ 244 (793)
T PLN00181 182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS---RTMSSLRH-----R----VLPPQIL----L-NWPKEASF 244 (793)
T ss_pred EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH---HHHHHHHH-----h----hcChhhh----h-cCHHHHHH
Confidence 99999999999999999999999999999987754211 11111110 0 0111110 0 11234567
Q ss_pred HHhchhcCCCCCCCHHHHHHH
Q 046270 519 GILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 519 ~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
+.+|++.+|.+||+|.|++++
T Consensus 245 ~~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 245 CLWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred HHHhCCCChhhCcChHHHhhc
Confidence 788999999999999999863
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.9e-26 Score=240.00 Aligned_cols=195 Identities=26% Similarity=0.370 Sum_probs=162.7
Q ss_pred CCCccceecccCcEEEEEEEEcC-CcEEEEEEeecCCC--------CChHHHHHHHHHHHhcC---CCCccccceeEEec
Q 046270 265 GFSQNNLIGQGASGIVYKGTLRH-GNLVAVKQILDLDT--------KGDEDFTNEVEIISKIR---HRNLLSLRGCCVTS 332 (590)
Q Consensus 265 ~f~~~~~LG~G~fG~Vykg~~~~-g~~vAvK~l~~~~~--------~~~~~f~~Ev~il~~l~---H~nlv~l~g~~~~~ 332 (590)
+|+..+.+|+|+||.|+.++++. ...|+||.+.+..- ...-.+-.|+.+|+.++ |+||++++.|+++
T Consensus 562 ~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd- 640 (772)
T KOG1152|consen 562 DYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED- 640 (772)
T ss_pred cceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec-
Confidence 47788899999999999999985 45788888754211 11113557999999997 9999999999984
Q ss_pred cCCCCceEEEEEee-CCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEE
Q 046270 333 DDSSGKRRFLVYDY-MPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAK 411 (590)
Q Consensus 333 ~~~~~~~~~LV~E~-~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~k 411 (590)
....||++|- -++.+|.+++. .+..+++.+..-|++||+-|+++|| ..+|||||||-+||.+|.+|-+|
T Consensus 641 ----dd~yyl~te~hg~gIDLFd~IE---~kp~m~E~eAk~IFkQV~agi~hlh---~~~ivhrdikdenvivd~~g~~k 710 (772)
T KOG1152|consen 641 ----DDYYYLETEVHGEGIDLFDFIE---FKPRMDEPEAKLIFKQVVAGIKHLH---DQGIVHRDIKDENVIVDSNGFVK 710 (772)
T ss_pred ----CCeeEEEecCCCCCcchhhhhh---ccCccchHHHHHHHHHHHhcccccc---ccCceecccccccEEEecCCeEE
Confidence 4568999986 45667888884 4567999999999999999999999 99999999999999999999999
Q ss_pred EEeeCCcccccCCCcccccccccCCCccCccccccCCCC-cchhHHHHHHHHHHHHhCCCCCC
Q 046270 412 VADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALYGQLT-EKSDVYSFGIVILELMSGRKVLD 473 (590)
Q Consensus 412 L~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t-~ksDVySfGvvLlELltG~~p~~ 473 (590)
|+|||.+.....+ ......||.+|.|||++.+.+|- ..-|||++||+||.++....|+.
T Consensus 711 lidfgsaa~~ksg---pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 711 LIDFGSAAYTKSG---PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred EeeccchhhhcCC---CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 9999998765443 23457899999999999987764 56799999999999998888874
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-26 Score=248.14 Aligned_cols=250 Identities=27% Similarity=0.351 Sum_probs=196.6
Q ss_pred hcCCCccceecccCcEEEEEEEEcC-CcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEE
Q 046270 263 TNGFSQNNLIGQGASGIVYKGTLRH-GNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRF 341 (590)
Q Consensus 263 t~~f~~~~~LG~G~fG~Vykg~~~~-g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~ 341 (590)
.++|....++|.|.||.|||+++.. +...|+|.++-.......-+..|+-+++..+|+|||.++|-+...+ ..+
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~d-----klw 88 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRD-----KLW 88 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhc-----CcE
Confidence 4577888899999999999999864 8889999998777777777889999999999999999999998543 489
Q ss_pred EEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccc
Q 046270 342 LVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQS 421 (590)
Q Consensus 342 LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~ 421 (590)
++|||+.+|+|.+..+ -.+.|++.++....+...+||+||| ..+-+|||||-.|||+++++.+|++|||.+-..
T Consensus 89 icMEycgggslQdiy~---~TgplselqiayvcRetl~gl~ylh---s~gk~hRdiKGanilltd~gDvklaDfgvsaqi 162 (829)
T KOG0576|consen 89 ICMEYCGGGSLQDIYH---VTGPLSELQIAYVCRETLQGLKYLH---SQGKIHRDIKGANILLTDEGDVKLADFGVSAQI 162 (829)
T ss_pred EEEEecCCCcccceee---ecccchhHHHHHHHhhhhccchhhh---cCCcccccccccceeecccCceeecccCchhhh
Confidence 9999999999999775 4468999999999999999999999 899999999999999999999999999998654
Q ss_pred cCCCcccccccccCCCccCccccc---cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHH-hcC-Cch
Q 046270 422 LEGHSHLTTRVAGTFGYLAPEYAL---YGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLA-KSG-KVD 496 (590)
Q Consensus 422 ~~~~~~~~~~~~gt~~Y~APE~~~---~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~-~~~-~~~ 496 (590)
... -.....+.||+.|||||+.. .+.|..++|||+.|+...|+---+.|.-.....+. + .+. +.+ +..
T Consensus 163 tat-i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~-l-----~LmTkS~~qpp 235 (829)
T KOG0576|consen 163 TAT-IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRA-L-----FLMTKSGFQPP 235 (829)
T ss_pred hhh-hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHH-H-----HHhhccCCCCC
Confidence 321 11234467999999999864 67899999999999999999877666432211111 1 111 111 011
Q ss_pred hhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHH
Q 046270 497 DIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDAL 537 (590)
Q Consensus 497 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl 537 (590)
.+-|+ ....+-+-+++..|+-.+|.+|||.+.++
T Consensus 236 ~lkDk-------~kws~~fh~fvK~altknpKkRptaeklL 269 (829)
T KOG0576|consen 236 TLKDK-------TKWSEFFHNFVKGALTKNPKKRPTAEKLL 269 (829)
T ss_pred cccCC-------ccchHHHHHHHHHHhcCCCccCCChhhhe
Confidence 11111 12234677788899999999999987653
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.4e-26 Score=231.58 Aligned_cols=265 Identities=26% Similarity=0.370 Sum_probs=195.9
Q ss_pred HHHHhcCCCccceecccCcEEEEEEEEcC----CcEEEEEEeecCCCCChHHHHHHHHHHHhc-CCCCccccceeEEecc
Q 046270 259 LEQATNGFSQNNLIGQGASGIVYKGTLRH----GNLVAVKQILDLDTKGDEDFTNEVEIISKI-RHRNLLSLRGCCVTSD 333 (590)
Q Consensus 259 l~~at~~f~~~~~LG~G~fG~Vykg~~~~----g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l-~H~nlv~l~g~~~~~~ 333 (590)
+....+.|..+++||+|.|++||++++.. ...||+|.+...+ ....+.+|+++|..+ .+.||+++.++...
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rn-- 106 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRN-- 106 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhcc--
Confidence 33445678889999999999999998754 5689999986543 345689999999999 59999999998874
Q ss_pred CCCCceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCC-CcEEE
Q 046270 334 DSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSE-LNAKV 412 (590)
Q Consensus 334 ~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~-~~~kL 412 (590)
+....+|+||++.....+++. .++..++..+++.+.+||.++| ..|||||||||+|+|.+.. +.-.|
T Consensus 107 ---nd~v~ivlp~~~H~~f~~l~~------~l~~~~i~~Yl~~ll~Al~~~h---~~GIvHRDiKpsNFL~n~~t~rg~L 174 (418)
T KOG1167|consen 107 ---NDQVAIVLPYFEHDRFRDLYR------SLSLAEIRWYLRNLLKALAHLH---KNGIVHRDIKPSNFLYNRRTQRGVL 174 (418)
T ss_pred ---CCeeEEEecccCccCHHHHHh------cCCHHHHHHHHHHHHHHhhhhh---ccCccccCCCccccccccccCCceE
Confidence 445899999999988888773 5788999999999999999999 9999999999999999876 56789
Q ss_pred EeeCCcccccC--------C-----Cc------------------------------ccccccccCCCccCccccc-cCC
Q 046270 413 ADFGLAKQSLE--------G-----HS------------------------------HLTTRVAGTFGYLAPEYAL-YGQ 448 (590)
Q Consensus 413 ~DFGla~~~~~--------~-----~~------------------------------~~~~~~~gt~~Y~APE~~~-~~~ 448 (590)
.|||+|..... . .. ......+||+||.|||++. .+.
T Consensus 175 vDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~ 254 (418)
T KOG1167|consen 175 VDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPR 254 (418)
T ss_pred EechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccC
Confidence 99999972100 0 00 0011246999999999976 567
Q ss_pred CCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHH----HHH-----HhcCC-----------chhhhhH-------
Q 046270 449 LTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWA----WVL-----AKSGK-----------VDDIFDE------- 501 (590)
Q Consensus 449 ~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~----~~~-----~~~~~-----------~~~~~d~------- 501 (590)
.+++.||||-||+++-+++++.||-...++...+.+.+ +.- ...|. ..+....
T Consensus 255 QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~ 334 (418)
T KOG1167|consen 255 QTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIE 334 (418)
T ss_pred cCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChh
Confidence 89999999999999999999999966555444332221 110 11111 1111111
Q ss_pred HHhh---------hhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 502 FIRA---------EGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 502 ~l~~---------~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
.+.. ...+-....++++...|+..||.+|-|++|.++.
T Consensus 335 ~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 335 SIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred hcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 0000 0011122367888999999999999999999864
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.1e-25 Score=213.69 Aligned_cols=253 Identities=20% Similarity=0.331 Sum_probs=181.9
Q ss_pred cCCCccceecccCcEEEEEEEEcC-CcEEEEEEeecCCCCChHHHHHHHHHHHhc-CCCCccccceeEEeccCCCCceEE
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLRH-GNLVAVKQILDLDTKGDEDFTNEVEIISKI-RHRNLLSLRGCCVTSDDSSGKRRF 341 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l-~H~nlv~l~g~~~~~~~~~~~~~~ 341 (590)
+.|.+.+.||+|.||.+-.+.++. .+.+++|-+.. .....++|.+|...--.| .|.||+.-+..-... ....+
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~-p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt----~d~Yv 98 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPR-PQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQT----SDAYV 98 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCc-chhhHHHHHHHhccceeeccchhhhHHHHHHhhc----CceEE
Confidence 568888999999999999999985 55788887643 233467899998776666 689999776654332 23578
Q ss_pred EEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEE-CCC-CcEEEEeeCCcc
Q 046270 342 LVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILL-DSE-LNAKVADFGLAK 419 (590)
Q Consensus 342 LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILL-d~~-~~~kL~DFGla~ 419 (590)
+++||+|.|+|...+. ...+-+..-.+++.|++.||.|+| ++++||||||.+|||+ +.+ .++||+|||+.+
T Consensus 99 F~qE~aP~gdL~snv~----~~GigE~~~K~v~~ql~SAi~fMH---sknlVHRdlK~eNiLif~~df~rvKlcDFG~t~ 171 (378)
T KOG1345|consen 99 FVQEFAPRGDLRSNVE----AAGIGEANTKKVFAQLLSAIEFMH---SKNLVHRDLKAENILIFDADFYRVKLCDFGLTR 171 (378)
T ss_pred EeeccCccchhhhhcC----cccccHHHHHHHHHHHHHHHHHhh---ccchhhcccccceEEEecCCccEEEeeeccccc
Confidence 9999999999998774 345778888999999999999999 9999999999999999 333 479999999987
Q ss_pred cccCCCcccccccccCCCccCcccccc---C--CCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCC
Q 046270 420 QSLEGHSHLTTRVAGTFGYLAPEYALY---G--QLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGK 494 (590)
Q Consensus 420 ~~~~~~~~~~~~~~gt~~Y~APE~~~~---~--~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~ 494 (590)
.... ......-+..|.+||.... + +..+.+|||.|||+++..+||+.|++.......-. |-|..|..+.
T Consensus 172 k~g~----tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y--~~~~~w~~rk 245 (378)
T KOG1345|consen 172 KVGT----TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPY--WEWEQWLKRK 245 (378)
T ss_pred ccCc----eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchH--HHHHHHhccc
Confidence 4322 1222334668999997653 2 34678999999999999999999997433322222 4445555554
Q ss_pred chhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHh
Q 046270 495 VDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKML 540 (590)
Q Consensus 495 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L 540 (590)
...+-+..-. ..++..++-..-+.+++++|--+.++.+|.
T Consensus 246 ~~~~P~~F~~------fs~~a~r~Fkk~lt~~~~drcki~~~kk~r 285 (378)
T KOG1345|consen 246 NPALPKKFNP------FSEKALRLFKKSLTPRFKDRCKIWTAKKMR 285 (378)
T ss_pred CccCchhhcc------cCHHHHHHHHHhcCCcccccchhHHHHHHH
Confidence 4332222111 112344444566788898886666666554
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.8e-25 Score=230.67 Aligned_cols=266 Identities=21% Similarity=0.211 Sum_probs=198.7
Q ss_pred HHHhcCCCccceecccCcEEEEEEEEcC-CcEEEEEEeecCCCCChHHHHHHHHHHHhcC------CCCccccceeEEec
Q 046270 260 EQATNGFSQNNLIGQGASGIVYKGTLRH-GNLVAVKQILDLDTKGDEDFTNEVEIISKIR------HRNLLSLRGCCVTS 332 (590)
Q Consensus 260 ~~at~~f~~~~~LG~G~fG~Vykg~~~~-g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~------H~nlv~l~g~~~~~ 332 (590)
+..-..|......|+|-|++|.+|.... |+.||||++.+.... .+.=..|+++|.+|+ ..++++|+-.|.
T Consensus 428 E~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M-~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~-- 504 (752)
T KOG0670|consen 428 ELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM-HKTGLKELEILKKLNDADPEDKFHCLRLFRHFK-- 504 (752)
T ss_pred hhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH-hhhhhHHHHHHHHhhccCchhhhHHHHHHHHhh--
Confidence 3455678888889999999999998764 889999999775432 334567999999995 347888888776
Q ss_pred cCCCCceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCC-CcEE
Q 046270 333 DDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSE-LNAK 411 (590)
Q Consensus 333 ~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~-~~~k 411 (590)
..++++||+|-+ ..+|.++|......-.|....+..++.|+.-||..|. ..+|+|.||||.|||+++. ..+|
T Consensus 505 ---hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK---~c~vlHaDIKPDNiLVNE~k~iLK 577 (752)
T KOG0670|consen 505 ---HKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLK---KCGVLHADIKPDNILVNESKNILK 577 (752)
T ss_pred ---hcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHH---hcCeeecccCccceEeccCcceee
Confidence 356799999988 4689999977666777999999999999999999999 8999999999999999987 4579
Q ss_pred EEeeCCcccccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhh------HH
Q 046270 412 VADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLIT------DW 485 (590)
Q Consensus 412 L~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~------~~ 485 (590)
|+|||.|....+... +...-+..|.|||++.+-.|+...|+||.||.||||.||+..|......+.+-. .+
T Consensus 578 LCDfGSA~~~~enei---tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~ 654 (752)
T KOG0670|consen 578 LCDFGSASFASENEI---TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKF 654 (752)
T ss_pred eccCccccccccccc---cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCC
Confidence 999999976654332 222334579999999999999999999999999999999988865443322100 00
Q ss_pred HHHHHhcCCc---------------------------hhhhhH------HHhh-----hhHHHHHHHHHHHHHhchhcCC
Q 046270 486 AWVLAKSGKV---------------------------DDIFDE------FIRA-----EGARAVMERFVLVGILCAHVMV 527 (590)
Q Consensus 486 ~~~~~~~~~~---------------------------~~~~d~------~l~~-----~~~~~~~~~l~~l~~~Cl~~dp 527 (590)
...+.+.|.+ ...+.| .+.. .........|..+.-.|+..||
T Consensus 655 p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP 734 (752)
T KOG0670|consen 655 PNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDP 734 (752)
T ss_pred cHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccCh
Confidence 1111111111 111111 1111 0112344567778889999999
Q ss_pred CCCCCHHHHHH
Q 046270 528 ALRPTITDALK 538 (590)
Q Consensus 528 ~~RPtm~eVl~ 538 (590)
++|-|..++++
T Consensus 735 ~KRit~nqAL~ 745 (752)
T KOG0670|consen 735 EKRITVNQALK 745 (752)
T ss_pred hhcCCHHHHhc
Confidence 99999999875
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.1e-23 Score=221.93 Aligned_cols=176 Identities=16% Similarity=0.159 Sum_probs=133.8
Q ss_pred HHHhcCCCccceecccCcEEEEEEEEc--CCcEEEEEEeecCC-----CCChHHHHHHHHHHHhcCCCCccccceeEEec
Q 046270 260 EQATNGFSQNNLIGQGASGIVYKGTLR--HGNLVAVKQILDLD-----TKGDEDFTNEVEIISKIRHRNLLSLRGCCVTS 332 (590)
Q Consensus 260 ~~at~~f~~~~~LG~G~fG~Vykg~~~--~g~~vAvK~l~~~~-----~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~ 332 (590)
....++|...+.||+|+||+||+|.+. +++.||||++.... ....+.|.+|+++|++++|+|+++.+..+
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~--- 90 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT--- 90 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---
Confidence 445678999999999999999999875 47778999875321 11245689999999999999998633221
Q ss_pred cCCCCceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCC-CCCceEECCCCcEE
Q 046270 333 DDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDI-KSTNILLDSELNAK 411 (590)
Q Consensus 333 ~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDI-Kp~NILLd~~~~~k 411 (590)
...+|||||+++++|.... ... ...++.+++++|.||| +.+|+|||| ||+|||++.++++|
T Consensus 91 -----~~~~LVmE~~~G~~L~~~~----~~~------~~~~~~~i~~aL~~lH---~~gIiHrDL~KP~NILv~~~~~ik 152 (365)
T PRK09188 91 -----GKDGLVRGWTEGVPLHLAR----PHG------DPAWFRSAHRALRDLH---RAGITHNDLAKPQNWLMGPDGEAA 152 (365)
T ss_pred -----CCcEEEEEccCCCCHHHhC----ccc------hHHHHHHHHHHHHHHH---HCCCeeCCCCCcceEEEcCCCCEE
Confidence 2379999999999996311 111 1467889999999999 899999999 99999999999999
Q ss_pred EEeeCCcccccCCCcc-------cccccccCCCccCccccccCC------CCcchhHH
Q 046270 412 VADFGLAKQSLEGHSH-------LTTRVAGTFGYLAPEYALYGQ------LTEKSDVY 456 (590)
Q Consensus 412 L~DFGla~~~~~~~~~-------~~~~~~gt~~Y~APE~~~~~~------~t~ksDVy 456 (590)
|+|||+++........ ..+...+++.|+|||++...+ .+..+|-|
T Consensus 153 LiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 153 VIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred EEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 9999999976443211 124567889999999987433 23346666
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.2e-21 Score=196.44 Aligned_cols=259 Identities=26% Similarity=0.355 Sum_probs=192.0
Q ss_pred CCccceecccCcEEEEEEEEcCCcEEEEEEeecCCCC---ChHHHHHHHHHHHhcCCC-CccccceeEEeccCCCCceEE
Q 046270 266 FSQNNLIGQGASGIVYKGTLRHGNLVAVKQILDLDTK---GDEDFTNEVEIISKIRHR-NLLSLRGCCVTSDDSSGKRRF 341 (590)
Q Consensus 266 f~~~~~LG~G~fG~Vykg~~~~g~~vAvK~l~~~~~~---~~~~f~~Ev~il~~l~H~-nlv~l~g~~~~~~~~~~~~~~ 341 (590)
|.....||.|+||.||++... ..+++|.+...... ....+.+|+.+++.+.|+ +++++.+++.. ....+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~-----~~~~~ 74 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQD-----EGSLY 74 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEec-----CCEEE
Confidence 556678999999999999988 78899998654433 366799999999999988 79999998842 23379
Q ss_pred EEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCC-cEEEEeeCCccc
Q 046270 342 LVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSEL-NAKVADFGLAKQ 420 (590)
Q Consensus 342 LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~-~~kL~DFGla~~ 420 (590)
++++++.++++.+++........++......++.+++.++.|+| ..+++|||+||+||+++... .+++.|||+++.
T Consensus 75 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H---~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~ 151 (384)
T COG0515 75 LVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKL 151 (384)
T ss_pred EEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeecCCCCeEEEeccCccee
Confidence 99999999999966532111126889999999999999999999 88999999999999999998 799999999986
Q ss_pred ccCCCcc-----cccccccCCCccCcccccc---CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc--hhhhhHHHHHHH
Q 046270 421 SLEGHSH-----LTTRVAGTFGYLAPEYALY---GQLTEKSDVYSFGIVILELMSGRKVLDTSTSP--FQLITDWAWVLA 490 (590)
Q Consensus 421 ~~~~~~~-----~~~~~~gt~~Y~APE~~~~---~~~t~ksDVySfGvvLlELltG~~p~~~~~~~--~~~l~~~~~~~~ 490 (590)
....... ......|+..|++||.+.. .......|+||+|++++++++|+.|+...... ........+...
T Consensus 152 ~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 231 (384)
T COG0515 152 LPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELP 231 (384)
T ss_pred cCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcC
Confidence 5443322 2456789999999999987 67899999999999999999999997654431 111111111111
Q ss_pred hcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 491 KSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 491 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
.. ........... ......+..+...|+..+|..|.++.+....
T Consensus 232 ~~-~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 232 TP-SLASPLSPSNP----ELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred Cc-ccccccCcccc----chhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 00 00000000000 1112355667778888899999998887653
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.1e-21 Score=201.98 Aligned_cols=259 Identities=18% Similarity=0.202 Sum_probs=187.9
Q ss_pred CCCccceecccCcEEEEEEEEcCC--cEEEEEEeecCCCCChHHHHHHHHHHHhcCC----CCccccceeEEeccCCCCc
Q 046270 265 GFSQNNLIGQGASGIVYKGTLRHG--NLVAVKQILDLDTKGDEDFTNEVEIISKIRH----RNLLSLRGCCVTSDDSSGK 338 (590)
Q Consensus 265 ~f~~~~~LG~G~fG~Vykg~~~~g--~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H----~nlv~l~g~~~~~~~~~~~ 338 (590)
+|...++||+|+||.||++..... ..+|+|............+..|..++..+.+ +++..++.... ..+.
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~----~~~~ 94 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGR----STED 94 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEecc----CCCc
Confidence 788999999999999999998764 4788887665433333378899999999974 46666666553 1345
Q ss_pred eEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCC-----CcEEEE
Q 046270 339 RRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSE-----LNAKVA 413 (590)
Q Consensus 339 ~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~-----~~~kL~ 413 (590)
..++||+.. +.+|.++..... .+.++....++|+.|++.+|.+|| +.+++||||||.|+++... ..+.|.
T Consensus 95 ~~~iVM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH---~~G~iHRDiKp~N~~~g~~~~~~~~~~~ll 169 (322)
T KOG1164|consen 95 FNFIVMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLH---SKGFIHRDIKPENFVVGQSSRSEVRTLYLL 169 (322)
T ss_pred eeEEEEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHH---hcCcccCCcCHHHeeecCCCCcccceEEEE
Confidence 689999988 789999764333 467999999999999999999999 9999999999999999765 468999
Q ss_pred eeCCcc--cccCCCc----cc---ccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhH
Q 046270 414 DFGLAK--QSLEGHS----HL---TTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITD 484 (590)
Q Consensus 414 DFGla~--~~~~~~~----~~---~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~ 484 (590)
|||+++ ....... .. .....||..|.++....+...+.+.|+||++-++.|++.|..|+........ ...
T Consensus 170 DfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~-~~~ 248 (322)
T KOG1164|consen 170 DFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL-KSK 248 (322)
T ss_pred ecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch-HHH
Confidence 999999 3322221 11 1235699999999999999999999999999999999999999854332211 110
Q ss_pred HHHHHHhcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhccC
Q 046270 485 WAWVLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEGD 543 (590)
Q Consensus 485 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~~ 543 (590)
.... .. ...... . .......+..+...+-..+..++|....+...|...
T Consensus 249 ~~~~-~~----~~~~~~-~----~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~ 297 (322)
T KOG1164|consen 249 FEKD-PR----KLLTDR-F----GDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDV 297 (322)
T ss_pred HHHH-hh----hhcccc-c----cCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHH
Confidence 0000 00 000000 0 001123445555555668999999999988887654
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.3e-22 Score=197.34 Aligned_cols=246 Identities=21% Similarity=0.324 Sum_probs=179.7
Q ss_pred ceecccCcEEEEEEEEcCCcEEEEEEee--cCCCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEEEEEeeC
Q 046270 270 NLIGQGASGIVYKGTLRHGNLVAVKQIL--DLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFLVYDYM 347 (590)
Q Consensus 270 ~~LG~G~fG~Vykg~~~~g~~vAvK~l~--~~~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~LV~E~~ 347 (590)
.+|.+...|+.|+|+|+ |..+++|++. .......++|..|.-.|+-+.||||.+++|.|... ..+.++..||
T Consensus 196 tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsp-----pnlv~isq~m 269 (448)
T KOG0195|consen 196 TKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSP-----PNLVIISQYM 269 (448)
T ss_pred hhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCC-----CCceEeeeec
Confidence 46888999999999998 4556667663 33444467899999999999999999999999854 3489999999
Q ss_pred CCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccccCCCcc
Q 046270 348 PNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSH 427 (590)
Q Consensus 348 ~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~~~~~~~ 427 (590)
|.|+|...|+.. ..-..+-.+..+++.+||+|++|||+- ++-|.---|.+..|++|++.+++|+= +-++....
T Consensus 270 p~gslynvlhe~-t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarism-ad~kfsfq---- 342 (448)
T KOG0195|consen 270 PFGSLYNVLHEQ-TSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISM-ADTKFSFQ---- 342 (448)
T ss_pred cchHHHHHHhcC-ccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheec-ccceeeee----
Confidence 999999999743 234577889999999999999999953 34454556899999999999998851 11121111
Q ss_pred cccccccCCCccCccccccCCC---CcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhhhHHHh
Q 046270 428 LTTRVAGTFGYLAPEYALYGQL---TEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDEFIR 504 (590)
Q Consensus 428 ~~~~~~gt~~Y~APE~~~~~~~---t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 504 (590)
.....-.+.||+||.+...+- -..+|+|||+|+||||.|...||..-....--. .+.-+.++
T Consensus 343 -e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgm--------------kialeglr 407 (448)
T KOG0195|consen 343 -EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGM--------------KIALEGLR 407 (448)
T ss_pred -ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhh--------------hhhhcccc
Confidence 111223578999999986653 357999999999999999999997543321100 01111122
Q ss_pred hhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhccC
Q 046270 505 AEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEGD 543 (590)
Q Consensus 505 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~~ 543 (590)
-..+......+.+++.-|+.+||.+||.+..++-.||..
T Consensus 408 v~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 408 VHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred ccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 222223334566777789999999999999999998864
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.7e-20 Score=181.50 Aligned_cols=139 Identities=16% Similarity=0.217 Sum_probs=108.9
Q ss_pred cceecccCcEEEEEEEEcCCcEEEEEEeecCCCC--C-------hHHH-----------------HHHHHHHHhcCCCCc
Q 046270 269 NNLIGQGASGIVYKGTLRHGNLVAVKQILDLDTK--G-------DEDF-----------------TNEVEIISKIRHRNL 322 (590)
Q Consensus 269 ~~~LG~G~fG~Vykg~~~~g~~vAvK~l~~~~~~--~-------~~~f-----------------~~Ev~il~~l~H~nl 322 (590)
...||+|+||.||+|...+|+.||||+++..... . ...| ..|++.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 3579999999999999988999999998653211 1 1122 349999999998887
Q ss_pred cccceeEEeccCCCCceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHH-HhcCCCCeEecCCCCCc
Q 046270 323 LSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYL-HYGLKPGIYHRDIKSTN 401 (590)
Q Consensus 323 v~l~g~~~~~~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yL-H~~~~~~ivHrDIKp~N 401 (590)
.....+.. . ..+|||||++++++..... ....+++.....++.|++.+|.|+ | ..+|+||||||+|
T Consensus 82 ~~p~~~~~--~-----~~~iVmE~i~g~~l~~~~~---~~~~~~~~~~~~i~~qi~~~L~~l~H---~~giiHrDlkP~N 148 (190)
T cd05147 82 PCPEPILL--K-----SHVLVMEFIGDDGWAAPRL---KDAPLSESKARELYLQVIQIMRILYQ---DCRLVHADLSEYN 148 (190)
T ss_pred CCCcEEEe--c-----CCEEEEEEeCCCCCcchhh---hcCCCCHHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHH
Confidence 54333221 1 1389999999887765432 234689999999999999999999 7 7899999999999
Q ss_pred eEECCCCcEEEEeeCCcccc
Q 046270 402 ILLDSELNAKVADFGLAKQS 421 (590)
Q Consensus 402 ILLd~~~~~kL~DFGla~~~ 421 (590)
||++ ++.++|+|||++...
T Consensus 149 Ili~-~~~v~LiDFG~a~~~ 167 (190)
T cd05147 149 LLYH-DGKLYIIDVSQSVEH 167 (190)
T ss_pred EEEE-CCcEEEEEccccccC
Confidence 9998 478999999999743
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=1e-20 Score=186.60 Aligned_cols=178 Identities=12% Similarity=0.145 Sum_probs=137.5
Q ss_pred HHhcCCCccceecccCcEEEEEEEEcCCcEEEEEEeecCCCCChHH---------HHHHHHHHHhcCCCCccccceeEEe
Q 046270 261 QATNGFSQNNLIGQGASGIVYKGTLRHGNLVAVKQILDLDTKGDED---------FTNEVEIISKIRHRNLLSLRGCCVT 331 (590)
Q Consensus 261 ~at~~f~~~~~LG~G~fG~Vykg~~~~g~~vAvK~l~~~~~~~~~~---------f~~Ev~il~~l~H~nlv~l~g~~~~ 331 (590)
...++|...++||.|+||.||.... ++..+|||.+.+........ +.+|++.+.+++|++|..+..++..
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~ 106 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL 106 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence 3468899999999999999999655 57789999997544333322 6789999999999999999988665
Q ss_pred ccCC---CCceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCC
Q 046270 332 SDDS---SGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSEL 408 (590)
Q Consensus 332 ~~~~---~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~ 408 (590)
.+.. .....+|||||++|.+|.++.. ++. ....+++.+|..+| +.+++|||+||+||+++.++
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH---~~gi~H~Dikp~Nili~~~g 172 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLH---QHGMVSGDPHKGNFIVSKNG 172 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHH---HcCCccCCCChHHEEEeCCC
Confidence 4211 1245899999999999977631 222 24569999999999 99999999999999999988
Q ss_pred cEEEEeeCCcccccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHh
Q 046270 409 NAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS 467 (590)
Q Consensus 409 ~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELlt 467 (590)
++|+|||..+...+.... ..++....+..++|+|+||+.+.-+..
T Consensus 173 -i~liDfg~~~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~~~ 217 (232)
T PRK10359 173 -LRIIDLSGKRCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIYKK 217 (232)
T ss_pred -EEEEECCCcccccchhhH-------------HHHHHHhHhcccccccceeEeehHHHH
Confidence 999999988765332211 114455567789999999999887653
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.2e-19 Score=175.46 Aligned_cols=140 Identities=17% Similarity=0.183 Sum_probs=111.3
Q ss_pred cceecccCcEEEEEEEEcCCcEEEEEEeecCCCC---------------------C-----hHHHHHHHHHHHhcCCCCc
Q 046270 269 NNLIGQGASGIVYKGTLRHGNLVAVKQILDLDTK---------------------G-----DEDFTNEVEIISKIRHRNL 322 (590)
Q Consensus 269 ~~~LG~G~fG~Vykg~~~~g~~vAvK~l~~~~~~---------------------~-----~~~f~~Ev~il~~l~H~nl 322 (590)
...||+|+||.||+|++.+|+.||||++...... . ...+..|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 3579999999999999888999999998754211 0 1123578999999999988
Q ss_pred cccceeEEeccCCCCceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCC-CCeEecCCCCCc
Q 046270 323 LSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLK-PGIYHRDIKSTN 401 (590)
Q Consensus 323 v~l~g~~~~~~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~-~~ivHrDIKp~N 401 (590)
.....+... ..+|||||++++++..... ....++......++.+++.++.++| . .+|+||||||+|
T Consensus 82 ~~p~~~~~~-------~~~lVmE~~~g~~~~~~~l---~~~~~~~~~~~~i~~~l~~~l~~lH---~~~givHrDlkP~N 148 (190)
T cd05145 82 PVPEPILLK-------KNVLVMEFIGDDGSPAPRL---KDVPLEEEEAEELYEQVVEQMRRLY---QEAGLVHGDLSEYN 148 (190)
T ss_pred CCceEEEec-------CCEEEEEEecCCCchhhhh---hhccCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCChhh
Confidence 655444321 1489999999886544321 2345788899999999999999999 7 899999999999
Q ss_pred eEECCCCcEEEEeeCCccccc
Q 046270 402 ILLDSELNAKVADFGLAKQSL 422 (590)
Q Consensus 402 ILLd~~~~~kL~DFGla~~~~ 422 (590)
||++ +++++|+|||++....
T Consensus 149 Ill~-~~~~~liDFG~a~~~~ 168 (190)
T cd05145 149 ILYH-DGKPYIIDVSQAVELD 168 (190)
T ss_pred EEEE-CCCEEEEEcccceecC
Confidence 9999 7899999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=4.7e-20 Score=198.26 Aligned_cols=215 Identities=27% Similarity=0.405 Sum_probs=159.0
Q ss_pred HHhcCCCCccccceeEEeccCCCCceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCe-
Q 046270 314 ISKIRHRNLLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGI- 392 (590)
Q Consensus 314 l~~l~H~nlv~l~g~~~~~~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~i- 392 (590)
|+.+.|.|+.+++|.+.. +...++|.+|+..|+|.|.+.. ....++|.....++++|++||+||| ...|
T Consensus 1 l~~l~h~n~~~f~g~~~~-----~~~~~~i~~~c~rGsl~D~i~~--~~~~~d~~F~~s~~rdi~~Gl~ylh---~s~i~ 70 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVD-----GPEMIVIWEYCSRGSLLDILSN--EDIKLDYFFILSFIRDISKGLAYLH---NSPIG 70 (484)
T ss_pred CcccchhhhhhheeeEec-----CCceEEEEeeecCccHHhHHhc--cccCccHHHHHHHHHHHHHHHHHHh---cCcce
Confidence 356899999999999994 4669999999999999999974 3557999999999999999999999 4444
Q ss_pred EecCCCCCceEECCCCcEEEEeeCCcccccCC-CcccccccccCCCccCccccccC-------CCCcchhHHHHHHHHHH
Q 046270 393 YHRDIKSTNILLDSELNAKVADFGLAKQSLEG-HSHLTTRVAGTFGYLAPEYALYG-------QLTEKSDVYSFGIVILE 464 (590)
Q Consensus 393 vHrDIKp~NILLd~~~~~kL~DFGla~~~~~~-~~~~~~~~~gt~~Y~APE~~~~~-------~~t~ksDVySfGvvLlE 464 (590)
+|+.++++|.++|..+.+||+|||+....... .........-..-|.|||.+... ..+.+.||||||++++|
T Consensus 71 ~hg~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~e 150 (484)
T KOG1023|consen 71 YHGALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYE 150 (484)
T ss_pred eeeeeccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHH
Confidence 99999999999999999999999998766421 11111112234579999988753 14678999999999999
Q ss_pred HHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhccC
Q 046270 465 LMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEGD 543 (590)
Q Consensus 465 LltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~~ 543 (590)
+++.+.||+........ .+.+..+.+.+ ...+-+.+.... +..+.++.++..||..+|++||+++.|-..++..
T Consensus 151 i~~r~~~~~~~~~~~~~-~eii~~~~~~~--~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~ 224 (484)
T KOG1023|consen 151 ILFRSGPFDLRNLVEDP-DEIILRVKKGG--SNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTI 224 (484)
T ss_pred HHhccCccccccccCCh-HHHHHHHHhcC--CCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhh
Confidence 99999999764432221 11111111111 111222221111 3344788899999999999999999998877653
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.5e-20 Score=210.35 Aligned_cols=252 Identities=22% Similarity=0.236 Sum_probs=180.9
Q ss_pred ccceecccCcEEEEEEEEcC-CcEEEEEEeecC--CCCCh----HHHHHHHHHHHhcCCCCccccceeEEeccCCCCceE
Q 046270 268 QNNLIGQGASGIVYKGTLRH-GNLVAVKQILDL--DTKGD----EDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRR 340 (590)
Q Consensus 268 ~~~~LG~G~fG~Vykg~~~~-g~~vAvK~l~~~--~~~~~----~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~ 340 (590)
..+++|.|.+|.|+...... ....+.|..... ..... ..+..|+.+-..++|+|++..+..+.+... .
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~-----~ 396 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDG-----I 396 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhccc-----c
Confidence 45789999999887776543 333444433210 11111 125567777888999999887776664332 3
Q ss_pred EEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCccc
Q 046270 341 FLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQ 420 (590)
Q Consensus 341 ~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~ 420 (590)
.-+|||+++ +|...+. ....++..++..++.|+.+|+.|+| ..+|.|||+|++|+++..++.+||+|||.+..
T Consensus 397 ~~~mE~~~~-Dlf~~~~---~~~~~~~~e~~c~fKqL~~Gv~y~h---~~GiahrdlK~enll~~~~g~lki~Dfg~~~v 469 (601)
T KOG0590|consen 397 LQSMEYCPY-DLFSLVM---SNGKLTPLEADCFFKQLLRGVKYLH---SMGLAHRDLKLENLLVTENGILKIIDFGAASV 469 (601)
T ss_pred hhhhhcccH-HHHHHHh---cccccchhhhhHHHHHHHHHHHHHH---hcCceeccCccccEEEecCCceEEeecCccee
Confidence 444999999 9988874 2246888999999999999999999 99999999999999999999999999999876
Q ss_pred ccCCCc---ccccccccCCCccCccccccCCCCc-chhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCch
Q 046270 421 SLEGHS---HLTTRVAGTFGYLAPEYALYGQLTE-KSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVD 496 (590)
Q Consensus 421 ~~~~~~---~~~~~~~gt~~Y~APE~~~~~~~t~-ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 496 (590)
+..... .....+.|+..|+|||.+...+|.+ ..||||.||++..|++|+.||...........+ ....+...
T Consensus 470 f~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~----~~~~~~~~ 545 (601)
T KOG0590|consen 470 FRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKT----NNYSDQRN 545 (601)
T ss_pred eccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhh----hccccccc
Confidence 543332 5567788999999999999999877 579999999999999999998644332221100 00000000
Q ss_pred hhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 046270 497 DIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALK 538 (590)
Q Consensus 497 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~ 538 (590)
....+ ......+..+...++..+++++|.+|-||.+|++
T Consensus 546 ~~~~~---~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 546 IFEGP---NRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred cccCh---HHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 00000 0112234556777888999999999999999986
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=5.2e-19 Score=169.99 Aligned_cols=201 Identities=21% Similarity=0.280 Sum_probs=163.2
Q ss_pred hcCCCccceecccCcEEEEEEEE-cCCcEEEEEEeecCCCCChHHHHHHHHHHHhcCC-CCccccceeEEeccCCCCceE
Q 046270 263 TNGFSQNNLIGQGASGIVYKGTL-RHGNLVAVKQILDLDTKGDEDFTNEVEIISKIRH-RNLLSLRGCCVTSDDSSGKRR 340 (590)
Q Consensus 263 t~~f~~~~~LG~G~fG~Vykg~~-~~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H-~nlv~l~g~~~~~~~~~~~~~ 340 (590)
.++|..+++||.|+||.+|.|.. .+|..||||.=.. .....++..|.++...|+| ..|..+.-|.. ++.+-
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~--~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~-----e~~yn 86 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESS--KAKHPQLLYESKVYRILQGGVGIPHIRHYGT-----EKDYN 86 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecc--cCCCcchhHHHHHHHHhccCCCCchhhhhcc-----ccccc
Confidence 45788999999999999999975 5799999997433 3345578899999999976 45555555554 45567
Q ss_pred EEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCC---CcEEEEeeCC
Q 046270 341 FLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSE---LNAKVADFGL 417 (590)
Q Consensus 341 ~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~---~~~kL~DFGl 417 (590)
.||||.. +.||.+.+.... ..++....+-++-|++.-++|+| .+++|||||||+|+|..-+ ..+.++|||+
T Consensus 87 vlVMdLL-GPsLEdLfnfC~--R~ftmkTvLMLaDQml~RiEyvH---~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGL 160 (341)
T KOG1163|consen 87 VLVMDLL-GPSLEDLFNFCS--RRFTMKTVLMLADQMLSRIEYVH---LRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGL 160 (341)
T ss_pred eeeeecc-CccHHHHHHHHh--hhhhHHhHHHHHHHHHHHHHHHH---hhccccccCCccceeeccccccceEEEEeccc
Confidence 9999998 789998775432 45889999999999999999999 8999999999999999644 5688999999
Q ss_pred cccccCCCcc------cccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 046270 418 AKQSLEGHSH------LTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTST 476 (590)
Q Consensus 418 a~~~~~~~~~------~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~ 476 (590)
++...+..+. ......||..|.+--...+...+.+-|+-|+|-+|..+--|..||+...
T Consensus 161 aKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglk 225 (341)
T KOG1163|consen 161 AKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLK 225 (341)
T ss_pred hhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccc
Confidence 9977554322 1234679999998887777788899999999999999999999997543
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=4.6e-20 Score=207.08 Aligned_cols=250 Identities=27% Similarity=0.295 Sum_probs=180.3
Q ss_pred CCCccceecccCcEEEEEEEEcCCcEEEEEEeecCC-CCChHHHHHHHHHH--HhcCCCCccccceeEEeccCCCCceEE
Q 046270 265 GFSQNNLIGQGASGIVYKGTLRHGNLVAVKQILDLD-TKGDEDFTNEVEII--SKIRHRNLLSLRGCCVTSDDSSGKRRF 341 (590)
Q Consensus 265 ~f~~~~~LG~G~fG~Vykg~~~~g~~vAvK~l~~~~-~~~~~~f~~Ev~il--~~l~H~nlv~l~g~~~~~~~~~~~~~~ 341 (590)
++...+.||.+.|=.|.++++++|. |+||++.+.. .-..+.|.++++-+ ..++|||.+++.-.-. ..+..|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~-----t~kAAy 97 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLV-----TDKAAY 97 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHH-----hhHHHH
Confidence 5666788999999999999999887 8899986554 33455565554444 4458999998876543 234468
Q ss_pred EEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccc
Q 046270 342 LVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQS 421 (590)
Q Consensus 342 LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~ 421 (590)
||-+|..+ +|.|.|. .+.-|...+...|+.|++.||.-.| ..+|+|||||.+||||+.-.-+.|+||...+..
T Consensus 98 lvRqyvkh-nLyDRlS---TRPFL~~iEKkWiaFQLL~al~qcH---~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPt 170 (1431)
T KOG1240|consen 98 LVRQYVKH-NLYDRLS---TRPFLVLIEKKWIAFQLLKALSQCH---KLGVCHGDIKSENILITSWNWLYLTDFASFKPT 170 (1431)
T ss_pred HHHHHHhh-hhhhhhc---cchHHHHHHHHHHHHHHHHHHHHHH---HcCccccccccceEEEeeechhhhhcccccCCc
Confidence 88888854 8888774 4566888889999999999999999 999999999999999999999999999877642
Q ss_pred --cCCCccccc----ccccCCCccCccccccC-----------CCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhh
Q 046270 422 --LEGHSHLTT----RVAGTFGYLAPEYALYG-----------QLTEKSDVYSFGIVILELMS-GRKVLDTSTSPFQLIT 483 (590)
Q Consensus 422 --~~~~~~~~~----~~~gt~~Y~APE~~~~~-----------~~t~ksDVySfGvvLlELlt-G~~p~~~~~~~~~~l~ 483 (590)
+++.....+ .-..-..|+|||.+..+ .++++.||||.||++.||++ |+++|... .+-
T Consensus 171 YLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS-----QL~ 245 (1431)
T KOG1240|consen 171 YLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS-----QLL 245 (1431)
T ss_pred cCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH-----HHH
Confidence 232222111 11223579999987641 26789999999999999999 67777521 111
Q ss_pred HHHHHHHhcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhcc
Q 046270 484 DWAWVLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEG 542 (590)
Q Consensus 484 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~ 542 (590)
. .+.|. .......+..-.+ ..+..+++.|++.||.+|-++++.++.-.+
T Consensus 246 a-----Yr~~~-~~~~e~~Le~Ied----~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG 294 (1431)
T KOG1240|consen 246 A-----YRSGN-ADDPEQLLEKIED----VSLRNLILSMIQRDPSKRLSAEDYLQKYRG 294 (1431)
T ss_pred h-----HhccC-ccCHHHHHHhCcC----ccHHHHHHHHHccCchhccCHHHHHHhhhc
Confidence 1 22332 1111112211111 256778889999999999999999987444
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=1e-18 Score=171.38 Aligned_cols=141 Identities=18% Similarity=0.217 Sum_probs=108.5
Q ss_pred CccceecccCcEEEEEEEEcCCcEEEEEEeecCCCCChHHHHHHHHHHHhc-----CCCCccccceeEEeccCCCCceEE
Q 046270 267 SQNNLIGQGASGIVYKGTLRHGNLVAVKQILDLDTKGDEDFTNEVEIISKI-----RHRNLLSLRGCCVTSDDSSGKRRF 341 (590)
Q Consensus 267 ~~~~~LG~G~fG~Vykg~~~~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l-----~H~nlv~l~g~~~~~~~~~~~~~~ 341 (590)
+...+||+|+||.||. +++....+||++........+++.+|++++.++ .||||++++|++.+... .+....
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g-~g~v~~ 81 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCG-TGYVYD 81 (210)
T ss_pred CCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCC-CeEEEE
Confidence 4457899999999996 544333479988665445567899999999999 57999999999976432 122244
Q ss_pred EEEee--CCCCCcchhhhhhcccccCChhhHHHHHHHHHHHH-HHHHhcCCCCeEecCCCCCceEECC----CCcEEEEe
Q 046270 342 LVYDY--MPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGI-AYLHYGLKPGIYHRDIKSTNILLDS----ELNAKVAD 414 (590)
Q Consensus 342 LV~E~--~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL-~yLH~~~~~~ivHrDIKp~NILLd~----~~~~kL~D 414 (590)
+|+|| +++|+|.+++.. ..+++. ..++.+++.++ +||| +.+|+||||||+|||++. +.+++|+|
T Consensus 82 ~I~e~~G~~~~tL~~~l~~----~~~~e~--~~~~~~~L~~l~~yLh---~~~IvhrDlKp~NILl~~~~~~~~~~~LiD 152 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQ----CRYEED--VAQLRQLLKKLKRYLL---DNRIVTMELKPQNILCQRISESEVIPVVCD 152 (210)
T ss_pred EEecCCCCcchhHHHHHHc----ccccHh--HHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEeccCCCCCcEEEEE
Confidence 78999 668999999942 235555 35678888888 9999 999999999999999973 34899999
Q ss_pred eCCcc
Q 046270 415 FGLAK 419 (590)
Q Consensus 415 FGla~ 419 (590)
|+.++
T Consensus 153 g~G~~ 157 (210)
T PRK10345 153 NIGES 157 (210)
T ss_pred CCCCc
Confidence 55443
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=7.3e-19 Score=175.81 Aligned_cols=200 Identities=20% Similarity=0.316 Sum_probs=163.5
Q ss_pred cCCCccceecccCcEEEEEEEE-cCCcEEEEEEeecCCCCChHHHHHHHHHHHhcC-CCCccccceeEEeccCCCCceEE
Q 046270 264 NGFSQNNLIGQGASGIVYKGTL-RHGNLVAVKQILDLDTKGDEDFTNEVEIISKIR-HRNLLSLRGCCVTSDDSSGKRRF 341 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~-~~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~-H~nlv~l~g~~~~~~~~~~~~~~ 341 (590)
-+|...++||+|.||+++.|+. -+++.||||.=. ......++..|.+..+.|. -++|...+-|-. +|.+-.
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEP--rkS~APQLrdEYr~YKlL~g~~GIP~vYYFGq-----eG~~Ni 100 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEP--RKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQ-----EGKYNI 100 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEecc--ccCCcchHHHHHHHHHHHcCCCCCCceeeecc-----ccchhh
Confidence 3688889999999999999985 368999999632 2233567889999999884 577777655443 677889
Q ss_pred EEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECC-----CCcEEEEeeC
Q 046270 342 LVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDS-----ELNAKVADFG 416 (590)
Q Consensus 342 LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~-----~~~~kL~DFG 416 (590)
||+|.+ +.||.|++.-. .+.++.+....|+.|+..-++|+| .+.+|.|||||+|+||.. ...+.|+|||
T Consensus 101 LVidLL-GPSLEDLFD~C--gR~FSvKTV~miA~Qmi~rie~vH---~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFG 174 (449)
T KOG1165|consen 101 LVIDLL-GPSLEDLFDLC--GRRFSVKTVAMIAKQMITRIEYVH---EKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFG 174 (449)
T ss_pred hhhhhh-CcCHHHHHHHh--cCcccHHhHHHHHHHHHHHHHHHH---hcceeecccCccceeecCCCCCCCceEEEEecc
Confidence 999998 78999876432 346999999999999999999999 899999999999999953 3457899999
Q ss_pred CcccccCCCcc--c----ccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 046270 417 LAKQSLEGHSH--L----TTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTST 476 (590)
Q Consensus 417 la~~~~~~~~~--~----~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~ 476 (590)
+|+...+..+. . .....||.+||+--...+.+.+.+-|.=|+|-+++..+-|..||....
T Consensus 175 mAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLK 240 (449)
T KOG1165|consen 175 MAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK 240 (449)
T ss_pred chhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCcccccc
Confidence 99987654332 2 123569999999999999999999999999999999999999997543
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.3e-18 Score=166.88 Aligned_cols=185 Identities=14% Similarity=0.056 Sum_probs=137.2
Q ss_pred CccceecccCcEEEEEEEEcCCcEEEEEEeecCCCCC----hHHHHHHHHHHHhcC-CCCccccceeEEeccCCCCceEE
Q 046270 267 SQNNLIGQGASGIVYKGTLRHGNLVAVKQILDLDTKG----DEDFTNEVEIISKIR-HRNLLSLRGCCVTSDDSSGKRRF 341 (590)
Q Consensus 267 ~~~~~LG~G~fG~Vykg~~~~g~~vAvK~l~~~~~~~----~~~f~~Ev~il~~l~-H~nlv~l~g~~~~~~~~~~~~~~ 341 (590)
.....|++|+||+||.+.. .+..++.+.+.....-. ..-+.+|+++|++|+ |+++.+++++. ..+
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~---------~~~ 74 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHWD---------GRH 74 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEc---------CEE
Confidence 4557899999999997665 57778877765433211 124789999999995 57888888752 269
Q ss_pred EEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCC-CCCceEECCCCcEEEEeeCCccc
Q 046270 342 LVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDI-KSTNILLDSELNAKVADFGLAKQ 420 (590)
Q Consensus 342 LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDI-Kp~NILLd~~~~~kL~DFGla~~ 420 (590)
++|||+++.+|...+. . ....++.+++++|.++| ..+|+|||| ||+|||++.++.++|+|||++..
T Consensus 75 lvmeyI~G~~L~~~~~----~------~~~~~~~qi~~~L~~lH---~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~ 141 (218)
T PRK12274 75 LDRSYLAGAAMYQRPP----R------GDLAYFRAARRLLQQLH---RCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVR 141 (218)
T ss_pred EEEeeecCccHHhhhh----h------hhHHHHHHHHHHHHHHH---HCcCccCCCCCcceEEEcCCCCEEEEECCCcee
Confidence 9999999988865431 1 12357889999999999 899999999 79999999999999999999985
Q ss_pred ccCCCcc----c--------ccccccCCCccCccccccC-CCC-cchhHHHHHHHHHHHHhCCCCCCC
Q 046270 421 SLEGHSH----L--------TTRVAGTFGYLAPEYALYG-QLT-EKSDVYSFGIVILELMSGRKVLDT 474 (590)
Q Consensus 421 ~~~~~~~----~--------~~~~~gt~~Y~APE~~~~~-~~t-~ksDVySfGvvLlELltG~~p~~~ 474 (590)
....... . ......++.|++|+...-- ..+ ...+.++-|.-+|.++||+.+.-.
T Consensus 142 ~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 142 GNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred cCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 4432210 0 1112357788888854321 233 567999999999999999877543
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.76 E-value=3.9e-18 Score=195.14 Aligned_cols=201 Identities=23% Similarity=0.267 Sum_probs=159.4
Q ss_pred HHHHHHhcCCCccceecccCcEEEEEEEEcCCcEEEEEEeecCCCCChHHHHHHHHHHHhcC---CCCccccceeEEecc
Q 046270 257 SELEQATNGFSQNNLIGQGASGIVYKGTLRHGNLVAVKQILDLDTKGDEDFTNEVEIISKIR---HRNLLSLRGCCVTSD 333 (590)
Q Consensus 257 ~el~~at~~f~~~~~LG~G~fG~Vykg~~~~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~---H~nlv~l~g~~~~~~ 333 (590)
.+++.....|.+.+.||+|+||.||+|...+|+.||+|.=+.. ...+|.-=.+++.||+ -+-+..+...+...+
T Consensus 691 ~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~---~~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~ 767 (974)
T KOG1166|consen 691 TEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPP---NPWEFYICLQVMERLKPQMLPSIMHISSAHVFQN 767 (974)
T ss_pred ceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCC---CceeeeehHHHHHhhchhhhcchHHHHHHHccCC
Confidence 3455556778889999999999999999999999999985443 2345555566667776 223334443333322
Q ss_pred CCCCceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECC-------
Q 046270 334 DSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDS------- 406 (590)
Q Consensus 334 ~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~------- 406 (590)
.-+||+||.+.|+|.+++. ..+.++|.....++.|+++-++.|| ..+||||||||+|.||..
T Consensus 768 -----~S~lv~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH---~~~IIHgDiKPDNfll~~~~~~~~~ 836 (974)
T KOG1166|consen 768 -----ASVLVSEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLH---AMGIIHGDIKPDNFLLRREICADSD 836 (974)
T ss_pred -----cceeeeeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHH---hcceecccCCcceeEeecccCCCCc
Confidence 3689999999999999985 5568999999999999999999999 999999999999999932
Q ss_pred CCcEEEEeeCCcccccCC-CcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCC
Q 046270 407 ELNAKVADFGLAKQSLEG-HSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKV 471 (590)
Q Consensus 407 ~~~~kL~DFGla~~~~~~-~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p 471 (590)
+.-++|+|||-+-.+.-- .......+++|-++-.+|...+..++.+.|.|.++-+++-|+.|+..
T Consensus 837 ~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 837 SKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred ccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 345899999988644211 11244567889999999999999999999999999999999999843
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.75 E-value=7.5e-18 Score=171.10 Aligned_cols=236 Identities=22% Similarity=0.274 Sum_probs=148.9
Q ss_pred CCccceecccCcEEEEEEEEcC-CcEEEEEEeecCCC---CChHHHHHHHHHHHhcCC-----------CCccccceeEE
Q 046270 266 FSQNNLIGQGASGIVYKGTLRH-GNLVAVKQILDLDT---KGDEDFTNEVEIISKIRH-----------RNLLSLRGCCV 330 (590)
Q Consensus 266 f~~~~~LG~G~fG~Vykg~~~~-g~~vAvK~l~~~~~---~~~~~f~~Ev~il~~l~H-----------~nlv~l~g~~~ 330 (590)
+.....||.|+++.||.+++.+ |+.+|||...-... ...+++++|.-.+..+.+ .-++++ +...
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~-d~~~ 92 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPL-DLLR 92 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---S-EEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeee-EEEE
Confidence 3456789999999999999986 88999999854332 234567777766655433 122222 1111
Q ss_pred ecc-C------CCCc-----eEEEEEeeCCCCCcchhhhhhc----ccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEe
Q 046270 331 TSD-D------SSGK-----RRFLVYDYMPNGTLSDNISISH----KRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYH 394 (590)
Q Consensus 331 ~~~-~------~~~~-----~~~LV~E~~~~gsL~~~L~~~~----~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivH 394 (590)
... . .... ..+++|+-+ .++|.+++..-. ....+....|+.+..|+.+.+++|| ..+++|
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh---~~GlVH 168 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLH---SYGLVH 168 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTEEE
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHh---hcceEe
Confidence 110 0 0011 136788877 568877754211 1223556677888899999999999 899999
Q ss_pred cCCCCCceEECCCCcEEEEeeCCcccccCCCcccccccccCCCccCccccccC--------CCCcchhHHHHHHHHHHHH
Q 046270 395 RDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALYG--------QLTEKSDVYSFGIVILELM 466 (590)
Q Consensus 395 rDIKp~NILLd~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~--------~~t~ksDVySfGvvLlELl 466 (590)
+||||+|++++.+|.++|+||+.......... . ...+..|.+||..... .++.+.|.|++|+++|.|.
T Consensus 169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~--~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lW 244 (288)
T PF14531_consen 169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTRYR--C--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLW 244 (288)
T ss_dssp ST-SGGGEEE-TTS-EEE--GGGEEETTEEEE--G--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHH
T ss_pred cccceeeEEEcCCCCEEEcChHHHeecCceee--c--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHH
Confidence 99999999999999999999987765433211 1 2345789999976542 4788999999999999999
Q ss_pred hCCCCCCCCCCchhhhhHHHHHHHhcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCC
Q 046270 467 SGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALR 530 (590)
Q Consensus 467 tG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~R 530 (590)
+|+-|++....... .+| .+. ... +.++.+..++...++.+|++|
T Consensus 245 C~~lPf~~~~~~~~--~~~----------------~f~-~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 245 CGRLPFGLSSPEAD--PEW----------------DFS-RCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HSS-STCCCGGGST--SGG----------------GGT-TSS----HHHHHHHHHHT-SSGGGS
T ss_pred HccCCCCCCCcccc--ccc----------------cch-hcC-CcCHHHHHHHHHHccCCcccC
Confidence 99999986433211 101 111 122 556677788889999999988
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.5e-17 Score=161.75 Aligned_cols=146 Identities=21% Similarity=0.182 Sum_probs=112.1
Q ss_pred HHHHHHhcCCCccceecccCcEEEEEEEEcCCcEEEEEEeecCCCC----------------------ChHHHHHHHHHH
Q 046270 257 SELEQATNGFSQNNLIGQGASGIVYKGTLRHGNLVAVKQILDLDTK----------------------GDEDFTNEVEII 314 (590)
Q Consensus 257 ~el~~at~~f~~~~~LG~G~fG~Vykg~~~~g~~vAvK~l~~~~~~----------------------~~~~f~~Ev~il 314 (590)
.++......|...+.||+|+||.||++..++|+.||||++...... ....+..|..++
T Consensus 8 ~~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 87 (198)
T cd05144 8 HTLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAAL 87 (198)
T ss_pred HHHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHH
Confidence 3444444447777899999999999999988999999987542210 012367789999
Q ss_pred HhcCCCCc--cccceeEEeccCCCCceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCe
Q 046270 315 SKIRHRNL--LSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGI 392 (590)
Q Consensus 315 ~~l~H~nl--v~l~g~~~~~~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~i 392 (590)
.++.|+++ ...++. ...++||||+++++|.+... ......++.+++.++.++| ..+|
T Consensus 88 ~~l~~~~i~v~~~~~~---------~~~~lv~e~~~g~~L~~~~~---------~~~~~~~~~~i~~~l~~lh---~~gi 146 (198)
T cd05144 88 KALYEEGFPVPKPIDW---------NRHAVVMEYIDGVELYRVRV---------LEDPEEVLDEILEEIVKAY---KHGI 146 (198)
T ss_pred HHHHHcCCCCCceeec---------CCceEEEEEeCCcchhhccc---------cccHHHHHHHHHHHHHHHH---HCCC
Confidence 99988753 333321 23589999999999876542 0345678899999999999 8999
Q ss_pred EecCCCCCceEECCCCcEEEEeeCCcccccC
Q 046270 393 YHRDIKSTNILLDSELNAKVADFGLAKQSLE 423 (590)
Q Consensus 393 vHrDIKp~NILLd~~~~~kL~DFGla~~~~~ 423 (590)
+||||||+||++++++.++|+|||++.....
T Consensus 147 ~H~Dl~p~Nill~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 147 IHGDLSEFNILVDDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred CcCCCCcccEEEcCCCcEEEEECCccccCCC
Confidence 9999999999999999999999999965433
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.8e-17 Score=162.26 Aligned_cols=134 Identities=24% Similarity=0.357 Sum_probs=111.0
Q ss_pred ceecccCcEEEEEEEEcCCcEEEEEEeecCCCCC--------hHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEE
Q 046270 270 NLIGQGASGIVYKGTLRHGNLVAVKQILDLDTKG--------DEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRF 341 (590)
Q Consensus 270 ~~LG~G~fG~Vykg~~~~g~~vAvK~l~~~~~~~--------~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~ 341 (590)
+.||+|++|.||+|.+ .|..+++|+........ ...+.+|++++.+++|+|+.....++... ...+
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~-----~~~~ 75 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDP-----ENFI 75 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeC-----CCCE
Confidence 5799999999999988 57789999865432211 23577899999999999998877776533 3478
Q ss_pred EEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCccc
Q 046270 342 LVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQ 420 (590)
Q Consensus 342 LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~ 420 (590)
+||||+++++|.+++.. ..+ .+..++.+++.+|.++| ..+++|||++|.|||++ ++.++|+|||+++.
T Consensus 76 lv~e~~~G~~L~~~~~~------~~~-~~~~i~~~i~~~l~~lH---~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 76 IVMEYIEGEPLKDLINS------NGM-EELELSREIGRLVGKLH---SAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EEEEEeCCcCHHHHHHh------ccH-HHHHHHHHHHHHHHHHH---hCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999999988742 122 88899999999999999 89999999999999999 78999999999864
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.73 E-value=2e-17 Score=165.51 Aligned_cols=144 Identities=17% Similarity=0.145 Sum_probs=109.7
Q ss_pred cCCCccceecccCcEEEEEEE--EcCCcEEEEEEeecCCCC-------------------C-----hHHHHHHHHHHHhc
Q 046270 264 NGFSQNNLIGQGASGIVYKGT--LRHGNLVAVKQILDLDTK-------------------G-----DEDFTNEVEIISKI 317 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~--~~~g~~vAvK~l~~~~~~-------------------~-----~~~f~~Ev~il~~l 317 (590)
..|...+.||+|+||.||+|+ ..+|+.||+|++...... . ...+.+|++.+.++
T Consensus 28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L 107 (237)
T smart00090 28 ILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL 107 (237)
T ss_pred chHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 347778899999999999998 457999999998643210 0 12356899999999
Q ss_pred CCCCccccceeEEeccCCCCceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCC-eEecC
Q 046270 318 RHRNLLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPG-IYHRD 396 (590)
Q Consensus 318 ~H~nlv~l~g~~~~~~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~-ivHrD 396 (590)
.+.++ .....+.. ...++||||+++++|...+. ....+...+...++.||+.+|.||| ..+ |+|||
T Consensus 108 ~~~~i-~~p~~~~~------~~~~lV~E~~~g~~L~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH---~~g~iiH~D 174 (237)
T smart00090 108 YEAGV-PVPKPIAW------RRNVLVMEFIGGDGLPAPRL---KDVEPEEEEEFELYDDILEEMRKLY---KEGELVHGD 174 (237)
T ss_pred HhcCC-CCCeeeEe------cCceEEEEEecCCccccccc---ccCCcchHHHHHHHHHHHHHHHHHH---hcCCEEeCC
Confidence 76432 22222211 12489999999988876542 2234556667899999999999999 888 99999
Q ss_pred CCCCceEECCCCcEEEEeeCCcccc
Q 046270 397 IKSTNILLDSELNAKVADFGLAKQS 421 (590)
Q Consensus 397 IKp~NILLd~~~~~kL~DFGla~~~ 421 (590)
|||+||+++ +++++|+|||.+...
T Consensus 175 ikp~NIli~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 175 LSEYNILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred CChhhEEEE-CCCEEEEEChhhhcc
Confidence 999999999 889999999998743
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.72 E-value=2.2e-17 Score=184.48 Aligned_cols=141 Identities=23% Similarity=0.338 Sum_probs=111.4
Q ss_pred HHHHhcCCCccceecccCcEEEEEEEEcCCcEEEEEEe-ecCCCC-------ChHHHHHHHHHHHhcCCCCccccceeEE
Q 046270 259 LEQATNGFSQNNLIGQGASGIVYKGTLRHGNLVAVKQI-LDLDTK-------GDEDFTNEVEIISKIRHRNLLSLRGCCV 330 (590)
Q Consensus 259 l~~at~~f~~~~~LG~G~fG~Vykg~~~~g~~vAvK~l-~~~~~~-------~~~~f~~Ev~il~~l~H~nlv~l~g~~~ 330 (590)
.......|...++||+|+||.||+|.+.+.. +++|+. ...... ..+.+.+|++++.+++|++++....++.
T Consensus 328 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~ 406 (535)
T PRK09605 328 EEEVKRRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDV 406 (535)
T ss_pred ccccccccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEE
Confidence 3344455667889999999999999987544 444432 221111 1245889999999999999988777766
Q ss_pred eccCCCCceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcE
Q 046270 331 TSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNA 410 (590)
Q Consensus 331 ~~~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~ 410 (590)
.. ...++||||+++++|.+++. .+..++.+++++|.||| +.+++||||||+|||+ +++.+
T Consensus 407 ~~-----~~~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH---~~giiHrDlkp~NILl-~~~~~ 466 (535)
T PRK09605 407 DP-----EEKTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLH---KAGIVHGDLTTSNFIV-RDDRL 466 (535)
T ss_pred eC-----CCCEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHH---hCCCccCCCChHHEEE-ECCcE
Confidence 42 23689999999999988773 35679999999999999 8999999999999999 67799
Q ss_pred EEEeeCCccc
Q 046270 411 KVADFGLAKQ 420 (590)
Q Consensus 411 kL~DFGla~~ 420 (590)
+|+|||+++.
T Consensus 467 ~liDFGla~~ 476 (535)
T PRK09605 467 YLIDFGLGKY 476 (535)
T ss_pred EEEeCccccc
Confidence 9999999975
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.72 E-value=6.3e-17 Score=157.01 Aligned_cols=130 Identities=26% Similarity=0.434 Sum_probs=104.4
Q ss_pred eecccCcEEEEEEEEcCCcEEEEEEeecCCCCC--------hHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEEE
Q 046270 271 LIGQGASGIVYKGTLRHGNLVAVKQILDLDTKG--------DEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFL 342 (590)
Q Consensus 271 ~LG~G~fG~Vykg~~~~g~~vAvK~l~~~~~~~--------~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~L 342 (590)
+||+|+||.||+|.+. |..|++|+........ ...+.+|++++.+++|+++.....++... ...++
T Consensus 1 ~ig~G~~~~vy~~~~~-~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~-----~~~~l 74 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFL-GLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDP-----DNKTI 74 (199)
T ss_pred CCCCCceEEEEEeecC-CccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEC-----CCCEE
Confidence 4899999999999964 6789999865432111 24577899999999998876655555432 23689
Q ss_pred EEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCccc
Q 046270 343 VYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQ 420 (590)
Q Consensus 343 V~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~ 420 (590)
||||+++++|.+++... . . .++.+++++|.+|| ..+++|||++|.||+++ ++.+++.|||+++.
T Consensus 75 v~e~~~g~~l~~~~~~~---~-~------~~~~~i~~~l~~lH---~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 75 VMEYIEGKPLKDVIEEG---N-D------ELLREIGRLVGKLH---KAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred EEEEECCccHHHHHhhc---H-H------HHHHHHHHHHHHHH---HCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 99999999998877421 1 1 78999999999999 89999999999999999 78999999999864
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.69 E-value=4.2e-18 Score=180.30 Aligned_cols=174 Identities=21% Similarity=0.313 Sum_probs=130.4
Q ss_pred eEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCc
Q 046270 339 RRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLA 418 (590)
Q Consensus 339 ~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla 418 (590)
++++.|+++...+|.++|.........+|...+.++.|++.|+.| ++.+|+|+||.||+...+..+||+|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhhe
Confidence 588999999999999999755566678999999999999999999 68999999999999999999999999998
Q ss_pred ccccCCC-----cccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhhHHHHHHHhc
Q 046270 419 KQSLEGH-----SHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLDTSTSPFQLITDWAWVLAKS 492 (590)
Q Consensus 419 ~~~~~~~-----~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELlt-G~~p~~~~~~~~~~l~~~~~~~~~~ 492 (590)
....... ....+...||..||+||.+.+.+|+.|+|||++|++|+||++ =...++. .. .-.-.++
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er-------~~--t~~d~r~ 474 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFER-------IA--TLTDIRD 474 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHH-------HH--hhhhhhc
Confidence 7654443 223456789999999999999999999999999999999997 1111110 00 0011223
Q ss_pred CCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHH
Q 046270 493 GKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDA 536 (590)
Q Consensus 493 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eV 536 (590)
|.+. +.....++. =..+..+++++.|.+||+..++
T Consensus 475 g~ip----~~~~~d~p~-----e~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 475 GIIP----PEFLQDYPE-----EYTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred CCCC----hHHhhcCcH-----HHHHHHHhcCCCcccCchHHHH
Confidence 3322 111111222 1346678999999999954443
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.67 E-value=1.3e-17 Score=179.68 Aligned_cols=185 Identities=29% Similarity=0.401 Sum_probs=151.4
Q ss_pred ecccCcEEEEEEE----EcCCcEEEEEEeecCCCCC--hHHHHHHHHHHHhcC-CCCccccceeEEeccCCCCceEEEEE
Q 046270 272 IGQGASGIVYKGT----LRHGNLVAVKQILDLDTKG--DEDFTNEVEIISKIR-HRNLLSLRGCCVTSDDSSGKRRFLVY 344 (590)
Q Consensus 272 LG~G~fG~Vykg~----~~~g~~vAvK~l~~~~~~~--~~~f~~Ev~il~~l~-H~nlv~l~g~~~~~~~~~~~~~~LV~ 344 (590)
+|+|.||.|+... .+.|..+|.|.+++..... ......|..++..++ |+.+|++.-.+.. ....+++.
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt-----~~kl~l~l 76 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQT-----DGKLYLIL 76 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeecc-----ccchhHhh
Confidence 7899999998653 2346778888775432221 124567888999997 9999999877763 34589999
Q ss_pred eeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccccCC
Q 046270 345 DYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEG 424 (590)
Q Consensus 345 E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~~~~ 424 (590)
+|..+|.|...+. +...++..........++-+++++| +.+|+|||+|++||+++.+|.+|+.|||+++...+.
T Consensus 77 d~~rgg~lft~l~---~~~~f~~~~~~~~~aelaLald~lh---~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~ 150 (612)
T KOG0603|consen 77 DFLRGGDLFTRLS---KEVMFDELDVAFYLAELALALDHLH---KLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKE 150 (612)
T ss_pred hhcccchhhhccc---cCCchHHHHHHHHHHHHHHHHhhcc---hhHHHHhcccccceeecccCccccCCchhhhHhHhh
Confidence 9999999988774 4456777777888899999999999 999999999999999999999999999999976544
Q ss_pred CcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 046270 425 HSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDT 474 (590)
Q Consensus 425 ~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~ 474 (590)
... .||..|||||++. ......|-||||++++||+||--||..
T Consensus 151 ~~~-----cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 151 KIA-----CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred hhc-----ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 322 7899999999987 567789999999999999999999865
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.66 E-value=5.6e-16 Score=148.74 Aligned_cols=136 Identities=19% Similarity=0.213 Sum_probs=97.7
Q ss_pred cceecccCcEEEEEEEEcCCcEEEEEEeecCCCCC--hHH----------------------HHHHHHHHHhcCCCC--c
Q 046270 269 NNLIGQGASGIVYKGTLRHGNLVAVKQILDLDTKG--DED----------------------FTNEVEIISKIRHRN--L 322 (590)
Q Consensus 269 ~~~LG~G~fG~Vykg~~~~g~~vAvK~l~~~~~~~--~~~----------------------f~~Ev~il~~l~H~n--l 322 (590)
.+.||+|+||.||+|.+.+|+.||||++....... ... ...|.+.+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 36799999999999998889999999886532211 111 134566666664443 2
Q ss_pred cccceeEEeccCCCCceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCC-CCeEecCCCCCc
Q 046270 323 LSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLK-PGIYHRDIKSTN 401 (590)
Q Consensus 323 v~l~g~~~~~~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~-~~ivHrDIKp~N 401 (590)
.+.+++ ...++||||++++.+....... .... .+...++.+++.++.++| . .+|+||||||+|
T Consensus 82 ~~~~~~---------~~~~lv~e~~~g~~~~~~~l~~---~~~~-~~~~~~~~~~~~~l~~lh---~~~~ivH~Dl~p~N 145 (187)
T cd05119 82 PKPIDL---------NRHVLVMEFIGGDGIPAPRLKD---VRLL-EDPEELYDQILELMRKLY---REAGLVHGDLSEYN 145 (187)
T ss_pred CceEec---------CCCEEEEEEeCCCCccChhhhh---hhhc-ccHHHHHHHHHHHHHHHh---hccCcCcCCCChhh
Confidence 233322 1258999999996553221110 0011 667889999999999999 7 899999999999
Q ss_pred eEECCCCcEEEEeeCCcccc
Q 046270 402 ILLDSELNAKVADFGLAKQS 421 (590)
Q Consensus 402 ILLd~~~~~kL~DFGla~~~ 421 (590)
|+++ ++.++|+|||.+...
T Consensus 146 ili~-~~~~~liDfg~a~~~ 164 (187)
T cd05119 146 ILVD-DGKVYIIDVPQAVEI 164 (187)
T ss_pred EEEE-CCcEEEEECcccccc
Confidence 9999 889999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.65 E-value=1.9e-15 Score=137.77 Aligned_cols=135 Identities=19% Similarity=0.201 Sum_probs=111.5
Q ss_pred ccceecccCcEEEEEEEEcCCcEEEEEEeecCCCCChHHHHHHHHHHHhcCC--CCccccceeEEeccCCCCceEEEEEe
Q 046270 268 QNNLIGQGASGIVYKGTLRHGNLVAVKQILDLDTKGDEDFTNEVEIISKIRH--RNLLSLRGCCVTSDDSSGKRRFLVYD 345 (590)
Q Consensus 268 ~~~~LG~G~fG~Vykg~~~~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H--~nlv~l~g~~~~~~~~~~~~~~LV~E 345 (590)
..+.||+|.++.||++...+ ..+++|....... ...+.+|+.++..++| .++.+++++... +...+++||
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~-----~~~~~~v~e 73 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGES-----DGWSYLLME 73 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCC-----CCccEEEEE
Confidence 35689999999999999875 7899998755432 4679999999999977 478887776653 245899999
Q ss_pred eCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCccc
Q 046270 346 YMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQ 420 (590)
Q Consensus 346 ~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~ 420 (590)
|++++.+..+ ++.....++.+++++|++||.....+++|+|++|+||+++..+.+++.|||.++.
T Consensus 74 ~~~g~~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 74 WIEGETLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecCCeecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 9998777543 5667788999999999999954446899999999999999989999999999864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.62 E-value=1.6e-15 Score=155.08 Aligned_cols=200 Identities=22% Similarity=0.274 Sum_probs=135.5
Q ss_pred CCCCccccceeEEeccC----------------------CCCceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHH
Q 046270 318 RHRNLLSLRGCCVTSDD----------------------SSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIV 375 (590)
Q Consensus 318 ~H~nlv~l~g~~~~~~~----------------------~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~ 375 (590)
+|||||++.+++.++-. .++..+||||.-.+ .+|.+++.. ...+...+.-|+.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~----~~~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWT----RHRSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhc----CCCchHHHHHHHH
Confidence 59999999998765421 24567899998775 488888852 3456667777999
Q ss_pred HHHHHHHHHHhcCCCCeEecCCCCCceEE--CCCC--cEEEEeeCCcccccCCC-----cccccccccCCCccCcccccc
Q 046270 376 DVAKGIAYLHYGLKPGIYHRDIKSTNILL--DSEL--NAKVADFGLAKQSLEGH-----SHLTTRVAGTFGYLAPEYALY 446 (590)
Q Consensus 376 ~ia~gL~yLH~~~~~~ivHrDIKp~NILL--d~~~--~~kL~DFGla~~~~~~~-----~~~~~~~~gt~~Y~APE~~~~ 446 (590)
|+++|+.||| +++|.|||+|+.|||| |++. ...|+|||.+--..... ....-...|...-||||+...
T Consensus 349 QlLEav~hL~---~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta 425 (598)
T KOG4158|consen 349 QLLEAVTHLH---KHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA 425 (598)
T ss_pred HHHHHHHHHH---HccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence 9999999999 9999999999999998 4444 46789999875322110 011122346778899998763
Q ss_pred --CCC----CcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhhhHHHhhhhHHHHHHHHHHHHH
Q 046270 447 --GQL----TEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDEFIRAEGARAVMERFVLVGI 520 (590)
Q Consensus 447 --~~~----t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~ 520 (590)
|+. -.|+|.|+.|.+.||+++...||....+ ..+..- . ..+..+. .+ ++.+...+.+++.
T Consensus 426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGe--m~L~~r--~-Yqe~qLP-----al----p~~vpp~~rqlV~ 491 (598)
T KOG4158|consen 426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGE--MLLDTR--T-YQESQLP-----AL----PSRVPPVARQLVF 491 (598)
T ss_pred CCCCceeeccchhhhhhhhhhHHHHhccCCcccccch--heechh--h-hhhhhCC-----CC----cccCChHHHHHHH
Confidence 222 3599999999999999999999975222 111100 0 1111111 11 1122234566778
Q ss_pred hchhcCCCCCCCHHHHHHH
Q 046270 521 LCAHVMVALRPTITDALKM 539 (590)
Q Consensus 521 ~Cl~~dp~~RPtm~eVl~~ 539 (590)
..++.||.+||+..-....
T Consensus 492 ~lL~r~pskRvsp~iAANv 510 (598)
T KOG4158|consen 492 DLLKRDPSKRVSPNIAANV 510 (598)
T ss_pred HHhcCCccccCCccHHHhH
Confidence 8899999999986544443
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.60 E-value=9.6e-15 Score=146.45 Aligned_cols=152 Identities=17% Similarity=0.182 Sum_probs=111.8
Q ss_pred CCccccHHHHHHHhcCCCccceec-ccCcEEEEEEEEcCCcEEEEEEeecCC-------------CCChHHHHHHHHHHH
Q 046270 250 GAKWFHVSELEQATNGFSQNNLIG-QGASGIVYKGTLRHGNLVAVKQILDLD-------------TKGDEDFTNEVEIIS 315 (590)
Q Consensus 250 ~~~~f~~~el~~at~~f~~~~~LG-~G~fG~Vykg~~~~g~~vAvK~l~~~~-------------~~~~~~f~~Ev~il~ 315 (590)
...+|+.+.... ....|| .||.|+||+.... +..++||++.... ......+.+|++++.
T Consensus 23 ~~~~~~~~~~~~------~~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~ 95 (239)
T PRK01723 23 DPALFDPDFWQQ------QARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLA 95 (239)
T ss_pred chhhcCHHHHhh------cCceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHH
Confidence 344666544432 235788 8999999999886 6778999874311 112345788999999
Q ss_pred hcCCCCc--cccceeEEeccCCCCceEEEEEeeCCC-CCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCe
Q 046270 316 KIRHRNL--LSLRGCCVTSDDSSGKRRFLVYDYMPN-GTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGI 392 (590)
Q Consensus 316 ~l~H~nl--v~l~g~~~~~~~~~~~~~~LV~E~~~~-gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~i 392 (590)
+|+|+++ +..+++...... .....++|+|++++ .+|.+++.. ..++.. .+.+|+.+|.+|| +.+|
T Consensus 96 ~L~~~gi~vP~pl~~~~~~~~-~~~~~~lV~e~l~G~~~L~~~l~~----~~l~~~----~~~~i~~~l~~lH---~~GI 163 (239)
T PRK01723 96 QLYEAGLPVPRPIAARVVRHG-LFYRADILIERIEGARDLVALLQE----APLSEE----QWQAIGQLIARFH---DAGV 163 (239)
T ss_pred HHHhCCCCCceeEeeeeeecC-cceeeeEEEEecCCCCCHHHHHhc----CCCCHH----HHHHHHHHHHHHH---HCCC
Confidence 9998885 566666543221 11234699999997 688887742 234433 3678999999999 9999
Q ss_pred EecCCCCCceEECCCCcEEEEeeCCccc
Q 046270 393 YHRDIKSTNILLDSELNAKVADFGLAKQ 420 (590)
Q Consensus 393 vHrDIKp~NILLd~~~~~kL~DFGla~~ 420 (590)
+||||||.|||++.++.++|+|||.++.
T Consensus 164 ~HrDlkp~NILv~~~~~v~LIDfg~~~~ 191 (239)
T PRK01723 164 YHADLNAHNILLDPDGKFWLIDFDRGEL 191 (239)
T ss_pred CCCCCCchhEEEcCCCCEEEEECCCccc
Confidence 9999999999999988999999998874
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.56 E-value=2.6e-15 Score=169.26 Aligned_cols=164 Identities=30% Similarity=0.464 Sum_probs=119.4
Q ss_pred cCCCccceecccCcEEEEEEEEcC-CcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEEE
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLRH-GNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFL 342 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~L 342 (590)
.+|..+++|..|.||.||..+++. .+.+|.|. .+.. .+. +||..+-| ..++
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~-----lil-----------Rnilt~a~-----------npfv 134 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQN-----LIL-----------RNILTFAG-----------NPFV 134 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhcc-cccc-----hhh-----------hccccccC-----------Ccce
Confidence 578899999999999999999885 45677743 2210 111 12222211 1233
Q ss_pred EEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCccccc
Q 046270 343 VYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSL 422 (590)
Q Consensus 343 V~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~~ 422 (590)
| |+-...+. .-+.++.. ++.+++||| ..+|+|||+||.|.+|..-|.+|+.|||+.+...
T Consensus 135 v------gDc~tllk---~~g~lPvd--------mvla~Eylh---~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GL 194 (1205)
T KOG0606|consen 135 V------GDCATLLK---NIGPLPVD--------MVLAVEYLH---SYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGL 194 (1205)
T ss_pred e------chhhhhcc---cCCCCcch--------hhHHhHhhc---cCCeecCCCCCCcceeeecccccccchhhhhhhh
Confidence 3 33333332 22234322 278899999 9999999999999999999999999999998643
Q ss_pred CCC------------c--ccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 046270 423 EGH------------S--HLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTS 475 (590)
Q Consensus 423 ~~~------------~--~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~ 475 (590)
... . .....+.||+.|.|||++....|....|.|++|+++||.+-|+.||...
T Consensus 195 ms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGd 261 (1205)
T KOG0606|consen 195 MSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGD 261 (1205)
T ss_pred hhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCC
Confidence 211 1 1123468999999999999999999999999999999999999999764
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.49 E-value=1.7e-13 Score=149.12 Aligned_cols=146 Identities=21% Similarity=0.259 Sum_probs=103.2
Q ss_pred CCCccceecccCcEEEEEEEEcCCcEEEEEEeecCCCCCh----------------------------------------
Q 046270 265 GFSQNNLIGQGASGIVYKGTLRHGNLVAVKQILDLDTKGD---------------------------------------- 304 (590)
Q Consensus 265 ~f~~~~~LG~G~fG~Vykg~~~~g~~vAvK~l~~~~~~~~---------------------------------------- 304 (590)
.|+ .+.||.|++|.||+|++++|+.||||+.+.......
T Consensus 119 ~fd-~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~E 197 (437)
T TIGR01982 119 EFE-EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRE 197 (437)
T ss_pred hCC-CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHH
Confidence 344 368999999999999999999999999854321100
Q ss_pred HHHHHHHHHHHhcC----CCCccccceeEEeccCCCCceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHH-
Q 046270 305 EDFTNEVEIISKIR----HRNLLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAK- 379 (590)
Q Consensus 305 ~~f~~Ev~il~~l~----H~nlv~l~g~~~~~~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~- 379 (590)
-+|.+|.+.+.+++ |.+-+.+-..+.+. ....+|||||+++++|.+...... ... .+.+++..+++
T Consensus 198 ldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~----~~~~vLvmE~i~G~~L~~~~~~~~--~~~---~~~~ia~~~~~~ 268 (437)
T TIGR01982 198 LDLRREAANASELGENFKNDPGVYVPEVYWDR----TSERVLTMEWIDGIPLSDIAALDE--AGL---DRKALAENLARS 268 (437)
T ss_pred HCHHHHHHHHHHHHHhcCCCCCEEeCCEehhh----cCCceEEEEeECCcccccHHHHHh--cCC---CHHHHHHHHHHH
Confidence 02445555555552 33334444444322 224799999999999998764211 112 35567777776
Q ss_pred HHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccccC
Q 046270 380 GIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLE 423 (590)
Q Consensus 380 gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~~~ 423 (590)
.+..+| ..+++|+|+||.||++++++++++.|||++....+
T Consensus 269 ~l~ql~---~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 269 FLNQVL---RDGFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred HHHHHH---hCCceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 467888 89999999999999999999999999999976543
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.39 E-value=3e-14 Score=159.91 Aligned_cols=254 Identities=23% Similarity=0.268 Sum_probs=180.2
Q ss_pred CCCccceecccCcEEEEEEEEcC--CcEEEEEEeecCC--CCChHHHHHHHHHHHhcC-CCCccccceeEEeccCCCCce
Q 046270 265 GFSQNNLIGQGASGIVYKGTLRH--GNLVAVKQILDLD--TKGDEDFTNEVEIISKIR-HRNLLSLRGCCVTSDDSSGKR 339 (590)
Q Consensus 265 ~f~~~~~LG~G~fG~Vykg~~~~--g~~vAvK~l~~~~--~~~~~~f~~Ev~il~~l~-H~nlv~l~g~~~~~~~~~~~~ 339 (590)
.|...+.||+|.|+.|-...... ...+|+|.+.... ....+....|..+-..+. |+|++++++... ....
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~-----~~~~ 95 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSS-----SPRS 95 (601)
T ss_pred cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccC-----CCcc
Confidence 45566679999999998887644 3356666654432 222334456777777786 999999999876 3455
Q ss_pred EEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCC-cEEEEeeCCc
Q 046270 340 RFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSEL-NAKVADFGLA 418 (590)
Q Consensus 340 ~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~-~~kL~DFGla 418 (590)
.+++.||..++++.+.+.. ......+....-..+.|+..++.|+|. ..++.|+||||+|.+++..+ ..|++|||+|
T Consensus 96 ~~~~~~~s~g~~~f~~i~~-~~~~~~~~~~~~~~~~ql~s~l~~~H~--~~~~~h~~ikP~n~~l~~s~~~l~~~df~~A 172 (601)
T KOG0590|consen 96 YLLSLSYSDGGSLFSKISH-PDSTGTSSSSASRYLPQLNSGLSYLHP--ENGVTHRDIKPSNSLLDESGSALKIADFGLA 172 (601)
T ss_pred cccccCccccccccccccc-CCccCCCCcchhhhhhhhccCccccCc--ccccccCCCCCccchhccCCCcccCCCchhh
Confidence 8999999999999887731 112245666777889999999999995 57899999999999999999 9999999999
Q ss_pred ccccC--CCccccccccc-CCCccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCC
Q 046270 419 KQSLE--GHSHLTTRVAG-TFGYLAPEYALYG-QLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGK 494 (590)
Q Consensus 419 ~~~~~--~~~~~~~~~~g-t~~Y~APE~~~~~-~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~ 494 (590)
..... +.........| ++.|+|||...+. ...+..|+||.|+++.-+++|..|++...........|.... +.
T Consensus 173 t~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~---~~ 249 (601)
T KOG0590|consen 173 TAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNK---GR 249 (601)
T ss_pred ccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccc---cc
Confidence 87655 33333445567 9999999988874 556789999999999999999999876544332222222110 01
Q ss_pred chhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHH
Q 046270 495 VDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDAL 537 (590)
Q Consensus 495 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl 537 (590)
.....- .........+...++..+|..|.+.+++.
T Consensus 250 ~~~~~~--------~~~~~~~~~~l~k~l~~~~~~r~s~~~~~ 284 (601)
T KOG0590|consen 250 FTQLPW--------NSISDQAHDLLHKILKENPSNRLSIEELK 284 (601)
T ss_pred cccCcc--------ccCChhhhhcccccccCCchhcccccccc
Confidence 001111 11122444555667778999999888764
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.34 E-value=1.6e-12 Score=130.60 Aligned_cols=207 Identities=19% Similarity=0.219 Sum_probs=142.2
Q ss_pred HHHhcCCCCccccceeEEeccCCCCceEEEEEeeCCCCCcchhhhhhcc-cccCChhhHHHHHHHHHHHHHHHHhcCCCC
Q 046270 313 IISKIRHRNLLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHK-RKQLTWPQRKKIIVDVAKGIAYLHYGLKPG 391 (590)
Q Consensus 313 il~~l~H~nlv~l~g~~~~~~~~~~~~~~LV~E~~~~gsL~~~L~~~~~-~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ 391 (590)
-|-.+-|-|||+++.|+.+....+..+..++.|||+.|+|..+|....+ ...+....-.++.-||..||.|||.. .+.
T Consensus 120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~Pp 198 (458)
T KOG1266|consen 120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-DPP 198 (458)
T ss_pred HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-CCc
Confidence 3455679999999999877655466778999999999999999976543 34577777889999999999999954 799
Q ss_pred eEecCCCCCceEECCCCcEEEEeeCCcccc---cCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhC
Q 046270 392 IYHRDIKSTNILLDSELNAKVADFGLAKQS---LEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSG 468 (590)
Q Consensus 392 ivHrDIKp~NILLd~~~~~kL~DFGla~~~---~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG 468 (590)
|+|+++..+-|++..++-+||+--.-.... ............+-++|.+||+=...+.+..+|||+||+..+||.-|
T Consensus 199 iihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemail 278 (458)
T KOG1266|consen 199 IIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAIL 278 (458)
T ss_pred cccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHh
Confidence 999999999999999998888521110000 00011112234567899999988777888899999999999999987
Q ss_pred CCCCCCCCCchhhhhHHHHHHHhcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 046270 469 RKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALK 538 (590)
Q Consensus 469 ~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~ 538 (590)
..-.....+... . .+.+...+..... .+-...+..|++..|+.||+|++++.
T Consensus 279 Eiq~tnseS~~~--~------------ee~ia~~i~~len----~lqr~~i~kcl~~eP~~rp~ar~llf 330 (458)
T KOG1266|consen 279 EIQSTNSESKVE--V------------EENIANVIIGLEN----GLQRGSITKCLEGEPNGRPDARLLLF 330 (458)
T ss_pred eeccCCCcceee--h------------hhhhhhheeeccC----ccccCcCcccccCCCCCCcchhhhhc
Confidence 642211111110 0 0000000000000 01122445799999999999998754
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.33 E-value=7.9e-12 Score=117.64 Aligned_cols=127 Identities=16% Similarity=0.093 Sum_probs=95.0
Q ss_pred ceecccCcEEEEEEEEcCCcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEEEEEeeCCC
Q 046270 270 NLIGQGASGIVYKGTLRHGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFLVYDYMPN 349 (590)
Q Consensus 270 ~~LG~G~fG~Vykg~~~~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~LV~E~~~~ 349 (590)
+.|+.|.++.||++... |..+++|....... ....+.+|++++..+.+.++++-+-.+. . ...++||||+++
T Consensus 4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~-~-----~~~~lv~e~i~G 75 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD-P-----ETGVLITEFIEG 75 (170)
T ss_pred eecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe-C-----CCCeEEEEecCC
Confidence 56889999999999876 77899998654321 2345789999999997766654332221 1 124799999999
Q ss_pred CCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCC-----eEecCCCCCceEECCCCcEEEEeeCCcc
Q 046270 350 GTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPG-----IYHRDIKSTNILLDSELNAKVADFGLAK 419 (590)
Q Consensus 350 gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~-----ivHrDIKp~NILLd~~~~~kL~DFGla~ 419 (590)
.++.+.. .....++.+++++|+.|| ..+ ++|+|++|+||+++ ++.++++|||.+.
T Consensus 76 ~~l~~~~-----------~~~~~~~~~l~~~l~~LH---~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 76 SELLTED-----------FSDPENLEKIAKLLKKLH---SSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred Ccccccc-----------ccCHHHHHHHHHHHHHHh---CCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 8876420 112346789999999999 555 59999999999999 6689999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.27 E-value=1.5e-11 Score=135.79 Aligned_cols=149 Identities=17% Similarity=0.204 Sum_probs=94.6
Q ss_pred hcCCCccceecccCcEEEEEEEEcC-CcEEEEEEeecCCCCC----------------------------------hH--
Q 046270 263 TNGFSQNNLIGQGASGIVYKGTLRH-GNLVAVKQILDLDTKG----------------------------------DE-- 305 (590)
Q Consensus 263 t~~f~~~~~LG~G~fG~Vykg~~~~-g~~vAvK~l~~~~~~~----------------------------------~~-- 305 (590)
-..|+. +.||.|++|.||+|++++ |+.||||++++...+. .+
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 345776 789999999999999988 9999999986432100 01
Q ss_pred ----HHHHHHHHHHhcC----CCCccccceeEEeccCCCCceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHH
Q 046270 306 ----DFTNEVEIISKIR----HRNLLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDV 377 (590)
Q Consensus 306 ----~f~~Ev~il~~l~----H~nlv~l~g~~~~~~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~i 377 (590)
+|.+|+.-+.+++ +.+.+.+-..+.+- ....+|||||++|+.+.++-... ....+ +..++...
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~----st~~VLvmE~i~G~~l~d~~~l~--~~g~d---~~~la~~~ 268 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDY----CSETVMVMERMYGIPVSDVAALR--AAGTD---MKLLAERG 268 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeeccc----CCCceEEEeeecCccHHhHHHHH--hcCCC---HHHHHHHH
Confidence 1334444444442 33444433333321 23478999999999998743211 11122 22233222
Q ss_pred HHHHHHHHhcCCCCeEecCCCCCceEECCCC----cEEEEeeCCcccccC
Q 046270 378 AKGIAYLHYGLKPGIYHRDIKSTNILLDSEL----NAKVADFGLAKQSLE 423 (590)
Q Consensus 378 a~gL~yLH~~~~~~ivHrDIKp~NILLd~~~----~~kL~DFGla~~~~~ 423 (590)
++. |++.-...+++|+|+||.||+++.++ ++++.|||++....+
T Consensus 269 v~~--~~~Qif~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 269 VEV--FFTQVFRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HHH--HHHHHHhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 222 22222267999999999999999888 999999999986644
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.22 E-value=1.1e-11 Score=133.99 Aligned_cols=246 Identities=22% Similarity=0.227 Sum_probs=170.7
Q ss_pred CCCccceecc--cCcEEEEEEEE--c-CCcEEEEEEeecCCC--CChHHHHHHHHHHHhc-CCCCccccceeEEeccCCC
Q 046270 265 GFSQNNLIGQ--GASGIVYKGTL--R-HGNLVAVKQILDLDT--KGDEDFTNEVEIISKI-RHRNLLSLRGCCVTSDDSS 336 (590)
Q Consensus 265 ~f~~~~~LG~--G~fG~Vykg~~--~-~g~~vAvK~l~~~~~--~~~~~f~~Ev~il~~l-~H~nlv~l~g~~~~~~~~~ 336 (590)
.|.....+|. |.+|.||++.. . ++..+|+|+-+..-. .....=.+|+...+++ .|+|.++....+. .
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e-----~ 189 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWE-----G 189 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccc-----c
Confidence 3556678999 99999999987 3 477899997432211 2222334677777777 5999999665554 4
Q ss_pred CceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHH----HHHHHHhcCCCCeEecCCCCCceEECCC-CcEE
Q 046270 337 GKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAK----GIAYLHYGLKPGIYHRDIKSTNILLDSE-LNAK 411 (590)
Q Consensus 337 ~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~----gL~yLH~~~~~~ivHrDIKp~NILLd~~-~~~k 411 (590)
+...++-.|++. .+|..+.+. ...-++....+.+..+... ||.++| ...++|-|+||.||++..+ ...+
T Consensus 190 ~~~lfiqtE~~~-~sl~~~~~~--~~~~~p~~~l~~~~~~~~~~~~~al~~~h---s~~~~~~~~kp~~i~~~~~~~s~~ 263 (524)
T KOG0601|consen 190 SGILFIQTELCG-ESLQSYCHT--PCNFLPDNLLWNSLRDWLSRDVTALSHLH---SNNIVHDDLKPANIFTTSDWTSCK 263 (524)
T ss_pred CCcceeeecccc-chhHHhhhc--ccccCCchhhhhHHhhhhhcccccccccC---CCcccccccchhheecccccceee
Confidence 556788888874 677777642 2233666777777777777 999999 9999999999999999999 8899
Q ss_pred EEeeCCcccccCCCcc----cccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHH
Q 046270 412 VADFGLAKQSLEGHSH----LTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAW 487 (590)
Q Consensus 412 L~DFGla~~~~~~~~~----~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~ 487 (590)
++|||+...+..+.-. ...+..|...|++||.. .+.++..+|+|++|.+.+|-.+|.+....... ..|.
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~-----~~W~- 336 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGKN-----SSWS- 336 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCCC-----CCcc-
Confidence 9999999877655422 12233577889999954 57889999999999999999998876543211 1121
Q ss_pred HHHhcCC-chhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 046270 488 VLAKSGK-VDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALK 538 (590)
Q Consensus 488 ~~~~~~~-~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~ 538 (590)
..+.+- ..|..+.. ..++..+...+++.+|-.|++...+..
T Consensus 337 -~~r~~~ip~e~~~~~---------s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 337 -QLRQGYIPLEFCEGG---------SSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred -ccccccCchhhhcCc---------chhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 111111 11111111 112333677889999999998887654
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.17 E-value=5.3e-10 Score=109.59 Aligned_cols=145 Identities=20% Similarity=0.288 Sum_probs=110.6
Q ss_pred ceecccCcEEEEEEEEcCCcEEEEEEeecCCC-CChHHHHHHHHHHHhcCCCC--ccccceeEEeccCCCCceEEEEEee
Q 046270 270 NLIGQGASGIVYKGTLRHGNLVAVKQILDLDT-KGDEDFTNEVEIISKIRHRN--LLSLRGCCVTSDDSSGKRRFLVYDY 346 (590)
Q Consensus 270 ~~LG~G~fG~Vykg~~~~g~~vAvK~l~~~~~-~~~~~f~~Ev~il~~l~H~n--lv~l~g~~~~~~~~~~~~~~LV~E~ 346 (590)
+.|+.|..+.||++...+|..+++|....... .....+.+|++++..+++.+ +.+++.+..... ..+..++||||
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~--~~~~~~~v~e~ 81 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPS--VLGTPFYVMER 81 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCC--ccCCceEEEEE
Confidence 56899999999999988778899998754322 13557899999999997644 456666654221 11246899999
Q ss_pred CCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhc---------------------------------------
Q 046270 347 MPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYG--------------------------------------- 387 (590)
Q Consensus 347 ~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~--------------------------------------- 387 (590)
+++.++.+.+. ...++..++..++.+++++|.+||..
T Consensus 82 i~G~~l~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (223)
T cd05154 82 VDGRVLRDRLL----RPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAM 157 (223)
T ss_pred eCCEecCCCCC----CCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHH
Confidence 99998887652 13578888889999999999999842
Q ss_pred --------------CCCCeEecCCCCCceEECC--CCcEEEEeeCCccc
Q 046270 388 --------------LKPGIYHRDIKSTNILLDS--ELNAKVADFGLAKQ 420 (590)
Q Consensus 388 --------------~~~~ivHrDIKp~NILLd~--~~~~kL~DFGla~~ 420 (590)
....++|+|+++.||++++ +..+.|+||+.+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 158 ERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 1356799999999999998 56689999998764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.09 E-value=8.4e-10 Score=106.85 Aligned_cols=135 Identities=13% Similarity=0.150 Sum_probs=96.3
Q ss_pred ceecccCcEEEEEEEEcC-------CcEEEEEEeecCC------------C---------CC-hHHHH----HHHHHHHh
Q 046270 270 NLIGQGASGIVYKGTLRH-------GNLVAVKQILDLD------------T---------KG-DEDFT----NEVEIISK 316 (590)
Q Consensus 270 ~~LG~G~fG~Vykg~~~~-------g~~vAvK~l~~~~------------~---------~~-~~~f~----~Ev~il~~ 316 (590)
..||.|.=+.||.|.-.+ +..+|||..+-.. . .+ .+.+. +|.+.|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999998653 4789999863210 0 01 12233 89999999
Q ss_pred cCCC--CccccceeEEeccCCCCceEEEEEeeCCCCCcch-hhhhhcccccCChhhHHHHHHHHHHHHHHH-HhcCCCCe
Q 046270 317 IRHR--NLLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSD-NISISHKRKQLTWPQRKKIIVDVAKGIAYL-HYGLKPGI 392 (590)
Q Consensus 317 l~H~--nlv~l~g~~~~~~~~~~~~~~LV~E~~~~gsL~~-~L~~~~~~~~l~~~~r~~I~~~ia~gL~yL-H~~~~~~i 392 (590)
++.. ++..++++. ..+|||||+.++.+.. .+ +...++.++...+..+++.+|.+| | +.+|
T Consensus 83 l~~~Gv~vP~pi~~~---------~~~lvME~Ig~~~~~~~~L----kd~~~~~~~~~~i~~~i~~~l~~l~H---~~gl 146 (197)
T cd05146 83 MQKAGIPCPEVVVLK---------KHVLVMSFIGDDQVPAPKL----KDAKLNDEEMKNAYYQVLSMMKQLYK---ECNL 146 (197)
T ss_pred HHHcCCCCCeEEEec---------CCEEEEEEcCCCCccchhh----hccccCHHHHHHHHHHHHHHHHHHHH---hCCe
Confidence 9643 444555431 2589999998754432 22 122344556677889999999998 7 8899
Q ss_pred EecCCCCCceEECCCCcEEEEeeCCcccc
Q 046270 393 YHRDIKSTNILLDSELNAKVADFGLAKQS 421 (590)
Q Consensus 393 vHrDIKp~NILLd~~~~~kL~DFGla~~~ 421 (590)
+||||++.|||+++ +.+.|+|||.+-..
T Consensus 147 VHGDLs~~NIL~~~-~~v~iIDF~qav~~ 174 (197)
T cd05146 147 VHADLSEYNMLWHD-GKVWFIDVSQSVEP 174 (197)
T ss_pred ecCCCCHHHEEEEC-CcEEEEECCCceeC
Confidence 99999999999974 68999999988644
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.03 E-value=2.3e-09 Score=117.51 Aligned_cols=165 Identities=16% Similarity=0.176 Sum_probs=121.2
Q ss_pred cCCcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEEEEEeeCCCCCcchhhhhhcccccC
Q 046270 286 RHGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQL 365 (590)
Q Consensus 286 ~~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l 365 (590)
.++.+|.|...+...........+-++.|+.+|||||++++..+.. ....|||.|-+. .|..++. .+
T Consensus 35 ~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~-----~~~~ylvTErV~--Pl~~~lk------~l 101 (690)
T KOG1243|consen 35 ADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEE-----EGTLYLVTERVR--PLETVLK------EL 101 (690)
T ss_pred ccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcc-----cCceEEEeeccc--cHHHHHH------Hh
Confidence 4588888888766555334557788999999999999999988774 346899999875 4666663 23
Q ss_pred ChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccccCCCcccccccccCCCccCccccc
Q 046270 366 TWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYAL 445 (590)
Q Consensus 366 ~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~ 445 (590)
......-.+.||+.||.|||+ +.+++|++|.-..|++++.|+.||++|.++........ ......--..|..|+.+.
T Consensus 102 ~~~~v~~Gl~qIl~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~ 178 (690)
T KOG1243|consen 102 GKEEVCLGLFQILAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEID 178 (690)
T ss_pred HHHHHHHHHHHHHHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcC
Confidence 355566678999999999985 57999999999999999999999999988764322111 000011112466666443
Q ss_pred cCCCCcchhHHHHHHHHHHHHhC
Q 046270 446 YGQLTEKSDVYSFGIVILELMSG 468 (590)
Q Consensus 446 ~~~~t~ksDVySfGvvLlELltG 468 (590)
... -..|.|-||++++|++.|
T Consensus 179 ~s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 179 PSE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred ccc--cchhhhhHHHHHHHHhCc
Confidence 222 346999999999999999
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.00 E-value=1.5e-08 Score=108.04 Aligned_cols=172 Identities=21% Similarity=0.293 Sum_probs=131.0
Q ss_pred EEEEEEEEc-CCcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEEEEEeeCCC-CCcchh
Q 046270 278 GIVYKGTLR-HGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFLVYDYMPN-GTLSDN 355 (590)
Q Consensus 278 G~Vykg~~~-~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~LV~E~~~~-gsL~~~ 355 (590)
.+.||+... ||..+++|++.....+.......-++.++++.|.|+|++...+..... ...-++|||+|.|+ ++|.+.
T Consensus 290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF-~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTF-GDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred ceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhcc-CcceEEEEEecCCCCchHHHH
Confidence 588999865 799999999944333333334567899999999999999998874322 34568999999986 667665
Q ss_pred hhhhc------------ccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccccC
Q 046270 356 ISISH------------KRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLE 423 (590)
Q Consensus 356 L~~~~------------~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~~~ 423 (590)
.+... .....++..++.++.|+..||.++| +.|+.-+-|.+++||++++.+++|+..|......+
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIH---ssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIH---SSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHH---hcCceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 54321 2235788899999999999999999 88999999999999999999999998887665544
Q ss_pred CCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCC
Q 046270 424 GHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKV 471 (590)
Q Consensus 424 ~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p 471 (590)
+.. |-+.. -.+-|.=-||.+++.|.||...
T Consensus 446 d~~---------------~~le~---~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 446 DPT---------------EPLES---QQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CCC---------------cchhH---HhhhhHHHHHHHHHHHhhcccc
Confidence 321 11111 2356899999999999999654
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.00 E-value=2.7e-10 Score=123.51 Aligned_cols=257 Identities=16% Similarity=0.179 Sum_probs=172.3
Q ss_pred ccccHHH-HHHHhcCCCccceecccCcEEEEEEEEc--CCcEEEEEEeecCCCCChHHH--HHHHHHHHhc-CCCCcccc
Q 046270 252 KWFHVSE-LEQATNGFSQNNLIGQGASGIVYKGTLR--HGNLVAVKQILDLDTKGDEDF--TNEVEIISKI-RHRNLLSL 325 (590)
Q Consensus 252 ~~f~~~e-l~~at~~f~~~~~LG~G~fG~Vykg~~~--~g~~vAvK~l~~~~~~~~~~f--~~Ev~il~~l-~H~nlv~l 325 (590)
+.|.-.+ ....+.+|..+..||.|.|+.|++...+ ++..+++|.+.+.......+. ..|+-+...+ .|.++++.
T Consensus 252 ~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~ 331 (524)
T KOG0601|consen 252 NIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGK 331 (524)
T ss_pred heecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCC
Confidence 3444444 4556678999999999999999998754 467899998866544333332 3466666665 57777776
Q ss_pred ceeEEeccCCCCceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEC
Q 046270 326 RGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLD 405 (590)
Q Consensus 326 ~g~~~~~~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd 405 (590)
..-+... ...|+--||++++++...+. -...++...++++..+++.++.++| ++.++|+|+||+||++.
T Consensus 332 ~~~W~~~-----r~~~ip~e~~~~~s~~l~~~---~~~~~d~~~~~~~~~q~~~~l~~i~---s~~~~~~d~~psni~i~ 400 (524)
T KOG0601|consen 332 NSSWSQL-----RQGYIPLEFCEGGSSSLRSV---TSQMLDEDPRLRLTAQILTALNVIH---SKLFVHLDVKPSNILIS 400 (524)
T ss_pred CCCcccc-----ccccCchhhhcCcchhhhhH---HHHhcCcchhhhhHHHHHhcccccc---chhhhcccccccceeec
Confidence 5544422 23678889999999876552 2346888899999999999999999 99999999999999998
Q ss_pred CC-CcEEEEeeCCcccccCCCcccccccccCCCcc--CccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhh
Q 046270 406 SE-LNAKVADFGLAKQSLEGHSHLTTRVAGTFGYL--APEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLI 482 (590)
Q Consensus 406 ~~-~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~--APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l 482 (590)
.+ +.-+++|||.+..+.... ....+.-+++ +++......+-.+.|+||||.-+.|.++|.........
T Consensus 401 ~~~~~~~~~~~~~~t~~~~~~----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~----- 471 (524)
T KOG0601|consen 401 NDGFFSKLGDFGCWTRLAFSS----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ----- 471 (524)
T ss_pred cchhhhhccccccccccceec----ccccccccccccchhhccccccccccccccccccccccccCcccCccccc-----
Confidence 76 888999999986421111 1112223344 45555566788999999999999999999754322111
Q ss_pred hHHHHHHHhcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhcc
Q 046270 483 TDWAWVLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEG 542 (590)
Q Consensus 483 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~ 542 (590)
|. ....+.....-. .. +.+..+..-...+++..||.+.+...+.+.
T Consensus 472 --~~--~i~~~~~p~~~~---------~~-~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~ 517 (524)
T KOG0601|consen 472 --SL--TIRSGDTPNLPG---------LK-LQLQVLLKVMINPDRKRRPSAVELSLHSEF 517 (524)
T ss_pred --ce--eeecccccCCCc---------hH-HhhhhhhhhhcCCccccchhhhhhcccchh
Confidence 11 111121111100 00 233334445678888889988887665543
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.95 E-value=8.7e-09 Score=97.25 Aligned_cols=130 Identities=28% Similarity=0.398 Sum_probs=96.6
Q ss_pred eecccCcEEEEEEEEcCCcEEEEEEeec-CCC--CC-----hHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEEE
Q 046270 271 LIGQGASGIVYKGTLRHGNLVAVKQILD-LDT--KG-----DEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFL 342 (590)
Q Consensus 271 ~LG~G~fG~Vykg~~~~g~~vAvK~l~~-~~~--~~-----~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~L 342 (590)
.+++|+-..+|.+.+. |..+++|.-.. .-. .- .+.-.+|++++.+++--.|-...-+..+. ....+
T Consensus 3 ~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~-----~~~~I 76 (204)
T COG3642 3 LIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDP-----DNGLI 76 (204)
T ss_pred hhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcC-----CCCEE
Confidence 5789999999999776 44456664322 111 11 12356899999999766555444444433 34689
Q ss_pred EEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCccc
Q 046270 343 VYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQ 420 (590)
Q Consensus 343 V~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~ 420 (590)
+|||+++..|.+.+... +..++..+-+-+.-|| ..+|+|+||.++||++.++. +.++||||+..
T Consensus 77 ~me~I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH---~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 77 VMEYIEGELLKDALEEA----------RPDLLREVGRLVGKLH---KAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred EEEEeCChhHHHHHHhc----------chHHHHHHHHHHHHHH---hcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 99999999998888422 3667888888888999 99999999999999998774 99999999974
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.90 E-value=1.5e-08 Score=97.66 Aligned_cols=125 Identities=26% Similarity=0.326 Sum_probs=83.7
Q ss_pred EEEEEEEcCCcEEEEEEeecCCC-------------C--------C-----hHHHHHHHHHHHhcCCCC--ccccceeEE
Q 046270 279 IVYKGTLRHGNLVAVKQILDLDT-------------K--------G-----DEDFTNEVEIISKIRHRN--LLSLRGCCV 330 (590)
Q Consensus 279 ~Vykg~~~~g~~vAvK~l~~~~~-------------~--------~-----~~~f~~Ev~il~~l~H~n--lv~l~g~~~ 330 (590)
.||.|...+|..+|||..+.... . . .....+|.+.|.++...+ +.+++.+.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 49999999999999998743110 0 0 123568999999998764 44444332
Q ss_pred eccCCCCceEEEEEeeCC--CCCcchhhhhhcccccCChhhHHHHHHHHHHHHHH-HHhcCCCCeEecCCCCCceEECCC
Q 046270 331 TSDDSSGKRRFLVYDYMP--NGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAY-LHYGLKPGIYHRDIKSTNILLDSE 407 (590)
Q Consensus 331 ~~~~~~~~~~~LV~E~~~--~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~y-LH~~~~~~ivHrDIKp~NILLd~~ 407 (590)
...|||||++ +..+..+.. ..++.+....++.++++.+.. +| ..+|+||||.+.|||++++
T Consensus 80 --------~~~ivME~I~~~G~~~~~l~~-----~~~~~~~~~~~~~~il~~~~~~~~---~~givHGDLs~~NIlv~~~ 143 (188)
T PF01163_consen 80 --------RNVIVMEYIGEDGVPLPRLKD-----VDLSPEEPKELLEEILEEIIKMLH---KAGIVHGDLSEYNILVDDG 143 (188)
T ss_dssp --------TTEEEEE--EETTEEGGCHHH-----CGGGGSTHHHHHHHHHHHHHHHHH---CTTEEESS-STTSEEEETT
T ss_pred --------CCEEEEEecCCCccchhhHHh-----ccccchhHHHHHHHHHHHHHHHHH---hcCceecCCChhhEEeecc
Confidence 1489999998 544544321 123356677788888886655 57 8999999999999999988
Q ss_pred CcEEEEeeCCcccc
Q 046270 408 LNAKVADFGLAKQS 421 (590)
Q Consensus 408 ~~~kL~DFGla~~~ 421 (590)
.+.|+|||.+...
T Consensus 144 -~~~iIDf~qav~~ 156 (188)
T PF01163_consen 144 -KVYIIDFGQAVDS 156 (188)
T ss_dssp -CEEE--GTTEEET
T ss_pred -eEEEEecCcceec
Confidence 9999999988654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.90 E-value=2.8e-08 Score=101.20 Aligned_cols=144 Identities=16% Similarity=0.123 Sum_probs=102.1
Q ss_pred eecccCcEEEEEEEEcCCcEEEEEEeecCCC-----------CChHHHHHHHHHHHhcCCCCcc--ccceeEEeccCCCC
Q 046270 271 LIGQGASGIVYKGTLRHGNLVAVKQILDLDT-----------KGDEDFTNEVEIISKIRHRNLL--SLRGCCVTSDDSSG 337 (590)
Q Consensus 271 ~LG~G~fG~Vykg~~~~g~~vAvK~l~~~~~-----------~~~~~f~~Ev~il~~l~H~nlv--~l~g~~~~~~~~~~ 337 (590)
.+-+-....|++..+. |+.+.||+...... .....+.+|.+.+.++...+|. .++++.........
T Consensus 29 ~v~~~~~rrvvr~~~~-g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~ 107 (268)
T PRK15123 29 VFRELEGRRTLRFELA-GKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPAT 107 (268)
T ss_pred EEecCCCceEEEEEEC-CEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcc
Confidence 4444444557777764 77899997643221 1112478999999999655444 44556543222123
Q ss_pred ceEEEEEeeCCCC-CcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECC-------CCc
Q 046270 338 KRRFLVYDYMPNG-TLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDS-------ELN 409 (590)
Q Consensus 338 ~~~~LV~E~~~~g-sL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~-------~~~ 409 (590)
...+||+|++++- +|.+++.... ....+...+..++.+++..+.-|| ..+|+|+|++++|||++. +..
T Consensus 108 ~~s~LVte~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH---~~Gi~HgDL~~~NiLl~~~~~~~~~~~~ 183 (268)
T PRK15123 108 RTSFIITEDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMH---AAGINHRDCYICHFLLHLPFPGREEDLK 183 (268)
T ss_pred ceeEEEEeeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHH---HCcCccCCCChhhEEEeccccCCCCCce
Confidence 4578999999986 7888874221 234556778899999999999999 999999999999999975 467
Q ss_pred EEEEeeCCcc
Q 046270 410 AKVADFGLAK 419 (590)
Q Consensus 410 ~kL~DFGla~ 419 (590)
+.++||+.++
T Consensus 184 ~~LIDl~r~~ 193 (268)
T PRK15123 184 LSVIDLHRAQ 193 (268)
T ss_pred EEEEECCccc
Confidence 8999999885
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.83 E-value=4.6e-08 Score=92.03 Aligned_cols=143 Identities=22% Similarity=0.282 Sum_probs=102.2
Q ss_pred ccceecccCcEEEEEEEEcCCcEEEEEEe-ecCCCC-------ChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCce
Q 046270 268 QNNLIGQGASGIVYKGTLRHGNLVAVKQI-LDLDTK-------GDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKR 339 (590)
Q Consensus 268 ~~~~LG~G~fG~Vykg~~~~g~~vAvK~l-~~~~~~-------~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~ 339 (590)
...+|-+|.-+.|+++.+. |+...||.- .+.-.. ......+|+++|.+++--.|....-++.+.. .
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~-----~ 84 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTY-----G 84 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecC-----C
Confidence 4568889999999999987 676666642 221111 1345778999999997666654444454332 2
Q ss_pred EEEEEeeCCC-CCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCC---cEEEEee
Q 046270 340 RFLVYDYMPN-GTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSEL---NAKVADF 415 (590)
Q Consensus 340 ~~LV~E~~~~-gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~---~~kL~DF 415 (590)
-.++|||+++ .++.+++...-.. ....+....++..|-+.+.-|| ...|+||||..+||+|..++ .+.++||
T Consensus 85 ~~i~ME~~~g~~~vk~~i~~~~~~-~~~d~~~~~~~~~iG~~igklH---~ndiiHGDLTTSNill~~~~~~~~~~lIdf 160 (229)
T KOG3087|consen 85 GQIYMEFIDGASTVKDFILSTMED-ESEDEGLAELARRIGELIGKLH---DNDIIHGDLTTSNILLRSDGNQITPILIDF 160 (229)
T ss_pred CeEEEEeccchhHHHHHHHHHccC-cccchhHHHHHHHHHHHHHHhh---hCCeecccccccceEEecCCCcCceEEEee
Confidence 5899999976 4777877543322 2222333688899999999999 99999999999999996654 4589999
Q ss_pred CCccc
Q 046270 416 GLAKQ 420 (590)
Q Consensus 416 Gla~~ 420 (590)
|++..
T Consensus 161 gls~~ 165 (229)
T KOG3087|consen 161 GLSSV 165 (229)
T ss_pred cchhc
Confidence 99864
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.63 E-value=2.7e-07 Score=92.10 Aligned_cols=133 Identities=22% Similarity=0.225 Sum_probs=95.9
Q ss_pred CccceecccCcEEEEEEEEcCCcEEEEEEeecCCC----------------C------ChHHHHHHHHHHHhcCCC--Cc
Q 046270 267 SQNNLIGQGASGIVYKGTLRHGNLVAVKQILDLDT----------------K------GDEDFTNEVEIISKIRHR--NL 322 (590)
Q Consensus 267 ~~~~~LG~G~fG~Vykg~~~~g~~vAvK~l~~~~~----------------~------~~~~f~~Ev~il~~l~H~--nl 322 (590)
...+.||.|.-+.||.|..++|.++|||.-+.... . ......+|.++|.+|... .+
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V 173 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV 173 (304)
T ss_pred hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence 34578999999999999999999999996422100 0 112356899999999655 55
Q ss_pred cccceeEEeccCCCCceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCce
Q 046270 323 LSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNI 402 (590)
Q Consensus 323 v~l~g~~~~~~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NI 402 (590)
.+.+++ +...+||||+++-.|... .++-+..-.|+..|.+-+.-+- ..||||+|+.+-||
T Consensus 174 P~P~~~---------nRHaVvMe~ieG~eL~~~--------r~~~en~~~il~~il~~~~~~~---~~GiVHGDlSefNI 233 (304)
T COG0478 174 PKPIAW---------NRHAVVMEYIEGVELYRL--------RLDVENPDEILDKILEEVRKAY---RRGIVHGDLSEFNI 233 (304)
T ss_pred CCcccc---------ccceeeeehcccceeecc--------cCcccCHHHHHHHHHHHHHHHH---HcCccccCCchheE
Confidence 555543 457899999998666442 1234444455556666555555 68899999999999
Q ss_pred EECCCCcEEEEeeCCcc
Q 046270 403 LLDSELNAKVADFGLAK 419 (590)
Q Consensus 403 LLd~~~~~kL~DFGla~ 419 (590)
++++++.+.++||--+.
T Consensus 234 lV~~dg~~~vIDwPQ~v 250 (304)
T COG0478 234 LVTEDGDIVVIDWPQAV 250 (304)
T ss_pred EEecCCCEEEEeCcccc
Confidence 99999999999996543
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.62 E-value=3.4e-07 Score=89.80 Aligned_cols=111 Identities=24% Similarity=0.363 Sum_probs=86.1
Q ss_pred hHHHHHHHHHHHhcCCCC--ccccceeEEeccCCCCceEEEEEeeCCCC-CcchhhhhhcccccCChhhHHHHHHHHHHH
Q 046270 304 DEDFTNEVEIISKIRHRN--LLSLRGCCVTSDDSSGKRRFLVYDYMPNG-TLSDNISISHKRKQLTWPQRKKIIVDVAKG 380 (590)
Q Consensus 304 ~~~f~~Ev~il~~l~H~n--lv~l~g~~~~~~~~~~~~~~LV~E~~~~g-sL~~~L~~~~~~~~l~~~~r~~I~~~ia~g 380 (590)
.....+|...+.+|+... ....+++...... .....+||+|++++- +|.+++... ..++...+..++.++++.
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~-~~~~s~lite~l~~~~~L~~~~~~~---~~~~~~~~~~ll~~l~~~ 130 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKG-GGYRSYLITEALPGAQDLRDLLQQW---EQLDPSQRRELLRALARL 130 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCC-CceeEEEEEEeCCCcccHHHHHHhh---cccchhhHHHHHHHHHHH
Confidence 345788999988886444 4455666654332 224568999999984 788887532 226677788999999999
Q ss_pred HHHHHhcCCCCeEecCCCCCceEECCCC---cEEEEeeCCcccc
Q 046270 381 IAYLHYGLKPGIYHRDIKSTNILLDSEL---NAKVADFGLAKQS 421 (590)
Q Consensus 381 L~yLH~~~~~~ivHrDIKp~NILLd~~~---~~kL~DFGla~~~ 421 (590)
+.-|| ..+|+|+|+++.|||++.+. .+.++||+-++..
T Consensus 131 i~~lH---~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 131 IAKLH---DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHH---HCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 99999 99999999999999998886 7899999987643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.58 E-value=1.3e-06 Score=85.23 Aligned_cols=144 Identities=15% Similarity=0.113 Sum_probs=106.1
Q ss_pred ecccCcEEEEEEEEcCCcEEEEEEeecCC------CCChHHHHHHHHHHHhcCCCC--ccccceeEEeccCCCCceEEEE
Q 046270 272 IGQGASGIVYKGTLRHGNLVAVKQILDLD------TKGDEDFTNEVEIISKIRHRN--LLSLRGCCVTSDDSSGKRRFLV 343 (590)
Q Consensus 272 LG~G~fG~Vykg~~~~g~~vAvK~l~~~~------~~~~~~f~~Ev~il~~l~H~n--lv~l~g~~~~~~~~~~~~~~LV 343 (590)
-|+||-+.|++-.++ |..+-+|+-.+.- .-+...|.+|...|.+|...+ +.+.. ++.........+.+||
T Consensus 26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 467899999998776 4578899864211 335678999999999996433 33444 4332222234557899
Q ss_pred EeeCCC-CCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCc--EEEEeeCCccc
Q 046270 344 YDYMPN-GTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELN--AKVADFGLAKQ 420 (590)
Q Consensus 344 ~E~~~~-gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~--~kL~DFGla~~ 420 (590)
+|-+++ -+|.+++... ...+.+..++..++.+|++.+.-|| ..++.|+|+.+.||+++.++. ++++||.-++.
T Consensus 104 Te~L~g~~~L~~~l~~~-~~~~~~~~~k~~il~~va~~ia~LH---~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 104 TEDMAGFISIADWYAQH-AVSPYSDEVRQAMLKAVALAFKKMH---SVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEeCCCCccHHHHHhcC-CcCCcchHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 997764 5787777422 1235677888999999999999999 999999999999999986666 89999987764
Q ss_pred c
Q 046270 421 S 421 (590)
Q Consensus 421 ~ 421 (590)
.
T Consensus 180 ~ 180 (216)
T PRK09902 180 R 180 (216)
T ss_pred h
Confidence 3
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.57 E-value=1.5e-08 Score=115.52 Aligned_cols=205 Identities=20% Similarity=0.256 Sum_probs=139.5
Q ss_pred HhcCCCccceecccCcEEEEEEEEcC-CcEEEEEEeecC---CCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCC
Q 046270 262 ATNGFSQNNLIGQGASGIVYKGTLRH-GNLVAVKQILDL---DTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSG 337 (590)
Q Consensus 262 at~~f~~~~~LG~G~fG~Vykg~~~~-g~~vAvK~l~~~---~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~ 337 (590)
.-+.|...+-+-+|.++.++...-.. |...++|..... .....+....+-.++-..+||-++....-+. ..
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~-----~r 876 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFP-----CR 876 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCC-----CC
Confidence 44667777788899999998775432 333333332211 1111222223333333334555554433211 23
Q ss_pred ceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCC
Q 046270 338 KRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGL 417 (590)
Q Consensus 338 ~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGl 417 (590)
...+||++|..+++|...|+. .+.++.+-.+..+..+...++||| ...+.|+|++|.|+|...++..++.|||.
T Consensus 877 sP~~L~~~~~~~~~~~Skl~~---~~~~saepaRs~i~~~vqs~e~L~---s~~r~h~~~~p~~~l~~~~gh~~l~~~~t 950 (1205)
T KOG0606|consen 877 SPLPLVGHYLNGGDLPSKLHN---SGCLSAEPARSPILERVQSLESLH---SSLRKHRDLKPDSLLIAYDGHRPLTDFGT 950 (1205)
T ss_pred CCcchhhHHhccCCchhhhhc---CCCcccccccchhHHHHhhhhccc---cchhhcccccccchhhcccCCcccCcccc
Confidence 457999999999999888753 334565556667777888999999 77799999999999999999999999984
Q ss_pred cccccC---------------------CC---------cccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHh
Q 046270 418 AKQSLE---------------------GH---------SHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS 467 (590)
Q Consensus 418 a~~~~~---------------------~~---------~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELlt 467 (590)
...... .. ......+.||..|.+||...+......+|.|++|++++|.++
T Consensus 951 ~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~ 1030 (1205)
T KOG0606|consen 951 LSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLT 1030 (1205)
T ss_pred ccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhc
Confidence 332100 00 001223568999999999999999999999999999999999
Q ss_pred CCCCCCCCCC
Q 046270 468 GRKVLDTSTS 477 (590)
Q Consensus 468 G~~p~~~~~~ 477 (590)
|..||.....
T Consensus 1031 g~pp~na~tp 1040 (1205)
T KOG0606|consen 1031 GIPPFNAETP 1040 (1205)
T ss_pred CCCCCCCcch
Confidence 9999875443
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.57 E-value=3.5e-07 Score=100.82 Aligned_cols=146 Identities=21% Similarity=0.274 Sum_probs=96.0
Q ss_pred CCCccceecccCcEEEEEEEEcCCcEEEEEEeecCCCCCh------------------------------H---------
Q 046270 265 GFSQNNLIGQGASGIVYKGTLRHGNLVAVKQILDLDTKGD------------------------------E--------- 305 (590)
Q Consensus 265 ~f~~~~~LG~G~fG~Vykg~~~~g~~vAvK~l~~~~~~~~------------------------------~--------- 305 (590)
.|+. +-|+.++-|.||+|++++|+.||||+.++.-.+.. +
T Consensus 127 eF~~-~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~E 205 (517)
T COG0661 127 EFEP-EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREE 205 (517)
T ss_pred HcCC-CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHH
Confidence 4543 57999999999999999999999998754221110 0
Q ss_pred -HHHHHHHHHHhcC----CCCccccceeEEeccCCCCceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHH
Q 046270 306 -DFTNEVEIISKIR----HRNLLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKG 380 (590)
Q Consensus 306 -~f~~Ev~il~~l~----H~nlv~l~g~~~~~~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~g 380 (590)
++.+|..-+.+++ +..-+++-..|.+. .+...|+|||++|-.+.+...... ..++ +..|+..++++
T Consensus 206 lDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~----t~~~VLtmE~i~Gi~i~d~~~l~~--~g~d---~k~ia~~~~~~ 276 (517)
T COG0661 206 LDYRREAANAERFRENFKDDPDVYVPKVYWEY----TTRRVLTMEWIDGIKISDIAALKS--AGID---RKELAELLVRA 276 (517)
T ss_pred hCHHHHHHHHHHHHHHcCCCCCeEeceeehhc----cCCcEEEEEeeCCEecccHHHHHh--cCCC---HHHHHHHHHHH
Confidence 1334444444442 22222333333321 234799999999999988753222 3455 34444444443
Q ss_pred -HHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccccC
Q 046270 381 -IAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLE 423 (590)
Q Consensus 381 -L~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~~~ 423 (590)
+.-+- ..+++|.|.+|.||+++.+++.-+.|||+.....+
T Consensus 277 f~~q~~---~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 277 FLRQLL---RDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred HHHHHH---hcCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 22222 56999999999999999999999999999876544
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.50 E-value=2.3e-08 Score=110.17 Aligned_cols=150 Identities=21% Similarity=0.272 Sum_probs=99.6
Q ss_pred HHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccccCCCcccc--------cccccCCCccCccccccC
Q 046270 376 DVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLT--------TRVAGTFGYLAPEYALYG 447 (590)
Q Consensus 376 ~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~~~~~~~~~--------~~~~gt~~Y~APE~~~~~ 447 (590)
+++.||.|+|. +.++||++|.|++|.++.++..||+.|+.+........... .-..-...|.|||++.+.
T Consensus 107 ~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~ 184 (700)
T KOG2137|consen 107 NVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT 184 (700)
T ss_pred cccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence 44599999995 67999999999999999999999999998765433211100 011234689999999998
Q ss_pred CCCcchhHHHHHHHHHHHHhCCCC-CCCCCCchhhhhHHHHHHHhcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcC
Q 046270 448 QLTEKSDVYSFGIVILELMSGRKV-LDTSTSPFQLITDWAWVLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVM 526 (590)
Q Consensus 448 ~~t~ksDVySfGvvLlELltG~~p-~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~d 526 (590)
..+.++|+||+|++++-+..|.++ +........ .... ...+..-......+++.++.+=+...+..+
T Consensus 185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~--~~~~----------~~~~~~~~~~~s~~~p~el~~~l~k~l~~~ 252 (700)
T KOG2137|consen 185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLS--YSFS----------RNLLNAGAFGYSNNLPSELRESLKKLLNGD 252 (700)
T ss_pred cccccccceeeeeEEEEEecCCcchhhccCCcch--hhhh----------hcccccccccccccCcHHHHHHHHHHhcCC
Confidence 889999999999999999955444 332221110 0000 000100001112334456666666788999
Q ss_pred CCCCCCHHHHHHH
Q 046270 527 VALRPTITDALKM 539 (590)
Q Consensus 527 p~~RPtm~eVl~~ 539 (590)
+..||++.++...
T Consensus 253 ~~~rp~~~~l~~~ 265 (700)
T KOG2137|consen 253 SAVRPTLDLLLSI 265 (700)
T ss_pred cccCcchhhhhcc
Confidence 9999988776543
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.31 E-value=9.1e-06 Score=85.25 Aligned_cols=197 Identities=16% Similarity=0.170 Sum_probs=125.6
Q ss_pred ccceecccCcEEEEEEEEcCCcEEEEEEeecCCCCChHHHHHHHHHHHhc-CCCCccccceeEEec--cCCCCceEEEEE
Q 046270 268 QNNLIGQGASGIVYKGTLRHGNLVAVKQILDLDTKGDEDFTNEVEIISKI-RHRNLLSLRGCCVTS--DDSSGKRRFLVY 344 (590)
Q Consensus 268 ~~~~LG~G~fG~Vykg~~~~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l-~H~nlv~l~g~~~~~--~~~~~~~~~LV~ 344 (590)
....||+||-+.+|----- +..| .|+......... .+-++.|.+. .||-+-.-+.+=... ...++...-+.|
T Consensus 15 ~gr~LgqGgea~ly~l~e~-~d~V-AKIYh~Pppa~~---aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm 89 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEV-RDQV-AKIYHAPPPAAQ---AQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM 89 (637)
T ss_pred CCccccCCccceeeecchh-hchh-heeecCCCchHH---HHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence 3467999999999964211 2223 344432222111 1233344444 566433311111000 111233356777
Q ss_pred eeCCCCC-cchhhhh---hcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCccc
Q 046270 345 DYMPNGT-LSDNISI---SHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQ 420 (590)
Q Consensus 345 E~~~~gs-L~~~L~~---~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~ 420 (590)
..+++.- ...++.- .+......|...++.++.+|.+.+-|| ..|.+-+|++++|+|+.++..+.|.|-.....
T Consensus 90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH---~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi 166 (637)
T COG4248 90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLH---EHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQI 166 (637)
T ss_pred ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHH---hcCCcccccCccceeeecCceEEEEcccceee
Confidence 7766542 2222211 122345899999999999999999999 89999999999999999999999998654443
Q ss_pred ccCCCcccccccccCCCccCccccc-----cCCCCcchhHHHHHHHHHHHHhC-CCCCCC
Q 046270 421 SLEGHSHLTTRVAGTFGYLAPEYAL-----YGQLTEKSDVYSFGIVILELMSG-RKVLDT 474 (590)
Q Consensus 421 ~~~~~~~~~~~~~gt~~Y~APE~~~-----~~~~t~ksDVySfGvvLlELltG-~~p~~~ 474 (590)
...+ .......|...|.+||.-. +..-+...|-|.+||++++|+.| ++||..
T Consensus 167 ~~ng--~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysG 224 (637)
T COG4248 167 NANG--TLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSG 224 (637)
T ss_pred ccCC--ceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCc
Confidence 3222 2233456888999999654 33457789999999999999986 899864
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.27 E-value=6.2e-06 Score=90.87 Aligned_cols=147 Identities=21% Similarity=0.250 Sum_probs=94.0
Q ss_pred CCCccceecccCcEEEEEEEEcCCcEEEEEEeecCCCCCh-------------------------------------HHH
Q 046270 265 GFSQNNLIGQGASGIVYKGTLRHGNLVAVKQILDLDTKGD-------------------------------------EDF 307 (590)
Q Consensus 265 ~f~~~~~LG~G~fG~Vykg~~~~g~~vAvK~l~~~~~~~~-------------------------------------~~f 307 (590)
.|+. +.||.-+.|.||+|++++|+.||||+-++.-.... -+|
T Consensus 163 ~f~~-~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF 241 (538)
T KOG1235|consen 163 EFDE-EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDF 241 (538)
T ss_pred hcCc-chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcch
Confidence 3443 57999999999999999999999998644221110 014
Q ss_pred HHHHHHHHhc----CCCC---ccccceeEEeccCCCCceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHH
Q 046270 308 TNEVEIISKI----RHRN---LLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKG 380 (590)
Q Consensus 308 ~~Ev~il~~l----~H~n---lv~l~g~~~~~~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~g 380 (590)
.+|.+-..+. +|-+ -|.+-..+.+. ...+.|+||||+|..+.|.-... ...++...+. ..+.++
T Consensus 242 ~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~----st~RVLtME~~~G~~i~Dl~~i~--~~gi~~~~i~---~~l~~~ 312 (538)
T KOG1235|consen 242 TKEAKNAERFRENFKDFSLLTYVLVPKVYWDL----STKRVLTMEYVDGIKINDLDAID--KRGISPHDIL---NKLVEA 312 (538)
T ss_pred HHHHHhHHHHHHHHHhcccccceeCCeehhhc----CcceEEEEEecCCccCCCHHHHH--HcCCCHHHHH---HHHHHH
Confidence 4444433333 4555 22233333322 23589999999999998865432 2345555433 333332
Q ss_pred HHHHHhcCCCCeEecCCCCCceEECC----CCcEEEEeeCCcccccC
Q 046270 381 IAYLHYGLKPGIYHRDIKSTNILLDS----ELNAKVADFGLAKQSLE 423 (590)
Q Consensus 381 L~yLH~~~~~~ivHrDIKp~NILLd~----~~~~kL~DFGla~~~~~ 423 (590)
|++.-...|++|+|-+|.||+++. ++++.+-|||+......
T Consensus 313 --~~~qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 313 --YLEQIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred --HHHHHHhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 222222468999999999999983 67899999999876543
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.27 E-value=1.7e-05 Score=77.70 Aligned_cols=143 Identities=15% Similarity=0.195 Sum_probs=92.3
Q ss_pred HhcCCCccceecccCcEEEEEEEEcCCcEEEEEEeecCCCCChHH---------HHHHHHHHHhcCCCC---ccccceeE
Q 046270 262 ATNGFSQNNLIGQGASGIVYKGTLRHGNLVAVKQILDLDTKGDED---------FTNEVEIISKIRHRN---LLSLRGCC 329 (590)
Q Consensus 262 at~~f~~~~~LG~G~fG~Vykg~~~~g~~vAvK~l~~~~~~~~~~---------f~~Ev~il~~l~H~n---lv~l~g~~ 329 (590)
..++|...+++-......|.+-..+ |...++|..++......+. ..+++..+.+++... .+.++...
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei~-~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEID-GKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEEC-CcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 3466777777777776677666655 6788899876544332222 234444455554332 22322222
Q ss_pred EeccCCCCceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCc
Q 046270 330 VTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELN 409 (590)
Q Consensus 330 ~~~~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~ 409 (590)
......-....+|+|||++|..|.++.. ++. .+...+..++.-|| +.|++|+|.+|+|++++++ .
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH---~~G~~HGD~hpgNFlv~~~-~ 172 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLH---KHGFYHGDPHPGNFLVSNN-G 172 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHH---HcCCccCCCCcCcEEEECC-c
Confidence 2222112344679999999988877542 222 25566778899999 9999999999999999865 4
Q ss_pred EEEEeeCCccc
Q 046270 410 AKVADFGLAKQ 420 (590)
Q Consensus 410 ~kL~DFGla~~ 420 (590)
+++.||+..+.
T Consensus 173 i~iID~~~k~~ 183 (229)
T PF06176_consen 173 IRIIDTQGKRM 183 (229)
T ss_pred EEEEECccccc
Confidence 99999987653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.26 E-value=1.4e-05 Score=79.50 Aligned_cols=132 Identities=17% Similarity=0.118 Sum_probs=81.3
Q ss_pred ceecccCcEEEEEEEEcCCcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCc--cccceeEEeccCCCCceEEEEEeeC
Q 046270 270 NLIGQGASGIVYKGTLRHGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNL--LSLRGCCVTSDDSSGKRRFLVYDYM 347 (590)
Q Consensus 270 ~~LG~G~fG~Vykg~~~~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nl--v~l~g~~~~~~~~~~~~~~LV~E~~ 347 (590)
..||+|..+.||+. .|..+++|..... .......+|.+++..+..-++ .+.+++.. .+....+|||++
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~--~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~-----~~~~~glv~e~i 76 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPG--FDKETIKREFDASRKVFSLGIPTPHPFDLVE-----DGGRLGLIYELI 76 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCC--CCHHHHHHHHHHHHHHHHcCCCCCceEEEEe-----cCCeeeeeeeec
Confidence 47899999999984 2456778876442 234567899999999975555 34455543 233467899999
Q ss_pred CCCC-cchhhhhhcccccCChhhHHHHHHHHHHH---------------------------------------HHHHHh-
Q 046270 348 PNGT-LSDNISISHKRKQLTWPQRKKIIVDVAKG---------------------------------------IAYLHY- 386 (590)
Q Consensus 348 ~~gs-L~~~L~~~~~~~~l~~~~r~~I~~~ia~g---------------------------------------L~yLH~- 386 (590)
+|.. +...+. .+...+..++..+++. ..+|..
T Consensus 77 ~G~~~~~~~~~-------~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~ 149 (226)
T TIGR02172 77 VGKRSFSRIIS-------DNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEV 149 (226)
T ss_pred CCccchhhhhc-------CCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhC
Confidence 9863 221110 0001111111111111 122221
Q ss_pred cCCCCeEecCCCCCceEECCCCcEEEEeeCCcc
Q 046270 387 GLKPGIYHRDIKSTNILLDSELNAKVADFGLAK 419 (590)
Q Consensus 387 ~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~ 419 (590)
.....++|+|+.|.||++++++ +.|+||+.+.
T Consensus 150 ~~~~~~~HgD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 150 PDTSTCLHGDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCCCceEecCCCCCcEEEcCCC-cEEEechhcC
Confidence 1134578999999999999888 9999999775
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.26 E-value=3.8e-06 Score=81.16 Aligned_cols=104 Identities=23% Similarity=0.294 Sum_probs=83.8
Q ss_pred HHHHHHHHhcCC-CCccccceeEEeccCCCCceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHh
Q 046270 308 TNEVEIISKIRH-RNLLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHY 386 (590)
Q Consensus 308 ~~Ev~il~~l~H-~nlv~l~g~~~~~~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~ 386 (590)
.+|.-++..+++ +++.+++|+|- .++|.||...+++...-..-..--..+|..|.+|+.++++.+.+|++
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG---------~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~ 77 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG---------RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDH 77 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC---------CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhc
Confidence 368888999976 59999999994 58899999987664210000111257999999999999999999997
Q ss_pred cCCCCeEecCCCCCceEECCCCcEEEEeeCCccc
Q 046270 387 GLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQ 420 (590)
Q Consensus 387 ~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~ 420 (590)
.....+.-.|++++|+-+++++++|+.|...+..
T Consensus 78 ~~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 78 GPLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred CCCCcEEEeecchHHeEEeCCCcEEEEechhcch
Confidence 7667788999999999999999999999987653
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.22 E-value=7.6e-06 Score=80.38 Aligned_cols=146 Identities=18% Similarity=0.245 Sum_probs=86.0
Q ss_pred cceecccCcEEEEEEEEcCCcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCC--ccccceeEEeccCCCCceEEEEEee
Q 046270 269 NNLIGQGASGIVYKGTLRHGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRN--LLSLRGCCVTSDDSSGKRRFLVYDY 346 (590)
Q Consensus 269 ~~~LG~G~fG~Vykg~~~~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~n--lv~l~g~~~~~~~~~~~~~~LV~E~ 346 (590)
.+.|+.|..+.||+....+ ..+++|..... .....+.+|..+++.+.... +.+++.+..... .....+++|++
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~--~~~~~~~~~~~ 76 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDE--FNGFPYLLMEY 76 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETE--ETSEEEEEEEE
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeeccccc--ccccceEEEEE
Confidence 3578999999999999987 68999986443 34567889999999996444 345555443222 23447999999
Q ss_pred CCCCCcch----------------hhhhhcc----cccCChhh---------HHHH------------HHHHHH-HHHHH
Q 046270 347 MPNGTLSD----------------NISISHK----RKQLTWPQ---------RKKI------------IVDVAK-GIAYL 384 (590)
Q Consensus 347 ~~~gsL~~----------------~L~~~~~----~~~l~~~~---------r~~I------------~~~ia~-gL~yL 384 (590)
+++..+.. .+..-.. ...+.+.. .... ...+.+ .+..+
T Consensus 77 i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (239)
T PF01636_consen 77 IPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQEL 156 (239)
T ss_dssp ESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHH
T ss_pred eccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHH
Confidence 99988776 1110000 00111100 0000 112222 23333
Q ss_pred Hh----cCCCCeEecCCCCCceEEC-CCCcEEEEeeCCcc
Q 046270 385 HY----GLKPGIYHRDIKSTNILLD-SELNAKVADFGLAK 419 (590)
Q Consensus 385 H~----~~~~~ivHrDIKp~NILLd-~~~~~kL~DFGla~ 419 (590)
+. .....++|+|+.|.|||++ +++.+-|.||+.+.
T Consensus 157 ~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 157 EALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred HhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 32 2357899999999999999 55666799998765
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.19 E-value=3e-05 Score=76.89 Aligned_cols=152 Identities=19% Similarity=0.217 Sum_probs=98.8
Q ss_pred ccHHHHHHHhcCCCccceec---ccCcEEEEEEEEcCCcEEEEEEeecCCCCC---------hHH---------------
Q 046270 254 FHVSELEQATNGFSQNNLIG---QGASGIVYKGTLRHGNLVAVKQILDLDTKG---------DED--------------- 306 (590)
Q Consensus 254 f~~~el~~at~~f~~~~~LG---~G~fG~Vykg~~~~g~~vAvK~l~~~~~~~---------~~~--------------- 306 (590)
.+.+.+.....+.....+.| .|.-..||+|.-.++..+|||+.+...... +..
T Consensus 35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W 114 (268)
T COG1718 35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAW 114 (268)
T ss_pred HHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHH
Confidence 45666666666666666655 566679999998889999999985422111 111
Q ss_pred HHHHHHHHHhcC--CCCccccceeEEeccCCCCceEEEEEeeCCCCCcc-hhhhhhcccccCChhhHHHHHHHHHHHHHH
Q 046270 307 FTNEVEIISKIR--HRNLLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLS-DNISISHKRKQLTWPQRKKIIVDVAKGIAY 383 (590)
Q Consensus 307 f~~Ev~il~~l~--H~nlv~l~g~~~~~~~~~~~~~~LV~E~~~~gsL~-~~L~~~~~~~~l~~~~r~~I~~~ia~gL~y 383 (590)
..+|..-|.++. +-.+.+-+++. .-.|||||+....+. -.| +.-++..++...+..++++.+.-
T Consensus 115 ~~kEf~NL~R~~eAGVrvP~Pi~~~---------~nVLvMEfIg~~g~pAP~L----kDv~~e~~e~~~~~~~~v~~~~~ 181 (268)
T COG1718 115 ARKEFRNLKRAYEAGVRVPEPIAFR---------NNVLVMEFIGDDGLPAPRL----KDVPLELEEAEGLYEDVVEYMRR 181 (268)
T ss_pred HHHHHHHHHHHHHcCCCCCCceeec---------CCeEEEEeccCCCCCCCCc----ccCCcCchhHHHHHHHHHHHHHH
Confidence 234555555553 22333333332 358999999754211 112 11223333566777788888888
Q ss_pred HHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccc
Q 046270 384 LHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQS 421 (590)
Q Consensus 384 LH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~ 421 (590)
|-. ..++||+||..-|||+. ++.+.|+|||-+...
T Consensus 182 l~~--~a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~ 216 (268)
T COG1718 182 LYK--EAGLVHGDLSEYNILVH-DGEPYIIDVSQAVTI 216 (268)
T ss_pred HHH--hcCcccccchhhheEEE-CCeEEEEECcccccc
Confidence 772 37999999999999999 889999999987643
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.96 E-value=1.1e-06 Score=96.02 Aligned_cols=181 Identities=18% Similarity=0.123 Sum_probs=128.8
Q ss_pred ceecccCcEEEEEEEEcCCcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCC-ccccceeEEeccCCCCceEEEEEeeCC
Q 046270 270 NLIGQGASGIVYKGTLRHGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRN-LLSLRGCCVTSDDSSGKRRFLVYDYMP 348 (590)
Q Consensus 270 ~~LG~G~fG~Vykg~~~~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~n-lv~l~g~~~~~~~~~~~~~~LV~E~~~ 348 (590)
+-+++|.++.+||.+-...+....+.+... ....-++++|.+++||| .++.++-+. .+....+++++..
T Consensus 248 h~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~-----~E~~~~i~~~i~s 317 (829)
T KOG0576|consen 248 HNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYD-----GEDYLWIPMRICS 317 (829)
T ss_pred HHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCC-----cccccchhhhhhc
Confidence 457899999999987654444445554322 45667899999999999 444443332 3456789999998
Q ss_pred CC-CcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccccCCCcc
Q 046270 349 NG-TLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSH 427 (590)
Q Consensus 349 ~g-sL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~~~~~~~ 427 (590)
.+ +-..... .....+..-+...+.+.-+++++||| +..-+|+| ||+..+ ...|..||+....+....
T Consensus 318 ~~rs~~~~~~--~se~~~~~~~~~~~~r~et~~l~~l~---~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~-- 385 (829)
T KOG0576|consen 318 TGRSSALEMT--VSEIALEQYQFAYPLRKETRPLAELH---SSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM-- 385 (829)
T ss_pred CCccccccCC--hhhHhhhhhhhhhhhhhhcccccccc---cccccCcc----cccccc-cccccccccCCcccCccc--
Confidence 77 2222111 11122334445566677788999999 55568888 777765 578999999987665443
Q ss_pred cccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCC
Q 046270 428 LTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVL 472 (590)
Q Consensus 428 ~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~ 472 (590)
......+|+.|+|||....+.+..+.|+|+.|+--.++.-|-.|-
T Consensus 386 ~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 386 KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 344567899999999999999999999999999877777777664
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.94 E-value=0.00017 Score=85.19 Aligned_cols=83 Identities=11% Similarity=0.236 Sum_probs=57.6
Q ss_pred cceecccCcEEEEEEEEcCC---cEEEEEEeecCC-CCChHHHHHHHHHHHhcC-CCCc--cccceeEEeccCCCCceEE
Q 046270 269 NNLIGQGASGIVYKGTLRHG---NLVAVKQILDLD-TKGDEDFTNEVEIISKIR-HRNL--LSLRGCCVTSDDSSGKRRF 341 (590)
Q Consensus 269 ~~~LG~G~fG~Vykg~~~~g---~~vAvK~l~~~~-~~~~~~f~~Ev~il~~l~-H~nl--v~l~g~~~~~~~~~~~~~~ 341 (590)
...|+.|.+..+|+....++ ..+++|+..... ......+.+|+++++.+. |.++ .+++++|.+.. ..+..|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~--v~G~~f 120 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDAS--VIGTAF 120 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCC--cCCCce
Confidence 46789999999999887654 367777653322 123457889999999995 6765 56666665432 223478
Q ss_pred EEEeeCCCCCcc
Q 046270 342 LVYDYMPNGTLS 353 (590)
Q Consensus 342 LV~E~~~~gsL~ 353 (590)
+||||+++..+.
T Consensus 121 lVME~v~G~~~~ 132 (822)
T PLN02876 121 YIMEYLEGRIFV 132 (822)
T ss_pred EEEEecCCcccC
Confidence 999999986543
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.94 E-value=0.00011 Score=73.66 Aligned_cols=139 Identities=15% Similarity=0.082 Sum_probs=80.7
Q ss_pred ecccCc-EEEEEEEEcCCcEEEEEEeecCCCCChHHHHHHHHHHHhcC-CCCccccceeEEeccCCCCceEEEEEeeCCC
Q 046270 272 IGQGAS-GIVYKGTLRHGNLVAVKQILDLDTKGDEDFTNEVEIISKIR-HRNLLSLRGCCVTSDDSSGKRRFLVYDYMPN 349 (590)
Q Consensus 272 LG~G~f-G~Vykg~~~~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~-H~nlv~l~g~~~~~~~~~~~~~~LV~E~~~~ 349 (590)
|-.|.. ..||+...+ +..+.||+..... ..++.+|++++..+. +--+.+++++... +...++|||+++|
T Consensus 6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~-----~~~~~lv~e~i~G 76 (244)
T cd05150 6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSD-----DGRAWLLTSAVPG 76 (244)
T ss_pred cCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEec-----CCccEEEEEeeCC
Confidence 444555 789999765 4678888764432 345778999999984 3233355555432 2347899999999
Q ss_pred CCcchhhh----------------hhcc----cccCC--hhhHHHHHH--------------------HHHHHHHHHHh-
Q 046270 350 GTLSDNIS----------------ISHK----RKQLT--WPQRKKIIV--------------------DVAKGIAYLHY- 386 (590)
Q Consensus 350 gsL~~~L~----------------~~~~----~~~l~--~~~r~~I~~--------------------~ia~gL~yLH~- 386 (590)
.+|..... .-+. ...+. +..+..... .+...+..|-.
T Consensus 77 ~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 156 (244)
T cd05150 77 VPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEAT 156 (244)
T ss_pred ccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhh
Confidence 88764320 0000 00000 000110000 01111222211
Q ss_pred ---cCCCCeEecCCCCCceEECCCCcEEEEeeCCcc
Q 046270 387 ---GLKPGIYHRDIKSTNILLDSELNAKVADFGLAK 419 (590)
Q Consensus 387 ---~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~ 419 (590)
.....++|+|+.|.|||++++....|+||+.+.
T Consensus 157 ~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 157 RPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred CCCcCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 124568999999999999998778899998774
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.89 E-value=0.00017 Score=71.91 Aligned_cols=77 Identities=10% Similarity=0.159 Sum_probs=46.1
Q ss_pred ceecccCcE-EEEEEEEcCCcEEEEEEeecCCCCChHHHHHHHHHHHhcCCC-C--ccccceeEEeccCCCCceEEEEEe
Q 046270 270 NLIGQGASG-IVYKGTLRHGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHR-N--LLSLRGCCVTSDDSSGKRRFLVYD 345 (590)
Q Consensus 270 ~~LG~G~fG-~Vykg~~~~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~-n--lv~l~g~~~~~~~~~~~~~~LV~E 345 (590)
+.|+.||.. .||+. +..+++|.... ......+.+|.+++..+... . +.+.++.....+ .....+++|+
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~--~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~--~~~~~~~l~~ 74 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSA--AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGE--GYPWPWSVYR 74 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCc--cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCcc--CCCcceEEEE
Confidence 467877776 48875 23466775433 22345789999999988642 1 222222221110 1124588999
Q ss_pred eCCCCCcch
Q 046270 346 YMPNGTLSD 354 (590)
Q Consensus 346 ~~~~gsL~~ 354 (590)
+++|.++.+
T Consensus 75 ~i~G~~l~~ 83 (235)
T cd05155 75 WLEGETATA 83 (235)
T ss_pred eecCCCCCc
Confidence 999988753
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.82 E-value=9e-05 Score=69.90 Aligned_cols=129 Identities=18% Similarity=0.210 Sum_probs=88.5
Q ss_pred ccceecccCcEEEEEEEEcCCcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEEEEEeeC
Q 046270 268 QNNLIGQGASGIVYKGTLRHGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFLVYDYM 347 (590)
Q Consensus 268 ~~~~LG~G~fG~Vykg~~~~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~LV~E~~ 347 (590)
....||+|++|.||+|.+. |..+|+|+-+.. .....+..|+++|..+.--++.+=+-++- +-++.|||+
T Consensus 26 v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~d--s~r~~l~kEakiLeil~g~~~~p~vy~yg--------~~~i~me~i 94 (201)
T COG2112 26 VEKELAKGTTSVVYLGEWR-GGEVALKVRRRD--SPRRNLEKEAKILEILAGEGVTPEVYFYG--------EDFIRMEYI 94 (201)
T ss_pred hhhhhhcccccEEEEeecc-CceEEEEEecCC--cchhhHHHHHHHHHHhhhcCCCceEEEec--------hhhhhhhhh
Confidence 3467999999999999998 558888875443 33567999999999998887765443332 135669999
Q ss_pred CCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCC-CCceEECCCCcEEEEeeCCccc
Q 046270 348 PNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIK-STNILLDSELNAKVADFGLAKQ 420 (590)
Q Consensus 348 ~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIK-p~NILLd~~~~~kL~DFGla~~ 420 (590)
.+-.|.+.... .+-+ -+..+++.---|. ..+|-|+.|. |..++|-.+..+.|+||.-|..
T Consensus 95 ~G~~L~~~~~~------~~rk----~l~~vlE~a~~LD---~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 95 DGRPLGKLEIG------GDRK----HLLRVLEKAYKLD---RLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred cCcchhhhhhc------ccHH----HHHHHHHHHHHHH---HhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 98888765421 1222 2334444433355 6788888886 4444444444999999998863
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.74 E-value=0.00083 Score=69.69 Aligned_cols=79 Identities=10% Similarity=0.027 Sum_probs=56.6
Q ss_pred cceecccCcEEEEEEEEcCCcEEEEEEeecCCCCChHHHHHHHHHHHhcCC---CCccccceeEEeccCCCCceEEEEEe
Q 046270 269 NNLIGQGASGIVYKGTLRHGNLVAVKQILDLDTKGDEDFTNEVEIISKIRH---RNLLSLRGCCVTSDDSSGKRRFLVYD 345 (590)
Q Consensus 269 ~~~LG~G~fG~Vykg~~~~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H---~nlv~l~g~~~~~~~~~~~~~~LV~E 345 (590)
...||.|..+.||+-...+++ +.+|..+. ......|..|.+.|+.|.. -.+.+++++|.... ..+..+||||
T Consensus 19 ~~~i~~G~~~~vy~~~~~~~~-~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~--~~g~~~LVmE 93 (297)
T PRK10593 19 VECISEQPYAALWALYDSQGN-PMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQ--SPGPDVLLLE 93 (297)
T ss_pred eeecCCccceeEEEEEcCCCC-EEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCC--cCCCeEEEEe
Confidence 457999999999999876664 66666432 1123578999999999954 35667777765422 2345899999
Q ss_pred eCCCCCc
Q 046270 346 YMPNGTL 352 (590)
Q Consensus 346 ~~~~gsL 352 (590)
+++++++
T Consensus 94 ~i~G~~~ 100 (297)
T PRK10593 94 RLRGVSV 100 (297)
T ss_pred ccCCEec
Confidence 9998766
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.65 E-value=0.00024 Score=68.97 Aligned_cols=130 Identities=24% Similarity=0.424 Sum_probs=93.4
Q ss_pred cCCCccceecccCc-EEEEEEEEcCCcEEEEEEeecC---C---------C---------CChHHHHHHHHHHHhcC---
Q 046270 264 NGFSQNNLIGQGAS-GIVYKGTLRHGNLVAVKQILDL---D---------T---------KGDEDFTNEVEIISKIR--- 318 (590)
Q Consensus 264 ~~f~~~~~LG~G~f-G~Vykg~~~~g~~vAvK~l~~~---~---------~---------~~~~~f~~Ev~il~~l~--- 318 (590)
.+++..+.||.|.- |.|||..+. |+.+|+|.++.. . . .....|..|.+...+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~-g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEID-GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEEC-CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 77888899999999 999999998 779999994220 0 0 01135889999988885
Q ss_pred CCCc--cccceeEEeccC-------------CCCceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHH
Q 046270 319 HRNL--LSLRGCCVTSDD-------------SSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAY 383 (590)
Q Consensus 319 H~nl--v~l~g~~~~~~~-------------~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~y 383 (590)
+.++ |+.+||..-..+ .......+|.||++... .++ .+-+.+|.+-|..
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~----~~~~~~~~~dl~~ 179 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQ----IRDIPQMLRDLKI 179 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccc----hhHHHHHHHHHHH
Confidence 4456 888998754421 11233567888876532 122 2334567777888
Q ss_pred HHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCc
Q 046270 384 LHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLA 418 (590)
Q Consensus 384 LH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla 418 (590)
+| +.+|+-+|+|+.|.. .-||+|||.+
T Consensus 180 ~~---k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 180 LH---KLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HH---HCCeeeccCcccccc-----CCEEEecccC
Confidence 99 999999999999987 5689999864
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.62 E-value=0.00094 Score=65.04 Aligned_cols=129 Identities=19% Similarity=0.244 Sum_probs=88.4
Q ss_pred ccceecccCcEEEEEEEEcCCcEEEEEEeecCC----------------CCChHHHHHHHHHHHhcC------CCCcccc
Q 046270 268 QNNLIGQGASGIVYKGTLRHGNLVAVKQILDLD----------------TKGDEDFTNEVEIISKIR------HRNLLSL 325 (590)
Q Consensus 268 ~~~~LG~G~fG~Vykg~~~~g~~vAvK~l~~~~----------------~~~~~~f~~Ev~il~~l~------H~nlv~l 325 (590)
....||+|+.-.||. +++.....||++.... ....++..+|+.-...+. +..|.++
T Consensus 5 ~~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 5 ESDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CCcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 456899999999996 4555667888876544 223567778888777776 7889999
Q ss_pred ceeEEeccCCCCceEEEEEeeCCC--CC----cchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCC
Q 046270 326 RGCCVTSDDSSGKRRFLVYDYMPN--GT----LSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKS 399 (590)
Q Consensus 326 ~g~~~~~~~~~~~~~~LV~E~~~~--gs----L~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp 399 (590)
+|+..+.-. .-+|+|.+.+ |+ |.+++ ..+.++. ...+.+.+. ..||- +..|+.+|++|
T Consensus 83 ~G~veT~~G-----~Glv~e~I~d~dG~~s~TL~~~l----~~~~~~~-~~~~~L~~f---~~~l~---~~~Iv~~dl~~ 146 (199)
T PF10707_consen 83 YGFVETNLG-----LGLVVELIRDADGNISPTLEDYL----KEGGLTE-ELRQALDEF---KRYLL---DHHIVIRDLNP 146 (199)
T ss_pred eEEEecCCc-----eEEEEEEEECCCCCcCccHHHHH----HcCCccH-HHHHHHHHH---HHHHH---HcCCeecCCCc
Confidence 999876443 6788887653 33 55555 3345665 444444444 44555 67799999999
Q ss_pred CceEECCC--C--cEEEEe
Q 046270 400 TNILLDSE--L--NAKVAD 414 (590)
Q Consensus 400 ~NILLd~~--~--~~kL~D 414 (590)
.||++... + .+.|+|
T Consensus 147 ~NIv~~~~~~~~~~lvlID 165 (199)
T PF10707_consen 147 HNIVVQRRDSGEFRLVLID 165 (199)
T ss_pred ccEEEEecCCCceEEEEEe
Confidence 99999533 2 467777
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.60 E-value=0.0005 Score=70.92 Aligned_cols=147 Identities=15% Similarity=0.169 Sum_probs=87.0
Q ss_pred cceecccCcEEEEEEEEcCCcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCC--ccccceeEEecc-CCCCceEEEEEe
Q 046270 269 NNLIGQGASGIVYKGTLRHGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRN--LLSLRGCCVTSD-DSSGKRRFLVYD 345 (590)
Q Consensus 269 ~~~LG~G~fG~Vykg~~~~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~n--lv~l~g~~~~~~-~~~~~~~~LV~E 345 (590)
.+.|..|-...+|+....+ ..+++|+... ...+....|++++..+++.+ +.+++....... ...++..++|++
T Consensus 19 i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTTDS-GRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEeCC-CcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 4567777778999987654 4688887654 33456778999999886544 333332110000 001235689999
Q ss_pred eCCCCCcch----hh----------hhhcc--------cccCChhhHH----------HHHHHHHHHHHHHHh----cCC
Q 046270 346 YMPNGTLSD----NI----------SISHK--------RKQLTWPQRK----------KIIVDVAKGIAYLHY----GLK 389 (590)
Q Consensus 346 ~~~~gsL~~----~L----------~~~~~--------~~~l~~~~r~----------~I~~~ia~gL~yLH~----~~~ 389 (590)
|++|..+.. .+ +.... .....|.... .....+...+.++.. ...
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 999877643 01 10000 0112332221 111223344555542 224
Q ss_pred CCeEecCCCCCceEECCCCcEEEEeeCCcc
Q 046270 390 PGIYHRDIKSTNILLDSELNAKVADFGLAK 419 (590)
Q Consensus 390 ~~ivHrDIKp~NILLd~~~~~kL~DFGla~ 419 (590)
.+++|+|+.|.|||++++....|.||+.+.
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 579999999999999998777899998775
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.53 E-value=0.00058 Score=69.03 Aligned_cols=137 Identities=12% Similarity=0.102 Sum_probs=77.5
Q ss_pred ecccCcEEEEEEEEcCCcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCccc-cceeEEeccCCCCceEEEEEeeCCCC
Q 046270 272 IGQGASGIVYKGTLRHGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLS-LRGCCVTSDDSSGKRRFLVYDYMPNG 350 (590)
Q Consensus 272 LG~G~fG~Vykg~~~~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv~-l~g~~~~~~~~~~~~~~LV~E~~~~g 350 (590)
+..|-.+.+|+... +|..+++|........-.-+..+|.++++.+....+++ +++... ..+||||+++.
T Consensus 4 ~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~---------~~~v~e~i~G~ 73 (256)
T TIGR02721 4 LSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE---------HWLLVEWLEGE 73 (256)
T ss_pred CCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC---------CEEEEEeccCc
Confidence 45566778998874 46678888754322221124678999999997555543 232211 36899999987
Q ss_pred Ccchh-------h----------hhhc-ccccCChhhHH-HHHHH---------HHHHHHHHHh-----cCCCCeEecCC
Q 046270 351 TLSDN-------I----------SISH-KRKQLTWPQRK-KIIVD---------VAKGIAYLHY-----GLKPGIYHRDI 397 (590)
Q Consensus 351 sL~~~-------L----------~~~~-~~~~l~~~~r~-~I~~~---------ia~gL~yLH~-----~~~~~ivHrDI 397 (590)
.+... + +... ....++...+. ....+ +.+-+..+-. .....++|+|+
T Consensus 74 ~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl 153 (256)
T TIGR02721 74 VITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDV 153 (256)
T ss_pred ccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCC
Confidence 76431 0 1000 01111211111 11111 1111222211 11346899999
Q ss_pred CCCceEECCCCcEEEEeeCCcc
Q 046270 398 KSTNILLDSELNAKVADFGLAK 419 (590)
Q Consensus 398 Kp~NILLd~~~~~kL~DFGla~ 419 (590)
.|.||++++++ ++|+||..+.
T Consensus 154 ~~~Nil~~~~~-~~lIDwE~a~ 174 (256)
T TIGR02721 154 HAYNLVVTPQG-LKLIDWEYAS 174 (256)
T ss_pred CcCcEEEeCCC-CEEEeccccC
Confidence 99999999876 7899998875
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.50 E-value=0.00098 Score=66.21 Aligned_cols=75 Identities=19% Similarity=0.193 Sum_probs=48.7
Q ss_pred ceecccCcEEEEEEEEcC--CcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEEEEEeeC
Q 046270 270 NLIGQGASGIVYKGTLRH--GNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFLVYDYM 347 (590)
Q Consensus 270 ~~LG~G~fG~Vykg~~~~--g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~LV~E~~ 347 (590)
+.|..|-...+|+....+ +..+++|..... ....-+..+|+.++..+...++++-+ ++.. + ..++|||+
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~-~~~~~d~~~E~~~~~~l~~~gl~P~v-~~~~-~------~~~l~e~i 74 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNK-TELIIDRERELRIHKLLSKHGLAPKL-YATF-Q------NGLIYEFI 74 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCC-ccceecHHHHHHHHHHHHhCCCCCeE-EEEe-C------CcEEEEee
Confidence 457777778999998764 567888865432 22222345799999999655554433 1111 1 14799999
Q ss_pred CCCCcc
Q 046270 348 PNGTLS 353 (590)
Q Consensus 348 ~~gsL~ 353 (590)
++.++.
T Consensus 75 ~G~~l~ 80 (235)
T cd05157 75 PGRTLE 80 (235)
T ss_pred CCCcCC
Confidence 997764
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.40 E-value=0.003 Score=65.96 Aligned_cols=143 Identities=15% Similarity=0.249 Sum_probs=79.2
Q ss_pred ceecccCcEEEEEEEEcCCcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCc--cccceeEEeccC----CCCceEEEE
Q 046270 270 NLIGQGASGIVYKGTLRHGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNL--LSLRGCCVTSDD----SSGKRRFLV 343 (590)
Q Consensus 270 ~~LG~G~fG~Vykg~~~~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nl--v~l~g~~~~~~~----~~~~~~~LV 343 (590)
+.|+.|....+|+....+| .+++|+... ...+....|++++..|...++ .+.+. ..+. ..++..+++
T Consensus 28 ~~l~~G~~n~~y~v~t~~g-~~vLK~~~~---~~~~~l~~~~~~l~~L~~~glpvP~~i~---~~~G~~~~~~~g~~~~l 100 (319)
T PRK05231 28 KGIAEGIENSNFFLTTTQG-EYVLTLFER---LTAEDLPFFLGLMQHLAARGVPVPAPVA---RRDGAALGELAGKPAAI 100 (319)
T ss_pred chhccccccceEEEEeCCC-cEEEEEecc---CChHHhHHHHHHHHHHHHCCCCCCccee---CCCCCEeeeeCCEEEEE
Confidence 4566677779999887655 588887641 233455567777777743332 22221 1110 013457899
Q ss_pred EeeCCCCCcch-----------hh---hhhcc--------cccCCh-hhHHH------------HH-HHHHHHHHHHHh-
Q 046270 344 YDYMPNGTLSD-----------NI---SISHK--------RKQLTW-PQRKK------------II-VDVAKGIAYLHY- 386 (590)
Q Consensus 344 ~E~~~~gsL~~-----------~L---~~~~~--------~~~l~~-~~r~~------------I~-~~ia~gL~yLH~- 386 (590)
+||++|..+.. .| +.... ...+.| ..... .+ ..+...+..+..
T Consensus 101 ~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 180 (319)
T PRK05231 101 VTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASA 180 (319)
T ss_pred EEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhcc
Confidence 99999876521 11 10000 001212 21111 11 111112233321
Q ss_pred ---cCCCCeEecCCCCCceEECCCCcEEEEeeCCcc
Q 046270 387 ---GLKPGIYHRDIKSTNILLDSELNAKVADFGLAK 419 (590)
Q Consensus 387 ---~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~ 419 (590)
....+++|+|+++.||+++++...-|+||+.+.
T Consensus 181 ~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 181 AWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred ccccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 135689999999999999976556899999875
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.32 E-value=0.00076 Score=79.07 Aligned_cols=201 Identities=17% Similarity=0.159 Sum_probs=131.1
Q ss_pred HHHHHHHHHhcCCCCccccceeEEeccCCCCceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHh
Q 046270 307 FTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHY 386 (590)
Q Consensus 307 f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~ 386 (590)
...|++.+.++.|+|++.+++|-..... .+-...+.-|++..-++...+. .-...+....+.+..+..+||.|+|
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~-~g~~~~v~~~~~s~~~~~~~~q---~v~~i~~~~~r~~~~~~~~GL~~~h- 303 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLF-RGIVLDVLQEICSKVELRSLLQ---SVGSIPLETLRILHQKLLEGLAYLH- 303 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhc-chHHHHHHHhhcCccchHHHHh---hccccCHHHHHHHHHHHhhhHHHHH-
Confidence 3457788889999999999988775432 1212234457777777777663 4456888899999999999999999
Q ss_pred cCCCCeEecCCCCC---ceEECCCCcEEEE--eeCCcccccCCCcccccccccCCCccCccccccCCCCc--chhHHHHH
Q 046270 387 GLKPGIYHRDIKST---NILLDSELNAKVA--DFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALYGQLTE--KSDVYSFG 459 (590)
Q Consensus 387 ~~~~~ivHrDIKp~---NILLd~~~~~kL~--DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~--ksDVySfG 459 (590)
.....|.-+..+ +...+.++...++ ||+..+......... ...-+..|.+||......+.. ..|+|.+|
T Consensus 304 --~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~--~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lg 379 (1351)
T KOG1035|consen 304 --SLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSF--SDLLAEIRNADEDLKENTAKKSRLTDLWCLG 379 (1351)
T ss_pred --HhccceeEEecccccccccCccceeecchhhhcccccCCCcccch--hhcCccccccccccccccchhhhhhHHHHHH
Confidence 555555544444 4445666667776 888877554322211 112245677888776655444 47999999
Q ss_pred HHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 460 IVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 460 vvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
..++.+..|..+-....... .+++... . ..+......|...++++|+...+++.+
T Consensus 380 ll~~~~~~~~~i~~~~~~~~-----------------~~l~~~~----~----~~~~d~~~~~~~~~~~~Rl~~~~ll~~ 434 (1351)
T KOG1035|consen 380 LLLLQLSQGEDISEKSAVPV-----------------SLLDVLS----T----SELLDALPKCLDEDSEERLSALELLTH 434 (1351)
T ss_pred HHHhhhhhcCcccccccchh-----------------hhhcccc----c----hhhhhhhhhhcchhhhhccchhhhhhc
Confidence 99999998875432211111 1111110 0 023344557999999999999999876
Q ss_pred hc
Q 046270 540 LE 541 (590)
Q Consensus 540 L~ 541 (590)
.-
T Consensus 435 ~f 436 (1351)
T KOG1035|consen 435 PF 436 (1351)
T ss_pred hh
Confidence 53
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.31 E-value=0.0033 Score=67.72 Aligned_cols=75 Identities=17% Similarity=0.119 Sum_probs=52.0
Q ss_pred ceecccCcEEEEEEEEcCC-cEEEEEEeecCC-------CCChHHHHHHHHHHHhcC-C--CCccccceeEEeccCCCCc
Q 046270 270 NLIGQGASGIVYKGTLRHG-NLVAVKQILDLD-------TKGDEDFTNEVEIISKIR-H--RNLLSLRGCCVTSDDSSGK 338 (590)
Q Consensus 270 ~~LG~G~fG~Vykg~~~~g-~~vAvK~l~~~~-------~~~~~~f~~Ev~il~~l~-H--~nlv~l~g~~~~~~~~~~~ 338 (590)
+.||.|.+..||+....+| +.++||.-.... .-..+.+..|.+.|..+. + .++.+++.+- ..
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D-------~~ 104 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD-------EE 104 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC-------CC
Confidence 5689999999999999887 489999853211 123456778888888873 2 3455555542 22
Q ss_pred eEEEEEeeCCCCC
Q 046270 339 RRFLVYDYMPNGT 351 (590)
Q Consensus 339 ~~~LV~E~~~~gs 351 (590)
..++||||+++..
T Consensus 105 ~~~lVME~L~~~~ 117 (401)
T PRK09550 105 LAVTVMEDLSDHK 117 (401)
T ss_pred CCEEEEecCCCcc
Confidence 3689999998744
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.20 E-value=0.0094 Score=61.95 Aligned_cols=148 Identities=15% Similarity=0.185 Sum_probs=84.6
Q ss_pred cceecccCcEEEEEEEEcCCcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCC--ccccceeEEec-cCCCCceEEEEEe
Q 046270 269 NNLIGQGASGIVYKGTLRHGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRN--LLSLRGCCVTS-DDSSGKRRFLVYD 345 (590)
Q Consensus 269 ~~~LG~G~fG~Vykg~~~~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~n--lv~l~g~~~~~-~~~~~~~~~LV~E 345 (590)
...++.|--..+|+....+| .+++|+.... ...++...|++++..|.... +.+++...... ....++..++++|
T Consensus 27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~--~~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e 103 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKR--VKAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE 103 (307)
T ss_pred ccccCCccccceEEEEeCCC-cEEEEEecCC--CCHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence 34566676689999876655 5777875432 22455677888888885433 33333321100 0012345789999
Q ss_pred eCCCCCcchh--------------hhhhccc---------ccCChhhHH------------HHHHHHHHHHHHHHh----
Q 046270 346 YMPNGTLSDN--------------ISISHKR---------KQLTWPQRK------------KIIVDVAKGIAYLHY---- 386 (590)
Q Consensus 346 ~~~~gsL~~~--------------L~~~~~~---------~~l~~~~r~------------~I~~~ia~gL~yLH~---- 386 (590)
|++|..+... ++..... ..-.|.... .....+.+.++++..
T Consensus 104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~ 183 (307)
T TIGR00938 104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR 183 (307)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence 9998665311 1100000 011222111 011223345555542
Q ss_pred cCCCCeEecCCCCCceEECCCCcEEEEeeCCcc
Q 046270 387 GLKPGIYHRDIKSTNILLDSELNAKVADFGLAK 419 (590)
Q Consensus 387 ~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~ 419 (590)
....+++|+|+++.||+++++....|.||+.+.
T Consensus 184 ~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 184 DLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred cCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 235789999999999999988777899999774
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.00 E-value=0.0013 Score=67.76 Aligned_cols=132 Identities=20% Similarity=0.173 Sum_probs=90.2
Q ss_pred CCCccceecccCcEEEEEEEEcCCcEEEEEEeecC----------------CCCC------hHHHHHHHHHHHhcCC-C-
Q 046270 265 GFSQNNLIGQGASGIVYKGTLRHGNLVAVKQILDL----------------DTKG------DEDFTNEVEIISKIRH-R- 320 (590)
Q Consensus 265 ~f~~~~~LG~G~fG~Vykg~~~~g~~vAvK~l~~~----------------~~~~------~~~f~~Ev~il~~l~H-~- 320 (590)
-++..+.||-|.-+.||.+...+|++.++|.-+-. ..++ .-...+|...|+.|.. .
T Consensus 93 v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 35677899999999999999999999998853110 0000 0124568888888843 2
Q ss_pred CccccceeEEeccCCCCceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCC
Q 046270 321 NLLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKST 400 (590)
Q Consensus 321 nlv~l~g~~~~~~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~ 400 (590)
-+.+.+++ ...++|||++.+-.|...-+ ..+...++.-+.++ +.-|. ..|+||+|..-=
T Consensus 173 pVPkpiD~---------~RH~Vvmelv~g~Pl~~v~~------v~d~~~ly~~lm~~---Iv~la---~~GlIHgDFNEF 231 (465)
T KOG2268|consen 173 PVPKPIDH---------NRHCVVMELVDGYPLRQVRH------VEDPPTLYDDLMGL---IVRLA---NHGLIHGDFNEF 231 (465)
T ss_pred CCCCcccc---------cceeeHHHhhcccceeeeee------cCChHHHHHHHHHH---HHHHH---HcCceecccchh
Confidence 23333433 34799999999888865321 23333333333333 34455 789999999999
Q ss_pred ceEECCCCcEEEEeeCC
Q 046270 401 NILLDSELNAKVADFGL 417 (590)
Q Consensus 401 NILLd~~~~~kL~DFGl 417 (590)
||+++++..++++||--
T Consensus 232 Nimv~dd~~i~vIDFPQ 248 (465)
T KOG2268|consen 232 NIMVKDDDKIVVIDFPQ 248 (465)
T ss_pred eeEEecCCCEEEeechH
Confidence 99999999999999953
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.99 E-value=0.0099 Score=61.02 Aligned_cols=32 Identities=25% Similarity=0.410 Sum_probs=26.0
Q ss_pred CCCeEecCCCCCceEECCCCc-EEEEeeCCccc
Q 046270 389 KPGIYHRDIKSTNILLDSELN-AKVADFGLAKQ 420 (590)
Q Consensus 389 ~~~ivHrDIKp~NILLd~~~~-~kL~DFGla~~ 420 (590)
...++|+|+++.|||++++++ .-|.||+.+..
T Consensus 184 ~~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 184 HTVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CCeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 345899999999999997555 46999998753
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.75 E-value=0.013 Score=60.50 Aligned_cols=140 Identities=24% Similarity=0.265 Sum_probs=82.6
Q ss_pred ceecccCcEEEEEEEEcC-------CcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCcc-ccceeEEeccCCCCceEE
Q 046270 270 NLIGQGASGIVYKGTLRH-------GNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLL-SLRGCCVTSDDSSGKRRF 341 (590)
Q Consensus 270 ~~LG~G~fG~Vykg~~~~-------g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv-~l~g~~~~~~~~~~~~~~ 341 (590)
+.|..|--..+|+....+ +..+++|...... ....+..+|.+++..+...++. ++++++. -.
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~---------~~ 73 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFP---------NG 73 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeC---------CC
Confidence 345555556899988765 4778888864432 2334567899999998655444 3344332 13
Q ss_pred EEEeeCCCCCcchh-h----------------hhhcccc--------cCChhhHHH------------------------
Q 046270 342 LVYDYMPNGTLSDN-I----------------SISHKRK--------QLTWPQRKK------------------------ 372 (590)
Q Consensus 342 LV~E~~~~gsL~~~-L----------------~~~~~~~--------~l~~~~r~~------------------------ 372 (590)
+|+||++|..+... + +...... ..-|..+..
T Consensus 74 ~v~e~i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (302)
T cd05156 74 RIEEFIPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVEL 153 (302)
T ss_pred chhheeCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhH
Confidence 58999998777431 1 1000000 001111111
Q ss_pred --HHHHHHHHHHHHHh------cCCCCeEecCCCCCceEECCC----CcEEEEeeCCcc
Q 046270 373 --IIVDVAKGIAYLHY------GLKPGIYHRDIKSTNILLDSE----LNAKVADFGLAK 419 (590)
Q Consensus 373 --I~~~ia~gL~yLH~------~~~~~ivHrDIKp~NILLd~~----~~~kL~DFGla~ 419 (590)
+...+.+-+.+|.. .....++|+|+.+.|||++++ +.++++||..+.
T Consensus 154 ~~~~~~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 154 SLFLEDEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred HHHHHHHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 11122222334431 245689999999999999985 789999998875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.49 E-value=0.019 Score=60.82 Aligned_cols=140 Identities=17% Similarity=0.189 Sum_probs=80.1
Q ss_pred eecccCcEEEEEEEEcC-----CcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCcc-ccceeEEeccCCCCceEEEEE
Q 046270 271 LIGQGASGIVYKGTLRH-----GNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLL-SLRGCCVTSDDSSGKRRFLVY 344 (590)
Q Consensus 271 ~LG~G~fG~Vykg~~~~-----g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv-~l~g~~~~~~~~~~~~~~LV~ 344 (590)
.|-.|---.+|+..+.+ +..+++|....... ..-+-.+|..++..+...++. +++++.. . ..|+
T Consensus 43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~-~~idR~~E~~~~~~l~~~gl~P~~~~~~~-----~----g~v~ 112 (344)
T PLN02236 43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVE-LFFDRDDEIRTFECMSRHGQGPRLLGRFP-----N----GRVE 112 (344)
T ss_pred EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCC-eeechHHHHHHHHHHHHcCCCCceEEEEC-----C----ceEE
Confidence 34345556888887543 35788887654332 222346799999999766555 4444432 1 2589
Q ss_pred eeCCCCCcchh-----------------hhhhc---ccccCChhhHHHHHHH-----------------HHHHHHHHH--
Q 046270 345 DYMPNGTLSDN-----------------ISISH---KRKQLTWPQRKKIIVD-----------------VAKGIAYLH-- 385 (590)
Q Consensus 345 E~~~~gsL~~~-----------------L~~~~---~~~~l~~~~r~~I~~~-----------------ia~gL~yLH-- 385 (590)
||+++.+|... ++... ......|.+..++..+ +...+..|.
T Consensus 113 efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~ 192 (344)
T PLN02236 113 EFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKE 192 (344)
T ss_pred EeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHH
Confidence 99988777421 01100 0001123333233211 111222222
Q ss_pred --h-cCCCCeEecCCCCCceEECC-CCcEEEEeeCCccc
Q 046270 386 --Y-GLKPGIYHRDIKSTNILLDS-ELNAKVADFGLAKQ 420 (590)
Q Consensus 386 --~-~~~~~ivHrDIKp~NILLd~-~~~~kL~DFGla~~ 420 (590)
. .....++|+|+++.|||+++ +..+.++||..+..
T Consensus 193 ~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 193 LSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred hcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 1 22457899999999999986 46799999988764
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.47 E-value=0.044 Score=57.17 Aligned_cols=136 Identities=17% Similarity=0.211 Sum_probs=80.3
Q ss_pred ccCcE-EEEEEEEcCCcEEEEEEee-cCCCCChHHHHHHHHHHHhcCCCC--ccccceeEEeccCCCCceEEEEEeeCCC
Q 046270 274 QGASG-IVYKGTLRHGNLVAVKQIL-DLDTKGDEDFTNEVEIISKIRHRN--LLSLRGCCVTSDDSSGKRRFLVYDYMPN 349 (590)
Q Consensus 274 ~G~fG-~Vykg~~~~g~~vAvK~l~-~~~~~~~~~f~~Ev~il~~l~H~n--lv~l~g~~~~~~~~~~~~~~LV~E~~~~ 349 (590)
+||+. .+|..... ++..++++-. ...........+|.++|+.+.--- +-..+++|.... -...+.||+|.++
T Consensus 34 ~~G~sn~t~~~~~~-~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~---~g~pf~v~~~veG 109 (321)
T COG3173 34 SGGWSNDTFRLGDT-GQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGY---LGTPFYVMEWVEG 109 (321)
T ss_pred cCCcccceEEEecC-CceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCC---CCCceEEEEEecc
Confidence 34443 34444333 6777777211 122233456778888888885422 234455554322 2357999999998
Q ss_pred CCcchhhhhhcccccCChhhHHHHH-HHHHHHHHHHHh------------------------------------------
Q 046270 350 GTLSDNISISHKRKQLTWPQRKKII-VDVAKGIAYLHY------------------------------------------ 386 (590)
Q Consensus 350 gsL~~~L~~~~~~~~l~~~~r~~I~-~~ia~gL~yLH~------------------------------------------ 386 (590)
..+.+.+... ... .+++ ..+++.|+-||.
T Consensus 110 e~~~~~~~~~----~~~----~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~ 181 (321)
T COG3173 110 EVVWSALPPE----SLG----RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLAD 181 (321)
T ss_pred eeccCcCCcc----cch----HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHH
Confidence 6554433210 011 1111 245555555552
Q ss_pred --------c-----CCCCeEecCCCCCceEECCCCcEEEEeeCCcccc
Q 046270 387 --------G-----LKPGIYHRDIKSTNILLDSELNAKVADFGLAKQS 421 (590)
Q Consensus 387 --------~-----~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~ 421 (590)
. ....++|||+++.||+++.+.-.-|.||+++...
T Consensus 182 ~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 182 RLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred HHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence 1 1456999999999999999888999999998643
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.32 E-value=0.041 Score=56.98 Aligned_cols=69 Identities=14% Similarity=0.161 Sum_probs=41.9
Q ss_pred EEEEEEEcCCcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCccccceeEEeccC----CCCceEEEEEeeCCCCCcc
Q 046270 279 IVYKGTLRHGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDD----SSGKRRFLVYDYMPNGTLS 353 (590)
Q Consensus 279 ~Vykg~~~~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~----~~~~~~~LV~E~~~~gsL~ 353 (590)
.||+...++| .+++|+... ....+..|+.++..|....+ ++.......+. ..++..++++||++|..+.
T Consensus 11 ~v~~v~t~~g-~~~LK~~~~----~~~~~~~~~~~~~~L~~~g~-~vp~~i~t~~g~~~~~~~~~~~~l~~~i~G~~~~ 83 (313)
T TIGR02906 11 NVYKVETDSG-NKCLKKINY----PPERLLFILGAQEHLRKNGF-NIPKILKTKDGELYVKYNGDLYVLTEWIEGRECD 83 (313)
T ss_pred cEEEEEeCCC-CeEEEEcCC----CHHHHHHHHHHHHHHHHcCC-CCCceeecCCCCEEEEECCEEEEEehhccCcCCC
Confidence 4888876655 578888632 23456678888888854443 33222222111 0134689999999986653
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.30 E-value=0.43 Score=57.88 Aligned_cols=147 Identities=16% Similarity=0.295 Sum_probs=81.7
Q ss_pred ceecccCcEEEEEEEEcCCcEEEEEEeecCCCCChHHHHHHHHHHHhcCC--CC-----ccccc-eeEE-eccCCCCc-e
Q 046270 270 NLIGQGASGIVYKGTLRHGNLVAVKQILDLDTKGDEDFTNEVEIISKIRH--RN-----LLSLR-GCCV-TSDDSSGK-R 339 (590)
Q Consensus 270 ~~LG~G~fG~Vykg~~~~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H--~n-----lv~l~-g~~~-~~~~~~~~-~ 339 (590)
+.|+ |..-.+|+....+|..+++|+..... .......|.++|..|.. +. +++-. |-.. .....++. +
T Consensus 31 ~~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~--~~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~ 107 (1013)
T PRK06148 31 TPLD-GERDLNFRLTTDDGADYILKIVNPSE--PRVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPR 107 (1013)
T ss_pred eecC-CcCCceEEEEeCCCCeEEEEEcCCcc--chhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceE
Confidence 3453 45577898888888889999886532 33445566677766632 22 22211 1111 11111222 4
Q ss_pred EEEEEeeCCCCCcchhh-----------------hh------h-cccccCChhh-----------------HHHHHHHHH
Q 046270 340 RFLVYDYMPNGTLSDNI-----------------SI------S-HKRKQLTWPQ-----------------RKKIIVDVA 378 (590)
Q Consensus 340 ~~LV~E~~~~gsL~~~L-----------------~~------~-~~~~~l~~~~-----------------r~~I~~~ia 378 (590)
.+-+++|+++..|.+.. +. . .....+.|.. +..++.++.
T Consensus 108 ~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~~ 187 (1013)
T PRK06148 108 LLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERFL 187 (1013)
T ss_pred EEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHHH
Confidence 67789999998775410 00 0 0012244432 122233333
Q ss_pred HHHHH----HHhcCCCCeEecCCCCCceEECCCC--cEE-EEeeCCcc
Q 046270 379 KGIAY----LHYGLKPGIYHRDIKSTNILLDSEL--NAK-VADFGLAK 419 (590)
Q Consensus 379 ~gL~y----LH~~~~~~ivHrDIKp~NILLd~~~--~~k-L~DFGla~ 419 (590)
....- .......++||+|+.+.|||++.+. ++. |+|||-+.
T Consensus 188 ~~~~~~v~p~l~~Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~ 235 (1013)
T PRK06148 188 ARFERNVAPRLAALPAQVIHNDANDYNILVDADDGERISGLIDFGDAV 235 (1013)
T ss_pred HHHHHHHHHHHhcCCcceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence 32221 1123357899999999999999875 555 99999775
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.26 E-value=0.066 Score=56.30 Aligned_cols=140 Identities=18% Similarity=0.321 Sum_probs=84.2
Q ss_pred CcEEEEEEEEcCCcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCcc------ccceeEEeccCCCCceEEEEEeeCCC
Q 046270 276 ASGIVYKGTLRHGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLL------SLRGCCVTSDDSSGKRRFLVYDYMPN 349 (590)
Q Consensus 276 ~fG~Vykg~~~~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv------~l~g~~~~~~~~~~~~~~LV~E~~~~ 349 (590)
.-..||+....+|+. ++|..... ....++..|+..+..|.-.++. .+-|-....-. .+.+.+-+++|++|
T Consensus 37 ~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~-~~~r~a~lf~~l~G 112 (331)
T COG2334 37 EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALS-GGPRPAALFEYLPG 112 (331)
T ss_pred ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhcc-CCceeEEEEEecCC
Confidence 446799998888777 77765543 5567788899999988433322 22221111111 11478899999999
Q ss_pred CCcch-h----h----------hhhc---------ccccCChhh-------------HHHHHHHHHHHHHHHHhc----C
Q 046270 350 GTLSD-N----I----------SISH---------KRKQLTWPQ-------------RKKIIVDVAKGIAYLHYG----L 388 (590)
Q Consensus 350 gsL~~-~----L----------~~~~---------~~~~l~~~~-------------r~~I~~~ia~gL~yLH~~----~ 388 (590)
..+.. - + +... ......|.. .......+...+..+... .
T Consensus 113 ~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~~l 192 (331)
T COG2334 113 RPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPAHL 192 (331)
T ss_pred cCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchhhC
Confidence 88873 1 0 1000 011244431 112233344444444432 2
Q ss_pred CCC---eEecCCCCCceEECCCCc-EEEEeeCCcc
Q 046270 389 KPG---IYHRDIKSTNILLDSELN-AKVADFGLAK 419 (590)
Q Consensus 389 ~~~---ivHrDIKp~NILLd~~~~-~kL~DFGla~ 419 (590)
... +||+|+.|.||++|++.. ..+.|||-+.
T Consensus 193 p~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 193 PALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred CcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 233 999999999999999985 8899999775
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.88 E-value=0.039 Score=60.22 Aligned_cols=49 Identities=14% Similarity=0.208 Sum_probs=37.8
Q ss_pred hHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEEEEEeeCCCCCcchhhh
Q 046270 304 DEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNIS 357 (590)
Q Consensus 304 ~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~LV~E~~~~gsL~~~L~ 357 (590)
..++.-...+++.+.|+|+...+.+.... .....+|+|++ +.||.+.+.
T Consensus 26 s~~ilgr~~~lktl~~~~l~~yl~~~r~~----~~r~IVV~e~~-~~Sled~~~ 74 (725)
T KOG1093|consen 26 SIQILGRFQYLKSLQHDNLCQYLDFSRGK----HERVIVVMEHY-TMSLEDILK 74 (725)
T ss_pred HHHHhhhhHHHHhhcCccceeeEeeecCc----cceEEEEehhh-ccchHHHHH
Confidence 44567778889999999999888776543 33488999998 678888774
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.74 E-value=0.2 Score=52.58 Aligned_cols=74 Identities=14% Similarity=0.109 Sum_probs=46.8
Q ss_pred cCcEEEEEEEEcCCcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCC--ccccc---eeEEeccCCCCceEEEEEeeCCC
Q 046270 275 GASGIVYKGTLRHGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRN--LLSLR---GCCVTSDDSSGKRRFLVYDYMPN 349 (590)
Q Consensus 275 G~fG~Vykg~~~~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~n--lv~l~---g~~~~~~~~~~~~~~LV~E~~~~ 349 (590)
+.-..||+...++|..+++|.... ......++..|++.+..|.... ++... |-.... -++..+.++++++|
T Consensus 36 s~eN~vy~v~~~~~~~~vlKv~r~-~~~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~---~~g~~~~l~~~~~G 111 (325)
T PRK11768 36 SYENRVYQFGDEDGRRVVAKFYRP-ERWSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHE---HQGFRFALFPRRGG 111 (325)
T ss_pred cccceEEEEecCCCCEEEEEEcCc-ccCCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEE---ECCEEEEEEeeeCC
Confidence 444689999888888899997642 2235667888999988884322 22221 211110 13457889999987
Q ss_pred CCc
Q 046270 350 GTL 352 (590)
Q Consensus 350 gsL 352 (590)
...
T Consensus 112 ~~~ 114 (325)
T PRK11768 112 RAP 114 (325)
T ss_pred CCC
Confidence 654
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=95.72 E-value=0.0019 Score=77.55 Aligned_cols=160 Identities=13% Similarity=0.010 Sum_probs=109.6
Q ss_pred HHHHHHHhcCCCCccccceeEEeccCCCCceEEEEEeeCCCCCcchhhhhhc-ccccCChhhHHHHHHHHHHHHHHHH--
Q 046270 309 NEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISH-KRKQLTWPQRKKIIVDVAKGIAYLH-- 385 (590)
Q Consensus 309 ~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~LV~E~~~~gsL~~~L~~~~-~~~~l~~~~r~~I~~~ia~gL~yLH-- 385 (590)
.|..-++...|++++.... ...+.+..+.+.+++|+..|.+.+.|.... +...++..-......+..-...-.|
T Consensus 1278 ~e~de~~~~~h~~~~~~p~---rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~ 1354 (2724)
T KOG1826|consen 1278 SERDELREAKHYLTEVDPL---RIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSL 1354 (2724)
T ss_pred hhhhhhhhhhceeeecccc---cCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhc
Confidence 3444555668888876543 223334556789999999999998875432 2333443333333333233333333
Q ss_pred hcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHH
Q 046270 386 YGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILEL 465 (590)
Q Consensus 386 ~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlEL 465 (590)
+....--+|+++|+-|.+|+.+.++|++++|+.+...+. ........+++.|+.|+....-+++.++|+|..|+.++++
T Consensus 1355 tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~-~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~r 1433 (2724)
T KOG1826|consen 1355 TNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPV-LSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLR 1433 (2724)
T ss_pred ccCCccchhhhhhhhccceecCCcccccccccccccCch-HhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHH
Confidence 223455789999999999999999999999999833222 2223345567889999999888999999999999999998
Q ss_pred HhCCCCC
Q 046270 466 MSGRKVL 472 (590)
Q Consensus 466 ltG~~p~ 472 (590)
--|..++
T Consensus 1434 s~~n~~f 1440 (2724)
T KOG1826|consen 1434 SDGNAYF 1440 (2724)
T ss_pred hcccHHH
Confidence 8776654
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=95.67 E-value=0.057 Score=53.08 Aligned_cols=153 Identities=18% Similarity=0.224 Sum_probs=98.2
Q ss_pred cCcEEEEEEEEcCCcEEEEEEeecCCCC-ChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEEEEEeeCCCCCcc
Q 046270 275 GASGIVYKGTLRHGNLVAVKQILDLDTK-GDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLS 353 (590)
Q Consensus 275 G~fG~Vykg~~~~g~~vAvK~l~~~~~~-~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~LV~E~~~~gsL~ 353 (590)
+|..+.-+|+-+-| +..+|++....-. ...-|.++.+++++++ .|++|.. + ++...-++.|++-...
T Consensus 73 ~gNsTl~~~kt~iG-~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~N------D-n~~~yGvIlE~Cy~~~-- 140 (308)
T PF07387_consen 73 NGNSTLLIGKTKIG-PLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKN------D-NNYKYGVILERCYKIK-- 140 (308)
T ss_pred CCceEEEEeccccc-hhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeec------C-CCceeEEEEeeccCcc--
Confidence 34455555554443 4567777665555 5667889999999885 3555551 1 4455678889874311
Q ss_pred hhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccccCCCcccccccc
Q 046270 354 DNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVA 433 (590)
Q Consensus 354 ~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~~~~~~~~~~~~~ 433 (590)
.+. ..++.-=.+.|.-.|.+ ..+.+|||..|+||+-|..|.+||.|=+..-..
T Consensus 141 ----------i~~----~N~i~agi~~L~~fH~~-~~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll~~------------ 193 (308)
T PF07387_consen 141 ----------INF----SNFITAGIKDLMDFHSE-NQHCLHGDCNPDNIMCDKFGYLKLVDPVCLLEN------------ 193 (308)
T ss_pred ----------cch----hHHHHHhHHHHHHhhcc-CCCeecCCCChhheeecCCCCEEecChhhhhhh------------
Confidence 111 11222224667788854 578999999999999999999999996643210
Q ss_pred cCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCC
Q 046270 434 GTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRK 470 (590)
Q Consensus 434 gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~ 470 (590)
+.-|.--| +...|.++.+=+|=.-+++++...+
T Consensus 194 -~V~~vN~~---Y~~lT~~aE~~~fv~s~l~~v~~~~ 226 (308)
T PF07387_consen 194 -QVNMVNIE---YESLTQEAEVKVFVKSCLKLVEKQR 226 (308)
T ss_pred -eeeEEeee---ccccChHHHHHHHHHHHHHHHHHHh
Confidence 11233322 3456888899898888888887554
|
The function of this family is unknown. |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.57 E-value=0.072 Score=56.01 Aligned_cols=126 Identities=21% Similarity=0.175 Sum_probs=82.4
Q ss_pred ccccceeEEeccCCCCceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCc
Q 046270 322 LLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTN 401 (590)
Q Consensus 322 lv~l~g~~~~~~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~N 401 (590)
++.+...|....+ ++.+.|++|++. +++|.. ...-.|++.+.|+.+.+.-++-+.. ....-|||+.-.|
T Consensus 284 ~~~~e~~~vv~~d-e~~y~yl~~kdh-gt~is~-------ik~~~~~e~lsff~s~~sil~~lek--kf~fehrnlt~~n 352 (488)
T COG5072 284 SVFLETLKVVSLD-ETLYLYLHFKDH-GTPISI-------IKADRSEEELSFFWSCISILDILEK--KFPFEHRNLTLDN 352 (488)
T ss_pred chhhhcceEEecC-CceEEEEEEecC-Cceeee-------eecccHHHHHHHHHHHHHHHhhhhh--cCCcccccccccc
Confidence 3333333443322 456778888875 555532 2346799999999999988888773 5678899999999
Q ss_pred eEECCCCcEEEEeeCCcccccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCC
Q 046270 402 ILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGR 469 (590)
Q Consensus 402 ILLd~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~ 469 (590)
|||| +|++.|+||-++|....+..-.. ...-.|..+. |.-+.+-|||-+ |--|+.|+
T Consensus 353 iLId-~GnvtLIDfklsRl~~~q~~isy------~rldhp~lF~-G~dd~QFeIYrl---Mr~l~~g~ 409 (488)
T COG5072 353 ILID-EGNVTLIDFKLSRLSYSQGIISY------NRLDHPDLFN-GVDDYQFEIYRL---MRRLLKGR 409 (488)
T ss_pred eeee-cCceEEEEeeeeecccCCceeec------cccCchhhhc-CccceeeeHHHH---HHHHhcCc
Confidence 9999 99999999999995433221111 1223344444 555777788863 33344454
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=95.56 E-value=0.1 Score=54.24 Aligned_cols=32 Identities=16% Similarity=0.232 Sum_probs=28.6
Q ss_pred CCCeEecCCCCCceEECCCCcEEEEeeCCccc
Q 046270 389 KPGIYHRDIKSTNILLDSELNAKVADFGLAKQ 420 (590)
Q Consensus 389 ~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~ 420 (590)
..+++|+|+.+.|||+++++...|+||..+..
T Consensus 195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 56899999999999999999999999987753
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=95.47 E-value=0.19 Score=54.21 Aligned_cols=73 Identities=15% Similarity=0.099 Sum_probs=47.8
Q ss_pred cceecccCcEEEEEEEEcCCcEEEEEEeecCCC-------CChHHHHHHHHHHHhcC---CCCccccceeEEeccCCCCc
Q 046270 269 NNLIGQGASGIVYKGTLRHGNLVAVKQILDLDT-------KGDEDFTNEVEIISKIR---HRNLLSLRGCCVTSDDSSGK 338 (590)
Q Consensus 269 ~~~LG~G~fG~Vykg~~~~g~~vAvK~l~~~~~-------~~~~~f~~Ev~il~~l~---H~nlv~l~g~~~~~~~~~~~ 338 (590)
.+.||.|....||+.... ++.++||+-..... -....-..|.+.|..+. ..++.+++.++.+
T Consensus 37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded------- 108 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT------- 108 (418)
T ss_pred EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC-------
Confidence 357899999999998865 55688998542111 12223344567776653 2466677777652
Q ss_pred eEEEEEeeCCC
Q 046270 339 RRFLVYDYMPN 349 (590)
Q Consensus 339 ~~~LV~E~~~~ 349 (590)
..+++|||+++
T Consensus 109 ~~vlvME~L~~ 119 (418)
T PLN02756 109 MALIGMRYLEP 119 (418)
T ss_pred CCEEEEeecCC
Confidence 25889999977
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=95.40 E-value=0.2 Score=53.25 Aligned_cols=74 Identities=15% Similarity=0.090 Sum_probs=46.4
Q ss_pred eecccCcEEEEEEEEcCC-cEEEEEEeecCC-------CCChHHHHHHHHHHHhcC--CCCccccceeEEeccCCCCceE
Q 046270 271 LIGQGASGIVYKGTLRHG-NLVAVKQILDLD-------TKGDEDFTNEVEIISKIR--HRNLLSLRGCCVTSDDSSGKRR 340 (590)
Q Consensus 271 ~LG~G~fG~Vykg~~~~g-~~vAvK~l~~~~-------~~~~~~f~~Ev~il~~l~--H~nlv~l~g~~~~~~~~~~~~~ 340 (590)
.||.|....||++..++| +.|+||.-...- .-..+...-|.+.|.... -|..|+-+-++ +....
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~------D~e~~ 75 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF------DTEMA 75 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE------ccccc
Confidence 478999999999998765 589999753211 112334556777776653 34444432222 22346
Q ss_pred EEEEeeCCCC
Q 046270 341 FLVYDYMPNG 350 (590)
Q Consensus 341 ~LV~E~~~~g 350 (590)
.+|||+++..
T Consensus 76 ~~vMEdL~~~ 85 (370)
T TIGR01767 76 VTVMEDLSHH 85 (370)
T ss_pred eehHhhCccc
Confidence 7999999753
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=95.35 E-value=0.047 Score=53.36 Aligned_cols=31 Identities=29% Similarity=0.428 Sum_probs=21.8
Q ss_pred CCeEecCCCCCceEE-CCCCcEEEEeeCCccc
Q 046270 390 PGIYHRDIKSTNILL-DSELNAKVADFGLAKQ 420 (590)
Q Consensus 390 ~~ivHrDIKp~NILL-d~~~~~kL~DFGla~~ 420 (590)
..+.|+|+.+.|||+ +.++.++++||..+..
T Consensus 143 ~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 143 LVFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred ceEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 467899999999999 8889999999988764
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.25 E-value=0.18 Score=53.17 Aligned_cols=137 Identities=17% Similarity=0.236 Sum_probs=91.5
Q ss_pred eecccCcEEEEEEEEcCCcEEEEEEeecC-----C----CCCh------------H----H-HHHHHHHHHhcCCCCccc
Q 046270 271 LIGQGASGIVYKGTLRHGNLVAVKQILDL-----D----TKGD------------E----D-FTNEVEIISKIRHRNLLS 324 (590)
Q Consensus 271 ~LG~G~fG~Vykg~~~~g~~vAvK~l~~~-----~----~~~~------------~----~-f~~Ev~il~~l~H~nlv~ 324 (590)
-|..|.-..||.++-.+|..+|||+++-. + ..+. + - ..+|++-|.+|+.-.|..
T Consensus 151 CiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGIP~ 230 (520)
T KOG2270|consen 151 CISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGIPC 230 (520)
T ss_pred ccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 46678889999999999999999986321 0 0000 0 0 235677777776555433
Q ss_pred cceeEEeccCCCCceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEE
Q 046270 325 LRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILL 404 (590)
Q Consensus 325 l~g~~~~~~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILL 404 (590)
.--+.. ....|||+|+.......-. -+...++......+-.++++-|.-|.. ..++||.||.--|+|+
T Consensus 231 PePIlL-------k~hVLVM~FlGrdgw~aPk---LKd~~ls~~ka~~~Y~~~v~~MR~lY~--~c~LVHADLSEfN~Ly 298 (520)
T KOG2270|consen 231 PEPILL-------KNHVLVMEFLGRDGWAAPK---LKDASLSTSKARELYQQCVRIMRRLYQ--KCRLVHADLSEFNLLY 298 (520)
T ss_pred CCceee-------ecceEeeeeccCCCCcCcc---cccccCChHHHHHHHHHHHHHHHHHHH--HhceeccchhhhhheE
Confidence 222222 2257999998643322111 133457777788888888888888875 4589999999999998
Q ss_pred CCCCcEEEEeeCCccc
Q 046270 405 DSELNAKVADFGLAKQ 420 (590)
Q Consensus 405 d~~~~~kL~DFGla~~ 420 (590)
-+ |.+.|+|.+-+..
T Consensus 299 hd-G~lyiIDVSQSVE 313 (520)
T KOG2270|consen 299 HD-GKLYIIDVSQSVE 313 (520)
T ss_pred EC-CEEEEEEcccccc
Confidence 65 5899999876653
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=95.11 E-value=0.077 Score=54.80 Aligned_cols=74 Identities=18% Similarity=0.230 Sum_probs=45.4
Q ss_pred ccceecccCcEEEEEEEEcCCcEEEEEEeecCCCCChHHHHHHHHHHHhcC---CCCccccceeEEeccCCCCceEEEEE
Q 046270 268 QNNLIGQGASGIVYKGTLRHGNLVAVKQILDLDTKGDEDFTNEVEIISKIR---HRNLLSLRGCCVTSDDSSGKRRFLVY 344 (590)
Q Consensus 268 ~~~~LG~G~fG~Vykg~~~~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~---H~nlv~l~g~~~~~~~~~~~~~~LV~ 344 (590)
..+.++.|....+|+.. .+++.+.||.-. ......|..|.+-|+.|. --.+.+.+++....+ ..+||+
T Consensus 21 ~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~-----~~fLll 91 (288)
T PF03881_consen 21 SIEPVSGGDINEAYRLD-TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDD-----DAFLLL 91 (288)
T ss_dssp EEEEE--SSSSEEEEEE-TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SS-----CCEEEE
T ss_pred eeEecCCCChhheEEEE-CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecC-----CceEEE
Confidence 34578889999999987 667889999865 233456889999999884 234556677665432 249999
Q ss_pred eeCCCC
Q 046270 345 DYMPNG 350 (590)
Q Consensus 345 E~~~~g 350 (590)
||++.+
T Consensus 92 e~l~~~ 97 (288)
T PF03881_consen 92 EFLEMG 97 (288)
T ss_dssp E-----
T ss_pred EeecCC
Confidence 999877
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=94.91 E-value=0.24 Score=52.23 Aligned_cols=140 Identities=18% Similarity=0.196 Sum_probs=77.9
Q ss_pred eecccCcEEEEEEEEcC----CcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCcc-ccceeEEeccCCCCceEEEEEe
Q 046270 271 LIGQGASGIVYKGTLRH----GNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLL-SLRGCCVTSDDSSGKRRFLVYD 345 (590)
Q Consensus 271 ~LG~G~fG~Vykg~~~~----g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv-~l~g~~~~~~~~~~~~~~LV~E 345 (590)
.|..|=-..+|+....+ +..+++|....... ..-+-.+|..++..+...++. +++++.. .| +|.+
T Consensus 21 ~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~-~~IdR~~E~~il~~l~~~gl~P~~l~~~~-----~G----~i~~ 90 (330)
T PLN02421 21 RISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD-YVIDRERELQAIKYLSAAGFGAKLLGVFG-----NG----MIQS 90 (330)
T ss_pred EeCCcccceEEEEEecCCCCCCceEEEEEecCCcC-eEechHHHHHHHHHHHhcCCCCceeEEeC-----Cc----Eeeh
Confidence 34445556788886553 23788887654322 222346899999999766665 4444431 11 5899
Q ss_pred eCCCCCcchh-------h----------hhhc---ccccCChhhHHHHHHHH----------------------HHHHHH
Q 046270 346 YMPNGTLSDN-------I----------SISH---KRKQLTWPQRKKIIVDV----------------------AKGIAY 383 (590)
Q Consensus 346 ~~~~gsL~~~-------L----------~~~~---~~~~l~~~~r~~I~~~i----------------------a~gL~y 383 (590)
|+++..|... + +... ....--|....++..++ .+-+..
T Consensus 91 fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 170 (330)
T PLN02421 91 FINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVE 170 (330)
T ss_pred hhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHH
Confidence 9987766321 1 1100 00011233322222221 111222
Q ss_pred HHh-----cCCCCeEecCCCCCceEECC-CCcEEEEeeCCccc
Q 046270 384 LHY-----GLKPGIYHRDIKSTNILLDS-ELNAKVADFGLAKQ 420 (590)
Q Consensus 384 LH~-----~~~~~ivHrDIKp~NILLd~-~~~~kL~DFGla~~ 420 (590)
+.. ....-+.|+|+.+.|||+++ ++.++++||..|-.
T Consensus 171 l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 171 LKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred HHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 211 12235789999999999975 47899999998764
|
|
| >PF08693 SKG6: Transmembrane alpha-helix domain; InterPro: IPR014805 SKG6 and AXL2 are membrane proteins that show polarised intracellular localisation [, ] | Back alignment and domain information |
|---|
Probab=94.76 E-value=0.016 Score=40.66 Aligned_cols=27 Identities=19% Similarity=0.285 Sum_probs=14.0
Q ss_pred ceEEEehHHHHHHHHHHHHHHHHHHHh
Q 046270 197 TIKLVIGLLGALLGFLLASGLIILYRK 223 (590)
Q Consensus 197 ~~~i~i~v~~~~~~~~~~~~~~~~~~~ 223 (590)
.+..+++++++++++++++++++||||
T Consensus 12 aIa~~VvVPV~vI~~vl~~~l~~~~rR 38 (40)
T PF08693_consen 12 AIAVGVVVPVGVIIIVLGAFLFFWYRR 38 (40)
T ss_pred EEEEEEEechHHHHHHHHHHhheEEec
Confidence 344455566665555554445445554
|
This entry represents the highly conserved transmembrane alpha-helical domain found in these proteins [, ]. The full-length AXL2 protein has a negative regulatory function in cytokinesis []. |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.53 E-value=0.32 Score=52.32 Aligned_cols=74 Identities=19% Similarity=0.237 Sum_probs=44.9
Q ss_pred ceecccCcEEEEEEEEcCCc--E-----EEEEEeecCCCCChHHHHHHHHHHHhcCCCCcccc-ceeEEeccCCCCceEE
Q 046270 270 NLIGQGASGIVYKGTLRHGN--L-----VAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSL-RGCCVTSDDSSGKRRF 341 (590)
Q Consensus 270 ~~LG~G~fG~Vykg~~~~g~--~-----vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv~l-~g~~~~~~~~~~~~~~ 341 (590)
+.|..|--..+|+....++. . |.++.. .......-+-.+|++++..+...++.+- ++.+. -.
T Consensus 56 ~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~-g~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~---------~g 125 (383)
T PTZ00384 56 KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKS-STYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFG---------DF 125 (383)
T ss_pred EEeCCcccceEEEEEecCCCCCccccceEEEEec-cCCCceEeccHHHHHHHHHHHhCCCCCeEEEecC---------CE
Confidence 34545667889998765432 2 333332 1111112234679999999977766654 44332 36
Q ss_pred EEEeeCCCCCcc
Q 046270 342 LVYDYMPNGTLS 353 (590)
Q Consensus 342 LV~E~~~~gsL~ 353 (590)
+|+||+++.+|.
T Consensus 126 ~l~efIeGr~l~ 137 (383)
T PTZ00384 126 TIQEWVEGNTMG 137 (383)
T ss_pred EEEEEeccccCC
Confidence 999999998775
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.42 E-value=0.11 Score=55.39 Aligned_cols=62 Identities=16% Similarity=0.111 Sum_probs=44.4
Q ss_pred EEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCC
Q 046270 340 RFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSE 407 (590)
Q Consensus 340 ~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~ 407 (590)
..|+=+|+++.++..++. ....+++.+.+++.-.++||.-+-. --+++|.|+.|.||++.-+
T Consensus 320 ~vl~E~~~~Gl~v~~~v~----~~~~pe~l~kkva~lg~~AllkMl~--vDNFvHaDlHPGNVlirf~ 381 (565)
T KOG1236|consen 320 LVLVETYERGLSVLRFVK----WKSQPEALVKKVAKLGVNALLKMLI--VDNFVHADLHPGNVLIRFN 381 (565)
T ss_pred ceeeeeccccccHHhhhh----cccChHHHHHHHHHHHHHHHHHHHH--hhcceecccCCCcEEEEec
Confidence 456677888888888874 2335556777777777777554331 4689999999999999543
|
|
| >PF04655 APH_6_hur: Aminoglycoside/hydroxyurea antibiotic resistance kinase; InterPro: IPR006748 The aminoglycosides are a large group of biologically active bacterial secondary metabolites, best known for their antibiotic properties [] | Back alignment and domain information |
|---|
Probab=93.86 E-value=0.2 Score=50.74 Aligned_cols=75 Identities=16% Similarity=0.136 Sum_probs=53.5
Q ss_pred ceecccCcEEEEEEEEcCCcEEEEEEeecCCCCChHHHHHHH---HHHHhcCCCCccccceeEEeccCCCCceEEEEEee
Q 046270 270 NLIGQGASGIVYKGTLRHGNLVAVKQILDLDTKGDEDFTNEV---EIISKIRHRNLLSLRGCCVTSDDSSGKRRFLVYDY 346 (590)
Q Consensus 270 ~~LG~G~fG~Vykg~~~~g~~vAvK~l~~~~~~~~~~f~~Ev---~il~~l~H~nlv~l~g~~~~~~~~~~~~~~LV~E~ 346 (590)
..+..|..+.|++++..+|.++++|....... +..|. ..|+..+-...|+++..-. ....|.+|.
T Consensus 8 ~~~~~g~~s~V~pv~~~dG~~avLKl~~p~~~-----~~~E~~g~~~L~~w~G~GaVrll~~d~-------~~~AlLLEr 75 (253)
T PF04655_consen 8 GPPAHGSSSLVVPVRRADGTPAVLKLAPPHAE-----AEHEARGEAALRWWNGRGAVRLLAADP-------ERGALLLER 75 (253)
T ss_pred CCCCCCcceEEEEEEcCCCCeEEEEecCCccc-----chhhhhHHhHhheeCCCCceeeecccc-------ccchhhhhh
Confidence 34667889999999999999999998754322 22333 5577778888899987632 235788898
Q ss_pred C-CCCCcchhh
Q 046270 347 M-PNGTLSDNI 356 (590)
Q Consensus 347 ~-~~gsL~~~L 356 (590)
. ++.+|.+..
T Consensus 76 l~~g~~L~~~~ 86 (253)
T PF04655_consen 76 LDPGRSLASLP 86 (253)
T ss_pred ccCCCchhhcc
Confidence 8 555775543
|
Aminoglycoside phosphotransferases achieve inactivation of these enzymes by phosphorylation, utilising ATP. Likewise, hydroxyurea is inactivated by phosphorylation of the hydroxy group in the hydroxylamine moiety.; GO: 0016773 phosphotransferase activity, alcohol group as acceptor, 0006468 protein phosphorylation, 0019748 secondary metabolic process |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 590 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 8e-55 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 3e-54 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-42 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-41 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-38 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-38 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 4e-38 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-35 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-25 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-25 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 9e-24 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-23 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-23 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-23 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-23 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-23 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-23 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-23 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-23 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-23 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 3e-23 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-23 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 3e-23 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-23 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 4e-23 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 4e-23 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 5e-23 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 5e-23 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 4e-22 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 6e-22 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-21 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 3e-21 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 3e-21 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 5e-19 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 7e-19 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 8e-19 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 8e-19 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-18 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-18 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-18 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-18 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 3e-18 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 3e-18 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 8e-18 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 8e-18 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 9e-18 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-17 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-17 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-17 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-17 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-17 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-17 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-17 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-17 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-17 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-17 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-17 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-17 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-17 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-17 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-17 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-17 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-17 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-17 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-17 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-17 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-17 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-17 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-17 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-17 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-17 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-17 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 3e-17 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 3e-17 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 3e-17 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 3e-17 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 3e-17 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 3e-17 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 3e-17 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 3e-17 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 3e-17 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 3e-17 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 3e-17 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 3e-17 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 3e-17 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 3e-17 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 3e-17 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-17 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-17 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 3e-17 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 3e-17 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 3e-17 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 3e-17 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-17 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 3e-17 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 3e-17 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 3e-17 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 3e-17 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 4e-17 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 4e-17 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 4e-17 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 4e-17 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 4e-17 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-17 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 4e-17 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 4e-17 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 4e-17 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 4e-17 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 4e-17 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 4e-17 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 4e-17 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 4e-17 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-17 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 4e-17 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-17 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-17 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 4e-17 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 4e-17 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 4e-17 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-17 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 5e-17 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 5e-17 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-17 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-17 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 5e-17 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 5e-17 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 5e-17 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-17 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 5e-17 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 5e-17 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 5e-17 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 5e-17 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-17 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 6e-17 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 6e-17 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 7e-17 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 7e-17 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 7e-17 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 7e-17 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 8e-17 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 8e-17 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 8e-17 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 8e-17 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 8e-17 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 9e-17 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 9e-17 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 9e-17 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-17 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 9e-17 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 9e-17 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 9e-17 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 9e-17 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 9e-17 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-16 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-16 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-16 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-16 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-16 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-16 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-16 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-16 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-16 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-16 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-16 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-16 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-16 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-16 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-16 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-16 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-16 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 1e-16 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-16 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-16 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-16 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-16 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-16 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-16 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-16 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-16 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-16 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-16 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-16 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-16 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-16 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-16 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-16 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-16 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-16 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-16 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-16 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-16 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 3e-16 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 3e-16 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 3e-16 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 3e-16 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 3e-16 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 3e-16 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 3e-16 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 3e-16 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 3e-16 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 3e-16 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 3e-16 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 3e-16 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 3e-16 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 3e-16 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 3e-16 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 4e-16 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 4e-16 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 5e-16 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 5e-16 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 5e-16 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 6e-16 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 7e-16 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 8e-16 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 8e-16 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 8e-16 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-15 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-15 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-15 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-15 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-15 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-15 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-15 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-15 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-15 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-15 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-15 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-15 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-15 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-15 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-15 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-15 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 3e-15 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 3e-15 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 4e-15 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 4e-15 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 4e-15 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 6e-15 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-15 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 7e-15 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 7e-15 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 7e-15 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 7e-15 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 8e-15 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 8e-15 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-15 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 8e-15 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 8e-15 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 8e-15 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 8e-15 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 8e-15 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 9e-15 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 9e-15 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 9e-15 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 9e-15 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-14 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-14 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-14 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-14 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-14 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-14 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-14 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-14 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-14 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-14 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-14 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 3e-14 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 3e-14 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 3e-14 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 4e-14 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 4e-14 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 4e-14 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 4e-14 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 4e-14 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-14 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 4e-14 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-14 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 5e-14 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-14 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 5e-14 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 6e-14 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 6e-14 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 6e-14 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 6e-14 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 6e-14 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 7e-14 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 8e-14 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 8e-14 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 9e-14 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 9e-14 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-13 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-13 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-13 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-13 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-13 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 1e-13 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 1e-13 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 1e-13 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-13 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-13 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-13 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-13 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-13 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-13 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-13 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-13 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-13 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-13 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-13 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-13 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-13 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-13 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-13 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-13 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-13 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-13 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-13 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-13 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-13 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-13 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-13 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-13 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-13 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-13 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-13 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-13 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-13 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-13 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-13 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-13 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-13 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-13 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 3e-13 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-13 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 3e-13 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 3e-13 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 3e-13 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 3e-13 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 3e-13 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 3e-13 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-13 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 3e-13 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-13 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 3e-13 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 4e-13 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 4e-13 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-13 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 4e-13 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 4e-13 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 4e-13 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 5e-13 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 5e-13 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 5e-13 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 5e-13 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 5e-13 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 5e-13 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 5e-13 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 6e-13 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-13 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 6e-13 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-13 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-13 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 7e-13 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 7e-13 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 8e-13 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 9e-13 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 9e-13 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 9e-13 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 9e-13 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 9e-13 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 1e-12 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-12 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 1e-12 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 1e-12 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-12 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-12 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-12 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-12 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-12 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-12 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-12 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-12 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-12 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-12 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-12 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-12 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-12 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-12 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-12 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-12 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-12 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 2e-12 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-12 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-12 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-12 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-12 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-12 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-12 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-12 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-12 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-12 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-12 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-12 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 3e-12 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-12 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 3e-12 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 3e-12 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 3e-12 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 3e-12 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 3e-12 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 3e-12 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 3e-12 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 3e-12 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-12 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-12 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 5e-12 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-12 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-12 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-12 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 5e-12 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 6e-12 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 6e-12 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 7e-12 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 7e-12 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 7e-12 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 7e-12 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 7e-12 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 7e-12 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 8e-12 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 8e-12 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 9e-12 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 9e-12 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 9e-12 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-11 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-11 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-11 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 1e-11 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-11 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-11 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-11 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 1e-11 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 1e-11 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 1e-11 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-11 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-11 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-11 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-11 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-11 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-11 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-11 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-11 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-11 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-11 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-11 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-11 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-11 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-11 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-11 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-11 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-11 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-11 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-11 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-11 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-11 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-11 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-11 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 2e-11 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-11 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-11 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-11 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-11 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-11 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-11 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-11 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-11 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-11 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 3e-11 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 3e-11 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 3e-11 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 3e-11 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-11 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-11 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 3e-11 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 3e-11 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-11 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 3e-11 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 3e-11 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-11 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-11 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 3e-11 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-11 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-11 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 3e-11 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 3e-11 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 3e-11 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 3e-11 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-11 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 3e-11 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 4e-11 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-11 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 4e-11 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 4e-11 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 4e-11 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 4e-11 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-11 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 4e-11 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 4e-11 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-11 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 4e-11 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-11 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 4e-11 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 4e-11 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 5e-11 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 5e-11 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 5e-11 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 6e-11 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 6e-11 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 6e-11 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 7e-11 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 7e-11 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 7e-11 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 8e-11 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 8e-11 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-11 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 9e-11 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 9e-11 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-10 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-10 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-10 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 1e-10 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-10 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 1e-10 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-10 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-10 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-10 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-10 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-10 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-10 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 1e-10 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-10 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 1e-10 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 1e-10 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-10 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-10 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-10 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 1e-10 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-10 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 1e-10 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 1e-10 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-10 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-10 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-10 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-10 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-10 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-10 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-10 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-10 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-10 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-10 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-10 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-10 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-10 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-10 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 2e-10 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 3e-10 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 3e-10 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-10 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-10 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-10 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-10 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 3e-10 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-10 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 3e-10 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-10 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 3e-10 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 3e-10 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 3e-10 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 3e-10 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-10 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-10 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 3e-10 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 4e-10 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 4e-10 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 4e-10 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 4e-10 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 4e-10 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 4e-10 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 4e-10 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 4e-10 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 4e-10 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-10 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 4e-10 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-10 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 4e-10 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-10 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 5e-10 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 5e-10 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 5e-10 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-10 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 6e-10 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 6e-10 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 6e-10 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-10 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 6e-10 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 6e-10 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 6e-10 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 7e-10 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 7e-10 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 7e-10 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 7e-10 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 7e-10 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 7e-10 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 7e-10 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 7e-10 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 7e-10 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 7e-10 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 7e-10 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 7e-10 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 7e-10 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 7e-10 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 8e-10 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 8e-10 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 8e-10 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 8e-10 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 8e-10 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 8e-10 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 8e-10 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 8e-10 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 8e-10 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 8e-10 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-10 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 8e-10 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 8e-10 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 8e-10 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 9e-10 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 9e-10 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 9e-10 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 9e-10 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 9e-10 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 9e-10 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 9e-10 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 9e-10 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 9e-10 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-09 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-09 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 1e-09 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-09 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 1e-09 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-09 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-09 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-09 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-09 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-09 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-09 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-09 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-09 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-09 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-09 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-09 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-09 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 2e-09 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-09 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-09 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-09 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 3e-09 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-09 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 3e-09 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 3e-09 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 3e-09 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 3e-09 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 3e-09 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-09 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 3e-09 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 3e-09 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 3e-09 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 3e-09 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 3e-09 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 3e-09 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 3e-09 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-09 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 3e-09 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 3e-09 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 3e-09 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-09 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 3e-09 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 3e-09 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 3e-09 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 4e-09 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 4e-09 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 4e-09 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 4e-09 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 4e-09 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 4e-09 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 4e-09 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 4e-09 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 4e-09 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-09 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 5e-09 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 5e-09 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 6e-09 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 6e-09 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 6e-09 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 6e-09 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 6e-09 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 6e-09 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 7e-09 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 7e-09 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 7e-09 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 7e-09 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 7e-09 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 8e-09 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 8e-09 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 8e-09 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 8e-09 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 8e-09 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 8e-09 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 9e-09 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-08 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-08 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-08 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 1e-08 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-08 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 1e-08 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-08 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-08 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-08 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-08 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-08 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-08 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-08 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-08 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-08 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-08 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-08 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 1e-08 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-08 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-08 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-08 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-08 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-08 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-08 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 2e-08 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-08 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-08 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-08 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-08 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-08 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-08 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-08 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-08 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-08 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-08 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 2e-08 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-08 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-08 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-08 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-08 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-08 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-08 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-08 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-08 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-08 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-08 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-08 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-08 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-08 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-08 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-08 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-08 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-08 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-08 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-08 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-08 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-08 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-08 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-08 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-08 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-08 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-08 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-08 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-08 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-08 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 3e-08 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 3e-08 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 3e-08 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 3e-08 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 3e-08 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 3e-08 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 3e-08 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 3e-08 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 3e-08 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 3e-08 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 3e-08 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 3e-08 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 3e-08 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 3e-08 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 3e-08 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 3e-08 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 3e-08 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 3e-08 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 3e-08 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 3e-08 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 3e-08 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-08 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 3e-08 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 3e-08 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 3e-08 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-08 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 3e-08 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 3e-08 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 3e-08 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 3e-08 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-08 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-08 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 3e-08 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 3e-08 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-08 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 3e-08 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 3e-08 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 4e-08 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 4e-08 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 4e-08 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 4e-08 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 4e-08 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 4e-08 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 4e-08 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 4e-08 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 4e-08 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 4e-08 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-08 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 4e-08 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-08 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 4e-08 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 4e-08 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 4e-08 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 4e-08 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 4e-08 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 5e-08 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 5e-08 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 5e-08 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 5e-08 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 6e-08 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 6e-08 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 6e-08 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 7e-08 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 7e-08 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 7e-08 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-08 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 7e-08 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 7e-08 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 7e-08 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 7e-08 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 8e-08 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 8e-08 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 8e-08 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 9e-08 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 9e-08 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 9e-08 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 9e-08 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 9e-08 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 9e-08 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 9e-08 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 9e-08 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 9e-08 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 9e-08 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 9e-08 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-07 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 1e-07 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-07 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-07 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-07 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-07 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-07 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-07 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-07 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-07 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-07 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-07 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-07 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-07 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-07 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-07 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-07 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 2e-07 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-07 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-07 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 2e-07 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-07 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 3e-07 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 3e-07 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 3e-07 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 3e-07 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 3e-07 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 3e-07 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 3e-07 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-07 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 4e-07 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-07 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 4e-07 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-07 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 4e-07 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 5e-07 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 5e-07 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 6e-07 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 6e-07 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 6e-07 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-07 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-07 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 8e-07 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 8e-07 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-07 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-07 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 9e-07 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-06 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 1e-06 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-06 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 1e-06 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-06 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-06 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-06 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-06 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 2e-06 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-06 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 3e-06 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-06 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 3e-06 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 3e-06 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 3e-06 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 3e-06 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 3e-06 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 3e-06 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 3e-06 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 3e-06 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 3e-06 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 3e-06 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-06 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 3e-06 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 3e-06 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 3e-06 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 4e-06 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 4e-06 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 4e-06 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-06 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 5e-06 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-06 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 5e-06 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 5e-06 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-05 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 1e-05 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 1e-05 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 1e-05 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 1e-05 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-05 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 1e-05 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 1e-05 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 1e-05 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 1e-05 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 1e-05 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 1e-05 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 1e-05 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 1e-05 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 1e-05 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-05 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-05 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-05 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 2e-05 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-05 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-05 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-05 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-05 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 3e-05 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 4e-05 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 5e-05 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 5e-05 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 6e-05 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 6e-05 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 8e-05 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 8e-05 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 9e-05 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 1e-04 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 1e-04 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 1e-04 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 1e-04 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 3e-04 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 4e-04 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 5e-04 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 6e-04 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 7e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 408 bits (1050), Expect = e-140
Identities = 119/298 (39%), Positives = 178/298 (59%), Gaps = 10/298 (3%)
Query: 251 AKWFHVSELEQATNGFSQNNLIGQGASGIVYKGTLRHGNLVAVKQILDLDTKGDE-DFTN 309
K F + EL+ A++ FS N++G+G G VYKG L G LVAVK++ + T+G E F
Sbjct: 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQT 76
Query: 310 EVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNI-SISHKRKQLTWP 368
EVE+IS HRNLL LRG C+T R LVY YM NG+++ + + L WP
Sbjct: 77 EVEMISMAVHRNLLRLRGFCMT-----PTERLLVYPYMANGSVASCLRERPESQPPLDWP 131
Query: 369 QRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHL 428
+R++I + A+G+AYLH P I HRD+K+ NILLD E A V DFGLAK +H+
Sbjct: 132 KRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 191
Query: 429 TTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSP---FQLITDW 485
TT V GT G++APEY G+ +EK+DV+ +G+++LEL++G++ D + ++ DW
Sbjct: 192 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDW 251
Query: 486 AWVLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEGD 543
L K K++ + D ++ +E+ + V +LC RP +++ ++MLEGD
Sbjct: 252 VKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 377 bits (971), Expect = e-128
Identities = 111/311 (35%), Positives = 166/311 (53%), Gaps = 11/311 (3%)
Query: 239 SNLQASVLPNSGAKWFHVSELEQATNGFSQNNLIGQGASGIVYKGTLRHGNLVAVKQILD 298
L +S L + + +LE+ATN F LIG G G VYKG LR G VA+K+
Sbjct: 14 DALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTP 73
Query: 299 LDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISI 358
++G E+F E+E +S RH +L+SL G C L+Y YM NG L ++
Sbjct: 74 ESSQGIEEFETEIETLSFCRHPHLVSLIGFCD-----ERNEMILIYKYMENGNLKRHLYG 128
Query: 359 SHKRKQ-LTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGL 417
S ++W QR +I + A+G+ YLH I HRD+KS NILLD K+ DFG+
Sbjct: 129 SDLPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGI 185
Query: 418 AKQSLEG-HSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTST 476
+K+ E +HL+T V GT GY+ PEY + G+LTEKSDVYSFG+V+ E++ R + S
Sbjct: 186 SKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSL 245
Query: 477 SPFQL-ITDWAWVLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITD 535
+ + +WA +G+++ I D + + + +F + C + RP++ D
Sbjct: 246 PREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGD 305
Query: 536 ALKMLEGDIDI 546
L LE + +
Sbjct: 306 VLWKLEYALRL 316
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 350 bits (900), Expect = e-117
Identities = 103/310 (33%), Positives = 159/310 (51%), Gaps = 24/310 (7%)
Query: 246 LPNSGAKWFHVSELEQATNGFSQ------NNLIGQGASGIVYKGTLRHGNLVAVKQILDL 299
+ ++ F EL+ TN F + N +G+G G+VYKG + VAVK++ +
Sbjct: 7 VSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN-NTTVAVKKLAAM 65
Query: 300 DTK----GDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDN 355
+ F E+++++K +H NL+ L G G LVY YMPNG+L D
Sbjct: 66 VDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSD-----GDDLCLVYVYMPNGSLLDR 120
Query: 356 ISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADF 415
+S L+W R KI A GI +LH + HRDIKS NILLD AK++DF
Sbjct: 121 LSCLDGTPPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDF 177
Query: 416 GLAKQSLEG-HSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDT 474
GLA+ S + + +T+R+ GT Y+APE L G++T KSD+YSFG+V+LE+++G +D
Sbjct: 178 GLARASEKFAQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDE 236
Query: 475 STSPFQLITDWAW-VLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTI 533
QL+ D + + ++D D+ + + + +E V C H RP I
Sbjct: 237 H-REPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTS-VEAMYSVASQCLHEKKNKRPDI 294
Query: 534 TDALKMLEGD 543
++L+
Sbjct: 295 KKVQQLLQEM 304
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 251 bits (642), Expect = 6e-79
Identities = 77/311 (24%), Positives = 120/311 (38%), Gaps = 33/311 (10%)
Query: 254 FHVSELEQATNGFSQNNLIGQGASGIVYKGTLRHGNLVAVKQILDLDTKGDEDFTNEVEI 313
L + + +G G V+K L VAVK I + K EV
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVK-IFPIQDKQSWQNEYEVYS 71
Query: 314 ISKIRHRNLLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKI 373
+ ++H N+L G +L+ + G+LSD + K ++W + I
Sbjct: 72 LPGMKHENILQFIGAEKRGTSVD-VDLWLITAFHEKGSLSDFL----KANVVSWNELCHI 126
Query: 374 IVDVAKGIAYLH-------YGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHS 426
+A+G+AYLH G KP I HRDIKS N+LL + L A +ADFGLA + G S
Sbjct: 127 AETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKS 186
Query: 427 HL-TTRVAGTFGYLAPEYA-----LYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQ 480
T GT Y+APE + D+Y+ G+V+ EL S D +
Sbjct: 187 AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYM 246
Query: 481 LITDWAWVLAKSGKVDDIFDEFIRAEGAR----------AVMERFVLVGILCAHVMVALR 530
L + + + ++D+ + + + R A M C R
Sbjct: 247 LP--FEEEIGQHPSLEDMQEVVVH-KKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEAR 303
Query: 531 PTITDALKMLE 541
+ + +
Sbjct: 304 LSAGCVGERIT 314
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 222 bits (566), Expect = 1e-67
Identities = 73/341 (21%), Positives = 117/341 (34%), Gaps = 46/341 (13%)
Query: 254 FHVSELEQATNGFSQNNLIGQGASGIVYKGTLRHGNLVAVKQILDLDTKGDEDFTNEVEI 313
SE + LIG+G G VYKG+L VAVK ++F NE I
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSLD-ERPVAVKV---FSFANRQNFINEKNI 58
Query: 314 --ISKIRHRNLLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRK 371
+ + H N+ LV +Y PNG+L + W
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL----SLHTSDWVSSC 114
Query: 372 KIIVDVAKGIAYLH------YGLKPGIYHRDIKSTNILLDSELNAKVADFGLAK------ 419
++ V +G+AYLH KP I HRD+ S N+L+ ++ ++DFGL+
Sbjct: 115 RLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNR 174
Query: 420 -QSLEGHSHLTTRVAGTFGYLAPEYA-------LYGQLTEKSDVYSFGIVILELMSGRKV 471
+ GT Y+APE ++ D+Y+ G++ E+
Sbjct: 175 LVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTD 234
Query: 472 LDTSTS--PFQLITDWAWVLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVAL 529
L S +Q+ + + +D+ R E R L +
Sbjct: 235 LFPGESVPEYQMA--FQTEVGNHPTFEDMQVLVSR-EKQRPKFPEAWKENSLAVRSLKET 291
Query: 530 -----------RPTITDALKMLEGDIDIPKLPDRPLPLSHE 559
R T A + + + I + P +H
Sbjct: 292 IEDCWDQDAEARLTAQXAEERMAELMMIWERNKSVSPTAHH 332
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 204 bits (521), Expect = 3e-61
Identities = 76/302 (25%), Positives = 133/302 (44%), Gaps = 42/302 (13%)
Query: 272 IGQGASGIVYKGTLRHGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVT 331
+G+GA G+V K R VA+KQI + + F E+ +S++ H N++ L G C+
Sbjct: 16 VGRGAFGVVCKAKWR-AKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGACL- 71
Query: 332 SDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPG 391
LV +Y G+L + + + T + ++G+AYLH
Sbjct: 72 ------NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA 125
Query: 392 IYHRDIKSTNILLDSELN-AKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALYGQLT 450
+ HRD+K N+LL + K+ DFG A + +H+T G+ ++APE +
Sbjct: 126 LIHRDLKPPNLLLVAGGTVLKICDFGTAC---DIQTHMTNNK-GSAAWMAPEVFEGSNYS 181
Query: 451 EKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSG------KVDDIFDEFIR 504
EK DV+S+GI++ E+++ RK PF I A+ + + + + I
Sbjct: 182 EKCDVFSWGIILWEVITRRK-------PFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPI- 233
Query: 505 AEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEGDIDIPKLPDRPLPLSHECLRSS 564
++M R C + RP++ + +K++ + P PL + C S
Sbjct: 234 ----ESLMTR-------CWSKDPSQRPSMEEIVKIMT-HLMR-YFPGADEPLQYPCQHSL 280
Query: 565 PS 566
P
Sbjct: 281 PP 282
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 202 bits (517), Expect = 1e-60
Identities = 70/201 (34%), Positives = 109/201 (54%), Gaps = 12/201 (5%)
Query: 272 IGQGASGIVYKGTLRHGNLVAVKQIL--DLDTKGDEDFTNEVEIISKIRHRNLLSLRGCC 329
IG G+ G V++ G+ VAVK ++ D + +F EV I+ ++RH N++ G
Sbjct: 45 IGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 330 VTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLK 389
+V +Y+ G+L + S R+QL +R + DVAKG+ YLH
Sbjct: 104 TQPP-----NLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-NRN 157
Query: 390 PGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLT-TRVAGTFGYLAPEYALYGQ 448
P I HR++KS N+L+D + KV DFGL++ L+ + L+ AGT ++APE
Sbjct: 158 PPIVHRNLKSPNLLVDKKYTVKVCDFGLSR--LKASTFLSSKSAAGTPEWMAPEVLRDEP 215
Query: 449 LTEKSDVYSFGIVILELMSGR 469
EKSDVYSFG+++ EL + +
Sbjct: 216 SNEKSDVYSFGVILWELATLQ 236
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 200 bits (511), Expect = 3e-60
Identities = 48/204 (23%), Positives = 93/204 (45%), Gaps = 19/204 (9%)
Query: 272 IGQGASGIVYKGTLRHGNLVAVKQIL--DLDTKGDEDFTNEVEIISKIRHRNLLSLRGCC 329
+ + SG ++KG + GN + VK + D T+ DF E + H N+L + G C
Sbjct: 18 LNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGAC 76
Query: 330 VTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLK 389
L+ +MP G+L + + + Q K +D+A+G+A+LH L+
Sbjct: 77 Q---SPPAPHPTLITHWMPYGSLYNVL-HEGTNFVVDQSQAVKFALDMARGMAFLH-TLE 131
Query: 390 PGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYAL---- 445
P I + S ++++D ++ A+++ + S + ++APE AL
Sbjct: 132 PLIPRHALNSRSVMIDEDMTARISMADVKF------SFQSPGRMYAPAWVAPE-ALQKKP 184
Query: 446 YGQLTEKSDVYSFGIVILELMSGR 469
+D++SF +++ EL++
Sbjct: 185 EDTNRRSADMWSFAVLLWELVTRE 208
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 197 bits (503), Expect = 6e-59
Identities = 72/244 (29%), Positives = 122/244 (50%), Gaps = 38/244 (15%)
Query: 243 ASVLPNSGAKWFHVSELEQATNGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDT 301
S P S +E+E IG+G G+V+KG L ++VA+K ++ D+
Sbjct: 5 GSEFPKSRLPTLADNEIEY-------EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDS 57
Query: 302 KGD-------EDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSD 354
+G+ ++F EV I+S + H N++ L G +V +++P G L
Sbjct: 58 EGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMH-------NPPRMVMEFVPCGDLYH 110
Query: 355 NISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDS-----ELN 409
+ K + W + ++++D+A GI Y+ P I HRD++S NI L S +
Sbjct: 111 --RLLDKAHPIKWSVKLRLMLDIALGIEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVC 167
Query: 410 AKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALYGQL---TEKSDVYSFGIVILELM 466
AKVADFGL++QS H + + G F ++APE + + TEK+D YSF +++ ++
Sbjct: 168 AKVADFGLSQQS----VHSVSGLLGNFQWMAPE-TIGAEEESYTEKADTYSFAMILYTIL 222
Query: 467 SGRK 470
+G
Sbjct: 223 TGEG 226
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 191 bits (488), Expect = 2e-56
Identities = 78/308 (25%), Positives = 117/308 (37%), Gaps = 40/308 (12%)
Query: 272 IGQGASGIVYKGTLR-HGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCV 330
+G+G G K T R G ++ +K+++ D + F EV+++ + H N+L G
Sbjct: 18 LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 331 TSDDSSGKRRFLVYDYMPNGTLSDNISISHKRK-QLTWPQRKKIIVDVAKGIAYLHYGLK 389
KR + +Y+ GTL I Q W QR D+A G+AYLH
Sbjct: 78 -----KDKRLNFITEYIKGGTLRGII---KSMDSQYPWSQRVSFAKDIASGMAYLH---S 126
Query: 390 PGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTR-------------VAGTF 436
I HRD+ S N L+ N VADFGLA+ ++ + V G
Sbjct: 127 MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNP 186
Query: 437 GYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVD 496
++APE EK DV+SFGIV+ E++ R D P +
Sbjct: 187 YWMAPEMINGRSYDEKVDVFSFGIVLCEIIG-RVNADPDYLPRTMD------------FG 233
Query: 497 DIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEGDIDIPKLPDRPLPL 556
F+ F + + C + RP+ LE + + PL
Sbjct: 234 LNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLE-TLRMHLAGHLPLGP 292
Query: 557 SHECLRSS 564
E L
Sbjct: 293 QLEQLDRG 300
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 191 bits (486), Expect = 3e-56
Identities = 63/228 (27%), Positives = 105/228 (46%), Gaps = 26/228 (11%)
Query: 270 NLIGQGASGIVYKGTLRHGNLVAVKQILDLDTKGDEDFTNEVEI--ISKIRHRNLLSLRG 327
+G+G G V++G+ + G VAVK D ++ + E E+ +RH N+L
Sbjct: 14 ECVGKGRYGEVWRGSWQ-GENVAVKIFSSRD---EKSWFRETELYNTVMLRHENILGFIA 69
Query: 328 CCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLH-- 385
+TS SS + +L+ Y G+L D + + L +I++ +A G+A+LH
Sbjct: 70 SDMTSRHSSTQL-WLITHYHEMGSLYDYL----QLTTLDTVSCLRIVLSIASGLAHLHIE 124
Query: 386 ---YGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHL---TTRVAGTFGYL 439
KP I HRD+KS NIL+ +AD GLA + + L GT Y+
Sbjct: 125 IFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYM 184
Query: 440 APE------YALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQL 481
APE ++ D+++FG+V+ E+ R V + ++
Sbjct: 185 APEVLDETIQVDCFDSYKRVDIWAFGLVLWEVAR-RMVSNGIVEDYKP 231
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 190 bits (484), Expect = 1e-55
Identities = 66/229 (28%), Positives = 96/229 (41%), Gaps = 28/229 (12%)
Query: 270 NLIGQGASGIVYKGTLRHGNLVAVKQILDLDTKGDEDFTNEVEI--ISKIRHRNLLSLRG 327
IG+G G V+ G R G VAVK + + + E EI +RH N+L
Sbjct: 43 KQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIA 98
Query: 328 CCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLH-- 385
S + +L+ DY NG+L D + K L K+ G+ +LH
Sbjct: 99 AD-IKGTGSWTQLYLITDYHENGSLYDYL----KSTTLDAKSMLKLAYSSVSGLCHLHTE 153
Query: 386 ---YGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHL---TTRVAGTFGYL 439
KP I HRD+KS NIL+ +AD GLA + + + + GT Y+
Sbjct: 154 IFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYM 213
Query: 440 APEYALYGQL-------TEKSDVYSFGIVILELMSGRKVLDTSTSPFQL 481
PE L L +D+YSFG+++ E+ R V +QL
Sbjct: 214 PPE-VLDESLNRNHFQSYIMADMYSFGLILWEVAR-RCVSGGIVEEYQL 260
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 2e-55
Identities = 65/205 (31%), Positives = 100/205 (48%), Gaps = 21/205 (10%)
Query: 272 IGQGASGIVYKGTLRHGNLVAVKQIL--DLDTKGDEDFTNEVEIISKIRHRNLLSLRGCC 329
IG G+ G VYKG VAVK + + + F NEV ++ K RH N+L G
Sbjct: 32 IGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 330 VTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRK-QLTWPQRKKIIVDVAKGIAYLHYGL 388
+ + +V + +L ++ H + + + I A+G+ YLH
Sbjct: 90 ------TAPQLAIVTQWCEGSSLYHHL---HASETKFEMKKLIDIARQTARGMDYLH--- 137
Query: 389 KPGIYHRDIKSTNILLDSELNAKVADFGLAK-QSLEGHSHLTTRVAGTFGYLAPE---YA 444
I HRD+KS NI L + K+ DFGLA +S SH +++G+ ++APE
Sbjct: 138 AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 197
Query: 445 LYGQLTEKSDVYSFGIVILELMSGR 469
+ +SDVY+FGIV+ ELM+G+
Sbjct: 198 DSNPYSFQSDVYAFGIVLYELMTGQ 222
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 3e-55
Identities = 60/210 (28%), Positives = 103/210 (49%), Gaps = 25/210 (11%)
Query: 272 IGQGASGIVYKGTLRHGNLVAVKQIL----DLDTKGDEDFTNEVEIISKIRHRNLLSLRG 327
IG G G VY+ G+ VAVK + ++ E+ E ++ + ++H N+++LRG
Sbjct: 15 IGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73
Query: 328 CCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYG 387
C+ LV ++ G L+ + K++ V +A+G+ YLH
Sbjct: 74 VCLKEP-----NLCLVMEFARGGPLNRVL----SGKRIPPDILVNWAVQIARGMNYLHDE 124
Query: 388 LKPGIYHRDIKSTNILLDSEL--------NAKVADFGLAKQSLEGHSHLTTRVAGTFGYL 439
I HRD+KS+NIL+ ++ K+ DFGLA+ E H AG + ++
Sbjct: 125 AIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR---EWHRTTKMSAAGAYAWM 181
Query: 440 APEYALYGQLTEKSDVYSFGIVILELMSGR 469
APE ++ SDV+S+G+++ EL++G
Sbjct: 182 APEVIRASMFSKGSDVWSYGVLLWELLTGE 211
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 4e-54
Identities = 77/320 (24%), Positives = 128/320 (40%), Gaps = 60/320 (18%)
Query: 270 NLIGQGASGIVYKGTLRHGNLVAVKQILDLDTKGDEDFTNEVEI--ISKIRHRNLLSLRG 327
IG+G G V++G R G VAVK + + + E EI +RH N+L
Sbjct: 48 ESIGKGRFGEVWRGKWR-GEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIA 103
Query: 328 CCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLH-- 385
D+ + + +LV DY +G+L D + R +T K+ + A G+A+LH
Sbjct: 104 AD-NKDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHME 158
Query: 386 ---YGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLT---TRVAGTFGYL 439
KP I HRD+KS NIL+ +AD GLA + + GT Y+
Sbjct: 159 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 218
Query: 440 APEYALYGQL-------TEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKS 492
APE L + +++D+Y+ G+V E+ R + +QL
Sbjct: 219 APE-VLDDSINMKHFESFKRADIYAMGLVFWEIAR-RCSIGGIHEDYQL----------- 265
Query: 493 GKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEGDIDIPKLPDR 552
+ + + ++ + M + V LRP I + + E + K
Sbjct: 266 -----PYYDLVPSDPSVEEMRKVV--------CEQKLRPNIPNRWQSCEALRVMAK---- 308
Query: 553 PLPLSHECLRSSPS-RYSFS 571
+ EC ++ + R +
Sbjct: 309 ---IMRECWYANGAARLTAL 325
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 3e-53
Identities = 69/307 (22%), Positives = 107/307 (34%), Gaps = 51/307 (16%)
Query: 270 NLIGQGASGIVYKGTLRHGNLVAVKQIL--DLDTKGDEDFTNEVEIISKIRHRNLLSLRG 327
LIG+G G VY G VA++ I + + F EV + RH N++ G
Sbjct: 39 ELIGKGRFGQVYHGRWH--GEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96
Query: 328 CCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRK-QLTWPQRKKIIVDVAKGIAYLHY 386
C++ ++ TL + K L + ++I ++ KG+ YLH
Sbjct: 97 ACMSPP-----HLAIITSLCKGRTLYSVV---RDAKIVLDVNKTRQIAQEIVKGMGYLH- 147
Query: 387 GLKPGIYHRDIKSTNILLDSELNAKVADFGLAK----QSLEGHSHLTTRVAGTFGYLAPE 442
GI H+D+KS N+ D + DFGL G +LAPE
Sbjct: 148 --AKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPE 204
Query: 443 ---------YALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWA--WVLAK 491
++ SDV++ G + EL + PF+ A W +
Sbjct: 205 IIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREW-------PFKTQPAEAIIWQMGT 257
Query: 492 SGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEGDIDIPKLPD 551
K + + ++ C RPT T + MLE +PK
Sbjct: 258 GMKPNLSQIGMGKE--ISDILLF-------CWAFEQEERPTFTKLMDMLE---KLPKRNR 305
Query: 552 RPLPLSH 558
R H
Sbjct: 306 RLSHPGH 312
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 5e-43
Identities = 65/275 (23%), Positives = 107/275 (38%), Gaps = 28/275 (10%)
Query: 269 NNLIGQGASGIVYKGT-LRHGNLVAVKQILDLDTKGDE--DFTNEVEIISKIRHRNLLSL 325
+ IG+G+ VYKG VA ++ D E F E E++ ++H N++
Sbjct: 31 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 90
Query: 326 RGCCVTSDDSSGKRRFLVY-DYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYL 384
GK+ ++ + M +GTL + K + + + KG+ +L
Sbjct: 91 YDSWE--STVKGKKCIVLVTELMTSGTLKT---YLKRFKVMKIKVLRSWCRQILKGLQFL 145
Query: 385 HYGLKPGIYHRDIKSTNILLDSEL-NAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEY 443
H P I HRD+K NI + + K+ D GLA + V GT ++APE
Sbjct: 146 H-TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK---RASFAKAVIGTPEFMAPEM 201
Query: 444 ALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDEFI 503
+ E DVY+FG+ +LE+ + + Q+ SG FD+
Sbjct: 202 -YEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYR-----RVTSGVKPASFDKVA 255
Query: 504 RAEGARAVMERFVLVGILCAHVMVALRPTITDALK 538
E ++ + C R +I D L
Sbjct: 256 IPE-----VKEIIE---GCIRQNKDERYSIKDLLN 282
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 2e-38
Identities = 55/209 (26%), Positives = 102/209 (48%), Gaps = 24/209 (11%)
Query: 272 IGQGASGIVYKGTLRHGN---LVAVKQI-LDLDTKGDEDFTNEVEIISKIRHRNLLSLRG 327
+G G G V +G R VA+K + + E+ E +I+ ++ + ++ L G
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 328 CCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYL--- 384
C + LV + G L + KR+++ +++ V+ G+ YL
Sbjct: 78 VC------QAEALMLVMEMAGGGPLHK--FLVGKREEIPVSNVAELLHQVSMGMKYLEEK 129
Query: 385 HYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTF--GYLAPE 442
++ + HRD+ + N+LL + AK++DFGL+K S+ T R AG + + APE
Sbjct: 130 NF-----V-HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPE 183
Query: 443 YALYGQLTEKSDVYSFGIVILELMS-GRK 470
+ + + +SDV+S+G+ + E +S G+K
Sbjct: 184 CINFRKFSSRSDVWSYGVTMWEALSYGQK 212
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 2e-38
Identities = 61/203 (30%), Positives = 92/203 (45%), Gaps = 15/203 (7%)
Query: 272 IGQGASGIVYKGTLR-----HGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLR 326
+G+G G V G LVAVKQ+ DF E++I+ + ++ R
Sbjct: 31 LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90
Query: 327 GCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHY 386
G S LV +Y+P+G L D + R +L + + KG+ YL
Sbjct: 91 GVSYGPGRQS---LRLVMEYLPSGCLRD--FLQRHRARLDASRLLLYSSQICKGMEYLG- 144
Query: 387 GLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTF--GYLAPEYA 444
HRD+ + NIL++SE + K+ADFGLAK + R G + APE
Sbjct: 145 --SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESL 202
Query: 445 LYGQLTEKSDVYSFGIVILELMS 467
+ +SDV+SFG+V+ EL +
Sbjct: 203 SDNIFSRQSDVWSFGVVLYELFT 225
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 3e-38
Identities = 57/198 (28%), Positives = 102/198 (51%), Gaps = 15/198 (7%)
Query: 272 IGQGASGIVYKGTLRHGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVT 331
+G G G V+ G VAVK + + + F E ++ +++H+ L+ L
Sbjct: 21 LGAGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLVRLYAVV-- 77
Query: 332 SDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPG 391
+ + +++ +YM NG+L D + + +LT + + +A+G+A++ +
Sbjct: 78 ----TQEPIYIITEYMENGSLVDFLK-TPSGIKLTINKLLDMAAQIAEGMAFIE---ERN 129
Query: 392 IYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGY--LAPEYALYGQL 449
HRD+++ NIL+ L+ K+ADFGLA+ + + T R F APE YG
Sbjct: 130 YIHRDLRAANILVSDTLSCKIADFGLARLIED--NEYTAREGAKFPIKWTAPEAINYGTF 187
Query: 450 TEKSDVYSFGIVILELMS 467
T KSDV+SFGI++ E+++
Sbjct: 188 TIKSDVWSFGILLTEIVT 205
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 4e-38
Identities = 55/225 (24%), Positives = 98/225 (43%), Gaps = 17/225 (7%)
Query: 272 IGQGASGIVYKGTL-----RHGNLVAVKQI-LDLDTKGDEDFTNEVEIISKIRHRNLLSL 325
+G+G G V G VAVK + + D E+EI+ + H N++
Sbjct: 29 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 326 RGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLH 385
+G C + G L+ +++P+G+L + + + ++ Q+ K V + KG+ YL
Sbjct: 89 KGICT---EDGGNGIKLIMEFLPSGSLKE--YLPKNKNKINLKQQLKYAVQICKGMDYLG 143
Query: 386 YGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTF--GYLAPEY 443
HRD+ + N+L++SE K+ DFGL K + T + + APE
Sbjct: 144 ---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPEC 200
Query: 444 ALYGQLTEKSDVYSFGIVILELMS-GRKVLDTSTSPFQLITDWAW 487
+ + SDV+SFG+ + EL++ ++I
Sbjct: 201 LMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHG 245
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 5e-38
Identities = 54/223 (24%), Positives = 91/223 (40%), Gaps = 24/223 (10%)
Query: 271 LIGQGASGIVYKGTLRH-GNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCC 329
+G+G V H G+ A+K+IL + + E+ E ++ H N+L L C
Sbjct: 36 KLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC 95
Query: 330 VTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQ-LTWPQRKKIIVDVAKGIAYLHYGL 388
+ + +L+ + GTL + I + LT Q +++ + +G+ +H
Sbjct: 96 LRERGA-KHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH--- 151
Query: 389 KPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVA--------GTFGYLA 440
G HRD+K TNILL E + D G Q+ + T Y A
Sbjct: 152 AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRA 211
Query: 441 PE---YALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQ 480
PE + + E++DV+S G V+ +M G P+
Sbjct: 212 PELFSVQSHCVIDERTDVWSLGCVLYAMMFG-------EGPYD 247
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 5e-38
Identities = 54/203 (26%), Positives = 98/203 (48%), Gaps = 15/203 (7%)
Query: 272 IGQGASGIVYKGTLR-----HGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLR 326
+G+G G V G +VAVK++ + DF E+EI+ ++H N++ +
Sbjct: 18 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 327 GCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHY 386
G C ++ + L+ +Y+P G+L D + ++++ + + + KG+ YL
Sbjct: 78 GVCYSAGRRN---LKLIMEYLPYGSLRD--YLQKHKERIDHIKLLQYTSQICKGMEYLG- 131
Query: 387 GLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTF--GYLAPEYA 444
HRD+ + NIL+++E K+ DFGL K + + G + APE
Sbjct: 132 --TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESL 189
Query: 445 LYGQLTEKSDVYSFGIVILELMS 467
+ + SDV+SFG+V+ EL +
Sbjct: 190 TESKFSVASDVWSFGVVLYELFT 212
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 6e-38
Identities = 67/198 (33%), Positives = 99/198 (50%), Gaps = 11/198 (5%)
Query: 270 NLIGQGASGIVYKGTLRHGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCC 329
+GQG G V+ GT VA+K + T E F E +++ K+RH L+ L
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 248
Query: 330 VTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLK 389
S + ++V +YM G+L D + K L PQ + +A G+AY+ +
Sbjct: 249 ------SEEPIYIVTEYMSKGSLLDFL-KGETGKYLRLPQLVDMAAQIASGMAYVE---R 298
Query: 390 PGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALYGQL 449
HRD+++ NIL+ L KVADFGLA+ + + APE ALYG+
Sbjct: 299 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF 358
Query: 450 TEKSDVYSFGIVILELMS 467
T KSDV+SFGI++ EL +
Sbjct: 359 TIKSDVWSFGILLTELTT 376
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 6e-38
Identities = 49/217 (22%), Positives = 95/217 (43%), Gaps = 19/217 (8%)
Query: 271 LIGQGASGIVYKGTLRH-GNLVAVKQI--LDLDTKGDEDFTNEVEIISKIRHRNLLSLRG 327
IG G+ G K + G ++ K++ + + +EV ++ +++H N++
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 328 CCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRK--KIIVDVAKGIAYLH 385
+ D + ++V +Y G L+ I+ +++ + +++ + + H
Sbjct: 73 RII---DRTNTTLYIVMEYCEGGDLASVIT-KGTKERQYLDEEFVLRVMTQLTLALKECH 128
Query: 386 YGLKPG--IYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEY 443
G + HRD+K N+ LD + N K+ DFGLA+ L + GT Y++PE
Sbjct: 129 RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI-LNHDTSFAKTFVGTPYYMSPEQ 187
Query: 444 ALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQ 480
EKSD++S G ++ EL + PF
Sbjct: 188 MNRMSYNEKSDIWSLGCLLYELCALMP-------PFT 217
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 6e-38
Identities = 64/220 (29%), Positives = 103/220 (46%), Gaps = 19/220 (8%)
Query: 272 IGQGASGIVYKGTLR-----HGNLVAVKQI-LDLDTKGDEDFTNEVEIISKIRHRNLLSL 325
+G+G G V G +VAVK + D + + E++I+ + H +++
Sbjct: 39 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 326 RGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLH 385
+GCC + +S LV +Y+P G+L D + R + Q + +G+AYLH
Sbjct: 99 KGCCEDAGAAS---LQLVMEYVPLGSLRDYL----PRHSIGLAQLLLFAQQICEGMAYLH 151
Query: 386 YGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTF--GYLAPEY 443
HRD+ + N+LLD++ K+ DFGLAK EGH + R G + APE
Sbjct: 152 ---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPEC 208
Query: 444 ALYGQLTEKSDVYSFGIVILELMS-GRKVLDTSTSPFQLI 482
+ SDV+SFG+ + EL++ T +LI
Sbjct: 209 LKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELI 248
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 7e-38
Identities = 52/213 (24%), Positives = 90/213 (42%), Gaps = 22/213 (10%)
Query: 270 NLIGQGASGIVYKGTLRH-GNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGC 328
LIG G G V+K R G +K++ +E EV+ ++K+ H N++ GC
Sbjct: 17 ELIGSGGFGQVFKAKHRIDGKTYVIKRV----KYNNEKAEREVKALAKLDHVNIVHYNGC 72
Query: 329 CVTSDDSSGKRR-----------FLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDV 377
D F+ ++ GTL I + ++L ++ +
Sbjct: 73 WDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIE-KRRGEKLDKVLALELFEQI 131
Query: 378 AKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFG 437
KG+ Y+H + +RD+K +NI L K+ DFGL L+ T GT
Sbjct: 132 TKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTS-LKNDGKRTRSK-GTLR 186
Query: 438 YLAPEYALYGQLTEKSDVYSFGIVILELMSGRK 470
Y++PE ++ D+Y+ G+++ EL+
Sbjct: 187 YMSPEQISSQDYGKEVDLYALGLILAELLHVCD 219
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 7e-38
Identities = 51/210 (24%), Positives = 101/210 (48%), Gaps = 26/210 (12%)
Query: 272 IGQGASGIVYKGTLRHGNL---VAVKQILD--LDTKGDEDFTNEVEIISKIRHRNLLSLR 326
+G G G V KG + + VAVK + + D ++ E ++ ++ + ++ +
Sbjct: 25 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 327 GCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYL-- 384
G C + LV + G L+ + + + + +++ V+ G+ YL
Sbjct: 85 GIC------EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLEE 135
Query: 385 -HYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTF--GYLAP 441
++ + HRD+ + N+LL ++ AK++DFGL+K ++ + G + + AP
Sbjct: 136 SNF-----V-HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAP 189
Query: 442 EYALYGQLTEKSDVYSFGIVILELMS-GRK 470
E Y + + KSDV+SFG+++ E S G+K
Sbjct: 190 ECINYYKFSSKSDVWSFGVLMWEAFSYGQK 219
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 1e-37
Identities = 61/205 (29%), Positives = 99/205 (48%), Gaps = 22/205 (10%)
Query: 272 IGQGASGIVYKGTLRHGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVT 331
IG G G+V+ G + + VA+K I + +EDF E E++ K+ H L+ L G C
Sbjct: 16 IGSGQFGLVHLGYWLNKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLVQLYGVC-- 72
Query: 332 SDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYL---HYGL 388
LV ++M +G LSD + +R + +DV +G+AYL
Sbjct: 73 ---LEQAPICLVTEFMEHGCLSD--YLRTQRGLFAAETLLGMCLDVCEGMAYLEEACV-- 125
Query: 389 KPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGY--LAPEYALY 446
I HRD+ + N L+ KV+DFG+ + L+ T+ F +PE +
Sbjct: 126 ---I-HRDLAARNCLVGENQVIKVSDFGMTRFVLD--DQYTSSTGTKFPVKWASPEVFSF 179
Query: 447 GQLTEKSDVYSFGIVILELMS-GRK 470
+ + KSDV+SFG+++ E+ S G+
Sbjct: 180 SRYSSKSDVWSFGVLMWEVFSEGKI 204
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 1e-37
Identities = 57/226 (25%), Positives = 92/226 (40%), Gaps = 39/226 (17%)
Query: 271 LIGQGASGIVYKGTLRH-GNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCC 329
++GQGA G V K A+K+I + +EV +++ + H+ ++
Sbjct: 13 VLGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVMLLASLNHQYVVRYYAAW 71
Query: 330 VTSDDSSGKRR--------FLVYDYMPNGTLSDNISISHKRKQLTWPQR-KKIIVDVAKG 380
+ + F+ +Y NGTL D I H ++ + +
Sbjct: 72 LERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLI---HSENLNQQRDEYWRLFRQILEA 128
Query: 381 IAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQ--------------SLEGHS 426
++Y+H GI HRD+K NI +D N K+ DFGLAK
Sbjct: 129 LSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSD 185
Query: 427 HLTTRVAGTFGYLAPE----YALYGQLTEKSDVYSFGIVILELMSG 468
+LT+ + GT Y+A E Y EK D+YS GI+ E++
Sbjct: 186 NLTSAI-GTAMYVATEVLDGTGHYN---EKIDMYSLGIIFFEMIYP 227
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 2e-37
Identities = 54/203 (26%), Positives = 99/203 (48%), Gaps = 15/203 (7%)
Query: 272 IGQGASGIVYKGTL-----RHGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLR 326
+G+G G V G +VAVK++ + DF E+EI+ ++H N++ +
Sbjct: 49 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108
Query: 327 GCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHY 386
G C ++ + L+ +Y+P G+L D + ++++ + + + KG+ YL
Sbjct: 109 GVCYSAGRRN---LKLIMEYLPYGSLRD--YLQKHKERIDHIKLLQYTSQICKGMEYLG- 162
Query: 387 GLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTF--GYLAPEYA 444
HRD+ + NIL+++E K+ DFGL K + + + G + APE
Sbjct: 163 --TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESL 220
Query: 445 LYGQLTEKSDVYSFGIVILELMS 467
+ + SDV+SFG+V+ EL +
Sbjct: 221 TESKFSVASDVWSFGVVLYELFT 243
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 2e-37
Identities = 56/200 (28%), Positives = 101/200 (50%), Gaps = 15/200 (7%)
Query: 270 NLIGQGASGIVYKGTLRHGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCC 329
+G G G V+ T VAVK + + E F E ++ ++H L+ L
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMKP-GSMSVEAFLAEANVMKTLQHDKLVKLHAVV 252
Query: 330 VTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLK 389
+ + +++ ++M G+L D + S + + P+ +A+G+A++ +
Sbjct: 253 ------TKEPIYIITEFMAKGSLLDFL-KSDEGSKQPLPKLIDFSAQIAEGMAFIE---Q 302
Query: 390 PGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGY--LAPEYALYG 447
HRD+++ NIL+ + L K+ADFGLA + +E + + T R F APE +G
Sbjct: 303 RNYIHRDLRAANILVSASLVCKIADFGLA-RVIEDNEY-TAREGAKFPIKWTAPEAINFG 360
Query: 448 QLTEKSDVYSFGIVILELMS 467
T KSDV+SFGI+++E+++
Sbjct: 361 SFTIKSDVWSFGILLMEIVT 380
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 2e-37
Identities = 61/236 (25%), Positives = 103/236 (43%), Gaps = 33/236 (13%)
Query: 247 PNSGAKWFHVSELEQATNGFSQNNLIGQGASGIVYKGTLRHGNL-----VAVKQILDLDT 301
PN A + E E F + ++G GA G VYKG VA+K++ + +
Sbjct: 4 PNQ-ALLRILKETE-----FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS 57
Query: 302 KGD-EDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISH 360
++ +E +++ + + ++ L G C L+ MP G L D +
Sbjct: 58 PKANKEILDEAYVMASVDNPHVCRLLGIC------LTSTVQLITQLMPFGCLLD--YVRE 109
Query: 361 KRKQLTWPQRKKIIVDVAKGIAYL---HYGLKPGIYHRDIKSTNILLDSELNAKVADFGL 417
+ + V +AKG+ YL + HRD+ + N+L+ + + K+ DFGL
Sbjct: 110 HKDNIGSQYLLNWCVQIAKGMNYLEDRRL-----V-HRDLAARNVLVKTPQHVKITDFGL 163
Query: 418 AKQSLEGHSHLTTRVAGTF--GYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRK 470
AK L G ++A E L+ T +SDV+S+G+ + ELM+ G K
Sbjct: 164 AK-LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK 218
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 3e-37
Identities = 68/204 (33%), Positives = 101/204 (49%), Gaps = 20/204 (9%)
Query: 270 NLIGQGASGIVYKGTLRHGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCC 329
IG+G G V G R GN VAVK I + T + F E +++++RH NL+ L G
Sbjct: 27 QTIGKGEFGDVMLGDYR-GNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVI 83
Query: 330 VTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLK 389
V ++V +YM G+L D + S R L K +DV + + YL
Sbjct: 84 VEEKGGL----YIVTEYMAKGSLVDYLR-SRGRSVLGGDCLLKFSLDVCEAMEYLE---G 135
Query: 390 PGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGY--LAPEYALYG 447
HRD+ + N+L+ + AKV+DFGL K++ +T+ G APE
Sbjct: 136 NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS------STQDTGKLPVKWTAPEALREK 189
Query: 448 QLTEKSDVYSFGIVILELMS-GRK 470
+ + KSDV+SFGI++ E+ S GR
Sbjct: 190 KFSTKSDVWSFGILLWEIYSFGRV 213
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 4e-37
Identities = 57/242 (23%), Positives = 100/242 (41%), Gaps = 36/242 (14%)
Query: 248 NSGAKWFHVSELEQATNGFSQNNLIGQGASGIVYKGT-LRHGNLVAVKQI--LDLDTKGD 304
+ G + + +E+ + + IG+G+ G G +K+I + +K
Sbjct: 12 DLGTENLYFQSMEK----YVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKER 67
Query: 305 EDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQ 364
E+ EV +++ ++H N++ R + ++V DY G L I+ + K
Sbjct: 68 EESRREVAVLANMKHPNIVQYRESFEENGSL-----YIVMDYCEGGDLFKRIN-AQKGVL 121
Query: 365 LTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEG 424
Q V + + ++H I HRDIKS NI L + ++ DFG+A+ L
Sbjct: 122 FQEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARV-LNS 177
Query: 425 HSHLTTRVAGTFGYLAPE------YALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSP 478
L GT YL+PE Y KSD+++ G V+ EL + +
Sbjct: 178 TVELARACIGTPYYLSPEICENKPY------NNKSDIWALGCVLYELCTLKH-------A 224
Query: 479 FQ 480
F+
Sbjct: 225 FE 226
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 4e-37
Identities = 67/198 (33%), Positives = 99/198 (50%), Gaps = 11/198 (5%)
Query: 270 NLIGQGASGIVYKGTLRHGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCC 329
+GQG G V+ GT VA+K + T E F E +++ K+RH L+ L
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 331
Query: 330 VTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLK 389
S + ++V +YM G+L D + K L PQ + +A G+AY+ +
Sbjct: 332 ------SEEPIYIVTEYMSKGSLLDFL-KGETGKYLRLPQLVDMAAQIASGMAYVE---R 381
Query: 390 PGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALYGQL 449
HRD+++ NIL+ L KVADFGLA+ + + APE ALYG+
Sbjct: 382 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF 441
Query: 450 TEKSDVYSFGIVILELMS 467
T KSDV+SFGI++ EL +
Sbjct: 442 TIKSDVWSFGILLTELTT 459
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 5e-37
Identities = 53/200 (26%), Positives = 92/200 (46%), Gaps = 15/200 (7%)
Query: 272 IGQGASGIVYKGTLRHGNL-VAVKQILDLDTKGD-EDFTNEVEIISKIRHRNLLSLRGCC 329
IG+G G V+ G LR N VAVK + F E I+ + H N++ L G C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 330 VTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLK 389
+ + ++V + + G + + +L +++ D A G+ YL
Sbjct: 182 -----TQKQPIYIVMELVQGGDFLT--FLRTEGARLRVKTLLQMVGDAAAGMEYLE---S 231
Query: 390 PGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGY--LAPEYALYG 447
HRD+ + N L+ + K++DFG++++ +G + + APE YG
Sbjct: 232 KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADG-VYAASGGLRQVPVKWTAPEALNYG 290
Query: 448 QLTEKSDVYSFGIVILELMS 467
+ + +SDV+SFGI++ E S
Sbjct: 291 RYSSESDVWSFGILLWETFS 310
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 5e-37
Identities = 51/206 (24%), Positives = 97/206 (47%), Gaps = 13/206 (6%)
Query: 268 QNNLIGQGASGIVYKGT-LRHGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLR 326
++G+G GIVY G L + +A+K+I + D++ + E+ + ++H+N++
Sbjct: 26 DRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYL 85
Query: 327 GCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHY 386
G + + + +P G+LS + + + +G+ YLH
Sbjct: 86 GSFSENGFIK-----IFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH- 139
Query: 387 GLKPGIYHRDIKSTNILLDSEL-NAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYAL 445
I HRDIK N+L+++ K++DFG +K+ + T GT Y+APE
Sbjct: 140 --DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET-FTGTLQYMAPEIID 196
Query: 446 YGQL--TEKSDVYSFGIVILELMSGR 469
G + +D++S G I+E+ +G+
Sbjct: 197 KGPRGYGKAADIWSLGCTIIEMATGK 222
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 8e-37
Identities = 55/205 (26%), Positives = 103/205 (50%), Gaps = 22/205 (10%)
Query: 272 IGQGASGIVYKGTLRHGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVT 331
+G G G+V G R VA+K I + + +++F E +++ + H L+ L G C
Sbjct: 32 LGTGQFGVVKYGKWRGQYDVAIKMIKE-GSMSEDEFIEEAKVMMNLSHEKLVQLYGVC-- 88
Query: 332 SDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYL---HYGL 388
+ + F++ +YM NG L + + R + Q ++ DV + + YL +
Sbjct: 89 ---TKQRPIFIITEYMANGCLLN--YLREMRHRFQTQQLLEMCKDVCEAMEYLESKQF-- 141
Query: 389 KPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGY--LAPEYALY 446
+ HRD+ + N L++ + KV+DFGL++ L+ T+ V F PE +Y
Sbjct: 142 ---L-HRDLAARNCLVNDQGVVKVSDFGLSRYVLD--DEYTSSVGSKFPVRWSPPEVLMY 195
Query: 447 GQLTEKSDVYSFGIVILELMS-GRK 470
+ + KSD+++FG+++ E+ S G+
Sbjct: 196 SKFSSKSDIWAFGVLMWEIYSLGKM 220
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 1e-36
Identities = 54/209 (25%), Positives = 100/209 (47%), Gaps = 24/209 (11%)
Query: 272 IGQGASGIVYKGTLRHGN---LVAVKQI-LDLDTKGDEDFTNEVEIISKIRHRNLLSLRG 327
+G G G V +G R VA+K + + E+ E +I+ ++ + ++ L G
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 328 CCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYL--- 384
C + LV + G L + KR+++ +++ V+ G+ YL
Sbjct: 404 VC------QAEALMLVMEMAGGGPLHK--FLVGKREEIPVSNVAELLHQVSMGMKYLEEK 455
Query: 385 HYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGY--LAPE 442
++ HR++ + N+LL + AK++DFGL+K S+ T R AG + APE
Sbjct: 456 NF------VHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPE 509
Query: 443 YALYGQLTEKSDVYSFGIVILELMS-GRK 470
+ + + +SDV+S+G+ + E +S G+K
Sbjct: 510 CINFRKFSSRSDVWSYGVTMWEALSYGQK 538
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 1e-36
Identities = 55/213 (25%), Positives = 97/213 (45%), Gaps = 27/213 (12%)
Query: 272 IGQGASGIVYKGTLRHGN----LVAVKQI-LDLDTKGD-EDFTNEVEIISKIRHRNLLSL 325
+G+G G V +G L+ + VAVK + LD ++ + E+F +E + H N++ L
Sbjct: 42 LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101
Query: 326 RGCCVTSDDSSGKRRFLVYDYMPNGTLSD---NISISHKRKQLTWPQRKKIIVDVAKGIA 382
G C+ + ++ +M G L + K + K +VD+A G+
Sbjct: 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGME 161
Query: 383 YL---HYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYL 439
YL ++ + HRD+ + N +L ++ VADFGL+K+ G + G +
Sbjct: 162 YLSNRNF-----L-HRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYY----RQGRIAKM 211
Query: 440 -----APEYALYGQLTEKSDVYSFGIVILELMS 467
A E T KSDV++FG+ + E+ +
Sbjct: 212 PVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 244
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 1e-36
Identities = 67/201 (33%), Positives = 99/201 (49%), Gaps = 25/201 (12%)
Query: 272 IGQGASGIVYKGTLRHGNLVAVKQILDLDTKGD---EDFTNEVEIISKIRHRNLLSLRGC 328
IG+G G V G R GN VAVK I K D + F E +++++RH NL+ L G
Sbjct: 201 IGKGEFGDVMLGDYR-GNKVAVKCI-----KNDATAQAFLAEASVMTQLRHSNLVQLLGV 254
Query: 329 CVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGL 388
V ++V +YM G+L D + S R L K +DV + + YL
Sbjct: 255 IVEEKGGL----YIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYLE--- 306
Query: 389 KPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGY--LAPEYALY 446
HRD+ + N+L+ + AKV+DFGL K++ +T+ G APE
Sbjct: 307 GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS------STQDTGKLPVKWTAPEALRE 360
Query: 447 GQLTEKSDVYSFGIVILELMS 467
+ + KSDV+SFGI++ E+ S
Sbjct: 361 KKFSTKSDVWSFGILLWEIYS 381
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 136 bits (346), Expect = 2e-36
Identities = 64/215 (29%), Positives = 92/215 (42%), Gaps = 24/215 (11%)
Query: 271 LIGQGASGIVYKGT-LRHGNLVAVKQILDLDTKGDED----FTNEVEIISKIRHRNLLSL 325
+G G VY VA+K + + + E+ F EV S++ H+N++S
Sbjct: 18 KLGGGGMSTVYLAEDTILNIKVAIK-AIFIPPREKEETLKRFEREVHNSSQLSHQNIVS- 75
Query: 326 RGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLH 385
+ D +LV +Y+ TLS+ I L+ + GI + H
Sbjct: 76 ----MIDVDEEDDCYYLVMEYIEGPTLSEYI---ESHGPLSVDTAINFTNQILDGIKHAH 128
Query: 386 YGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYAL 445
I HRDIK NIL+DS K+ DFG+AK E T V GT Y +PE A
Sbjct: 129 ---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAK 185
Query: 446 YGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQ 480
E +D+YS GIV+ E++ G PF
Sbjct: 186 GEATDECTDIYSIGIVLYEMLVGEP-------PFN 213
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 136 bits (346), Expect = 2e-36
Identities = 57/203 (28%), Positives = 98/203 (48%), Gaps = 16/203 (7%)
Query: 272 IGQGASGIVYKGTLRHGNL-VAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCV 330
+G G G VY+G + +L VAVK + + DT E+F E ++ +I+H NL+ L G C
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVC- 78
Query: 331 TSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKP 390
+ +++ ++M G L D + R++++ + ++ + YL K
Sbjct: 79 ----TREPPFYIITEFMTYGNLLDYLR-ECNRQEVSAVVLLYMATQISSAMEYLE---KK 130
Query: 391 GIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGY--LAPEYALYGQ 448
HRD+ + N L+ KVADFGL++ T F APE Y +
Sbjct: 131 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTG--DTYTAHAGAKFPIKWTAPESLAYNK 188
Query: 449 LTEKSDVYSFGIVILELMS-GRK 470
+ KSDV++FG+++ E+ + G
Sbjct: 189 FSIKSDVWAFGVLLWEIATYGMS 211
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 2e-36
Identities = 60/202 (29%), Positives = 100/202 (49%), Gaps = 16/202 (7%)
Query: 272 IGQGASGIVYKGTLRHGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVT 331
+G G G+V G + VAVK I + + +++F E + + K+ H L+ G C
Sbjct: 16 LGSGQFGVVKLGKWKGQYDVAVKMIKE-GSMSEDEFFQEAQTMMKLSHPKLVKFYGVC-- 72
Query: 332 SDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPG 391
S ++V +Y+ NG L + + K L Q ++ DV +G+A+L
Sbjct: 73 ---SKEYPIYIVTEYISNGCLLN--YLRSHGKGLEPSQLLEMCYDVCEGMAFLE---SHQ 124
Query: 392 IYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGY--LAPEYALYGQL 449
HRD+ + N L+D +L KV+DFG+ + L+ + V F APE Y +
Sbjct: 125 FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLD--DQYVSSVGTKFPVKWSAPEVFHYFKY 182
Query: 450 TEKSDVYSFGIVILELMS-GRK 470
+ KSDV++FGI++ E+ S G+
Sbjct: 183 SSKSDVWAFGILMWEVFSLGKM 204
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 2e-36
Identities = 67/212 (31%), Positives = 98/212 (46%), Gaps = 29/212 (13%)
Query: 270 NLIGQGASGIVYKGTLRHGN----LVAVKQILDLDTKGD-EDFTNEVEIISKIRHRNLLS 324
+IG+G G VY GTL + AVK + + G+ F E I+ H N+LS
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 325 LRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYL 384
L G C+ S+ S +V YM +G L + I ++ T + VAKG+ YL
Sbjct: 91 LLGICLRSEGS----PLVVLPYMKHGDLRN--FIRNETHNPTVKDLIGFGLQVAKGMKYL 144
Query: 385 ---HYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYL-- 439
+ HRD+ + N +LD + KVADFGLA+ + + V G
Sbjct: 145 ASKKF------VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYY---SVHNKTGAKLP 195
Query: 440 ----APEYALYGQLTEKSDVYSFGIVILELMS 467
A E + T KSDV+SFG+++ ELM+
Sbjct: 196 VKWMALESLQTQKFTTKSDVWSFGVLLWELMT 227
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 3e-36
Identities = 58/208 (27%), Positives = 93/208 (44%), Gaps = 21/208 (10%)
Query: 272 IGQGASGIVYKGTLRHGNL-----VAVKQI-LDLDTKGDEDFTNEVEIISKIRHRNLLSL 325
+G G G V+KG V +K I + + T+ + I + H +++ L
Sbjct: 21 LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80
Query: 326 RGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLH 385
G C G LV Y+P G+L D + R L V +AKG+ YL
Sbjct: 81 LGLC------PGSSLQLVTQYLPLGSLLD--HVRQHRGALGPQLLLNWGVQIAKGMYYLE 132
Query: 386 YGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTF--GYLAPEY 443
+ G+ HR++ + N+LL S +VADFG+A L ++A E
Sbjct: 133 ---EHGMVHRNLAARNVLLKSPSQVQVADFGVADL-LPPDDKQLLYSEAKTPIKWMALES 188
Query: 444 ALYGQLTEKSDVYSFGIVILELMS-GRK 470
+G+ T +SDV+S+G+ + ELM+ G +
Sbjct: 189 IHFGKYTHQSDVWSYGVTVWELMTFGAE 216
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 136 bits (346), Expect = 3e-36
Identities = 61/219 (27%), Positives = 104/219 (47%), Gaps = 26/219 (11%)
Query: 271 LIGQGASGIVYKGT-LRHGNLVAVKQILDLDTKGDED----FTNEVEIISKIRHRNLLSL 325
++G G V+ LR VAVK +L D D F E + + + H ++++
Sbjct: 19 ILGFGGMSEVHLARDLRDHRDVAVK-VLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 77
Query: 326 --RGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAY 383
G ++ +G ++V +Y+ TL D + H +T + ++I D + + +
Sbjct: 78 YDTG---EAETPAGPLPYIVMEYVDGVTLRDIV---HTEGPMTPKRAIEVIADACQALNF 131
Query: 384 LHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTT--RVAGTFGYLAP 441
H + GI HRD+K NI++ + KV DFG+A+ + + +T V GT YL+P
Sbjct: 132 SH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 188
Query: 442 EYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQ 480
E A + +SDVYS G V+ E+++G PF
Sbjct: 189 EQARGDSVDARSDVYSLGCVLYEVLTGEP-------PFT 220
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 3e-36
Identities = 51/256 (19%), Positives = 103/256 (40%), Gaps = 39/256 (15%)
Query: 271 LIGQGASGIVYKGTLRH-GNLVAVKQI-LDLDTKGDEDFTNEVEIISKIRHRNLLSLRGC 328
+G+G G+V++ + A+K+I L E EV+ ++K+ H ++
Sbjct: 12 CLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 71
Query: 329 CVTSDDSSGKRR-------FLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGI 381
+ + + + ++ L D ++ ++ I + +A+ +
Sbjct: 72 WLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAV 131
Query: 382 AYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQ------------SLEGHSHLT 429
+LH G+ HRD+K +NI + KV DFGL + ++ T
Sbjct: 132 EFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHT 188
Query: 430 TRVAGTFGYLAPEYALYGQL-TEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWV 488
+V GT Y++PE ++G + K D++S G+++ EL+ PF +
Sbjct: 189 GQV-GTKLYMSPE-QIHGNSYSHKVDIFSLGLILFELL----------YPFSTQMERVRT 236
Query: 489 LAK--SGKVDDIFDEF 502
L + K +F +
Sbjct: 237 LTDVRNLKFPPLFTQK 252
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 3e-36
Identities = 54/237 (22%), Positives = 93/237 (39%), Gaps = 33/237 (13%)
Query: 247 PNSGAKWFHVSELEQATNGFSQNNLIGQGASGIVYKGTLRHGNL----VAVKQILDLDT- 301
P + E + +G G+ G+V +G + VAVK +
Sbjct: 7 PLQSLTCL-IGEKD-----LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLS 60
Query: 302 --KGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISIS 359
+ +DF EV + + HRNL+ L G +V + P G+L D +
Sbjct: 61 QPEAMDDFIREVNAMHSLDHRNLIRLYGVV------LTPPMKMVTELAPLGSLLDRLR-- 112
Query: 360 HKRKQLTWPQRKKIIVDVAKGIAYL---HYGLKPGIYHRDIKSTNILLDSELNAKVADFG 416
+ + V VA+G+ YL + I HRD+ + N+LL + K+ DFG
Sbjct: 113 KHQGHFLLGTLSRYAVQVAEGMGYLESKRF-----I-HRDLAARNLLLATRDLVKIGDFG 166
Query: 417 LAKQSLEGHSHLTTRVAGTFGY--LAPEYALYGQLTEKSDVYSFGIVILELMS-GRK 470
L + + H + + APE + SD + FG+ + E+ + G++
Sbjct: 167 LMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQE 223
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 3e-36
Identities = 56/201 (27%), Positives = 102/201 (50%), Gaps = 15/201 (7%)
Query: 270 NLIGQGASGIVYKGTLRHGNL-VAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGC 328
+ +G G G VY+G + +L VAVK + + DT E+F E ++ +I+H NL+ L G
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGV 284
Query: 329 CVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGL 388
C + +++ ++M G L D + R++++ + ++ + YL
Sbjct: 285 C-----TREPPFYIITEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQISSAMEYLE--- 335
Query: 389 KPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGY--LAPEYALY 446
K HR++ + N L+ KVADFGL+ + + G ++ T F APE Y
Sbjct: 336 KKNFIHRNLAARNCLVGENHLVKVADFGLS-RLMTGDTY-TAHAGAKFPIKWTAPESLAY 393
Query: 447 GQLTEKSDVYSFGIVILELMS 467
+ + KSDV++FG+++ E+ +
Sbjct: 394 NKFSIKSDVWAFGVLLWEIAT 414
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 7e-36
Identities = 54/214 (25%), Positives = 92/214 (42%), Gaps = 28/214 (13%)
Query: 272 IGQGASGIVYKGTLRHGN----LVAVKQI-LDLDTKGD-EDFTNEVEIISKIRHRNLLSL 325
+G+G G V + L+ + VAVK + D+ D E+F E + + H ++ L
Sbjct: 31 LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKL 90
Query: 326 RGCCVTSDDSSGKRR-FLVYDYMPNGTLSD---NISISHKRKQLTWPQRKKIIVDVAKGI 381
G + S ++ +M +G L I L + +VD+A G+
Sbjct: 91 VGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGM 150
Query: 382 AYL---HYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGY 438
YL ++ I HRD+ + N +L ++ VADFGL+++ G + G
Sbjct: 151 EYLSSRNF-----I-HRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYY----RQGCASK 200
Query: 439 L-----APEYALYGQLTEKSDVYSFGIVILELMS 467
L A E T SDV++FG+ + E+M+
Sbjct: 201 LPVKWLALESLADNLYTVHSDVWAFGVTMWEIMT 234
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 136 bits (343), Expect = 2e-35
Identities = 66/211 (31%), Positives = 97/211 (45%), Gaps = 27/211 (12%)
Query: 270 NLIGQGASGIVYKGTLRHGN----LVAVKQILDLDTKGD-EDFTNEVEIISKIRHRNLLS 324
+IG+G G VY GTL + AVK + + G+ F E I+ H N+LS
Sbjct: 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154
Query: 325 LRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYL 384
L G C+ S+ S +V YM +G L + I ++ T + VAKG+ +L
Sbjct: 155 LLGICLRSEGS----PLVVLPYMKHGDLRN--FIRNETHNPTVKDLIGFGLQVAKGMKFL 208
Query: 385 ---HYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYL-- 439
+ HRD+ + N +LD + KVADFGLA+ + T L
Sbjct: 209 ASKKF------VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVH--NKTGAKLPV 260
Query: 440 ---APEYALYGQLTEKSDVYSFGIVILELMS 467
A E + T KSDV+SFG+++ ELM+
Sbjct: 261 KWMALESLQTQKFTTKSDVWSFGVLLWELMT 291
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 2e-35
Identities = 61/233 (26%), Positives = 103/233 (44%), Gaps = 27/233 (11%)
Query: 247 PNSGAKWFHVSELEQATNGFSQNNLIGQGASGIVYKGTLRHGN-----LVAVKQILDLDT 301
PN A + E E F + ++G GA G VYKG VA+K++ + +
Sbjct: 4 PNQ-ALLRILKETE-----FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS 57
Query: 302 KGD-EDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISH 360
++ +E +++ + + ++ L G C L+ MP G L D +
Sbjct: 58 PKANKEILDEAYVMASVDNPHVCRLLGIC------LTSTVQLITQLMPFGCLLD--YVRE 109
Query: 361 KRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQ 420
+ + V +AKG+ YL + HRD+ + N+L+ + + K+ DFGLAK
Sbjct: 110 HKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAK- 165
Query: 421 SLEGHSHLTTRVAGTF--GYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRK 470
L G ++A E L+ T +SDV+S+G+ + ELM+ G K
Sbjct: 166 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK 218
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 2e-35
Identities = 67/211 (31%), Positives = 101/211 (47%), Gaps = 25/211 (11%)
Query: 272 IGQGASGIVYKGTLRHGN-----LVAVKQI-LDLDTKGDEDFTNEVEIISKIRHRNLLSL 325
IG G G VYKG L+ + VA+K + K DF E I+ + H N++ L
Sbjct: 52 IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 111
Query: 326 RGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYL- 384
G S K ++ +YM NG L + K + + Q ++ +A G+ YL
Sbjct: 112 EGVI-----SKYKPMMIITEYMENGALDK--FLREKDGEFSVLQLVGMLRGIAAGMKYLA 164
Query: 385 --HYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGY--LA 440
+Y + HRD+ + NIL++S L KV+DFGL++ + T G A
Sbjct: 165 NMNY-----V-HRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA 218
Query: 441 PEYALYGQLTEKSDVYSFGIVILELMS-GRK 470
PE Y + T SDV+SFGIV+ E+M+ G +
Sbjct: 219 PEAISYRKFTSASDVWSFGIVMWEVMTYGER 249
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 3e-35
Identities = 56/211 (26%), Positives = 92/211 (43%), Gaps = 27/211 (12%)
Query: 270 NLIGQGASGIVYKGTLRHGN----LVAVKQILDLDTKGD-EDFTNEVEIISKIRHRNLLS 324
+IG+G G+VY G A+K + + E F E ++ + H N+L+
Sbjct: 27 RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86
Query: 325 LRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYL 384
L G + + ++ YM +G L I ++ T + VA+G+ YL
Sbjct: 87 LIGIMLPPEGLP----HVLLPYMCHGDLLQ--FIRSPQRNPTVKDLISFGLQVARGMEYL 140
Query: 385 ---HYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYL-- 439
+ + HRD+ + N +LD KVADFGLA+ L+ + L
Sbjct: 141 AEQKF-----V-HRDLAARNCMLDESFTVKVADFGLARDILD--REYYSVQQHRHARLPV 192
Query: 440 ---APEYALYGQLTEKSDVYSFGIVILELMS 467
A E + T KSDV+SFG+++ EL++
Sbjct: 193 KWTALESLQTYRFTTKSDVWSFGVLLWELLT 223
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 4e-35
Identities = 64/245 (26%), Positives = 112/245 (45%), Gaps = 28/245 (11%)
Query: 226 KKRKQIALHEQFVSNLQASVLPNSGAKWFHVSELEQATNGFSQNNLIGQGASGIVYKGTL 285
+ + HEQF + L+ V IG+G++GIV
Sbjct: 19 YFQSGVVTHEQFKAALRMVVDQGDPRLLLDSYVK------------IGEGSTGIVCLARE 66
Query: 286 RH-GNLVAVKQILDLDTKGD-EDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFLV 343
+H G VAVK + DL + E NEV I+ +H N++ + + ++ +++
Sbjct: 67 KHSGRQVAVKMM-DLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEE-----LWVL 120
Query: 344 YDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNIL 403
+++ G L+D + + +L Q + V + +AYLH G+ HRDIKS +IL
Sbjct: 121 MEFLQGGALTDIV----SQVRLNEEQIATVCEAVLQALAYLH---AQGVIHRDIKSDSIL 173
Query: 404 LDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVIL 463
L + K++DFG Q + + V GT ++APE + D++S GI+++
Sbjct: 174 LTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAPEVISRSLYATEVDIWSLGIMVI 232
Query: 464 ELMSG 468
E++ G
Sbjct: 233 EMVDG 237
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 4e-35
Identities = 57/288 (19%), Positives = 115/288 (39%), Gaps = 48/288 (16%)
Query: 270 NLIGQGASGIVYKGTLRHGNLVAVKQI--LDLDTKGDEDFTNEVEIISKIRHRNL--LSL 325
IG G S V++ + A+K + + D + + + NE+ ++K++ + + L
Sbjct: 34 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93
Query: 326 RGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLH 385
+T ++V + N L+ + K+K + +RK ++ + + +H
Sbjct: 94 YDYEITDQYI-----YMVMECG-NIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTIH 144
Query: 386 YGLKPGIYHRDIKSTNILLDSELNAKVADFGLAK--QSLEGHSHLTTRVAGTFGYLAPE- 442
+ GI H D+K N L+ + K+ DFG+A Q ++V GT Y+ PE
Sbjct: 145 ---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQV-GTVNYMPPEA 199
Query: 443 ----------YALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKS 492
+++ KSDV+S G ++ + G+ +PFQ I + L
Sbjct: 200 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK-------TPFQQIINQISKLHAI 252
Query: 493 GKVDDIFD--EFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALK 538
+ + + + + V++ C R +I + L
Sbjct: 253 IDPNHEIEFPDIPEKD-LQDVLKC-------CLKRDPKQRISIPELLA 292
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 5e-35
Identities = 63/210 (30%), Positives = 98/210 (46%), Gaps = 24/210 (11%)
Query: 272 IGQGASGIVYKGTLRHGN----LVAVKQI-LDLDTKGDEDFTNEVEIISKIRHRNLLSLR 326
IG G SG V G LR VA+K + + DF +E I+ + H N++ L
Sbjct: 57 IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116
Query: 327 GCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYL-- 384
G + G+ +V +YM NG+L + Q T Q ++ V G+ YL
Sbjct: 117 GVV-----TRGRLAMIVTEYMENGSLDT--FLRTHDGQFTIMQLVGMLRGVGAGMRYLSD 169
Query: 385 -HYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYL--AP 441
Y + HRD+ + N+L+DS L KV+DFGL++ + T G AP
Sbjct: 170 LGY-----V-HRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAP 223
Query: 442 EYALYGQLTEKSDVYSFGIVILELMS-GRK 470
E + + SDV+SFG+V+ E+++ G +
Sbjct: 224 EAIAFRTFSSASDVWSFGVVMWEVLAYGER 253
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 5e-35
Identities = 51/223 (22%), Positives = 95/223 (42%), Gaps = 37/223 (16%)
Query: 271 LIGQGASGIVYKGT-LRHGNLVAVKQILDL----DTKGDEDFTNEVEIISKIRHRNLLSL 325
IG+G VY+ L G VA+K++ + D K D E++++ ++ H N++
Sbjct: 39 KIGRGQFSEVYRAACLLDGVPVALKKV-QIFDLMDAKARADCIKEIDLLKQLNHPNVIKY 97
Query: 326 RGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRK--KIIVDVAKGIAY 383
+ ++ +V + G LS I K+++ P+R K V + + +
Sbjct: 98 YASFIEDNEL-----NIVLELADAGDLSRMIK-HFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 384 LHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPE- 442
+H + HRDIK N+ + + K+ D GL + + + GT Y++PE
Sbjct: 152 MH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRF-FSSKTTAAHSLVGTPYYMSPER 207
Query: 443 -----YALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQ 480
Y KSD++S G ++ E+ + + PF
Sbjct: 208 IHENGY------NFKSDIWSLGCLLYEMAALQS-------PFY 237
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 7e-35
Identities = 62/237 (26%), Positives = 110/237 (46%), Gaps = 28/237 (11%)
Query: 234 HEQFVSNLQASVLPNSGAKWFHVSELEQATNGFSQNNLIGQGASGIVYKGT-LRHGNLVA 292
E+ + L++ V K + E IGQGASG VY + G VA
Sbjct: 2 DEEILEKLRSIVSVGDPKKKYTRFEK------------IGQGASGTVYTAMDVATGQEVA 49
Query: 293 VKQILDLDTKGD-EDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFLVYDYMPNGT 351
++Q+ +L + E NE+ ++ + ++ N+++ + D+ ++V +Y+ G+
Sbjct: 50 IRQM-NLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDE-----LWVVMEYLAGGS 103
Query: 352 LSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAK 411
L+D + + Q + + + + +LH + HRDIKS NILL + + K
Sbjct: 104 LTDVV----TETCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVK 156
Query: 412 VADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSG 468
+ DFG Q S +T V GT ++APE K D++S GI+ +E++ G
Sbjct: 157 LTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG 212
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 9e-35
Identities = 58/292 (19%), Positives = 117/292 (40%), Gaps = 48/292 (16%)
Query: 266 FSQNNLIGQGASGIVYKGTLRHGNLVAVKQIL--DLDTKGDEDFTNEVEIISKIRHRNL- 322
+S IG G S V++ + A+K + + D + + + NE+ ++K++ +
Sbjct: 11 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 70
Query: 323 -LSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGI 381
+ L +T ++V + N L+ + K+K + +RK ++ + +
Sbjct: 71 IIRLYDYEITDQYI-----YMVMEC-GNIDLNSWL---KKKKSIDPWERKSYWKNMLEAV 121
Query: 382 AYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAK--QSLEGHSHLTTRVAGTFGYL 439
+H + GI H D+K N L+ + K+ DFG+A Q ++V GT Y+
Sbjct: 122 HTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQV-GTVNYM 176
Query: 440 APE-----------YALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWV 488
PE +++ KSDV+S G ++ + G+ +PFQ I +
Sbjct: 177 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK-------TPFQQIINQISK 229
Query: 489 LAKSGKVDDIFD--EFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALK 538
L + + + + + V++ C R +I + L
Sbjct: 230 LHAIIDPNHEIEFPDIPEKD-LQDVLKC-------CLKRDPKQRISIPELLA 273
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 1e-34
Identities = 51/218 (23%), Positives = 100/218 (45%), Gaps = 22/218 (10%)
Query: 266 FSQNNLIGQGASGIVYKGTLRH-GNLVAVKQILDLDTKGDED-FTNEVEIISKIRHRNLL 323
+ ++++GQGA+ V++G + G+L A+K ++ D E E++ K+ H+N++
Sbjct: 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70
Query: 324 SLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAY 383
L ++++ + + L+ ++ P G+L + L + ++ DV G+ +
Sbjct: 71 KLFAI---EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127
Query: 384 LHYGLKPGIYHRDIKSTNILL----DSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYL 439
L + GI HR+IK NI+ D + K+ DFG A++ LE + GT YL
Sbjct: 128 LR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE-LEDDEQFVSLY-GTEEYL 182
Query: 440 APE--------YALYGQLTEKSDVYSFGIVILELMSGR 469
P+ + D++S G+ +G
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-34
Identities = 64/210 (30%), Positives = 98/210 (46%), Gaps = 24/210 (11%)
Query: 272 IGQGASGIVYKGTLRHGN----LVAVKQI-LDLDTKGDEDFTNEVEIISKIRHRNLLSLR 326
+G G G V G L+ + VA+K + + K DF E I+ + H N++ L
Sbjct: 53 VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 327 GCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYL-- 384
G + K +V +YM NG+L + Q T Q ++ +A G+ YL
Sbjct: 113 GVV-----TKSKPVMIVTEYMENGSLDS--FLRKHDAQFTVIQLVGMLRGIASGMKYLSD 165
Query: 385 -HYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYL--AP 441
Y + HRD+ + NIL++S L KV+DFGL + + T G +P
Sbjct: 166 MGY-----V-HRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSP 219
Query: 442 EYALYGQLTEKSDVYSFGIVILELMS-GRK 470
E Y + T SDV+S+GIV+ E+MS G +
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMSYGER 249
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 2e-34
Identities = 50/211 (23%), Positives = 91/211 (43%), Gaps = 29/211 (13%)
Query: 272 IGQGASGIVYKGTLRHGNL----VAVKQI-LDLDTKGDEDFTNEVEIISKIRHRNLLSLR 326
+G+G G VY+G + VAVK D E F +E I+ + H +++ L
Sbjct: 20 LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79
Query: 327 GCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYL-- 384
G + +++ + P G L + + L + + K +AYL
Sbjct: 80 GII------EEEPTWIIMELYPYGELGH--YLERNKNSLKVLTLVLYSLQICKAMAYLES 131
Query: 385 -HYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGT---FGYLA 440
+ + HRDI NIL+ S K+ DFGL++ + + + T +++
Sbjct: 132 INC-----V-HRDIAVRNILVASPECVKLGDFGLSRYIEDED---YYKASVTRLPIKWMS 182
Query: 441 PEYALYGQLTEKSDVYSFGIVILELMS-GRK 470
PE + + T SDV+ F + + E++S G++
Sbjct: 183 PESINFRRFTTASDVWMFAVCMWEILSFGKQ 213
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 3e-34
Identities = 62/206 (30%), Positives = 100/206 (48%), Gaps = 17/206 (8%)
Query: 266 FSQNNLIGQGASGIVYKGT-LRHGNLVAVKQILDLDTKGD--EDFTNEVEIISKIRHRNL 322
F++ IG+G+ G V+KG R +VA+K I DL+ D ED E+ ++S+ +
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKII-DLEEAEDEIEDIQQEITVLSQCDSPYV 82
Query: 323 LSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIA 382
G + + +++ +Y+ G+ D + + L Q I+ ++ KG+
Sbjct: 83 TKYYGSYL-----KDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILREILKGLD 133
Query: 383 YLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPE 442
YLH HRDIK+ N+LL K+ADFG+A Q + T V GT ++APE
Sbjct: 134 YLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPE 189
Query: 443 YALYGQLTEKSDVYSFGIVILELMSG 468
K+D++S GI +EL G
Sbjct: 190 VIKQSAYDSKADIWSLGITAIELARG 215
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 4e-34
Identities = 59/222 (26%), Positives = 101/222 (45%), Gaps = 41/222 (18%)
Query: 272 IGQGASGIVYKGTLRHGN------LVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSL 325
+G+GA G V+ + LVAVK + + +DF E E+++ ++H++++
Sbjct: 49 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 326 RGCCVTSDDSSGKRRFLVYDYMPNGTL------------SDNISISHKRKQLTWPQRKKI 373
G C + G+ +V++YM +G L L Q +
Sbjct: 109 FGVC-----TEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 163
Query: 374 IVDVAKGIAYL---HYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTT 430
VA G+ YL H+ + HRD+ + N L+ L K+ DFG+++ + +S
Sbjct: 164 ASQVAAGMVYLAGLHF-----V-HRDLATRNCLVGQGLVVKIGDFGMSR---DIYSTDYY 214
Query: 431 RVAGTFGYL-----APEYALYGQLTEKSDVYSFGIVILELMS 467
RV G L PE LY + T +SDV+SFG+V+ E+ +
Sbjct: 215 RVGGR-TMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 255
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 5e-34
Identities = 58/223 (26%), Positives = 104/223 (46%), Gaps = 42/223 (18%)
Query: 272 IGQGASGIVYKGTLRHGN------LVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSL 325
+G+GA G V+ + + LVAVK + D +DF E E+++ ++H +++
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 326 RGCCVTSDDSSGKRRFLVYDYMPNGTLSD-------------NISISHKRKQLTWPQRKK 372
G C G +V++YM +G L+ + + +L Q
Sbjct: 83 YGVC-----GDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 137
Query: 373 IIVDVAKGIAYL---HYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLT 429
I +A G+ YL H+ + HRD+ + N L+ + L K+ DFG+++ + +S
Sbjct: 138 IASQIASGMVYLASQHF-----V-HRDLATRNCLVGANLLVKIGDFGMSR---DVYSTDY 188
Query: 430 TRVAGTFGYL-----APEYALYGQLTEKSDVYSFGIVILELMS 467
RV G L PE +Y + T +SDV+SFG+++ E+ +
Sbjct: 189 YRVGGH-TMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 230
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 6e-34
Identities = 76/293 (25%), Positives = 120/293 (40%), Gaps = 54/293 (18%)
Query: 272 IGQGASGIVYKGT-LRHGNLVAVKQILDLDTKGD--EDFTNEVEIISKIRHRNLLSLRGC 328
IG GA+ +V VA+K+I +L+ ++ E++ +S+ H N++S
Sbjct: 23 IGSGATAVVQAAYCAPKKEKVAIKRI-NLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTS 81
Query: 329 CVTSDDSSGKRRFLVYDYMPNGTLSDNISIS-----HKRKQLTWPQRKKIIVDVAKGIAY 383
V D+ +LV + G++ D I HK L I+ +V +G+ Y
Sbjct: 82 FVVKDE-----LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEY 136
Query: 384 LHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTF-G---YL 439
LH K G HRD+K+ NILL + + ++ADFG++ G +V TF G ++
Sbjct: 137 LH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWM 193
Query: 440 APE----YALYGQLTEKSDVYSFGIVILELMSGR---------KVL-DTSTSPFQLITDW 485
APE Y K+D++SFGI +EL +G KVL T + +
Sbjct: 194 APEVMEQVRGYD---FKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETG 250
Query: 486 AWVLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALK 538
K F + I LC RPT + L+
Sbjct: 251 VQDKEMLKKYGKSFRKMIS----------------LCLQKDPEKRPTAAELLR 287
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 7e-34
Identities = 57/205 (27%), Positives = 90/205 (43%), Gaps = 20/205 (9%)
Query: 270 NLIGQGASGIVYKGTLRH-GNLVAVKQILD----LDTKGDEDFTNEVEIISKIRHRNLLS 324
+G+G G VY + ++A+K +L + EVEI S +RH N+L
Sbjct: 15 RPLGKGKFGNVYLAREKQSKFILALK-VLFKAQLEKAGVEHQLRREVEIQSHLRHPNILR 73
Query: 325 LRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYL 384
L G + R +L+ +Y P GT+ + K + + I ++A ++Y
Sbjct: 74 LYGYFHDA-----TRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYITELANALSYC 125
Query: 385 HYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYA 444
H + HRDIK N+LL S K+ADFG + + GT YL PE
Sbjct: 126 H---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHA-PSSRRTDL--CGTLDYLPPEMI 179
Query: 445 LYGQLTEKSDVYSFGIVILELMSGR 469
EK D++S G++ E + G+
Sbjct: 180 EGRMHDEKVDLWSLGVLCYEFLVGK 204
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 1e-33
Identities = 47/210 (22%), Positives = 84/210 (40%), Gaps = 27/210 (12%)
Query: 272 IGQGASGIVYKGTLRHGN----LVAVKQI-LDLDTKGDEDFTNEVEIISKIRHRNLLSLR 326
IG+G G V++G VA+K E F E + + H +++ L
Sbjct: 23 IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 327 GCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYL-- 384
G + +++ + G L + ++ L ++ +AYL
Sbjct: 83 GVI------TENPVWIIMELCTLGELRS--FLQVRKYSLDLASLILYAYQLSTALAYLES 134
Query: 385 -HYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTF--GYLAP 441
+ HRDI + N+L+ S K+ DFGL++ + S G ++AP
Sbjct: 135 KRF------VHRDIAARNVLVSSNDCVKLGDFGLSRYMED--STYYKASKGKLPIKWMAP 186
Query: 442 EYALYGQLTEKSDVYSFGIVILELMS-GRK 470
E + + T SDV+ FG+ + E++ G K
Sbjct: 187 ESINFRRFTSASDVWMFGVCMWEILMHGVK 216
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 1e-33
Identities = 61/204 (29%), Positives = 105/204 (51%), Gaps = 14/204 (6%)
Query: 266 FSQNNLIGQGASGIVYKGT-LRHGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLS 324
F +G+G+ G VYK G +VA+KQ+ +++ ++ E+ I+ + +++
Sbjct: 31 FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQV-PVESD-LQEIIKEISIMQQCDSPHVVK 88
Query: 325 LRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYL 384
G + D ++V +Y G++SD I + +K LT + I+ KG+ YL
Sbjct: 89 YYGSYFKNTDL-----WIVMEYCGAGSVSDIIRLRNKT--LTEDEIATILQSTLKGLEYL 141
Query: 385 HYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYA 444
H HRDIK+ NILL++E +AK+ADFG+A Q + + T + GT ++APE
Sbjct: 142 H---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI-GTPFWMAPEVI 197
Query: 445 LYGQLTEKSDVYSFGIVILELMSG 468
+D++S GI +E+ G
Sbjct: 198 QEIGYNCVADIWSLGITAIEMAEG 221
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-33
Identities = 45/219 (20%), Positives = 89/219 (40%), Gaps = 22/219 (10%)
Query: 257 SELEQATNGFSQNNLIGQGASGIVYKGT-LRHGNLVAVKQILDLDTKGDEDFTNEVEIIS 315
E + + + +G+G+ G V++ + G AVK++ L+ E E+ +
Sbjct: 51 YEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKV-RLEVFRVE----ELVACA 105
Query: 316 KIRHRNLLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIV 375
+ ++ L G + + + + G+L I + L + +
Sbjct: 106 GLSSPRIVPLYGAVREGPWVN-----IFMELLEGGSLGQLIK---QMGCLPEDRALYYLG 157
Query: 376 DVAKGIAYLHYGLKPGIYHRDIKSTNILLDSE-LNAKVADFGLAKQSLEGHSHLTTR--- 431
+G+ YLH I H D+K+ N+LL S+ A + DFG A +
Sbjct: 158 QALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGD 214
Query: 432 -VAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGR 469
+ GT ++APE + K D++S ++L +++G
Sbjct: 215 YIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGC 253
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 1e-33
Identities = 51/218 (23%), Positives = 100/218 (45%), Gaps = 22/218 (10%)
Query: 266 FSQNNLIGQGASGIVYKGTLRH-GNLVAVKQILDLDTKGDED-FTNEVEIISKIRHRNLL 323
+ ++++GQGA+ V++G + G+L A+K ++ D E E++ K+ H+N++
Sbjct: 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70
Query: 324 SLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAY 383
L ++++ + + L+ ++ P G+L + L + ++ DV G+ +
Sbjct: 71 KLFAI---EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127
Query: 384 LHYGLKPGIYHRDIKSTNILL----DSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYL 439
L + GI HR+IK NI+ D + K+ DFG A++ LE + GT YL
Sbjct: 128 LR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE-LEDDEQFVSLY-GTEEYL 182
Query: 440 APE--------YALYGQLTEKSDVYSFGIVILELMSGR 469
P+ + D++S G+ +G
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 2e-33
Identities = 59/204 (28%), Positives = 92/204 (45%), Gaps = 11/204 (5%)
Query: 272 IGQGASGIVYKGTLRH-GNLVAVKQI-LDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCC 329
+G G G V + + G VA+KQ +L K E + E++I+ K+ H N++S R
Sbjct: 22 LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 81
Query: 330 VTSDD-SSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGL 388
+ L +Y G L ++ L + ++ D++ + YLH
Sbjct: 82 DGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH--- 138
Query: 389 KPGIYHRDIKSTNILLDSE---LNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYAL 445
+ I HRD+K NI+L L K+ D G AK+ L+ T V GT YLAPE
Sbjct: 139 ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKE-LDQGELCTEFV-GTLQYLAPELLE 196
Query: 446 YGQLTEKSDVYSFGIVILELMSGR 469
+ T D +SFG + E ++G
Sbjct: 197 QKKYTVTVDYWSFGTLAFECITGF 220
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 2e-33
Identities = 51/214 (23%), Positives = 89/214 (41%), Gaps = 25/214 (11%)
Query: 266 FSQNNLIGQGASGIVYKGTLRHGNLVAVKQILDLDTKGDEDFTNEVEIISKI-RHRNLLS 324
F +++G GA G + + VAVK+IL + EV+++ + H N++
Sbjct: 26 FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRIL---PECFSFADREVQLLRESDEHPNVIR 82
Query: 325 LRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYL 384
+++ + TL + + K + ++ G+A+L
Sbjct: 83 YFCTEKDRQF-----QYIAIELCA-ATLQE--YVEQKDFAHLGLEPITLLQQTTSGLAHL 134
Query: 385 HYGLKPGIYHRDIKSTNILL-----DSELNAKVADFGLAKQSLEGHSHLTTR--VAGTFG 437
H I HRD+K NIL+ ++ A ++DFGL K+ G + R V GT G
Sbjct: 135 H---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEG 191
Query: 438 YLAPEY---ALYGQLTEKSDVYSFGIVILELMSG 468
++APE T D++S G V ++S
Sbjct: 192 WIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISE 225
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 2e-33
Identities = 45/217 (20%), Positives = 88/217 (40%), Gaps = 28/217 (12%)
Query: 271 LIGQGASGIVYKGT-LRHGNLVAVKQILDLDTKGDED----FTNEVEIISKIRHRNLLSL 325
L+G+G G VY+ +VA+K ++ D E +++ +++ +
Sbjct: 41 LVGRGGMGDVYEAEDTVRERIVALK-LMSETLSSDPVFRTRMQREARTAGRLQEPHVVPI 99
Query: 326 --RGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAY 383
G D + ++ + L+ + ++ L P+ I+ + +
Sbjct: 100 HDFG----EIDG---QLYVDMRLINGVDLAAML---RRQGPLAPPRAVAIVRQIGSALDA 149
Query: 384 LHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEY 443
H G HRD+K NIL+ ++ A + DFG+A + + GT Y+APE
Sbjct: 150 AH---AAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPER 206
Query: 444 ALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQ 480
T ++D+Y+ V+ E ++G P+Q
Sbjct: 207 FSESHATYRADIYALTCVLYECLTGSP-------PYQ 236
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 2e-33
Identities = 63/221 (28%), Positives = 101/221 (45%), Gaps = 38/221 (17%)
Query: 270 NLIGQGASGIVYKGTLRHGNL---VAVKQILDLDTKGD-EDFTNEVEIISKI-RHRNLLS 324
++IG+G G V K ++ L A+K++ + +K D DF E+E++ K+ H N+++
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90
Query: 325 LRGCCVTSDDSSGKRRFLVYDYMPNGTLSD-------------NISISHKRKQLTWPQRK 371
L G C +L +Y P+G L D + L+ Q
Sbjct: 91 LLGAC-----EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 145
Query: 372 KIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTR 431
DVA+G+ YL + HRD+ + NIL+ AK+ADFGL++
Sbjct: 146 HFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEV-------Y 195
Query: 432 VAGTFGYL-----APEYALYGQLTEKSDVYSFGIVILELMS 467
V T G L A E Y T SDV+S+G+++ E++S
Sbjct: 196 VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-33
Identities = 58/290 (20%), Positives = 111/290 (38%), Gaps = 52/290 (17%)
Query: 270 NLIGQGASGIVYKGTLRHGNLVAVKQI--LDLDTKGDEDFTNEVEIISKIRHRNL--LSL 325
IG G S V++ + A+K + + D + + + NE+ ++K++ + + L
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 326 RGCCVTSDDSSGKRRFLVYDYM--PNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAY 383
+T +Y M N L+ + K+K + +RK ++ + +
Sbjct: 122 YDYEITDQY--------IYMVMECGNIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHT 170
Query: 384 LHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAK--QSLEGHSHLTTRVAGTFGYLAP 441
+H + GI H D+K N L+ K+ DFG+A Q ++V G Y+ P
Sbjct: 171 IH---QHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQV-GAVNYMPP 225
Query: 442 E-----------YALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLA 490
E +++ KSDV+S G ++ + G+ PFQ I + L
Sbjct: 226 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT-------PFQQIINQISKLH 278
Query: 491 K--SGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALK 538
+ F + + + V++ C R +I + L
Sbjct: 279 AIIDPNHEIEFPDIPEKD-LQDVLKC-------CLKRDPKQRISIPELLA 320
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 5e-33
Identities = 64/234 (27%), Positives = 108/234 (46%), Gaps = 14/234 (5%)
Query: 243 ASVLPNSGAKWFHVSELEQATNGFSQNNLIGQGASGIVYKGT-LRHGNLVAVKQILDLDT 301
AS P +S L F L+G G G VYKG ++ G L A+K + D+
Sbjct: 3 ASDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVM-DVTG 61
Query: 302 KGDEDFTNEVEIISKI-RHRNLLSLRGCCVTSDDSSGKRR-FLVYDYMPNGTLSDNISIS 359
+E+ E+ ++ K HRN+ + G + + + +LV ++ G+++D I +
Sbjct: 62 DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIK-N 120
Query: 360 HKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAK 419
K L I ++ +G+++LH + + HRDIK N+LL K+ DFG++
Sbjct: 121 TKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSA 177
Query: 420 QSLEGHSHLTTRVAGTFGYLAPEYALYGQLTE-----KSDVYSFGIVILELMSG 468
Q T GT ++APE + + KSD++S GI +E+ G
Sbjct: 178 QLDRTVGRRNT-FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 230
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 6e-33
Identities = 52/210 (24%), Positives = 103/210 (49%), Gaps = 19/210 (9%)
Query: 266 FSQNNLIGQGASGIVYKGT-LRHGNLVAVKQILDLDTKGD-EDFTNEVEIISKIRHRNLL 323
+ +G GA G VYK G L A K I + ++ + ED+ E+EI++ H ++
Sbjct: 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVI-ETKSEEELEDYIVEIEILATCDHPYIV 79
Query: 324 SLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAY 383
L G +++ ++ P G + + + LT PQ + + + + + +
Sbjct: 80 KLLGAYYHDGKL-----WIMIEFCPGGAVDA--IMLELDRGLTEPQIQVVCRQMLEALNF 132
Query: 384 LHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEY 443
LH I HRD+K+ N+L+ E + ++ADFG++ ++L+ + + GT ++APE
Sbjct: 133 LH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-GTPYWMAPEV 188
Query: 444 ALYGQLTE-----KSDVYSFGIVILELMSG 468
+ + + K+D++S GI ++E+
Sbjct: 189 VMCETMKDTPYDYKADIWSLGITLIEMAQI 218
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 9e-33
Identities = 80/323 (24%), Positives = 121/323 (37%), Gaps = 77/323 (23%)
Query: 272 IGQGASGIVYKGTLRHGN------LVAVKQILDLDTKGDE-DFTNEVEIISKIRHRNLLS 324
+G GA G VY+G + VAVK + ++ ++ DE DF E IISK H+N++
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 325 LRGCCVTSDDSSGKRRFLVYDYMPNGTLSD----NISISHKRKQLTWPQRKKIIVDVAKG 380
G RF++ + M G L + L + D+A G
Sbjct: 98 CIGVS-----LQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 152
Query: 381 IAYL---HYGLKPGIYHRDIKSTNILLDSE---LNAKVADFGLAKQSLEGHSHLTTRVAG 434
YL H+ I HRDI + N LL AK+ DFG+A+ R G
Sbjct: 153 CQYLEENHF-----I-HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAS---YYRKGG 203
Query: 435 TFGYL-----APEYALYGQLTEKSDVYSFGIVILELMS-GRKVLDTSTSPFQLITDWAWV 488
L PE + G T K+D +SFG+++ E+ S G P+ ++ V
Sbjct: 204 C-AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGY-------MPYPSKSNQE-V 254
Query: 489 LAKSGKVDDIFDEFIRAEGAR------------AVMERFVLVGILCAHVMVALRPTITDA 536
L EF+ G R +M + C RP
Sbjct: 255 L-----------EFVT-SGGRMDPPKNCPGPVYRIMTQ-------CWQHQPEDRPNFAII 295
Query: 537 LKMLEGDIDIPKLPDRPLPLSHE 559
L+ +E P + + LP+ +
Sbjct: 296 LERIEYCTQDPDVINTALPIEYG 318
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 9e-33
Identities = 49/218 (22%), Positives = 96/218 (44%), Gaps = 37/218 (16%)
Query: 272 IGQGASGIVYKGTLRHGN------LVAVKQILDLDTKGD-EDFTNEVEIISKIRHRNLLS 324
+GQG+ G+VY+G + VA+K + + + + +F NE ++ + +++
Sbjct: 33 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 325 LRGCCVTSDDSSGKRRFLVYDYMPNGTL-------SDNISISHKRKQLTWPQRKKIIVDV 377
L G S G+ ++ + M G L ++ + + + ++ ++
Sbjct: 93 LLGVV-----SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEI 147
Query: 378 AKGIAYL---HYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAG 434
A G+AYL + HRD+ + N ++ + K+ DFG+ + E + G
Sbjct: 148 ADGMAYLNANKF------VHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY----RKG 197
Query: 435 TFGYL-----APEYALYGQLTEKSDVYSFGIVILELMS 467
G L +PE G T SDV+SFG+V+ E+ +
Sbjct: 198 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 1e-32
Identities = 50/221 (22%), Positives = 99/221 (44%), Gaps = 37/221 (16%)
Query: 272 IGQGASGIVYKGTLRHGN------LVAVKQILDLDTKGD-EDFTNEVEIISKIRHRNLLS 324
+G+ G VYKG L VA+K + D E+F +E + ++++H N++
Sbjct: 17 LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76
Query: 325 LRGCCVTSDDSSGKRRFLVYDYMPNGTLSD-------------NISISHKRKQLTWPQRK 371
L G + + +++ Y +G L + + L P
Sbjct: 77 LLGVV-----TKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFV 131
Query: 372 KIIVDVAKGIAYL---HYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHL 428
++ +A G+ YL H + H+D+ + N+L+ +LN K++D GL ++ + +
Sbjct: 132 HLVAQIAAGMEYLSSHHV-----V-HKDLATRNVLVYDKLNVKISDLGLFRE-VYAADYY 184
Query: 429 TTRVAGTF--GYLAPEYALYGQLTEKSDVYSFGIVILELMS 467
++APE +YG+ + SD++S+G+V+ E+ S
Sbjct: 185 KLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-32
Identities = 54/221 (24%), Positives = 83/221 (37%), Gaps = 18/221 (8%)
Query: 266 FSQNNLIGQGASGIVYKGTLRH-GNLVAVKQI--LDLDTKGDEDFTNEVEIISKI-RHRN 321
F + + +G G+ G V+K + G L AVK+ K EV K+ +H
Sbjct: 59 FQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPC 118
Query: 322 LLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGI 381
+ L +L + +L + L Q + D +
Sbjct: 119 CVRLEQAWEEGG-----ILYLQTELC-GPSLQQHCE--AWGASLPEAQVWGYLRDTLLAL 170
Query: 382 AYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAP 441
A+LH G+ H D+K NI L K+ DFGL + L + G Y+AP
Sbjct: 171 AHLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVE-LGTAGAGEVQE-GDPRYMAP 225
Query: 442 EYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLI 482
E L G +DV+S G+ ILE+ ++ QL
Sbjct: 226 E-LLQGSYGTAADVFSLGLTILEVACNMELPHGGEGWQQLR 265
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-32
Identities = 36/346 (10%), Positives = 83/346 (23%), Gaps = 50/346 (14%)
Query: 226 KKRKQIALHEQFVSNLQASVLPNSGAKWFHVSELEQATNGFSQNNLIGQGASGIVYKGT- 284
R++ + + + A+ S L Q + G +V+
Sbjct: 24 YCREEALKEPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRD 83
Query: 285 LRHGNLVAVKQIL---DLDTKGDEDFTNEVEIISKIRHRNLLSLRGCC------------ 329
+ A+K + E +++ + R
Sbjct: 84 VERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQ 143
Query: 330 ---------VTSDDSSGKRRFLVYDYMPNGTLSDNIS----ISHKRKQLTWPQRKKIIVD 376
DD + L+ + L S + R +
Sbjct: 144 SQPPFAQLSPGQDDYAVANYLLLMPAA-SVDLELLFSTLDFVYVFRGDEGILALHILTAQ 202
Query: 377 VAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTF 436
+ + A L G+ H N+ + + + D + +
Sbjct: 203 LIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWK----VGTRGPASSVPV 255
Query: 437 GYLAPEYAL--YGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGK 494
Y E+ T + + G+ I + PF L+T K
Sbjct: 256 TYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF-------LPFGLVTPGIKGSWKRPS 308
Query: 495 VDDIFDEFIRAEGARAVME--RFVLVGILCAHVMVALRPTITDALK 538
+ + + + + + ++ L R +A++
Sbjct: 309 LRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFD--RRRRLLPLEAME 352
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 2e-32
Identities = 45/220 (20%), Positives = 85/220 (38%), Gaps = 39/220 (17%)
Query: 272 IGQGASGIVYKGTLRHGNL--------VAVKQILDLDTKGDEDFTNEVEIISKIRHRNLL 323
+GQG ++KG R V +K + E F ++SK+ H++L+
Sbjct: 16 LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 324 SLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAY 383
G C G LV +++ G+L + + + + ++ +A + +
Sbjct: 76 LNYGVC-----VCGDENILVQEFVKFGSLDT--YLKKNKNCINILWKLEVAKQLAAAMHF 128
Query: 384 L---HYGLKPGIYHRDIKSTNILLDSELN--------AKVADFGLAKQSLEGHSHLTTRV 432
L I H ++ + NILL E + K++D G++ ++ L R+
Sbjct: 129 LEENTL-----I-HGNVCAKNILLIREEDRKTGNPPFIKLSDPGISI-TVLPKDILQERI 181
Query: 433 AGTFGYLAPEYALYGQL-TEKSDVYSFGIVILELMS-GRK 470
PE + +D +SFG + E+ S G K
Sbjct: 182 PWV----PPECIENPKNLNLATDKWSFGTTLWEICSGGDK 217
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-32
Identities = 56/222 (25%), Positives = 90/222 (40%), Gaps = 37/222 (16%)
Query: 272 IGQGASGIVYKGTLRHGN------LVAVKQILDLDTKGD-EDFTNEVEIISKI-RHRNLL 323
+G+GA G V + + VAVK + + T + +E++I+ I H N++
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 324 SLRGCCVTSDDSSGKRRFLVYDYMPNGTLSD-------------NISISHKRKQLTWPQR 370
+L G C G ++ ++ G LS + LT
Sbjct: 95 NLLGACTKP----GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150
Query: 371 KKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTT 430
VAKG+ +L HRD+ + NILL + K+ DFGLA+ + +
Sbjct: 151 ICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY--- 204
Query: 431 RVAGTFGYL-----APEYALYGQLTEKSDVYSFGIVILELMS 467
V L APE T +SDV+SFG+++ E+ S
Sbjct: 205 -VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 3e-32
Identities = 62/207 (29%), Positives = 103/207 (49%), Gaps = 23/207 (11%)
Query: 271 LIGQGASGIVYKGT-LRHGNLVAVKQILD---LDTKGDED-FTNEVEIISKIRHRNLLSL 325
L+G+G+ VY+ + G VA+K ++D + G NEV+I +++H ++L L
Sbjct: 18 LLGKGSFAGVYRAESIHTGLEVAIK-MIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILEL 76
Query: 326 RGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLH 385
S +LV + NG ++ + ++ K + + + + + G+ YLH
Sbjct: 77 YNYFEDS-----NYVYLVLEMCHNGEMNR--YLKNRVKPFSENEARHFMHQIITGMLYLH 129
Query: 386 YGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYA- 444
GI HRD+ +N+LL +N K+ADFGLA Q H T + GT Y++PE A
Sbjct: 130 ---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT-LCGTPNYISPEIAT 185
Query: 445 --LYGQLTEKSDVYSFGIVILELMSGR 469
+G +SDV+S G + L+ GR
Sbjct: 186 RSAHG---LESDVWSLGCMFYTLLIGR 209
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 3e-32
Identities = 51/216 (23%), Positives = 95/216 (43%), Gaps = 27/216 (12%)
Query: 271 LIGQGASGIVYKGT-LRHGNLVAVKQILD---LDTKGDED-FTNEVEIISKIRHRNLLSL 325
+G+G ++ + + A K I+ L + + E+ I + H++++
Sbjct: 22 FLGKGGFAKCFEISDADTKEVFAGK-IVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 80
Query: 326 RGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLH 385
G +D F+V + +L + +RK LT P+ + + + G YLH
Sbjct: 81 HGFFEDNDFV-----FVVLELCRRRSLLELHK---RRKALTEPEARYYLRQIVLGCQYLH 132
Query: 386 YGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYAL 445
+ + HRD+K N+ L+ +L K+ DFGLA + + GT Y+APE L
Sbjct: 133 ---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPE-VL 187
Query: 446 YGQL-TEKSDVYSFGIVILELMSGRKVLDTSTSPFQ 480
+ + + DV+S G ++ L+ G+ PF+
Sbjct: 188 SKKGHSFEVDVWSIGCIMYTLLVGK-------PPFE 216
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 6e-32
Identities = 51/216 (23%), Positives = 95/216 (43%), Gaps = 27/216 (12%)
Query: 271 LIGQGASGIVYKGT-LRHGNLVAVKQILD---LDTKGDED-FTNEVEIISKIRHRNLLSL 325
+G+G ++ + + A K I+ L + + E+ I + H++++
Sbjct: 48 FLGKGGFAKCFEISDADTKEVFAGK-IVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 106
Query: 326 RGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLH 385
G +D F+V + +L + +RK LT P+ + + + G YLH
Sbjct: 107 HGFFEDNDFV-----FVVLELCRRRSLLELHK---RRKALTEPEARYYLRQIVLGCQYLH 158
Query: 386 YGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYAL 445
+ + HRD+K N+ L+ +L K+ DFGLA + + GT Y+APE L
Sbjct: 159 ---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPE-VL 213
Query: 446 YGQL-TEKSDVYSFGIVILELMSGRKVLDTSTSPFQ 480
+ + + DV+S G ++ L+ G+ PF+
Sbjct: 214 SKKGHSFEVDVWSIGCIMYTLLVGK-------PPFE 242
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 6e-32
Identities = 51/228 (22%), Positives = 89/228 (39%), Gaps = 26/228 (11%)
Query: 271 LIGQGASGIVYKGTLRH-GNLVAVKQILDLDTKGDEDFTNEVEIISKIR-HRNLLSLRGC 328
++ +G VY+ G A+K++L + + + EV + K+ H N++
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 329 CVTSDDSS--GKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHY 386
+ S G+ FL+ + G L + + R L+ KI + + ++H
Sbjct: 95 ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR 154
Query: 387 GLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVA-----------GT 435
KP I HRD+K N+LL ++ K+ DFG A + + T
Sbjct: 155 -QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTT 213
Query: 436 FGYLAPE-YALYGQL--TEKSDVYSFGIVILELMSGRKVLDTSTSPFQ 480
Y PE LY EK D+++ G ++ L PF+
Sbjct: 214 PMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFR-------QHPFE 254
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 9e-32
Identities = 45/225 (20%), Positives = 85/225 (37%), Gaps = 41/225 (18%)
Query: 272 IGQGASGIVYKGTLRH-GNLVAVKQILD------------------LDTKGDEDFTNEVE 312
+ QG + A+K + +DF NE++
Sbjct: 39 LNQGKFNKIILC--EKDNKFYALK-KYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQ 95
Query: 313 IISKIRHRNLLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHK-----RKQLTW 367
II+ I++ L+ G +++Y+YM N ++ +
Sbjct: 96 IITDIKNEYCLTCEGIITNY-----DEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPI 150
Query: 368 PQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSH 427
K II V +Y+H + I HRD+K +NIL+D K++DFG ++ ++
Sbjct: 151 QVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK--K 206
Query: 428 LTTRVAGTFGYLAPEYALYGQLT---EKSDVYSFGIVILELMSGR 469
+ GT+ ++ PE + + K D++S GI + +
Sbjct: 207 IKG-SRGTYEFMPPE-FFSNESSYNGAKVDIWSLGICLYVMFYNV 249
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-31
Identities = 63/218 (28%), Positives = 92/218 (42%), Gaps = 37/218 (16%)
Query: 272 IGQGASGIVYKGTLRHGN------LVAVKQILDLDTKGDE-DFTNEVEIISKIRHRNLLS 324
+G GA G VY+G + VAVK + ++ ++ DE DF E IISK H+N++
Sbjct: 79 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 325 LRGCCVTSDDSSGKRRFLVYDYMPNGTLSD----NISISHKRKQLTWPQRKKIIVDVAKG 380
G RF++ + M G L + L + D+A G
Sbjct: 139 CIGVS-----LQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 193
Query: 381 IAYL---HYGLKPGIYHRDIKSTNILLDSE---LNAKVADFGLAKQSLEGHSHLTTRVAG 434
YL H+ I HRDI + N LL AK+ DFG+A+ R G
Sbjct: 194 CQYLEENHF-----I-HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAG---YYRK-G 243
Query: 435 TFGYL-----APEYALYGQLTEKSDVYSFGIVILELMS 467
L PE + G T K+D +SFG+++ E+ S
Sbjct: 244 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-31
Identities = 52/232 (22%), Positives = 94/232 (40%), Gaps = 51/232 (21%)
Query: 272 IGQGASGIVYKGTLRHGN------LVAVKQILDLDTKGD-EDFTNEVEIISKIRHRNLLS 324
+G+G G V K T H VAVK + + + + D +E ++ ++ H +++
Sbjct: 31 LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 325 LRGCCVTSDDSSGKRRFLVYDYMPNGTLSD---------------------NISISHKRK 363
L G C S L+ +Y G+L + +
Sbjct: 91 LYGAC-----SQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDER 145
Query: 364 QLTWPQRKKIIVDVAKGIAYL---HYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQ 420
LT +++G+ YL + HRD+ + NIL+ K++DFGL++
Sbjct: 146 ALTMGDLISFAWQISQGMQYLAEMKL-----V-HRDLAARNILVAEGRKMKISDFGLSRD 199
Query: 421 SLEGHSHLTTRVAGTFGYL-----APEYALYGQLTEKSDVYSFGIVILELMS 467
E S+ V + G + A E T +SDV+SFG+++ E+++
Sbjct: 200 VYEEDSY----VKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 125 bits (314), Expect = 2e-31
Identities = 46/215 (21%), Positives = 81/215 (37%), Gaps = 30/215 (13%)
Query: 272 IGQGAS--GIVYKGT-LRHGNLVAVKQILDLDTKGDEDFT---NEVEIISKIRHRNLLSL 325
IG+G V G V V++I +L+ +E T E+ + H N++
Sbjct: 33 IGKGFEDLMTVNLARYKPTGEYVTVRRI-NLEACSNEMVTFLQGELHVSKLFNHPNIVPY 91
Query: 326 RGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLH 385
R + ++ ++V +M G+ D I +H + I+ V K + Y+H
Sbjct: 92 RATFIADNE-----LWVVTSFMAYGSAKDLIC-THFMDGMNELAIAYILQGVLKALDYIH 145
Query: 386 YGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTR------VAGTFGYL 439
G HR +K+++IL+ + ++ + +L
Sbjct: 146 ---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWL 202
Query: 440 APE-----YALYGQLTEKSDVYSFGIVILELMSGR 469
+PE Y KSD+YS GI EL +G
Sbjct: 203 SPEVLQQNLQGYD---AKSDIYSVGITACELANGH 234
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 3e-31
Identities = 42/272 (15%), Positives = 81/272 (29%), Gaps = 40/272 (14%)
Query: 257 SELEQATNGFSQNNLIGQGASGIVYKGTLRH------GNLVAVKQILDLDTKGDEDFTNE 310
+E + + ++L+G+GA VY+ T +K + T
Sbjct: 58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQL 117
Query: 311 VEIISKIRHRNLLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISI--SHKRKQLTWP 368
+E + + + + S LV + GTL + I++ + K +
Sbjct: 118 MERLKPSMQHMFMKFYSAHLFQNGS-----VLVGELYSYGTLLNAINLYKNTPEKVMPQG 172
Query: 369 QRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILL-----------DSELNAKVADFGL 417
+ + I +H I H DIK N +L D + D G
Sbjct: 173 LVISFAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQ 229
Query: 418 AKQ-SLEGHSHLTTRVAGTFGYLAPEYALYGQL-TEKSDVYSFGIVILELMSGRKVLDTS 475
+ L + T T G+ E L + + D + + ++ G
Sbjct: 230 SIDMKLFPKGTIFTAKCETSGFQCVE-MLSNKPWNYQIDYFGVAATVYCMLFGT------ 282
Query: 476 TSPFQLITDWAWVLAKSGK---VDDIFDEFIR 504
+ D+++EF
Sbjct: 283 -YMKVKNEGGECKPEGLFRRLPHLDMWNEFFH 313
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 3e-31
Identities = 51/204 (25%), Positives = 87/204 (42%), Gaps = 20/204 (9%)
Query: 271 LIGQGASGIVYKGTLRH-GNLVAVKQILD----LDTKGDEDFTNEVEIISKIRHRNLLSL 325
+G+G G VY + ++A+K +L + E+EI S +RH N+L +
Sbjct: 21 PLGKGKFGNVYLAREKQNKFIMALK-VLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRM 79
Query: 326 RGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLH 385
KR +L+ ++ P G L + K + + + ++A + Y H
Sbjct: 80 YNYFHDR-----KRIYLMLEFAPRGELYKELQ---KHGRFDEQRSATFMEELADALHYCH 131
Query: 386 YGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYAL 445
+ + HRDIK N+L+ + K+ADFG + + T GT YL PE
Sbjct: 132 ---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHA-PSLRRRTM--CGTLDYLPPEMIE 185
Query: 446 YGQLTEKSDVYSFGIVILELMSGR 469
EK D++ G++ E + G
Sbjct: 186 GKTHDEKVDLWCAGVLCYEFLVGM 209
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 3e-31
Identities = 55/225 (24%), Positives = 97/225 (43%), Gaps = 42/225 (18%)
Query: 270 NLIGQGASGIVYKGTLRHGN------LVAVKQILDLDTKGD-EDFTNEVEIISKI-RHRN 321
+G GA G V + T VAVK + + E +E++I+S + +H N
Sbjct: 52 KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 322 LLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSD-----------NISISHKRKQLTWPQR 370
+++L G C + G ++ +Y G L + + + + +
Sbjct: 112 IVNLLGAC-----THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDL 166
Query: 371 KKIIVDVAKGIAYL---HYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSH 427
VA+G+A+L + I HRD+ + N+LL + AK+ DFGLA+ + ++
Sbjct: 167 LHFSSQVAQGMAFLASKNC-----I-HRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNY 220
Query: 428 LTTRVAGTFGYL-----APEYALYGQLTEKSDVYSFGIVILELMS 467
+ L APE T +SDV+S+GI++ E+ S
Sbjct: 221 ----IVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 3e-31
Identities = 57/224 (25%), Positives = 88/224 (39%), Gaps = 40/224 (17%)
Query: 272 IGQGASGIVYKGTLRHGN------LVAVKQILDLDTKGD-EDFTNEVEIISKI-RHRNLL 323
+G GA G V + T VAVK + + E +E++++S + H N++
Sbjct: 31 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90
Query: 324 SLRGCCVTSDDSSGKRRFLVYDYMPNGTLSD---------------NISISHKRKQLTWP 368
+L G C + G ++ +Y G L + + L
Sbjct: 91 NLLGAC-----TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 145
Query: 369 QRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHL 428
VAKG+A+L HRD+ + NILL K+ DFGLA+ ++
Sbjct: 146 DLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY- 201
Query: 429 TTRVAGTFGYL-----APEYALYGQLTEKSDVYSFGIVILELMS 467
V L APE T +SDV+S+GI + EL S
Sbjct: 202 ---VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 3e-31
Identities = 56/212 (26%), Positives = 87/212 (41%), Gaps = 29/212 (13%)
Query: 272 IGQGASGIVYKGTLRH-GNLVAVKQI--------LDLDTKGDEDFTNEVEIISKIRHRNL 322
+G GA G V R VA++ I + + E+EI+ K+ H +
Sbjct: 143 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 202
Query: 323 LSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIA 382
+ ++ D ++V + M G L D + K+L K + +
Sbjct: 203 IKIKNFFDAED------YYIVLELMEGGELFDKVV---GNKRLKEATCKLYFYQMLLAVQ 253
Query: 383 YLHYGLKPGIYHRDIKSTNILLDS---ELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYL 439
YLH + GI HRD+K N+LL S + K+ DFG +K E S + T GT YL
Sbjct: 254 YLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET-SLMRTLC-GTPTYL 308
Query: 440 APE---YALYGQLTEKSDVYSFGIVILELMSG 468
APE D +S G+++ +SG
Sbjct: 309 APEVLVSVGTAGYNRAVDCWSLGVILFICLSG 340
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 4e-31
Identities = 64/288 (22%), Positives = 113/288 (39%), Gaps = 60/288 (20%)
Query: 221 YRKWNKKRKQIALHEQFVSNLQASVLPNSGAKWFHVSELEQATNG---FSQNNL-----I 272
++ + R + L + + S F+V E + F + NL +
Sbjct: 1 HKYKKQFRYESQLQ---MVQVTGSSDNEY----FYVDFREYEYDLKWEFPRENLEFGKVL 53
Query: 273 GQGASGIVYKGTLRHGN------LVAVKQILDLDTKGD-EDFTNEVEIISKI-RHRNLLS 324
G GA G V T + VAVK + + + E +E+++++++ H N+++
Sbjct: 54 GSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVN 113
Query: 325 LRGCCVTSDDSSGKRRFLVYDYMPNGTLSD--------------------NISISHKRKQ 364
L G C + +L+++Y G L + +
Sbjct: 114 LLGAC-----TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 168
Query: 365 LTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEG 424
LT+ VAKG+ +L HRD+ + N+L+ K+ DFGLA+ +
Sbjct: 169 LTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSD 225
Query: 425 HSHLTTRVAGTFGYL-----APEYALYGQLTEKSDVYSFGIVILELMS 467
++ V L APE G T KSDV+S+GI++ E+ S
Sbjct: 226 SNY----VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 5e-31
Identities = 63/219 (28%), Positives = 92/219 (42%), Gaps = 27/219 (12%)
Query: 272 IGQGASGIVYKGTLRH-GNLVAVKQIL--DLDTKGDEDFTNEVEIISKIRHRNLLSLRGC 328
+G GA G V + A+K I + T + EV ++ + H N++ L
Sbjct: 45 LGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDF 104
Query: 329 CVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGL 388
D + +LV + G L D I R + II V G+ YLH
Sbjct: 105 F--EDKRN---YYLVMECYKGGELFDEII---HRMKFNEVDAAVIIKQVLSGVTYLH--- 153
Query: 389 KPGIYHRDIKSTNILLDS---ELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYAL 445
K I HRD+K N+LL+S + K+ DFGL+ GT Y+APE L
Sbjct: 154 KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKM--KERLGTAYYIAPE-VL 210
Query: 446 YGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITD 484
+ EK DV+S G+++ L++G PF TD
Sbjct: 211 RKKYDEKCDVWSIGVILFILLAGYP-------PFGGQTD 242
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 6e-31
Identities = 56/224 (25%), Positives = 96/224 (42%), Gaps = 40/224 (17%)
Query: 272 IGQGASGIVYKGTLRHGN--------LVAVKQILDLDTKGD-EDFTNEVEIISKI-RHRN 321
+G+GA G V + VAVK + D T+ D D +E+E++ I +H+N
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 322 LLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSD-------------NISISHKRKQLTWP 368
+++L G C + +++ +Y G L + +Q+T+
Sbjct: 103 IINLLGAC-----TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157
Query: 369 QRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHL 428
+A+G+ YL HRD+ + N+L+ K+ADFGLA+ +
Sbjct: 158 DLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY- 213
Query: 429 TTRVAGTFGYL-----APEYALYGQLTEKSDVYSFGIVILELMS 467
T G L APE T +SDV+SFG+++ E+ +
Sbjct: 214 ---KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-30
Identities = 68/198 (34%), Positives = 94/198 (47%), Gaps = 21/198 (10%)
Query: 272 IGQGASGIVYKGTLRH-GNLVAVKQIL--DLDTKGDEDFTNEVEIISKIRHRNLLSLRGC 328
+G+G+ G V K R AVK I K EVE++ K+ H N++ L
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 329 CVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGL 388
S ++V + G L D I KRK+ + +II V GI Y+H
Sbjct: 90 LEDSSS-----FYIVGELYTGGELFDEII---KRKRFSEHDAARIIKQVFSGITYMH--- 138
Query: 389 KPGIYHRDIKSTNILLDS---ELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYAL 445
K I HRD+K NILL+S + + K+ DFGL+ + + R+ GT Y+APE L
Sbjct: 139 KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK-MKDRI-GTAYYIAPE-VL 195
Query: 446 YGQLTEKSDVYSFGIVIL 463
G EK DV+S G VIL
Sbjct: 196 RGTYDEKCDVWSAG-VIL 212
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 119 bits (302), Expect = 1e-30
Identities = 56/201 (27%), Positives = 89/201 (44%), Gaps = 26/201 (12%)
Query: 272 IGQGASGIVYKGTLRH-GNLVAVKQIL--DLDTKGDEDFTNEVEIISKIRHRNLLSLRGC 328
+G+GA +V + + G A K I L + + E I K++H N++ L
Sbjct: 14 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 73
Query: 329 CVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGL 388
+LV+D + G L ++I R+ + I + + IAY H
Sbjct: 74 IQEESF-----HYLVFDLVTGGELFEDIV---AREFYSEADASHCIQQILESIAYCH--- 122
Query: 389 KPGIYHRDIKSTNILLDSELNA---KVADFGLAKQSLEGHSHLTTRVAGTFGYLAPE--- 442
GI HR++K N+LL S+ K+ADFGLA + + + GT GYL+PE
Sbjct: 123 SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA-WHGFA-GTPGYLSPEVLK 180
Query: 443 YALYGQLTEKSDVYSFGIVIL 463
Y + D+++ G VIL
Sbjct: 181 KDPYS---KPVDIWACG-VIL 197
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-30
Identities = 55/232 (23%), Positives = 90/232 (38%), Gaps = 42/232 (18%)
Query: 266 FSQNNLIGQGASGIVYKGTLRHGNLVAVKQILDLDTKGDEDF-TNEVEIISKI-RHRNLL 323
++G G+SG V G VAVK++L D E++++++ H N++
Sbjct: 17 VVSEKILGYGSSGTVVFQGSFQGRPVAVKRML----IDFCDIALMEIKLLTESDDHPNVI 72
Query: 324 SLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNI----SISHKRKQLTWPQRKKIIVDVAK 379
T ++ + N L D + K ++ +A
Sbjct: 73 RYYCSETTDRF-----LYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIAS 126
Query: 380 GIAYLHYGLKPGIYHRDIKSTNILLDSE-------------LNAKVADFGLAKQSLEGHS 426
G+A+LH I HRD+K NIL+ + L ++DFGL K+ G S
Sbjct: 127 GVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQS 183
Query: 427 HLTTR---VAGTFGYLAPE-------YALYGQLTEKSDVYSFGIVILELMSG 468
T +GT G+ APE +LT D++S G V ++S
Sbjct: 184 SFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 2e-30
Identities = 47/210 (22%), Positives = 86/210 (40%), Gaps = 27/210 (12%)
Query: 272 IGQGASGIVYKGTLRHGN----LVAVKQI-LDLDTKGDEDFTNEVEIISKIRHRNLLSLR 326
IG+G G V++G VA+K E F E + + H +++ L
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 327 GCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYL-- 384
G + +++ + G L + ++ L ++ +AYL
Sbjct: 458 GVI------TENPVWIIMELCTLGELRS--FLQVRKFSLDLASLILYAYQLSTALAYLES 509
Query: 385 -HYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTF--GYLAP 441
+ HRDI + N+L+ S K+ DFGL++ +E ++ G ++AP
Sbjct: 510 KRF------VHRDIAARNVLVSSNDCVKLGDFGLSRY-MEDSTY-YKASKGKLPIKWMAP 561
Query: 442 EYALYGQLTEKSDVYSFGIVILELMS-GRK 470
E + + T SDV+ FG+ + E++ G K
Sbjct: 562 ESINFRRFTSASDVWMFGVCMWEILMHGVK 591
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-30
Identities = 57/207 (27%), Positives = 83/207 (40%), Gaps = 30/207 (14%)
Query: 272 IGQGASGIVYKGTLRH-GNLVAVKQI--------LDLDTKGDEDFTNEVEIISKIRHRNL 322
+G GA G V R VA+K I + + E+EI+ K+ H +
Sbjct: 18 LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 323 LSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIA 382
+ ++ D ++V + M G L D + K+L K + +
Sbjct: 78 IKIKNFFDAED------YYIVLELMEGGELFDKVV---GNKRLKEATCKLYFYQMLLAVQ 128
Query: 383 YLHYGLKPGIYHRDIKSTNILLDS---ELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYL 439
YLH + GI HRD+K N+LL S + K+ DFG +K E + T GT YL
Sbjct: 129 YLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL-MRTLC-GTPTYL 183
Query: 440 APE---YALYGQLTEKSDVYSFGIVIL 463
APE D +S G VIL
Sbjct: 184 APEVLVSVGTAGYNRAVDCWSLG-VIL 209
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 2e-30
Identities = 56/224 (25%), Positives = 96/224 (42%), Gaps = 40/224 (17%)
Query: 272 IGQGASGIVYKGTLRHGN--------LVAVKQILDLDTKGD-EDFTNEVEIISKI-RHRN 321
+G+GA G V + VAVK + T+ D D +E+E++ I +H+N
Sbjct: 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 322 LLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSD-------------NISISHKRKQLTWP 368
+++L G C + +++ +Y G L + + +QL+
Sbjct: 137 IINLLGAC-----TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 191
Query: 369 QRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHL 428
VA+G+ YL HRD+ + N+L+ + K+ADFGLA+ +
Sbjct: 192 DLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY- 247
Query: 429 TTRVAGTFGYL-----APEYALYGQLTEKSDVYSFGIVILELMS 467
T G L APE T +SDV+SFG+++ E+ +
Sbjct: 248 ---KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-30
Identities = 52/196 (26%), Positives = 88/196 (44%), Gaps = 19/196 (9%)
Query: 272 IGQGASGIVYKGTLRH-GNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCV 330
IG+G+ G V + A K+I + + F E+EI+ + H N++ L
Sbjct: 17 IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE 76
Query: 331 TSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKP 390
+ D +LV + G L + + ++ +I+ DV +AY H K
Sbjct: 77 DNTD-----IYLVMELCTGGELFERVV---HKRVFRESDAARIMKDVLSAVAYCH---KL 125
Query: 391 GIYHRDIKSTNILLDS---ELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALYG 447
+ HRD+K N L + + K+ DFGLA + G + T+V GT Y++P+ L G
Sbjct: 126 NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM-MRTKV-GTPYYVSPQ-VLEG 182
Query: 448 QLTEKSDVYSFGIVIL 463
+ D +S G V++
Sbjct: 183 LYGPECDEWSAG-VMM 197
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-30
Identities = 60/252 (23%), Positives = 113/252 (44%), Gaps = 34/252 (13%)
Query: 226 KKRKQIALHEQFVSNLQASVLPNSGAKWFHVSELEQATNGFSQNNLIGQGASGIVYKGTL 285
KK +++ L EQ L+A + + E+ + +G G G+V+K
Sbjct: 2 KKLEELELDEQQRKRLEAFLTQKQKVGELKDDDFEKI-------SELGAGNGGVVFKV-- 52
Query: 286 RH---GNLVAVKQI-LDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRF 341
H G ++A K I L++ E++++ + ++ G + + S
Sbjct: 53 SHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS----- 107
Query: 342 LVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTN 401
+ ++M G+L + K ++ K+ + V KG+ YL K I HRD+K +N
Sbjct: 108 ICMEHMDGGSLDQ---VLKKAGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSN 162
Query: 402 ILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTF----GYLAPEYALYGQLTEKSDVYS 457
IL++S K+ DFG++ Q L +A +F Y++PE + +SD++S
Sbjct: 163 ILVNSRGEIKLCDFGVSGQ-------LIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWS 215
Query: 458 FGIVILELMSGR 469
G+ ++E+ GR
Sbjct: 216 MGLSLVEMAVGR 227
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 3e-30
Identities = 54/215 (25%), Positives = 91/215 (42%), Gaps = 26/215 (12%)
Query: 272 IGQGASGIVYKGTLRH-GNLVAVKQILDLDTKGD-EDFTNEVEIISKIRHRNLLSLRGCC 329
+G GA G V+ R G +K I ++ E E+E++ + H N++ +
Sbjct: 30 LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89
Query: 330 VTSDDSSGKRRFLVYDYMPNGTLSDNI-SISHKRKQLTWPQRKKIIVDVAKGIAYLHYGL 388
+ ++V + G L + I S + K L+ +++ + +AY H
Sbjct: 90 EDYHNM-----YIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH--- 141
Query: 389 KPGIYHRDIKSTNILLDS---ELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYAL 445
+ H+D+K NIL K+ DFGLA+ H T GT Y+APE
Sbjct: 142 SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE-HSTNAA-GTALYMAPE-VF 198
Query: 446 YGQLTEKSDVYSFGIVIL-ELMSGRKVLDTSTSPF 479
+T K D++S G V++ L++G PF
Sbjct: 199 KRDVTFKCDIWSAG-VVMYFLLTGC-------LPF 225
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 3e-30
Identities = 56/227 (24%), Positives = 96/227 (42%), Gaps = 46/227 (20%)
Query: 272 IGQGASGIVYKGTLRHGN--------LVAVKQILDLDTKGD-EDFTNEVEIISKI-RHRN 321
+G+G G V + VAVK + D T+ D D +E+E++ I +H+N
Sbjct: 89 LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 322 LLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSD-------------NISISHKRKQLTWP 368
+++L G C + +++ +Y G L + +Q+T+
Sbjct: 149 IINLLGAC-----TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 203
Query: 369 QRKKIIVDVAKGIAYL---HYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGH 425
+A+G+ YL I HRD+ + N+L+ K+ADFGLA+
Sbjct: 204 DLVSCTYQLARGMEYLASQKC-----I-HRDLAARNVLVTENNVMKIADFGLARDINNID 257
Query: 426 SHLTTRVAGTFGYL-----APEYALYGQLTEKSDVYSFGIVILELMS 467
+ T G L APE T +SDV+SFG+++ E+ +
Sbjct: 258 YY----KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 4e-30
Identities = 62/212 (29%), Positives = 95/212 (44%), Gaps = 27/212 (12%)
Query: 266 FSQNNLIGQGASGIVYKGT-LRHGNLVAVKQI-LDLDTKGDE--DFTNEVEIISKIRHRN 321
FS IG G+ G VY +R+ +VA+K++ ++ D EV + K+RH N
Sbjct: 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 322 LLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGI 381
+ RGC + + +LV +Y G+ SD + +K L + + +G+
Sbjct: 116 TIQYRGCYLREHTA-----WLVMEYCL-GSASD--LLEVHKKPLQEVEIAAVTHGALQGL 167
Query: 382 AYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTR--VAGTFGYL 439
AYLH + HRD+K+ NILL K+ DFG A + GT ++
Sbjct: 168 AYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASI-------MAPANSFVGTPYWM 217
Query: 440 APEYALYGQLTE---KSDVYSFGIVILELMSG 468
APE L + K DV+S GI +EL
Sbjct: 218 APEVILAMDEGQYDGKVDVWSLGITCIELAER 249
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 4e-30
Identities = 65/205 (31%), Positives = 97/205 (47%), Gaps = 21/205 (10%)
Query: 272 IGQGASGIVYKGTLRH-GNLVAVKQIL--DLDTKGD-EDFTNEVEIISKIRHRNLLSLRG 327
+G+G+ G V + G AVK I + K D E EV+++ ++ H N++ L
Sbjct: 34 LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 93
Query: 328 CCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYG 387
D +LV + G L D I RK+ + +II V GI Y+H
Sbjct: 94 FF--EDKGY---FYLVGEVYTGGELFDEII---SRKRFSEVDAARIIRQVLSGITYMH-- 143
Query: 388 LKPGIYHRDIKSTNILLDS---ELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYA 444
K I HRD+K N+LL+S + N ++ DFGL+ GT Y+APE
Sbjct: 144 -KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM--KDKIGTAYYIAPE-V 199
Query: 445 LYGQLTEKSDVYSFGIVILELMSGR 469
L+G EK DV+S G+++ L+SG
Sbjct: 200 LHGTYDEKCDVWSTGVILYILLSGC 224
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 4e-30
Identities = 66/224 (29%), Positives = 107/224 (47%), Gaps = 35/224 (15%)
Query: 261 QATNGFSQN----NLIGQGASGIVYKGTLRH-GNLVAVKQI----LDLDTKGD-----ED 306
+T+GF +N ++G+G S +V + + AVK I + + E
Sbjct: 10 HSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREA 69
Query: 307 FTNEVEIISKI-RHRNLLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQL 365
EV+I+ K+ H N++ L+ T+ FLV+D M G L D ++ ++ L
Sbjct: 70 TLKEVDILRKVSGHPNIIQLKDTYETNTF-----FFLVFDLMKKGELFDYLT---EKVTL 121
Query: 366 TWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGH 425
+ + +KI+ + + I LH K I HRD+K NILLD ++N K+ DFG + Q L+
Sbjct: 122 SEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ-LDPG 177
Query: 426 SHLTTRVAGTFGYLAPE------YALYGQLTEKSDVYSFGIVIL 463
L GT YLAPE + ++ D++S G VI+
Sbjct: 178 EKLREVC-GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTG-VIM 219
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 4e-30
Identities = 56/232 (24%), Positives = 98/232 (42%), Gaps = 51/232 (21%)
Query: 272 IGQGASGIVYKGTLRHGN------LVAVKQILDLDTKGD-EDFTNEVEIISKIRHRNLLS 324
IG+GA G V++ +VAVK + + + DF E ++++ + N++
Sbjct: 55 IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 325 LRGCCVTSDDSSGKRRFLVYDYMPNGTL---------------------SDNISISHKRK 363
L G C + GK L+++YM G L + S
Sbjct: 115 LLGVC-----AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPP 169
Query: 364 QLTWPQRKKIIVDVAKGIAYL---HYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQ 420
L+ ++ I VA G+AYL + + HRD+ + N L+ + K+ADFGL++
Sbjct: 170 PLSCAEQLCIARQVAAGMAYLSERKF-----V-HRDLATRNCLVGENMVVKIADFGLSRN 223
Query: 421 SLEGHSHLTTRVAGTFGYL-----APEYALYGQLTEKSDVYSFGIVILELMS 467
+ A + PE Y + T +SDV+++G+V+ E+ S
Sbjct: 224 IYSADYY----KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 5e-30
Identities = 70/204 (34%), Positives = 100/204 (49%), Gaps = 20/204 (9%)
Query: 272 IGQGASGIVYKGTLRH-GNLVAVKQIL--DLDTKGDEDFTNEVEIISKIRHRNLLSLRGC 328
+G+G+ G V K R AVK I K EVE++ K+ H N++ L
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 329 CVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGL 388
D SS ++V + G L D I KRK+ + +II V GI Y+H
Sbjct: 90 L--EDSSS---FYIVGELYTGGELFDEII---KRKRFSEHDAARIIKQVFSGITYMH--- 138
Query: 389 KPGIYHRDIKSTNILLDS---ELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYAL 445
K I HRD+K NILL+S + + K+ DFGL+ + + R+ GT Y+APE L
Sbjct: 139 KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK-MKDRI-GTAYYIAPE-VL 195
Query: 446 YGQLTEKSDVYSFGIVILELMSGR 469
G EK DV+S G+++ L+SG
Sbjct: 196 RGTYDEKCDVWSAGVILYILLSGT 219
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 6e-30
Identities = 66/223 (29%), Positives = 98/223 (43%), Gaps = 23/223 (10%)
Query: 272 IGQGASGIVYKGTLRH---GNLVAVKQI-LDLDTKGDEDFTNEVEII-SKIRHRNLLSLR 326
IG+GA G V K H G ++AVK+I +D K + +++++ ++
Sbjct: 30 IGRGAYGSVNKM--VHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFY 87
Query: 327 GCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQR--KKIIVDVAKGIAYL 384
G D + + M + + + P+ KI + K + +L
Sbjct: 88 GALFREGDCW-----ICMELM-STSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHL 141
Query: 385 HYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPE-- 442
LK I HRDIK +NILLD N K+ DFG++ Q L S TR AG Y+APE
Sbjct: 142 KENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQ-LV-DSIAKTRDAGCRPYMAPERI 197
Query: 443 --YALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLIT 483
A +SDV+S GI + EL +GR S F +T
Sbjct: 198 DPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLT 240
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 8e-30
Identities = 48/350 (13%), Positives = 94/350 (26%), Gaps = 48/350 (13%)
Query: 241 LQASVLPNSGAKWFHVSELEQATNGFSQNNLIGQGASGIVYKGTLRH-GNLVAVKQILDL 299
+ S+ SEL + + ++GQ + T + G V
Sbjct: 56 VSTSLWNTGQPFRVE-SELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFT 114
Query: 300 DTKGD---EDFTNEVEIISKIRH----------------RNLLSLRGCCVTSDDSSGKRR 340
+ + EV + +R +L+ +R
Sbjct: 115 ERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERD 174
Query: 341 FLVYDY-----MPNGTLSDNI----SISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPG 391
V L S S K L R ++ + V + +A LH G
Sbjct: 175 MWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYG 231
Query: 392 IYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALYGQ--- 448
+ H ++ +I+LD + F + R A +GQ
Sbjct: 232 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHP 291
Query: 449 --LTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWA---WVLAKSGKVDDIFDEFI 503
+T D ++ G+ I + P W+ + +
Sbjct: 292 TLMTFAFDTWTLGLAIYWIWCAD-------LPNTDDAALGGSEWIFRSCKNIPQPVRALL 344
Query: 504 RAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEGDIDIPKLPDRP 553
+R + + + LR ++ AL + + D + + P
Sbjct: 345 EGFLRYPKEDRLLPLQAMETPEYEQLRTELSAALPLYQTDGEPTREGGAP 394
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 9e-30
Identities = 57/199 (28%), Positives = 90/199 (45%), Gaps = 23/199 (11%)
Query: 271 LIGQGASGIVYKGTLRH-GNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCC 329
++G GA V+ R G L A+K I D NE+ ++ KI+H N+++L
Sbjct: 16 VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75
Query: 330 VTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLK 389
++ +LV + G L D I +R T +I V + YLH +
Sbjct: 76 ESTT-----HYYLVMQLVSGGELFDRIL---ERGVYTEKDASLVIQQVLSAVKYLH---E 124
Query: 390 PGIYHRDIKSTNILL-----DSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYA 444
GI HRD+K N+L +S++ + DFGL+K + + + GT GY+APE
Sbjct: 125 NGIVHRDLKPENLLYLTPEENSKI--MITDFGLSKM---EQNGIMSTACGTPGYVAPEVL 179
Query: 445 LYGQLTEKSDVYSFGIVIL 463
++ D +S G VI
Sbjct: 180 AQKPYSKAVDCWSIG-VIT 197
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 9e-30
Identities = 55/221 (24%), Positives = 99/221 (44%), Gaps = 20/221 (9%)
Query: 272 IGQGASGIVYKGTLRH---GNLVAVKQI-LDLDTKGDEDFTNEVEII-SKIRHRNLLSLR 326
+G+GA G+V K RH G ++AVK+I ++++ + +++I + ++
Sbjct: 15 LGRGAYGVVEKM--RHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFY 72
Query: 327 GCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHY 386
G D + + M + K + + KI V + K + +LH
Sbjct: 73 GALFREGDVW-----ICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS 127
Query: 387 GLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPE---- 442
L + HRD+K +N+L+++ K+ DFG++ L AG Y+APE
Sbjct: 128 KLS--VIHRDVKPSNVLINALGQVKMCDFGISGY-LV-DDVAKDIDAGCKPYMAPERINP 183
Query: 443 YALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLIT 483
+ KSD++S GI ++EL R D+ +PFQ +
Sbjct: 184 ELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLK 224
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 1e-29
Identities = 65/216 (30%), Positives = 109/216 (50%), Gaps = 18/216 (8%)
Query: 260 EQATNGFSQNNLIGQGASGIVYKGTLRHGNLVAVKQILDLDTKGDEDFTN-EVEIISKIR 318
EQ ++ +IG G+ G+V++ L + VA+K++L D+ F N E++I+ ++
Sbjct: 36 EQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQ-----DKRFKNRELQIMRIVK 90
Query: 319 HRNLLSLRGCCVTSDDSSGKRR-FLVYDYMPNGTLSDNISISHKRKQ-LTWPQRKKIIVD 376
H N++ L+ ++ D + LV +Y+P T+ K KQ + K +
Sbjct: 91 HPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQ 149
Query: 377 VAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNA-KVADFGLAKQSLEGHSHLTTRVAGT 435
+ + +AY+H GI HRDIK N+LLD K+ DFG AK + G + + +
Sbjct: 150 LLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEP-NVSYIC-S 204
Query: 436 FGYLAPEYALYG--QLTEKSDVYSFGIVILELMSGR 469
Y APE ++G T D++S G V+ ELM G+
Sbjct: 205 RYYRAPE-LIFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-29
Identities = 58/211 (27%), Positives = 99/211 (46%), Gaps = 36/211 (17%)
Query: 272 IGQGASGIVYKGTLRH-GNLVAVKQI--------LDLDTKGDEDFTNEVEIISKIR-HRN 321
IG+G S +V + R G+ AVK + + + E E I+ ++ H +
Sbjct: 102 IGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPH 161
Query: 322 LLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGI 381
+++L +S FLV+D M G L D ++ ++ L+ + + I+ + + +
Sbjct: 162 IITLIDSYESSSFM-----FLVFDLMRKGELFDYLT---EKVALSEKETRSIMRSLLEAV 213
Query: 382 AYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAP 441
++LH I HRD+K NILLD + +++DFG + G L GT GYLAP
Sbjct: 214 SFLH---ANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEK-LRELC-GTPGYLAP 268
Query: 442 E---------YALYGQLTEKSDVYSFGIVIL 463
E + YG ++ D+++ G VIL
Sbjct: 269 EILKCSMDETHPGYG---KEVDLWACG-VIL 295
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 5e-29
Identities = 42/205 (20%), Positives = 82/205 (40%), Gaps = 24/205 (11%)
Query: 271 LIGQGASGIVYKG--TLRHGNLVAVKQILDLDTKGDED----FTNEVEIISKIRHRNLLS 324
I G G +Y +G V +K L GD + E + ++++ H +++
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLKG---LVHSGDAEAQAMAMAERQFLAEVVHPSIVQ 143
Query: 325 LRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYL 384
+ +D ++V +Y+ +L K ++L + ++++ ++YL
Sbjct: 144 IFNFVEHTDRHGDPVGYIVMEYVGGQSLKR-----SKGQKLPVAEAIAYLLEILPALSYL 198
Query: 385 HYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYA 444
H G+ + D+K NI+L E K+ D G + + GT G+ APE
Sbjct: 199 H---SIGLVYNDLKPENIMLTEE-QLKLIDLGAVS-RINS----FGYLYGTPGFQAPEIV 249
Query: 445 LYGQLTEKSDVYSFGIVILELMSGR 469
T +D+Y+ G + L
Sbjct: 250 R-TGPTVATDIYTVGRTLAALTLDL 273
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 5e-29
Identities = 56/201 (27%), Positives = 89/201 (44%), Gaps = 26/201 (12%)
Query: 272 IGQGASGIVYKGTLRH-GNLVAVKQIL--DLDTKGDEDFTNEVEIISKIRHRNLLSLRGC 328
+G+GA +V + + G A K I L + + E I K++H N++ L
Sbjct: 37 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 96
Query: 329 CVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGL 388
+LV+D + G L ++I R+ + I + + IAY H
Sbjct: 97 IQEESF-----HYLVFDLVTGGELFEDIV---AREFYSEADASHCIQQILESIAYCH--- 145
Query: 389 KPGIYHRDIKSTNILLDSELNA---KVADFGLAKQSLEGHSHLTTRVAGTFGYLAPE--- 442
GI HR++K N+LL S+ K+ADFGLA + + + GT GYL+PE
Sbjct: 146 SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA-WHGFA-GTPGYLSPEVLK 203
Query: 443 YALYGQLTEKSDVYSFGIVIL 463
Y + D+++ G VIL
Sbjct: 204 KDPYS---KPVDIWACG-VIL 220
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 6e-29
Identities = 53/205 (25%), Positives = 83/205 (40%), Gaps = 26/205 (12%)
Query: 272 IGQGASGIVYKGTLRH-GNLVAVKQI-----LDLDTKGDEDFTNEVEIISKIRHRNLLSL 325
IG+G +V + R G AVK + ED E I ++H +++ L
Sbjct: 32 IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 326 RGCCVTSDDSSGKRRFLVYDYMPNGTLSDNI-SISHKRKQLTWPQRKKIIVDVAKGIAYL 384
SS ++V+++M L I + + + + + + Y
Sbjct: 92 LETY-----SSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYC 146
Query: 385 HYGLKPGIYHRDIKSTNILLDSELNA---KVADFGLAKQSLEGHSHLTTRVAGTFGYLAP 441
H I HRD+K +LL S+ N+ K+ FG+A Q E RV GT ++AP
Sbjct: 147 H---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV-GTPHFMAP 202
Query: 442 E---YALYGQLTEKSDVYSFGIVIL 463
E YG + DV+ G VIL
Sbjct: 203 EVVKREPYG---KPVDVWGCG-VIL 223
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 6e-29
Identities = 70/213 (32%), Positives = 108/213 (50%), Gaps = 23/213 (10%)
Query: 266 FSQNNLIGQGASGIVYKGTLRH-GNLVAVKQILDLDTKGDEDFTN-EVEIISKIRHRNLL 323
++ +IG G+ G+VY+ L G LVA+K++L D+ F N E++I+ K+ H N++
Sbjct: 56 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNIV 110
Query: 324 SLRGCCVTSDDSSGKRR-FLVYDYMPNGTLSDNISISHKRKQ-LTWPQRKKIIVDVAKGI 381
LR +S + + LV DY+P T+ + KQ L K + + + +
Sbjct: 111 RLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 169
Query: 382 AYLHYGLKPGIYHRDIKSTNILLDSELNA-KVADFGLAKQSLEGHSHLTTRVAGTFGYLA 440
AY+H GI HRDIK N+LLD + K+ DFG AKQ + G + + + Y A
Sbjct: 170 AYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE-PNVSYIC-SRYYRA 224
Query: 441 PEYAL----YGQLTEKSDVYSFGIVILELMSGR 469
PE Y T DV+S G V+ EL+ G+
Sbjct: 225 PELIFGATDY---TSSIDVWSAGCVLAELLLGQ 254
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 7e-29
Identities = 54/302 (17%), Positives = 101/302 (33%), Gaps = 78/302 (25%)
Query: 271 LIGQGASGIVYKGTLRH-GNLVAVKQI-LDLDTKGDEDFTNEVEIISKIRHRNLLSLRGC 328
+G+G G+V++ + A+K+I L E EV+ ++K+ H ++
Sbjct: 13 CMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 72
Query: 329 ---------------------CVTSDDSSGKRR--------------------------- 340
SS
Sbjct: 73 WLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSP 132
Query: 341 ----FLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRD 396
++ L D ++ + I + +A+ + +LH G+ HRD
Sbjct: 133 KVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLH---SKGLMHRD 189
Query: 397 IKSTNILLDSELNAKVADFGLAK------------QSLEGHSHLTTRVAGTFGYLAPEYA 444
+K +NI + KV DFGL + ++ T +V GT Y++PE
Sbjct: 190 LKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQV-GTKLYMSPEQI 248
Query: 445 LYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDEFIR 504
+ K D++S G+++ EL+ T ++ITD ++ K +F +
Sbjct: 249 HGNNYSHKVDIFSLGLILFELLYS---FSTQMERVRIITD-----VRNLKFPLLFTQKYP 300
Query: 505 AE 506
E
Sbjct: 301 QE 302
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 8e-29
Identities = 55/201 (27%), Positives = 91/201 (45%), Gaps = 25/201 (12%)
Query: 272 IGQGASGIVYKGTLRH-GNLVAVKQIL--DLDTKGDEDFTNEVEIISKIRHRNLLSLRGC 328
+G+GA +V + G A I L + + E I ++H N++ L
Sbjct: 19 LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 78
Query: 329 CVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGL 388
S +L++D + G L ++I R+ + I + + + + H
Sbjct: 79 I-----SEEGHHYLIFDLVTGGELFEDIV---AREYYSEADASHCIQQILEAVLHCH--- 127
Query: 389 KPGIYHRDIKSTNILLDSELNA---KVADFGLAKQSLEGHSHLTTRVAGTFGYLAPE--- 442
+ G+ HR++K N+LL S+L K+ADFGLA + +EG AGT GYL+PE
Sbjct: 128 QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIE-VEGEQQAWFGFAGTPGYLSPEVLR 186
Query: 443 YALYGQLTEKSDVYSFGIVIL 463
YG + D+++ G VIL
Sbjct: 187 KDPYG---KPVDLWACG-VIL 203
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 9e-29
Identities = 67/232 (28%), Positives = 100/232 (43%), Gaps = 38/232 (16%)
Query: 270 NLIGQGASGIVYKGTLRH-GNLVAVKQI-------------LDLDTKGDEDFTNEVEIIS 315
+G GA G V ++ + A+K I K E+ NE+ ++
Sbjct: 42 RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLK 101
Query: 316 KIRHRNLLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIV 375
+ H N++ L D K +LV ++ G L + I R + I+
Sbjct: 102 SLDHPNIIKLFDVF--EDK---KYFYLVTEFYEGGELFEQII---NRHKFDECDAANIMK 153
Query: 376 DVAKGIAYLHYGLKPGIYHRDIKSTNILLDS---ELNAKVADFGLAKQSLEGHSHLTTRV 432
+ GI YLH K I HRDIK NILL++ LN K+ DFGL+ + + L R+
Sbjct: 154 QILSGICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYK-LRDRL 209
Query: 433 AGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITD 484
GT Y+APE L + EK DV+S G+++ L+ G PF D
Sbjct: 210 -GTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGY-------PPFGGQND 252
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 9e-29
Identities = 54/222 (24%), Positives = 102/222 (45%), Gaps = 24/222 (10%)
Query: 272 IGQGASGIVYKGTLRH---GNLVAVKQI-LDLDTKGDEDFTNEVEIISK-IRHRNLLSLR 326
+G G G V+K R G+++AVKQ+ + + ++ +++++ K ++
Sbjct: 33 MGSGTCGQVWKM--RFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCF 90
Query: 327 GCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHY 386
G +T+ D + + M GT ++ + + + K+ V + K + YL
Sbjct: 91 GTFITNTDVF-----IAMELM--GTCAEKL-KKRMQGPIPERILGKMTVAIVKALYYLKE 142
Query: 387 GLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPE---- 442
+ HRD+K +NILLD K+ DFG++ + L R AG Y+APE
Sbjct: 143 KHG--VIHRDVKPSNILLDERGQIKLCDFGISGR-LV-DDKAKDRSAGCAAYMAPERIDP 198
Query: 443 -YALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLIT 483
++DV+S GI ++EL +G+ + F+++T
Sbjct: 199 PDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLT 240
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 1e-28
Identities = 50/311 (16%), Positives = 106/311 (34%), Gaps = 82/311 (26%)
Query: 266 FSQNNLIGQGASGIVYKGTLRH-GNLVAVKQI--LDLDTKGDEDFTNEVEIISKI-RHRN 321
F + IG G G V+K R G + A+K+ + +++ EV + + +H +
Sbjct: 13 FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSH 72
Query: 322 LLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQ-LTWPQRKKIIVDVAKG 380
++ D + +Y G+L+D IS +++ + K +++ V +G
Sbjct: 73 VVRYFSAWAEDD-----HMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 127
Query: 381 IAYLHYGLKPGIYHRDIKSTNILLD-------------------SELNAKVADFGLAKQS 421
+ Y+H + H DIK +NI + +++ K+ D G +
Sbjct: 128 LRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI 184
Query: 422 LEGHSHLTTRVAGTFGYLAPE-------YALYGQLTEKSDVYSFGIVILELMSGRKVLDT 474
G +LA E + K+D+++ + ++
Sbjct: 185 SSPQV-----EEGDSRFLANEVLQENYTH------LPKADIFALALTVVCAAGAE----- 228
Query: 475 STSPFQLITDWAWVLAKSGKVDDI-------FDEFIRAEGARAVMERFVLVGILCAHVMV 527
+ W + + G++ I F E ++ + H
Sbjct: 229 --PLPRNGDQWHEI--RQGRLPRIPQVLSQEFTELLK----------------VMIHPDP 268
Query: 528 ALRPTITDALK 538
RP+ +K
Sbjct: 269 ERRPSAMALVK 279
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-28
Identities = 63/218 (28%), Positives = 100/218 (45%), Gaps = 24/218 (11%)
Query: 266 FSQNNLIGQGASGIVYKGTLRH-GNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLS 324
S+ ++G G G V+K G +A K I K E+ NE+ +++++ H NL+
Sbjct: 91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQ 150
Query: 325 LRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYL 384
L + +D LV +Y+ G L D I + LT + + +GI ++
Sbjct: 151 LYDAFESKNDI-----VLVMEYVDGGELFDR--IIDESYNLTELDTILFMKQICEGIRHM 203
Query: 385 HYGLKPGIYHRDIKSTNILLDSELNA--KVADFGLAKQSLEGHSHLTTRVAGTFGYLAPE 442
H + I H D+K NIL + K+ DFGLA++ + L GT +LAPE
Sbjct: 204 H---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARR-YKPREKLKVNF-GTPEFLAPE 258
Query: 443 YALYGQLTEKSDVYSFGIVIL-ELMSGRKVLDTSTSPF 479
Y ++ +D++S G VI L+SG SPF
Sbjct: 259 VVNYDFVSFPTDMWSVG-VIAYMLLSG-------LSPF 288
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 3e-28
Identities = 47/211 (22%), Positives = 94/211 (44%), Gaps = 22/211 (10%)
Query: 272 IGQGASGIVYKGTLRH-GNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCV 330
+G GA G+V++ + G + K I NE+ I++++ H L++L
Sbjct: 59 LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE 118
Query: 331 TSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKP 390
+ L+ +++ G L D I+ + +++ + + +G+ ++H +
Sbjct: 119 DKYE-----MVLILEFLSGGELFDR--IAAEDYKMSEAEVINYMRQACEGLKHMH---EH 168
Query: 391 GIYHRDIKSTNILLDSELNA--KVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALYGQ 448
I H DIK NI+ +++ + K+ DFGLA + L + T + APE
Sbjct: 169 SIVHLDIKPENIMCETKKASSVKIIDFGLATK-LNPDEIVKVTT-ATAEFAAPEIVDREP 226
Query: 449 LTEKSDVYSFGIVILELMSGRKVLDTSTSPF 479
+ +D+++ G++ L+SG SPF
Sbjct: 227 VGFYTDMWAIGVLGYVLLSG-------LSPF 250
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 2e-27
Identities = 53/216 (24%), Positives = 101/216 (46%), Gaps = 22/216 (10%)
Query: 272 IGQGASGIVYKGTLRH-GNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCV 330
+G GA G+V++ T R GN A K ++ E E++ +S +RH L++L
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE 224
Query: 331 TSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKP 390
++ ++Y++M G L + ++ + +++ + + + V KG+ ++H +
Sbjct: 225 DDNEM-----VMIYEFMSGGELFEK--VADEHNKMSEDEAVEYMRQVCKGLCHMH---EN 274
Query: 391 GIYHRDIKSTNILLDSELNA--KVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALYGQ 448
H D+K NI+ ++ + K+ DFGL L+ + GT + APE A
Sbjct: 275 NYVHLDLKPENIMFTTKRSNELKLIDFGLTAH-LDPKQSVKVTT-GTAEFAAPEVAEGKP 332
Query: 449 LTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITD 484
+ +D++S G++ L+SG SPF D
Sbjct: 333 VGYYTDMWSVGVLSYILLSG-------LSPFGGEND 361
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 3e-27
Identities = 52/208 (25%), Positives = 87/208 (41%), Gaps = 32/208 (15%)
Query: 272 IGQGASGIVYKGTLRH-GNLVAVKQILDLDTKGDEDFTNEVEIISKIR-HRNLLSLRGCC 329
+G+G+ I K + AVK I + + + E+ + H N++ L
Sbjct: 19 LGEGSFSICRKCVHKKSNQAFAVKII---SKRMEANTQKEITALKLCEGHPNIVKLHEVF 75
Query: 330 VTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLK 389
FLV + + G L + I K+K + + I+ + ++++H
Sbjct: 76 -----HDQLHTFLVMELLNGGELFERI---KKKKHFSETEASYIMRKLVSAVSHMH---D 124
Query: 390 PGIYHRDIKSTNILL-----DSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPE-- 442
G+ HRD+K N+L + E+ K+ DFG A+ + L T T Y APE
Sbjct: 125 VGVVHRDLKPENLLFTDENDNLEI--KIIDFGFARLKPPDNQPLKTPC-FTLHYAAPELL 181
Query: 443 -YALYGQLTEKSDVYSFGIVIL-ELMSG 468
Y E D++S G VIL ++SG
Sbjct: 182 NQNGYD---ESCDLWSLG-VILYTMLSG 205
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 4e-27
Identities = 41/275 (14%), Positives = 82/275 (29%), Gaps = 57/275 (20%)
Query: 239 SNLQASVLPNSGAKWFHVSELEQATNGFSQNNLIGQGASGIVYKGTLRH-GNLVAVKQIL 297
S + S+ SEL + + ++GQ + T + G V
Sbjct: 49 SLVSTSLWNTGQPFRVE-SELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPY 107
Query: 298 DLDTKGDED----------------------------FTNEVEIISKIRHRNLLSLRGCC 329
+ F +++ + + ++ +R
Sbjct: 108 FTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRL-- 165
Query: 330 VTSDDSSGKRRFLVYDYMPNGTLSDNI----SISHKRKQLTWPQRKKIIVDVAKGIAYLH 385
D RF +Y L S S K L R ++ + V + +A LH
Sbjct: 166 -DERDMWVLSRFFLY-PRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH 223
Query: 386 YGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYAL 445
G+ H ++ +I+LD + F + +G +++ + G+ PE
Sbjct: 224 ---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVR--DGARVVSS---VSRGFEPPELEA 275
Query: 446 Y-----------GQLTEKSDVYSFGIVILELMSGR 469
+T D ++ G+VI +
Sbjct: 276 RRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 8e-27
Identities = 59/221 (26%), Positives = 97/221 (43%), Gaps = 33/221 (14%)
Query: 256 VSELEQATNGFSQN----NLIGQGASGIVYKGTLRH-GNLVAVKQILDLDTKGDEDFTNE 310
V +L + + F+ IG G+ + + + AVK I K D T E
Sbjct: 10 VQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIID----KSKRDPTEE 65
Query: 311 VEIISK-IRHRNLLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQ 369
+EI+ + +H N+++L+ GK ++V + M G L D I ++K + +
Sbjct: 66 IEILLRYGQHPNIITLKDVY-----DDGKYVYVVTELMKGGELLDKI---LRQKFFSERE 117
Query: 370 RKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNA----KVADFGLAKQSLEGH 425
++ + K + YLH G+ HRD+K +NIL E ++ DFG AKQ +
Sbjct: 118 ASAVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN 174
Query: 426 SHLTTRVAGTFGYLAPE---YALYGQLTEKSDVYSFGIVIL 463
L T T ++APE Y D++S G V+L
Sbjct: 175 GLLMTPC-YTANFVAPEVLERQGYD---AACDIWSLG-VLL 210
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 55/223 (24%), Positives = 96/223 (43%), Gaps = 25/223 (11%)
Query: 260 EQATNGFSQNNLIGQGASGIVYKGTLRH-GNLVAVKQILDLDTKGDEDFTN-EVEII--- 314
+ + F + GQG G V G + G VA+K+++ D F N E++I+
Sbjct: 19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQ-----DPRFRNRELQIMQDL 73
Query: 315 SKIRHRNLLSLRGCCVTSDDSSGKRRFL--VYDYMPNGTLSDNI-SISHKRKQLTWPQRK 371
+ + H N++ L+ T + + +L V +Y+P+ TL + ++ K
Sbjct: 74 AVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIK 132
Query: 372 KIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNA-KVADFGLAKQSLEGHSHLTT 430
+ + + I LH + HRDIK N+L++ K+ DFG AK+ +
Sbjct: 133 VFLFQLIRSIGCLHLP-SVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPN-VA 190
Query: 431 RVAGTFGYLAPEYAL----YGQLTEKSDVYSFGIVILELMSGR 469
+ + Y APE Y T D++S G + E+M G
Sbjct: 191 YICSRY-YRAPELIFGNQHY---TTAVDIWSVGCIFAEMMLGE 229
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 59/216 (27%), Positives = 91/216 (42%), Gaps = 36/216 (16%)
Query: 268 QNNLIGQGASGIVYKGTLRH-GNLVAVKQILDLDTKGDEDFTNEVEIISKIR-HRNLLSL 325
Q +++G+GA V AVK I EVE++ + + HRN+L L
Sbjct: 17 QEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLEL 76
Query: 326 RGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLH 385
D R +LV++ M G++ +I HKR+ + ++ DVA + +LH
Sbjct: 77 IEFFEEED-----RFYLVFEKMRGGSILSHI---HKRRHFNELEASVVVQDVASALDFLH 128
Query: 386 YGLKPGIYHRDIKSTNILLDSE---LNAKVADFGLAKQSLEGHSH-------LTTRVAGT 435
GI HRD+K NIL + K+ DF L L T G+
Sbjct: 129 ---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPC-GS 184
Query: 436 FGYLAPE--------YALYGQLTEKSDVYSFGIVIL 463
Y+APE ++Y ++ D++S G VIL
Sbjct: 185 AEYMAPEVVEAFSEEASIYD---KRCDLWSLG-VIL 216
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 45/214 (21%), Positives = 92/214 (42%), Gaps = 29/214 (13%)
Query: 272 IGQGASGIVYKGTLRH-GNLVAVKQILDLDTKGD--EDFTNEVEIISKIRHRNLLSLRGC 328
+G+G GIV++ K + KG E+ I++ RHRN+L L
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFV---KVKGTDQVLVKKEISILNIARHRNILHLHES 69
Query: 329 CVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGL 388
+ ++ ++++++ + + I+ +L + + V + + +LH
Sbjct: 70 FESMEEL-----VMIFEFISGLDIFER--INTSAFELNEREIVSYVHQVCEALQFLH--- 119
Query: 389 KPGIYHRDIKSTNILLDSELNA--KVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALY 446
I H DI+ NI+ + ++ K+ +FG A+Q L+ + Y APE +
Sbjct: 120 SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQ-LKPGDNFRLLF-TAPEYYAPEVHQH 177
Query: 447 GQLTEKSDVYSFGIVIL-ELMSGRKVLDTSTSPF 479
++ +D++S G ++ L+SG +PF
Sbjct: 178 DVVSTATDMWSLG-TLVYVLLSG-------INPF 203
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 54/199 (27%), Positives = 91/199 (45%), Gaps = 24/199 (12%)
Query: 271 LIGQGASGIVYKGTLRH-GNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCC 329
+G+GA+ IVY+ + A+K + T + E+ ++ ++ H N++ L+
Sbjct: 60 ELGRGATSIVYRCKQKGTQKPYALKVLKK--TVDKKIVRTEIGVLLRLSHPNIIKLKEIF 117
Query: 330 VTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLK 389
T + LV + + G L D I ++ + + + + +AYLH +
Sbjct: 118 ETPTE-----ISLVLELVTGGELFDRIV---EKGYYSERDAADAVKQILEAVAYLH---E 166
Query: 390 PGIYHRDIKSTNILL-----DSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYA 444
GI HRD+K N+L D+ L K+ADFGL+K + T V GT GY APE
Sbjct: 167 NGIVHRDLKPENLLYATPAPDAPL--KIADFGLSKIVEHQ-VLMKT-VCGTPGYCAPEIL 222
Query: 445 LYGQLTEKSDVYSFGIVIL 463
+ D++S G +I
Sbjct: 223 RGCAYGPEVDMWSVG-IIT 240
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 57/219 (26%), Positives = 94/219 (42%), Gaps = 31/219 (14%)
Query: 272 IGQGASGIVYKGTLRH-GNLVAVKQI------LDLDTKGDEDFTNEVEIISKIRHRNLLS 324
+G G IV K + G A K I E+ EV I+ ++ H N+++
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 325 LRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYL 384
L D L+ + + G L D ++ +++ L+ + I + G+ YL
Sbjct: 80 LHDVYENRTD-----VVLILELVSGGELFDFLA---QKESLSEEEATSFIKQILDGVNYL 131
Query: 385 HYGLKPGIYHRDIKSTNILLDSE----LNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLA 440
H I H D+K NI+L + + K+ DFGLA + +E GT ++A
Sbjct: 132 H---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE-IEDGVEFKNIF-GTPEFVA 186
Query: 441 PEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPF 479
PE Y L ++D++S G++ L+SG SPF
Sbjct: 187 PEIVNYEPLGLEADMWSIGVITYILLSG-------ASPF 218
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 3e-26
Identities = 58/206 (28%), Positives = 97/206 (47%), Gaps = 25/206 (12%)
Query: 272 IGQGASGIVYKGTLRH---GNLVAVKQILD---LDTKGDEDFTNEVEIISKIRHRNLLSL 325
IG+G V RH G VA+K I+D L+ + EV I+ + H N++ L
Sbjct: 23 IGKGNFAKVKLA--RHILTGREVAIK-IIDKTQLNPTSLQKLFREVRIMKILNHPNIVKL 79
Query: 326 RGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLH 385
T +L+ +Y G + D + ++H R + + + + + Y H
Sbjct: 80 FEVIETEKTL-----YLIMEYASGGEVFDYL-VAHGR--MKEKEARSKFRQIVSAVQYCH 131
Query: 386 YGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYAL 445
+ I HRD+K+ N+LLD+++N K+ADFG + + G L G Y APE
Sbjct: 132 ---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG-KLDAFC-GAPPYAAPE-LF 185
Query: 446 YGQLTE--KSDVYSFGIVILELMSGR 469
G+ + + DV+S G+++ L+SG
Sbjct: 186 QGKKYDGPEVDVWSLGVILYTLVSGS 211
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 3e-26
Identities = 55/233 (23%), Positives = 98/233 (42%), Gaps = 49/233 (21%)
Query: 271 LIGQGASGIVYKGTLRH---GNLVAVKQILD--------------------LDTKGDEDF 307
IG+G+ G+V + A+K +L G
Sbjct: 20 EIGKGSYGVVKLA--YNENDNTYYAMK-VLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQP 76
Query: 308 TN-------EVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISH 360
E+ I+ K+ H N++ L V DD + ++V++ + G + + +
Sbjct: 77 RGPIEQVYQEIAILKKLDHPNVVKLV--EVL-DDPNEDHLYMVFELVNQGPVME--VPTL 131
Query: 361 KRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQ 420
K L+ Q + D+ KGI YLHY I HRDIK +N+L+ + + K+ADFG++ +
Sbjct: 132 KP--LSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNE 186
Query: 421 SLEGHSHLTTRVAGTFGYLAPEYALYGQLTE----KSDVYSFGIVILELMSGR 469
+ L+ GT ++APE +L DV++ G+ + + G+
Sbjct: 187 FKGSDALLSN-TVGTPAFMAPE-SLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 47/216 (21%), Positives = 94/216 (43%), Gaps = 27/216 (12%)
Query: 272 IGQGASGIVYKGTLRH-GNLVAVKQIL--DLDTKGDEDFTNEVEIISKIRHR-NLLSLRG 327
+G+G +V + + G A K + + +E+ ++ + +++L
Sbjct: 37 LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96
Query: 328 CCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYG 387
+ + L+ +Y G + + + ++ ++I + +G+ YLH
Sbjct: 97 VYENTSE-----IILILEYAAGGEIFSLC-LPELAEMVSENDVIRLIKQILEGVYYLH-- 148
Query: 388 LKPGIYHRDIKSTNILLDSE---LNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYA 444
+ I H D+K NILL S + K+ DFG++++ + L + GT YLAPE
Sbjct: 149 -QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRK-IGHACELREIM-GTPEYLAPEIL 205
Query: 445 LYGQLTEKSDVYSFGIVIL-ELMSGRKVLDTSTSPF 479
Y +T +D+++ G +I L++ TSPF
Sbjct: 206 NYDPITTATDMWNIG-IIAYMLLTH-------TSPF 233
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 5e-26
Identities = 60/220 (27%), Positives = 96/220 (43%), Gaps = 33/220 (15%)
Query: 272 IGQGASGIVYKGTLRH-GNLVAVKQI-----LDLDTKGD-EDFTNEVEIISKIRHRNLLS 324
+G G IV K + G A K I E+ EV I+ +IRH N+++
Sbjct: 13 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 325 LRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYL 384
L D L+ + + G L D ++ +++ LT + + + + G+ YL
Sbjct: 73 LHDIFENKTD-----VVLILELVSGGELFDFLA---EKESLTEDEATQFLKQILDGVHYL 124
Query: 385 HYGLKPGIYHRDIKSTNILLDSELNA----KVADFGLAKQSLEGHSHLTTRVAGTFGYLA 440
H I H D+K NI+L + K+ DFG+A + +E + GT ++A
Sbjct: 125 H---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK-IEAGNEFKNIF-GTPEFVA 179
Query: 441 PEYALYGQLTEKSDVYSFGIVIL-ELMSGRKVLDTSTSPF 479
PE Y L ++D++S G VI L+SG SPF
Sbjct: 180 PEIVNYEPLGLEADMWSIG-VITYILLSG-------ASPF 211
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 5e-26
Identities = 58/261 (22%), Positives = 88/261 (33%), Gaps = 71/261 (27%)
Query: 272 IGQGASGIVYKGTLRH-GNLVAVKQI----LDLDTKGD-EDFTNEVEIISKIRHRNLLSL 325
IGQG+ G+V + A+K + + D E EV ++ K+ H N+ L
Sbjct: 34 IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 326 RGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQR--------------- 370
LV + G L D +++
Sbjct: 94 YEVYEDEQ-----YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEE 148
Query: 371 ----------------------KKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSEL 408
I+ + + YLH GI HRDIK N L +
Sbjct: 149 AINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGICHRDIKPENFLFSTNK 205
Query: 409 NA--KVADFGLAK---QSLEGHSHLTTRVAGTFGYLAPE-----YALYGQLTEKSDVYSF 458
+ K+ DFGL+K + G + T AGT ++APE YG K D +S
Sbjct: 206 SFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYG---PKCDAWSA 262
Query: 459 GIVILELMSGRKVLDTSTSPF 479
G+++ L+ G PF
Sbjct: 263 GVLLHLLLMGA-------VPF 276
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 56/213 (26%), Positives = 104/213 (48%), Gaps = 26/213 (12%)
Query: 272 IGQGASGIVYKGT-LRHGNLVAVKQI-LDLDTKGDEDFTN--EVEIISKIRHRNLLSLRG 327
IGQG G V+K + G VA+K++ ++ + +G T E++I+ ++H N+++L
Sbjct: 25 IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEG-FPITALREIKILQLLKHENVVNLIE 83
Query: 328 CCVTSDDSSGKRR---FLVYDYMPN--GTLSDNISISHKRKQLTWPQRKKIIVDVAKGIA 382
C T + + +LV+D+ + L N+ + + T + K+++ + G+
Sbjct: 84 ICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV-----KFTLSEIKRVMQMLLNGLY 138
Query: 383 YLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQ----SLEGHSHLTTRVAGTFGY 438
Y+H + I HRD+K+ N+L+ + K+ADFGLA+ + T RV T Y
Sbjct: 139 YIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV-TLWY 194
Query: 439 LAPEYALYG--QLTEKSDVYSFGIVILELMSGR 469
PE L G D++ G ++ E+ +
Sbjct: 195 RPPEL-LLGERDYGPPIDLWGAGCIMAEMWTRS 226
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 57/219 (26%), Positives = 94/219 (42%), Gaps = 31/219 (14%)
Query: 272 IGQGASGIVYKGTLRH-GNLVAVKQI------LDLDTKGDEDFTNEVEIISKIRHRNLLS 324
+G G IV K + G A K I E+ EV I+ ++ H N+++
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 325 LRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYL 384
L D L+ + + G L D ++ +++ L+ + I + G+ YL
Sbjct: 80 LHDVYENRTD-----VVLILELVSGGELFDFLA---QKESLSEEEATSFIKQILDGVNYL 131
Query: 385 HYGLKPGIYHRDIKSTNILLDSE----LNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLA 440
H I H D+K NI+L + + K+ DFGLA + +E GT ++A
Sbjct: 132 H---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE-IEDGVEFKNIF-GTPEFVA 186
Query: 441 PEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPF 479
PE Y L ++D++S G++ L+SG SPF
Sbjct: 187 PEIVNYEPLGLEADMWSIGVITYILLSG-------ASPF 218
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 104 bits (263), Expect = 4e-25
Identities = 59/215 (27%), Positives = 88/215 (40%), Gaps = 20/215 (9%)
Query: 266 FSQNNLIGQGASGIVYKGTLRH-GNLVAVKQI-LDLDTKGDEDF--TNEVEI-----ISK 316
+ IG GA G VYK H G+ VA+K + + G + E+ +
Sbjct: 11 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEA 70
Query: 317 IRHRNLLSLRGCCVTSDDSSGKRRFLVYDYMPN--GTLSDNISISHKRKQLTWPQRKKII 374
H N++ L C TS + LV++++ T D L K ++
Sbjct: 71 FEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDK----APPPGLPAETIKDLM 126
Query: 375 VDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAG 434
+G+ +LH I HRD+K NIL+ S K+ADFGLA+ LT V
Sbjct: 127 RQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLAR-IYSYQMALTPVVV- 181
Query: 435 TFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGR 469
T Y APE L D++S G + E+ +
Sbjct: 182 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 4e-25
Identities = 52/201 (25%), Positives = 87/201 (43%), Gaps = 25/201 (12%)
Query: 271 LIGQGASGIVYKGTLRH-GNLVAVKQILDLDTKGDEDFTNEVEIISKI-RHRNLLSLRGC 328
++G G +G V + R G A+K + D EV+ + +++ +
Sbjct: 36 VLGLGVNGKVLECFHRRTGQKCALKLLYD-----SPKARQEVDHHWQASGGPHIVCILD- 89
Query: 329 CVTSDDSSGKRRF-LVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYG 387
V + GKR ++ + M G L I + T + +I+ D+ I +LH
Sbjct: 90 -VYENMHHGKRCLLIIMECMEGGELFSRI-QERGDQAFTEREAAEIMRDIGTAIQFLH-- 145
Query: 388 LKPGIYHRDIKSTNILL-----DSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPE 442
I HRD+K N+L D+ L K+ DFG AK++ + L T T Y+APE
Sbjct: 146 -SHNIAHRDVKPENLLYTSKEKDAVL--KLTDFGFAKETTQN--ALQTPC-YTPYYVAPE 199
Query: 443 YALYGQLTEKSDVYSFGIVIL 463
+ + D++S G VI+
Sbjct: 200 VLGPEKYDKSCDMWSLG-VIM 219
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 5e-25
Identities = 58/219 (26%), Positives = 94/219 (42%), Gaps = 31/219 (14%)
Query: 272 IGQGASGIVYKGTLRH-GNLVAVKQIL------DLDTKGDEDFTNEVEIISKIRHRNLLS 324
+G G +V K + G A K I ED EV I+ +I+H N+++
Sbjct: 19 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 325 LRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYL 384
L D L+ + + G L D ++ +++ LT + + + + G+ YL
Sbjct: 79 LHEVYENKTD-----VILILELVAGGELFDFLA---EKESLTEEEATEFLKQILNGVYYL 130
Query: 385 HYGLKPGIYHRDIKSTNILLDSELNA----KVADFGLAKQSLEGHSHLTTRVAGTFGYLA 440
H I H D+K NI+L K+ DFGLA + G+ GT ++A
Sbjct: 131 H---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKNIF-GTPEFVA 185
Query: 441 PEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPF 479
PE Y L ++D++S G++ L+SG SPF
Sbjct: 186 PEIVNYEPLGLEADMWSIGVITYILLSG-------ASPF 217
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 7e-25
Identities = 59/211 (27%), Positives = 107/211 (50%), Gaps = 23/211 (10%)
Query: 266 FSQNNLIGQGASGIVYKGTLRHGNLVAVKQI-LDLDTKGDEDFTN--EVEIISKIRHRNL 322
+ + +G+G G+VYK G +VA+K+I LD + +G T E+ ++ ++ H N+
Sbjct: 23 YQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEG-IPSTAIREISLLKELHHPNI 81
Query: 323 LSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSD-NISISHKRKQLTWPQRKKIIVDVAKGI 381
+SL + + LV+++M D + + L Q K + + +G+
Sbjct: 82 VSLIDVIHSE-----RCLTLVFEFME----KDLKKVLDENKTGLQDSQIKIYLYQLLRGV 132
Query: 382 AYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQ-SLEGHSHLTTRVAGTFGYLA 440
A+ H + I HRD+K N+L++S+ K+ADFGLA+ + S T V T Y A
Sbjct: 133 AHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRS-YTHEVV-TLWYRA 187
Query: 441 PEYALYG--QLTEKSDVYSFGIVILELMSGR 469
P+ L G + + D++S G + E+++G+
Sbjct: 188 PD-VLMGSKKYSTSVDIWSIGCIFAEMITGK 217
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 8e-25
Identities = 53/201 (26%), Positives = 90/201 (44%), Gaps = 26/201 (12%)
Query: 272 IGQGASGIVYKGTLRH-GNLVAVKQILDLDTKGDEDFTNEVEIISKI-RHRNLLSLRGCC 329
+G G +G V + + A+K + D EVE+ + + +++ +
Sbjct: 70 LGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVD-- 122
Query: 330 VTSDDSSGKRRF-LVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGL 388
V + +G++ +V + + G L I + T + +I+ + + I YLH
Sbjct: 123 VYENLYAGRKCLLIVMECLDGGELFSRI-QDRGDQAFTEREASEIMKSIGEAIQYLH--- 178
Query: 389 KPGIYHRDIKSTNILLDSEL-NA--KVADFGLAKQSLEGHSHLTTRVAGTFGYLAPE--- 442
I HRD+K N+L S+ NA K+ DFG AK+ H+ LTT T Y+APE
Sbjct: 179 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE-TTSHNSLTTPC-YTPYYVAPEVLG 236
Query: 443 YALYGQLTEKSDVYSFGIVIL 463
Y + D++S G VI+
Sbjct: 237 PEKYD---KSCDMWSLG-VIM 253
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 9e-25
Identities = 63/212 (29%), Positives = 93/212 (43%), Gaps = 33/212 (15%)
Query: 271 LIGQGASGIVYKGTLRH---GNLVAVKQILDLDTKGD--EDFTNEVEIISKIRHRNLLSL 325
+G+GA G V + VAVK I+D+ D E+ E+ I + H N++
Sbjct: 14 TLGEGAYGEVQLA--VNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENVVKF 70
Query: 326 RGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQ-RKK---IIVDVAKGI 381
G + +L +Y G L D I + P ++ ++ G+
Sbjct: 71 YGHRREGNIQ-----YLFLEYCSGGELFDRI-EPDIG--MPEPDAQRFFHQLM----AGV 118
Query: 382 AYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHS--HLTTRVAGTFGYL 439
YLH GI HRDIK N+LLD N K++DFGLA + L GT Y+
Sbjct: 119 VYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYV 174
Query: 440 APEYALYGQL--TEKSDVYSFGIVILELMSGR 469
APE L + E DV+S GIV+ +++G
Sbjct: 175 APE-LLKRREFHAEPVDVWSCGIVLTAMLAGE 205
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 59/249 (23%), Positives = 103/249 (41%), Gaps = 49/249 (19%)
Query: 259 LEQATNGFSQNNLIGQGASGIVYKGTLRH-GNLVAVKQILDLDTKGDEDFTN-EVEIISK 316
LE ++ +S +G G+ GIV + G A+K++L D + N E++I+
Sbjct: 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQ-----DPRYKNRELDIMKV 56
Query: 317 IRHRNLLSLRGCCVTSDDSSGKRRF---------------------------------LV 343
+ H N++ L T+ D K ++
Sbjct: 57 LDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVI 116
Query: 344 YDYMPNGTLSDNISISHKRKQ-LTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNI 402
+Y+P+ TL + + + + I + + + ++H GI HRDIK N+
Sbjct: 117 MEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL---GICHRDIKPQNL 172
Query: 403 LLDSELNA-KVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYAL-YGQLTEKSDVYSFGI 460
L++S+ N K+ DFG AK+ + + F Y APE L + T D++S G
Sbjct: 173 LVNSKDNTLKLCDFGSAKKLIPSEPS-VAYICSRF-YRAPELMLGATEYTPSIDLWSIGC 230
Query: 461 VILELMSGR 469
V EL+ G+
Sbjct: 231 VFGELILGK 239
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 4e-24
Identities = 55/223 (24%), Positives = 93/223 (41%), Gaps = 29/223 (13%)
Query: 266 FSQNNLIGQGASGIVY----KGTLRHGNLVAVKQILDLDT---KGDEDFT-NEVEIISKI 317
F ++G+G G V+ K T G L A K L+ + E +I++K+
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKAT---GKLYACK-KLNKKRLKKRKGYQGAMVEKKILAKV 242
Query: 318 RHRNLLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKI-IVD 376
R ++SL T LV M G + +I + R
Sbjct: 243 HSRFIVSLAYAFETKT-----DLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQ 297
Query: 377 VAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTF 436
+ G+ +LH + I +RD+K N+LLD + N +++D GLA + G + GT
Sbjct: 298 IVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA-GTP 353
Query: 437 GYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPF 479
G++APE L + D ++ G+ + E+++ R PF
Sbjct: 354 GFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR-------GPF 389
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 4e-24
Identities = 58/213 (27%), Positives = 102/213 (47%), Gaps = 23/213 (10%)
Query: 266 FSQNNLIGQGASGIVYKGTLRH-GNLVAVKQI-LDLDTKGDE--DFTN--EVEIISKIRH 319
+ + + +G+G VYK ++ +VA+K+I L ++ + + T E++++ ++ H
Sbjct: 12 YEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSH 71
Query: 320 RNLLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSD-NISISHKRKQLTWPQRKKIIVDVA 378
N++ L + LV+D+M +D + I LT K ++
Sbjct: 72 PNIIGLLDA-FGHKSNI----SLVFDFME----TDLEVIIKDNSLVLTPSHIKAYMLMTL 122
Query: 379 KGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGY 438
+G+ YLH + I HRD+K N+LLD K+ADFGLAK + T +V T Y
Sbjct: 123 QGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVV-TRWY 178
Query: 439 LAPEYALYG--QLTEKSDVYSFGIVILELMSGR 469
APE L+G D+++ G ++ EL+
Sbjct: 179 RAPE-LLFGARMYGVGVDMWAVGCILAELLLRV 210
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 4e-24
Identities = 63/211 (29%), Positives = 93/211 (44%), Gaps = 31/211 (14%)
Query: 271 LIGQGASGIVYKGTLRH---GNLVAVKQILDLDTKGD--EDFTNEVEIISKIRHRNLLSL 325
+G+GA G V + VAVK I+D+ D E+ E+ I + H N++
Sbjct: 14 TLGEGAYGEVQLA--VNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENVVKF 70
Query: 326 RGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKI---IVDVAKGIA 382
G + +L +Y G L D I + P ++ ++ G+
Sbjct: 71 YGHRREGNIQ-----YLFLEYCSGGELFDRI-EPDIG--MPEPDAQRFFHQLMA---GVV 119
Query: 383 YLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHS--HLTTRVAGTFGYLA 440
YLH GI HRDIK N+LLD N K++DFGLA + L GT Y+A
Sbjct: 120 YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVA 175
Query: 441 PEYALYGQL--TEKSDVYSFGIVILELMSGR 469
PE L + E DV+S GIV+ +++G
Sbjct: 176 PE-LLKRREFHAEPVDVWSCGIVLTAMLAGE 205
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 5e-24
Identities = 53/206 (25%), Positives = 103/206 (50%), Gaps = 20/206 (9%)
Query: 272 IGQGASGIVYKGT-LRHGNLVAVKQILDLDTKGDEDFTN--EVEIISKIRHRNLLSLRGC 328
+G G VYKG G VA+K++ LD++ T E+ ++ +++H N++ L
Sbjct: 13 LGNGTYATVYKGLNKTTGVYVALKEVK-LDSEEGTPSTAIREISLMKELKHENIVRLYDV 71
Query: 329 CVTSDDSSGKRRFLVYDYMPN--GTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHY 386
T + + LV+++M N D+ ++ + + L K + +G+A+ H
Sbjct: 72 IHTEN-----KLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH- 125
Query: 387 GLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQ-SLEGHSHLTTRVAGTFGYLAPEYAL 445
+ I HRD+K N+L++ K+ DFGLA+ + ++ ++ V T Y AP+ L
Sbjct: 126 --ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNT-FSSEVV-TLWYRAPD-VL 180
Query: 446 YG--QLTEKSDVYSFGIVILELMSGR 469
G + D++S G ++ E+++G+
Sbjct: 181 MGSRTYSTSIDIWSCGCILAEMITGK 206
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 6e-24
Identities = 58/210 (27%), Positives = 99/210 (47%), Gaps = 21/210 (10%)
Query: 266 FSQNNLIGQGASGIVYKGTLRHGNLVAVKQI-LDLDTKGDEDFTN--EVEIISKIRHRNL 322
+ IG+G G+VYK +G A+K+I L+ + +G T E+ I+ +++H N+
Sbjct: 4 YHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEG-IPSTTIREISILKELKHSNI 62
Query: 323 LSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNIS-ISHKRKQLTWPQRKKIIVDVAKGI 381
+ L T KR LV++++ D + L K ++ + GI
Sbjct: 63 VKLYDVIHTK-----KRLVLVFEHLD----QDLKKLLDVCEGGLESVTAKSFLLQLLNGI 113
Query: 382 AYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAP 441
AY H + HRD+K N+L++ E K+ADFGLA+ T + T Y AP
Sbjct: 114 AYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV-TLWYRAP 169
Query: 442 EYALYG--QLTEKSDVYSFGIVILELMSGR 469
+ L G + + D++S G + E+++G
Sbjct: 170 D-VLMGSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 7e-24
Identities = 58/206 (28%), Positives = 98/206 (47%), Gaps = 20/206 (9%)
Query: 270 NLIGQGASGIVYKGTLRH-GNLVAVKQI-LDLDTKGDEDFTN--EVEIISKIRHRNLLSL 325
L+G+G+ G+V K + G +VA+K+ D K + E++++ ++RH NL++L
Sbjct: 31 GLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVK-KIAMREIKLLKQLRHENLVNL 89
Query: 326 RGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLH 385
C KR +LV++++ + T+ D + L + +K + + GI + H
Sbjct: 90 LEVCKKK-----KRWYLVFEFVDH-TILD--DLELFPNGLDYQVVQKYLFQIINGIGFCH 141
Query: 386 YGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYAL 445
I HRDIK NIL+ K+ DFG A+ VA T Y APE L
Sbjct: 142 ---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVA-TRWYRAPE-LL 196
Query: 446 YG--QLTEKSDVYSFGIVILELMSGR 469
G + + DV++ G ++ E+ G
Sbjct: 197 VGDVKYGKAVDVWAIGCLVTEMFMGE 222
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 9e-24
Identities = 54/210 (25%), Positives = 96/210 (45%), Gaps = 21/210 (10%)
Query: 266 FSQNNLIGQGASGIVYKGTLRH-GNLVAVKQILDLDTKGDEDFTN--EVEIISKIRHRNL 322
+ + + +G+G VYKG + NLVA+K+I L+ + T EV ++ ++H N+
Sbjct: 4 YIKLDKLGEGTYATVYKGKSKLTDNLVALKEIR-LEHEEGAPCTAIREVSLLKDLKHANI 62
Query: 323 LSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSD-NISISHKRKQLTWPQRKKIIVDVAKGI 381
++L T K LV++Y+ D + + K + + +G+
Sbjct: 63 VTLHDIIHTE-----KSLTLVFEYLD----KDLKQYLDDCGNIINMHNVKLFLFQLLRGL 113
Query: 382 AYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAP 441
AY H + + HRD+K N+L++ K+ADFGLA+ V T Y P
Sbjct: 114 AYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV-TLWYRPP 169
Query: 442 EYALYG--QLTEKSDVYSFGIVILELMSGR 469
+ L G + + D++ G + E+ +GR
Sbjct: 170 D-ILLGSTDYSTQIDMWGVGCIFYEMATGR 198
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 55/205 (26%), Positives = 93/205 (45%), Gaps = 22/205 (10%)
Query: 272 IGQGASGIVYKGTLRH-GNLVAVKQI-LDLDTKGDEDFTN--EVEIISKIRHRNLLSLRG 327
IG+G+ G+V+K R G +VA+K+ D + E+ ++ +++H NL++L
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIK-KIALREIRMLKQLKHPNLVNLLE 69
Query: 328 CCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYG 387
+R LV++Y + T+ + ++ + K I + + + H
Sbjct: 70 VFRRK-----RRLHLVFEYCDH-TVLH--ELDRYQRGVPEHLVKSITWQTLQAVNFCH-- 119
Query: 388 LKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALYG 447
K HRD+K NIL+ K+ DFG A+ + VA T Y +PE L G
Sbjct: 120 -KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVA-TRWYRSPE-LLVG 176
Query: 448 QLTEKS---DVYSFGIVILELMSGR 469
T+ DV++ G V EL+SG
Sbjct: 177 D-TQYGPPVDVWAIGCVFAELLSGV 200
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 1e-23
Identities = 62/208 (29%), Positives = 100/208 (48%), Gaps = 26/208 (12%)
Query: 271 LIGQGASGIVYKGTLRH---GNLVAVKQILDLDTKGDEDFTN----EVEIISKIRHRNLL 323
+G G G V G H G+ VAVK IL+ D E++ + RH +++
Sbjct: 18 TLGVGTFGKVKIG--EHQLTGHKVAVK-ILNRQKIRSLDVVGKIKREIQNLKLFRHPHII 74
Query: 324 SLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAY 383
L T D F+V +Y+ G L D I H R + + +++ + + Y
Sbjct: 75 KLYQVISTPTDF-----FMVMEYVSGGELFDYI-CKHGR--VEEMEARRLFQQILSAVDY 126
Query: 384 LHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEY 443
H + + HRD+K N+LLD+ +NAK+ADFGL+ +G L T G+ Y APE
Sbjct: 127 CH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE-FLRT-SCGSPNYAAPE- 180
Query: 444 ALYGQLTE--KSDVYSFGIVILELMSGR 469
+ G+L + D++S G+++ L+ G
Sbjct: 181 VISGRLYAGPEVDIWSCGVILYALLCGT 208
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 58/260 (22%), Positives = 106/260 (40%), Gaps = 34/260 (13%)
Query: 272 IGQGASGIVYKGTLRHGNLVAVKQILDLDTKGDED--FTN---------EVEIISKIRHR 320
I G+ G V G G VA+K++ + + G ++ E+ +++ H
Sbjct: 30 ISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHP 89
Query: 321 NLLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSD--NISISHKRKQLTWPQRKKIIVDVA 378
N+L LR V ++ + + +LV + M +D + I +R ++ + + +
Sbjct: 90 NILGLRDIFVHFEEPAMHKLYLVTELMR----TDLAQV-IHDQRIVISPQHIQYFMYHIL 144
Query: 379 KGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGY 438
G+ LH G+ HRD+ NILL + + DF LA+ ++ T V Y
Sbjct: 145 LGLHVLHEA---GVVHRDLHPGNILLADNNDITICDFNLAR-EDTADANKTHYVT-HRWY 199
Query: 439 LAPEYAL-YGQLTEKSDVYSFGIVILELMSGRKVLDTSTSP---FQLITDWAWVLAKSGK 494
APE + + T+ D++S G V+ E+ RK L ++ I + V+ G
Sbjct: 200 RAPELVMQFKGFTKLVDMWSAGCVMAEMF-NRKALFRGSTFYNQLNKIVE---VV---GT 252
Query: 495 VDDIFDEFIRAEGARAVMER 514
+ AR +
Sbjct: 253 PKIEDVVMFSSPSARDYLRN 272
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 99.5 bits (249), Expect = 2e-23
Identities = 51/215 (23%), Positives = 97/215 (45%), Gaps = 24/215 (11%)
Query: 266 FSQNNLIGQGASGIVYKGTLRH-GNLVAVKQI-LDLDTKGDEDFTN--EVEIISKIRHRN 321
+ + IG+G G V+K R +VA+K++ LD D +G + E+ ++ +++H+N
Sbjct: 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEG-VPSSALREICLLKELKHKN 62
Query: 322 LLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSD-NISISHKRKQLTWPQRKKIIVDVAKG 380
++ L + K+ LV+++ D L K + + KG
Sbjct: 63 IVRLHDVLHSD-----KKLTLVFEFCD----QDLKKYFDSCNGDLDPEIVKSFLFQLLKG 113
Query: 381 IAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQ-SLEGHSHLTTRVAGTFGYL 439
+ + H + HRD+K N+L++ K+A+FGLA+ + + V T Y
Sbjct: 114 LGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC-YSAEVV-TLWYR 168
Query: 440 APEYALYG--QLTEKSDVYSFGIVILELMSGRKVL 472
P+ L+G + D++S G + EL + + L
Sbjct: 169 PPD-VLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 3e-23
Identities = 57/219 (26%), Positives = 98/219 (44%), Gaps = 35/219 (15%)
Query: 272 IGQGASGIVYKGTLRH---GNLVAVKQILDLDTKGDEDFTN----EVEIISKIRHRNLLS 324
+G+G G VYK + A+KQI + E+ ++ +++H N++S
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQI------EGTGISMSACREIALLRELKHPNVIS 82
Query: 325 LRGCCVTSDDSSGKRRFLVYDYMPN--GTLSDNIS---ISHKRKQLTWPQRKKIIVDVAK 379
L+ ++ D ++ +L++DY + + + K QL K ++ +
Sbjct: 83 LQKVFLSHAD---RKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILD 139
Query: 380 GIAYLHYGLKPGIYHRDIKSTNILLDSELNA----KVADFGLAKQ---SLEGHSHLTTRV 432
GI YLH + HRD+K NIL+ E K+AD G A+ L+ + L V
Sbjct: 140 GIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 196
Query: 433 AGTFGYLAPEYALYG--QLTEKSDVYSFGIVILELMSGR 469
TF Y APE L G T+ D+++ G + EL++
Sbjct: 197 V-TFWYRAPEL-LLGARHYTKAIDIWAIGCIFAELLTSE 233
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 3e-23
Identities = 54/214 (25%), Positives = 90/214 (42%), Gaps = 20/214 (9%)
Query: 266 FSQNNLIGQGASGIVYKG--TLRHGNLVAVKQI-LDLDTKGDEDFTNEVEI-----ISKI 317
+ IG+GA G V+K G VA+K++ + +G + E+ +
Sbjct: 13 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG-MPLSTIREVAVLRHLETF 71
Query: 318 RHRNLLSLRGCCVTSDDSSGKRRFLVYDYMPN--GTLSDNISISHKRKQLTWPQRKKIIV 375
H N++ L C S + LV++++ T D + K ++
Sbjct: 72 EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDK----VPEPGVPTETIKDMMF 127
Query: 376 DVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGT 435
+ +G+ +LH + HRD+K NIL+ S K+ADFGLA+ LT+ V T
Sbjct: 128 QLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLAR-IYSFQMALTSVVV-T 182
Query: 436 FGYLAPEYALYGQLTEKSDVYSFGIVILELMSGR 469
Y APE L D++S G + E+ +
Sbjct: 183 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 3e-23
Identities = 61/223 (27%), Positives = 97/223 (43%), Gaps = 30/223 (13%)
Query: 266 FSQNNLIGQGASGIVY----KGTLRHGNLVAVKQILDLDT---KGDEDFT-NEVEIISKI 317
F Q ++G+G G V + T G + A K L+ + E NE +I+ K+
Sbjct: 186 FRQYRVLGKGGFGEVCACQVRAT---GKMYACK-KLEKKRIKKRKGEAMALNEKQILEKV 241
Query: 318 RHRNLLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDV 377
R ++SL T D LV M G L +I + + ++
Sbjct: 242 NSRFVVSLAYAYETKD-----ALCLVLTLMNGGDLKFHIY-HMGQAGFPEARAVFYAAEI 295
Query: 378 AKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFG 437
G+ LH + I +RD+K NILLD + +++D GLA EG + GT G
Sbjct: 296 CCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRVGTVG 350
Query: 438 YLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQ 480
Y+APE + T D ++ G ++ E+++G+ SPFQ
Sbjct: 351 YMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ-------SPFQ 386
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 4e-23
Identities = 56/209 (26%), Positives = 90/209 (43%), Gaps = 30/209 (14%)
Query: 271 LIGQGASGIVYKGTLRH---GNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRG 327
IG G G+ R LVAVK ++ DE+ E+ +RH N++ +
Sbjct: 27 DIGSGNFGVARLM--RDKLTKELVAVK-YIERGAAIDENVQREIINHRSLRHPNIVRFKE 83
Query: 328 CCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQ-RKKI--IVDVAKGIAYL 384
+T ++ +Y G L + I + R + + R ++ G++Y
Sbjct: 84 VILTPTHL-----AIIMEYASGGELYERI-CNAGR--FSEDEARFFFQQLLS---GVSYC 132
Query: 385 HYGLKPGIYHRDIKSTNILLDS--ELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPE 442
H I HRD+K N LLD K+ DFG +K S+ S + V GT Y+APE
Sbjct: 133 H---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTV-GTPAYIAPE 187
Query: 443 YALYGQLTE--KSDVYSFGIVILELMSGR 469
L Q + +DV+S G+ + ++ G
Sbjct: 188 -VLLRQEYDGKIADVWSCGVTLYVMLVGA 215
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-22
Identities = 64/258 (24%), Positives = 105/258 (40%), Gaps = 32/258 (12%)
Query: 233 LHEQFVSNLQASVLPNSGAKWFHVSELEQAT-NGFSQNNLIGQGASGIVYKGTLRH-GNL 290
L S +W +V T N FS + +IG+G G VY G +
Sbjct: 157 LRGDVFQKFIESDKFTRFCQWKNVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKM 216
Query: 291 VAVKQILDLDT---KGDEDFT-NEVEIISKI---RHRNLLSLRGCCVTSDDSSGKRRFLV 343
A+K LD K E NE ++S + ++ + T D + +
Sbjct: 217 YAMK-CLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD-----KLSFI 270
Query: 344 YDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNIL 403
D M G L ++S + + + ++ G+ ++H + +RD+K NIL
Sbjct: 271 LDLMNGGDLHYHLS---QHGVFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANIL 324
Query: 404 LDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKS-DVYSFGIVI 462
LD + +++D GLA + H V GT GY+APE G + S D +S G ++
Sbjct: 325 LDEHGHVRISDLGLACDFSKKKPH--ASV-GTHGYMAPEVLQKGVAYDSSADWFSLGCML 381
Query: 463 LELMSGRKVLDTSTSPFQ 480
+L+ G SPF+
Sbjct: 382 FKLLRGH-------SPFR 392
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 99.1 bits (247), Expect = 3e-22
Identities = 63/208 (30%), Positives = 102/208 (49%), Gaps = 26/208 (12%)
Query: 271 LIGQGASGIVYKGTLRH---GNLVAVKQILDLDTKGDEDFTN----EVEIISKIRHRNLL 323
+G G G V G +H G+ VAVK IL+ D E++ + RH +++
Sbjct: 23 TLGVGTFGKVKVG--KHELTGHKVAVK-ILNRQKIRSLDVVGKIRREIQNLKLFRHPHII 79
Query: 324 SLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAY 383
L T D F+V +Y+ G L D I + R L + +++ + G+ Y
Sbjct: 80 KLYQVISTPSDI-----FMVMEYVSGGELFDYI-CKNGR--LDEKESRRLFQQILSGVDY 131
Query: 384 LHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEY 443
H + + HRD+K N+LLD+ +NAK+ADFGL+ +G L T G+ Y APE
Sbjct: 132 CH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE-FLRTSC-GSPNYAAPE- 185
Query: 444 ALYGQLTE--KSDVYSFGIVILELMSGR 469
+ G+L + D++S G+++ L+ G
Sbjct: 186 VISGRLYAGPEVDIWSSGVILYALLCGT 213
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 3e-22
Identities = 51/212 (24%), Positives = 79/212 (37%), Gaps = 30/212 (14%)
Query: 272 IGQGASGIVYKGTLRH---GNLVAVKQI--------LDLDTKGDEDFTNEVEIISKIRHR 320
+G GA G V+ V VK I ++ T E+ I+S++ H
Sbjct: 32 LGSGAFGFVWTA--VDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHA 89
Query: 321 NLLSLRGCCVTSDDSSGKRRFLVYDYMPNGT-LSDNISISHKRKQLTWPQRKKIIVDVAK 379
N++ + LV + +G L I + +L P I +
Sbjct: 90 NIIKVLDIFENQGFF-----QLVMEKHGSGLDLFAFID---RHPRLDEPLASYIFRQLVS 141
Query: 380 GIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYL 439
+ YL I HRDIK NI++ + K+ DFG A G T GT Y
Sbjct: 142 AVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGK-LFYT-FCGTIEYC 196
Query: 440 APEYALYGQLTE--KSDVYSFGIVILELMSGR 469
APE L G + +++S G+ + L+
Sbjct: 197 APE-VLMGNPYRGPELEMWSLGVTLYTLVFEE 227
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 6e-22
Identities = 50/216 (23%), Positives = 91/216 (42%), Gaps = 28/216 (12%)
Query: 266 FSQNNLIGQGASGIVYKGT-LRHGNLVAVKQI-LDLDTKGDEDFTN--EVEIISKIRHRN 321
+ + +G+G G VYK VA+K+I L+ + +G T EV ++ +++HRN
Sbjct: 36 YRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEG-VPGTAIREVSLLKELQHRN 94
Query: 322 LLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGI 381
++ L+ + R L+++Y +D K ++ K + + G+
Sbjct: 95 IIELKSVIHHNH-----RLHLIFEYAE----NDLKKYMDKNPDVSMRVIKSFLYQLINGV 145
Query: 382 AYLHYGLKPGIYHRDIKSTNILLDSELNA-----KVADFGLAKQ-SLEGHSHLTTRVAGT 435
+ H HRD+K N+LL + K+ DFGLA+ + T + T
Sbjct: 146 NFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQ-FTHEII-T 200
Query: 436 FGYLAPEYALYG--QLTEKSDVYSFGIVILELMSGR 469
Y PE L G + D++S + E++
Sbjct: 201 LWYRPPE-ILLGSRHYSTSVDIWSIACIWAEMLMKT 235
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 7e-22
Identities = 51/210 (24%), Positives = 90/210 (42%), Gaps = 22/210 (10%)
Query: 271 LIGQGASGIVYKGT-LRHGNLVAVKQI----LDLDTKGDEDFTNEVEIISKIRHRNLLSL 325
L+G+G+ G V + AVK + L G+ + E++++ ++RH+N++ L
Sbjct: 12 LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71
Query: 326 RGCCVTSDDSSGKRRFLVYDYMPNGT--LSDNISISHKRKQLTWPQRKKIIVDVAKGIAY 383
V ++ K ++V +Y G + D S+ KR Q + G+ Y
Sbjct: 72 VD--VLYNEEKQKM-YMVMEYCVCGMQEMLD--SVPEKR--FPVCQAHGYFCQLIDGLEY 124
Query: 384 LHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLA--KQSLEGHSHLTTRVAGTFGYLAP 441
LH GI H+DIK N+LL + K++ G+A T G+ + P
Sbjct: 125 LH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRT-SQGSPAFQPP 180
Query: 442 EYALYGQLTE--KSDVYSFGIVILELMSGR 469
E A K D++S G+ + + +G
Sbjct: 181 EIANGLDTFSGFKVDIWSAGVTLYNITTGL 210
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 7e-22
Identities = 51/229 (22%), Positives = 89/229 (38%), Gaps = 43/229 (18%)
Query: 266 FSQNNLIGQGASGIVYKGTLRH-GNLVAVKQILDLDT---KGDEDFTN-EVEIISKIRHR 320
F ++G+G+ V A+K IL+ + + E +++S++ H
Sbjct: 32 FKFGKILGEGSFSTVVLARELATSREYAIK-ILEKRHIIKENKVPYVTRERDVMSRLDHP 90
Query: 321 NLLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAK- 379
+ L + + + Y NG L + + RK +
Sbjct: 91 FFVKLYFTFQDDE-----KLYFGLSYAKNGEL-----LKYIRKI------GSFDETCTRF 134
Query: 380 -------GIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTR- 431
+ YLH GI HRD+K NILL+ +++ ++ DFG AK
Sbjct: 135 YTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANS 191
Query: 432 VAGTFGYLAPEYALYGQLTEKS-DVYSFGIVILELMSGRKVLDTSTSPF 479
GT Y++PE L + KS D+++ G +I +L++G PF
Sbjct: 192 FVGTAQYVSPE-LLTEKSACKSSDLWALGCIIYQLVAGL-------PPF 232
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 2e-21
Identities = 51/212 (24%), Positives = 84/212 (39%), Gaps = 28/212 (13%)
Query: 271 LIGQGASGIVYKGT-LRHGNLVAVKQIL--DLDTKGDEDFTN----EVEIISKIRHR--N 321
L+G G G VY G + VA+K + + G+ EV ++ K+
Sbjct: 50 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109
Query: 322 LLSLRGCCVTSDDSSGKRRFLVYDY-MPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKG 380
++ L D L+ + P L D I+ +R L + V +
Sbjct: 110 VIRLLDWFERPDSF-----VLILERPEPVQDLFDFIT---ERGALQEELARSFFWQVLEA 161
Query: 381 IAYLHYGLKPGIYHRDIKSTNILLDSE-LNAKVADFGLAKQSLEGHSHLTTRVAGTFGYL 439
+ + H G+ HRDIK NIL+D K+ DFG +L + T GT Y
Sbjct: 162 VRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSG--ALLKDTVYTDFD-GTRVYS 215
Query: 440 APEYALYGQLTE--KSDVYSFGIVILELMSGR 469
PE+ + + V+S GI++ +++ G
Sbjct: 216 PPEW-IRYHRYHGRSAAVWSLGILLYDMVCGD 246
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 2e-21
Identities = 62/208 (29%), Positives = 96/208 (46%), Gaps = 27/208 (12%)
Query: 271 LIGQGASGIVYKGTLRH---GNLVAVKQILDLDTKGDEDFTN----EVEIISKIRHRNLL 323
+G+G+ G V H VA+K + D E+ + +RH +++
Sbjct: 16 TLGEGSFGKVKLA--THYKTQQKVALK-FISRQLLKKSDMHMRVEREISYLKLLRHPHII 72
Query: 324 SLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAY 383
L T D +V +Y G L D I + KR +T + ++ + I Y
Sbjct: 73 KLYDVITTPTDI-----VMVIEYA-GGELFDYI-VEKKR--MTEDEGRRFFQQIICAIEY 123
Query: 384 LHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEY 443
H + I HRD+K N+LLD LN K+ADFGL+ +G+ L T G+ Y APE
Sbjct: 124 CH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN-FLKT-SCGSPNYAAPE- 177
Query: 444 ALYGQLTE--KSDVYSFGIVILELMSGR 469
+ G+L + DV+S GIV+ ++ GR
Sbjct: 178 VINGKLYAGPEVDVWSCGIVLYVMLVGR 205
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 1e-20
Identities = 41/201 (20%), Positives = 77/201 (38%), Gaps = 47/201 (23%)
Query: 272 IGQGASGIVYKGTLRH-GNLVAVKQILDLDTKGDEDFTNEVEIISKI-RHRNLLSLRGCC 329
+G G +G V + + A+K + D EVE+ + + +++ +
Sbjct: 26 LGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVY 80
Query: 330 VTSDDSSGKRRF--LVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYG 387
++ R+ +V + + G L I + T + +I+ + + I YLH
Sbjct: 81 ---ENLYAGRKCLLIVMECLDGGELFSRI-QDRGDQAFTEREASEIMKSIGEAIQYLH-- 134
Query: 388 LKPGIYHRDIKSTNILL-----DSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPE 442
I HRD+K N+L ++ L K+ DFG AK++
Sbjct: 135 -SINIAHRDVKPENLLYTSKRPNAIL--KLTDFGFAKETTGEK----------------- 174
Query: 443 YALYGQLTEKSDVYSFGIVIL 463
Y + D++S G VI+
Sbjct: 175 ---YD---KSCDMWSLG-VIM 188
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 2e-20
Identities = 54/228 (23%), Positives = 93/228 (40%), Gaps = 41/228 (17%)
Query: 271 LIGQGASGIVYKGTLRH-GNLVAVKQILDLDT---KGDEDFT-NEVEIISKIRHRNLLSL 325
IG+G+ G V + A+K ++ + + E++I+ + H L++L
Sbjct: 22 AIGKGSFGKVCIVQKNDTKKMYAMK-YMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNL 80
Query: 326 RGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWP-QRKKI-IVDVAKGIAY 383
+D F+V D + G L H ++ + + + K+ I ++ + Y
Sbjct: 81 WYSFQDEED-----MFMVVDLLLGGDL-----RYHLQQNVHFKEETVKLFICELVMALDY 130
Query: 384 LHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPE- 442
L I HRD+K NILLD + + DF +A T +AGT Y+APE
Sbjct: 131 LQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT--MAGTKPYMAPEM 185
Query: 443 -----YALYGQLTEKS-DVYSFGIVILELMSGRKVLDTSTSPFQLITD 484
A Y + D +S G+ EL+ GR P+ + +
Sbjct: 186 FSSRKGAGYS----FAVDWWSLGVTAYELLRGR-------RPYHIRSS 222
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 5e-20
Identities = 55/259 (21%), Positives = 106/259 (40%), Gaps = 42/259 (16%)
Query: 272 IGQGASGIVYKGT-LRHGNLVAVKQILDLDTKGDEDFTN---------EVEIISKIRHRN 321
+G GA G V R G VA+K++ F + E+ ++ ++H N
Sbjct: 32 VGSGAYGSVCSAIDKRSGEKVAIKKLSRP-------FQSEIFAKRAYRELLLLKHMQHEN 84
Query: 322 LLSLRGC-CVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKG 380
++ L S + +LV +M L + + + + + ++ + KG
Sbjct: 85 VIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIM-----GLKFSEEKIQYLVYQMLKG 138
Query: 381 IAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLA 440
+ Y+H G+ HRD+K N+ ++ + K+ DFGLA+ + + +T V T Y A
Sbjct: 139 LKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHA---DAEMTGYVV-TRWYRA 191
Query: 441 PEYAL-YGQLTEKSDVYSFGIVILELMSGRKVLDTSTSP---FQLITDWAWVLAKSGKVD 496
PE L + + D++S G ++ E++ K L I V G
Sbjct: 192 PEVILSWMHYNQTVDIWSVGCIMAEML-TGKTLFKGKDYLDQLTQILK---VT---GVPG 244
Query: 497 DIFDEFIRAEGARAVMERF 515
F + + + A++ ++
Sbjct: 245 TEFVQKLNDKAAKSYIQSL 263
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 6e-20
Identities = 54/210 (25%), Positives = 94/210 (44%), Gaps = 31/210 (14%)
Query: 272 IGQGASGIVYKGTLRH-GNLVAVKQILDLDTKGDEDFTN---------EVEIISKIRHRN 321
IG GA GIV VA+K++ F N E+ ++ + H+N
Sbjct: 33 IGSGAQGIVCAAYDAILERNVAIKKLSRP-------FQNQTHAKRAYRELVLMKCVNHKN 85
Query: 322 LLSLRGCCVTSDDSSGKRR--FLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAK 379
++ L T S + + ++V + M ++ + + +L + ++ +
Sbjct: 86 IIGLLNV-FTPQKSLEEFQDVYIVMELMD----ANLCQVI--QMELDHERMSYLLYQMLC 138
Query: 380 GIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYL 439
GI +LH GI HRD+K +NI++ S+ K+ DFGLA+ + +T V T Y
Sbjct: 139 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF-MMTPYVV-TRYYR 193
Query: 440 APEYALYGQLTEKSDVYSFGIVILELMSGR 469
APE L E D++S G ++ E++ G
Sbjct: 194 APEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 7e-20
Identities = 52/238 (21%), Positives = 87/238 (36%), Gaps = 59/238 (24%)
Query: 266 FSQNNLIGQGASGIVY----KGTLRHGNLVAVKQILDLDT---KGDEDFT-NEVEIISKI 317
+ +IG+GA G V K T + A+K +L + D F E +I++
Sbjct: 71 YEVVKVIGRGAFGEVQLVRHKST---RKVYAMK-LLSKFEMIKRSDSAFFWEERDIMAFA 126
Query: 318 RHRNLLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDV 377
++ L ++V +YMP G L + +
Sbjct: 127 NSPWVVQLFYAFQDDR-----YLYMVMEYMPGGDL------------VNLMSNYDVPEKW 169
Query: 378 AK--------GIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLT 429
A+ + +H G HRD+K N+LLD + K+ADFG + +
Sbjct: 170 ARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRC 226
Query: 430 TRVAGTFGYLAPE-------YALYGQLTEKS-DVYSFGIVILELMSGRKVLDTSTSPF 479
GT Y++PE YG + D +S G+ + E++ G +PF
Sbjct: 227 DTAVGTPDYISPEVLKSQGGDGYYG----RECDWWSVGVFLYEMLVGD-------TPF 273
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 1e-19
Identities = 63/254 (24%), Positives = 108/254 (42%), Gaps = 27/254 (10%)
Query: 272 IGQGASGIVYKGT-LRHGNLVAVKQILDLDTKGDEDFT-NEVEIISKIRHRNLLSLRGCC 329
IG+GA G+V + VA+K+I + + T E++I+ + RH N++ +
Sbjct: 35 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 330 VTSDDSSGKRRFLVYDYMPNGT-LSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGL 388
K ++V D M T L + K + L+ + + +G+ Y+H
Sbjct: 95 RAPTIEQMKDVYIVQDLM--ETDLYKLL----KTQHLSNDHICYFLYQILRGLKYIHSA- 147
Query: 389 KPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSH---LTTRVAGTFGYLAPEYAL 445
+ HRD+K +N+LL++ + K+ DFGLA+ + H H LT VA T Y APE L
Sbjct: 148 --NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA-TRWYRAPEIML 204
Query: 446 -YGQLTEKSDVYSFGIVILELMSGRKVLDTSTSP---FQLITDWAWVLAKSGKVDDIFDE 501
T+ D++S G ++ E++ + + I +L G
Sbjct: 205 NSKGYTKSIDIWSVGCILAEML-SNRPIFPGKHYLDQLNHILG---IL---GSPSQEDLN 257
Query: 502 FIRAEGARAVMERF 515
I AR +
Sbjct: 258 CIINLKARNYLLSL 271
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 1e-19
Identities = 55/216 (25%), Positives = 82/216 (37%), Gaps = 34/216 (15%)
Query: 271 LIGQGASGIVYKGTLRH---GNLVAVKQIL---DLDTKGDEDFTN---EVEIISKIR--- 318
L+G+G G V+ G VA+K I L D EV ++ K+
Sbjct: 38 LLGKGGFGTVFAG--HRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGG 95
Query: 319 -HRNLLSLRGCCVTSDDSSGKRRFLVYDY-MPNGTLSDNISISHKRKQLTWPQRKKIIVD 376
H ++ L T + LV + +P L D I L +
Sbjct: 96 GHPGVIRLLDWFETQEGF-----MLVLERPLPAQDLFDYI-TEKGP--LGEGPSRCFFGQ 147
Query: 377 VAKGIAYLHYGLKPGIYHRDIKSTNILLDSE-LNAKVADFGLAKQSLEGHSHLTTRVAGT 435
V I + H G+ HRDIK NIL+D AK+ DFG +L T GT
Sbjct: 148 VVAAIQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSG--ALLHDEPYTDFD-GT 201
Query: 436 FGYLAPEYALYGQLTE--KSDVYSFGIVILELMSGR 469
Y PE+ + + V+S GI++ +++ G
Sbjct: 202 RVYSPPEW-ISRHQYHALPATVWSLGILLYDMVCGD 236
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 2e-19
Identities = 65/278 (23%), Positives = 120/278 (43%), Gaps = 49/278 (17%)
Query: 254 FHVSELEQATNGFSQNNLIGQGASGIVYKGT-LRHGNLVAVKQILDLDTKGDEDFTN--- 309
+ V + + +G GA G V R G VA+K++ F +
Sbjct: 21 WEVRAVYRDLQ------PVGSGAYGAVCSAVDGRTGAKVAIKKLYRP-------FQSELF 67
Query: 310 ------EVEIISKIRHRNLLSLRGCCVTSDDSSGKRR--FLVYDYMPNGTLSDNISISHK 361
E+ ++ +RH N++ L T D++ +LV +M L + K
Sbjct: 68 AKRAYRELRLLKHMRHENVIGLLDV-FTPDETLDDFTDFYLVMPFMGT-DLGKLM----K 121
Query: 362 RKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQS 421
++L + + ++ + KG+ Y+H GI HRD+K N+ ++ + K+ DFGLA+Q+
Sbjct: 122 HEKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQA 178
Query: 422 LEGHSHLTTRVAGTFGYLAPEYAL-YGQLTEKSDVYSFGIVILELMSGRKVLDTSTSP-- 478
S +T V T Y APE L + + T+ D++S G ++ E++ K L +
Sbjct: 179 ---DSEMTGYVV-TRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMI-TGKTLFKGSDHLD 233
Query: 479 -FQLITDWAWVLAKSGKVDDIFDEFIRAEGARAVMERF 515
+ I V G F + ++++ A+ M+
Sbjct: 234 QLKEIMK---VT---GTPPAEFVQRLQSDEAKNYMKGL 265
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 3e-19
Identities = 55/220 (25%), Positives = 89/220 (40%), Gaps = 36/220 (16%)
Query: 271 LIGQGASGIVY----KGTLRHGNLVAVKQILDLDTKGDEDFTNEVE-------IISKIRH 319
L+G+G G V K T G A+K + K +EV ++ RH
Sbjct: 155 LLGKGTFGKVILVKEKAT---GRYYAMKIL----KKEVIVAKDEVAHTLTENRVLQNSRH 207
Query: 320 RNLLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAK 379
L +L+ T D R V +Y G L ++ + + + + + ++
Sbjct: 208 PFLTALKYSFQTHD-----RLCFVMEYANGGELFFHL---SRERVFSEDRARFYGAEIVS 259
Query: 380 GIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYL 439
+ YLH + +RD+K N++LD + + K+ DFGL K+ + GT YL
Sbjct: 260 ALDYLHSEK--NVVYRDLKLENLMLDKDGHIKITDFGLCKEGI-KDGATMKTFCGTPEYL 316
Query: 440 APEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPF 479
APE D + G+V+ E+M GR PF
Sbjct: 317 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR-------LPF 349
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 89.5 bits (222), Expect = 3e-19
Identities = 53/209 (25%), Positives = 92/209 (44%), Gaps = 29/209 (13%)
Query: 272 IGQGASGIVYKGT-LRHGNLVAVKQILDLDTKGDEDFTN---------EVEIISKIRHRN 321
IG GA GIV VA+K++ F N E+ ++ + H+N
Sbjct: 70 IGSGAQGIVCAAYDAVLDRNVAIKKLSRP-------FQNQTHAKRAYRELVLMKCVNHKN 122
Query: 322 LLSLRGC-CVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKG 380
++SL + +LV + M ++ + + +L + ++ + G
Sbjct: 123 IISLLNVFTPQKTLEEFQDVYLVMELMD----ANLCQVI--QMELDHERMSYLLYQMLCG 176
Query: 381 IAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLA 440
I +LH GI HRD+K +NI++ S+ K+ DFGLA+ + +T V T Y A
Sbjct: 177 IKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF-MMTPYVV-TRYYRA 231
Query: 441 PEYALYGQLTEKSDVYSFGIVILELMSGR 469
PE L E D++S G ++ E++ +
Sbjct: 232 PEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 88.3 bits (219), Expect = 7e-19
Identities = 50/235 (21%), Positives = 93/235 (39%), Gaps = 50/235 (21%)
Query: 266 FSQNNLIGQGASGIVY----KGTLRHGNLVAVKQILDLDT---KGDEDFTN-EVEIISKI 317
F +IG+GA G V K + A+K IL+ + + E +++
Sbjct: 76 FEILKVIGRGAFGEVAVVKLKNA---DKVFAMK-ILNKWEMLKRAETACFREERDVLVNG 131
Query: 318 RHRNLLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDV 377
+ + +L + +LV DY G L ++ K ++ ++
Sbjct: 132 DSKWITTLHYAFQDDN-----NLYLVMDYYVGGDL-----LTLLSKF-----EDRLPEEM 176
Query: 378 AK--------GIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLT 429
A+ I +H + HRDIK NIL+D + ++ADFG + +E + +
Sbjct: 177 ARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQS 233
Query: 430 TRVAGTFGYLAPEYALYGQLTEKS-----DVYSFGIVILELMSGRKVLDTSTSPF 479
+ GT Y++PE + + D +S G+ + E++ G +PF
Sbjct: 234 SVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE-------TPF 281
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 8e-19
Identities = 52/231 (22%), Positives = 89/231 (38%), Gaps = 50/231 (21%)
Query: 271 LIGQGASGIVY----KGTLRHGNLVAVKQI--LDLDTKGDEDFT-NEVEIISKIRHRNLL 323
+IG+GA V K T G + A+K + D+ +G+ E +++ R +
Sbjct: 68 VIGRGAFSEVAVVKMKQT---GQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWIT 124
Query: 324 SLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAK---- 379
L + +LV +Y G L ++ K ++I ++A+
Sbjct: 125 QLHFAFQDEN-----YLYLVMEYYVGGDL-----LTLLSKF-----GERIPAEMARFYLA 169
Query: 380 ----GIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGT 435
I +H + G HRDIK NILLD + ++ADFG + + + GT
Sbjct: 170 EIVMAIDSVH---RLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGT 226
Query: 436 FGYLAPEYALYGQLTEKSDVY-------SFGIVILELMSGRKVLDTSTSPF 479
YL+PE + Y + G+ E+ G+ +PF
Sbjct: 227 PDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQ-------TPF 270
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 87.6 bits (217), Expect = 2e-18
Identities = 43/196 (21%), Positives = 75/196 (38%), Gaps = 30/196 (15%)
Query: 272 IGQGASGIVYKGT-LRHGNLVAVKQILDLDTKGDEDFTN---------EVEIISKIRHRN 321
IG G+ G V + +VA+K+IL F + E+ I++++ H +
Sbjct: 61 IGTGSYGHVCEAYDKLEKRVVAIKKILR-------VFEDLIDCKRILREIAILNRLNHDH 113
Query: 322 LLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGI 381
++ + + D ++V + SD + LT K ++ ++ G+
Sbjct: 114 VVKVLDIVIPKDVEKFDELYVVLEIAD----SDFKKLFRTPVYLTELHIKTLLYNLLVGV 169
Query: 382 AYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLA------KQSLEGHSHLTTRVAGT 435
Y+H GI HRD+K N L++ + + KV DFGLA +
Sbjct: 170 KYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMN 226
Query: 436 FGYLAPEYALYGQLTE 451
L QLT
Sbjct: 227 LVTFPHTKNLKRQLTG 242
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 2e-18
Identities = 60/220 (27%), Positives = 91/220 (41%), Gaps = 37/220 (16%)
Query: 271 LIGQGASGIV----YKGTLRHGNLVAVKQILDLDTKGDEDFTNEVE-------IISKIRH 319
L+G+G G V K T G A+K IL K +EV ++ RH
Sbjct: 12 LLGKGTFGKVILVREKAT---GRYYAMK-ILR---KEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 320 RNLLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAK 379
L +L+ T D R V +Y G L ++S + + T + + ++
Sbjct: 65 PFLTALKYAFQTHD-----RLCFVMEYANGGELFFHLS---RERVFTEERARFYGAEIVS 116
Query: 380 GIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYL 439
+ YLH + +RDIK N++LD + + K+ DFGL K+ + GT YL
Sbjct: 117 ALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD-GATMKTFCGTPEYL 172
Query: 440 APEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPF 479
APE D + G+V+ E+M GR PF
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR-------LPF 205
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 2e-18
Identities = 63/260 (24%), Positives = 113/260 (43%), Gaps = 43/260 (16%)
Query: 272 IGQGASGIVYKGT-LRHGNLVAVKQILDLDTKGDEDFTN---------EVEIISKIRHRN 321
+G GA G V + G VAVK++ F + E+ ++ ++H N
Sbjct: 37 VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-------FQSIIHAKRTYRELRLLKHMKHEN 89
Query: 322 LLSLRGCCVTSDDSSGKRR--FLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAK 379
++ L T S + +LV M L++ + K ++LT + +I + +
Sbjct: 90 VIGLLDV-FTPARSLEEFNDVYLVTHLMGA-DLNNIV----KCQKLTDDHVQFLIYQILR 143
Query: 380 GIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYL 439
G+ Y+H I HRD+K +N+ ++ + K+ DFGLA+ + +T VA T Y
Sbjct: 144 GLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHT---ADEMTGYVA-TRWYR 196
Query: 440 APEYAL-YGQLTEKSDVYSFGIVILELMSGRKVLDTSTSP---FQLITDWAWVLAKSGKV 495
APE L + + D++S G ++ EL+ + L T +LI ++ G
Sbjct: 197 APEIMLNWMHYNQTVDIWSVGCIMAELL-TGRTLFPGTDHIDQLKLILR---LV---GTP 249
Query: 496 DDIFDEFIRAEGARAVMERF 515
+ I +E AR ++
Sbjct: 250 GAELLKKISSESARNYIQSL 269
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 3e-18
Identities = 48/223 (21%), Positives = 100/223 (44%), Gaps = 44/223 (19%)
Query: 272 IGQGASGIVYKGT-LRHGNLVAVKQILDLDTKGDEDFTN---------EVEIISKIRHRN 321
+G G +G+V+ VA+K+I+ T+ E++II ++ H N
Sbjct: 19 LGCGGNGLVFSAVDNDCDKRVAIKKIV---------LTDPQSVKHALREIKIIRRLDHDN 69
Query: 322 LLSL---------RGCCVTSDDSSGKRRFLVYDYMPNGT-LSDNISISHKRKQLTWPQRK 371
++ + + + ++V +YM T L++ + ++ L +
Sbjct: 70 IVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM--ETDLANVL----EQGPLLEEHAR 123
Query: 372 KIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSE-LNAKVADFGLAKQSLEGHSH--- 427
+ + +G+ Y+H + HRD+K N+ +++E L K+ DFGLA+ +SH
Sbjct: 124 LFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGH 180
Query: 428 LTTRVAGTFGYLAPEYAL-YGQLTEKSDVYSFGIVILELMSGR 469
L+ + T Y +P L T+ D+++ G + E+++G+
Sbjct: 181 LSEGLV-TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 84.9 bits (211), Expect = 3e-18
Identities = 60/217 (27%), Positives = 103/217 (47%), Gaps = 27/217 (12%)
Query: 271 LIGQGASGIVY----KGTLRHGNLVAVKQIL--DLDTKGDEDFTNEVEIISKIRHRNLLS 324
++GQG+ G V+ L A+K + L + E +I+ ++ H ++
Sbjct: 31 VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVK 90
Query: 325 LRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYL 384
L T + +L+ D++ G L +S K T K + ++A + +L
Sbjct: 91 LHYAFQTEG-----KLYLILDFLRGGDLFTRLS---KEVMFTEEDVKFYLAELALALDHL 142
Query: 385 HYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYA 444
H GI +RD+K NILLD E + K+ DFGL+K+S++ H GT Y+APE
Sbjct: 143 H---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESID-HEKKAYSFCGTVEYMAPE-V 197
Query: 445 LYGQLTEKS-DVYSFGIVILELMSGRKVLDTSTSPFQ 480
+ + +S D +SFG+++ E+++G PFQ
Sbjct: 198 VNRRGHTQSADWWSFGVLMFEMLTGT-------LPFQ 227
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 5e-18
Identities = 21/216 (9%), Positives = 56/216 (25%), Gaps = 47/216 (21%)
Query: 271 LIGQGASGIVYKGT-LRHGNLVAVKQILDLDTKGDED----FTNEVEIISKIRHRNLLSL 325
G ++ VA+ +D +D + +S+I + +
Sbjct: 38 FHGGVPPLQFWQALDTALDRQVALT-FVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV 96
Query: 326 RGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLH 385
V + +V +++ G+L + + + + +A H
Sbjct: 97 LD--VVHTRA---GGLVVAEWIRGGSLQEVA-----DTSPSPVGAIRAMQSLAAAADAAH 146
Query: 386 YGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYAL 445
+ G+ + + + + + +A +
Sbjct: 147 ---RAGVALSIDHPSRVRVSIDGDVVLAY---------------------PATMPDA--- 179
Query: 446 YGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQL 481
+ D+ G + L+ R L + L
Sbjct: 180 ----NPQDDIRGIGASLYALLVNRWPLPEAGVRSGL 211
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 84.1 bits (209), Expect = 5e-18
Identities = 65/233 (27%), Positives = 100/233 (42%), Gaps = 56/233 (24%)
Query: 266 FSQNNLIGQGASGIVYKGTLRH-GNLVAVK-----QILDLDTKGDEDFT-NEVEIISKIR 318
F +G G+ G V+ RH G A+K ++ L + T +E ++S +
Sbjct: 8 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLK---QVEHTNDERLMLSIVT 64
Query: 319 HRNLLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVA 378
H ++ + G + + F++ DY+ G L S RK ++ VA
Sbjct: 65 HPFIIRMWGTFQDAQ-----QIFMIMDYIEGGEL-----FSLLRKS------QRFPNPVA 108
Query: 379 K--------GIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTT 430
K + YLH I +RD+K NILLD + K+ DFG AK + T
Sbjct: 109 KFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV----TY 161
Query: 431 RVAGTFGYLAPEYAL---YGQLTEKS-DVYSFGIVILELMSGRKVLDTSTSPF 479
+ GT Y+APE Y KS D +SFGI+I E+++G +PF
Sbjct: 162 TLCGTPDYIAPEVVSTKPYN----KSIDWWSFGILIYEMLAGY-------TPF 203
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 6e-18
Identities = 59/268 (22%), Positives = 109/268 (40%), Gaps = 47/268 (17%)
Query: 272 IGQGASGIVYKGTLRH-GNLVAVKQILDLDTKGDEDFTN---------EVEIISKIRHRN 321
+G+GA G+V T + G +VA+K+I E F E++I+ +H N
Sbjct: 19 LGEGAYGVVCSATHKPTGEIVAIKKI--------EPFDKPLFALRTLREIKILKHFKHEN 70
Query: 322 LLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGI 381
++++ + +++ + M +D + + L+ + I + +
Sbjct: 71 IITIFNIQRPDSFENFNEVYIIQELMQ----TDLHRVI-STQMLSDDHIQYFIYQTLRAV 125
Query: 382 AYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLA----------KQSLEGHSHLTTR 431
LH + HRD+K +N+L++S + KV DFGLA + S +
Sbjct: 126 KVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEF 182
Query: 432 VAGTFGYLAPEYAL-YGQLTEKSDVYSFGIVILELMSGRKVLDTSTSP---FQLITDWAW 487
VA T Y APE L + + DV+S G ++ EL R+ + LI
Sbjct: 183 VA-TRWYRAPEVMLTSAKYSRAMDVWSCGCILAELF-LRRPIFPGRDYRHQLLLIFG--- 237
Query: 488 VLAKSGKVDDIFDEFIRAEGARAVMERF 515
++ +D+ I + AR ++
Sbjct: 238 IIGTPHSDNDL--RCIESPRAREYIKSL 263
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 86.2 bits (213), Expect = 8e-18
Identities = 60/222 (27%), Positives = 102/222 (45%), Gaps = 38/222 (17%)
Query: 271 LIGQGASGIV----YKGTLRHGNLVAVKQILDLDTKGDEDFTNEVE--------IISKIR 318
++G+G+ G V KGT L AVK + K ++VE + +
Sbjct: 348 VLGKGSFGKVMLSERKGT---DELYAVKIL----KKDVVIQDDDVECTMVEKRVLALPGK 400
Query: 319 HRNLLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVA 378
L L C T D R + V +Y+ G L +I + + P ++A
Sbjct: 401 PPFLTQLHSCFQTMD-----RLYFVMEYVNGGDLMYHI---QQVGRFKEPHAVFYAAEIA 452
Query: 379 KGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGY 438
G+ +L GI +RD+K N++LDSE + K+ADFG+ K+++ T GT Y
Sbjct: 453 IGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI-WDGVTTKTFCGTPDY 508
Query: 439 LAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQ 480
+APE Y + D ++FG+++ E+++G+ +PF+
Sbjct: 509 IAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ-------APFE 543
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 1e-17
Identities = 64/225 (28%), Positives = 103/225 (45%), Gaps = 46/225 (20%)
Query: 271 LIGQGASGIVY----KGTLRHGNLVAVKQILDLDTKGDEDFTNEVE-------IISKI-R 318
++G+G+ G V K T G+L AVK +L K ++VE I+S
Sbjct: 30 VLGKGSFGKVMLARVKET---GDLYAVK-VLK---KDVILQDDDVECTMTEKRILSLARN 82
Query: 319 HRNLLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVA 378
H L L C T D R F V +++ G L +I K ++ + + ++
Sbjct: 83 HPFLTQLFCCFQTPD-----RLFFVMEFVNGGDLMFHI---QKSRRFDEARARFYAAEII 134
Query: 379 KGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGY 438
+ +LH GI +RD+K N+LLD E + K+ADFG+ K+ + T GT Y
Sbjct: 135 SALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICN-GVTTATFCGTPDY 190
Query: 439 LAPE---YALYGQLTEKS-DVYSFGIVILELMSGRKVLDTSTSPF 479
+APE LYG + D ++ G+++ E++ G +PF
Sbjct: 191 IAPEILQEMLYG----PAVDWWAMGVLLYEMLCGH-------APF 224
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 2e-17
Identities = 59/220 (26%), Positives = 98/220 (44%), Gaps = 36/220 (16%)
Query: 271 LIGQGASGIV----YKGTLRHGNLVAVK-----QILDLDTKGDEDFTN-EVEIISK-IRH 319
++G+G+ G V +K T A+K +L D D + T E ++S H
Sbjct: 24 MLGKGSFGKVFLAEFKKT---NQFFAIKALKKDVVLMDD---DVECTMVEKRVLSLAWEH 77
Query: 320 RNLLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAK 379
L + T + F V +Y+ G L +I + + ++
Sbjct: 78 PFLTHMFCTFQTKE-----NLFFVMEYLNGGDLMYHI---QSCHKFDLSRATFYAAEIIL 129
Query: 380 GIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYL 439
G+ +LH GI +RD+K NILLD + + K+ADFG+ K+++ T GT Y+
Sbjct: 130 GLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENM-LGDAKTNTFCGTPDYI 185
Query: 440 APEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPF 479
APE L + D +SFG+++ E++ G+ SPF
Sbjct: 186 APEILLGQKYNHSVDWWSFGVLLYEMLIGQ-------SPF 218
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 2e-17
Identities = 63/263 (23%), Positives = 103/263 (39%), Gaps = 52/263 (19%)
Query: 234 HEQFVSNLQASVLPNSGAKWFHVSELEQATNGFSQNNLIGQGASGIVYKGTLRH-GNLVA 292
++ V A + KW S+ + F + +G G+ G V + GN A
Sbjct: 11 EQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYA 70
Query: 293 VKQILD----LDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFLVYDYMP 348
+K ILD + K E NE I+ + L+ L + ++V +Y+
Sbjct: 71 MK-ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS-----NLYMVMEYVA 124
Query: 349 NGTLSDNISISHKRKQLTWPQRKKIIVDVAK--------GIAYLHYGLKPGIYHRDIKST 400
G + SH R+ + + A+ YLH + +RD+K
Sbjct: 125 GGEM-----FSHLRRIGRFSE------PHARFYAAQIVLTFEYLH---SLDLIYRDLKPE 170
Query: 401 NILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYAL---YGQLTEKS-DVY 456
N+L+D + +V DFG AK+ T + GT LAPE L Y K+ D +
Sbjct: 171 NLLIDQQGYIQVTDFGFAKRV----KGRTWTLCGTPEALAPEIILSKGYN----KAVDWW 222
Query: 457 SFGIVILELMSGRKVLDTSTSPF 479
+ G++I E+ +G PF
Sbjct: 223 ALGVLIYEMAAGY-------PPF 238
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 2e-17
Identities = 44/191 (23%), Positives = 80/191 (41%), Gaps = 25/191 (13%)
Query: 272 IGQGASGIVYKGTLRH-GNLVAVKQILDLDTKGDEDFTN---------EVEIISKIRHRN 321
IG+G+ G VY ++ VA+K++ + F + E+ I+++++
Sbjct: 34 IGRGSYGYVYLAYDKNTEKNVAIKKVNRM-------FEDLIDCKRILREITILNRLKSDY 86
Query: 322 LLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGI 381
++ L + D ++V + SD + LT K I+ ++ G
Sbjct: 87 IIRLYDLIIPDDLLKFDELYIVLEIAD----SDLKKLFKTPIFLTEEHIKTILYNLLLGE 142
Query: 382 AYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLA-KQSLEGHSHLTTRVAGTFGYLA 440
++H GI HRD+K N LL+ + + KV DFGLA + E +++ +
Sbjct: 143 NFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGP 199
Query: 441 PEYALYGQLTE 451
L QLT
Sbjct: 200 HNKNLKKQLTS 210
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 3e-17
Identities = 63/240 (26%), Positives = 112/240 (46%), Gaps = 36/240 (15%)
Query: 271 LIGQGASGIVY----KGTLRHGNLVAVKQIL---DLDTKGDEDFT-NEVEIISKI-RHRN 321
+IG+G+ V K T + A+K ++ ++ D D+ E + + H
Sbjct: 16 VIGRGSYAKVLLVRLKKT---DRIYAMK-VVKKELVNDDEDIDWVQTEKHVFEQASNHPF 71
Query: 322 LLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGI 381
L+ L C T R F V +Y+ G L ++ ++++L + +++ +
Sbjct: 72 LVGLHSCFQTES-----RLFFVIEYVNGGDLMFHM---QRQRKLPEEHARFYSAEISLAL 123
Query: 382 AYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAP 441
YLH + GI +RD+K N+LLDSE + K+ D+G+ K+ L T+ GT Y+AP
Sbjct: 124 NYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP-GDTTSTFCGTPNYIAP 179
Query: 442 EYALYGQLTEKS-DVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFD 500
E L G+ S D ++ G+++ E+M+GR SPF ++ + D +F
Sbjct: 180 E-ILRGEDYGFSVDWWALGVLMFEMMAGR-------SPFDIVGSSDNPDQNT--EDYLFQ 229
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 81.8 bits (203), Expect = 3e-17
Identities = 49/218 (22%), Positives = 98/218 (44%), Gaps = 27/218 (12%)
Query: 271 LIGQGASGIVY---KGTLRH-GNLVAVKQI--LDLDTKGDE-DFT-NEVEIISKIRHRNL 322
++G+G G V+ K T + G + A+K + + + T E I+ +++H +
Sbjct: 24 VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83
Query: 323 LSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIA 382
+ L T + +L+ +Y+ G L + + + +++ +
Sbjct: 84 VDLIYAFQTGG-----KLYLILEYLSGGELFMQL---EREGIFMEDTACFYLAEISMALG 135
Query: 383 YLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPE 442
+LH + GI +RD+K NI+L+ + + K+ DFGL K+S+ +T GT Y+APE
Sbjct: 136 HLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHD-GTVTHTFCGTIEYMAPE 191
Query: 443 YALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQ 480
+ D +S G ++ ++++G PF
Sbjct: 192 ILMRSGHNRAVDWWSLGALMYDMLTGA-------PPFT 222
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 5e-17
Identities = 62/240 (25%), Positives = 112/240 (46%), Gaps = 36/240 (15%)
Query: 271 LIGQGASGIVY----KGTLRHGNLVAVKQIL---DLDTKGDEDFT-NEVEIISKI-RHRN 321
+IG+G+ V K T + A++ ++ ++ D D+ E + + H
Sbjct: 59 VIGRGSYAKVLLVRLKKT---DRIYAMR-VVKKELVNDDEDIDWVQTEKHVFEQASNHPF 114
Query: 322 LLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGI 381
L+ L C T R F V +Y+ G L ++ ++++L + +++ +
Sbjct: 115 LVGLHSCFQTES-----RLFFVIEYVNGGDLMFHM---QRQRKLPEEHARFYSAEISLAL 166
Query: 382 AYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAP 441
YLH + GI +RD+K N+LLDSE + K+ D+G+ K+ L T+ GT Y+AP
Sbjct: 167 NYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL-RPGDTTSTFCGTPNYIAP 222
Query: 442 EYALYGQLTEKS-DVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFD 500
E L G+ S D ++ G+++ E+M+GR SPF ++ + D +F
Sbjct: 223 E-ILRGEDYGFSVDWWALGVLMFEMMAGR-------SPFDIVGSSDNPDQNT--EDYLFQ 272
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 5e-17
Identities = 62/221 (28%), Positives = 104/221 (47%), Gaps = 38/221 (17%)
Query: 271 LIGQGASGIV----YKGTLRHGNLVAVKQILDLDTKGDEDFTNEVE-------IISKI-R 318
++G+G+ G V KGT L AVK IL K ++VE +++ +
Sbjct: 27 VLGKGSFGKVMLSERKGT---DELYAVK-ILK---KDVVIQDDDVECTMVEKRVLALPGK 79
Query: 319 HRNLLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVA 378
L L C T D R + V +Y+ G L +I + + P ++A
Sbjct: 80 PPFLTQLHSCFQTMD-----RLYFVMEYVNGGDLMYHI---QQVGRFKEPHAVFYAAEIA 131
Query: 379 KGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGY 438
G+ +L GI +RD+K N++LDSE + K+ADFG+ K+++ T GT Y
Sbjct: 132 IGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD-GVTTKTFCGTPDY 187
Query: 439 LAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPF 479
+APE Y + D ++FG+++ E+++G+ +PF
Sbjct: 188 IAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ-------APF 221
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 6e-17
Identities = 60/224 (26%), Positives = 104/224 (46%), Gaps = 37/224 (16%)
Query: 271 LIGQGASGIVY---KGTLRH-GNLVAVKQIL-DLDTKGDEDFT---NEVEIISKIRHRN- 321
++G GA G V+ K + G L A+K + + + E +++ IR
Sbjct: 61 VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 120
Query: 322 LLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISH--KRKQLTWPQRKKIIVDVAK 379
L++L T + L+ DY+ G L +H +R++ T + + + ++
Sbjct: 121 LVTLHYAFQTET-----KLHLILDYINGGEL-----FTHLSQRERFTEHEVQIYVGEIVL 170
Query: 380 GIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYL 439
+ +LH K GI +RDIK NILLDS + + DFGL+K+ + + GT Y+
Sbjct: 171 ALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYM 227
Query: 440 APE---YALYGQLTEKS-DVYSFGIVILELMSGRKVLDTSTSPF 479
AP+ G +K+ D +S G+++ EL++G SPF
Sbjct: 228 APDIVRGGDSGH--DKAVDWWSLGVLMYELLTGA-------SPF 262
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 9e-17
Identities = 63/220 (28%), Positives = 105/220 (47%), Gaps = 34/220 (15%)
Query: 271 LIGQGASGIVY----KGTLRHGNLVAVKQILDLDT---KGDEDFT-NEVEIISK-IRHRN 321
+IG+G+ G V K AVK +L K +E +E ++ K ++H
Sbjct: 45 VIGKGSFGKVLLARHKAE---EVFYAVK-VLQKKAILKKKEEKHIMSERNVLLKNVKHPF 100
Query: 322 LLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGI 381
L+ L T+D + + V DY+ G L ++ + + P+ + ++A +
Sbjct: 101 LVGLHFSFQTAD-----KLYFVLDYINGGELFYHL---QRERCFLEPRARFYAAEIASAL 152
Query: 382 AYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAP 441
YLH I +RD+K NILLDS+ + + DFGL K+++E H+ T+ GT YLAP
Sbjct: 153 GYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE-HNSTTSTFCGTPEYLAP 208
Query: 442 EYALYGQLTEKS-DVYSFGIVILELMSGRKVLDTSTSPFQ 480
E L+ Q +++ D + G V+ E++ G PF
Sbjct: 209 E-VLHKQPYDRTVDWWCLGAVLYEMLYGL-------PPFY 240
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 6e-16
Identities = 45/206 (21%), Positives = 93/206 (45%), Gaps = 23/206 (11%)
Query: 272 IGQGASGIVYKGT-LRHGNLVAVKQILDLDTKGDEDFTN-EVEIISKIR-HRNLLSLRGC 328
+G+G V++ + + V VK + + E++I+ +R N+++L
Sbjct: 44 LGRGKYSEVFEAINITNNEKVVVKIL----KPVKKKKIKREIKILENLRGGPNIITLA-- 97
Query: 329 CVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGL 388
+ D S + LV++++ N + LT + + ++ K + Y H
Sbjct: 98 DIVKDPVS-RTPALVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCH--- 147
Query: 389 KPGIYHRDIKSTNILLDSELNA-KVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALYG 447
GI HRD+K N+++D E ++ D+GLA+ G RVA + + PE +
Sbjct: 148 SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE-YNVRVA-SRYFKGPELLVDY 205
Query: 448 QLTEKS-DVYSFGIVILELMSGRKVL 472
Q+ + S D++S G ++ ++ ++
Sbjct: 206 QMYDYSLDMWSLGCMLASMIFRKEPF 231
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 78.4 bits (193), Expect = 7e-16
Identities = 54/268 (20%), Positives = 87/268 (32%), Gaps = 79/268 (29%)
Query: 272 IGQGASGIVYKGTLRH------GNLVAVKQILDLDTKGD-EDFTNEVE------------ 312
+G+GA G V + VAVK + + T + +E++
Sbjct: 30 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 89
Query: 313 ---------------IISKIRHRNLLS-LRGCCVT------------------------- 331
I+ + NL + LR
Sbjct: 90 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDL 149
Query: 332 ---SDDSSGKRRFLVYDYMPNGTLSDNISISH----KRKQLTWPQRKKIIVDVAKGIAYL 384
D + + ++ +LSD + LT VAKG+ +L
Sbjct: 150 KRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFL 209
Query: 385 HYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYL----- 439
HRD+ + NILL + K+ DFGLA+ + + V L
Sbjct: 210 A---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY----VRKGDARLPLKWM 262
Query: 440 APEYALYGQLTEKSDVYSFGIVILELMS 467
APE T +SDV+SFG+++ E+ S
Sbjct: 263 APETIFDRVYTIQSDVWSFGVLLWEIFS 290
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 2e-14
Identities = 78/281 (27%), Positives = 128/281 (45%), Gaps = 64/281 (22%)
Query: 272 IGQGASGIVYKGT-LRHGNLVAVKQILDLDTKGDEDFTN---------EVEIISKIR-HR 320
+G+GA GIV+K R G +VAVK+I D F N E+ I++++ H
Sbjct: 17 LGKGAYGIVWKSIDRRTGEVVAVKKIFDA-------FQNSTDAQRTFREIMILTELSGHE 69
Query: 321 NLLSLRGCCVTSDDSSGKRRFLVYDYMPNGT-LSDNISISHKRKQLTWPQRKKIIVDVAK 379
N+++L +D + +LV+DYM T L I + L ++ ++ + K
Sbjct: 70 NIVNLLNVLRADND---RDVYLVFDYM--ETDLHAVI----RANILEPVHKQYVVYQLIK 120
Query: 380 GIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLA--------------------- 418
I YLH G G+ HRD+K +NILL++E + KVADFGL+
Sbjct: 121 VIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENT 177
Query: 419 KQSLEGHSHLTTRVAGTFGYLAPEYAL-YGQLTEKSDVYSFGIVILELMSGRKVLDTSTS 477
+ + LT VA T Y APE L + T+ D++S G ++ E++ K + +S
Sbjct: 178 ENFDDDQPILTDYVA-TRWYRAPEILLGSTKYTKGIDMWSLGCILGEIL-CGKPIFPGSS 235
Query: 478 PF---QLITDWAWVLAKSGKVDDIFDEFIRAEGARAVMERF 515
+ I V+ + E I++ A+ ++E
Sbjct: 236 TMNQLERIIG---VI---DFPSNEDVESIQSPFAKTMIESL 270
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 71.8 bits (175), Expect = 1e-13
Identities = 35/213 (16%), Positives = 58/213 (27%), Gaps = 49/213 (23%)
Query: 262 ATNGFSQNNLIGQGASGIVYKGTLRHGNLVAVKQIL--DLDTKGDEDFTNEVEIISKI-- 317
T + IG+G G V++ H VA+K I D EI+ +I
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTIADHTP-VAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 318 -------------RHRNLLSLRGCCV-------------------------TSDDSSGKR 339
R + L D +
Sbjct: 77 SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136
Query: 340 RFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKS 399
F+V ++ G + + + K + K I+ + +A HRD+
Sbjct: 137 LFIVLEFEFGGIDLEQM----RTKLSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHW 190
Query: 400 TNILLDSELNAKVADFGLAKQSLEGHSHLTTRV 432
N+LL K+ K S L +
Sbjct: 191 GNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSI 223
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 64.2 bits (156), Expect = 3e-11
Identities = 53/261 (20%), Positives = 88/261 (33%), Gaps = 68/261 (26%)
Query: 272 IGQGASGIVYKG-TLRHGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSL-RGCC 329
+G G V+ ++ VA+K ++ E +E+ ++ +R+ + R
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMK-VVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMV 103
Query: 330 VTSDDS------SGKRRFLVYDYMPNG-TLSDNISISHKRKQLTWPQRKKIIVDVAKGIA 382
V D +G +V++ + G L I S+ + L P KKII V +G+
Sbjct: 104 VQLLDDFKISGVNGTHICMVFEVL--GHHLLKWIIKSNYQG-LPLPCVKKIIQQVLQGLD 160
Query: 383 YLHYGLKPGIYHRDIKSTNILLDSE----------------------------------- 407
YLH K I H DIK NILL
Sbjct: 161 YLHT--KCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAG 218
Query: 408 --------------LNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKS 453
L K+AD G A + + T Y + E + +
Sbjct: 219 NFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQ----TRQYRSLEVLIGSGYNTPA 274
Query: 454 DVYSFGIVILELMSGRKVLDT 474
D++S + EL +G + +
Sbjct: 275 DIWSTACMAFELATGDYLFEP 295
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 62.1 bits (151), Expect = 2e-10
Identities = 54/258 (20%), Positives = 100/258 (38%), Gaps = 53/258 (20%)
Query: 271 LIGQGASGIVYKGT-LRHGNLVAVKQILDLDTKGDEDFTN----EVEIISKIRHRNLLSL 325
+IG+G+ G V K + VA+K + + ++ F E+ I+ +R ++ +
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMV-----RNEKRFHRQAAEEIRILEHLRKQDKDN- 157
Query: 326 RGCCVTSDDSSGKRRFL----------VYDYMPNGTLSDNISISHKRKQLTWPQRKKIIV 375
+ ++ R + +Y+ + K + + P +K
Sbjct: 158 TMNVIHMLENFTFRNHICMTFELLSMNLYELIKKN----------KFQGFSLPLVRKFAH 207
Query: 376 DVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNA--KVADFGLAKQSLEGHSHLT---T 430
+ + + LH K I H D+K NILL + + KV DFG + E T +
Sbjct: 208 SILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSS--CYEHQRVYTYIQS 262
Query: 431 RVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQL--ITDW--- 485
R F Y APE L + D++S G ++ EL++G +L QL + +
Sbjct: 263 R----F-YRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGM 317
Query: 486 --AWVLAKSGKVDDIFDE 501
+L S + +
Sbjct: 318 PSQKLLDASKRAKNFVSS 335
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 2e-10
Identities = 47/233 (20%), Positives = 95/233 (40%), Gaps = 42/233 (18%)
Query: 271 LIGQGASGIVYKGT-LRHGNLVAVKQILDLDTKGDEDFTN----EVEIISKIRH----RN 321
+G G V+ + + VA+K + +GD+ +T E++++ ++ +
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIV-----RGDKVYTEAAEDEIKLLQRVNDADNTKE 80
Query: 322 LLSLRGCCVTSDDS------SGKRRFLVYDYMPNGTLSDNISISHKR---KQLTWPQRKK 372
+ D +G +V++ L +N+ K+ + + K+
Sbjct: 81 DSMGANHILKLLDHFNHKGPNGVHVVMVFE-----VLGENLLALIKKYEHRGIPLIYVKQ 135
Query: 373 IIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSE------LNAKVADFGLAKQSLEGHS 426
I + G+ Y+H + GI H DIK N+L++ + K+AD G A E ++
Sbjct: 136 ISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYT 193
Query: 427 -HLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSP 478
+ TR Y +PE L +D++S +I EL++G + +
Sbjct: 194 NSIQTRE-----YRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGH 241
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 61.7 bits (150), Expect = 2e-10
Identities = 54/266 (20%), Positives = 103/266 (38%), Gaps = 45/266 (16%)
Query: 260 EQATNGFSQNNLIGQGASGIVYKGT-LRHGNLVAVKQILDLDTKGDEDFTN----EVEII 314
E+ + + ++LIG+G+ G V K VA+K I K + F N EV ++
Sbjct: 50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKII-----KNKKAFLNQAQIEVRLL 104
Query: 315 SKIRHRNLLSLRGCCVTSDDSSGKRRFL----------VYDYMPNGTLSDNISISHKRKQ 364
+ + ++ V R L +YD + N +
Sbjct: 105 ELMNKHDT-EMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRN----------TNFRG 153
Query: 365 LTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNA--KVADFGLAKQSL 422
++ +K + + +L + I H D+K NILL + + K+ DFG + Q
Sbjct: 154 VSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL- 211
Query: 423 EGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQL- 481
+ + F Y +PE L D++S G +++E+ +G + + Q+
Sbjct: 212 --GQRIYQYIQSRF-YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMN 268
Query: 482 -ITDW-----AWVLAKSGKVDDIFDE 501
I + A +L ++ K F++
Sbjct: 269 KIVEVLGIPPAHILDQAPKARKFFEK 294
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 58.7 bits (141), Expect = 4e-09
Identities = 66/464 (14%), Positives = 130/464 (28%), Gaps = 149/464 (32%)
Query: 165 ILNDPKDEAAVACILRLPISSSKTKNSSSNNRTIKLVIGLLGALLGFLLASGLIILYRKW 224
I+ + LRL + +K + V +L FL++
Sbjct: 54 IIMSKDAVSGT---LRL-FWTLLSKQEEMVQK---FVEEVLRINYKFLMS--------PI 98
Query: 225 NKKRKQIAL-HEQFVSNLQASVLPNSGAKW--FHVSELEQATNGFSQNNLIGQGASGIVY 281
+++Q ++ ++ Q L N + ++VS L+ + L+
Sbjct: 99 KTEQRQPSMMTRMYIE--QRDRLYNDNQVFAKYNVSRLQPYLK--LRQALLE-------- 146
Query: 282 KGTLRHGNLVAV-------KQILDLDTKGDED----FTNEVEIISKIRHRN-----LLSL 325
LR V + K + LD ++ ++ +++ N L L
Sbjct: 147 ---LRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLN-LKNCNSPETVLEML 202
Query: 326 RGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKK--IIVDVAKGIAY 383
+ D + R D+ N L + + R+ L + +++
Sbjct: 203 QKLLYQIDPNWTSRS----DHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLL------- 251
Query: 384 LHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEY 443
++++ NA F L+ + L LTTR +L+
Sbjct: 252 ------------NVQNAKAW-----NA----FNLSCKIL-----LTTRFKQVTDFLSAAT 285
Query: 444 ALYGQLTEKSDVYSFGIVILELMSGRKVLDTS----------TSPFQL------ITDWA- 486
+ L S + V L+ K LD T+P +L I D
Sbjct: 286 TTHISLDHHSMTLTPDEV-KSLLL--KYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLA 342
Query: 487 ----WVLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEG 542
W K+ I + + + F D L +
Sbjct: 343 TWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMF-------------------DRLSVFPP 383
Query: 543 DIDIP----------KLPDRPLPLSHECLRSS-------PSRYS 569
IP + + + ++ + S S S
Sbjct: 384 SAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTIS 427
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 53.3 bits (127), Expect = 2e-07
Identities = 72/544 (13%), Positives = 146/544 (26%), Gaps = 165/544 (30%)
Query: 23 LDPNGKFCCATLLSLIGMG------LAAH-LRETSL---FQFP-------NETASAFCLS 65
L P + + G+ +A + F N + L
Sbjct: 147 LRPAKN------VLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLE 200
Query: 66 ELQGRLATLSINPSVVPTCFPNATQ-----------FASNTSFCAGIVTIED-W-KKLVG 112
LQ L + N + N + + ++ + + K
Sbjct: 201 MLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAW- 259
Query: 113 PTSALDPACK------NFSGFSQCSSCVEAGYSVNAKLLSIQPNSTKCFYFAVLYATGIL 166
+A + +CK S+ S++ +++ P+ K L +
Sbjct: 260 --NAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVK-----SLLLKYLD 312
Query: 167 NDPKDEAAVACILRLPISSSKTKNSSSNNRTIKLVIGLLGALLGFLLASGLIIL--YRKW 224
P+D T + ++ + GL ++
Sbjct: 313 CRPQDLPREVL------------------TTNPRRLSIIAE----SIRDGLATWDNWKHV 350
Query: 225 NKKRKQIALHEQFVSNLQA----------SVLPNSGAK---------WFHVS--ELEQAT 263
N + + E ++ L+ SV P S A WF V ++
Sbjct: 351 NCDKLTTII-ESSLNVLEPAEYRKMFDRLSVFPPS-AHIPTILLSLIWFDVIKSDVMVVV 408
Query: 264 NGFSQNNLIGQGASGIVYKGTLRHGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLL 323
N + +L+ + ++ + L+ K + NE + HR+++
Sbjct: 409 NKLHKYSLVEKQPKESTI--SI-PS--------IYLELKVKLE--NEYAL-----HRSIV 450
Query: 324 SLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAY 383
D + + F D +P D SH I +
Sbjct: 451 ---------DHYNIPKTFDSDDLIPP--YLDQYFYSH--------------------IGH 479
Query: 384 LHYGLKP-GIYHRDIKSTNILLDSE-LNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAP 441
H LK R + LD L K+ A + + ++ Y+
Sbjct: 480 -H--LKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICD 536
Query: 442 EYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDE 501
Y +L + + F L + + T + +A + + IF+E
Sbjct: 537 NDPKYERLV--NAILDF----LPKIEENLICSKYTDLLR--------IALMAEDEAIFEE 582
Query: 502 FIRA 505
+
Sbjct: 583 AHKQ 586
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 50.6 bits (120), Expect = 1e-06
Identities = 54/369 (14%), Positives = 105/369 (28%), Gaps = 85/369 (23%)
Query: 281 YKGTLRHGNLVAVKQILDLDTKGDEDFTN------EVEIISKIRHRNLLSLRGC-CVTSD 333
YK L A + D K +D E++ I + +LR + S
Sbjct: 18 YKDILSV-FEDAFVD--NFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLSK 74
Query: 334 DSSGKRRF----LVYDYMPNGTLSDNISISHKRKQLTWP----QRKKIIVDVAKGIAY-- 383
++F L +Y L I ++ + QR ++ D Y
Sbjct: 75 QEEMVQKFVEEVLRINY---KFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNV 131
Query: 384 ----LHYGLKPGIYHRDIKSTNILLDSELNAKVADFG---LAKQSLEGHSHLTTRVAG-- 434
+ L+ + + N+L+D V G +A +
Sbjct: 132 SRLQPYLKLRQALL-ELRPAKNVLIDG-----VLGSGKTWVALDVCLSYKVQCKMDFKIF 185
Query: 435 --TFGY-------LAPEYALYGQLTEKSDVYSFGI--VILELMSGRKVLDT--STSPFQ- 480
L L Q+ S + L + S + L + P++
Sbjct: 186 WLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYEN 245
Query: 481 --LITD--W-AWVLAKSGKVDDIFDEFIRAE-----GARAVMERFVLVGILCAHV-MVAL 529
L+ A + F+ + + + V + L H+ +
Sbjct: 246 CLLVLLNVQNAKAW-------NAFN--LSCKILLTTRFKQVTD--FLSAATTTHISLDHH 294
Query: 530 RPTIT--DALKMLEG--DIDIPKLPDR-----PLPLS--HECLRSSPSRYSFSTSTDRSA 578
T+T + +L D LP P LS E +R + + +
Sbjct: 295 SMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDK 354
Query: 579 TSSSMTSTI 587
++ + S++
Sbjct: 355 LTTIIESSL 363
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 6e-06
Identities = 29/182 (15%), Positives = 60/182 (32%), Gaps = 40/182 (21%)
Query: 272 IGQGASGIVYKGT---------LRHGNLVAVK----------QILDLDTKGDEDFTNEVE 312
+ GI+Y+ ++K + N+ +
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109
Query: 313 IISKIRHRNLLSLRGCCVTSDDSSGKRRFLVYDYM-PNGTLSDNISISHKRKQLTWPQRK 371
+ + + G V K RFLV + + L + +S + L+ +
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQ----DKYRFLVLPSLGRS--LQSALDVSP-KHVLS----E 158
Query: 372 KIIVDVAK----GIAYLHYGLKPGIYHRDIKSTNILLDSELNAKV--ADFGLAKQSLEGH 425
+ ++ VA + +LH H ++ + NI +D E ++V A +G A +
Sbjct: 159 RSVLQVACRLLDALEFLHE---NEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSG 215
Query: 426 SH 427
H
Sbjct: 216 KH 217
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 47.5 bits (113), Expect = 7e-06
Identities = 41/233 (17%), Positives = 79/233 (33%), Gaps = 50/233 (21%)
Query: 271 LIGQGASGIVYKGTLRHGNLVAVKQ--ILDLDTKGDEDFTNEVEI---------ISKIRH 319
IGQG G +Y + V ++ ++ + E++ I K
Sbjct: 42 PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101
Query: 320 RNLLSLRG-----CCVTSDDSSGKRRFLVYDYM-PNGTLSDNISISHKRKQLTWPQRKKI 373
L G D + RF++ D + L + KR K
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSD--LQKIYEANAKRFSR------KT 153
Query: 374 IVDVA----KGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKV--ADFGLAKQ--SLEGH 425
++ ++ + Y+H + H DIK++N+LL+ + +V D+GLA + H
Sbjct: 154 VLQLSLRILDILEYIH---EHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVH 210
Query: 426 SHLTTR----VAGTFGYLAPEYA-----LYGQLTEKSDVYSFGIVILELMSGR 469
GT E+ + + D+ G +++ ++G
Sbjct: 211 KAYAADPKRCHDGT-----IEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGH 258
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 9e-06
Identities = 42/217 (19%), Positives = 79/217 (36%), Gaps = 38/217 (17%)
Query: 272 IGQGASGIVYKGT-LRHGNLVAVKQILDLDTKGDEDFTNEVEIISKIRH-RNLLSLRGCC 329
IG G G + G L VA+K + + ++ E ++ + +
Sbjct: 17 IGCGNFGELRLGKNLYTNEYVAIK-LEPMKSRAP-QLHLEYRFYKQLGSGDGIPQVYYFG 74
Query: 330 VTSDDSSGKRRFLVYDYM-PNGTLSDNISISHKRKQLTWPQRKKIIVDVAK----GIAYL 384
GK +V + + P+ L D + + L K ++ +A + Y+
Sbjct: 75 PC-----GKYNAMVLELLGPS--LEDLFDLCDRTFSL------KTVLMIAIQLISRMEYV 121
Query: 385 HYGLKPGIYHRDIKSTNILLDSELNAK-----VADFGLAKQ--SLEGHSHLTTR----VA 433
H + +RD+K N L+ N + DF LAK+ E H+ R +
Sbjct: 122 HS---KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLT 178
Query: 434 GTFGYLAPEYALYG-QLTEKSDVYSFGIVILELMSGR 469
GT Y G + + + D+ + G + + + G
Sbjct: 179 GTARY-MSINTHLGKEQSRRDDLEALGHMFMYFLRGS 214
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 1e-05
Identities = 46/249 (18%), Positives = 86/249 (34%), Gaps = 64/249 (25%)
Query: 271 LIGQGASGIVYKG--TLRHGNLVAVKQILDLDTKGDEDFTN----EVEIISKIRHRNLLS 324
+G+G G V + R + VA+K I + + E+ ++ KI+ ++ +
Sbjct: 26 NLGEGTFGKVVECLDHARGKSQVALKII-----RNVGKYREAARLEINVLKKIKEKDKEN 80
Query: 325 LRGCCVTSDDSSGKRRFL----------VYDYMPNGTLSDNISISHKRKQLTWPQRKKII 374
+ CV D + ++++ + + P + +
Sbjct: 81 -KFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKE----------NNFQPYPLPHVRHMA 129
Query: 375 VDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNA-------------------KVADF 415
+ + +LH + + H D+K NIL + +VADF
Sbjct: 130 YQLCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADF 186
Query: 416 GLAKQSLEGHSHLT---TRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVL 472
G A + + H T TR Y PE L + DV+S G ++ E G +
Sbjct: 187 GSA--TFDHEHHTTIVATRH-----YRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLF 239
Query: 473 DTSTSPFQL 481
T + L
Sbjct: 240 QTHENREHL 248
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 1e-05
Identities = 45/228 (19%), Positives = 82/228 (35%), Gaps = 43/228 (18%)
Query: 271 LIGQGASGIVYKGT-LRHGNLVAVKQILDLDTKGDEDFTNEVEI---------ISKIRHR 320
IG G G++Y A ++ ++ + + +E++ I K R
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARH-VVKVEYQENGPLFSELKFYQRVAKKDCIKKWIER 102
Query: 321 NLLSLRG-----CCVTSDDSSGKRRFLVYDYM-PNGTLSDNISISHKRKQLTWPQRKKII 374
L G ++ RF+V + + + L IS + K +
Sbjct: 103 KQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGID--LQK---ISGQNGTFK----KSTV 153
Query: 375 VDVA----KGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKV--ADFGLAKQ--SLEGHS 426
+ + + Y+H + H DIK+ N+LL + +V AD+GL+ + H
Sbjct: 154 LQLGIRMLDVLEYIH---ENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHK 210
Query: 427 HLTTRVA----GTFGYLAPEYALYG-QLTEKSDVYSFGIVILELMSGR 469
GT + A G L+ +SDV G +L + G+
Sbjct: 211 QYQENPRKGHNGTIEF-TSLDAHKGVALSRRSDVEILGYCMLRWLCGK 257
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 2e-05
Identities = 51/215 (23%), Positives = 85/215 (39%), Gaps = 36/215 (16%)
Query: 272 IGQGASGIVYKGT-LRHGNLVAVKQILDLDTKGDEDFTNEVEIISKIRH-RNLLSLRGCC 329
IG G+ G +Y GT + G VA+K + E +I ++ + ++R C
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKL--ECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCG 74
Query: 330 VTSDDSSGKRRFLVYDYM-PNGTLSDNISISHKRKQLTWPQRKKIIVDVA----KGIAYL 384
G +V + + P+ L D + ++ L K ++ +A I Y+
Sbjct: 75 AE-----GDYNVMVMELLGPS--LEDLFNFCSRKFSL------KTVLLLADQMISRIEYI 121
Query: 385 HYGLKPGIYHRDIKSTNILLDSELNAK---VADFGLAKQ--SLEGHSHLTTR----VAGT 435
H HRD+K N L+ + DFGLAK+ H H+ R + GT
Sbjct: 122 HS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGT 178
Query: 436 FGYLAPEYALYG-QLTEKSDVYSFGIVILELMSGR 469
Y A G + + + D+ S G V++ G
Sbjct: 179 ARY-ASINTHLGIEQSRRDDLESLGYVLMYFNLGS 212
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 3e-05
Identities = 54/261 (20%), Positives = 89/261 (34%), Gaps = 84/261 (32%)
Query: 271 LIGQGASGIVYKGT-LRHGNLVAVKQILDLDTKGDEDFTN----EVEIISKIRHR----- 320
+G G G V + + AVK + + + +T E +I+ KI++
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVKVV-----RNIKKYTRSAKIEADILKKIQNDDINNN 96
Query: 321 NLLSLRGC-------CVTSD--DSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRK 371
N++ G C+ + S +Y+ + + K
Sbjct: 97 NIVKYHGKFMYYDHMCLIFEPLGPS------LYEIITR----------NNYNGFHIEDIK 140
Query: 372 KIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNA--------------------- 410
+++ K + YL K + H D+K NILLD
Sbjct: 141 LYCIEILKALNYLR---KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTK 197
Query: 411 ----KVADFGLAKQSLEGHSHLT---TRVAGTFGYLAPEYAL---YGQLTEKSDVYSFGI 460
K+ DFG A + + H + TR Y APE L + SD++SFG
Sbjct: 198 STGIKLIDFGCA--TFKSDYHGSIINTR----Q-YRAPEVILNLGWDV---SSDMWSFGC 247
Query: 461 VILELMSGRKVLDTSTSPFQL 481
V+ EL +G + T L
Sbjct: 248 VLAELYTGSLLFRTHEHMEHL 268
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 4e-05
Identities = 51/254 (20%), Positives = 84/254 (33%), Gaps = 74/254 (29%)
Query: 271 LIGQGASGIVYKG--TLRHGNLVAVKQILDLDTKGDEDFTN----EVEIISKIRHR---- 320
+G+GA G V + G VAVK + K + + E++++ +
Sbjct: 21 TLGEGAFGKVVECIDHKAGGRHVAVKIV-----KNVDRYCEAARSEIQVLEHLNTTDPNS 75
Query: 321 --NLLSLRGC-------CVTSD--DSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQ 369
+ + C+ + S YD++ +
Sbjct: 76 TFRCVQMLEWFEHHGHICIVFELLGLS------TYDFIKE----------NGFLPFRLDH 119
Query: 370 RKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNA------------------- 410
+K+ + K + +LH + H D+K NIL
Sbjct: 120 IRKMAYQICKSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDI 176
Query: 411 KVADFGLAKQSLEGHSHLT---TRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS 467
KV DFG A + + H T TR Y APE L ++ DV+S G +++E
Sbjct: 177 KVVDFGSA--TYDDEHHSTLVSTRH-----YRAPEVILALGWSQPCDVWSIGCILIEYYL 229
Query: 468 GRKVLDTSTSPFQL 481
G V T S L
Sbjct: 230 GFTVFPTHDSKEHL 243
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 7e-05
Identities = 43/217 (19%), Positives = 82/217 (37%), Gaps = 38/217 (17%)
Query: 272 IGQGASGIVYKGT-LRHGNLVAVKQILDLDTKGDEDFTNEVEIISKIRH-RNLLSLRGCC 329
IG+G+ G++++GT L + VA+K + +E + + ++
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKF--EPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFG 75
Query: 330 VTSDDSSGKRRFLVYDYM-PNGTLSDNISISHKRKQLTWPQRKKIIVDVAK----GIAYL 384
G LV D + P+ L D + + ++ + K + AK + +
Sbjct: 76 QE-----GLHNVLVIDLLGPS--LEDLLDLCGRKFSV------KTVAMAAKQMLARVQSI 122
Query: 385 HYGLKPGIYHRDIKSTNILLDSELNAK-----VADFGLAKQ--SLEGHSHLTTR----VA 433
H + +RDIK N L+ + V DFG+ K H+ R ++
Sbjct: 123 HE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLS 179
Query: 434 GTFGYLAPEYALYG-QLTEKSDVYSFGIVILELMSGR 469
GT Y G + + + D+ + G V + + G
Sbjct: 180 GTARY-MSINTHLGREQSRRDDLEALGHVFMYFLRGS 215
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 43.8 bits (103), Expect = 1e-04
Identities = 51/215 (23%), Positives = 86/215 (40%), Gaps = 36/215 (16%)
Query: 272 IGQGASGIVYKGT-LRHGNLVAVKQILDLDTKGDEDFTNEVEIISKIR-HRNLLSLRGCC 329
IG G+ G +Y GT ++ VA+K + E +I ++ + ++R
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKL--ENVKTKHPQLLYESKIYRILQGGTGIPNVRWFG 72
Query: 330 VTSDDSSGKRRFLVYDYM-PNGTLSDNISISHKRKQLTWPQRKKIIVDVAK----GIAYL 384
G LV D + P+ L D + ++ L K ++ +A + ++
Sbjct: 73 -----VEGDYNVLVMDLLGPS--LEDLFNFCSRKLSL------KTVLMLADQMINRVEFV 119
Query: 385 HYGLKPGIYHRDIKSTNILLDSELNAK---VADFGLAKQ--SLEGHSHLTTR----VAGT 435
H HRDIK N L+ A + DFGLAK+ H H+ R + GT
Sbjct: 120 HS---KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGT 176
Query: 436 FGYLAPEYALYG-QLTEKSDVYSFGIVILELMSGR 469
Y A G + + + D+ S G V++ + G
Sbjct: 177 ARY-ASVNTHLGIEQSRRDDLESLGYVLMYFLRGS 210
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 590 | |||
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.95 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.93 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.89 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.78 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.66 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.3 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.19 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.04 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.03 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.66 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.58 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.38 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.22 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.21 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.2 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.05 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.03 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.94 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.53 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.46 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.39 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.14 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.13 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.1 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.83 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.82 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.81 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.63 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.42 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.68 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 94.87 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.41 | |
| 3a2e_A | 108 | Ginkbilobin-2; domain 26 unknown function (DUF26), | 93.08 | |
| 2e79_A | 108 | Ginkbilobin-2; DUF26 fold, C-X8-C-X2-C motif, lect | 92.82 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 91.42 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 88.71 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 87.81 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 87.41 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 82.13 |
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-55 Score=455.40 Aligned_cols=260 Identities=25% Similarity=0.405 Sum_probs=203.8
Q ss_pred cCCCccceecccCcEEEEEEEEc------CCcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCC
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLR------HGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSG 337 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~------~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~ 337 (590)
++|...++||+|+||.||+|++. ++..||||++........++|.+|+++|++++|||||+++|+|.+ +
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~-----~ 115 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTE-----G 115 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-----S
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-----C
Confidence 35667789999999999999875 367899999977665566789999999999999999999999974 4
Q ss_pred ceEEEEEeeCCCCCcchhhhhhc------------ccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEC
Q 046270 338 KRRFLVYDYMPNGTLSDNISISH------------KRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLD 405 (590)
Q Consensus 338 ~~~~LV~E~~~~gsL~~~L~~~~------------~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd 405 (590)
...+||||||++|+|.++|.... ....++|.++++|+.|||+||+||| +.+||||||||+||||+
T Consensus 116 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLKp~NILl~ 192 (329)
T 4aoj_A 116 RPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA---GLHFVHRDLATRNCLVG 192 (329)
T ss_dssp SSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEE
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHhhEEEC
Confidence 45899999999999999986432 1246999999999999999999999 89999999999999999
Q ss_pred CCCcEEEEeeCCcccccCCCc-ccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhh
Q 046270 406 SELNAKVADFGLAKQSLEGHS-HLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLDTSTSPFQLIT 483 (590)
Q Consensus 406 ~~~~~kL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELlt-G~~p~~~~~~~~~~l~ 483 (590)
+++.+||+|||+++....... ...+...||+.|||||++.+..++.++|||||||+||||+| |+.||...... ..+
T Consensus 193 ~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~-~~~- 270 (329)
T 4aoj_A 193 QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT-EAI- 270 (329)
T ss_dssp TTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHH-HHH-
T ss_pred CCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHH-HHH-
Confidence 999999999999987644332 23455779999999999999999999999999999999999 89999754321 111
Q ss_pred HHHHHHHhcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhccCCCC
Q 046270 484 DWAWVLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEGDIDI 546 (590)
Q Consensus 484 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~~~~~ 546 (590)
. ....+...+ .+......+.+++..||+.||++||||.||+++|+.....
T Consensus 271 ---~-~i~~g~~~~---------~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 271 ---D-CITQGRELE---------RPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp ---H-HHHHTCCCC---------CCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred ---H-HHHcCCCCC---------CcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 1 112222111 1112334678899999999999999999999999876443
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-54 Score=448.75 Aligned_cols=255 Identities=23% Similarity=0.392 Sum_probs=206.6
Q ss_pred CCccceecccCcEEEEEEEEc------CCcEEEEEEeecCCC-CChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCc
Q 046270 266 FSQNNLIGQGASGIVYKGTLR------HGNLVAVKQILDLDT-KGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGK 338 (590)
Q Consensus 266 f~~~~~LG~G~fG~Vykg~~~------~g~~vAvK~l~~~~~-~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~ 338 (590)
+...+.||+|+||+||+|++. +++.||||++..... ...++|.+|+.++++++|||||+++|+|.. ..
T Consensus 28 ~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-----~~ 102 (308)
T 4gt4_A 28 VRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTK-----DQ 102 (308)
T ss_dssp EEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-----SS
T ss_pred CeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEE-----CC
Confidence 345678999999999999973 367899999965433 345789999999999999999999999974 34
Q ss_pred eEEEEEeeCCCCCcchhhhhhc-------------ccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEC
Q 046270 339 RRFLVYDYMPNGTLSDNISISH-------------KRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLD 405 (590)
Q Consensus 339 ~~~LV~E~~~~gsL~~~L~~~~-------------~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd 405 (590)
..+||||||++|+|.++|.... ....++|.++++|+.|||+||+||| +.+||||||||+||||+
T Consensus 103 ~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLK~~NILl~ 179 (308)
T 4gt4_A 103 PLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLS---SHHVVHKDLATRNVLVY 179 (308)
T ss_dssp SCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEC
T ss_pred EEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCccccceEEC
Confidence 5899999999999999996432 1346999999999999999999999 88999999999999999
Q ss_pred CCCcEEEEeeCCcccccCCCc-ccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhh
Q 046270 406 SELNAKVADFGLAKQSLEGHS-HLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLDTSTSPFQLIT 483 (590)
Q Consensus 406 ~~~~~kL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELlt-G~~p~~~~~~~~~~l~ 483 (590)
+++++||+|||+++....... ...+...||+.|||||++.++.++.++|||||||+||||+| |+.||...... .+.
T Consensus 180 ~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~--~~~ 257 (308)
T 4gt4_A 180 DKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ--DVV 257 (308)
T ss_dssp GGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHH--HHH
T ss_pred CCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHH--HHH
Confidence 999999999999987644332 23455789999999999999999999999999999999999 89998754321 111
Q ss_pred HHHHHHHhcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhccC
Q 046270 484 DWAWVLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEGD 543 (590)
Q Consensus 484 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~~ 543 (590)
. ....+..... +.+.+..+.+++..||+.||++||||.||+++|+..
T Consensus 258 ---~-~i~~~~~~~~---------p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 258 ---E-MIRNRQVLPC---------PDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp ---H-HHHTTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred ---H-HHHcCCCCCC---------cccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 1 1222322211 122345678899999999999999999999999864
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-55 Score=448.74 Aligned_cols=257 Identities=25% Similarity=0.440 Sum_probs=208.7
Q ss_pred cCCCccceecccCcEEEEEEEEc------CCcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCC
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLR------HGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSG 337 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~------~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~ 337 (590)
++|...+.||+|+||+||+|++. ++..||||++........++|.+|+++|++++|||||+++|+|.+ +
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~-----~ 87 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVE-----G 87 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-----S
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEee-----C
Confidence 45677889999999999999874 367899999987665566789999999999999999999999984 3
Q ss_pred ceEEEEEeeCCCCCcchhhhhhc----------ccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCC
Q 046270 338 KRRFLVYDYMPNGTLSDNISISH----------KRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSE 407 (590)
Q Consensus 338 ~~~~LV~E~~~~gsL~~~L~~~~----------~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~ 407 (590)
...+||||||++|+|.++|.... ....++|.++++|+.|||+||+||| +++|+||||||+||||+++
T Consensus 88 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDlKp~NILl~~~ 164 (299)
T 4asz_A 88 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGEN 164 (299)
T ss_dssp SSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGG
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccCHhhEEECCC
Confidence 45899999999999999996432 2346999999999999999999999 8999999999999999999
Q ss_pred CcEEEEeeCCcccccCCCcc-cccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhhHH
Q 046270 408 LNAKVADFGLAKQSLEGHSH-LTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLDTSTSPFQLITDW 485 (590)
Q Consensus 408 ~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELlt-G~~p~~~~~~~~~~l~~~ 485 (590)
+++||+|||+++........ ......||+.|||||++.++.++.++|||||||+||||+| |+.||...... ..+
T Consensus 165 ~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~-~~~--- 240 (299)
T 4asz_A 165 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN-EVI--- 240 (299)
T ss_dssp GCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH-HHH---
T ss_pred CcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH-HHH---
Confidence 99999999999866443322 2344678999999999999999999999999999999999 89999754321 111
Q ss_pred HHHHHhcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhccC
Q 046270 486 AWVLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEGD 543 (590)
Q Consensus 486 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~~ 543 (590)
.. ...+...+ .+....+.+.+++..||+.||++||||+||+++|+..
T Consensus 241 -~~-i~~~~~~~---------~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~ 287 (299)
T 4asz_A 241 -EC-ITQGRVLQ---------RPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNL 287 (299)
T ss_dssp -HH-HHHTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -HH-HHcCCCCC---------CCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 11 12222111 1122335778899999999999999999999999864
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-53 Score=438.54 Aligned_cols=258 Identities=28% Similarity=0.394 Sum_probs=200.0
Q ss_pred hcCCCccceecccCcEEEEEEEEcCCcEEEEEEeecCCC--CChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceE
Q 046270 263 TNGFSQNNLIGQGASGIVYKGTLRHGNLVAVKQILDLDT--KGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRR 340 (590)
Q Consensus 263 t~~f~~~~~LG~G~fG~Vykg~~~~g~~vAvK~l~~~~~--~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~ 340 (590)
.++|...++||+|+||+||+|++++ .||||+++.... +..++|.+|++++++++|||||+++|+|.. ...
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~------~~~ 106 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK------DNL 106 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS------SSC
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC------CeE
Confidence 3567778899999999999999763 599999864332 234679999999999999999999999852 237
Q ss_pred EEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCccc
Q 046270 341 FLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQ 420 (590)
Q Consensus 341 ~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~ 420 (590)
+||||||++|+|.++|.. ....++|.+++.|+.|||+||+||| +.+||||||||+||||++++++||+|||+|+.
T Consensus 107 ~iVmEy~~gGsL~~~l~~--~~~~l~~~~~~~i~~qia~gL~yLH---~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~ 181 (307)
T 3omv_A 107 AIVTQWCEGSSLYKHLHV--QETKFQMFQLIDIARQTAQGMDYLH---AKNIIHRDMKSNNIFLHEGLTVKIGDFGLATV 181 (307)
T ss_dssp EEEEECCSSCBHHHHHHT--SCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCSSSEEEETTEEEEECCCSSCBC
T ss_pred EEEEEcCCCCCHHHHHhh--cCCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCccCHHHEEECCCCcEEEeeccCcee
Confidence 999999999999999963 3456999999999999999999999 88999999999999999999999999999987
Q ss_pred ccCCC-cccccccccCCCccCccccc---cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCch
Q 046270 421 SLEGH-SHLTTRVAGTFGYLAPEYAL---YGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVD 496 (590)
Q Consensus 421 ~~~~~-~~~~~~~~gt~~Y~APE~~~---~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 496 (590)
..... ........||+.|||||++. .+.|+.++|||||||+||||+||+.||........ + ......+...
T Consensus 182 ~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~-~----~~~~~~~~~~ 256 (307)
T 3omv_A 182 KSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQ-I----IFMVGRGYAS 256 (307)
T ss_dssp ------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH-H----HHHHHTTCCC
T ss_pred cccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHH-H----HHHHhcCCCC
Confidence 64332 23345678999999999986 34699999999999999999999999975443221 1 1112222111
Q ss_pred hhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhccC
Q 046270 497 DIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEGD 543 (590)
Q Consensus 497 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~~ 543 (590)
..+. ....+....+.+++..||+.||++||||.||+++|+..
T Consensus 257 p~~~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l 298 (307)
T 3omv_A 257 PDLS-----KLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELL 298 (307)
T ss_dssp CCST-----TSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHH
T ss_pred CCcc-----cccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 1010 01112334677899999999999999999999988753
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-51 Score=425.17 Aligned_cols=264 Identities=26% Similarity=0.315 Sum_probs=198.2
Q ss_pred CCCccceecccCcEEEEEEEEcCCcEEEEEEeecCCCCChHHHH--HHHHHHHhcCCCCccccceeEEeccCCCCceEEE
Q 046270 265 GFSQNNLIGQGASGIVYKGTLRHGNLVAVKQILDLDTKGDEDFT--NEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFL 342 (590)
Q Consensus 265 ~f~~~~~LG~G~fG~Vykg~~~~g~~vAvK~l~~~~~~~~~~f~--~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~L 342 (590)
++...+.||+|+||+||+|+++ |+.||||++... ..+++. .|+..+.+++|||||+++|+|...+. .....+|
T Consensus 4 ~i~L~~~iG~G~fG~Vy~~~~~-g~~VAvK~l~~~---~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~-~~~~~~l 78 (303)
T 3hmm_A 4 TIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNG-TWTQLWL 78 (303)
T ss_dssp GEEEEEEEEECSSSEEEEEEET-TEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECS-SSEEEEE
T ss_pred EEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECcc---chhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCC-CceEEEE
Confidence 4566789999999999999985 899999998543 233444 45555678899999999999986543 2346899
Q ss_pred EEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhc-----CCCCeEecCCCCCceEECCCCcEEEEeeCC
Q 046270 343 VYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYG-----LKPGIYHRDIKSTNILLDSELNAKVADFGL 417 (590)
Q Consensus 343 V~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~-----~~~~ivHrDIKp~NILLd~~~~~kL~DFGl 417 (590)
|||||++|+|.++|. ...++|+.+++|+.|+++||+|||+. ..++|+||||||+|||||.++++||+|||+
T Consensus 79 V~Ey~~~gsL~~~l~----~~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGl 154 (303)
T 3hmm_A 79 VSDYHEHGSLFDYLN----RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp EEECCTTCBHHHHHH----HCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EecCCCCCcHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCC
Confidence 999999999999995 34699999999999999999999943 134999999999999999999999999999
Q ss_pred cccccCCCcc---cccccccCCCccCccccccC------CCCcchhHHHHHHHHHHHHhCCCCCCCCCCch---h-----
Q 046270 418 AKQSLEGHSH---LTTRVAGTFGYLAPEYALYG------QLTEKSDVYSFGIVILELMSGRKVLDTSTSPF---Q----- 480 (590)
Q Consensus 418 a~~~~~~~~~---~~~~~~gt~~Y~APE~~~~~------~~t~ksDVySfGvvLlELltG~~p~~~~~~~~---~----- 480 (590)
++........ ......||+.|||||++.+. .++.++|||||||+||||+||+.|+....... .
T Consensus 155 a~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~ 234 (303)
T 3hmm_A 155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 234 (303)
T ss_dssp CEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCS
T ss_pred CccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccc
Confidence 9876544322 22346799999999998753 47789999999999999999988775432211 1
Q ss_pred --hhhHHHHHHHhcCCchhhhhHHHhhh-hHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhcc
Q 046270 481 --LITDWAWVLAKSGKVDDIFDEFIRAE-GARAVMERFVLVGILCAHVMVALRPTITDALKMLEG 542 (590)
Q Consensus 481 --~l~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~ 542 (590)
...++... ...+.. ++.+... ...+..+.+.+++..||+.||++||||.||+++|+.
T Consensus 235 ~~~~~~~~~~-~~~~~~----rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 294 (303)
T 3hmm_A 235 DPSVEEMRKV-VCEQKL----RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 294 (303)
T ss_dssp SCCHHHHHHH-HTTSCC----CCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHH
T ss_pred cchHHHHHHH-HhcccC----CCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence 11111111 111111 1111111 122445678899999999999999999999999975
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-52 Score=437.33 Aligned_cols=268 Identities=24% Similarity=0.343 Sum_probs=215.2
Q ss_pred ccHHHHHHHhcCCCccceecccCcEEEEEEEEcC------CcEEEEEEeecCCCC-ChHHHHHHHHHHHhcCC-CCcccc
Q 046270 254 FHVSELEQATNGFSQNNLIGQGASGIVYKGTLRH------GNLVAVKQILDLDTK-GDEDFTNEVEIISKIRH-RNLLSL 325 (590)
Q Consensus 254 f~~~el~~at~~f~~~~~LG~G~fG~Vykg~~~~------g~~vAvK~l~~~~~~-~~~~f~~Ev~il~~l~H-~nlv~l 325 (590)
++..+.+...++|...+.||+|+||.||+|++.. ++.||||++...... ..++|.+|+++|.+++| ||||++
T Consensus 54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l 133 (353)
T 4ase_A 54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 133 (353)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence 3445556667889999999999999999998753 357999999764433 24579999999999965 899999
Q ss_pred ceeEEeccCCCCceEEEEEeeCCCCCcchhhhhhcc-------------cccCChhhHHHHHHHHHHHHHHHHhcCCCCe
Q 046270 326 RGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHK-------------RKQLTWPQRKKIIVDVAKGIAYLHYGLKPGI 392 (590)
Q Consensus 326 ~g~~~~~~~~~~~~~~LV~E~~~~gsL~~~L~~~~~-------------~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~i 392 (590)
+|+|... +...+||||||++|+|.++|..... ...++|.+++.|+.|||+||+||| +++|
T Consensus 134 ~g~~~~~----~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH---~~~i 206 (353)
T 4ase_A 134 LGACTKP----GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKC 206 (353)
T ss_dssp EEEECCT----TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHH---HTTC
T ss_pred EEEEEec----CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHh---hCCe
Confidence 9999743 3458999999999999999964322 245899999999999999999999 8999
Q ss_pred EecCCCCCceEECCCCcEEEEeeCCcccccCCCcc-cccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCC
Q 046270 393 YHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSH-LTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRK 470 (590)
Q Consensus 393 vHrDIKp~NILLd~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELlt-G~~ 470 (590)
|||||||+||||++++.+||+|||+|+........ ......||+.|||||++.++.|+.++|||||||+||||+| |+.
T Consensus 207 iHRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~ 286 (353)
T 4ase_A 207 IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS 286 (353)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCC
T ss_pred ecCccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCC
Confidence 99999999999999999999999999976554433 3445679999999999999999999999999999999998 899
Q ss_pred CCCCCCCchhhhhHHHHHHHhcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhcc
Q 046270 471 VLDTSTSPFQLITDWAWVLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEG 542 (590)
Q Consensus 471 p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~ 542 (590)
||......... ......+..... +......+.+++..||+.||++||||.||+++|+.
T Consensus 287 Pf~~~~~~~~~-----~~~i~~g~~~~~---------p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~ 344 (353)
T 4ase_A 287 PYPGVKIDEEF-----CRRLKEGTRMRA---------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 344 (353)
T ss_dssp SSTTCCCSHHH-----HHHHHHTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCCCCHHHHH-----HHHHHcCCCCCC---------CccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHH
Confidence 99754433221 112222321111 11123467788999999999999999999999875
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-50 Score=412.05 Aligned_cols=248 Identities=25% Similarity=0.358 Sum_probs=197.3
Q ss_pred CccceecccCcEEEEEEEEcC-CcEEEEEEeecCC--CCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEEEE
Q 046270 267 SQNNLIGQGASGIVYKGTLRH-GNLVAVKQILDLD--TKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFLV 343 (590)
Q Consensus 267 ~~~~~LG~G~fG~Vykg~~~~-g~~vAvK~l~~~~--~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~LV 343 (590)
...+.||+|+||.||+|++.. +..||+|++.... ....+.|.+|++++++++|||||++++++..... .....+||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~-~~~~~~lv 107 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVK-GKKCIVLV 107 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEET-TEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccC-CCcEEEEE
Confidence 344679999999999999874 7899999986532 2234579999999999999999999999875432 24568999
Q ss_pred EeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCCceEECC-CCcEEEEeeCCccc
Q 046270 344 YDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPG--IYHRDIKSTNILLDS-ELNAKVADFGLAKQ 420 (590)
Q Consensus 344 ~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~--ivHrDIKp~NILLd~-~~~~kL~DFGla~~ 420 (590)
||||++|+|.+++. +...+++..+..|+.||+.||+||| +.+ |+||||||+||||++ ++.+||+|||+|+.
T Consensus 108 mEy~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~ylH---~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~ 181 (290)
T 3fpq_A 108 TELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp EECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EeCCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHH---HCCCCEEecccChhheeEECCCCCEEEEeCcCCEe
Confidence 99999999999995 3457999999999999999999999 766 999999999999985 78999999999985
Q ss_pred ccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhhh
Q 046270 421 SLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFD 500 (590)
Q Consensus 421 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 500 (590)
... .......||+.|||||.+. ++|+.++|||||||+||||+||+.||.......... .....+.....++
T Consensus 182 ~~~---~~~~~~~GTp~YmAPE~~~-~~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~-----~~i~~~~~~~~~~ 252 (290)
T 3fpq_A 182 KRA---SFAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIY-----RRVTSGVKPASFD 252 (290)
T ss_dssp CCT---TSBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHH-----HHHTTTCCCGGGG
T ss_pred CCC---CccCCcccCccccCHHHcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHH-----HHHHcCCCCCCCC
Confidence 432 2344578999999999875 579999999999999999999999996543322111 1122222111122
Q ss_pred HHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 046270 501 EFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALK 538 (590)
Q Consensus 501 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~ 538 (590)
+. ....+.+++..|++.||++|||+.|+++
T Consensus 253 ~~--------~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 253 KV--------AIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp GC--------CCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cc--------CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11 1235677889999999999999999986
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-50 Score=419.92 Aligned_cols=249 Identities=25% Similarity=0.368 Sum_probs=205.0
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEEE
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFL 342 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~L 342 (590)
..|+..+.||+|+||.||+|++. +|+.||||++........+.+.+|+++|++++|||||++++++.+ ....||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~-----~~~~~i 148 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLV-----GDELWV 148 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEE-----TTEEEE
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-----CCEEEE
Confidence 45778889999999999999986 488999999976655666779999999999999999999999985 446999
Q ss_pred EEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCccccc
Q 046270 343 VYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSL 422 (590)
Q Consensus 343 V~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~~ 422 (590)
||||+++|+|.+++. +..+++.++..|+.||+.||+||| +.+|+||||||+||||+.++.+||+|||+++...
T Consensus 149 vmEy~~gg~L~~~l~----~~~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 221 (346)
T 4fih_A 149 VMEFLEGGALTDIVT----HTRMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVS 221 (346)
T ss_dssp EECCCTTEEHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEeCCCCCcHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEECCCCCEEEecCcCceecC
Confidence 999999999999884 346999999999999999999999 8999999999999999999999999999998764
Q ss_pred CCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhhhHH
Q 046270 423 EGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDEF 502 (590)
Q Consensus 423 ~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 502 (590)
... .......||+.|||||++.+..|+.++|||||||++|||++|+.||..... ...+. . ...+.....
T Consensus 222 ~~~-~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~-~~~~~----~-i~~~~~~~~---- 290 (346)
T 4fih_A 222 KEV-PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP-LKAMK----M-IRDNLPPRL---- 290 (346)
T ss_dssp SSS-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-HHHHH----H-HHHSSCCCC----
T ss_pred CCC-CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH-HHHHH----H-HHcCCCCCC----
Confidence 432 234557899999999999999999999999999999999999999965322 11111 1 111110000
Q ss_pred HhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 046270 503 IRAEGARAVMERFVLVGILCAHVMVALRPTITDALK 538 (590)
Q Consensus 503 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~ 538 (590)
. ....+...+.+++..|++.||++|||+.|+++
T Consensus 291 -~--~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 291 -K--NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp -S--CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -C--ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0 01122346778889999999999999999986
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-50 Score=418.99 Aligned_cols=251 Identities=19% Similarity=0.171 Sum_probs=200.6
Q ss_pred cCCCccceecccCcEEEEEEEEcC-CcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEEE
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLRH-GNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFL 342 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~L 342 (590)
+.|...++||+|+||.||+|+++. |+.||||++..... +.+|++++++++|||||++++++.+ +...||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~-----~~~~~i 127 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVRE-----GPWVNI 127 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEE-----TTEEEE
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEE-----CCEEEE
Confidence 457777899999999999999864 88999999965322 2479999999999999999999974 456999
Q ss_pred EEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCC-cEEEEeeCCcccc
Q 046270 343 VYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSEL-NAKVADFGLAKQS 421 (590)
Q Consensus 343 V~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~-~~kL~DFGla~~~ 421 (590)
||||+++|+|.++|. +.+.+++.+.+.|+.||+.||+||| +.+|+||||||+||||+.++ .+||+|||+|+..
T Consensus 128 vmEy~~gg~L~~~l~---~~~~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~ 201 (336)
T 4g3f_A 128 FMELLEGGSLGQLIK---QMGCLPEDRALYYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCL 201 (336)
T ss_dssp EECCCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC
T ss_pred EEeccCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEeCCCCEEEEeeCCCCeEc
Confidence 999999999999995 3457999999999999999999999 89999999999999999987 6999999999876
Q ss_pred cCCCcc----cccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchh
Q 046270 422 LEGHSH----LTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDD 497 (590)
Q Consensus 422 ~~~~~~----~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 497 (590)
...... ....+.||+.|||||.+.+..|+.++|||||||++|||+||+.||....... .+. ..........
T Consensus 202 ~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~-~~~----~i~~~~~~~~ 276 (336)
T 4g3f_A 202 QPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGP-LCL----KIASEPPPIR 276 (336)
T ss_dssp ------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSC-CHH----HHHHSCCGGG
T ss_pred cCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH-HHH----HHHcCCCCch
Confidence 543221 1234679999999999999999999999999999999999999997543322 111 1111111100
Q ss_pred hhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhccC
Q 046270 498 IFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEGD 543 (590)
Q Consensus 498 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~~ 543 (590)
..+..+...+.+++..|++.||.+|||+.|+++.|...
T Consensus 277 --------~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~ 314 (336)
T 4g3f_A 277 --------EIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKA 314 (336)
T ss_dssp --------GSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --------hcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 11112334677888999999999999999999887653
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-50 Score=423.05 Aligned_cols=250 Identities=23% Similarity=0.322 Sum_probs=198.0
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCC--CChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceE
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDT--KGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRR 340 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~--~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~ 340 (590)
++|...+.||+|+||+||+|++. +|+.||||++..... ...+.|.+|+++|++|+|||||++++++.+ ....
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~-----~~~~ 98 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEE-----NGSL 98 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEE-----CCEE
Confidence 57999999999999999999986 589999999965432 234679999999999999999999999974 4569
Q ss_pred EEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCccc
Q 046270 341 FLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQ 420 (590)
Q Consensus 341 ~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~ 420 (590)
||||||+++|+|.++|... +...+++.+.+.|+.||+.||+||| +.+|+||||||+||||+.++.+||+|||+++.
T Consensus 99 yiVmEy~~gg~L~~~i~~~-~~~~~~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~ 174 (350)
T 4b9d_A 99 YIVMDYCEGGDLFKRINAQ-KGVLFQEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARV 174 (350)
T ss_dssp EEEEECCTTCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHH---HTTCEETTCCGGGEEECTTCCEEECSTTEESC
T ss_pred EEEEeCCCCCcHHHHHHHc-CCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCCEEEccccccee
Confidence 9999999999999999532 3345789999999999999999999 89999999999999999999999999999986
Q ss_pred ccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhhh
Q 046270 421 SLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFD 500 (590)
Q Consensus 421 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 500 (590)
.... ....+...||+.|||||.+.+..|+.++|||||||+||||+||+.||...... .. ...... +.....
T Consensus 175 ~~~~-~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~-~~----~~~i~~-~~~~~~-- 245 (350)
T 4b9d_A 175 LNST-VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMK-NL----VLKIIS-GSFPPV-- 245 (350)
T ss_dssp CCHH-HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH-HH----HHHHHH-TCCCCC--
T ss_pred ecCC-cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH-HH----HHHHHc-CCCCCC--
Confidence 5332 12234567999999999999999999999999999999999999999753321 11 111111 221110
Q ss_pred HHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 046270 501 EFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALK 538 (590)
Q Consensus 501 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~ 538 (590)
+..+...+.+++..|++.||++|||+.|+++
T Consensus 246 -------~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 246 -------SLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp -------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -------CccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1112346778899999999999999999986
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-49 Score=411.04 Aligned_cols=247 Identities=19% Similarity=0.266 Sum_probs=203.8
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecC---CCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCce
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDL---DTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKR 339 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~---~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~ 339 (590)
++|...+.||+|+||+||+++.. +|+.||||++... .....+.+.+|+++|++++|||||++++++.+ ...
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-----~~~ 106 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQD-----DEK 106 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-----SSE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEe-----CCE
Confidence 46889999999999999999986 4889999999642 23445679999999999999999999999973 456
Q ss_pred EEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcc
Q 046270 340 RFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAK 419 (590)
Q Consensus 340 ~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~ 419 (590)
.||||||+++|+|.+++. +.+.+++.+...++.||+.||+||| +.+|+||||||+||||+.++.+||+|||+|+
T Consensus 107 ~yivmEy~~gG~L~~~i~---~~~~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDlKPeNILl~~~g~vKl~DFGla~ 180 (311)
T 4aw0_A 107 LYFGLSYAKNGELLKYIR---KIGSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAK 180 (311)
T ss_dssp EEEEECCCTTEEHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEEecCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEEcCCCCEEEEEcCCce
Confidence 999999999999999995 4467999999999999999999999 8999999999999999999999999999999
Q ss_pred cccCCCc-ccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhh
Q 046270 420 QSLEGHS-HLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDI 498 (590)
Q Consensus 420 ~~~~~~~-~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 498 (590)
....... .......||+.|||||.+.+..|+.++||||+||+||||+||+.||..... ...+. ... .+...
T Consensus 181 ~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~-~~~~~----~i~-~~~~~-- 252 (311)
T 4aw0_A 181 VLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE-GLIFA----KII-KLEYD-- 252 (311)
T ss_dssp ECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHH----HHH-HTCCC--
T ss_pred ecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHH----HHH-cCCCC--
Confidence 7654332 334567899999999999999999999999999999999999999975332 11111 111 11110
Q ss_pred hhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHH
Q 046270 499 FDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDAL 537 (590)
Q Consensus 499 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl 537 (590)
.+..+...+.+++..|++.||++|||++|++
T Consensus 253 --------~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 253 --------FPEKFFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp --------CCTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred --------CCcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 0111233567888999999999999999863
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-49 Score=420.84 Aligned_cols=249 Identities=25% Similarity=0.368 Sum_probs=205.6
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEEE
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFL 342 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~L 342 (590)
+.|...+.||+|+||.||+|++. .|+.||||++........+.+.+|+++|++++|||||++++++.. +...||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~-----~~~~~i 225 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLV-----GDELWV 225 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEE-----TTEEEE
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEE-----CCEEEE
Confidence 46888899999999999999986 489999999977666667789999999999999999999999985 446999
Q ss_pred EEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCccccc
Q 046270 343 VYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSL 422 (590)
Q Consensus 343 V~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~~ 422 (590)
|||||++|+|.+++. ...+++.++..|+.||+.||+||| +.+||||||||+||||+.++.+||+|||+++...
T Consensus 226 VmEy~~gG~L~~~i~----~~~l~e~~~~~~~~qil~aL~ylH---~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~ 298 (423)
T 4fie_A 226 VMEFLEGGALTDIVT----HTRMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVS 298 (423)
T ss_dssp EEECCTTEEHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSTTTEEECTTCCEEECCCTTCEECC
T ss_pred EEeCCCCCcHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEecCccceECC
Confidence 999999999999884 346999999999999999999999 8999999999999999999999999999998764
Q ss_pred CCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhhhHH
Q 046270 423 EGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDEF 502 (590)
Q Consensus 423 ~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 502 (590)
... .......||+.|||||++.+..|+.++|||||||++|||++|+.||..... ...+. . ...+....
T Consensus 299 ~~~-~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~-~~~~~----~-i~~~~~~~----- 366 (423)
T 4fie_A 299 KEV-PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP-LKAMK----M-IRDNLPPR----- 366 (423)
T ss_dssp SSC-CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-HHHHH----H-HHHSCCCC-----
T ss_pred CCC-ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH-HHHHH----H-HHcCCCCC-----
Confidence 432 234557899999999999999999999999999999999999999965322 11111 1 11111000
Q ss_pred HhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 046270 503 IRAEGARAVMERFVLVGILCAHVMVALRPTITDALK 538 (590)
Q Consensus 503 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~ 538 (590)
+. ....+...+.+++..||+.||++|||+.|+++
T Consensus 367 ~~--~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 367 LK--NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp CS--CTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred Cc--ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 00 01112346778889999999999999999986
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=396.99 Aligned_cols=245 Identities=22% Similarity=0.340 Sum_probs=187.2
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCC---CCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCce
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLD---TKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKR 339 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~---~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~ 339 (590)
++|...+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|++++++++|||||++++++.+ ...
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~-----~~~ 87 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKS-----KDE 87 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----SSE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE-----CCE
Confidence 57999999999999999999976 58999999986432 2235679999999999999999999999874 456
Q ss_pred EEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcc
Q 046270 340 RFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAK 419 (590)
Q Consensus 340 ~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~ 419 (590)
.++||||+ +|+|.+++. +++.+++.+...++.||+.||+||| +.+|+||||||+||||++++++||+|||+|+
T Consensus 88 ~~ivmEy~-~g~L~~~l~---~~~~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDiKP~NILl~~~~~vkl~DFGla~ 160 (275)
T 3hyh_A 88 IIMVIEYA-GNELFDYIV---QRDKMSEQEARRFFQQIISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSN 160 (275)
T ss_dssp EEEEEECC-CEEHHHHHH---HSCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTCCEEECCSSCC-
T ss_pred EEEEEeCC-CCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCChHHeEECCCCCEEEeecCCCe
Confidence 99999999 689998885 4567999999999999999999999 8999999999999999999999999999998
Q ss_pred cccCCCcccccccccCCCccCccccccCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhh
Q 046270 420 QSLEGHSHLTTRVAGTFGYLAPEYALYGQL-TEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDI 498 (590)
Q Consensus 420 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~-t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 498 (590)
...... ......||+.|||||.+.+..+ +.++||||+||++|||+||+.||..... .... ... ..+...
T Consensus 161 ~~~~~~--~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~-~~~~----~~i-~~~~~~-- 230 (275)
T 3hyh_A 161 IMTDGN--FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESI-PVLF----KNI-SNGVYT-- 230 (275)
T ss_dssp ----------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHH----HHH-HHTCCC--
T ss_pred ecCCCC--ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCH-HHHH----HHH-HcCCCC--
Confidence 654322 2345689999999999988776 5799999999999999999999975322 1111 111 112110
Q ss_pred hhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 046270 499 FDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALK 538 (590)
Q Consensus 499 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~ 538 (590)
+ +......+.+++..|++.||++|||++|+++
T Consensus 231 ~--------p~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 231 L--------PKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp C--------CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred C--------CCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 0 1112346678889999999999999999987
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-48 Score=400.27 Aligned_cols=254 Identities=19% Similarity=0.308 Sum_probs=189.1
Q ss_pred CCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCCC-ChHHHHHHHHHHHhcCCCCccccceeEEeccCC-------
Q 046270 265 GFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDTK-GDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDS------- 335 (590)
Q Consensus 265 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~~-~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~------- 335 (590)
+|+..+.||+|+||+||+|+++ +|+.||||++...... ..+.+.+|+++|++++|||||++++++...+..
T Consensus 6 dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~ 85 (299)
T 4g31_A 6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSS 85 (299)
T ss_dssp HEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC---------
T ss_pred hCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccC
Confidence 5888899999999999999986 5889999998654332 245789999999999999999999998765421
Q ss_pred CCceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEee
Q 046270 336 SGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADF 415 (590)
Q Consensus 336 ~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DF 415 (590)
.....|+||||+++|+|.+++.........++...+.|+.||+.||+||| +.+|+||||||+||||+.++.+||+||
T Consensus 86 ~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH---~~~IiHRDlKp~NILl~~~~~vKl~DF 162 (299)
T 4g31_A 86 PKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDF 162 (299)
T ss_dssp -CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCC
T ss_pred CCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHH---HCcCccccCcHHHeEECCCCcEEEccC
Confidence 23457999999999999999964433345677788999999999999999 899999999999999999999999999
Q ss_pred CCcccccCCCcc-----------cccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhH
Q 046270 416 GLAKQSLEGHSH-----------LTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITD 484 (590)
Q Consensus 416 Gla~~~~~~~~~-----------~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~ 484 (590)
|+|+........ ..+...||+.|||||.+.+..|+.++|||||||++|||++ ||... ......
T Consensus 163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~---~~~~~~ 236 (299)
T 4g31_A 163 GLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQ---MERVRT 236 (299)
T ss_dssp CCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSH---HHHHHH
T ss_pred ccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCc---cHHHHH
Confidence 999876443221 1234579999999999999999999999999999999996 55421 111111
Q ss_pred HHHHHHhcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 046270 485 WAWVLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALK 538 (590)
Q Consensus 485 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~ 538 (590)
+ ...........+. +.......++..|++.||++|||+.|+++
T Consensus 237 ~--~~~~~~~~p~~~~---------~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 237 L--TDVRNLKFPPLFT---------QKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp H--HHHHTTCCCHHHH---------HHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred H--HHHhcCCCCCCCc---------ccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1 1112222222111 11224456888999999999999999987
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-49 Score=404.96 Aligned_cols=247 Identities=25% Similarity=0.354 Sum_probs=192.6
Q ss_pred cCCCccceecccCcEEEEEEEEc----CCcEEEEEEeecCC--CCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCC
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLR----HGNLVAVKQILDLD--TKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSG 337 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~----~g~~vAvK~l~~~~--~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~ 337 (590)
++|...+.||+|+||+||+|+.. .++.||||++.... ......+.+|+++|++++|||||++++++.+ .
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-----~ 98 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQT-----E 98 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEE-----T
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE-----C
Confidence 46889999999999999999863 36789999986432 2223468899999999999999999999984 3
Q ss_pred ceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCC
Q 046270 338 KRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGL 417 (590)
Q Consensus 338 ~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGl 417 (590)
...|+||||+++|+|.+++. +.+.+++.+...++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+
T Consensus 99 ~~~~ivmEy~~gg~L~~~l~---~~~~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGl 172 (304)
T 3ubd_A 99 GKLYLILDFLRGGDLFTRLS---KEVMFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGL 172 (304)
T ss_dssp TEEEEEECCCTTCEEHHHHH---HHCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTSCEEEESSEE
T ss_pred CEEEEEEEcCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHeEEcCCCCEEeccccc
Confidence 46999999999999999995 3457999999999999999999999 89999999999999999999999999999
Q ss_pred cccccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchh
Q 046270 418 AKQSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDD 497 (590)
Q Consensus 418 a~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 497 (590)
|+...... .......||+.|||||.+.+..++.++|||||||++|||+||+.||...... ..+. .... +...
T Consensus 173 a~~~~~~~-~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~-~~~~----~i~~-~~~~- 244 (304)
T 3ubd_A 173 SKESIDHE-KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRK-ETMT----MILK-AKLG- 244 (304)
T ss_dssp EEC------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHH----HHHH-CCCC-
T ss_pred ceeccCCC-ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHH-HHHH----HHHc-CCCC-
Confidence 98654332 2334568999999999999999999999999999999999999999753321 1111 1111 1110
Q ss_pred hhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCC-----HHHHHH
Q 046270 498 IFDEFIRAEGARAVMERFVLVGILCAHVMVALRPT-----ITDALK 538 (590)
Q Consensus 498 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt-----m~eVl~ 538 (590)
.+..+...+.+++..|++.||++||| ++|+++
T Consensus 245 ---------~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 245 ---------MPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp ---------CCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred ---------CCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 01112346778889999999999998 467664
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-47 Score=396.61 Aligned_cols=294 Identities=40% Similarity=0.694 Sum_probs=246.3
Q ss_pred CCCccccHHHHHHHhcCCCccceecccCcEEEEEEEEcCCcEEEEEEeecCCCC-ChHHHHHHHHHHHhcCCCCccccce
Q 046270 249 SGAKWFHVSELEQATNGFSQNNLIGQGASGIVYKGTLRHGNLVAVKQILDLDTK-GDEDFTNEVEIISKIRHRNLLSLRG 327 (590)
Q Consensus 249 ~~~~~f~~~el~~at~~f~~~~~LG~G~fG~Vykg~~~~g~~vAvK~l~~~~~~-~~~~f~~Ev~il~~l~H~nlv~l~g 327 (590)
.....|++.++..++++|...+.||+|+||.||+|++.+|+.||||++...... ....+.+|++++++++||||+++++
T Consensus 15 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 94 (326)
T 3uim_A 15 GQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG 94 (326)
T ss_dssp CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCE
T ss_pred CccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEE
Confidence 345678999999999999999999999999999999888999999998654322 2347999999999999999999999
Q ss_pred eEEeccCCCCceEEEEEeeCCCCCcchhhhhhc-ccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECC
Q 046270 328 CCVTSDDSSGKRRFLVYDYMPNGTLSDNISISH-KRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDS 406 (590)
Q Consensus 328 ~~~~~~~~~~~~~~LV~E~~~~gsL~~~L~~~~-~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~ 406 (590)
++.. ....++||||+++|+|.+++.... ....++|..+..|+.|++.||.|||.....+|+||||||+|||++.
T Consensus 95 ~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~ 169 (326)
T 3uim_A 95 FCMT-----PTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDE 169 (326)
T ss_dssp EECC-----SSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECT
T ss_pred EEec-----CCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECC
Confidence 9974 345799999999999999986432 2345999999999999999999999433339999999999999999
Q ss_pred CCcEEEEeeCCcccccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC---CCCchhhhh
Q 046270 407 ELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDT---STSPFQLIT 483 (590)
Q Consensus 407 ~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~---~~~~~~~l~ 483 (590)
++.+||+|||+++..............||..|+|||.+.++.++.++||||||+++|||++|+.||+. .......+.
T Consensus 170 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~ 249 (326)
T 3uim_A 170 EFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLL 249 (326)
T ss_dssp TCCEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHH
T ss_pred CCCEEeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHH
Confidence 99999999999987665555555566799999999999999999999999999999999999999962 112223555
Q ss_pred HHHHHHHhcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhccCCCCC
Q 046270 484 DWAWVLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEGDIDIP 547 (590)
Q Consensus 484 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~~~~~~ 547 (590)
+|.............++..+......+..+.+.+++..|++.||.+|||+.||+++|++.....
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~~~ 313 (326)
T 3uim_A 250 DWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLAE 313 (326)
T ss_dssp HHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSCSS
T ss_pred HHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcchhh
Confidence 6776666677777777777666666677789999999999999999999999999999864443
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-47 Score=392.43 Aligned_cols=284 Identities=38% Similarity=0.627 Sum_probs=238.0
Q ss_pred ccccHHHHHHHhcCCCccceecccCcEEEEEEEEcCCcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCccccceeEEe
Q 046270 252 KWFHVSELEQATNGFSQNNLIGQGASGIVYKGTLRHGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVT 331 (590)
Q Consensus 252 ~~f~~~el~~at~~f~~~~~LG~G~fG~Vykg~~~~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~ 331 (590)
..+.+.+++.++++|...+.||+|+||.||+|++++|+.||||++........+.+.+|++++++++||||+++++++..
T Consensus 27 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 106 (321)
T 2qkw_B 27 YRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDE 106 (321)
T ss_dssp ---CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCC
T ss_pred eeecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC
Confidence 44666677888999999999999999999999998899999999877666667889999999999999999999999873
Q ss_pred ccCCCCceEEEEEeeCCCCCcchhhhhhcc-cccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcE
Q 046270 332 SDDSSGKRRFLVYDYMPNGTLSDNISISHK-RKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNA 410 (590)
Q Consensus 332 ~~~~~~~~~~LV~E~~~~gsL~~~L~~~~~-~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~ 410 (590)
+...++||||+++|+|.+++..... ...++|.+++.|+.||+.||.||| +.+|+||||||+|||++.++.+
T Consensus 107 -----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~ 178 (321)
T 2qkw_B 107 -----RNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVP 178 (321)
T ss_dssp -----TTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCSTTEEECTTCCE
T ss_pred -----CCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhc---CCCeecCCCCHHHEEECCCCCE
Confidence 4458999999999999999864321 235999999999999999999999 8899999999999999999999
Q ss_pred EEEeeCCcccccCCC-cccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchh-hhhHHHHH
Q 046270 411 KVADFGLAKQSLEGH-SHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQ-LITDWAWV 488 (590)
Q Consensus 411 kL~DFGla~~~~~~~-~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~-~l~~~~~~ 488 (590)
||+|||+++...... ........||..|+|||.+.++.++.++||||||+++|||++|+.||........ ....|...
T Consensus 179 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~ 258 (321)
T 2qkw_B 179 KITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVE 258 (321)
T ss_dssp EECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHH
T ss_pred EEeecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhh
Confidence 999999998654322 2233445689999999999999999999999999999999999999975443222 44556666
Q ss_pred HHhcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhccC
Q 046270 489 LAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEGD 543 (590)
Q Consensus 489 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~~ 543 (590)
....+.....+++.+......+..+.+.+++..|++.||++|||+.||+++|+..
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 313 (321)
T 2qkw_B 259 SHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYA 313 (321)
T ss_dssp HHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ccccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 6666666666766655555556777899999999999999999999999999864
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-45 Score=390.69 Aligned_cols=265 Identities=21% Similarity=0.308 Sum_probs=201.8
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCCC--ChHHHHHHHHHHHhcCCCCccccceeEEeccC-CCCce
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDTK--GDEDFTNEVEIISKIRHRNLLSLRGCCVTSDD-SSGKR 339 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~~--~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~-~~~~~ 339 (590)
++|...+.||+|+||.||+|++. .|+.||||++...... ..+.+.+|+++|++++|||||++++++..... .+...
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 57889999999999999999986 5899999999654322 23568899999999999999999998865422 23467
Q ss_pred EEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcc
Q 046270 340 RFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAK 419 (590)
Q Consensus 340 ~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~ 419 (590)
.|||||||+ |+|.+++. +.+.+++.++..|+.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++
T Consensus 134 ~~ivmE~~~-g~L~~~i~---~~~~l~~~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~ 206 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIH---SSQPLTLEHVRYFLYQLLRGLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMAR 206 (398)
T ss_dssp EEEEEECCS-EEHHHHHT---SSSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEEeCCC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHH---HCcCcCCCcCccccccCCCCCEEEeecceee
Confidence 999999995 77988885 4567999999999999999999999 8999999999999999999999999999998
Q ss_pred cccCCC---cccccccccCCCccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCc
Q 046270 420 QSLEGH---SHLTTRVAGTFGYLAPEYALYG-QLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKV 495 (590)
Q Consensus 420 ~~~~~~---~~~~~~~~gt~~Y~APE~~~~~-~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~ 495 (590)
...... ........||+.|||||++.+. .++.++||||+||++|||++|+.||....... .+..... ..+..
T Consensus 207 ~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~-~l~~I~~---~~g~p 282 (398)
T 4b99_A 207 GLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVH-QLQLIMM---VLGTP 282 (398)
T ss_dssp CC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH-HHHHHHH---HHCCC
T ss_pred ecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHH-HHHHHHH---hcCCC
Confidence 764322 2234557899999999998765 56999999999999999999999997543321 2211111 11111
Q ss_pred hhhhh---------HHHh----------hhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 496 DDIFD---------EFIR----------AEGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 496 ~~~~d---------~~l~----------~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
..... ..+. ..........+.+++..|++.||++|||+.|++++
T Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 283 SPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp CGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred ChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 10000 0000 00000123467789999999999999999999874
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-45 Score=385.77 Aligned_cols=262 Identities=21% Similarity=0.340 Sum_probs=198.7
Q ss_pred HHhcCCCccceecccCcEEEEEEEEc----CCcEEEEEEeecCCCCChHHHHHHHHHHHhc-CCCCccccceeEEeccCC
Q 046270 261 QATNGFSQNNLIGQGASGIVYKGTLR----HGNLVAVKQILDLDTKGDEDFTNEVEIISKI-RHRNLLSLRGCCVTSDDS 335 (590)
Q Consensus 261 ~at~~f~~~~~LG~G~fG~Vykg~~~----~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l-~H~nlv~l~g~~~~~~~~ 335 (590)
...+.|...+.||+|+||+||+|+.+ .++.||||++... .....+.+|+++|.++ +|||||++++++..
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~--~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~---- 91 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT--SHPIRIAAELQCLTVAGGQDNVMGVKYCFRK---- 91 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT--SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEE----
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc--cCHHHHHHHHHHHHHhcCCCCCceEEEEEEE----
Confidence 35678999999999999999999864 3578999998653 3456788999999999 69999999999874
Q ss_pred CCceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCC-CcEEEEe
Q 046270 336 SGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSE-LNAKVAD 414 (590)
Q Consensus 336 ~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~-~~~kL~D 414 (590)
..+.++||||+++|+|.+++. .+++.+...++.||+.||+||| +.+|+||||||+|||++.+ +.+||+|
T Consensus 92 -~~~~~lvmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH---~~gIiHRDiKPeNiLl~~~~~~~kl~D 161 (361)
T 4f9c_A 92 -NDHVVIAMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIH---QFGIVHRDVKPSNFLYNRRLKKYALVD 161 (361)
T ss_dssp -TTEEEEEEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECC
T ss_pred -CCEEEEEEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCcCCHHHeEEeCCCCeEEECc
Confidence 456999999999999999882 5899999999999999999999 8999999999999999877 7999999
Q ss_pred eCCcccccCCCc---------------------------ccccccccCCCccCccccccC-CCCcchhHHHHHHHHHHHH
Q 046270 415 FGLAKQSLEGHS---------------------------HLTTRVAGTFGYLAPEYALYG-QLTEKSDVYSFGIVILELM 466 (590)
Q Consensus 415 FGla~~~~~~~~---------------------------~~~~~~~gt~~Y~APE~~~~~-~~t~ksDVySfGvvLlELl 466 (590)
||+|+....... ...+...||+.|||||.+.+. .++.++||||+||+++||+
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell 241 (361)
T 4f9c_A 162 FGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLL 241 (361)
T ss_dssp CTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHH
T ss_pred CCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHH
Confidence 999986533211 112335799999999998765 5899999999999999999
Q ss_pred hCCCCCCCCCCchhhhhHHHHHHHh---------------------cCCchhhhhHH---------Hh---------hhh
Q 046270 467 SGRKVLDTSTSPFQLITDWAWVLAK---------------------SGKVDDIFDEF---------IR---------AEG 507 (590)
Q Consensus 467 tG~~p~~~~~~~~~~l~~~~~~~~~---------------------~~~~~~~~d~~---------l~---------~~~ 507 (590)
||+.||....++...+......+-. ........... +. ...
T Consensus 242 ~G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~ 321 (361)
T 4f9c_A 242 SGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEG 321 (361)
T ss_dssp HTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------
T ss_pred HCCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccc
Confidence 9999997655543332221110000 00000000000 00 000
Q ss_pred HHHHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 046270 508 ARAVMERFVLVGILCAHVMVALRPTITDALK 538 (590)
Q Consensus 508 ~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~ 538 (590)
.....+.+.+++..|++.||++|||++|+++
T Consensus 322 ~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~ 352 (361)
T 4f9c_A 322 WNEVPDEAYDLLDKLLDLNPASRITAEEALL 352 (361)
T ss_dssp CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred cccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 0112346778999999999999999999986
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-44 Score=366.80 Aligned_cols=282 Identities=36% Similarity=0.598 Sum_probs=228.0
Q ss_pred CCccccHHHHHHHhcCCCcc------ceecccCcEEEEEEEEcCCcEEEEEEeecCC----CCChHHHHHHHHHHHhcCC
Q 046270 250 GAKWFHVSELEQATNGFSQN------NLIGQGASGIVYKGTLRHGNLVAVKQILDLD----TKGDEDFTNEVEIISKIRH 319 (590)
Q Consensus 250 ~~~~f~~~el~~at~~f~~~------~~LG~G~fG~Vykg~~~~g~~vAvK~l~~~~----~~~~~~f~~Ev~il~~l~H 319 (590)
....|++.++..++++|... +.||+|+||.||+|++ +++.||||++.... ....+.+.+|++++++++|
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 89 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH 89 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence 45779999999999999988 8999999999999997 47899999986432 2235679999999999999
Q ss_pred CCccccceeEEeccCCCCceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCC
Q 046270 320 RNLLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKS 399 (590)
Q Consensus 320 ~nlv~l~g~~~~~~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp 399 (590)
|||+++++++.. +...++||||+++|+|.+++........++|..++.|+.||+.||.||| +.+|+||||||
T Consensus 90 ~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp 161 (307)
T 2nru_A 90 ENLVELLGFSSD-----GDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKS 161 (307)
T ss_dssp TTBCCEEEEECS-----SSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCG
T ss_pred CCeEEEEEEEec-----CCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecCCCCH
Confidence 999999999874 3458999999999999999875545567999999999999999999999 88999999999
Q ss_pred CceEECCCCcEEEEeeCCcccccCCCc-ccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc
Q 046270 400 TNILLDSELNAKVADFGLAKQSLEGHS-HLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSP 478 (590)
Q Consensus 400 ~NILLd~~~~~kL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~ 478 (590)
+||+++.++.+||+|||+++....... .......||..|+|||.+. +.++.++||||||+++|||++|+.||......
T Consensus 162 ~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~ 240 (307)
T 2nru_A 162 ANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDEHREP 240 (307)
T ss_dssp GGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHT-TEECTHHHHHHHHHHHHHHHHCCCSBCTTBSS
T ss_pred HHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhc-CCCCccchhHHHHHHHHHHHHCCCCcccCcch
Confidence 999999999999999999986544322 2234567899999999775 46899999999999999999999999765443
Q ss_pred hhhhhHHHHHHHhc-CCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhccC
Q 046270 479 FQLITDWAWVLAKS-GKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEGD 543 (590)
Q Consensus 479 ~~~l~~~~~~~~~~-~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~~ 543 (590)
. .+..+....... ..+.+.+++.+. .......+.+..++..|++.+|.+|||+.+|+++|+..
T Consensus 241 ~-~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l 304 (307)
T 2nru_A 241 Q-LLLDIKEEIEDEEKTIEDYIDKKMN-DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM 304 (307)
T ss_dssp S-BTTHHHHHHHTTSCCHHHHSCSSCS-CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred H-HHHHHHHHhhhhhhhhhhhcccccc-ccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 2 223333322222 223344443332 12334566888999999999999999999999999864
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-44 Score=367.18 Aligned_cols=257 Identities=28% Similarity=0.423 Sum_probs=207.1
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEEE
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFL 342 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~L 342 (590)
++|...+.||+|+||.||+|++. ++..||+|++........+.|.+|++++++++||||+++++++.. +...++
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~~~~~l 84 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYK-----DKRLNF 84 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-----TTEEEE
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEec-----CCeeEE
Confidence 46778899999999999999986 488999999876655667789999999999999999999999984 456899
Q ss_pred EEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCccccc
Q 046270 343 VYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSL 422 (590)
Q Consensus 343 V~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~~ 422 (590)
||||+++|+|.+++.. ....++|.+++.|+.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++...
T Consensus 85 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 159 (310)
T 3s95_A 85 ITEYIKGGTLRGIIKS--MDSQYPWSQRVSFAKDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMV 159 (310)
T ss_dssp EEECCTTCBHHHHHHH--CCTTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEECTTSCEEECCCTTCEECC
T ss_pred EEEecCCCcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCcCeEEECCCCCEEEeecccceecc
Confidence 9999999999999863 2457999999999999999999999 8999999999999999999999999999998654
Q ss_pred CCCccc-------------ccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHH
Q 046270 423 EGHSHL-------------TTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVL 489 (590)
Q Consensus 423 ~~~~~~-------------~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~ 489 (590)
...... .....||+.|+|||.+.+..++.++||||||+++|||++|..|+...........
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~------ 233 (310)
T 3s95_A 160 DEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFG------ 233 (310)
T ss_dssp --------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSS------
T ss_pred cccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHh------
Confidence 332211 1145799999999999999999999999999999999999998865333221100
Q ss_pred HhcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhccC
Q 046270 490 AKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEGD 543 (590)
Q Consensus 490 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~~ 543 (590)
......+....+......+.+++..|++.||++|||+.++++.|+..
T Consensus 234 -------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l 280 (310)
T 3s95_A 234 -------LNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETL 280 (310)
T ss_dssp -------BCHHHHHHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -------hhhhccccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 00011111111122234677889999999999999999999998864
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=397.37 Aligned_cols=252 Identities=23% Similarity=0.305 Sum_probs=205.4
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEEE
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFL 342 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~L 342 (590)
++|...+.||+|+||.||+++.+ .|+.||+|++........+.+.+|+++|++++|||||++++++. .....+|
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~-----~~~~~~i 231 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE-----DDNEMVM 231 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEE-----CSSEEEE
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEE-----ECCEEEE
Confidence 67999999999999999999986 48899999997655555667899999999999999999999997 3557999
Q ss_pred EEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCC--CcEEEEeeCCccc
Q 046270 343 VYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSE--LNAKVADFGLAKQ 420 (590)
Q Consensus 343 V~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~--~~~kL~DFGla~~ 420 (590)
|||||++|+|.++|.. +...+++.+...++.||+.||.||| +.+|+||||||+|||++.+ +.+||+|||+++.
T Consensus 232 v~E~~~gg~L~~~i~~--~~~~l~e~~~~~~~~qi~~al~ylH---~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~ 306 (573)
T 3uto_A 232 IYEFMSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAH 306 (573)
T ss_dssp EEECCCCCBHHHHHTC--TTSCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCSSCEE
T ss_pred EEeecCCCcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhccccCCCCCCEEEeeccceeE
Confidence 9999999999998852 3457999999999999999999999 8999999999999999854 8999999999997
Q ss_pred ccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhhh
Q 046270 421 SLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFD 500 (590)
Q Consensus 421 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 500 (590)
..... ......||+.|||||.+.+..|+.++||||+||++|||++|+.||....... .+. ..........+..
T Consensus 307 ~~~~~--~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~-~~~---~i~~~~~~~~~~~- 379 (573)
T 3uto_A 307 LDPKQ--SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE-TLR---NVKSCDWNMDDSA- 379 (573)
T ss_dssp CCTTS--EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH-HHH---HHHTTCCCCCSGG-
T ss_pred ccCCC--ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH-HHH---HHHhCCCCCCccc-
Confidence 65433 2344679999999999999999999999999999999999999997543321 111 0001111111111
Q ss_pred HHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 501 EFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 501 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
...+.+.+.+++..||+.||.+|||+.|++++
T Consensus 380 -------~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 380 -------FSGISEDGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp -------GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred -------ccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11123466788899999999999999999874
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-43 Score=358.69 Aligned_cols=267 Identities=25% Similarity=0.353 Sum_probs=206.7
Q ss_pred hcCCCccceecccCcEEEEEEEEcCCcEEEEEEeecCCCCChHHHHHHHHHHHh--cCCCCccccceeEEeccCCCCceE
Q 046270 263 TNGFSQNNLIGQGASGIVYKGTLRHGNLVAVKQILDLDTKGDEDFTNEVEIISK--IRHRNLLSLRGCCVTSDDSSGKRR 340 (590)
Q Consensus 263 t~~f~~~~~LG~G~fG~Vykg~~~~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~--l~H~nlv~l~g~~~~~~~~~~~~~ 340 (590)
.++|...+.||+|+||.||+|++ +|+.||||++.. .....+..|.+++.. ++||||+++++++..... .....
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~---~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~-~~~~~ 81 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGFIASDMTSRH-SSTQL 81 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECG---GGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEET-TEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEecc---ccchhhHHHHHHHHHhhccCcCeeeEEEeeccccC-CCcee
Confidence 46788999999999999999998 488999999854 345567778888877 799999999999876543 35668
Q ss_pred EEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcC-----CCCeEecCCCCCceEECCCCcEEEEee
Q 046270 341 FLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGL-----KPGIYHRDIKSTNILLDSELNAKVADF 415 (590)
Q Consensus 341 ~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~-----~~~ivHrDIKp~NILLd~~~~~kL~DF 415 (590)
++||||+++|+|.+++. ...+++..++.|+.||+.||+|||... +.+|+||||||+|||++.++.+||+||
T Consensus 82 ~lv~e~~~~g~L~~~l~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 157 (301)
T 3q4u_A 82 WLITHYHEMGSLYDYLQ----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADL 157 (301)
T ss_dssp EEEECCCTTCBHHHHHT----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCC
T ss_pred EEehhhccCCCHHHHHh----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeC
Confidence 99999999999999984 346999999999999999999999432 679999999999999999999999999
Q ss_pred CCcccccCCCccc---ccccccCCCccCccccccC------CCCcchhHHHHHHHHHHHHhC----------CCCCCCCC
Q 046270 416 GLAKQSLEGHSHL---TTRVAGTFGYLAPEYALYG------QLTEKSDVYSFGIVILELMSG----------RKVLDTST 476 (590)
Q Consensus 416 Gla~~~~~~~~~~---~~~~~gt~~Y~APE~~~~~------~~t~ksDVySfGvvLlELltG----------~~p~~~~~ 476 (590)
|+++......... .....||+.|+|||.+.+. .++.++||||||+++|||+|| +.||....
T Consensus 158 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~ 237 (301)
T 3q4u_A 158 GLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVV 237 (301)
T ss_dssp TTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred CCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccC
Confidence 9998654433221 2334789999999999876 456799999999999999999 77775433
Q ss_pred CchhhhhHHHHHHHhcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhcc
Q 046270 477 SPFQLITDWAWVLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEG 542 (590)
Q Consensus 477 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~ 542 (590)
........+.......+........ .........+.+++..|++.||++|||+.||+++|+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~ 299 (301)
T 3q4u_A 238 PNDPSFEDMRKVVCVDQQRPNIPNR----WFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK 299 (301)
T ss_dssp CSSCCHHHHHHHHTTSCCCCCCCGG----GGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHH
T ss_pred CCCcchhhhhHHHhccCCCCCCChh----hccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhc
Confidence 3222222222222222211111111 1122345678899999999999999999999999974
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-43 Score=391.29 Aligned_cols=248 Identities=21% Similarity=0.263 Sum_probs=195.3
Q ss_pred cCCCccceecccCcEEEEEEEEcC-CcEEEEEEeecC---CCCChHHHHH---HHHHHHhcCCCCccccceeEEeccCCC
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLRH-GNLVAVKQILDL---DTKGDEDFTN---EVEIISKIRHRNLLSLRGCCVTSDDSS 336 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~vAvK~l~~~---~~~~~~~f~~---Ev~il~~l~H~nlv~l~g~~~~~~~~~ 336 (590)
++|...+.||+|+||.||+++... |+.||||++... .......+.+ ++.+++.++|||||++++++.+
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~----- 263 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT----- 263 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC-----
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEE-----
Confidence 568899999999999999999874 889999998542 1222333444 4666777899999999999984
Q ss_pred CceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeC
Q 046270 337 GKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFG 416 (590)
Q Consensus 337 ~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFG 416 (590)
....||||||+++|+|.++|. +.+.+++.....++.||+.||+||| +.+||||||||+|||||.++.+||+|||
T Consensus 264 ~~~lylVmEy~~GGdL~~~l~---~~~~l~E~~a~~y~~qIl~aL~yLH---~~gIiHRDLKPeNILld~~G~vKL~DFG 337 (689)
T 3v5w_A 264 PDKLSFILDLMNGGDLHYHLS---QHGVFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLG 337 (689)
T ss_dssp SSEEEEEECCCCSCBHHHHHH---HHCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred CCEEEEEEecCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHeEEeCCCCEEecccc
Confidence 456999999999999999995 3467999999999999999999999 9999999999999999999999999999
Q ss_pred CcccccCCCcccccccccCCCccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCc
Q 046270 417 LAKQSLEGHSHLTTRVAGTFGYLAPEYALY-GQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKV 495 (590)
Q Consensus 417 la~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~ 495 (590)
+|+...... .....||+.|||||++.. ..|+.++|+||+||+||||++|+.||........ ......... ...
T Consensus 338 lA~~~~~~~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~--~~i~~~i~~-~~~ 411 (689)
T 3v5w_A 338 LACDFSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK--HEIDRMTLT-MAV 411 (689)
T ss_dssp TCEECSSCC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCH--HHHHHHHHH-CCC
T ss_pred eeeecCCCC---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHhhcC-CCC
Confidence 998764432 344689999999999975 4799999999999999999999999965332211 001111111 110
Q ss_pred hhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCC-----HHHHHH
Q 046270 496 DDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPT-----ITDALK 538 (590)
Q Consensus 496 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt-----m~eVl~ 538 (590)
..+..+...+.+++..|++.||.+|++ +.||.+
T Consensus 412 ----------~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 412 ----------ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp ----------CCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred ----------CCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 011122346778889999999999998 678754
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=360.26 Aligned_cols=262 Identities=24% Similarity=0.320 Sum_probs=213.0
Q ss_pred ccccHHHHHHHhcC----------CCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCCCChHHHHHHHHHHHhcCCC
Q 046270 252 KWFHVSELEQATNG----------FSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHR 320 (590)
Q Consensus 252 ~~f~~~el~~at~~----------f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~ 320 (590)
..|++++++.+++. |...+.||+|+||.||+|++. +|+.||||++........+.+.+|+.++++++||
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence 45788898888875 666779999999999999987 6899999999876666778899999999999999
Q ss_pred CccccceeEEeccCCCCceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCC
Q 046270 321 NLLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKST 400 (590)
Q Consensus 321 nlv~l~g~~~~~~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~ 400 (590)
||+++++++.. +...++||||+++|+|.+++. ...++|..+..++.||+.||.||| +.+|+||||||+
T Consensus 103 niv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~----~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~ 170 (321)
T 2c30_A 103 NVVEMYKSYLV-----GEELWVLMEFLQGGALTDIVS----QVRLNEEQIATVCEAVLQALAYLH---AQGVIHRDIKSD 170 (321)
T ss_dssp TBCCEEEEEEE-----TTEEEEEECCCCSCBHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGG
T ss_pred CcceEEEEEEE-----CCEEEEEEecCCCCCHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHH
Confidence 99999999984 346899999999999999884 346999999999999999999999 889999999999
Q ss_pred ceEECCCCcEEEEeeCCcccccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchh
Q 046270 401 NILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQ 480 (590)
Q Consensus 401 NILLd~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~ 480 (590)
|||++.++.+||+|||+++....... ......||+.|+|||++.++.++.++||||||+++|||++|+.||...... .
T Consensus 171 NIll~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~-~ 248 (321)
T 2c30_A 171 SILLTLDGRVKLSDFGFCAQISKDVP-KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPV-Q 248 (321)
T ss_dssp GEEECTTCCEEECCCTTCEECCSSSC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-H
T ss_pred HEEECCCCcEEEeeeeeeeecccCcc-ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-H
Confidence 99999999999999999986644322 234567999999999999999999999999999999999999999653221 1
Q ss_pred hhhHHHHHHHhcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 481 LITDWAWVLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 481 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
.+ ..... ........ .......+.+++..|++.||++|||+.|+++.
T Consensus 249 ~~----~~~~~-~~~~~~~~-------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 249 AM----KRLRD-SPPPKLKN-------SHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp HH----HHHHH-SSCCCCTT-------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HH----HHHhc-CCCCCcCc-------cccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11 11111 11110000 01122357778889999999999999999874
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=367.38 Aligned_cols=266 Identities=27% Similarity=0.349 Sum_probs=206.3
Q ss_pred hcCCCccceecccCcEEEEEEEEcCCcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEEE
Q 046270 263 TNGFSQNNLIGQGASGIVYKGTLRHGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFL 342 (590)
Q Consensus 263 t~~f~~~~~LG~G~fG~Vykg~~~~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~L 342 (590)
.++|...+.||+|+||.||+|++. ++.||||++.... .....+..|+.++.+++||||+++++++..... .....++
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~-~~~~~~l 99 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTS-VDVDLWL 99 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECS-SSEEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCC-CCceEEE
Confidence 357888999999999999999987 7899999985432 233456678999999999999999999986543 2456899
Q ss_pred EEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCC----------CeEecCCCCCceEECCCCcEEE
Q 046270 343 VYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKP----------GIYHRDIKSTNILLDSELNAKV 412 (590)
Q Consensus 343 V~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~----------~ivHrDIKp~NILLd~~~~~kL 412 (590)
||||+++|+|.+++. ...++|..++.|+.||+.||+||| +. +|+||||||+|||++.++.+||
T Consensus 100 v~e~~~~g~L~~~l~----~~~~~~~~~~~i~~qi~~al~~LH---~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL 172 (322)
T 3soc_A 100 ITAFHEKGSLSDFLK----ANVVSWNELCHIAETMARGLAYLH---EDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACI 172 (322)
T ss_dssp EEECCTTCBHHHHHH----HCCBCHHHHHHHHHHHHHHHHHHT---CCEEEETTEEECEEECSCCSGGGEEECTTCCEEE
T ss_pred EEecCCCCCHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHH---hhccccccccCCCEEeCCCChHhEEECCCCeEEE
Confidence 999999999999984 245999999999999999999999 77 9999999999999999999999
Q ss_pred EeeCCcccccCCCcc-cccccccCCCccCcccccc-----CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhh-----
Q 046270 413 ADFGLAKQSLEGHSH-LTTRVAGTFGYLAPEYALY-----GQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQL----- 481 (590)
Q Consensus 413 ~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~~~~-----~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~----- 481 (590)
+|||+++........ ......||..|+|||.+.+ ..++.++||||||+++|||+||+.||.........
T Consensus 173 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~ 252 (322)
T 3soc_A 173 ADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEE 252 (322)
T ss_dssp CCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHH
T ss_pred ccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhh
Confidence 999999876543322 2334678999999999876 35667899999999999999999999754432210
Q ss_pred ------hhHHHHHHHhcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhcc
Q 046270 482 ------ITDWAWVLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEG 542 (590)
Q Consensus 482 ------l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~ 542 (590)
..++...... ......+.... ........+.+++..|++.||++|||+.||+++|+.
T Consensus 253 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 315 (322)
T 3soc_A 253 IGQHPSLEDMQEVVVH-KKKRPVLRDYW---QKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQ 315 (322)
T ss_dssp HCSSCCHHHHHHHHTT-SCCCCCCCGGG---GSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred hccCCchhhhhhhhhc-ccCCCCccccc---cccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 1111111111 11111111111 111234568899999999999999999999999975
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-43 Score=362.17 Aligned_cols=263 Identities=28% Similarity=0.403 Sum_probs=200.7
Q ss_pred HHHHhcCCCccceecccCcEEEEEEEEcCCcEEEEEEeecCCCC--ChHHHHHHHHHHHhcCCCCccccceeEEeccCCC
Q 046270 259 LEQATNGFSQNNLIGQGASGIVYKGTLRHGNLVAVKQILDLDTK--GDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSS 336 (590)
Q Consensus 259 l~~at~~f~~~~~LG~G~fG~Vykg~~~~g~~vAvK~l~~~~~~--~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~ 336 (590)
+....++|...+.||+|+||.||+|++. |+.||||++...... ..+++.+|++++++++||||+++++++..
T Consensus 32 ~~i~~~~y~i~~~lG~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----- 105 (309)
T 3p86_A 32 MDIPWCDLNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQ----- 105 (309)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-----
T ss_pred ccCChhHceeeeEeecCCCeEEEEEEEC-CCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE-----
Confidence 3344567888999999999999999874 889999998654322 23578999999999999999999999874
Q ss_pred CceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCCceEECCCCcEEEEe
Q 046270 337 GKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPG--IYHRDIKSTNILLDSELNAKVAD 414 (590)
Q Consensus 337 ~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~--ivHrDIKp~NILLd~~~~~kL~D 414 (590)
....++||||+++|+|.+++........+++..++.|+.||+.||+||| +.+ |+||||||+|||++.++.+||+|
T Consensus 106 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~~~ivH~Dikp~NIll~~~~~~kL~D 182 (309)
T 3p86_A 106 PPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH---NRNPPIVHRNLKSPNLLVDKKYTVKVCD 182 (309)
T ss_dssp TTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHH---TSSSCCCCTTCCGGGEEECTTCCEEECC
T ss_pred CCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH---cCCCCEECCCCChhhEEEeCCCcEEECC
Confidence 3458999999999999999965433445999999999999999999999 888 99999999999999999999999
Q ss_pred eCCcccccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCC
Q 046270 415 FGLAKQSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGK 494 (590)
Q Consensus 415 FGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~ 494 (590)
||+++...... .......||..|+|||.+.+..++.++||||||+++|||++|+.||....... .. ........
T Consensus 183 fg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~-~~----~~~~~~~~ 256 (309)
T 3p86_A 183 FGLSRLKASTF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQ-VV----AAVGFKCK 256 (309)
T ss_dssp CC------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHH-HH----HHHHHSCC
T ss_pred CCCCccccccc-cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HH----HHHHhcCC
Confidence 99998543322 22344678999999999999999999999999999999999999997543211 11 11111111
Q ss_pred chhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhccCCC
Q 046270 495 VDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEGDID 545 (590)
Q Consensus 495 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~~~~ 545 (590)
..+ .+......+.+++..|++.||.+|||+.+++++|+....
T Consensus 257 ~~~---------~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~ 298 (309)
T 3p86_A 257 RLE---------IPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIK 298 (309)
T ss_dssp CCC---------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred CCC---------CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 111 011122367788999999999999999999999987643
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=355.07 Aligned_cols=251 Identities=24% Similarity=0.382 Sum_probs=205.7
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEE
Q 046270 263 TNGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRF 341 (590)
Q Consensus 263 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~ 341 (590)
.++|...+.||+|+||.||+|... +|+.||||++........+.+.+|+.++++++||||+++++++.. +...+
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~~~~~ 93 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV-----GDELW 93 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEE-----CCEEE
Confidence 357889999999999999999974 588999999976666667789999999999999999999999984 44689
Q ss_pred EEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccc
Q 046270 342 LVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQS 421 (590)
Q Consensus 342 LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~ 421 (590)
+||||+++|+|.+++. ...+++.++..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++..
T Consensus 94 lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~ 166 (297)
T 3fxz_A 94 VVMEYLAGGSLTDVVT----ETCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI 166 (297)
T ss_dssp EEEECCTTCBHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEECCCCCCHHHHHh----hcCCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEECCCCCEEEeeCCCceec
Confidence 9999999999999884 236999999999999999999999 889999999999999999999999999999866
Q ss_pred cCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhhhH
Q 046270 422 LEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDE 501 (590)
Q Consensus 422 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 501 (590)
..... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||........ + ......+.....
T Consensus 167 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-~----~~~~~~~~~~~~--- 237 (297)
T 3fxz_A 167 TPEQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA-L----YLIATNGTPELQ--- 237 (297)
T ss_dssp CSTTC-CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-H----HHHHHHCSCCCS---
T ss_pred CCccc-ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-H----HHHHhCCCCCCC---
Confidence 44332 23446799999999999999999999999999999999999999965332111 1 111111111000
Q ss_pred HHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 502 FIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 502 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
.+......+.+++..|++.||++|||+.|+++.
T Consensus 238 -----~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 238 -----NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp -----CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred -----CccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 011223467788999999999999999999863
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-43 Score=350.84 Aligned_cols=256 Identities=26% Similarity=0.403 Sum_probs=208.8
Q ss_pred hcCCCccceecccCcEEEEEEEEcCCcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEEE
Q 046270 263 TNGFSQNNLIGQGASGIVYKGTLRHGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFL 342 (590)
Q Consensus 263 t~~f~~~~~LG~G~fG~Vykg~~~~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~L 342 (590)
.++|...+.||+|+||.||+|.++++..||+|++.... ...+++.+|++++.+++||||+++++++.. ....++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~~l 80 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSK-----EYPIYI 80 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECS-----SSSEEE
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEcc-----CCceEE
Confidence 45688889999999999999999988899999986543 346779999999999999999999999863 445899
Q ss_pred EEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCccccc
Q 046270 343 VYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSL 422 (590)
Q Consensus 343 V~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~~ 422 (590)
||||+++++|.+++.. ....+++.+++.|+.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++...
T Consensus 81 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~ 155 (268)
T 3sxs_A 81 VTEYISNGCLLNYLRS--HGKGLEPSQLLEMCYDVCEGMAFLE---SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVL 155 (268)
T ss_dssp EEECCTTCBHHHHHHH--HGGGCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCSGGGEEECTTCCEEECCTTCEEECC
T ss_pred EEEccCCCcHHHHHHH--cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCcceEEECCCCCEEEccCccceecc
Confidence 9999999999999853 2346999999999999999999999 8899999999999999999999999999998765
Q ss_pred CCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhhHHHHHHHhcCCchhhhhH
Q 046270 423 EGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDE 501 (590)
Q Consensus 423 ~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 501 (590)
...........+|..|+|||.+.+..++.++||||||++++||+| |+.||........ . .. ...+... ..
T Consensus 156 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~-~----~~-~~~~~~~--~~- 226 (268)
T 3sxs_A 156 DDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEV-V----LK-VSQGHRL--YR- 226 (268)
T ss_dssp TTCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHH-H----HH-HHTTCCC--CC-
T ss_pred hhhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHH-H----HH-HHcCCCC--CC-
Confidence 544433444556778999999998899999999999999999999 9999865433211 1 11 1111100 00
Q ss_pred HHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhccCC
Q 046270 502 FIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEGDI 544 (590)
Q Consensus 502 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~~~ 544 (590)
+......+.+++..|++.||++|||+.|+++.|+...
T Consensus 227 ------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~ 263 (268)
T 3sxs_A 227 ------PHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLR 263 (268)
T ss_dssp ------CTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGC
T ss_pred ------CCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 0111236778899999999999999999999998754
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-43 Score=352.66 Aligned_cols=253 Identities=26% Similarity=0.429 Sum_probs=206.2
Q ss_pred cCCCccceecccCcEEEEEEEEcCCcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEEEE
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLRHGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFLV 343 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~LV 343 (590)
++|...+.||+|+||.||+|++.+++.||+|++.... ...+++.+|++++++++||||+++++++.. ....++|
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv 83 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLE-----QAPICLV 83 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECS-----SSSEEEE
T ss_pred hhceeeheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEec-----CCceEEE
Confidence 4678889999999999999999889999999986543 346789999999999999999999999874 3458999
Q ss_pred EeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccccC
Q 046270 344 YDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLE 423 (590)
Q Consensus 344 ~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~~~ 423 (590)
|||+++++|.+++.. ....+++..++.|+.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++....
T Consensus 84 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 158 (269)
T 4hcu_A 84 FEFMEHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 158 (269)
T ss_dssp EECCTTCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred EEeCCCCcHHHHHHh--cCcccCHHHHHHHHHHHHHHHHHHH---hCCeecCCcchheEEEcCCCCEEeccccccccccc
Confidence 999999999999853 3456999999999999999999999 89999999999999999999999999999986644
Q ss_pred CCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhhHHHHHHHhcCCchhhhhHH
Q 046270 424 GHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDEF 502 (590)
Q Consensus 424 ~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 502 (590)
..........+|..|+|||.+....++.++||||||++++||++ |+.||...... .... .. ..+...
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~-~~~~----~~-~~~~~~------ 226 (269)
T 4hcu_A 159 DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS-EVVE----DI-STGFRL------ 226 (269)
T ss_dssp HHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-HHHH----HH-HTTCCC------
T ss_pred cccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH-HHHH----HH-hcCccC------
Confidence 33333444567788999999999999999999999999999999 89998653321 1111 11 111000
Q ss_pred HhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhcc
Q 046270 503 IRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEG 542 (590)
Q Consensus 503 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~ 542 (590)
..+......+.+++..|++.||++|||+.+++++|+.
T Consensus 227 ---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~ 263 (269)
T 4hcu_A 227 ---YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAE 263 (269)
T ss_dssp ---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ---CCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHH
Confidence 0011112467788899999999999999999999975
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-43 Score=381.96 Aligned_cols=262 Identities=24% Similarity=0.401 Sum_probs=211.8
Q ss_pred HHHHHHhcCCCccceecccCcEEEEEEEEcCCcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCC
Q 046270 257 SELEQATNGFSQNNLIGQGASGIVYKGTLRHGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSS 336 (590)
Q Consensus 257 ~el~~at~~f~~~~~LG~G~fG~Vykg~~~~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~ 336 (590)
.+.+...++|...+.||+|+||.||+|.++++..||||++.... ...++|.+|++++++++||||+++++++.
T Consensus 181 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~------ 253 (454)
T 1qcf_A 181 DAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT------ 253 (454)
T ss_dssp TCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC------
T ss_pred cceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe------
Confidence 44455667888999999999999999999988999999987543 45778999999999999999999999985
Q ss_pred CceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeC
Q 046270 337 GKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFG 416 (590)
Q Consensus 337 ~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFG 416 (590)
....++||||+++|+|.+++... ....+++..++.++.||+.||+||| +.+|+||||||+|||++.++.+||+|||
T Consensus 254 ~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DFG 329 (454)
T 1qcf_A 254 KEPIYIITEFMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFG 329 (454)
T ss_dssp SSSCEEEECCCTTCBHHHHHHSH-HHHTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTCCEEECSTT
T ss_pred CCccEEEEeecCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEEECCCCcEEEeeCC
Confidence 23479999999999999999633 2346899999999999999999999 8899999999999999999999999999
Q ss_pred CcccccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhhHHHHHHHhcCCc
Q 046270 417 LAKQSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLDTSTSPFQLITDWAWVLAKSGKV 495 (590)
Q Consensus 417 la~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~ 495 (590)
+++..............++..|+|||.+..+.++.++|||||||++|||+| |+.||...... ..+ ..+ ..+..
T Consensus 330 ~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~-~~~----~~i-~~~~~ 403 (454)
T 1qcf_A 330 LARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP-EVI----RAL-ERGYR 403 (454)
T ss_dssp GGGGBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-HHH----HHH-HHTCC
T ss_pred CceEcCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH-HHH----HHH-HcCCC
Confidence 998754332222333456788999999999999999999999999999999 99998653321 111 111 11110
Q ss_pred hhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhccCC
Q 046270 496 DDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEGDI 544 (590)
Q Consensus 496 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~~~ 544 (590)
. ..+......+.+++..|++.||++|||+++|+++|+...
T Consensus 404 ~---------~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~ 443 (454)
T 1qcf_A 404 M---------PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFY 443 (454)
T ss_dssp C---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred C---------CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence 0 011123346788999999999999999999999999754
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=365.93 Aligned_cols=256 Identities=29% Similarity=0.435 Sum_probs=202.0
Q ss_pred cCCCccceecccCcEEEEEEEEc----CCcEEEEEEeecCCC-CChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCc
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLR----HGNLVAVKQILDLDT-KGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGK 338 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~----~g~~vAvK~l~~~~~-~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~ 338 (590)
++|...+.||+|+||.||+|++. .+..||||++..... ...+.|.+|++++++++||||+++++++.. +.
T Consensus 49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~ 123 (325)
T 3kul_A 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTR-----GR 123 (325)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECG-----GG
T ss_pred hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe-----CC
Confidence 45677799999999999999985 345699999875432 234679999999999999999999999864 34
Q ss_pred eEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCc
Q 046270 339 RRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLA 418 (590)
Q Consensus 339 ~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla 418 (590)
..++||||+++|+|.+++.. ....+++.+++.|+.||+.||.||| +.+|+||||||+|||++.++.+||+|||++
T Consensus 124 ~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 198 (325)
T 3kul_A 124 LAMIVTEYMENGSLDTFLRT--HDGQFTIMQLVGMLRGVGAGMRYLS---DLGYVHRDLAARNVLVDSNLVCKVSDFGLS 198 (325)
T ss_dssp CCEEEEECCTTCBHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCSSC
T ss_pred ccEEEeeCCCCCcHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEECCCCCEEECCCCcc
Confidence 58999999999999999853 3357999999999999999999999 899999999999999999999999999999
Q ss_pred ccccCCCcc--cccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhhHHHHHHHhcCCc
Q 046270 419 KQSLEGHSH--LTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLDTSTSPFQLITDWAWVLAKSGKV 495 (590)
Q Consensus 419 ~~~~~~~~~--~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~ 495 (590)
+........ ......+|..|+|||.+.+..++.++||||||+++|||++ |+.||....... ... . ...+..
T Consensus 199 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~-~~~----~-~~~~~~ 272 (325)
T 3kul_A 199 RVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRD-VIS----S-VEEGYR 272 (325)
T ss_dssp EECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH-HHH----H-HHTTCC
T ss_pred cccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHH-HHH----H-HHcCCC
Confidence 876543222 2233456778999999999999999999999999999999 999986533211 111 1 111110
Q ss_pred hhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhccCC
Q 046270 496 DDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEGDI 544 (590)
Q Consensus 496 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~~~ 544 (590)
.. .+......+.+++..|++.||.+|||+.+|+++|+...
T Consensus 273 ~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~ 312 (325)
T 3kul_A 273 LP---------APMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALI 312 (325)
T ss_dssp CC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CC---------CCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 00 11122346788999999999999999999999998754
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-43 Score=369.51 Aligned_cols=258 Identities=25% Similarity=0.395 Sum_probs=205.4
Q ss_pred hcCCCccceecccCcEEEEEEEEc--------CCcEEEEEEeecCCCC-ChHHHHHHHHHHHhc-CCCCccccceeEEec
Q 046270 263 TNGFSQNNLIGQGASGIVYKGTLR--------HGNLVAVKQILDLDTK-GDEDFTNEVEIISKI-RHRNLLSLRGCCVTS 332 (590)
Q Consensus 263 t~~f~~~~~LG~G~fG~Vykg~~~--------~g~~vAvK~l~~~~~~-~~~~f~~Ev~il~~l-~H~nlv~l~g~~~~~ 332 (590)
.++|...+.||+|+||.||+|++. ++..||||++...... ..+.+.+|+++++++ +||||+++++++..
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~- 158 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ- 158 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS-
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc-
Confidence 367888899999999999999863 3457999998654322 245789999999999 89999999999874
Q ss_pred cCCCCceEEEEEeeCCCCCcchhhhhhcc-------------cccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCC
Q 046270 333 DDSSGKRRFLVYDYMPNGTLSDNISISHK-------------RKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKS 399 (590)
Q Consensus 333 ~~~~~~~~~LV~E~~~~gsL~~~L~~~~~-------------~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp 399 (590)
....++||||+++|+|.+++..... ...+++.+++.++.||++||+||| +.+|+||||||
T Consensus 159 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp 231 (370)
T 2psq_A 159 ----DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAA 231 (370)
T ss_dssp ----SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCG
T ss_pred ----CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccch
Confidence 3458999999999999999964321 235899999999999999999999 89999999999
Q ss_pred CceEECCCCcEEEEeeCCcccccCCCc-ccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCC
Q 046270 400 TNILLDSELNAKVADFGLAKQSLEGHS-HLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLDTSTS 477 (590)
Q Consensus 400 ~NILLd~~~~~kL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELlt-G~~p~~~~~~ 477 (590)
+|||++.++.+||+|||+++....... .......+|+.|+|||.+.+..++.++|||||||++|||+| |+.||.....
T Consensus 232 ~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~ 311 (370)
T 2psq_A 232 RNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 311 (370)
T ss_dssp GGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred hhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 999999999999999999986544332 22344567889999999999999999999999999999999 9999865432
Q ss_pred chhhhhHHHHHHHhcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhccC
Q 046270 478 PFQLITDWAWVLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEGD 543 (590)
Q Consensus 478 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~~ 543 (590)
.. .. . ....+...+ .+......+.+++..|++.||++|||+.|+++.|+..
T Consensus 312 ~~-~~----~-~~~~~~~~~---------~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~i 362 (370)
T 2psq_A 312 EE-LF----K-LLKEGHRMD---------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 362 (370)
T ss_dssp GG-HH----H-HHHTTCCCC---------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HH-HH----H-HHhcCCCCC---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 11 11 1 112221111 1112234677889999999999999999999999763
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-42 Score=356.74 Aligned_cols=252 Identities=28% Similarity=0.384 Sum_probs=201.7
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCC-CChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEE
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDT-KGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRF 341 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~-~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~ 341 (590)
++|...+.||+|+||.||+|++. +++.||||++..... ...+.+.+|+.++++++||||+++++++. .+...+
T Consensus 7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-----~~~~~~ 81 (323)
T 3tki_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR-----EGNIQY 81 (323)
T ss_dssp TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEE-----CSSEEE
T ss_pred hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEe-----cCCeEE
Confidence 57889999999999999999987 588999999864332 22456899999999999999999999987 455689
Q ss_pred EEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccc
Q 046270 342 LVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQS 421 (590)
Q Consensus 342 LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~ 421 (590)
+||||+++|+|.+++. ....+++.+++.|+.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++..
T Consensus 82 lv~e~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 155 (323)
T 3tki_A 82 LFLEYCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVF 155 (323)
T ss_dssp EEEECCTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEcCCCCcHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccccchHHEEEeCCCCEEEEEeecccee
Confidence 9999999999999884 3456999999999999999999999 899999999999999999999999999999865
Q ss_pred cCCC-cccccccccCCCccCccccccCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhh
Q 046270 422 LEGH-SHLTTRVAGTFGYLAPEYALYGQL-TEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIF 499 (590)
Q Consensus 422 ~~~~-~~~~~~~~gt~~Y~APE~~~~~~~-t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 499 (590)
.... ........||+.|+|||.+.+..+ +.++||||||+++|||++|+.||............|.. .......
T Consensus 156 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~----~~~~~~~- 230 (323)
T 3tki_A 156 RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE----KKTYLNP- 230 (323)
T ss_dssp EETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHT----TCTTSTT-
T ss_pred ccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhc----ccccCCc-
Confidence 4332 223345679999999999987775 77999999999999999999999765543333322211 1111000
Q ss_pred hHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 500 DEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 500 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
.......+.+++..|++.||++|||+.|+++.
T Consensus 231 --------~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 231 --------WKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp --------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred --------cccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 01122466778899999999999999999875
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=352.68 Aligned_cols=261 Identities=27% Similarity=0.333 Sum_probs=203.8
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCCCC---hHHHHHHHHHHHhcCCCCccccceeEEeccCCCCc
Q 046270 263 TNGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDTKG---DEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGK 338 (590)
Q Consensus 263 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~~~---~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~ 338 (590)
.++|...+.||+|+||.||+++.. .+..||+|++....... .+.+.+|++++.+++||||+++++++. .+.
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~-----~~~ 84 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDE-----EDD 84 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEE-----CSS
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeee-----eCC
Confidence 357888999999999999999976 58899999986543332 356889999999999999999999987 345
Q ss_pred eEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCc
Q 046270 339 RRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLA 418 (590)
Q Consensus 339 ~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla 418 (590)
..++||||+++|+|.+++. ..+.+++..++.++.|++.||+||| +.+|+||||||+|||++.++.+||+|||++
T Consensus 85 ~~~lv~e~~~g~~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~ 158 (294)
T 4eqm_A 85 CYYLVMEYIEGPTLSEYIE---SHGPLSVDTAINFTNQILDGIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIA 158 (294)
T ss_dssp EEEEEEECCCSCBHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCSSS
T ss_pred eEEEEEeCCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEEeCCCc
Confidence 6999999999999999985 3457999999999999999999999 889999999999999999999999999999
Q ss_pred ccccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhh
Q 046270 419 KQSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDI 498 (590)
Q Consensus 419 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 498 (590)
+..............||+.|+|||.+.+..++.++||||||+++|||+||+.||........ ....... .....
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~-----~~~~~~~-~~~~~ 232 (294)
T 4eqm_A 159 KALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSI-----AIKHIQD-SVPNV 232 (294)
T ss_dssp TTC-------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHH-----HHHHHSS-CCCCH
T ss_pred cccccccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH-----HHHHhhc-cCCCc
Confidence 87654443344556799999999999999999999999999999999999999975432111 1111111 11111
Q ss_pred hhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCC-CHHHHHHHhccCCC
Q 046270 499 FDEFIRAEGARAVMERFVLVGILCAHVMVALRP-TITDALKMLEGDID 545 (590)
Q Consensus 499 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-tm~eVl~~L~~~~~ 545 (590)
.. ....+....+.+++..|++.||++|| ++.++.+.|+....
T Consensus 233 -~~----~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~ 275 (294)
T 4eqm_A 233 -TT----DVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLH 275 (294)
T ss_dssp -HH----HSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred -ch----hcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence 11 11122335778899999999999999 99999999987543
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=363.22 Aligned_cols=265 Identities=23% Similarity=0.402 Sum_probs=202.1
Q ss_pred cCCCccceecccCcEEEEEEEEc-----CCcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCc
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLR-----HGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGK 338 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~-----~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~ 338 (590)
++|...+.||+|+||.||++++. +++.||||++........+.+.+|++++++++||||+++++++...+ ..
T Consensus 10 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---~~ 86 (295)
T 3ugc_A 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG---RR 86 (295)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHH---HT
T ss_pred HHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC---CC
Confidence 56788899999999999999852 57899999997655555678999999999999999999999986542 23
Q ss_pred eEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCc
Q 046270 339 RRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLA 418 (590)
Q Consensus 339 ~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla 418 (590)
..++||||+++|+|.+++... ...+++.+++.++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++
T Consensus 87 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~ 161 (295)
T 3ugc_A 87 NLKLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLT 161 (295)
T ss_dssp SCEEEEECCTTCBHHHHHHHC--GGGCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCSC
T ss_pred ceEEEEEeCCCCCHHHHHHhc--ccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHhhEEEcCCCeEEEccCccc
Confidence 479999999999999998632 345999999999999999999999 899999999999999999999999999999
Q ss_pred ccccCCCcc--cccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCch
Q 046270 419 KQSLEGHSH--LTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVD 496 (590)
Q Consensus 419 ~~~~~~~~~--~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 496 (590)
+........ ......++..|+|||.+.+..++.++||||||+++|||+||..|+...... +.... ......
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~------~~~~~-~~~~~~ 234 (295)
T 3ugc_A 162 KVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE------FMRMI-GNDKQG 234 (295)
T ss_dssp C-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHH------HHHHH-CTTCCT
T ss_pred ccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHH------HHhhh-cCcccc
Confidence 876443221 223345677899999999999999999999999999999999887532110 11000 111110
Q ss_pred hhhh----HHHh----hhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhccC
Q 046270 497 DIFD----EFIR----AEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEGD 543 (590)
Q Consensus 497 ~~~d----~~l~----~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~~ 543 (590)
.... ..+. ...+......+.+++..|++.||++|||+.|++++|+..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l 289 (295)
T 3ugc_A 235 QMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 289 (295)
T ss_dssp HHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred chhHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 0000 0000 001122345788899999999999999999999999753
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=373.33 Aligned_cols=256 Identities=28% Similarity=0.414 Sum_probs=193.2
Q ss_pred cCCCccceecccCcEEEEEEEEc----CCcEEEEEEeecCCC-CChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCc
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLR----HGNLVAVKQILDLDT-KGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGK 338 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~----~g~~vAvK~l~~~~~-~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~ 338 (590)
++|...+.||+|+||.||+|++. .+..||||++..... ...++|.+|++++++++||||+++++++.. +.
T Consensus 45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~~ 119 (373)
T 2qol_A 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK-----SK 119 (373)
T ss_dssp GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-----SS
T ss_pred hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee-----CC
Confidence 57888999999999999999876 467899999865432 234679999999999999999999999874 34
Q ss_pred eEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCc
Q 046270 339 RRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLA 418 (590)
Q Consensus 339 ~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla 418 (590)
..++||||+++|+|.+++.. ....+++.+++.|+.||++||+||| +.+|+||||||+|||++.++.+||+|||++
T Consensus 120 ~~~lv~e~~~~~sL~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 194 (373)
T 2qol_A 120 PVMIVTEYMENGSLDSFLRK--HDAQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLG 194 (373)
T ss_dssp SCEEEEECCTTCBHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC---
T ss_pred ceEEEEeCCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEEcCCCCEEECcCccc
Confidence 58999999999999999853 3346999999999999999999999 889999999999999999999999999999
Q ss_pred ccccCCCccc--ccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhhHHHHHHHhcCCc
Q 046270 419 KQSLEGHSHL--TTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLDTSTSPFQLITDWAWVLAKSGKV 495 (590)
Q Consensus 419 ~~~~~~~~~~--~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~ 495 (590)
+......... .....++..|+|||++.++.++.++||||||+++|||++ |+.||...... . +. .. ...+.
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~-~-~~---~~-i~~~~- 267 (373)
T 2qol_A 195 RVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ-D-VI---KA-VDEGY- 267 (373)
T ss_dssp -------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHH-H-HH---HH-HHTTE-
T ss_pred cccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHH-H-HH---HH-HHcCC-
Confidence 8765432221 222345778999999999999999999999999999998 99998643321 1 11 11 11110
Q ss_pred hhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhccCC
Q 046270 496 DDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEGDI 544 (590)
Q Consensus 496 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~~~ 544 (590)
....+......+.+++..|++.||.+||++.+|+++|+...
T Consensus 268 --------~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~ 308 (373)
T 2qol_A 268 --------RLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308 (373)
T ss_dssp --------ECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --------CCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHH
Confidence 00011123347788999999999999999999999997643
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-42 Score=371.96 Aligned_cols=265 Identities=20% Similarity=0.228 Sum_probs=208.5
Q ss_pred ccHHHHHHHhcCCCccceecccCcEEEEEEEEcC-CcEEEEEEeecC---CCCChHHHHHHHHHHHhcCCCCccccceeE
Q 046270 254 FHVSELEQATNGFSQNNLIGQGASGIVYKGTLRH-GNLVAVKQILDL---DTKGDEDFTNEVEIISKIRHRNLLSLRGCC 329 (590)
Q Consensus 254 f~~~el~~at~~f~~~~~LG~G~fG~Vykg~~~~-g~~vAvK~l~~~---~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~ 329 (590)
+.+.++...+++|...++||+|+||.||+|++++ ++.||+|++... .......+.+|+.++.+++||||+++++++
T Consensus 64 ~~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 143 (437)
T 4aw2_A 64 SKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAF 143 (437)
T ss_dssp HHHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred chhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 4466777778899999999999999999999875 778999998642 122234488999999999999999999999
Q ss_pred EeccCCCCceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCc
Q 046270 330 VTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELN 409 (590)
Q Consensus 330 ~~~~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~ 409 (590)
. .+...++||||+++|+|.+++.. ....+++..++.++.||+.||.||| +.+|+||||||+||||+.++.
T Consensus 144 ~-----~~~~~~lV~Ey~~gg~L~~~l~~--~~~~l~e~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILl~~~g~ 213 (437)
T 4aw2_A 144 Q-----DDNNLYLVMDYYVGGDLLTLLSK--FEDRLPEEMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGH 213 (437)
T ss_dssp E-----CSSEEEEEECCCTTCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSC
T ss_pred e-----eCCEEEEEEecCCCCcHHHHHHH--ccCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeeEcCCCC
Confidence 7 34569999999999999999953 2457999999999999999999999 899999999999999999999
Q ss_pred EEEEeeCCcccccCCCcccccccccCCCccCccccc-----cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhH
Q 046270 410 AKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYAL-----YGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITD 484 (590)
Q Consensus 410 ~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~-----~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~ 484 (590)
+||+|||+++..............||+.|+|||++. .+.++.++|||||||++|||++|+.||....... ....
T Consensus 214 vkL~DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~-~~~~ 292 (437)
T 4aw2_A 214 IRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE-TYGK 292 (437)
T ss_dssp EEECCCTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHH
T ss_pred EEEcchhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhH-HHHh
Confidence 999999999876655544455578999999999987 5679999999999999999999999997543211 1111
Q ss_pred HHHHHHhcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCC--CCCHHHHHHH
Q 046270 485 WAWVLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVAL--RPTITDALKM 539 (590)
Q Consensus 485 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~--RPtm~eVl~~ 539 (590)
..... ..-..... .......+.+++..|++.+|++ ||+++|+++.
T Consensus 293 i~~~~-~~~~~p~~---------~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 293 IMNHK-ERFQFPTQ---------VTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp HHTHH-HHCCCCSS---------CCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred hhhcc-ccccCCcc---------cccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 10000 00000000 0012235667777888777777 9999999874
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-43 Score=368.08 Aligned_cols=268 Identities=24% Similarity=0.346 Sum_probs=212.0
Q ss_pred ccHHHHHHHhcCCCccceecccCcEEEEEEEEc------CCcEEEEEEeecCCCC-ChHHHHHHHHHHHhc-CCCCcccc
Q 046270 254 FHVSELEQATNGFSQNNLIGQGASGIVYKGTLR------HGNLVAVKQILDLDTK-GDEDFTNEVEIISKI-RHRNLLSL 325 (590)
Q Consensus 254 f~~~el~~at~~f~~~~~LG~G~fG~Vykg~~~------~g~~vAvK~l~~~~~~-~~~~f~~Ev~il~~l-~H~nlv~l 325 (590)
+...+.+...++|...+.||+|+||.||+|++. +++.||||++...... ..+.+.+|++++.++ +||||+++
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~ 91 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 91 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence 455666777889999999999999999999853 3578999999754332 245699999999999 89999999
Q ss_pred ceeEEeccCCCCceEEEEEeeCCCCCcchhhhhhcc--------------------------------------------
Q 046270 326 RGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHK-------------------------------------------- 361 (590)
Q Consensus 326 ~g~~~~~~~~~~~~~~LV~E~~~~gsL~~~L~~~~~-------------------------------------------- 361 (590)
++++... +...++||||+++|+|.+++.....
T Consensus 92 ~~~~~~~----~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (359)
T 3vhe_A 92 LGACTKP----GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGF 167 (359)
T ss_dssp EEEECST----TSCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------
T ss_pred eeeeecC----CCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccc
Confidence 9998753 3458999999999999999864321
Q ss_pred -------------------cccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCccccc
Q 046270 362 -------------------RKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSL 422 (590)
Q Consensus 362 -------------------~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~~ 422 (590)
...+++..++.|+.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++...
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 244 (359)
T 3vhe_A 168 VEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIY 244 (359)
T ss_dssp ----------------CTTTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTT
T ss_pred ccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCcEEEEeccceeeec
Confidence 112899999999999999999999 8899999999999999999999999999998654
Q ss_pred CCCc-ccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhhHHHHHHHhcCCchhhhh
Q 046270 423 EGHS-HLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFD 500 (590)
Q Consensus 423 ~~~~-~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 500 (590)
.... .......||..|+|||.+.+..++.++||||||+++|||+| |+.||.......... .....+.....
T Consensus 245 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~-----~~~~~~~~~~~-- 317 (359)
T 3vhe_A 245 KDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC-----RRLKEGTRMRA-- 317 (359)
T ss_dssp SCTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHH-----HHHHHTCCCCC--
T ss_pred ccccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHH-----HHHHcCCCCCC--
Confidence 4332 23345668899999999999999999999999999999999 999997544332211 11111211110
Q ss_pred HHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhcc
Q 046270 501 EFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEG 542 (590)
Q Consensus 501 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~ 542 (590)
+......+.+++..|++.||++|||+.|++++|+.
T Consensus 318 -------~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 352 (359)
T 3vhe_A 318 -------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 352 (359)
T ss_dssp -------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -------CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHH
Confidence 11122367788899999999999999999999975
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=351.23 Aligned_cols=255 Identities=24% Similarity=0.397 Sum_probs=204.2
Q ss_pred HhcCCCccceecccCcEEEEEEEEcCCcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEE
Q 046270 262 ATNGFSQNNLIGQGASGIVYKGTLRHGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRF 341 (590)
Q Consensus 262 at~~f~~~~~LG~G~fG~Vykg~~~~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~ 341 (590)
..++|...+.||+|+||.||+|.+.++..||||++.... ...+++.+|++++.+++|+||+++++++.. ....+
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~~ 95 (283)
T 3gen_A 22 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTK-----QRPIF 95 (283)
T ss_dssp CGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECS-----SSSEE
T ss_pred CHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEec-----CCCeE
Confidence 345788889999999999999999988899999986543 346789999999999999999999999863 44589
Q ss_pred EEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccc
Q 046270 342 LVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQS 421 (590)
Q Consensus 342 LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~ 421 (590)
+||||+++|+|.+++.. ....+++.+++.|+.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++..
T Consensus 96 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 170 (283)
T 3gen_A 96 IITEYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV 170 (283)
T ss_dssp EEECCCTTCBHHHHHHC--GGGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTSCEEECSTTGGGGB
T ss_pred EEEeccCCCcHHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCccceEEEcCCCCEEEccccccccc
Confidence 99999999999999853 2456999999999999999999999 899999999999999999999999999999866
Q ss_pred cCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhhHHHHHHHhcCCchhhhh
Q 046270 422 LEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFD 500 (590)
Q Consensus 422 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 500 (590)
............+|..|+|||.+....++.++||||||+++|||+| |+.||....... . .... ..+...
T Consensus 171 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~-~----~~~~-~~~~~~---- 240 (283)
T 3gen_A 171 LDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE-T----AEHI-AQGLRL---- 240 (283)
T ss_dssp CCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH-H----HHHH-HTTCCC----
T ss_pred cccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhH-H----HHHH-hcccCC----
Confidence 4433333334556788999999999999999999999999999999 999986543211 1 1111 111100
Q ss_pred HHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhcc
Q 046270 501 EFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEG 542 (590)
Q Consensus 501 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~ 542 (590)
..+....+.+.+++..|++.+|++|||+.++++.|+.
T Consensus 241 -----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~ 277 (283)
T 3gen_A 241 -----YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 277 (283)
T ss_dssp -----CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred -----CCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHH
Confidence 0011112467789999999999999999999999875
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=362.03 Aligned_cols=254 Identities=25% Similarity=0.395 Sum_probs=198.0
Q ss_pred cCCCccceecccCcEEEEEEEEcC-Cc----EEEEEEeecC-CCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCC
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLRH-GN----LVAVKQILDL-DTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSG 337 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~~-g~----~vAvK~l~~~-~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~ 337 (590)
++|...+.||+|+||.||+|++.. ++ .||+|.+... .....+.|.+|++++++++||||+++++++...
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----- 89 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS----- 89 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS-----
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-----
Confidence 468888999999999999999753 44 3688887543 234567899999999999999999999999742
Q ss_pred ceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCC
Q 046270 338 KRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGL 417 (590)
Q Consensus 338 ~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGl 417 (590)
..++|+||+++|+|.+++.. ....+++..++.|+.||+.||.||| +.+|+||||||+|||++.++++||+|||+
T Consensus 90 -~~~~v~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~ 163 (327)
T 3poz_A 90 -TVQLITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGL 163 (327)
T ss_dssp -SEEEEEECCTTCBHHHHHHH--STTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTH
T ss_pred -CeEEEEEecCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCChheEEECCCCCEEEccCcc
Confidence 37899999999999999863 3456999999999999999999999 88999999999999999999999999999
Q ss_pred cccccCCCcc-cccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhhHHHHHHHhcCCc
Q 046270 418 AKQSLEGHSH-LTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLDTSTSPFQLITDWAWVLAKSGKV 495 (590)
Q Consensus 418 a~~~~~~~~~-~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~ 495 (590)
++........ ......||..|+|||++.++.++.++||||||+++|||+| |+.||....... +... ...+..
T Consensus 164 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~~~----~~~~~~ 237 (327)
T 3poz_A 164 AKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--ISSI----LEKGER 237 (327)
T ss_dssp HHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--HHHH----HHTTCC
T ss_pred eeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH--HHHH----HHcCCC
Confidence 9876443322 2334556889999999999999999999999999999999 999997543321 1111 111111
Q ss_pred hhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhccC
Q 046270 496 DDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEGD 543 (590)
Q Consensus 496 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~~ 543 (590)
.. .+......+..++..|++.+|.+|||+.|++++|+..
T Consensus 238 ~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~ 276 (327)
T 3poz_A 238 LP---------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 276 (327)
T ss_dssp CC---------CCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHH
T ss_pred CC---------CCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 00 0111234677899999999999999999999998764
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-42 Score=353.39 Aligned_cols=257 Identities=19% Similarity=0.275 Sum_probs=200.3
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCC-CChHHHHHHHHHHHhcCCCCccccceeEEeccC------
Q 046270 263 TNGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDT-KGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDD------ 334 (590)
Q Consensus 263 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~-~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~------ 334 (590)
.++|...+.||+|+||.||+|++. +|+.||||++..... ...+.+.+|++++++++||||+++++++.....
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 356888999999999999999987 688999999865433 345679999999999999999999999875432
Q ss_pred ----------------------------------------------CCCceEEEEEeeCCCCCcchhhhhhcccccCChh
Q 046270 335 ----------------------------------------------SSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWP 368 (590)
Q Consensus 335 ----------------------------------------------~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~ 368 (590)
......++||||+++|+|.+++.........++.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 1223489999999999999999755555567788
Q ss_pred hHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccccCCCc-----------ccccccccCCC
Q 046270 369 QRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHS-----------HLTTRVAGTFG 437 (590)
Q Consensus 369 ~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~~~~~~-----------~~~~~~~gt~~ 437 (590)
.++.|+.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++....... .......||+.
T Consensus 165 ~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp HHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred HHHHHHHHHHHHHHHHH---hCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence 89999999999999999 89999999999999999999999999999987654321 12234568999
Q ss_pred ccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhhhHHHhhhhHHHHHHHHHH
Q 046270 438 YLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDEFIRAEGARAVMERFVL 517 (590)
Q Consensus 438 Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~ 517 (590)
|+|||.+.+..++.++||||||+++|||++|..|+. ... . ............. .......+.+
T Consensus 242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~------~~~-~-~~~~~~~~~~~~~---------~~~~~~~~~~ 304 (332)
T 3qd2_B 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM------ERV-R-IITDVRNLKFPLL---------FTQKYPQEHM 304 (332)
T ss_dssp GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH------HHH-H-HHHHHHTTCCCHH---------HHHHCHHHHH
T ss_pred ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh------HHH-H-HHHHhhccCCCcc---------cccCChhHHH
Confidence 999999999999999999999999999999876531 111 0 1111112221111 1122235677
Q ss_pred HHHhchhcCCCCCCCHHHHHHH
Q 046270 518 VGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 518 l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
++..|++.||++|||+.|+++.
T Consensus 305 li~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 305 MVQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HHHHHHCSSGGGSCCHHHHHHS
T ss_pred HHHHHccCCCCcCCCHHHHhhc
Confidence 8899999999999999999863
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=376.08 Aligned_cols=262 Identities=29% Similarity=0.403 Sum_probs=205.3
Q ss_pred HHHHhcCCCccceecccCcEEEEEEEEcCCcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCc
Q 046270 259 LEQATNGFSQNNLIGQGASGIVYKGTLRHGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGK 338 (590)
Q Consensus 259 l~~at~~f~~~~~LG~G~fG~Vykg~~~~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~ 338 (590)
.+...++|...+.||+|+||.||+|.++++..||||++.... ...++|.+|++++++++||||+++++++.. .
T Consensus 179 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~------~ 251 (452)
T 1fmk_A 179 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE------E 251 (452)
T ss_dssp SBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS------S
T ss_pred cccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC------C
Confidence 334556788889999999999999999988889999987543 346789999999999999999999999853 3
Q ss_pred eEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCc
Q 046270 339 RRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLA 418 (590)
Q Consensus 339 ~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla 418 (590)
..++||||+++|+|.+++... ....+++.+++.|+.||+.||+||| +.+|+||||||+|||+++++.+||+|||++
T Consensus 252 ~~~iv~e~~~~gsL~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a 327 (452)
T 1fmk_A 252 PIYIVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLA 327 (452)
T ss_dssp SCEEEECCCTTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTT
T ss_pred ceEEEehhhcCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEECCCCCEEECCCccc
Confidence 479999999999999999632 2346999999999999999999999 899999999999999999999999999999
Q ss_pred ccccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhhHHHHHHHhcCCchh
Q 046270 419 KQSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLDTSTSPFQLITDWAWVLAKSGKVDD 497 (590)
Q Consensus 419 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 497 (590)
+..............++..|+|||.+..+.++.++||||||+++|||+| |+.||...... ..+ .. ...+....
T Consensus 328 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~-~~~----~~-i~~~~~~~ 401 (452)
T 1fmk_A 328 RLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-EVL----DQ-VERGYRMP 401 (452)
T ss_dssp C--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-HHH----HH-HHTTCCCC
T ss_pred eecCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHH-HHH----HH-HHcCCCCC
Confidence 8765433333334456789999999999999999999999999999999 89998643321 111 11 11121100
Q ss_pred hhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhccCCCC
Q 046270 498 IFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEGDIDI 546 (590)
Q Consensus 498 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~~~~~ 546 (590)
.+....+.+.+++..|++.||++|||+++++++|+.....
T Consensus 402 ---------~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~ 441 (452)
T 1fmk_A 402 ---------CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 441 (452)
T ss_dssp ---------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred ---------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence 1112334677899999999999999999999999986543
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-42 Score=357.80 Aligned_cols=248 Identities=23% Similarity=0.311 Sum_probs=201.9
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCC--CChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCce
Q 046270 263 TNGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDT--KGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKR 339 (590)
Q Consensus 263 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~--~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~ 339 (590)
.++|...+.||+|+||.||+|++. .|+.||||++..... ...+.+.+|++++++++||||+++++++.. ...
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-----~~~ 88 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIET-----EKT 88 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----SSE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE-----CCE
Confidence 457889999999999999999984 689999999865422 234568899999999999999999999873 456
Q ss_pred EEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcc
Q 046270 340 RFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAK 419 (590)
Q Consensus 340 ~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~ 419 (590)
.++||||+++|+|.+++. ..+.+++.++..++.||+.||+||| +.+|+||||||+|||++.++++||+|||+++
T Consensus 89 ~~lv~e~~~~~~L~~~l~---~~~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~ 162 (328)
T 3fe3_A 89 LYLIMEYASGGEVFDYLV---AHGRMKEKEARSKFRQIVSAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSN 162 (328)
T ss_dssp EEEEECCCTTCBHHHHHH---HHCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTCCG
T ss_pred EEEEEECCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCCHHHEEEcCCCCEEEeeccCce
Confidence 999999999999999985 3457999999999999999999999 8899999999999999999999999999998
Q ss_pred cccCCCcccccccccCCCccCccccccCCCC-cchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhh
Q 046270 420 QSLEGHSHLTTRVAGTFGYLAPEYALYGQLT-EKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDI 498 (590)
Q Consensus 420 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t-~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 498 (590)
...... ......||+.|+|||.+.+..+. .++|||||||++|||++|+.||...... +....... +...
T Consensus 163 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-----~~~~~i~~-~~~~-- 232 (328)
T 3fe3_A 163 EFTVGG--KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLK-----ELRERVLR-GKYR-- 232 (328)
T ss_dssp GGSSSC--GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHHHHHH-CCCC--
T ss_pred ecCCCC--ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHH-----HHHHHHHh-CCCC--
Confidence 654432 33456799999999999888765 7999999999999999999999753321 11111111 1110
Q ss_pred hhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 499 FDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 499 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
.+......+.+++..|++.||.+|||++|+++.
T Consensus 233 --------~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 233 --------IPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp --------CCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred --------CCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 001122356778899999999999999999874
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=350.66 Aligned_cols=272 Identities=19% Similarity=0.280 Sum_probs=212.1
Q ss_pred cCCCccceecccCcEEEEEEEEcC-CcEEEEEEeecCC-CCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEE
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLRH-GNLVAVKQILDLD-TKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRF 341 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~vAvK~l~~~~-~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~ 341 (590)
++|...++||+|+||.||+|++.. |+.||||++.... ....+.+.+|++++++++||||+++++++.... ....+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---~~~~~ 85 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETT---TRHKV 85 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTT---TCCEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCC---CceEE
Confidence 568888999999999999999875 8899999986533 234567889999999999999999999987542 34689
Q ss_pred EEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEE----CCCCcEEEEeeCC
Q 046270 342 LVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILL----DSELNAKVADFGL 417 (590)
Q Consensus 342 LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILL----d~~~~~kL~DFGl 417 (590)
+||||+++|+|.+++........+++.+++.|+.||+.||+||| +.+|+||||||+|||+ +.++.+||+|||+
T Consensus 86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~ 162 (319)
T 4euu_A 86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA 162 (319)
T ss_dssp EEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEECTTSCEEEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEeccCCCCceEEEccCCC
Confidence 99999999999999975544445999999999999999999999 8899999999999999 8888899999999
Q ss_pred cccccCCCcccccccccCCCccCccccc--------cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHH
Q 046270 418 AKQSLEGHSHLTTRVAGTFGYLAPEYAL--------YGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVL 489 (590)
Q Consensus 418 a~~~~~~~~~~~~~~~gt~~Y~APE~~~--------~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~ 489 (590)
++...... ......||..|+|||.+. ...++.++||||||+++|||++|+.||........... .....
T Consensus 163 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~-~~~~~ 239 (319)
T 4euu_A 163 ARELEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKE-VMYKI 239 (319)
T ss_dssp CEECCTTC--CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHH-HHHHH
T ss_pred ceecCCCC--ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHH-HHHHH
Confidence 98764433 223456899999999886 57889999999999999999999999975544332221 11111
Q ss_pred HhcCC---chhh---------hhHHHh--hhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhccCC
Q 046270 490 AKSGK---VDDI---------FDEFIR--AEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEGDI 544 (590)
Q Consensus 490 ~~~~~---~~~~---------~d~~l~--~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~~~ 544 (590)
..... ...+ +.+.+. ..........+..++..|++.||++|||+.|+++....+.
T Consensus 240 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~ 308 (319)
T 4euu_A 240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (319)
T ss_dssp HHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred hcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence 11110 0000 000000 1122445567888999999999999999999999987643
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-42 Score=361.40 Aligned_cols=270 Identities=14% Similarity=0.182 Sum_probs=206.0
Q ss_pred HhcCCCccceecccCcEEEEEEEEcC------CcEEEEEEeecCCCCC-----------hHHHHHHHHHHHhcCCCCccc
Q 046270 262 ATNGFSQNNLIGQGASGIVYKGTLRH------GNLVAVKQILDLDTKG-----------DEDFTNEVEIISKIRHRNLLS 324 (590)
Q Consensus 262 at~~f~~~~~LG~G~fG~Vykg~~~~------g~~vAvK~l~~~~~~~-----------~~~f~~Ev~il~~l~H~nlv~ 324 (590)
..++|...+.||+|+||.||+|.+.. ++.||||++....... ...+..|+..+.+++|+||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 45678999999999999999999875 3689999986543211 112334555666778999999
Q ss_pred cceeEEeccCCCCceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEE
Q 046270 325 LRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILL 404 (590)
Q Consensus 325 l~g~~~~~~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILL 404 (590)
+++++..... .....++||||+ +++|.+++.. ....++|.+++.|+.||+.||+||| +.+|+||||||+|||+
T Consensus 113 ~~~~~~~~~~-~~~~~~lv~e~~-g~~L~~~~~~--~~~~l~~~~~~~i~~qi~~~l~~lH---~~~iiHrDlkp~Nill 185 (364)
T 3op5_A 113 YWGSGLHDKN-GKSYRFMIMDRF-GSDLQKIYEA--NAKRFSRKTVLQLSLRILDILEYIH---EHEYVHGDIKASNLLL 185 (364)
T ss_dssp EEEEEEEEET-TEEEEEEEEECE-EEEHHHHHHH--TTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEE
T ss_pred EEeeeeeccC-CcceEEEEEeCC-CCCHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHH---HCCeEEecCCHHHEEE
Confidence 9999986543 345689999999 9999999853 3357999999999999999999999 8899999999999999
Q ss_pred C--CCCcEEEEeeCCcccccCCCcc------cccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 046270 405 D--SELNAKVADFGLAKQSLEGHSH------LTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTST 476 (590)
Q Consensus 405 d--~~~~~kL~DFGla~~~~~~~~~------~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~ 476 (590)
+ .++.+||+|||+++........ ......||+.|+|||.+.+..++.++|||||||++|||+||+.||....
T Consensus 186 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~ 265 (364)
T 3op5_A 186 NYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNL 265 (364)
T ss_dssp ESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred ecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccc
Confidence 9 8899999999999865433221 1133459999999999999999999999999999999999999997533
Q ss_pred CchhhhhHHHHHHHhcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhccC
Q 046270 477 SPFQLITDWAWVLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEGD 543 (590)
Q Consensus 477 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~~ 543 (590)
....... +..... ...+.+++++.+.. ......+..++..|++.+|.+||++.+++++|+..
T Consensus 266 ~~~~~~~-~~~~~~-~~~~~~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~ 327 (364)
T 3op5_A 266 KDPKYVR-DSKIRY-RENIASLMDKCFPA---ANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQG 327 (364)
T ss_dssp TCHHHHH-HHHHHH-HHCHHHHHHHHSCT---TCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred cCHHHHH-HHHHHh-hhhHHHHHHHhccc---ccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Confidence 3222211 111111 12334444444321 12234778899999999999999999999998764
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=360.51 Aligned_cols=255 Identities=27% Similarity=0.409 Sum_probs=200.2
Q ss_pred cCCCccceecccCcEEEEEEEEcC-Cc----EEEEEEeecCC-CCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCC
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLRH-GN----LVAVKQILDLD-TKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSG 337 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~~-g~----~vAvK~l~~~~-~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~ 337 (590)
++|...+.||+|+||.||+|++.. +. .||+|.+.... ......+.+|+.++.+++||||+++++++. +
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~------~ 86 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP------G 86 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC------B
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc------C
Confidence 467788999999999999999764 44 38888875433 233456889999999999999999999885 2
Q ss_pred ceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCC
Q 046270 338 KRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGL 417 (590)
Q Consensus 338 ~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGl 417 (590)
...++||||+++|+|.+++.. ....+++..++.|+.||+.||+||| +.+|+||||||+|||++.++.+||+|||+
T Consensus 87 ~~~~~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~ 161 (325)
T 3kex_A 87 SSLQLVTQYLPLGSLLDHVRQ--HRGALGPQLLLNWGVQIAKGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGV 161 (325)
T ss_dssp SSEEEEEECCTTCBSHHHHHS--SGGGSCTTHHHHHHHHHHHHHHHHH---HTTCCCSCCSSTTEEESSSSCEEECSCSG
T ss_pred CccEEEEEeCCCCCHHHHHHH--ccccCCHHHHHHHHHHHHHHHHHHH---hCCCCCCccchheEEECCCCeEEECCCCc
Confidence 348999999999999999853 2457999999999999999999999 88999999999999999999999999999
Q ss_pred cccccCCCcc-cccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhhHHHHHHHhcCCc
Q 046270 418 AKQSLEGHSH-LTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLDTSTSPFQLITDWAWVLAKSGKV 495 (590)
Q Consensus 418 a~~~~~~~~~-~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~ 495 (590)
++........ ......||..|+|||.+..+.++.++||||||+++|||+| |+.||....... +.+ ....+..
T Consensus 162 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~----~~~~~~~ 235 (325)
T 3kex_A 162 ADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE--VPD----LLEKGER 235 (325)
T ss_dssp GGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTH--HHH----HHHTTCB
T ss_pred ccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHH--HHH----HHHcCCC
Confidence 9876544332 2345667889999999999999999999999999999999 999997543321 111 1111111
Q ss_pred hhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhccCC
Q 046270 496 DDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEGDI 544 (590)
Q Consensus 496 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~~~ 544 (590)
... +......+..++..|++.||.+|||+.|++++|+...
T Consensus 236 ~~~---------~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~ 275 (325)
T 3kex_A 236 LAQ---------PQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMA 275 (325)
T ss_dssp CCC---------CTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHT
T ss_pred CCC---------CCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 000 0011235667888999999999999999999997654
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=381.29 Aligned_cols=259 Identities=22% Similarity=0.357 Sum_probs=210.4
Q ss_pred HHhcCCCccceecccCcEEEEEEEEcC-CcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCce
Q 046270 261 QATNGFSQNNLIGQGASGIVYKGTLRH-GNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKR 339 (590)
Q Consensus 261 ~at~~f~~~~~LG~G~fG~Vykg~~~~-g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~ 339 (590)
....+|...+.||+|+||.||+|+++. +..||||.+.... ...++|.+|++++++++||||++++++|.. ...
T Consensus 217 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-----~~~ 290 (495)
T 1opk_A 217 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTR-----EPP 290 (495)
T ss_dssp CCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-----SSS
T ss_pred cCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEec-----CCc
Confidence 345678888999999999999999986 7899999986543 346789999999999999999999999974 345
Q ss_pred EEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcc
Q 046270 340 RFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAK 419 (590)
Q Consensus 340 ~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~ 419 (590)
.++||||+++|+|.+++... ....+++..++.|+.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++
T Consensus 291 ~~lv~E~~~~g~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~ 366 (495)
T 1opk_A 291 FYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSR 366 (495)
T ss_dssp CEEEEECCTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCEEECCTTCEE
T ss_pred EEEEEEccCCCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChhhEEECCCCcEEEeecccce
Confidence 89999999999999999642 2346999999999999999999999 8999999999999999999999999999998
Q ss_pred cccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhhHHHHHHHhcCCchhh
Q 046270 420 QSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLDTSTSPFQLITDWAWVLAKSGKVDDI 498 (590)
Q Consensus 420 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 498 (590)
..............++..|+|||.+..+.++.++|||||||++|||+| |+.||....... +.+. ...+...
T Consensus 367 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~--~~~~----~~~~~~~-- 438 (495)
T 1opk_A 367 LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--VYEL----LEKDYRM-- 438 (495)
T ss_dssp CCTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG--HHHH----HHTTCCC--
T ss_pred eccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHH--HHHH----HHcCCCC--
Confidence 765443333344556789999999999999999999999999999999 889986543211 1111 1111100
Q ss_pred hhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhccCC
Q 046270 499 FDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEGDI 544 (590)
Q Consensus 499 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~~~ 544 (590)
..+......+.+++..|++.||++|||+.+++++|+...
T Consensus 439 -------~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 439 -------ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp -------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred -------CCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 111122346788899999999999999999999999754
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-43 Score=371.24 Aligned_cols=256 Identities=23% Similarity=0.368 Sum_probs=203.4
Q ss_pred HhcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCCC-ChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCce
Q 046270 262 ATNGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDTK-GDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKR 339 (590)
Q Consensus 262 at~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~~-~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~ 339 (590)
..++|...+.||+|+||.||+|++. +++.||||.+...... ..++|.+|++++++++||||+++++++.. +..
T Consensus 112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-----~~~ 186 (377)
T 3cbl_A 112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ-----KQP 186 (377)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECS-----SSS
T ss_pred chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEec-----CCC
Confidence 3457888899999999999999997 6889999998654222 23468899999999999999999999974 345
Q ss_pred EEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcc
Q 046270 340 RFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAK 419 (590)
Q Consensus 340 ~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~ 419 (590)
.++||||+++|+|.+++.. ....+++..++.++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++
T Consensus 187 ~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~ 261 (377)
T 3cbl_A 187 IYIVMELVQGGDFLTFLRT--EGARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSR 261 (377)
T ss_dssp CEEEEECCTTCBHHHHHHH--HGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCE
T ss_pred cEEEEEcCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHH---HCCcCCcccCHHHEEEcCCCcEEECcCCCce
Confidence 8999999999999999863 2346999999999999999999999 8999999999999999999999999999998
Q ss_pred cccCCCcccc-cccccCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhhHHHHHHHhcCCchh
Q 046270 420 QSLEGHSHLT-TRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLDTSTSPFQLITDWAWVLAKSGKVDD 497 (590)
Q Consensus 420 ~~~~~~~~~~-~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 497 (590)
.......... ....++..|+|||.+..+.++.++||||||+++|||+| |+.|+...... .+. .....+....
T Consensus 262 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~--~~~----~~~~~~~~~~ 335 (377)
T 3cbl_A 262 EEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ--QTR----EFVEKGGRLP 335 (377)
T ss_dssp ECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH--HHH----HHHHTTCCCC
T ss_pred ecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--HHH----HHHHcCCCCC
Confidence 6443221111 12235678999999999999999999999999999999 99998653321 111 1112221111
Q ss_pred hhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhcc
Q 046270 498 IFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEG 542 (590)
Q Consensus 498 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~ 542 (590)
.+......+.+++..|++.||++|||+.++++.|+.
T Consensus 336 ---------~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~ 371 (377)
T 3cbl_A 336 ---------CPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQS 371 (377)
T ss_dssp ---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ---------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHH
Confidence 011123467788999999999999999999999975
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=349.34 Aligned_cols=255 Identities=26% Similarity=0.430 Sum_probs=197.6
Q ss_pred cCCCccceecccCcEEEEEEEEcCCcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEEEE
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLRHGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFLV 343 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~LV 343 (590)
++|...+.||+|+||.||+|++. ++.||||++.. ....+.|.+|++++++++||||+++++++.. ..++|
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-------~~~lv 77 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIES--ESERKAFIVELRQLSRVNHPNIVKLYGACLN-------PVCLV 77 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSS--TTHHHHHHHHHHHHHHCCCTTBCCEEEBCTT-------TTEEE
T ss_pred hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecC--hhHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-------CcEEE
Confidence 45778899999999999999986 78899999853 2345679999999999999999999998752 26899
Q ss_pred EeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCc-EEEEeeCCccccc
Q 046270 344 YDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELN-AKVADFGLAKQSL 422 (590)
Q Consensus 344 ~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~-~kL~DFGla~~~~ 422 (590)
|||+++|+|.+++........+++..++.++.|+++||+|||+....+|+||||||+|||++.++. +||+|||+++...
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~ 157 (307)
T 2eva_A 78 MEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ 157 (307)
T ss_dssp EECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-----
T ss_pred EEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccc
Confidence 999999999999965444446889999999999999999999332289999999999999998876 7999999997543
Q ss_pred CCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhhhHH
Q 046270 423 EGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDEF 502 (590)
Q Consensus 423 ~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 502 (590)
.. .....||..|+|||.+.+..++.++||||||+++|||++|+.||.........+ .+... .+......
T Consensus 158 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~---~~~~~-~~~~~~~~--- 226 (307)
T 2eva_A 158 TH----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRI---MWAVH-NGTRPPLI--- 226 (307)
T ss_dssp -----------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHH---HHHHH-TTCCCCCB---
T ss_pred cc----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHH---HHHHh-cCCCCCcc---
Confidence 22 233468999999999999999999999999999999999999997544322211 11111 11111111
Q ss_pred HhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhccCCC
Q 046270 503 IRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEGDID 545 (590)
Q Consensus 503 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~~~~ 545 (590)
......+.+++..|++.||++|||+.+++++|+....
T Consensus 227 ------~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 263 (307)
T 2eva_A 227 ------KNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMR 263 (307)
T ss_dssp ------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGG
T ss_pred ------cccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 1122467788899999999999999999999987543
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=351.25 Aligned_cols=256 Identities=27% Similarity=0.408 Sum_probs=207.5
Q ss_pred HhcCCCccceecccCcEEEEEEEEcCCcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEE
Q 046270 262 ATNGFSQNNLIGQGASGIVYKGTLRHGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRF 341 (590)
Q Consensus 262 at~~f~~~~~LG~G~fG~Vykg~~~~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~ 341 (590)
..++|...+.||+|+||.||+|.+.++..||||++.... ...+.+.+|++++++++||||+++++++.. ...+
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~------~~~~ 83 (279)
T 1qpc_A 11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ------EPIY 83 (279)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS------SSCE
T ss_pred CHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC------CCcE
Confidence 346788889999999999999999888899999986543 346789999999999999999999998752 2379
Q ss_pred EEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccc
Q 046270 342 LVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQS 421 (590)
Q Consensus 342 LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~ 421 (590)
+||||+++++|.+++... ....+++.+++.++.|++.||+||| +.+|+||||||+|||+++++.+||+|||+++..
T Consensus 84 ~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 159 (279)
T 1qpc_A 84 IITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLI 159 (279)
T ss_dssp EEEECCTTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEecCCCCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHhhEEEcCCCCEEECCCcccccc
Confidence 999999999999998532 2236999999999999999999999 899999999999999999999999999999876
Q ss_pred cCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhhHHHHHHHhcCCchhhhh
Q 046270 422 LEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFD 500 (590)
Q Consensus 422 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 500 (590)
............++..|+|||.+..+.++.++||||||++++||++ |+.||...... ..+ ... ..+....
T Consensus 160 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-~~~----~~~-~~~~~~~--- 230 (279)
T 1qpc_A 160 EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP-EVI----QNL-ERGYRMV--- 230 (279)
T ss_dssp SSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-HHH----HHH-HTTCCCC---
T ss_pred cCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH-HHH----HHH-hcccCCC---
Confidence 5544333344567889999999998999999999999999999999 89888653321 111 111 1111000
Q ss_pred HHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhccC
Q 046270 501 EFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEGD 543 (590)
Q Consensus 501 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~~ 543 (590)
.+....+.+.+++..|++.||++|||+.+++++|+..
T Consensus 231 ------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 267 (279)
T 1qpc_A 231 ------RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267 (279)
T ss_dssp ------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------CcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence 0111234678899999999999999999999999864
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-43 Score=362.29 Aligned_cols=267 Identities=25% Similarity=0.336 Sum_probs=208.2
Q ss_pred cCCCccceecccCcEEEEEEEE-----cCCcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCc
Q 046270 264 NGFSQNNLIGQGASGIVYKGTL-----RHGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGK 338 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~-----~~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~ 338 (590)
++|...+.||+|+||.||++++ ..+..||||++........+.+.+|++++++++|+||+++++++... ...
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~~ 99 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGP---GRQ 99 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS---SSC
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecC---CCc
Confidence 4678889999999999999985 35789999999766555566799999999999999999999998743 345
Q ss_pred eEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCc
Q 046270 339 RRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLA 418 (590)
Q Consensus 339 ~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla 418 (590)
..++||||+++++|.+++... ...+++.+++.|+.||+.||+||| +.+|+||||||+|||++.++.+||+|||++
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~ 174 (327)
T 3lxl_A 100 SLRLVMEYLPSGCLRDFLQRH--RARLDASRLLLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLA 174 (327)
T ss_dssp EEEEEEECCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCGGGC
T ss_pred eEEEEEeecCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChhhEEECCCCCEEEcccccc
Confidence 689999999999999998632 346999999999999999999999 899999999999999999999999999999
Q ss_pred ccccCCCcc--cccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCC--
Q 046270 419 KQSLEGHSH--LTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGK-- 494 (590)
Q Consensus 419 ~~~~~~~~~--~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~-- 494 (590)
+........ ......||..|+|||.+.+..++.++||||||++++||++|+.|+....... .........
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~------~~~~~~~~~~~ 248 (327)
T 3lxl_A 175 KLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEF------LRMMGCERDVP 248 (327)
T ss_dssp EECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH------HHHCC----CC
T ss_pred eecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchh------hhhcccccccc
Confidence 876543322 2334567888999999999999999999999999999999999875321110 000000000
Q ss_pred -chhhhhHH---HhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhccCC
Q 046270 495 -VDDIFDEF---IRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEGDI 544 (590)
Q Consensus 495 -~~~~~d~~---l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~~~ 544 (590)
..++.+.. .....+......+.+++..|++.||++|||+.|++++|+...
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 302 (327)
T 3lxl_A 249 ALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLW 302 (327)
T ss_dssp HHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-
T ss_pred cHHHHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 01111100 000111223457888999999999999999999999998754
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-41 Score=350.97 Aligned_cols=248 Identities=22% Similarity=0.294 Sum_probs=201.9
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecC---CCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCce
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDL---DTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKR 339 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~---~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~ 339 (590)
++|...+.||+|+||.||+++.+ +|+.||+|++... .......+.+|++++++++||||+++++++.. ...
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-----~~~ 79 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT-----HDR 79 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC-----SSE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEe-----CCE
Confidence 57888999999999999999987 4889999998653 23445678999999999999999999999974 456
Q ss_pred EEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcc
Q 046270 340 RFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAK 419 (590)
Q Consensus 340 ~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~ 419 (590)
.++||||+++|+|.+++. ..+.+++..++.++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++
T Consensus 80 ~~lv~E~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~ 153 (337)
T 1o6l_A 80 LCFVMEYANGGELFFHLS---RERVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK 153 (337)
T ss_dssp EEEEEECCTTCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEEEeCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCCHHHEEECCCCCEEEeeccchh
Confidence 999999999999999885 3457999999999999999999999 8899999999999999999999999999998
Q ss_pred cccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhh
Q 046270 420 QSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIF 499 (590)
Q Consensus 420 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 499 (590)
...... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||...... . ....... +...
T Consensus 154 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~-~----~~~~i~~-~~~~--- 223 (337)
T 1o6l_A 154 EGISDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-R----LFELILM-EEIR--- 223 (337)
T ss_dssp CSCCTT-CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-H----HHHHHHH-CCCC---
T ss_pred hcccCC-CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHH-H----HHHHHHc-CCCC---
Confidence 643222 2234567999999999999999999999999999999999999999653221 1 1111111 1110
Q ss_pred hHHHhhhhHHHHHHHHHHHHHhchhcCCCCCC-----CHHHHHHH
Q 046270 500 DEFIRAEGARAVMERFVLVGILCAHVMVALRP-----TITDALKM 539 (590)
Q Consensus 500 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-----tm~eVl~~ 539 (590)
.+......+.+++..|++.||++|| ++.|+++.
T Consensus 224 -------~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 224 -------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp -------CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred -------CCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 0111234677788999999999999 89999764
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=353.70 Aligned_cols=268 Identities=25% Similarity=0.340 Sum_probs=198.4
Q ss_pred hcCCCccceecccCcEEEEEEEEcCCcEEEEEEeecCCCCChHHHHHHHHHHH--hcCCCCccccceeEEeccCCCCceE
Q 046270 263 TNGFSQNNLIGQGASGIVYKGTLRHGNLVAVKQILDLDTKGDEDFTNEVEIIS--KIRHRNLLSLRGCCVTSDDSSGKRR 340 (590)
Q Consensus 263 t~~f~~~~~LG~G~fG~Vykg~~~~g~~vAvK~l~~~~~~~~~~f~~Ev~il~--~l~H~nlv~l~g~~~~~~~~~~~~~ 340 (590)
.++|...+.||+|+||.||+|++. ++.||||++... ....+..|.+++. .++|+||+++++++...........
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSLD-ERPVAVKVFSFA---NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEET-TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred hHHhheeeecccCCCeEEEEEEEC-CeEEEEEEeecc---chhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence 357888899999999999999874 789999998642 3445555665544 5899999999998766554455678
Q ss_pred EEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCC---------CeEecCCCCCceEECCCCcEE
Q 046270 341 FLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKP---------GIYHRDIKSTNILLDSELNAK 411 (590)
Q Consensus 341 ~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~---------~ivHrDIKp~NILLd~~~~~k 411 (590)
++||||+++|+|.+++. ...++|..+..|+.||++||.||| +. +|+||||||+|||++.++.+|
T Consensus 88 ~lv~e~~~~g~L~~~l~----~~~~~~~~~~~i~~qi~~~L~~LH---~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k 160 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLS----LHTSDWVSSCRLAHSVTRGLAYLH---TELPRGDHYKPAISHRDLNSRNVLVKNDGTCV 160 (336)
T ss_dssp EEEECCCTTCBHHHHHH----HCCBCHHHHHHHHHHHHHHHHHHH---CCBCCGGGCBCCEECSSCSGGGEEECTTSCEE
T ss_pred EEEEecCCCCcHHHHHh----hcccchhHHHHHHHHHHHHHHHHH---hhhccccccccceeecccccceEEEcCCCcEE
Confidence 99999999999999984 335699999999999999999999 67 999999999999999999999
Q ss_pred EEeeCCcccccCCC-------cccccccccCCCccCcccccc-------CCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 046270 412 VADFGLAKQSLEGH-------SHLTTRVAGTFGYLAPEYALY-------GQLTEKSDVYSFGIVILELMSGRKVLDTSTS 477 (590)
Q Consensus 412 L~DFGla~~~~~~~-------~~~~~~~~gt~~Y~APE~~~~-------~~~t~ksDVySfGvvLlELltG~~p~~~~~~ 477 (590)
|+|||+++...... ........||..|+|||.+.+ ..++.++||||||+++|||++|+.|+.....
T Consensus 161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~ 240 (336)
T 3g2f_A 161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES 240 (336)
T ss_dssp ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSC
T ss_pred EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccc
Confidence 99999998654322 112234568999999999876 4567899999999999999999877643322
Q ss_pred chhhhhHHH------------HHHHhcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhccC
Q 046270 478 PFQLITDWA------------WVLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEGD 543 (590)
Q Consensus 478 ~~~~l~~~~------------~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~~ 543 (590)
.......+. ............+..... ........+.+++..|++.||++|||+.|++++|+..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~l 316 (336)
T 3g2f_A 241 VPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWK--ENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAEL 316 (336)
T ss_dssp CCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCC--CCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred hhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccc--cccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHH
Confidence 111000000 000111110000000000 0112445788999999999999999999999998764
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=350.33 Aligned_cols=256 Identities=15% Similarity=0.182 Sum_probs=203.4
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCCCChHHHHHHHHHHHhc-CCCCccccceeEEeccCCCCceE
Q 046270 263 TNGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDTKGDEDFTNEVEIISKI-RHRNLLSLRGCCVTSDDSSGKRR 340 (590)
Q Consensus 263 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l-~H~nlv~l~g~~~~~~~~~~~~~ 340 (590)
.++|...+.||+|+||.||+|+.. +|+.||||.+.... ..+.+.+|+++++++ +|+||+++++++.. +...
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~-----~~~~ 80 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGPC-----GKYN 80 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEEE-----TTEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEec-----CCcc
Confidence 357888999999999999999974 58899999986543 234688999999999 99999999999874 4568
Q ss_pred EEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCc-----EEEEee
Q 046270 341 FLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELN-----AKVADF 415 (590)
Q Consensus 341 ~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~-----~kL~DF 415 (590)
++||||+ +++|.+++... ...+++..++.|+.||+.||+||| +.+|+||||||+|||++.++. +||+||
T Consensus 81 ~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH---~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DF 154 (330)
T 2izr_A 81 AMVLELL-GPSLEDLFDLC--DRTFSLKTVLMIAIQLISRMEYVH---SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDF 154 (330)
T ss_dssp EEEEECC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTCTTSEEECCC
T ss_pred EEEEEeC-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeeccCCCCCCceEEEEEc
Confidence 9999999 99999998632 457999999999999999999999 889999999999999999887 999999
Q ss_pred CCcccccCCCcc------cccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchh--hhhHHHH
Q 046270 416 GLAKQSLEGHSH------LTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQ--LITDWAW 487 (590)
Q Consensus 416 Gla~~~~~~~~~------~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~--~l~~~~~ 487 (590)
|+++........ ......||..|+|||.+.+..++.++||||||+++|||++|+.||........ .+..+..
T Consensus 155 g~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~ 234 (330)
T 2izr_A 155 ALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGD 234 (330)
T ss_dssp TTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHH
T ss_pred ccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHh
Confidence 999875443221 12456799999999999999999999999999999999999999976433221 1111100
Q ss_pred HHHhcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhcc
Q 046270 488 VLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEG 542 (590)
Q Consensus 488 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~ 542 (590)
.... ... ..+. .... .+..++..|++.+|.+||++.++.++|+.
T Consensus 235 ~~~~--~~~----~~~~----~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~ 278 (330)
T 2izr_A 235 TKRA--TPI----EVLC----ENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTD 278 (330)
T ss_dssp HHHH--SCH----HHHT----TTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHH
T ss_pred hhcc--CCH----HHHh----ccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHH
Confidence 0000 000 0000 1122 77889999999999999999999998864
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=368.87 Aligned_cols=251 Identities=30% Similarity=0.389 Sum_probs=202.7
Q ss_pred HhcCCCccceecccCcEEEEEEEEcCCcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEE
Q 046270 262 ATNGFSQNNLIGQGASGIVYKGTLRHGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRF 341 (590)
Q Consensus 262 at~~f~~~~~LG~G~fG~Vykg~~~~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~ 341 (590)
..++|...+.||+|+||.||+|.++ |+.||||+++... ..+.|.+|++++++++||||+++++++... ....+
T Consensus 191 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~----~~~~~ 263 (450)
T 1k9a_A 191 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEE----KGGLY 263 (450)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECT----TSCEE
T ss_pred ChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcC----CCceE
Confidence 3457888899999999999999987 7899999987543 457899999999999999999999998753 23589
Q ss_pred EEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccc
Q 046270 342 LVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQS 421 (590)
Q Consensus 342 LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~ 421 (590)
+||||+++|+|.+++... ....+++..++.++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++..
T Consensus 264 iv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~ 339 (450)
T 1k9a_A 264 IVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA 339 (450)
T ss_dssp EEEECCTTCBHHHHHHHH-CTTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEecCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEECCCCCEEEeeCCCcccc
Confidence 999999999999999643 2334799999999999999999999 889999999999999999999999999999854
Q ss_pred cCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhhHHHHHHHhcCCchhhhh
Q 046270 422 LEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFD 500 (590)
Q Consensus 422 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 500 (590)
... .....++..|+|||.+.++.++.++||||||+++|||+| |+.||....... .. . ....+....
T Consensus 340 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~-~~----~-~i~~~~~~~--- 406 (450)
T 1k9a_A 340 SST----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-VV----P-RVEKGYKMD--- 406 (450)
T ss_dssp C----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT-HH----H-HHHTTCCCC---
T ss_pred ccc----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-HH----H-HHHcCCCCC---
Confidence 322 122356889999999999999999999999999999999 999987543321 11 1 111221111
Q ss_pred HHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhcc
Q 046270 501 EFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEG 542 (590)
Q Consensus 501 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~ 542 (590)
.+......+.+++..|++.||++|||+.++++.|+.
T Consensus 407 ------~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~ 442 (450)
T 1k9a_A 407 ------APDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEH 442 (450)
T ss_dssp ------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ------CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 111223467788999999999999999999999875
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-41 Score=341.08 Aligned_cols=251 Identities=30% Similarity=0.491 Sum_probs=200.3
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCCCCh-------HHHHHHHHHHHhcCCCCccccceeEEeccCC
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDTKGD-------EDFTNEVEIISKIRHRNLLSLRGCCVTSDDS 335 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~~~~-------~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~ 335 (590)
++|...+.||+|+||.||+|++. +++.||+|++........ +.+.+|++++++++||||+++++++...
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--- 95 (287)
T 4f0f_A 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP--- 95 (287)
T ss_dssp TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT---
T ss_pred ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC---
Confidence 57888899999999999999985 588999999865433221 6789999999999999999999988521
Q ss_pred CCceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCCceEECCCCc----
Q 046270 336 SGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPG--IYHRDIKSTNILLDSELN---- 409 (590)
Q Consensus 336 ~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~--ivHrDIKp~NILLd~~~~---- 409 (590)
.++||||+++|+|.+++.. ....+++..++.++.|++.||+||| +.+ |+||||||+|||++.++.
T Consensus 96 ----~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~~ivH~dikp~Nil~~~~~~~~~~ 166 (287)
T 4f0f_A 96 ----PRMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIALGIEYMQ---NQNPPIVHRDLRSPNIFLQSLDENAPV 166 (287)
T ss_dssp ----TEEEEECCTTCBHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCSCCSGGGEEESCCCTTCSC
T ss_pred ----CeEEEEecCCCCHHHHHhc--ccCCccHHHHHHHHHHHHHHHHHHH---hCCCCeecCCCCcceEEEeccCCCCce
Confidence 2799999999999888853 3457999999999999999999999 788 999999999999988776
Q ss_pred -EEEEeeCCcccccCCCcccccccccCCCccCccccc--cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHH
Q 046270 410 -AKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYAL--YGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWA 486 (590)
Q Consensus 410 -~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~--~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~ 486 (590)
+||+|||+++.... ......||..|+|||.+. ...++.++||||||+++|||++|+.||...........
T Consensus 167 ~~kl~Dfg~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~--- 239 (287)
T 4f0f_A 167 CAKVADFGLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFI--- 239 (287)
T ss_dssp CEEECCCTTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHH---
T ss_pred eEEeCCCCccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHH---
Confidence 99999999985433 234467899999999983 45678999999999999999999999976544332111
Q ss_pred HHHHhcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhcc
Q 046270 487 WVLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEG 542 (590)
Q Consensus 487 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~ 542 (590)
......+.... + +......+.+++..|++.||++|||+.|+++.|+.
T Consensus 240 ~~~~~~~~~~~-~--------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 240 NMIREEGLRPT-I--------PEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp HHHHHSCCCCC-C--------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred HHHhccCCCCC-C--------CcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 11111111111 1 11223467889999999999999999999999975
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=357.94 Aligned_cols=271 Identities=23% Similarity=0.304 Sum_probs=195.4
Q ss_pred HHHhcCCCccceecccCcEEEEEEEEcCCc----EEEEEEeecC--CCCChHHHHHHHHHHHhcCCCCccccceeEEecc
Q 046270 260 EQATNGFSQNNLIGQGASGIVYKGTLRHGN----LVAVKQILDL--DTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSD 333 (590)
Q Consensus 260 ~~at~~f~~~~~LG~G~fG~Vykg~~~~g~----~vAvK~l~~~--~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~ 333 (590)
....++|...+.||+|+||.||+|++.... .||||++... .....+.+.+|++++++++||||+++++++....
T Consensus 19 ~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 98 (323)
T 3qup_A 19 LIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSR 98 (323)
T ss_dssp BCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-
T ss_pred ccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccc
Confidence 344568999999999999999999976532 7999998654 2334567999999999999999999999997543
Q ss_pred CC-CCceEEEEEeeCCCCCcchhhhhhcc---cccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCc
Q 046270 334 DS-SGKRRFLVYDYMPNGTLSDNISISHK---RKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELN 409 (590)
Q Consensus 334 ~~-~~~~~~LV~E~~~~gsL~~~L~~~~~---~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~ 409 (590)
.. .....++||||+++|+|.+++..... ...+++.+++.|+.||+.||.||| +.+|+||||||+|||+++++.
T Consensus 99 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~ivH~Dikp~NIli~~~~~ 175 (323)
T 3qup_A 99 AKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLS---SRNFIHRDLAARNCMLAEDMT 175 (323)
T ss_dssp ------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSC
T ss_pred cccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHH---cCCcccCCCCcceEEEcCCCC
Confidence 21 11224999999999999999864332 125999999999999999999999 889999999999999999999
Q ss_pred EEEEeeCCcccccCCCcc-cccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhhHHHH
Q 046270 410 AKVADFGLAKQSLEGHSH-LTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLDTSTSPFQLITDWAW 487 (590)
Q Consensus 410 ~kL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELlt-G~~p~~~~~~~~~~l~~~~~ 487 (590)
+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |+.||....... .. .
T Consensus 176 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~-~~----~ 250 (323)
T 3qup_A 176 VCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE-IY----N 250 (323)
T ss_dssp EEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-HH----H
T ss_pred EEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH-HH----H
Confidence 999999999865443322 2233456789999999999999999999999999999999 899987543321 11 1
Q ss_pred HHHhcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhccCCCCCC
Q 046270 488 VLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEGDIDIPK 548 (590)
Q Consensus 488 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~~~~~~~ 548 (590)
... .+.... .+......+.+++..|++.||++|||+.++++.|+.....+.
T Consensus 251 ~~~-~~~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~ 301 (323)
T 3qup_A 251 YLI-GGNRLK---------QPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLS 301 (323)
T ss_dssp HHH-TTCCCC---------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred HHh-cCCCCC---------CCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhh
Confidence 111 111100 011223467889999999999999999999999987654443
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=351.23 Aligned_cols=257 Identities=21% Similarity=0.315 Sum_probs=195.8
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCCCC---hHHHHHHHHHHHhcCCCCccccceeEEeccCCCCc
Q 046270 263 TNGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDTKG---DEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGK 338 (590)
Q Consensus 263 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~~~---~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~ 338 (590)
.++|...+.||+|+||.||++++. +++.||||++....... ...+.+|++++++++||||+++++++..... .+.
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~-~~~ 89 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETP-AGP 89 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEET-TEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCC-CCc
Confidence 367888999999999999999974 58899999987643333 3468899999999999999999999876553 344
Q ss_pred eEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCc
Q 046270 339 RRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLA 418 (590)
Q Consensus 339 ~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla 418 (590)
..++||||+++|+|.+++. ....+++.+++.|+.||+.||+||| +.+|+||||||+|||++.++.+||+|||++
T Consensus 90 ~~~lv~e~~~g~~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a 163 (311)
T 3ork_A 90 LPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIA 163 (311)
T ss_dssp EEEEEEECCCEEEHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEETTSCEEECCCSCC
T ss_pred ccEEEEecCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEcCCCCEEEeeccCc
Confidence 5699999999999999985 3457999999999999999999999 889999999999999999999999999999
Q ss_pred ccccCCCcc--cccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCch
Q 046270 419 KQSLEGHSH--LTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVD 496 (590)
Q Consensus 419 ~~~~~~~~~--~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 496 (590)
+........ ......||..|+|||.+.+..++.++||||||+++|||++|+.||....... ............
T Consensus 164 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~-----~~~~~~~~~~~~ 238 (311)
T 3ork_A 164 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS-----VAYQHVREDPIP 238 (311)
T ss_dssp ------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-----HHHHHHHCCCCC
T ss_pred ccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH-----HHHHHhcCCCCC
Confidence 865443222 2334568999999999999999999999999999999999999996533211 111122222111
Q ss_pred hhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 046270 497 DIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALK 538 (590)
Q Consensus 497 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~ 538 (590)
. .. ........+..++..|++.||++||++.+++.
T Consensus 239 ~---~~----~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~ 273 (311)
T 3ork_A 239 P---SA----RHEGLSADLDAVVLKALAKNPENRYQTAAEMR 273 (311)
T ss_dssp H---HH----HSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHH
T ss_pred c---cc----ccCCCCHHHHHHHHHHHhcCHhhChhhHHHHH
Confidence 0 00 01112346778999999999999997666553
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-41 Score=346.86 Aligned_cols=269 Identities=25% Similarity=0.321 Sum_probs=202.2
Q ss_pred HHHHhcCCCccceecccCcEEEEEEEEcCCcEEEEEEeecCCCCChHHHHHHHHHHHhc--CCCCccccceeEEeccCCC
Q 046270 259 LEQATNGFSQNNLIGQGASGIVYKGTLRHGNLVAVKQILDLDTKGDEDFTNEVEIISKI--RHRNLLSLRGCCVTSDDSS 336 (590)
Q Consensus 259 l~~at~~f~~~~~LG~G~fG~Vykg~~~~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l--~H~nlv~l~g~~~~~~~~~ 336 (590)
-....++|...+.||+|+||.||+|++. |+.||||++... ....+..|.+++..+ +||||+++++++..... .
T Consensus 32 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~-~ 106 (337)
T 3mdy_A 32 QRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTG-S 106 (337)
T ss_dssp HTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCG-G
T ss_pred ccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCC-C
Confidence 3445578999999999999999999987 899999998542 344566677777665 99999999999886432 2
Q ss_pred CceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCC--------CeEecCCCCCceEECCCC
Q 046270 337 GKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKP--------GIYHRDIKSTNILLDSEL 408 (590)
Q Consensus 337 ~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~--------~ivHrDIKp~NILLd~~~ 408 (590)
....++||||+++|+|.+++. ...+++..++.|+.|++.||.||| .. +|+||||||+|||++.++
T Consensus 107 ~~~~~lv~e~~~~g~L~~~l~----~~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~~~~ivH~Dikp~Nill~~~~ 179 (337)
T 3mdy_A 107 WTQLYLITDYHENGSLYDYLK----STTLDAKSMLKLAYSSVSGLCHLH---TEIFSTQGKPAIAHRDLKSKNILVKKNG 179 (337)
T ss_dssp GCEEEEEECCCTTCBHHHHHH----HCCBCHHHHHHHHHHHHHHHHHHH---SCBCSTTCBCCEECSCCCGGGEEECTTS
T ss_pred CCceEEEEeccCCCcHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHH---HhhhhhccCCCEEecccchHHEEECCCC
Confidence 257899999999999999984 346999999999999999999999 66 999999999999999999
Q ss_pred cEEEEeeCCcccccCCCccc---ccccccCCCccCccccccCCCCcc------hhHHHHHHHHHHHHhC----------C
Q 046270 409 NAKVADFGLAKQSLEGHSHL---TTRVAGTFGYLAPEYALYGQLTEK------SDVYSFGIVILELMSG----------R 469 (590)
Q Consensus 409 ~~kL~DFGla~~~~~~~~~~---~~~~~gt~~Y~APE~~~~~~~t~k------sDVySfGvvLlELltG----------~ 469 (590)
.+||+|||+++......... .....||..|+|||.+.....+.+ +|||||||++|||+|| +
T Consensus 180 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~ 259 (337)
T 3mdy_A 180 TCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQ 259 (337)
T ss_dssp CEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred CEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccccc
Confidence 99999999997654433221 224578999999999987766665 9999999999999999 4
Q ss_pred CCCCCCCCchhhhhHHHHHHHhcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhccC
Q 046270 470 KVLDTSTSPFQLITDWAWVLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEGD 543 (590)
Q Consensus 470 ~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~~ 543 (590)
.|+............+... .........+.... ...+..+.+.+++..|++.||++|||+.||+++|+..
T Consensus 260 ~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l 329 (337)
T 3mdy_A 260 LPYHDLVPSDPSYEDMREI-VCIKKLRPSFPNRW---SSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKM 329 (337)
T ss_dssp CTTTTTSCSSCCHHHHHHH-HTTSCCCCCCCGGG---GGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred ccHhhhcCCCCchhhhHHH-HhhhccCccccccc---hhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHH
Confidence 5554322211111111111 11111111111111 1224556788999999999999999999999999864
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=338.81 Aligned_cols=258 Identities=16% Similarity=0.200 Sum_probs=205.0
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCCCChHHHHHHHHHHHhc-CCCCccccceeEEeccCCCCceE
Q 046270 263 TNGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDTKGDEDFTNEVEIISKI-RHRNLLSLRGCCVTSDDSSGKRR 340 (590)
Q Consensus 263 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l-~H~nlv~l~g~~~~~~~~~~~~~ 340 (590)
.++|...+.||+|+||.||+|+.. +|+.||||++.... ..+.+.+|++++.++ +|+|++++++++.. +...
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~-----~~~~ 81 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQE-----GLHN 81 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEE-----TTEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCC-----Ccee
Confidence 357888999999999999999974 58899999986433 334688999999999 89999999999873 4568
Q ss_pred EEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCc-----EEEEee
Q 046270 341 FLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELN-----AKVADF 415 (590)
Q Consensus 341 ~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~-----~kL~DF 415 (590)
++||||+ +++|.+++... ...+++..++.|+.||+.||+||| +.+|+||||||+|||++.++. +||+||
T Consensus 82 ~lv~e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Df 155 (298)
T 1csn_A 82 VLVIDLL-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDF 155 (298)
T ss_dssp EEEEECC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCC
T ss_pred EEEEEec-CCCHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEeccCCCCCCCeEEEEEC
Confidence 9999999 99999998532 346999999999999999999999 899999999999999987766 999999
Q ss_pred CCcccccCCCcc------cccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchh--hhhHHHH
Q 046270 416 GLAKQSLEGHSH------LTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQ--LITDWAW 487 (590)
Q Consensus 416 Gla~~~~~~~~~------~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~--~l~~~~~ 487 (590)
|+++........ ......||..|+|||.+.+..++.++||||||+++|||++|+.||........ .+.....
T Consensus 156 g~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 235 (298)
T 1csn_A 156 GMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGE 235 (298)
T ss_dssp TTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHH
T ss_pred ccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHh
Confidence 999876543221 23456799999999999999999999999999999999999999976443221 1111100
Q ss_pred HHHhcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhccC
Q 046270 488 VLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEGD 543 (590)
Q Consensus 488 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~~ 543 (590)
. ....... .......+.+.+++..|++.||++|||+.+|++.|+..
T Consensus 236 ~-~~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~ 281 (298)
T 1csn_A 236 K-KQSTPLR---------ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV 281 (298)
T ss_dssp H-HHHSCHH---------HHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred h-ccCccHH---------HHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHH
Confidence 0 0000000 00112345788899999999999999999999998864
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=349.43 Aligned_cols=245 Identities=23% Similarity=0.293 Sum_probs=191.8
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCCC--ChHHHHHHHHHHHhc-CCCCccccceeEEeccCCCCce
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDTK--GDEDFTNEVEIISKI-RHRNLLSLRGCCVTSDDSSGKR 339 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~~--~~~~f~~Ev~il~~l-~H~nlv~l~g~~~~~~~~~~~~ 339 (590)
++|...++||+|+||+||+|++. +|+.||||++...... ....+..|+..+.++ +|+||+++++++.. +..
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~-----~~~ 131 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEE-----GGI 131 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEe-----CCE
Confidence 57999999999999999999987 6899999998653322 233455666666666 99999999999974 456
Q ss_pred EEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcc
Q 046270 340 RFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAK 419 (590)
Q Consensus 340 ~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~ 419 (590)
.++||||+ +++|.+++... ...++|..++.|+.||+.||+||| +.+|+||||||+|||++.++++||+|||+++
T Consensus 132 ~~lv~e~~-~~~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~ 205 (311)
T 3p1a_A 132 LYLQTELC-GPSLQQHCEAW--GASLPEAQVWGYLRDTLLALAHLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLV 205 (311)
T ss_dssp EEEEEECC-CCBHHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECGGGCEEECCCTTCE
T ss_pred EEEEEecc-CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEccceeee
Confidence 99999999 67898887532 356999999999999999999999 7899999999999999999999999999998
Q ss_pred cccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhh
Q 046270 420 QSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIF 499 (590)
Q Consensus 420 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 499 (590)
...... ......||++|+|||++.+ .++.++|||||||++|||++|+.++... .. | .....+.....+
T Consensus 206 ~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~----~~---~--~~~~~~~~~~~~ 273 (311)
T 3p1a_A 206 ELGTAG--AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG----EG---W--QQLRQGYLPPEF 273 (311)
T ss_dssp ECC--------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH----HH---H--HHHTTTCCCHHH
T ss_pred ecccCC--CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc----cH---H--HHHhccCCCccc
Confidence 654322 2344568999999998764 7999999999999999999998765421 11 1 112222221111
Q ss_pred hHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 500 DEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 500 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
.......+.+++..|++.||++|||+.|++++
T Consensus 274 --------~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 274 --------TAGLSSELRSVLVMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp --------HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred --------ccCCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence 11233578889999999999999999999863
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=359.19 Aligned_cols=263 Identities=25% Similarity=0.414 Sum_probs=208.4
Q ss_pred HHHHhcCCCccceecccCcEEEEEEEEcC------CcEEEEEEeecCCCC-ChHHHHHHHHHHHhcCCCCccccceeEEe
Q 046270 259 LEQATNGFSQNNLIGQGASGIVYKGTLRH------GNLVAVKQILDLDTK-GDEDFTNEVEIISKIRHRNLLSLRGCCVT 331 (590)
Q Consensus 259 l~~at~~f~~~~~LG~G~fG~Vykg~~~~------g~~vAvK~l~~~~~~-~~~~f~~Ev~il~~l~H~nlv~l~g~~~~ 331 (590)
+....++|...+.||+|+||.||+|++.+ ++.||||++...... ..+.+.+|++++++++||||+++++++..
T Consensus 42 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 121 (343)
T 1luf_A 42 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV 121 (343)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred eEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc
Confidence 34456789999999999999999999853 478999998754322 24678999999999999999999999874
Q ss_pred ccCCCCceEEEEEeeCCCCCcchhhhhhcc---------------------cccCChhhHHHHHHHHHHHHHHHHhcCCC
Q 046270 332 SDDSSGKRRFLVYDYMPNGTLSDNISISHK---------------------RKQLTWPQRKKIIVDVAKGIAYLHYGLKP 390 (590)
Q Consensus 332 ~~~~~~~~~~LV~E~~~~gsL~~~L~~~~~---------------------~~~l~~~~r~~I~~~ia~gL~yLH~~~~~ 390 (590)
+...++||||+++|+|.+++..... ...+++.+++.|+.||++||.||| +.
T Consensus 122 -----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH---~~ 193 (343)
T 1luf_A 122 -----GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ER 193 (343)
T ss_dssp -----SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HT
T ss_pred -----CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHH---hC
Confidence 4458999999999999999864321 256999999999999999999999 88
Q ss_pred CeEecCCCCCceEECCCCcEEEEeeCCcccccCCCc-ccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHh-C
Q 046270 391 GIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHS-HLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS-G 468 (590)
Q Consensus 391 ~ivHrDIKp~NILLd~~~~~kL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELlt-G 468 (590)
+|+||||||+|||++.++.+||+|||+++....... .......||..|+|||.+..+.++.++||||||+++|||+| |
T Consensus 194 ~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g 273 (343)
T 1luf_A 194 KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYG 273 (343)
T ss_dssp TCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTT
T ss_pred CeecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcC
Confidence 999999999999999999999999999986543221 12334567899999999999999999999999999999999 9
Q ss_pred CCCCCCCCCchhhhhHHHHHHHhcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhccCC
Q 046270 469 RKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEGDI 544 (590)
Q Consensus 469 ~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~~~ 544 (590)
+.||...... . ... ....+..... +......+.+++..|++.||++|||+.+++++|+...
T Consensus 274 ~~p~~~~~~~-~----~~~-~~~~~~~~~~---------~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~ 334 (343)
T 1luf_A 274 LQPYYGMAHE-E----VIY-YVRDGNILAC---------PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 334 (343)
T ss_dssp CCTTTTSCHH-H----HHH-HHHTTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCcCCCCChH-H----HHH-HHhCCCcCCC---------CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHH
Confidence 9998643321 1 111 1222222111 1112346788999999999999999999999998754
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-43 Score=370.43 Aligned_cols=261 Identities=25% Similarity=0.357 Sum_probs=204.0
Q ss_pred cCCCccceecccCcEEEEEEEEc------CCcEEEEEEeecCC-CCChHHHHHHHHHHHhcCCCCccccceeEEeccCCC
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLR------HGNLVAVKQILDLD-TKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSS 336 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~------~g~~vAvK~l~~~~-~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~ 336 (590)
++|...+.||+|+||.||+|++. .+..||||++.... ......+.+|+.++++++||||+++++++..
T Consensus 71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~----- 145 (367)
T 3l9p_A 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ----- 145 (367)
T ss_dssp GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-----
T ss_pred hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEec-----
Confidence 56888899999999999999954 35689999986542 2334578899999999999999999999874
Q ss_pred CceEEEEEeeCCCCCcchhhhhhcc----cccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCC---c
Q 046270 337 GKRRFLVYDYMPNGTLSDNISISHK----RKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSEL---N 409 (590)
Q Consensus 337 ~~~~~LV~E~~~~gsL~~~L~~~~~----~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~---~ 409 (590)
+...++||||+++|+|.+++..... ...+++.+++.|+.||+.||+||| +.+|+||||||+|||++.++ .
T Consensus 146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~~~ 222 (367)
T 3l9p_A 146 SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRV 222 (367)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCC
T ss_pred CCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEEecCCCCce
Confidence 3457999999999999999964321 245999999999999999999999 88999999999999999554 5
Q ss_pred EEEEeeCCcccccCCC-cccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhhHHHH
Q 046270 410 AKVADFGLAKQSLEGH-SHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLDTSTSPFQLITDWAW 487 (590)
Q Consensus 410 ~kL~DFGla~~~~~~~-~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELlt-G~~p~~~~~~~~~~l~~~~~ 487 (590)
+||+|||+++...... ........||+.|+|||.+.++.++.++|||||||++|||++ |+.||...... . + ..
T Consensus 223 ~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~-~-~---~~ 297 (367)
T 3l9p_A 223 AKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ-E-V---LE 297 (367)
T ss_dssp EEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-H-H---HH
T ss_pred EEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH-H-H---HH
Confidence 9999999998543221 122334567899999999999999999999999999999998 99998653321 1 1 11
Q ss_pred HHHhcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhccCCCCC
Q 046270 488 VLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEGDIDIP 547 (590)
Q Consensus 488 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~~~~~~ 547 (590)
.. ..+.... .+......+.+++..|++.||++|||+.+|++.|+.....+
T Consensus 298 ~i-~~~~~~~---------~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~ 347 (367)
T 3l9p_A 298 FV-TSGGRMD---------PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 347 (367)
T ss_dssp HH-HTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred HH-HcCCCCC---------CCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhCh
Confidence 11 1111110 01112346778999999999999999999999997754433
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-41 Score=361.39 Aligned_cols=260 Identities=18% Similarity=0.221 Sum_probs=206.2
Q ss_pred HHHHHHHhcCCCccceecccCcEEEEEEEEcC-CcEEEEEEeecC---CCCChHHHHHHHHHHHhcCCCCccccceeEEe
Q 046270 256 VSELEQATNGFSQNNLIGQGASGIVYKGTLRH-GNLVAVKQILDL---DTKGDEDFTNEVEIISKIRHRNLLSLRGCCVT 331 (590)
Q Consensus 256 ~~el~~at~~f~~~~~LG~G~fG~Vykg~~~~-g~~vAvK~l~~~---~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~ 331 (590)
+.++....++|...+.||+|+||.||+++++. ++.||+|++... .....+.+.+|+++++.++|||||++++++.
T Consensus 61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~- 139 (410)
T 3v8s_A 61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQ- 139 (410)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEE-
T ss_pred HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEE-
Confidence 45566677889999999999999999999875 789999998642 1223445889999999999999999999997
Q ss_pred ccCCCCceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEE
Q 046270 332 SDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAK 411 (590)
Q Consensus 332 ~~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~k 411 (590)
.+...++||||+++|+|.+++. ...+++..+..++.||+.||+||| +.+|+||||||+||||+.++.+|
T Consensus 140 ----~~~~~~lV~E~~~gg~L~~~l~----~~~~~e~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ik 208 (410)
T 3v8s_A 140 ----DDRYLYMVMEYMPGGDLVNLMS----NYDVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLK 208 (410)
T ss_dssp ----CSSEEEEEECCCTTEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEE
T ss_pred ----ECCEEEEEEeCCCCCcHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeeECCCCCEE
Confidence 3557999999999999999884 246899999999999999999999 89999999999999999999999
Q ss_pred EEeeCCcccccCCCcccccccccCCCccCccccccCC----CCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHH
Q 046270 412 VADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALYGQ----LTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAW 487 (590)
Q Consensus 412 L~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~----~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~ 487 (590)
|+|||+++..............||+.|+|||++.... ++.++|||||||++|||++|+.||....... .......
T Consensus 209 L~DFG~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~-~~~~i~~ 287 (410)
T 3v8s_A 209 LADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG-TYSKIMN 287 (410)
T ss_dssp ECCCTTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHT
T ss_pred EeccceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhh-HHHHHHh
Confidence 9999999876554433445678999999999988655 8899999999999999999999997533211 1111100
Q ss_pred HHHhcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCC--CCCHHHHHHH
Q 046270 488 VLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVAL--RPTITDALKM 539 (590)
Q Consensus 488 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~--RPtm~eVl~~ 539 (590)
.... -... ........+.+++..|++.+|.+ ||++.|++++
T Consensus 288 ~~~~-~~~p----------~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 288 HKNS-LTFP----------DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp HHHH-CCCC----------TTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred cccc-ccCC----------CcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 0000 0000 00012346677888999988988 9999999875
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=346.24 Aligned_cols=251 Identities=26% Similarity=0.326 Sum_probs=202.2
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCCC------ChHHHHHHHHHHHhcCCCCccccceeEEeccCCC
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDTK------GDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSS 336 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~~------~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~ 336 (590)
++|...+.||+|+||.||+++.. +|..||+|.+...... ..+.+.+|++++++++||||+++++++. .
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~ 85 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYE-----N 85 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----C
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEE-----e
Confidence 56888899999999999999987 4889999998654322 3567999999999999999999999987 3
Q ss_pred CceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCC----cEEE
Q 046270 337 GKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSEL----NAKV 412 (590)
Q Consensus 337 ~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~----~~kL 412 (590)
....++||||+++|+|.+++. ....+++.+++.++.||+.||.||| +.+|+||||||+|||++.++ .+||
T Consensus 86 ~~~~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~kl 159 (326)
T 2y0a_A 86 KTDVILILELVAGGELFDFLA---EKESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKI 159 (326)
T ss_dssp SSEEEEEEECCCSCBHHHHHT---TSSCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCSSSSSCCEEE
T ss_pred CCEEEEEEEcCCCCCHHHHHH---hcCCcCHHHHHHHHHHHHHHHHHHH---HCCeEcCCCCHHHEEEecCCCCCCCEEE
Confidence 456999999999999999985 3457999999999999999999999 89999999999999999887 8999
Q ss_pred EeeCCcccccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhc
Q 046270 413 ADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKS 492 (590)
Q Consensus 413 ~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~ 492 (590)
+|||+++...... ......||+.|+|||.+....++.++||||||+++|||++|+.||...... ..+... ....
T Consensus 160 ~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~~---~~~~ 233 (326)
T 2y0a_A 160 IDFGLAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ-ETLANV---SAVN 233 (326)
T ss_dssp CCCTTCEECCTTS--CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH-HHHHHH---HHTC
T ss_pred EECCCCeECCCCC--ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH-HHHHHH---HhcC
Confidence 9999998764332 234457999999999999899999999999999999999999999653321 111110 0011
Q ss_pred CCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 493 GKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 493 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
..... . ........+.+++..|++.||++|||+.|+++.
T Consensus 234 ~~~~~---~-----~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 234 YEFED---E-----YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp CCCCH---H-----HHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred CCcCc---c-----ccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 11110 0 011123467788999999999999999999874
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-42 Score=343.46 Aligned_cols=253 Identities=26% Similarity=0.413 Sum_probs=205.1
Q ss_pred cCCCccceecccCcEEEEEEEEcCCcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEEEE
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLRHGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFLV 343 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~LV 343 (590)
++|...+.||+|+||.||+|.+.+++.||+|++.... ...+++.+|++++++++||||+++++++.. ....++|
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv 81 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLE-----QAPICLV 81 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTT-BCHHHHHHHHHHHHTCCCTTBCCEEEEECS-----SSSCEEE
T ss_pred hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcc-----CCCeEEE
Confidence 4677889999999999999999888899999987543 345789999999999999999999999874 3458999
Q ss_pred EeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccccC
Q 046270 344 YDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLE 423 (590)
Q Consensus 344 ~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~~~ 423 (590)
|||+++++|.+++.. ....+++..++.++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++....
T Consensus 82 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 156 (267)
T 3t9t_A 82 TEFMEHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 156 (267)
T ss_dssp ECCCTTCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred EeCCCCCcHHHHHhh--CcccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEECCCCCEEEccccccccccc
Confidence 999999999999853 2356899999999999999999999 89999999999999999999999999999986543
Q ss_pred CCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhhHHHHHHHhcCCchhhhhHH
Q 046270 424 GHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDEF 502 (590)
Q Consensus 424 ~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 502 (590)
..........++..|+|||.+....++.++||||||+++|||++ |+.||...... .. .... ..+... .
T Consensus 157 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-~~----~~~i-~~~~~~-~---- 225 (267)
T 3t9t_A 157 DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS-EV----VEDI-STGFRL-Y---- 225 (267)
T ss_dssp HHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-HH----HHHH-HTTCCC-C----
T ss_pred ccccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHH-HH----HHHH-hcCCcC-C----
Confidence 32223334557788999999998999999999999999999999 88888653221 11 1111 111100 0
Q ss_pred HhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhcc
Q 046270 503 IRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEG 542 (590)
Q Consensus 503 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~ 542 (590)
.+......+.+++..|++.||++|||+.+++++|+.
T Consensus 226 ----~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~ 261 (267)
T 3t9t_A 226 ----KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAE 261 (267)
T ss_dssp ----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ----CCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 001122467788999999999999999999999975
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=355.50 Aligned_cols=263 Identities=24% Similarity=0.375 Sum_probs=206.5
Q ss_pred HHHhcCCCccceecccCcEEEEEEEEc------CCcEEEEEEeecCC-CCChHHHHHHHHHHHhc-CCCCccccceeEEe
Q 046270 260 EQATNGFSQNNLIGQGASGIVYKGTLR------HGNLVAVKQILDLD-TKGDEDFTNEVEIISKI-RHRNLLSLRGCCVT 331 (590)
Q Consensus 260 ~~at~~f~~~~~LG~G~fG~Vykg~~~------~g~~vAvK~l~~~~-~~~~~~f~~Ev~il~~l-~H~nlv~l~g~~~~ 331 (590)
+...++|...+.||+|+||.||+|++. .+..||||++.... ....+.+.+|++++.++ +||||+++++++..
T Consensus 41 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 120 (344)
T 1rjb_A 41 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL 120 (344)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee
Confidence 334578889999999999999999972 35689999986532 23456799999999999 99999999999874
Q ss_pred ccCCCCceEEEEEeeCCCCCcchhhhhhcc--------------------cccCChhhHHHHHHHHHHHHHHHHhcCCCC
Q 046270 332 SDDSSGKRRFLVYDYMPNGTLSDNISISHK--------------------RKQLTWPQRKKIIVDVAKGIAYLHYGLKPG 391 (590)
Q Consensus 332 ~~~~~~~~~~LV~E~~~~gsL~~~L~~~~~--------------------~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ 391 (590)
....++||||+++|+|.+++..... ...++|..++.|+.||+.||+||| +.+
T Consensus 121 -----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ 192 (344)
T 1rjb_A 121 -----SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKS 192 (344)
T ss_dssp -----SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTT
T ss_pred -----CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHH---hCC
Confidence 3458999999999999999964321 134899999999999999999999 899
Q ss_pred eEecCCCCCceEECCCCcEEEEeeCCcccccCCCcc-cccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CC
Q 046270 392 IYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSH-LTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GR 469 (590)
Q Consensus 392 ivHrDIKp~NILLd~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELlt-G~ 469 (590)
|+||||||+|||++.++.+||+|||+++........ ......||+.|+|||.+.++.++.++||||||+++|||+| |+
T Consensus 193 ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~ 272 (344)
T 1rjb_A 193 CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGV 272 (344)
T ss_dssp EEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSC
T ss_pred cccCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCC
Confidence 999999999999999999999999999866443322 2334567889999999999999999999999999999998 99
Q ss_pred CCCCCCCCchhhhhHHHHHHHhcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhccCC
Q 046270 470 KVLDTSTSPFQLITDWAWVLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEGDI 544 (590)
Q Consensus 470 ~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~~~ 544 (590)
.||......... . .....+.... .+......+..++..|++.||.+|||+.+++++|+...
T Consensus 273 ~p~~~~~~~~~~-~----~~~~~~~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~ 333 (344)
T 1rjb_A 273 NPYPGIPVDANF-Y----KLIQNGFKMD---------QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQL 333 (344)
T ss_dssp CSSTTCCCSHHH-H----HHHHTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred CCcccCCcHHHH-H----HHHhcCCCCC---------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 999765432221 1 1112221100 01112346778899999999999999999999998754
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=352.31 Aligned_cols=251 Identities=25% Similarity=0.342 Sum_probs=202.9
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCCC------ChHHHHHHHHHHHhcCCCCccccceeEEeccCC
Q 046270 263 TNGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDTK------GDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDS 335 (590)
Q Consensus 263 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~~------~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~ 335 (590)
.+.|...+.||+|+||.||+++.. +|..||+|.+...... ..+.+.+|++++.+++||||+++++++.
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~----- 85 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYE----- 85 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEE-----
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEE-----
Confidence 467888999999999999999987 4889999998754322 2467999999999999999999999987
Q ss_pred CCceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCC----cEE
Q 046270 336 SGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSEL----NAK 411 (590)
Q Consensus 336 ~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~----~~k 411 (590)
.....++||||+++|+|.+++. ....+++..+..++.||+.||.||| +.+|+||||||+|||+++++ .+|
T Consensus 86 ~~~~~~lv~e~~~gg~L~~~l~---~~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~~~vk 159 (361)
T 2yab_A 86 NRTDVVLILELVSGGELFDFLA---QKESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIK 159 (361)
T ss_dssp CSSEEEEEEECCCSCBHHHHHT---TCSCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEE
T ss_pred eCCEEEEEEEcCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeCCCCCccCEE
Confidence 3456999999999999999984 3457999999999999999999999 88999999999999998876 799
Q ss_pred EEeeCCcccccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHh
Q 046270 412 VADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAK 491 (590)
Q Consensus 412 L~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~ 491 (590)
|+|||+++...... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||...... ..+. . ..
T Consensus 160 l~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~-~~~~----~-i~ 231 (361)
T 2yab_A 160 LIDFGLAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ-ETLA----N-IT 231 (361)
T ss_dssp ECCCSSCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH-HHHH----H-HH
T ss_pred EEecCCceEcCCCC--ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH-HHHH----H-HH
Confidence 99999998764432 234567999999999999889999999999999999999999999653321 1111 1 11
Q ss_pred cCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 046270 492 SGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALK 538 (590)
Q Consensus 492 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~ 538 (590)
.+... +++.. .......+.+++..|++.||.+|||+.|+++
T Consensus 232 ~~~~~--~~~~~----~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 232 AVSYD--FDEEF----FSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp TTCCC--CCHHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hcCCC--CCchh----ccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 11110 01111 1112346778899999999999999999985
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-42 Score=355.82 Aligned_cols=268 Identities=24% Similarity=0.390 Sum_probs=203.5
Q ss_pred CCccceecccCcEEEEEEEEc-----CCcEEEEEEeecCCC-CChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCce
Q 046270 266 FSQNNLIGQGASGIVYKGTLR-----HGNLVAVKQILDLDT-KGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKR 339 (590)
Q Consensus 266 f~~~~~LG~G~fG~Vykg~~~-----~g~~vAvK~l~~~~~-~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~ 339 (590)
|...+.||+|+||.||++.+. +++.||||++..... ...+.+.+|++++++++||||+++++++...+ ...
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---~~~ 109 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAG---AAS 109 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT---TTE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCC---Cce
Confidence 477899999999999998753 578899999875432 23456899999999999999999999998642 356
Q ss_pred EEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcc
Q 046270 340 RFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAK 419 (590)
Q Consensus 340 ~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~ 419 (590)
.++||||+++|+|.+++. ...+++.+++.|+.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++
T Consensus 110 ~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~i~~~l~~~l~~LH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~ 182 (318)
T 3lxp_A 110 LQLVMEYVPLGSLRDYLP----RHSIGLAQLLLFAQQICEGMAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAK 182 (318)
T ss_dssp EEEEECCCTTCBHHHHGG----GSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCE
T ss_pred EEEEEecccCCcHHHHHh----hCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEEcCCCCEEECCccccc
Confidence 899999999999999984 335999999999999999999999 8899999999999999999999999999998
Q ss_pred cccCCCcc--cccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchh
Q 046270 420 QSLEGHSH--LTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDD 497 (590)
Q Consensus 420 ~~~~~~~~--~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 497 (590)
........ ......||..|+|||.+.+..++.++||||||+++|||+||+.|+............+...........+
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (318)
T 3lxp_A 183 AVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTE 262 (318)
T ss_dssp ECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHH
T ss_pred cccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHH
Confidence 76544322 2334567888999999999999999999999999999999999986422111000000000000000011
Q ss_pred hhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhccC
Q 046270 498 IFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEGD 543 (590)
Q Consensus 498 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~~ 543 (590)
.++.......+......+.+++..|++.||.+|||+.|++++|+..
T Consensus 263 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l 308 (318)
T 3lxp_A 263 LLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTV 308 (318)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 1111111111122345788899999999999999999999999763
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-41 Score=352.17 Aligned_cols=269 Identities=15% Similarity=0.157 Sum_probs=201.2
Q ss_pred hcCCCccceecccCcEEEEEEEEc----CCcEEEEEEeecCCCC-----------ChHHHHHHHHHHHhcCCCCccccce
Q 046270 263 TNGFSQNNLIGQGASGIVYKGTLR----HGNLVAVKQILDLDTK-----------GDEDFTNEVEIISKIRHRNLLSLRG 327 (590)
Q Consensus 263 t~~f~~~~~LG~G~fG~Vykg~~~----~g~~vAvK~l~~~~~~-----------~~~~f~~Ev~il~~l~H~nlv~l~g 327 (590)
.++|...+.||+|+||.||+|++. .+..+|||++...... ....+.+|+..+..++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 357888999999999999999986 4678999998654322 1234667888999999999999999
Q ss_pred eEEeccCCCCceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCC
Q 046270 328 CCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSE 407 (590)
Q Consensus 328 ~~~~~~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~ 407 (590)
++..... .....++||||+ +++|.+++.. .+.+++.+++.|+.||+.||+||| +.+|+||||||+|||++.+
T Consensus 116 ~~~~~~~-~~~~~~lv~e~~-~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~ 187 (345)
T 2v62_A 116 SGLTEFK-GRSYRFMVMERL-GIDLQKISGQ---NGTFKKSTVLQLGIRMLDVLEYIH---ENEYVHGDIKAANLLLGYK 187 (345)
T ss_dssp EEEEESS-SCEEEEEEEECE-EEEHHHHCBG---GGBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEESS
T ss_pred ccccccC-CCcEEEEEEecc-CCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCcCHHHEEEccC
Confidence 9986432 356799999999 9999999853 347999999999999999999999 8899999999999999888
Q ss_pred C--cEEEEeeCCcccccCCCc------ccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCch
Q 046270 408 L--NAKVADFGLAKQSLEGHS------HLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPF 479 (590)
Q Consensus 408 ~--~~kL~DFGla~~~~~~~~------~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~ 479 (590)
+ .+||+|||+++....... .......||..|+|||.+.+..++.++||||||+++|||++|+.||.......
T Consensus 188 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~ 267 (345)
T 2v62_A 188 NPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDP 267 (345)
T ss_dssp STTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCH
T ss_pred CCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccccc
Confidence 7 999999999986543221 11244578999999999999899999999999999999999999996433222
Q ss_pred hhhhHHHHHHHhcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhccCC
Q 046270 480 QLITDWAWVLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEGDI 544 (590)
Q Consensus 480 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~~~ 544 (590)
..+...... ... .....+..... .......+.+++..|++.||++|||+.+|+++|+...
T Consensus 268 ~~~~~~~~~-~~~-~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 327 (345)
T 2v62_A 268 VAVQTAKTN-LLD-ELPQSVLKWAP---SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG 327 (345)
T ss_dssp HHHHHHHHH-HHH-TTTHHHHHHSC---TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred HHHHHHHHh-hcc-cccHHHHhhcc---ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence 222111111 111 11111111110 0123447888999999999999999999999998753
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-42 Score=363.00 Aligned_cols=260 Identities=25% Similarity=0.376 Sum_probs=206.7
Q ss_pred HhcCCCccceecccCcEEEEEEEEc--------CCcEEEEEEeecCCCC-ChHHHHHHHHHHHhc-CCCCccccceeEEe
Q 046270 262 ATNGFSQNNLIGQGASGIVYKGTLR--------HGNLVAVKQILDLDTK-GDEDFTNEVEIISKI-RHRNLLSLRGCCVT 331 (590)
Q Consensus 262 at~~f~~~~~LG~G~fG~Vykg~~~--------~g~~vAvK~l~~~~~~-~~~~f~~Ev~il~~l-~H~nlv~l~g~~~~ 331 (590)
..++|...+.||+|+||.||+|++. .+..||||++...... ..+.+.+|+++++++ +||||+++++++..
T Consensus 67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 146 (382)
T 3tt0_A 67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 146 (382)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence 3467888899999999999999863 2357999998654332 246789999999999 99999999999974
Q ss_pred ccCCCCceEEEEEeeCCCCCcchhhhhhcc-------------cccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCC
Q 046270 332 SDDSSGKRRFLVYDYMPNGTLSDNISISHK-------------RKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIK 398 (590)
Q Consensus 332 ~~~~~~~~~~LV~E~~~~gsL~~~L~~~~~-------------~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIK 398 (590)
+...++||||+++|+|.+++..... ...+++.+++.|+.||+.||.||| +.+|+|||||
T Consensus 147 -----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlk 218 (382)
T 3tt0_A 147 -----DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLA 218 (382)
T ss_dssp -----SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCC
T ss_pred -----CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCEecCCCC
Confidence 3458999999999999999964321 235999999999999999999999 8899999999
Q ss_pred CCceEECCCCcEEEEeeCCcccccCCCc-ccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 046270 399 STNILLDSELNAKVADFGLAKQSLEGHS-HLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLDTST 476 (590)
Q Consensus 399 p~NILLd~~~~~kL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELlt-G~~p~~~~~ 476 (590)
|+|||++.++.+||+|||+++....... .......+|..|+|||.+.+..++.++||||||++++||++ |+.||....
T Consensus 219 p~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~ 298 (382)
T 3tt0_A 219 ARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 298 (382)
T ss_dssp GGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred cceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999999986644322 22344567889999999999999999999999999999999 999986432
Q ss_pred CchhhhhHHHHHHHhcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhccCC
Q 046270 477 SPFQLITDWAWVLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEGDI 544 (590)
Q Consensus 477 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~~~ 544 (590)
.. . .. .....+...+. +......+.+++..|++.||++|||+.||++.|+...
T Consensus 299 ~~--~---~~-~~~~~~~~~~~---------~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 351 (382)
T 3tt0_A 299 VE--E---LF-KLLKEGHRMDK---------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 351 (382)
T ss_dssp HH--H---HH-HHHHTTCCCCC---------CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HH--H---HH-HHHHcCCCCCC---------CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 21 1 11 11122211110 1112346788999999999999999999999998754
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-42 Score=351.18 Aligned_cols=259 Identities=24% Similarity=0.351 Sum_probs=205.8
Q ss_pred HhcCCCccceecccCcEEEEEEEEc------CCcEEEEEEeecCCC-CChHHHHHHHHHHHhcCCCCccccceeEEeccC
Q 046270 262 ATNGFSQNNLIGQGASGIVYKGTLR------HGNLVAVKQILDLDT-KGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDD 334 (590)
Q Consensus 262 at~~f~~~~~LG~G~fG~Vykg~~~------~g~~vAvK~l~~~~~-~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~ 334 (590)
..++|...+.||+|+||.||+|+.. ++..||||++..... ...+.+.+|++++++++||||+++++++..
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--- 97 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQ--- 97 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS---
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEec---
Confidence 3467888899999999999999872 357899999865432 234678999999999999999999999874
Q ss_pred CCCceEEEEEeeCCCCCcchhhhhhcc---------------------cccCChhhHHHHHHHHHHHHHHHHhcCCCCeE
Q 046270 335 SSGKRRFLVYDYMPNGTLSDNISISHK---------------------RKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIY 393 (590)
Q Consensus 335 ~~~~~~~LV~E~~~~gsL~~~L~~~~~---------------------~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~iv 393 (590)
....++||||+++|+|.+++..... ...+++.+++.++.||++||.||| +.+|+
T Consensus 98 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~iv 172 (314)
T 2ivs_A 98 --DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA---EMKLV 172 (314)
T ss_dssp --SSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHH---HTTEE
T ss_pred --CCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHH---HCCCc
Confidence 3458999999999999999964322 234899999999999999999999 88999
Q ss_pred ecCCCCCceEECCCCcEEEEeeCCcccccCCCcc-cccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCC
Q 046270 394 HRDIKSTNILLDSELNAKVADFGLAKQSLEGHSH-LTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKV 471 (590)
Q Consensus 394 HrDIKp~NILLd~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELlt-G~~p 471 (590)
||||||+|||++.++.+||+|||+++........ ......+|..|+|||.+.+..++.++||||||+++|||++ |+.|
T Consensus 173 H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p 252 (314)
T 2ivs_A 173 HRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 252 (314)
T ss_dssp CCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCS
T ss_pred ccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCC
Confidence 9999999999999999999999999866443322 2334457889999999999999999999999999999999 9999
Q ss_pred CCCCCCchhhhhHHHHHHHhcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhccC
Q 046270 472 LDTSTSPFQLITDWAWVLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEGD 543 (590)
Q Consensus 472 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~~ 543 (590)
|....... +. .....+.... .+....+.+.+++..|++.||++|||+.|++++|+..
T Consensus 253 ~~~~~~~~--~~----~~~~~~~~~~---------~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~ 309 (314)
T 2ivs_A 253 YPGIPPER--LF----NLLKTGHRME---------RPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKM 309 (314)
T ss_dssp STTCCGGG--HH----HHHHTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCHHH--HH----HHhhcCCcCC---------CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 86543321 11 1112221111 0112234678899999999999999999999998753
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-42 Score=347.78 Aligned_cols=254 Identities=20% Similarity=0.301 Sum_probs=191.8
Q ss_pred hcCCCccceecccCcEEEEEEEEcC----CcEEEEEEeecCCCC-ChHHHHHHHHHHHhcCCCCccccceeEEeccCCCC
Q 046270 263 TNGFSQNNLIGQGASGIVYKGTLRH----GNLVAVKQILDLDTK-GDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSG 337 (590)
Q Consensus 263 t~~f~~~~~LG~G~fG~Vykg~~~~----g~~vAvK~l~~~~~~-~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~ 337 (590)
.++|...+.||+|+||.||+|++.. +..||+|++...... ..+.+.+|+.++++++||||+++++++..
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------ 87 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE------ 87 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS------
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEcc------
Confidence 4578888999999999999999853 457999998654322 24578999999999999999999998742
Q ss_pred ceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCC
Q 046270 338 KRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGL 417 (590)
Q Consensus 338 ~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGl 417 (590)
...++||||+++|+|.+++.. ....+++..++.++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 162 (281)
T 1mp8_A 88 NPVWIIMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGL 162 (281)
T ss_dssp SSCEEEEECCTTEEHHHHHHH--TTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC---
T ss_pred CccEEEEecCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHEEECCCCCEEECcccc
Confidence 347999999999999999853 2346999999999999999999999 88999999999999999999999999999
Q ss_pred cccccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhhHHHHHHHhcCCch
Q 046270 418 AKQSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLDTSTSPFQLITDWAWVLAKSGKVD 496 (590)
Q Consensus 418 a~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 496 (590)
++..............+|+.|+|||.+....++.++||||||+++|||++ |+.||....... .+. .. ..+...
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~-~~~----~i-~~~~~~ 236 (281)
T 1mp8_A 163 SRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND-VIG----RI-ENGERL 236 (281)
T ss_dssp ----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-HHH----HH-HTTCCC
T ss_pred ccccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH-HHH----HH-HcCCCC
Confidence 98765443333344557789999999999999999999999999999997 999987543321 111 11 111111
Q ss_pred hhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhcc
Q 046270 497 DIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEG 542 (590)
Q Consensus 497 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~ 542 (590)
. .+......+.+++..|++.||++|||+.|++++|+.
T Consensus 237 ~---------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~ 273 (281)
T 1mp8_A 237 P---------MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLST 273 (281)
T ss_dssp C---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred C---------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 1 011123467788999999999999999999999875
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=340.29 Aligned_cols=249 Identities=28% Similarity=0.433 Sum_probs=191.4
Q ss_pred cCCCccceecccCcEEEEEEEEcCCcEEEEEEeecCCC----CChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCce
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLRHGNLVAVKQILDLDT----KGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKR 339 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~~g~~vAvK~l~~~~~----~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~ 339 (590)
++|...+.||+|+||.||+|++. |+.||||++..... ...+.+.+|++++++++||||+++++++.. +..
T Consensus 7 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~ 80 (271)
T 3dtc_A 7 AELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLK-----EPN 80 (271)
T ss_dssp TSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECC-----C--
T ss_pred hheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec-----CCc
Confidence 57888899999999999999986 88999999865322 234678999999999999999999999874 445
Q ss_pred EEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCC---eEecCCCCCceEECC--------CC
Q 046270 340 RFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPG---IYHRDIKSTNILLDS--------EL 408 (590)
Q Consensus 340 ~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~---ivHrDIKp~NILLd~--------~~ 408 (590)
.++||||+++++|.+++. ...+++..++.++.|++.||.||| +.+ |+||||||+|||++. ++
T Consensus 81 ~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH---~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~ 153 (271)
T 3dtc_A 81 LCLVMEFARGGPLNRVLS----GKRIPPDILVNWAVQIARGMNYLH---DEAIVPIIHRDLKSSNILILQKVENGDLSNK 153 (271)
T ss_dssp CEEEEECCTTEEHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHH---HSSSSCCCCSCCSGGGEEESSCCSSSCCSSC
T ss_pred eEEEEEcCCCCCHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHH---hCCCCceeecCCchHHEEEecccccccccCc
Confidence 899999999999999883 457999999999999999999999 666 999999999999986 67
Q ss_pred cEEEEeeCCcccccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHH
Q 046270 409 NAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWV 488 (590)
Q Consensus 409 ~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~ 488 (590)
.+||+|||+++...... .....||..|+|||.+.+..++.++||||||++++||++|+.||........ ...
T Consensus 154 ~~kl~Dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-----~~~ 225 (271)
T 3dtc_A 154 ILKITDFGLAREWHRTT---KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAV-----AYG 225 (271)
T ss_dssp CEEECCCCC----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHH-----HHH
T ss_pred ceEEccCCccccccccc---ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-----HHh
Confidence 89999999998654322 2245689999999999999999999999999999999999999975432111 111
Q ss_pred HHhcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhcc
Q 046270 489 LAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEG 542 (590)
Q Consensus 489 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~ 542 (590)
......... . +......+.+++..|++.||++|||+.|++++|+.
T Consensus 226 ~~~~~~~~~-~--------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 226 VAMNKLALP-I--------PSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp HHTSCCCCC-C--------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred hhcCCCCCC-C--------CcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 111111100 0 11123467789999999999999999999999974
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=349.20 Aligned_cols=260 Identities=25% Similarity=0.347 Sum_probs=206.7
Q ss_pred HhcCCCccceecccCcEEEEEEEE------cCCcEEEEEEeecCCC-CChHHHHHHHHHHHhc-CCCCccccceeEEecc
Q 046270 262 ATNGFSQNNLIGQGASGIVYKGTL------RHGNLVAVKQILDLDT-KGDEDFTNEVEIISKI-RHRNLLSLRGCCVTSD 333 (590)
Q Consensus 262 at~~f~~~~~LG~G~fG~Vykg~~------~~g~~vAvK~l~~~~~-~~~~~f~~Ev~il~~l-~H~nlv~l~g~~~~~~ 333 (590)
..++|...+.||+|+||.||+|++ ..+..||||++..... ...+.+.+|++++.++ +||||+++++++..
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~-- 98 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI-- 98 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEec--
Confidence 346788899999999999999986 2367899999875433 2346789999999999 99999999999874
Q ss_pred CCCCceEEEEEeeCCCCCcchhhhhhcc---------------cccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCC
Q 046270 334 DSSGKRRFLVYDYMPNGTLSDNISISHK---------------RKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIK 398 (590)
Q Consensus 334 ~~~~~~~~LV~E~~~~gsL~~~L~~~~~---------------~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIK 398 (590)
+...++||||+++|+|.+++..... ...+++.+++.++.||+.||.||| +.+|+|||||
T Consensus 99 ---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlk 172 (313)
T 1t46_A 99 ---GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLA 172 (313)
T ss_dssp ---SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCS
T ss_pred ---CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCc
Confidence 3457999999999999999864321 124899999999999999999999 8899999999
Q ss_pred CCceEECCCCcEEEEeeCCcccccCCCcc-cccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 046270 399 STNILLDSELNAKVADFGLAKQSLEGHSH-LTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLDTST 476 (590)
Q Consensus 399 p~NILLd~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELlt-G~~p~~~~~ 476 (590)
|+|||++.++.+||+|||+++........ ......||..|+|||.+.+..++.++||||||+++|||+| |+.||....
T Consensus 173 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 252 (313)
T 1t46_A 173 ARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP 252 (313)
T ss_dssp GGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred cceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCccc
Confidence 99999999999999999999876544332 2334557889999999999999999999999999999999 999987544
Q ss_pred CchhhhhHHHHHHHhcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhccC
Q 046270 477 SPFQLITDWAWVLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEGD 543 (590)
Q Consensus 477 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~~ 543 (590)
...... .....+... ..+......+.+++..|++.||.+|||+.|++++|+..
T Consensus 253 ~~~~~~-----~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 305 (313)
T 1t46_A 253 VDSKFY-----KMIKEGFRM---------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305 (313)
T ss_dssp SSHHHH-----HHHHHTCCC---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred chhHHH-----HHhccCCCC---------CCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 322211 111111100 00111234678889999999999999999999999864
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=341.59 Aligned_cols=250 Identities=22% Similarity=0.288 Sum_probs=195.2
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCCC--------------------------ChHHHHHHHHHHHh
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDTK--------------------------GDEDFTNEVEIISK 316 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~~--------------------------~~~~f~~Ev~il~~ 316 (590)
++|...+.||+|+||.||+|+.. +|+.||||++...... ..+.+.+|++++++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 92 (298)
T 2zv2_A 13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK 92 (298)
T ss_dssp TTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred cceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence 57888999999999999999986 4789999998653211 13568999999999
Q ss_pred cCCCCccccceeEEeccCCCCceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecC
Q 046270 317 IRHRNLLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRD 396 (590)
Q Consensus 317 l~H~nlv~l~g~~~~~~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrD 396 (590)
++||||+++++++... .+...++||||+++++|.+++. ...+++.+++.++.||+.||+||| +.+|+|||
T Consensus 93 l~h~~iv~~~~~~~~~---~~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~D 162 (298)
T 2zv2_A 93 LDHPNVVKLVEVLDDP---NEDHLYMVFELVNQGPVMEVPT----LKPLSEDQARFYFQDLIKGIEYLH---YQKIIHRD 162 (298)
T ss_dssp CCCTTBCCEEEEEECS---SSSEEEEEEECCTTCBSCCSSC----SSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCC
T ss_pred CCCCCCCeEEEEEEcC---CCCEEEEEEecCCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccC
Confidence 9999999999998753 2457899999999999998763 457999999999999999999999 88999999
Q ss_pred CCCCceEECCCCcEEEEeeCCcccccCCCcccccccccCCCccCccccccCC---CCcchhHHHHHHHHHHHHhCCCCCC
Q 046270 397 IKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALYGQ---LTEKSDVYSFGIVILELMSGRKVLD 473 (590)
Q Consensus 397 IKp~NILLd~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~---~t~ksDVySfGvvLlELltG~~p~~ 473 (590)
|||+|||++.++.+||+|||+++....... ......||+.|+|||.+.... ++.++||||||+++|||++|+.||.
T Consensus 163 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~ 241 (298)
T 2zv2_A 163 IKPSNLLVGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFM 241 (298)
T ss_dssp CCGGGEEECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CCHHHEEECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCC
Confidence 999999999999999999999987644322 234467999999999987655 4789999999999999999999996
Q ss_pred CCCCchhhhhHHHHHHHhcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 046270 474 TSTSPFQLITDWAWVLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALK 538 (590)
Q Consensus 474 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~ 538 (590)
..... .+.... ..+.... . ......+.+.+++..|++.||++|||+.|+++
T Consensus 242 ~~~~~-----~~~~~~-~~~~~~~-~-------~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 242 DERIM-----CLHSKI-KSQALEF-P-------DQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp CSSHH-----HHHHHH-HHCCCCC-C-------SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CccHH-----HHHHHH-hcccCCC-C-------CccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 43211 111111 1111100 0 00112346778899999999999999999875
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=347.41 Aligned_cols=262 Identities=22% Similarity=0.291 Sum_probs=198.4
Q ss_pred hcCCCccceecccCcEEEEEEEEcCCcEEEEEEeecCCCC--ChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceE
Q 046270 263 TNGFSQNNLIGQGASGIVYKGTLRHGNLVAVKQILDLDTK--GDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRR 340 (590)
Q Consensus 263 t~~f~~~~~LG~G~fG~Vykg~~~~g~~vAvK~l~~~~~~--~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~ 340 (590)
.++|...+.||+|+||.||+|++.+|+.||+|++...... ....+.+|++++++++||||+++++++.. +...
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~~~~ 94 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHS-----ERCL 94 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECC-----SSCE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEcc-----CCEE
Confidence 4678889999999999999999988999999998643222 24678899999999999999999999873 4468
Q ss_pred EEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCccc
Q 046270 341 FLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQ 420 (590)
Q Consensus 341 ~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~ 420 (590)
++||||+++ +|.+++.. ....+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++.
T Consensus 95 ~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~ 168 (311)
T 3niz_A 95 TLVFEFMEK-DLKKVLDE--NKTGLQDSQIKIYLYQLLRGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARA 168 (311)
T ss_dssp EEEEECCSE-EHHHHHHT--CTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEcCCCC-CHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCchHhEEECCCCCEEEccCcCcee
Confidence 999999984 77777742 3446999999999999999999999 88999999999999999999999999999986
Q ss_pred ccCCCcccccccccCCCccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCch---
Q 046270 421 SLEGHSHLTTRVAGTFGYLAPEYALY-GQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVD--- 496 (590)
Q Consensus 421 ~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~--- 496 (590)
..... .......||..|+|||.+.+ ..++.++||||||+++|||++|+.||........ +....... ......
T Consensus 169 ~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~i~~~~-~~~~~~~~~ 245 (311)
T 3niz_A 169 FGIPV-RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQ-LPKIFSIL-GTPNPREWP 245 (311)
T ss_dssp TTSCC-C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTH-HHHHHHHH-CCCCTTTSG
T ss_pred cCCCc-ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHH-CCCChHHhh
Confidence 54322 22334568999999999876 5689999999999999999999999976544322 22111111 111000
Q ss_pred hhh-------------hHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 046270 497 DIF-------------DEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALK 538 (590)
Q Consensus 497 ~~~-------------d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~ 538 (590)
... +..............+.+++..|++.||++|||+.|+++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 246 QVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp GGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 000 000000000112346778999999999999999999986
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=349.74 Aligned_cols=257 Identities=23% Similarity=0.369 Sum_probs=209.2
Q ss_pred HHhcCCCccceecccCcEEEEEEEEcC-CcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCce
Q 046270 261 QATNGFSQNNLIGQGASGIVYKGTLRH-GNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKR 339 (590)
Q Consensus 261 ~at~~f~~~~~LG~G~fG~Vykg~~~~-g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~ 339 (590)
...++|...+.||+|+||.||+|.+.+ +..||+|.+... ....+.+.+|++++++++||||+++++++.. ...
T Consensus 10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~ 83 (288)
T 3kfa_A 10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR-----EPP 83 (288)
T ss_dssp CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECS-----SSS
T ss_pred ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc-----CCC
Confidence 345678889999999999999999875 778999998643 3346789999999999999999999999863 445
Q ss_pred EEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcc
Q 046270 340 RFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAK 419 (590)
Q Consensus 340 ~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~ 419 (590)
.++||||+++++|.+++... ....+++..++.|+.+|+.||.||| +.+|+||||||+||+++.++.+||+|||+++
T Consensus 84 ~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~ 159 (288)
T 3kfa_A 84 FYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSR 159 (288)
T ss_dssp EEEEEECCTTEEHHHHHHHC-CTTTSCHHHHHHHHHHHHHHHHHHH---HHTCCCSCCSGGGEEECGGGCEEECCCCGGG
T ss_pred EEEEEEcCCCCcHHHHHHhc-ccCCccHhHHHHHHHHHHHHHHHHH---HCCccCCCCCcceEEEcCCCCEEEccCccce
Confidence 89999999999999998542 3456999999999999999999999 8899999999999999999999999999998
Q ss_pred cccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhhHHHHHHHhcCCchhh
Q 046270 420 QSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLDTSTSPFQLITDWAWVLAKSGKVDDI 498 (590)
Q Consensus 420 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 498 (590)
..............+|..|+|||.+.+..++.++||||||+++|||++ |+.||....... +.+. ...+...
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~--~~~~----~~~~~~~-- 231 (288)
T 3kfa_A 160 LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--VYEL----LEKDYRM-- 231 (288)
T ss_dssp TSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG--HHHH----HHTTCCC--
T ss_pred eccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHH----HhccCCC--
Confidence 765544444445567889999999999999999999999999999999 888886543221 1111 1111000
Q ss_pred hhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhcc
Q 046270 499 FDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEG 542 (590)
Q Consensus 499 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~ 542 (590)
..+......+.+++..|++.||.+|||+.+++++|+.
T Consensus 232 -------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~ 268 (288)
T 3kfa_A 232 -------ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFET 268 (288)
T ss_dssp -------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -------CCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHH
Confidence 0111223467889999999999999999999999875
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=352.40 Aligned_cols=264 Identities=22% Similarity=0.356 Sum_probs=202.4
Q ss_pred cCCCccceecccCcEEEEEEEE-----cCCcEEEEEEeecCC-CCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCC
Q 046270 264 NGFSQNNLIGQGASGIVYKGTL-----RHGNLVAVKQILDLD-TKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSG 337 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~-----~~g~~vAvK~l~~~~-~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~ 337 (590)
+.|...+.||+|+||.||++++ ..++.||||++.... ....+.+.+|++++++++||||+++++++...+ +
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~---~ 97 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDG---G 97 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC------
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCC---C
Confidence 3477889999999999999984 357899999987433 334578999999999999999999999987542 2
Q ss_pred ceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCC
Q 046270 338 KRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGL 417 (590)
Q Consensus 338 ~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGl 417 (590)
...++||||+++|+|.+++.. ....+++.+++.|+.|++.||+||| +.+|+||||||+|||++.++.+||+|||+
T Consensus 98 ~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~ 172 (302)
T 4e5w_A 98 NGIKLIMEFLPSGSLKEYLPK--NKNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGL 172 (302)
T ss_dssp CCEEEEEECCTTCBHHHHHHH--HTTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTT
T ss_pred ceEEEEEEeCCCCcHHHHHHh--ccccCCHHHHHHHHHHHHHHHHHhh---cCCcccCCCchheEEEcCCCCEEECcccc
Confidence 458999999999999999853 3356999999999999999999999 89999999999999999999999999999
Q ss_pred cccccCCCc--ccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCc
Q 046270 418 AKQSLEGHS--HLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKV 495 (590)
Q Consensus 418 a~~~~~~~~--~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~ 495 (590)
++....... .......||..|+|||.+.+..++.++||||||+++|||+||+.|+.... .. +. ........
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~---~~-~~~~~~~~ 245 (302)
T 4e5w_A 173 TKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPM---AL---FL-KMIGPTHG 245 (302)
T ss_dssp CEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHH---HH---HH-HHHCSCCG
T ss_pred cccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchh---hH---Hh-hccCCccc
Confidence 987654432 22344567888999999999999999999999999999999998753211 00 00 00000000
Q ss_pred ---hhhhhHHHhh----hhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhcc
Q 046270 496 ---DDIFDEFIRA----EGARAVMERFVLVGILCAHVMVALRPTITDALKMLEG 542 (590)
Q Consensus 496 ---~~~~d~~l~~----~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~ 542 (590)
...+...+.. ..+....+.+.+++..|++.||.+|||+.+++++|+.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 299 (302)
T 4e5w_A 246 QMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEA 299 (302)
T ss_dssp GGHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred ccCHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHH
Confidence 0000000000 0112233578889999999999999999999999975
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=378.27 Aligned_cols=261 Identities=29% Similarity=0.407 Sum_probs=210.1
Q ss_pred HHHHhcCCCccceecccCcEEEEEEEEcCCcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCc
Q 046270 259 LEQATNGFSQNNLIGQGASGIVYKGTLRHGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGK 338 (590)
Q Consensus 259 l~~at~~f~~~~~LG~G~fG~Vykg~~~~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~ 338 (590)
.+...++|...++||+|+||.||+|+++++..||||++.... ...++|.+|+++|++++|+||+++++++.. .
T Consensus 262 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~------~ 334 (535)
T 2h8h_A 262 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE------E 334 (535)
T ss_dssp SBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS------S
T ss_pred eecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee------c
Confidence 344556788889999999999999999988899999987543 346789999999999999999999999853 3
Q ss_pred eEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCc
Q 046270 339 RRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLA 418 (590)
Q Consensus 339 ~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla 418 (590)
..++||||+++|+|.++|... ....+++.+++.|+.||+.||+||| +.+|+||||||+|||+++++.+||+|||++
T Consensus 335 ~~~lv~e~~~~gsL~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a 410 (535)
T 2h8h_A 335 PIYIVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLA 410 (535)
T ss_dssp SCEEEECCCTTEEHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCTTST
T ss_pred cceEeeehhcCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEEcCCCcEEEcccccc
Confidence 479999999999999999632 2346999999999999999999999 899999999999999999999999999999
Q ss_pred ccccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhhHHHHHHHhcCCchh
Q 046270 419 KQSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLDTSTSPFQLITDWAWVLAKSGKVDD 497 (590)
Q Consensus 419 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 497 (590)
+..............++..|+|||.+..+.++.++|||||||+||||+| |+.||...... ..+ .. ...+....
T Consensus 411 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~-~~~----~~-i~~~~~~~ 484 (535)
T 2h8h_A 411 RLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-EVL----DQ-VERGYRMP 484 (535)
T ss_dssp TTCCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHH-HHH----HH-HHTTCCCC
T ss_pred eecCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-HHH----HH-HHcCCCCC
Confidence 8654322222233456789999999999999999999999999999999 89998643221 111 11 11221110
Q ss_pred hhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhccCCC
Q 046270 498 IFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEGDID 545 (590)
Q Consensus 498 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~~~~ 545 (590)
.+....+.+.+++..|++.||++|||+.+|+++|+....
T Consensus 485 ---------~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~ 523 (535)
T 2h8h_A 485 ---------CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 523 (535)
T ss_dssp ---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred ---------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence 011223467789999999999999999999999997643
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=347.60 Aligned_cols=267 Identities=23% Similarity=0.266 Sum_probs=205.5
Q ss_pred HhcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceE
Q 046270 262 ATNGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRR 340 (590)
Q Consensus 262 at~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~ 340 (590)
..++|...+.||+|+||.||+++.. +|+.||||++........+.+.+|++++++++||||+++++++..... .....
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~~~ 105 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERG-AKHEA 105 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEET-TEEEE
T ss_pred CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccC-CCcee
Confidence 3467889999999999999999984 688999999876555556789999999999999999999999975432 34578
Q ss_pred EEEEeeCCCCCcchhhhhhc-ccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcc
Q 046270 341 FLVYDYMPNGTLSDNISISH-KRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAK 419 (590)
Q Consensus 341 ~LV~E~~~~gsL~~~L~~~~-~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~ 419 (590)
++||||+++|+|.+++.... ....+++.+++.|+.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++
T Consensus 106 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~ 182 (317)
T 2buj_A 106 WLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMN 182 (317)
T ss_dssp EEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCSSCE
T ss_pred EEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCCEEEEecCcch
Confidence 99999999999999986432 2456999999999999999999999 8899999999999999999999999999987
Q ss_pred cccCCCcc--------cccccccCCCccCccccccCC---CCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHH
Q 046270 420 QSLEGHSH--------LTTRVAGTFGYLAPEYALYGQ---LTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWV 488 (590)
Q Consensus 420 ~~~~~~~~--------~~~~~~gt~~Y~APE~~~~~~---~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~ 488 (590)
........ ......||..|+|||.+.... ++.++||||||+++|||++|+.||.........+..
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~---- 258 (317)
T 2buj_A 183 QACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVAL---- 258 (317)
T ss_dssp ESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHH----
T ss_pred hcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhH----
Confidence 54321110 112345799999999987543 789999999999999999999998521110001100
Q ss_pred HHhcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhccCCC
Q 046270 489 LAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEGDID 545 (590)
Q Consensus 489 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~~~~ 545 (590)
..... ............+.+++..|++.||.+|||+.++++.|+....
T Consensus 259 ~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 306 (317)
T 2buj_A 259 AVQNQ---------LSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP 306 (317)
T ss_dssp HHHCC-----------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred Hhhcc---------CCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCC
Confidence 00100 0000011123467889999999999999999999999997543
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=344.20 Aligned_cols=251 Identities=20% Similarity=0.319 Sum_probs=200.3
Q ss_pred cCCCccceecccCcEEEEEEEEcC-C-------cEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCccccceeEEeccCC
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLRH-G-------NLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDS 335 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~~-g-------~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~ 335 (590)
++|...+.||+|+||.||+|++.. + ..||+|.+........+.+.+|++++++++||||+++++++..
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---- 83 (289)
T 4fvq_A 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVC---- 83 (289)
T ss_dssp GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECC----
T ss_pred hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEe----
Confidence 567888999999999999998764 3 4799999976665667789999999999999999999999974
Q ss_pred CCceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCc------
Q 046270 336 SGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELN------ 409 (590)
Q Consensus 336 ~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~------ 409 (590)
+...++||||+++|+|.+++.. ....+++..++.|+.||+.||.||| +.+|+||||||+|||++.++.
T Consensus 84 -~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~ 157 (289)
T 4fvq_A 84 -GDENILVQEFVKFGSLDTYLKK--NKNCINILWKLEVAKQLAAAMHFLE---ENTLIHGNVCAKNILLIREEDRKTGNP 157 (289)
T ss_dssp -TTCCEEEEECCTTCBHHHHHHH--TGGGCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEEECCBGGGTBC
T ss_pred -CCCCEEEEECCCCCCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHh---hCCeECCCcCcceEEEecCCccccccc
Confidence 3457999999999999999963 2345999999999999999999999 899999999999999998887
Q ss_pred --EEEEeeCCcccccCCCcccccccccCCCccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHH
Q 046270 410 --AKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALY-GQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWA 486 (590)
Q Consensus 410 --~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~ 486 (590)
+||+|||+++.... .....||..|+|||.+.+ ..++.++||||||+++|||++|..|+...........
T Consensus 158 ~~~kl~Dfg~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~--- 229 (289)
T 4fvq_A 158 PFIKLSDPGISITVLP-----KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQ--- 229 (289)
T ss_dssp CEEEECCCCSCTTTSC-----HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH---
T ss_pred ceeeeccCcccccccC-----ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHH---
Confidence 99999999875432 123457899999999987 7799999999999999999997655443322221111
Q ss_pred HHHHhcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhccCCC
Q 046270 487 WVLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEGDID 545 (590)
Q Consensus 487 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~~~~ 545 (590)
........... ....+.+++..|++.||++|||+.|+++.|+....
T Consensus 230 -~~~~~~~~~~~------------~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~ 275 (289)
T 4fvq_A 230 -FYEDRHQLPAP------------KAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275 (289)
T ss_dssp -HHHTTCCCCCC------------SSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred -HhhccCCCCCC------------CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 11111111110 12356778889999999999999999999997654
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=344.66 Aligned_cols=255 Identities=24% Similarity=0.328 Sum_probs=199.8
Q ss_pred HhcCCCccceecccCcEEEEEEEEcC----CcEEEEEEeecCCC-CChHHHHHHHHHHHhcCCCCccccceeEEeccCCC
Q 046270 262 ATNGFSQNNLIGQGASGIVYKGTLRH----GNLVAVKQILDLDT-KGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSS 336 (590)
Q Consensus 262 at~~f~~~~~LG~G~fG~Vykg~~~~----g~~vAvK~l~~~~~-~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~ 336 (590)
..++|...+.||+|+||.||+|++.+ +..||+|.+..... ...+.+.+|++++++++||||+++++++..
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----- 84 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE----- 84 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-----
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-----
Confidence 34678888999999999999998753 23699999865422 235679999999999999999999998753
Q ss_pred CceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeC
Q 046270 337 GKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFG 416 (590)
Q Consensus 337 ~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFG 416 (590)
...++||||+++++|.+++.. ....+++..++.++.|++.||.||| +.+|+||||||+|||++.++.+||+|||
T Consensus 85 -~~~~~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg 158 (281)
T 3cc6_A 85 -EPTWIIMELYPYGELGHYLER--NKNSLKVLTLVLYSLQICKAMAYLE---SINCVHRDIAVRNILVASPECVKLGDFG 158 (281)
T ss_dssp -SSCEEEEECCTTCBHHHHHHH--HTTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEEETTEEEECCCC
T ss_pred -CCCEEEEecCCCCCHHHHHHh--ccccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEECCCCcEEeCccC
Confidence 236899999999999999853 2346999999999999999999999 8999999999999999999999999999
Q ss_pred CcccccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhhHHHHHHHhcCCc
Q 046270 417 LAKQSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLDTSTSPFQLITDWAWVLAKSGKV 495 (590)
Q Consensus 417 la~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~ 495 (590)
+++..............++..|+|||.+....++.++||||||+++|||+| |+.||....... ... .. ..+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~-~~~----~~-~~~~~ 232 (281)
T 3cc6_A 159 LSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD-VIG----VL-EKGDR 232 (281)
T ss_dssp GGGCC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG-HHH----HH-HHTCC
T ss_pred CCcccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH-HHH----HH-hcCCC
Confidence 998765443333444567889999999998999999999999999999998 999986433321 111 11 11111
Q ss_pred hhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhcc
Q 046270 496 DDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEG 542 (590)
Q Consensus 496 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~ 542 (590)
.. .+......+.+++..|++.||++|||+.|++++|+.
T Consensus 233 ~~---------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~ 270 (281)
T 3cc6_A 233 LP---------KPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSD 270 (281)
T ss_dssp CC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CC---------CCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHH
Confidence 00 001122467788999999999999999999999875
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=346.17 Aligned_cols=252 Identities=20% Similarity=0.258 Sum_probs=202.7
Q ss_pred hcCCCccceecccCcEEEEEEEEcC-CcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEE
Q 046270 263 TNGFSQNNLIGQGASGIVYKGTLRH-GNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRF 341 (590)
Q Consensus 263 t~~f~~~~~LG~G~fG~Vykg~~~~-g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~ 341 (590)
.++|...+.||+|+||.||+++... +..+|+|.+... ......+.+|++++++++||||+++++++.. ....+
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-----~~~~~ 77 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFES-----MEELV 77 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEE-----TTEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEec-----CCEEE
Confidence 4678889999999999999999874 778999988643 2345578899999999999999999999974 34699
Q ss_pred EEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECC--CCcEEEEeeCCcc
Q 046270 342 LVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDS--ELNAKVADFGLAK 419 (590)
Q Consensus 342 LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~--~~~~kL~DFGla~ 419 (590)
+||||+++|+|.+++.. ....+++.+++.++.||+.||.||| +.+|+||||||+|||++. ++.+||+|||+++
T Consensus 78 lv~e~~~g~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH---~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~ 152 (321)
T 1tki_A 78 MIFEFISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQAR 152 (321)
T ss_dssp EEECCCCCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCE
T ss_pred EEEEeCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEccCCCCCEEEEECCCCe
Confidence 99999999999998852 2346999999999999999999999 889999999999999987 7899999999998
Q ss_pred cccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhh
Q 046270 420 QSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIF 499 (590)
Q Consensus 420 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 499 (590)
...... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...... ..+ ..... +... +
T Consensus 153 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~----~~i~~-~~~~--~ 222 (321)
T 1tki_A 153 QLKPGD--NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ-QII----ENIMN-AEYT--F 222 (321)
T ss_dssp ECCTTC--EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH-HHH----HHHHH-TCCC--C
T ss_pred ECCCCC--ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHH-HHH----HHHHc-CCCC--C
Confidence 765433 234456899999999999888999999999999999999999999753321 111 11111 1110 0
Q ss_pred hHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 500 DEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 500 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
+.. ........+.+++..|++.||.+|||+.|+++.
T Consensus 223 ~~~----~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 223 DEE----AFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp CHH----HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred Chh----hhccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 000 011223467889999999999999999999884
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=335.97 Aligned_cols=259 Identities=19% Similarity=0.246 Sum_probs=205.4
Q ss_pred hcCCCccceecccCcEEEEEEEE-cCCcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEE
Q 046270 263 TNGFSQNNLIGQGASGIVYKGTL-RHGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRF 341 (590)
Q Consensus 263 t~~f~~~~~LG~G~fG~Vykg~~-~~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~ 341 (590)
.++|...+.||+|+||.||+|+. .+|+.||||++.... ..+++.+|++++.+++|++++..++++... +...+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~----~~~~~ 81 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAE----GDYNV 81 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS--SCCHHHHHHHHHHHHTTSTTCCCEEEEEEE----TTEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc--chhHHHHHHHHHHHhhcCCCCCccccccCC----CCceE
Confidence 46789999999999999999997 468899999986543 235689999999999999988888777653 45689
Q ss_pred EEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEE---CCCCcEEEEeeCCc
Q 046270 342 LVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILL---DSELNAKVADFGLA 418 (590)
Q Consensus 342 LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILL---d~~~~~kL~DFGla 418 (590)
+||||+ +++|.+++.. ....+++.+++.|+.||+.||+||| +.+|+||||||+|||+ +.++.+||+|||++
T Consensus 82 lv~e~~-~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~ 155 (296)
T 3uzp_A 82 MVMELL-GPSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA 155 (296)
T ss_dssp EEEECC-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCTTC
T ss_pred EEEEec-CCCHHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCc
Confidence 999999 9999999853 2356999999999999999999999 8899999999999999 48889999999999
Q ss_pred ccccCCCcc------cccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchh--hhhHHHHHHH
Q 046270 419 KQSLEGHSH------LTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQ--LITDWAWVLA 490 (590)
Q Consensus 419 ~~~~~~~~~------~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~--~l~~~~~~~~ 490 (590)
+........ ......||..|+|||.+.+..++.++||||||+++|||++|+.||........ .+........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 235 (296)
T 3uzp_A 156 KKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM 235 (296)
T ss_dssp EECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhccccc
Confidence 876544321 12456789999999999999999999999999999999999999975433211 1111111110
Q ss_pred hcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhccC
Q 046270 491 KSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEGD 543 (590)
Q Consensus 491 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~~ 543 (590)
.. . . +.+ .......+.+++..|++.||.+|||+.+++++|+..
T Consensus 236 ~~-~-~----~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~ 278 (296)
T 3uzp_A 236 ST-P-I----EVL----CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 278 (296)
T ss_dssp HS-C-H----HHH----TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred CC-c-h----HHH----HhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHH
Confidence 00 0 0 000 112234788899999999999999999999999864
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=336.66 Aligned_cols=260 Identities=18% Similarity=0.235 Sum_probs=202.1
Q ss_pred HhcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceE
Q 046270 262 ATNGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRR 340 (590)
Q Consensus 262 at~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~ 340 (590)
..++|...+.||+|+||.||+|+.. +++.||||++..... ...+.+|++++.+++|+|++..++++... +...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~----~~~~ 80 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAE----GDYN 80 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEE----TTEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCC----CCce
Confidence 4578999999999999999999974 588999998654332 34588999999999999999888887653 4568
Q ss_pred EEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEE---CCCCcEEEEeeCC
Q 046270 341 FLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILL---DSELNAKVADFGL 417 (590)
Q Consensus 341 ~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILL---d~~~~~kL~DFGl 417 (590)
++||||+ +++|.+++.. ....+++..++.++.||+.||.||| +.+|+||||||+|||+ +.++.+||+|||+
T Consensus 81 ~lv~e~~-~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~ 154 (296)
T 4hgt_A 81 VMVMELL-GPSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGL 154 (296)
T ss_dssp EEEEECC-CCBHHHHHHH--TTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECCGGGTTCEEECCCTT
T ss_pred EEEEEcc-CCCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeeeeccCCCCeEEEecCcc
Confidence 9999999 9999998853 2456999999999999999999999 8899999999999999 7889999999999
Q ss_pred cccccCCCcc------cccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchh--hhhHHHHHH
Q 046270 418 AKQSLEGHSH------LTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQ--LITDWAWVL 489 (590)
Q Consensus 418 a~~~~~~~~~------~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~--~l~~~~~~~ 489 (590)
++........ ......||..|+|||.+.+..++.++||||||+++|||++|+.||........ .+.......
T Consensus 155 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 234 (296)
T 4hgt_A 155 AKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK 234 (296)
T ss_dssp CEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHH
T ss_pred ceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhccc
Confidence 9876543321 22356789999999999999999999999999999999999999975433221 111111110
Q ss_pred HhcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhccC
Q 046270 490 AKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEGD 543 (590)
Q Consensus 490 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~~ 543 (590)
... . . +. ........+.+++..|++.||++|||+.+++++|+..
T Consensus 235 ~~~-~-~----~~----~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 278 (296)
T 4hgt_A 235 MST-P-I----EV----LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 278 (296)
T ss_dssp HHS-C-H----HH----HTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred ccc-h-h----hh----hhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHH
Confidence 000 0 0 00 0011234788899999999999999999999998764
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=344.73 Aligned_cols=275 Identities=25% Similarity=0.322 Sum_probs=210.5
Q ss_pred HHHHHHHhcCCCccceecccCcEEEEEEEEcCCcEEEEEEeecCCCCChHHHHHHHHHHHh--cCCCCccccceeEEecc
Q 046270 256 VSELEQATNGFSQNNLIGQGASGIVYKGTLRHGNLVAVKQILDLDTKGDEDFTNEVEIISK--IRHRNLLSLRGCCVTSD 333 (590)
Q Consensus 256 ~~el~~at~~f~~~~~LG~G~fG~Vykg~~~~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~--l~H~nlv~l~g~~~~~~ 333 (590)
+..-....++|...+.||+|+||.||+|++. |+.||||++.. .....+.+|++++.. ++||||+++++++...+
T Consensus 34 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~---~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~ 109 (342)
T 1b6c_B 34 LLVQRTIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFIAADNKDN 109 (342)
T ss_dssp HHHHHHHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEECG---GGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCC
T ss_pred eeecccccccEEEEeeecCCCCcEEEEEEEc-CccEEEEEeCc---hhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccC
Confidence 3334455678999999999999999999985 89999999854 345678899999988 79999999999987543
Q ss_pred CCCCceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcC-----CCCeEecCCCCCceEECCCC
Q 046270 334 DSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGL-----KPGIYHRDIKSTNILLDSEL 408 (590)
Q Consensus 334 ~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~-----~~~ivHrDIKp~NILLd~~~ 408 (590)
. .....++||||+++|+|.+++. ...+++.+++.++.|++.||.|||... +.+|+||||||+|||++.++
T Consensus 110 ~-~~~~~~lv~e~~~~g~L~~~l~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~ 184 (342)
T 1b6c_B 110 G-TWTQLWLVSDYHEHGSLFDYLN----RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG 184 (342)
T ss_dssp S-SCCCEEEEECCCTTCBHHHHHH----HCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTS
T ss_pred C-ccceeEEEEeecCCCcHHHHHh----ccCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCC
Confidence 2 2236899999999999999984 246999999999999999999999422 47899999999999999999
Q ss_pred cEEEEeeCCcccccCCCcc---cccccccCCCccCccccccC------CCCcchhHHHHHHHHHHHHhC----------C
Q 046270 409 NAKVADFGLAKQSLEGHSH---LTTRVAGTFGYLAPEYALYG------QLTEKSDVYSFGIVILELMSG----------R 469 (590)
Q Consensus 409 ~~kL~DFGla~~~~~~~~~---~~~~~~gt~~Y~APE~~~~~------~~t~ksDVySfGvvLlELltG----------~ 469 (590)
++||+|||+++........ ......||..|+|||.+... .++.++||||||+++|||+|| +
T Consensus 185 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~ 264 (342)
T 1b6c_B 185 TCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ 264 (342)
T ss_dssp CEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred CEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccc
Confidence 9999999999876543322 23445789999999998765 334789999999999999999 6
Q ss_pred CCCCCCCCchhhhhHHHHHHHhcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhccC
Q 046270 470 KVLDTSTSPFQLITDWAWVLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEGD 543 (590)
Q Consensus 470 ~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~~ 543 (590)
.||............+...... ......+.... ...+....+.+++..|++.||++|||+.+|+++|+..
T Consensus 265 ~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i 334 (342)
T 1b6c_B 265 LPYYDLVPSDPSVEEMRKVVCE-QKLRPNIPNRW---QSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 334 (342)
T ss_dssp CTTTTTSCSSCCHHHHHHHHTT-SCCCCCCCGGG---GTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred cCccccCcCcccHHHHHHHHHH-HHhCCCCcccc---cchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence 6765433322222223222222 11111111111 1224456788999999999999999999999999863
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=353.97 Aligned_cols=253 Identities=23% Similarity=0.346 Sum_probs=199.1
Q ss_pred cCCCccceecccCcEEEEEEEEcC-CcEEEEEEeecCC---CCChHHHHHHHHHHHhc-CCCCccccceeEEeccCCCCc
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLRH-GNLVAVKQILDLD---TKGDEDFTNEVEIISKI-RHRNLLSLRGCCVTSDDSSGK 338 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~vAvK~l~~~~---~~~~~~f~~Ev~il~~l-~H~nlv~l~g~~~~~~~~~~~ 338 (590)
++|...+.||+|+||.||+++++. ++.||+|++.... ....+.+.+|..++.++ +||||+++++++.. ..
T Consensus 52 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~-----~~ 126 (396)
T 4dc2_A 52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT-----ES 126 (396)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEEC-----SS
T ss_pred hHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEE-----CC
Confidence 568889999999999999999875 7789999997542 22334688999999988 89999999999873 45
Q ss_pred eEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCc
Q 046270 339 RRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLA 418 (590)
Q Consensus 339 ~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla 418 (590)
..++||||+++|+|.+++. ....+++..++.++.||+.||+||| +.+|+||||||+||||+.++.+||+|||++
T Consensus 127 ~~~lV~E~~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFGla 200 (396)
T 4dc2_A 127 RLFFVIEYVNGGDLMFHMQ---RQRKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMC 200 (396)
T ss_dssp EEEEEEECCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEEEEEcCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEECCCCCEEEeeccee
Confidence 6999999999999999885 3457999999999999999999999 899999999999999999999999999999
Q ss_pred ccccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchh---hhhHHHHHHHhcCCc
Q 046270 419 KQSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQ---LITDWAWVLAKSGKV 495 (590)
Q Consensus 419 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~---~l~~~~~~~~~~~~~ 495 (590)
+..... ........||+.|+|||++.+..++.++|||||||++|||++|+.||........ ...++.......+..
T Consensus 201 ~~~~~~-~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~ 279 (396)
T 4dc2_A 201 KEGLRP-GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI 279 (396)
T ss_dssp BCCCCT-TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCC
T ss_pred eecccC-CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcccc
Confidence 853322 2234556899999999999999999999999999999999999999964332111 111111111111111
Q ss_pred hhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCH------HHHHH
Q 046270 496 DDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTI------TDALK 538 (590)
Q Consensus 496 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm------~eVl~ 538 (590)
..+......+..++..|++.||.+||++ .|+++
T Consensus 280 ----------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~ 318 (396)
T 4dc2_A 280 ----------RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 318 (396)
T ss_dssp ----------CCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHH
T ss_pred ----------CCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhc
Confidence 0111223467788999999999999985 56654
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-42 Score=354.77 Aligned_cols=262 Identities=24% Similarity=0.352 Sum_probs=206.8
Q ss_pred HHHHhcCCCccceecccCcEEEEEEEEcC------CcEEEEEEeecCCC-CChHHHHHHHHHHHhc-CCCCccccceeEE
Q 046270 259 LEQATNGFSQNNLIGQGASGIVYKGTLRH------GNLVAVKQILDLDT-KGDEDFTNEVEIISKI-RHRNLLSLRGCCV 330 (590)
Q Consensus 259 l~~at~~f~~~~~LG~G~fG~Vykg~~~~------g~~vAvK~l~~~~~-~~~~~f~~Ev~il~~l-~H~nlv~l~g~~~ 330 (590)
++...++|...+.||+|+||.||+|.+.. +..||+|.+..... ...+.+.+|++++.++ +||||+++++++.
T Consensus 41 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 120 (333)
T 2i1m_A 41 WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACT 120 (333)
T ss_dssp GBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 34456789999999999999999999753 24799999865432 2346789999999999 8999999999987
Q ss_pred eccCCCCceEEEEEeeCCCCCcchhhhhhcc-----------cccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCC
Q 046270 331 TSDDSSGKRRFLVYDYMPNGTLSDNISISHK-----------RKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKS 399 (590)
Q Consensus 331 ~~~~~~~~~~~LV~E~~~~gsL~~~L~~~~~-----------~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp 399 (590)
. +...++||||+++|+|.+++..... ...+++..++.++.||+.||.||| +.+|+||||||
T Consensus 121 ~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp 192 (333)
T 2i1m_A 121 H-----GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA---SKNCIHRDVAA 192 (333)
T ss_dssp S-----SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSG
T ss_pred c-----CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCccc
Confidence 4 3458999999999999999864321 245899999999999999999999 88999999999
Q ss_pred CceEECCCCcEEEEeeCCcccccCCCcc-cccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCC
Q 046270 400 TNILLDSELNAKVADFGLAKQSLEGHSH-LTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLDTSTS 477 (590)
Q Consensus 400 ~NILLd~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELlt-G~~p~~~~~~ 477 (590)
+|||++.++.+||+|||+++........ ......||..|+|||.+.+..++.++||||||+++|||+| |+.||.....
T Consensus 193 ~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 272 (333)
T 2i1m_A 193 RNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILV 272 (333)
T ss_dssp GGCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCS
T ss_pred ceEEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccch
Confidence 9999999999999999999865443322 2334557889999999999999999999999999999999 8889875443
Q ss_pred chhhhhHHHHHHHhcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhcc
Q 046270 478 PFQLITDWAWVLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEG 542 (590)
Q Consensus 478 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~ 542 (590)
... + ......+.... .+......+..++..|++.||.+|||+.|++++|+.
T Consensus 273 ~~~-~----~~~~~~~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~ 323 (333)
T 2i1m_A 273 NSK-F----YKLVKDGYQMA---------QPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQE 323 (333)
T ss_dssp SHH-H----HHHHHHTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred hHH-H----HHHHhcCCCCC---------CCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHH
Confidence 221 1 11111111000 001112467788999999999999999999999975
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-41 Score=349.34 Aligned_cols=262 Identities=22% Similarity=0.225 Sum_probs=200.2
Q ss_pred HHHHHhcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecC-----CCCChHHHHHHHHHHHhcCCCCccccceeEEe
Q 046270 258 ELEQATNGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDL-----DTKGDEDFTNEVEIISKIRHRNLLSLRGCCVT 331 (590)
Q Consensus 258 el~~at~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~-----~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~ 331 (590)
++....++|...+.||+|+||.||+|+.. ++..||+|++... .....+.+.+|++++++++||||+++++++.
T Consensus 20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~- 98 (345)
T 3hko_A 20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYE- 98 (345)
T ss_dssp CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEE-
T ss_pred hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhc-
Confidence 45667788999999999999999999986 4778999998543 3344578999999999999999999999997
Q ss_pred ccCCCCceEEEEEeeCCCCCcchhhhhhc-------------------------------------ccccCChhhHHHHH
Q 046270 332 SDDSSGKRRFLVYDYMPNGTLSDNISISH-------------------------------------KRKQLTWPQRKKII 374 (590)
Q Consensus 332 ~~~~~~~~~~LV~E~~~~gsL~~~L~~~~-------------------------------------~~~~l~~~~r~~I~ 374 (590)
.....++||||+++|+|.+++.... ....+++..++.|+
T Consensus 99 ----~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 174 (345)
T 3hko_A 99 ----DEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIM 174 (345)
T ss_dssp ----CSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHH
T ss_pred ----cCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHH
Confidence 3456999999999999999884110 02234677888999
Q ss_pred HHHHHHHHHHHhcCCCCeEecCCCCCceEECCCC--cEEEEeeCCcccccCCC---cccccccccCCCccCcccccc--C
Q 046270 375 VDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSEL--NAKVADFGLAKQSLEGH---SHLTTRVAGTFGYLAPEYALY--G 447 (590)
Q Consensus 375 ~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~--~~kL~DFGla~~~~~~~---~~~~~~~~gt~~Y~APE~~~~--~ 447 (590)
.||+.||+||| +.+|+||||||+|||++.++ .+||+|||+++...... ........||+.|+|||.+.. .
T Consensus 175 ~qi~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 251 (345)
T 3hko_A 175 RQIFSALHYLH---NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNE 251 (345)
T ss_dssp HHHHHHHHHHH---HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSS
T ss_pred HHHHHHHHHHH---HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCC
Confidence 99999999999 88999999999999998776 89999999998654322 112345678999999999875 6
Q ss_pred CCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCC
Q 046270 448 QLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMV 527 (590)
Q Consensus 448 ~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp 527 (590)
.++.++||||||+++|||++|+.||........ ............ .+. .......+.+++..|++.||
T Consensus 252 ~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-----~~~~~~~~~~~~--~~~-----~~~~~~~~~~li~~~l~~~p 319 (345)
T 3hko_A 252 SYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADT-----ISQVLNKKLCFE--NPN-----YNVLSPLARDLLSNLLNRNV 319 (345)
T ss_dssp CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-----HHHHHHCCCCTT--SGG-----GGGSCHHHHHHHHHHSCSCT
T ss_pred CCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHH-----HHHHHhcccccC--Ccc-----cccCCHHHHHHHHHHcCCCh
Confidence 789999999999999999999999965433211 111112111100 000 01123467788999999999
Q ss_pred CCCCCHHHHHHH
Q 046270 528 ALRPTITDALKM 539 (590)
Q Consensus 528 ~~RPtm~eVl~~ 539 (590)
.+|||+.++++.
T Consensus 320 ~~Rps~~~~l~h 331 (345)
T 3hko_A 320 DERFDAMRALQH 331 (345)
T ss_dssp TTSCCHHHHHHS
T ss_pred hHCCCHHHHhcC
Confidence 999999999873
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=352.66 Aligned_cols=251 Identities=20% Similarity=0.302 Sum_probs=193.2
Q ss_pred hcCCCccceecccCcEEEEEEEEcCCcEEEEEEeecCCCC--ChHHHHHHHHHHHhcCC--CCccccceeEEeccCCCCc
Q 046270 263 TNGFSQNNLIGQGASGIVYKGTLRHGNLVAVKQILDLDTK--GDEDFTNEVEIISKIRH--RNLLSLRGCCVTSDDSSGK 338 (590)
Q Consensus 263 t~~f~~~~~LG~G~fG~Vykg~~~~g~~vAvK~l~~~~~~--~~~~f~~Ev~il~~l~H--~nlv~l~g~~~~~~~~~~~ 338 (590)
.++|...+.||+|+||.||++...+++.||||++...... ..+.+.+|++++.+++| +||+++++++. .+.
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~-----~~~ 82 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI-----TDQ 82 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE-----CSS
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEe-----eCC
Confidence 4568889999999999999999988999999998654322 24678999999999976 99999999987 345
Q ss_pred eEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCc
Q 046270 339 RRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLA 418 (590)
Q Consensus 339 ~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla 418 (590)
..++||| +.+|+|.+++. ....+++.++..|+.||+.||+||| +.+|+||||||+|||++ ++.+||+|||++
T Consensus 83 ~~~lv~e-~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~al~~lH---~~~iiHrDikp~NIll~-~~~~kl~DFG~a 154 (343)
T 3dbq_A 83 YIYMVME-CGNIDLNSWLK---KKKSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIA 154 (343)
T ss_dssp EEEEEEC-CCSEEHHHHHH---HSCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEE-TTEEEECCCSSS
T ss_pred EEEEEEe-CCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEE-CCcEEEeecccc
Confidence 7999999 56889999985 3457999999999999999999999 88999999999999997 578999999999
Q ss_pred ccccCCCcc-cccccccCCCccCcccccc-----------CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHH
Q 046270 419 KQSLEGHSH-LTTRVAGTFGYLAPEYALY-----------GQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWA 486 (590)
Q Consensus 419 ~~~~~~~~~-~~~~~~gt~~Y~APE~~~~-----------~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~ 486 (590)
+........ ......||+.|+|||++.. +.++.++|||||||++|||++|+.||.........+.
T Consensus 155 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~--- 231 (343)
T 3dbq_A 155 NQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLH--- 231 (343)
T ss_dssp CCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHH---
T ss_pred cccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHH---
Confidence 876543322 2345679999999999865 6789999999999999999999999975433211111
Q ss_pred HHHHhcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 487 WVLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 487 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
....... ....+......+.+++..|++.||.+|||+.|+++.
T Consensus 232 -~~~~~~~---------~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 232 -AIIDPNH---------EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp -HHHCTTS---------CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred -HHhcCCc---------ccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 1111100 000011112356788899999999999999999875
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-41 Score=341.39 Aligned_cols=258 Identities=28% Similarity=0.416 Sum_probs=193.4
Q ss_pred hcCCCccceecccCcEEEEEEEEcCCcEEEEEEeecCCCC--ChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceE
Q 046270 263 TNGFSQNNLIGQGASGIVYKGTLRHGNLVAVKQILDLDTK--GDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRR 340 (590)
Q Consensus 263 t~~f~~~~~LG~G~fG~Vykg~~~~g~~vAvK~l~~~~~~--~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~ 340 (590)
.++|...++||+|+||.||+|++.+ .||||++...... ..+.|.+|++++++++|+||+++++++. ....
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~------~~~~ 94 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST------APQL 94 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC------SSSC
T ss_pred ccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeecc------CCcc
Confidence 4678889999999999999998753 5999998654322 2457899999999999999999999763 2347
Q ss_pred EEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCccc
Q 046270 341 FLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQ 420 (590)
Q Consensus 341 ~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~ 420 (590)
++||||+++++|.+++.. ....+++..++.|+.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++.
T Consensus 95 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~ 169 (289)
T 3og7_A 95 AIVTQWCEGSSLYHHLHA--SETKFEMKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATE 169 (289)
T ss_dssp EEEEECCCEEEHHHHHTT--C---CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEEEECCCC----
T ss_pred EEEEEecCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccccCccceEEECCCCCEEEccceeccc
Confidence 999999999999998853 3456999999999999999999999 88999999999999999999999999999976
Q ss_pred ccCCC-cccccccccCCCccCccccc---cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCch
Q 046270 421 SLEGH-SHLTTRVAGTFGYLAPEYAL---YGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVD 496 (590)
Q Consensus 421 ~~~~~-~~~~~~~~gt~~Y~APE~~~---~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 496 (590)
..... ........||..|+|||.+. ...++.++||||||+++|||++|+.||........... ....+...
T Consensus 170 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~-----~~~~~~~~ 244 (289)
T 3og7_A 170 KSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIE-----MVGRGSLS 244 (289)
T ss_dssp --------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHH-----HHHHTSCC
T ss_pred cccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHH-----HhcccccC
Confidence 54322 22234467899999999986 66789999999999999999999999976544322111 11122211
Q ss_pred hhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhccC
Q 046270 497 DIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEGD 543 (590)
Q Consensus 497 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~~ 543 (590)
..+... .......+.+++..|++.+|.+|||+.+++++|+..
T Consensus 245 ~~~~~~-----~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l 286 (289)
T 3og7_A 245 PDLSKV-----RSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEEL 286 (289)
T ss_dssp CCTTSS-----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred cchhhc-----cccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence 111110 111234778899999999999999999999999864
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=340.33 Aligned_cols=264 Identities=19% Similarity=0.239 Sum_probs=199.3
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCCC--ChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceE
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDTK--GDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRR 340 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~~--~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~ 340 (590)
++|...+.||+|+||.||+|+.. +|+.||||++...... ..+.+.+|++++++++||||+++++++.. +...
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~ 76 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS-----DKKL 76 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-----TTEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEe-----CCEE
Confidence 46888899999999999999986 4889999998654332 24678899999999999999999999974 4568
Q ss_pred EEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCccc
Q 046270 341 FLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQ 420 (590)
Q Consensus 341 ~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~ 420 (590)
++||||+++ +|.+++. .....+++..+..|+.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++.
T Consensus 77 ~lv~e~~~~-~l~~~~~--~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~ 150 (292)
T 3o0g_A 77 TLVFEFCDQ-DLKKYFD--SCNGDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARA 150 (292)
T ss_dssp EEEEECCSE-EHHHHHH--HTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEecCCC-CHHHHHH--hCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeeccccee
Confidence 999999975 5555443 23457999999999999999999999 88999999999999999999999999999986
Q ss_pred ccCCCcccccccccCCCccCccccccCC-CCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcC--Cchh
Q 046270 421 SLEGHSHLTTRVAGTFGYLAPEYALYGQ-LTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSG--KVDD 497 (590)
Q Consensus 421 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~-~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~--~~~~ 497 (590)
..... .......||..|+|||.+.+.. ++.++||||||++++||++|+.|+.........+........... ....
T Consensus 151 ~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 229 (292)
T 3o0g_A 151 FGIPV-RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPS 229 (292)
T ss_dssp CCSCC-SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTT
T ss_pred cCCcc-ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhh
Confidence 54322 2234457899999999988765 899999999999999999999887544443333332221111100 0000
Q ss_pred hhh---H---------HHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 498 IFD---E---------FIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 498 ~~d---~---------~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
..+ . .............+.+++..|++.||++|||++|+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 230 MTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp GGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 000 0 00000001123467789999999999999999999863
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=346.07 Aligned_cols=253 Identities=22% Similarity=0.271 Sum_probs=200.7
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecC-----CCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCC
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDL-----DTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSG 337 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~-----~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~ 337 (590)
+.|...+.||+|+||.||+++.. +|+.||||++... .....+.+.+|++++++++||||+++++++.. .
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-----~ 98 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSS-----D 98 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----T
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEe-----C
Confidence 46888899999999999999986 5889999998532 22246789999999999999999999999874 3
Q ss_pred ceEEEEEeeCCCCCcchhhhhhc-ccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCc---EEEE
Q 046270 338 KRRFLVYDYMPNGTLSDNISISH-KRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELN---AKVA 413 (590)
Q Consensus 338 ~~~~LV~E~~~~gsL~~~L~~~~-~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~---~kL~ 413 (590)
...++||||+++|+|.+++.... ....+++..+..|+.||+.||+||| +.+|+||||||+|||++.++. +||+
T Consensus 99 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivHrDlkp~NIl~~~~~~~~~vkl~ 175 (351)
T 3c0i_A 99 GMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLG 175 (351)
T ss_dssp TEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECSSSTTCCEEEC
T ss_pred CEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChHHeEEecCCCCCcEEEe
Confidence 46899999999999988875432 2335899999999999999999999 889999999999999987654 9999
Q ss_pred eeCCcccccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcC
Q 046270 414 DFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSG 493 (590)
Q Consensus 414 DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~ 493 (590)
|||+++...... .......||+.|+|||.+....++.++|||||||++|||++|+.||.... ..... . ...+
T Consensus 176 Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~--~~~~~----~-i~~~ 247 (351)
T 3c0i_A 176 GFGVAIQLGESG-LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK--ERLFE----G-IIKG 247 (351)
T ss_dssp CCTTCEECCTTS-CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH--HHHHH----H-HHHT
T ss_pred cCcceeEecCCC-eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH--HHHHH----H-HHcC
Confidence 999998765432 22344579999999999999999999999999999999999999996531 11111 1 1111
Q ss_pred CchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 046270 494 KVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALK 538 (590)
Q Consensus 494 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~ 538 (590)
... ..+.. .......+.+++..|++.||++|||+.|+++
T Consensus 248 ~~~--~~~~~----~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 248 KYK--MNPRQ----WSHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp CCC--CCHHH----HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCC--CCccc----cccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 111 00000 0112346778999999999999999999986
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=347.64 Aligned_cols=269 Identities=24% Similarity=0.342 Sum_probs=211.7
Q ss_pred ccHHHHHHHhcCCCccceecccCcEEEEEEEEc------CCcEEEEEEeecCCCC-ChHHHHHHHHHHHhc-CCCCcccc
Q 046270 254 FHVSELEQATNGFSQNNLIGQGASGIVYKGTLR------HGNLVAVKQILDLDTK-GDEDFTNEVEIISKI-RHRNLLSL 325 (590)
Q Consensus 254 f~~~el~~at~~f~~~~~LG~G~fG~Vykg~~~------~g~~vAvK~l~~~~~~-~~~~f~~Ev~il~~l-~H~nlv~l 325 (590)
+...+.....++|...+.||+|+||.||+|++. .++.||||++...... ..+.+.+|++++.++ +||||+++
T Consensus 17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence 445555666788999999999999999999852 3578999998654332 245789999999999 79999999
Q ss_pred ceeEEeccCCCCceEEEEEeeCCCCCcchhhhhhcc-------------cccCChhhHHHHHHHHHHHHHHHHhcCCCCe
Q 046270 326 RGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHK-------------RKQLTWPQRKKIIVDVAKGIAYLHYGLKPGI 392 (590)
Q Consensus 326 ~g~~~~~~~~~~~~~~LV~E~~~~gsL~~~L~~~~~-------------~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~i 392 (590)
++++... +...++||||+++|+|.+++..... ...+++..++.++.||+.||.||| +.+|
T Consensus 97 ~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i 169 (316)
T 2xir_A 97 LGACTKP----GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKC 169 (316)
T ss_dssp EEEECCT----TSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHH---HTTC
T ss_pred EEEEecC----CCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHH---hCCc
Confidence 9998743 3458999999999999999864321 122899999999999999999999 8899
Q ss_pred EecCCCCCceEECCCCcEEEEeeCCcccccCCCcc-cccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCC
Q 046270 393 YHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSH-LTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRK 470 (590)
Q Consensus 393 vHrDIKp~NILLd~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELlt-G~~ 470 (590)
+||||||+|||++.++.+||+|||+++........ ......||..|+|||.+.+..++.++||||||+++|||+| |+.
T Consensus 170 ~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~ 249 (316)
T 2xir_A 170 IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS 249 (316)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred ccccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCC
Confidence 99999999999999999999999999866443322 2334567889999999999999999999999999999998 999
Q ss_pred CCCCCCCchhhhhHHHHHHHhcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhccC
Q 046270 471 VLDTSTSPFQLITDWAWVLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEGD 543 (590)
Q Consensus 471 p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~~ 543 (590)
||........... ....+..... +......+.+++..|++.||.+|||+.|+++.|+..
T Consensus 250 p~~~~~~~~~~~~-----~~~~~~~~~~---------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 308 (316)
T 2xir_A 250 PYPGVKIDEEFCR-----RLKEGTRMRA---------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308 (316)
T ss_dssp SSTTCCCSHHHHH-----HHHHTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCcccchhHHHHH-----HhccCccCCC---------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 9875443322111 1111211110 011223677888999999999999999999999753
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-41 Score=354.24 Aligned_cols=248 Identities=24% Similarity=0.343 Sum_probs=196.3
Q ss_pred hcCCCccceecccCcEEEEEEEEcC-CcEEEEEEeecC---CCCChHHHHHHHHHHHhc-CCCCccccceeEEeccCCCC
Q 046270 263 TNGFSQNNLIGQGASGIVYKGTLRH-GNLVAVKQILDL---DTKGDEDFTNEVEIISKI-RHRNLLSLRGCCVTSDDSSG 337 (590)
Q Consensus 263 t~~f~~~~~LG~G~fG~Vykg~~~~-g~~vAvK~l~~~---~~~~~~~f~~Ev~il~~l-~H~nlv~l~g~~~~~~~~~~ 337 (590)
.++|...+.||+|+||.||+++.+. |+.||||++... .....+.+.+|.+++.++ +||||+++++++.. .
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~-----~ 96 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQT-----P 96 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-----S
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEe-----C
Confidence 4689999999999999999999874 889999998643 223456688999999998 79999999999873 4
Q ss_pred ceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCC
Q 046270 338 KRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGL 417 (590)
Q Consensus 338 ~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGl 417 (590)
...++||||+++|+|.+++. ....+++..++.++.||+.||+||| +.+|+||||||+||||+.++.+||+|||+
T Consensus 97 ~~~~lv~E~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NILl~~~g~ikL~DFG~ 170 (353)
T 3txo_A 97 DRLFFVMEFVNGGDLMFHIQ---KSRRFDEARARFYAAEIISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGM 170 (353)
T ss_dssp SEEEEEEECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred CEEEEEEeCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCCHHHEEECCCCCEEEccccc
Confidence 56999999999999999885 3457999999999999999999999 88999999999999999999999999999
Q ss_pred cccccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchh
Q 046270 418 AKQSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDD 497 (590)
Q Consensus 418 a~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 497 (590)
++..... ........||+.|+|||.+.+..++.++|||||||++|||++|+.||...... ... ..... +...
T Consensus 171 a~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~-~~~----~~i~~-~~~~- 242 (353)
T 3txo_A 171 CKEGICN-GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENED-DLF----EAILN-DEVV- 242 (353)
T ss_dssp CBCSCC----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHH----HHHHH-CCCC-
T ss_pred eeecccC-CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHH-HHH----HHHHc-CCCC-
Confidence 9854322 22344567999999999999889999999999999999999999999754321 111 11111 1110
Q ss_pred hhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCH------HHHHH
Q 046270 498 IFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTI------TDALK 538 (590)
Q Consensus 498 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm------~eVl~ 538 (590)
.+......+..++..|++.||.+||++ .|+++
T Consensus 243 ---------~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 243 ---------YPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp ---------CCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred ---------CCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 011122356778899999999999998 77765
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=342.45 Aligned_cols=244 Identities=25% Similarity=0.324 Sum_probs=200.2
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecC---CCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCce
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDL---DTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKR 339 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~---~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~ 339 (590)
++|...+.||+|+||.||+++.. +|+.||+|++... .....+.+.+|+.++++++||||+++++++. ....
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-----~~~~ 80 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQ-----DAQQ 80 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEE-----CSSE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEE-----eCCE
Confidence 56888899999999999999986 5889999998643 2234567889999999999999999999987 3456
Q ss_pred EEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcc
Q 046270 340 RFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAK 419 (590)
Q Consensus 340 ~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~ 419 (590)
.++||||+++|+|.+++. ....+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++
T Consensus 81 ~~lv~e~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~ 154 (318)
T 1fot_A 81 IFMIMDYIEGGELFSLLR---KSQRFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAK 154 (318)
T ss_dssp EEEEECCCCSCBHHHHHH---HTSSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCE
T ss_pred EEEEEeCCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChheEEEcCCCCEEEeecCcce
Confidence 999999999999999985 3457999999999999999999999 8999999999999999999999999999998
Q ss_pred cccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhh
Q 046270 420 QSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIF 499 (590)
Q Consensus 420 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 499 (590)
.... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||...... .. ...... +...
T Consensus 155 ~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-~~----~~~i~~-~~~~--- 221 (318)
T 1fot_A 155 YVPD----VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM-KT----YEKILN-AELR--- 221 (318)
T ss_dssp ECSS----CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH-HH----HHHHHH-CCCC---
T ss_pred ecCC----ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH-HH----HHHHHh-CCCC---
Confidence 6543 233467999999999999999999999999999999999999999653221 11 111111 1110
Q ss_pred hHHHhhhhHHHHHHHHHHHHHhchhcCCCCCC-----CHHHHHH
Q 046270 500 DEFIRAEGARAVMERFVLVGILCAHVMVALRP-----TITDALK 538 (590)
Q Consensus 500 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-----tm~eVl~ 538 (590)
.+......+.+++..|++.||++|| +++|+++
T Consensus 222 -------~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 222 -------FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp -------CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred -------CCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 0111223677788999999999999 8899875
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=345.15 Aligned_cols=248 Identities=21% Similarity=0.321 Sum_probs=190.5
Q ss_pred cCCCccceecccCcEEEEEEEE----cCCcEEEEEEeecCC----CCChHHHHHHHHHHHhcCCCCccccceeEEeccCC
Q 046270 264 NGFSQNNLIGQGASGIVYKGTL----RHGNLVAVKQILDLD----TKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDS 335 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~----~~g~~vAvK~l~~~~----~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~ 335 (590)
++|...+.||+|+||.||+++. ..|+.||+|++.... ......+.+|++++++++||||+++++++..
T Consensus 17 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~---- 92 (327)
T 3a62_A 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQT---- 92 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEEC----
T ss_pred HHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEc----
Confidence 5688899999999999999997 368899999986532 2234568899999999999999999999974
Q ss_pred CCceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEee
Q 046270 336 SGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADF 415 (590)
Q Consensus 336 ~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DF 415 (590)
+...++||||+++|+|.+++. ....+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+||
T Consensus 93 -~~~~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~Df 165 (327)
T 3a62_A 93 -GGKLYLILEYLSGGELFMQLE---REGIFMEDTACFYLAEISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDF 165 (327)
T ss_dssp -SSCEEEEEECCTTEEHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTSCEEECCC
T ss_pred -CCEEEEEEeCCCCCcHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEcccCCHHHeEECCCCcEEEEeC
Confidence 446999999999999999885 3456899999999999999999999 889999999999999999999999999
Q ss_pred CCcccccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCc
Q 046270 416 GLAKQSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKV 495 (590)
Q Consensus 416 Gla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~ 495 (590)
|+++...... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||....... .+ ..... +..
T Consensus 166 g~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~----~~i~~-~~~ 238 (327)
T 3a62_A 166 GLCKESIHDG-TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKK-TI----DKILK-CKL 238 (327)
T ss_dssp SCC-----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HH----HHHHH-TCC
T ss_pred CcccccccCC-ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHH-HH----HHHHh-CCC
Confidence 9998543322 22344678999999999999999999999999999999999999997533211 11 11111 110
Q ss_pred hhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCC-----CHHHHHHH
Q 046270 496 DDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRP-----TITDALKM 539 (590)
Q Consensus 496 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-----tm~eVl~~ 539 (590)
. .+......+.+++..|++.||++|| ++.|+++.
T Consensus 239 ~----------~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 239 N----------LPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp C----------CCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred C----------CCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence 0 0111234677888999999999999 77788763
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=351.76 Aligned_cols=270 Identities=20% Similarity=0.365 Sum_probs=212.4
Q ss_pred cccHHHHHHHhcCCCccceecccCcEEEEEEEEc------CCcEEEEEEeecCCC-CChHHHHHHHHHHHhcCCCCcccc
Q 046270 253 WFHVSELEQATNGFSQNNLIGQGASGIVYKGTLR------HGNLVAVKQILDLDT-KGDEDFTNEVEIISKIRHRNLLSL 325 (590)
Q Consensus 253 ~f~~~el~~at~~f~~~~~LG~G~fG~Vykg~~~------~g~~vAvK~l~~~~~-~~~~~f~~Ev~il~~l~H~nlv~l 325 (590)
.+..++++...++|...+.||+|+||.||+|++. .+..||||.+..... .....+.+|++++++++||||+++
T Consensus 14 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 93 (322)
T 1p4o_A 14 VYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRL 93 (322)
T ss_dssp CCCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCE
T ss_pred ccChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeee
Confidence 3455566677889999999999999999999875 267899999865432 224568899999999999999999
Q ss_pred ceeEEeccCCCCceEEEEEeeCCCCCcchhhhhhcc-------cccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCC
Q 046270 326 RGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHK-------RKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIK 398 (590)
Q Consensus 326 ~g~~~~~~~~~~~~~~LV~E~~~~gsL~~~L~~~~~-------~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIK 398 (590)
++++.. +...++||||+++|+|.+++..... ...+++..++.|+.||+.||.||| +.+|+|||||
T Consensus 94 ~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dik 165 (322)
T 1p4o_A 94 LGVVSQ-----GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLA 165 (322)
T ss_dssp EEEECS-----SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCS
T ss_pred EEEEcc-----CCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCCccCCCc
Confidence 999864 3458999999999999999864321 145799999999999999999999 8899999999
Q ss_pred CCceEECCCCcEEEEeeCCcccccCCCcc-cccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 046270 399 STNILLDSELNAKVADFGLAKQSLEGHSH-LTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLDTST 476 (590)
Q Consensus 399 p~NILLd~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELlt-G~~p~~~~~ 476 (590)
|+|||++.++.+||+|||+++........ ......||..|+|||.+.++.++.++||||||+++|||++ |+.||....
T Consensus 166 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~ 245 (322)
T 1p4o_A 166 ARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS 245 (322)
T ss_dssp GGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC
T ss_pred cceEEEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCC
Confidence 99999999999999999999865433221 2233456889999999999999999999999999999999 888886432
Q ss_pred CchhhhhHHHHHHHhcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhccCCC
Q 046270 477 SPFQLITDWAWVLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEGDID 545 (590)
Q Consensus 477 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~~~~ 545 (590)
.. . .... ...+..... +......+.+++..|++.||.+|||+.|+++.|+....
T Consensus 246 ~~--~---~~~~-~~~~~~~~~---------~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 246 NE--Q---VLRF-VMEGGLLDK---------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp HH--H---HHHH-HHTTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HH--H---HHHH-HHcCCcCCC---------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 21 1 1111 112221111 11123467788999999999999999999999987543
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=350.86 Aligned_cols=261 Identities=19% Similarity=0.239 Sum_probs=191.0
Q ss_pred HhcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCCCChHHHHHHHHHHHhcC-CCCccccceeEEeccC---CC
Q 046270 262 ATNGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDTKGDEDFTNEVEIISKIR-HRNLLSLRGCCVTSDD---SS 336 (590)
Q Consensus 262 at~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~-H~nlv~l~g~~~~~~~---~~ 336 (590)
...+|...+.||+|+||.||+|++. +|+.||||++........+.+.+|+.++.++. ||||+++++++..... ..
T Consensus 26 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 105 (337)
T 3ll6_A 26 GELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG 105 (337)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred cCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccC
Confidence 3457888999999999999999985 58899999987665555677999999999996 9999999999864322 24
Q ss_pred CceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCCceEECCCCcEEEEe
Q 046270 337 GKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPG--IYHRDIKSTNILLDSELNAKVAD 414 (590)
Q Consensus 337 ~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~--ivHrDIKp~NILLd~~~~~kL~D 414 (590)
....++||||+. |+|.+++........+++.+++.|+.||+.||.||| +.+ |+||||||+|||++.++.+||+|
T Consensus 106 ~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~~~ivH~Dikp~NIl~~~~~~~kl~D 181 (337)
T 3ll6_A 106 QAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH---RQKPPIIHRDLKVENLLLSNQGTIKLCD 181 (337)
T ss_dssp SEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCCCCCGGGCEECTTSCEEBCC
T ss_pred CceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCEEEccCCcccEEECCCCCEEEec
Confidence 556899999995 799998865445567999999999999999999999 778 99999999999999999999999
Q ss_pred eCCcccccCCCcc-----------cccccccCCCccCcccc---ccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchh
Q 046270 415 FGLAKQSLEGHSH-----------LTTRVAGTFGYLAPEYA---LYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQ 480 (590)
Q Consensus 415 FGla~~~~~~~~~-----------~~~~~~gt~~Y~APE~~---~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~ 480 (590)
||+++........ ......||+.|+|||.+ ....++.++||||||+++|||++|+.||.......
T Consensus 182 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~- 260 (337)
T 3ll6_A 182 FGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR- 260 (337)
T ss_dssp CTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred CccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH-
Confidence 9999876443221 11134589999999998 56678999999999999999999999986432211
Q ss_pred hhhHHHHHHHhcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhccCC
Q 046270 481 LITDWAWVLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEGDI 544 (590)
Q Consensus 481 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~~~ 544 (590)
... +.... .........+..++..|++.||.+|||+.|+++.|+...
T Consensus 261 ----~~~-----~~~~~--------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~ 307 (337)
T 3ll6_A 261 ----IVN-----GKYSI--------PPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIA 307 (337)
T ss_dssp --------------CCC--------CTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----hhc-----CcccC--------CcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 000 00000 000011124667888999999999999999999998754
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-41 Score=363.20 Aligned_cols=248 Identities=22% Similarity=0.284 Sum_probs=191.9
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecC---CCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCc
Q 046270 263 TNGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDL---DTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGK 338 (590)
Q Consensus 263 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~---~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~ 338 (590)
.++|...+.||+|+||.||+++.. +|+.||||++... .......+.+|++++++++||||+++++++.. ..
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~-----~~ 221 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQT-----HD 221 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEE-----TT
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEee-----CC
Confidence 367889999999999999999986 4889999998643 23334568899999999999999999999984 34
Q ss_pred eEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCC-CCeEecCCCCCceEECCCCcEEEEeeCC
Q 046270 339 RRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLK-PGIYHRDIKSTNILLDSELNAKVADFGL 417 (590)
Q Consensus 339 ~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~-~~ivHrDIKp~NILLd~~~~~kL~DFGl 417 (590)
..++||||+++|+|.+++. ....+++..+..++.||+.||+||| + .+|+||||||+||||+.++.+||+|||+
T Consensus 222 ~~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH---~~~giiHrDlkp~NIll~~~~~~kl~DFG~ 295 (446)
T 4ejn_A 222 RLCFVMEYANGGELFFHLS---RERVFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGL 295 (446)
T ss_dssp EEEEEECCCSSCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCCCGGGEEECSSSCEEECCCCC
T ss_pred EEEEEEeeCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHh---hcCCEEECCCCHHHEEECCCCCEEEccCCC
Confidence 6899999999999999885 3457999999999999999999999 6 8999999999999999999999999999
Q ss_pred cccccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcC-Cch
Q 046270 418 AKQSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSG-KVD 496 (590)
Q Consensus 418 a~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~-~~~ 496 (590)
++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||....... . ........ ...
T Consensus 296 a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-~----~~~i~~~~~~~p 369 (446)
T 4ejn_A 296 CKEGIKDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK-L----FELILMEEIRFP 369 (446)
T ss_dssp CCTTCC------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-H----HHHHHHCCCCCC
T ss_pred ceeccCCC-cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH-H----HHHHHhCCCCCC
Confidence 98643322 22345679999999999999999999999999999999999999996533211 1 11111111 111
Q ss_pred hhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCC-----CHHHHHHH
Q 046270 497 DIFDEFIRAEGARAVMERFVLVGILCAHVMVALRP-----TITDALKM 539 (590)
Q Consensus 497 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-----tm~eVl~~ 539 (590)
......+.+++..|++.||.+|| +++|+++.
T Consensus 370 ------------~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h 405 (446)
T 4ejn_A 370 ------------RTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH 405 (446)
T ss_dssp ------------TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred ------------ccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence 11224677888999999999999 99999863
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=351.95 Aligned_cols=246 Identities=25% Similarity=0.327 Sum_probs=194.3
Q ss_pred ccceecccCcEEEEEEEEc-CCcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEEEEEee
Q 046270 268 QNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFLVYDY 346 (590)
Q Consensus 268 ~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~LV~E~ 346 (590)
..+.||+|+||.||+|+.. +|..||+|++........+.+.+|++++++++||||+++++++.. ....++||||
T Consensus 93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-----~~~~~lv~E~ 167 (373)
T 2x4f_A 93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFES-----KNDIVLVMEY 167 (373)
T ss_dssp EEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEC-----SSEEEEEEEC
T ss_pred cceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEE-----CCEEEEEEeC
Confidence 3567999999999999986 588999999976554556789999999999999999999999973 4569999999
Q ss_pred CCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEE--CCCCcEEEEeeCCcccccCC
Q 046270 347 MPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILL--DSELNAKVADFGLAKQSLEG 424 (590)
Q Consensus 347 ~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILL--d~~~~~kL~DFGla~~~~~~ 424 (590)
+++|+|.+++.. ....+++..++.|+.||++||.||| +.+|+||||||+|||+ ++++.+||+|||+++.....
T Consensus 168 ~~~~~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~ 242 (373)
T 2x4f_A 168 VDGGELFDRIID--ESYNLTELDTILFMKQICEGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR 242 (373)
T ss_dssp CTTCEEHHHHHH--TGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTT
T ss_pred CCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCc
Confidence 999999998853 3346999999999999999999999 8899999999999999 67789999999999876443
Q ss_pred CcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcC-CchhhhhHHH
Q 046270 425 HSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSG-KVDDIFDEFI 503 (590)
Q Consensus 425 ~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~-~~~~~~d~~l 503 (590)
.. .....||+.|+|||++..+.++.++|||||||++|||++|+.||...... ..+... .... ... ..
T Consensus 243 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~-~~~~~i----~~~~~~~~---~~-- 310 (373)
T 2x4f_A 243 EK--LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA-ETLNNI----LACRWDLE---DE-- 310 (373)
T ss_dssp CB--CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH-HHHHHH----HHTCCCSC---SG--
T ss_pred cc--cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHH----HhccCCCC---hh--
Confidence 22 23446899999999999899999999999999999999999999754321 111111 1111 110 00
Q ss_pred hhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 046270 504 RAEGARAVMERFVLVGILCAHVMVALRPTITDALK 538 (590)
Q Consensus 504 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~ 538 (590)
........+.+++..|++.||.+|||+.|+++
T Consensus 311 ---~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 311 ---EFQDISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp ---GGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ---hhccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 01112346788999999999999999999987
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=350.32 Aligned_cols=253 Identities=26% Similarity=0.344 Sum_probs=201.8
Q ss_pred HhcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCC--CChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCc
Q 046270 262 ATNGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDT--KGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGK 338 (590)
Q Consensus 262 at~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~--~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~ 338 (590)
..++|...+.||+|+||.||+++.. +|..||+|++..... ...+.+.+|++++++++||||+++++++. ...
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~-----~~~ 101 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ-----EES 101 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CSS
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE-----eCC
Confidence 4567999999999999999999986 488999999865432 23456889999999999999999999987 345
Q ss_pred eEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCC---cEEEEee
Q 046270 339 RRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSEL---NAKVADF 415 (590)
Q Consensus 339 ~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~---~~kL~DF 415 (590)
..++||||+++|+|.+++. ....+++..+..++.||+.||.||| +.+|+||||||+|||++.++ .+||+||
T Consensus 102 ~~~lv~e~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~Df 175 (362)
T 2bdw_A 102 FHYLVFDLVTGGELFEDIV---AREFYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADF 175 (362)
T ss_dssp EEEEEECCCCSCBHHHHHT---TCSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEESCSSTTCCEEECCC
T ss_pred EEEEEEecCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEeec
Confidence 6899999999999998885 3457999999999999999999999 88999999999999998654 5999999
Q ss_pred CCcccccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCc
Q 046270 416 GLAKQSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKV 495 (590)
Q Consensus 416 Gla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~ 495 (590)
|+++...... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||...... .... ....+..
T Consensus 176 G~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~-~~~~-----~i~~~~~ 247 (362)
T 2bdw_A 176 GLAIEVNDSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH-RLYA-----QIKAGAY 247 (362)
T ss_dssp TTCBCCTTCC--SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHH-----HHHHTCC
T ss_pred CcceEecCCc--ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH-HHHH-----HHHhCCC
Confidence 9998664332 234467999999999999889999999999999999999999999653321 1111 1111211
Q ss_pred hhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 496 DDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 496 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
.. ..+. ...+...+.+++..|++.||++|||+.|+++.
T Consensus 248 ~~-~~~~-----~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 248 DY-PSPE-----WDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp CC-CTTG-----GGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred CC-Cccc-----ccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 10 0000 01123467788999999999999999999864
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=347.30 Aligned_cols=269 Identities=23% Similarity=0.337 Sum_probs=198.3
Q ss_pred HHHHHHhcCCCccceecccCcEEEEEEEEcC----CcEEEEEEeecCCC--CChHHHHHHHHHHHhcCCCCccccceeEE
Q 046270 257 SELEQATNGFSQNNLIGQGASGIVYKGTLRH----GNLVAVKQILDLDT--KGDEDFTNEVEIISKIRHRNLLSLRGCCV 330 (590)
Q Consensus 257 ~el~~at~~f~~~~~LG~G~fG~Vykg~~~~----g~~vAvK~l~~~~~--~~~~~f~~Ev~il~~l~H~nlv~l~g~~~ 330 (590)
.++....++|...+.||+|+||.||+|.+.. +..||+|++..... ...+.+.+|++++++++||||+++++++.
T Consensus 27 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 106 (313)
T 3brb_A 27 EDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCI 106 (313)
T ss_dssp TTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEE
T ss_pred HhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEe
Confidence 3444456678888999999999999998753 34799999864432 22457899999999999999999999998
Q ss_pred eccCCCCceEEEEEeeCCCCCcchhhhhhc---ccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCC
Q 046270 331 TSDDSSGKRRFLVYDYMPNGTLSDNISISH---KRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSE 407 (590)
Q Consensus 331 ~~~~~~~~~~~LV~E~~~~gsL~~~L~~~~---~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~ 407 (590)
..+.......++||||+++|+|.+++.... ....+++..++.|+.||++||.||| +.+|+||||||+|||++.+
T Consensus 107 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~ 183 (313)
T 3brb_A 107 EMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLS---NRNFLHRDLAARNCMLRDD 183 (313)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCSGGGEEECTT
T ss_pred eccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCC
Confidence 654433345799999999999999885332 3356999999999999999999999 8999999999999999999
Q ss_pred CcEEEEeeCCcccccCCCcc-cccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhhHH
Q 046270 408 LNAKVADFGLAKQSLEGHSH-LTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLDTSTSPFQLITDW 485 (590)
Q Consensus 408 ~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELlt-G~~p~~~~~~~~~~l~~~ 485 (590)
+.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |+.||....... ..
T Consensus 184 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-~~--- 259 (313)
T 3brb_A 184 MTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE-MY--- 259 (313)
T ss_dssp SCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG-HH---
T ss_pred CcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHH-HH---
Confidence 99999999999865443221 2234457889999999999999999999999999999999 888886543221 11
Q ss_pred HHHHHhcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhccC
Q 046270 486 AWVLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEGD 543 (590)
Q Consensus 486 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~~ 543 (590)
... ..+.... .+......+.+++..|++.||.+|||+.+++++|+..
T Consensus 260 -~~~-~~~~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l 306 (313)
T 3brb_A 260 -DYL-LHGHRLK---------QPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKL 306 (313)
T ss_dssp -HHH-HTTCCCC---------CBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred -HHH-HcCCCCC---------CCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 111 1111110 0112234678899999999999999999999999764
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-40 Score=346.00 Aligned_cols=276 Identities=21% Similarity=0.311 Sum_probs=205.6
Q ss_pred ccHHHHHHHhcCCCccceecccCcEEEEEEEEcCCcEEEEEEeecCCCCC-----------hHHHHHHHHHHHhcCCCCc
Q 046270 254 FHVSELEQATNGFSQNNLIGQGASGIVYKGTLRHGNLVAVKQILDLDTKG-----------DEDFTNEVEIISKIRHRNL 322 (590)
Q Consensus 254 f~~~el~~at~~f~~~~~LG~G~fG~Vykg~~~~g~~vAvK~l~~~~~~~-----------~~~f~~Ev~il~~l~H~nl 322 (590)
..+.++....++|...+.||+|+||.||+|+..+|..||||++....... .+.+.+|++++++++||||
T Consensus 12 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 91 (362)
T 3pg1_A 12 DLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI 91 (362)
T ss_dssp HHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTB
T ss_pred HHHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCc
Confidence 34678888999999999999999999999999889999999986533221 2678999999999999999
Q ss_pred cccceeEEeccCCCCceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCce
Q 046270 323 LSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNI 402 (590)
Q Consensus 323 v~l~g~~~~~~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NI 402 (590)
+++++++...+.......++||||++ |+|.+++. .....+++..+..|+.||+.||.||| +.+|+||||||+||
T Consensus 92 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NI 165 (362)
T 3pg1_A 92 LGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIH--DQRIVISPQHIQYFMYHILLGLHVLH---EAGVVHRDLHPGNI 165 (362)
T ss_dssp CCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHH--CTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGE
T ss_pred cceeeeEEeccCCCcceEEEEEccCC-CCHHHHHH--hcccCCCHHHHHHHHHHHHHHHHHHH---HCcCEecCCChHHE
Confidence 99999998766556678999999998 68887775 23456999999999999999999999 88999999999999
Q ss_pred EECCCCcEEEEeeCCcccccCCCcccccccccCCCccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhh
Q 046270 403 LLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALY-GQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQL 481 (590)
Q Consensus 403 LLd~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~ 481 (590)
|++.++.+||+|||+++...... ......||..|+|||.+.+ ..++.++||||||+++|||++|+.||...... ..
T Consensus 166 l~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~ 242 (362)
T 3pg1_A 166 LLADNNDITICDFNLAREDTADA--NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFY-NQ 242 (362)
T ss_dssp EECTTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HH
T ss_pred EEcCCCCEEEEecCccccccccc--ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHH-HH
Confidence 99999999999999997543322 2344568999999999876 67999999999999999999999999754321 11
Q ss_pred hhHHHHHHHhcCCchhhh-----------hHHHh-------hhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 482 ITDWAWVLAKSGKVDDIF-----------DEFIR-------AEGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 482 l~~~~~~~~~~~~~~~~~-----------d~~l~-------~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
+..... ........+.. ...+. ..........+.+++..|++.||++|||+.|+++.
T Consensus 243 ~~~i~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 243 LNKIVE-VVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp HHHHHH-HHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHH-HcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 111111 11111111100 00000 00001123467889999999999999999999874
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=333.07 Aligned_cols=253 Identities=28% Similarity=0.400 Sum_probs=203.4
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCC-CChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceE
Q 046270 263 TNGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDT-KGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRR 340 (590)
Q Consensus 263 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~-~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~ 340 (590)
.++|...+.||+|+||.||+|+.. +++.||||++..... ...+.+.+|++++++++||||+++++++.. +...
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~ 80 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE-----GNIQ 80 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-----TTEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEc-----CCEE
Confidence 356888899999999999999986 588999999864432 335678999999999999999999999874 4568
Q ss_pred EEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCccc
Q 046270 341 FLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQ 420 (590)
Q Consensus 341 ~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~ 420 (590)
++||||+++++|.+++. ....+++..++.++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++..
T Consensus 81 ~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 154 (276)
T 2yex_A 81 YLFLEYCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATV 154 (276)
T ss_dssp EEEEECCTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEEecCCCcHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCChHHEEEccCCCEEEeeCCCccc
Confidence 99999999999999884 3456999999999999999999999 88999999999999999999999999999986
Q ss_pred ccCCCc-ccccccccCCCccCccccccCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhh
Q 046270 421 SLEGHS-HLTTRVAGTFGYLAPEYALYGQL-TEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDI 498 (590)
Q Consensus 421 ~~~~~~-~~~~~~~gt~~Y~APE~~~~~~~-t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 498 (590)
...... .......||..|+|||.+.+..+ +.++||||||++++||++|+.||............|. .....
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-----~~~~~-- 227 (276)
T 2yex_A 155 FRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWK-----EKKTY-- 227 (276)
T ss_dssp CEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHH-----TTCTT--
T ss_pred cCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhh-----hcccc--
Confidence 543222 22345678999999999987665 7899999999999999999999976554333332221 11100
Q ss_pred hhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 499 FDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 499 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
... .......+.+++..|++.||.+|||+.|+++.
T Consensus 228 ~~~------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 228 LNP------WKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp STT------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred cCc------hhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence 000 01123466788999999999999999999863
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=348.06 Aligned_cols=252 Identities=23% Similarity=0.301 Sum_probs=188.2
Q ss_pred HhcCCCccceecccCcEEEEEEEEcC-CcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceE
Q 046270 262 ATNGFSQNNLIGQGASGIVYKGTLRH-GNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRR 340 (590)
Q Consensus 262 at~~f~~~~~LG~G~fG~Vykg~~~~-g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~ 340 (590)
..++|...+.||+|+||.||+|++.. ++.||||++.... ..+.+.+|++++.+++||||+++++++.. +...
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~~~~ 123 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFET-----PTEI 123 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEEC-----SSEE
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEec-----CCeE
Confidence 45778999999999999999999874 7789999987542 34568899999999999999999999973 4569
Q ss_pred EEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECC---CCcEEEEeeCC
Q 046270 341 FLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDS---ELNAKVADFGL 417 (590)
Q Consensus 341 ~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~---~~~~kL~DFGl 417 (590)
++||||+++|+|.+++. ....+++.+++.++.||+.||.||| +.+|+||||||+|||++. ++.+||+|||+
T Consensus 124 ~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~ 197 (349)
T 2w4o_A 124 SLVLELVTGGELFDRIV---EKGYYSERDAADAVKQILEAVAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGL 197 (349)
T ss_dssp EEEECCCCSCBHHHHHT---TCSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESSSSTTCCEEECCCC-
T ss_pred EEEEEeCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCcccEEEecCCCCCCEEEccCcc
Confidence 99999999999999885 3456999999999999999999999 889999999999999975 88999999999
Q ss_pred cccccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchh
Q 046270 418 AKQSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDD 497 (590)
Q Consensus 418 a~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 497 (590)
++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.........+.. ...+...
T Consensus 198 a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~-----i~~~~~~- 269 (349)
T 2w4o_A 198 SKIVEHQ--VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRR-----ILNCEYY- 269 (349)
T ss_dssp -----------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHH-----HHTTCCC-
T ss_pred ccccCcc--cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHH-----HHhCCCc-
Confidence 9865432 2234467899999999999989999999999999999999999999754443222111 1111110
Q ss_pred hhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 498 IFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 498 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
...+. ..+....+.+++..|++.||++|||+.|+++.
T Consensus 270 ~~~~~-----~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 270 FISPW-----WDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp CCTTT-----TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred cCCch-----hhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000 01123467789999999999999999999873
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-40 Score=331.81 Aligned_cols=250 Identities=22% Similarity=0.289 Sum_probs=202.3
Q ss_pred hcCCCccceecccCcEEEEEEEEcC-CcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEE
Q 046270 263 TNGFSQNNLIGQGASGIVYKGTLRH-GNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRF 341 (590)
Q Consensus 263 t~~f~~~~~LG~G~fG~Vykg~~~~-g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~ 341 (590)
.++|...+.||+|+||.||+|+... +..||+|++........+.+.+|++++++++||||+++++++. .+...+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 82 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE-----DNTDIY 82 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSSEEE
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEe-----cCCeEE
Confidence 4568889999999999999999875 6689999998766667788999999999999999999999997 345699
Q ss_pred EEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEE---CCCCcEEEEeeCCc
Q 046270 342 LVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILL---DSELNAKVADFGLA 418 (590)
Q Consensus 342 LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILL---d~~~~~kL~DFGla 418 (590)
+||||+++++|.+++. ....+++..++.|+.|++.||.||| +.+|+||||||+|||+ +.++.+||+|||++
T Consensus 83 lv~e~~~~~~L~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~ 156 (277)
T 3f3z_A 83 LVMELCTGGELFERVV---HKRVFRESDAARIMKDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLA 156 (277)
T ss_dssp EEEECCCSCBHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEeccCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEecCCCCCcEEEEecccc
Confidence 9999999999999885 3456999999999999999999999 8999999999999999 78899999999999
Q ss_pred ccccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhh
Q 046270 419 KQSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDI 498 (590)
Q Consensus 419 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 498 (590)
....... ......||+.|+|||.+.+ .++.++||||||++++||++|+.||....... ... . ...+....
T Consensus 157 ~~~~~~~--~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~~----~-~~~~~~~~- 226 (277)
T 3f3z_A 157 ARFKPGK--MMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSE-VML----K-IREGTFTF- 226 (277)
T ss_dssp EECCTTS--CBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHH----H-HHHCCCCC-
T ss_pred eeccCcc--chhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHHH-HHH----H-HHhCCCCC-
Confidence 8654332 2334568999999998764 59999999999999999999999997533211 111 1 11121110
Q ss_pred hhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 046270 499 FDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALK 538 (590)
Q Consensus 499 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~ 538 (590)
.... .......+.+++..|++.||++|||+.++++
T Consensus 227 ~~~~-----~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 227 PEKD-----WLNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp CHHH-----HTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred Cchh-----hhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000 0112346778899999999999999999975
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-41 Score=360.66 Aligned_cols=264 Identities=20% Similarity=0.221 Sum_probs=207.2
Q ss_pred ccHHHHHHHhcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCC---CCChHHHHHHHHHHHhcCCCCccccceeE
Q 046270 254 FHVSELEQATNGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLD---TKGDEDFTNEVEIISKIRHRNLLSLRGCC 329 (590)
Q Consensus 254 f~~~el~~at~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~---~~~~~~f~~Ev~il~~l~H~nlv~l~g~~ 329 (590)
+.++++....++|...+.||+|+||.||+++.+ +|+.||||++.... ....+.+.+|.+++.+++||||+++++++
T Consensus 51 ~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 130 (412)
T 2vd5_A 51 VRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF 130 (412)
T ss_dssp HHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred hhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence 455666677889999999999999999999986 58899999986421 12234588999999999999999999998
Q ss_pred EeccCCCCceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCc
Q 046270 330 VTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELN 409 (590)
Q Consensus 330 ~~~~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~ 409 (590)
.+ ....++||||+++|+|.+++.. ....+++..++.++.||+.||+||| +.+|+||||||+|||++.++.
T Consensus 131 ~~-----~~~~~lVmE~~~gg~L~~~l~~--~~~~l~~~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILld~~g~ 200 (412)
T 2vd5_A 131 QD-----ENYLYLVMEYYVGGDLLTLLSK--FGERIPAEMARFYLAEIVMAIDSVH---RLGYVHRDIKPDNILLDRCGH 200 (412)
T ss_dssp EC-----SSEEEEEECCCCSCBHHHHHHH--HSSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSC
T ss_pred ee-----CCEEEEEEcCCCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccCHHHeeecCCCC
Confidence 73 4569999999999999999953 2346999999999999999999999 899999999999999999999
Q ss_pred EEEEeeCCcccccCCCcccccccccCCCccCccccc-------cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhh
Q 046270 410 AKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYAL-------YGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLI 482 (590)
Q Consensus 410 ~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~-------~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l 482 (590)
+||+|||+++..............||+.|+|||++. .+.++.++|||||||++|||++|+.||....... ..
T Consensus 201 vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~-~~ 279 (412)
T 2vd5_A 201 IRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAE-TY 279 (412)
T ss_dssp EEECCCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-HH
T ss_pred EEEeechhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHH-HH
Confidence 999999999876554433344568999999999987 3578999999999999999999999997543211 11
Q ss_pred hHHHHHHHhcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCC---CCHHHHHHH
Q 046270 483 TDWAWVLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALR---PTITDALKM 539 (590)
Q Consensus 483 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~R---Ptm~eVl~~ 539 (590)
....... ..-... . ........+.+++..|++ +|.+| |+++|++++
T Consensus 280 ~~i~~~~-~~~~~p-----~----~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 280 GKIVHYK-EHLSLP-----L----VDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp HHHHTHH-HHCCCC-------------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred HHHHhcc-cCcCCC-----c----cccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 1110000 000000 0 011223467788889999 99998 689999764
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=354.19 Aligned_cols=270 Identities=20% Similarity=0.278 Sum_probs=209.9
Q ss_pred cCCCccceecccCcEEEEEEEEcC-CcEEEEEEeecCC-CCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEE
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLRH-GNLVAVKQILDLD-TKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRF 341 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~vAvK~l~~~~-~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~ 341 (590)
++|...++||+|+||.||+|++.. |+.||||++.... ....+.+.+|++++++++||||+++++++...+ +...+
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~---~~~~~ 85 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETT---TRHKV 85 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTT---TCCEE
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCC---CCeeE
Confidence 468888999999999999999875 8899999986533 234567889999999999999999999987542 34689
Q ss_pred EEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEE----CCCCcEEEEeeCC
Q 046270 342 LVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILL----DSELNAKVADFGL 417 (590)
Q Consensus 342 LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILL----d~~~~~kL~DFGl 417 (590)
+||||+++|+|.+++........+++..++.|+.||+.||+||| +.+|+||||||+|||+ +.++.+||+|||+
T Consensus 86 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~ 162 (396)
T 4eut_A 86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA 162 (396)
T ss_dssp EEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEECTTSCEEEEECCGGG
T ss_pred EEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEEECCcCHHHEEEeecCCCceeEEEecCCC
Confidence 99999999999999975444445999999999999999999999 8899999999999999 7888899999999
Q ss_pred cccccCCCcccccccccCCCccCcccccc--------CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHH
Q 046270 418 AKQSLEGHSHLTTRVAGTFGYLAPEYALY--------GQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVL 489 (590)
Q Consensus 418 a~~~~~~~~~~~~~~~gt~~Y~APE~~~~--------~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~ 489 (590)
++...... ......||..|+|||.+.. ..++.++|||||||++|||++|+.||........... .....
T Consensus 163 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~-~~~~~ 239 (396)
T 4eut_A 163 ARELEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKE-VMYKI 239 (396)
T ss_dssp CEECCCGG--GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHH-HHHHH
T ss_pred ceEccCCC--ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHH-HHHHH
Confidence 98654332 2334568999999998865 5678899999999999999999999975443322111 11111
Q ss_pred HhcCCchhhh-------------hHHHh--hhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhccC
Q 046270 490 AKSGKVDDIF-------------DEFIR--AEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEGD 543 (590)
Q Consensus 490 ~~~~~~~~~~-------------d~~l~--~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~~ 543 (590)
.. +.....+ ...+. ..........+..++..|++.||++||++.++++.|+..
T Consensus 240 ~~-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~i 307 (396)
T 4eut_A 240 IT-GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (396)
T ss_dssp HH-SCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred hc-CCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHH
Confidence 11 1111000 00000 112244556778899999999999999999999887664
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-41 Score=378.38 Aligned_cols=246 Identities=23% Similarity=0.363 Sum_probs=196.1
Q ss_pred eecccCcEEEEEEEEc---CCcEEEEEEeecCCC-CChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEEEEEee
Q 046270 271 LIGQGASGIVYKGTLR---HGNLVAVKQILDLDT-KGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFLVYDY 346 (590)
Q Consensus 271 ~LG~G~fG~Vykg~~~---~g~~vAvK~l~~~~~-~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~LV~E~ 346 (590)
.||+|+||.||+|++. ++..||||+++.... ...++|.+|++++++++|||||++++++.. ...++||||
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~------~~~~lv~E~ 416 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA------EALMLVMEM 416 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES------SSEEEEEEC
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc------CCeEEEEEe
Confidence 7999999999999875 456799999976433 346789999999999999999999999863 238999999
Q ss_pred CCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccccCCCc
Q 046270 347 MPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHS 426 (590)
Q Consensus 347 ~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~~~~~~ 426 (590)
+++|+|.+++.. ....+++..++.|+.||+.||+||| +.+|+||||||+||||++++.+||+|||+++.......
T Consensus 417 ~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~ 491 (613)
T 2ozo_A 417 AGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDS 491 (613)
T ss_dssp CTTCBHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC----
T ss_pred CCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCc
Confidence 999999999853 3456999999999999999999999 88999999999999999999999999999987644332
Q ss_pred ccc--cccccCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhhHHHHHHHhcCCchhhhhHHH
Q 046270 427 HLT--TRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDEFI 503 (590)
Q Consensus 427 ~~~--~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 503 (590)
... ....++..|+|||++..+.++.++|||||||++|||+| |+.||....... +. .....+....
T Consensus 492 ~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~--~~----~~i~~~~~~~------ 559 (613)
T 2ozo_A 492 YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE--VM----AFIEQGKRME------ 559 (613)
T ss_dssp ----------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH--HH----HHHHTTCCCC------
T ss_pred eeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH--HH----HHHHcCCCCC------
Confidence 222 22345689999999999999999999999999999998 999997644321 11 1112222111
Q ss_pred hhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhcc
Q 046270 504 RAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEG 542 (590)
Q Consensus 504 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~ 542 (590)
.+......+.+++..|++.+|++||++.+|+++|+.
T Consensus 560 ---~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~ 595 (613)
T 2ozo_A 560 ---CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA 595 (613)
T ss_dssp ---CCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHH
T ss_pred ---CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 111233477889999999999999999999999976
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=334.72 Aligned_cols=257 Identities=25% Similarity=0.376 Sum_probs=204.7
Q ss_pred HhcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCccccceeEEeccC------
Q 046270 262 ATNGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDD------ 334 (590)
Q Consensus 262 at~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~------ 334 (590)
..++|...+.||+|+||.||+|++. +|+.||+|++.... +.+.+|++++++++||||+++++++...+.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 3456888999999999999999987 68999999986532 457899999999999999999998864211
Q ss_pred -----CCCceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCc
Q 046270 335 -----SSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELN 409 (590)
Q Consensus 335 -----~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~ 409 (590)
......++||||+++|+|.+++... ....+++..++.|+.||+.||.||| +.+|+||||||+|||++.++.
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~ 160 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKR-RGEKLDKVLALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQ 160 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHG-GGSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTE
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHEEEcCCCC
Confidence 1244589999999999999998643 2357999999999999999999999 889999999999999999999
Q ss_pred EEEEeeCCcccccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHH
Q 046270 410 AKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVL 489 (590)
Q Consensus 410 ~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~ 489 (590)
+||+|||+++...... ......||..|+|||.+.+..++.++||||||+++|||++|..|+.. ...+. ..
T Consensus 161 ~kl~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~-------~~~~~-~~ 230 (284)
T 2a19_B 161 VKIGDFGLVTSLKNDG--KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE-------TSKFF-TD 230 (284)
T ss_dssp EEECCCTTCEESSCCS--CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHH-------HHHHH-HH
T ss_pred EEECcchhheeccccc--cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchh-------HHHHH-HH
Confidence 9999999998764432 23345689999999999999999999999999999999999887531 11111 11
Q ss_pred HhcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhccCCCCCC
Q 046270 490 AKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEGDIDIPK 548 (590)
Q Consensus 490 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~~~~~~~ 548 (590)
...+...+. ....+..++..|++.||.+|||+.|++++|+.....+.
T Consensus 231 ~~~~~~~~~------------~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~ 277 (284)
T 2a19_B 231 LRDGIISDI------------FDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPE 277 (284)
T ss_dssp HHTTCCCTT------------SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC---
T ss_pred hhccccccc------------CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCC
Confidence 122222211 12356678889999999999999999999987554433
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=346.43 Aligned_cols=244 Identities=23% Similarity=0.299 Sum_probs=200.5
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecC---CCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCce
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDL---DTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKR 339 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~---~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~ 339 (590)
++|...+.||+|+||.||+++.. +|+.||+|++... .....+.+.+|++++++++||||+++++++.. ...
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~~~ 115 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD-----NSN 115 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-----SSE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc-----CCE
Confidence 56888999999999999999986 5889999998643 22345678999999999999999999999873 456
Q ss_pred EEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcc
Q 046270 340 RFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAK 419 (590)
Q Consensus 340 ~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~ 419 (590)
.++||||+++|+|.+++. ..+.+++..++.++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++
T Consensus 116 ~~lv~e~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~ 189 (350)
T 1rdq_E 116 LYMVMEYVAGGEMFSHLR---RIGRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK 189 (350)
T ss_dssp EEEEEECCTTCBHHHHHH---HHCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEEcCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCccceEEECCCCCEEEcccccce
Confidence 999999999999999985 3356999999999999999999999 8999999999999999999999999999998
Q ss_pred cccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhh
Q 046270 420 QSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIF 499 (590)
Q Consensus 420 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 499 (590)
..... .....||+.|+|||.+.+..++.++|||||||++|||++|+.||..... .... .... .+...
T Consensus 190 ~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-~~~~----~~i~-~~~~~--- 256 (350)
T 1rdq_E 190 RVKGR----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP-IQIY----EKIV-SGKVR--- 256 (350)
T ss_dssp ECSSC----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHH----HHHH-HCCCC---
T ss_pred eccCC----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCH-HHHH----HHHH-cCCCC---
Confidence 65432 2345789999999999999999999999999999999999999975322 1111 1111 11110
Q ss_pred hHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCC-----HHHHHH
Q 046270 500 DEFIRAEGARAVMERFVLVGILCAHVMVALRPT-----ITDALK 538 (590)
Q Consensus 500 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt-----m~eVl~ 538 (590)
.+......+..++..|++.||.+||+ ++|+++
T Consensus 257 -------~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 257 -------FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp -------CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred -------CCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 01112346778889999999999998 888875
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-41 Score=348.58 Aligned_cols=256 Identities=25% Similarity=0.384 Sum_probs=197.2
Q ss_pred cCCCccceecccCcEEEEEEEEcC-Cc----EEEEEEeecC-CCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCC
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLRH-GN----LVAVKQILDL-DTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSG 337 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~~-g~----~vAvK~l~~~-~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~ 337 (590)
++|...+.||+|+||.||+|++.. ++ .||+|.+... .....+.+.+|++++++++||||+++++++...
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~----- 89 (327)
T 3lzb_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS----- 89 (327)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS-----
T ss_pred hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC-----
Confidence 568889999999999999999753 44 3678877543 334567899999999999999999999999742
Q ss_pred ceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCC
Q 046270 338 KRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGL 417 (590)
Q Consensus 338 ~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGl 417 (590)
..++|+||+++|+|.+++.. ....+++..++.|+.||+.||.||| +.+|+||||||+|||++.++.+||+|||+
T Consensus 90 -~~~~v~~~~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kL~DfG~ 163 (327)
T 3lzb_A 90 -TVQLITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGL 163 (327)
T ss_dssp -SEEEEECCCSSCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTC
T ss_pred -CceEEEEecCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHh---hCCCcCCCCCHHHEEEcCCCCEEEccCcc
Confidence 37899999999999999863 2456999999999999999999999 88999999999999999999999999999
Q ss_pred cccccCCCcc-cccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhhHHHHHHHhcCCc
Q 046270 418 AKQSLEGHSH-LTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLDTSTSPFQLITDWAWVLAKSGKV 495 (590)
Q Consensus 418 a~~~~~~~~~-~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~ 495 (590)
++........ ......+|..|+|||.+.+..++.++||||||+++|||++ |+.||....... +... ...+..
T Consensus 164 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~--~~~~----~~~~~~ 237 (327)
T 3lzb_A 164 AKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--ISSI----LEKGER 237 (327)
T ss_dssp ----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--HHHH----HHTTCC
T ss_pred eeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH--HHHH----HHcCCC
Confidence 9875433222 2233456788999999999999999999999999999999 999997543321 1111 111111
Q ss_pred hhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhccCCC
Q 046270 496 DDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEGDID 545 (590)
Q Consensus 496 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~~~~ 545 (590)
.. .+......+..++..|++.||.+|||+.|+++.|+....
T Consensus 238 ~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 278 (327)
T 3lzb_A 238 LP---------QPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp CC---------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred CC---------CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 00 011122367788999999999999999999999987543
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=340.24 Aligned_cols=261 Identities=23% Similarity=0.297 Sum_probs=196.3
Q ss_pred cCCCccceecccCcEEEEEEEEcCCcEEEEEEeecCCC--CChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEE
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLRHGNLVAVKQILDLDT--KGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRF 341 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~~g~~vAvK~l~~~~~--~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~ 341 (590)
++|...+.||+|+||.||+|+...|+.||+|++..... ...+.+.+|++++++++||||+++++++.. ....+
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~ 76 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT-----KKRLV 76 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC-----SSCEE
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEcc-----CCeEE
Confidence 46888899999999999999998899999999864322 234678899999999999999999999874 34689
Q ss_pred EEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccc
Q 046270 342 LVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQS 421 (590)
Q Consensus 342 LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~ 421 (590)
+||||+++ +|.+++.. ....+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++..
T Consensus 77 lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 150 (288)
T 1ob3_A 77 LVFEHLDQ-DLKKLLDV--CEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAF 150 (288)
T ss_dssp EEEECCSE-EHHHHHHT--STTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHH
T ss_pred EEEEecCC-CHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEeECcccccc
Confidence 99999975 88888753 2356999999999999999999999 889999999999999999999999999999865
Q ss_pred cCCCcccccccccCCCccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCC---chh
Q 046270 422 LEGHSHLTTRVAGTFGYLAPEYALY-GQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGK---VDD 497 (590)
Q Consensus 422 ~~~~~~~~~~~~gt~~Y~APE~~~~-~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~---~~~ 497 (590)
.... .......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||....... .+...... ..... ...
T Consensus 151 ~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~~~~~-~~~~~~~~~~~ 227 (288)
T 1ob3_A 151 GIPV-RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD-QLMRIFRI-LGTPNSKNWPN 227 (288)
T ss_dssp CC----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHH-HCCCCTTTSTT
T ss_pred Cccc-cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHH-HCCCChhhchh
Confidence 4322 12334568999999999875 458999999999999999999999997543321 11111111 11000 000
Q ss_pred -----hhhHHHh-------hhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 046270 498 -----IFDEFIR-------AEGARAVMERFVLVGILCAHVMVALRPTITDALK 538 (590)
Q Consensus 498 -----~~d~~l~-------~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~ 538 (590)
..++... ........+.+.+++..|++.||++|||+.|+++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 228 VTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp GGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0000000 0001123346788999999999999999999986
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-41 Score=349.84 Aligned_cols=258 Identities=25% Similarity=0.385 Sum_probs=203.9
Q ss_pred hcCCCccceecccCcEEEEEEEEc--------CCcEEEEEEeecCCC-CChHHHHHHHHHHHhc-CCCCccccceeEEec
Q 046270 263 TNGFSQNNLIGQGASGIVYKGTLR--------HGNLVAVKQILDLDT-KGDEDFTNEVEIISKI-RHRNLLSLRGCCVTS 332 (590)
Q Consensus 263 t~~f~~~~~LG~G~fG~Vykg~~~--------~g~~vAvK~l~~~~~-~~~~~f~~Ev~il~~l-~H~nlv~l~g~~~~~ 332 (590)
.++|...+.||+|+||.||+|.+. ++..||||++..... ...+.+.+|+++++++ +||||+++++++..
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~- 112 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ- 112 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc-
Confidence 467888999999999999999874 467899999865432 2345789999999999 99999999999874
Q ss_pred cCCCCceEEEEEeeCCCCCcchhhhhhcc-------------cccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCC
Q 046270 333 DDSSGKRRFLVYDYMPNGTLSDNISISHK-------------RKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKS 399 (590)
Q Consensus 333 ~~~~~~~~~LV~E~~~~gsL~~~L~~~~~-------------~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp 399 (590)
....++||||+++|+|.+++..... ...+++..++.++.||+.||.||| +.+|+||||||
T Consensus 113 ----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp 185 (334)
T 2pvf_A 113 ----DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAA 185 (334)
T ss_dssp ----SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSG
T ss_pred ----CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCcc
Confidence 3458999999999999999864321 234899999999999999999999 88999999999
Q ss_pred CceEECCCCcEEEEeeCCcccccCCCcc-cccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCC
Q 046270 400 TNILLDSELNAKVADFGLAKQSLEGHSH-LTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLDTSTS 477 (590)
Q Consensus 400 ~NILLd~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELlt-G~~p~~~~~~ 477 (590)
+|||++.++.+||+|||+++........ ......+|..|+|||.+.+..++.++||||||+++|||++ |+.||.....
T Consensus 186 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 265 (334)
T 2pvf_A 186 RNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 265 (334)
T ss_dssp GGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred ceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCH
Confidence 9999999999999999999866543322 2334457889999999998899999999999999999999 9999865322
Q ss_pred chhhhhHHHHHHHhcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhccC
Q 046270 478 PFQLITDWAWVLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEGD 543 (590)
Q Consensus 478 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~~ 543 (590)
. . .... ...+.... .+......+..++..|++.+|.+|||+.|+++.|+..
T Consensus 266 ~--~---~~~~-~~~~~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l 316 (334)
T 2pvf_A 266 E--E---LFKL-LKEGHRMD---------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316 (334)
T ss_dssp H--H---HHHH-HHHTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred H--H---HHHH-HhcCCCCC---------CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 1 1 1111 11111110 0111234677889999999999999999999999864
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=351.31 Aligned_cols=268 Identities=18% Similarity=0.248 Sum_probs=201.0
Q ss_pred hcCCCccceeccc--CcEEEEEEEEc-CCcEEEEEEeecCCC--CChHHHHHHHHHHHhcCCCCccccceeEEeccCCCC
Q 046270 263 TNGFSQNNLIGQG--ASGIVYKGTLR-HGNLVAVKQILDLDT--KGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSG 337 (590)
Q Consensus 263 t~~f~~~~~LG~G--~fG~Vykg~~~-~g~~vAvK~l~~~~~--~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~ 337 (590)
.++|...+.||+| +||.||+++.. +|+.||||++..... ...+.+.+|++++++++|||||++++++.. +
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~ 98 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIA-----D 98 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----T
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEE-----C
Confidence 3568889999999 99999999987 588999999965432 224568889999999999999999999984 4
Q ss_pred ceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCC
Q 046270 338 KRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGL 417 (590)
Q Consensus 338 ~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGl 417 (590)
...++||||+++|+|.+++... ....+++..+..|+.||+.||+||| +.+|+||||||+|||++.++.+||+|||+
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~kl~dfg~ 174 (389)
T 3gni_B 99 NELWVVTSFMAYGSAKDLICTH-FMDGMNELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRS 174 (389)
T ss_dssp TEEEEEEECCTTCBHHHHHHHT-CTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCGGG
T ss_pred CEEEEEEEccCCCCHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEccccc
Confidence 4699999999999999998643 2356999999999999999999999 89999999999999999999999999999
Q ss_pred cccccCCCc------ccccccccCCCccCcccccc--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHH
Q 046270 418 AKQSLEGHS------HLTTRVAGTFGYLAPEYALY--GQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVL 489 (590)
Q Consensus 418 a~~~~~~~~------~~~~~~~gt~~Y~APE~~~~--~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~ 489 (590)
+........ .......||..|+|||.+.. ..++.++|||||||++|||++|+.||............+....
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 254 (389)
T 3gni_B 175 NLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTV 254 (389)
T ss_dssp CEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-----
T ss_pred ceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCC
Confidence 865432211 11223468999999999987 5799999999999999999999999976444322111000000
Q ss_pred ---Hhc------------------CCchhhhhHHH---------hhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 490 ---AKS------------------GKVDDIFDEFI---------RAEGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 490 ---~~~------------------~~~~~~~d~~l---------~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
... ....+.+.... ...........+.+++..|++.||++|||+.|+++.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 255 PCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp ---------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred CccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 000 00000000000 000112233468889999999999999999999864
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=339.48 Aligned_cols=269 Identities=23% Similarity=0.267 Sum_probs=201.5
Q ss_pred HhcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCC-----CChHHHHHHHHHHHhcC---CCCccccceeEEec
Q 046270 262 ATNGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDT-----KGDEDFTNEVEIISKIR---HRNLLSLRGCCVTS 332 (590)
Q Consensus 262 at~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~-----~~~~~f~~Ev~il~~l~---H~nlv~l~g~~~~~ 332 (590)
.+++|...+.||+|+||.||+|++. +|+.||||++..... .....+.+|++++++++ ||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 4678999999999999999999975 588999999864321 22356788888888775 99999999999875
Q ss_pred cCCCCceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEE
Q 046270 333 DDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKV 412 (590)
Q Consensus 333 ~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL 412 (590)
........++||||+. |+|.+++... ....+++.+++.|+.||+.||+||| +.+|+||||||+|||++.++.+||
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl 161 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKA-PPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKL 161 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTC-CTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCTTTEEECTTSCEEE
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEE
Confidence 5433446899999997 6999988532 2234999999999999999999999 889999999999999999999999
Q ss_pred EeeCCcccccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhc
Q 046270 413 ADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKS 492 (590)
Q Consensus 413 ~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~ 492 (590)
+|||+++...... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||....... .+..........
T Consensus 162 ~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~i~~~~~~~ 238 (308)
T 3g33_A 162 ADFGLARIYSYQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD-QLGKIFDLIGLP 238 (308)
T ss_dssp CSCSCTTTSTTCC--CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHH-HHHHHHHHHCCC
T ss_pred eeCccccccCCCc--ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCC
Confidence 9999998654322 2345678999999999999999999999999999999999999997543321 222111111000
Q ss_pred --CCchh-------hhhHH---HhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 046270 493 --GKVDD-------IFDEF---IRAEGARAVMERFVLVGILCAHVMVALRPTITDALK 538 (590)
Q Consensus 493 --~~~~~-------~~d~~---l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~ 538 (590)
..... .+.+. .......+..+.+.+++..|++.||++|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 239 PEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp CTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 00000 00000 000001123346788999999999999999999986
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=353.40 Aligned_cols=253 Identities=21% Similarity=0.291 Sum_probs=203.1
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEE
Q 046270 263 TNGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRF 341 (590)
Q Consensus 263 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~ 341 (590)
.++|...+.||+|+||.||+|+.. +|+.||+|.+..........+.+|++++.+++||||+++++++. .+...+
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~-----~~~~~~ 124 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE-----DKYEMV 124 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEE-----CSSEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEE-----eCCEEE
Confidence 467899999999999999999986 48899999987654444567899999999999999999999997 345699
Q ss_pred EEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECC--CCcEEEEeeCCcc
Q 046270 342 LVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDS--ELNAKVADFGLAK 419 (590)
Q Consensus 342 LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~--~~~~kL~DFGla~ 419 (590)
+||||+++|+|.+++.. ....+++.+++.++.||+.||+||| +.+|+||||||+|||++. ++.+||+|||+++
T Consensus 125 lv~E~~~gg~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~ 199 (387)
T 1kob_A 125 LILEFLSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLAT 199 (387)
T ss_dssp EEEECCCCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCE
T ss_pred EEEEcCCCCcHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccchHHeEEecCCCCceEEEecccce
Confidence 99999999999998852 2346999999999999999999999 889999999999999974 4789999999998
Q ss_pred cccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhh
Q 046270 420 QSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIF 499 (590)
Q Consensus 420 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 499 (590)
...... ......||+.|+|||.+....++.++|||||||++|||++|+.||...... ..+. .... .... +
T Consensus 200 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~-~~~~----~i~~-~~~~--~ 269 (387)
T 1kob_A 200 KLNPDE--IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL-ETLQ----NVKR-CDWE--F 269 (387)
T ss_dssp ECCTTS--CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH-HHHH----HHHH-CCCC--C
T ss_pred ecCCCc--ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHH-HHHH----HHHh-CCCC--C
Confidence 764432 233457899999999999999999999999999999999999999753321 1111 1111 1100 0
Q ss_pred hHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 500 DEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 500 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
+. .........+.+++..|++.||.+|||+.|+++.
T Consensus 270 ~~----~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 270 DE----DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp CS----STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred Cc----cccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 00 0001123467789999999999999999999974
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=342.86 Aligned_cols=265 Identities=19% Similarity=0.289 Sum_probs=188.5
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCC-CChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceE
Q 046270 263 TNGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDT-KGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRR 340 (590)
Q Consensus 263 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~-~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~ 340 (590)
.++|...+.||+|+||.||+|+.. +|+.||+|++..... ...+.+.+|++++++++||||+++++++.. +...
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~~~~ 78 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHT-----ENKL 78 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECC-----TTEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEE-----CCeE
Confidence 457888999999999999999986 488999999865433 334678999999999999999999999873 4569
Q ss_pred EEEEeeCCCCCcchhhhhhc---ccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCC
Q 046270 341 FLVYDYMPNGTLSDNISISH---KRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGL 417 (590)
Q Consensus 341 ~LV~E~~~~gsL~~~L~~~~---~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGl 417 (590)
++||||++ |+|.+++.... ....+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+
T Consensus 79 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 154 (317)
T 2pmi_A 79 TLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGL 154 (317)
T ss_dssp EEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCSS
T ss_pred EEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCChHHeEEcCCCCEEECcCcc
Confidence 99999998 69998885432 1245899999999999999999999 88999999999999999999999999999
Q ss_pred cccccCCCcccccccccCCCccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcC-C-
Q 046270 418 AKQSLEGHSHLTTRVAGTFGYLAPEYALY-GQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSG-K- 494 (590)
Q Consensus 418 a~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~-~- 494 (590)
++...... .......||..|+|||.+.+ ..++.++|||||||++|||++|+.||....... .+........... .
T Consensus 155 ~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~ 232 (317)
T 2pmi_A 155 ARAFGIPV-NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEE-QLKLIFDIMGTPNESL 232 (317)
T ss_dssp CEETTSCC-CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCSCCTTT
T ss_pred ceecCCCc-ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCChhH
Confidence 98654322 12334568999999999876 468999999999999999999999997543321 1211111110000 0
Q ss_pred c-----------------hhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 046270 495 V-----------------DDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALK 538 (590)
Q Consensus 495 ~-----------------~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~ 538 (590)
. ...+...+...........+.+++..|++.||++|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 233 WPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp CGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 0 0000111111111122347888999999999999999999986
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-40 Score=338.55 Aligned_cols=252 Identities=25% Similarity=0.336 Sum_probs=203.2
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCCC------ChHHHHHHHHHHHhcCCCCccccceeEEeccCC
Q 046270 263 TNGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDTK------GDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDS 335 (590)
Q Consensus 263 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~~------~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~ 335 (590)
.++|...+.||+|+||.||+++.. +|..||+|.+...... ..+.+.+|++++.+++||||+++++++.
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~----- 85 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYE----- 85 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEe-----
Confidence 456888999999999999999987 4889999998654322 3567999999999999999999999987
Q ss_pred CCceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCC----cEE
Q 046270 336 SGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSEL----NAK 411 (590)
Q Consensus 336 ~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~----~~k 411 (590)
.+...++||||+++++|.+++. ....+++..++.++.||+.||+||| +.+|+||||||+|||++.++ .+|
T Consensus 86 ~~~~~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~lH---~~~ivH~dikp~NIl~~~~~~~~~~~k 159 (321)
T 2a2a_A 86 NRTDVVLILELVSGGELFDFLA---QKESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIK 159 (321)
T ss_dssp CSSEEEEEECCCCSCBHHHHHH---TCSCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEE
T ss_pred cCCEEEEEEEcCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChHHEEEecCCCCcCCEE
Confidence 3456999999999999999985 3457999999999999999999999 88999999999999999887 799
Q ss_pred EEeeCCcccccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHh
Q 046270 412 VADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAK 491 (590)
Q Consensus 412 L~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~ 491 (590)
|+|||+++...... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...... ..+. .. .
T Consensus 160 l~Dfg~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~----~i-~ 231 (321)
T 2a2a_A 160 LIDFGLAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ-ETLA----NI-T 231 (321)
T ss_dssp ECCCTTCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH-HHHH----HH-H
T ss_pred EccCccceecCccc--cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHH-HHHH----HH-H
Confidence 99999998664432 234456899999999999999999999999999999999999999653321 1111 11 1
Q ss_pred cCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 492 SGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 492 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
.... .+++... ......+.+++..|++.||++|||+.|+++.
T Consensus 232 ~~~~--~~~~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 232 SVSY--DFDEEFF----SHTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp TTCC--CCCHHHH----TTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred hccc--ccChhhh----cccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 1111 0111111 1123467789999999999999999999873
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-40 Score=349.24 Aligned_cols=249 Identities=22% Similarity=0.289 Sum_probs=199.9
Q ss_pred cCCCccceecccCcEEEEEEEEcC-CcEEEEEEeecC---CCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCce
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLRH-GNLVAVKQILDL---DTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKR 339 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~vAvK~l~~~---~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~ 339 (590)
++|...+.||+|+||.||++.... ++.||+|++... .....+.+.+|++++++++|||||++++++.. ...
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~-----~~~ 89 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQD-----EED 89 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----SSE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe-----CCE
Confidence 568888999999999999999875 789999998642 23345678999999999999999999999974 456
Q ss_pred EEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcc
Q 046270 340 RFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAK 419 (590)
Q Consensus 340 ~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~ 419 (590)
.++||||+++|+|.+++. ....+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++
T Consensus 90 ~~lv~e~~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~ 163 (384)
T 4fr4_A 90 MFMVVDLLLGGDLRYHLQ---QNVHFKEETVKLFICELVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAA 163 (384)
T ss_dssp EEEEECCCTTEEHHHHHH---TTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEEecCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEECCCCCEEEeccceee
Confidence 999999999999999885 3457999999999999999999999 8999999999999999999999999999998
Q ss_pred cccCCCcccccccccCCCccCcccccc---CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCch
Q 046270 420 QSLEGHSHLTTRVAGTFGYLAPEYALY---GQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVD 496 (590)
Q Consensus 420 ~~~~~~~~~~~~~~gt~~Y~APE~~~~---~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 496 (590)
..... .......||+.|+|||++.. ..++.++|||||||++|||++|+.||........ ......... ...
T Consensus 164 ~~~~~--~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~--~~~~~~~~~-~~~- 237 (384)
T 4fr4_A 164 MLPRE--TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSS--KEIVHTFET-TVV- 237 (384)
T ss_dssp ECCTT--CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCH--HHHHHHHHH-CCC-
T ss_pred eccCC--CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccH--HHHHHHHhh-ccc-
Confidence 65433 23345679999999999874 4589999999999999999999999975433221 111111111 100
Q ss_pred hhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCC-HHHHHH
Q 046270 497 DIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPT-ITDALK 538 (590)
Q Consensus 497 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt-m~eVl~ 538 (590)
..+......+..++..|++.||.+||+ +.++.+
T Consensus 238 ---------~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 238 ---------TYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp ---------CCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred ---------CCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 011122346788899999999999998 777764
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=341.22 Aligned_cols=259 Identities=17% Similarity=0.237 Sum_probs=196.4
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCCCC---hHHHHHHHHHHHhcCCCCccccceeEEeccCCCCc
Q 046270 263 TNGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDTKG---DEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGK 338 (590)
Q Consensus 263 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~~~---~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~ 338 (590)
-++|...+.||+|+||.||+|+.. +++.||+|++....... .+.+.+|++++.+++||||+++++++.. +.
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~-----~~ 107 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEI-----DG 107 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-----TT
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEee-----CC
Confidence 467899999999999999999986 57899999986543222 3678899999999999999999999874 34
Q ss_pred eEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCc
Q 046270 339 RRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLA 418 (590)
Q Consensus 339 ~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla 418 (590)
..++||||+++++|.+++. ....+++.+++.++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++
T Consensus 108 ~~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~ 181 (309)
T 2h34_A 108 QLYVDMRLINGVDLAAMLR---RQGPLAPPRAVAIVRQIGSALDAAH---AAGATHRDVKPENILVSADDFAYLVDFGIA 181 (309)
T ss_dssp EEEEEEECCCCEEHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSCCC-
T ss_pred eEEEEEEecCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHH---HCcCCcCCCChHHEEEcCCCCEEEecCccC
Confidence 6899999999999999985 3357999999999999999999999 889999999999999999999999999999
Q ss_pred ccccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCC-chh
Q 046270 419 KQSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGK-VDD 497 (590)
Q Consensus 419 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~-~~~ 497 (590)
+..............|+..|+|||.+.+..++.++||||||+++|||++|+.||...... . ......... ...
T Consensus 182 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~----~~~~~~~~~~~~~ 255 (309)
T 2h34_A 182 SATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS--V----MGAHINQAIPRPS 255 (309)
T ss_dssp ---------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH--H----HHHHHHSCCCCGG
T ss_pred ccccccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH--H----HHHHhccCCCCcc
Confidence 866544333344567899999999999999999999999999999999999999643211 1 111111111 111
Q ss_pred hhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCC-CHHHHHHHhccCCCC
Q 046270 498 IFDEFIRAEGARAVMERFVLVGILCAHVMVALRP-TITDALKMLEGDIDI 546 (590)
Q Consensus 498 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-tm~eVl~~L~~~~~~ 546 (590)
.. .......+.+++..|++.||++|| +++++++.|+.....
T Consensus 256 ~~--------~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~ 297 (309)
T 2h34_A 256 TV--------RPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALAT 297 (309)
T ss_dssp GT--------STTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC-
T ss_pred cc--------CCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHh
Confidence 11 112234677889999999999999 999999999875443
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=340.27 Aligned_cols=256 Identities=29% Similarity=0.397 Sum_probs=197.4
Q ss_pred cCCCccceecccCcEEEEEEEEcCC----cEEEEEEeecCCCC-ChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCc
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLRHG----NLVAVKQILDLDTK-GDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGK 338 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~~g----~~vAvK~l~~~~~~-~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~ 338 (590)
.+|...+.||+|+||.||+|++.++ ..+|+|.+...... ..+.+.+|++++++++||||+++++++... ..
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----~~ 100 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS----EG 100 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCS----SS
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcC----CC
Confidence 3567778999999999999997532 25899988654332 346789999999999999999999997643 34
Q ss_pred eEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCc
Q 046270 339 RRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLA 418 (590)
Q Consensus 339 ~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla 418 (590)
..++||||+++|+|.+++.. ....+++..++.|+.|++.||.||| +.+|+||||||+|||+++++.+||+|||++
T Consensus 101 ~~~~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~ql~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a 175 (298)
T 3f66_A 101 SPLVVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLA 175 (298)
T ss_dssp CCEEEEECCTTCBHHHHHHC--TTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSCGGG
T ss_pred ceEEEEeCCCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEECCCCCEEECccccc
Confidence 57999999999999999853 3456899999999999999999999 889999999999999999999999999999
Q ss_pred ccccCCCc---ccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCC-CCCCCCCCchhhhhHHHHHHHhcCC
Q 046270 419 KQSLEGHS---HLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGR-KVLDTSTSPFQLITDWAWVLAKSGK 494 (590)
Q Consensus 419 ~~~~~~~~---~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~-~p~~~~~~~~~~l~~~~~~~~~~~~ 494 (590)
+....... .......||..|+|||.+.+..++.++||||||++++||++|. .|+..... ..... . ...+.
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~-~~~~~----~-~~~~~ 249 (298)
T 3f66_A 176 RDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-FDITV----Y-LLQGR 249 (298)
T ss_dssp CCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCT-TTHHH----H-HHTTC
T ss_pred ccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCH-HHHHH----H-HhcCC
Confidence 86543321 1233456788999999999999999999999999999999955 45443222 21111 1 11111
Q ss_pred chhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhccC
Q 046270 495 VDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEGD 543 (590)
Q Consensus 495 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~~ 543 (590)
... .+......+.+++..|++.||++|||+.|++++|+..
T Consensus 250 ~~~---------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 289 (298)
T 3f66_A 250 RLL---------QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 289 (298)
T ss_dssp CCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCC---------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 100 0011223677889999999999999999999999764
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-41 Score=336.32 Aligned_cols=252 Identities=20% Similarity=0.303 Sum_probs=199.6
Q ss_pred cCCCccceecccCcEEEEEEEEcCCcEEEEEEeecCCC--CChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEE
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLRHGNLVAVKQILDLDT--KGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRF 341 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~~g~~vAvK~l~~~~~--~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~ 341 (590)
++|...+.||+|+||.||+|+++ |+.||||++..... ...+.|.+|++++++++||||+++++++... .+...+
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~~~~~ 85 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSP---PAPHPT 85 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTT---TSSSCE
T ss_pred HHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccC---CCCCeE
Confidence 46788899999999999999986 88999999865432 2345799999999999999999999998743 235689
Q ss_pred EEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCCceEECCCCcEEEEeeCCcc
Q 046270 342 LVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPG--IYHRDIKSTNILLDSELNAKVADFGLAK 419 (590)
Q Consensus 342 LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~--ivHrDIKp~NILLd~~~~~kL~DFGla~ 419 (590)
+||||+++|+|.+++... ....+++.+++.|+.||+.||.||| +.+ |+||||||+|||++.++.+||.|||++.
T Consensus 86 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~ 161 (271)
T 3kmu_A 86 LITHWMPYGSLYNVLHEG-TNFVVDQSQAVKFALDMARGMAFLH---TLEPLIPRHALNSRSVMIDEDMTARISMADVKF 161 (271)
T ss_dssp EEEECCTTCBHHHHHHSC-SSCCCCHHHHHHHHHHHHHHHHHHT---TSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCC
T ss_pred eeecccCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHh---cCCCceecCCCccceEEEcCCcceeEEecccee
Confidence 999999999999999632 2235999999999999999999999 778 9999999999999999999999998875
Q ss_pred cccCCCcccccccccCCCccCccccccCCCCc---chhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCch
Q 046270 420 QSLEGHSHLTTRVAGTFGYLAPEYALYGQLTE---KSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVD 496 (590)
Q Consensus 420 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~---ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 496 (590)
.... ....||+.|+|||.+.+..++. ++||||||+++|||++|+.||....... ........+...
T Consensus 162 ~~~~------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-----~~~~~~~~~~~~ 230 (271)
T 3kmu_A 162 SFQS------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNME-----IGMKVALEGLRP 230 (271)
T ss_dssp TTSC------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHH-----HHHHHHHSCCCC
T ss_pred eecc------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHH-----HHHHHHhcCCCC
Confidence 4222 2346789999999988665444 8999999999999999999996543211 111112222111
Q ss_pred hhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhccC
Q 046270 497 DIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEGD 543 (590)
Q Consensus 497 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~~ 543 (590)
.. +......+.+++..|++.||++|||+.++++.|+..
T Consensus 231 ~~---------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l 268 (271)
T 3kmu_A 231 TI---------PPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKM 268 (271)
T ss_dssp CC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CC---------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence 11 111234677888999999999999999999999753
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=348.38 Aligned_cols=252 Identities=23% Similarity=0.302 Sum_probs=191.9
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEE
Q 046270 263 TNGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRF 341 (590)
Q Consensus 263 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~ 341 (590)
.++|...+.||+|+||.||+++.. .++.||||++.... ...+.+.+|+.++++++||||+++++++.. ....+
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-----~~~~~ 92 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILT-----PTHLA 92 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-----SSEEE
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEee-----CCEEE
Confidence 457889999999999999999987 58899999986543 335678999999999999999999999983 45699
Q ss_pred EEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCc--EEEEeeCCcc
Q 046270 342 LVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELN--AKVADFGLAK 419 (590)
Q Consensus 342 LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~--~kL~DFGla~ 419 (590)
+||||+++|+|.+++. ..+.+++..++.|+.||+.||+||| +.+|+||||||+|||++.++. +||+|||+++
T Consensus 93 lv~e~~~~~~L~~~l~---~~~~~~~~~~~~i~~ql~~~L~~LH---~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~ 166 (361)
T 3uc3_A 93 IIMEYASGGELYERIC---NAGRFSEDEARFFFQQLLSGVSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSK 166 (361)
T ss_dssp EEEECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHH---HTTCCSCCCCGGGEEECSSSSCCEEECCCCCC-
T ss_pred EEEEeCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCceEEEeecCccc
Confidence 9999999999999885 3456999999999999999999999 899999999999999987765 9999999997
Q ss_pred cccCCCcccccccccCCCccCccccccCCCCcc-hhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcC-Cchh
Q 046270 420 QSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEK-SDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSG-KVDD 497 (590)
Q Consensus 420 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~k-sDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~-~~~~ 497 (590)
...... ......||+.|+|||.+.+..++.+ +||||||+++|||++|+.||........... ......... ....
T Consensus 167 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~-~~~~~~~~~~~~~~ 243 (361)
T 3uc3_A 167 SSVLHS--QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRK-TIQRILSVKYSIPD 243 (361)
T ss_dssp ----------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHH-HHHHHHTTCCCCCT
T ss_pred cccccC--CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHH-HHHHHhcCCCCCCC
Confidence 433221 2234568999999999988887766 8999999999999999999975443222111 111111110 0000
Q ss_pred hhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 498 IFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 498 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
.......+.+++..|++.||++|||+.|+++.
T Consensus 244 ----------~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 244 ----------DIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp ----------TSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred ----------cCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 00122467789999999999999999999874
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-41 Score=356.04 Aligned_cols=255 Identities=28% Similarity=0.396 Sum_probs=190.5
Q ss_pred CCCccceecccCcEEEEEEEEcC--C--cEEEEEEeecCCC-CChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCce
Q 046270 265 GFSQNNLIGQGASGIVYKGTLRH--G--NLVAVKQILDLDT-KGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKR 339 (590)
Q Consensus 265 ~f~~~~~LG~G~fG~Vykg~~~~--g--~~vAvK~l~~~~~-~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~ 339 (590)
.|...+.||+|+||.||+|++.+ + ..||||.+..... ...+.|.+|++++++++||||+++++++... ...
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~----~~~ 165 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS----EGS 165 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCC----SSC
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcC----CCC
Confidence 35566889999999999998753 2 3689999865433 3356799999999999999999999998643 235
Q ss_pred EEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcc
Q 046270 340 RFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAK 419 (590)
Q Consensus 340 ~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~ 419 (590)
.++||||+++|+|.+++.. ....+++..++.++.||++||.||| +.+|+||||||+|||+++++.+||+|||+++
T Consensus 166 ~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~ 240 (373)
T 3c1x_A 166 PLVVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLAR 240 (373)
T ss_dssp CEEEEECCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC----
T ss_pred eEEEEECCCCCCHHHHHhh--cccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCccchheEEECCCCCEEEeeccccc
Confidence 7999999999999999852 3456899999999999999999999 8899999999999999999999999999998
Q ss_pred cccCCCcc---cccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhhHHHHHHHhcCCc
Q 046270 420 QSLEGHSH---LTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLDTSTSPFQLITDWAWVLAKSGKV 495 (590)
Q Consensus 420 ~~~~~~~~---~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~ 495 (590)
........ ......+|..|+|||.+....++.++||||||+++|||+| |..||....... ... . ...+..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~-~~~-~----~~~~~~ 314 (373)
T 3c1x_A 241 DMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD-ITV-Y----LLQGRR 314 (373)
T ss_dssp -----------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC-HHH-H----HHTTCC
T ss_pred cccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH-HHH-H----HHcCCC
Confidence 65433211 2234457789999999999999999999999999999999 566665433221 111 1 111211
Q ss_pred hhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhccC
Q 046270 496 DDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEGD 543 (590)
Q Consensus 496 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~~ 543 (590)
.. .+......+.+++..|++.||++|||+.|+++.|+..
T Consensus 315 ~~---------~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i 353 (373)
T 3c1x_A 315 LL---------QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 353 (373)
T ss_dssp CC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CC---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 00 0111234677889999999999999999999999864
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=347.00 Aligned_cols=249 Identities=23% Similarity=0.330 Sum_probs=200.4
Q ss_pred HHhcCCCccceecccCcEEEEEEEEcC-CcEEEEEEeecCC---CCChHHHHHHHHHHHhc-CCCCccccceeEEeccCC
Q 046270 261 QATNGFSQNNLIGQGASGIVYKGTLRH-GNLVAVKQILDLD---TKGDEDFTNEVEIISKI-RHRNLLSLRGCCVTSDDS 335 (590)
Q Consensus 261 ~at~~f~~~~~LG~G~fG~Vykg~~~~-g~~vAvK~l~~~~---~~~~~~f~~Ev~il~~l-~H~nlv~l~g~~~~~~~~ 335 (590)
...++|...+.||+|+||.||+|+++. |+.||||++.... ....+.+..|.+++.++ +||||+++++++..
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~---- 89 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT---- 89 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC----
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEe----
Confidence 445789999999999999999999874 7899999986531 33456788999999987 99999999999873
Q ss_pred CCceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEee
Q 046270 336 SGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADF 415 (590)
Q Consensus 336 ~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DF 415 (590)
....++||||+++|+|.+++. ....+++.++..++.||+.||+||| +.+|+||||||+|||++.++.+||+||
T Consensus 90 -~~~~~lv~E~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DF 162 (345)
T 1xjd_A 90 -KENLFFVMEYLNGGDLMYHIQ---SCHKFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADF 162 (345)
T ss_dssp -SSEEEEEEECCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCC
T ss_pred -CCEEEEEEeCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCChhhEEECCCCCEEEeEC
Confidence 456999999999999999985 3457999999999999999999999 889999999999999999999999999
Q ss_pred CCcccccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCc
Q 046270 416 GLAKQSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKV 495 (590)
Q Consensus 416 Gla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~ 495 (590)
|+++...... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||...... ... ..... +..
T Consensus 163 G~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~-~~~----~~i~~-~~~ 235 (345)
T 1xjd_A 163 GMCKENMLGD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE-ELF----HSIRM-DNP 235 (345)
T ss_dssp TTCBCCCCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHH----HHHHH-CCC
T ss_pred hhhhhcccCC-CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHH-HHH----HHHHh-CCC
Confidence 9998643322 2244567999999999999999999999999999999999999999753321 111 11111 110
Q ss_pred hhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHH-HHH
Q 046270 496 DDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTIT-DAL 537 (590)
Q Consensus 496 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~-eVl 537 (590)
. .+......+.+++..|++.||++||++. +++
T Consensus 236 ~----------~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 236 F----------YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp C----------CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred C----------CCcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 0 0111224677888999999999999997 664
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=354.05 Aligned_cols=250 Identities=20% Similarity=0.295 Sum_probs=193.7
Q ss_pred cCCCccceecccCcEEEEEEEEcCCcEEEEEEeecCCC--CChHHHHHHHHHHHhcC--CCCccccceeEEeccCCCCce
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLRHGNLVAVKQILDLDT--KGDEDFTNEVEIISKIR--HRNLLSLRGCCVTSDDSSGKR 339 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~~g~~vAvK~l~~~~~--~~~~~f~~Ev~il~~l~--H~nlv~l~g~~~~~~~~~~~~ 339 (590)
++|...+.||+|+||.||++...+++.||||++..... ...+.+.+|++++.+++ |+||+++++++.. ...
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~-----~~~ 130 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT-----DQY 130 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-----SSE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEec-----CCE
Confidence 45888999999999999999998899999999865432 23467899999999996 5999999999884 456
Q ss_pred EEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcc
Q 046270 340 RFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAK 419 (590)
Q Consensus 340 ~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~ 419 (590)
.++||| +.+++|.+++. ....+++.++..|+.||+.||.||| +.+|+||||||+|||++ ++.+||+|||+++
T Consensus 131 ~~lv~E-~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~ 202 (390)
T 2zmd_A 131 IYMVME-CGNIDLNSWLK---KKKSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIAN 202 (390)
T ss_dssp EEEEEE-CCSEEHHHHHH---HCSSCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCCGGGEEES-SSCEEECCCSSSC
T ss_pred EEEEEe-cCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEEE-CCeEEEEecCccc
Confidence 999999 56889999885 3457899999999999999999999 89999999999999996 5789999999998
Q ss_pred cccCCCcc-cccccccCCCccCcccccc-----------CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHH
Q 046270 420 QSLEGHSH-LTTRVAGTFGYLAPEYALY-----------GQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAW 487 (590)
Q Consensus 420 ~~~~~~~~-~~~~~~gt~~Y~APE~~~~-----------~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~ 487 (590)
........ ......||+.|+|||++.. ..++.++|||||||++|||++|+.||.........+.
T Consensus 203 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~---- 278 (390)
T 2zmd_A 203 QMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLH---- 278 (390)
T ss_dssp CC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHH----
T ss_pred cccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHH----
Confidence 76543322 2345679999999999864 4689999999999999999999999975433211111
Q ss_pred HHHhcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 488 VLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 488 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
.........+ .+......+.+++..|++.||.+|||+.|+++.
T Consensus 279 ~~~~~~~~~~---------~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 279 AIIDPNHEIE---------FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp HHHCTTSCCC---------CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHhCccccCC---------CCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 1111110000 000112367788899999999999999999875
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-40 Score=357.03 Aligned_cols=199 Identities=26% Similarity=0.403 Sum_probs=156.9
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCCC--ChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCce
Q 046270 263 TNGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDTK--GDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKR 339 (590)
Q Consensus 263 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~~--~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~ 339 (590)
.++|...+.||+|+||.||+|++. .|+.||||++...... ..+.+.+|+++|++++|||||++++++...+......
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 367899999999999999999876 5889999998653222 2457889999999999999999999997654334567
Q ss_pred EEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcc
Q 046270 340 RFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAK 419 (590)
Q Consensus 340 ~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~ 419 (590)
.++||||+ +|+|.+++. ....+++..+..|+.||+.||+||| +.+|+||||||+||||+.++.+||+|||+++
T Consensus 132 ~~lv~e~~-~~~L~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH---~~~iiHrDlKp~NILl~~~~~~kl~DFGla~ 204 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFR---TPVYLTELHIKTLLYNLLVGVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLAR 204 (458)
T ss_dssp EEEEECCC-SEEHHHHHH---SSCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEEecc-ccchhhhcc---cCCCCCHHHHHHHHHHHHHHHHHHH---hCCcCCCCCChhhEEECCCCCEeecccccch
Confidence 99999998 578888874 3457999999999999999999999 8899999999999999999999999999998
Q ss_pred cccCCCc--------------------------ccccccccCCCccCcccc-ccCCCCcchhHHHHHHHHHHHHhC
Q 046270 420 QSLEGHS--------------------------HLTTRVAGTFGYLAPEYA-LYGQLTEKSDVYSFGIVILELMSG 468 (590)
Q Consensus 420 ~~~~~~~--------------------------~~~~~~~gt~~Y~APE~~-~~~~~t~ksDVySfGvvLlELltG 468 (590)
....... ...+...||+.|+|||++ ....++.++|||||||++|||++|
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 7542211 123445789999999976 456799999999999999999994
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=346.10 Aligned_cols=253 Identities=24% Similarity=0.342 Sum_probs=199.1
Q ss_pred cCCCccceecccCcEEEEEEEEcC-CcEEEEEEeecCCCCC---hHHHHHHHHHHHhc-CCCCccccceeEEeccCCCCc
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLRH-GNLVAVKQILDLDTKG---DEDFTNEVEIISKI-RHRNLLSLRGCCVTSDDSSGK 338 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~vAvK~l~~~~~~~---~~~f~~Ev~il~~l-~H~nlv~l~g~~~~~~~~~~~ 338 (590)
++|...+.||+|+||.||+++++. |+.||+|++....... .+.+.+|+.++.++ +||||+++++++.. ..
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~-----~~ 83 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT-----ES 83 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-----SS
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEe-----CC
Confidence 468888999999999999999874 7899999997543222 34578999999998 89999999999873 45
Q ss_pred eEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCc
Q 046270 339 RRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLA 418 (590)
Q Consensus 339 ~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla 418 (590)
..++||||+++|+|.+++. ....+++..++.++.||+.||+||| +.+|+||||||+|||++.++.+||+|||++
T Consensus 84 ~~~lv~e~~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFG~a 157 (345)
T 3a8x_A 84 RLFFVIEYVNGGDLMFHMQ---RQRKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMC 157 (345)
T ss_dssp EEEEEECCCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCGGGC
T ss_pred EEEEEEeCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEEecccc
Confidence 6999999999999999885 3357999999999999999999999 889999999999999999999999999999
Q ss_pred ccccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchh---hhhHHHHHHHhcCCc
Q 046270 419 KQSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQ---LITDWAWVLAKSGKV 495 (590)
Q Consensus 419 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~---~l~~~~~~~~~~~~~ 495 (590)
+...... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||........ ............+..
T Consensus 158 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~ 236 (345)
T 3a8x_A 158 KEGLRPG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI 236 (345)
T ss_dssp BCSCCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCC
T ss_pred ccccCCC-CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCC
Confidence 8643222 234456799999999999999999999999999999999999999965322111 111111111111111
Q ss_pred hhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCH------HHHHH
Q 046270 496 DDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTI------TDALK 538 (590)
Q Consensus 496 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm------~eVl~ 538 (590)
. .+......+..++..|++.||.+||++ .|+++
T Consensus 237 ~----------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~ 275 (345)
T 3a8x_A 237 R----------IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 275 (345)
T ss_dssp C----------CCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHT
T ss_pred C----------CCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhc
Confidence 0 111223467788899999999999995 66654
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-40 Score=357.43 Aligned_cols=262 Identities=24% Similarity=0.312 Sum_probs=196.6
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecC--CCCChHHHHHHHHHHHhcCCCCccccceeEEeccC-CCCc
Q 046270 263 TNGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDL--DTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDD-SSGK 338 (590)
Q Consensus 263 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~--~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~-~~~~ 338 (590)
.++|...+.||+|+||.||+|+.. .|+.||||++... .....+.+.+|++++++++||||+++++++..... .+..
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 467999999999999999999876 4889999999653 22234578899999999999999999999875432 2346
Q ss_pred eEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCc
Q 046270 339 RRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLA 418 (590)
Q Consensus 339 ~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla 418 (590)
..++||||++++ |.+.+. ..+++.++..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||++
T Consensus 141 ~~~lv~E~~~~~-l~~~~~-----~~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDlkp~NIll~~~~~~kl~DFG~a 211 (464)
T 3ttj_A 141 DVYLVMELMDAN-LCQVIQ-----MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLA 211 (464)
T ss_dssp EEEEEEECCSEE-HHHHHT-----SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred eEEEEEeCCCCC-HHHHHh-----hcCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChHhEEEeCCCCEEEEEEEee
Confidence 789999999764 555542 34999999999999999999999 889999999999999999999999999999
Q ss_pred ccccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCc-h-
Q 046270 419 KQSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKV-D- 496 (590)
Q Consensus 419 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~-~- 496 (590)
+..... ...+...||+.|+|||++.+..++.++|||||||+++||++|+.||....... . |......-|.. .
T Consensus 212 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~-~---~~~i~~~lg~p~~~ 285 (464)
T 3ttj_A 212 RTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID-Q---WNKVIEQLGTPCPE 285 (464)
T ss_dssp -----C--CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-H---HHHHHHHHCSCCHH
T ss_pred eecCCC--cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHH-H---HHHHHHhcCCCCHH
Confidence 865432 23445679999999999999999999999999999999999999997543211 1 11111111110 0
Q ss_pred -------------------------hhhhHHHh---hhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 497 -------------------------DIFDEFIR---AEGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 497 -------------------------~~~d~~l~---~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
..+...+. ..........+.+++..|++.||++|||++|+++.
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 286 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp HHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000000 00111224578889999999999999999999875
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-41 Score=350.46 Aligned_cols=256 Identities=29% Similarity=0.411 Sum_probs=195.8
Q ss_pred cCCCccceecccCcEEEEEEEEcC-----CcEEEEEEeecCCC-CChHHHHHHHHHHHhcCCCCccccceeEEeccCCCC
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLRH-----GNLVAVKQILDLDT-KGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSG 337 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~~-----g~~vAvK~l~~~~~-~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~ 337 (590)
.+|...+.||+|+||.||+|++.. +..||||++..... .....+.+|++++++++||||+++++++.. .
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~ 118 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK-----Y 118 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-----S
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEec-----C
Confidence 345667899999999999998763 23599999865432 234568999999999999999999999863 4
Q ss_pred ceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCC
Q 046270 338 KRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGL 417 (590)
Q Consensus 338 ~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGl 417 (590)
...++||||+++|+|.+++.. ....+++.+++.++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+
T Consensus 119 ~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 193 (333)
T 1mqb_A 119 KPMMIITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGL 193 (333)
T ss_dssp SSEEEEEECCTTEEHHHHHHH--TTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred CCcEEEEeCCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChheEEECCCCcEEECCCCc
Confidence 468999999999999999853 3357999999999999999999999 88999999999999999999999999999
Q ss_pred cccccCCCcc--cccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhhHHHHHHHhcCC
Q 046270 418 AKQSLEGHSH--LTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLDTSTSPFQLITDWAWVLAKSGK 494 (590)
Q Consensus 418 a~~~~~~~~~--~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~ 494 (590)
++........ ......+|..|+|||.+....++.++||||||+++|||++ |+.||...... ... . ....+.
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~-~~~----~-~~~~~~ 267 (333)
T 1mqb_A 194 SRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH-EVM----K-AINDGF 267 (333)
T ss_dssp -----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-HHH----H-HHHTTC
T ss_pred chhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHH-HHH----H-HHHCCC
Confidence 9876443221 1223446788999999999999999999999999999999 99998643321 111 1 111111
Q ss_pred chhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhccCC
Q 046270 495 VDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEGDI 544 (590)
Q Consensus 495 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~~~ 544 (590)
... .+......+.+++..|++.+|++||++.+++++|+...
T Consensus 268 ~~~---------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~ 308 (333)
T 1mqb_A 268 RLP---------TPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI 308 (333)
T ss_dssp CCC---------CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred cCC---------CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 100 01112346788999999999999999999999998643
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=349.48 Aligned_cols=254 Identities=24% Similarity=0.307 Sum_probs=201.2
Q ss_pred cCCCccceecccCcEEEEEEEE----cCCcEEEEEEeecCC----CCChHHHHHHHHHHHhc-CCCCccccceeEEeccC
Q 046270 264 NGFSQNNLIGQGASGIVYKGTL----RHGNLVAVKQILDLD----TKGDEDFTNEVEIISKI-RHRNLLSLRGCCVTSDD 334 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~----~~g~~vAvK~l~~~~----~~~~~~f~~Ev~il~~l-~H~nlv~l~g~~~~~~~ 334 (590)
++|...+.||+|+||.||+++. ..|+.||||++.... ....+.+.+|++++.++ +||||+++++++..
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~--- 130 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT--- 130 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE---
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEee---
Confidence 5788899999999999999998 368899999986432 23345678899999999 69999999999874
Q ss_pred CCCceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEe
Q 046270 335 SSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVAD 414 (590)
Q Consensus 335 ~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~D 414 (590)
....++||||+++|+|.+++. ....+++..+..++.||+.||.||| +.+|+||||||+|||++.++++||+|
T Consensus 131 --~~~~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~D 202 (355)
T 1vzo_A 131 --ETKLHLILDYINGGELFTHLS---QRERFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTD 202 (355)
T ss_dssp --TTEEEEEECCCCSCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESC
T ss_pred --CceEEEEeecCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCcEEEee
Confidence 346899999999999999985 3357999999999999999999999 88999999999999999999999999
Q ss_pred eCCcccccCCCcccccccccCCCccCcccccc--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhc
Q 046270 415 FGLAKQSLEGHSHLTTRVAGTFGYLAPEYALY--GQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKS 492 (590)
Q Consensus 415 FGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~--~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~ 492 (590)
||+++..............||..|+|||++.+ ..++.++|||||||++|||++|+.||........ ...+.......
T Consensus 203 fG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~-~~~~~~~~~~~ 281 (355)
T 1vzo_A 203 FGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS-QAEISRRILKS 281 (355)
T ss_dssp SSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC-HHHHHHHHHHC
T ss_pred CCCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccch-HHHHHHHHhcc
Confidence 99998765444444455679999999999885 3478999999999999999999999975433221 11121111111
Q ss_pred CCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCC-----CHHHHHHHh
Q 046270 493 GKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRP-----TITDALKML 540 (590)
Q Consensus 493 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-----tm~eVl~~L 540 (590)
.. ..+.+....+.+++..|++.||.+|| ++.|+++..
T Consensus 282 ~~-----------~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 282 EP-----------PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp CC-----------CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred CC-----------CCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 10 01112234667888999999999999 999998765
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=336.93 Aligned_cols=254 Identities=22% Similarity=0.346 Sum_probs=202.8
Q ss_pred cCCCccc-eecccCcEEEEEEEEc---CCcEEEEEEeecCCC-CChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCc
Q 046270 264 NGFSQNN-LIGQGASGIVYKGTLR---HGNLVAVKQILDLDT-KGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGK 338 (590)
Q Consensus 264 ~~f~~~~-~LG~G~fG~Vykg~~~---~g~~vAvK~l~~~~~-~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~ 338 (590)
++|.... .||+|+||.||+|++. .+..||||++..... ...+.+.+|++++++++||||+++++++.. .
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~------~ 82 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA------E 82 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES------S
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEecC------C
Confidence 3455555 8999999999999864 477899999876432 235678999999999999999999999842 2
Q ss_pred eEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCc
Q 046270 339 RRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLA 418 (590)
Q Consensus 339 ~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla 418 (590)
..++||||+++++|.+++.. ....+++..++.++.||+.||.||| +.+|+||||||+||+++.++.+||+|||++
T Consensus 83 ~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~ 157 (287)
T 1u59_A 83 ALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLS 157 (287)
T ss_dssp SEEEEEECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTC
T ss_pred CcEEEEEeCCCCCHHHHHHh--CCccCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCchheEEEcCCCCEEECcccce
Confidence 48999999999999998852 3456999999999999999999999 889999999999999999999999999999
Q ss_pred ccccCCCccc--ccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhhHHHHHHHhcCCc
Q 046270 419 KQSLEGHSHL--TTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLDTSTSPFQLITDWAWVLAKSGKV 495 (590)
Q Consensus 419 ~~~~~~~~~~--~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~ 495 (590)
+......... .....||..|+|||.+....++.++||||||+++|||+| |+.||....... +. . ....+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~---~-~i~~~~~ 231 (287)
T 1u59_A 158 KALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE--VM---A-FIEQGKR 231 (287)
T ss_dssp EECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH--HH---H-HHHTTCC
T ss_pred eeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH--HH---H-HHhcCCc
Confidence 8765433222 233456889999999998899999999999999999999 999997544321 11 1 1111211
Q ss_pred hhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhccC
Q 046270 496 DDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEGD 543 (590)
Q Consensus 496 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~~ 543 (590)
.. .+......+.+++..|++.+|++||++.+++++|+..
T Consensus 232 ~~---------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 270 (287)
T 1u59_A 232 ME---------CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 270 (287)
T ss_dssp CC---------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred CC---------CCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 11 1112234778899999999999999999999999864
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=337.37 Aligned_cols=255 Identities=26% Similarity=0.369 Sum_probs=199.6
Q ss_pred CCccceecccCcEEEEEEEEcC-C---cEEEEEEeecCCC-CChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceE
Q 046270 266 FSQNNLIGQGASGIVYKGTLRH-G---NLVAVKQILDLDT-KGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRR 340 (590)
Q Consensus 266 f~~~~~LG~G~fG~Vykg~~~~-g---~~vAvK~l~~~~~-~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~ 340 (590)
|...++||+|+||.||+|++.+ + ..||+|.+..... ...+.+.+|++++++++||||+++++++...+ ...
T Consensus 23 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----~~~ 98 (298)
T 3pls_A 23 THSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPE----GLP 98 (298)
T ss_dssp EEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSS----SCC
T ss_pred EccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCC----CCc
Confidence 4456889999999999998643 2 2799999865433 23467899999999999999999999987532 335
Q ss_pred EEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCccc
Q 046270 341 FLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQ 420 (590)
Q Consensus 341 ~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~ 420 (590)
++||||+.+|+|.+++.. ....+++..++.|+.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.
T Consensus 99 ~~v~e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 173 (298)
T 3pls_A 99 HVLLPYMCHGDLLQFIRS--PQRNPTVKDLISFGLQVARGMEYLA---EQKFVHRDLAARNCMLDESFTVKVADFGLARD 173 (298)
T ss_dssp EEEECCCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECCTTSSCT
T ss_pred EEEEecccCCCHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcEEeCcCCCccc
Confidence 899999999999999853 3457899999999999999999999 88999999999999999999999999999986
Q ss_pred ccCCCc---ccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchh
Q 046270 421 SLEGHS---HLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDD 497 (590)
Q Consensus 421 ~~~~~~---~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 497 (590)
...... .......+|..|+|||.+.+..++.++||||||+++|||++|+.|+........... . ...+....
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~-~----~~~~~~~~ 248 (298)
T 3pls_A 174 ILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTH-F----LAQGRRLP 248 (298)
T ss_dssp TTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHH-H----HHTTCCCC
T ss_pred ccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHH-H----hhcCCCCC
Confidence 543221 123345678899999999999999999999999999999997766544333322111 1 11111100
Q ss_pred hhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhccC
Q 046270 498 IFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEGD 543 (590)
Q Consensus 498 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~~ 543 (590)
.+......+.+++..|++.||.+|||+.+++++|+..
T Consensus 249 ---------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~ 285 (298)
T 3pls_A 249 ---------QPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQI 285 (298)
T ss_dssp ---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---------CCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 0111224677899999999999999999999999864
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=343.14 Aligned_cols=249 Identities=21% Similarity=0.304 Sum_probs=177.8
Q ss_pred cceecccCcEEEEEEEEc-CCcEEEEEEeecCCCCChHHHHHHHHHHHhcC-CCCccccceeEEeccCCCCceEEEEEee
Q 046270 269 NNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDTKGDEDFTNEVEIISKIR-HRNLLSLRGCCVTSDDSSGKRRFLVYDY 346 (590)
Q Consensus 269 ~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~-H~nlv~l~g~~~~~~~~~~~~~~LV~E~ 346 (590)
.+.||+|+||.||++++. +|+.||||++.. .....+.+|++++.+++ ||||+++++++. .+...++||||
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~e~~~l~~l~~h~niv~~~~~~~-----~~~~~~lv~e~ 87 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISK---RMEANTQKEITALKLCEGHPNIVKLHEVFH-----DQLHTFLVMEL 87 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEG---GGHHHHHHHHHHHHHTTTCTTBCCEEEEEE-----CSSEEEEEECC
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEECh---hhhhhHHHHHHHHHHhcCCCCeeEEEEEEE-----cCCEEEEEEEc
Confidence 368999999999999986 488999999864 24567889999999997 999999999997 34568999999
Q ss_pred CCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCC---cEEEEeeCCcccccC
Q 046270 347 MPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSEL---NAKVADFGLAKQSLE 423 (590)
Q Consensus 347 ~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~---~~kL~DFGla~~~~~ 423 (590)
+++|+|.+++. ....+++.++..|+.||+.||+||| +.+|+||||||+|||++.++ .+||+|||+++....
T Consensus 88 ~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~ 161 (325)
T 3kn6_A 88 LNGGELFERIK---KKKHFSETEASYIMRKLVSAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPP 161 (325)
T ss_dssp CCSCBHHHHHH---HCSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC
T ss_pred cCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHH---HCCCeecCCCHHHEEEecCCCcccEEEeccccceecCC
Confidence 99999999985 3457999999999999999999999 89999999999999997665 899999999986543
Q ss_pred CCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchh--hhhHHHHHHHhcCCchhhhhH
Q 046270 424 GHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQ--LITDWAWVLAKSGKVDDIFDE 501 (590)
Q Consensus 424 ~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~--~l~~~~~~~~~~~~~~~~~d~ 501 (590)
.. .......||..|+|||.+.+..++.++||||||+++|||++|+.||........ ...+.. .....+....
T Consensus 162 ~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~-~~i~~~~~~~---- 235 (325)
T 3kn6_A 162 DN-QPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIM-KKIKKGDFSF---- 235 (325)
T ss_dssp -----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHH-HHHTTTCCCC----
T ss_pred CC-CcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHH-HHHHcCCCCC----
Confidence 32 223445689999999999999999999999999999999999999975433211 111111 1112221110
Q ss_pred HHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 502 FIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 502 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
...........+.+++..|++.||.+|||+.|+++.
T Consensus 236 --~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 236 --EGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp --CSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred --CcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 000111234567889999999999999999998753
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=331.28 Aligned_cols=250 Identities=25% Similarity=0.357 Sum_probs=198.6
Q ss_pred CCccceecccCcEEEEEEEEcC-CcEEEEEEeecCC--CCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEEE
Q 046270 266 FSQNNLIGQGASGIVYKGTLRH-GNLVAVKQILDLD--TKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFL 342 (590)
Q Consensus 266 f~~~~~LG~G~fG~Vykg~~~~-g~~vAvK~l~~~~--~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~L 342 (590)
|...+.||+|+||.||+|.+.. +..||+|++.... ....+.+.+|++++++++||||+++++++..... .+...++
T Consensus 28 ~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~~~~~l 106 (290)
T 1t4h_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVK-GKKCIVL 106 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESS-SCEEEEE
T ss_pred EEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccC-CCceEEE
Confidence 5566789999999999999864 7789999986532 2234578999999999999999999999876543 4567899
Q ss_pred EEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCCceEEC-CCCcEEEEeeCCcc
Q 046270 343 VYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPG--IYHRDIKSTNILLD-SELNAKVADFGLAK 419 (590)
Q Consensus 343 V~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~--ivHrDIKp~NILLd-~~~~~kL~DFGla~ 419 (590)
||||+++|+|.+++. ....+++..++.|+.||+.||.||| +.+ |+||||||+|||++ .++.+||+|||++.
T Consensus 107 v~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~ 180 (290)
T 1t4h_A 107 VTELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp EEECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred EEEecCCCCHHHHHH---HccCCCHHHHHHHHHHHHHHHHHHH---cCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence 999999999999985 3357999999999999999999999 777 99999999999998 78999999999997
Q ss_pred cccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhh
Q 046270 420 QSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIF 499 (590)
Q Consensus 420 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 499 (590)
..... ......||+.|+|||.+. +.++.++||||||+++|||++|+.||.......... .. ...+.....+
T Consensus 181 ~~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~----~~-~~~~~~~~~~ 251 (290)
T 1t4h_A 181 LKRAS---FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIY----RR-VTSGVKPASF 251 (290)
T ss_dssp GCCTT---SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHH----HH-HTTTCCCGGG
T ss_pred ccccc---ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHH----HH-HhccCCcccc
Confidence 54332 233456899999999776 569999999999999999999999997544322211 11 1122111111
Q ss_pred hHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 500 DEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 500 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
+. .....+.+++..|++.||.+|||+.|+++.
T Consensus 252 ~~--------~~~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 252 DK--------VAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp GG--------CCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CC--------CCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 11 112367788999999999999999999863
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=349.13 Aligned_cols=262 Identities=15% Similarity=0.176 Sum_probs=203.2
Q ss_pred cCCCccceecccCcEEEEEEEEcC---------CcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCccc----------
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLRH---------GNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLS---------- 324 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~~---------g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv~---------- 324 (590)
++|...+.||+|+||.||+|++.. ++.||||.+... +.+.+|++++.+++||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 116 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL 116 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence 578889999999999999999874 788999998643 46889999999999999998
Q ss_pred -----cceeEEeccCCCCceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCC
Q 046270 325 -----LRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKS 399 (590)
Q Consensus 325 -----l~g~~~~~~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp 399 (590)
+++++.. .+...++||||+ +++|.+++... ....+++.+++.|+.||+.||.||| +.+|+||||||
T Consensus 117 ~~i~~~~~~~~~----~~~~~~lv~e~~-~~~L~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp 187 (352)
T 2jii_A 117 LAIPTCMGFGVH----QDKYRFLVLPSL-GRSLQSALDVS-PKHVLSERSVLQVACRLLDALEFLH---ENEYVHGNVTA 187 (352)
T ss_dssp CSCCCCCEEEEE----TTTEEEEEEECC-CEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCG
T ss_pred cCccchhhcccc----CCcEEEEEecCC-CcCHHHHHHhC-CcCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCH
Confidence 4566654 245789999999 99999999632 2357999999999999999999999 88999999999
Q ss_pred CceEECCCC--cEEEEeeCCcccccCCCcc------cccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCC
Q 046270 400 TNILLDSEL--NAKVADFGLAKQSLEGHSH------LTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKV 471 (590)
Q Consensus 400 ~NILLd~~~--~~kL~DFGla~~~~~~~~~------~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p 471 (590)
+|||++.++ .+||+|||+++........ ......||+.|+|||.+.+..++.++||||||+++|||++|+.|
T Consensus 188 ~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p 267 (352)
T 2jii_A 188 ENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLP 267 (352)
T ss_dssp GGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCT
T ss_pred HHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 999999998 8999999999865432211 12345789999999999998999999999999999999999999
Q ss_pred CCCCCCchhhhhHHHHHHHhcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhccCC
Q 046270 472 LDTSTSPFQLITDWAWVLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEGDI 544 (590)
Q Consensus 472 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~~~ 544 (590)
|.........+..+....... ...+.+.... .......+.+++..|++.||++|||+.+++++|+...
T Consensus 268 f~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 335 (352)
T 2jii_A 268 WTNCLPNTEDIMKQKQKFVDK--PGPFVGPCGH---WIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALL 335 (352)
T ss_dssp TGGGTTCHHHHHHHHHHHHHS--CCCEECTTSC---EECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred cccCCcCHHHHHHHHHhccCC--hhhhhhhccc---cCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHH
Confidence 976543222222222111111 1111111000 0011246788899999999999999999999998743
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=351.54 Aligned_cols=264 Identities=23% Similarity=0.410 Sum_probs=204.2
Q ss_pred cCCCccceecccCcEEEEEEEE-----cCCcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCc
Q 046270 264 NGFSQNNLIGQGASGIVYKGTL-----RHGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGK 338 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~-----~~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~ 338 (590)
++|...+.||+|+||.||++++ .+|+.||||++........+.+.+|++++++++||||+++++++...+ ..
T Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---~~ 117 (326)
T 2w1i_A 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG---RR 117 (326)
T ss_dssp GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC-------
T ss_pred HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecC---CC
Confidence 4577889999999999999985 358899999997765555678999999999999999999999886432 23
Q ss_pred eEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCc
Q 046270 339 RRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLA 418 (590)
Q Consensus 339 ~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla 418 (590)
..++||||+++++|.+++.. ....+++.+++.++.||+.||.||| +.+|+||||||+|||++.++.+||+|||++
T Consensus 118 ~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~kL~Dfg~~ 192 (326)
T 2w1i_A 118 NLKLIMEYLPYGSLRDYLQK--HKERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLT 192 (326)
T ss_dssp CCEEEECCCTTCBHHHHHHH--STTSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred ceEEEEECCCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEEcCCCcEEEecCcch
Confidence 57999999999999999853 2346999999999999999999999 889999999999999999999999999999
Q ss_pred ccccCCCcc--cccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCch
Q 046270 419 KQSLEGHSH--LTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVD 496 (590)
Q Consensus 419 ~~~~~~~~~--~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 496 (590)
+........ ......++..|+|||.+.+..++.++||||||+++|||+||+.|+..... .+.... ......
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~------~~~~~~-~~~~~~ 265 (326)
T 2w1i_A 193 KVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPA------EFMRMI-GNDKQG 265 (326)
T ss_dssp EECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHH------HHHHHH-CTTCCT
T ss_pred hhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHH------HHHHhh-ccccch
Confidence 876543322 12334567789999999988999999999999999999999988753211 011000 000000
Q ss_pred hhh----hHHHh----hhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhcc
Q 046270 497 DIF----DEFIR----AEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEG 542 (590)
Q Consensus 497 ~~~----d~~l~----~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~ 542 (590)
... ...+. ...+......+.+++..|++.||++|||+.|++++|+.
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~ 319 (326)
T 2w1i_A 266 QMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQ 319 (326)
T ss_dssp HHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred hhhHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 000 00000 00112233578889999999999999999999999875
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=341.16 Aligned_cols=259 Identities=22% Similarity=0.269 Sum_probs=195.9
Q ss_pred cCCCc-cceecccCcEEEEEEEEc-CCcEEEEEEeecCCCCChHHHHHHHHHHHhc-CCCCccccceeEEeccCCCCceE
Q 046270 264 NGFSQ-NNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDTKGDEDFTNEVEIISKI-RHRNLLSLRGCCVTSDDSSGKRR 340 (590)
Q Consensus 264 ~~f~~-~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l-~H~nlv~l~g~~~~~~~~~~~~~ 340 (590)
+.|.. .+.||+|+||.||+|+.. +++.||||++........+.+.+|++++.++ +||||+++++++.. +...
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~-----~~~~ 86 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEE-----EDRF 86 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-----TTEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEee-----CCEE
Confidence 45665 368999999999999975 5889999999776666677899999999995 79999999999974 3469
Q ss_pred EEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCc---EEEEeeCC
Q 046270 341 FLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELN---AKVADFGL 417 (590)
Q Consensus 341 ~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~---~kL~DFGl 417 (590)
++||||+++|+|.+++.. ...+++..+..++.||+.||+||| +.+|+||||||+|||++.++. +||+|||+
T Consensus 87 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~ 160 (316)
T 2ac3_A 87 YLVFEKMRGGSILSHIHK---RRHFNELEASVVVQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDL 160 (316)
T ss_dssp EEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESCSSSSCSEEECCTTC
T ss_pred EEEEEcCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEEccCCCcCceEEEEccC
Confidence 999999999999999853 357999999999999999999999 889999999999999998776 99999999
Q ss_pred cccccCCCc------ccccccccCCCccCcccccc-----CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhh----
Q 046270 418 AKQSLEGHS------HLTTRVAGTFGYLAPEYALY-----GQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLI---- 482 (590)
Q Consensus 418 a~~~~~~~~------~~~~~~~gt~~Y~APE~~~~-----~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l---- 482 (590)
++....... .......||..|+|||.+.. ..++.++||||||+++|||++|+.||..........
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~ 240 (316)
T 2ac3_A 161 GSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGE 240 (316)
T ss_dssp CC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----
T ss_pred ccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccc
Confidence 976532211 11223468999999999875 568999999999999999999999997543321100
Q ss_pred -----hHHHHHHHhcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 483 -----TDWAWVLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 483 -----~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
..........+... .... ........+.+++..|++.||.+|||+.|+++.
T Consensus 241 ~~~~~~~~~~~~i~~~~~~-~~~~-----~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 241 ACPACQNMLFESIQEGKYE-FPDK-----DWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp CCHHHHHHHHHHHHHCCCC-CCHH-----HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred cchhHHHHHHHHHhccCcc-cCch-----hcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 00000111111110 0000 001123467889999999999999999999874
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=332.54 Aligned_cols=252 Identities=22% Similarity=0.319 Sum_probs=196.7
Q ss_pred CCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEEEE
Q 046270 265 GFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFLV 343 (590)
Q Consensus 265 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~LV 343 (590)
+|.....||+|+||.||+|+.. ++..||||.+........+.+.+|+.++++++||||+++++++.. ....++|
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv 97 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSE-----NGFIKIF 97 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEE-----TTEEEEE
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEe-----CCcEEEE
Confidence 4555679999999999999975 578999999977666667789999999999999999999999974 3468999
Q ss_pred EeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECC-CCcEEEEeeCCccccc
Q 046270 344 YDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDS-ELNAKVADFGLAKQSL 422 (590)
Q Consensus 344 ~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~-~~~~kL~DFGla~~~~ 422 (590)
|||+++++|.+++........+++..+..++.||+.||.||| +.+|+||||||+||+++. ++.+||+|||+++...
T Consensus 98 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~ 174 (295)
T 2clq_A 98 MEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLA 174 (295)
T ss_dssp EECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTCCEEECCTTTCEESC
T ss_pred EEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHH---hCCEEccCCChhhEEEECCCCCEEEeecccccccC
Confidence 999999999999865433445778999999999999999999 889999999999999987 8999999999998654
Q ss_pred CCCcccccccccCCCccCccccccCC--CCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhhh
Q 046270 423 EGHSHLTTRVAGTFGYLAPEYALYGQ--LTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFD 500 (590)
Q Consensus 423 ~~~~~~~~~~~gt~~Y~APE~~~~~~--~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 500 (590)
... .......||..|+|||.+..+. ++.++||||||+++|||++|+.||........... ..... ....
T Consensus 175 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~--~~~~~--~~~~---- 245 (295)
T 2clq_A 175 GIN-PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMF--KVGMF--KVHP---- 245 (295)
T ss_dssp C------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHH--HHHHH--CCCC----
T ss_pred CCC-CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHH--hhccc--cccc----
Confidence 322 2233456899999999987654 88999999999999999999999864333221111 00000 0000
Q ss_pred HHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 046270 501 EFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALK 538 (590)
Q Consensus 501 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~ 538 (590)
..+......+.+++..|++.||++|||+.++++
T Consensus 246 -----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 246 -----EIPESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp -----CCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred -----cccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 011112346778889999999999999999986
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-40 Score=354.99 Aligned_cols=254 Identities=22% Similarity=0.291 Sum_probs=200.8
Q ss_pred HhcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCC--CChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCc
Q 046270 262 ATNGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDT--KGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGK 338 (590)
Q Consensus 262 at~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~--~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~ 338 (590)
..++|...+.||+|+||.||+++.. .|+.+|+|++..... ...+.+.+|++++++++||||+++++++. ...
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-----~~~ 83 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSIS-----EEG 83 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEE-----CSS
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEE-----ECC
Confidence 4567889999999999999999876 588999999865432 22456889999999999999999999987 455
Q ss_pred eEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEC---CCCcEEEEee
Q 046270 339 RRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLD---SELNAKVADF 415 (590)
Q Consensus 339 ~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd---~~~~~kL~DF 415 (590)
..++||||+++|+|.+++. .+..+++..+..++.||+.||.||| +.+|+||||||+|||++ .++.+||+||
T Consensus 84 ~~~lv~E~~~gg~L~~~i~---~~~~~~e~~~~~i~~qil~aL~~lH---~~givHrDlKp~NIll~~~~~~~~vkL~DF 157 (444)
T 3soa_A 84 HHYLIFDLVTGGELFEDIV---AREYYSEADASHCIQQILEAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADF 157 (444)
T ss_dssp EEEEEECCCBCCBHHHHHH---HCSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSSTTEEESBSSTTCCEEECCC
T ss_pred EEEEEEEeCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEeccCCCCcEEEccC
Confidence 7999999999999999885 3457999999999999999999999 88999999999999998 4578999999
Q ss_pred CCcccccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCc
Q 046270 416 GLAKQSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKV 495 (590)
Q Consensus 416 Gla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~ 495 (590)
|+++...... .......||+.|+|||.+....++.++|||||||++|||++|+.||...... .... ....+..
T Consensus 158 G~a~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~-~~~~-----~i~~~~~ 230 (444)
T 3soa_A 158 GLAIEVEGEQ-QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQH-RLYQ-----QIKAGAY 230 (444)
T ss_dssp SSCBCCCTTC-CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHH-----HHHHTCC
T ss_pred ceeEEecCCC-ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHH-HHHH-----HHHhCCC
Confidence 9998654432 2234567999999999999889999999999999999999999999653321 1111 1111211
Q ss_pred hhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 496 DDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 496 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
.. ..+. .......+.+++..|++.||.+|||+.|+++.
T Consensus 231 ~~-~~~~-----~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 231 DF-PSPE-----WDTVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp CC-CTTT-----TTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CC-Cccc-----cccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 00 0000 01123467788999999999999999999874
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=329.94 Aligned_cols=252 Identities=26% Similarity=0.350 Sum_probs=200.8
Q ss_pred hcCCCccceecccCcEEEEEEEEcC-CcEEEEEEeecCCC--CChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCce
Q 046270 263 TNGFSQNNLIGQGASGIVYKGTLRH-GNLVAVKQILDLDT--KGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKR 339 (590)
Q Consensus 263 t~~f~~~~~LG~G~fG~Vykg~~~~-g~~vAvK~l~~~~~--~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~ 339 (590)
.++|...+.||+|+||.||+|.+.. |+.||+|++..... ...+.+.+|++++++++||||+++++++. .+..
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~ 79 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ-----EESF 79 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CSSE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEE-----cCCE
Confidence 4688999999999999999999864 88999999865332 23456889999999999999999999987 3456
Q ss_pred EEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCc---EEEEeeC
Q 046270 340 RFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELN---AKVADFG 416 (590)
Q Consensus 340 ~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~---~kL~DFG 416 (590)
.++||||+++++|.+++. ....+++..+..++.|++.||.||| +.+|+||||||+||+++.++. +||+|||
T Consensus 80 ~~~v~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg 153 (284)
T 3kk8_A 80 HYLVFDLVTGGELFEDIV---AREFYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFG 153 (284)
T ss_dssp EEEEECCCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSTTCCEEECCCT
T ss_pred EEEEEecCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHH---HCCcCcCCCCHHHEEEecCCCCCcEEEeece
Confidence 899999999999988885 3456999999999999999999999 889999999999999987655 9999999
Q ss_pred CcccccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCch
Q 046270 417 LAKQSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVD 496 (590)
Q Consensus 417 la~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 496 (590)
++....... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...... .... . ...+...
T Consensus 154 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-~~~~----~-~~~~~~~ 225 (284)
T 3kk8_A 154 LAIEVNDSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH-RLYA----Q-IKAGAYD 225 (284)
T ss_dssp TCEECCSSC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHH----H-HHHTCCC
T ss_pred eeEEcccCc--cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchh-HHHH----H-HHhcccc
Confidence 997654332 233467899999999999999999999999999999999999999653321 1111 1 1111110
Q ss_pred hhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 497 DIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 497 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
. ..+. .......+.+++..|++.||++|||+.|+++.
T Consensus 226 ~-~~~~-----~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 226 Y-PSPE-----WDTVTPEAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp C-CTTT-----TTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred C-Cchh-----hcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 0 0000 01122467788999999999999999999873
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-40 Score=336.21 Aligned_cols=260 Identities=22% Similarity=0.288 Sum_probs=195.3
Q ss_pred cCCCccceecccCcEEEEEEEEcC-CcEEEEEEeecCCCCC--hHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceE
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLRH-GNLVAVKQILDLDTKG--DEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRR 340 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~vAvK~l~~~~~~~--~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~ 340 (590)
++|...+.||+|+||.||+|++.. |+.||||++....... .+.+.+|++++++++||||+++++++.. +...
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~ 77 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRR-----KRRL 77 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeec-----CCeE
Confidence 578889999999999999999875 8899999986543322 4568899999999999999999999974 4468
Q ss_pred EEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCccc
Q 046270 341 FLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQ 420 (590)
Q Consensus 341 ~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~ 420 (590)
++||||+++++|.+++. ....+++..+..|+.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++.
T Consensus 78 ~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~i~~~l~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 151 (311)
T 4agu_A 78 HLVFEYCDHTVLHELDR---YQRGVPEHLVKSITWQTLQAVNFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFARL 151 (311)
T ss_dssp EEEEECCSEEHHHHHHH---TSSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEEeCCCchHHHHHh---hhcCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCChhhEEEcCCCCEEEeeCCCchh
Confidence 99999999999988774 3456999999999999999999999 88999999999999999999999999999986
Q ss_pred ccCCCcccccccccCCCccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhh
Q 046270 421 SLEGHSHLTTRVAGTFGYLAPEYALY-GQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIF 499 (590)
Q Consensus 421 ~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 499 (590)
..... .......||..|+|||.+.+ ..++.++||||||+++|||++|+.||........ +...... . +......
T Consensus 152 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~-~--~~~~~~~ 226 (311)
T 4agu_A 152 LTGPS-DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQ-LYLIRKT-L--GDLIPRH 226 (311)
T ss_dssp CC-------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHH-H--CSCCHHH
T ss_pred ccCcc-cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHH-h--ccccccc
Confidence 54322 22334568999999999875 6789999999999999999999999975443221 1111100 0 0000000
Q ss_pred hHHH-------------------hhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 500 DEFI-------------------RAEGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 500 d~~l-------------------~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
.... ...........+.+++..|++.||.+|||++|+++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 227 QQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp HHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred ccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 0000 000001223467889999999999999999999864
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-40 Score=352.06 Aligned_cols=254 Identities=26% Similarity=0.354 Sum_probs=193.0
Q ss_pred HHhcCCCccceecccCcEEEEEEEEcC-CcEEEEEEeecCC--------CCChHHHHHHHHHHHhcCCCCccccceeEEe
Q 046270 261 QATNGFSQNNLIGQGASGIVYKGTLRH-GNLVAVKQILDLD--------TKGDEDFTNEVEIISKIRHRNLLSLRGCCVT 331 (590)
Q Consensus 261 ~at~~f~~~~~LG~G~fG~Vykg~~~~-g~~vAvK~l~~~~--------~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~ 331 (590)
...++|...+.||+|+||.||+|+... ++.||||++.... ......+.+|++++++++||||+++++++.
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~- 210 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD- 210 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence 456789999999999999999999864 7899999986431 111235889999999999999999999975
Q ss_pred ccCCCCceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCC---C
Q 046270 332 SDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSE---L 408 (590)
Q Consensus 332 ~~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~---~ 408 (590)
....++||||+++|+|.+++. ....+++.++..|+.||+.||+||| +.+|+||||||+|||++.+ +
T Consensus 211 -----~~~~~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~~ 279 (419)
T 3i6u_A 211 -----AEDYYIVLELMEGGELFDKVV---GNKRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDC 279 (419)
T ss_dssp -----SSEEEEEEECCTTCBGGGGTS---SSCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSSSC
T ss_pred -----cCceEEEEEcCCCCcHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCCCcc
Confidence 234799999999999999885 3457999999999999999999999 8899999999999999654 4
Q ss_pred cEEEEeeCCcccccCCCcccccccccCCCccCccccc---cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHH
Q 046270 409 NAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYAL---YGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDW 485 (590)
Q Consensus 409 ~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~---~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~ 485 (590)
.+||+|||+++..... .......||+.|+|||++. ...++.++|||||||++|||++|+.||...........
T Consensus 280 ~~kl~DFG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~-- 355 (419)
T 3i6u_A 280 LIKITDFGHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKD-- 355 (419)
T ss_dssp CEEECCSSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHH--
T ss_pred eEEEeecccceecCCC--ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHH--
Confidence 5999999999875432 2334567999999999986 36788999999999999999999999975443222111
Q ss_pred HHHHHhcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 486 AWVLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 486 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
....+.... ..+. .......+.+++..|++.||++|||+.|+++.
T Consensus 356 ---~i~~~~~~~-~~~~-----~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 356 ---QITSGKYNF-IPEV-----WAEVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp ---HHHTTCCCC-CHHH-----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ---HHhcCCCCC-Cchh-----hcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 111222111 0000 11123467889999999999999999999873
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=349.65 Aligned_cols=256 Identities=21% Similarity=0.241 Sum_probs=191.5
Q ss_pred cCCCcc-ceecccCcEEEEEEEEc-CCcEEEEEEeecCCCCChHHHHHHHHHHHhc-CCCCccccceeEEeccCCCCceE
Q 046270 264 NGFSQN-NLIGQGASGIVYKGTLR-HGNLVAVKQILDLDTKGDEDFTNEVEIISKI-RHRNLLSLRGCCVTSDDSSGKRR 340 (590)
Q Consensus 264 ~~f~~~-~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l-~H~nlv~l~g~~~~~~~~~~~~~ 340 (590)
++|... +.||+|+||.||++++. .|+.||||++.. ...+.+|++++.++ +||||+++++++..... .....
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~-~~~~~ 134 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYA-GRKCL 134 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEET-TEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeeccc-CCcEE
Confidence 355554 68999999999999987 488999999853 35678899988555 89999999999875322 34568
Q ss_pred EEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECC---CCcEEEEeeCC
Q 046270 341 FLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDS---ELNAKVADFGL 417 (590)
Q Consensus 341 ~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~---~~~~kL~DFGl 417 (590)
++||||+++|+|.+++... ....+++.++..|+.||+.||.||| +.+|+||||||+|||++. ++.+||+|||+
T Consensus 135 ~lv~E~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~ 210 (400)
T 1nxk_A 135 LIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGF 210 (400)
T ss_dssp EEEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEEEeCCCCcHHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCcceEEEecCCCCccEEEEeccc
Confidence 9999999999999998632 2346999999999999999999999 889999999999999998 78999999999
Q ss_pred cccccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchh
Q 046270 418 AKQSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDD 497 (590)
Q Consensus 418 a~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 497 (590)
++...... ......||+.|+|||++....++.++|||||||++|||++|+.||........... . ......+...-
T Consensus 211 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~-~-~~~i~~~~~~~ 286 (400)
T 1nxk_A 211 AKETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG-M-KTRIRMGQYEF 286 (400)
T ss_dssp CEECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCS-H-HHHHHHTCCCC
T ss_pred ccccCCCC--ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHH-H-HHHHHcCcccC
Confidence 98654322 23456789999999999999999999999999999999999999975433211000 0 00111111100
Q ss_pred hhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 498 IFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 498 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
..+ ........+.+++..|++.||++|||+.|+++.
T Consensus 287 -~~~-----~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 287 -PNP-----EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp -CTT-----TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred -CCc-----ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 000 001123467889999999999999999999985
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=330.96 Aligned_cols=246 Identities=26% Similarity=0.395 Sum_probs=197.0
Q ss_pred hcCCCccceecccCcEEEEEEEEcC-CcEEEEEEeecCC---CCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCc
Q 046270 263 TNGFSQNNLIGQGASGIVYKGTLRH-GNLVAVKQILDLD---TKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGK 338 (590)
Q Consensus 263 t~~f~~~~~LG~G~fG~Vykg~~~~-g~~vAvK~l~~~~---~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~ 338 (590)
.++|...+.||+|+||.||+|.... +..||||++.... ......+.+|++++++++||||+++++++. ...
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~ 82 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH-----DAT 82 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSS
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEe-----cCC
Confidence 4578889999999999999999875 6789999985421 223567899999999999999999999997 345
Q ss_pred eEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCc
Q 046270 339 RRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLA 418 (590)
Q Consensus 339 ~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla 418 (590)
..++||||+++|+|.+++. ....+++..++.++.||+.||.||| +.+|+||||||+|||++.++.+||+|||++
T Consensus 83 ~~~lv~e~~~~~~l~~~l~---~~~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~ 156 (279)
T 3fdn_A 83 RVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS 156 (279)
T ss_dssp EEEEEECCCTTEEHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHH---TTTCEECCCCGGGEEECTTSCEEECSCCEE
T ss_pred EEEEEEecCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHhEEEcCCCCEEEEecccc
Confidence 6899999999999999885 3356999999999999999999999 899999999999999999999999999998
Q ss_pred ccccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHh-cCCchh
Q 046270 419 KQSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAK-SGKVDD 497 (590)
Q Consensus 419 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~-~~~~~~ 497 (590)
...... ......||..|+|||.+.+..++.++||||||+++|||++|+.||....... .. ..... .....
T Consensus 157 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~----~~~~~~~~~~~- 227 (279)
T 3fdn_A 157 VHAPSS---RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE-TY----KRISRVEFTFP- 227 (279)
T ss_dssp SCC-----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-HH----HHHHHTCCCCC-
T ss_pred ccCCcc---cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHH-HH----HHHHhCCCCCC-
Confidence 654332 2234578999999999999899999999999999999999999997432211 11 11111 11111
Q ss_pred hhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 498 IFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 498 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
......+.+++..|++.||.+|||+.|+++.
T Consensus 228 -----------~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 228 -----------DFVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp -----------TTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred -----------CcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 1122356778899999999999999999974
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-40 Score=337.09 Aligned_cols=259 Identities=19% Similarity=0.278 Sum_probs=194.5
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCC---CChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCce
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDT---KGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKR 339 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~---~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~ 339 (590)
++|...+.||+|+||.||+|... +|..||||++..... ...+.+.+|++++++++||||+++++++.. ...
T Consensus 32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~ 106 (310)
T 2wqm_A 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE-----DNE 106 (310)
T ss_dssp GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-----TTE
T ss_pred cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc-----CCc
Confidence 46888999999999999999975 688999999875332 234578899999999999999999999984 346
Q ss_pred EEEEEeeCCCCCcchhhhhhc-ccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCc
Q 046270 340 RFLVYDYMPNGTLSDNISISH-KRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLA 418 (590)
Q Consensus 340 ~~LV~E~~~~gsL~~~L~~~~-~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla 418 (590)
.++||||+++|+|.+++.... ....+++..++.++.||+.||.||| +.+|+||||||+||+++.++.+||+|||++
T Consensus 107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~ 183 (310)
T 2wqm_A 107 LNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLG 183 (310)
T ss_dssp EEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCC---
T ss_pred EEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCcHHHEEEcCCCCEEEEeccce
Confidence 899999999999999886432 2456999999999999999999999 889999999999999999999999999999
Q ss_pred ccccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhh
Q 046270 419 KQSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDI 498 (590)
Q Consensus 419 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 498 (590)
+...... .......|+..|+|||.+....++.++||||||+++|||++|+.||......... +... ...+.....
T Consensus 184 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~---~~~~-~~~~~~~~~ 258 (310)
T 2wqm_A 184 RFFSSKT-TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYS---LCKK-IEQCDYPPL 258 (310)
T ss_dssp ----------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHH---HHHH-HHTTCSCCC
T ss_pred eeecCCC-ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHH---HHHH-hhcccCCCC
Confidence 8654322 2233456899999999999999999999999999999999999998653322111 1111 111211111
Q ss_pred hhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhccC
Q 046270 499 FDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEGD 543 (590)
Q Consensus 499 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~~ 543 (590)
.. ......+.+++..|++.||++|||+.+|+++|+..
T Consensus 259 ~~--------~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l 295 (310)
T 2wqm_A 259 PS--------DHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRM 295 (310)
T ss_dssp CT--------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cc--------cccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 10 11234677889999999999999999999999864
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=328.99 Aligned_cols=250 Identities=26% Similarity=0.352 Sum_probs=198.7
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCC------CChHHHHHHHHHHHhcCCCCccccceeEEeccCCC
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDT------KGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSS 336 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~------~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~ 336 (590)
++|...+.||+|+||.||+++.. +|+.||+|.+..... ...+.+.+|++++++++||||+++++++..
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----- 79 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFEN----- 79 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecC-----
Confidence 46888899999999999999987 588999999865322 135789999999999999999999999873
Q ss_pred CceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCC----cEEE
Q 046270 337 GKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSEL----NAKV 412 (590)
Q Consensus 337 ~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~----~~kL 412 (590)
+...++||||+++++|.+++. ....+++.+++.++.||+.||.||| +.+|+||||||+||+++.++ .+||
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~~~~kl 153 (283)
T 3bhy_A 80 KTDVVLILELVSGGELFDFLA---EKESLTEDEATQFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKL 153 (283)
T ss_dssp SSEEEEEEECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSSSSCCEEE
T ss_pred CCeEEEEEeecCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChHHEEEecCCCCCCceEE
Confidence 456899999999999999985 3457999999999999999999999 88999999999999998877 8999
Q ss_pred EeeCCcccccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhc
Q 046270 413 ADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKS 492 (590)
Q Consensus 413 ~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~ 492 (590)
+|||+++...... ......|+..|+|||.+....++.++||||||++++||++|+.||...... ..+.. ...
T Consensus 154 ~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~-----~~~ 225 (283)
T 3bhy_A 154 IDFGIAHKIEAGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQ-ETLTN-----ISA 225 (283)
T ss_dssp CCCTTCEECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHH-HHHHH-----HHT
T ss_pred EecccceeccCCC--cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchH-HHHHH-----hHh
Confidence 9999998654322 223456899999999999899999999999999999999999998653321 11111 111
Q ss_pred CCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 046270 493 GKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALK 538 (590)
Q Consensus 493 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~ 538 (590)
.... ..... .....+.+.+++..|++.||++|||+.|+++
T Consensus 226 ~~~~--~~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 226 VNYD--FDEEY----FSNTSELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp TCCC--CCHHH----HTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred cccC--Ccchh----cccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 1110 01111 1122346788999999999999999999987
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=347.52 Aligned_cols=265 Identities=26% Similarity=0.378 Sum_probs=191.4
Q ss_pred HhcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCC--CCChHHHHHHHHHHHhcC-CCCccccceeEEeccCCCC
Q 046270 262 ATNGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLD--TKGDEDFTNEVEIISKIR-HRNLLSLRGCCVTSDDSSG 337 (590)
Q Consensus 262 at~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~--~~~~~~f~~Ev~il~~l~-H~nlv~l~g~~~~~~~~~~ 337 (590)
..++|...+.||+|+||.||+|.+. .|+.||||++.... ......+.+|+.++.++. ||||+++++++... ++
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~---~~ 83 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRAD---ND 83 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECT---TS
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecC---CC
Confidence 4578999999999999999999986 58899999985432 223456789999999997 99999999998753 23
Q ss_pred ceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCC
Q 046270 338 KRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGL 417 (590)
Q Consensus 338 ~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGl 417 (590)
...++||||++ |+|.+++. ...+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+
T Consensus 84 ~~~~lv~e~~~-~~L~~~~~----~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~ 155 (388)
T 3oz6_A 84 RDVYLVFDYME-TDLHAVIR----ANILEPVHKQYVVYQLIKVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGL 155 (388)
T ss_dssp SCEEEEEECCS-EEHHHHHH----HTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred CEEEEEecccC-cCHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHeEEcCCCCEEecCCcc
Confidence 46899999997 68888774 347999999999999999999999 88999999999999999999999999999
Q ss_pred cccccCC--------------------CcccccccccCCCccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 046270 418 AKQSLEG--------------------HSHLTTRVAGTFGYLAPEYALY-GQLTEKSDVYSFGIVILELMSGRKVLDTST 476 (590)
Q Consensus 418 a~~~~~~--------------------~~~~~~~~~gt~~Y~APE~~~~-~~~t~ksDVySfGvvLlELltG~~p~~~~~ 476 (590)
++..... .....+...||+.|+|||.+.+ ..++.++|||||||+++||++|+.||....
T Consensus 156 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 235 (388)
T 3oz6_A 156 SRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSS 235 (388)
T ss_dssp CEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9865321 1112344679999999999876 679999999999999999999999997543
Q ss_pred CchhhhhHHHHHHHhcCC-----------chhhhh---------------------HHHhhh-hHHHHHHHHHHHHHhch
Q 046270 477 SPFQLITDWAWVLAKSGK-----------VDDIFD---------------------EFIRAE-GARAVMERFVLVGILCA 523 (590)
Q Consensus 477 ~~~~~l~~~~~~~~~~~~-----------~~~~~d---------------------~~l~~~-~~~~~~~~l~~l~~~Cl 523 (590)
... .+..... ...... ....+. ..+... ........+.+++..|+
T Consensus 236 ~~~-~~~~i~~-~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L 313 (388)
T 3oz6_A 236 TMN-QLERIIG-VIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLL 313 (388)
T ss_dssp HHH-HHHHHHH-HHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHC
T ss_pred HHH-HHHHHHH-hcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhh
Confidence 321 1111111 000000 000000 000000 00022346788999999
Q ss_pred hcCCCCCCCHHHHHHH
Q 046270 524 HVMVALRPTITDALKM 539 (590)
Q Consensus 524 ~~dp~~RPtm~eVl~~ 539 (590)
+.||++|||++|+++.
T Consensus 314 ~~dP~~R~t~~e~l~H 329 (388)
T 3oz6_A 314 QFNPNKRISANDALKH 329 (388)
T ss_dssp CSSGGGSCCHHHHTTS
T ss_pred ccCcccCCCHHHHhCC
Confidence 9999999999999875
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=346.36 Aligned_cols=246 Identities=30% Similarity=0.400 Sum_probs=196.2
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCCCC---hHHHHHHHHHHHhcCCCCccccceeEEeccCCCCce
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDTKG---DEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKR 339 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~~~---~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~ 339 (590)
+.|...+.||+|+||.||+|+.. +|+.||||++....... .+.+.+|++++++++||||+++++++.. +..
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-----~~~ 128 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-----EHT 128 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE-----CCe
Confidence 44788899999999999999974 68899999986543322 3468899999999999999999999984 346
Q ss_pred EEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcc
Q 046270 340 RFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAK 419 (590)
Q Consensus 340 ~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~ 419 (590)
.++||||++ |+|.+++.. ....+++..+..|+.|+++||.||| +.+|+||||||+|||++.++.+||+|||+++
T Consensus 129 ~~lv~e~~~-g~l~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~ 202 (348)
T 1u5q_A 129 AWLVMEYCL-GSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSAS 202 (348)
T ss_dssp EEEEEECCS-EEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCB
T ss_pred EEEEEecCC-CCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEeeccCce
Confidence 899999997 688777743 3457999999999999999999999 8899999999999999999999999999998
Q ss_pred cccCCCcccccccccCCCccCccccc---cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCch
Q 046270 420 QSLEGHSHLTTRVAGTFGYLAPEYAL---YGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVD 496 (590)
Q Consensus 420 ~~~~~~~~~~~~~~gt~~Y~APE~~~---~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 496 (590)
..... ....||+.|+|||.+. .+.++.++|||||||++|||++|+.||....... ...........
T Consensus 203 ~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~-----~~~~~~~~~~~- 271 (348)
T 1u5q_A 203 IMAPA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-----ALYHIAQNESP- 271 (348)
T ss_dssp SSSSB-----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-----HHHHHHHSCCC-
T ss_pred ecCCC-----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-----HHHHHHhcCCC-
Confidence 65332 2356899999999985 5789999999999999999999999986433211 11112221111
Q ss_pred hhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 497 DIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 497 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
.... ....+.+.+++..|++.||++|||+.++++.
T Consensus 272 ~~~~--------~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 272 ALQS--------GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp CCCC--------TTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred CCCC--------CCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 1000 1122356778899999999999999999874
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-40 Score=346.26 Aligned_cols=248 Identities=24% Similarity=0.339 Sum_probs=200.4
Q ss_pred hcCCCccceecccCcEEEEEEEEcC-CcEEEEEEeecC---CCCChHHHHHHHHHHHhc-CCCCccccceeEEeccCCCC
Q 046270 263 TNGFSQNNLIGQGASGIVYKGTLRH-GNLVAVKQILDL---DTKGDEDFTNEVEIISKI-RHRNLLSLRGCCVTSDDSSG 337 (590)
Q Consensus 263 t~~f~~~~~LG~G~fG~Vykg~~~~-g~~vAvK~l~~~---~~~~~~~f~~Ev~il~~l-~H~nlv~l~g~~~~~~~~~~ 337 (590)
.++|...+.||+|+||.||+++.+. |+.||||++... .....+.+..|.+++..+ +||||+++++++.. .
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~-----~ 93 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT-----M 93 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEEC-----S
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEc-----C
Confidence 4678999999999999999999875 778999998653 233456788999999988 89999999999873 4
Q ss_pred ceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCC
Q 046270 338 KRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGL 417 (590)
Q Consensus 338 ~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGl 417 (590)
...++||||+++|+|.+++. ..+.+++..++.++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+
T Consensus 94 ~~~~lv~E~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~ 167 (353)
T 2i0e_A 94 DRLYFVMEYVNGGDLMYHIQ---QVGRFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGM 167 (353)
T ss_dssp SEEEEEEECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred CEEEEEEeCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEEcCCCcEEEEeCCc
Confidence 56999999999999999985 3356999999999999999999999 88999999999999999999999999999
Q ss_pred cccccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchh
Q 046270 418 AKQSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDD 497 (590)
Q Consensus 418 a~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 497 (590)
++...... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||...... .. ...... +...
T Consensus 168 a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~-~~----~~~i~~-~~~~- 239 (353)
T 2i0e_A 168 CKENIWDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED-EL----FQSIME-HNVA- 239 (353)
T ss_dssp CBCCCCTT-CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HH----HHHHHH-CCCC-
T ss_pred ccccccCC-cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHH-HH----HHHHHh-CCCC-
Confidence 98643222 2344567999999999999999999999999999999999999999753221 11 111111 1110
Q ss_pred hhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCC-----HHHHHH
Q 046270 498 IFDEFIRAEGARAVMERFVLVGILCAHVMVALRPT-----ITDALK 538 (590)
Q Consensus 498 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt-----m~eVl~ 538 (590)
.+......+..++..|++.||.+||+ ++++++
T Consensus 240 ---------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 240 ---------YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp ---------CCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred ---------CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 01122346778889999999999995 477764
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=346.16 Aligned_cols=270 Identities=23% Similarity=0.257 Sum_probs=207.1
Q ss_pred CccccHHHHHHHhcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCCCChHHHHHHHHHHHhcC-----CCCccc
Q 046270 251 AKWFHVSELEQATNGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDTKGDEDFTNEVEIISKIR-----HRNLLS 324 (590)
Q Consensus 251 ~~~f~~~el~~at~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~-----H~nlv~ 324 (590)
...|++++.....++|...++||+|+||.||+|++. +++.||||++... ......+..|++++++++ ||||++
T Consensus 22 ~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~ 100 (360)
T 3llt_A 22 IVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVK 100 (360)
T ss_dssp GGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCC
T ss_pred ceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeec
Confidence 344566666667889999999999999999999985 5889999998642 233456788999999997 999999
Q ss_pred cceeEEeccCCCCceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEE
Q 046270 325 LRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILL 404 (590)
Q Consensus 325 l~g~~~~~~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILL 404 (590)
+++++.. ....++||||+ +++|.+++... ....+++..++.|+.||+.||+||| +.+|+||||||+|||+
T Consensus 101 ~~~~~~~-----~~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll 170 (360)
T 3llt_A 101 YHGKFMY-----YDHMCLIFEPL-GPSLYEIITRN-NYNGFHIEDIKLYCIEILKALNYLR---KMSLTHTDLKPENILL 170 (360)
T ss_dssp EEEEEEE-----TTEEEEEECCC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEE
T ss_pred ccceeeE-----CCeeEEEEcCC-CCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCcccEEE
Confidence 9999985 34689999999 99999998643 2335999999999999999999999 8999999999999999
Q ss_pred CC-------------------------CCcEEEEeeCCcccccCCCcccccccccCCCccCccccccCCCCcchhHHHHH
Q 046270 405 DS-------------------------ELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFG 459 (590)
Q Consensus 405 d~-------------------------~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfG 459 (590)
+. ++.+||+|||+++..... .....||+.|+|||.+.+..++.++||||||
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG 246 (360)
T 3llt_A 171 DDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLGWDVSSDMWSFG 246 (360)
T ss_dssp SCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHH
T ss_pred ccccccccccchhcccccccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCCCCCccchHHHH
Confidence 86 789999999999864332 2345789999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhhhHHHh---------------------------------hh
Q 046270 460 IVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDEFIR---------------------------------AE 506 (590)
Q Consensus 460 vvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~---------------------------------~~ 506 (590)
|++|||++|+.||....... .+... .... .......+..... ..
T Consensus 247 ~il~ell~g~~pf~~~~~~~-~~~~~-~~~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~ 323 (360)
T 3llt_A 247 CVLAELYTGSLLFRTHEHME-HLAMM-ESII-QPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPL 323 (360)
T ss_dssp HHHHHHHHSSCSCCCSSHHH-HHHHH-HHHT-CCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCH
T ss_pred HHHHHHHHCCCCCCCCcHHH-HHHHH-HHhc-CCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccc
Confidence 99999999999997543321 11111 0000 0001111100000 00
Q ss_pred hHHHHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 046270 507 GARAVMERFVLVGILCAHVMVALRPTITDALK 538 (590)
Q Consensus 507 ~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~ 538 (590)
......+.+.+++..|++.||++|||+.|+++
T Consensus 324 ~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~ 355 (360)
T 3llt_A 324 YKIIKHELFCDFLYSILQIDPTLRPSPAELLK 355 (360)
T ss_dssp HHHCCCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred cccchHHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 00001146778999999999999999999985
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=344.82 Aligned_cols=246 Identities=25% Similarity=0.336 Sum_probs=197.9
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecC---CCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCce
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDL---DTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKR 339 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~---~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~ 339 (590)
++|...+.||+|+||.||+|++. .|+.||||++... .......+.+|++++++++||||+++++++.. ...
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-----~~~ 83 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITT-----PTD 83 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEEC-----SSE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEe-----CCE
Confidence 57888999999999999999985 5889999998642 12334578999999999999999999999974 456
Q ss_pred EEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcc
Q 046270 340 RFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAK 419 (590)
Q Consensus 340 ~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~ 419 (590)
.++||||+ +|+|.+++. ..+.+++.+++.++.||+.||.||| +.+|+||||||+|||+++++++||+|||+++
T Consensus 84 ~~lv~E~~-~g~l~~~l~---~~~~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~DFG~s~ 156 (336)
T 3h4j_B 84 IVMVIEYA-GGELFDYIV---EKKRMTEDEGRRFFQQIICAIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSN 156 (336)
T ss_dssp EEEEECCC-CEEHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCSTTTEEECTTCCEEECCSSCTB
T ss_pred EEEEEECC-CCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCchhhEEEcCCCCEEEEEeccce
Confidence 89999999 788988885 3457999999999999999999999 8899999999999999999999999999998
Q ss_pred cccCCCcccccccccCCCccCccccccCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhh
Q 046270 420 QSLEGHSHLTTRVAGTFGYLAPEYALYGQL-TEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDI 498 (590)
Q Consensus 420 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~-t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 498 (590)
...... ......||+.|+|||.+.+..+ +.++||||||+++|||++|+.||+....... ... ...+.. .
T Consensus 157 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~-~~~-----i~~~~~--~ 226 (336)
T 3h4j_B 157 IMTDGN--FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL-FKK-----VNSCVY--V 226 (336)
T ss_dssp TTTTSB--TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC-BCC-----CCSSCC--C
T ss_pred eccCCc--ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH-HHH-----HHcCCC--C
Confidence 654432 2344579999999999987776 7899999999999999999999975432211 000 000000 0
Q ss_pred hhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 499 FDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 499 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
+ +......+.+++..|++.||.+|||+.|+++.
T Consensus 227 ~--------p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 227 M--------PDFLSPGAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp C--------CTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred C--------cccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 0 01122356778899999999999999999874
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-40 Score=345.01 Aligned_cols=254 Identities=15% Similarity=0.157 Sum_probs=200.8
Q ss_pred HHHHHhcCCCccceecccCcEEEEEEE------EcCCcEEEEEEeecCCCCChHHHHHHHHHHHhcC---CCCcccccee
Q 046270 258 ELEQATNGFSQNNLIGQGASGIVYKGT------LRHGNLVAVKQILDLDTKGDEDFTNEVEIISKIR---HRNLLSLRGC 328 (590)
Q Consensus 258 el~~at~~f~~~~~LG~G~fG~Vykg~------~~~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~---H~nlv~l~g~ 328 (590)
+++...++|...+.||+|+||.||+|+ ...++.||||++.. ....++..|++++.+++ |+|+++++++
T Consensus 59 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~---~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~ 135 (365)
T 3e7e_A 59 EFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKP---ANPWEFYIGTQLMERLKPSMQHMFMKFYSA 135 (365)
T ss_dssp EEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESS---CCHHHHHHHHHHHHHSCGGGGGGBCCEEEE
T ss_pred eEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCC---CChhHHHHHHHHHHHhhhhhhhhhhhhhee
Confidence 334456789999999999999999994 34578999999864 34667889999999987 9999999999
Q ss_pred EEeccCCCCceEEEEEeeCCCCCcchhhhhhc--ccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECC
Q 046270 329 CVTSDDSSGKRRFLVYDYMPNGTLSDNISISH--KRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDS 406 (590)
Q Consensus 329 ~~~~~~~~~~~~~LV~E~~~~gsL~~~L~~~~--~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~ 406 (590)
+.. +...++||||+++|+|.+++.... ....++|..++.|+.||++||+||| +.+|+||||||+||||+.
T Consensus 136 ~~~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH---~~~ivHrDiKp~NIll~~ 207 (365)
T 3e7e_A 136 HLF-----QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH---DCEIIHGDIKPDNFILGN 207 (365)
T ss_dssp EEC-----SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECG
T ss_pred eec-----CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEecc
Confidence 984 445899999999999999996432 2456999999999999999999999 899999999999999998
Q ss_pred -----------CCcEEEEeeCCcccccC-CCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 046270 407 -----------ELNAKVADFGLAKQSLE-GHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDT 474 (590)
Q Consensus 407 -----------~~~~kL~DFGla~~~~~-~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~ 474 (590)
++.+||+|||+++.... ..........||.+|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus 208 ~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~ 287 (365)
T 3e7e_A 208 GFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVK 287 (365)
T ss_dssp GGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEE
T ss_pred cccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCcccc
Confidence 89999999999976432 222334556799999999999999999999999999999999999999853
Q ss_pred CCCchhhhhHHHHHHHhcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCC-CCHHHHHHHhcc
Q 046270 475 STSPFQLITDWAWVLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALR-PTITDALKMLEG 542 (590)
Q Consensus 475 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~R-Ptm~eVl~~L~~ 542 (590)
.......+. ..... ... .+.+..+...|++.+|.+| |++.++.+.|+.
T Consensus 288 ~~~~~~~~~---------~~~~~--------~~~---~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~ 336 (365)
T 3e7e_A 288 NEGGECKPE---------GLFRR--------LPH---LDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKK 336 (365)
T ss_dssp EETTEEEEC---------SCCTT--------CSS---HHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHH
T ss_pred CCCCceeec---------hhccc--------cCc---HHHHHHHHHHHcCCCCCCcchHHHHHHHHHHH
Confidence 322111000 00000 011 1245567778999999998 578888877765
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=377.18 Aligned_cols=246 Identities=23% Similarity=0.351 Sum_probs=195.0
Q ss_pred ceecccCcEEEEEEEEc---CCcEEEEEEeecCCC--CChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEEEEE
Q 046270 270 NLIGQGASGIVYKGTLR---HGNLVAVKQILDLDT--KGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFLVY 344 (590)
Q Consensus 270 ~~LG~G~fG~Vykg~~~---~g~~vAvK~l~~~~~--~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~LV~ 344 (590)
+.||+|+||.||+|.+. .+..||||+++.... ...++|.+|++++.+++|||||++++++.. ...++||
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~------~~~~lv~ 448 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA------ESWMLVM 448 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES------SSEEEEE
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec------CCEEEEE
Confidence 47999999999999764 356899999975432 235789999999999999999999999852 2378999
Q ss_pred eeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccccCC
Q 046270 345 DYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEG 424 (590)
Q Consensus 345 E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~~~~ 424 (590)
||+++|+|.+++. ....+++..++.|+.||+.||+||| +.+|+||||||+||||+.++.+||+|||+++.....
T Consensus 449 E~~~~g~L~~~l~---~~~~l~~~~~~~i~~qi~~~L~yLH---~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~ 522 (635)
T 4fl3_A 449 EMAELGPLNKYLQ---QNRHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD 522 (635)
T ss_dssp ECCTTEEHHHHHH---HCTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-
T ss_pred EccCCCCHHHHHh---hCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccC
Confidence 9999999999995 3457999999999999999999999 889999999999999999999999999999876543
Q ss_pred Ccc--cccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhhHHHHHHHhcCCchhhhhH
Q 046270 425 HSH--LTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDE 501 (590)
Q Consensus 425 ~~~--~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 501 (590)
... ......+|..|+|||++....++.++|||||||++|||++ |+.||....... + ......+....
T Consensus 523 ~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~--~----~~~i~~~~~~~---- 592 (635)
T 4fl3_A 523 ENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE--V----TAMLEKGERMG---- 592 (635)
T ss_dssp ------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--H----HHHHHTTCCCC----
T ss_pred ccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--H----HHHHHcCCCCC----
Confidence 322 2333456789999999999999999999999999999999 999996543211 1 11122222111
Q ss_pred HHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhcc
Q 046270 502 FIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEG 542 (590)
Q Consensus 502 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~ 542 (590)
.+......+.+++..|++.||++|||+.+|+++|+.
T Consensus 593 -----~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~ 628 (635)
T 4fl3_A 593 -----CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 628 (635)
T ss_dssp -----CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred -----CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 111223477889999999999999999999999975
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-41 Score=340.87 Aligned_cols=254 Identities=23% Similarity=0.349 Sum_probs=199.0
Q ss_pred hcCCCccc-eecccCcEEEEEEEEc---CCcEEEEEEeecCCCC--ChHHHHHHHHHHHhcCCCCccccceeEEeccCCC
Q 046270 263 TNGFSQNN-LIGQGASGIVYKGTLR---HGNLVAVKQILDLDTK--GDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSS 336 (590)
Q Consensus 263 t~~f~~~~-~LG~G~fG~Vykg~~~---~g~~vAvK~l~~~~~~--~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~ 336 (590)
.++|...+ .||+|+||.||+|.+. .+..||||++...... ..+++.+|++++++++||||+++++++.
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~------ 88 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE------ 88 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEE------
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEC------
Confidence 34566666 8999999999999653 3678999998654322 2567999999999999999999999983
Q ss_pred CceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeC
Q 046270 337 GKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFG 416 (590)
Q Consensus 337 ~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFG 416 (590)
....++||||+++++|.+++. ....+++..++.++.||+.||.||| +.+|+||||||+|||++.++.+||+|||
T Consensus 89 ~~~~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg 162 (291)
T 1xbb_A 89 AESWMLVMEMAELGPLNKYLQ---QNRHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFG 162 (291)
T ss_dssp SSSEEEEEECCTTEEHHHHHH---HCTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCT
T ss_pred CCCcEEEEEeCCCCCHHHHHH---hCcCCCHHHHHHHHHHHHHHHHHHH---hCCeEcCCCCcceEEEeCCCcEEEccCC
Confidence 234899999999999999985 3456999999999999999999999 8899999999999999999999999999
Q ss_pred CcccccCCCccc--ccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhhHHHHHHHhcC
Q 046270 417 LAKQSLEGHSHL--TTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLDTSTSPFQLITDWAWVLAKSG 493 (590)
Q Consensus 417 la~~~~~~~~~~--~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~ 493 (590)
+++......... .....++..|+|||.+....++.++||||||+++|||++ |+.||...... .+. .....+
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~----~~~~~~ 236 (291)
T 1xbb_A 163 LSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--EVT----AMLEKG 236 (291)
T ss_dssp TCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHH----HHHHTT
T ss_pred cceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH--HHH----HHHHcC
Confidence 998765443322 223446788999999998899999999999999999999 99998753321 111 111222
Q ss_pred CchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhccC
Q 046270 494 KVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEGD 543 (590)
Q Consensus 494 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~~ 543 (590)
.... .+......+..++..|++.||.+||++.+++++|+..
T Consensus 237 ~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 277 (291)
T 1xbb_A 237 ERMG---------CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 277 (291)
T ss_dssp CCCC---------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCCC---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 1111 0112234678899999999999999999999999763
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=336.68 Aligned_cols=250 Identities=30% Similarity=0.397 Sum_probs=194.7
Q ss_pred hcCCCccceecccCcEEEEEEEEcCCcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEEE
Q 046270 263 TNGFSQNNLIGQGASGIVYKGTLRHGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFL 342 (590)
Q Consensus 263 t~~f~~~~~LG~G~fG~Vykg~~~~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~L 342 (590)
.++|...+.||+|+||.||+|.++ |+.||||.+... ...+.+.+|++++++++||||+++++++... ....++
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----~~~~~l 92 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEE----KGGLYI 92 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC------CCEE
T ss_pred hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC----CCceEE
Confidence 356888899999999999999886 889999998643 3456799999999999999999999987642 235799
Q ss_pred EEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCccccc
Q 046270 343 VYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSL 422 (590)
Q Consensus 343 V~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~~ 422 (590)
||||+++|+|.+++... ....+++..++.++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++...
T Consensus 93 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~ 168 (278)
T 1byg_A 93 VTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 168 (278)
T ss_dssp EECCCTTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred EEecCCCCCHHHHHHhc-ccccCCHHHHHHHHHHHHHHHHHHH---hCCccccCCCcceEEEeCCCcEEEeecccccccc
Confidence 99999999999998532 2234899999999999999999999 8899999999999999999999999999997543
Q ss_pred CCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhhHHHHHHHhcCCchhhhhH
Q 046270 423 EGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDE 501 (590)
Q Consensus 423 ~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 501 (590)
.. .....++..|+|||.+.+..++.++||||||++++||+| |+.||....... .. .. ...+....
T Consensus 169 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~-~~----~~-~~~~~~~~---- 234 (278)
T 1byg_A 169 ST----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-VV----PR-VEKGYKMD---- 234 (278)
T ss_dssp -----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG-HH----HH-HTTTCCCC----
T ss_pred cc----ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH-HH----HH-HhcCCCCC----
Confidence 32 123356889999999999999999999999999999998 999986543211 11 11 11111100
Q ss_pred HHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhcc
Q 046270 502 FIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEG 542 (590)
Q Consensus 502 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~ 542 (590)
.+......+.+++..|++.||++|||+.|+++.|+.
T Consensus 235 -----~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~ 270 (278)
T 1byg_A 235 -----APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEH 270 (278)
T ss_dssp -----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -----CcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHH
Confidence 011123467788899999999999999999999875
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=337.61 Aligned_cols=259 Identities=21% Similarity=0.303 Sum_probs=203.3
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCC--CChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCce
Q 046270 263 TNGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDT--KGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKR 339 (590)
Q Consensus 263 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~--~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~ 339 (590)
.++|...+.||+|+||.||+++.. +|+.||+|++..... ...+.+.+|++++++++||||+++++++.... +..
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---~~~ 81 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRT---NTT 81 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGG---GTE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCC---Cce
Confidence 357888899999999999999986 588999999865432 23456899999999999999999999886542 346
Q ss_pred EEEEEeeCCCCCcchhhhhhc-ccccCChhhHHHHHHHHHHHHHHHHhcCCCC-----eEecCCCCCceEECCCCcEEEE
Q 046270 340 RFLVYDYMPNGTLSDNISISH-KRKQLTWPQRKKIIVDVAKGIAYLHYGLKPG-----IYHRDIKSTNILLDSELNAKVA 413 (590)
Q Consensus 340 ~~LV~E~~~~gsL~~~L~~~~-~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~-----ivHrDIKp~NILLd~~~~~kL~ 413 (590)
.++||||+++|+|.+++.... ....+++..++.|+.|++.||+||| +.+ |+||||||+|||++.++.+||+
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~ 158 (279)
T 2w5a_A 82 LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH---RRSDGGHTVLHRDLKPANVFLDGKQNVKLG 158 (279)
T ss_dssp EEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HHC------CCCCCSGGGEEECSSSCEEEC
T ss_pred EEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHh---cccCCCCeeEEeccchhhEEEcCCCCEEEe
Confidence 899999999999999986433 2345999999999999999999999 666 9999999999999999999999
Q ss_pred eeCCcccccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcC
Q 046270 414 DFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSG 493 (590)
Q Consensus 414 DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~ 493 (590)
|||+++....... ......||..|+|||.+.+..++.++||||||+++|||++|+.||...... .+ .. ....+
T Consensus 159 dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~---~~-~i~~~ 231 (279)
T 2w5a_A 159 DFGLARILNHDTS-FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK--EL---AG-KIREG 231 (279)
T ss_dssp CCCHHHHC---CH-HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HH---HH-HHHHT
T ss_pred cCchheeeccccc-cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHH--HH---HH-HHhhc
Confidence 9999986543321 223456899999999999889999999999999999999999998754321 11 11 11222
Q ss_pred CchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhccC
Q 046270 494 KVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEGD 543 (590)
Q Consensus 494 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~~ 543 (590)
..... +......+.+++..|++.||++|||+.|+++.+...
T Consensus 232 ~~~~~---------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~ 272 (279)
T 2w5a_A 232 KFRRI---------PYRYSDELNEIITRMLNLKDYHRPSVEEILENPLIL 272 (279)
T ss_dssp CCCCC---------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCC
T ss_pred ccccC---------CcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhh
Confidence 21111 111234677889999999999999999999877643
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=333.08 Aligned_cols=248 Identities=27% Similarity=0.362 Sum_probs=179.2
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCC---CCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCce
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLD---TKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKR 339 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~---~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~ 339 (590)
++|...+.||+|+||.||+|+.. +|+.||||.+.... ....+.+.+|++++.+++||||+++++++.. ...
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~ 85 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFED-----SNY 85 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEEC-----SSE
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEcc-----CCe
Confidence 56888899999999999999985 68899999985431 2234678999999999999999999999873 456
Q ss_pred EEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcc
Q 046270 340 RFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAK 419 (590)
Q Consensus 340 ~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~ 419 (590)
.++||||+++++|.+++.. ....+++.+++.++.|+++||.||| +.+|+||||||+||+++.++.+||+|||++.
T Consensus 86 ~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~ 160 (278)
T 3cok_A 86 VYLVLEMCHNGEMNRYLKN--RVKPFSENEARHFMHQIITGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLAT 160 (278)
T ss_dssp EEEEEECCTTEEHHHHHHT--CSSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSSCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEecCCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEEeeccee
Confidence 8999999999999998852 2356999999999999999999999 8899999999999999999999999999998
Q ss_pred cccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhh
Q 046270 420 QSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIF 499 (590)
Q Consensus 420 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 499 (590)
....... ......||+.|+|||.+....++.++||||||+++|||++|+.||........ +. .. .....
T Consensus 161 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~----~~-~~~~~---- 229 (278)
T 3cok_A 161 QLKMPHE-KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT-LN----KV-VLADY---- 229 (278)
T ss_dssp ECC-----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC----------C-CSSCC----
T ss_pred eccCCCC-cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH-HH----HH-hhccc----
Confidence 6543221 22345689999999999988999999999999999999999999975433211 00 00 00000
Q ss_pred hHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 046270 500 DEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALK 538 (590)
Q Consensus 500 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~ 538 (590)
.+ +......+.+++..|++.||++|||+.++++
T Consensus 230 --~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 230 --EM----PSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp --CC----CTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred --CC----ccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 00 0112236678899999999999999999985
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=329.69 Aligned_cols=251 Identities=23% Similarity=0.282 Sum_probs=194.9
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCC-CCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEE
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLD-TKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRF 341 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~-~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~ 341 (590)
++|...+.||+|+||.||++... ++..||+|++.... ....+.+.+|++++++++||||+++++++. .....+
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~~~~ 96 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFE-----DYHNMY 96 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSSEEE
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHhee-----cCCeEE
Confidence 56888899999999999999986 47899999986543 334678999999999999999999999997 345689
Q ss_pred EEEeeCCCCCcchhhhhhc-ccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEE---CCCCcEEEEeeCC
Q 046270 342 LVYDYMPNGTLSDNISISH-KRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILL---DSELNAKVADFGL 417 (590)
Q Consensus 342 LV~E~~~~gsL~~~L~~~~-~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILL---d~~~~~kL~DFGl 417 (590)
+||||+++|+|.+++.... ....+++..++.|+.||+.||+||| +.+|+||||||+|||+ +.++.+||+|||+
T Consensus 97 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~ 173 (285)
T 3is5_A 97 IVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGL 173 (285)
T ss_dssp EEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEESSSSTTCCEEECCCCC
T ss_pred EEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCCCHHHEEEecCCCCCCEEEEeeec
Confidence 9999999999999886432 3357999999999999999999999 8899999999999999 4567899999999
Q ss_pred cccccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchh
Q 046270 418 AKQSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDD 497 (590)
Q Consensus 418 a~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 497 (590)
++...... ......||..|+|||.+. +.++.++||||||++++||++|+.||....... +... ..........
T Consensus 174 a~~~~~~~--~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~--~~~~--~~~~~~~~~~ 246 (285)
T 3is5_A 174 AELFKSDE--HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEE--VQQK--ATYKEPNYAV 246 (285)
T ss_dssp CCC------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHH--HHHCCCCCCC
T ss_pred ceecCCcc--cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHH--HHhh--hccCCccccc
Confidence 98654322 234456899999999875 678999999999999999999999997533211 1100 0111111100
Q ss_pred hhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 046270 498 IFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALK 538 (590)
Q Consensus 498 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~ 538 (590)
.. ......+.+++..|++.||++|||+.|+++
T Consensus 247 ~~---------~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 247 EC---------RPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp -----------CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred cc---------CcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00 001236678889999999999999999985
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=335.08 Aligned_cols=259 Identities=19% Similarity=0.284 Sum_probs=201.1
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCCCChHHHHHHHHHHHhcC-CCCccccceeEEeccCCCCceEE
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDTKGDEDFTNEVEIISKIR-HRNLLSLRGCCVTSDDSSGKRRF 341 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~-H~nlv~l~g~~~~~~~~~~~~~~ 341 (590)
++|...+.||+|+||.||+|+.. +++.||||++.. ...+.+.+|++++++++ ||||+++++++... .....+
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~---~~~~~~ 109 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP---VKKKKIKREIKILENLRGGPNIITLADIVKDP---VSRTPA 109 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS---CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECT---TTCCEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecc---cchHHHHHHHHHHHHcCCCCCEEEeeeeeccC---CCCceE
Confidence 56888899999999999999875 588999999864 34678999999999997 99999999998753 245689
Q ss_pred EEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCC-cEEEEeeCCccc
Q 046270 342 LVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSEL-NAKVADFGLAKQ 420 (590)
Q Consensus 342 LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~-~~kL~DFGla~~ 420 (590)
+||||+++++|.+++. .+++.++..++.||+.||+||| +.+|+||||||+|||++.++ .+||+|||+++.
T Consensus 110 lv~e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~ 180 (330)
T 3nsz_A 110 LVFEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF 180 (330)
T ss_dssp EEEECCCCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEEeccCchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceE
Confidence 9999999999998873 4899999999999999999999 89999999999999999776 899999999986
Q ss_pred ccCCCcccccccccCCCccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHH--------h
Q 046270 421 SLEGHSHLTTRVAGTFGYLAPEYALY-GQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLA--------K 491 (590)
Q Consensus 421 ~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~--------~ 491 (590)
...... .....||..|+|||.+.. ..++.++||||||++++||++|+.||.........+........ .
T Consensus 181 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 258 (330)
T 3nsz_A 181 YHPGQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYID 258 (330)
T ss_dssp CCTTCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHH
T ss_pred cCCCCc--cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHH
Confidence 544332 334568999999999876 67899999999999999999999999655544333222211110 0
Q ss_pred cC--CchhhhhH------------HHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 492 SG--KVDDIFDE------------FIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 492 ~~--~~~~~~d~------------~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
.. .....+.. .............+.+++..|++.||++|||++|+++.
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 259 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp HTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 00 00000000 00001111134578889999999999999999999863
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=354.32 Aligned_cols=246 Identities=26% Similarity=0.383 Sum_probs=201.1
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCC---CCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCce
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLD---TKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKR 339 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~---~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~ 339 (590)
++|...+.||+|+||.||+|++. .|+.||||++.... ....+.+.+|++++++++||||+++++++.. ...
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~-----~~~ 90 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVIST-----PSD 90 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEEC-----SSE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-----CCE
Confidence 56888899999999999999987 58999999986431 2335678999999999999999999999874 456
Q ss_pred EEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcc
Q 046270 340 RFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAK 419 (590)
Q Consensus 340 ~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~ 419 (590)
.++||||+++|+|.+++. ..+.+++.+++.++.||+.||+||| +.+|+||||||+|||++.++++||+|||+++
T Consensus 91 ~~lv~E~~~gg~L~~~l~---~~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDLkp~NIll~~~~~vkL~DFG~a~ 164 (476)
T 2y94_A 91 IFMVMEYVSGGELFDYIC---KNGRLDEKESRRLFQQILSGVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSN 164 (476)
T ss_dssp EEEEEECCSSEEHHHHTT---SSSSCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEECTTCCEEECCCSSCE
T ss_pred EEEEEeCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHH---HCCCCcccccHHHEEEecCCCeEEEeccchh
Confidence 999999999999999985 3457999999999999999999999 8999999999999999999999999999998
Q ss_pred cccCCCcccccccccCCCccCccccccCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhh
Q 046270 420 QSLEGHSHLTTRVAGTFGYLAPEYALYGQL-TEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDI 498 (590)
Q Consensus 420 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~-t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 498 (590)
...... ......||+.|+|||.+.+..+ +.++|||||||++|||++|+.||+...... . .... ..+...
T Consensus 165 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~-~----~~~i-~~~~~~-- 234 (476)
T 2y94_A 165 MMSDGE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPT-L----FKKI-CDGIFY-- 234 (476)
T ss_dssp ECCTTC--CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHH-H----HHHH-HTTCCC--
T ss_pred hccccc--cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHH-H----HHHH-hcCCcC--
Confidence 764432 2344579999999999987765 689999999999999999999997543321 1 1111 111110
Q ss_pred hhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 046270 499 FDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALK 538 (590)
Q Consensus 499 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~ 538 (590)
.+......+.+++..|++.||.+|||+.|+++
T Consensus 235 --------~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 235 --------TPQYLNPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp --------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred --------CCccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 00111235678889999999999999999987
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=333.01 Aligned_cols=246 Identities=20% Similarity=0.332 Sum_probs=195.8
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCC--CChHHHHHHHHHHHhc-CCCCccccceeEEeccCCCCc
Q 046270 263 TNGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDT--KGDEDFTNEVEIISKI-RHRNLLSLRGCCVTSDDSSGK 338 (590)
Q Consensus 263 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~--~~~~~f~~Ev~il~~l-~H~nlv~l~g~~~~~~~~~~~ 338 (590)
.++|...+.||+|+||.||+|+.. +++.||||++..... ....++.+|+..+.++ +||||+++++++.. ..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~-----~~ 84 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAE-----DD 84 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEE-----TT
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeec-----CC
Confidence 467888999999999999999987 688999999875432 3356788999999999 99999999999974 34
Q ss_pred eEEEEEeeCCCCCcchhhhhhcc-cccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECC-----------
Q 046270 339 RRFLVYDYMPNGTLSDNISISHK-RKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDS----------- 406 (590)
Q Consensus 339 ~~~LV~E~~~~gsL~~~L~~~~~-~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~----------- 406 (590)
..++||||+++|+|.+++..... ...+++.+++.|+.||+.||.||| +.+|+||||||+|||++.
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~~~~~~~~ 161 (289)
T 1x8b_A 85 HMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEG 161 (289)
T ss_dssp EEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEC------------
T ss_pred eEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeecCCCHHHEEEcCCCCCccccccc
Confidence 68999999999999999964322 256999999999999999999999 889999999999999984
Q ss_pred --------CCcEEEEeeCCcccccCCCcccccccccCCCccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 046270 407 --------ELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALYG-QLTEKSDVYSFGIVILELMSGRKVLDTSTS 477 (590)
Q Consensus 407 --------~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~t~ksDVySfGvvLlELltG~~p~~~~~~ 477 (590)
...+||+|||++....... ...||..|+|||.+... .++.++||||||++++||++|+.++....
T Consensus 162 ~~~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~- 235 (289)
T 1x8b_A 162 DEDDWASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD- 235 (289)
T ss_dssp --------CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH-
T ss_pred ccccccCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh-
Confidence 4479999999998654322 23589999999998765 66789999999999999999987653211
Q ss_pred chhhhhHHHHHHHhcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 478 PFQLITDWAWVLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 478 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
. | .....+..... +......+.+++..|++.||++|||+.|+++.
T Consensus 236 ---~---~--~~~~~~~~~~~---------~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 236 ---Q---W--HEIRQGRLPRI---------PQVLSQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp ---H---H--HHHHTTCCCCC---------SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred ---H---H--HHHHcCCCCCC---------CcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 1 1 11122222111 11122467788899999999999999999863
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=331.57 Aligned_cols=248 Identities=22% Similarity=0.320 Sum_probs=200.6
Q ss_pred cCCCccceecccCcEEEEEEEEcC-CcEEEEEEeecCCC---CChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCce
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLRH-GNLVAVKQILDLDT---KGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKR 339 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~vAvK~l~~~~~---~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~ 339 (590)
++|...+.||+|+||.||++...+ ++.||+|.+..... ...+.+.+|++++++++|+||+++++++.. +..
T Consensus 15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~ 89 (294)
T 2rku_A 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFED-----NDF 89 (294)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----SSE
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeecc-----CCE
Confidence 568888999999999999999875 77899999865422 234578899999999999999999999973 456
Q ss_pred EEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcc
Q 046270 340 RFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAK 419 (590)
Q Consensus 340 ~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~ 419 (590)
.++||||+++++|.+++. ....+++.+++.++.|+++||+||| +.+|+||||||+|||++.++.+||+|||+++
T Consensus 90 ~~lv~e~~~~~~L~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 163 (294)
T 2rku_A 90 VFVVLELCRRRSLLELHK---RRKALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLAT 163 (294)
T ss_dssp EEEEEECCTTCBHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEecCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEcCCCCEEEEeccCce
Confidence 899999999999999874 3457999999999999999999999 8899999999999999999999999999998
Q ss_pred cccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhh
Q 046270 420 QSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIF 499 (590)
Q Consensus 420 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 499 (590)
...... .......||..|+|||.+.+..++.++||||||++++||++|+.||....... . +. . ...+...
T Consensus 164 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~---~~-~-~~~~~~~--- 233 (294)
T 2rku_A 164 KVEYDG-ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE-T---YL-R-IKKNEYS--- 233 (294)
T ss_dssp ECCSTT-CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-H---HH-H-HHTTCCC---
T ss_pred ecccCc-cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-H---HH-H-HhhccCC---
Confidence 654322 22334568999999999998899999999999999999999999997533211 1 11 1 1111110
Q ss_pred hHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 500 DEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 500 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
.+......+.+++..|++.||++|||+.|+++.
T Consensus 234 -------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 234 -------IPKHINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp -------CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred -------CccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 001122356778899999999999999999874
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=340.27 Aligned_cols=266 Identities=22% Similarity=0.307 Sum_probs=203.1
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCCCC-hHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceE
Q 046270 263 TNGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDTKG-DEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRR 340 (590)
Q Consensus 263 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~~~-~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~ 340 (590)
.++|...+.||+|+||.||+|+.. ++..||||++....... .+.+.+|++++.+++||||+++++++...........
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 457899999999999999999986 57789999986543222 3678899999999999999999999976554345678
Q ss_pred EEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCccc
Q 046270 341 FLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQ 420 (590)
Q Consensus 341 ~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~ 420 (590)
++||||++ |+|.+++. ...+++.++..|+.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++.
T Consensus 106 ~iv~e~~~-~~L~~~l~----~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~ 177 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLK----TQHLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARV 177 (364)
T ss_dssp EEEEECCS-EEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEcccC-cCHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChHhEEECCCCCEEEEeCcceEe
Confidence 99999997 58888874 346999999999999999999999 88999999999999999999999999999986
Q ss_pred ccCCCcc--cccccccCCCccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchh
Q 046270 421 SLEGHSH--LTTRVAGTFGYLAPEYALY-GQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDD 497 (590)
Q Consensus 421 ~~~~~~~--~~~~~~gt~~Y~APE~~~~-~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 497 (590)
....... ......||+.|+|||.+.. ..++.++||||||+++|||++|+.||........ +...... .... ..+
T Consensus 178 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-~~~i~~~-~~~~-~~~ 254 (364)
T 3qyz_A 178 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ-LNHILGI-LGSP-SQE 254 (364)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGH-HHHHHHH-HCSC-CHH
T ss_pred cCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHH-HHHHHHH-hCCC-CHH
Confidence 6433222 2345679999999998764 4589999999999999999999999975443221 1111110 0000 000
Q ss_pred hhhHH--------Hh----------hhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 498 IFDEF--------IR----------AEGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 498 ~~d~~--------l~----------~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
.+... .. ..........+.+++..|++.||.+|||+.|+++.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 255 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp HHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000 00 00001123467889999999999999999999974
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=332.96 Aligned_cols=250 Identities=27% Similarity=0.373 Sum_probs=198.9
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEE
Q 046270 263 TNGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRF 341 (590)
Q Consensus 263 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~ 341 (590)
.++|...+.||+|+||.||+++.. +|+.||+|.+........+.+.+|++++++++||||+++++++. .+...+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 82 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYE-----STTHYY 82 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEE-----CSSEEE
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcc-----cCCEEE
Confidence 356888899999999999999986 58899999997655545667999999999999999999999987 345689
Q ss_pred EEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEE---CCCCcEEEEeeCCc
Q 046270 342 LVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILL---DSELNAKVADFGLA 418 (590)
Q Consensus 342 LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILL---d~~~~~kL~DFGla 418 (590)
+||||+++++|.+++. ..+.+++..+..++.|++.||.||| +.+|+||||||+||++ ++++.+||+|||++
T Consensus 83 lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~ 156 (304)
T 2jam_A 83 LVMQLVSGGELFDRIL---ERGVYTEKDASLVIQQVLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLS 156 (304)
T ss_dssp EEECCCCSCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTT
T ss_pred EEEEcCCCccHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEecCCCCCCEEEccCCcc
Confidence 9999999999999885 3457999999999999999999999 8899999999999999 78899999999999
Q ss_pred ccccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhh
Q 046270 419 KQSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDI 498 (590)
Q Consensus 419 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 498 (590)
+..... ......||..|+|||.+.+..++.++||||||+++|||++|+.||...... .... . ...+... .
T Consensus 157 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~----~-i~~~~~~-~ 226 (304)
T 2jam_A 157 KMEQNG---IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETES-KLFE----K-IKEGYYE-F 226 (304)
T ss_dssp CCCCCB---TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHH-HHHH----H-HHHCCCC-C
T ss_pred eecCCC---ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH-HHHH----H-HHcCCCC-C
Confidence 754322 223456899999999999999999999999999999999999998653321 1111 1 1111110 0
Q ss_pred hhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 046270 499 FDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALK 538 (590)
Q Consensus 499 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~ 538 (590)
.. .........+.+++..|++.||++|||+.|+++
T Consensus 227 ~~-----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 227 ES-----PFWDDISESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp CT-----TTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred Cc-----cccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 00 001112346778999999999999999999987
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=334.75 Aligned_cols=248 Identities=25% Similarity=0.372 Sum_probs=201.7
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCC-CCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEE
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLD-TKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRF 341 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~-~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~ 341 (590)
+.|...+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.. ....+
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~ 96 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK-----DTKLW 96 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTEEE
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec-----CCeEE
Confidence 46888899999999999999876 58899999986543 3345789999999999999999999999884 34689
Q ss_pred EEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccc
Q 046270 342 LVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQS 421 (590)
Q Consensus 342 LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~ 421 (590)
+||||+++++|.+++. ...+++..++.++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++...
T Consensus 97 lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~ 169 (303)
T 3a7i_A 97 IIMEYLGGGSALDLLE----PGPLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQL 169 (303)
T ss_dssp EEEECCTTEEHHHHHT----TSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEeCCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChheEEECCCCCEEEeecccceec
Confidence 9999999999999884 356999999999999999999999 889999999999999999999999999999865
Q ss_pred cCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhhhH
Q 046270 422 LEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDE 501 (590)
Q Consensus 422 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 501 (590)
.... .......||..|+|||.+.+..++.++||||||+++|||++|+.|+....... .. .. ...+....
T Consensus 170 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~----~~-~~~~~~~~---- 238 (303)
T 3a7i_A 170 TDTQ-IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMK-VL----FL-IPKNNPPT---- 238 (303)
T ss_dssp BTTB-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HH----HH-HHHSCCCC----
T ss_pred Cccc-cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHH-HH----HH-hhcCCCCC----
Confidence 4332 22344578999999999999999999999999999999999999986432211 11 11 11111111
Q ss_pred HHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 502 FIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 502 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
+ .......+..++..|++.||.+|||+.++++.
T Consensus 239 -~----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 239 -L----EGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp -C----CSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred -C----ccccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 0 01122367788999999999999999999874
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=341.72 Aligned_cols=255 Identities=27% Similarity=0.382 Sum_probs=198.4
Q ss_pred cCCCccceecccCcEEEEEEEEcC-CcE--EEEEEeecCC-CCChHHHHHHHHHHHhc-CCCCccccceeEEeccCCCCc
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLRH-GNL--VAVKQILDLD-TKGDEDFTNEVEIISKI-RHRNLLSLRGCCVTSDDSSGK 338 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~--vAvK~l~~~~-~~~~~~f~~Ev~il~~l-~H~nlv~l~g~~~~~~~~~~~ 338 (590)
++|...+.||+|+||.||+|++.. |.. +|+|++.... ....+.+.+|++++.++ +||||+++++++.. ..
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~-----~~ 99 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH-----RG 99 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEE-----TT
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeee-----CC
Confidence 468888999999999999999764 554 5999986532 33456799999999999 99999999999974 44
Q ss_pred eEEEEEeeCCCCCcchhhhhhc-------------ccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEC
Q 046270 339 RRFLVYDYMPNGTLSDNISISH-------------KRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLD 405 (590)
Q Consensus 339 ~~~LV~E~~~~gsL~~~L~~~~-------------~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd 405 (590)
..++||||+++|+|.+++.... ....+++.+++.|+.||+.||.||| +.+|+||||||+|||++
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~ 176 (327)
T 1fvr_A 100 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVG 176 (327)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEC
T ss_pred ceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCccceEEEc
Confidence 6899999999999999986432 1246999999999999999999999 89999999999999999
Q ss_pred CCCcEEEEeeCCcccccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhhH
Q 046270 406 SELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLDTSTSPFQLITD 484 (590)
Q Consensus 406 ~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELlt-G~~p~~~~~~~~~~l~~ 484 (590)
.++.+||+|||+++..... .......++..|+|||.+....++.++||||||+++|||+| |+.||.......
T Consensus 177 ~~~~~kL~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~----- 249 (327)
T 1fvr_A 177 ENYVAKIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE----- 249 (327)
T ss_dssp GGGCEEECCTTCEESSCEE--CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-----
T ss_pred CCCeEEEcccCcCcccccc--ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHH-----
Confidence 9999999999999743221 12233456889999999998899999999999999999998 999986533211
Q ss_pred HHHHHHhcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhccC
Q 046270 485 WAWVLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEGD 543 (590)
Q Consensus 485 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~~ 543 (590)
.... ...+... ..+......+.+++..|++.||.+|||+.|+++.|+..
T Consensus 250 ~~~~-~~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 298 (327)
T 1fvr_A 250 LYEK-LPQGYRL---------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 298 (327)
T ss_dssp HHHH-GGGTCCC---------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHH-hhcCCCC---------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 1111 1111100 00111234678899999999999999999999988764
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=346.58 Aligned_cols=262 Identities=20% Similarity=0.323 Sum_probs=200.6
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCC-CChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEE
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDT-KGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRF 341 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~-~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~ 341 (590)
++|...+.||+|+||.||++++. +|..||+|++..... ...+.+.+|++++++++||||+++++++.. +...+
T Consensus 33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~ 107 (360)
T 3eqc_A 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-----DGEIS 107 (360)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEE-----TTEEE
T ss_pred ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEE-----CCEEE
Confidence 56888899999999999999987 588999999875432 234678999999999999999999999984 44689
Q ss_pred EEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCC-CeEecCCCCCceEECCCCcEEEEeeCCccc
Q 046270 342 LVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKP-GIYHRDIKSTNILLDSELNAKVADFGLAKQ 420 (590)
Q Consensus 342 LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~-~ivHrDIKp~NILLd~~~~~kL~DFGla~~ 420 (590)
+||||+++|+|.+++. ....+++..+..|+.+++.||.||| .. +|+||||||+|||++.++.+||+|||+++.
T Consensus 108 lv~e~~~~~~L~~~l~---~~~~~~~~~~~~i~~~i~~~l~~lh---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 181 (360)
T 3eqc_A 108 ICMEHMDGGSLDQVLK---KAGRIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQ 181 (360)
T ss_dssp EEECCCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHH---HHHCCCCSCCSGGGEEECTTCCEEECCCCCCHH
T ss_pred EEEECCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHH---HhCCEEcCCccHHHEEECCCCCEEEEECCCCcc
Confidence 9999999999999985 3356999999999999999999999 64 899999999999999999999999999975
Q ss_pred ccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhh-----------------
Q 046270 421 SLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLIT----------------- 483 (590)
Q Consensus 421 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~----------------- 483 (590)
.... ......||..|+|||.+.+..++.++||||||+++|||++|+.||...........
T Consensus 182 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (360)
T 3eqc_A 182 LIDS---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPR 258 (360)
T ss_dssp HHHH---C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC---------------
T ss_pred cccc---cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcc
Confidence 4321 22345789999999999999999999999999999999999999975432211000
Q ss_pred -------HHHHHHHhcCCchhhhhHHHhhh----hHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 484 -------DWAWVLAKSGKVDDIFDEFIRAE----GARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 484 -------~~~~~~~~~~~~~~~~d~~l~~~----~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
.+...........+.++...... ........+.+++..|++.||++|||+.|+++.
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 325 (360)
T 3eqc_A 259 TPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 325 (360)
T ss_dssp ---------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred cCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 00000000001112222222111 011123467889999999999999999999863
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=336.86 Aligned_cols=249 Identities=21% Similarity=0.317 Sum_probs=201.0
Q ss_pred hcCCCccceecccCcEEEEEEEEcC-CcEEEEEEeecCCC---CChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCc
Q 046270 263 TNGFSQNNLIGQGASGIVYKGTLRH-GNLVAVKQILDLDT---KGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGK 338 (590)
Q Consensus 263 t~~f~~~~~LG~G~fG~Vykg~~~~-g~~vAvK~l~~~~~---~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~ 338 (590)
.++|...+.||+|+||.||++++.+ ++.||+|.+..... ...+.+.+|++++++++|+||+++++++.. ..
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~ 114 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFED-----ND 114 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----SS
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-----CC
Confidence 3568888999999999999999875 77899999865422 234578899999999999999999999973 45
Q ss_pred eEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCc
Q 046270 339 RRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLA 418 (590)
Q Consensus 339 ~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla 418 (590)
..++||||+++++|.+++. ....+++.+++.|+.||++||.||| +.+|+||||||+|||++.++.+||+|||++
T Consensus 115 ~~~lv~e~~~~~~L~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 188 (335)
T 2owb_A 115 FVFVVLELCRRRSLLELHK---RRKALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLA 188 (335)
T ss_dssp EEEEEECCCTTCBHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecCCCCCHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHH---HCCCEecCCCchhEEEcCCCCEEEeeccCc
Confidence 6999999999999999874 3457999999999999999999999 889999999999999999999999999999
Q ss_pred ccccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhh
Q 046270 419 KQSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDI 498 (590)
Q Consensus 419 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 498 (590)
+...... .......||..|+|||.+.+..++.++||||||+++|||++|+.||....... . +............
T Consensus 189 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~---~~~~~~~~~~~~~- 262 (335)
T 2owb_A 189 TKVEYDG-ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE-T---YLRIKKNEYSIPK- 262 (335)
T ss_dssp EECCSTT-CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-H---HHHHHHTCCCCCT-
T ss_pred eecccCc-ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHH-H---HHHHhcCCCCCCc-
Confidence 8654322 22334568999999999998899999999999999999999999996533211 1 1111111111111
Q ss_pred hhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 499 FDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 499 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
.....+.+++..|++.||++|||+.|+++.
T Consensus 263 -----------~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 263 -----------HINPVAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp -----------TSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred -----------cCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 122356778899999999999999999873
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=341.67 Aligned_cols=261 Identities=22% Similarity=0.303 Sum_probs=195.5
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCCC--ChHHHHHHHHHHHhcCCCCccccceeEEeccCC-CCc
Q 046270 263 TNGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDTK--GDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDS-SGK 338 (590)
Q Consensus 263 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~~--~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~-~~~ 338 (590)
.++|...+.||+|+||.||+|++. .|+.||||++...... ..+.+.+|++++++++||||+++++++...+.. ...
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 467889999999999999999985 5889999998543222 245688999999999999999999998754321 234
Q ss_pred eEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCc
Q 046270 339 RRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLA 418 (590)
Q Consensus 339 ~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla 418 (590)
..++||||+ +++|.+++. ...+++..+..++.||++||.||| +.+|+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~lv~e~~-~~~L~~~~~----~~~l~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 175 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMK----HEKLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLA 175 (367)
T ss_dssp CCEEEEECC-SEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCHHHEEEcCCCCEEEEeeecc
Confidence 579999999 889998884 246999999999999999999999 889999999999999999999999999999
Q ss_pred ccccCCCcccccccccCCCccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchh
Q 046270 419 KQSLEGHSHLTTRVAGTFGYLAPEYALY-GQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDD 497 (590)
Q Consensus 419 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 497 (590)
+..... .+...||..|+|||.+.+ ..++.++|||||||+++||++|+.||....... .+.... ...+....
T Consensus 176 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~l~~i~---~~~g~~~~ 247 (367)
T 1cm8_A 176 RQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD-QLKEIM---KVTGTPPA 247 (367)
T ss_dssp EECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHH---HHHCCCCH
T ss_pred cccccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHH---HhcCCCCH
Confidence 865432 334578999999999886 689999999999999999999999997543211 111111 11121111
Q ss_pred hhhHHHhhh-------------------hHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 498 IFDEFIRAE-------------------GARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 498 ~~d~~l~~~-------------------~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
-+.+.+... ........+.+++..|++.||.+|||+.|+++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 248 EFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp HHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 111100000 001123467889999999999999999999984
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=340.65 Aligned_cols=268 Identities=25% Similarity=0.266 Sum_probs=195.0
Q ss_pred HHHhcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCCC-----ChHHHHHHHHHHHhcCCCCccccceeEEecc
Q 046270 260 EQATNGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDTK-----GDEDFTNEVEIISKIRHRNLLSLRGCCVTSD 333 (590)
Q Consensus 260 ~~at~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~~-----~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~ 333 (590)
....++|...+.||+|+||.||+|++. +|+.||||++...... ..+.+.+|++++++++||||+++++++..
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-- 83 (346)
T 1ua2_A 6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH-- 83 (346)
T ss_dssp -------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECC--
T ss_pred HHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEee--
Confidence 344578999999999999999999986 4889999998643221 13468899999999999999999999873
Q ss_pred CCCCceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEE
Q 046270 334 DSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVA 413 (590)
Q Consensus 334 ~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~ 413 (590)
....++||||+++ +|.+++.. ....+++.++..++.|++.||+||| +.+|+||||||+|||++.++.+||+
T Consensus 84 ---~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl~ 154 (346)
T 1ua2_A 84 ---KSNISLVFDFMET-DLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLA 154 (346)
T ss_dssp ---TTCCEEEEECCSE-EHHHHHTT--CCSSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEEC
T ss_pred ---CCceEEEEEcCCC-CHHHHHHh--cCcCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCCHHHEEEcCCCCEEEE
Confidence 3458999999985 78877742 3356999999999999999999999 8899999999999999999999999
Q ss_pred eeCCcccccCCCcccccccccCCCccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhc
Q 046270 414 DFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALYG-QLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKS 492 (590)
Q Consensus 414 DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~ 492 (590)
|||+++...... .......||+.|+|||.+.+. .++.++||||||+++|||++|+.||...... ..+..........
T Consensus 155 Dfg~a~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~-~~~~~i~~~~~~~ 232 (346)
T 1ua2_A 155 DFGLAKSFGSPN-RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL-DQLTRIFETLGTP 232 (346)
T ss_dssp CCGGGSTTTSCC-CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCCC
T ss_pred ecccceeccCCc-ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHH-HHHHHHHHHcCCC
Confidence 999998654322 223445789999999998754 5899999999999999999999988654322 1222111111000
Q ss_pred --CCchhh---hhHH----Hh----hhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHh
Q 046270 493 --GKVDDI---FDEF----IR----AEGARAVMERFVLVGILCAHVMVALRPTITDALKML 540 (590)
Q Consensus 493 --~~~~~~---~d~~----l~----~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L 540 (590)
....+. .+.. .. ..........+.+++..|++.||++|||+.|++++-
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~ 293 (346)
T 1ua2_A 233 TEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMK 293 (346)
T ss_dssp CTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSG
T ss_pred ChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcCh
Confidence 000000 0000 00 000011234778899999999999999999999864
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=336.26 Aligned_cols=261 Identities=19% Similarity=0.237 Sum_probs=201.4
Q ss_pred HHHHHHHhcCCCcc-ceecccCcEEEEEEEEc-CCcEEEEEEeecCC--CCChHHHHHHHHHHHhc-CCCCccccceeEE
Q 046270 256 VSELEQATNGFSQN-NLIGQGASGIVYKGTLR-HGNLVAVKQILDLD--TKGDEDFTNEVEIISKI-RHRNLLSLRGCCV 330 (590)
Q Consensus 256 ~~el~~at~~f~~~-~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~--~~~~~~f~~Ev~il~~l-~H~nlv~l~g~~~ 330 (590)
++..+...+.|... +.||+|+||.||+|+.. +|+.||+|++.... ......+.+|+.++.++ +||||+++++++.
T Consensus 20 ~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~ 99 (327)
T 3lm5_A 20 FQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYE 99 (327)
T ss_dssp SBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred HHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEE
Confidence 34445556667776 78999999999999987 48899999986532 23357899999999999 5699999999987
Q ss_pred eccCCCCceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECC---C
Q 046270 331 TSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDS---E 407 (590)
Q Consensus 331 ~~~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~---~ 407 (590)
.+...++||||+++|+|.+++... ....+++.+++.|+.||+.||+||| +.+|+||||||+|||++. +
T Consensus 100 -----~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~ql~~~L~~LH---~~givH~Dikp~NIl~~~~~~~ 170 (327)
T 3lm5_A 100 -----NTSEIILILEYAAGGEIFSLCLPE-LAEMVSENDVIRLIKQILEGVYYLH---QNNIVHLDLKPQNILLSSIYPL 170 (327)
T ss_dssp -----CSSEEEEEEECCTTEEGGGGGSSC-C-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESCBTTB
T ss_pred -----eCCeEEEEEEecCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCChHHEEEecCCCC
Confidence 345699999999999999988532 2357999999999999999999999 889999999999999998 7
Q ss_pred CcEEEEeeCCcccccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHH
Q 046270 408 LNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAW 487 (590)
Q Consensus 408 ~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~ 487 (590)
+.+||+|||+++...... ......||+.|+|||.+....++.++||||||+++|||++|+.||........ .. .
T Consensus 171 ~~~kL~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~---~ 244 (327)
T 3lm5_A 171 GDIKIVDFGMSRKIGHAC--ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQET-YL---N 244 (327)
T ss_dssp CCEEECCGGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HH---H
T ss_pred CcEEEeeCccccccCCcc--ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH-HH---H
Confidence 899999999998654322 23345789999999999999999999999999999999999999965432211 11 0
Q ss_pred HHHhcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 488 VLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 488 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
........... ........+.+++..|++.||++|||+.++++.
T Consensus 245 i~~~~~~~~~~--------~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 245 ISQVNVDYSEE--------TFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp HHHTCCCCCTT--------TTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred HHhcccccCch--------hhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 00011111100 001123467788999999999999999999864
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-41 Score=348.79 Aligned_cols=260 Identities=25% Similarity=0.351 Sum_probs=199.7
Q ss_pred hcCCCccceecccCcEEEEEEEEc------CCcEEEEEEeecCCC-CChHHHHHHHHHHHhcCCCCccccceeEEeccCC
Q 046270 263 TNGFSQNNLIGQGASGIVYKGTLR------HGNLVAVKQILDLDT-KGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDS 335 (590)
Q Consensus 263 t~~f~~~~~LG~G~fG~Vykg~~~------~g~~vAvK~l~~~~~-~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~ 335 (590)
.++|...+.||+|+||.||+|++. .+..||||++..... ....++.+|+.++++++||||+++++++..
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---- 104 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ---- 104 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS----
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcC----
Confidence 467889999999999999999843 467899999864322 334578999999999999999999999874
Q ss_pred CCceEEEEEeeCCCCCcchhhhhhcc----cccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECC---CC
Q 046270 336 SGKRRFLVYDYMPNGTLSDNISISHK----RKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDS---EL 408 (590)
Q Consensus 336 ~~~~~~LV~E~~~~gsL~~~L~~~~~----~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~---~~ 408 (590)
....++||||+++|+|.+++..... ...+++.+++.++.||+.||.||| +.+|+||||||+|||++. +.
T Consensus 105 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~i~H~dlkp~NIli~~~~~~~ 180 (327)
T 2yfx_A 105 -SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGR 180 (327)
T ss_dssp -SSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTC
T ss_pred -CCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeecCcCCHhHEEEecCCCcc
Confidence 3447999999999999999964321 145899999999999999999999 889999999999999984 45
Q ss_pred cEEEEeeCCcccccCCCc-ccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhhHHH
Q 046270 409 NAKVADFGLAKQSLEGHS-HLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLDTSTSPFQLITDWA 486 (590)
Q Consensus 409 ~~kL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELlt-G~~p~~~~~~~~~~l~~~~ 486 (590)
.+||+|||+++....... .......||..|+|||.+..+.++.++||||||+++|||+| |+.||...... .+.
T Consensus 181 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~~~--- 255 (327)
T 2yfx_A 181 VAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ--EVL--- 255 (327)
T ss_dssp CEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--HHH---
T ss_pred eEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH--HHH---
Confidence 699999999975533322 12334567889999999999999999999999999999998 88888653221 111
Q ss_pred HHHHhcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhccCCC
Q 046270 487 WVLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEGDID 545 (590)
Q Consensus 487 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~~~~ 545 (590)
.. ...+.... ........+.+++..|++.||.+|||+.+++++|+....
T Consensus 256 ~~-~~~~~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 304 (327)
T 2yfx_A 256 EF-VTSGGRMD---------PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 304 (327)
T ss_dssp HH-HHTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HH-HhcCCCCC---------CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence 11 11111110 011123467789999999999999999999999986543
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=338.54 Aligned_cols=261 Identities=23% Similarity=0.332 Sum_probs=191.7
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCCCC-hHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEE
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDTKG-DEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRF 341 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~~~-~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~ 341 (590)
++|...+.||+|+||.||+|+.. +++.||||++....... ...+.+|++++++++||||+++++++.. +...+
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~ 76 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHT-----EKSLT 76 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEEC-----SSCEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEee-----CCEEE
Confidence 46888899999999999999987 58899999986433221 2245689999999999999999999974 44589
Q ss_pred EEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccc
Q 046270 342 LVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQS 421 (590)
Q Consensus 342 LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~ 421 (590)
+||||++ |+|.+++.. ....+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++..
T Consensus 77 lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~ 150 (324)
T 3mtl_A 77 LVFEYLD-KDLKQYLDD--CGNIINMHNVKLFLFQLLRGLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAK 150 (324)
T ss_dssp EEEECCS-EEHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCCGGGEEECTTCCEEECSSSEEECC
T ss_pred EEecccc-cCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCcCHHHEEECCCCCEEEccCcccccc
Confidence 9999997 588888753 2446999999999999999999999 899999999999999999999999999999854
Q ss_pred cCCCcccccccccCCCccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCC---chh
Q 046270 422 LEGHSHLTTRVAGTFGYLAPEYALY-GQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGK---VDD 497 (590)
Q Consensus 422 ~~~~~~~~~~~~gt~~Y~APE~~~~-~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~---~~~ 497 (590)
.... .......||..|+|||.+.+ ..++.++||||||+++|||++|+.||....... .+. .......... ...
T Consensus 151 ~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~-~i~~~~~~~~~~~~~~ 227 (324)
T 3mtl_A 151 SIPT-KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEE-QLH-FIFRILGTPTEETWPG 227 (324)
T ss_dssp -------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHH-HHHHHHCCCCTTTSTT
T ss_pred cCCc-cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHH-HHHHHhCCCChHhchh
Confidence 3322 22334568999999999876 568999999999999999999999997543322 221 1111111110 111
Q ss_pred hhhHH-Hh------------hhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 046270 498 IFDEF-IR------------AEGARAVMERFVLVGILCAHVMVALRPTITDALK 538 (590)
Q Consensus 498 ~~d~~-l~------------~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~ 538 (590)
..... .. ..........+.+++..|++.||.+|||++|+++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 228 ILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp GGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 11000 00 0000112346778999999999999999999987
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=326.87 Aligned_cols=245 Identities=21% Similarity=0.341 Sum_probs=199.6
Q ss_pred cCCCccceecccCcEEEEEEEEcC-CcEEEEEEeecC---CCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCce
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLRH-GNLVAVKQILDL---DTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKR 339 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~vAvK~l~~~---~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~ 339 (590)
++|...+.||+|+||.||+|+... +..||+|++... .....+.+.+|++++++++||||+++++++.. +..
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~ 88 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHD-----RKR 88 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----SSE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEc-----CCE
Confidence 468888999999999999999874 778999998542 22335679999999999999999999999873 456
Q ss_pred EEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcc
Q 046270 340 RFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAK 419 (590)
Q Consensus 340 ~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~ 419 (590)
.++||||+++|+|.+++. ....+++..++.++.||+.||.||| +.+|+||||||+||+++.++.+||+|||++.
T Consensus 89 ~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~ 162 (284)
T 2vgo_A 89 IYLMLEFAPRGELYKELQ---KHGRFDEQRSATFMEELADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSV 162 (284)
T ss_dssp EEEEECCCTTEEHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEEeCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEEcCCCCEEEecccccc
Confidence 899999999999999885 3346999999999999999999999 8999999999999999999999999999987
Q ss_pred cccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhh
Q 046270 420 QSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIF 499 (590)
Q Consensus 420 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 499 (590)
...... .....|+..|+|||.+.+..++.++||||||+++|||++|+.||....... . .... ......
T Consensus 163 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~----~~~~-~~~~~~--- 230 (284)
T 2vgo_A 163 HAPSLR---RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE-T----HRRI-VNVDLK--- 230 (284)
T ss_dssp ECSSSC---BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-H----HHHH-HTTCCC---
T ss_pred cCcccc---cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhH-H----HHHH-hccccC---
Confidence 554322 234568999999999999999999999999999999999999997533211 1 1111 111110
Q ss_pred hHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 046270 500 DEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALK 538 (590)
Q Consensus 500 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~ 538 (590)
.+......+.+++..|++.||.+|||+.++++
T Consensus 231 -------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 231 -------FPPFLSDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp -------CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -------CCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 01112246678899999999999999999986
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=352.67 Aligned_cols=248 Identities=15% Similarity=0.169 Sum_probs=187.3
Q ss_pred HhcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecC---CCCChHHHHHHH---HHHHhcCCCCccccc-------e
Q 046270 262 ATNGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDL---DTKGDEDFTNEV---EIISKIRHRNLLSLR-------G 327 (590)
Q Consensus 262 at~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~---~~~~~~~f~~Ev---~il~~l~H~nlv~l~-------g 327 (590)
..++|...+.||+|+||.||+|++. +|+.||||++... .....+.+.+|+ +++++++|||||+++ +
T Consensus 71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~ 150 (377)
T 3byv_A 71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 150 (377)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred CCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence 3467888899999999999999974 5899999999743 233456789999 555566899999998 4
Q ss_pred eEEeccC--------CCC----ceEEEEEeeCCCCCcchhhhhhcc----cccCChhhHHHHHHHHHHHHHHHHhcCCCC
Q 046270 328 CCVTSDD--------SSG----KRRFLVYDYMPNGTLSDNISISHK----RKQLTWPQRKKIIVDVAKGIAYLHYGLKPG 391 (590)
Q Consensus 328 ~~~~~~~--------~~~----~~~~LV~E~~~~gsL~~~L~~~~~----~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ 391 (590)
++...+. .++ ...++||||+ +|+|.+++..... ...++|..++.|+.||+.||+||| +.+
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ 226 (377)
T 3byv_A 151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYG 226 (377)
T ss_dssp EEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHH---HTT
T ss_pred hhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHH---hCC
Confidence 4432210 000 0378999999 6899999864321 123556899999999999999999 889
Q ss_pred eEecCCCCCceEECCCCcEEEEeeCCcccccCCCcccccccccCCCccCccccccC-----------CCCcchhHHHHHH
Q 046270 392 IYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALYG-----------QLTEKSDVYSFGI 460 (590)
Q Consensus 392 ivHrDIKp~NILLd~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-----------~~t~ksDVySfGv 460 (590)
|+||||||+|||++.++.+||+|||+++.... ......| ..|+|||++... .++.++|||||||
T Consensus 227 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~ 301 (377)
T 3byv_A 227 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL 301 (377)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred eecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence 99999999999999999999999999985322 2344567 999999999887 8999999999999
Q ss_pred HHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 046270 461 VILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALK 538 (590)
Q Consensus 461 vLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~ 538 (590)
++|||++|+.||........ ...... .. ......+.+++..|++.||++|||+.|+++
T Consensus 302 il~elltg~~Pf~~~~~~~~--------------~~~~~~-~~-----~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 302 VIYWIWCADLPITKDAALGG--------------SEWIFR-SC-----KNIPQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHHHHSSCCC------CC--------------SGGGGS-SC-----CCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHHHHCCCCCcccccccc--------------hhhhhh-hc-----cCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 99999999999864332111 000000 00 112246778889999999999999999986
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-40 Score=343.84 Aligned_cols=243 Identities=22% Similarity=0.280 Sum_probs=198.2
Q ss_pred HhcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCCC--------ChHHHHHHHHHHHhcCCCCccccceeEEec
Q 046270 262 ATNGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDTK--------GDEDFTNEVEIISKIRHRNLLSLRGCCVTS 332 (590)
Q Consensus 262 at~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~~--------~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~ 332 (590)
..++|...+.||+|+||.||+|+.. +++.||||++...... ....+.+|++++++++||||+++++++.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~-- 99 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFE-- 99 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEE--
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEe--
Confidence 3467899999999999999999975 5789999998754321 2345788999999999999999999997
Q ss_pred cCCCCceEEEEEeeCCCC-CcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEE
Q 046270 333 DDSSGKRRFLVYDYMPNG-TLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAK 411 (590)
Q Consensus 333 ~~~~~~~~~LV~E~~~~g-sL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~k 411 (590)
.....++||||+.+| +|.+++. ....+++..++.|+.||+.||.||| +.+|+||||||+|||++.++.+|
T Consensus 100 ---~~~~~~lv~e~~~~g~~l~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~k 170 (335)
T 3dls_A 100 ---NQGFFQLVMEKHGSGLDLFAFID---RHPRLDEPLASYIFRQLVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIK 170 (335)
T ss_dssp ---CSSEEEEEEECCTTSCBHHHHHH---TCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEE
T ss_pred ---eCCEEEEEEEeCCCCccHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEEeccCHHHEEEcCCCcEE
Confidence 345689999999877 9988884 3457999999999999999999999 88999999999999999999999
Q ss_pred EEeeCCcccccCCCcccccccccCCCccCccccccCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHH
Q 046270 412 VADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALYGQL-TEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLA 490 (590)
Q Consensus 412 L~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~-t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~ 490 (590)
|+|||+++...... ......||+.|+|||.+.+..+ +.++||||||+++|||++|+.||........
T Consensus 171 L~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---------- 238 (335)
T 3dls_A 171 LIDFGSAAYLERGK--LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVE---------- 238 (335)
T ss_dssp ECCCTTCEECCTTC--CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGTT----------
T ss_pred EeecccceECCCCC--ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHHh----------
Confidence 99999998664432 2334678999999999988776 8899999999999999999999864211000
Q ss_pred hcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 491 KSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 491 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
..... +......+..++..|++.||++|||+.++++.
T Consensus 239 ~~~~~------------~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 239 AAIHP------------PYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp TCCCC------------SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred hccCC------------CcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000 00122367788899999999999999999974
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-39 Score=351.05 Aligned_cols=258 Identities=19% Similarity=0.242 Sum_probs=201.3
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEE
Q 046270 263 TNGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRF 341 (590)
Q Consensus 263 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~ 341 (590)
.++|...++||+|+||.||+|++. +++.||||++..... ..++.+|++++..++|++.+..+.++.. .+...+
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~----~~~~~~ 79 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGV----EGDYNV 79 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEE----ETTEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEe----eCCEEE
Confidence 467899999999999999999974 588999998765432 3458899999999988665555554443 345689
Q ss_pred EEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEE---CCCCcEEEEeeCCc
Q 046270 342 LVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILL---DSELNAKVADFGLA 418 (590)
Q Consensus 342 LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILL---d~~~~~kL~DFGla 418 (590)
|||||+ +++|.+++.. ....+++.+++.|+.||+.||+||| +.+|+||||||+|||| +.++.+||+|||++
T Consensus 80 lvme~~-g~sL~~ll~~--~~~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla 153 (483)
T 3sv0_A 80 LVMDLL-GPSLEDLFNF--CSRKLSLKTVLMLADQMINRVEFVH---SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153 (483)
T ss_dssp EEEECC-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTTCEEECCCTTC
T ss_pred EEEECC-CCCHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCcceEEEecCCCCCeEEEEeCCcc
Confidence 999999 9999999853 2456999999999999999999999 8899999999999999 68899999999999
Q ss_pred ccccCCCcc------cccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchh--hhhHHHHHHH
Q 046270 419 KQSLEGHSH------LTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQ--LITDWAWVLA 490 (590)
Q Consensus 419 ~~~~~~~~~------~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~--~l~~~~~~~~ 490 (590)
+........ ......||..|+|||.+.+..++.++|||||||+||||++|+.||........ .+..+....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~- 232 (483)
T 3sv0_A 154 KKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK- 232 (483)
T ss_dssp EECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHH-
T ss_pred eeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcc-
Confidence 876543321 12356799999999999999999999999999999999999999976443221 111111100
Q ss_pred hcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhcc
Q 046270 491 KSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEG 542 (590)
Q Consensus 491 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~ 542 (590)
....+.. ........+.+++..|++.+|++||++.+|+++|+.
T Consensus 233 ----~~~~~~~-----l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~ 275 (483)
T 3sv0_A 233 ----VATSIEA-----LCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRD 275 (483)
T ss_dssp ----HHSCHHH-----HHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHH
T ss_pred ----ccccHHH-----HhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHH
Confidence 0001111 111223578889999999999999999999998765
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=359.10 Aligned_cols=254 Identities=24% Similarity=0.304 Sum_probs=203.1
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecC---CCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCc
Q 046270 263 TNGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDL---DTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGK 338 (590)
Q Consensus 263 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~---~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~ 338 (590)
.++|...+.||+|+||.||+++.. +|+.||+|++... .......+.+|+++|++++|||||++++++.. ..
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~-----~~ 257 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYET-----KD 257 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----SS
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEee-----CC
Confidence 456888999999999999999986 5889999998642 23345678899999999999999999999873 45
Q ss_pred eEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCc
Q 046270 339 RRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLA 418 (590)
Q Consensus 339 ~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla 418 (590)
..++||||+++|+|.+++... ....+++..++.++.||+.||+||| +.+|+||||||+||||+.++.+||+|||++
T Consensus 258 ~l~lVmEy~~gg~L~~~l~~~-~~~~l~e~~~~~i~~qIl~aL~yLH---~~gIvHrDLKPeNILld~~g~vKL~DFGla 333 (576)
T 2acx_A 258 ALCLVLTLMNGGDLKFHIYHM-GQAGFPEARAVFYAAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLA 333 (576)
T ss_dssp EEEEEECCCCSCBHHHHHHSS-SSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEEEEEcCCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCchheEEEeCCCCeEEEecccc
Confidence 699999999999999988532 2335999999999999999999999 889999999999999999999999999999
Q ss_pred ccccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhh
Q 046270 419 KQSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDI 498 (590)
Q Consensus 419 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 498 (590)
+...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||........ .......... ...
T Consensus 334 ~~~~~~~--~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~-~~~i~~~i~~-~~~--- 406 (576)
T 2acx_A 334 VHVPEGQ--TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK-REEVERLVKE-VPE--- 406 (576)
T ss_dssp EECCTTC--CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCC-HHHHHHHHHH-CCC---
T ss_pred eecccCc--cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchh-HHHHHHHhhc-ccc---
Confidence 8765433 23345799999999999998999999999999999999999999976433211 1111111111 100
Q ss_pred hhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCC-----CHHHHHHH
Q 046270 499 FDEFIRAEGARAVMERFVLVGILCAHVMVALRP-----TITDALKM 539 (590)
Q Consensus 499 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-----tm~eVl~~ 539 (590)
..+......+.+++..|++.||.+|| ++.|+++.
T Consensus 407 -------~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 407 -------EYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp -------CCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred -------cCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 01111234677888999999999999 78888753
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=341.47 Aligned_cols=252 Identities=25% Similarity=0.346 Sum_probs=197.3
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCCCChHHHHHHHHHHHhc-CCCCccccceeEEeccCCCCceE
Q 046270 263 TNGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDTKGDEDFTNEVEIISKI-RHRNLLSLRGCCVTSDDSSGKRR 340 (590)
Q Consensus 263 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l-~H~nlv~l~g~~~~~~~~~~~~~ 340 (590)
.++|...+.||+|+||.||+++.+ +|+.||||++..... .+.+|++++.++ +||||+++++++. .+...
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~-----~~~~~ 91 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYD-----DGKYV 91 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEE-----CSSEE
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEE-----cCCEE
Confidence 457888999999999999999987 478999999865432 245789999988 7999999999987 45679
Q ss_pred EEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCC----CcEEEEeeC
Q 046270 341 FLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSE----LNAKVADFG 416 (590)
Q Consensus 341 ~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~----~~~kL~DFG 416 (590)
++||||+++|+|.+++. ..+.+++.++..++.||+.||+||| +.+|+||||||+|||+.++ +.+||+|||
T Consensus 92 ~lv~E~~~gg~L~~~i~---~~~~~~~~~~~~~~~qi~~al~~lH---~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg 165 (342)
T 2qr7_A 92 YVVTELMKGGELLDKIL---RQKFFSEREASAVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFG 165 (342)
T ss_dssp EEEECCCCSCBHHHHHH---TCTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSCSGGGEEECCCT
T ss_pred EEEEeCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHH---HCCcEeccCCHHHEEEecCCCCcCeEEEEECC
Confidence 99999999999999885 3456999999999999999999999 8899999999999998543 359999999
Q ss_pred CcccccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCch
Q 046270 417 LAKQSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVD 496 (590)
Q Consensus 417 la~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 496 (590)
+++....... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||........ .+.... ...+...
T Consensus 166 ~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~--~~~~~~-i~~~~~~ 241 (342)
T 2qr7_A 166 FAKQLRAENG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTP--EEILAR-IGSGKFS 241 (342)
T ss_dssp TCEECBCTTC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCH--HHHHHH-HHHCCCC
T ss_pred CcccCcCCCC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCH--HHHHHH-HccCCcc
Confidence 9986544322 23446789999999999888899999999999999999999999975332111 111111 1112211
Q ss_pred hhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 497 DIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 497 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
. ...........+.+++..|++.||++|||+.++++.
T Consensus 242 ~------~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h 278 (342)
T 2qr7_A 242 L------SGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH 278 (342)
T ss_dssp C------CSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred c------CccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0 000011123467788999999999999999999863
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=343.05 Aligned_cols=268 Identities=23% Similarity=0.296 Sum_probs=197.8
Q ss_pred HHHHhcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCccccceeEEeccC---
Q 046270 259 LEQATNGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDD--- 334 (590)
Q Consensus 259 l~~at~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~--- 334 (590)
++...++|...+.||+|+||.||+|++. +|+.||||++...... ..+|++++++++||||+++++++.....
T Consensus 2 l~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~ 77 (383)
T 3eb0_A 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEP 77 (383)
T ss_dssp ----CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEEEEC-----
T ss_pred CccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhheeeecCcccc
Confidence 3456788999999999999999999975 5889999998654322 3479999999999999999999876432
Q ss_pred ------------------------------CCCceEEEEEeeCCCCCcchhhhhh-cccccCChhhHHHHHHHHHHHHHH
Q 046270 335 ------------------------------SSGKRRFLVYDYMPNGTLSDNISIS-HKRKQLTWPQRKKIIVDVAKGIAY 383 (590)
Q Consensus 335 ------------------------------~~~~~~~LV~E~~~~gsL~~~L~~~-~~~~~l~~~~r~~I~~~ia~gL~y 383 (590)
......++||||++ |+|.+.+... .....+++..+..++.||++||+|
T Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~ 156 (383)
T 3eb0_A 78 KPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGF 156 (383)
T ss_dssp --------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence 23456889999998 5887777532 234579999999999999999999
Q ss_pred HHhcCCCCeEecCCCCCceEEC-CCCcEEEEeeCCcccccCCCcccccccccCCCccCccccccC-CCCcchhHHHHHHH
Q 046270 384 LHYGLKPGIYHRDIKSTNILLD-SELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALYG-QLTEKSDVYSFGIV 461 (590)
Q Consensus 384 LH~~~~~~ivHrDIKp~NILLd-~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~t~ksDVySfGvv 461 (590)
|| +.+|+||||||+|||++ .++.+||+|||+++...... ......||..|+|||.+.+. .++.++|||||||+
T Consensus 157 LH---~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i 231 (383)
T 3eb0_A 157 IH---SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE--PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV 231 (383)
T ss_dssp HH---TTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS--CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred HH---HCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC--CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence 99 89999999999999998 67899999999998664433 23345689999999988764 58999999999999
Q ss_pred HHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhh---------------hHHHhhhhHHHHHHHHHHHHHhchhcC
Q 046270 462 ILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIF---------------DEFIRAEGARAVMERFVLVGILCAHVM 526 (590)
Q Consensus 462 LlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~---------------d~~l~~~~~~~~~~~l~~l~~~Cl~~d 526 (590)
+|||++|+.||....... .+......+ .......+. ........+......+.+++..|++.|
T Consensus 232 l~ell~g~~pf~~~~~~~-~~~~i~~~~-g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 309 (383)
T 3eb0_A 232 FGELILGKPLFSGETSID-QLVRIIQIM-GTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYE 309 (383)
T ss_dssp HHHHHHSSCSSCCSSHHH-HHHHHHHHH-CCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSS
T ss_pred HHHHHhCCCCCCCCChHH-HHHHHHHHh-CCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCC
Confidence 999999999997543322 222221111 000000000 000000111123346788999999999
Q ss_pred CCCCCCHHHHHH
Q 046270 527 VALRPTITDALK 538 (590)
Q Consensus 527 p~~RPtm~eVl~ 538 (590)
|.+|||+.|+++
T Consensus 310 P~~R~t~~e~l~ 321 (383)
T 3eb0_A 310 PDLRINPYEAMA 321 (383)
T ss_dssp GGGSCCHHHHHT
T ss_pred hhhCCCHHHHhc
Confidence 999999999985
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=337.56 Aligned_cols=257 Identities=23% Similarity=0.360 Sum_probs=203.4
Q ss_pred HHHHHHhcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCCCC--------hHHHHHHHHHHHhc-CCCCccccc
Q 046270 257 SELEQATNGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDTKG--------DEDFTNEVEIISKI-RHRNLLSLR 326 (590)
Q Consensus 257 ~el~~at~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~~~--------~~~f~~Ev~il~~l-~H~nlv~l~ 326 (590)
.......++|...+.||+|+||.||+|++. +|+.||||++....... .+.+.+|++++.++ +||||++++
T Consensus 87 ~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 166 (365)
T 2y7j_A 87 AAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLI 166 (365)
T ss_dssp HHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred hhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence 344555678999999999999999999986 68999999986543221 34578999999999 899999999
Q ss_pred eeEEeccCCCCceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECC
Q 046270 327 GCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDS 406 (590)
Q Consensus 327 g~~~~~~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~ 406 (590)
+++.. ....++||||+++++|.+++. ....+++..+..++.||+.||.||| +.+|+||||||+|||++.
T Consensus 167 ~~~~~-----~~~~~lv~e~~~g~~L~~~l~---~~~~l~~~~~~~i~~qi~~~L~~LH---~~gi~H~Dlkp~NIl~~~ 235 (365)
T 2y7j_A 167 DSYES-----SSFMFLVFDLMRKGELFDYLT---EKVALSEKETRSIMRSLLEAVSFLH---ANNIVHRDLKPENILLDD 235 (365)
T ss_dssp EEEEB-----SSEEEEEECCCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECT
T ss_pred EEEee-----CCEEEEEEEeCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECC
Confidence 99873 456999999999999999985 3457999999999999999999999 889999999999999999
Q ss_pred CCcEEEEeeCCcccccCCCcccccccccCCCccCcccccc------CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchh
Q 046270 407 ELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALY------GQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQ 480 (590)
Q Consensus 407 ~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~------~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~ 480 (590)
++.+||+|||++....... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||...... .
T Consensus 236 ~~~ikl~DfG~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~-~ 312 (365)
T 2y7j_A 236 NMQIRLSDFGFSCHLEPGE--KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQI-L 312 (365)
T ss_dssp TCCEEECCCTTCEECCTTC--CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-H
T ss_pred CCCEEEEecCcccccCCCc--ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHH-H
Confidence 9999999999998664432 2344679999999998863 35889999999999999999999999653221 1
Q ss_pred hhhHHHHHHHhcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 046270 481 LITDWAWVLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALK 538 (590)
Q Consensus 481 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~ 538 (590)
.+. ....+.... ..+.. ......+.+++..|++.||++|||+.|+++
T Consensus 313 ~~~-----~i~~~~~~~-~~~~~-----~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 313 MLR-----MIMEGQYQF-SSPEW-----DDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp HHH-----HHHHTCCCC-CHHHH-----SSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHH-----HHHhCCCCC-CCccc-----ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 111 111111110 00000 112346778999999999999999999987
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=332.96 Aligned_cols=252 Identities=23% Similarity=0.356 Sum_probs=196.2
Q ss_pred hcCCCccceecccCcEEEEEEEEcC-CcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEE
Q 046270 263 TNGFSQNNLIGQGASGIVYKGTLRH-GNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRF 341 (590)
Q Consensus 263 t~~f~~~~~LG~G~fG~Vykg~~~~-g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~ 341 (590)
.++|...+.||+|+||.||+|++.. |..||+|++........+.+.+|++++++++||||+++++++.. ....+
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~ 92 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYH-----DGKLW 92 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----C-CEE
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeee-----CCeEE
Confidence 4578889999999999999999874 88999999877666667889999999999999999999999974 34689
Q ss_pred EEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccc
Q 046270 342 LVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQS 421 (590)
Q Consensus 342 LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~ 421 (590)
+||||+++++|.+++.. ....+++..++.++.||+.||.||| +.+|+||||||+|||++.++.+||+|||++...
T Consensus 93 lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 167 (302)
T 2j7t_A 93 IMIEFCPGGAVDAIMLE--LDRGLTEPQIQVVCRQMLEALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKN 167 (302)
T ss_dssp EEEECCTTEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTSCEEECCCHHHHHH
T ss_pred EEEEeCCCCcHHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEECCCCCEEEEECCCCccc
Confidence 99999999999998853 2456999999999999999999999 889999999999999999999999999987643
Q ss_pred cCCCcccccccccCCCccCccccc-----cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCch
Q 046270 422 LEGHSHLTTRVAGTFGYLAPEYAL-----YGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVD 496 (590)
Q Consensus 422 ~~~~~~~~~~~~gt~~Y~APE~~~-----~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 496 (590)
... ........||..|+|||.+. ...++.++||||||+++|||++|+.|+....... .+ .........
T Consensus 168 ~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~----~~~~~~~~~- 240 (302)
T 2j7t_A 168 LKT-LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR-VL----LKIAKSDPP- 240 (302)
T ss_dssp HHH-HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HH----HHHHHSCCC-
T ss_pred ccc-ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHH-HH----HHHhccCCc-
Confidence 211 11123356899999999984 5678999999999999999999999987543211 11 111111111
Q ss_pred hhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 046270 497 DIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALK 538 (590)
Q Consensus 497 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~ 538 (590)
.... +......+..++..|++.||++|||+.++++
T Consensus 241 ~~~~-------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 241 TLLT-------PSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp CCSS-------GGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred ccCC-------ccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 1100 1112246778899999999999999999875
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=336.74 Aligned_cols=267 Identities=24% Similarity=0.375 Sum_probs=201.4
Q ss_pred ccccHHHHHHHhcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCCCChHHHHHHHHHHHhc-CCCCccccceeE
Q 046270 252 KWFHVSELEQATNGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDTKGDEDFTNEVEIISKI-RHRNLLSLRGCC 329 (590)
Q Consensus 252 ~~f~~~el~~at~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l-~H~nlv~l~g~~ 329 (590)
..+++.++....++|...+.||+|+||.||+|++. +|+.||||++.... ...+.+.+|++++.++ +||||+++++++
T Consensus 12 ~~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 90 (326)
T 2x7f_A 12 DEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAF 90 (326)
T ss_dssp ----CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEE
T ss_pred hhccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEE
Confidence 34555666677889999999999999999999985 58899999986433 3467899999999999 899999999999
Q ss_pred EeccCC-CCceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCC
Q 046270 330 VTSDDS-SGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSEL 408 (590)
Q Consensus 330 ~~~~~~-~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~ 408 (590)
...... .....++||||+++|+|.+++... ....+++..++.|+.||+.||.||| +.+|+||||||+|||++.++
T Consensus 91 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~ 166 (326)
T 2x7f_A 91 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENA 166 (326)
T ss_dssp EECC--CCCCEEEEEEECCTTEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTC
T ss_pred eeccCccccceEEEEEEcCCCCcHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCcHHHEEEcCCC
Confidence 864321 245789999999999999998643 2357999999999999999999999 88999999999999999999
Q ss_pred cEEEEeeCCcccccCCCcccccccccCCCccCccccc-----cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhh
Q 046270 409 NAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYAL-----YGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLIT 483 (590)
Q Consensus 409 ~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~-----~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~ 483 (590)
.+||+|||++....... .......||..|+|||.+. ...++.++||||||+++|||++|+.||....... .+
T Consensus 167 ~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~- 243 (326)
T 2x7f_A 167 EVKLVDFGVSAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR-AL- 243 (326)
T ss_dssp CEEECCCTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH-HH-
T ss_pred CEEEeeCcCceecCcCc-cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH-HH-
Confidence 99999999998654321 1223456899999999987 5678999999999999999999999986433211 11
Q ss_pred HHHHHHHhcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 046270 484 DWAWVLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALK 538 (590)
Q Consensus 484 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~ 538 (590)
....... ...... ......+..++..|++.||.+|||+.++++
T Consensus 244 ---~~~~~~~-~~~~~~--------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 244 ---FLIPRNP-APRLKS--------KKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp ---HHHHHSC-CCCCSC--------SCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred ---HHhhcCc-cccCCc--------cccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 1111111 111100 112246778889999999999999999987
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-40 Score=341.29 Aligned_cols=262 Identities=24% Similarity=0.397 Sum_probs=195.9
Q ss_pred cCCCccceecccCcEEEEEEEEcC-CcEEEEEEeecCCCCC--hHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceE
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLRH-GNLVAVKQILDLDTKG--DEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRR 340 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~vAvK~l~~~~~~~--~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~ 340 (590)
++|...+.||+|+||.||+|+... |+.||||++....... .+.+.+|++++++++||||+++++++.. +...
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~ 99 (331)
T 4aaa_A 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKK-----KKRW 99 (331)
T ss_dssp GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTEE
T ss_pred hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeec-----CCEE
Confidence 468888999999999999999875 8899999986543332 3457899999999999999999999974 4568
Q ss_pred EEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCccc
Q 046270 341 FLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQ 420 (590)
Q Consensus 341 ~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~ 420 (590)
++||||+++++|.+++. ....+++..+..|+.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++.
T Consensus 100 ~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 173 (331)
T 4aaa_A 100 YLVFEFVDHTILDDLEL---FPNGLDYQVVQKYLFQIINGIGFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFART 173 (331)
T ss_dssp EEEEECCSEEHHHHHHH---STTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCTTC--
T ss_pred EEEEecCCcchHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHH---HCCEEccCcChheEEEcCCCcEEEEeCCCcee
Confidence 99999999999988764 3456999999999999999999999 88999999999999999999999999999986
Q ss_pred ccCCCcccccccccCCCccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHH----------H
Q 046270 421 SLEGHSHLTTRVAGTFGYLAPEYALYG-QLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWV----------L 489 (590)
Q Consensus 421 ~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~----------~ 489 (590)
..... .......||..|+|||.+.+. .++.++||||||+++|||++|+.||........ +...... .
T Consensus 174 ~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~ 251 (331)
T 4aaa_A 174 LAAPG-EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQ-LYHIMMCLGNLIPRHQEL 251 (331)
T ss_dssp -----------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCSCCHHHHHH
T ss_pred ecCCc-cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHH-HHHHHHHhCCCChhhhhH
Confidence 54322 223345689999999998765 789999999999999999999999975443221 1111110 0
Q ss_pred HhcC------CchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 046270 490 AKSG------KVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALK 538 (590)
Q Consensus 490 ~~~~------~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~ 538 (590)
+... ...+...............+.+.+++..|++.||++|||+.|+++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 252 FNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp HHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred hhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0000 000000000000001123457888999999999999999999876
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=353.28 Aligned_cols=254 Identities=22% Similarity=0.286 Sum_probs=202.2
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecC---CCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCce
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDL---DTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKR 339 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~---~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~ 339 (590)
++|...+.||+|+||.||+++++ .|+.||+|++... .......+.+|++++++++||||+++++++.. ...
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~-----~~~ 259 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFET-----KTD 259 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----SSE
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEee-----CCE
Confidence 56888899999999999999986 4899999998643 22345678999999999999999999999873 456
Q ss_pred EEEEEeeCCCCCcchhhhhhc-ccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCc
Q 046270 340 RFLVYDYMPNGTLSDNISISH-KRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLA 418 (590)
Q Consensus 340 ~~LV~E~~~~gsL~~~L~~~~-~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla 418 (590)
.++||||+++|+|.+++.... ....+++..++.++.||+.||.||| +.+|+||||||+|||++.++.+||+|||++
T Consensus 260 l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH---~~gIvHrDLKP~NILl~~~g~vkL~DFGla 336 (543)
T 3c4z_A 260 LCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLA 336 (543)
T ss_dssp EEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHH---HcCCcccCCChHHEEEeCCCCEEEeeccee
Confidence 999999999999999886432 2346999999999999999999999 889999999999999999999999999999
Q ss_pred ccccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhh
Q 046270 419 KQSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDI 498 (590)
Q Consensus 419 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 498 (590)
+....... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||........ ..++...... +..
T Consensus 337 ~~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~-~~~~~~~i~~-~~~--- 410 (543)
T 3c4z_A 337 VELKAGQT-KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE-NKELKQRVLE-QAV--- 410 (543)
T ss_dssp EECCTTCC-CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCC-HHHHHHHHHH-CCC---
T ss_pred eeccCCCc-ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchh-HHHHHHHHhh-ccc---
Confidence 87644332 23445799999999999999999999999999999999999999976433211 1111111111 110
Q ss_pred hhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCH-----HHHHH
Q 046270 499 FDEFIRAEGARAVMERFVLVGILCAHVMVALRPTI-----TDALK 538 (590)
Q Consensus 499 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm-----~eVl~ 538 (590)
..+......+..++..|++.||.+||++ .++++
T Consensus 411 -------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 411 -------TYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp -------CCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred -------CCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 0111223466778899999999999975 56654
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=346.86 Aligned_cols=243 Identities=23% Similarity=0.323 Sum_probs=187.7
Q ss_pred cCCCccceecccCcEEEEEEEEcC-CcEEEEEEeecCCC---CChHHHHHHHHH-HHhcCCCCccccceeEEeccCCCCc
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLRH-GNLVAVKQILDLDT---KGDEDFTNEVEI-ISKIRHRNLLSLRGCCVTSDDSSGK 338 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~vAvK~l~~~~~---~~~~~f~~Ev~i-l~~l~H~nlv~l~g~~~~~~~~~~~ 338 (590)
++|...+.||+|+||.||+++.+. +..||||++..... .....+.+|..+ ++.++||||+++++++.. ..
T Consensus 38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~-----~~ 112 (373)
T 2r5t_A 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQT-----AD 112 (373)
T ss_dssp GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEEC-----SS
T ss_pred hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEe-----CC
Confidence 568889999999999999999875 78899999965432 223456677776 567899999999999874 45
Q ss_pred eEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCc
Q 046270 339 RRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLA 418 (590)
Q Consensus 339 ~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla 418 (590)
..++||||+++|+|.+++. +...+++..++.++.||+.||+||| +.+|+||||||+|||++.++.+||+|||++
T Consensus 113 ~~~lv~E~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~ikL~DFG~a 186 (373)
T 2r5t_A 113 KLYFVLDYINGGELFYHLQ---RERCFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLC 186 (373)
T ss_dssp EEEEEEECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCBC
T ss_pred EEEEEEeCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEeeCccc
Confidence 7999999999999999885 3457899999999999999999999 899999999999999999999999999999
Q ss_pred ccccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhh
Q 046270 419 KQSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDI 498 (590)
Q Consensus 419 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 498 (590)
+...... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||...... ... ..... +...
T Consensus 187 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~-~~~----~~i~~-~~~~-- 257 (373)
T 2r5t_A 187 KENIEHN-STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA-EMY----DNILN-KPLQ-- 257 (373)
T ss_dssp GGGBCCC-CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHH-HHH----HHHHH-SCCC--
T ss_pred cccccCC-CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH-HHH----HHHHh-cccC--
Confidence 8643322 2344567999999999999999999999999999999999999999653221 111 11111 1100
Q ss_pred hhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHH
Q 046270 499 FDEFIRAEGARAVMERFVLVGILCAHVMVALRPTIT 534 (590)
Q Consensus 499 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~ 534 (590)
.+......+.+++..|++.||.+||++.
T Consensus 258 --------~~~~~~~~~~~li~~lL~~dp~~R~~~~ 285 (373)
T 2r5t_A 258 --------LKPNITNSARHLLEGLLQKDRTKRLGAK 285 (373)
T ss_dssp --------CCSSSCHHHHHHHHHHTCSSGGGSTTTT
T ss_pred --------CCCCCCHHHHHHHHHHcccCHHhCCCCC
Confidence 0111223667788999999999999985
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=337.28 Aligned_cols=264 Identities=25% Similarity=0.352 Sum_probs=183.9
Q ss_pred HHhcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCC-CCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCc
Q 046270 261 QATNGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLD-TKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGK 338 (590)
Q Consensus 261 ~at~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~-~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~ 338 (590)
...++|...+.||+|+||.||+|... +++.||||++.... ....+++.+|++++.+++||||+++++++.. ..
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~ 86 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVV-----KD 86 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEES-----SS
T ss_pred cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEee-----cC
Confidence 34578999999999999999999875 58899999885432 2335678899999999999999999999974 34
Q ss_pred eEEEEEeeCCCCCcchhhhhhc-----ccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEE
Q 046270 339 RRFLVYDYMPNGTLSDNISISH-----KRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVA 413 (590)
Q Consensus 339 ~~~LV~E~~~~gsL~~~L~~~~-----~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~ 413 (590)
..++||||+++++|.+++.... ....+++..++.++.||+.||.||| +.+|+||||||+||+++.++.+||+
T Consensus 87 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~ 163 (303)
T 2vwi_A 87 ELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIA 163 (303)
T ss_dssp CEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEEEC
T ss_pred CcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCCChhhEEEcCCCCEEEE
Confidence 5899999999999999885321 2346999999999999999999999 8899999999999999999999999
Q ss_pred eeCCcccccCCCc----ccccccccCCCccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHH
Q 046270 414 DFGLAKQSLEGHS----HLTTRVAGTFGYLAPEYALY-GQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWV 488 (590)
Q Consensus 414 DFGla~~~~~~~~----~~~~~~~gt~~Y~APE~~~~-~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~ 488 (590)
|||+++....... .......||..|+|||.+.. ..++.++||||||+++|||++|+.||.......... .
T Consensus 164 dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~----~- 238 (303)
T 2vwi_A 164 DFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLM----L- 238 (303)
T ss_dssp CCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHH----H-
T ss_pred eccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHH----H-
Confidence 9999876543221 12234568999999999875 568999999999999999999999997644322111 1
Q ss_pred HHhcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 046270 489 LAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALK 538 (590)
Q Consensus 489 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~ 538 (590)
... +.....................+.+++..|++.||.+|||+.|+++
T Consensus 239 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 239 TLQ-NDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp HHT-SSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred Hhc-cCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 111 1111100000000001112246778899999999999999999986
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=325.62 Aligned_cols=247 Identities=24% Similarity=0.364 Sum_probs=191.9
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecC---CCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCce
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDL---DTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKR 339 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~---~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~ 339 (590)
++|...+.||+|+||.||+|++. +|+.||||++... .....+.+.+|++++++++||||+++++++.. ...
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~ 85 (276)
T 2h6d_A 11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVIST-----PTD 85 (276)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----SSE
T ss_pred ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEec-----CCe
Confidence 57888899999999999999987 6889999998643 22345678999999999999999999999873 456
Q ss_pred EEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcc
Q 046270 340 RFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAK 419 (590)
Q Consensus 340 ~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~ 419 (590)
.++||||+++++|.+++. ....+++..+..++.||+.||.||| +.+|+||||||+||+++.++.+||+|||++.
T Consensus 86 ~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~ 159 (276)
T 2h6d_A 86 FFMVMEYVSGGELFDYIC---KHGRVEEMEARRLFQQILSAVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSN 159 (276)
T ss_dssp EEEEEECCCSCBHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHH---HHCSSCCCCCGGGEEECTTSCEEECCCCGGG
T ss_pred EEEEEeccCCCcHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChhhEEECCCCCEEEeeccccc
Confidence 999999999999999985 3356999999999999999999999 8899999999999999999999999999998
Q ss_pred cccCCCcccccccccCCCccCccccccCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhh
Q 046270 420 QSLEGHSHLTTRVAGTFGYLAPEYALYGQL-TEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDI 498 (590)
Q Consensus 420 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~-t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 498 (590)
...... ......|+..|+|||.+.+..+ +.++||||||++++||++|+.||...... . .... ...+...
T Consensus 160 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~---~~~~-~~~~~~~-- 229 (276)
T 2h6d_A 160 MMSDGE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVP--T---LFKK-IRGGVFY-- 229 (276)
T ss_dssp CCCC---------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHH--H---HHHH-HHHCCCC--
T ss_pred ccCCCc--ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHH--H---HHHH-hhcCccc--
Confidence 654332 2234568999999999887765 68999999999999999999998653221 1 1111 1111100
Q ss_pred hhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 499 FDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 499 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
.+......+..++..|++.||++|||+.|+++.
T Consensus 230 --------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 230 --------IPEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp --------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred --------CchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 001122356778899999999999999999984
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=347.17 Aligned_cols=264 Identities=23% Similarity=0.319 Sum_probs=198.8
Q ss_pred cCCCccceecccCcEEEEEEEEcCCcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCccccceeEEeccC-CCCceEEE
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLRHGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDD-SSGKRRFL 342 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~-~~~~~~~L 342 (590)
.+|...+.||+|+||.||+|++.++..||+|++...... ..+|++++++++||||+++++++..... ......++
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l 115 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL 115 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence 468888999999999999999988888999998654322 2369999999999999999999976653 23445789
Q ss_pred EEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEC-CCCcEEEEeeCCcccc
Q 046270 343 VYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLD-SELNAKVADFGLAKQS 421 (590)
Q Consensus 343 V~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd-~~~~~kL~DFGla~~~ 421 (590)
||||++++.+............+++..+..++.||++||+||| +.+|+||||||+|||++ .++.+||+|||+++..
T Consensus 116 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~ 192 (394)
T 4e7w_A 116 VLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL 192 (394)
T ss_dssp EEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEcCCCCcEEEeeCCCcccc
Confidence 9999987554443332334567999999999999999999999 88999999999999999 7899999999999876
Q ss_pred cCCCcccccccccCCCccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhhh
Q 046270 422 LEGHSHLTTRVAGTFGYLAPEYALYG-QLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFD 500 (590)
Q Consensus 422 ~~~~~~~~~~~~gt~~Y~APE~~~~~-~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 500 (590)
..... .....||+.|+|||.+.+. .++.++|||||||++|||++|+.||....... .+......+ .... .+.+.
T Consensus 193 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~-~l~~i~~~~-g~p~-~~~~~ 267 (394)
T 4e7w_A 193 IAGEP--NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGID-QLVEIIKVL-GTPS-REQIK 267 (394)
T ss_dssp CTTCC--CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHH-CCCC-HHHHH
T ss_pred cCCCC--CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHh-CCCC-HHHHH
Confidence 44332 2345689999999998754 58999999999999999999999997644322 222121111 0000 00000
Q ss_pred HH----------------HhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 501 EF----------------IRAEGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 501 ~~----------------l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
.. +...........+.+++..|++.||.+|||+.|+++.
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 268 TMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp HHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred hhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 00 0000111133478889999999999999999999874
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=339.70 Aligned_cols=258 Identities=22% Similarity=0.312 Sum_probs=202.0
Q ss_pred hcCCCccceecccCcEEEEEEEEcCCcEEEEEEeecCCCCC-----------------hHHHHHHHHHHHhcCCCCcccc
Q 046270 263 TNGFSQNNLIGQGASGIVYKGTLRHGNLVAVKQILDLDTKG-----------------DEDFTNEVEIISKIRHRNLLSL 325 (590)
Q Consensus 263 t~~f~~~~~LG~G~fG~Vykg~~~~g~~vAvK~l~~~~~~~-----------------~~~f~~Ev~il~~l~H~nlv~l 325 (590)
.++|...+.||+|+||.||+|+. +|+.||||++....... .+.+.+|++++.+++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 46789999999999999999999 79999999986432111 1789999999999999999999
Q ss_pred ceeEEeccCCCCceEEEEEeeCCCCCcchh------hhhhcccccCChhhHHHHHHHHHHHHHHHHhcCC-CCeEecCCC
Q 046270 326 RGCCVTSDDSSGKRRFLVYDYMPNGTLSDN------ISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLK-PGIYHRDIK 398 (590)
Q Consensus 326 ~g~~~~~~~~~~~~~~LV~E~~~~gsL~~~------L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~-~~ivHrDIK 398 (590)
++++.. ....++||||+++|+|.++ +.. .....+++..++.|+.||+.||.||| + .+|+|||||
T Consensus 109 ~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~~~l~~-~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dl~ 179 (348)
T 2pml_X 109 EGIITN-----YDEVYIIYEYMENDSILKFDEYFFVLDK-NYTCFIPIQVIKCIIKSVLNSFSYIH---NEKNICHRDVK 179 (348)
T ss_dssp SEEEES-----SSEEEEEEECCTTCBSSEESSSEESSCS-SSCCCCCHHHHHHHHHHHHHHHHHHH---HTSCEECCCCC
T ss_pred EEEEee-----CCeEEEEEeccCCCcHHHHHHHhhhhhh-ccccCCCHHHHHHHHHHHHHHHHHHh---ccCCEeecCCC
Confidence 999974 4569999999999999998 532 12467999999999999999999999 6 899999999
Q ss_pred CCceEECCCCcEEEEeeCCcccccCCCcccccccccCCCccCccccccC-CCCc-chhHHHHHHHHHHHHhCCCCCCCCC
Q 046270 399 STNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALYG-QLTE-KSDVYSFGIVILELMSGRKVLDTST 476 (590)
Q Consensus 399 p~NILLd~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~t~-ksDVySfGvvLlELltG~~p~~~~~ 476 (590)
|+|||++.++.+||+|||+++..... ......||..|+|||.+.+. .++. ++||||||++++||++|+.||....
T Consensus 180 p~Nil~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 256 (348)
T 2pml_X 180 PSNILMDKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKI 256 (348)
T ss_dssp GGGEEECTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred hHhEEEcCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999865433 23446789999999999877 6666 9999999999999999999997654
Q ss_pred CchhhhhHHHHHHHhcCCchh------hhhHHH---hhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 046270 477 SPFQLITDWAWVLAKSGKVDD------IFDEFI---RAEGARAVMERFVLVGILCAHVMVALRPTITDALK 538 (590)
Q Consensus 477 ~~~~~l~~~~~~~~~~~~~~~------~~d~~l---~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~ 538 (590)
....... . ...+...- ...+.. ...........+.+++..|++.||.+|||+.|+++
T Consensus 257 ~~~~~~~----~-i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 257 SLVELFN----N-IRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp CSHHHHH----H-HTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred cHHHHHH----H-HhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 4222111 1 11111100 000000 00011223347788999999999999999999986
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=335.88 Aligned_cols=256 Identities=25% Similarity=0.367 Sum_probs=194.4
Q ss_pred cCCCccceecccCcEEEEEEEEcC--Cc--EEEEEEeecCC---CCChHHHHHHHHHHHhcCCCCccccceeEEeccCCC
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLRH--GN--LVAVKQILDLD---TKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSS 336 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~~--g~--~vAvK~l~~~~---~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~ 336 (590)
++|...+.||+|+||.||+|++.. +. .||||++.... ....+.+.+|++++++++||||+++++++...
T Consensus 18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---- 93 (291)
T 1u46_A 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP---- 93 (291)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS----
T ss_pred hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccC----
Confidence 568888999999999999998642 33 68999886532 23356789999999999999999999998642
Q ss_pred CceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeC
Q 046270 337 GKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFG 416 (590)
Q Consensus 337 ~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFG 416 (590)
..++||||+++|+|.+++... ...+++..+..++.||+.||.||| +.+|+||||||+||+++.++.+||+|||
T Consensus 94 --~~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg 166 (291)
T 1u46_A 94 --PMKMVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFG 166 (291)
T ss_dssp --SCEEEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCT
T ss_pred --CceeeEecccCCCHHHHHHhc--cCCcCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEEcCCCCEEEcccc
Confidence 278999999999999998632 356999999999999999999999 8899999999999999999999999999
Q ss_pred CcccccCCCcc--cccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhhHHHHHHHhcC
Q 046270 417 LAKQSLEGHSH--LTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLDTSTSPFQLITDWAWVLAKSG 493 (590)
Q Consensus 417 la~~~~~~~~~--~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~ 493 (590)
+++........ ......+|..|+|||.+....++.++||||||+++|||++ |+.||...... . ........+
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-~----~~~~~~~~~ 241 (291)
T 1u46_A 167 LMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS-Q----ILHKIDKEG 241 (291)
T ss_dssp TCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-H----HHHHHHTSC
T ss_pred ccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHH-H----HHHHHHccC
Confidence 99876543322 2234557889999999998889999999999999999999 99998654321 1 111111211
Q ss_pred CchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhccCC
Q 046270 494 KVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEGDI 544 (590)
Q Consensus 494 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~~~ 544 (590)
.... ........+.+++..|++.||++|||+.+++++|+...
T Consensus 242 ~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 283 (291)
T 1u46_A 242 ERLP---------RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 283 (291)
T ss_dssp CCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred CCCC---------CCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhC
Confidence 1110 01122346788999999999999999999999998643
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-39 Score=340.30 Aligned_cols=265 Identities=23% Similarity=0.259 Sum_probs=200.9
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCCCChHHHHHHHHHHHhcC--------CCCccccceeEEecc
Q 046270 263 TNGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDTKGDEDFTNEVEIISKIR--------HRNLLSLRGCCVTSD 333 (590)
Q Consensus 263 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~--------H~nlv~l~g~~~~~~ 333 (590)
.++|...++||+|+||.||+|+.. +++.||||++... ....+.+.+|++++++++ |+||+++++++....
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 467999999999999999999876 4789999998642 233567889999999996 788999999987543
Q ss_pred CCCCceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCC-CeEecCCCCCceEECCCC----
Q 046270 334 DSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKP-GIYHRDIKSTNILLDSEL---- 408 (590)
Q Consensus 334 ~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~-~ivHrDIKp~NILLd~~~---- 408 (590)
. .+...++||||+ +++|.+++... ....+++..++.|+.||+.||+||| +. +|+||||||+|||++.++
T Consensus 115 ~-~~~~~~lv~e~~-~~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH---~~~givHrDikp~NIll~~~~~~~~ 188 (397)
T 1wak_A 115 V-NGTHICMVFEVL-GHHLLKWIIKS-NYQGLPLPCVKKIIQQVLQGLDYLH---TKCRIIHTDIKPENILLSVNEQYIR 188 (397)
T ss_dssp T-TEEEEEEEECCC-CCBHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECCCCSGGGEEECCCHHHHH
T ss_pred C-CCceEEEEEecc-CccHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHeeEeccchhhh
Confidence 2 356799999999 56666666432 2356999999999999999999999 77 999999999999999775
Q ss_pred ---------------------------------------------cEEEEeeCCcccccCCCcccccccccCCCccCccc
Q 046270 409 ---------------------------------------------NAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEY 443 (590)
Q Consensus 409 ---------------------------------------------~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~ 443 (590)
.+||+|||+++..... .....||..|+|||.
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~ 264 (397)
T 1wak_A 189 RLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEV 264 (397)
T ss_dssp HHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHH
T ss_pred hhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChh
Confidence 7999999999865432 234568999999999
Q ss_pred cccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchh--hhhHHHHHHHhcCCc-hhhhh--------------------
Q 046270 444 ALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQ--LITDWAWVLAKSGKV-DDIFD-------------------- 500 (590)
Q Consensus 444 ~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~--~l~~~~~~~~~~~~~-~~~~d-------------------- 500 (590)
+.+..++.++|||||||++|||+||+.||........ ............+.. .+.+.
T Consensus 265 ~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (397)
T 1wak_A 265 LIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITK 344 (397)
T ss_dssp HHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCC
T ss_pred hcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccc
Confidence 9999999999999999999999999999975443221 111010000001111 00000
Q ss_pred -------HHHhh--hhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 046270 501 -------EFIRA--EGARAVMERFVLVGILCAHVMVALRPTITDALK 538 (590)
Q Consensus 501 -------~~l~~--~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~ 538 (590)
..+.. ....+....+.+++..|++.||++|||+.|+++
T Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 345 LKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp CCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred cCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 00100 123445668899999999999999999999986
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=339.36 Aligned_cols=267 Identities=24% Similarity=0.320 Sum_probs=200.0
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCCC-ChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceE
Q 046270 263 TNGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDTK-GDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRR 340 (590)
Q Consensus 263 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~~-~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~ 340 (590)
.++|...+.||+|+||.||+|++. +|+.||||++...... ....+.+|++++++++||||+++++++...........
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 467889999999999999999987 4889999998643322 24568899999999999999999998875433344679
Q ss_pred EEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCccc
Q 046270 341 FLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQ 420 (590)
Q Consensus 341 ~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~ 420 (590)
++||||++ |+|.+++. ...+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++.
T Consensus 90 ~lv~e~~~-~~L~~~~~----~~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVIS----TQMLSDDHIQYFIYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARI 161 (353)
T ss_dssp EEEECCCS-EEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEeccC-ccHHHHHh----hcCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEcCCCcEEEEecccccc
Confidence 99999997 68888874 246999999999999999999999 88999999999999999999999999999986
Q ss_pred ccCCCcc---------cccccccCCCccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHH
Q 046270 421 SLEGHSH---------LTTRVAGTFGYLAPEYALY-GQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLA 490 (590)
Q Consensus 421 ~~~~~~~---------~~~~~~gt~~Y~APE~~~~-~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~ 490 (590)
....... ......||..|+|||.+.. ..++.++||||||+++|||++|+.||........ +... ....
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~-~~~~ 239 (353)
T 2b9h_A 162 IDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQ-LLLI-FGII 239 (353)
T ss_dssp CC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHH-HHHH
T ss_pred cccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHH-HHHH-HHHh
Confidence 5432211 1223568999999998764 6789999999999999999999999975432211 1111 1111
Q ss_pred hcCC----chhh----hhHHHh----------hhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 491 KSGK----VDDI----FDEFIR----------AEGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 491 ~~~~----~~~~----~d~~l~----------~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
.... .... ....+. ..........+.+++..|++.||++|||+.|+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (353)
T 2b9h_A 240 GTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306 (353)
T ss_dssp CCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 1000 0000 000000 00001233467889999999999999999999873
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-39 Score=336.95 Aligned_cols=267 Identities=23% Similarity=0.309 Sum_probs=198.9
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCC--CChHHHHHHHHHHHhcCCCCccccceeEEeccC---CCC
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDT--KGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDD---SSG 337 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~--~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~---~~~ 337 (590)
++|...+.||+|+||.||+|+.. +|+.||||++..... .....+.+|++++++++||||+++++++..... ..+
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 57888999999999999999985 588999999854332 234578899999999999999999999986432 124
Q ss_pred ceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCC
Q 046270 338 KRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGL 417 (590)
Q Consensus 338 ~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGl 417 (590)
...++||||+++ +|.+.+.. ....+++.+++.|+.||+.||+||| +.+|+||||||+|||++.++.+||+|||+
T Consensus 97 ~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 170 (351)
T 3mi9_A 97 GSIYLVFDFCEH-DLAGLLSN--VLVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGL 170 (351)
T ss_dssp CEEEEEEECCSE-EHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred ceEEEEEeccCC-CHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCCEEEccchh
Confidence 568999999975 77666642 3356999999999999999999999 88999999999999999999999999999
Q ss_pred cccccCCC---cccccccccCCCccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcC
Q 046270 418 AKQSLEGH---SHLTTRVAGTFGYLAPEYALY-GQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSG 493 (590)
Q Consensus 418 a~~~~~~~---~~~~~~~~gt~~Y~APE~~~~-~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~ 493 (590)
++...... ........||+.|+|||.+.+ ..++.++|||||||+++||++|+.||....... .+.... .....
T Consensus 171 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~~~i~-~~~~~- 247 (351)
T 3mi9_A 171 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH-QLALIS-QLCGS- 247 (351)
T ss_dssp CEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHH-HHHCC-
T ss_pred cccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHH-HHhCC-
Confidence 98654322 122344678999999998875 458999999999999999999999997543322 111111 11110
Q ss_pred CchhhhhH------------------HHhhh-hHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 494 KVDDIFDE------------------FIRAE-GARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 494 ~~~~~~d~------------------~l~~~-~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
...+.... .+... ........+.+++..|++.||++|||+.|+++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 248 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp CCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 00000000 00000 000012357789999999999999999999974
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-39 Score=345.62 Aligned_cols=264 Identities=27% Similarity=0.346 Sum_probs=195.6
Q ss_pred CCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCccccceeEEeccCC-CCceEEE
Q 046270 265 GFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDS-SGKRRFL 342 (590)
Q Consensus 265 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~-~~~~~~L 342 (590)
+|...+.||+|+||.||+|++. .|+.||||++..... .+.+|++++++++|+|||++++++...... .....++
T Consensus 55 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~l 130 (420)
T 1j1b_A 55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 130 (420)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEE
T ss_pred eEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEe
Confidence 5778899999999999999986 488999999865322 234799999999999999999998765431 3345679
Q ss_pred EEeeCCCCCcchhhhh-hcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCC-CcEEEEeeCCccc
Q 046270 343 VYDYMPNGTLSDNISI-SHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSE-LNAKVADFGLAKQ 420 (590)
Q Consensus 343 V~E~~~~gsL~~~L~~-~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~-~~~kL~DFGla~~ 420 (590)
||||+++ +|.+.+.. ......+++..++.++.||++||+||| +.+|+||||||+||||+.+ +.+||+|||+++.
T Consensus 131 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~ 206 (420)
T 1j1b_A 131 VLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 206 (420)
T ss_dssp EEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred ehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChhhEEEeCCCCeEEeccchhhhh
Confidence 9999986 55555532 223467999999999999999999999 8999999999999999965 5789999999987
Q ss_pred ccCCCcccccccccCCCccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHh--------
Q 046270 421 SLEGHSHLTTRVAGTFGYLAPEYALYG-QLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAK-------- 491 (590)
Q Consensus 421 ~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~-------- 491 (590)
...... .....||..|+|||++.+. .++.++|||||||++|||++|+.||...... ..+......+-.
T Consensus 207 ~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~-~~l~~i~~~lg~p~~~~~~~ 283 (420)
T 1j1b_A 207 LVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV-DQLVEIIKVLGTPTREQIRE 283 (420)
T ss_dssp CCTTCC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCSCCHHHHHH
T ss_pred cccCCC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCCHHHHHh
Confidence 644322 2345789999999998764 7999999999999999999999999764332 222222221100
Q ss_pred -cCCchhhhhHH-----HhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 492 -SGKVDDIFDEF-----IRAEGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 492 -~~~~~~~~d~~-----l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
.....+...+. ............+.+++..|++.||.+|||+.|+++.
T Consensus 284 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h 337 (420)
T 1j1b_A 284 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337 (420)
T ss_dssp HCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence 00000000000 0000011123477889999999999999999999864
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=349.16 Aligned_cols=203 Identities=25% Similarity=0.369 Sum_probs=167.4
Q ss_pred hcCCCccceecccCcEEEEEEEEcC-CcEEEEEEeecCCCC--ChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCce
Q 046270 263 TNGFSQNNLIGQGASGIVYKGTLRH-GNLVAVKQILDLDTK--GDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKR 339 (590)
Q Consensus 263 t~~f~~~~~LG~G~fG~Vykg~~~~-g~~vAvK~l~~~~~~--~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~ 339 (590)
.++|...+.||+|+||.||+|++.. |+.||||++...... ..+.+.+|+++|++++|+||+++++++...+......
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 4689999999999999999999864 778999999653222 2457889999999999999999999987654333467
Q ss_pred EEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcc
Q 046270 340 RFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAK 419 (590)
Q Consensus 340 ~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~ 419 (590)
.++||||+. |+|.+++. ....+++..+..|+.||++||.||| +.+|+||||||+|||++.++.+||+|||+++
T Consensus 105 ~~lv~e~~~-~~L~~~~~---~~~~l~~~~~~~i~~qil~aL~~LH---~~givHrDlkp~NILl~~~~~~kL~DFGla~ 177 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFK---TPIFLTEEHIKTILYNLLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLAR 177 (432)
T ss_dssp EEEEEECCS-EEHHHHHH---SSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEecCC-cCHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCHHHeEECCCCCEEEccCCCcc
Confidence 999999986 69998884 3456999999999999999999999 8899999999999999999999999999998
Q ss_pred cccCCCc---------------------ccccccccCCCccCcccc-ccCCCCcchhHHHHHHHHHHHHhCCCCC
Q 046270 420 QSLEGHS---------------------HLTTRVAGTFGYLAPEYA-LYGQLTEKSDVYSFGIVILELMSGRKVL 472 (590)
Q Consensus 420 ~~~~~~~---------------------~~~~~~~gt~~Y~APE~~-~~~~~t~ksDVySfGvvLlELltG~~p~ 472 (590)
....... ...+...||+.|+|||.+ ....++.++|||||||++|||++|..|+
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp EC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred cccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 7643321 123556789999999986 4667999999999999999999865544
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=334.10 Aligned_cols=252 Identities=26% Similarity=0.346 Sum_probs=195.7
Q ss_pred HhcCCCccceecccCcEEEEEEEEcC-CcEEEEEEeecCCC--------CChHHHHHHHHHHHhcCCCCccccceeEEec
Q 046270 262 ATNGFSQNNLIGQGASGIVYKGTLRH-GNLVAVKQILDLDT--------KGDEDFTNEVEIISKIRHRNLLSLRGCCVTS 332 (590)
Q Consensus 262 at~~f~~~~~LG~G~fG~Vykg~~~~-g~~vAvK~l~~~~~--------~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~ 332 (590)
..++|...+.||+|+||.||+|+... ++.||||.+..... .....+.+|++++++++||||+++++++..
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~- 86 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA- 86 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES-
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC-
Confidence 34678899999999999999999864 78999999854321 122358899999999999999999999853
Q ss_pred cCCCCceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCc---
Q 046270 333 DDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELN--- 409 (590)
Q Consensus 333 ~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~--- 409 (590)
...++||||+++|+|.+++. ....+++..++.++.||+.||.||| +.+|+||||||+|||++.++.
T Consensus 87 -----~~~~lv~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~ 155 (322)
T 2ycf_A 87 -----EDYYIVLELMEGGELFDKVV---GNKRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCL 155 (322)
T ss_dssp -----SSEEEEEECCTTEETHHHHS---TTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSSSCC
T ss_pred -----CceEEEEecCCCCcHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEecCCCCCe
Confidence 23799999999999999885 3457999999999999999999999 889999999999999987654
Q ss_pred EEEEeeCCcccccCCCcccccccccCCCccCccccc---cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHH
Q 046270 410 AKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYAL---YGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWA 486 (590)
Q Consensus 410 ~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~---~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~ 486 (590)
+||+|||+++..... .......||..|+|||.+. ...++.++||||||+++|||++|+.||........... .
T Consensus 156 ~kl~Dfg~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~-~- 231 (322)
T 2ycf_A 156 IKITDFGHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKD-Q- 231 (322)
T ss_dssp EEECCCTTCEECCCC--HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHH-H-
T ss_pred EEEccCccceecccc--cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHH-H-
Confidence 999999999865432 2233456899999999874 56789999999999999999999999975443322111 1
Q ss_pred HHHHhcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 046270 487 WVLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALK 538 (590)
Q Consensus 487 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~ 538 (590)
...+.... .+.. .......+.+++..|++.||++|||+.++++
T Consensus 232 ---~~~~~~~~--~~~~----~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 232 ---ITSGKYNF--IPEV----WAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp ---HHHTCCCC--CHHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ---HHhCcccc--Cchh----hhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 11121110 0111 1122347788999999999999999999875
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-39 Score=329.78 Aligned_cols=264 Identities=19% Similarity=0.267 Sum_probs=194.9
Q ss_pred cCCCccceecccCcEEEEEEEEcC-CcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCccccceeEEeccC--------
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLRH-GNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDD-------- 334 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~-------- 334 (590)
++|...+.||+|+||.||+|+... |+.||||++........+.+.+|++++++++||||+++++++.....
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 90 (320)
T 2i6l_A 11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGS 90 (320)
T ss_dssp TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----
T ss_pred CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccc
Confidence 578889999999999999999875 88999999876555556789999999999999999999998753311
Q ss_pred -CCCceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEC-CCCcEEE
Q 046270 335 -SSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLD-SELNAKV 412 (590)
Q Consensus 335 -~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd-~~~~~kL 412 (590)
......++||||++ |+|.+++. ...+++..++.++.||+.||+||| +.+|+||||||+|||++ +++.+||
T Consensus 91 ~~~~~~~~lv~e~~~-~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~kl 162 (320)
T 2i6l_A 91 LTELNSVYIVQEYME-TDLANVLE----QGPLLEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDLVLKI 162 (320)
T ss_dssp CCSCSEEEEEEECCS-EEHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTTEEEE
T ss_pred ccccCceeEEeeccC-CCHHHHhh----cCCccHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCeEEE
Confidence 13467899999997 69998884 356999999999999999999999 88999999999999997 5679999
Q ss_pred EeeCCcccccCCCc--ccccccccCCCccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHH
Q 046270 413 ADFGLAKQSLEGHS--HLTTRVAGTFGYLAPEYALY-GQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVL 489 (590)
Q Consensus 413 ~DFGla~~~~~~~~--~~~~~~~gt~~Y~APE~~~~-~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~ 489 (590)
+|||+++....... .......+|..|+|||.+.. ..++.++||||||+++|||++|+.||....... .+.....
T Consensus 163 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-~~~~~~~-- 239 (320)
T 2i6l_A 163 GDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELE-QMQLILE-- 239 (320)
T ss_dssp CCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHH--
T ss_pred ccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHH-HHHHHHH--
Confidence 99999986543221 12234567899999998865 678999999999999999999999997543311 1111110
Q ss_pred HhcCC------------chhhhhHHHhh------hhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 490 AKSGK------------VDDIFDEFIRA------EGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 490 ~~~~~------------~~~~~d~~l~~------~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
..+. ....+...... .........+.+++..|++.||++|||+.|+++.
T Consensus 240 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (320)
T 2i6l_A 240 -SIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH 306 (320)
T ss_dssp -HSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred -hcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence 0000 00001100000 0001234578889999999999999999999873
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=339.34 Aligned_cols=264 Identities=19% Similarity=0.255 Sum_probs=190.7
Q ss_pred HHhcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCCC--ChHHHHHHHHHHHhcCCCCccccceeEEeccCCCC
Q 046270 261 QATNGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDTK--GDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSG 337 (590)
Q Consensus 261 ~at~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~~--~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~ 337 (590)
...++|...+.||+|+||.||+|+.. +++.||||++...... ..+.+.+|++++++++||||+++++++.. +
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~ 105 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHH-----N 105 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEE-----T
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEec-----C
Confidence 34568999999999999999999876 5889999998643322 24567899999999999999999999974 4
Q ss_pred ceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEE-----CCCCcEEE
Q 046270 338 KRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILL-----DSELNAKV 412 (590)
Q Consensus 338 ~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILL-----d~~~~~kL 412 (590)
...++||||++ |+|.+++. ....+++..++.|+.||+.||.||| +.+|+||||||+|||+ ++++.+||
T Consensus 106 ~~~~lv~e~~~-~~L~~~~~---~~~~~~~~~~~~i~~ql~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~kl 178 (329)
T 3gbz_A 106 HRLHLIFEYAE-NDLKKYMD---KNPDVSMRVIKSFLYQLINGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKI 178 (329)
T ss_dssp TEEEEEEECCS-EEHHHHHH---HCTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEC-----CCEEEE
T ss_pred CEEEEEEecCC-CCHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHH---hCCEECCCCCHHHEEEecCCCCccceEEE
Confidence 56999999997 58988885 3456999999999999999999999 8899999999999999 45566999
Q ss_pred EeeCCcccccCCCcccccccccCCCccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHh
Q 046270 413 ADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALYG-QLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAK 491 (590)
Q Consensus 413 ~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~ 491 (590)
+|||+++...... .......||..|+|||.+.+. .++.++|||||||++|||++|+.||....... .+.........
T Consensus 179 ~Dfg~a~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~~~~~~~~~~ 256 (329)
T 3gbz_A 179 GDFGLARAFGIPI-RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEID-QLFKIFEVLGL 256 (329)
T ss_dssp CCTTHHHHHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCC
T ss_pred CcCCCccccCCcc-cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHH-HHHHHHHHhCC
Confidence 9999998654322 223345679999999998864 48999999999999999999999997543321 12111111100
Q ss_pred cC--Cc-------------hhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 046270 492 SG--KV-------------DDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALK 538 (590)
Q Consensus 492 ~~--~~-------------~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~ 538 (590)
.. .. .......+...........+.+++..|++.||++|||+.|+++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 257 PDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp CCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 00 00 0000000000011112346788999999999999999999986
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=328.01 Aligned_cols=251 Identities=26% Similarity=0.368 Sum_probs=197.4
Q ss_pred HhcCCCccceecccCcEEEEEEEEcC-CcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceE
Q 046270 262 ATNGFSQNNLIGQGASGIVYKGTLRH-GNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRR 340 (590)
Q Consensus 262 at~~f~~~~~LG~G~fG~Vykg~~~~-g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~ 340 (590)
..++|...+.||+|+||.||+|++.. |+.||||++... ...+.+.+|++++.+++||||+++++++.. ....
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~ 99 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVKYYGSYFK-----NTDL 99 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETT--SCCHHHHHHHHHHHTCCCTTBCCEEEEEEE-----TTEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCch--HHHHHHHHHHHHHHhCCCCCCccEEEEEEe-----CCEE
Confidence 45678899999999999999999874 889999998653 345679999999999999999999999974 3468
Q ss_pred EEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCccc
Q 046270 341 FLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQ 420 (590)
Q Consensus 341 ~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~ 420 (590)
++||||+++++|.+++.. ....+++..++.++.+|+.||.||| +.+|+||||||+||+++.++.+||+|||++..
T Consensus 100 ~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 174 (314)
T 3com_A 100 WIVMEYCGAGSVSDIIRL--RNKTLTEDEIATILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQ 174 (314)
T ss_dssp EEEEECCTTEEHHHHHHH--HTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEeecCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCcCHHHEEECCCCCEEEeecccchh
Confidence 999999999999998852 3457999999999999999999999 89999999999999999999999999999986
Q ss_pred ccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhhh
Q 046270 421 SLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFD 500 (590)
Q Consensus 421 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 500 (590)
..... .......||..|+|||.+.+..++.++||||||+++|||++|+.||........ ......... .....
T Consensus 175 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-----~~~~~~~~~-~~~~~ 247 (314)
T 3com_A 175 LTDTM-AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRA-----IFMIPTNPP-PTFRK 247 (314)
T ss_dssp CBTTB-SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH-----HHHHHHSCC-CCCSS
T ss_pred hhhhc-cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHH-----HHHHhcCCC-cccCC
Confidence 54332 223345689999999999999999999999999999999999999865332111 111111111 00000
Q ss_pred HHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 046270 501 EFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALK 538 (590)
Q Consensus 501 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~ 538 (590)
+......+.+++..|++.||.+|||+.++++
T Consensus 248 -------~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 248 -------PELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp -------GGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred -------cccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 1112246778899999999999999999986
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=333.24 Aligned_cols=275 Identities=20% Similarity=0.251 Sum_probs=195.2
Q ss_pred HHHHHHhcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCccccceeEEeccC-
Q 046270 257 SELEQATNGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDD- 334 (590)
Q Consensus 257 ~el~~at~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~- 334 (590)
.+.....++|...+.||+|+||.||+|++. +|..||||++.... .....+.+|++.+.+++||||+++++++...+.
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence 456677789999999999999999999986 58899999986543 334467789999999999999999999976543
Q ss_pred -CCCceEEEEEeeCCCCCcchhhh-hhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECC-CCcEE
Q 046270 335 -SSGKRRFLVYDYMPNGTLSDNIS-ISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDS-ELNAK 411 (590)
Q Consensus 335 -~~~~~~~LV~E~~~~gsL~~~L~-~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~-~~~~k 411 (590)
......++||||+++ +|.+.+. .......+++..+..++.|++.||.|||. .+.+|+||||||+|||++. ++.+|
T Consensus 95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~~~ivH~Dlkp~NIll~~~~~~~k 172 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHL-PSVNVCHRDIKPHNVLVNEADGTLK 172 (360)
T ss_dssp CTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTS-TTTCCBCSCCCGGGEEEETTTTEEE
T ss_pred cccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhC-CCCCeecCcCCHHHEEEeCCCCcEE
Confidence 133447899999986 4444332 22345678999999999999999999993 2579999999999999997 89999
Q ss_pred EEeeCCcccccCCCcccccccccCCCccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHH
Q 046270 412 VADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALYG-QLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLA 490 (590)
Q Consensus 412 L~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~ 490 (590)
|+|||+++...... ......||..|+|||.+.+. .++.++||||||+++|||++|+.||....... .+........
T Consensus 173 l~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~-~~~~~~~~~~ 249 (360)
T 3e3p_A 173 LCDFGSAKKLSPSE--PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAG-QLHEIVRVLG 249 (360)
T ss_dssp ECCCTTCBCCCTTS--CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHC
T ss_pred EeeCCCceecCCCC--CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHH-HHHHHHHHcC
Confidence 99999998664433 23345689999999998654 48999999999999999999999997644322 2222211110
Q ss_pred hcCCchhhhhHH-------------------HhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 491 KSGKVDDIFDEF-------------------IRAEGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 491 ~~~~~~~~~d~~-------------------l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
....+.+... +...........+.+++..|++.||.+|||+.|+++.
T Consensus 250 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 250 --CPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp --CCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred --CCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 0011111100 0000011134578899999999999999999999874
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=336.74 Aligned_cols=262 Identities=23% Similarity=0.322 Sum_probs=192.6
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCC--CChHHHHHHHHHHHhcCCCCccccceeEEeccC-CCCc
Q 046270 263 TNGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDT--KGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDD-SSGK 338 (590)
Q Consensus 263 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~--~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~-~~~~ 338 (590)
.++|...+.||+|+||.||+|... .|+.||||++..... ...+.+.+|++++++++||||+++++++...+. ....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 367889999999999999999976 488999999865322 224568899999999999999999999875432 1334
Q ss_pred eEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCc
Q 046270 339 RRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLA 418 (590)
Q Consensus 339 ~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla 418 (590)
..++||||++ |+|.+++. ..+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 174 (371)
T 2xrw_A 104 DVYIVMELMD-ANLCQVIQ-----MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLA 174 (371)
T ss_dssp EEEEEEECCS-EEHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred ceEEEEEcCC-CCHHHHHh-----hccCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEEEeecc
Confidence 7899999997 46777663 35899999999999999999999 889999999999999999999999999999
Q ss_pred ccccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCc---
Q 046270 419 KQSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKV--- 495 (590)
Q Consensus 419 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~--- 495 (590)
+..... .......||..|+|||.+.+..++.++|||||||++|||++|+.||....... .|.......+..
T Consensus 175 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~----~~~~i~~~~~~~~~~ 248 (371)
T 2xrw_A 175 RTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHID----QWNKVIEQLGTPCPE 248 (371)
T ss_dssp -----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHC-CCCCCHH
T ss_pred cccccc--cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHHHhCCCCHH
Confidence 865432 22344578999999999999999999999999999999999999997543211 111111100100
Q ss_pred ------------------------hhhhhHHHh---hhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 496 ------------------------DDIFDEFIR---AEGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 496 ------------------------~~~~d~~l~---~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
...+..... ..........+.+++..|++.||.+|||++|+++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 249 FMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp HHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 000000000 00112234578899999999999999999999874
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=323.93 Aligned_cols=253 Identities=19% Similarity=0.250 Sum_probs=197.1
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCC----CCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCC
Q 046270 263 TNGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLD----TKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSG 337 (590)
Q Consensus 263 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~----~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~ 337 (590)
.++|...+.||+|+||.||++... ++..||+|++.... ....+.+.+|++++++++|+||+++++++... ++
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~ 80 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNE---EK 80 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC-----
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcC---CC
Confidence 468999999999999999999986 47899999986432 23456799999999999999999999998643 23
Q ss_pred ceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCC
Q 046270 338 KRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGL 417 (590)
Q Consensus 338 ~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGl 417 (590)
...++||||++++ |.+++... ....+++..++.++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+
T Consensus 81 ~~~~lv~e~~~~~-l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~NIl~~~~~~~kl~dfg~ 155 (305)
T 2wtk_C 81 QKMYMVMEYCVCG-MQEMLDSV-PEKRFPVCQAHGYFCQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGV 155 (305)
T ss_dssp -CEEEEEECCSEE-HHHHHHHS-TTCSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred CeEEEEehhccCC-HHHHHHhC-cccccCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEcCCCcEEeecccc
Confidence 4689999999877 66666432 3457999999999999999999999 88999999999999999999999999999
Q ss_pred cccccCCC-cccccccccCCCccCccccccCC--CCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCC
Q 046270 418 AKQSLEGH-SHLTTRVAGTFGYLAPEYALYGQ--LTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGK 494 (590)
Q Consensus 418 a~~~~~~~-~~~~~~~~gt~~Y~APE~~~~~~--~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~ 494 (590)
++...... ........||..|+|||.+.+.. ++.++||||||+++|||++|+.||...... . .... ...+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~----~~~~-i~~~~ 229 (305)
T 2wtk_C 156 AEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIY-K----LFEN-IGKGS 229 (305)
T ss_dssp CEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHH-H----HHHH-HHHCC
T ss_pred ccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHH-H----HHHH-HhcCC
Confidence 98654322 22234456899999999987643 478999999999999999999999753211 1 1111 11111
Q ss_pred chhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 495 VDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 495 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
.. .+......+.+++..|++.||.+|||+.|+++.
T Consensus 230 ~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 230 YA----------IPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp CC----------CCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred CC----------CCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 10 001122466788899999999999999999974
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-40 Score=337.33 Aligned_cols=264 Identities=24% Similarity=0.338 Sum_probs=199.9
Q ss_pred HHHHHHHhcCCCccceecccCcEEEEEEEEcCCcEEEEEEeecCC--CCChHHHHHHHHHHHhcCCCCccccceeEEecc
Q 046270 256 VSELEQATNGFSQNNLIGQGASGIVYKGTLRHGNLVAVKQILDLD--TKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSD 333 (590)
Q Consensus 256 ~~el~~at~~f~~~~~LG~G~fG~Vykg~~~~g~~vAvK~l~~~~--~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~ 333 (590)
.++.+...++|...+.||+|+||.||+|++++ .+|+|++.... ....+.+.+|++++++++|+||+++++++..
T Consensus 25 ~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-- 100 (319)
T 2y4i_B 25 LQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMS-- 100 (319)
T ss_dssp GGGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEEC--
T ss_pred cccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEec--
Confidence 34444556788999999999999999999864 49999986432 2334568899999999999999999999984
Q ss_pred CCCCceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEE
Q 046270 334 DSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVA 413 (590)
Q Consensus 334 ~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~ 413 (590)
....++||||+++++|.+++.. ....+++..++.|+.||+.||+||| +.+|+||||||+|||++ ++.+||+
T Consensus 101 ---~~~~~iv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~NIl~~-~~~~~l~ 171 (319)
T 2y4i_B 101 ---PPHLAIITSLCKGRTLYSVVRD--AKIVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYD-NGKVVIT 171 (319)
T ss_dssp ---SSCEEEECBCCCSEEHHHHTTS--SCCCCCSHHHHHHHHHHHHHHHHHH---HTTCCCCCCCSTTEEEC---CCEEC
T ss_pred ---CCceEEEeecccCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChhhEEEe-CCCEEEe
Confidence 3458999999999999999853 2346999999999999999999999 88999999999999998 6799999
Q ss_pred eeCCcccccCCC----cccccccccCCCccCcccccc---------CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchh
Q 046270 414 DFGLAKQSLEGH----SHLTTRVAGTFGYLAPEYALY---------GQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQ 480 (590)
Q Consensus 414 DFGla~~~~~~~----~~~~~~~~gt~~Y~APE~~~~---------~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~ 480 (590)
|||+++...... ........||..|+|||.+.. ..++.++||||||+++|||++|+.||.......
T Consensus 172 Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~- 250 (319)
T 2y4i_B 172 DFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEA- 250 (319)
T ss_dssp CCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHH-
T ss_pred ecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-
Confidence 999987543211 112233468999999999874 457899999999999999999999997533211
Q ss_pred hhhHHHHHHHhcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhccCCCC
Q 046270 481 LITDWAWVLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEGDIDI 546 (590)
Q Consensus 481 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~~~~~ 546 (590)
..+.. ..+........ .....+.+++..|++.||++|||+.+++++|+.....
T Consensus 251 ----~~~~~-~~~~~~~~~~~--------~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~ 303 (319)
T 2y4i_B 251 ----IIWQM-GTGMKPNLSQI--------GMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKR 303 (319)
T ss_dssp ----HHHHH-HTTCCCCCCCS--------SCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC---
T ss_pred ----HHHHh-ccCCCCCCCcC--------CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence 11111 11111111110 1223577888999999999999999999999976543
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=363.11 Aligned_cols=249 Identities=23% Similarity=0.342 Sum_probs=201.4
Q ss_pred HhcCCCccceecccCcEEEEEEEEcC-CcEEEEEEeecC---CCCChHHHHHHHHHHHhc-CCCCccccceeEEeccCCC
Q 046270 262 ATNGFSQNNLIGQGASGIVYKGTLRH-GNLVAVKQILDL---DTKGDEDFTNEVEIISKI-RHRNLLSLRGCCVTSDDSS 336 (590)
Q Consensus 262 at~~f~~~~~LG~G~fG~Vykg~~~~-g~~vAvK~l~~~---~~~~~~~f~~Ev~il~~l-~H~nlv~l~g~~~~~~~~~ 336 (590)
..++|...+.||+|+||.||+|++.. ++.||||++... .....+.+..|.+++..+ +|+||+++++++. .
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~-----~ 413 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQ-----T 413 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECB-----C
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEE-----e
Confidence 34678999999999999999999874 778999998642 233456788999999988 7999999999886 3
Q ss_pred CceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeC
Q 046270 337 GKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFG 416 (590)
Q Consensus 337 ~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFG 416 (590)
....+|||||+++|+|.+++. ..+.+++..++.|+.||+.||+||| +.+|+||||||+||||+.++.+||+|||
T Consensus 414 ~~~~~lV~E~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH---~~gIiHrDLKp~NILl~~~g~ikL~DFG 487 (674)
T 3pfq_A 414 MDRLYFVMEYVNGGDLMYHIQ---QVGRFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFG 487 (674)
T ss_dssp SSEEEEEEECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHH---HTSEECCCCCSTTEEECSSSCEEECCCT
T ss_pred CCEEEEEEeCcCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEeccCChhhEEEcCCCcEEEeecc
Confidence 456999999999999999985 3357999999999999999999999 8899999999999999999999999999
Q ss_pred CcccccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCch
Q 046270 417 LAKQSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVD 496 (590)
Q Consensus 417 la~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 496 (590)
+++...... .......||+.|+|||++.+..++.++|||||||+||||++|+.||...... ... ..... +...
T Consensus 488 la~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~-~~~----~~i~~-~~~~ 560 (674)
T 3pfq_A 488 MCKENIWDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED-ELF----QSIME-HNVA 560 (674)
T ss_dssp TCEECCCTT-CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHH----HHHHS-SCCC
T ss_pred eeeccccCC-cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHH-HHH----HHHHh-CCCC
Confidence 998643322 2345578999999999999999999999999999999999999999753321 111 11111 1110
Q ss_pred hhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCH-----HHHHH
Q 046270 497 DIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTI-----TDALK 538 (590)
Q Consensus 497 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm-----~eVl~ 538 (590)
.+......+.+++..|++.||++||++ +||++
T Consensus 561 ----------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 561 ----------YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp ----------CCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred ----------CCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 111223467788899999999999997 77754
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=329.93 Aligned_cols=252 Identities=23% Similarity=0.290 Sum_probs=184.7
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCCCC--hHHHHHHHHHHHhcCCCCccccceeEEeccCCCCce
Q 046270 263 TNGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDTKG--DEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKR 339 (590)
Q Consensus 263 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~~~--~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~ 339 (590)
.++|...+.||+|+||.||+++.. +|+.||||++....... .+.+.++...++.++||||+++++++.. +..
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~-----~~~ 80 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFR-----EGD 80 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEC-----SSS
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeec-----cCC
Confidence 467888999999999999999985 58899999986542221 2234455556888899999999999984 445
Q ss_pred EEEEEeeCCCCCcchhhhhh-cccccCChhhHHHHHHHHHHHHHHHHhcCCC-CeEecCCCCCceEECCCCcEEEEeeCC
Q 046270 340 RFLVYDYMPNGTLSDNISIS-HKRKQLTWPQRKKIIVDVAKGIAYLHYGLKP-GIYHRDIKSTNILLDSELNAKVADFGL 417 (590)
Q Consensus 340 ~~LV~E~~~~gsL~~~L~~~-~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~-~ivHrDIKp~NILLd~~~~~kL~DFGl 417 (590)
.++||||++ |+|.+++... .....+++..++.|+.|++.||.||| +. +|+||||||+|||++.++.+||+|||+
T Consensus 81 ~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T 3fme_A 81 VWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH---SKLSVIHRDVKPSNVLINALGQVKMCDFGI 156 (290)
T ss_dssp EEEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HHSCCCCCCCSGGGCEECTTCCEEBCCC--
T ss_pred EEEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeecCC
Confidence 899999997 5888777532 23457999999999999999999999 66 999999999999999999999999999
Q ss_pred cccccCCCcccccccccCCCccCcccc----ccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcC
Q 046270 418 AKQSLEGHSHLTTRVAGTFGYLAPEYA----LYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSG 493 (590)
Q Consensus 418 a~~~~~~~~~~~~~~~gt~~Y~APE~~----~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~ 493 (590)
++...... ......||+.|+|||.+ ....++.++||||||+++|||++|+.||.........+... ....
T Consensus 157 ~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~----~~~~ 230 (290)
T 3fme_A 157 SGYLVDDV--AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQV----VEEP 230 (290)
T ss_dssp ---------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHH----HHSC
T ss_pred cccccccc--cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHH----hccC
Confidence 98654332 22334689999999996 56678999999999999999999999997644433322211 1111
Q ss_pred CchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 046270 494 KVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALK 538 (590)
Q Consensus 494 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~ 538 (590)
.... . .......+.+++..|++.||++|||+.|+++
T Consensus 231 ~~~~-~--------~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 231 SPQL-P--------ADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp CCCC-C--------TTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCc-c--------cccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 1110 0 0112346778899999999999999999976
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=325.18 Aligned_cols=252 Identities=27% Similarity=0.346 Sum_probs=200.0
Q ss_pred HhcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCC---------CChHHHHHHHHHHHhcC-CCCccccceeEE
Q 046270 262 ATNGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDT---------KGDEDFTNEVEIISKIR-HRNLLSLRGCCV 330 (590)
Q Consensus 262 at~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~---------~~~~~f~~Ev~il~~l~-H~nlv~l~g~~~ 330 (590)
..++|...+.||+|+||.||+|++. +|+.||||++..... ...+.+.+|++++++++ ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 3467889999999999999999986 478999999865431 11346789999999995 999999999987
Q ss_pred eccCCCCceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcE
Q 046270 331 TSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNA 410 (590)
Q Consensus 331 ~~~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~ 410 (590)
.....++||||+++++|.+++. ....+++..++.++.||+.||.||| +.+|+||||||+||+++.++.+
T Consensus 95 -----~~~~~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~ 163 (298)
T 1phk_A 95 -----TNTFFFLVFDLMKKGELFDYLT---EKVTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNI 163 (298)
T ss_dssp -----CSSEEEEEEECCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCE
T ss_pred -----cCCeEEEEEeccCCCcHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEcCCCcE
Confidence 3457999999999999999985 3457999999999999999999999 8899999999999999999999
Q ss_pred EEEeeCCcccccCCCcccccccccCCCccCccccc------cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhH
Q 046270 411 KVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYAL------YGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITD 484 (590)
Q Consensus 411 kL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~------~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~ 484 (590)
||+|||+++...... ......|+..|+|||.+. ...++.++||||||++++||++|+.||...... ..
T Consensus 164 kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~--- 237 (298)
T 1phk_A 164 KLTDFGFSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM-LM--- 237 (298)
T ss_dssp EECCCTTCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HH---
T ss_pred EEecccchhhcCCCc--ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHH-HH---
Confidence 999999998654332 234456899999999885 456889999999999999999999998653221 11
Q ss_pred HHHHHHhcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 046270 485 WAWVLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALK 538 (590)
Q Consensus 485 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~ 538 (590)
.... ..+.... ..+ ........+.+++..|++.||++|||+.|+++
T Consensus 238 -~~~~-~~~~~~~-~~~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 238 -LRMI-MSGNYQF-GSP-----EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp -HHHH-HHTCCCC-CTT-----TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred -HHHH-hcCCccc-Ccc-----cccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 1111 1111110 000 00122346788999999999999999999986
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-39 Score=339.81 Aligned_cols=261 Identities=22% Similarity=0.309 Sum_probs=183.6
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCC--CChHHHHHHHHHHHhcCCCCccccceeEEeccC-CCCc
Q 046270 263 TNGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDT--KGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDD-SSGK 338 (590)
Q Consensus 263 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~--~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~-~~~~ 338 (590)
.++|...+.||+|+||.||+|+.. +|+.||||++..... ...+.+.+|++++++++||||+++++++..... ....
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 368899999999999999999975 588999999865322 234578899999999999999999999865321 1234
Q ss_pred eEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCc
Q 046270 339 RRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLA 418 (590)
Q Consensus 339 ~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla 418 (590)
..++|+||+ +++|.+++. ...+++..+..++.||++||.||| +.+|+||||||+|||++.++.+||+|||++
T Consensus 108 ~~~lv~e~~-~~~L~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kL~DFG~a 179 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA 179 (367)
T ss_dssp CCEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECC----
T ss_pred eEEEEeccc-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHhhEEECCCCCEEEeecccc
Confidence 579999999 789998884 256999999999999999999999 899999999999999999999999999999
Q ss_pred ccccCCCcccccccccCCCccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCc-h
Q 046270 419 KQSLEGHSHLTTRVAGTFGYLAPEYALY-GQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKV-D 496 (590)
Q Consensus 419 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~-~ 496 (590)
+..... .....||..|+|||.+.+ ..++.++|||||||+++||++|+.||....... .+...... -|.. .
T Consensus 180 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~l~~i~~~---~g~p~~ 251 (367)
T 2fst_X 180 RHTADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID-QLKLILRL---VGTPGA 251 (367)
T ss_dssp ---------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHH---HCSCCH
T ss_pred cccccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHH---hCCCCH
Confidence 865332 334578999999999876 689999999999999999999999997543211 12111111 1111 1
Q ss_pred hhhhH--------HHhh----------hhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 497 DIFDE--------FIRA----------EGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 497 ~~~d~--------~l~~----------~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
+.+.. .+.. .........+.+++..|++.||.+|||+.|+++.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 252 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp HHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 11100 0000 0000112457889999999999999999999874
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=336.29 Aligned_cols=260 Identities=20% Similarity=0.284 Sum_probs=196.6
Q ss_pred ccHHHHHHHhcCCCccceecccCcEEEEEEEEcCCcEEEEEEeecCCC--CChHHHHHHHHHHHhcC--CCCccccceeE
Q 046270 254 FHVSELEQATNGFSQNNLIGQGASGIVYKGTLRHGNLVAVKQILDLDT--KGDEDFTNEVEIISKIR--HRNLLSLRGCC 329 (590)
Q Consensus 254 f~~~el~~at~~f~~~~~LG~G~fG~Vykg~~~~g~~vAvK~l~~~~~--~~~~~f~~Ev~il~~l~--H~nlv~l~g~~ 329 (590)
+.++.+....++|...+.||+|+||.||+++..+++.||||++..... ...+.+.+|++++.+++ |+||+++++++
T Consensus 18 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~ 97 (313)
T 3cek_A 18 LYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 97 (313)
T ss_dssp --CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEE
T ss_pred CCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEe
Confidence 444455556678999999999999999999998899999999865332 23467899999999997 59999999998
Q ss_pred EeccCCCCceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCc
Q 046270 330 VTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELN 409 (590)
Q Consensus 330 ~~~~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~ 409 (590)
.. +...++||| +.+++|.+++. ....+++.+++.|+.||++||.||| +.+|+||||||+|||+++ +.
T Consensus 98 ~~-----~~~~~lv~e-~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~-~~ 164 (313)
T 3cek_A 98 IT-----DQYIYMVME-CGNIDLNSWLK---KKKSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIVD-GM 164 (313)
T ss_dssp EC-----SSEEEEEEC-CCSEEHHHHHH---HCSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEET-TE
T ss_pred ec-----CCEEEEEEe-cCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEEEC-Ce
Confidence 73 456999999 66889999985 3457999999999999999999999 889999999999999965 79
Q ss_pred EEEEeeCCcccccCCCcc-cccccccCCCccCcccccc-----------CCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 046270 410 AKVADFGLAKQSLEGHSH-LTTRVAGTFGYLAPEYALY-----------GQLTEKSDVYSFGIVILELMSGRKVLDTSTS 477 (590)
Q Consensus 410 ~kL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~~~~-----------~~~t~ksDVySfGvvLlELltG~~p~~~~~~ 477 (590)
+||+|||+++........ ......||..|+|||.+.. ..++.++||||||+++|||++|+.||.....
T Consensus 165 ~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 244 (313)
T 3cek_A 165 LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN 244 (313)
T ss_dssp EEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCS
T ss_pred EEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHH
Confidence 999999999866443322 2234568999999999875 4788999999999999999999999975433
Q ss_pred chhhhhHHHHHHHhcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 478 PFQLITDWAWVLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 478 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
....+. .......... .+......+.+++..|++.||.+|||+.|+++.
T Consensus 245 ~~~~~~----~~~~~~~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 245 QISKLH----AIIDPNHEIE---------FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp HHHHHH----HHHCTTSCCC---------CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHH----HHHhcccccC---------CcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 221111 1111111000 000112367788899999999999999999874
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=328.64 Aligned_cols=269 Identities=23% Similarity=0.284 Sum_probs=202.8
Q ss_pred HHhcCCCccceecccCcEEEEEEEEc--CCcEEEEEEeecCC--CCChHHHHHHHHHHHhc---CCCCccccceeEEecc
Q 046270 261 QATNGFSQNNLIGQGASGIVYKGTLR--HGNLVAVKQILDLD--TKGDEDFTNEVEIISKI---RHRNLLSLRGCCVTSD 333 (590)
Q Consensus 261 ~at~~f~~~~~LG~G~fG~Vykg~~~--~g~~vAvK~l~~~~--~~~~~~f~~Ev~il~~l---~H~nlv~l~g~~~~~~ 333 (590)
.+.++|...+.||+|+||.||+|++. +|+.||+|++.... ......+.+|+++++++ +||||+++++++....
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 35578999999999999999999983 57899999986432 22234677888888777 8999999999987543
Q ss_pred CCCCceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEE
Q 046270 334 DSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVA 413 (590)
Q Consensus 334 ~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~ 413 (590)
.......++||||++ |+|.+++... ....+++..++.++.||+.||.||| +.+|+||||||+|||++.++.+||+
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~lH---~~gi~H~dlkp~Nili~~~~~~kl~ 162 (326)
T 1blx_A 88 TDRETKLTLVFEHVD-QDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLA 162 (326)
T ss_dssp CSSEEEEEEEEECCS-CBHHHHHHHS-CTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEEC
T ss_pred cCCCceEEEEEecCC-CCHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHHHeEEcCCCCEEEe
Confidence 334567899999998 6999988533 2345999999999999999999999 8899999999999999999999999
Q ss_pred eeCCcccccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcC
Q 046270 414 DFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSG 493 (590)
Q Consensus 414 DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~ 493 (590)
|||+++..... .......||..|+|||.+..+.++.++||||||+++|||++|+.||....... .+....... ...
T Consensus 163 Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~i~~~~-~~~ 238 (326)
T 1blx_A 163 DFGLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD-QLGKILDVI-GLP 238 (326)
T ss_dssp SCCSCCCCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHH-CCC
T ss_pred cCcccccccCC--CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHH-HHHHHHHHc-CCC
Confidence 99999865322 22344678999999999999999999999999999999999999997543321 121111111 000
Q ss_pred Cchh----------hhhH---HHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 046270 494 KVDD----------IFDE---FIRAEGARAVMERFVLVGILCAHVMVALRPTITDALK 538 (590)
Q Consensus 494 ~~~~----------~~d~---~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~ 538 (590)
...+ .+.. .............+.+++..|++.||++|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 239 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp CGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0000 0000 0000011123346778999999999999999999985
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=340.62 Aligned_cols=265 Identities=24% Similarity=0.322 Sum_probs=182.2
Q ss_pred CCc-cceecccCcEEEEEEEEc---CCcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEE
Q 046270 266 FSQ-NNLIGQGASGIVYKGTLR---HGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRF 341 (590)
Q Consensus 266 f~~-~~~LG~G~fG~Vykg~~~---~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~ 341 (590)
|.. .++||+|+||.||+|++. ++..||||++... .....+.+|+++|++++||||+++++++... .+...+
T Consensus 22 y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~---~~~~~~ 96 (405)
T 3rgf_A 22 FEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLSH---ADRKVW 96 (405)
T ss_dssp EECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSS--SCCHHHHHHHHHHHHCCCTTBCCCCEEEEET---TTTEEE
T ss_pred hhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCC--CCCHHHHHHHHHHHhcCCCCeeeEeeEEecC---CCCeEE
Confidence 443 357999999999999976 4778999998643 2345788999999999999999999999753 245799
Q ss_pred EEEeeCCCCCcchhhhhhc------ccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEE----CCCCcEE
Q 046270 342 LVYDYMPNGTLSDNISISH------KRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILL----DSELNAK 411 (590)
Q Consensus 342 LV~E~~~~gsL~~~L~~~~------~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILL----d~~~~~k 411 (590)
+||||++ |+|.+++.... ....+++..++.|+.||+.||.||| +.+|+||||||+|||| +.++.+|
T Consensus 97 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~k 172 (405)
T 3rgf_A 97 LLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVK 172 (405)
T ss_dssp EEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECCSSTTTTCEE
T ss_pred EEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeCCCcCHHHeEEecCCCCCCcEE
Confidence 9999996 57777774322 1224999999999999999999999 8899999999999999 7778999
Q ss_pred EEeeCCcccccCCCc--ccccccccCCCccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCch--------h
Q 046270 412 VADFGLAKQSLEGHS--HLTTRVAGTFGYLAPEYALY-GQLTEKSDVYSFGIVILELMSGRKVLDTSTSPF--------Q 480 (590)
Q Consensus 412 L~DFGla~~~~~~~~--~~~~~~~gt~~Y~APE~~~~-~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~--------~ 480 (590)
|+|||+++....... .......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||....... .
T Consensus 173 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~ 252 (405)
T 3rgf_A 173 IADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHD 252 (405)
T ss_dssp ECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHH
T ss_pred EEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHH
Confidence 999999987643222 22345678999999999887 458999999999999999999999996543321 1
Q ss_pred hhhHHHHHHHhcC--Cchhh---------hhHHHhhhh----HH--------HHHHHHHHHHHhchhcCCCCCCCHHHHH
Q 046270 481 LITDWAWVLAKSG--KVDDI---------FDEFIRAEG----AR--------AVMERFVLVGILCAHVMVALRPTITDAL 537 (590)
Q Consensus 481 ~l~~~~~~~~~~~--~~~~~---------~d~~l~~~~----~~--------~~~~~l~~l~~~Cl~~dp~~RPtm~eVl 537 (590)
.+......+-... .+.++ ......... .. .....+.+++..|++.||.+|||+.|++
T Consensus 253 ~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L 332 (405)
T 3rgf_A 253 QLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAM 332 (405)
T ss_dssp HHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred HHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHh
Confidence 1211111110000 00000 000000000 00 0124677899999999999999999999
Q ss_pred HH
Q 046270 538 KM 539 (590)
Q Consensus 538 ~~ 539 (590)
+.
T Consensus 333 ~h 334 (405)
T 3rgf_A 333 QD 334 (405)
T ss_dssp TS
T ss_pred cC
Confidence 85
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=344.85 Aligned_cols=259 Identities=10% Similarity=0.021 Sum_probs=181.5
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCCC---ChHHHHHHHHHHHhc--CCCCccccc-------eeE
Q 046270 263 TNGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDTK---GDEDFTNEVEIISKI--RHRNLLSLR-------GCC 329 (590)
Q Consensus 263 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~~---~~~~f~~Ev~il~~l--~H~nlv~l~-------g~~ 329 (590)
..+|...+.||+|+||.||+|++. +|+.||||++...... ..+.+.+|++++..+ +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 445888899999999999999976 5889999999765432 244577886555555 699988754 333
Q ss_pred EeccCC------------CCceEEEEEeeCCCCCcchhhhhhcccccCChhhH------HHHHHHHHHHHHHHHhcCCCC
Q 046270 330 VTSDDS------------SGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQR------KKIIVDVAKGIAYLHYGLKPG 391 (590)
Q Consensus 330 ~~~~~~------------~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r------~~I~~~ia~gL~yLH~~~~~~ 391 (590)
...... .....++||||++ |+|.+++... ...+.+..+ +.|+.||+.||+||| +.+
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH---~~~ 214 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL--DFVYVFRGDEGILALHILTAQLIRLAANLQ---SKG 214 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH--HHSCCCCHHHHHHHHHHHHHHHHHHHHHHH---HTT
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh--ccccchhhhhhhhhHHHHHHHHHHHHHHHH---HCC
Confidence 221110 0145899999999 8999999643 335677777 888899999999999 899
Q ss_pred eEecCCCCCceEECCCCcEEEEeeCCcccccCCCcccccccccCCCccCcccccc--CCCCcchhHHHHHHHHHHHHhCC
Q 046270 392 IYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALY--GQLTEKSDVYSFGIVILELMSGR 469 (590)
Q Consensus 392 ivHrDIKp~NILLd~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~--~~~t~ksDVySfGvvLlELltG~ 469 (590)
|+||||||+|||++.++.+||+|||+++..... .....+|+.|+|||.+.+ ..++.++|||||||++|||++|+
T Consensus 215 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~ 290 (371)
T 3q60_A 215 LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290 (371)
T ss_dssp EEETTCSGGGEEECTTSCEEECCGGGEEETTCE----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSS
T ss_pred CccCcCCHHHEEECCCCCEEEEecceeeecCCC----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCC
Confidence 999999999999999999999999999865321 224456799999999987 67999999999999999999999
Q ss_pred CCCCCCCCchhhhhHHHHHHHhcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 046270 470 KVLDTSTSPFQLITDWAWVLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALK 538 (590)
Q Consensus 470 ~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~ 538 (590)
.||.......... | ........................+.+++..|++.||++|||+.++++
T Consensus 291 ~Pf~~~~~~~~~~--~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 291 LPFGLVTPGIKGS--W-----KRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp CSTTBCCTTCTTC--C-----CBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCCCCcCcccccc--h-----hhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 9997543221100 0 000000000000000000122346778899999999999999999874
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=348.89 Aligned_cols=252 Identities=27% Similarity=0.352 Sum_probs=198.9
Q ss_pred HhcCCCccceecccCcEEEEEEEEcC-CcEEEEEEeecCCC-------------CChHHHHHHHHHHHhcCCCCccccce
Q 046270 262 ATNGFSQNNLIGQGASGIVYKGTLRH-GNLVAVKQILDLDT-------------KGDEDFTNEVEIISKIRHRNLLSLRG 327 (590)
Q Consensus 262 at~~f~~~~~LG~G~fG~Vykg~~~~-g~~vAvK~l~~~~~-------------~~~~~f~~Ev~il~~l~H~nlv~l~g 327 (590)
..++|...+.||+|+||.||+|+... +..||||++..... ...+.+.+|++++++++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 45789999999999999999999874 78999999865321 23567899999999999999999999
Q ss_pred eEEeccCCCCceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCC
Q 046270 328 CCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSE 407 (590)
Q Consensus 328 ~~~~~~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~ 407 (590)
++. .+...++||||+++|+|.+++. ....+++..+..|+.||+.||.||| +.+|+||||||+|||++.+
T Consensus 114 ~~~-----~~~~~~lv~e~~~gg~L~~~l~---~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~ 182 (504)
T 3q5i_A 114 VFE-----DKKYFYLVTEFYEGGELFEQII---NRHKFDECDAANIMKQILSGICYLH---KHNIVHRDIKPENILLENK 182 (504)
T ss_dssp EEE-----CSSEEEEEEECCTTCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESST
T ss_pred EEE-----cCCEEEEEEecCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCcHHHEEEecC
Confidence 997 4557999999999999999885 3457999999999999999999999 8899999999999999877
Q ss_pred C---cEEEEeeCCcccccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhH
Q 046270 408 L---NAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITD 484 (590)
Q Consensus 408 ~---~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~ 484 (590)
+ .+||+|||+++...... ......||+.|+|||.+. +.++.++|||||||++|||++|+.||...... ..+
T Consensus 183 ~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~-- 256 (504)
T 3q5i_A 183 NSLLNIKIVDFGLSSFFSKDY--KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ-DII-- 256 (504)
T ss_dssp TCCSSEEECCCTTCEECCTTS--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHH--
T ss_pred CCCccEEEEECCCCEEcCCCC--ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH-HHH--
Confidence 5 69999999998664432 234457999999999876 57999999999999999999999999753321 111
Q ss_pred HHHHHHhcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 485 WAWVLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 485 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
.. ...+....-.. ....+...+.+++..|++.||.+|||+.|+++.
T Consensus 257 --~~-i~~~~~~~~~~------~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 257 --KK-VEKGKYYFDFN------DWKNISDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp --HH-HHHCCCCCCHH------HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred --HH-HHcCCCCCCcc------ccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 11 11222110000 001123467889999999999999999999863
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=347.64 Aligned_cols=250 Identities=26% Similarity=0.341 Sum_probs=195.2
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCC--CCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCce
Q 046270 263 TNGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLD--TKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKR 339 (590)
Q Consensus 263 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~--~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~ 339 (590)
.+.|...+.||+|+||.||+|+.. .+..||+|++.... ......+.+|++++++++||||+++++++. ....
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~~~~ 110 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFE-----DKRN 110 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSSE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEE-----eCCE
Confidence 456888999999999999999987 57899999986543 334567999999999999999999999997 3456
Q ss_pred EEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCC---CcEEEEeeC
Q 046270 340 RFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSE---LNAKVADFG 416 (590)
Q Consensus 340 ~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~---~~~kL~DFG 416 (590)
.++||||+++|+|.+++. ....+++..+..|+.||+.||.||| +.+|+||||||+|||++.+ +.+||+|||
T Consensus 111 ~~lv~e~~~~g~L~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG 184 (494)
T 3lij_A 111 YYLVMECYKGGELFDEII---HRMKFNEVDAAVIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFG 184 (494)
T ss_dssp EEEEEECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred EEEEEecCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChhhEEEeCCCCCCcEEEEECC
Confidence 999999999999998885 3457999999999999999999999 8899999999999999764 459999999
Q ss_pred CcccccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCch
Q 046270 417 LAKQSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVD 496 (590)
Q Consensus 417 la~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 496 (590)
+++...... ......||+.|+|||.+. +.++.++|||||||++|||++|+.||...... ..+. . ...+...
T Consensus 185 ~a~~~~~~~--~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~----~-i~~~~~~ 255 (494)
T 3lij_A 185 LSAVFENQK--KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQ-EILR----K-VEKGKYT 255 (494)
T ss_dssp TCEECBTTB--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHH----H-HHHTCCC
T ss_pred CCeECCCCc--cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH-HHHH----H-HHhCCCC
Confidence 998764432 234457999999999875 67999999999999999999999999754321 1111 1 1111111
Q ss_pred hhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 046270 497 DIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALK 538 (590)
Q Consensus 497 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~ 538 (590)
. ..+.. ......+.+++..|++.||.+|||+.|+++
T Consensus 256 ~-~~~~~-----~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 256 F-DSPEW-----KNVSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp C-CSGGG-----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred C-Cchhc-----ccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 0 00000 112346778899999999999999999985
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-38 Score=331.37 Aligned_cols=262 Identities=18% Similarity=0.238 Sum_probs=199.8
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCCCChHHHHHHHHHHHhcC-----------CCCccccceeEEe
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDTKGDEDFTNEVEIISKIR-----------HRNLLSLRGCCVT 331 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~-----------H~nlv~l~g~~~~ 331 (590)
++|...+.||+|+||.||+|+.. +++.||||++... ....+.+.+|++++.+++ |+||+++++++..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~ 97 (373)
T 1q8y_A 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 97 (373)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence 57888999999999999999975 5889999998632 223567889999999986 8999999999986
Q ss_pred ccCCCCceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCC-CeEecCCCCCceEEC-----
Q 046270 332 SDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKP-GIYHRDIKSTNILLD----- 405 (590)
Q Consensus 332 ~~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~-~ivHrDIKp~NILLd----- 405 (590)
.+. .+...++||||+ +++|.+++... ....+++..++.|+.||+.||+||| +. +|+||||||+|||++
T Consensus 98 ~~~-~~~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH---~~~~ivH~Dikp~NIll~~~~~~ 171 (373)
T 1q8y_A 98 KGP-NGVHVVMVFEVL-GENLLALIKKY-EHRGIPLIYVKQISKQLLLGLDYMH---RRCGIIHTDIKPENVLMEIVDSP 171 (373)
T ss_dssp EET-TEEEEEEEECCC-CEEHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECSCCSGGGEEEEEEETT
T ss_pred cCC-CCceEEEEEecC-CCCHHHHHHHh-hccCCcHHHHHHHHHHHHHHHHHHH---hcCCEEecCCChHHeEEeccCCC
Confidence 543 345789999999 89999988643 2345999999999999999999999 77 999999999999994
Q ss_pred -CCCcEEEEeeCCcccccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCch-----
Q 046270 406 -SELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPF----- 479 (590)
Q Consensus 406 -~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~----- 479 (590)
..+.+||+|||+++..... .....||..|+|||.+.+..++.++||||||+++|||+||+.||.......
T Consensus 172 ~~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 247 (373)
T 1q8y_A 172 ENLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 247 (373)
T ss_dssp TTEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred cCcceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChH
Confidence 4458999999999865432 234568999999999999999999999999999999999999997543211
Q ss_pred hhhhHHHHHHHhcCCchhh----------------------------hhHHHhh--hhHHHHHHHHHHHHHhchhcCCCC
Q 046270 480 QLITDWAWVLAKSGKVDDI----------------------------FDEFIRA--EGARAVMERFVLVGILCAHVMVAL 529 (590)
Q Consensus 480 ~~l~~~~~~~~~~~~~~~~----------------------------~d~~l~~--~~~~~~~~~l~~l~~~Cl~~dp~~ 529 (590)
..+...... .+..... +...+.. ..+......+.+++..|++.||++
T Consensus 248 ~~~~~~~~~---~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 324 (373)
T 1q8y_A 248 DHIAQIIEL---LGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRK 324 (373)
T ss_dssp HHHHHHHHH---HCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTT
T ss_pred HHHHHHHHh---cCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccc
Confidence 111111110 1111100 0011111 123455668889999999999999
Q ss_pred CCCHHHHHHH
Q 046270 530 RPTITDALKM 539 (590)
Q Consensus 530 RPtm~eVl~~ 539 (590)
|||+.|+++.
T Consensus 325 Rpt~~ell~h 334 (373)
T 1q8y_A 325 RADAGGLVNH 334 (373)
T ss_dssp CBCHHHHHTC
T ss_pred cCCHHHHhhC
Confidence 9999999873
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=322.23 Aligned_cols=257 Identities=26% Similarity=0.358 Sum_probs=191.7
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCccccceeEEeccC-------
Q 046270 263 TNGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDD------- 334 (590)
Q Consensus 263 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~------- 334 (590)
.++|...+.||+|+||.||+|+.. +|+.||||++... ....+.+.+|++++++++||||+++++++.....
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 457888999999999999999985 6889999998542 2335678999999999999999999999875321
Q ss_pred -CCCceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEE
Q 046270 335 -SSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVA 413 (590)
Q Consensus 335 -~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~ 413 (590)
......++||||+++|+|.+++.. ....+++..++.++.||+.||+||| +.+|+||||||+|||++.++.+||+
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dlkp~Nil~~~~~~~kl~ 158 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHS--ENLNQQRDEYWRLFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIG 158 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHH--SCGGGCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEEC
T ss_pred cccCCceEEEEecCCCCCHHHhhhc--cccccchHHHHHHHHHHHHHHHHHH---hCCeecccCCHHhEEEcCCCCEEEe
Confidence 134678999999999999999863 3346889999999999999999999 8899999999999999999999999
Q ss_pred eeCCcccccCCC-------------cccccccccCCCccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCch
Q 046270 414 DFGLAKQSLEGH-------------SHLTTRVAGTFGYLAPEYALY-GQLTEKSDVYSFGIVILELMSGRKVLDTSTSPF 479 (590)
Q Consensus 414 DFGla~~~~~~~-------------~~~~~~~~gt~~Y~APE~~~~-~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~ 479 (590)
|||+++...... ........||..|+|||.+.+ +.++.++||||||+++|||++ |+....
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~--- 232 (303)
T 1zy4_A 159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM--- 232 (303)
T ss_dssp CCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH---
T ss_pred eCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch---
Confidence 999998654221 112234568999999999875 478999999999999999998 332111
Q ss_pred hhhhHHHHHHHhcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 480 QLITDWAWVLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 480 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
. ..+..... ...... + ...........+.+++..|++.||.+|||+.++++.
T Consensus 233 ~-~~~~~~~~-~~~~~~--~----~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 233 E-RVNILKKL-RSVSIE--F----PPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp H-HHHHHHHH-HSTTCC--C----CTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred h-HHHHHHhc-cccccc--c----CccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 1 11111111 111100 0 011111223467788999999999999999999973
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-39 Score=350.27 Aligned_cols=251 Identities=27% Similarity=0.385 Sum_probs=201.1
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCC---CCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCc
Q 046270 263 TNGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLD---TKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGK 338 (590)
Q Consensus 263 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~---~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~ 338 (590)
.++|...+.||+|+||.||+++.. .|+.||||++.... ....+.+.+|++++++++||||+++++++. ...
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~~~ 99 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFE-----DKG 99 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSS
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----eCC
Confidence 356888999999999999999987 58899999986532 334677999999999999999999999997 345
Q ss_pred eEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEE---CCCCcEEEEee
Q 046270 339 RRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILL---DSELNAKVADF 415 (590)
Q Consensus 339 ~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILL---d~~~~~kL~DF 415 (590)
..++||||+++|+|.+++. ....+++..+..|+.||+.||.||| +.+|+||||||+|||+ +.++.+||+||
T Consensus 100 ~~~lv~e~~~~~~L~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Df 173 (484)
T 3nyv_A 100 YFYLVGEVYTGGELFDEII---SRKRFSEVDAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDF 173 (484)
T ss_dssp EEEEEECCCCSCBHHHHHH---TCSCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCT
T ss_pred EEEEEEecCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEecCCCCCcEEEEee
Confidence 7999999999999999885 3457999999999999999999999 8899999999999999 56789999999
Q ss_pred CCcccccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCc
Q 046270 416 GLAKQSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKV 495 (590)
Q Consensus 416 Gla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~ 495 (590)
|+++...... ......||+.|+|||.+.+ .++.++|||||||++|||++|+.||..... ...+. . ...+..
T Consensus 174 g~a~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~----~-i~~~~~ 244 (484)
T 3nyv_A 174 GLSTHFEASK--KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANE-YDILK----K-VEKGKY 244 (484)
T ss_dssp THHHHBCCCC--SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHH----H-HHHCCC
T ss_pred eeeEEccccc--ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCH-HHHHH----H-HHcCCC
Confidence 9998654432 2344569999999998764 799999999999999999999999975332 11111 1 112221
Q ss_pred hhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 496 DDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 496 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
..... ........+.+++..|++.||.+|||+.|+++.
T Consensus 245 ~~~~~------~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 245 TFELP------QWKKVSESAKDLIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp CCCSG------GGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CCCCc------ccccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence 10000 001123467789999999999999999999863
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=347.08 Aligned_cols=251 Identities=29% Similarity=0.392 Sum_probs=198.8
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecC--CCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCce
Q 046270 263 TNGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDL--DTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKR 339 (590)
Q Consensus 263 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~--~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~ 339 (590)
.++|...+.||+|+||.||+++.. +|+.||||++... .......+.+|++++++++||||+++++++. ....
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~~~~ 95 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILE-----DSSS 95 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CSSE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEE-----cCCE
Confidence 356888999999999999999986 5889999998542 2344678999999999999999999999987 3456
Q ss_pred EEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEC---CCCcEEEEeeC
Q 046270 340 RFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLD---SELNAKVADFG 416 (590)
Q Consensus 340 ~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd---~~~~~kL~DFG 416 (590)
.++||||+++|+|.+++. ....+++..+..|+.||+.||.||| +.+|+||||||+|||++ .++.+||+|||
T Consensus 96 ~~lv~e~~~~~~L~~~~~---~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg 169 (486)
T 3mwu_A 96 FYIVGELYTGGELFDEII---KRKRFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFG 169 (486)
T ss_dssp EEEEECCCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEESSSSTTCCEEECSCS
T ss_pred EEEEEEcCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEEECC
Confidence 999999999999998885 3457999999999999999999999 88999999999999995 45679999999
Q ss_pred CcccccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCch
Q 046270 417 LAKQSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVD 496 (590)
Q Consensus 417 la~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 496 (590)
+++...... ......||+.|+|||.+. +.++.++|||||||++|||++|+.||..... ...+. . ...+...
T Consensus 170 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~----~-i~~~~~~ 240 (486)
T 3mwu_A 170 LSTCFQQNT--KMKDRIGTAYYIAPEVLR-GTYDEKCDVWSAGVILYILLSGTPPFYGKNE-YDILK----R-VETGKYA 240 (486)
T ss_dssp CTTTBCCC------CCTTGGGGCCGGGGG-SCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHH----H-HHHTCCC
T ss_pred cCeECCCCC--ccCCCcCCCCCCCHHHhC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHH----H-HHhCCCC
Confidence 998654332 234457899999999876 4699999999999999999999999965332 11111 1 1112111
Q ss_pred hhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 497 DIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 497 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
.... . .......+.+++..|++.||.+|||+.++++.
T Consensus 241 ~~~~-~-----~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 241 FDLP-Q-----WRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp SCSG-G-----GGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred CCCc-c-----cCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000 0 01123467788999999999999999999984
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-39 Score=365.46 Aligned_cols=257 Identities=21% Similarity=0.302 Sum_probs=200.3
Q ss_pred HHHhcCCCccceecccCcEEEEEEEEcC----CcEEEEEEeecCCCC-ChHHHHHHHHHHHhcCCCCccccceeEEeccC
Q 046270 260 EQATNGFSQNNLIGQGASGIVYKGTLRH----GNLVAVKQILDLDTK-GDEDFTNEVEIISKIRHRNLLSLRGCCVTSDD 334 (590)
Q Consensus 260 ~~at~~f~~~~~LG~G~fG~Vykg~~~~----g~~vAvK~l~~~~~~-~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~ 334 (590)
+...++|...+.||+|+||.||+|++.. +..||||++...... ..+.|.+|+.++++++||||+++++++..
T Consensus 386 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--- 462 (656)
T 2j0j_A 386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE--- 462 (656)
T ss_dssp BCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS---
T ss_pred ccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec---
Confidence 3345678888999999999999999853 457999998654322 24679999999999999999999999842
Q ss_pred CCCceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEe
Q 046270 335 SSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVAD 414 (590)
Q Consensus 335 ~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~D 414 (590)
...++||||+++|+|.+++.. ....+++..++.++.||+.||.||| +.+|+||||||+|||++.++.+||+|
T Consensus 463 ---~~~~lv~E~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDikp~NILl~~~~~vkL~D 534 (656)
T 2j0j_A 463 ---NPVWIIMELCTLGELRSFLQV--RKFSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGD 534 (656)
T ss_dssp ---SSCEEEEECCTTCBHHHHHHH--TTTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC
T ss_pred ---CceEEEEEcCCCCcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchHhEEEeCCCCEEEEe
Confidence 247999999999999999853 2346999999999999999999999 88999999999999999999999999
Q ss_pred eCCcccccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhhHHHHHHHhcC
Q 046270 415 FGLAKQSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLDTSTSPFQLITDWAWVLAKSG 493 (590)
Q Consensus 415 FGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~ 493 (590)
||+++..............+|..|+|||.+....++.++||||||+++|||++ |+.||...... ..+ ... ..+
T Consensus 535 FG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~-~~~----~~i-~~~ 608 (656)
T 2j0j_A 535 FGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN-DVI----GRI-ENG 608 (656)
T ss_dssp CCCCCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-HHH----HHH-HHT
T ss_pred cCCCeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH-HHH----HHH-HcC
Confidence 99998765444333444567889999999999999999999999999999997 99998653321 111 111 111
Q ss_pred CchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhcc
Q 046270 494 KVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEG 542 (590)
Q Consensus 494 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~ 542 (590)
.... .+......+.+++..|++.||++|||+.+++++|+.
T Consensus 609 ~~~~---------~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~ 648 (656)
T 2j0j_A 609 ERLP---------MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLST 648 (656)
T ss_dssp CCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCC---------CCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 1111 011223467789999999999999999999999875
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-38 Score=332.97 Aligned_cols=260 Identities=21% Similarity=0.310 Sum_probs=195.1
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCCCC--hHHHHHHHHHHHhcCCCCccccceeEEeccCC-CCc
Q 046270 263 TNGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDTKG--DEDFTNEVEIISKIRHRNLLSLRGCCVTSDDS-SGK 338 (590)
Q Consensus 263 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~~~--~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~-~~~ 338 (590)
.++|...+.||+|+||.||+|++. +|+.||||++....... .+.+.+|++++++++||||+++++++...+.. ...
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 467888999999999999999986 48899999986543222 45788999999999999999999999754431 112
Q ss_pred eEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCc
Q 046270 339 RRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLA 418 (590)
Q Consensus 339 ~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla 418 (590)
..++||||+. ++|.+++. ..+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||++
T Consensus 121 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a 191 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMG-----MEFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLA 191 (371)
T ss_dssp CCEEEEECCC-EEHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECSTTCC
T ss_pred eEEEEEcccc-ccHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCcCHHHeEECCCCCEEEEecCcc
Confidence 3499999997 67877662 35999999999999999999999 889999999999999999999999999999
Q ss_pred ccccCCCcccccccccCCCccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCc-h
Q 046270 419 KQSLEGHSHLTTRVAGTFGYLAPEYALY-GQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKV-D 496 (590)
Q Consensus 419 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~-~ 496 (590)
+..... .....||..|+|||.+.+ ..++.++||||||++++||++|+.||....... .+...... .+.. .
T Consensus 192 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~i~~~---~~~~~~ 263 (371)
T 4exu_A 192 RHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD-QLTQILKV---TGVPGT 263 (371)
T ss_dssp ------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHH---HCCCCH
T ss_pred cccccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHH---hCCCcH
Confidence 855332 334568999999999887 689999999999999999999999997543221 11111110 1110 0
Q ss_pred hhhh--------HHHhh----------hhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 497 DIFD--------EFIRA----------EGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 497 ~~~d--------~~l~~----------~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
+.+. ..+.. .........+.+++..|++.||++|||+.|+++.
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 264 EFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp HHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 1000 00000 0001123477889999999999999999999874
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-38 Score=340.26 Aligned_cols=199 Identities=23% Similarity=0.308 Sum_probs=169.1
Q ss_pred hcCCCccceecccCcEEEEEEEEcC-CcEEEEEEeecCCCCChHHHHHHHHHHHhc------CCCCccccceeEEeccCC
Q 046270 263 TNGFSQNNLIGQGASGIVYKGTLRH-GNLVAVKQILDLDTKGDEDFTNEVEIISKI------RHRNLLSLRGCCVTSDDS 335 (590)
Q Consensus 263 t~~f~~~~~LG~G~fG~Vykg~~~~-g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l------~H~nlv~l~g~~~~~~~~ 335 (590)
.++|...+.||+|+||.||+|.... ++.||||++... .....++.+|++++..+ +|+||+++++++..
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~---- 170 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTF---- 170 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEE----
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeeccc----
Confidence 4568889999999999999998865 789999998642 22345688899999888 56799999999874
Q ss_pred CCceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCc--EEEE
Q 046270 336 SGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELN--AKVA 413 (590)
Q Consensus 336 ~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~--~kL~ 413 (590)
....++||||+. ++|.+++... ....+++..++.|+.||+.||+||| +.+|+||||||+|||++.++. +||+
T Consensus 171 -~~~~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NILl~~~~~~~vkL~ 244 (429)
T 3kvw_A 171 -RNHICMTFELLS-MNLYELIKKN-KFQGFSLPLVRKFAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVI 244 (429)
T ss_dssp -TTEEEEEECCCC-CBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHH---HHTEECSCCSGGGEEESSTTSCCEEEC
T ss_pred -CCeEEEEEeccC-CCHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEccCCCcceEEe
Confidence 456899999996 6898888543 2345999999999999999999999 789999999999999999887 9999
Q ss_pred eeCCcccccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 046270 414 DFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTST 476 (590)
Q Consensus 414 DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~ 476 (590)
|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 245 DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~ 303 (429)
T 3kvw_A 245 DFGSSCYEHQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED 303 (429)
T ss_dssp CCTTCEETTCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ecccceecCCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 99999754322 234578999999999999999999999999999999999999997543
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-38 Score=324.67 Aligned_cols=258 Identities=22% Similarity=0.278 Sum_probs=197.8
Q ss_pred hcCCCccceecccCcEEEEEEEE-c-CCcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCC------ccccceeEEeccC
Q 046270 263 TNGFSQNNLIGQGASGIVYKGTL-R-HGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRN------LLSLRGCCVTSDD 334 (590)
Q Consensus 263 t~~f~~~~~LG~G~fG~Vykg~~-~-~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~n------lv~l~g~~~~~~~ 334 (590)
.++|...+.||+|+||.||+|.. . +|+.||||++... ....+.+.+|++++++++|+| ++++++++..
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~--- 88 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEH--- 88 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEE---
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccccc---
Confidence 35788999999999999999987 3 5789999998643 233467889999999997665 8999998874
Q ss_pred CCCceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECC--------
Q 046270 335 SSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDS-------- 406 (590)
Q Consensus 335 ~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~-------- 406 (590)
....++||||+ +++|.+++... ....+++..++.++.||+.||+||| +.+|+||||||+|||++.
T Consensus 89 --~~~~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~ 161 (339)
T 1z57_A 89 --HGHICIVFELL-GLSTYDFIKEN-GFLPFRLDHIRKMAYQICKSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYN 161 (339)
T ss_dssp --TTEEEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCCCEEEEEC
T ss_pred --CCcEEEEEcCC-CCCHHHHHHhc-CCCCCcHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeccccccccC
Confidence 34699999999 89999988532 2236899999999999999999999 889999999999999987
Q ss_pred -----------CCcEEEEeeCCcccccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 046270 407 -----------ELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTS 475 (590)
Q Consensus 407 -----------~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~ 475 (590)
++.+||+|||+++..... .....||..|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 162 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 237 (339)
T 1z57_A 162 PKIKRDERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTH 237 (339)
T ss_dssp ----CEEEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred CccccccccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence 668999999999864332 23457899999999999999999999999999999999999999754
Q ss_pred CCchhhhhHHHHHHHhcCCchhhhhH----------------------HHh---------hhhHHHHHHHHHHHHHhchh
Q 046270 476 TSPFQLITDWAWVLAKSGKVDDIFDE----------------------FIR---------AEGARAVMERFVLVGILCAH 524 (590)
Q Consensus 476 ~~~~~~l~~~~~~~~~~~~~~~~~d~----------------------~l~---------~~~~~~~~~~l~~l~~~Cl~ 524 (590)
.... .+....... ......++.. .+. ........+.+.+++..|++
T Consensus 238 ~~~~-~~~~~~~~~--~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 314 (339)
T 1z57_A 238 DSKE-HLAMMERIL--GPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLE 314 (339)
T ss_dssp CHHH-HHHHHHHHH--CSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTC
T ss_pred ChHH-HHHHHHHHh--CCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhC
Confidence 3322 111111100 0000000000 000 00111234578899999999
Q ss_pred cCCCCCCCHHHHHH
Q 046270 525 VMVALRPTITDALK 538 (590)
Q Consensus 525 ~dp~~RPtm~eVl~ 538 (590)
.||.+|||+.|+++
T Consensus 315 ~dP~~Rpt~~ell~ 328 (339)
T 1z57_A 315 YDPAKRITLREALK 328 (339)
T ss_dssp SSTTTSCCHHHHTT
T ss_pred cCcccccCHHHHhc
Confidence 99999999999985
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-38 Score=328.72 Aligned_cols=257 Identities=21% Similarity=0.251 Sum_probs=173.4
Q ss_pred hcCCCcc-ceecccCcEEEEEEEEc-CCcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceE
Q 046270 263 TNGFSQN-NLIGQGASGIVYKGTLR-HGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRR 340 (590)
Q Consensus 263 t~~f~~~-~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~ 340 (590)
.++|... ++||+|+||.||+|++. +|+.||||++... .....+....+..++||||+++++++..... .+...
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~-~~~~~ 101 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS----PKARQEVDHHWQASGGPHIVCILDVYENMHH-GKRCL 101 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET-TEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc----HHHHHHHHHHHHhcCCCChHHHHHHHhhccC-CCceE
Confidence 4678874 46999999999999987 5889999998542 2223333344667799999999999876443 34568
Q ss_pred EEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECC---CCcEEEEeeCC
Q 046270 341 FLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDS---ELNAKVADFGL 417 (590)
Q Consensus 341 ~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~---~~~~kL~DFGl 417 (590)
++||||+++|+|.+++... ....+++.+++.|+.||+.||.||| +.+|+||||||+|||++. ++.+||+|||+
T Consensus 102 ~lv~e~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~ql~~~l~~LH---~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~ 177 (336)
T 3fhr_A 102 LIIMECMEGGELFSRIQER-GDQAFTEREAAEIMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGF 177 (336)
T ss_dssp EEEEECCTTEEHHHHHHTC--CCCCBHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEeccCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEEecCCCceEEEecccc
Confidence 9999999999999998632 2346999999999999999999999 889999999999999976 45599999999
Q ss_pred cccccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchh
Q 046270 418 AKQSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDD 497 (590)
Q Consensus 418 a~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 497 (590)
++..... ......||+.|+|||.+....++.++||||||+++|||++|+.||......... ..... ....+..
T Consensus 178 ~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~~~~~-~~~~~~~-- 250 (336)
T 3fhr_A 178 AKETTQN---ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAIS-PGMKR-RIRLGQY-- 250 (336)
T ss_dssp CEEC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------------------------
T ss_pred ceecccc---ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhh-hhHHH-hhhcccc--
Confidence 9865432 223456899999999998889999999999999999999999999654332110 00000 0000000
Q ss_pred hhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 498 IFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 498 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
.............+.+++..|++.||.+|||+.|+++.
T Consensus 251 ----~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 288 (336)
T 3fhr_A 251 ----GFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNH 288 (336)
T ss_dssp ----CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred ----ccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 00000001223467788999999999999999999983
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=326.90 Aligned_cols=260 Identities=21% Similarity=0.309 Sum_probs=194.8
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCCC--ChHHHHHHHHHHHhcCCCCccccceeEEeccCC-CCc
Q 046270 263 TNGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDTK--GDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDS-SGK 338 (590)
Q Consensus 263 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~~--~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~-~~~ 338 (590)
.++|...+.||+|+||.||+|++. +|+.||||++...... ..+.+.+|+.++++++||||+++++++...+.. ...
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 357888899999999999999986 4889999998653322 245688999999999999999999998754321 112
Q ss_pred eEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCc
Q 046270 339 RRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLA 418 (590)
Q Consensus 339 ~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla 418 (590)
..++||||++ ++|.+++. ..+++.++..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||++
T Consensus 103 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 173 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMG-----LKFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLA 173 (353)
T ss_dssp CCEEEEECCS-EEGGGTTT-----SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred eEEEEecccc-CCHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEeECCCCcEEEeecccc
Confidence 4699999997 68888763 35999999999999999999999 889999999999999999999999999999
Q ss_pred ccccCCCcccccccccCCCccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCc-h
Q 046270 419 KQSLEGHSHLTTRVAGTFGYLAPEYALY-GQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKV-D 496 (590)
Q Consensus 419 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~-~ 496 (590)
+..... .....||..|+|||.+.+ ..++.++||||||++++||++|+.||...... ..+...... .+.. .
T Consensus 174 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~-~~~~~i~~~---~~~~~~ 245 (353)
T 3coi_A 174 RHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL-DQLTQILKV---TGVPGT 245 (353)
T ss_dssp TC------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHH-HHHHHHHHH---HCBCCH
T ss_pred cCCCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHH---hCCCCH
Confidence 864322 234568999999999876 67899999999999999999999999754321 111111110 0110 0
Q ss_pred hhh--------hHHHhh----------hhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 497 DIF--------DEFIRA----------EGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 497 ~~~--------d~~l~~----------~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
+.. ...+.. .........+.+++..|++.||++|||+.++++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 246 EFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp HHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 000 000000 0001223577889999999999999999999864
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-38 Score=323.72 Aligned_cols=246 Identities=24% Similarity=0.297 Sum_probs=189.9
Q ss_pred HHHHHhcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCCC------ChHHHHHHHHHHHhc----CCCCccccc
Q 046270 258 ELEQATNGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDTK------GDEDFTNEVEIISKI----RHRNLLSLR 326 (590)
Q Consensus 258 el~~at~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~~------~~~~f~~Ev~il~~l----~H~nlv~l~ 326 (590)
+.+...++|...+.||+|+||.||+|+.. +++.||||++...... ....+.+|++++.++ +|+||++++
T Consensus 25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~ 104 (312)
T 2iwi_A 25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL 104 (312)
T ss_dssp --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence 34455678999999999999999999875 5789999998654322 223466899999999 899999999
Q ss_pred eeEEeccCCCCceEEEEEee-CCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEC
Q 046270 327 GCCVTSDDSSGKRRFLVYDY-MPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLD 405 (590)
Q Consensus 327 g~~~~~~~~~~~~~~LV~E~-~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd 405 (590)
+++.. ....++|||| +++++|.+++.. ...+++..++.++.||+.||.||| +.+|+||||||+||+++
T Consensus 105 ~~~~~-----~~~~~~v~e~~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~ 173 (312)
T 2iwi_A 105 DWFET-----QEGFMLVLERPLPAQDLFDYITE---KGPLGEGPSRCFFGQVVAAIQHCH---SRGVVHRDIKDENILID 173 (312)
T ss_dssp EEC----------CEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHH---HHTEECCCCSGGGEEEE
T ss_pred EEEec-----CCeEEEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChhhEEEe
Confidence 99874 3457999999 889999999853 456999999999999999999999 78999999999999999
Q ss_pred -CCCcEEEEeeCCcccccCCCcccccccccCCCccCccccccCCCC-cchhHHHHHHHHHHHHhCCCCCCCCCCchhhhh
Q 046270 406 -SELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALYGQLT-EKSDVYSFGIVILELMSGRKVLDTSTSPFQLIT 483 (590)
Q Consensus 406 -~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t-~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~ 483 (590)
.++.+||+|||+++...... .....||..|+|||.+....+. .++||||||+++|||++|+.||.... .+.
T Consensus 174 ~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~----~~~ 246 (312)
T 2iwi_A 174 LRRGCAKLIDFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ----EIL 246 (312)
T ss_dssp TTTTEEEECCCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH----HHH
T ss_pred CCCCeEEEEEcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH----HHh
Confidence 88999999999998664332 3345689999999998877764 59999999999999999999986311 000
Q ss_pred HHHHHHHhcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 484 DWAWVLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 484 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
....... ......+.+++..|++.||++|||+.|+++.
T Consensus 247 ------~~~~~~~------------~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 247 ------EAELHFP------------AHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp ------HTCCCCC------------TTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred ------hhccCCc------------ccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000110 1122367788899999999999999999984
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=330.60 Aligned_cols=255 Identities=26% Similarity=0.357 Sum_probs=174.8
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCC-CChHHHHHHHH-HHHhcCCCCccccceeEEeccCCCCce
Q 046270 263 TNGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDT-KGDEDFTNEVE-IISKIRHRNLLSLRGCCVTSDDSSGKR 339 (590)
Q Consensus 263 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~-~~~~~f~~Ev~-il~~l~H~nlv~l~g~~~~~~~~~~~~ 339 (590)
.++|...+.||+|+||.||+|... +|+.||||++..... ....++..|+. +++.++||||+++++++.. ...
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~-----~~~ 95 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFR-----EGD 95 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEEC-----SSE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEe-----CCc
Confidence 367888899999999999999986 588999999875432 22345666666 6777899999999999984 456
Q ss_pred EEEEEeeCCCCCcchhhhhhc--ccccCChhhHHHHHHHHHHHHHHHHhcCCC-CeEecCCCCCceEECCCCcEEEEeeC
Q 046270 340 RFLVYDYMPNGTLSDNISISH--KRKQLTWPQRKKIIVDVAKGIAYLHYGLKP-GIYHRDIKSTNILLDSELNAKVADFG 416 (590)
Q Consensus 340 ~~LV~E~~~~gsL~~~L~~~~--~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~-~ivHrDIKp~NILLd~~~~~kL~DFG 416 (590)
.++||||+++ +|.+++.... ....+++..+..++.|++.||.||| +. +|+||||||+|||++.++.+||+|||
T Consensus 96 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~ivH~dlkp~NIll~~~~~~kl~Dfg 171 (327)
T 3aln_A 96 CWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK---ENLKIIHRDIKPSNILLDRSGNIKLCDFG 171 (327)
T ss_dssp EEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHH---HHHSCCCSCCCGGGEEEETTTEEEECCCS
T ss_pred eEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHh---ccCCEeECCCCHHHEEEcCCCCEEEccCC
Confidence 8999999985 7877764321 2457999999999999999999999 66 99999999999999999999999999
Q ss_pred CcccccCCCcccccccccCCCccCcccc----ccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhc
Q 046270 417 LAKQSLEGHSHLTTRVAGTFGYLAPEYA----LYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKS 492 (590)
Q Consensus 417 la~~~~~~~~~~~~~~~gt~~Y~APE~~----~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~ 492 (590)
+++...... ......||..|+|||.+ ....++.++||||||+++|||++|+.||.........+.. ...
T Consensus 172 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~-----~~~ 244 (327)
T 3aln_A 172 ISGQLVDSI--AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQ-----VVK 244 (327)
T ss_dssp SSCC--------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CC-----CCC
T ss_pred Cceeccccc--ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHH-----Hhc
Confidence 998654332 22334689999999998 4567899999999999999999999999753321111100 001
Q ss_pred CCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 046270 493 GKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALK 538 (590)
Q Consensus 493 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~ 538 (590)
+....+ ...........+.+++..|++.||++|||+.++++
T Consensus 245 ~~~~~~-----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 245 GDPPQL-----SNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp SCCCCC-----CCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCCC-----CCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 111110 00000112346788999999999999999999865
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=317.79 Aligned_cols=251 Identities=29% Similarity=0.361 Sum_probs=198.8
Q ss_pred HhcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCC--CCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCc
Q 046270 262 ATNGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLD--TKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGK 338 (590)
Q Consensus 262 at~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~--~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~ 338 (590)
..++|...+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++.. ..
T Consensus 20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~ 94 (287)
T 2wei_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILED-----SS 94 (287)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----SS
T ss_pred HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeC-----CC
Confidence 3467899999999999999999986 58899999986432 3446789999999999999999999999873 45
Q ss_pred eEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCC---CcEEEEee
Q 046270 339 RRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSE---LNAKVADF 415 (590)
Q Consensus 339 ~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~---~~~kL~DF 415 (590)
..++||||+++++|.+++. ....+++.+++.++.||+.||.||| +.+|+||||||+||+++.+ +.+||+||
T Consensus 95 ~~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIlv~~~~~~~~~kL~Df 168 (287)
T 2wei_A 95 SFYIVGELYTGGELFDEII---KRKRFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDF 168 (287)
T ss_dssp EEEEEECCCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEECST
T ss_pred eEEEEEEccCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChhhEEEecCCCcccEEEecc
Confidence 6899999999999998885 3357999999999999999999999 8899999999999999764 47999999
Q ss_pred CCcccccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCc
Q 046270 416 GLAKQSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKV 495 (590)
Q Consensus 416 Gla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~ 495 (590)
|+++...... ......||..|+|||.+.+ .++.++||||||+++|||++|+.||...... .. ... ...+..
T Consensus 169 g~~~~~~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~----~~~-~~~~~~ 239 (287)
T 2wei_A 169 GLSTCFQQNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY-DI----LKR-VETGKY 239 (287)
T ss_dssp TGGGTBCCCS--SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HH----HHH-HHHCCC
T ss_pred CcceeecCCC--ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHH-HH----HHH-HHcCCC
Confidence 9998654332 2233457899999998764 5899999999999999999999998653321 11 111 112221
Q ss_pred hhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 046270 496 DDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALK 538 (590)
Q Consensus 496 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~ 538 (590)
...... .......+.+++..|++.||++|||+.|+++
T Consensus 240 ~~~~~~------~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 240 AFDLPQ------WRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp CCCSGG------GTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCchh------hhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 100000 0112346778999999999999999999987
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-38 Score=338.94 Aligned_cols=250 Identities=24% Similarity=0.292 Sum_probs=183.0
Q ss_pred CCccceecccCcEEEEEEEEcCCcEEEEEEeecCCCCChHHHHHHHHHHHhc-CCCCccccceeEEeccCCCCceEEEEE
Q 046270 266 FSQNNLIGQGASGIVYKGTLRHGNLVAVKQILDLDTKGDEDFTNEVEIISKI-RHRNLLSLRGCCVTSDDSSGKRRFLVY 344 (590)
Q Consensus 266 f~~~~~LG~G~fG~Vykg~~~~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l-~H~nlv~l~g~~~~~~~~~~~~~~LV~ 344 (590)
|...+.||+|+||+||.+...+|+.||||++... ..+.+.+|++++.++ +||||+++++++. .+...++||
T Consensus 17 ~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~-----~~~~~~lv~ 88 (434)
T 2rio_A 17 VVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSET-----TDRFLYIAL 88 (434)
T ss_dssp EEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEE-----CSSEEEEEE
T ss_pred eeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEe-----cCCeEEEEE
Confidence 4446789999999998776677999999998642 345678999999987 8999999999886 345699999
Q ss_pred eeCCCCCcchhhhhhccc----ccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCC-------------
Q 046270 345 DYMPNGTLSDNISISHKR----KQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSE------------- 407 (590)
Q Consensus 345 E~~~~gsL~~~L~~~~~~----~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~------------- 407 (590)
||+. |+|.+++...... ...++..++.|+.||+.||+||| +.+|+||||||+|||++.+
T Consensus 89 E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~ 164 (434)
T 2rio_A 89 ELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAEN 164 (434)
T ss_dssp CCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEECCHHHHSCCTTCCCS
T ss_pred ecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCcccccccccCCCc
Confidence 9995 6999998643211 11245567889999999999999 8899999999999999653
Q ss_pred CcEEEEeeCCcccccCCCcc---cccccccCCCccCcccccc-------CCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 046270 408 LNAKVADFGLAKQSLEGHSH---LTTRVAGTFGYLAPEYALY-------GQLTEKSDVYSFGIVILELMS-GRKVLDTST 476 (590)
Q Consensus 408 ~~~kL~DFGla~~~~~~~~~---~~~~~~gt~~Y~APE~~~~-------~~~t~ksDVySfGvvLlELlt-G~~p~~~~~ 476 (590)
+.+||+|||+++........ ......||++|+|||.+.+ ..++.++|||||||++|||+| |+.||....
T Consensus 165 ~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~ 244 (434)
T 2rio_A 165 LRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKY 244 (434)
T ss_dssp CEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTT
T ss_pred eEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCch
Confidence 58999999999876544322 1234579999999999875 678999999999999999999 999986543
Q ss_pred CchhhhhHHHHHHHhcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 046270 477 SPFQLITDWAWVLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALK 538 (590)
Q Consensus 477 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~ 538 (590)
.....+ .. ..-..... ...........+.+++..|++.||.+|||+.||++
T Consensus 245 ~~~~~i---~~---~~~~~~~~-----~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 245 SRESNI---IR---GIFSLDEM-----KCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp THHHHH---HH---TCCCCCCC-----TTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhHHHH---hc---CCCCcccc-----cccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 322111 11 00011110 00011234457888999999999999999999986
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=321.73 Aligned_cols=258 Identities=19% Similarity=0.255 Sum_probs=195.0
Q ss_pred hcCCCccceecccCcEEEEEEEEcC-C-cEEEEEEeecCCCCChHHHHHHHHHHHhcCCCC------ccccceeEEeccC
Q 046270 263 TNGFSQNNLIGQGASGIVYKGTLRH-G-NLVAVKQILDLDTKGDEDFTNEVEIISKIRHRN------LLSLRGCCVTSDD 334 (590)
Q Consensus 263 t~~f~~~~~LG~G~fG~Vykg~~~~-g-~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~n------lv~l~g~~~~~~~ 334 (590)
.++|...+.||+|+||.||+|+... + ..||||++... ....+.+.+|++++++++|+| ++.+.+++..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~--- 93 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNF--- 93 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEE---
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeee---
Confidence 4678999999999999999999853 4 68999998642 233567889999999998766 8888888764
Q ss_pred CCCceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEE----------
Q 046270 335 SSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILL---------- 404 (590)
Q Consensus 335 ~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILL---------- 404 (590)
....++||||+ +++|.+++... ....+++.+++.|+.||+.||+||| +.+|+||||||+|||+
T Consensus 94 --~~~~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~ 166 (355)
T 2eu9_A 94 --HGHMCIAFELL-GKNTFEFLKEN-NFQPYPLPHVRHMAYQLCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYN 166 (355)
T ss_dssp --TTEEEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEESCCCEEEEEC
T ss_pred --CCeEEEEEecc-CCChHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeccccccccc
Confidence 44689999999 66776766432 2346999999999999999999999 8999999999999999
Q ss_pred ---------CCCCcEEEEeeCCcccccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 046270 405 ---------DSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTS 475 (590)
Q Consensus 405 ---------d~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~ 475 (590)
+.++.+||+|||+++..... .....||..|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 167 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 242 (355)
T 2eu9_A 167 EHKSCEEKSVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTH 242 (355)
T ss_dssp CC-CCCEEEESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccccccccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCC
Confidence 56789999999999864332 23457899999999999999999999999999999999999999754
Q ss_pred CCchhhhhHHHHHHHhcCCchhhhhH----------------------HHhh---------hhHHHHHHHHHHHHHhchh
Q 046270 476 TSPFQLITDWAWVLAKSGKVDDIFDE----------------------FIRA---------EGARAVMERFVLVGILCAH 524 (590)
Q Consensus 476 ~~~~~~l~~~~~~~~~~~~~~~~~d~----------------------~l~~---------~~~~~~~~~l~~l~~~Cl~ 524 (590)
.... .+..... .. ......++.. .+.. .........+.+++..|++
T Consensus 243 ~~~~-~~~~~~~-~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 319 (355)
T 2eu9_A 243 ENRE-HLVMMEK-IL-GPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLE 319 (355)
T ss_dssp SHHH-HHHHHHH-HH-CCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTC
T ss_pred CHHH-HHHHHHH-Hc-CCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhc
Confidence 4322 1111111 10 0000000000 0000 0011223478889999999
Q ss_pred cCCCCCCCHHHHHH
Q 046270 525 VMVALRPTITDALK 538 (590)
Q Consensus 525 ~dp~~RPtm~eVl~ 538 (590)
.||++|||+.|+++
T Consensus 320 ~dP~~Rpt~~e~l~ 333 (355)
T 2eu9_A 320 FDPAQRITLAEALL 333 (355)
T ss_dssp SSTTTSCCHHHHTT
T ss_pred CChhhCcCHHHHhc
Confidence 99999999999975
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-37 Score=326.41 Aligned_cols=206 Identities=22% Similarity=0.293 Sum_probs=170.5
Q ss_pred HHHHHhcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCCCChHHHHHHHHHHHhcC-CCC-----ccccceeEE
Q 046270 258 ELEQATNGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDTKGDEDFTNEVEIISKIR-HRN-----LLSLRGCCV 330 (590)
Q Consensus 258 el~~at~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~-H~n-----lv~l~g~~~ 330 (590)
+.+...++|...+.||+|+||.||+|+.. +++.||||++... .....++..|++++..++ |+| ++++++++.
T Consensus 48 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~ 126 (382)
T 2vx3_A 48 NGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFM 126 (382)
T ss_dssp TTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEE
T ss_pred cCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeec
Confidence 33445678999999999999999999987 4778999998642 223456788999999885 554 889999887
Q ss_pred eccCCCCceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEC--CCC
Q 046270 331 TSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLD--SEL 408 (590)
Q Consensus 331 ~~~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd--~~~ 408 (590)
. ....++||||++ |+|.+++... ....+++..++.|+.||+.||.|||.. +.+|+||||||+|||++ .++
T Consensus 127 ~-----~~~~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~ 198 (382)
T 2vx3_A 127 F-----RNHLCLVFEMLS-YNLYDLLRNT-NFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRS 198 (382)
T ss_dssp E-----TTEEEEEEECCC-CBHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSC
T ss_pred c-----CCceEEEEecCC-CCHHHHHhhc-CcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCC
Confidence 4 356999999996 5999988643 224699999999999999999999932 46899999999999994 578
Q ss_pred cEEEEeeCCcccccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 046270 409 NAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTST 476 (590)
Q Consensus 409 ~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~ 476 (590)
.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||+||+.||....
T Consensus 199 ~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~ 262 (382)
T 2vx3_A 199 AIKIVDFGSSCQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN 262 (382)
T ss_dssp CEEECCCTTCEETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cEEEEeccCceecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 8999999999865432 234578999999999999999999999999999999999999997543
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=319.90 Aligned_cols=251 Identities=23% Similarity=0.346 Sum_probs=176.1
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCCCC--hHHHHHHHHHHHhcCCCCccccceeEEeccCCCCce
Q 046270 263 TNGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDTKG--DEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKR 339 (590)
Q Consensus 263 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~~~--~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~ 339 (590)
.++|...+.||+|+||.||+|++. +|+.||||++....... .+.+.++..+++.++||||+++++++.. +..
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~-----~~~ 98 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFIT-----NTD 98 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-----SSE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEec-----CCc
Confidence 457888899999999999999986 58899999987543222 2234455567888899999999999974 456
Q ss_pred EEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCC-CeEecCCCCCceEECCCCcEEEEeeCCc
Q 046270 340 RFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKP-GIYHRDIKSTNILLDSELNAKVADFGLA 418 (590)
Q Consensus 340 ~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~-~ivHrDIKp~NILLd~~~~~kL~DFGla 418 (590)
.++||||+ ++.+..+.. .....+++..++.++.||+.||.||| .. +|+||||||+|||++.++.+||+|||++
T Consensus 99 ~~lv~e~~-~~~~~~l~~--~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~ 172 (318)
T 2dyl_A 99 VFIAMELM-GTCAEKLKK--RMQGPIPERILGKMTVAIVKALYYLK---EKHGVIHRDVKPSNILLDERGQIKLCDFGIS 172 (318)
T ss_dssp EEEEECCC-SEEHHHHHH--HHTSCCCHHHHHHHHHHHHHHHHHHH---HHHCCCCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEEEecc-CCcHHHHHH--HhccCCCHHHHHHHHHHHHHHHHHHH---hhCCEEeCCCCHHHEEECCCCCEEEEECCCc
Confidence 99999999 444444332 22457999999999999999999999 64 9999999999999999999999999999
Q ss_pred ccccCCCcccccccccCCCccCccccc-----cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcC
Q 046270 419 KQSLEGHSHLTTRVAGTFGYLAPEYAL-----YGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSG 493 (590)
Q Consensus 419 ~~~~~~~~~~~~~~~gt~~Y~APE~~~-----~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~ 493 (590)
+...... ......||..|+|||.+. ...++.++||||||+++|||++|+.||.........+. ......
T Consensus 173 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~----~~~~~~ 246 (318)
T 2dyl_A 173 GRLVDDK--AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLT----KVLQEE 246 (318)
T ss_dssp ----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHH----HHHHSC
T ss_pred hhccCCc--cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHH----HHhccC
Confidence 7654322 233456899999999984 56789999999999999999999999975443322221 111111
Q ss_pred CchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 046270 494 KVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALK 538 (590)
Q Consensus 494 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~ 538 (590)
. ..... .......+..++..|++.||.+|||+.++++
T Consensus 247 ~-~~~~~-------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 247 P-PLLPG-------HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp C-CCCCS-------SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred C-CCCCc-------cCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 1 00000 0012246778889999999999999999976
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=323.39 Aligned_cols=246 Identities=24% Similarity=0.347 Sum_probs=196.2
Q ss_pred HHHHHhcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCCC------ChHHHHHHHHHHHhcC--CCCcccccee
Q 046270 258 ELEQATNGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDTK------GDEDFTNEVEIISKIR--HRNLLSLRGC 328 (590)
Q Consensus 258 el~~at~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~~------~~~~f~~Ev~il~~l~--H~nlv~l~g~ 328 (590)
+.+...++|...+.||+|+||.||+|+.. +++.||||++...... ..+.+.+|++++++++ |+||++++++
T Consensus 37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~ 116 (320)
T 3a99_A 37 EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW 116 (320)
T ss_dssp ---CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEE
T ss_pred ccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEE
Confidence 33445577999999999999999999875 5789999998654322 2245778999999996 5999999999
Q ss_pred EEeccCCCCceEEEEEeeCCC-CCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEC-C
Q 046270 329 CVTSDDSSGKRRFLVYDYMPN-GTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLD-S 406 (590)
Q Consensus 329 ~~~~~~~~~~~~~LV~E~~~~-gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd-~ 406 (590)
+.. ....++|||++.+ ++|.+++. ....+++..++.|+.||+.||+||| +.+|+||||||+|||++ +
T Consensus 117 ~~~-----~~~~~lv~e~~~~~~~L~~~l~---~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~ 185 (320)
T 3a99_A 117 FER-----PDSFVLILERPEPVQDLFDFIT---ERGALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLN 185 (320)
T ss_dssp EEC-----SSEEEEEEECCSSEEEHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETT
T ss_pred Eec-----CCcEEEEEEcCCCCccHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHH---HCCcEeCCCCHHHEEEeCC
Confidence 973 4568999999976 89999885 3457999999999999999999999 89999999999999999 7
Q ss_pred CCcEEEEeeCCcccccCCCcccccccccCCCccCccccccCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHH
Q 046270 407 ELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALYGQL-TEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDW 485 (590)
Q Consensus 407 ~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~-t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~ 485 (590)
++.+||+|||+++..... ......||..|+|||.+....+ +.++||||||+++|||++|+.||.... . +
T Consensus 186 ~~~~kL~Dfg~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~---~-~--- 255 (320)
T 3a99_A 186 RGELKLIDFGSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE---E-I--- 255 (320)
T ss_dssp TTEEEECCCTTCEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH---H-H---
T ss_pred CCCEEEeeCccccccccc---cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh---h-h---
Confidence 799999999999865432 2234568999999999887766 688999999999999999999986321 0 0
Q ss_pred HHHHHhcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 486 AWVLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 486 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
.. +... + .......+.+++..|++.||++|||+.|+++.
T Consensus 256 ----~~-~~~~--~--------~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 256 ----IR-GQVF--F--------RQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp ----HH-CCCC--C--------SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ----hc-cccc--c--------cccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 01 1100 0 01122467788999999999999999999873
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=334.73 Aligned_cols=249 Identities=23% Similarity=0.289 Sum_probs=184.2
Q ss_pred hcCCCccceecccCcEEEEEEEEcCCcEEEEEEeecCCCCChHHHHHHHHHHHhc-CCCCccccceeEEeccCCCCceEE
Q 046270 263 TNGFSQNNLIGQGASGIVYKGTLRHGNLVAVKQILDLDTKGDEDFTNEVEIISKI-RHRNLLSLRGCCVTSDDSSGKRRF 341 (590)
Q Consensus 263 t~~f~~~~~LG~G~fG~Vykg~~~~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l-~H~nlv~l~g~~~~~~~~~~~~~~ 341 (590)
..+|...+.||+|+||+||.....+|+.||||++.... ...+.+|+++++++ +|||||++++++.. ....+
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~l~~~~~~-----~~~~~ 94 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVIRYFCTEKD-----RQFQY 94 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTT---EEECHHHHHHHHHSCCCTTBCCEEEEEEE-----TTEEE
T ss_pred cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEec-----CCEEE
Confidence 34688889999999998665555678999999986532 23467899999999 89999999998874 45689
Q ss_pred EEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEC-----CCCcEEEEeeC
Q 046270 342 LVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLD-----SELNAKVADFG 416 (590)
Q Consensus 342 LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd-----~~~~~kL~DFG 416 (590)
+||||++ |+|.+++.. ....+.+..++.|+.||+.||.||| +.+|+||||||+|||++ ....+||+|||
T Consensus 95 lv~E~~~-g~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG 168 (432)
T 3p23_A 95 IAIELCA-ATLQEYVEQ--KDFAHLGLEPITLLQQTTSGLAHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFG 168 (432)
T ss_dssp EEEECCS-EEHHHHHHS--SSCCCCSSCHHHHHHHHHHHHHHHH---HTTCCCCCCSTTSEEECCCBTTTBCCEEECCTT
T ss_pred EEEECCC-CCHHHHHHh--cCCCccchhHHHHHHHHHHHHHHHH---HCcCEeCCCCHHHEEEecCCCCCceeEEEeccc
Confidence 9999996 699998853 2334666778899999999999999 88999999999999994 33468899999
Q ss_pred CcccccCCCc--ccccccccCCCccCccccc---cCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhhHHHHHHH
Q 046270 417 LAKQSLEGHS--HLTTRVAGTFGYLAPEYAL---YGQLTEKSDVYSFGIVILELMS-GRKVLDTSTSPFQLITDWAWVLA 490 (590)
Q Consensus 417 la~~~~~~~~--~~~~~~~gt~~Y~APE~~~---~~~~t~ksDVySfGvvLlELlt-G~~p~~~~~~~~~~l~~~~~~~~ 490 (590)
+++....... .......||++|+|||.+. ...++.++|||||||++|||++ |+.||........ ....
T Consensus 169 ~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~------~~~~ 242 (432)
T 3p23_A 169 LCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQA------NILL 242 (432)
T ss_dssp EEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHH------HHHT
T ss_pred ceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHH------HHHh
Confidence 9987654322 2234567999999999987 4677889999999999999999 8888854332211 1111
Q ss_pred hcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 046270 491 KSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALK 538 (590)
Q Consensus 491 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~ 538 (590)
..... +...+ .......+.+++..|++.||.+|||+.||++
T Consensus 243 ~~~~~-~~~~~------~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 243 GACSL-DCLHP------EKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp TCCCC-TTSCT------TCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccCCc-cccCc------cccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 11111 11111 0112235677889999999999999999984
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-37 Score=349.32 Aligned_cols=242 Identities=19% Similarity=0.285 Sum_probs=190.9
Q ss_pred hcCCCccceecccCcEEEEEEEEc--CCcEEEEEEeecCCC-CChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCce
Q 046270 263 TNGFSQNNLIGQGASGIVYKGTLR--HGNLVAVKQILDLDT-KGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKR 339 (590)
Q Consensus 263 t~~f~~~~~LG~G~fG~Vykg~~~--~g~~vAvK~l~~~~~-~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~ 339 (590)
.++|...+.||+|+||.||+|++. +|+.||||++..... .....+.+|++++.+++||||+++++++...+......
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 367999999999999999999986 588999999865332 23456889999999999999999999998765422334
Q ss_pred EEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcc
Q 046270 340 RFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAK 419 (590)
Q Consensus 340 ~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~ 419 (590)
.+|||||+++++|.+++. ..++|.+++.|+.||+.||.||| +.+|+||||||+|||++.+ .+||+|||+++
T Consensus 159 ~~lv~E~~~g~~L~~~~~-----~~l~~~~~~~~~~qi~~aL~~lH---~~giiHrDlkp~NIll~~~-~~kl~DFG~a~ 229 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKG-----QKLPVAEAIAYLLEILPALSYLH---SIGLVYNDLKPENIMLTEE-QLKLIDLGAVS 229 (681)
T ss_dssp EEEEEECCCCEECC---------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSS-CEEECCCTTCE
T ss_pred eEEEEEeCCCCcHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHH---HCCCeecccChHHeEEeCC-cEEEEecccch
Confidence 699999999999998763 26999999999999999999999 8899999999999999986 99999999998
Q ss_pred cccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhh
Q 046270 420 QSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIF 499 (590)
Q Consensus 420 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 499 (590)
..... ....||++|+|||++.++. +.++|||||||+++||++|..|+...... + ..+ .
T Consensus 230 ~~~~~-----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~--------------~-~~~-~ 287 (681)
T 2pzi_A 230 RINSF-----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVD--------------G-LPE-D 287 (681)
T ss_dssp ETTCC-----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECS--------------S-CCT-T
T ss_pred hcccC-----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccc--------------c-ccc-c
Confidence 65432 3456899999999887654 89999999999999999998887532110 0 000 0
Q ss_pred hHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCC-HHHHHHHhc
Q 046270 500 DEFIRAEGARAVMERFVLVGILCAHVMVALRPT-ITDALKMLE 541 (590)
Q Consensus 500 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt-m~eVl~~L~ 541 (590)
.+ .......+..++..|++.||.+||+ ++++.+.|.
T Consensus 288 ~~------~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~ 324 (681)
T 2pzi_A 288 DP------VLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLT 324 (681)
T ss_dssp CH------HHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred cc------ccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHH
Confidence 00 0112246778899999999999995 555555544
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-37 Score=328.46 Aligned_cols=248 Identities=16% Similarity=0.147 Sum_probs=181.7
Q ss_pred HHhcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCCC---ChHHHHHHHHHHHhcCC-CCcccccee-------
Q 046270 261 QATNGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDTK---GDEDFTNEVEIISKIRH-RNLLSLRGC------- 328 (590)
Q Consensus 261 ~at~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~~---~~~~f~~Ev~il~~l~H-~nlv~l~g~------- 328 (590)
..+.+|...++||+|+||.||+|++. +|+.||||++...... ..+.|.+|+.+++.++| +|......+
T Consensus 75 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~ 154 (413)
T 3dzo_A 75 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF 154 (413)
T ss_dssp SCCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCC
T ss_pred CCceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccch
Confidence 34456777889999999999999965 5889999998743322 35679999999999987 332221111
Q ss_pred --EEe------------ccCCCCceEEEEEeeCCCCCcchhhhhh----cccccCChhhHHHHHHHHHHHHHHHHhcCCC
Q 046270 329 --CVT------------SDDSSGKRRFLVYDYMPNGTLSDNISIS----HKRKQLTWPQRKKIIVDVAKGIAYLHYGLKP 390 (590)
Q Consensus 329 --~~~------------~~~~~~~~~~LV~E~~~~gsL~~~L~~~----~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~ 390 (590)
... .........+++|+++ +++|.+++... .....++|..++.|+.||++||+||| +.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~ 230 (413)
T 3dzo_A 155 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HY 230 (413)
T ss_dssp EEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HT
T ss_pred hhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHH---hC
Confidence 110 0000122356777765 68999888421 12456899999999999999999999 89
Q ss_pred CeEecCCCCCceEECCCCcEEEEeeCCcccccCCCcccccccccCCCccCcccc----------ccCCCCcchhHHHHHH
Q 046270 391 GIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYA----------LYGQLTEKSDVYSFGI 460 (590)
Q Consensus 391 ~ivHrDIKp~NILLd~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~----------~~~~~t~ksDVySfGv 460 (590)
+|+||||||+||||+.++.+||+|||+++..... .....| ..|+|||++ ....++.++|||||||
T Consensus 231 ~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGv 305 (413)
T 3dzo_A 231 GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGL 305 (413)
T ss_dssp TEECSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHH
T ss_pred CcccCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHH
Confidence 9999999999999999999999999998864322 344567 999999999 5556889999999999
Q ss_pred HHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHH
Q 046270 461 VILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDAL 537 (590)
Q Consensus 461 vLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl 537 (590)
++|||+||+.||........ ....+.. . ....+.+.+++..|++.||++|||+.+++
T Consensus 306 il~elltg~~Pf~~~~~~~~--------------~~~~~~~----~--~~~~~~~~~li~~~l~~dP~~Rpt~~~~l 362 (413)
T 3dzo_A 306 AIYWIWCADLPNTDDAALGG--------------SEWIFRS----C--KNIPQPVRALLEGFLRYPKEDRLLPLQAM 362 (413)
T ss_dssp HHHHHHHSSCCCCTTGGGSC--------------SGGGGSS----C--CCCCHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred HHHHHHHCCCCCCCcchhhh--------------HHHHHhh----c--ccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 99999999999965332111 0011110 0 01224678888999999999999977764
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-36 Score=308.09 Aligned_cols=229 Identities=11% Similarity=0.079 Sum_probs=178.7
Q ss_pred cCCCccceecccCcEEEEEEEEcC-CcEEEEEEeecCCCCC---hHHHHHHHHHHHhcCCCCccccceeEEeccCCCCce
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLRH-GNLVAVKQILDLDTKG---DEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKR 339 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~vAvK~l~~~~~~~---~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~ 339 (590)
++|...+.||+|+||.||+|++.. |+.||||++....... .+.+.+|++++.+++||||+++++++.. ...
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~-----~~~ 105 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHT-----RAG 105 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-----TTE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEE-----CCc
Confidence 578889999999999999999875 8899999987544332 3678999999999999999999999874 346
Q ss_pred EEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcc
Q 046270 340 RFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAK 419 (590)
Q Consensus 340 ~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~ 419 (590)
.++||||+++++|.+++. .+ ....+..+|+.||+.||+||| +.+|+||||||+|||++.++.+||+++
T Consensus 106 ~~lv~e~~~g~~L~~~l~----~~-~~~~~~~~i~~ql~~aL~~lH---~~givH~Dikp~NIll~~~g~~kl~~~---- 173 (286)
T 3uqc_A 106 GLVVAEWIRGGSLQEVAD----TS-PSPVGAIRAMQSLAAAADAAH---RAGVALSIDHPSRVRVSIDGDVVLAYP---- 173 (286)
T ss_dssp EEEEEECCCEEEHHHHHT----TC-CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEETTSCEEECSC----
T ss_pred EEEEEEecCCCCHHHHHh----cC-CChHHHHHHHHHHHHHHHHHH---HCCCccCCCCcccEEEcCCCCEEEEec----
Confidence 899999999999999984 12 355678899999999999999 899999999999999999999999743
Q ss_pred cccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhh
Q 046270 420 QSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIF 499 (590)
Q Consensus 420 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 499 (590)
+|++| ++.++||||||+++|||+||+.||............+ . ...+....
T Consensus 174 -----------------~~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~--~-~~~~~~~~-- 224 (286)
T 3uqc_A 174 -----------------ATMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAE--R-DTAGQPIE-- 224 (286)
T ss_dssp -----------------CCCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECC--B-CTTSCBCC--
T ss_pred -----------------cccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHH--H-HhccCCCC--
Confidence 34443 6899999999999999999999997644321100000 0 00011000
Q ss_pred hHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhccC
Q 046270 500 DEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEGD 543 (590)
Q Consensus 500 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~~ 543 (590)
...+ .......+..++..|++.||++| |+.|+++.|+..
T Consensus 225 ~~~~----~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~ 263 (286)
T 3uqc_A 225 PADI----DRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQA 263 (286)
T ss_dssp HHHH----CTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHH
T ss_pred hhhc----ccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHH
Confidence 0001 11223467889999999999999 999999999874
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=349.02 Aligned_cols=263 Identities=24% Similarity=0.328 Sum_probs=196.0
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCC-CCChHHHHHHHHHHHhcCCCCccccceeEEeccC-CCCceE
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLD-TKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDD-SSGKRR 340 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~-~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~-~~~~~~ 340 (590)
++|...+.||+|+||.||+|.+. +|+.||||++.... ....+.+.+|++++.+++||||+++++++..... ..+...
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 67999999999999999999985 48899999986532 2335678999999999999999999998754221 135668
Q ss_pred EEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCc---EEEEeeCC
Q 046270 341 FLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELN---AKVADFGL 417 (590)
Q Consensus 341 ~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~---~kL~DFGl 417 (590)
++||||+++|+|.+++........+++..++.|+.+++.||+||| +.+|+||||||+|||++.++. +||+|||+
T Consensus 94 ~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLH---s~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~ 170 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGY 170 (676)
T ss_dssp CCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHH---HTTBCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEeecCCCceeEEEccccc
Confidence 999999999999999975444456999999999999999999999 889999999999999987664 99999999
Q ss_pred cccccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCc--
Q 046270 418 AKQSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKV-- 495 (590)
Q Consensus 418 a~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~-- 495 (590)
++...... ......||..|+|||.+.++.++.++||||||+++|||++|+.||.....+. .|.......+..
T Consensus 171 a~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~----~~~~~i~~~~~~~~ 244 (676)
T 3qa8_A 171 AKELDQGE--LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPV----QWHGKVREKSNEHI 244 (676)
T ss_dssp CCBTTSCC--CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHH----HSSTTCC------C
T ss_pred cccccccc--ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchh----hhhhhhhcccchhh
Confidence 98764432 2344678999999999999999999999999999999999999996532211 111000000000
Q ss_pred --hhh------hhHHH--hhhhHHHHHHHHHHHHHhchhcCCCCCCCHHH
Q 046270 496 --DDI------FDEFI--RAEGARAVMERFVLVGILCAHVMVALRPTITD 535 (590)
Q Consensus 496 --~~~------~d~~l--~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~e 535 (590)
.+. +...+ ...........+.+++..|++.||++|||+.+
T Consensus 245 ~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~e 294 (676)
T 3qa8_A 245 VVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQ 294 (676)
T ss_dssp CSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTT
T ss_pred hhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHH
Confidence 000 00000 00111224457888999999999999999866
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-35 Score=302.25 Aligned_cols=235 Identities=20% Similarity=0.265 Sum_probs=177.8
Q ss_pred cCCCcc-ceecccCcEEEEEEEEc-CCcEEEEEEeecCCCCChHHHHHHHHHH-HhcCCCCccccceeEEeccCCCCceE
Q 046270 264 NGFSQN-NLIGQGASGIVYKGTLR-HGNLVAVKQILDLDTKGDEDFTNEVEII-SKIRHRNLLSLRGCCVTSDDSSGKRR 340 (590)
Q Consensus 264 ~~f~~~-~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~~~~~~f~~Ev~il-~~l~H~nlv~l~g~~~~~~~~~~~~~ 340 (590)
++|... +.||+|+||.||++... +++.||+|++.. ...+.+|++++ +.++||||+++++++..... .+...
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~-~~~~~ 90 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYA-GRKCL 90 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEET-TEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcC-CCceE
Confidence 456665 77999999999999985 588999999853 35678899998 55599999999999875322 34568
Q ss_pred EEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECC---CCcEEEEeeCC
Q 046270 341 FLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDS---ELNAKVADFGL 417 (590)
Q Consensus 341 ~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~---~~~~kL~DFGl 417 (590)
++||||+++|+|.+++... ....+++..++.|+.|++.||.||| +.+|+||||||+|||++. ++.+||+|||+
T Consensus 91 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~ 166 (299)
T 3m2w_A 91 LIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGF 166 (299)
T ss_dssp EEEECCCCSCBHHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEEeecCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEecCCCCCcEEEecccc
Confidence 9999999999999998642 2346999999999999999999999 899999999999999998 78999999999
Q ss_pred cccccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchh
Q 046270 418 AKQSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDD 497 (590)
Q Consensus 418 a~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 497 (590)
++... ...++.++||||||+++|||++|+.||........... .. .....+.. .
T Consensus 167 a~~~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~-~~-~~~~~~~~-~ 220 (299)
T 3m2w_A 167 AKETT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG-MK-TRIRMGQY-E 220 (299)
T ss_dssp CEECT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CC-SC-CSSCTTCC-S
T ss_pred ccccc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHH-HH-HHHhhccc-c
Confidence 86432 24567899999999999999999999965332110000 00 00000000 0
Q ss_pred hhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 498 IFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 498 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
...+ ........+..++..|++.||.+|||+.|+++.
T Consensus 221 ~~~~-----~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 221 FPNP-----EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp SCHH-----HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCch-----hcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 0000 001223467889999999999999999999973
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-35 Score=307.03 Aligned_cols=248 Identities=15% Similarity=0.143 Sum_probs=181.1
Q ss_pred hcCCCccceecccCcEEEEEEEEcCCcEEEEEEeecCCC--------CChHHHHHHHHHHHhcC---------CCCcccc
Q 046270 263 TNGFSQNNLIGQGASGIVYKGTLRHGNLVAVKQILDLDT--------KGDEDFTNEVEIISKIR---------HRNLLSL 325 (590)
Q Consensus 263 t~~f~~~~~LG~G~fG~Vykg~~~~g~~vAvK~l~~~~~--------~~~~~f~~Ev~il~~l~---------H~nlv~l 325 (590)
.++|...+.||+|+||.||+|++ +|+.||||++..... ...+.+.+|++++++++ |+|+|++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 35677889999999999999998 589999999975432 22378999999999986 6666666
Q ss_pred ceeEEecc-------------------------CCCCceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHH
Q 046270 326 RGCCVTSD-------------------------DSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKG 380 (590)
Q Consensus 326 ~g~~~~~~-------------------------~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~g 380 (590)
.+.+.... .......++||||+++|++.+.+. +..+++..++.|+.||+.|
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~----~~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR----TKLSSLATAKSILHQLTAS 173 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT----TTCCCHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH----hcCCCHHHHHHHHHHHHHH
Confidence 66543211 002467999999999998777663 2468999999999999999
Q ss_pred HHHHHhcCCCCeEecCCCCCceEECCCC--------------------cEEEEeeCCcccccCCCcccccccccCCCccC
Q 046270 381 IAYLHYGLKPGIYHRDIKSTNILLDSEL--------------------NAKVADFGLAKQSLEGHSHLTTRVAGTFGYLA 440 (590)
Q Consensus 381 L~yLH~~~~~~ivHrDIKp~NILLd~~~--------------------~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~A 440 (590)
|+|||+ +.+|+||||||+|||++.++ .+||+|||+++..... ...||+.|+|
T Consensus 174 L~~lH~--~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~y~a 245 (336)
T 2vuw_A 174 LAVAEA--SLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDVSMD 245 (336)
T ss_dssp HHHHHH--HHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCCTTC
T ss_pred HHHHHH--hCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeecccC
Confidence 999992 36899999999999999887 8999999999865432 3478999999
Q ss_pred ccccccCCCCcchhHHHHHHH-HHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhhhHHHhhhhHHHHHHHHHHHH
Q 046270 441 PEYALYGQLTEKSDVYSFGIV-ILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDEFIRAEGARAVMERFVLVG 519 (590)
Q Consensus 441 PE~~~~~~~t~ksDVySfGvv-LlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~ 519 (590)
||.+.+.. +.++||||+|++ .+++++|..||... ..+................. ...........+.+++
T Consensus 246 PE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~----~~~~~~~~~~~~~~~~~~~~----~~~~~~~~s~~~~dli 316 (336)
T 2vuw_A 246 EDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV----LWLHYLTDKMLKQMTFKTKC----NTPAMKQIKRKIQEFH 316 (336)
T ss_dssp SGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH----HHHHHHHHHHHHTCCCSSCC----CSHHHHHHHHHHHHHH
T ss_pred hhhhcCCC-ccceehhhhhCCCCcccccccCCCcch----hhhhHHHHhhhhhhccCccc----chhhhhhcCHHHHHHH
Confidence 99988655 899999998777 77788898876310 00000011111111100000 0111234556788999
Q ss_pred HhchhcCCCCCCCHHHHH
Q 046270 520 ILCAHVMVALRPTITDAL 537 (590)
Q Consensus 520 ~~Cl~~dp~~RPtm~eVl 537 (590)
..|++.| |+.|++
T Consensus 317 ~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 317 RTMLNFS-----SATDLL 329 (336)
T ss_dssp HHGGGSS-----SHHHHH
T ss_pred HHHhccC-----CHHHHH
Confidence 9999966 999988
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.1e-29 Score=283.72 Aligned_cols=184 Identities=17% Similarity=0.199 Sum_probs=127.1
Q ss_pred ecccCcEEEEEEEEc-CCcEEEEEEeecCCC----------CChHHHHHHHHHHHhc-CCCCccccceeEEeccCCCCce
Q 046270 272 IGQGASGIVYKGTLR-HGNLVAVKQILDLDT----------KGDEDFTNEVEIISKI-RHRNLLSLRGCCVTSDDSSGKR 339 (590)
Q Consensus 272 LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~----------~~~~~f~~Ev~il~~l-~H~nlv~l~g~~~~~~~~~~~~ 339 (590)
++.|++|.+.+++.. -|+.+|+|.+..... ...++|.+|+++|+++ .|+||+++++++. +...
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~e-----d~~~ 316 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGE-----NAQS 316 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEE-----CSSE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEE-----ECCE
Confidence 556666666655432 378899999865321 1235699999999999 7999999999997 4557
Q ss_pred EEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcc
Q 046270 340 RFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAK 419 (590)
Q Consensus 340 ~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~ 419 (590)
.||||||++|++|.++|. ..+.++.. +|+.||+.||+|+| +.+||||||||+||||++++++||+|||+++
T Consensus 317 ~yLVMEyv~G~~L~d~i~---~~~~l~~~---~I~~QIl~AL~ylH---~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr 387 (569)
T 4azs_A 317 GWLVMEKLPGRLLSDMLA---AGEEIDRE---KILGSLLRSLAALE---KQGFWHDDVRPWNVMVDARQHARLIDFGSIV 387 (569)
T ss_dssp EEEEEECCCSEEHHHHHH---TTCCCCHH---HHHHHHHHHHHHHH---HTTCEESCCCGGGEEECTTSCEEECCCTTEE
T ss_pred EEEEEecCCCCcHHHHHH---hCCCCCHH---HHHHHHHHHHHHHH---HCCceeccCchHhEEECCCCCEEEeecccCe
Confidence 999999999999999995 34456543 58999999999999 9999999999999999999999999999998
Q ss_pred cccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCC
Q 046270 420 QSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKV 471 (590)
Q Consensus 420 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p 471 (590)
....... ......||++|||||.+. +++..++|+||+|++++++.+|..+
T Consensus 388 ~~~~~~~-~~~t~vGTp~YmAPE~l~-g~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 388 TTPQDCS-WPTNLVQSFFVFVNELFA-ENKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp SCC---C-CSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred eCCCCCc-cccCceechhhccHHHhC-CCCCCcccccccccchhhhccccch
Confidence 7654332 334567999999999876 4677899999999998888766543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=7.9e-27 Score=259.21 Aligned_cols=184 Identities=17% Similarity=0.202 Sum_probs=144.1
Q ss_pred CccceecccCcEEEEEEEEcCCcEEEEEEeecCCCCC--------hHHHHHHHHHHHhcCCCCccccceeEEeccCCCCc
Q 046270 267 SQNNLIGQGASGIVYKGTLRHGNLVAVKQILDLDTKG--------DEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGK 338 (590)
Q Consensus 267 ~~~~~LG~G~fG~Vykg~~~~g~~vAvK~l~~~~~~~--------~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~ 338 (590)
...++||+|+||.||+|... +..+++|+........ .+.+.+|++++++++||||+++..++...+
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~~-~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~----- 412 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSYL-DFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLD----- 412 (540)
T ss_dssp ---------CCEEEEEEECS-SCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETT-----
T ss_pred CCCCEEeeCCCEEEEEEEEC-CCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCC-----
Confidence 44678999999999999554 7889999875432211 234789999999999999997777776433
Q ss_pred eEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCc
Q 046270 339 RRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLA 418 (590)
Q Consensus 339 ~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla 418 (590)
..+|||||+++++|.+++.. ++.|+.|+++||.||| +.+|+||||||+|||++. ++||+|||++
T Consensus 413 ~~~lVmE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH---~~gIiHrDiKp~NILl~~--~~kL~DFGla 476 (540)
T 3en9_A 413 NKRIMMSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLH---KNDVIHNDLTTSNFIFDK--DLYIIDFGLG 476 (540)
T ss_dssp TTEEEEECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHH---HTTEECTTCCTTSEEESS--SEEECCCTTC
T ss_pred ccEEEEECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHH---HCcCccCCCCHHHEEECC--eEEEEECccC
Confidence 35999999999999999852 5689999999999999 899999999999999999 9999999999
Q ss_pred ccccCCCccc------ccccccCCCccCcccccc--CCCCcchhHHHHHHHHHHHHhCCCCC
Q 046270 419 KQSLEGHSHL------TTRVAGTFGYLAPEYALY--GQLTEKSDVYSFGIVILELMSGRKVL 472 (590)
Q Consensus 419 ~~~~~~~~~~------~~~~~gt~~Y~APE~~~~--~~~t~ksDVySfGvvLlELltG~~p~ 472 (590)
+......... .....||+.|||||++.. ..|+.+.|+|+..+-.++-+.++.++
T Consensus 477 ~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 477 KISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp EECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred EECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 9765432211 235679999999999986 56888999999999999998887654
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=1.3e-23 Score=214.32 Aligned_cols=152 Identities=16% Similarity=0.136 Sum_probs=122.2
Q ss_pred HHHHHHhcCCCccceecccCcEEEEEEEEcCCcEEEEEEeecCCCC------------------ChHHHHHHHHHHHhcC
Q 046270 257 SELEQATNGFSQNNLIGQGASGIVYKGTLRHGNLVAVKQILDLDTK------------------GDEDFTNEVEIISKIR 318 (590)
Q Consensus 257 ~el~~at~~f~~~~~LG~G~fG~Vykg~~~~g~~vAvK~l~~~~~~------------------~~~~f~~Ev~il~~l~ 318 (590)
..+......|...+.||+|+||.||+|.+.+|+.||||.+...... ....+.+|++++++++
T Consensus 83 ~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~ 162 (282)
T 1zar_A 83 HRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ 162 (282)
T ss_dssp HHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc
Confidence 3444555566677999999999999999977999999998542211 2346889999999999
Q ss_pred CCCccccceeEEeccCCCCceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCC
Q 046270 319 HRNLLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIK 398 (590)
Q Consensus 319 H~nlv~l~g~~~~~~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIK 398 (590)
| +++.+++.. +..++||||+++|+|.+ +. ......++.||+.||.||| +.+|+|||||
T Consensus 163 --~-~~v~~~~~~------~~~~lvmE~~~g~~L~~-l~---------~~~~~~i~~qi~~~l~~lH---~~giiHrDlk 220 (282)
T 1zar_A 163 --G-LAVPKVYAW------EGNAVLMELIDAKELYR-VR---------VENPDEVLDMILEEVAKFY---HRGIVHGDLS 220 (282)
T ss_dssp --T-SSSCCEEEE------ETTEEEEECCCCEEGGG-CC---------CSCHHHHHHHHHHHHHHHH---HTTEECSCCS
T ss_pred --C-CCcCeEEec------cceEEEEEecCCCcHHH-cc---------hhhHHHHHHHHHHHHHHHH---HCCCEeCCCC
Confidence 5 777776543 23599999999999988 42 1335579999999999999 8999999999
Q ss_pred CCceEECCCCcEEEEeeCCcccccCCCcccccccccCCCccCccccc
Q 046270 399 STNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYAL 445 (590)
Q Consensus 399 p~NILLd~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~ 445 (590)
|+|||++ ++.+||+|||+++. +..|+|||++.
T Consensus 221 p~NILl~-~~~vkl~DFG~a~~--------------~~~~~a~e~l~ 252 (282)
T 1zar_A 221 QYNVLVS-EEGIWIIDFPQSVE--------------VGEEGWREILE 252 (282)
T ss_dssp TTSEEEE-TTEEEECCCTTCEE--------------TTSTTHHHHHH
T ss_pred HHHEEEE-CCcEEEEECCCCeE--------------CCCCCHHHHHH
Confidence 9999999 99999999999973 34578999875
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=5.2e-19 Score=177.74 Aligned_cols=143 Identities=15% Similarity=0.127 Sum_probs=105.1
Q ss_pred CCccceecccCcEEEEEEEE-cCCcE--EEEEEeecCCCCC------------------------hHHHHHHHHHHHhcC
Q 046270 266 FSQNNLIGQGASGIVYKGTL-RHGNL--VAVKQILDLDTKG------------------------DEDFTNEVEIISKIR 318 (590)
Q Consensus 266 f~~~~~LG~G~fG~Vykg~~-~~g~~--vAvK~l~~~~~~~------------------------~~~f~~Ev~il~~l~ 318 (590)
|...+.||+|+||.||+|.+ .+|+. ||||+++...... ...+.+|+++|.+++
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 45678999999999999998 67888 9999874321110 125789999999999
Q ss_pred CCCccccceeEEeccCCCCceEEEEEeeCC-CCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCC
Q 046270 319 HRNLLSLRGCCVTSDDSSGKRRFLVYDYMP-NGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDI 397 (590)
Q Consensus 319 H~nlv~l~g~~~~~~~~~~~~~~LV~E~~~-~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDI 397 (590)
|+|+.....+.. ...+|||||+. +|.+...|.... ...++.....++.|++.||.|||. ..+|+||||
T Consensus 129 ~~~i~~p~~~~~-------~~~~lVmE~~g~~g~~~~~L~~~~--~~~~~~~~~~i~~qi~~~l~~lH~--~~givHrDl 197 (258)
T 1zth_A 129 EAGVSVPQPYTY-------MKNVLLMEFIGEDELPAPTLVELG--RELKELDVEGIFNDVVENVKRLYQ--EAELVHADL 197 (258)
T ss_dssp HTTCCCCCEEEE-------ETTEEEEECCEETTEECCBHHHHG--GGGGGSCHHHHHHHHHHHHHHHHH--TSCEECSSC
T ss_pred hCCCCCCeEEEc-------CCCEEEEEecCCCCCccccHHHHh--hccChHHHHHHHHHHHHHHHHHHH--HCCEEeCCC
Confidence 887532222221 12589999994 253333332111 123466888999999999999994 468999999
Q ss_pred CCCceEECCCCcEEEEeeCCcccc
Q 046270 398 KSTNILLDSELNAKVADFGLAKQS 421 (590)
Q Consensus 398 Kp~NILLd~~~~~kL~DFGla~~~ 421 (590)
||+|||+++ .++|+|||++...
T Consensus 198 kp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 198 SEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp STTSEEESS--SEEECCCTTCEET
T ss_pred CHHHEEEcC--cEEEEECcccccC
Confidence 999999998 9999999999754
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.66 E-value=1.1e-16 Score=169.23 Aligned_cols=144 Identities=16% Similarity=0.134 Sum_probs=100.1
Q ss_pred CCCccceecccCcEEEEEEEEcCCcEEEEEEeecCC--------------CCChHHHHHHHHHHHhcCCCCccccceeEE
Q 046270 265 GFSQNNLIGQGASGIVYKGTLRHGNLVAVKQILDLD--------------TKGDEDFTNEVEIISKIRHRNLLSLRGCCV 330 (590)
Q Consensus 265 ~f~~~~~LG~G~fG~Vykg~~~~g~~vAvK~l~~~~--------------~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~ 330 (590)
-|...+.||+|+||.||+|...+|+.||||+++... .........++++.+...|+|+++++....
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 488889999999999999999999999999874311 011223334444444444555554432211
Q ss_pred eccC-CCCceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCC-
Q 046270 331 TSDD-SSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSEL- 408 (590)
Q Consensus 331 ~~~~-~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~- 408 (590)
.... ......+|||||+++++|.++.. .+....++.||+.+|.||| +.+||||||||.|||+++++
T Consensus 176 ~vp~p~~~~~~~LVME~i~G~~L~~l~~---------~~~~~~l~~qll~~l~~lH---~~gIVHrDLKp~NILl~~dgd 243 (397)
T 4gyi_A 176 PVPEPIAQSRHTIVMSLVDALPMRQVSS---------VPDPASLYADLIALILRLA---KHGLIHGDFNEFNILIREEKD 243 (397)
T ss_dssp SCCCEEEEETTEEEEECCSCEEGGGCCC---------CSCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEEEEEC
T ss_pred CCCeeeeccCceEEEEecCCccHhhhcc---------cHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeCCCC
Confidence 1000 00011379999999988866432 2244678899999999999 88999999999999998776
Q ss_pred ---------cEEEEeeCCccc
Q 046270 409 ---------NAKVADFGLAKQ 420 (590)
Q Consensus 409 ---------~~kL~DFGla~~ 420 (590)
.+.|+||+-+..
T Consensus 244 ~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 244 AEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp SSCTTSEEEEEEECCCTTCEE
T ss_pred cccccccccceEEEEeCCccc
Confidence 389999997653
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.30 E-value=6.7e-12 Score=125.24 Aligned_cols=147 Identities=14% Similarity=0.034 Sum_probs=111.7
Q ss_pred HHHHhcCCCccceecccCcEEEEEEEEcCCcEEEEEEeecCCCCChHHHHHHHHHHHhcC-CCCccccceeEEeccCCCC
Q 046270 259 LEQATNGFSQNNLIGQGASGIVYKGTLRHGNLVAVKQILDLDTKGDEDFTNEVEIISKIR-HRNLLSLRGCCVTSDDSSG 337 (590)
Q Consensus 259 l~~at~~f~~~~~LG~G~fG~Vykg~~~~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~-H~nlv~l~g~~~~~~~~~~ 337 (590)
+...-++|.....++.|+++.||+.... |+.+++|+...........+.+|+++++.+. |.++.++++++.. +
T Consensus 9 l~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~-----~ 82 (263)
T 3tm0_A 9 LKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERH-----D 82 (263)
T ss_dssp HHHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEE-----T
T ss_pred HHHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEec-----C
Confidence 3344467877778888889999999865 6889999986432233446899999999995 6677788888763 3
Q ss_pred ceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhc------------------------------
Q 046270 338 KRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYG------------------------------ 387 (590)
Q Consensus 338 ~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~------------------------------ 387 (590)
...++||||++|.+|.+.+ .+......++.+++++|..||..
T Consensus 83 ~~~~lv~e~i~G~~l~~~~--------~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (263)
T 3tm0_A 83 GWSNLLMSEADGVLCSEEY--------EDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVD 154 (263)
T ss_dssp TEEEEEEECCSSEEHHHHC--------CTTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCS
T ss_pred CceEEEEEecCCeehhhcc--------CCcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccc
Confidence 4689999999999887653 12234557899999999999961
Q ss_pred --------------------------CCCCeEecCCCCCceEECCCCcEEEEeeCCcc
Q 046270 388 --------------------------LKPGIYHRDIKSTNILLDSELNAKVADFGLAK 419 (590)
Q Consensus 388 --------------------------~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~ 419 (590)
....++|+|++|.|||++++....|+||+.+.
T Consensus 155 ~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 155 CENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp GGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 01558999999999999876556799998764
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.19 E-value=2.7e-11 Score=119.88 Aligned_cols=130 Identities=16% Similarity=0.147 Sum_probs=94.9
Q ss_pred eec-ccCcEEEEEEEEcCCcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCc--cccceeEEeccCCCCceEEEEEeeC
Q 046270 271 LIG-QGASGIVYKGTLRHGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNL--LSLRGCCVTSDDSSGKRRFLVYDYM 347 (590)
Q Consensus 271 ~LG-~G~fG~Vykg~~~~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nl--v~l~g~~~~~~~~~~~~~~LV~E~~ 347 (590)
.++ .|..+.||+....+|..+++|..... ....+.+|+++++.+++.++ .+++++... ++..++||||+
T Consensus 26 ~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~-----~~~~~~v~e~i 97 (264)
T 1nd4_A 26 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTE-----AGRDWLLLGEV 97 (264)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEEC-----SSCEEEEEECC
T ss_pred ecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccC-----CCCCEEEEEec
Confidence 344 55569999998877888999986543 23468899999999966554 346766542 34589999999
Q ss_pred CCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcC---------------------------------------
Q 046270 348 PNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGL--------------------------------------- 388 (590)
Q Consensus 348 ~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~--------------------------------------- 388 (590)
++.+|. +. .. ....++.++++.|..||...
T Consensus 98 ~G~~l~--~~------~~---~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (264)
T 1nd4_A 98 PGQDLL--SS------HL---APAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLA 166 (264)
T ss_dssp SSEETT--TS------CC---CHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCC
T ss_pred CCcccC--cC------cC---CHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCcc
Confidence 998884 21 11 12367778888888888421
Q ss_pred ----------------CCCeEecCCCCCceEECCCCcEEEEeeCCcc
Q 046270 389 ----------------KPGIYHRDIKSTNILLDSELNAKVADFGLAK 419 (590)
Q Consensus 389 ----------------~~~ivHrDIKp~NILLd~~~~~kL~DFGla~ 419 (590)
...++|+|++|.|||++++..++|+|||.+.
T Consensus 167 ~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 167 PAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp HHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 1239999999999999887667799999875
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.04 E-value=2.4e-10 Score=116.86 Aligned_cols=189 Identities=20% Similarity=0.232 Sum_probs=121.7
Q ss_pred cceecccCcEEEEEEEEcCCcEEEEEEeecCCCCChHHHHHHHHHHHhcC-CCCc--cccceeEEeccCCCCceEEEEEe
Q 046270 269 NNLIGQGASGIVYKGTLRHGNLVAVKQILDLDTKGDEDFTNEVEIISKIR-HRNL--LSLRGCCVTSDDSSGKRRFLVYD 345 (590)
Q Consensus 269 ~~~LG~G~fG~Vykg~~~~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~-H~nl--v~l~g~~~~~~~~~~~~~~LV~E 345 (590)
.+.++.|....||+.. ..+++|+.... .....+.+|.++++.+. +..+ .+++.... +.......|+|||
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~--~~~~~~~~~~vm~ 96 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGM--PSETYQMSFAGFT 96 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECC--CCSSCSCSCEEEE
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecC--CCCCCCcceEEEc
Confidence 3568999999999863 45888875321 23567899999999984 3333 22332221 1111123588999
Q ss_pred eCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhc--------------------------------------
Q 046270 346 YMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYG-------------------------------------- 387 (590)
Q Consensus 346 ~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~-------------------------------------- 387 (590)
++++.+|.+... ..++.+++..++.++++.|..||..
T Consensus 97 ~i~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (304)
T 3sg8_A 97 KIKGVPLTPLLL-----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMK 171 (304)
T ss_dssp CCCCEECCHHHH-----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHH
T ss_pred ccCCeECCcccc-----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHH
Confidence 999988875432 3578888888999999999999851
Q ss_pred -----------------CCCCeEecCCCCCceEECC--CCcEEEEeeCCcccccCCCcccc-------------cccccC
Q 046270 388 -----------------LKPGIYHRDIKSTNILLDS--ELNAKVADFGLAKQSLEGHSHLT-------------TRVAGT 435 (590)
Q Consensus 388 -----------------~~~~ivHrDIKp~NILLd~--~~~~kL~DFGla~~~~~~~~~~~-------------~~~~gt 435 (590)
....++|+|++|.||++++ ...+.|+||+.+........... ......
T Consensus 172 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~ 251 (304)
T 3sg8_A 172 KVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNH 251 (304)
T ss_dssp HHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHH
T ss_pred HHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHH
Confidence 1245899999999999998 45678999998875322110000 000001
Q ss_pred CCccC-ccccccCCCCcchhHHHHHHHHHHHHhCCCCC
Q 046270 436 FGYLA-PEYALYGQLTEKSDVYSFGIVILELMSGRKVL 472 (590)
Q Consensus 436 ~~Y~A-PE~~~~~~~t~ksDVySfGvvLlELltG~~p~ 472 (590)
.++.. |+.... .....+.|++|.+++++.+|+.++
T Consensus 252 Y~~~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 252 YKHKDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HTCSCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred cCCCCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHH
Confidence 11222 222111 122368999999999999998654
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.03 E-value=5.3e-10 Score=116.94 Aligned_cols=145 Identities=14% Similarity=0.182 Sum_probs=107.0
Q ss_pred ccceecccCcEEEEEEEEcCCcEEEEEEee--cCC-CCChHHHHHHHHHHHhcCC--CCccccceeEEeccCCCCceEEE
Q 046270 268 QNNLIGQGASGIVYKGTLRHGNLVAVKQIL--DLD-TKGDEDFTNEVEIISKIRH--RNLLSLRGCCVTSDDSSGKRRFL 342 (590)
Q Consensus 268 ~~~~LG~G~fG~Vykg~~~~g~~vAvK~l~--~~~-~~~~~~f~~Ev~il~~l~H--~nlv~l~g~~~~~~~~~~~~~~L 342 (590)
..+.|+.|.++.||+....+ ..+++|+.. ... ......+.+|+++++.+++ ..+.++++++...+ ..+..++
T Consensus 42 ~~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~--~~g~~~~ 118 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDES--VIGRAFY 118 (359)
T ss_dssp EEEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTT--TTSSCEE
T ss_pred eEEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCC--ccCCeEE
Confidence 35678999999999998764 678888764 221 1224568899999999974 45677787775432 1245799
Q ss_pred EEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcC----------------------------------
Q 046270 343 VYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGL---------------------------------- 388 (590)
Q Consensus 343 V~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~---------------------------------- 388 (590)
||||+++..+.+.. ...++..++..++.++++.|+.||...
T Consensus 119 vme~v~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (359)
T 3dxp_A 119 IMEFVSGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETES 193 (359)
T ss_dssp EEECCCCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSC
T ss_pred EEEecCCeecCCCc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcC
Confidence 99999998886522 134788899999999999999999621
Q ss_pred ---------------------CCCeEecCCCCCceEECCCCc--EEEEeeCCccc
Q 046270 389 ---------------------KPGIYHRDIKSTNILLDSELN--AKVADFGLAKQ 420 (590)
Q Consensus 389 ---------------------~~~ivHrDIKp~NILLd~~~~--~kL~DFGla~~ 420 (590)
...++|||+++.|||++.++. +.|.||+.+..
T Consensus 194 ~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 194 IPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp CHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred ChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 257999999999999997753 68999999874
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.38 E-value=1.6e-06 Score=88.59 Aligned_cols=137 Identities=14% Similarity=0.167 Sum_probs=91.9
Q ss_pred cceecccCcEEEEEEEEcCCcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCC---ccccceeEEeccCCCCceEEEEEe
Q 046270 269 NNLIGQGASGIVYKGTLRHGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRN---LLSLRGCCVTSDDSSGKRRFLVYD 345 (590)
Q Consensus 269 ~~~LG~G~fG~Vykg~~~~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~n---lv~l~g~~~~~~~~~~~~~~LV~E 345 (590)
...++.|....||+. |..+++|+-. .......+.+|.++|..+.+.. +.+.+.++.. ..+..++|||
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~----~~g~~~~v~e 93 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKR----SDGNPFVGYR 93 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEEC----TTSCEEEEEE
T ss_pred eeecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeeccc----CCCceEEEEe
Confidence 356888888999988 5668888742 1123457899999999997532 3344544431 2345789999
Q ss_pred eCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhc--------------------------------------
Q 046270 346 YMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYG-------------------------------------- 387 (590)
Q Consensus 346 ~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~-------------------------------------- 387 (590)
|++|.+|.+... ..++..++..++.++++.|+.||..
T Consensus 94 ~i~G~~l~~~~~-----~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~ 168 (306)
T 3tdw_A 94 KVQGQILGEDGM-----AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESL 168 (306)
T ss_dssp CCCSEECHHHHH-----TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHH
T ss_pred ccCCeECchhhh-----hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhh
Confidence 999988865321 1234445555555555555555521
Q ss_pred -------------------CCCCeEecCCCCCceEECC---CCcE-EEEeeCCccc
Q 046270 388 -------------------LKPGIYHRDIKSTNILLDS---ELNA-KVADFGLAKQ 420 (590)
Q Consensus 388 -------------------~~~~ivHrDIKp~NILLd~---~~~~-kL~DFGla~~ 420 (590)
....++|+|+++.|||++. ++.+ .|+||+.+..
T Consensus 169 ~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 169 RDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2346799999999999987 4554 8999998764
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.22 E-value=7.5e-06 Score=81.35 Aligned_cols=134 Identities=17% Similarity=0.126 Sum_probs=93.4
Q ss_pred eecccCcE-EEEEEEEcC-CcEEEEEEeecCCCCChHHHHHHHHHHHhcC-CCCccccceeEEeccCCCCceEEEEEeeC
Q 046270 271 LIGQGASG-IVYKGTLRH-GNLVAVKQILDLDTKGDEDFTNEVEIISKIR-HRNLLSLRGCCVTSDDSSGKRRFLVYDYM 347 (590)
Q Consensus 271 ~LG~G~fG-~Vykg~~~~-g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~-H~nlv~l~g~~~~~~~~~~~~~~LV~E~~ 347 (590)
.+..|..| .||+..... +..+++|+-... ...++..|..+|+.+. +--+-++++++.. +...++|||++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~-----~~~~~lvme~l 102 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRT-----PDDAWLLTTAI 102 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEE-----TTEEEEEEECC
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEE-----CCeEEEEEEee
Confidence 44555554 699887654 567888875432 3457889999999884 3234566776653 34589999999
Q ss_pred CCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhc----------------------------------------
Q 046270 348 PNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYG---------------------------------------- 387 (590)
Q Consensus 348 ~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~---------------------------------------- 387 (590)
++.++.+... .....+..+..++++.|.-||..
T Consensus 103 ~G~~~~~~~~-------~~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (272)
T 4gkh_A 103 PGKTAFQVLE-------EYPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWP 175 (272)
T ss_dssp CSEEHHHHHH-------HCGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCC
T ss_pred CCcccccccc-------CCHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchH
Confidence 9988766542 12234456777777777777731
Q ss_pred ---------------CCCCeEecCCCCCceEECCCCcEEEEeeCCcc
Q 046270 388 ---------------LKPGIYHRDIKSTNILLDSELNAKVADFGLAK 419 (590)
Q Consensus 388 ---------------~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~ 419 (590)
....++|+|+.+.|||++++..+-|+||+.+.
T Consensus 176 ~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 176 VEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 02237999999999999987777799998875
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.20 E-value=4e-06 Score=87.08 Aligned_cols=83 Identities=16% Similarity=0.115 Sum_probs=55.4
Q ss_pred cee-cccCcEEEEEEEEc-------CCcEEEEEEeecCC---CCChHHHHHHHHHHHhcCC---CCccccceeEEeccCC
Q 046270 270 NLI-GQGASGIVYKGTLR-------HGNLVAVKQILDLD---TKGDEDFTNEVEIISKIRH---RNLLSLRGCCVTSDDS 335 (590)
Q Consensus 270 ~~L-G~G~fG~Vykg~~~-------~g~~vAvK~l~~~~---~~~~~~f~~Ev~il~~l~H---~nlv~l~g~~~~~~~~ 335 (590)
+.| +.|....+|+.... ++..+++|+..... ......+.+|+.+++.+.. -.+.++++++...+
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~-- 103 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGD-- 103 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSST--
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCC--
Confidence 567 78888999998765 25678888754322 1123467899999998843 24556666654321
Q ss_pred CCceEEEEEeeCCCCCcch
Q 046270 336 SGKRRFLVYDYMPNGTLSD 354 (590)
Q Consensus 336 ~~~~~~LV~E~~~~gsL~~ 354 (590)
.....++||||+++..+.+
T Consensus 104 ~~g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 104 VLGTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp TTSSCEEEEECCCCBCCCB
T ss_pred ccCCceEEEEecCCCChhh
Confidence 1134689999999988764
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=98.05 E-value=3.4e-05 Score=77.74 Aligned_cols=80 Identities=18% Similarity=0.152 Sum_probs=58.2
Q ss_pred CCCccceecccCcEEEEEEEEcCCcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCC---ccccceeEEeccCCCCceEE
Q 046270 265 GFSQNNLIGQGASGIVYKGTLRHGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRN---LLSLRGCCVTSDDSSGKRRF 341 (590)
Q Consensus 265 ~f~~~~~LG~G~fG~Vykg~~~~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~n---lv~l~g~~~~~~~~~~~~~~ 341 (590)
.......+|.|..+.||+.++.||+.+.+|+...........|..|.+.|+.|.-.. +.+.+++. + .+
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~---~------~~ 86 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD---D------RT 86 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE---T------TE
T ss_pred CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc---C------ce
Confidence 345567899999999999999999999999865544444556889999999985322 22333321 1 37
Q ss_pred EEEeeCCCCCcc
Q 046270 342 LVYDYMPNGTLS 353 (590)
Q Consensus 342 LV~E~~~~gsL~ 353 (590)
+||||++.+...
T Consensus 87 lv~e~l~~~~~~ 98 (288)
T 3f7w_A 87 LAMEWVDERPPT 98 (288)
T ss_dssp EEEECCCCCCCC
T ss_pred EEEEeecccCCC
Confidence 899999887654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.03 E-value=1.5e-05 Score=81.58 Aligned_cols=141 Identities=19% Similarity=0.244 Sum_probs=81.9
Q ss_pred ceecccCcEEEEEEEEcCCcEEEEEEeecCCCCChHHHHHHHHHHHhcCCC--Ccccccee-----EEeccCCCCceEEE
Q 046270 270 NLIGQGASGIVYKGTLRHGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHR--NLLSLRGC-----CVTSDDSSGKRRFL 342 (590)
Q Consensus 270 ~~LG~G~fG~Vykg~~~~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~--nlv~l~g~-----~~~~~~~~~~~~~L 342 (590)
..|+.|..+.||+....+| .+++|+... ...++..|++++..|... .+.+++.. +.. .++..++
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~----~~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~----~~~~~~~ 108 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHR----PEKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSK----HGSFLFV 108 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECS----CHHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEE----ETTEEEE
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCC----CHHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEE----ECCEEEE
Confidence 4566667889999987655 488998754 234555677777766421 23333321 111 1345799
Q ss_pred EEeeCCCCCcch-----------h---hhhhccc-----------ccCChhhHH--------------------------
Q 046270 343 VYDYMPNGTLSD-----------N---ISISHKR-----------KQLTWPQRK-------------------------- 371 (590)
Q Consensus 343 V~E~~~~gsL~~-----------~---L~~~~~~-----------~~l~~~~r~-------------------------- 371 (590)
+|||+++..+.. . ++..... ..-.|...+
T Consensus 109 l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 188 (346)
T 2q83_A 109 VYDWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLY 188 (346)
T ss_dssp EEECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHH
T ss_pred EEEeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHH
Confidence 999999876631 1 1111000 011332211
Q ss_pred -----HHHHHHHHHHHHHHh----------cCCCCeEecCCCCCceEECCCCcEEEEeeCCcc
Q 046270 372 -----KIIVDVAKGIAYLHY----------GLKPGIYHRDIKSTNILLDSELNAKVADFGLAK 419 (590)
Q Consensus 372 -----~I~~~ia~gL~yLH~----------~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~ 419 (590)
.+...+.+++.+|+. .....++|||+++.|||++.++.+.|+||+.+.
T Consensus 189 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 189 LQEIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 111223445667763 136789999999999999888889999999774
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.94 E-value=4.4e-05 Score=80.51 Aligned_cols=75 Identities=13% Similarity=0.105 Sum_probs=48.5
Q ss_pred cceecccCcEEEEEEEEc-CCcEEEEEEeecCCC-------CChHHHHHHHHHHHhcCC--CCcc-ccceeEEeccCCCC
Q 046270 269 NNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDT-------KGDEDFTNEVEIISKIRH--RNLL-SLRGCCVTSDDSSG 337 (590)
Q Consensus 269 ~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~-------~~~~~f~~Ev~il~~l~H--~nlv-~l~g~~~~~~~~~~ 337 (590)
.+.||.|.++.||++... +++.++||....... ...+.+..|.++++.+.. +..+ +++.+ +.
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~----- 107 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DT----- 107 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ET-----
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cC-----
Confidence 457999999999999765 467899998643211 123457889999998843 3444 33332 11
Q ss_pred ceEEEEEeeCCCC
Q 046270 338 KRRFLVYDYMPNG 350 (590)
Q Consensus 338 ~~~~LV~E~~~~g 350 (590)
...++||||+++.
T Consensus 108 ~~~~lvmE~l~g~ 120 (397)
T 2olc_A 108 EMAVTVMEDLSHL 120 (397)
T ss_dssp TTTEEEECCCTTS
T ss_pred CccEEEEEeCCCc
Confidence 1248999999864
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.53 E-value=0.00062 Score=69.67 Aligned_cols=139 Identities=14% Similarity=0.125 Sum_probs=89.1
Q ss_pred ccceecccCcEEEEEEEEcCCcEEEEEEeecCCCCChHHHHHHHHHHHhcCC---CCccccceeEEeccCCCCceEEEEE
Q 046270 268 QNNLIGQGASGIVYKGTLRHGNLVAVKQILDLDTKGDEDFTNEVEIISKIRH---RNLLSLRGCCVTSDDSSGKRRFLVY 344 (590)
Q Consensus 268 ~~~~LG~G~fG~Vykg~~~~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H---~nlv~l~g~~~~~~~~~~~~~~LV~ 344 (590)
..+.|+.|....+|+.... +..+++|+.... ....+..|.+.|+.|.. ..+.++++++.. ....++||
T Consensus 40 ~~~~l~gG~~n~~y~v~~~-~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~-----~g~~~lvm 110 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLINDE-VQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNS-----QGHSFLLL 110 (312)
T ss_dssp EEEEECCSSSSEEEEEESS-SCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEEC-----SSEEEEEE
T ss_pred eeEEeCCccceeeeEEEEC-CCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeec-----CCceEEEE
Confidence 3467899999999998864 677888976532 35678899999999842 456677776652 34689999
Q ss_pred eeCCCCCcchh-----------hhhhcccc-------------------cCChhhHH---HHH--HH-------------
Q 046270 345 DYMPNGTLSDN-----------ISISHKRK-------------------QLTWPQRK---KII--VD------------- 376 (590)
Q Consensus 345 E~~~~gsL~~~-----------L~~~~~~~-------------------~l~~~~r~---~I~--~~------------- 376 (590)
||+++..+..- |+...... .-+|..-+ ++. .+
T Consensus 111 e~l~G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~ 190 (312)
T 3jr1_A 111 EALNKSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNID 190 (312)
T ss_dssp ECCCCCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHH
T ss_pred EeccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHH
Confidence 99999876321 11111100 12454321 111 11
Q ss_pred -HHHH-HHHHH-hcCCCCeEecCCCCCceEECCCCcEEEEeeC
Q 046270 377 -VAKG-IAYLH-YGLKPGIYHRDIKSTNILLDSELNAKVADFG 416 (590)
Q Consensus 377 -ia~g-L~yLH-~~~~~~ivHrDIKp~NILLd~~~~~kL~DFG 416 (590)
+..- ...|. ....+.++|+|+.+.||+++.++ +.|.|+.
T Consensus 191 ~l~~~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 191 LIVQIVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHHHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 1111 22342 12357899999999999999887 8888874
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.46 E-value=0.00021 Score=75.99 Aligned_cols=78 Identities=13% Similarity=0.149 Sum_probs=50.6
Q ss_pred CCCeEecCCCCCceEECCCCcEEEEeeCCcccccCCCccccccccc--CCCccCccccccC---CCCcchhHHHHHHHHH
Q 046270 389 KPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAG--TFGYLAPEYALYG---QLTEKSDVYSFGIVIL 463 (590)
Q Consensus 389 ~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~~~~~~~~~~~~~g--t~~Y~APE~~~~~---~~t~ksDVySfGvvLl 463 (590)
...++|||+++.|||++++. ++|+||+.+........ ...... ...|.+|++.... .-....++......+|
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~D--la~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFD--IGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTW 307 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHH--HHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHH--HHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHH
Confidence 68899999999999998876 99999998875322111 000000 1346666655321 1122456678888888
Q ss_pred HHHhCC
Q 046270 464 ELMSGR 469 (590)
Q Consensus 464 ELltG~ 469 (590)
+.++++
T Consensus 308 ~~y~~~ 313 (420)
T 2pyw_A 308 NLFNKR 313 (420)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 888764
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.39 E-value=0.00093 Score=67.88 Aligned_cols=162 Identities=12% Similarity=0.130 Sum_probs=89.3
Q ss_pred ccHHHHHHHhcCCCc-----cceecccCcEEEEEEEEcCCcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCc--cccc
Q 046270 254 FHVSELEQATNGFSQ-----NNLIGQGASGIVYKGTLRHGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNL--LSLR 326 (590)
Q Consensus 254 f~~~el~~at~~f~~-----~~~LG~G~fG~Vykg~~~~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nl--v~l~ 326 (590)
++.+++...-..|.. .+.|+.|....+|+....+| .+++|..... ...+++..|++++..+...++ .+++
T Consensus 7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~ 83 (322)
T 2ppq_A 7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPL 83 (322)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCccc
Confidence 344555555555543 24566788889999987766 5778887542 123457788888888853333 2333
Q ss_pred eeEEeccC--CCCceEEEEEeeCCCCCcchh--------------hhhhccc---------ccCChhhHHH---------
Q 046270 327 GCCVTSDD--SSGKRRFLVYDYMPNGTLSDN--------------ISISHKR---------KQLTWPQRKK--------- 372 (590)
Q Consensus 327 g~~~~~~~--~~~~~~~LV~E~~~~gsL~~~--------------L~~~~~~---------~~l~~~~r~~--------- 372 (590)
... .... ..++..+++|+|+++..+... ++..... ....|...+.
T Consensus 84 ~~~-~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~ 162 (322)
T 2ppq_A 84 PRK-DGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV 162 (322)
T ss_dssp CBT-TCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred CCC-CCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhh
Confidence 210 0000 012357899999998765320 1110000 0012332111
Q ss_pred ---HHHHHHHHHHHHHhc----CCCCeEecCCCCCceEECCCCcEEEEeeCCcc
Q 046270 373 ---IIVDVAKGIAYLHYG----LKPGIYHRDIKSTNILLDSELNAKVADFGLAK 419 (590)
Q Consensus 373 ---I~~~ia~gL~yLH~~----~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~ 419 (590)
+...+.+.+.+++.. ....++|+|+++.|||++++....|+||+.+.
T Consensus 163 ~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 163 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 011244455666532 24579999999999999987556899998764
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.14 E-value=0.0016 Score=65.66 Aligned_cols=72 Identities=11% Similarity=0.047 Sum_probs=45.0
Q ss_pred cceecccCcEEEEEEEEcCCcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCcc-ccceeEEeccCCCCceEEEEEeeC
Q 046270 269 NNLIGQGASGIVYKGTLRHGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLL-SLRGCCVTSDDSSGKRRFLVYDYM 347 (590)
Q Consensus 269 ~~~LG~G~fG~Vykg~~~~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv-~l~g~~~~~~~~~~~~~~LV~E~~ 347 (590)
.+.|+.|....+|+. ..+++|+....... ..+..+|+.+++.+...++. +++++. . ...++|+||+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~~--~-----~~~~~v~e~i 89 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHVD--P-----ATGVMVTRYI 89 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEEC--T-----TTCCEEEECC
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEEE--C-----CCCEEEEeec
Confidence 567888999999998 45888876542111 12345788888888544444 444332 1 1247899999
Q ss_pred -CCCCcc
Q 046270 348 -PNGTLS 353 (590)
Q Consensus 348 -~~gsL~ 353 (590)
++.+|.
T Consensus 90 ~~g~~l~ 96 (301)
T 3dxq_A 90 AGAQTMS 96 (301)
T ss_dssp TTCEECC
T ss_pred CCCccCC
Confidence 665554
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.13 E-value=0.0047 Score=62.72 Aligned_cols=145 Identities=12% Similarity=0.111 Sum_probs=84.5
Q ss_pred ceecccCcEEEEEEEEcCCcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCC--ccccceeEEeccC--CCCceEEEEEe
Q 046270 270 NLIGQGASGIVYKGTLRHGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRN--LLSLRGCCVTSDD--SSGKRRFLVYD 345 (590)
Q Consensus 270 ~~LG~G~fG~Vykg~~~~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~n--lv~l~g~~~~~~~--~~~~~~~LV~E 345 (590)
..|+ |....||+....+|+.+++|..... ......+..|..++..+.... +.+++.. .... ..++..+++||
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~-~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~--~g~~~~~~~g~~~~l~~ 107 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAF--NGQTLLNHQGFYFAVFP 107 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCB--TTBSCEEETTEEEEEEE
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCC-CCCHHHHHHHHHHHHHHHHcCCeecceeec--CCcEEEEECCEEEEEEE
Confidence 4566 7788999988777778999987532 124567888999998885333 3444433 1100 01345788999
Q ss_pred eCCCCCcch----h----------hhhhcc------cccCChhhH----HHH---------------HHHHHHHHHHHHh
Q 046270 346 YMPNGTLSD----N----------ISISHK------RKQLTWPQR----KKI---------------IVDVAKGIAYLHY 386 (590)
Q Consensus 346 ~~~~gsL~~----~----------L~~~~~------~~~l~~~~r----~~I---------------~~~ia~gL~yLH~ 386 (590)
|+++..+.. . ++.... ...+++... ..+ ...+.+.+..+..
T Consensus 108 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~ 187 (328)
T 1zyl_A 108 SVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTA 187 (328)
T ss_dssp CCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHH
T ss_pred ecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHH
Confidence 999865531 0 111000 111222111 001 1111122333322
Q ss_pred c----CCCCeEecCCCCCceEECCCCcEEEEeeCCccc
Q 046270 387 G----LKPGIYHRDIKSTNILLDSELNAKVADFGLAKQ 420 (590)
Q Consensus 387 ~----~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~ 420 (590)
. ....++|||+++.|||++ + .+.|+||+.+..
T Consensus 188 ~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 188 HWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp HCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred HhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 1 256789999999999999 4 899999988754
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.10 E-value=0.0012 Score=70.51 Aligned_cols=73 Identities=22% Similarity=0.324 Sum_probs=50.1
Q ss_pred ceecccCcEEEEEEEEcC--------CcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCc-cccceeEEeccCCCCceE
Q 046270 270 NLIGQGASGIVYKGTLRH--------GNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNL-LSLRGCCVTSDDSSGKRR 340 (590)
Q Consensus 270 ~~LG~G~fG~Vykg~~~~--------g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nl-v~l~g~~~~~~~~~~~~~ 340 (590)
+.|+.|-...||+....+ +..+++|+.... ...+.+.+|..+++.|...++ .++++.+. +
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~-----~---- 147 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFS-----G---- 147 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEET-----T----
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeC-----C----
Confidence 467888889999998763 468888876331 122567789999999965455 45555432 1
Q ss_pred EEEEeeCCCCCcc
Q 046270 341 FLVYDYMPNGTLS 353 (590)
Q Consensus 341 ~LV~E~~~~gsL~ 353 (590)
.+|+||+++.+|.
T Consensus 148 g~v~e~l~G~~l~ 160 (429)
T 1nw1_A 148 GRLEEYIPSRPLS 160 (429)
T ss_dssp EEEECCCCEEECC
T ss_pred CEEEEEeCCcccC
Confidence 3899999875553
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.83 E-value=0.0058 Score=65.84 Aligned_cols=75 Identities=13% Similarity=0.056 Sum_probs=48.4
Q ss_pred cceecccCcEEEEEEEEcC-CcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCcc-ccceeEEeccCCCCceEEEEEee
Q 046270 269 NNLIGQGASGIVYKGTLRH-GNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLL-SLRGCCVTSDDSSGKRRFLVYDY 346 (590)
Q Consensus 269 ~~~LG~G~fG~Vykg~~~~-g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv-~l~g~~~~~~~~~~~~~~LV~E~ 346 (590)
.+.|+.|-...+|+....+ +..+++|+..... ...-+..+|..++..|...+++ ++++++. . .+||||
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~-~~~idR~~E~~vl~~L~~~gl~P~ll~~~~-----~----G~v~e~ 182 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKT-DEIINREREKKISCILYNKNIAKKIYVFFT-----N----GRIEEF 182 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-C-CSCSCHHHHHHHHHHHTTSSSBCCEEEEET-----T----EEEEEC
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCCh-hhhcCHHHHHHHHHHHHhcCCCCCEEEEeC-----C----eEEEEe
Confidence 3568878889999998875 4678888764322 1111236899999999766664 5555541 1 259999
Q ss_pred CCCCCcc
Q 046270 347 MPNGTLS 353 (590)
Q Consensus 347 ~~~gsL~ 353 (590)
+++.+|.
T Consensus 183 I~G~~l~ 189 (458)
T 2qg7_A 183 MDGYALS 189 (458)
T ss_dssp CCSEECC
T ss_pred eCCccCC
Confidence 9986653
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.82 E-value=0.0041 Score=65.28 Aligned_cols=141 Identities=18% Similarity=0.217 Sum_probs=82.6
Q ss_pred ceecccCcEEEEEEEEcC--------CcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCcc-ccceeEEeccCCCCceE
Q 046270 270 NLIGQGASGIVYKGTLRH--------GNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLL-SLRGCCVTSDDSSGKRR 340 (590)
Q Consensus 270 ~~LG~G~fG~Vykg~~~~--------g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv-~l~g~~~~~~~~~~~~~ 340 (590)
+.|..|-...+|+....+ +..+++|+... .......+.+|.++++.|...++. ++++++. +
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~-~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~-----~---- 125 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGA-ILQGVDSLVLESVMFAILAERSLGPQLYGVFP-----E---- 125 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEET-----T----
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCC-ccchHHHHHHHHHHHHHHHhcCCCCeEEEEcC-----C----
Confidence 456666677889988752 46888887532 223456778999999998544443 4554432 1
Q ss_pred EEEEeeCCCCCcchh-h----------------hhhc--ccccC--ChhhHHHHHHHHHH-------------------H
Q 046270 341 FLVYDYMPNGTLSDN-I----------------SISH--KRKQL--TWPQRKKIIVDVAK-------------------G 380 (590)
Q Consensus 341 ~LV~E~~~~gsL~~~-L----------------~~~~--~~~~l--~~~~r~~I~~~ia~-------------------g 380 (590)
.+||||+++.+|..- + +... -.+.. -|.+..++..++.. .
T Consensus 126 g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~ 205 (379)
T 3feg_A 126 GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDE 205 (379)
T ss_dssp EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHH
T ss_pred ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHH
Confidence 289999998776421 1 0000 00111 23444444443321 2
Q ss_pred HHHHHh-----cCCCCeEecCCCCCceEECCC----CcEEEEeeCCccc
Q 046270 381 IAYLHY-----GLKPGIYHRDIKSTNILLDSE----LNAKVADFGLAKQ 420 (590)
Q Consensus 381 L~yLH~-----~~~~~ivHrDIKp~NILLd~~----~~~kL~DFGla~~ 420 (590)
+.+|.. .....++|+|+.+.|||++.+ +.+.|+||..+..
T Consensus 206 ~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 206 MGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 333321 224578999999999999876 6899999988753
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.81 E-value=0.0069 Score=61.80 Aligned_cols=33 Identities=33% Similarity=0.350 Sum_probs=28.4
Q ss_pred CCCeEecCCCCCceEECCC----CcEEEEeeCCcccc
Q 046270 389 KPGIYHRDIKSTNILLDSE----LNAKVADFGLAKQS 421 (590)
Q Consensus 389 ~~~ivHrDIKp~NILLd~~----~~~kL~DFGla~~~ 421 (590)
...++|||+.+.|||++.+ ..+.|+||+.+...
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 5689999999999999875 67899999988643
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.63 E-value=0.0031 Score=65.58 Aligned_cols=73 Identities=11% Similarity=0.090 Sum_probs=43.9
Q ss_pred ceecccCcEEEEEEEEcC---------CcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCcc-ccceeEEeccCCCCce
Q 046270 270 NLIGQGASGIVYKGTLRH---------GNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLL-SLRGCCVTSDDSSGKR 339 (590)
Q Consensus 270 ~~LG~G~fG~Vykg~~~~---------g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv-~l~g~~~~~~~~~~~~ 339 (590)
..|+.|....+|+....+ +..+++|+..... ....+...|.++++.+...+++ ++++.. +
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~~~~E~~~l~~L~~~g~~P~~~~~~---~------ 108 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV-DELYNTISEFEVYKTMSKYKIAPQLLNTF---N------ 108 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG-GGTSCHHHHHHHHHHHHHTTSSCCEEEEE---T------
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc-cceecHHHHHHHHHHHHhcCCCCceEEec---C------
Confidence 457777778999998764 2678888754321 1112346889999988644544 454432 1
Q ss_pred EEEEEeeCCCCCc
Q 046270 340 RFLVYDYMPNGTL 352 (590)
Q Consensus 340 ~~LV~E~~~~gsL 352 (590)
.++||||+++..+
T Consensus 109 ~~~v~e~i~G~~l 121 (369)
T 3c5i_A 109 GGRIEEWLYGDPL 121 (369)
T ss_dssp TEEEEECCCSEEC
T ss_pred CcEEEEEecCCcC
Confidence 2689999998655
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.42 E-value=0.014 Score=60.14 Aligned_cols=32 Identities=25% Similarity=0.334 Sum_probs=28.2
Q ss_pred CCCeEecCCCCCceEECCCCcEEEEeeCCccc
Q 046270 389 KPGIYHRDIKSTNILLDSELNAKVADFGLAKQ 420 (590)
Q Consensus 389 ~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~ 420 (590)
...++|+|+.+.||++++++.+.|+||+.+..
T Consensus 205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp GCEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred CceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 46799999999999999888899999987764
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=94.87 E-value=0.17 Score=48.65 Aligned_cols=170 Identities=15% Similarity=0.086 Sum_probs=87.7
Q ss_pred CCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccccCCCccc
Q 046270 349 NGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHL 428 (590)
Q Consensus 349 ~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~~~~~~~~ 428 (590)
.-||.+.|.. ...++++++.+.++.|.+++|.-+-. +..-..+=+-|..|+|..+|++.+.+ +.+.
T Consensus 32 ~vSL~eIL~~--~~~PlsEEqaWALc~Qc~~~L~~~~~--~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~--------- 97 (229)
T 2yle_A 32 ALSLEEILRL--YNQPINEEQAWAVCYQCCGSLRAAAR--RRQPRHRVRSAAQIRVWRDGAVTLAP-AADD--------- 97 (229)
T ss_dssp EEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCSGGGEEEETTSCEEECC-C------------
T ss_pred cccHHHHHHH--cCCCcCHHHHHHHHHHHHHHHHhhhh--cccCCceecCCcceEEecCCceeccc-cccc---------
Confidence 3468888853 45689999999999999999877621 11111222346899999999888764 1111
Q ss_pred ccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhhhHHHhh--h
Q 046270 429 TTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDEFIRA--E 506 (590)
Q Consensus 429 ~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~--~ 506 (590)
.....+.+||... ...+.+.=|||+|++||.-+-=.-+-+....-...+......+.....-....|..+.. +
T Consensus 98 ----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~e~eE~eLS~~LE~LL~~Mt~~~~d~~~~DeG~~~~~e 172 (229)
T 2yle_A 98 ----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLKENEERELSPPLEQLIDHMANTVEADGSNDEGYEAAEE 172 (229)
T ss_dssp -------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCCTTEEECCCHHHHHHHHHHTTCCC--------------
T ss_pred ----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCCcccchhhCHHHHHHHHHHHhccccccccccccccccc
Confidence 0123466888653 45578899999999999988633221110000012222222222221111233333321 1
Q ss_pred hHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhccCCCCC
Q 046270 507 GARAVMERFVLVGILCAHVMVALRPTITDALKMLEGDIDIP 547 (590)
Q Consensus 507 ~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~~~~~~ 547 (590)
++.+..+ ...+..|++.++|+++=+.....|
T Consensus 173 g~~d~~~----------~~~~~~~~sl~~Vi~~C~~hl~~p 203 (229)
T 2yle_A 173 GLGDEDE----------KRKISAIRSYRDVMKLCAAHLPTE 203 (229)
T ss_dssp ------C----------CSCCCCCCSHHHHHHHHHTTSSSG
T ss_pred ccccccc----------cccccCcCCHHHHHHHHHhhccCc
Confidence 1111110 245778999999999887765433
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.41 E-value=0.16 Score=53.94 Aligned_cols=141 Identities=11% Similarity=0.131 Sum_probs=84.2
Q ss_pred cceecccCcEEEEEEEEcC--------CcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCcc-ccceeEEeccCCCCce
Q 046270 269 NNLIGQGASGIVYKGTLRH--------GNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLL-SLRGCCVTSDDSSGKR 339 (590)
Q Consensus 269 ~~~LG~G~fG~Vykg~~~~--------g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv-~l~g~~~~~~~~~~~~ 339 (590)
.+.|..|--..+|+....+ +..+++|+..... ...-+..+|.++++.+...+++ ++++.+.
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~~--------- 144 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADFP--------- 144 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEET---------
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEcC---------
Confidence 3456667778999998763 5778888754322 2222346899999988544444 4443221
Q ss_pred EEEEEeeCCCCCcchh-h----------------hhhcc----------cccCChhhHHHHHHHH---------------
Q 046270 340 RFLVYDYMPNGTLSDN-I----------------SISHK----------RKQLTWPQRKKIIVDV--------------- 377 (590)
Q Consensus 340 ~~LV~E~~~~gsL~~~-L----------------~~~~~----------~~~l~~~~r~~I~~~i--------------- 377 (590)
.++||||+++..|..- + +.... ..+.-|.+..++..++
T Consensus 145 ~~~I~efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~ 224 (424)
T 3mes_A 145 EGRIEEFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKEL 224 (424)
T ss_dssp TEEEEECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHH
T ss_pred CCEEEEEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhcccc
Confidence 2789999998765321 1 10000 0111244433333222
Q ss_pred ----HHHHHHHHh---------------------cCCCCeEecCCCCCceEECCCCcEEEEeeCCccc
Q 046270 378 ----AKGIAYLHY---------------------GLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQ 420 (590)
Q Consensus 378 ----a~gL~yLH~---------------------~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~ 420 (590)
...+.+|.. .....++|+|+.+.||+ +.++.+.|+||..+..
T Consensus 225 ~~~l~~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 225 YSKILEEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp HHHHHHHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 223344331 12356899999999999 7788999999998864
|
| >3a2e_A Ginkbilobin-2; domain 26 unknown function (DUF26), C-X8-C-X2-C motif, antifungal protein, embryo-abundant protein (EAP), plant protein; 2.38A {Ginkgo biloba} | Back alignment and structure |
|---|
Probab=93.08 E-value=0.034 Score=47.38 Aligned_cols=40 Identities=18% Similarity=0.283 Sum_probs=31.7
Q ss_pred cccc-cCCCcccchHHHHhhhhhhhcccccCCCcc------ceeeeEEee
Q 046270 119 PACK-NFSGFSQCSSCVEAGYSVNAKLLSIQPNST------KCFYFAVLY 161 (590)
Q Consensus 119 ~~c~-~l~~~~~c~~c~~~~~~~~~~l~~~~~~~~------~c~~~~~~~ 161 (590)
+||+ |+ ++.+|+.|++..+..+. ..+.++++ .|++|++.|
T Consensus 60 ~qC~~Dl-s~~~C~~Cl~~a~~~~~--~~C~~~~g~~i~~~~C~lRY~~~ 106 (108)
T 3a2e_A 60 ATCKQSI-SQSDCTACLSNLVNRIF--SICNNAIGARVQLVDCFIQYEQR 106 (108)
T ss_dssp EEECTTS-CHHHHHHHHHHHHTTHH--HHTTSBSSEEEEETTEEEEEESS
T ss_pred EEEcCCC-CHHHHHHHHHHHHHHHH--HHCCCCceEEEECCCEEEEEeCC
Confidence 6899 99 89999999999987765 33444443 799999876
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=91.42 E-value=0.11 Score=54.50 Aligned_cols=30 Identities=27% Similarity=0.372 Sum_probs=25.0
Q ss_pred CeEecCCCCCceEE------CCCCcEEEEeeCCccc
Q 046270 391 GIYHRDIKSTNILL------DSELNAKVADFGLAKQ 420 (590)
Q Consensus 391 ~ivHrDIKp~NILL------d~~~~~kL~DFGla~~ 420 (590)
.++|+|+.+.|||+ +++..++++||..+..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 46799999999999 4456799999988864
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=88.71 E-value=0.18 Score=35.44 Aligned_cols=11 Identities=45% Similarity=0.791 Sum_probs=5.1
Q ss_pred EEehHHHHHHH
Q 046270 200 LVIGLLGALLG 210 (590)
Q Consensus 200 i~i~v~~~~~~ 210 (590)
|+.++++++++
T Consensus 13 IA~gVVgGv~~ 23 (44)
T 2ks1_B 13 IATGMVGALLL 23 (44)
T ss_dssp STHHHHHHHHH
T ss_pred EEeehhHHHHH
Confidence 44455554443
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=87.81 E-value=0.14 Score=35.87 Aligned_cols=10 Identities=20% Similarity=0.145 Sum_probs=4.1
Q ss_pred HHHHHHHHhh
Q 046270 215 SGLIILYRKW 224 (590)
Q Consensus 215 ~~~~~~~~~~ 224 (590)
+++++|.||+
T Consensus 29 l~~~~~~RRR 38 (44)
T 2jwa_A 29 VVFGILIKRR 38 (44)
T ss_dssp HHHHHHHHHH
T ss_pred HHHHhheehh
Confidence 3334444443
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=87.41 E-value=0.2 Score=35.09 Aligned_cols=11 Identities=27% Similarity=0.664 Sum_probs=4.9
Q ss_pred EEehHHHHHHH
Q 046270 200 LVIGLLGALLG 210 (590)
Q Consensus 200 i~i~v~~~~~~ 210 (590)
|+.++++++++
T Consensus 12 IA~gVVgGv~~ 22 (44)
T 2l2t_A 12 IAAGVIGGLFI 22 (44)
T ss_dssp HHHHHHHHHHH
T ss_pred EEEeehHHHHH
Confidence 44455544433
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=82.13 E-value=0.16 Score=54.51 Aligned_cols=60 Identities=7% Similarity=-0.031 Sum_probs=18.1
Q ss_pred ceecccCcEEEEEEEEcC-CcEEEE------EEeecCC--CCChHHHHHHHHHHHhcCCCCccccceeEEec
Q 046270 270 NLIGQGASGIVYKGTLRH-GNLVAV------KQILDLD--TKGDEDFTNEVEIISKIRHRNLLSLRGCCVTS 332 (590)
Q Consensus 270 ~~LG~G~fG~Vykg~~~~-g~~vAv------K~l~~~~--~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~ 332 (590)
+.|| ||+||+|.+.. ..+||| |...... .+....|.+|..++..++|+|+++.++|....
T Consensus 148 ~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~~ 216 (463)
T 3cxl_A 148 EHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVHT 216 (463)
T ss_dssp TTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEEEC
T ss_pred ccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEee
Confidence 4566 99999999875 357888 7665422 22234688899999999999999999987654
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 590 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-66 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-63 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-62 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-62 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-61 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-61 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 7e-61 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-60 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 4e-59 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 9e-59 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-58 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-57 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 4e-57 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 5e-57 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 7e-57 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 4e-56 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 6e-56 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-55 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-55 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 3e-55 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 6e-55 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 7e-54 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 3e-53 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-52 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 7e-52 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 8e-52 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-51 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-51 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-51 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 9e-49 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-48 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-48 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 5e-46 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 5e-46 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 6e-46 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 6e-46 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 3e-45 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 5e-45 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-44 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-43 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-43 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 4e-43 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-41 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-40 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-40 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-40 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-40 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 3e-40 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 4e-40 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-39 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 5e-39 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-37 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-36 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-36 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-36 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 9e-36 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-35 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 3e-33 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-32 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-31 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-30 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-29 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 4e-21 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (550), Expect = 2e-66
Identities = 76/282 (26%), Positives = 118/282 (41%), Gaps = 37/282 (13%)
Query: 270 NLIGQGASGIVYKGTLRHGNLVAVKQI--LDLDTKGDEDFTNEVEIISKIRHRNLLSLRG 327
IG G+ G VYKG + VAVK + + + F NEV ++ K RH N+L G
Sbjct: 14 QRIGSGSFGTVYKG--KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 71
Query: 328 CCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYG 387
+ + +V + +L ++ I + + I A+G+ YLH
Sbjct: 72 YS------TAPQLAIVTQWCEGSSLYHHLHI--IETKFEMIKLIDIARQTAQGMDYLHA- 122
Query: 388 LKPGIYHRDIKSTNILLDSELNAKVADFGLAKQ-SLEGHSHLTTRVAGTFGYLAPEYALY 446
I HRD+KS NI L +L K+ DFGLA S SH +++G+ ++APE
Sbjct: 123 --KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 180
Query: 447 ---GQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLIT--DWAWVLAKSGKVDDIFDE 501
+ +SDVY+FGIV+ ELM+G+ P+ I D + G + +
Sbjct: 181 QDKNPYSFQSDVYAFGIVLYELMTGQL-------PYSNINNRDQIIFMVGRGYLSPDLSK 233
Query: 502 FIR--AEGARAVMERFVLVGILCAHVMVALRPTITDALKMLE 541
+ + +M C RP L +E
Sbjct: 234 VRSNCPKAMKRLMAE-------CLKKKRDERPLFPQILASIE 268
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (528), Expect = 2e-63
Identities = 64/274 (23%), Positives = 121/274 (44%), Gaps = 29/274 (10%)
Query: 270 NLIGQGASGIVYKGTLRHGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCC 329
+G G G V+ G VAVK L + + F E ++ +++H+ L+ L
Sbjct: 19 ERLGAGQFGEVWMGYYNGHTKVAVK-SLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 330 VTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLK 389
+ + +++ +YM NG+L D + + +LT + + +A+G+A++ +
Sbjct: 78 ------TQEPIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFIE---E 127
Query: 390 PGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALYGQL 449
HRD+++ NIL+ L+ K+ADFGLA+ + + APE YG
Sbjct: 128 RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTF 187
Query: 450 TEKSDVYSFGIVILELMSGRKVLDTSTSPFQLIT--DWAWVLAKSGKVDDIFDEFIRAEG 507
T KSDV+SFGI++ E+++ ++ + ++I + + + + + + +R
Sbjct: 188 TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMR--- 244
Query: 508 ARAVMERFVLVGILCAHVMVALRPTITDALKMLE 541
LC RPT +LE
Sbjct: 245 -------------LCWKERPEDRPTFDYLRSVLE 265
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (524), Expect = 1e-62
Identities = 79/288 (27%), Positives = 118/288 (40%), Gaps = 25/288 (8%)
Query: 266 FSQNNLIGQGASGIVYKGTLRHGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSL 325
+GQG G V+ GT VA+K L T E F E +++ K+RH L+ L
Sbjct: 19 LRLEVKLGQGCFGEVWMGTWNGTTRVAIK-TLKPGTMSPEAFLQEAQVMKKLRHEKLVQL 77
Query: 326 RGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLH 385
S + ++V +YM G+L + K L PQ + +A G+AY+
Sbjct: 78 YAVV------SEEPIYIVTEYMSKGSL-LDFLKGETGKYLRLPQLVDMAAQIASGMAYVE 130
Query: 386 YGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYAL 445
HRD+++ NIL+ L KVADFGLA+ + + APE AL
Sbjct: 131 R---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL 187
Query: 446 YGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDEFIRA 505
YG+ T KSDV+SFGI++ EL + +V +++ + G E
Sbjct: 188 YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLD-----QVERGYRMPCPPEC--P 240
Query: 506 EGARAVMERFVLVGILCAHVMVALRPTITDALKMLEGDIDIPKLPDRP 553
E +M + C RPT LE + +P
Sbjct: 241 ESLHDLMCQ-------CWRKEPEERPTFEYLQAFLEDYFTSTEPQYQP 281
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (520), Expect = 2e-62
Identities = 62/272 (22%), Positives = 112/272 (41%), Gaps = 25/272 (9%)
Query: 270 NLIGQGASGIVYKGTLRHGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCC 329
IG G G+V+ G + + VA+K + +EDF E E++ K+ H L+ L G C
Sbjct: 11 QEIGSGQFGLVHLGYWLNKDKVAIK-TIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 69
Query: 330 VTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLK 389
+ LV+++M +G LSD + + +DV +G + Y +
Sbjct: 70 LEQA-----PICLVFEFMEHGCLSDYLRTQRGLF--AAETLLGMCLDVCEG---MAYLEE 119
Query: 390 PGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALYGQL 449
+ HRD+ + N L+ KV+DFG+ + L+ +T + +PE + +
Sbjct: 120 ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRY 179
Query: 450 TEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDEFIRAEGAR 509
+ KSDV+SFG+++ E+ S K + V+ ++ + +
Sbjct: 180 SSKSDVWSFGVLMWEVFSEGK-------IPYENRSNSEVVEDISTGFRLYKPRLASTHVY 232
Query: 510 AVMERFVLVGILCAHVMVALRPTITDALKMLE 541
+M C RP + L+ L
Sbjct: 233 QIMNH-------CWKERPEDRPAFSRLLRQLA 257
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (521), Expect = 1e-61
Identities = 51/221 (23%), Positives = 102/221 (46%), Gaps = 15/221 (6%)
Query: 259 LEQATNGFSQNNLIGQGASGIVYKGTLRH-GNLVAVKQI-LDLDTKGDEDFTNEVEIISK 316
+E + F + + +G G G+V+K + + G ++A K I L++ E++++ +
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 317 IRHRNLLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVD 376
++ G + + ++M G+L + K ++ K+ +
Sbjct: 61 CNSPYIVGFYGAFYSDG-----EISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIA 112
Query: 377 VAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTF 436
V KG+ YL K I HRD+K +NIL++S K+ DFG++ Q + GT
Sbjct: 113 VIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL---IDSMANSFVGTR 167
Query: 437 GYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTS 477
Y++PE + +SD++S G+ ++E+ GR + +
Sbjct: 168 SYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDA 208
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (514), Expect = 2e-61
Identities = 62/275 (22%), Positives = 119/275 (43%), Gaps = 26/275 (9%)
Query: 270 NLIGQGASGIVYKGTLRHGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCC 329
+G G G+V G R VA+K ++ + +++F E +++ + H L+ L G C
Sbjct: 10 KELGTGQFGVVKYGKWRGQYDVAIK-MIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 68
Query: 330 VTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLK 389
F++ +YM NG L + + R + Q ++ DV + + YL
Sbjct: 69 TKQR-----PIFIITEYMANGCLLNYLR--EMRHRFQTQQLLEMCKDVCEAMEYLES--- 118
Query: 390 PGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALYGQL 449
HRD+ + N L++ + KV+DFGL++ L+ + + PE +Y +
Sbjct: 119 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKF 178
Query: 450 TEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDEFIRAEGAR 509
+ KSD+++FG+++ E+ S K P++ T+ + + ++ + +E
Sbjct: 179 SSKSDIWAFGVLMWEIYSLGK------MPYERFTN-SETAEHIAQGLRLYRPHLASEKVY 231
Query: 510 AVMERFVLVGILCAHVMVALRPTITDALKMLEGDI 544
+M C H RPT L + D+
Sbjct: 232 TIMYS-------CWHEKADERPTFKILLSNIL-DV 258
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (513), Expect = 7e-61
Identities = 69/290 (23%), Positives = 112/290 (38%), Gaps = 27/290 (9%)
Query: 272 IGQGASGIVYKGTLRHGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVT 331
IG+G G V++G R G VAVK I + E+ +RH N+L
Sbjct: 11 IGKGRFGEVWRGKWR-GEEVAVK-IFSSREERSWFREAEIYQTVMLRHENILGFIAAD-N 67
Query: 332 SDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLH-----Y 386
D+ + + +LV DY +G+L D + R +T K+ + A G+A+LH
Sbjct: 68 KDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEIVGT 123
Query: 387 GLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHL---TTRVAGTFGYLAPEY 443
KP I HRD+KS NIL+ +AD GLA + + GT Y+APE
Sbjct: 124 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 183
Query: 444 AL------YGQLTEKSDVYSFGIVILELMSGRKVLDTSTS-----PFQLITDWAWVLAKS 492
+ + +++D+Y+ G+V E+ + + +D + +
Sbjct: 184 LDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRK 243
Query: 493 GKVDDIFDEFIRAEGARA-VMERFVLVGILCAHVMVALRPTITDALKMLE 541
+ I + + C + A R T K L
Sbjct: 244 VVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (507), Expect = 2e-60
Identities = 77/272 (28%), Positives = 117/272 (43%), Gaps = 29/272 (10%)
Query: 270 NLIGQGASGIVYKGTLRHGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCC 329
IG+G G V G R GN VAVK I + + F E +++++RH NL+ L G
Sbjct: 13 QTIGKGEFGDVMLGDYR-GNKVAVKCIKN--DATAQAFLAEASVMTQLRHSNLVQLLGVI 69
Query: 330 VTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLK 389
V ++V +YM G+L D + S R L K +DV + + YL
Sbjct: 70 VEEKG----GLYIVTEYMAKGSLVDYLR-SRGRSVLGGDCLLKFSLDVCEAMEYLE---G 121
Query: 390 PGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALYGQL 449
HRD+ + N+L+ + AKV+DFGL K+ S + APE +
Sbjct: 122 NNFVHRDLAARNVLVSEDNVAKVSDFGLTKE----ASSTQDTGKLPVKWTAPEALREKKF 177
Query: 450 TEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDEFIRAEGAR 509
+ KSDV+SFGI++ E+ S +V ++ + G D D
Sbjct: 178 STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVP-----RVEKGYKMDAPDGC--PPAVY 230
Query: 510 AVMERFVLVGILCAHVMVALRPTITDALKMLE 541
VM+ C H+ A+RP+ + LE
Sbjct: 231 EVMKN-------CWHLDAAMRPSFLQLREQLE 255
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 197 bits (501), Expect = 4e-59
Identities = 72/306 (23%), Positives = 119/306 (38%), Gaps = 42/306 (13%)
Query: 254 FHVSELEQATNGFSQN---------NLIGQGASGIVYKGTLRHGN----LVAVKQI-LDL 299
F + +A F++ +IG G G V G L+ VA+K +
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 300 DTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISIS 359
K DF +E I+ + H N++ L G S ++ ++M NG+L +
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKST-----PVMIITEFMENGSLDSFLR-- 119
Query: 360 HKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAK 419
Q T Q ++ +A G+ YL HRD+ + NIL++S L KV+DFGL++
Sbjct: 120 QNDGQFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSR 176
Query: 420 QSLEGHSHLTTRVA----GTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTS 475
+ S T A + APE Y + T SDV+S+GIV+ E+MS +
Sbjct: 177 FLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWD 236
Query: 476 TSPFQLITDWAWVLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITD 535
+ +I + ++ R + + C RP
Sbjct: 237 MTNQDVI--------------NAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQ 282
Query: 536 ALKMLE 541
+ L+
Sbjct: 283 IVNTLD 288
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (496), Expect = 9e-59
Identities = 68/276 (24%), Positives = 112/276 (40%), Gaps = 30/276 (10%)
Query: 269 NNLIGQGASGIVYKGTLRH-GNLVAVKQILD--LDTKGDEDFTNEVEIISKIRHRNLLSL 325
+ IG+G+ VYKG VA ++ D L + F E E++ ++H N++
Sbjct: 14 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73
Query: 326 RGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLH 385
++ K LV + M +GTL + + K + + + KG+ +LH
Sbjct: 74 YDSWESTVKG-KKCIVLVTELMTSGTLKTYL---KRFKVMKIKVLRSWCRQILKGLQFLH 129
Query: 386 YGLKPGIYHRDIKSTNILLDSELN-AKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYA 444
P I HRD+K NI + K+ D GLA + V GT ++APE
Sbjct: 130 T-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK---RASFAKAVIGTPEFMAPEM- 184
Query: 445 LYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAK--SGKVDDIFDEF 502
+ E DVY+FG+ +LE+ + P+ + A + + SG FD+
Sbjct: 185 YEEKYDESVDVYAFGMCMLEMATSEY-------PYSECQNAAQIYRRVTSGVKPASFDKV 237
Query: 503 IRAEGARAVMERFVLVGILCAHVMVALRPTITDALK 538
E + ++E C R +I D L
Sbjct: 238 AIPE-VKEIIEG-------CIRQNKDERYSIKDLLN 265
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 194 bits (494), Expect = 3e-58
Identities = 64/295 (21%), Positives = 117/295 (39%), Gaps = 25/295 (8%)
Query: 258 ELEQATNGFSQNNLIGQGASGIVYKGTLRH-GNLVAVKQILDLDTKGDEDFTNEVEIISK 316
+ E + + +G G G VY+G + VAVK L DT E+F E ++ +
Sbjct: 11 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVK-TLKEDTMEVEEFLKEAAVMKE 69
Query: 317 IRHRNLLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVD 376
I+H NL+ L G C +++ ++M G L D + R++++ +
Sbjct: 70 IKHPNLVQLLGVCTREP-----PFYIITEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQ 123
Query: 377 VAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTF 436
++ + YL K HRD+ + N L+ KVADFGL++
Sbjct: 124 ISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI 180
Query: 437 GYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVD 496
+ APE Y + + KSDV++FG+++ E+ + Q+
Sbjct: 181 KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY-------------- 226
Query: 497 DIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEGDIDIPKLPD 551
++ ++ R E E+ + C + RP+ + + E + D
Sbjct: 227 ELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISD 281
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 3e-57
Identities = 72/290 (24%), Positives = 121/290 (41%), Gaps = 32/290 (11%)
Query: 266 FSQNNLIGQGASGIVYKGTLRHGN-----LVAVKQI-LDLDTKGDEDFTNEVEIISKIRH 319
++ +IG G G VYKG L+ + VA+K + K DF E I+ + H
Sbjct: 9 VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSH 68
Query: 320 RNLLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAK 379
N++ L G ++ +YM NG L + K + + Q ++ +A
Sbjct: 69 HNIIRLEGVISKYK-----PMMIITEYMENGALDKFLR--EKDGEFSVLQLVGMLRGIAA 121
Query: 380 GIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEG--HSHLTTRVAGTFG 437
G+ YL HRD+ + NIL++S L KV+DFGL++ + ++ T+
Sbjct: 122 GMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIR 178
Query: 438 YLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDD 497
+ APE Y + T SDV+SFGIV+ E+M+ + S +++
Sbjct: 179 WTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVM--------------K 224
Query: 498 IFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEGDIDIP 547
++ R + + C A RP D + +L+ I P
Sbjct: 225 AINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 274
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (486), Expect = 4e-57
Identities = 57/291 (19%), Positives = 115/291 (39%), Gaps = 32/291 (10%)
Query: 258 ELEQATNGFSQNNL-IGQGASGIVYKGTLRHGN---LVAVKQI-LDLDTKGDEDFTNEVE 312
+L + ++ +G G G V +G R VA+K + + E+ E +
Sbjct: 2 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQ 61
Query: 313 IISKIRHRNLLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKK 372
I+ ++ + ++ L G C + LV + G L + KR+++ +
Sbjct: 62 IMHQLDNPYIVRLIGVC------QAEALMLVMEMAGGGPLHK--FLVGKREEIPVSNVAE 113
Query: 373 IIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQ--SLEGHSHLTT 430
++ V+ G+ YL HRD+ + N+LL + AK++DFGL+K + + + +
Sbjct: 114 LLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS 170
Query: 431 RVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLA 490
+ APE + + + +SDV+S+G+ + E +S + +++
Sbjct: 171 AGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMA-----FI 225
Query: 491 KSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLE 541
+ GK + E A+M C RP + +
Sbjct: 226 EQGKRMECPPEC--PPELYALMSD-------CWIYKWEDRPDFLTVEQRMR 267
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 5e-57
Identities = 58/276 (21%), Positives = 114/276 (41%), Gaps = 27/276 (9%)
Query: 270 NLIGQGASGIVYKGTLRH-GNLVAVKQIL--DLDTKGDEDFTNEVEIISKIRHRNLLSLR 326
IG G+ G K + G ++ K++ + + +EV ++ +++H N++
Sbjct: 10 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 69
Query: 327 GCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQ-LTWPQRKKIIVDVAKGIAYLH 385
+ D + ++V +Y G L+ I+ K +Q L +++ + + H
Sbjct: 70 DRII---DRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH 126
Query: 386 Y--GLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEY 443
+ HRD+K N+ LD + N K+ DFGLA+ L + GT Y++PE
Sbjct: 127 RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI-LNHDTSFAKAFVGTPYYMSPEQ 185
Query: 444 ALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLA-KSGKVDDIFDEF 502
EKSD++S G ++ EL + PF + + GK I +
Sbjct: 186 MNRMSYNEKSDIWSLGCLLYELCALM-------PPFTAFSQKELAGKIREGKFRRIPYRY 238
Query: 503 IRAEGARAVMERFVLVGILCAHVMVALRPTITDALK 538
++ ++ R ++ RP++ + L+
Sbjct: 239 --SDELNEIITR-------MLNLKDYHRPSVEEILE 265
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 191 bits (487), Expect = 7e-57
Identities = 70/280 (25%), Positives = 107/280 (38%), Gaps = 37/280 (13%)
Query: 266 FSQNNLIGQGASGIVYKGT-LRHGNLVAVKQI---LDLDTKGDEDFTNEVEIISKIRHRN 321
FS IG G+ G VY +R+ +VA+K++ + +D EV + K+RH N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 322 LLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGI 381
+ RGC + +LV +Y +K L + + +G+
Sbjct: 77 TIQYRGCYLREH-----TAWLVMEYCLGSASDLLE---VHKKPLQEVEIAAVTHGALQGL 128
Query: 382 AYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAP 441
AYLH + HRD+K+ NILL K+ DFG A GT ++AP
Sbjct: 129 AYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-----ANSFVGTPYWMAP 180
Query: 442 EYAL---YGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDI 498
E L GQ K DV+S GI +EL + P + + + +
Sbjct: 181 EVILAMDEGQYDGKVDVWSLGITCIELAERK-------PPLFNMNAMSALYHIAQNESPA 233
Query: 499 FDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALK 538
+E R ++ C + RPT LK
Sbjct: 234 LQSGHWSEYFRNFVDS-------CLQKIPQDRPTSEVLLK 266
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (478), Expect = 4e-56
Identities = 55/281 (19%), Positives = 108/281 (38%), Gaps = 33/281 (11%)
Query: 268 QNNLIGQGASGIVYKGTLRH---GNLVAVKQILD--LDTKGDEDFTNEVEIISKIRHRNL 322
++ +G G G V KG + VAVK + + D ++ E ++ ++ + +
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 323 LSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIA 382
+ + G C + LV + G L+ + + + + +++ V+ G+
Sbjct: 71 VRMIGIC------EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMK 121
Query: 383 YLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTR--VAGTFGYLA 440
YL HRD+ + N+LL ++ AK++DFGL+K ++ + + A
Sbjct: 122 YLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYA 178
Query: 441 PEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFD 500
PE Y + + KSDV+SFG+++ E S + ++ + + G+
Sbjct: 179 PECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTA-----MLEKGERMGCPA 233
Query: 501 EFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLE 541
+M C V RP L
Sbjct: 234 GC--PREMYDLMNL-------CWTYDVENRPGFAAVELRLR 265
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (480), Expect = 6e-56
Identities = 73/281 (25%), Positives = 117/281 (41%), Gaps = 31/281 (11%)
Query: 269 NNLIGQGASGIVYKGTLRHGN----LVAVKQILDLDTKGD-EDFTNEVEIISKIRHRNLL 323
N +IG+G G VY GTL + AVK + + G+ F E I+ H N+L
Sbjct: 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91
Query: 324 SLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAY 383
SL G C+ S+ +V YM +G L + I ++ T + VAKG+ +
Sbjct: 92 SLLGICLRSEG----SPLVVLPYMKHGDLRNFIR--NETHNPTVKDLIGFGLQVAKGMKF 145
Query: 384 LHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEG---HSHLTTRVAGTFGYLA 440
L HRD+ + N +LD + KVADFGLA+ + H T ++A
Sbjct: 146 LAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 202
Query: 441 PEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFD 500
E + T KSDV+SFG+++ ELM+ + F + + +
Sbjct: 203 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD-------ITVYLLQGRRLLQ 255
Query: 501 EFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLE 541
+ VM + C H +RP+ ++ + +
Sbjct: 256 PEYCPDPLYEVMLK-------CWHPKAEMRPSFSELVSRIS 289
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 1e-55
Identities = 71/273 (26%), Positives = 107/273 (39%), Gaps = 28/273 (10%)
Query: 270 NLIGQGASGIVYKGTLRH-GNLVAVKQI-LDLDTKGDEDFTNEVEIISKIRHRNLLSLRG 327
+G+GA G V R VAVK + + E+ E+ I + H N++ G
Sbjct: 11 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 70
Query: 328 CCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYG 387
+ ++L +Y G L D I + P ++ + G+ YLH
Sbjct: 71 HRREGN-----IQYLFLEYCSGGELFDRI---EPDIGMPEPDAQRFFHQLMAGVVYLH-- 120
Query: 388 LKPGIYHRDIKSTNILLDSELNAKVADFGLAKQ-SLEGHSHLTTRVAGTFGYLAPEYALY 446
GI HRDIK N+LLD N K++DFGLA L ++ GT Y+APE
Sbjct: 121 -GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 179
Query: 447 GQL-TEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDEFIRA 505
+ E DV+S GIV+ +++G D + Q +DW I
Sbjct: 180 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSA---- 235
Query: 506 EGARAVMERFVLVGILCAHVMVALRPTITDALK 538
A++ + + R TI D K
Sbjct: 236 --PLALLHK-------ILVENPSARITIPDIKK 259
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 2e-55
Identities = 57/276 (20%), Positives = 109/276 (39%), Gaps = 32/276 (11%)
Query: 270 NLIGQGASGIVYKGTLRH-GNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGC 328
+G GA G VYK + L A K I + ED+ E++I++ H N++ L
Sbjct: 18 GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77
Query: 329 CVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGL 388
+ +++ ++ G + + + LT Q + + + YLH
Sbjct: 78 FYYEN-----NLWILIEFCAGGAVDAVML--ELERPLTESQIQVVCKQTLDALNYLH--- 127
Query: 389 KPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALYGQ 448
I HRD+K+ NIL + + K+ADFG++ ++ + + GT ++APE +
Sbjct: 128 DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPYWMAPEVVMCET 186
Query: 449 L-----TEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLA-KSGKVDDIFDEF 502
K+DV+S GI ++E+ P + +L + +
Sbjct: 187 SKDRPYDYKADVWSLGITLIEMAEIE-------PPHHELNPMRVLLKIAKSEPPTLAQPS 239
Query: 503 IRAEGARAVMERFVLVGILCAHVMVALRPTITDALK 538
+ + +++ C V R T + L+
Sbjct: 240 RWSSNFKDFLKK-------CLEKNVDARWTTSQLLQ 268
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (471), Expect = 3e-55
Identities = 71/273 (26%), Positives = 118/273 (43%), Gaps = 34/273 (12%)
Query: 270 NLIGQGASGIVYKGTLRH-GNLVAVKQILD---LDTKGDEDFTNEVEIISKIRHRNLLSL 325
+G+G G VY + ++A+K + + EVEI S +RH N+L L
Sbjct: 12 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 71
Query: 326 RGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLH 385
G + R +L+ +Y P GT+ + K + + I ++A ++Y H
Sbjct: 72 YGYFHDAT-----RVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALSYCH 123
Query: 386 YGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYAL 445
+ HRDIK N+LL S K+ADFG + + S T + GT YL PE
Sbjct: 124 ---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHA---PSSRRTTLCGTLDYLPPEMIE 177
Query: 446 YGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDEFIRA 505
EK D++S G++ E + G+ PF+ + + +V+ F +F+
Sbjct: 178 GRMHDEKVDLWSLGVLCYEFLVGK-------PPFEA-NTYQETYKRISRVEFTFPDFV-T 228
Query: 506 EGARAVMERFVLVGILCAHVMVALRPTITDALK 538
EGAR ++ R + RP + + L+
Sbjct: 229 EGARDLISR-------LLKHNPSQRPMLREVLE 254
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 186 bits (472), Expect = 6e-55
Identities = 67/314 (21%), Positives = 121/314 (38%), Gaps = 51/314 (16%)
Query: 257 SELEQATNGFSQNNLIGQGASGIVYKGTLRH------GNLVAVKQI-LDLDTKGDEDFTN 309
LE N IG+GA G V++ +VAVK + + DF
Sbjct: 6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQR 65
Query: 310 EVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNI------------- 356
E ++++ + N++ L G C GK L+++YM G L++ +
Sbjct: 66 EAALMAEFDNPNIVKLLGVCAV-----GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSH 120
Query: 357 --------SISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSEL 408
S L+ ++ I VA G+AYL + HRD+ + N L+ +
Sbjct: 121 SDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENM 177
Query: 409 NAKVADFGLAKQSLEG-HSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS 467
K+ADFGL++ + A ++ PE Y + T +SDV+++G+V+ E+ S
Sbjct: 178 VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 237
Query: 468 GRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMV 527
+ ++I + G + + + LC +
Sbjct: 238 YGLQPYYGMAHEEVIYYV-----RDGNILACPEN---------CPLELYNLMRLCWSKLP 283
Query: 528 ALRPTITDALKMLE 541
A RP+ ++L+
Sbjct: 284 ADRPSFCSIHRILQ 297
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (467), Expect = 7e-54
Identities = 66/308 (21%), Positives = 123/308 (39%), Gaps = 35/308 (11%)
Query: 266 FSQNNLIGQGASGIVYKGTLRHGN-----LVAVKQI-LDLDTKGDEDFTNEVEIISKIRH 319
F + ++G GA G VYKG VA+K++ K +++ +E +++ + +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 320 RNLLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAK 379
++ L G C+TS L+ MP G L D + + + V +AK
Sbjct: 71 PHVCRLLGICLTST------VQLITQLMPFGCLLDYVR--EHKDNIGSQYLLNWCVQIAK 122
Query: 380 GIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQ-SLEGHSHLTTRVAGTFGY 438
G+ YL + HRD+ + N+L+ + + K+ DFGLAK E + +
Sbjct: 123 GMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 179
Query: 439 LAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDI 498
+A E L+ T +SDV+S+G+ + ELM+ ++ + + + G+
Sbjct: 180 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS-----ILEKGERLPQ 234
Query: 499 FDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEGDIDIPKLPDRPLPLSH 558
+M + C + RP + + + + P R L +
Sbjct: 235 PPIC--TIDVYMIMVK-------CWMIDADSRPKFRELIIEFS---KMARDPQRYLVIQG 282
Query: 559 ECLRSSPS 566
+ PS
Sbjct: 283 DERMHLPS 290
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (462), Expect = 3e-53
Identities = 69/296 (23%), Positives = 118/296 (39%), Gaps = 42/296 (14%)
Query: 264 NGFSQNNLIGQGASGIVYKGTLRHGNL---VAVKQILDLDTKGD-EDFTNEVEIISKI-R 318
N ++IG+G G V K ++ L A+K++ + +K D DF E+E++ K+
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 319 HRNLLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNI-------------SISHKRKQL 365
H N+++L G C +L +Y P+G L D + + L
Sbjct: 70 HPNIINLLGACEHRG-----YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTL 124
Query: 366 TWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGH 425
+ Q DVA+G+ YL + HRD+ + NIL+ AK+ADFGL++ +
Sbjct: 125 SSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR--GQEV 179
Query: 426 SHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDW 485
T ++A E Y T SDV+S+G+++ E++S + +L
Sbjct: 180 YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 239
Query: 486 AWVLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLE 541
G + + +M + C RP+ L L
Sbjct: 240 -----PQGYRLEKPLNC--DDEVYDLMRQ-------CWREKPYERPSFAQILVSLN 281
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (455), Expect = 2e-52
Identities = 67/270 (24%), Positives = 117/270 (43%), Gaps = 27/270 (10%)
Query: 270 NLIGQGASGIVYKGTLRH-GNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGC 328
IGQGASG VY G VA++Q+ E NE+ ++ + ++ N+++
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 329 CVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGL 388
+ D ++V +Y+ G+L+D + + Q + + + + +LH
Sbjct: 86 YLVGD-----ELWVVMEYLAGGSLTDVV----TETCMDEGQIAAVCRECLQALEFLH--- 133
Query: 389 KPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALYGQ 448
+ HRDIKS NILL + + K+ DFG Q S +T V GT ++APE
Sbjct: 134 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKA 192
Query: 449 LTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDEFIRAEGA 508
K D++S GI+ +E++ G L +++A +G + E + A
Sbjct: 193 YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL-----YLIATNGTPELQNPEKLSAI-F 246
Query: 509 RAVMERFVLVGILCAHVMVALRPTITDALK 538
R + R C + V R + + L+
Sbjct: 247 RDFLNR-------CLDMDVEKRGSAKELLQ 269
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 7e-52
Identities = 62/299 (20%), Positives = 101/299 (33%), Gaps = 45/299 (15%)
Query: 270 NLIGQGASGIVYKGTLRH------GNLVAVKQI-LDLDTKGDEDFTNEVEIISKI-RHRN 321
+G GA G V + T VAVK + E +E++++S + H N
Sbjct: 29 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88
Query: 322 LLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNI---------------SISHKRKQLT 366
+++L G C ++ +Y G L + + + L
Sbjct: 89 IVNLLGACTIGG-----PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALD 143
Query: 367 WPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHS 426
VAKG+A+L HRD+ + NILL K+ DFGLA+ +
Sbjct: 144 LEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSN 200
Query: 427 H-LTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDW 485
+ + ++APE T +SDV+S+GI + EL S
Sbjct: 201 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF--- 257
Query: 486 AWVLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEGDI 544
+ E R + C RPT ++++E I
Sbjct: 258 ----------YKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (448), Expect = 8e-52
Identities = 51/276 (18%), Positives = 101/276 (36%), Gaps = 30/276 (10%)
Query: 271 LIGQGASGIVYKGTLRHGN----LVAVKQILDLDTKGD-EDFTNEVEIISKIRHRNLLSL 325
IG+G G V++G VA+K + + E F E + + H +++ L
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73
Query: 326 RGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLH 385
G + +++ + G L + + L ++ +AYL
Sbjct: 74 IGVI------TENPVWIIMELCTLGELRSFLQVRKYS--LDLASLILYAYQLSTALAYLE 125
Query: 386 YGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYAL 445
HRDI + N+L+ S K+ DFGL++ + + ++ ++APE
Sbjct: 126 ---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN 182
Query: 446 YGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDEFIRA 505
+ + T SDV+ FG+ + E++ +I ++G+ +
Sbjct: 183 FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI-----ENGERLPMPPNC--P 235
Query: 506 EGARAVMERFVLVGILCAHVMVALRPTITDALKMLE 541
++M + C + RP T+ L
Sbjct: 236 PTLYSLMTK-------CWAYDPSRRPRFTELKAQLS 264
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 179 bits (454), Expect = 1e-51
Identities = 65/322 (20%), Positives = 128/322 (39%), Gaps = 33/322 (10%)
Query: 271 LIGQGASGIVYKGTLRH-GNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCC 329
+G GA G+V++ T R GN A K ++ E E++ +S +RH L++L
Sbjct: 33 ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 92
Query: 330 VTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLK 389
+ ++Y++M G L + ++ + +++ + + + V KG+ ++H +
Sbjct: 93 EDDN-----EMVMIYEFMSGGELFE--KVADEHNKMSEDEAVEYMRQVCKGLCHMH---E 142
Query: 390 PGIYHRDIKSTNILLDSELN--AKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALYG 447
H D+K NI+ ++ + K+ DFGL S T GT + APE A
Sbjct: 143 NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT--GTAEFAAPEVAEGK 200
Query: 448 QLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDEFIRAEG 507
+ +D++S G++ L+SG L V + +DD I +
Sbjct: 201 PVGYYTDMWSVGVLSYILLSGLSPFGGENDDETL----RNVKSCDWNMDDSAFSGISED- 255
Query: 508 ARAVMERFVLVGILCAHVMVALRPTITDALK---MLEGDI--DIPKLPDRPLPLSHECLR 562
+ + + R TI AL+ + G+ ++P + ++
Sbjct: 256 GKDFIRK-------LLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIRDSIK 308
Query: 563 SSPSRYSFST-STDRSATSSSM 583
+ + R + SS+
Sbjct: 309 TKYDAWPEPLPPLGRISNYSSL 330
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (448), Expect = 1e-51
Identities = 62/279 (22%), Positives = 107/279 (38%), Gaps = 33/279 (11%)
Query: 272 IGQGASGIVYKGTLR----HGNLVAVKQI---LDLDTKGDEDFTNEVEIISKIRHRNLLS 324
+G G+ G+V +G VAVK + + + +DF EV + + HRNL+
Sbjct: 16 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 325 LRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYL 384
L G +T +V + P G+L D + + + V VA+G+ YL
Sbjct: 76 LYGVVLTPP------MKMVTELAPLGSLLDRLR--KHQGHFLLGTLSRYAVQVAEGMGYL 127
Query: 385 HYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSH--LTTRVAGTFGYLAPE 442
HRD+ + N+LL + K+ DFGL + + H + F + APE
Sbjct: 128 E---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 184
Query: 443 YALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDEF 502
+ SD + FG+ + E+ + + + Q++ + K G+ ++
Sbjct: 185 SLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQIL----HKIDKEGERLPRPEDC 240
Query: 503 IRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLE 541
+ VM + C RPT L
Sbjct: 241 --PQDIYNVMVQ-------CWAHKPEDRPTFVALRDFLL 270
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (449), Expect = 2e-51
Identities = 63/300 (21%), Positives = 116/300 (38%), Gaps = 50/300 (16%)
Query: 271 LIGQGASGIVYKGTLRHGN------LVAVKQI-LDLDTKGDEDFTNEVEIISKI-RHRNL 322
++G GA G V T + VAVK + D+ E +E+++++++ H N+
Sbjct: 44 VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 103
Query: 323 LSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKR-------------------- 362
++L G C S +L+++Y G L + + ++
Sbjct: 104 VNLLGACTLSG-----PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDL 158
Query: 363 KQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSL 422
LT+ VAKG+ +L HRD+ + N+L+ K+ DFGLA+ +
Sbjct: 159 NVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIM 215
Query: 423 EGHSHLT-TRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQL 481
+++ ++APE G T KSDV+S+GI++ E+ S +P+
Sbjct: 216 SDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGV------NPYPG 269
Query: 482 ITDWAWVLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLE 541
I A + + + E ++ C RP+ + L
Sbjct: 270 IPVDANFYK-------LIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (430), Expect = 9e-49
Identities = 53/295 (17%), Positives = 115/295 (38%), Gaps = 37/295 (12%)
Query: 266 FSQNNLIGQGASGIVYKGTLRH------GNLVAVKQI-LDLDTKGDEDFTNEVEIISKIR 318
+ + +GQG+ G+VY+G + VA+K + + +F NE ++ +
Sbjct: 22 ITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFN 81
Query: 319 HRNLLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHK-------RKQLTWPQRK 371
+++ L G ++ + M G L + + +
Sbjct: 82 CHHVVRLLGVVSQGQ-----PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 136
Query: 372 KIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEG-HSHLTT 430
++ ++A G+AYL+ HRD+ + N ++ + K+ DFG+ + E +
Sbjct: 137 QMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 193
Query: 431 RVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLA 490
+ +++PE G T SDV+SFG+V+ E+ + + S Q++
Sbjct: 194 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV----- 248
Query: 491 KSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEGDID 545
G + D D + +M C +RP+ + + ++ +++
Sbjct: 249 MEGGLLDKPDNC--PDMLFELMRM-------CWQYNPKMRPSFLEIISSIKEEME 294
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 170 bits (432), Expect = 1e-48
Identities = 66/327 (20%), Positives = 130/327 (39%), Gaps = 38/327 (11%)
Query: 271 LIGQGASGIVYKGTLRH-GNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCC 329
+G GA G+V++ + G + K I NE+ I++++ H L++L
Sbjct: 36 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95
Query: 330 VTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLK 389
L+ +++ G L D I+ + +++ + + +G+ ++H +
Sbjct: 96 EDKY-----EMVLILEFLSGGELFD--RIAAEDYKMSEAEVINYMRQACEGLKHMH---E 145
Query: 390 PGIYHRDIKSTNILLDSELNA--KVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALYG 447
I H DIK NI+ +++ + K+ DFGLA + + T + APE
Sbjct: 146 HSIVHLDIKPENIMCETKKASSVKIIDFGLATKL--NPDEIVKVTTATAEFAAPEIVDRE 203
Query: 448 QLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDEFIRA-- 505
+ +D+++ G++ L+SG SPF D L + D FDE +
Sbjct: 204 PVGFYTDMWAIGVLGYVLLSGL-------SPFAGEDDLE-TLQNVKRCDWEFDEDAFSSV 255
Query: 506 -EGARAVMERFVLVGILCAHVMVALRPTITDALKM--LEGDID--IPKLPDRPLPLSHEC 560
A+ ++ R T+ DAL+ L+GD ++P +
Sbjct: 256 SPEAKDFIKN-------LLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNKIRQK 308
Query: 561 LRSSPSRY-SFSTSTDRSATSSSMTST 586
++ + + + + R A SS+
Sbjct: 309 IKEKYADWPAPQPAIGRIANFSSLRKH 335
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (424), Expect = 3e-48
Identities = 61/302 (20%), Positives = 112/302 (37%), Gaps = 39/302 (12%)
Query: 266 FSQNNLIGQGASGIVYKGT-LRHGNLVAVKQI---LDLDTKGDEDFTNEVEIISKIRHRN 321
F ++G+G+ V L A+K + + T E +++S++ H
Sbjct: 10 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 69
Query: 322 LLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGI 381
+ L + + + Y NG L I K + ++ +
Sbjct: 70 FVKLYFTFQDDE-----KLYFGLSYAKNGELLKYI---RKIGSFDETCTRFYTAEIVSAL 121
Query: 382 AYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAK-QSLEGHSHLTTRVAGTFGYLA 440
YLH GI HRD+K NILL+ +++ ++ DFG AK S E GT Y++
Sbjct: 122 EYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVS 178
Query: 441 PEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFD 500
PE + SD+++ G +I +L++G PF+ ++ + K K++ F
Sbjct: 179 PELLTEKSACKSSDLWALGCIIYQLVAGL-------PPFRAGNEYL-IFQKIIKLEYDFP 230
Query: 501 EFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEG-------DIDIPKLPDRP 553
E + AR ++E+ + R + + L +
Sbjct: 231 EKFFPK-ARDLVEK-------LLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQT 282
Query: 554 LP 555
P
Sbjct: 283 PP 284
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 161 bits (408), Expect = 5e-46
Identities = 65/285 (22%), Positives = 118/285 (41%), Gaps = 31/285 (10%)
Query: 263 TNGFSQNNLIGQGASGIVYKGT-LRHGNLVAVKQI---LDLDTKGDEDFTNEVEIISKIR 318
++ + ++G G V+ LR VAVK + L D F E + + +
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 319 HRNLLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVA 378
H ++++ + +G ++V +Y+ TL D + H +T + ++I D
Sbjct: 66 HPAIVAVYDTGEA-ETPAGPLPYIVMEYVDGVTLRDIV---HTEGPMTPKRAIEVIADAC 121
Query: 379 KGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHL--TTRVAGTF 436
+ + + H + GI HRD+K NI++ + KV DFG+A+ + + + T V GT
Sbjct: 122 QALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 178
Query: 437 GYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVD 496
YL+PE A + +SDVYS G V+ E+++G PF + + V + + D
Sbjct: 179 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE-------PPFTGDSPVS-VAYQHVRED 230
Query: 497 DIFDEFIRA---EGARAVMERFVLVGILCAHVMVALRPTITDALK 538
I AV+ + R ++
Sbjct: 231 PIPPSARHEGLSADLDAVVLK-------ALAKNPENRYQTAAEMR 268
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (414), Expect = 5e-46
Identities = 81/326 (24%), Positives = 137/326 (42%), Gaps = 34/326 (10%)
Query: 266 FSQNNLIGQGASGIVYKGTLRH-GNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLS 324
++ +IG G+ G+VY+ L G LVA+K++L + E++I+ K+ H N++
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIVR 77
Query: 325 LRGCCVTSDDSSGKRR-FLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAY 383
LR +S + + LV DY+P S ++ L K + + + +AY
Sbjct: 78 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 384 LHYGLKPGIYHRDIKSTNILLDSE-LNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPE 442
+H GI HRDIK N+LLD + K+ DFG AKQ + G +++ + Y APE
Sbjct: 138 IH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC--SRYYRAPE 192
Query: 443 YALYG-QLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQL---------ITDWAWVLAKS 492
T DV+S G V+ EL+ G+ + + QL T
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNP 252
Query: 493 GKVDDIFDEFIRAEGARAVMERFVLVGI-LCAHVMV---ALRPTITDALK------MLEG 542
+ F + + R I LC+ ++ R T +A + +
Sbjct: 253 NYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDP 312
Query: 543 DIDIPKLPDRPLP--LSHECLRSSPS 566
++ +P D P + + L S+P
Sbjct: 313 NVKLPNGRDTPALFNFTTQELSSNPP 338
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 6e-46
Identities = 68/318 (21%), Positives = 115/318 (36%), Gaps = 48/318 (15%)
Query: 246 LPNSGAKWFHVSELEQATNGFSQNNLIGQGASGIVYKGTLRH------GNLVAVKQILDL 299
LP +KW E + +G+GA G V + VAVK + +
Sbjct: 1 LPYDASKW------EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG 54
Query: 300 DTKGD-EDFTNEVEIISKIRHR-NLLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNIS 357
T + +E++I+ I H N+++L G C ++ ++ G LS +
Sbjct: 55 ATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG----PLMVIVEFCKFGNLSTYLR 110
Query: 358 ISHK-------------RKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILL 404
+ LT VAKG+ +L HRD+ + NILL
Sbjct: 111 SKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILL 167
Query: 405 DSELNAKVADFGLAKQSLEGHSHL-TTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVIL 463
+ K+ DFGLA+ + ++ ++APE T +SDV+SFG+++
Sbjct: 168 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLW 227
Query: 464 ELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCA 523
E+ S SP+ + E R + C
Sbjct: 228 EIFSLGA------SPYPGVKIDEEFC-------RRLKEGTRMRAPDYTTPEMYQTMLDCW 274
Query: 524 HVMVALRPTITDALKMLE 541
H + RPT ++ ++ L
Sbjct: 275 HGEPSQRPTFSELVEHLG 292
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 6e-46
Identities = 67/300 (22%), Positives = 118/300 (39%), Gaps = 48/300 (16%)
Query: 270 NLIGQGASGIVYKGTLRH--------GNLVAVKQI-LDLDTKGDEDFTNEVEIISKI-RH 319
+G+GA G V VAVK + D K D +E+E++ I +H
Sbjct: 19 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 78
Query: 320 RNLLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNI-------------SISHKRKQLT 366
+N+++L G C +++ +Y G L + + + +QL+
Sbjct: 79 KNIINLLGACTQDG-----PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLS 133
Query: 367 WPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHS 426
VA+G+ YL HRD+ + N+L+ + K+ADFGLA+
Sbjct: 134 SKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY 190
Query: 427 HLTTRVA-GTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLIT-D 484
+ T ++APE T +SDV+SFG+++ E+ + SP+ + +
Sbjct: 191 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGG------SPYPGVPVE 244
Query: 485 WAWVLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEGDI 544
+ L K G D +M C H + + RPT ++ L+ +
Sbjct: 245 ELFKLLKEGHRMDKPSNC--TNELYMMMRD-------CWHAVPSQRPTFKQLVEDLDRIV 295
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 160 bits (405), Expect = 3e-45
Identities = 69/307 (22%), Positives = 121/307 (39%), Gaps = 38/307 (12%)
Query: 258 ELEQATNGFSQNNLIGQGASGIVYKGTLRH-GNLVAVKQI-LDLDTKGDEDFTNEVEIIS 315
+ E + + +++G GA V + LVA+K I + NE+ ++
Sbjct: 3 QAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLH 62
Query: 316 KIRHRNLLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIV 375
KI+H N+++L + +L+ + G L D I ++ T ++I
Sbjct: 63 KIKHPNIVALDDIYESGG-----HLYLIMQLVSGGELFDRI---VEKGFYTERDASRLIF 114
Query: 376 DVAKGIAYLHYGLKPGIYHRDIKSTNILL---DSELNAKVADFGLAKQSLEGHSHLTTRV 432
V + YLH GI HRD+K N+L D + ++DFGL+K +E + +
Sbjct: 115 QVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK--MEDPGSVLSTA 169
Query: 433 AGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAW---VL 489
GT GY+APE ++ D +S G++ L+ G PF D +L
Sbjct: 170 CGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGY-------PPFYDENDAKLFEQIL 222
Query: 490 AKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKM--LEGDIDIP 547
+ D + + I A+ + R T AL+ + GD +
Sbjct: 223 KAEYEFDSPYWDDISDS-AKDFIRH-------LMEKDPEKRFTCEQALQHPWIAGDTALD 274
Query: 548 KLPDRPL 554
K + +
Sbjct: 275 KNIHQSV 281
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 5e-45
Identities = 61/324 (18%), Positives = 124/324 (38%), Gaps = 41/324 (12%)
Query: 271 LIGQGASGIVYKGTLRH-GNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCC 329
+G+G GIV++ K + + E+ I++ RHRN+L L
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAK-FVKVKGTDQVLVKKEISILNIARHRNILHLHESF 70
Query: 330 VTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLK 389
+ + ++++++ + + I+ +L + + V + + +LH
Sbjct: 71 ESME-----ELVMIFEFISGLDIFERIN--TSAFELNEREIVSYVHQVCEALQFLH---S 120
Query: 390 PGIYHRDIKSTNILLDSELNA--KVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALYG 447
I H DI+ NI+ + ++ K+ +FG A+Q G + Y APE +
Sbjct: 121 HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF--TAPEYYAPEVHQHD 178
Query: 448 QLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDEFIRA-- 505
++ +D++S G ++ L+SG +PF T+ ++ + FDE
Sbjct: 179 VVSTATDMWSLGTLVYVLLSGI-------NPFLAETNQQ-IIENIMNAEYTFDEEAFKEI 230
Query: 506 -EGARAVMERFVLVGILCAHVMVALRPTITDALKMLEGDIDIPKLPDRPLPLSHECLRSS 564
A ++R R T ++AL+ P L + +S + +R+
Sbjct: 231 SIEAMDFVDR-------LLVKERKSRMTASEALQH-------PWLKQKIERVSTKVIRTL 276
Query: 565 PSRYSFSTSTDRSATSSSMTSTIS 588
R + T + + IS
Sbjct: 277 KHRRYYHTLIKKDLNMVVSAARIS 300
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 157 bits (397), Expect = 2e-44
Identities = 73/292 (25%), Positives = 122/292 (41%), Gaps = 46/292 (15%)
Query: 266 FSQNNLIGQGASGIVYKGTLRH-GNLVAVKQI---------LDLDTKGDEDFTNEVEIIS 315
+ ++G+G S +V + + AVK I + + E EV+I+
Sbjct: 5 YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 64
Query: 316 KIR-HRNLLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKII 374
K+ H N++ L+ T+ FLV+D M G L D + ++ L+ + +KI+
Sbjct: 65 KVSGHPNIIQLKDTYETNT-----FFFLVFDLMKKGELFDYL---TEKVTLSEKETRKIM 116
Query: 375 VDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAG 434
+ + I LH K I HRD+K NILLD ++N K+ DFG + Q G V G
Sbjct: 117 RALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK--LREVCG 171
Query: 435 TFGYLAPEYAL------YGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWV 488
T YLAPE + ++ D++S G+++ L++G PF +
Sbjct: 172 TPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS-------PPFWHRKQMLML 224
Query: 489 LA-KSGKVDDIFDEFIR-AEGARAVMERFVLVGILCAHVMVALRPTITDALK 538
SG E+ ++ + ++ R V R T +AL
Sbjct: 225 RMIMSGNYQFGSPEWDDYSDTVKDLVSR-------FLVVQPQKRYTAEEALA 269
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (394), Expect = 2e-43
Identities = 63/320 (19%), Positives = 124/320 (38%), Gaps = 35/320 (10%)
Query: 271 LIGQGASGIVYKGTLRH-GNLVAVKQILDLDTKGDEDFTNEVEIISKI-RHRNLLSLRGC 328
++G G +G V + + A+K + + EVE+ + + +++ +
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCPHIVRIVDV 73
Query: 329 CVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGL 388
+ K +V + + G L I + T + +I+ + + I YLH
Sbjct: 74 YENLY-AGRKCLLIVMECLDGGELFSRIQ-DRGDQAFTEREASEIMKSIGEAIQYLH--- 128
Query: 389 KPGIYHRDIKSTNILLDSELN---AKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYAL 445
I HRD+K N+L S+ K+ DFG AK++ +S T T Y+APE
Sbjct: 129 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY--TPYYVAPEVLG 186
Query: 446 YGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDEFIRA 505
+ + D++S G+++ L+ G ++ I+ + G+ + E+
Sbjct: 187 PEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG--LAISPGMKTRIRMGQYEFPNPEWSEV 244
Query: 506 -EGARAVMERFVLVGILCAHVMVALRPTITDALK---MLEGDIDIPKLPDRPLPLSHECL 561
E + ++ R TIT+ + +++ K+P PL S L
Sbjct: 245 SEEVKMLIRN-------LLKTEPTQRMTITEFMNHPWIMQS----TKVPQTPLHTSR-VL 292
Query: 562 RSSPSRYSFSTSTDRSATSS 581
+ R+ SA ++
Sbjct: 293 KEDKERWEDVKEEMTSALAT 312
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 2e-43
Identities = 61/293 (20%), Positives = 120/293 (40%), Gaps = 35/293 (11%)
Query: 270 NLIGQGASGIVYKGTLRH-GNLVAVKQI---LDLDTKGDEDFTNEVEIISK-IRHRNLLS 324
++G+G+ G V+ + A+K + + L E E ++S H L
Sbjct: 8 KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 67
Query: 325 LRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYL 384
+ T + F V +Y+ G L +I + + ++ G+ +L
Sbjct: 68 MFCTFQTKE-----NLFFVMEYLNGGDLMYHI---QSCHKFDLSRATFYAAEIILGLQFL 119
Query: 385 HYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYA 444
H GI +RD+K NILLD + + K+ADFG+ K+++ G + T GT Y+APE
Sbjct: 120 H---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC-GTPDYIAPEIL 175
Query: 445 LYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDEFIR 504
L + D +SFG+++ E++ G+ SPF + + + + ++
Sbjct: 176 LGQKYNHSVDWWSFGVLLYEMLIGQ-------SPFHGQDEEE-LFHSIRMDNPFYPRWLE 227
Query: 505 AEGARAVMERFVLVGILCAHVMVALRPTITDALKMLE--GDIDIPKLPDRPLP 555
E A+ ++ + R + ++ +I+ +L + +
Sbjct: 228 KE-AKDLLVK-------LFVREPEKRLGVRGDIRQHPLFREINWEELERKEID 272
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 156 bits (395), Expect = 4e-43
Identities = 52/248 (20%), Positives = 96/248 (38%), Gaps = 22/248 (8%)
Query: 264 NGFSQNNLIGQGASGIVYKGTLRH-GNLVAVKQI---LDLDTKGDEDFTNEVEIISKIR- 318
N FS + +IG+G G VY G + A+K + +G+ NE ++S +
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 319 --HRNLLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVD 376
++ + T D + + D M G L ++ + + + +
Sbjct: 64 GDCPFIVCMSYAFHTPD-----KLSFILDLMNGGDLHYHL---SQHGVFSEADMRFYAAE 115
Query: 377 VAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTF 436
+ G+ ++H + +RD+K NILLD + +++D GLA + GT
Sbjct: 116 IILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PHASVGTH 169
Query: 437 GYLAPEYALYGQ-LTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKV 495
GY+APE G +D +S G ++ +L+ G + + D +
Sbjct: 170 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP 229
Query: 496 DDIFDEFI 503
D E
Sbjct: 230 DSFSPELR 237
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 1e-41
Identities = 55/224 (24%), Positives = 102/224 (45%), Gaps = 13/224 (5%)
Query: 263 TNGFSQNNLIGQGASGIVYKGTLRH-GNLVAVKQILDLDTKGD-EDFTNEVEIISKIRHR 320
++ + IG+GA G+V VA+K+I + + + E++I+ + RH
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 321 NLLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKG 380
N++ + K +LV ++ L + K + L+ + + +G
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVT-HLMGADLYKLL----KTQHLSNDHICYFLYQILRG 121
Query: 381 IAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLT--TRVAGTFGY 438
+ Y+H + HRD+K +N+LL++ + K+ DFGLA+ + H H T T Y
Sbjct: 122 LKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 178
Query: 439 LAPEYALYGQL-TEKSDVYSFGIVILELMSGRKVLDTSTSPFQL 481
APE L + T+ D++S G ++ E++S R + QL
Sbjct: 179 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQL 222
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 147 bits (373), Expect = 1e-40
Identities = 65/273 (23%), Positives = 111/273 (40%), Gaps = 30/273 (10%)
Query: 270 NLIGQGASGIVYKGTLRH-GNLVAVKQI---LDLDTKGDEDFTNEVEIISKIRHRNLLSL 325
+G G+ G V+ RH G A+K + + + K E +E ++S + H ++ +
Sbjct: 10 RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 69
Query: 326 RGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLH 385
G + + F++ DY+ G L + K ++ P K +V + YLH
Sbjct: 70 WGTFQDAQ-----QIFMIMDYIEGGELFS---LLRKSQRFPNPVAKFYAAEVCLALEYLH 121
Query: 386 YGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYAL 445
I +RD+K NILLD + K+ DFG AK +T + GT Y+APE
Sbjct: 122 ---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYV----PDVTYTLCGTPDYIAPEVVS 174
Query: 446 YGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDEFIRA 505
+ D +SFGI+I E+++G PF K + F F
Sbjct: 175 TKPYNKSIDWWSFGILIYEMLAGYT-------PFYDSNTMK-TYEKILNAELRFPPFFNE 226
Query: 506 EGARAVMERFVLVGILCAHVMVALRPTITDALK 538
+ + ++ R + + + L+ D
Sbjct: 227 D-VKDLLSRLITRD--LSQRLGNLQNGTEDVKN 256
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 2e-40
Identities = 54/219 (24%), Positives = 92/219 (42%), Gaps = 14/219 (6%)
Query: 270 NLIGQGASGIVYKGTLRH--GNLVAVKQIL--DLDTKGDEDFTNEVEIISKI---RHRNL 322
IG+GA G V+K G VA+K++ + EV ++ + H N+
Sbjct: 13 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 72
Query: 323 LSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIA 382
+ L C S + LV++++ + + + K ++ + +G+
Sbjct: 73 VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG--VPTETIKDMMFQLLRGLD 130
Query: 383 YLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPE 442
+LH + HRD+K NIL+ S K+ADFGLA+ + T V T Y APE
Sbjct: 131 FLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--TSVVVTLWYRAPE 185
Query: 443 YALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQL 481
L D++S G + E+ + + S+ QL
Sbjct: 186 VLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQL 224
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 2e-40
Identities = 74/293 (25%), Positives = 119/293 (40%), Gaps = 45/293 (15%)
Query: 266 FSQNNL---------IGQGASGIVYKGTLRH-GNLVAVKQILDLDTKGD------EDFTN 309
F Q N+ +G G +V K + G A K I TK ED
Sbjct: 3 FRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIER 62
Query: 310 EVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQ 369
EV I+ +I+H N+++L D L+ + + G L D + +++ LT +
Sbjct: 63 EVSILKEIQHPNVITLHEVYENKTD-----VILILELVAGGELFDFL---AEKESLTEEE 114
Query: 370 RKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSE----LNAKVADFGLAKQSLEGH 425
+ + + G+ YLH I H D+K NI+L K+ DFGLA + G+
Sbjct: 115 ATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN 171
Query: 426 SHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDW 485
+ GT ++APE Y L ++D++S G++ L+SG T L
Sbjct: 172 E--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL---- 225
Query: 486 AWVLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALK 538
A V A + + +D + A A+ + R R TI D+L+
Sbjct: 226 ANVSAVNYEFEDEYFSNTSAL-AKDFIRR-------LLVKDPKKRMTIQDSLQ 270
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 2e-40
Identities = 72/305 (23%), Positives = 117/305 (38%), Gaps = 38/305 (12%)
Query: 270 NLIGQGASGIVYKGTLRH-GNLVAVKQI-----LDLDTKGDEDFTNEVEIISKIRHRNLL 323
+ +G+G VYK ++ +VA+K+I + + E++++ ++ H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 324 SLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAY 383
L + LV+D+M I LT K ++ +G+ Y
Sbjct: 64 GLLDAFGHKSN-----ISLVFDFMETDLEVI---IKDNSLVLTPSHIKAYMLMTLQGLEY 115
Query: 384 LHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEY 443
LH + I HRD+K N+LLD K+ADFGLAK + T +V T Y APE
Sbjct: 116 LH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV-VTRWYRAPEL 171
Query: 444 ALYGQL-TEKSDVYSFGIVILELMSGRKVLDTSTSPFQL---------ITDWAWVLAKSG 493
++ D+++ G ++ EL+ L + QL T+ W S
Sbjct: 172 LFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSL 231
Query: 494 KVDDIFDEFIRAEGARAVMERFVLVGILCAHVMV---ALRPTITDALKMLEGDIDIPKLP 550
F F + L + + R T T ALKM
Sbjct: 232 PDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM-------KYFS 284
Query: 551 DRPLP 555
+RP P
Sbjct: 285 NRPGP 289
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 146 bits (369), Expect = 3e-40
Identities = 48/307 (15%), Positives = 94/307 (30%), Gaps = 31/307 (10%)
Query: 271 LIGQGASGIVYKGT-LRHGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCC 329
IG G+ G +Y GT + G VA+K E +I ++ + C
Sbjct: 14 KIGSGSFGDIYLGTDIAAGEEVAIKLECV--KTKHPQLHIESKIYKMMQGGVGIPTIRWC 71
Query: 330 VTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLK 389
D +V + + ++ + + + I Y+H
Sbjct: 72 GAEGD----YNVMVMELLGPSLEDLFN---FCSRKFSLKTVLLLADQMISRIEYIH---S 121
Query: 390 PGIYHRDIKSTNIL---LDSELNAKVADFGLAKQSLEGHSH------LTTRVAGTFGYLA 440
HRD+K N L + DFGLAK+ + +H + GT Y +
Sbjct: 122 KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYAS 181
Query: 441 PEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFD 500
L + + + D+ S G V++ G + + K ++
Sbjct: 182 INTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLC 241
Query: 501 EFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEGDIDIPKLPDRPLPLSHEC 560
+ +E + C + +P + ++ ++ +
Sbjct: 242 KGYPSE-FATYLNF-------CRSLRFDDKPDYSYLRQLFR-NLFHRQGFSYDYVFDWNM 292
Query: 561 LRSSPSR 567
L+ SR
Sbjct: 293 LKFGASR 299
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 145 bits (367), Expect = 4e-40
Identities = 60/284 (21%), Positives = 107/284 (37%), Gaps = 26/284 (9%)
Query: 270 NLIGQGASGIVYKGTLRHGNLVAVKQIL--DLDTKGDEDFTNEVEIISKIRHRNLLSLRG 327
IG+G G+VYK +G A+K+I D E+ I+ +++H N++ L
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 328 CCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYG 387
T KR LV++++ + L K ++ + GIAY H
Sbjct: 68 VIHT-----KKRLVLVFEHLDQDLKKL---LDVCEGGLESVTAKSFLLQLLNGIAYCH-- 117
Query: 388 LKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALYG 447
+ HRD+K N+L++ E K+ADFGLA+ T + +
Sbjct: 118 -DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSK 176
Query: 448 QLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDEFIRAEG 507
+ + D++S G + E+++G + + QL+ + + + K E + +
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236
Query: 508 ARAVMERFVLVGIL-------------CAHVMVALRPTITDALK 538
V E L + R T AL+
Sbjct: 237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 2e-39
Identities = 52/219 (23%), Positives = 100/219 (45%), Gaps = 13/219 (5%)
Query: 266 FSQNNLIGQGASGIVYKGTLRH-GNLVAVKQI-LDLDTKGD-EDFTNEVEIISKIRHRNL 322
F + IG+G G+VYK + G +VA+K+I LD +T+G E+ ++ ++ H N+
Sbjct: 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 323 LSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIA 382
+ L T + + +LV++++ + + P K + + +G+A
Sbjct: 64 VKLLDVIHTEN-----KLYLVFEFLHQDLKK--FMDASALTGIPLPLIKSYLFQLLQGLA 116
Query: 383 YLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPE 442
+ H + HRD+K N+L+++E K+ADFGLA+ T V +
Sbjct: 117 FCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEI 173
Query: 443 YALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQL 481
+ D++S G + E+++ R + + QL
Sbjct: 174 LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 212
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 5e-39
Identities = 68/302 (22%), Positives = 123/302 (40%), Gaps = 46/302 (15%)
Query: 270 NLIGQGASGIVYKGTLRH-GNLVAVKQIL--DLDTKGDEDFTNEVEIISKIRHRNLLSLR 326
IGQG G V+K R G VA+K++L + E++I+ ++H N+++L
Sbjct: 16 AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 75
Query: 327 GCCVTSDDSSGKRR---FLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAY 383
C T + + +LV+D+ + + + T + K+++ + G
Sbjct: 76 EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLS---NVLVKFTLSEIKRVMQMLLNG--- 129
Query: 384 LHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQ---SLEGHSHLTTRVAGTFGYLA 440
L+Y + I HRD+K+ N+L+ + K+ADFGLA+ + + T T Y
Sbjct: 130 LYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRP 189
Query: 441 PEYALYGQL-TEKSDVYSFGIVILELMSGRKVLDTSTSPFQL---------ITDWAW--- 487
PE L + D++ G ++ E+ + ++ +T QL IT W
Sbjct: 190 PELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNV 249
Query: 488 -----------VLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDA 536
V + KV D ++R A ++++ + A R DA
Sbjct: 250 DNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDK-------LLVLDPAQRIDSDDA 302
Query: 537 LK 538
L
Sbjct: 303 LN 304
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (352), Expect = 2e-37
Identities = 52/224 (23%), Positives = 99/224 (44%), Gaps = 19/224 (8%)
Query: 254 FHVSELEQATNGFSQN----NLIGQGASGIVYKGT-LRHGNLVAVKQIL--DLDTKGDED 306
F+ E+ + +G GA G V R G VA+K++ +
Sbjct: 4 FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63
Query: 307 FTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRF-LVYDYMPNGTLSDNISISHKRKQL 365
E+ ++ +RH N++ L + F LV +M GT + K ++L
Sbjct: 64 AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKL---MKHEKL 118
Query: 366 TWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGH 425
+ + ++ + KG+ Y+H GI HRD+K N+ ++ + K+ DFGLA+Q+
Sbjct: 119 GEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQA---D 172
Query: 426 SHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGR 469
S +T V + + + T+ D++S G ++ E+++G+
Sbjct: 173 SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 216
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 137 bits (345), Expect = 2e-36
Identities = 60/323 (18%), Positives = 112/323 (34%), Gaps = 31/323 (9%)
Query: 238 VSNLQASVLPNSGAKWFHVSELEQATNGFSQNNLIGQGASGIVYKGTLRH-GNLVAVKQI 296
V A + KW S+ + F + +G G+ G V + GN A+K +
Sbjct: 15 VKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL 74
Query: 297 ---LDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLS 353
+ K E NE I+ + L+ L + ++V +Y+ G +
Sbjct: 75 DKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS-----NLYMVMEYVAGGEMF 129
Query: 354 DNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVA 413
++ + + + P + + YLH + +RD+K N+L+D + +V
Sbjct: 130 SHL---RRIGRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVT 183
Query: 414 DFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLD 473
DFG AK+ T + GT LAPE L + D ++ G++I E+ +G
Sbjct: 184 DFGFAKR----VKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFF 239
Query: 474 TSTSPFQLITDWAWVLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTI 533
+ + + +R + +RF L+ +
Sbjct: 240 ADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRF-----------GNLKNGV 288
Query: 534 TDALK-MLEGDIDIPKLPDRPLP 555
D D + R +
Sbjct: 289 NDIKNHKWFATTDWIAIYQRKVE 311
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 135 bits (341), Expect = 2e-36
Identities = 36/211 (17%), Positives = 73/211 (34%), Gaps = 24/211 (11%)
Query: 271 LIGQGASGIVYKGT-LRHGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCC 329
IG+G+ G++++GT L + VA+K +E + +
Sbjct: 12 RIGEGSFGVIFEGTNLLNNQQVAIKFEPR--RSDAPQLRDEYRTYKLLAGCTGI----PN 65
Query: 330 VTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLK 389
V G LV D + + ++ + + + +H +
Sbjct: 66 VYYFGQEGLHNVLVIDLLGPSLEDL---LDLCGRKFSVKTVAMAAKQMLARVQSIH---E 119
Query: 390 PGIYHRDIKSTNILLDSELN-----AKVADFGLAKQSLEG------HSHLTTRVAGTFGY 438
+ +RDIK N L+ + V DFG+ K + ++GT Y
Sbjct: 120 KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARY 179
Query: 439 LAPEYALYGQLTEKSDVYSFGIVILELMSGR 469
++ L + + + D+ + G V + + G
Sbjct: 180 MSINTHLGREQSRRDDLEALGHVFMYFLRGS 210
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (340), Expect = 2e-36
Identities = 43/216 (19%), Positives = 84/216 (38%), Gaps = 14/216 (6%)
Query: 270 NLIGQGASGIVYKGTLRH-GNLVAVKQIL--DLDTKGDEDFTNEVEIISKIRHRNLLSLR 326
IG+G G V+K R +VA+K++ D D E+ ++ +++H+N++ L
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 327 GCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHY 386
+ K+ LV+++ L K + + KG+ + H
Sbjct: 68 DVLHS-----DKKLTLVFEFCDQDLKKYFD---SCNGDLDPEIVKSFLFQLLKGLGFCHS 119
Query: 387 GLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALY 446
+ HRD+K N+L++ K+A+FGLA+ + V +
Sbjct: 120 ---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGA 176
Query: 447 GQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLI 482
+ D++S G + EL + + L +
Sbjct: 177 KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQL 212
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (339), Expect = 9e-36
Identities = 54/210 (25%), Positives = 90/210 (42%), Gaps = 16/210 (7%)
Query: 264 NGFSQNNLIGQGASGIVYKGTLRH-GNLVAVKQI---LDLDTKGDEDFTNEVEIISKIRH 319
N F L+G+G G V + G A+K + + + E ++ RH
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 320 RNLLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAK 379
L +L+ T D R V +Y G L ++ + + T + + ++
Sbjct: 65 PFLTALKYAFQTHD-----RLCFVMEYANGGELFFHL---SRERVFTEERARFYGAEIVS 116
Query: 380 GIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYL 439
+ YLH + +RDIK N++LD + + K+ DFGL K+ + + + T GT YL
Sbjct: 117 ALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYL 172
Query: 440 APEYALYGQLTEKSDVYSFGIVILELMSGR 469
APE D + G+V+ E+M GR
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (333), Expect = 1e-35
Identities = 55/279 (19%), Positives = 98/279 (35%), Gaps = 46/279 (16%)
Query: 271 LIGQGASGIVYKGT-LRHGNLVAVKQIL------DLDTKGDEDFTNEVEIISKIR--HRN 321
L+G G G VY G + VA+K + + EV ++ K+
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 322 LLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGI 381
++ L D L+ + D +R L + V + +
Sbjct: 71 VIRLLDWFERPD-----SFVLILERPEPV--QDLFDFITERGALQEELARSFFWQVLEAV 123
Query: 382 AYLHYGLKPGIYHRDIKSTNILLD-SELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLA 440
+ H G+ HRDIK NIL+D + K+ DFG + T GT Y
Sbjct: 124 RHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSP 177
Query: 441 PEYALYGQL-TEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIF 499
PE+ Y + + V+S GI++ +++ G PF+ + + F
Sbjct: 178 PEWIRYHRYHGRSAAVWSLGILLYDMVCGD-------IPFEHDEEII-------RGQVFF 223
Query: 500 DEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALK 538
+ + +E + ++ C + + RPT +
Sbjct: 224 RQRVSSE-CQHLIRW-------CLALRPSDRPTFEEIQN 254
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 127 bits (320), Expect = 3e-33
Identities = 45/233 (19%), Positives = 93/233 (39%), Gaps = 21/233 (9%)
Query: 270 NLIGQGASGIVYKGT-LRHGNLVAVKQILDLDTKGDEDFTNEVEIISKIR-HRNLLSLRG 327
+G+G V++ + + V VK + + E++I+ +R N+++L
Sbjct: 41 RKLGRGKYSEVFEAINITNNEKVVVKIL---KPVKKKKIKREIKILENLRGGPNIITLAD 97
Query: 328 CCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYG 387
D + LV++++ N + LT + + ++ K + Y H
Sbjct: 98 IV---KDPVSRTPALVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCH-- 146
Query: 388 LKPGIYHRDIKSTNILLDSE-LNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYAL- 445
GI HRD+K N+++D E ++ D+GLA+ G + + + PE +
Sbjct: 147 -SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--NVRVASRYFKGPELLVD 203
Query: 446 YGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDI 498
Y D++S G ++ ++ ++ + + A VL D I
Sbjct: 204 YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYI 256
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (314), Expect = 3e-32
Identities = 47/223 (21%), Positives = 96/223 (43%), Gaps = 17/223 (7%)
Query: 254 FHVSELEQATNGFSQN----NLIGQGASGIVYKGT-LRHGNLVAVKQI--LDLDTKGDED 306
F+ EL + + + +G GA G V + G VAVK++ +
Sbjct: 4 FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR 63
Query: 307 FTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLT 366
E+ ++ ++H N++ L + + ++ L++ K ++LT
Sbjct: 64 TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI----VKCQKLT 119
Query: 367 WPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHS 426
+ +I + +G+ Y+H I HRD+K +N+ ++ + K+ DFGLA+ +
Sbjct: 120 DDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DD 173
Query: 427 HLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGR 469
+T VA + + + D++S G ++ EL++GR
Sbjct: 174 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (308), Expect = 2e-31
Identities = 52/203 (25%), Positives = 89/203 (43%), Gaps = 15/203 (7%)
Query: 271 LIGQGASGIVYKGT-LRHGNLVAVKQIL--DLDTKGDEDFTNEVEIISKIRHRNLLSLRG 327
IG GA GIV VA+K++ + + E+ ++ + H+N++SL
Sbjct: 24 PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83
Query: 328 CCVTSDD-SSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHY 386
+ +LV + M + +L + ++ + GI +LH
Sbjct: 84 VFTPQKTLEEFQDVYLVMELMDANLCQ------VIQMELDHERMSYLLYQMLCGIKHLH- 136
Query: 387 GLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALY 446
GI HRD+K +NI++ S+ K+ DFGLA+ G S + T T Y APE L
Sbjct: 137 --SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILG 192
Query: 447 GQLTEKSDVYSFGIVILELMSGR 469
E D++S G ++ E++ +
Sbjct: 193 MGYKENVDIWSVGCIMGEMVRHK 215
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (299), Expect = 2e-30
Identities = 62/258 (24%), Positives = 116/258 (44%), Gaps = 31/258 (12%)
Query: 270 NLIGQGASGIVYKGTLRH----GNLVAVKQI----LDLDTKGDEDFTNEVEIISKIRHRN 321
++G GA G V+ G L A+K + + K E E +++ IR
Sbjct: 30 KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 89
Query: 322 LLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGI 381
L ++ + L+ DY+ G L ++ +R++ T + + + ++ +
Sbjct: 90 FLVTLHYAFQTET----KLHLILDYINGGELFTHL---SQRERFTEHEVQIYVGEIVLAL 142
Query: 382 AYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAP 441
+LH K GI +RDIK NILLDS + + DFGL+K+ + + GT Y+AP
Sbjct: 143 EHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAP 199
Query: 442 EYALYGQ--LTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITD---WAWVLAKSGKVD 496
+ G + D +S G+++ EL++G SPF + + A + + K +
Sbjct: 200 DIVRGGDSGHDKAVDWWSLGVLMYELLTGA-------SPFTVDGEKNSQAEISRRILKSE 252
Query: 497 DIFDEFIRAEGARAVMER 514
+ + + A A+ +++R
Sbjct: 253 PPYPQEMSAL-AKDLIQR 269
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 117 bits (294), Expect = 1e-29
Identities = 42/214 (19%), Positives = 84/214 (39%), Gaps = 22/214 (10%)
Query: 271 LIGQGASGIVYKGT-LRHGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCC 329
+G G V+ + + VA+K I+ D E +E++++ ++ +
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMK-IVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 78
Query: 330 VTS--------DDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGI 381
+ +V + G + ++ + + K+I + G+
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138
Query: 382 AYLHYGLKPGIYHRDIKSTNILLDSE------LNAKVADFGLAKQSLEGHSHLTTRVAGT 435
Y+H + GI H DIK N+L++ + K+AD G A E +++ T
Sbjct: 139 DYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTN----SIQT 192
Query: 436 FGYLAPEYALYGQLTEKSDVYSFGIVILELMSGR 469
Y +PE L +D++S +I EL++G
Sbjct: 193 REYRSPEVLLGAPWGCGADIWSTACLIFELITGD 226
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 89.1 bits (220), Expect = 4e-21
Identities = 37/207 (17%), Positives = 67/207 (32%), Gaps = 33/207 (15%)
Query: 270 NLIGQGASGIVYKGTLRHGNLVAVK----------QILDLDTKGDEDFTNEVEIISKIRH 319
L+G+G V+ VK ++ + GD F+ ++
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 320 RNLLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAK 379
R L L+G V Y + N L + I + +++ + +
Sbjct: 66 RALQKLQGLAVPKV----------YAWEGNAVLMELIDAKELYRV-RVENPDEVLDMILE 114
Query: 380 GIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHS--HLTTRVAGTFG 437
+A + GI H D+ N+L+ E + DF + + E L V
Sbjct: 115 EVAKFY---HRGIVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEGWREILERDVRNIIT 170
Query: 438 YLAPEYALYGQLTEKSDVYSFGIVILE 464
Y + Y + D+ S IL+
Sbjct: 171 YFSRTY------RTEKDINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 590 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.89 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.44 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.91 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.36 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.34 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.69 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.52 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-52 Score=421.30 Aligned_cols=254 Identities=26% Similarity=0.419 Sum_probs=196.7
Q ss_pred cCCCccceecccCcEEEEEEEEcCCcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEEEE
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLRHGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFLV 343 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~LV 343 (590)
++|...+.||+|+||.||+|++.+++.||||++... ....++|.+|++++++++|||||+++|+|... ...++|
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~-----~~~~lv 78 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ-----APICLV 78 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSS-----SSCEEE
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceeccC-----CceEEE
Confidence 467788899999999999999998899999998653 44567899999999999999999999999743 458999
Q ss_pred EeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccccC
Q 046270 344 YDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLE 423 (590)
Q Consensus 344 ~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~~~ 423 (590)
|||+++|+|.+++.. ....++|..++.|+.|||+||+||| +.+|+||||||+|||+|+++++||+|||+++....
T Consensus 79 ~E~~~~g~L~~~l~~--~~~~~~~~~~~~i~~qia~gl~~lH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~ 153 (263)
T d1sm2a_ 79 FEFMEHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 153 (263)
T ss_dssp EECCTTCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCTTCSGGGEEECGGGCEEECSCC-------
T ss_pred EEecCCCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHhhh---ccceeecccchhheeecCCCCeEecccchheeccC
Confidence 999999999998853 3456999999999999999999999 89999999999999999999999999999987655
Q ss_pred CCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhhhHHH
Q 046270 424 GHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDEFI 503 (590)
Q Consensus 424 ~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 503 (590)
..........||..|+|||++..+.++.++|||||||++|||+||..|+.........+. . ...+... .
T Consensus 154 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~----~-i~~~~~~--~---- 222 (263)
T d1sm2a_ 154 DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVE----D-ISTGFRL--Y---- 222 (263)
T ss_dssp -----------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHH----H-HHHTCCC--C----
T ss_pred CCceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHH----H-HHhcCCC--C----
Confidence 444444556789999999999999999999999999999999996555543333222221 1 1111110 0
Q ss_pred hhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhcc
Q 046270 504 RAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEG 542 (590)
Q Consensus 504 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~ 542 (590)
.+....+++.+++..|++.||++||||+||+++|+.
T Consensus 223 ---~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~ 258 (263)
T d1sm2a_ 223 ---KPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAE 258 (263)
T ss_dssp ---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ---CccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence 011123467889999999999999999999999975
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-52 Score=421.63 Aligned_cols=255 Identities=25% Similarity=0.386 Sum_probs=209.5
Q ss_pred hcCCCccceecccCcEEEEEEEEcCCcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEEE
Q 046270 263 TNGFSQNNLIGQGASGIVYKGTLRHGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFL 342 (590)
Q Consensus 263 t~~f~~~~~LG~G~fG~Vykg~~~~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~L 342 (590)
.++|...+.||+|+||.||+|++++++.||||++... ....++|.+|++++++++|||||+++|++.. ...++
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~------~~~~i 84 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ------EPIYI 84 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS------SSCEE
T ss_pred HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccC-cCCHHHHHHHHHHHHhCCCCCEeEEEeeecc------CCeEE
Confidence 4567888999999999999999998889999998653 3456789999999999999999999998853 23689
Q ss_pred EEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCccccc
Q 046270 343 VYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSL 422 (590)
Q Consensus 343 V~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~~ 422 (590)
||||+++|+|.+++... ....++|.++++|+.||++||.||| +.+|+||||||+||||++++.+||+|||+++...
T Consensus 85 v~Ey~~~g~L~~~~~~~-~~~~l~~~~~~~i~~qi~~gl~~lH---~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~ 160 (272)
T d1qpca_ 85 ITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIE 160 (272)
T ss_dssp EEECCTTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred EEEeCCCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccchhheeeecccceeeccccceEEcc
Confidence 99999999999987543 2346999999999999999999999 8999999999999999999999999999999876
Q ss_pred CCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhhhHH
Q 046270 423 EGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDEF 502 (590)
Q Consensus 423 ~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 502 (590)
...........||+.|||||++..+.++.++|||||||++|||+||++|+.........+. ....+....
T Consensus 161 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~-----~i~~~~~~~----- 230 (272)
T d1qpca_ 161 DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQ-----NLERGYRMV----- 230 (272)
T ss_dssp SSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHH-----HHHTTCCCC-----
T ss_pred CCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHH-----HHHhcCCCC-----
Confidence 6555555667799999999999999999999999999999999997776654433322221 111221110
Q ss_pred HhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhcc
Q 046270 503 IRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEG 542 (590)
Q Consensus 503 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~ 542 (590)
.+....+.+.+++..|++.||++||||+||+++|+.
T Consensus 231 ----~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~ 266 (272)
T d1qpca_ 231 ----RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED 266 (272)
T ss_dssp ----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ----CcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhh
Confidence 011223467889999999999999999999999974
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.3e-51 Score=423.17 Aligned_cols=265 Identities=27% Similarity=0.393 Sum_probs=198.7
Q ss_pred ccHHHHHHHhcCCC---------ccceecccCcEEEEEEEEcC-C---cEEEEEEeecCCC-CChHHHHHHHHHHHhcCC
Q 046270 254 FHVSELEQATNGFS---------QNNLIGQGASGIVYKGTLRH-G---NLVAVKQILDLDT-KGDEDFTNEVEIISKIRH 319 (590)
Q Consensus 254 f~~~el~~at~~f~---------~~~~LG~G~fG~Vykg~~~~-g---~~vAvK~l~~~~~-~~~~~f~~Ev~il~~l~H 319 (590)
++++++..++.+|. ..++||+|+||+||+|+++. | ..||||++..... ...++|.+|+++|++++|
T Consensus 7 ~t~~d~~~a~~~f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H 86 (299)
T d1jpaa_ 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDH 86 (299)
T ss_dssp GGSSSHHHHHHHHSCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCC
T ss_pred CCHHHHHHHHhhhchhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCC
Confidence 55666666665553 45789999999999999863 2 2689998865433 334679999999999999
Q ss_pred CCccccceeEEeccCCCCceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCC
Q 046270 320 RNLLSLRGCCVTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKS 399 (590)
Q Consensus 320 ~nlv~l~g~~~~~~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp 399 (590)
||||+++|+|.. +...++||||+++|+|.+++.. ..+.++|.++++|+.|||+||+||| +.+|+||||||
T Consensus 87 pnIv~l~g~~~~-----~~~~~iv~Ey~~~g~L~~~~~~--~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHrDlKp 156 (299)
T d1jpaa_ 87 PNVIHLEGVVTK-----STPVMIITEFMENGSLDSFLRQ--NDGQFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAA 156 (299)
T ss_dssp TTBCCEEEEECS-----SSSCEEEEECCTTEEHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCG
T ss_pred CCCccEEEEEee-----CCEEEEEEEecCCCcceeeecc--ccCCCCHHHHHHHHHHHHHHHHHHh---hCCCccCcccc
Confidence 999999999974 3458999999999999998852 3456999999999999999999999 89999999999
Q ss_pred CceEECCCCcEEEEeeCCcccccCCCccc----ccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 046270 400 TNILLDSELNAKVADFGLAKQSLEGHSHL----TTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLDT 474 (590)
Q Consensus 400 ~NILLd~~~~~kL~DFGla~~~~~~~~~~----~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELlt-G~~p~~~ 474 (590)
+||||+.++.+||+|||+++......... .....||+.|||||.+.++.++.++|||||||++|||+| |+.||..
T Consensus 157 ~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~ 236 (299)
T d1jpaa_ 157 RNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWD 236 (299)
T ss_dssp GGEEECTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred ceEEECCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCC
Confidence 99999999999999999998765433221 223457899999999999999999999999999999998 8999865
Q ss_pred CCCchhhhhHHHHHHHhcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhccC
Q 046270 475 STSPFQLITDWAWVLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEGD 543 (590)
Q Consensus 475 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~~ 543 (590)
.... . + .... ..+.... .+.+..+.+.+++..||+.||.+||||.||+++|+..
T Consensus 237 ~~~~-~-~---~~~i-~~~~~~~---------~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~ 290 (299)
T d1jpaa_ 237 MTNQ-D-V---INAI-EQDYRLP---------PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM 290 (299)
T ss_dssp CCHH-H-H---HHHH-HTTCCCC---------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCHH-H-H---HHHH-HcCCCCC---------CCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 3321 1 1 1111 1111110 1122345678899999999999999999999999753
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-51 Score=413.88 Aligned_cols=258 Identities=28% Similarity=0.405 Sum_probs=201.1
Q ss_pred hcCCCccceecccCcEEEEEEEEcCCcEEEEEEeecC--CCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceE
Q 046270 263 TNGFSQNNLIGQGASGIVYKGTLRHGNLVAVKQILDL--DTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRR 340 (590)
Q Consensus 263 t~~f~~~~~LG~G~fG~Vykg~~~~g~~vAvK~l~~~--~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~ 340 (590)
.++|...+.||+|+||+||+|+++ ..||||++... .....+.|.+|++++++++|||||+++|++.. ...
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~------~~~ 78 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA------PQL 78 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS------SSC
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec------cEE
Confidence 467888899999999999999875 35999998643 33445789999999999999999999998752 347
Q ss_pred EEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCccc
Q 046270 341 FLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQ 420 (590)
Q Consensus 341 ~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~ 420 (590)
++||||+++|+|.+++.. ....++|.+++.|+.|||+||+||| +.+|+||||||+||||+.++.+||+|||+++.
T Consensus 79 ~lv~Ey~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~gl~yLH---~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~ 153 (276)
T d1uwha_ 79 AIVTQWCEGSSLYHHLHI--IETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATV 153 (276)
T ss_dssp EEEEECCCEEEHHHHHHT--SCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTSSEEECCCCCSCC
T ss_pred EEEEecCCCCCHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHh---cCCEeccccCHHHEEEcCCCCEEEccccceee
Confidence 999999999999999853 3356999999999999999999999 88999999999999999999999999999987
Q ss_pred ccCCCc-ccccccccCCCccCcccccc---CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCch
Q 046270 421 SLEGHS-HLTTRVAGTFGYLAPEYALY---GQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVD 496 (590)
Q Consensus 421 ~~~~~~-~~~~~~~gt~~Y~APE~~~~---~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 496 (590)
...... .......||+.|||||.+.. +.++.++|||||||+||||+||+.||.......... .....+...
T Consensus 154 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~-----~~~~~~~~~ 228 (276)
T d1uwha_ 154 KSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQII-----FMVGRGYLS 228 (276)
T ss_dssp ------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHH-----HHHHHTSCC
T ss_pred ccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHH-----HHHhcCCCC
Confidence 654322 23456789999999999864 458999999999999999999999997644322211 111222111
Q ss_pred hhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhccC
Q 046270 497 DIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEGD 543 (590)
Q Consensus 497 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~~ 543 (590)
..+. ....+..+.+.+++..|++.||.+||||+|++++|+..
T Consensus 229 p~~~-----~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l 270 (276)
T d1uwha_ 229 PDLS-----KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELL 270 (276)
T ss_dssp CCGG-----GSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred Ccch-----hccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 1111 01112334778899999999999999999999999854
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=8.9e-52 Score=421.89 Aligned_cols=258 Identities=23% Similarity=0.351 Sum_probs=211.9
Q ss_pred HhcCCCccceecccCcEEEEEEEEcC-CcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceE
Q 046270 262 ATNGFSQNNLIGQGASGIVYKGTLRH-GNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRR 340 (590)
Q Consensus 262 at~~f~~~~~LG~G~fG~Vykg~~~~-g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~ 340 (590)
..++|...+.||+|+||+||+|++.+ |+.||||++... ....++|.+|+++|++++|||||+++|+|.+ +...
T Consensus 15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-----~~~~ 88 (287)
T d1opja_ 15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR-----EPPF 88 (287)
T ss_dssp CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT-CSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-----SSSC
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCc-cchHHHHHHHHHHHHhCCCCCEecCCccEee-----CCee
Confidence 34678888999999999999999874 788999998654 3456789999999999999999999999974 3458
Q ss_pred EEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCccc
Q 046270 341 FLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQ 420 (590)
Q Consensus 341 ~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~ 420 (590)
++||||+++|+|.+++... ....++|..++.|+.||++||+||| +.+|+||||||+||||++++++||+|||+++.
T Consensus 89 ~iv~E~~~~g~l~~~l~~~-~~~~~~~~~~~~i~~qi~~gL~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~ 164 (287)
T d1opja_ 89 YIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRL 164 (287)
T ss_dssp EEEEECCTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCCTTT
T ss_pred EEEeecccCcchHHHhhhc-cccchHHHHHHHHHHHHHHHHHHHH---HCCcccCccccCeEEECCCCcEEEccccceee
Confidence 9999999999999998643 3457999999999999999999999 88999999999999999999999999999997
Q ss_pred ccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhhh
Q 046270 421 SLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFD 500 (590)
Q Consensus 421 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 500 (590)
.............|+..|+|||++.++.++.++|||||||++|||++|+.|+........ +. .....+...+
T Consensus 165 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~-~~----~~i~~~~~~~--- 236 (287)
T d1opja_ 165 MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-VY----ELLEKDYRME--- 236 (287)
T ss_dssp CCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-HH----HHHHTTCCCC---
T ss_pred cCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHH-HH----HHHhcCCCCC---
Confidence 765554445556789999999999999999999999999999999998877654333221 11 1112221111
Q ss_pred HHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhccC
Q 046270 501 EFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEGD 543 (590)
Q Consensus 501 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~~ 543 (590)
.+....+.+.+++..|++.||++||||.||+++|+..
T Consensus 237 ------~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~ 273 (287)
T d1opja_ 237 ------RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273 (287)
T ss_dssp ------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred ------CCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 1112334788899999999999999999999999864
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-51 Score=413.70 Aligned_cols=259 Identities=29% Similarity=0.400 Sum_probs=205.0
Q ss_pred hcCCCccceecccCcEEEEEEEEcCCcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEEE
Q 046270 263 TNGFSQNNLIGQGASGIVYKGTLRHGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFL 342 (590)
Q Consensus 263 t~~f~~~~~LG~G~fG~Vykg~~~~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~L 342 (590)
.++|+..+.||+|+||.||+|+++++..||||++... ....++|.+|+.++++++|||||+++|+|.. ...++
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~------~~~~l 88 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EPIYI 88 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS------SSCEE
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEec------CCeEE
Confidence 3568889999999999999999998889999998643 4456789999999999999999999999852 23689
Q ss_pred EEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCccccc
Q 046270 343 VYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSL 422 (590)
Q Consensus 343 V~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~~ 422 (590)
||||+++|+|.+++... ....++|.+++.|+.||+.||+||| +.+|+||||||+|||||.++++||+|||+++...
T Consensus 89 v~Ey~~~g~l~~~~~~~-~~~~l~~~~~~~i~~~i~~gl~~LH---~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~ 164 (285)
T d1fmka3 89 VTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIE 164 (285)
T ss_dssp EECCCTTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC---
T ss_pred EEEecCCCchhhhhhhc-ccccchHHHHHHHHHHHHHHHHHHh---hhheecccccceEEEECCCCcEEEcccchhhhcc
Confidence 99999999999888643 2346999999999999999999999 8899999999999999999999999999998765
Q ss_pred CCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhhhHH
Q 046270 423 EGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDEF 502 (590)
Q Consensus 423 ~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 502 (590)
...........||+.|+|||++..+.++.++|||||||++|||+||++|+.........+. + ...+...+
T Consensus 165 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~-~----i~~~~~~~----- 234 (285)
T d1fmka3 165 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLD-Q----VERGYRMP----- 234 (285)
T ss_dssp -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHH-H----HHTTCCCC-----
T ss_pred CCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHH-H----HHhcCCCC-----
Confidence 5544445556789999999999999999999999999999999998777655444333222 1 11121111
Q ss_pred HhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhccCCCC
Q 046270 503 IRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEGDIDI 546 (590)
Q Consensus 503 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~~~~~ 546 (590)
.+....+.+.+++..|++.||++||||++|+++|+.....
T Consensus 235 ----~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~ 274 (285)
T d1fmka3 235 ----CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 274 (285)
T ss_dssp ----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred ----CCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcC
Confidence 1112234678899999999999999999999999975443
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-50 Score=404.29 Aligned_cols=253 Identities=25% Similarity=0.398 Sum_probs=210.6
Q ss_pred cCCCccceecccCcEEEEEEEEcCCcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEEEE
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLRHGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFLV 343 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~LV 343 (590)
++|...+.||+|+||+||+|++++++.||||+++.. ....++|.+|++++++++|||||+++|+|.+ ....++|
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~-~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~-----~~~~~iv 77 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK-----QRPIFII 77 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESS-SSCHHHHHHHHHHHHTCCCTTBCCEEEEECC-----SSSEEEE
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcC-cCCHHHHHHHHHHHHhcCCCceeeEEEEEee-----CCceEEE
Confidence 578889999999999999999998889999998764 3456789999999999999999999999974 3458999
Q ss_pred EeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccccC
Q 046270 344 YDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLE 423 (590)
Q Consensus 344 ~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~~~ 423 (590)
|||+++|+|.+++.. ....++|..+++|+.||++||+||| +.+|+||||||+|||+++++.+||+|||+++....
T Consensus 78 ~Ey~~~g~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~~LH---~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~ 152 (258)
T d1k2pa_ 78 TEYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD 152 (258)
T ss_dssp EECCTTEEHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHH---HTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSS
T ss_pred EEccCCCcHHHhhhc--cccCCcHHHHHHHHHHHHHHHHHHh---hcCcccccccceeEEEcCCCcEEECcchhheeccC
Confidence 999999999998753 3457999999999999999999999 88999999999999999999999999999987665
Q ss_pred CCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhhHHHHHHHhcCCchhhhhHH
Q 046270 424 GHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDEF 502 (590)
Q Consensus 424 ~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 502 (590)
..........||..|+|||.+..+.++.++|||||||++|||+| |+.||....... + .+. ...+.... .
T Consensus 153 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~--~---~~~-i~~~~~~~--~-- 222 (258)
T d1k2pa_ 153 DEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE--T---AEH-IAQGLRLY--R-- 222 (258)
T ss_dssp SSCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH--H---HHH-HHTTCCCC--C--
T ss_pred CCceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHH--H---HHH-HHhCCCCC--C--
Confidence 54444555678999999999999999999999999999999998 788887543221 1 111 12221111 1
Q ss_pred HhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhcc
Q 046270 503 IRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEG 542 (590)
Q Consensus 503 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~ 542 (590)
+....+.+.+++..||+.||++|||++|+++.|..
T Consensus 223 -----p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 223 -----PHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp -----CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred -----cccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 11123467889999999999999999999999853
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-50 Score=409.39 Aligned_cols=257 Identities=28% Similarity=0.393 Sum_probs=198.3
Q ss_pred cCCCccceecccCcEEEEEEEEcCC-----cEEEEEEeecCCCC-ChHHHHHHHHHHHhcCCCCccccceeEEeccCCCC
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLRHG-----NLVAVKQILDLDTK-GDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSG 337 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~~g-----~~vAvK~l~~~~~~-~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~ 337 (590)
..|+..++||+|+||.||+|+++.+ ..||||++...... ...+|.+|++++++++|||||+++|++.. .
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~-----~ 81 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK-----Y 81 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-----S
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEec-----C
Confidence 4577889999999999999998742 37999998654332 34579999999999999999999999974 3
Q ss_pred ceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCC
Q 046270 338 KRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGL 417 (590)
Q Consensus 338 ~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGl 417 (590)
...++||||+.+|+|.+++.. ....++|.++++|+.||++||+||| +.+|+||||||+||||+.++.+||+|||+
T Consensus 82 ~~~~~v~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~~i~~gl~~lH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGl 156 (283)
T d1mqba_ 82 KPMMIITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGL 156 (283)
T ss_dssp SSEEEEEECCTTEEHHHHHHH--TTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred CceEEEEEecccCcchhhhhc--ccccccHHHHHHHHHHHHHhhhhcc---ccccccCccccceEEECCCCeEEEcccch
Confidence 458999999999999887752 3457999999999999999999999 89999999999999999999999999999
Q ss_pred cccccCCCcc--cccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCc
Q 046270 418 AKQSLEGHSH--LTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKV 495 (590)
Q Consensus 418 a~~~~~~~~~--~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~ 495 (590)
++........ ......||+.|||||++..+.++.++|||||||++|||++|+.|+.........+. ....+..
T Consensus 157 a~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~-----~i~~~~~ 231 (283)
T d1mqba_ 157 SRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMK-----AINDGFR 231 (283)
T ss_dssp -----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH-----HHHTTCC
T ss_pred hhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHH-----HHhccCC
Confidence 9876543322 23345689999999999999999999999999999999997776654333322211 1122211
Q ss_pred hhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhccCC
Q 046270 496 DDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEGDI 544 (590)
Q Consensus 496 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~~~ 544 (590)
. ..+.+....+.+++..||+.||++||||.||+++|+...
T Consensus 232 ~---------~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~ 271 (283)
T d1mqba_ 232 L---------PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI 271 (283)
T ss_dssp C---------CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred C---------CCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHh
Confidence 1 111223347788999999999999999999999998643
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-50 Score=410.58 Aligned_cols=253 Identities=23% Similarity=0.361 Sum_probs=203.9
Q ss_pred cCCCccc-eecccCcEEEEEEEEc---CCcEEEEEEeecCCCC-ChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCc
Q 046270 264 NGFSQNN-LIGQGASGIVYKGTLR---HGNLVAVKQILDLDTK-GDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGK 338 (590)
Q Consensus 264 ~~f~~~~-~LG~G~fG~Vykg~~~---~g~~vAvK~l~~~~~~-~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~ 338 (590)
++|...+ +||+|+||.||+|+++ ++..||||++...... ..++|.+|+++|++++|||||+++|++.. .
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~------~ 81 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA------E 81 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES------S
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc------C
Confidence 3455556 4999999999999875 3457999999754333 35679999999999999999999999853 2
Q ss_pred eEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCc
Q 046270 339 RRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLA 418 (590)
Q Consensus 339 ~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla 418 (590)
..++||||+++|+|.+++.. .+..++|.++++|+.||++||+||| +.+|+||||||+||||+.++.+||+|||++
T Consensus 82 ~~~lvmE~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~gL~ylH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla 156 (285)
T d1u59a_ 82 ALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLS 156 (285)
T ss_dssp SEEEEEECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTC
T ss_pred eEEEEEEeCCCCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCcCchhheeeccCCceeeccchhh
Confidence 37999999999999998742 3457999999999999999999999 899999999999999999999999999999
Q ss_pred ccccCCCcc--cccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhhHHHHHHHhcCCc
Q 046270 419 KQSLEGHSH--LTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLDTSTSPFQLITDWAWVLAKSGKV 495 (590)
Q Consensus 419 ~~~~~~~~~--~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~ 495 (590)
+........ ......||+.|+|||++..+.++.++|||||||++|||+| |+.||....... +. .....+..
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~--~~----~~i~~~~~ 230 (285)
T d1u59a_ 157 KALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE--VM----AFIEQGKR 230 (285)
T ss_dssp EECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH--HH----HHHHTTCC
T ss_pred hcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHH--HH----HHHHcCCC
Confidence 976544332 2334568999999999999999999999999999999998 899997644321 11 11223322
Q ss_pred hhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhcc
Q 046270 496 DDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEG 542 (590)
Q Consensus 496 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~ 542 (590)
.+. +......+.+++..||+.||++||||.+|++.|+.
T Consensus 231 ~~~---------p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~ 268 (285)
T d1u59a_ 231 MEC---------PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA 268 (285)
T ss_dssp CCC---------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred CCC---------CCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 211 11233467789999999999999999999998874
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-50 Score=403.38 Aligned_cols=251 Identities=29% Similarity=0.393 Sum_probs=201.0
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCC-CChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEE
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDT-KGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRF 341 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~-~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~ 341 (590)
++|+..+.||+|+||+||+|++. +|+.||||++..... ...+.+.+|++++++++|||||++++++.+ ++..+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~-----~~~~~ 79 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE-----GNIQY 79 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEE-----TTEEE
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeecc-----CceeE
Confidence 46888999999999999999986 588999999865432 234568999999999999999999999984 45689
Q ss_pred EEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccc
Q 046270 342 LVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQS 421 (590)
Q Consensus 342 LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~ 421 (590)
+||||+++|+|.+++. ....+++.+++.|+.||+.||+||| +.+|+||||||+|||+++++++||+|||+++..
T Consensus 80 ivmEy~~gg~L~~~l~---~~~~l~e~~~~~i~~qi~~al~ylH---~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~ 153 (271)
T d1nvra_ 80 LFLEYCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVF 153 (271)
T ss_dssp EEEECCTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEeccCCCcHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH---HcCCccCcccHHHEEECCCCCEEEccchhheee
Confidence 9999999999999984 4457999999999999999999999 899999999999999999999999999999876
Q ss_pred cCCCc-ccccccccCCCccCccccccCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhh
Q 046270 422 LEGHS-HLTTRVAGTFGYLAPEYALYGQL-TEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIF 499 (590)
Q Consensus 422 ~~~~~-~~~~~~~gt~~Y~APE~~~~~~~-t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 499 (590)
..... ...+...||+.|||||.+.+..+ +.++|||||||++|||+||+.||............+ .........
T Consensus 154 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~-----~~~~~~~~~ 228 (271)
T d1nvra_ 154 RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW-----KEKKTYLNP 228 (271)
T ss_dssp EETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHH-----HTTCTTSTT
T ss_pred ccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHH-----hcCCCCCCc
Confidence 54332 23456789999999999988776 578999999999999999999997544432222211 111111000
Q ss_pred hHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 046270 500 DEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALK 538 (590)
Q Consensus 500 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~ 538 (590)
.......+.+++..|++.||++|||++|+++
T Consensus 229 --------~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 229 --------WKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp --------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --------cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0112235667889999999999999999864
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-50 Score=407.47 Aligned_cols=246 Identities=24% Similarity=0.364 Sum_probs=195.9
Q ss_pred ceecccCcEEEEEEEEcC---CcEEEEEEeecCCCC--ChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEEEEE
Q 046270 270 NLIGQGASGIVYKGTLRH---GNLVAVKQILDLDTK--GDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFLVY 344 (590)
Q Consensus 270 ~~LG~G~fG~Vykg~~~~---g~~vAvK~l~~~~~~--~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~LV~ 344 (590)
++||+|+||.||+|.+++ ++.||||++...... ..++|.+|+++|++++|||||+++|+|.. ...+|||
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~------~~~~lvm 86 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA------ESWMLVM 86 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES------SSEEEEE
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc------CCEEEEE
Confidence 579999999999998754 457999998653322 24679999999999999999999999853 2378999
Q ss_pred eeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccccCC
Q 046270 345 DYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEG 424 (590)
Q Consensus 345 E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~~~~ 424 (590)
||+++|+|.+++. ....++|.+++.|+.||++||+||| +.+|+||||||+||||+.++.+||+|||+++.....
T Consensus 87 E~~~~g~L~~~l~---~~~~l~~~~~~~i~~qi~~gl~ylH---~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~ 160 (277)
T d1xbba_ 87 EMAELGPLNKYLQ---QNRHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD 160 (277)
T ss_dssp ECCTTEEHHHHHH---HCTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTT
T ss_pred EcCCCCcHHHHHh---hccCCCHHHHHHHHHHHHHHHhhHH---hCCcccCCCcchhhcccccCcccccchhhhhhcccc
Confidence 9999999999885 4457999999999999999999999 889999999999999999999999999999876544
Q ss_pred Ccc--cccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhhHHHHHHHhcCCchhhhhH
Q 046270 425 HSH--LTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDE 501 (590)
Q Consensus 425 ~~~--~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 501 (590)
... ......||+.|||||.+.++.++.++|||||||++|||+| |+.||...... .+. .....+...+.
T Consensus 161 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~--~~~----~~i~~~~~~~~--- 231 (277)
T d1xbba_ 161 ENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--EVT----AMLEKGERMGC--- 231 (277)
T ss_dssp CSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHH----HHHHTTCCCCC---
T ss_pred ccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH--HHH----HHHHcCCCCCC---
Confidence 332 2334678999999999999999999999999999999998 89999753321 111 11222221111
Q ss_pred HHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhcc
Q 046270 502 FIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEG 542 (590)
Q Consensus 502 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~ 542 (590)
+......+.+++..|++.||++||||++|+++|+.
T Consensus 232 ------p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~ 266 (277)
T d1xbba_ 232 ------PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 266 (277)
T ss_dssp ------CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred ------CcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence 11223467789999999999999999999998864
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-49 Score=400.73 Aligned_cols=249 Identities=24% Similarity=0.385 Sum_probs=205.0
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEEE
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFL 342 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~L 342 (590)
++|...+.||+|+||+||+|+.. +|+.||||++........+.+.+|++++++++|||||++++++.. ....++
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-----~~~~~i 94 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV-----GDELWV 94 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEE-----CCEEEE
Confidence 46889999999999999999975 589999999976655667789999999999999999999999985 346899
Q ss_pred EEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCccccc
Q 046270 343 VYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSL 422 (590)
Q Consensus 343 V~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~~ 422 (590)
||||+++|+|.+++. ...+++.+++.|+.||+.||+||| +.+|+||||||+|||++.++++||+|||+++...
T Consensus 95 vmEy~~gg~L~~~~~----~~~l~~~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~ 167 (293)
T d1yhwa1 95 VMEYLAGGSLTDVVT----ETCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 167 (293)
T ss_dssp EEECCTTCBHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEecCCCcHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCcHHHeEECCCCcEeeccchhheeec
Confidence 999999999998763 346999999999999999999999 8999999999999999999999999999998764
Q ss_pred CCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhhhHH
Q 046270 423 EGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDEF 502 (590)
Q Consensus 423 ~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 502 (590)
.... ......||+.|+|||.+.++.++.++|||||||++|||+||+.||....... .+ ......+...-.
T Consensus 168 ~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~-~~----~~~~~~~~~~~~---- 237 (293)
T d1yhwa1 168 PEQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR-AL----YLIATNGTPELQ---- 237 (293)
T ss_dssp STTC-CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HH----HHHHHHCSCCCS----
T ss_pred cccc-cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHH-HH----HHHHhCCCCCCC----
Confidence 4332 3345679999999999999999999999999999999999999996533211 11 111122211100
Q ss_pred HhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 046270 503 IRAEGARAVMERFVLVGILCAHVMVALRPTITDALK 538 (590)
Q Consensus 503 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~ 538 (590)
.+......+.+++..|++.||.+|||+.|+++
T Consensus 238 ----~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 238 ----NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp ----SGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ----CcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 01122346778899999999999999999975
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-49 Score=397.44 Aligned_cols=245 Identities=26% Similarity=0.398 Sum_probs=202.1
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecC---CCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCce
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDL---DTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKR 339 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~---~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~ 339 (590)
++|...+.||+|+||.||+|+++ +|+.||+|++... .....+.+.+|++++++++|||||++++++.+ ...
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-----~~~ 80 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHD-----ATR 80 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----SSE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEE-----CCE
Confidence 46888899999999999999986 4889999998642 23345678999999999999999999999983 456
Q ss_pred EEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcc
Q 046270 340 RFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAK 419 (590)
Q Consensus 340 ~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~ 419 (590)
.++||||+++|+|.+++. +...+++.+++.|+.||+.||+||| +.+|+||||||+|||++.++++||+|||+++
T Consensus 81 ~~ivmEy~~~g~L~~~l~---~~~~l~e~~~~~i~~qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~ 154 (263)
T d2j4za1 81 VYLILEYAPLGTVYRELQ---KLSKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSV 154 (263)
T ss_dssp EEEEEECCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCSCS
T ss_pred EEEEEeecCCCcHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeeeeccccceecCCCCEeecccceee
Confidence 999999999999999985 3457999999999999999999999 8999999999999999999999999999998
Q ss_pred cccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhh
Q 046270 420 QSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIF 499 (590)
Q Consensus 420 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 499 (590)
...... .....||+.|||||.+.+..++.++|||||||++|||++|+.||..... ...+. . ...+...
T Consensus 155 ~~~~~~---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-~~~~~----~-i~~~~~~--- 222 (263)
T d2j4za1 155 HAPSSR---RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY-QETYK----R-ISRVEFT--- 222 (263)
T ss_dssp CCCCCC---CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH-HHHHH----H-HHTTCCC---
T ss_pred ecCCCc---ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCH-HHHHH----H-HHcCCCC---
Confidence 654332 3456799999999999999999999999999999999999999965332 11111 1 1111110
Q ss_pred hHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 046270 500 DEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALK 538 (590)
Q Consensus 500 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~ 538 (590)
.+....+.+.+++..|++.||++|||++|+++
T Consensus 223 -------~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 223 -------FPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp -------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -------CCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 01112346777889999999999999999986
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-49 Score=412.39 Aligned_cols=257 Identities=25% Similarity=0.382 Sum_probs=203.9
Q ss_pred hcCCCccceecccCcEEEEEEEEcCC------cEEEEEEeecC-CCCChHHHHHHHHHHHhc-CCCCccccceeEEeccC
Q 046270 263 TNGFSQNNLIGQGASGIVYKGTLRHG------NLVAVKQILDL-DTKGDEDFTNEVEIISKI-RHRNLLSLRGCCVTSDD 334 (590)
Q Consensus 263 t~~f~~~~~LG~G~fG~Vykg~~~~g------~~vAvK~l~~~-~~~~~~~f~~Ev~il~~l-~H~nlv~l~g~~~~~~~ 334 (590)
.++|...+.||+|+||+||+|++... ..||||++... .......+.+|+.++.++ +|||||+++|++...
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~-- 113 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS-- 113 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS--
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeC--
Confidence 35788889999999999999997532 26999998643 333456799999999999 899999999999743
Q ss_pred CCCceEEEEEeeCCCCCcchhhhhhcc--------------------cccCChhhHHHHHHHHHHHHHHHHhcCCCCeEe
Q 046270 335 SSGKRRFLVYDYMPNGTLSDNISISHK--------------------RKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYH 394 (590)
Q Consensus 335 ~~~~~~~LV~E~~~~gsL~~~L~~~~~--------------------~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivH 394 (590)
...++||||+++|+|.++|...+. ...++|..++.|+.||++||+||| +.+|+|
T Consensus 114 ---~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH---~~~IiH 187 (325)
T d1rjba_ 114 ---GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVH 187 (325)
T ss_dssp ---SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEE
T ss_pred ---CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeee
Confidence 458999999999999999964321 235899999999999999999999 889999
Q ss_pred cCCCCCceEECCCCcEEEEeeCCcccccCCCcc-cccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCC
Q 046270 395 RDIKSTNILLDSELNAKVADFGLAKQSLEGHSH-LTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVL 472 (590)
Q Consensus 395 rDIKp~NILLd~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELlt-G~~p~ 472 (590)
|||||+|||++.++++||+|||+++........ ......||+.|||||.+.++.++.++|||||||++|||+| |+.||
T Consensus 188 RDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf 267 (325)
T d1rjba_ 188 RDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY 267 (325)
T ss_dssp TTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred ccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCC
Confidence 999999999999999999999999876544332 2345678999999999999999999999999999999998 89999
Q ss_pred CCCCCchhhhhHHHHHHHhcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhc
Q 046270 473 DTSTSPFQLITDWAWVLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLE 541 (590)
Q Consensus 473 ~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~ 541 (590)
........ +. .....+...+ .+....+.+.+++..|++.||++||||+||+++|.
T Consensus 268 ~~~~~~~~-~~----~~~~~~~~~~---------~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 268 PGIPVDAN-FY----KLIQNGFKMD---------QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp TTCCCSHH-HH----HHHHTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCCHHHH-HH----HHHhcCCCCC---------CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 75444322 11 1122221111 11122346788999999999999999999999995
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-48 Score=393.24 Aligned_cols=248 Identities=25% Similarity=0.358 Sum_probs=197.2
Q ss_pred CccceecccCcEEEEEEEEcC-CcEEEEEEeecCC--CCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEEEE
Q 046270 267 SQNNLIGQGASGIVYKGTLRH-GNLVAVKQILDLD--TKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFLV 343 (590)
Q Consensus 267 ~~~~~LG~G~fG~Vykg~~~~-g~~vAvK~l~~~~--~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~LV 343 (590)
...+.||+|+||+||+|++.. +..||+|++.... ....+.|.+|+++|++++|||||++++++..... .....++|
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~-~~~~~~iv 90 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVK-GKKCIVLV 90 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESS-SCEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccc-cCCEEEEE
Confidence 344679999999999999874 7899999986543 2234578999999999999999999999876433 34668999
Q ss_pred EeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCCceEEC-CCCcEEEEeeCCccc
Q 046270 344 YDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPG--IYHRDIKSTNILLD-SELNAKVADFGLAKQ 420 (590)
Q Consensus 344 ~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~--ivHrDIKp~NILLd-~~~~~kL~DFGla~~ 420 (590)
|||+++|+|.+++. +...+++..++.|+.||++||+||| +.+ |+||||||+||||+ +++.+||+|||+++.
T Consensus 91 mE~~~~g~L~~~l~---~~~~~~~~~~~~~~~qi~~gl~yLH---~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~ 164 (270)
T d1t4ha_ 91 TELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 164 (270)
T ss_dssp EECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EeCCCCCcHHHHHh---ccccccHHHHHHHHHHHHHHHHHHH---HCCCCEEeCCcChhhceeeCCCCCEEEeecCccee
Confidence 99999999999985 3457999999999999999999999 766 99999999999996 578999999999986
Q ss_pred ccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhhh
Q 046270 421 SLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFD 500 (590)
Q Consensus 421 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 500 (590)
.... ......||+.|||||.+. ++++.++|||||||++|||++|+.||.......... .....+.....++
T Consensus 165 ~~~~---~~~~~~GT~~Y~aPE~~~-~~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~-----~~i~~~~~~~~~~ 235 (270)
T d1t4ha_ 165 KRAS---FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIY-----RRVTSGVKPASFD 235 (270)
T ss_dssp CCTT---SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHH-----HHHTTTCCCGGGG
T ss_pred ccCC---ccCCcccCccccCHHHhC-CCCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHH-----HHHHcCCCCcccC
Confidence 4332 234567999999999876 569999999999999999999999997544322211 1122222211122
Q ss_pred HHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 046270 501 EFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALK 538 (590)
Q Consensus 501 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~ 538 (590)
+ .....+.+++..|++.||++|||+.|+++
T Consensus 236 ~--------~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 236 K--------VAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp G--------CCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred c--------cCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 1 11235678899999999999999999986
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-49 Score=401.07 Aligned_cols=256 Identities=21% Similarity=0.312 Sum_probs=192.0
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCC--CChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceE
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDT--KGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRR 340 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~--~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~ 340 (590)
++|...+.||+|+||+||+|+.+ +|+.||||++..... ...+.+.+|++++++++|||||++++++.+.. ....
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~---~~~~ 80 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRT---NTTL 80 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC-------CE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCC---CCEE
Confidence 56888999999999999999986 588999999865432 22456889999999999999999999987432 3458
Q ss_pred EEEEeeCCCCCcchhhhhhc-ccccCChhhHHHHHHHHHHHHHHHHhcC--CCCeEecCCCCCceEECCCCcEEEEeeCC
Q 046270 341 FLVYDYMPNGTLSDNISISH-KRKQLTWPQRKKIIVDVAKGIAYLHYGL--KPGIYHRDIKSTNILLDSELNAKVADFGL 417 (590)
Q Consensus 341 ~LV~E~~~~gsL~~~L~~~~-~~~~l~~~~r~~I~~~ia~gL~yLH~~~--~~~ivHrDIKp~NILLd~~~~~kL~DFGl 417 (590)
++||||+++|+|.+++.... ....+++..++.|+.||+.||.|||+.. ..+|+||||||+||||+.++.+||+|||+
T Consensus 81 ~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~ 160 (269)
T d2java1 81 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL 160 (269)
T ss_dssp EEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHH
T ss_pred EEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccc
Confidence 99999999999999986433 3457999999999999999999999421 23599999999999999999999999999
Q ss_pred cccccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchh
Q 046270 418 AKQSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDD 497 (590)
Q Consensus 418 a~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 497 (590)
++...... .......||+.|||||.+.+..++.++|||||||++|||+||+.||..... ..... ....+....
T Consensus 161 a~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~-~~~~~-----~i~~~~~~~ 233 (269)
T d2java1 161 ARILNHDT-SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ-KELAG-----KIREGKFRR 233 (269)
T ss_dssp HHHC------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHH-----HHHHTCCCC
T ss_pred eeecccCC-CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCH-HHHHH-----HHHcCCCCC
Confidence 98764432 233457899999999999999999999999999999999999999965322 11111 112222211
Q ss_pred hhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 046270 498 IFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALK 538 (590)
Q Consensus 498 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~ 538 (590)
. +....+.+.+++..|++.||.+|||+.|+++
T Consensus 234 ~---------~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 234 I---------PYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp C---------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred C---------CcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 1 1112346778889999999999999999975
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-48 Score=398.99 Aligned_cols=251 Identities=23% Similarity=0.309 Sum_probs=202.8
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEEE
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFL 342 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~L 342 (590)
+.|+..+.||+|+||.||+|++. +|..||||++........+.|.+|+++|++++|||||++++++.+ ....++
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-----~~~~~l 86 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYY-----ENNLWI 86 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEE-----TTEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee-----CCeEEE
Confidence 45788899999999999999986 488999999977666667789999999999999999999999984 346899
Q ss_pred EEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCccccc
Q 046270 343 VYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSL 422 (590)
Q Consensus 343 V~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~~ 422 (590)
||||+++|+|.+++.. ..+.+++.++..|+.||+.||.||| +.+|+||||||+|||++.++++||+|||+++...
T Consensus 87 vmEy~~~g~L~~~~~~--~~~~l~e~~~~~i~~qi~~gL~ylH---~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~ 161 (288)
T d2jfla1 87 LIEFCAGGAVDAVMLE--LERPLTESQIQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNT 161 (288)
T ss_dssp EEECCTTEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECH
T ss_pred EEecCCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHH---HCCEEEeecChhheeECCCCCEEEEechhhhccC
Confidence 9999999999998753 2456999999999999999999999 8999999999999999999999999999997543
Q ss_pred CCCcccccccccCCCccCccccc-----cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchh
Q 046270 423 EGHSHLTTRVAGTFGYLAPEYAL-----YGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDD 497 (590)
Q Consensus 423 ~~~~~~~~~~~gt~~Y~APE~~~-----~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 497 (590)
... .......||+.|+|||++. ...++.++|||||||++|||+||+.||....... .+. .... +....
T Consensus 162 ~~~-~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~-~~~----~i~~-~~~~~ 234 (288)
T d2jfla1 162 RTI-QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR-VLL----KIAK-SEPPT 234 (288)
T ss_dssp HHH-HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG-HHH----HHHH-SCCCC
T ss_pred CCc-ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH-HHH----HHHc-CCCCC
Confidence 221 1233467999999999984 4568999999999999999999999997543322 111 1111 11111
Q ss_pred hhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 046270 498 IFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALK 538 (590)
Q Consensus 498 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~ 538 (590)
... +......+.+++..|++.||++|||+.|+++
T Consensus 235 ~~~-------~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 235 LAQ-------PSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp CSS-------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCc-------cccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 100 1122346778889999999999999999976
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-49 Score=408.20 Aligned_cols=263 Identities=20% Similarity=0.309 Sum_probs=202.7
Q ss_pred HhcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCC-CChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCce
Q 046270 262 ATNGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDT-KGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKR 339 (590)
Q Consensus 262 at~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~-~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~ 339 (590)
..++|...+.||+|+||+||+|++. +|+.||+|++..... ...+.+.+|+++|++++|||||++++++.. ...
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-----~~~ 78 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-----DGE 78 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEEC-----SSE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-----CCE
Confidence 3578999999999999999999986 588999999865433 335678999999999999999999999984 456
Q ss_pred EEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCC-CCeEecCCCCCceEECCCCcEEEEeeCCc
Q 046270 340 RFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLK-PGIYHRDIKSTNILLDSELNAKVADFGLA 418 (590)
Q Consensus 340 ~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~-~~ivHrDIKp~NILLd~~~~~kL~DFGla 418 (590)
.++||||+++|+|.+++. +.+.+++..+..++.||+.||.||| + .+|+||||||+||||++++++||+|||+|
T Consensus 79 ~~iVmEy~~gg~L~~~l~---~~~~l~~~~~~~~~~qil~aL~yLH---~~~~IiHRDiKP~NILl~~~~~vkl~DFGla 152 (322)
T d1s9ja_ 79 ISICMEHMDGGSLDQVLK---KAGRIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVS 152 (322)
T ss_dssp EEEEEECCTTEEHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHH---HHHCCCCSCCSGGGEEECTTCCEEECCCCCC
T ss_pred EEEEEEcCCCCcHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHH---HhCCEEccccCHHHeeECCCCCEEEeeCCCc
Confidence 999999999999999985 3457999999999999999999999 5 48999999999999999999999999999
Q ss_pred ccccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHH-----------
Q 046270 419 KQSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAW----------- 487 (590)
Q Consensus 419 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~----------- 487 (590)
+..... ......||+.|+|||++.+..++.++||||+||+++||++|+.||...............
T Consensus 153 ~~~~~~---~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (322)
T d1s9ja_ 153 GQLIDS---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPR 229 (322)
T ss_dssp HHHHHH---TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC--------------
T ss_pred cccCCC---ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcc
Confidence 865332 234568999999999999999999999999999999999999999754432211000000
Q ss_pred ---------HHHhc----CCchhhhhHHHhhh----hHHHHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 046270 488 ---------VLAKS----GKVDDIFDEFIRAE----GARAVMERFVLVGILCAHVMVALRPTITDALK 538 (590)
Q Consensus 488 ---------~~~~~----~~~~~~~d~~l~~~----~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~ 538 (590)
..... ....+.++...... ........+.+++..|++.||.+|||++|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~ 297 (322)
T d1s9ja_ 230 PRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297 (322)
T ss_dssp ----------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 00000 00011111111000 00012246788999999999999999999986
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.5e-49 Score=404.37 Aligned_cols=264 Identities=25% Similarity=0.392 Sum_probs=209.2
Q ss_pred HHHHHHhcCCCccceecccCcEEEEEEEEc------CCcEEEEEEeecCCCC-ChHHHHHHHHHHHhcCCCCccccceeE
Q 046270 257 SELEQATNGFSQNNLIGQGASGIVYKGTLR------HGNLVAVKQILDLDTK-GDEDFTNEVEIISKIRHRNLLSLRGCC 329 (590)
Q Consensus 257 ~el~~at~~f~~~~~LG~G~fG~Vykg~~~------~g~~vAvK~l~~~~~~-~~~~f~~Ev~il~~l~H~nlv~l~g~~ 329 (590)
.+++...++|+..+.||+|+||.||+|+++ +++.||||++...... ..++|.+|+++|++++||||++++++|
T Consensus 6 ~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~ 85 (301)
T d1lufa_ 6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC 85 (301)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred hhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeee
Confidence 345556778999999999999999999875 3568999998654333 246799999999999999999999999
Q ss_pred EeccCCCCceEEEEEeeCCCCCcchhhhhhc---------------------ccccCChhhHHHHHHHHHHHHHHHHhcC
Q 046270 330 VTSDDSSGKRRFLVYDYMPNGTLSDNISISH---------------------KRKQLTWPQRKKIIVDVAKGIAYLHYGL 388 (590)
Q Consensus 330 ~~~~~~~~~~~~LV~E~~~~gsL~~~L~~~~---------------------~~~~l~~~~r~~I~~~ia~gL~yLH~~~ 388 (590)
.. ....++||||+++|+|.+++.... ....++|.+++.|+.||+.||+|||
T Consensus 86 ~~-----~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH--- 157 (301)
T d1lufa_ 86 AV-----GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS--- 157 (301)
T ss_dssp CS-----SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---
T ss_pred cc-----CCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcc---
Confidence 74 345899999999999999985321 1235899999999999999999999
Q ss_pred CCCeEecCCCCCceEECCCCcEEEEeeCCcccccCCCc-ccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHh
Q 046270 389 KPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLEGHS-HLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS 467 (590)
Q Consensus 389 ~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELlt 467 (590)
+.+|+||||||+|||||.++++||+|||+++....... ...+...||+.|+|||.+.+..++.++|||||||++|||++
T Consensus 158 ~~~ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~ 237 (301)
T d1lufa_ 158 ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 237 (301)
T ss_dssp HTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred cCCeEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHc
Confidence 89999999999999999999999999999986544322 23445678999999999999999999999999999999999
Q ss_pred CCC-CCCCCCCchhhhhHHHHHHHhcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhccC
Q 046270 468 GRK-VLDTSTSPFQLITDWAWVLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEGD 543 (590)
Q Consensus 468 G~~-p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~~ 543 (590)
|.. |+... .....+. . ...+...+. +...+.++.+++..||+.+|++||||.||+++|+..
T Consensus 238 ~~~~p~~~~-~~~e~~~----~-v~~~~~~~~---------p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i 299 (301)
T d1lufa_ 238 YGLQPYYGM-AHEEVIY----Y-VRDGNILAC---------PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM 299 (301)
T ss_dssp TTCCTTTTS-CHHHHHH----H-HHTTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred cCCCCCCCC-CHHHHHH----H-HHcCCCCCC---------CccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 964 55433 2222211 1 223332211 112334678899999999999999999999999864
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-48 Score=402.51 Aligned_cols=252 Identities=25% Similarity=0.415 Sum_probs=199.3
Q ss_pred CCCccceecccCcEEEEEEEEcC-Cc----EEEEEEeecC-CCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCc
Q 046270 265 GFSQNNLIGQGASGIVYKGTLRH-GN----LVAVKQILDL-DTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGK 338 (590)
Q Consensus 265 ~f~~~~~LG~G~fG~Vykg~~~~-g~----~vAvK~l~~~-~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~ 338 (590)
+|+..++||+|+||+||+|++.. |+ .||+|++... ..+..++|.+|++++++++|||||+++|+|.+.
T Consensus 10 dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~------ 83 (317)
T d1xkka_ 10 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS------ 83 (317)
T ss_dssp TEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS------
T ss_pred HCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC------
Confidence 58889999999999999999763 43 5899988653 344567899999999999999999999999742
Q ss_pred eEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCc
Q 046270 339 RRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLA 418 (590)
Q Consensus 339 ~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla 418 (590)
..++++||+.+|+|.+++.. ....++|..+++|+.|||+||+||| +.+|+||||||+||||+.++.+||+|||++
T Consensus 84 ~~~~v~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~yLH---~~~iiHrDlKp~NIll~~~~~~kl~DFGla 158 (317)
T d1xkka_ 84 TVQLITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLA 158 (317)
T ss_dssp SEEEEEECCTTCBHHHHHHH--TSSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCCSHH
T ss_pred CeeEEEEeccCCcccccccc--cccCCCHHHHHHHHHHHHHHHHHHH---HcCcccCcchhhcceeCCCCCeEeeccccc
Confidence 36889999999999988753 3567999999999999999999999 889999999999999999999999999999
Q ss_pred ccccCCCcc-cccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhhHHHHHHHhcCCch
Q 046270 419 KQSLEGHSH-LTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLDTSTSPFQLITDWAWVLAKSGKVD 496 (590)
Q Consensus 419 ~~~~~~~~~-~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 496 (590)
+........ ......||..|+|||.+.++.++.++|||||||++|||+| |+.||+..... . +.. ....+...
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~-~-~~~----~i~~~~~~ 232 (317)
T d1xkka_ 159 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS-E-ISS----ILEKGERL 232 (317)
T ss_dssp HHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGG-G-HHH----HHHHTCCC
T ss_pred eecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHH-H-HHH----HHHcCCCC
Confidence 976554433 2344578999999999999999999999999999999999 77887654322 1 111 11122111
Q ss_pred hhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhcc
Q 046270 497 DIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEG 542 (590)
Q Consensus 497 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~ 542 (590)
. .+......+.+++..|++.||.+|||+.|+++.|+.
T Consensus 233 ~---------~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~ 269 (317)
T d1xkka_ 233 P---------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSK 269 (317)
T ss_dssp C---------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred C---------CCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHH
Confidence 0 111223467889999999999999999999998865
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-48 Score=391.64 Aligned_cols=249 Identities=30% Similarity=0.395 Sum_probs=194.6
Q ss_pred cCCCccceecccCcEEEEEEEEcCCcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEEEE
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLRHGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFLV 343 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~LV 343 (590)
++|...+.||+|+||.||+|+++ |..||||+++.. ...++|.+|++++++++|||||+++|+|.+.. ...++|
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~----~~~~lv 79 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK----GGLYIV 79 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC------CCEEE
T ss_pred HHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecC----CcEEEE
Confidence 45677889999999999999996 789999998643 34578999999999999999999999986432 347999
Q ss_pred EeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccccC
Q 046270 344 YDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLE 423 (590)
Q Consensus 344 ~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~~~ 423 (590)
|||+++|+|.++|... ....++|..+++|+.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++....
T Consensus 80 ~ey~~~g~L~~~l~~~-~~~~l~~~~~~~i~~~i~~al~ylH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~ 155 (262)
T d1byga_ 80 TEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 155 (262)
T ss_dssp ECCCTTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred EeccCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHhhccccc---cCceeccccchHhheecCCCCEeecccccceecCC
Confidence 9999999999999643 2346999999999999999999999 89999999999999999999999999999986433
Q ss_pred CCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhhHHHHHHHhcCCchhhhhHH
Q 046270 424 GHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFDEF 502 (590)
Q Consensus 424 ~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 502 (590)
. .....+|..|+|||++.++.++.++|||||||++|||+| |+.|+..... . .+..++ ..+...+..
T Consensus 156 ~----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~-~-~~~~~i----~~~~~~~~~--- 222 (262)
T d1byga_ 156 T----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-K-DVVPRV----EKGYKMDAP--- 222 (262)
T ss_dssp ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG-G-GHHHHH----TTTCCCCCC---
T ss_pred C----CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCH-H-HHHHHH----HcCCCCCCC---
Confidence 2 233457899999999999999999999999999999999 5666654322 1 222121 222222111
Q ss_pred HhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhcc
Q 046270 503 IRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEG 542 (590)
Q Consensus 503 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~ 542 (590)
.....++.+++..|++.||.+||||.|++++|+.
T Consensus 223 ------~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~ 256 (262)
T d1byga_ 223 ------DGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEH 256 (262)
T ss_dssp ------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ------ccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence 1122467788999999999999999999999975
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-48 Score=396.24 Aligned_cols=252 Identities=29% Similarity=0.412 Sum_probs=200.3
Q ss_pred cceecccCcEEEEEEEEcCC----cEEEEEEeecCC-CCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEEEE
Q 046270 269 NNLIGQGASGIVYKGTLRHG----NLVAVKQILDLD-TKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFLV 343 (590)
Q Consensus 269 ~~~LG~G~fG~Vykg~~~~g----~~vAvK~l~~~~-~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~LV 343 (590)
.++||+|+||+||+|++.++ ..||||++.... ....++|.+|+++|++++|||||+++|++... ....++|
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~----~~~~~lv 107 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS----EGSPLVV 107 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEET----TTEEEEE
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEec----CCceEEE
Confidence 36799999999999998642 268999986533 23346799999999999999999999998753 3468999
Q ss_pred EeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccccC
Q 046270 344 YDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSLE 423 (590)
Q Consensus 344 ~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~~~ 423 (590)
|||+++|+|.+++.. ....++|..+++++.|+|+||.||| +.+|+||||||+|||||+++.+||+|||+++....
T Consensus 108 ~E~~~~g~l~~~~~~--~~~~~~~~~~~~i~~qia~gL~~lH---~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~ 182 (311)
T d1r0pa_ 108 LPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 182 (311)
T ss_dssp EECCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTT
T ss_pred EEEeecCchhhhhcc--ccccchHHHHHHHHHHHHHhhhhhc---ccCcccCCccHHhEeECCCCCEEEecccchhhccc
Confidence 999999999998853 3456889999999999999999999 89999999999999999999999999999987654
Q ss_pred CCcc---cccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhhh
Q 046270 424 GHSH---LTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFD 500 (590)
Q Consensus 424 ~~~~---~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 500 (590)
.... ......||..|+|||.+..+.++.++||||||+++|||+||+.|+........ +..+ ...+.... .
T Consensus 183 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~-~~~~----i~~g~~~~--~ 255 (311)
T d1r0pa_ 183 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD-ITVY----LLQGRRLL--Q 255 (311)
T ss_dssp TTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-------CHHH----HHTTCCCC--C
T ss_pred cccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHH-HHHH----HHcCCCCC--C
Confidence 4322 23346789999999999999999999999999999999998888765433222 1111 12222111 0
Q ss_pred HHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhccC
Q 046270 501 EFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEGD 543 (590)
Q Consensus 501 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~~ 543 (590)
+......+.+++..||+.||++||||.||+++|+..
T Consensus 256 -------p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i 291 (311)
T d1r0pa_ 256 -------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 291 (311)
T ss_dssp -------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -------cccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 111234677899999999999999999999999864
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-48 Score=394.79 Aligned_cols=247 Identities=20% Similarity=0.289 Sum_probs=199.3
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecC---CCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCce
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDL---DTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKR 339 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~---~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~ 339 (590)
++|...+.||+|+||.||+|+.. +|+.||||++... .....+.+.+|++++++++|||||++++++.+ ...
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-----~~~ 82 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQD-----DEK 82 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEEC-----SSE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEE-----CCE
Confidence 46888999999999999999986 5889999998642 23345679999999999999999999999873 456
Q ss_pred EEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcc
Q 046270 340 RFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAK 419 (590)
Q Consensus 340 ~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~ 419 (590)
.++||||+++|+|.+++. ..+.+++.+++.++.|++.||+||| +.+|+||||||+|||+++++.+||+|||+++
T Consensus 83 ~~ivmEy~~gg~L~~~~~---~~~~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~ 156 (288)
T d1uu3a_ 83 LYFGLSYAKNGELLKYIR---KIGSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAK 156 (288)
T ss_dssp EEEEECCCTTEEHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEEEccCCCCHHHhhh---ccCCCCHHHHHHHHHHHHHHHHhhc---cccEEcCcCCccccccCCCceEEecccccce
Confidence 999999999999999875 4467999999999999999999999 8999999999999999999999999999998
Q ss_pred cccCCC-cccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhh
Q 046270 420 QSLEGH-SHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDI 498 (590)
Q Consensus 420 ~~~~~~-~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 498 (590)
...... ........||+.|+|||++.+..++.++|||||||++|||+||+.||..... ..... . ...+...
T Consensus 157 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-~~~~~----~-i~~~~~~-- 228 (288)
T d1uu3a_ 157 VLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE-YLIFQ----K-IIKLEYD-- 228 (288)
T ss_dssp ECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHH----H-HHTTCCC--
T ss_pred ecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCH-HHHHH----H-HHcCCCC--
Confidence 764332 2234456799999999999999999999999999999999999999975322 11111 1 1112110
Q ss_pred hhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHH
Q 046270 499 FDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDAL 537 (590)
Q Consensus 499 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl 537 (590)
+ +......+.+++..|++.||.+|||++|++
T Consensus 229 ~--------p~~~s~~~~~li~~~L~~dP~~R~t~~e~~ 259 (288)
T d1uu3a_ 229 F--------PEKFFPKARDLVEKLLVLDATKRLGCEEME 259 (288)
T ss_dssp C--------CTTCCHHHHHHHHTTSCSSGGGSTTSGGGT
T ss_pred C--------CccCCHHHHHHHHHHccCCHhHCcCHHHHc
Confidence 0 111234677889999999999999999864
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-48 Score=393.25 Aligned_cols=254 Identities=20% Similarity=0.316 Sum_probs=193.2
Q ss_pred hcCCCccceecccCcEEEEEEEEcC----CcEEEEEEeecCCCCC-hHHHHHHHHHHHhcCCCCccccceeEEeccCCCC
Q 046270 263 TNGFSQNNLIGQGASGIVYKGTLRH----GNLVAVKQILDLDTKG-DEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSG 337 (590)
Q Consensus 263 t~~f~~~~~LG~G~fG~Vykg~~~~----g~~vAvK~l~~~~~~~-~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~ 337 (590)
.++|...+.||+|+||.||+|++.. +..||||++....... .+.|.+|++++++++|||||+++|++.+
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~------ 79 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE------ 79 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS------
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec------
Confidence 3568888999999999999998753 3468999886543332 4579999999999999999999999852
Q ss_pred ceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCC
Q 046270 338 KRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGL 417 (590)
Q Consensus 338 ~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGl 417 (590)
...++||||+++|+|.+++.. ....+++..++.++.||++||.||| +.+|+||||||+||++++++.+||+|||+
T Consensus 80 ~~~~iv~E~~~~g~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDlKp~NIll~~~~~~Kl~DfG~ 154 (273)
T d1mp8a_ 80 NPVWIIMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGL 154 (273)
T ss_dssp SSCEEEEECCTTEEHHHHHHH--TTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC---
T ss_pred CeEEEEEEeccCCcHHhhhhc--cCCCCCHHHHHHHHHHHHHHhhhhc---ccCeeccccchhheeecCCCcEEEccchh
Confidence 247999999999999988752 3457999999999999999999999 89999999999999999999999999999
Q ss_pred cccccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhhHHHHHHHhcCCch
Q 046270 418 AKQSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLDTSTSPFQLITDWAWVLAKSGKVD 496 (590)
Q Consensus 418 a~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 496 (590)
++..............||+.|+|||.+..+.++.++|||||||++|||+| |+.|+...... .... ....+...
T Consensus 155 a~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~-~~~~-----~i~~~~~~ 228 (273)
T d1mp8a_ 155 SRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN-DVIG-----RIENGERL 228 (273)
T ss_dssp ----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG-GHHH-----HHHTTCCC
T ss_pred heeccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHH-HHHH-----HHHcCCCC
Confidence 98765554445566778999999999999999999999999999999998 88888654332 1111 11222211
Q ss_pred hhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhcc
Q 046270 497 DIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEG 542 (590)
Q Consensus 497 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~ 542 (590)
.. +....+.+.+++..|++.||++|||+.||++.|+.
T Consensus 229 ~~---------~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~ 265 (273)
T d1mp8a_ 229 PM---------PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLST 265 (273)
T ss_dssp CC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CC---------CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 11 11223467889999999999999999999998874
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=2e-47 Score=400.13 Aligned_cols=251 Identities=22% Similarity=0.308 Sum_probs=204.5
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEEE
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFL 342 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~L 342 (590)
++|...+.||+|+||.||+|+.. +|+.||||++........+.+.+|+++|++++|||||++++++.+ +...++
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-----~~~~~i 100 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFED-----DNEMVM 100 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEE-----TTEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEE-----CCEEEE
Confidence 57999999999999999999986 588999999976554556678999999999999999999999984 456999
Q ss_pred EEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECC--CCcEEEEeeCCccc
Q 046270 343 VYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDS--ELNAKVADFGLAKQ 420 (590)
Q Consensus 343 V~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~--~~~~kL~DFGla~~ 420 (590)
||||+++|+|.+++.. ..+.+++.++..|+.||+.||.||| +.+|+||||||+|||++. ++.+||+|||+++.
T Consensus 101 vmE~~~gg~L~~~l~~--~~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~ 175 (350)
T d1koaa2 101 IYEFMSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAH 175 (350)
T ss_dssp EECCCCSCBHHHHHTC--TTSCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTSCCEEECCCTTCEE
T ss_pred EEEcCCCCCHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHH---hcCCeeeeechhHeeeccCCCCeEEEeecchhee
Confidence 9999999999998852 3456999999999999999999999 899999999999999954 57899999999987
Q ss_pred ccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHh-cCCchhhh
Q 046270 421 SLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAK-SGKVDDIF 499 (590)
Q Consensus 421 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~-~~~~~~~~ 499 (590)
..... ......||+.|||||++.+..++.++|||||||++|||++|+.||..... ...+. .... ........
T Consensus 176 ~~~~~--~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-~~~~~----~i~~~~~~~~~~~ 248 (350)
T d1koaa2 176 LDPKQ--SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND-DETLR----NVKSCDWNMDDSA 248 (350)
T ss_dssp CCTTS--CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHH----HHHHTCCCSCCGG
T ss_pred ccccc--ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCH-HHHHH----HHHhCCCCCCccc
Confidence 64432 23456799999999999999999999999999999999999999974322 11111 1111 11111111
Q ss_pred hHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 500 DEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 500 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
. ..+.+.+.+++..|++.||++|||+.|++++
T Consensus 249 ~--------~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 249 F--------SGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp G--------GGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred c--------cCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1 1123467788899999999999999999985
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-48 Score=395.41 Aligned_cols=261 Identities=24% Similarity=0.313 Sum_probs=198.0
Q ss_pred HHhcCCCccceecccCcEEEEEEEEcC------CcEEEEEEeecCCC-CChHHHHHHHHHHHhc-CCCCccccceeEEec
Q 046270 261 QATNGFSQNNLIGQGASGIVYKGTLRH------GNLVAVKQILDLDT-KGDEDFTNEVEIISKI-RHRNLLSLRGCCVTS 332 (590)
Q Consensus 261 ~at~~f~~~~~LG~G~fG~Vykg~~~~------g~~vAvK~l~~~~~-~~~~~f~~Ev~il~~l-~H~nlv~l~g~~~~~ 332 (590)
...++|...+.||+|+||.||+|++.. ++.||||++..... ...+.+.+|.+++.++ +|+|||.+++++...
T Consensus 10 i~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~ 89 (299)
T d1ywna1 10 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 89 (299)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred ccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccC
Confidence 334678889999999999999998742 45899999865333 2345688899988888 689999999988643
Q ss_pred cCCCCceEEEEEeeCCCCCcchhhhhhcc-------------cccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCC
Q 046270 333 DDSSGKRRFLVYDYMPNGTLSDNISISHK-------------RKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKS 399 (590)
Q Consensus 333 ~~~~~~~~~LV~E~~~~gsL~~~L~~~~~-------------~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp 399 (590)
+...++||||+++|+|.+++..... ...++|.+++.++.||++||+||| +.+|+||||||
T Consensus 90 ----~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~ivHrDlKp 162 (299)
T d1ywna1 90 ----GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAA 162 (299)
T ss_dssp ----TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCG
T ss_pred ----CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHH---hCCCcCCcCCc
Confidence 3458999999999999999964321 235899999999999999999999 89999999999
Q ss_pred CceEECCCCcEEEEeeCCcccccCCCcc-cccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCC-CCCCCCCC
Q 046270 400 TNILLDSELNAKVADFGLAKQSLEGHSH-LTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGR-KVLDTSTS 477 (590)
Q Consensus 400 ~NILLd~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~-~p~~~~~~ 477 (590)
+||||++++++||+|||+++........ ......||+.|+|||.+.++.++.++|||||||++|||+||. .||.....
T Consensus 163 ~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~ 242 (299)
T d1ywna1 163 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 242 (299)
T ss_dssp GGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC
T ss_pred cceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCH
Confidence 9999999999999999999876544332 344567999999999999999999999999999999999975 46654333
Q ss_pred chhhhhHHHHHHHhcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhcc
Q 046270 478 PFQLITDWAWVLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEG 542 (590)
Q Consensus 478 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~ 542 (590)
... .......+...+.. ......+.+++..|++.||++||||.|++++|+.
T Consensus 243 ~~~-----~~~~~~~~~~~~~~---------~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ 293 (299)
T d1ywna1 243 DEE-----FCRRLKEGTRMRAP---------DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 293 (299)
T ss_dssp SHH-----HHHHHHHTCCCCCC---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHH-----HHHHHhcCCCCCCC---------ccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 221 11122222221111 1123467889999999999999999999999975
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-48 Score=397.35 Aligned_cols=265 Identities=26% Similarity=0.306 Sum_probs=199.0
Q ss_pred CCCccceecccCcEEEEEEEEcCCcEEEEEEeecCCCCChHHHHHHHH--HHHhcCCCCccccceeEEeccCCCCceEEE
Q 046270 265 GFSQNNLIGQGASGIVYKGTLRHGNLVAVKQILDLDTKGDEDFTNEVE--IISKIRHRNLLSLRGCCVTSDDSSGKRRFL 342 (590)
Q Consensus 265 ~f~~~~~LG~G~fG~Vykg~~~~g~~vAvK~l~~~~~~~~~~f~~Ev~--il~~l~H~nlv~l~g~~~~~~~~~~~~~~L 342 (590)
.|...+.||+|+||.||+|+++ |+.||||++... ..+++..|.+ .+.+++|||||+++|+|...+. .....++
T Consensus 4 ~~~l~~~iG~G~fg~Vy~~~~~-g~~vAvK~~~~~---~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~-~~~~~~l 78 (303)
T d1vjya_ 4 TIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNG-TWTQLWL 78 (303)
T ss_dssp GEEEEEEEECCSSSEEEEEEET-TEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECS-SSEEEEE
T ss_pred EEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECcc---chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCC-cceEEEE
Confidence 4566788999999999999975 889999998542 2344444544 4567899999999999987653 3457899
Q ss_pred EEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhc-----CCCCeEecCCCCCceEECCCCcEEEEeeCC
Q 046270 343 VYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYG-----LKPGIYHRDIKSTNILLDSELNAKVADFGL 417 (590)
Q Consensus 343 V~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~-----~~~~ivHrDIKp~NILLd~~~~~kL~DFGl 417 (590)
||||+++|+|.++|. +..++|.++++++.|+|.||+|||+. ..++|+||||||+||||++++++||+|||+
T Consensus 79 v~Ey~~~g~L~~~l~----~~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl 154 (303)
T d1vjya_ 79 VSDYHEHGSLFDYLN----RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp EEECCTTCBHHHHHH----HCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EEecccCCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCc
Confidence 999999999999995 34699999999999999999999943 147999999999999999999999999999
Q ss_pred cccccCCCcc---cccccccCCCccCccccccC------CCCcchhHHHHHHHHHHHHhCCCCCCCCCCchh--------
Q 046270 418 AKQSLEGHSH---LTTRVAGTFGYLAPEYALYG------QLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQ-------- 480 (590)
Q Consensus 418 a~~~~~~~~~---~~~~~~gt~~Y~APE~~~~~------~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~-------- 480 (590)
++........ ......||++|+|||++... .++.|+|||||||+||||+||..|+........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~ 234 (303)
T d1vjya_ 155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 234 (303)
T ss_dssp CEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCS
T ss_pred cccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccc
Confidence 9876544322 23456799999999998754 367799999999999999999988753322111
Q ss_pred -hhhHHHHHHHhcCCchhhhhHHHhhh-hHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhcc
Q 046270 481 -LITDWAWVLAKSGKVDDIFDEFIRAE-GARAVMERFVLVGILCAHVMVALRPTITDALKMLEG 542 (590)
Q Consensus 481 -~l~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~ 542 (590)
............+... +.+... ...+.++.+..++..||+.||++||||.||+++|+.
T Consensus 235 ~~~~~~~~~~~~~~~~~----p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~ 294 (303)
T d1vjya_ 235 DPSVEEMRKVVCEQKLR----PNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 294 (303)
T ss_dssp SCCHHHHHHHHTTSCCC----CCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHH
T ss_pred cchHHHHHHHHhccccC----CCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence 0111111122211111 111111 123345678889999999999999999999999874
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.4e-47 Score=394.74 Aligned_cols=244 Identities=29% Similarity=0.377 Sum_probs=197.0
Q ss_pred CCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCCCC---hHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceE
Q 046270 265 GFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDTKG---DEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRR 340 (590)
Q Consensus 265 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~~~---~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~ 340 (590)
.|+..+.||+|+||+||+|+.. +|+.||||++....... .+.+.+|+++|++++|||||++++++.+ ....
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~-----~~~~ 90 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-----EHTA 90 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-----TTEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEE-----CCEE
Confidence 4888899999999999999976 57889999987544332 3468899999999999999999999984 3469
Q ss_pred EEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCccc
Q 046270 341 FLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQ 420 (590)
Q Consensus 341 ~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~ 420 (590)
++||||+++|+|..++. .++.+++.+++.|+.||+.||.||| +.+|+||||||+||||+.++++||+|||+++.
T Consensus 91 ~iv~E~~~~g~l~~~~~---~~~~l~e~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~ 164 (309)
T d1u5ra_ 91 WLVMEYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASI 164 (309)
T ss_dssp EEEEECCSEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBS
T ss_pred EEEEEecCCCchHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEECCCCCEEEeecccccc
Confidence 99999999999976653 3457999999999999999999999 89999999999999999999999999999986
Q ss_pred ccCCCcccccccccCCCccCccccc---cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchh
Q 046270 421 SLEGHSHLTTRVAGTFGYLAPEYAL---YGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDD 497 (590)
Q Consensus 421 ~~~~~~~~~~~~~gt~~Y~APE~~~---~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 497 (590)
... .....||+.|||||++. .+.|+.++|||||||++|||++|+.||....... .+ ..... +....
T Consensus 165 ~~~-----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~-~~----~~i~~-~~~~~ 233 (309)
T d1u5ra_ 165 MAP-----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-AL----YHIAQ-NESPA 233 (309)
T ss_dssp SSS-----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HH----HHHHH-SCCCC
T ss_pred cCC-----CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHH-HH----HHHHh-CCCCC
Confidence 533 23457999999999986 3568999999999999999999999986433211 11 11111 11111
Q ss_pred hhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 046270 498 IFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALK 538 (590)
Q Consensus 498 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~ 538 (590)
.... ...+.+.+++..|++.||++|||+.|+++
T Consensus 234 ~~~~--------~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 234 LQSG--------HWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp CSCT--------TSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCC--------CCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 1111 12346778899999999999999999986
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.1e-47 Score=395.10 Aligned_cols=252 Identities=25% Similarity=0.355 Sum_probs=187.6
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCC-CChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceE
Q 046270 263 TNGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDT-KGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRR 340 (590)
Q Consensus 263 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~-~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~ 340 (590)
.+.|...+.||+|+||+||+|+.. .|+.||||++..... ...+.+.+|+++|++++|||||++++++. .+...
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~-----~~~~~ 82 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYE-----SGGHL 82 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEE-----CSSEE
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----ECCEE
Confidence 466888999999999999999986 488999999865432 23456889999999999999999999987 34569
Q ss_pred EEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEC---CCCcEEEEeeCC
Q 046270 341 FLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLD---SELNAKVADFGL 417 (590)
Q Consensus 341 ~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd---~~~~~kL~DFGl 417 (590)
++||||+++|+|.+++. ..+.+++.++..|+.||+.||+||| +.+|+||||||+|||+. +++.+||+|||+
T Consensus 83 ~lvmE~~~gg~L~~~l~---~~~~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~ 156 (307)
T d1a06a_ 83 YLIMQLVSGGELFDRIV---EKGFYTERDASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGL 156 (307)
T ss_dssp EEEECCCCSCBHHHHHH---TCSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCC--
T ss_pred EEEEeccCCCcHHHhhh---cccCCCHHHHHHHHHHHHHHHHhhh---hceeeeEEecccceeecccCCCceEEEeccce
Confidence 99999999999999985 3557999999999999999999999 89999999999999994 578999999999
Q ss_pred cccccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchh
Q 046270 418 AKQSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDD 497 (590)
Q Consensus 418 a~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 497 (590)
++...... ......||+.|||||.+.+..++.++|||||||++|||++|+.||....... .. ............
T Consensus 157 a~~~~~~~--~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~-~~---~~i~~~~~~~~~ 230 (307)
T d1a06a_ 157 SKMEDPGS--VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK-LF---EQILKAEYEFDS 230 (307)
T ss_dssp ------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HH---HHHHTTCCCCCT
T ss_pred eEEccCCC--eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHH-HH---HHHhccCCCCCC
Confidence 98654332 2344679999999999999999999999999999999999999996533211 11 111111111111
Q ss_pred hhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 498 IFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 498 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
-. .....+.+.+++..|++.||++|||+.|+++.
T Consensus 231 ~~--------~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 231 PY--------WDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp TT--------TTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred cc--------ccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 00 11223467889999999999999999999884
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-46 Score=383.49 Aligned_cols=248 Identities=25% Similarity=0.329 Sum_probs=202.1
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCC------CChHHHHHHHHHHHhcCCCCccccceeEEeccCCC
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDT------KGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSS 336 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~------~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~ 336 (590)
+.|...+.||+|+||+||+|+++ +|+.||||++..... ...+.|.+|+++|++++|||||++++++.+
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~----- 84 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN----- 84 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-----
Confidence 57889999999999999999985 588999999864321 235679999999999999999999999973
Q ss_pred CceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCC----cEEE
Q 046270 337 GKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSEL----NAKV 412 (590)
Q Consensus 337 ~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~----~~kL 412 (590)
....++||||+++|+|.+++. ..+.+++.+++.++.||+.||+||| +.+|+||||||+|||++.++ .+||
T Consensus 85 ~~~~~iv~E~~~gg~L~~~i~---~~~~l~~~~~~~~~~qi~~al~yLH---~~~ivHrDiKp~Nill~~~~~~~~~vkl 158 (293)
T d1jksa_ 85 KTDVILILELVAGGELFDFLA---EKESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKI 158 (293)
T ss_dssp SSEEEEEEECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSSSSCCEEE
T ss_pred CCEEEEEEEcCCCccccchhc---cccccchhHHHHHHHHHHHHHHhhh---hcceeecccccceEEEecCCCcccceEe
Confidence 456999999999999999985 3457999999999999999999999 89999999999999998776 5999
Q ss_pred EeeCCcccccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhc
Q 046270 413 ADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKS 492 (590)
Q Consensus 413 ~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~ 492 (590)
+|||+++...... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||...... ..+. . ...
T Consensus 159 ~DfG~a~~~~~~~--~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~-~~~~----~-i~~ 230 (293)
T d1jksa_ 159 IDFGLAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ-ETLA----N-VSA 230 (293)
T ss_dssp CCCTTCEECTTSC--BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHH----H-HHT
T ss_pred cchhhhhhcCCCc--cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHH-HHHH----H-HHh
Confidence 9999998764432 234467899999999999999999999999999999999999999753321 1111 1 111
Q ss_pred CC--chhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 046270 493 GK--VDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALK 538 (590)
Q Consensus 493 ~~--~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~ 538 (590)
+. ..... .......+.+++..|++.||++|||++|+++
T Consensus 231 ~~~~~~~~~--------~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 231 VNYEFEDEY--------FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp TCCCCCHHH--------HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred cCCCCCchh--------cCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11 11111 1112346778899999999999999999986
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-48 Score=390.00 Aligned_cols=254 Identities=25% Similarity=0.363 Sum_probs=194.1
Q ss_pred cCCCccceecccCcEEEEEEEEcC--C--cEEEEEEeecCC---CCChHHHHHHHHHHHhcCCCCccccceeEEeccCCC
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLRH--G--NLVAVKQILDLD---TKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSS 336 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~~--g--~~vAvK~l~~~~---~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~ 336 (590)
++|+..+.||+|+||.||+|++.. + ..||||++.... .+..++|.+|+++|++++|||||+++|++.+.
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~---- 83 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP---- 83 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS----
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec----
Confidence 457888999999999999998753 2 378999986532 22346799999999999999999999999632
Q ss_pred CceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeC
Q 046270 337 GKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFG 416 (590)
Q Consensus 337 ~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFG 416 (590)
..++||||+++|+|.+++.. ....++|..++.++.|||+||.||| +++|+||||||+||||+.++++||+|||
T Consensus 84 --~~~lv~e~~~~~~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDikp~NIll~~~~~vkl~DfG 156 (273)
T d1u46a_ 84 --PMKMVTELAPLGSLLDRLRK--HQGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFG 156 (273)
T ss_dssp --SCEEEEECCTTCBHHHHHHH--HGGGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCT
T ss_pred --chheeeeeecCcchhhhhhc--ccCCCCHHHHHHHHHHHHHHHHHhh---hCCEeeeeecHHHhccccccceeeccch
Confidence 36899999999999988753 3456999999999999999999999 8999999999999999999999999999
Q ss_pred CcccccCCCcc--cccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCchhhhhHHHHHHHhcC
Q 046270 417 LAKQSLEGHSH--LTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLDTSTSPFQLITDWAWVLAKSG 493 (590)
Q Consensus 417 la~~~~~~~~~--~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELlt-G~~p~~~~~~~~~~l~~~~~~~~~~~ 493 (590)
+++........ ......|+..|+|||.+.+..++.++|||||||++|||+| |+.||....... + .....+.+
T Consensus 157 l~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~--~---~~~i~~~~ 231 (273)
T d1u46a_ 157 LMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ--I---LHKIDKEG 231 (273)
T ss_dssp TCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--H---HHHHHTSC
T ss_pred hhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHH--H---HHHHHhCC
Confidence 99976554332 2344567889999999999999999999999999999998 899986433211 1 12222332
Q ss_pred CchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhcc
Q 046270 494 KVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEG 542 (590)
Q Consensus 494 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~ 542 (590)
...+.. ......+.+++..||+.||++||||.||+++|+.
T Consensus 232 ~~~~~~---------~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~ 271 (273)
T d1u46a_ 232 ERLPRP---------EDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLE 271 (273)
T ss_dssp CCCCCC---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCCCc---------ccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 211111 1122467789999999999999999999999864
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-47 Score=391.78 Aligned_cols=256 Identities=26% Similarity=0.367 Sum_probs=199.5
Q ss_pred cCCCccceecccCcEEEEEEEEcC-Cc--EEEEEEeecCC-CCChHHHHHHHHHHHhc-CCCCccccceeEEeccCCCCc
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLRH-GN--LVAVKQILDLD-TKGDEDFTNEVEIISKI-RHRNLLSLRGCCVTSDDSSGK 338 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~~-g~--~vAvK~l~~~~-~~~~~~f~~Ev~il~~l-~H~nlv~l~g~~~~~~~~~~~ 338 (590)
++|...+.||+|+||.||+|++++ |. .||||++.... ....++|.+|+++|.++ +|||||+++|+|.. +.
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~-----~~ 84 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH-----RG 84 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEE-----TT
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEec-----CC
Confidence 567788999999999999999875 33 58889886543 33456799999999999 79999999999984 44
Q ss_pred eEEEEEeeCCCCCcchhhhhh-------------cccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEC
Q 046270 339 RRFLVYDYMPNGTLSDNISIS-------------HKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLD 405 (590)
Q Consensus 339 ~~~LV~E~~~~gsL~~~L~~~-------------~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd 405 (590)
..++||||+++|+|.++|... .....++|.++++++.|||+||.||| +.+|+||||||+|||++
T Consensus 85 ~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH---~~~iiHrDlkp~NIL~~ 161 (309)
T d1fvra_ 85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVG 161 (309)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEC
T ss_pred eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhh---cCCccccccccceEEEc
Confidence 699999999999999998643 12357999999999999999999999 89999999999999999
Q ss_pred CCCcEEEEeeCCcccccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCC-CCCCCCCchhhhhH
Q 046270 406 SELNAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRK-VLDTSTSPFQLITD 484 (590)
Q Consensus 406 ~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~-p~~~~~~~~~~l~~ 484 (590)
.++.+||+|||+++..... .......||..|+|||.+..+.++.++|||||||++|||++|.. |+... .... +.
T Consensus 162 ~~~~~kl~DfG~a~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~-~~~~-~~- 236 (309)
T d1fvra_ 162 ENYVAKIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM-TCAE-LY- 236 (309)
T ss_dssp GGGCEEECCTTCEESSCEE--CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC-CHHH-HH-
T ss_pred CCCceEEcccccccccccc--ccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCC-CHHH-HH-
Confidence 9999999999999854322 22234568999999999999999999999999999999999875 45432 2111 11
Q ss_pred HHHHHHhcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhccCC
Q 046270 485 WAWVLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEGDI 544 (590)
Q Consensus 485 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~~~ 544 (590)
.. ...+...+ .+....+.+.+++..|++.||++||||+||++.|+...
T Consensus 237 --~~-i~~~~~~~---------~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~ 284 (309)
T d1fvra_ 237 --EK-LPQGYRLE---------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 284 (309)
T ss_dssp --HH-GGGTCCCC---------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --HH-HHhcCCCC---------CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 11 11221111 11122347788899999999999999999999987643
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2e-46 Score=379.88 Aligned_cols=260 Identities=22% Similarity=0.307 Sum_probs=202.0
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCCCC---hHHHHHHHHHHHhcCCCCccccceeEEeccCCCCc
Q 046270 263 TNGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDTKG---DEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGK 338 (590)
Q Consensus 263 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~~~---~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~ 338 (590)
.++|...+.||+|+||.||+|++. .|+.||||++....... .+.|.+|++++++++|||||++++++...+. .+.
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~-~~~ 84 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETP-AGP 84 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECS-SSE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccC-CCc
Confidence 467889999999999999999975 58899999997543332 3468999999999999999999999987654 455
Q ss_pred eEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCc
Q 046270 339 RRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLA 418 (590)
Q Consensus 339 ~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla 418 (590)
..|+||||+++|+|.+++. ..+.+++.+++.|+.||+.||+||| +.+|+||||||+|||++.++..+|+|||.+
T Consensus 85 ~~~lvmE~~~g~~L~~~~~---~~~~l~~~~~~~i~~qi~~al~~lH---~~~iiHrDiKP~NIll~~~~~~~l~d~~~~ 158 (277)
T d1o6ya_ 85 LPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIA 158 (277)
T ss_dssp EEEEEEECCCEEEHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTSCEEECCCTTC
T ss_pred eEEEEEECCCCCEehhhhc---ccCCCCHHHHHHHHHHHHHHHHHHH---hCCccCccccCcccccCccccceeehhhhh
Confidence 6899999999999998874 4457999999999999999999999 899999999999999999999999999998
Q ss_pred ccccCCCc--ccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCc-
Q 046270 419 KQSLEGHS--HLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKV- 495 (590)
Q Consensus 419 ~~~~~~~~--~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~- 495 (590)
+....... .......||+.|+|||.+.+..++.++|||||||++|||+||+.||...... . ........+..
T Consensus 159 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-~----~~~~~~~~~~~~ 233 (277)
T d1o6ya_ 159 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV-S----VAYQHVREDPIP 233 (277)
T ss_dssp EECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH-H----HHHHHHHCCCCC
T ss_pred hhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHH-H----HHHHHHhcCCCC
Confidence 76543322 2344567999999999999999999999999999999999999999753321 1 11222222211
Q ss_pred hhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCC-CHHHHHHHhcc
Q 046270 496 DDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRP-TITDALKMLEG 542 (590)
Q Consensus 496 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-tm~eVl~~L~~ 542 (590)
..... .+..+.+.+++..|++.||++|| |++++++.|..
T Consensus 234 ~~~~~--------~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 234 PSARH--------EGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp GGGTS--------SSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred Cchhc--------cCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 11111 12234677899999999999999 89999887753
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.7e-46 Score=393.41 Aligned_cols=255 Identities=21% Similarity=0.288 Sum_probs=206.1
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEEE
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFL 342 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~L 342 (590)
++|...+.||+|+||.||+|+.. +|+.||||++........+.+.+|+++|++++|||||++++++. .+...++
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~-----~~~~~~i 103 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE-----DKYEMVL 103 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEE-----CSSEEEE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----ECCEEEE
Confidence 57889999999999999999985 58999999987654444567889999999999999999999987 3456999
Q ss_pred EEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEC--CCCcEEEEeeCCccc
Q 046270 343 VYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLD--SELNAKVADFGLAKQ 420 (590)
Q Consensus 343 V~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd--~~~~~kL~DFGla~~ 420 (590)
||||+++|+|.+++. .....+++.+++.|+.||+.||+||| +.+|+||||||+||||+ .++.+||+|||+++.
T Consensus 104 vmE~~~gg~L~~~~~--~~~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~ 178 (352)
T d1koba_ 104 ILEFLSGGELFDRIA--AEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATK 178 (352)
T ss_dssp EEECCCCCBHHHHTT--CTTCCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEE
T ss_pred EEEcCCCChHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccccccccccccCCCeEEEeeccccee
Confidence 999999999988774 23446999999999999999999999 89999999999999998 568999999999987
Q ss_pred ccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHh-cCCchhhh
Q 046270 421 SLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAK-SGKVDDIF 499 (590)
Q Consensus 421 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~-~~~~~~~~ 499 (590)
..... ......||+.|+|||++.+..++.++|||||||++|||+||+.||...... ..+. .... ........
T Consensus 179 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-~~~~----~i~~~~~~~~~~~ 251 (352)
T d1koba_ 179 LNPDE--IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL-ETLQ----NVKRCDWEFDEDA 251 (352)
T ss_dssp CCTTS--CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH-HHHH----HHHHCCCCCCSST
T ss_pred cCCCC--ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH-HHHH----HHHhCCCCCCccc
Confidence 65433 334567899999999999999999999999999999999999999653321 1111 1111 11111101
Q ss_pred hHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH--hccC
Q 046270 500 DEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKM--LEGD 543 (590)
Q Consensus 500 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~--L~~~ 543 (590)
...+...+.+++..|++.||.+|||+.|++++ +.+.
T Consensus 252 --------~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~ 289 (352)
T d1koba_ 252 --------FSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD 289 (352)
T ss_dssp --------TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred --------ccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence 11123467789999999999999999999874 5543
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-47 Score=390.25 Aligned_cols=260 Identities=25% Similarity=0.317 Sum_probs=206.3
Q ss_pred hcCCCccceecccCcEEEEEEEEc------CCcEEEEEEeecCCCC-ChHHHHHHHHHHHhc-CCCCccccceeEEeccC
Q 046270 263 TNGFSQNNLIGQGASGIVYKGTLR------HGNLVAVKQILDLDTK-GDEDFTNEVEIISKI-RHRNLLSLRGCCVTSDD 334 (590)
Q Consensus 263 t~~f~~~~~LG~G~fG~Vykg~~~------~g~~vAvK~l~~~~~~-~~~~f~~Ev~il~~l-~H~nlv~l~g~~~~~~~ 334 (590)
.++|...++||+|+||.||+|++. .+..||||++...... ...+|.+|+.+++++ +|||||+++|+|..
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~--- 98 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI--- 98 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS---
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEee---
Confidence 356778899999999999999863 3568999999754433 345689999999999 69999999999974
Q ss_pred CCCceEEEEEeeCCCCCcchhhhhhc---------------ccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCC
Q 046270 335 SSGKRRFLVYDYMPNGTLSDNISISH---------------KRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKS 399 (590)
Q Consensus 335 ~~~~~~~LV~E~~~~gsL~~~L~~~~---------------~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp 399 (590)
+...++||||+++|+|.+++.... ....+++..+++|+.||++||+||| +.+|+||||||
T Consensus 99 --~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH---~~~ivHrDLKp 173 (311)
T d1t46a_ 99 --GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAA 173 (311)
T ss_dssp --SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSG
T ss_pred --CCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccccc
Confidence 345899999999999999986432 2235999999999999999999999 89999999999
Q ss_pred CceEECCCCcEEEEeeCCcccccCCCcc-cccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc
Q 046270 400 TNILLDSELNAKVADFGLAKQSLEGHSH-LTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSP 478 (590)
Q Consensus 400 ~NILLd~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~ 478 (590)
+|||++.++.+||+|||+++........ ......||+.|+|||.+..+.++.++|||||||++|||+|++.|+......
T Consensus 174 ~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~ 253 (311)
T d1t46a_ 174 RNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253 (311)
T ss_dssp GGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred ccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCH
Confidence 9999999999999999999976554333 344577899999999999999999999999999999999965554433332
Q ss_pred hhhhhHHHHHHHhcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhccC
Q 046270 479 FQLITDWAWVLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEGD 543 (590)
Q Consensus 479 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~~ 543 (590)
...+... ...+.. ...+......+.+++..|++.||.+||||.+|+++|++.
T Consensus 254 ~~~~~~~----i~~~~~---------~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~ 305 (311)
T d1t46a_ 254 DSKFYKM----IKEGFR---------MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305 (311)
T ss_dssp SHHHHHH----HHHTCC---------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHH----HhcCCC---------CCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 2222211 122211 111112234788899999999999999999999999863
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-47 Score=389.03 Aligned_cols=259 Identities=20% Similarity=0.353 Sum_probs=206.1
Q ss_pred hcCCCccceecccCcEEEEEEEEc------CCcEEEEEEeecCCCC-ChHHHHHHHHHHHhcCCCCccccceeEEeccCC
Q 046270 263 TNGFSQNNLIGQGASGIVYKGTLR------HGNLVAVKQILDLDTK-GDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDS 335 (590)
Q Consensus 263 t~~f~~~~~LG~G~fG~Vykg~~~------~g~~vAvK~l~~~~~~-~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~ 335 (590)
.++|...+.||+|+||+||+|.+. ++..||||++...... ....|.+|++++++++|||||+++|+|..
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~---- 94 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ---- 94 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS----
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEec----
Confidence 467788899999999999999874 2568999998654322 23468999999999999999999999974
Q ss_pred CCceEEEEEeeCCCCCcchhhhhhcc-------cccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCC
Q 046270 336 SGKRRFLVYDYMPNGTLSDNISISHK-------RKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSEL 408 (590)
Q Consensus 336 ~~~~~~LV~E~~~~gsL~~~L~~~~~-------~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~ 408 (590)
....++||||+++|+|.+++...+. ...++|..+.+|+.|+|+||.||| +.+|+||||||+|||+|+++
T Consensus 95 -~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH---~~~ivHrDlk~~NiLld~~~ 170 (308)
T d1p4oa_ 95 -GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDF 170 (308)
T ss_dssp -SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTTC
T ss_pred -CCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeeceEcCCceeecCCc
Confidence 3458999999999999998864321 134799999999999999999999 88999999999999999999
Q ss_pred cEEEEeeCCcccccCCCcc-cccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCC-CCCCCCCCchhhhhHHH
Q 046270 409 NAKVADFGLAKQSLEGHSH-LTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGR-KVLDTSTSPFQLITDWA 486 (590)
Q Consensus 409 ~~kL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~-~p~~~~~~~~~~l~~~~ 486 (590)
++||+|||+++........ ......||+.|+|||.+.++.++.++||||||+++|||+||+ .|+... .... +.
T Consensus 171 ~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~-~~~~----~~ 245 (308)
T d1p4oa_ 171 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL-SNEQ----VL 245 (308)
T ss_dssp CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS-CHHH----HH
T ss_pred eEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCC-CHHH----HH
Confidence 9999999999876544332 234456899999999999999999999999999999999986 555432 2111 22
Q ss_pred HHHHhcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhccCC
Q 046270 487 WVLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEGDI 544 (590)
Q Consensus 487 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~~~ 544 (590)
... .++...+.. ......+.+++..|++.+|.+||||.+|+++|+...
T Consensus 246 ~~i-~~~~~~~~p---------~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~ 293 (308)
T d1p4oa_ 246 RFV-MEGGLLDKP---------DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 293 (308)
T ss_dssp HHH-HTTCCCCCC---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred HHH-HhCCCCCCc---------ccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 211 222221111 112347888999999999999999999999998764
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=7.3e-46 Score=383.01 Aligned_cols=245 Identities=25% Similarity=0.322 Sum_probs=200.8
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecC---CCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCce
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDL---DTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKR 339 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~---~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~ 339 (590)
++|...+.||+|+||+||+|+.+ +|+.||||++... .....+.+.+|+.++++++|||||++++++. ....
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~-----~~~~ 78 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQ-----DAQQ 78 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEE-----CSSE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEe-----eCCe
Confidence 46888999999999999999986 4899999998642 2344677999999999999999999999998 3457
Q ss_pred EEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcc
Q 046270 340 RFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAK 419 (590)
Q Consensus 340 ~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~ 419 (590)
.++||||+++|+|..++. ....+++.....++.||+.||+||| +.+|+||||||+||||+.++.+||+|||+++
T Consensus 79 ~~ivmE~~~gg~l~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~ 152 (316)
T d1fota_ 79 IFMIMDYIEGGELFSLLR---KSQRFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAK 152 (316)
T ss_dssp EEEEECCCCSCBHHHHHH---HTSSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCE
T ss_pred eeeEeeecCCcccccccc---ccccccccHHHHHHHHHHHhhhhhc---cCcEEccccCchheeEcCCCCEEEecCccce
Confidence 999999999999988874 4557899999999999999999999 9999999999999999999999999999998
Q ss_pred cccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhh
Q 046270 420 QSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIF 499 (590)
Q Consensus 420 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 499 (590)
..... .....||+.|||||.+.+..++.++|||||||++|||+||+.||...... ..+. ... .+...
T Consensus 153 ~~~~~----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~-~~~~----~i~-~~~~~--- 219 (316)
T d1fota_ 153 YVPDV----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM-KTYE----KIL-NAELR--- 219 (316)
T ss_dssp ECSSC----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH-HHHH----HHH-HCCCC---
T ss_pred Eeccc----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHH-HHHH----HHH-cCCCC---
Confidence 76432 33467999999999999989999999999999999999999999753321 1111 111 11110
Q ss_pred hHHHhhhhHHHHHHHHHHHHHhchhcCCCCCC-----CHHHHHHH
Q 046270 500 DEFIRAEGARAVMERFVLVGILCAHVMVALRP-----TITDALKM 539 (590)
Q Consensus 500 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-----tm~eVl~~ 539 (590)
.+......+.+++..|++.||.+|| |++|++++
T Consensus 220 -------~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 220 -------FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp -------CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred -------CCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 0111223567788899999999996 89998763
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-45 Score=384.35 Aligned_cols=247 Identities=22% Similarity=0.304 Sum_probs=202.4
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecC---CCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCce
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDL---DTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKR 339 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~---~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~ 339 (590)
++|...+.||+|+||.||+|+.+ +|+.||||++... .....+.+.+|+++|++++|||||++++++. +...
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~-----~~~~ 79 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQ-----THDR 79 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEE-----CSSE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeec-----cccc
Confidence 56889999999999999999985 5899999998642 2334677899999999999999999999998 4556
Q ss_pred EEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcc
Q 046270 340 RFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAK 419 (590)
Q Consensus 340 ~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~ 419 (590)
.++||||+++|+|.+++. +.+.+++...+.++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++
T Consensus 80 ~~iv~ey~~gg~L~~~~~---~~~~~~e~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~ 153 (337)
T d1o6la_ 80 LCFVMEYANGGELFFHLS---RERVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK 153 (337)
T ss_dssp EEEEEECCTTCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred cccceeccCCCchhhhhh---cccCCcHHHHHHHHHHHhhhhhhhh---hcCccccccCHHHeEecCCCCEEEeeccccc
Confidence 999999999999999885 4457999999999999999999999 8999999999999999999999999999998
Q ss_pred cccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhh
Q 046270 420 QSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIF 499 (590)
Q Consensus 420 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 499 (590)
...... .......||+.|+|||++.+..++.++||||+||++|||++|+.||...... .... . ...+...
T Consensus 154 ~~~~~~-~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~-~~~~----~-i~~~~~~--- 223 (337)
T d1o6la_ 154 EGISDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-RLFE----L-ILMEEIR--- 223 (337)
T ss_dssp CSCCTT-CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHH----H-HHHCCCC---
T ss_pred ccccCC-cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHH-HHHH----H-HhcCCCC---
Confidence 654322 2344568999999999999999999999999999999999999999754321 1111 1 1111110
Q ss_pred hHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCC-----HHHHHH
Q 046270 500 DEFIRAEGARAVMERFVLVGILCAHVMVALRPT-----ITDALK 538 (590)
Q Consensus 500 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt-----m~eVl~ 538 (590)
.+......+.+++..|++.||.+||+ +.|+++
T Consensus 224 -------~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 224 -------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp -------CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred -------CCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 01112335677889999999999995 788876
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-46 Score=386.10 Aligned_cols=257 Identities=26% Similarity=0.381 Sum_probs=201.0
Q ss_pred cCCCccceecccCcEEEEEEEEcC--------CcEEEEEEeecCCC-CChHHHHHHHHHHHhc-CCCCccccceeEEecc
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLRH--------GNLVAVKQILDLDT-KGDEDFTNEVEIISKI-RHRNLLSLRGCCVTSD 333 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~~--------g~~vAvK~l~~~~~-~~~~~f~~Ev~il~~l-~H~nlv~l~g~~~~~~ 333 (590)
++|...+.||+|+||.||+|+... +..||||++..... ....++.+|+..+.++ +|||||+++|+|.+
T Consensus 13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~-- 90 (299)
T d1fgka_ 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ-- 90 (299)
T ss_dssp GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccccc--
Confidence 467778899999999999998642 24799999865443 2346789999999999 89999999999974
Q ss_pred CCCCceEEEEEeeCCCCCcchhhhhhc-------------ccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCC
Q 046270 334 DSSGKRRFLVYDYMPNGTLSDNISISH-------------KRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKST 400 (590)
Q Consensus 334 ~~~~~~~~LV~E~~~~gsL~~~L~~~~-------------~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~ 400 (590)
....++||||+++|+|.++|.... ....++|.++++++.||+.||+||| +.+||||||||+
T Consensus 91 ---~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH---~~~ivHrDiKp~ 164 (299)
T d1fgka_ 91 ---DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAAR 164 (299)
T ss_dssp ---SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGG
T ss_pred ---CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhh---hCCEEeeeeccc
Confidence 345899999999999999996432 1245899999999999999999999 899999999999
Q ss_pred ceEECCCCcEEEEeeCCcccccCCCcc-cccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCc
Q 046270 401 NILLDSELNAKVADFGLAKQSLEGHSH-LTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMS-GRKVLDTSTSP 478 (590)
Q Consensus 401 NILLd~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELlt-G~~p~~~~~~~ 478 (590)
|||++.++.+||+|||+++........ ......||+.|+|||.+.++.++.++|||||||++|||++ |+.||.....
T Consensus 165 NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~- 243 (299)
T d1fgka_ 165 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV- 243 (299)
T ss_dssp GEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-
T ss_pred ceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH-
Confidence 999999999999999999876544332 3455678999999999999999999999999999999998 6777754332
Q ss_pred hhhhhHHHHHHHhcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhccC
Q 046270 479 FQLITDWAWVLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEGD 543 (590)
Q Consensus 479 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~~ 543 (590)
.. ....+..+...+. +......+.+++.+|++.||++|||+.||+++|++.
T Consensus 244 ~~-----~~~~i~~~~~~~~---------p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i 294 (299)
T d1fgka_ 244 EE-----LFKLLKEGHRMDK---------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294 (299)
T ss_dssp HH-----HHHHHHTTCCCCC---------CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HH-----HHHHHHcCCCCCC---------CccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 11 1122233321111 111234678899999999999999999999999763
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-45 Score=380.08 Aligned_cols=246 Identities=23% Similarity=0.345 Sum_probs=199.0
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecC---CCCChHHHHHHHHHHH-hcCCCCccccceeEEeccCCCCc
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDL---DTKGDEDFTNEVEIIS-KIRHRNLLSLRGCCVTSDDSSGK 338 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~---~~~~~~~f~~Ev~il~-~l~H~nlv~l~g~~~~~~~~~~~ 338 (590)
++|...+.||+|+||+||+|+.. +|+.||||++... .....+.+..|..++. .++|||||++++++. .+.
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~-----~~~ 76 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQ-----TKE 76 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEE-----CSS
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEc-----cCC
Confidence 57888999999999999999986 4889999999642 2334556777877766 689999999999998 455
Q ss_pred eEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCc
Q 046270 339 RRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLA 418 (590)
Q Consensus 339 ~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla 418 (590)
..|+||||+++|+|.+++. ....+++.+++.++.||+.||+||| +.+|+||||||+|||+++++++||+|||++
T Consensus 77 ~~yivmEy~~~g~L~~~i~---~~~~~~e~~~~~~~~qi~~al~ylH---~~~iiHrDikp~NiL~~~~~~~kl~DFG~a 150 (320)
T d1xjda_ 77 NLFFVMEYLNGGDLMYHIQ---SCHKFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMC 150 (320)
T ss_dssp EEEEEEECCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred ceeEEEeecCCCcHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCcccceeecCCCceeccccchh
Confidence 6999999999999999985 4457999999999999999999999 889999999999999999999999999999
Q ss_pred ccccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhh
Q 046270 419 KQSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDI 498 (590)
Q Consensus 419 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 498 (590)
+...... ...+...||+.|+|||++.++.++.++|||||||++|||+||+.||...... ... .....+...
T Consensus 151 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~-~~~-----~~i~~~~~~-- 221 (320)
T d1xjda_ 151 KENMLGD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE-ELF-----HSIRMDNPF-- 221 (320)
T ss_dssp BCCCCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHH-----HHHHHCCCC--
T ss_pred hhccccc-ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHH-HHH-----HHHHcCCCC--
Confidence 8654332 2344567999999999999999999999999999999999999999753321 111 111112110
Q ss_pred hhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHH-HHH
Q 046270 499 FDEFIRAEGARAVMERFVLVGILCAHVMVALRPTIT-DAL 537 (590)
Q Consensus 499 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~-eVl 537 (590)
+ +......+.+++..|++.||++|||+. |++
T Consensus 222 ~--------p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~ 253 (320)
T d1xjda_ 222 Y--------PRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 253 (320)
T ss_dssp C--------CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred C--------CccCCHHHHHHHHHhcccCCCCCcCHHHHHH
Confidence 0 111234677888999999999999995 675
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.1e-44 Score=379.26 Aligned_cols=244 Identities=23% Similarity=0.309 Sum_probs=200.8
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecC---CCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCce
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDL---DTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKR 339 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~---~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~ 339 (590)
++|...+.||+|+||.||+|+++ +|+.||||++... .....+.+.+|+++|++++|||||++++++.. ...
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-----~~~ 115 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD-----NSN 115 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-----SSE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccc-----ccc
Confidence 47889999999999999999986 5899999998532 23345678999999999999999999999873 456
Q ss_pred EEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcc
Q 046270 340 RFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAK 419 (590)
Q Consensus 340 ~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~ 419 (590)
.++||||+.+|+|.+++. +.+.+++.+++.|+.||+.||.||| +.+|+||||||+||||+.++.+||+|||+++
T Consensus 116 ~~~v~e~~~~g~l~~~l~---~~~~l~e~~~~~i~~qi~~aL~yLH---~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~ 189 (350)
T d1rdqe_ 116 LYMVMEYVAGGEMFSHLR---RIGRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK 189 (350)
T ss_dssp EEEEEECCTTCBHHHHHH---HHCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred cccccccccccchhhhHh---hcCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCcCCHHHcccCCCCCEEeeeceeee
Confidence 899999999999999885 3457999999999999999999999 8999999999999999999999999999998
Q ss_pred cccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhh
Q 046270 420 QSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIF 499 (590)
Q Consensus 420 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 499 (590)
..... .....||+.|||||.+.+..++.++|||||||++|||+||+.||..... ...+. ... .+...
T Consensus 190 ~~~~~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~-~~~~~----~i~-~~~~~--- 256 (350)
T d1rdqe_ 190 RVKGR----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP-IQIYE----KIV-SGKVR--- 256 (350)
T ss_dssp ECSSC----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHH----HHH-HCCCC---
T ss_pred ecccc----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCH-HHHHH----HHh-cCCCC---
Confidence 76432 2346799999999999999999999999999999999999999965322 11111 111 11110
Q ss_pred hHHHhhhhHHHHHHHHHHHHHhchhcCCCCC-----CCHHHHHH
Q 046270 500 DEFIRAEGARAVMERFVLVGILCAHVMVALR-----PTITDALK 538 (590)
Q Consensus 500 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~R-----Ptm~eVl~ 538 (590)
.+......+.+++..|++.||.+| ||++|+++
T Consensus 257 -------~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 257 -------FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp -------CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred -------CCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 011123467788899999999999 48999976
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-45 Score=375.51 Aligned_cols=256 Identities=24% Similarity=0.249 Sum_probs=192.1
Q ss_pred cceecccCcEEEEEEEEc-CCcEEEEEEeecCCCCC-----hHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEEE
Q 046270 269 NNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDTKG-----DEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFL 342 (590)
Q Consensus 269 ~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~~~-----~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~L 342 (590)
.++||+|+||+||+|++. .|+.||||++....... .+.+.+|++++++++|||||++++++.. ....++
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~-----~~~~~i 77 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH-----KSNISL 77 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECC-----TTCCEE
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeecc-----CCceee
Confidence 578999999999999986 48899999985432221 3468899999999999999999999974 345899
Q ss_pred EEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCccccc
Q 046270 343 VYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQSL 422 (590)
Q Consensus 343 V~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~~ 422 (590)
||||++++++..++. ....+++.++..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++...
T Consensus 78 vmE~~~~~~~~~~~~---~~~~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~ 151 (299)
T d1ua2a_ 78 VFDFMETDLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFG 151 (299)
T ss_dssp EEECCSEEHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTT
T ss_pred hhhhhcchHHhhhhh---cccCCCHHHHHHHHHHHHHHHHHhh---ccceecccCCcceEEecCCCccccccCccccccC
Confidence 999999887766552 4567999999999999999999999 8999999999999999999999999999998654
Q ss_pred CCCcccccccccCCCccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhh---
Q 046270 423 EGHSHLTTRVAGTFGYLAPEYALYG-QLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDI--- 498 (590)
Q Consensus 423 ~~~~~~~~~~~gt~~Y~APE~~~~~-~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~--- 498 (590)
.... ......||+.|+|||.+..+ .++.++|||||||++|||+||+.||...... ..+....... ........
T Consensus 152 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~-~~l~~i~~~~-~~~~~~~~~~~ 228 (299)
T d1ua2a_ 152 SPNR-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL-DQLTRIFETL-GTPTEEQWPDM 228 (299)
T ss_dssp SCCC-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHH-CCCCTTTSSST
T ss_pred CCcc-cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHH-HHHHHHHHhc-CCCChhhccch
Confidence 4332 23345789999999998754 5799999999999999999999998654332 2221111111 00000000
Q ss_pred h------------hHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 499 F------------DEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 499 ~------------d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
. ...+. .......+.+.+++..|++.||++|||++|++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 229 CSLPDYVTFKSFPGIPLH-HIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp TSSTTCCCCCCCCCCCHH-HHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hccchhhhhccCCCCChH-HhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence 0 00000 0001123467889999999999999999999873
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-45 Score=381.43 Aligned_cols=256 Identities=21% Similarity=0.246 Sum_probs=199.2
Q ss_pred cCCCccc-eecccCcEEEEEEEEc-CCcEEEEEEeecCCCCChHHHHHHHHHHHhc-CCCCccccceeEEeccCCCCceE
Q 046270 264 NGFSQNN-LIGQGASGIVYKGTLR-HGNLVAVKQILDLDTKGDEDFTNEVEIISKI-RHRNLLSLRGCCVTSDDSSGKRR 340 (590)
Q Consensus 264 ~~f~~~~-~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l-~H~nlv~l~g~~~~~~~~~~~~~ 340 (590)
++|.... .||+|+||.||+|++. +|+.||||++.. ...+.+|++++.++ +|||||++++++.+... .....
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~-~~~~~ 84 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYA-GRKCL 84 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEET-TEEEE
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeeccc-CCCEE
Confidence 5787764 5999999999999985 588999999854 45688999997765 89999999999875432 34568
Q ss_pred EEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECC---CCcEEEEeeCC
Q 046270 341 FLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDS---ELNAKVADFGL 417 (590)
Q Consensus 341 ~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~---~~~~kL~DFGl 417 (590)
|+||||+++|+|.++|... ....+++.+++.|+.||+.||+||| +.+|+||||||+|||++. ++.+||+|||+
T Consensus 85 ~ivmEy~~gg~L~~~i~~~-~~~~l~e~~~~~i~~qi~~al~ylH---~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~ 160 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGF 160 (335)
T ss_dssp EEEEECCCSEEHHHHHHSC-SCCCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEECCCCCcHHHHHHhc-CCCCcCHHHHHHHHHHHHHHHHHHH---HcCCccccccccccccccccccccccccccce
Confidence 9999999999999999532 2346999999999999999999999 899999999999999986 45799999999
Q ss_pred cccccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchh
Q 046270 418 AKQSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDD 497 (590)
Q Consensus 418 a~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 497 (590)
++...... ......||+.|||||++.+..++.++|||||||++|||+||+.||........ .. ........+...
T Consensus 161 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~-~~-~~~~~i~~~~~~- 235 (335)
T d2ozaa1 161 AKETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI-SP-GMKTRIRMGQYE- 235 (335)
T ss_dssp CEECCCCC--CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC----------CCCSCSSS-
T ss_pred eeeccCCC--ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHH-HH-HHHHHHhcCCCC-
Confidence 98765433 23456799999999999999999999999999999999999999965433211 10 000001111100
Q ss_pred hhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 498 IFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 498 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
.. ........+.+.+++..|++.||++|||+.|++++
T Consensus 236 ~~-----~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 236 FP-----NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp CC-----TTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CC-----CcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 00 01112234578889999999999999999999884
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=9.2e-45 Score=367.88 Aligned_cols=251 Identities=27% Similarity=0.364 Sum_probs=201.1
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCCCC---------hHHHHHHHHHHHhcC-CCCccccceeEEec
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDTKG---------DEDFTNEVEIISKIR-HRNLLSLRGCCVTS 332 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~~~---------~~~f~~Ev~il~~l~-H~nlv~l~g~~~~~ 332 (590)
++|...+.||+|+||+||+|+.. +|+.||||++....... .+.+.+|++++++++ |||||++++++.+
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~- 81 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET- 81 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC-
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc-
Confidence 57888999999999999999985 58899999986543221 235889999999997 9999999999973
Q ss_pred cCCCCceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEE
Q 046270 333 DDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKV 412 (590)
Q Consensus 333 ~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL 412 (590)
....+|||||+++|+|.++|. .++.+++.+++.++.||+.||+||| +.+|+||||||+|||++.++.+||
T Consensus 82 ----~~~~~ivmE~~~~g~L~~~l~---~~~~l~e~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~~kl 151 (277)
T d1phka_ 82 ----NTFFFLVFDLMKKGELFDYLT---EKVTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKL 151 (277)
T ss_dssp ----SSEEEEEEECCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEE
T ss_pred ----CcceEEEEEcCCCchHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHH---HcCCcccccccceEEEcCCCCeEE
Confidence 456999999999999999995 3457999999999999999999999 899999999999999999999999
Q ss_pred EeeCCcccccCCCcccccccccCCCccCcccccc------CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHH
Q 046270 413 ADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALY------GQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWA 486 (590)
Q Consensus 413 ~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~------~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~ 486 (590)
+|||+++...... ..+...||..|+|||++.. ..++.++||||+||+++||++|+.||....... ..
T Consensus 152 ~DFG~a~~~~~~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~-~~---- 224 (277)
T d1phka_ 152 TDFGFSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML-ML---- 224 (277)
T ss_dssp CCCTTCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HH----
T ss_pred ccchheeEccCCC--ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHH-HH----
Confidence 9999998765433 2345679999999999863 346889999999999999999999997543211 11
Q ss_pred HHHHhcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 487 WVLAKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 487 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
.....+...- ..+ ......+.+.+++..|++.||.+|||+.||++.
T Consensus 225 -~~i~~~~~~~-~~~-----~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 225 -RMIMSGNYQF-GSP-----EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp -HHHHHTCCCC-CTT-----TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred -HHHHhCCCCC-CCc-----ccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 1111222110 000 011233477889999999999999999999753
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.2e-44 Score=381.06 Aligned_cols=248 Identities=21% Similarity=0.273 Sum_probs=195.0
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCC---CCChHHHHHH---HHHHHhcCCCCccccceeEEeccCCC
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLD---TKGDEDFTNE---VEIISKIRHRNLLSLRGCCVTSDDSS 336 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~---~~~~~~f~~E---v~il~~l~H~nlv~l~g~~~~~~~~~ 336 (590)
++|...+.||+|+||.||+|+.. +|+.||||++.... ......+.+| +++++.++|||||++++++..
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~----- 78 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT----- 78 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC-----
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEE-----
Confidence 57889999999999999999986 48999999985321 1223334444 667777789999999999874
Q ss_pred CceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeC
Q 046270 337 GKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFG 416 (590)
Q Consensus 337 ~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFG 416 (590)
....++||||+++|+|.++|. +...+++..++.++.||+.||+||| +.+|+||||||+|||++.++.+||+|||
T Consensus 79 ~~~~~ivmE~~~gg~L~~~l~---~~~~~~e~~~~~~~~qi~~aL~ylH---~~~iiHrDlKP~NILl~~~g~iKl~DFG 152 (364)
T d1omwa3 79 PDKLSFILDLMNGGDLHYHLS---QHGVFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLG 152 (364)
T ss_dssp SSEEEEEECCCCSCBHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSSSCEEECCCT
T ss_pred CCEEEEEEEecCCCcHHHHHH---hcccccHHHHHHHHHHHHHHHHHHH---HCCccceeeccceeEEcCCCcEEEeeec
Confidence 456999999999999999985 3457899999999999999999999 8999999999999999999999999999
Q ss_pred CcccccCCCcccccccccCCCccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCc
Q 046270 417 LAKQSLEGHSHLTTRVAGTFGYLAPEYALYG-QLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKV 495 (590)
Q Consensus 417 la~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~ 495 (590)
+++...... .....||+.|+|||++..+ .++.++|||||||++|||+||+.||......... ..........
T Consensus 153 la~~~~~~~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~---~~~~~~~~~~- 225 (364)
T d1omwa3 153 LACDFSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH---EIDRMTLTMA- 225 (364)
T ss_dssp TCEECSSSC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHH---HHHHHSSSCC-
T ss_pred eeeecCCCc---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHhcccCC-
Confidence 998765432 3446799999999998754 6899999999999999999999999764432211 0000001110
Q ss_pred hhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCC-----HHHHHH
Q 046270 496 DDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPT-----ITDALK 538 (590)
Q Consensus 496 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt-----m~eVl~ 538 (590)
.. + +......+.+++..|++.||.+||| ++|+++
T Consensus 226 ~~-~--------~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 226 VE-L--------PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp CC-C--------CSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred CC-C--------CCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 00 0 1112346778889999999999999 588865
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-44 Score=373.99 Aligned_cols=251 Identities=19% Similarity=0.235 Sum_probs=201.4
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEE
Q 046270 263 TNGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRF 341 (590)
Q Consensus 263 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~ 341 (590)
.++|...+.||+|+||+||+|++. +|+.||||.+.... .....+.+|+++|++++|||||++++++.+ ....|
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~-----~~~~~ 77 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFES-----MEELV 77 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEE-----TTEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEE-----CCEEE
Confidence 467888999999999999999986 47899999986532 334568899999999999999999999974 45699
Q ss_pred EEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCC--CcEEEEeeCCcc
Q 046270 342 LVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSE--LNAKVADFGLAK 419 (590)
Q Consensus 342 LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~--~~~kL~DFGla~ 419 (590)
+||||+++|+|.+++.. ....+++.+++.|+.||+.||+||| +.+|+||||||+|||++.+ ..+||+|||+++
T Consensus 78 lvmE~~~gg~L~~~i~~--~~~~l~e~~~~~i~~qi~~al~yLH---~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~ 152 (321)
T d1tkia_ 78 MIFEFISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQAR 152 (321)
T ss_dssp EEECCCCCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCE
T ss_pred EEEecCCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHH---HcCCCcccccccceeecCCCceEEEEcccchhh
Confidence 99999999999998852 2346999999999999999999999 8999999999999999854 589999999998
Q ss_pred cccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhc-CCchhh
Q 046270 420 QSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKS-GKVDDI 498 (590)
Q Consensus 420 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~-~~~~~~ 498 (590)
...... ......||+.|+|||.+.+..++.++||||+||++|||++|+.||...... .. ....... ....+.
T Consensus 153 ~~~~~~--~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~-~~----~~~i~~~~~~~~~~ 225 (321)
T d1tkia_ 153 QLKPGD--NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ-QI----IENIMNAEYTFDEE 225 (321)
T ss_dssp ECCTTC--EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH-HH----HHHHHHTCCCCCHH
T ss_pred ccccCC--cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHH-HH----HHHHHhCCCCCChh
Confidence 764432 233456899999999999999999999999999999999999999754321 11 1111111 111111
Q ss_pred hhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 499 FDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 499 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
.. ......+.+++..|++.||.+|||+.|++++
T Consensus 226 ~~--------~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 226 AF--------KEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp HH--------TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred hc--------cCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11 1123467789999999999999999999873
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-44 Score=367.71 Aligned_cols=261 Identities=23% Similarity=0.310 Sum_probs=197.2
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCC--CCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceE
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLD--TKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRR 340 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~--~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~ 340 (590)
++|...+.||+|+||+||+|++. +|+.||||++.... ....+.+.+|++++++++|||||++++++.. +...
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~-----~~~~ 76 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT-----ENKL 76 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEE-----TTEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEecccccc-----ccce
Confidence 57899999999999999999985 58999999985432 2335679999999999999999999999984 4469
Q ss_pred EEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCccc
Q 046270 341 FLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQ 420 (590)
Q Consensus 341 ~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~ 420 (590)
++||||+.++.+ +++.. .....+++.++..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++.
T Consensus 77 ~iv~e~~~~~~~-~~~~~-~~~~~l~e~~~~~~~~qil~~L~yLH---~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~ 151 (298)
T d1gz8a_ 77 YLVFEFLHQDLK-KFMDA-SALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARA 151 (298)
T ss_dssp EEEEECCSEEHH-HHHHH-TTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTHHHH
T ss_pred eEEEeecCCchh-hhhhh-hcccCCCHHHHHHHHHHHHHHHHHhh---cCCEEccccCchheeecccCcceeccCCccee
Confidence 999999976544 44422 23456999999999999999999999 89999999999999999999999999999987
Q ss_pred ccCCCcccccccccCCCccCccccccCC-CCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhh
Q 046270 421 SLEGHSHLTTRVAGTFGYLAPEYALYGQ-LTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIF 499 (590)
Q Consensus 421 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~-~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 499 (590)
..... .......||+.|+|||.+.... ++.++|||||||++|||++|+.||....... .+..... ..+...+..
T Consensus 152 ~~~~~-~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~-~~~~i~~---~~~~~~~~~ 226 (298)
T d1gz8a_ 152 FGVPV-RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID-QLFRIFR---TLGTPDEVV 226 (298)
T ss_dssp HCCCS-BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHH---HHCCCCTTT
T ss_pred ccCCc-ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHH-HHHHHHH---hcCCCchhh
Confidence 64432 2334457899999999877655 5889999999999999999999997543221 1111111 111111100
Q ss_pred hHHH--------------hh---hhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 500 DEFI--------------RA---EGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 500 d~~l--------------~~---~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
.+.. .. .......+.+.+++..|++.||++|||+.|+++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 227 WPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp STTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 0000 00 0001122467888999999999999999999985
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-44 Score=367.98 Aligned_cols=268 Identities=23% Similarity=0.283 Sum_probs=201.0
Q ss_pred hcCCCccceecccCcEEEEEEEEc-C-CcEEEEEEeecCC--CCChHHHHHHHHHHHhc---CCCCccccceeEEeccCC
Q 046270 263 TNGFSQNNLIGQGASGIVYKGTLR-H-GNLVAVKQILDLD--TKGDEDFTNEVEIISKI---RHRNLLSLRGCCVTSDDS 335 (590)
Q Consensus 263 t~~f~~~~~LG~G~fG~Vykg~~~-~-g~~vAvK~l~~~~--~~~~~~f~~Ev~il~~l---~H~nlv~l~g~~~~~~~~ 335 (590)
.++|...+.||+|+||+||+|++. . ++.||||++.... ......+.+|+++++.| +||||+++++++......
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 468999999999999999999984 3 5679999986432 22234577888887776 799999999999766544
Q ss_pred CCceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEee
Q 046270 336 SGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADF 415 (590)
Q Consensus 336 ~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DF 415 (590)
.....+++|||++++++..... .....+++..++.++.||+.||+||| +.+|+||||||+|||+++++.+||+||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~yLH---~~~ivHrDiKp~NILi~~~~~~kl~df 160 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDK--VPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADF 160 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHH--SCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECSC
T ss_pred cCceEEEEEEeccCCchhhhhh--ccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecCCCccEEEEcCCCCeeecch
Confidence 5667899999999887654432 34457999999999999999999999 899999999999999999999999999
Q ss_pred CCcccccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCC-
Q 046270 416 GLAKQSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGK- 494 (590)
Q Consensus 416 Gla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~- 494 (590)
|+++..... .......||+.|+|||.+.+..++.++||||+||++|||++|+.||...... ..+..........+.
T Consensus 161 g~~~~~~~~--~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~~~~i~~~~~~~~~~ 237 (305)
T d1blxa_ 161 GLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV-DQLGKILDVIGLPGEE 237 (305)
T ss_dssp CSCCCCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCCCCGG
T ss_pred hhhhhhccc--ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHH-HHHHHHHHhhCCCchh
Confidence 999864332 2345567999999999999999999999999999999999999999754322 222211111100000
Q ss_pred -------c-hhhhhHHH---hhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 046270 495 -------V-DDIFDEFI---RAEGARAVMERFVLVGILCAHVMVALRPTITDALK 538 (590)
Q Consensus 495 -------~-~~~~d~~l---~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~ 538 (590)
. ........ .........+.+.+++..|++.||++|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 238 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp GSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 0 00000000 00011122346678899999999999999999986
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.9e-44 Score=366.58 Aligned_cols=262 Identities=23% Similarity=0.280 Sum_probs=197.1
Q ss_pred cCCCccceecccCcEEEEEEEEcCCcEEEEEEeecCC--CCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEE
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLRHGNLVAVKQILDLD--TKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRF 341 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~~g~~vAvK~l~~~~--~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~ 341 (590)
++|...+.||+|+||+||+|++++|+.||||++.... ....+.+.+|+.+|++++|||||++++++.. .+..+
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-----~~~~~ 76 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT-----KKRLV 76 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC-----SSCEE
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeeccc-----CCcee
Confidence 5788899999999999999999999999999985432 2335689999999999999999999999984 44589
Q ss_pred EEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcccc
Q 046270 342 LVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQS 421 (590)
Q Consensus 342 LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~~ 421 (590)
+++||+.++.+..+.. ..+.+++..+..|+.||+.||+||| +.+|+||||||+|||++.++.+||+|||++...
T Consensus 77 i~~e~~~~~~~~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH---~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~ 150 (286)
T d1ob3a_ 77 LVFEHLDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAF 150 (286)
T ss_dssp EEEECCSEEHHHHHHT---STTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHH
T ss_pred EEEEeehhhhHHHHHh---hcCCcchhhhHHHHHHHHHHHHHhc---cCcEEecCCCCceeeEcCCCCEEecccccceec
Confidence 9999998877766553 4567999999999999999999999 889999999999999999999999999999865
Q ss_pred cCCCcccccccccCCCccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcC--Cchhh
Q 046270 422 LEGHSHLTTRVAGTFGYLAPEYALYG-QLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSG--KVDDI 498 (590)
Q Consensus 422 ~~~~~~~~~~~~gt~~Y~APE~~~~~-~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~--~~~~~ 498 (590)
..... ......|++.|+|||.+... .++.++|||||||+++||++|+.||...... ..+....+...... .....
T Consensus 151 ~~~~~-~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~ 228 (286)
T d1ob3a_ 151 GIPVR-KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA-DQLMRIFRILGTPNSKNWPNV 228 (286)
T ss_dssp CC----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCCCCTTTSTTG
T ss_pred ccCcc-ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHH-HHHHHHHHhhCCCChhhccch
Confidence 43322 23344688999999998754 5699999999999999999999999754322 12221111110000 00000
Q ss_pred h-----hHHH-------hhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 046270 499 F-----DEFI-------RAEGARAVMERFVLVGILCAHVMVALRPTITDALK 538 (590)
Q Consensus 499 ~-----d~~l-------~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~ 538 (590)
. +... ...........+.+++..|++.||++|||++|+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 229 TELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp GGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 0000 00011112346778999999999999999999984
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-44 Score=361.06 Aligned_cols=239 Identities=24% Similarity=0.345 Sum_probs=191.5
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCCC------ChHHHHHHHHHHHhcC--CCCccccceeEEeccC
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDTK------GDEDFTNEVEIISKIR--HRNLLSLRGCCVTSDD 334 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~~------~~~~f~~Ev~il~~l~--H~nlv~l~g~~~~~~~ 334 (590)
++|...++||+|+||.||+|+.. +|+.||||++...... ....+.+|++++++++ |||||++++++..
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~--- 80 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER--- 80 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC---
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEee---
Confidence 56888999999999999999986 5889999998643211 1234678999999996 8999999999974
Q ss_pred CCCceEEEEEeeCCC-CCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCC-CcEEE
Q 046270 335 SSGKRRFLVYDYMPN-GTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSE-LNAKV 412 (590)
Q Consensus 335 ~~~~~~~LV~E~~~~-gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~-~~~kL 412 (590)
....++||||+.+ +++.+++. .+..+++.+++.++.||+.||+||| +.+|+||||||+|||++.+ +.+||
T Consensus 81 --~~~~~lv~e~~~~~~~l~~~~~---~~~~l~e~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NIll~~~~~~vkl 152 (273)
T d1xwsa_ 81 --PDSFVLILERPEPVQDLFDFIT---ERGALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKL 152 (273)
T ss_dssp --SSEEEEEEECCSSEEEHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEE
T ss_pred --CCeEEEEEEeccCcchHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHH---HCCCccccCcccceEEecCCCeEEE
Confidence 4568999999976 56666663 3457999999999999999999999 8999999999999999854 79999
Q ss_pred EeeCCcccccCCCcccccccccCCCccCccccccCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHh
Q 046270 413 ADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALYGQL-TEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAK 491 (590)
Q Consensus 413 ~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~-t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~ 491 (590)
+|||+++..... ..+...||+.|+|||++.+..+ +.++|||||||++|||+||+.||.... .+ .+
T Consensus 153 ~DFG~a~~~~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~----~i-------~~ 218 (273)
T d1xwsa_ 153 IDFGSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----EI-------IR 218 (273)
T ss_dssp CCCTTCEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH----HH-------HH
T ss_pred Cccccceecccc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch----HH-------hh
Confidence 999999865332 2345679999999999987766 567899999999999999999986421 11 01
Q ss_pred cCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 046270 492 SGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALK 538 (590)
Q Consensus 492 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~ 538 (590)
+... +. ......+.+++..|++.||++|||++|+++
T Consensus 219 -~~~~--~~--------~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 219 -GQVF--FR--------QRVSSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp -CCCC--CS--------SCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -cccC--CC--------CCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 1100 01 112246778889999999999999999986
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.3e-42 Score=355.27 Aligned_cols=257 Identities=19% Similarity=0.246 Sum_probs=196.3
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceEEE
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRRFL 342 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~~L 342 (590)
++|...+.||+|+||.||+|++. +|+.||||.+.... ..+++..|++++++++|+|++..++.+... +...++
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~----~~~~~i 80 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAE----GDYNVM 80 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEEE----TTEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc--cCHHHHHHHHHHHHccCCCcccEEEEEEec----CCEEEE
Confidence 46889999999999999999985 58899999876543 234588999999999988887777766543 446899
Q ss_pred EEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEC---CCCcEEEEeeCCcc
Q 046270 343 VYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLD---SELNAKVADFGLAK 419 (590)
Q Consensus 343 V~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd---~~~~~kL~DFGla~ 419 (590)
||||+ +++|.+.+. .....+++..++.++.|++.||+||| +.+|+||||||+|||++ .+..+||+|||+++
T Consensus 81 vme~~-~~~l~~~~~--~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~ 154 (299)
T d1ckia_ 81 VMELL-GPSLEDLFN--FCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 154 (299)
T ss_dssp EEECC-CCBHHHHHH--HTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCSSCE
T ss_pred EEEEc-CCchhhhhh--hccCCCcHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHhhccccccCCCceeeeeccCcce
Confidence 99999 456665553 23457999999999999999999999 89999999999999985 45679999999999
Q ss_pred cccCCCcc------cccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhh--hhHHHHHHHh
Q 046270 420 QSLEGHSH------LTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQL--ITDWAWVLAK 491 (590)
Q Consensus 420 ~~~~~~~~------~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~--l~~~~~~~~~ 491 (590)
........ ......||+.|||||.+.+..++.++|||||||++|||+||+.||......... ...+......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~ 234 (299)
T d1ckia_ 155 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS 234 (299)
T ss_dssp ECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHH
T ss_pred eccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCC
Confidence 76543322 234567999999999999999999999999999999999999999754432221 1111000000
Q ss_pred cCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhcc
Q 046270 492 SGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEG 542 (590)
Q Consensus 492 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~ 542 (590)
.. .+.+ ....+..+.+++..|++.+|++||++.++.++|+.
T Consensus 235 -~~-----~~~~----~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 275 (299)
T d1ckia_ 235 -TP-----IEVL----CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRN 275 (299)
T ss_dssp -SC-----HHHH----TTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHH
T ss_pred -CC-----hhHh----ccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHH
Confidence 00 0001 11233467889999999999999999999888764
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-43 Score=366.81 Aligned_cols=263 Identities=27% Similarity=0.355 Sum_probs=196.3
Q ss_pred CCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCccccceeEEeccC-CCCceEEE
Q 046270 265 GFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDD-SSGKRRFL 342 (590)
Q Consensus 265 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~-~~~~~~~L 342 (590)
+|...++||+|+||+||+|++. .|+.||||++..... .+.+|+++|++++|+||+++++++..... .+..+.+|
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 4677789999999999999986 488999999865432 23479999999999999999999876532 24456899
Q ss_pred EEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCC-cEEEEeeCCcccc
Q 046270 343 VYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSEL-NAKVADFGLAKQS 421 (590)
Q Consensus 343 V~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~-~~kL~DFGla~~~ 421 (590)
||||++++.+............+++.+++.|+.||+.||+||| +.+|+||||||+|||++.++ .+||+|||+++..
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH---~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHH---hcCCcccCCCcceEEEecCCCceeEecccchhhc
Confidence 9999987655444433344567999999999999999999999 89999999999999999775 8999999999876
Q ss_pred cCCCcccccccccCCCccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchhhhh
Q 046270 422 LEGHSHLTTRVAGTFGYLAPEYALY-GQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDDIFD 500 (590)
Q Consensus 422 ~~~~~~~~~~~~gt~~Y~APE~~~~-~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 500 (590)
..... .....||..|+|||.+.. ..++.++||||+||++|||++|+.||...... ..+....+.+ .....+.+.
T Consensus 174 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~-~~l~~i~~~~--g~~~~~~~~ 248 (350)
T d1q5ka_ 174 VRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV-DQLVEIIKVL--GTPTREQIR 248 (350)
T ss_dssp CTTSC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHH-HHHHHHHHHH--CCCCHHHHH
T ss_pred cCCcc--cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHH-HHHHHHHHHh--CCChHHhhh
Confidence 54332 234578999999998765 57899999999999999999999999754432 2222111110 000001110
Q ss_pred HHH----------------hhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 501 EFI----------------RAEGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 501 ~~l----------------~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
... ...........+.+++..|++.||++|||+.|++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 303 (350)
T d1q5ka_ 249 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303 (350)
T ss_dssp HHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000 000011123467788999999999999999999863
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-42 Score=362.82 Aligned_cols=267 Identities=21% Similarity=0.287 Sum_probs=196.1
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCCC-ChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceE
Q 046270 263 TNGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDTK-GDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRR 340 (590)
Q Consensus 263 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~~-~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~ 340 (590)
+.+|...++||+|+||+||+|+.. +|+.||||++...... ..+.+.+|+++|++++|||++++++++...........
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 356889999999999999999875 6899999999654332 24578899999999999999999999876543233334
Q ss_pred EEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCccc
Q 046270 341 FLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQ 420 (590)
Q Consensus 341 ~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~ 420 (590)
++ ++|+.+|+|.+++. ...+++..++.++.||+.||+||| +.+|+||||||+||||+.++.+||+|||+++.
T Consensus 87 ~l-~~~~~~g~L~~~l~----~~~l~~~~i~~i~~qil~al~yLH---~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~ 158 (345)
T d1pmea_ 87 YL-VTHLMGADLYKLLK----TQHLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARV 158 (345)
T ss_dssp EE-EEECCCEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EE-EEeecCCchhhhhh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCcceEEECCCCCEEEcccCceee
Confidence 44 56677999999984 246999999999999999999999 89999999999999999999999999999986
Q ss_pred ccCCCc--ccccccccCCCccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCchh
Q 046270 421 SLEGHS--HLTTRVAGTFGYLAPEYALY-GQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVDD 497 (590)
Q Consensus 421 ~~~~~~--~~~~~~~gt~~Y~APE~~~~-~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 497 (590)
...... .......||+.|+|||.+.. ..++.++||||+||+++||++|+.||........ ....... ........
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~-~~~~~~~-~~~~~~~~ 236 (345)
T d1pmea_ 159 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ-LNHILGI-LGSPSQED 236 (345)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHH-HCSCCHHH
T ss_pred ccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHH-HHHHhhh-ccCCChhh
Confidence 544322 22345679999999999854 4678999999999999999999999965432111 1111110 00000000
Q ss_pred --------hhhHHHh---------hhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 498 --------IFDEFIR---------AEGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 498 --------~~d~~l~---------~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
....... .........++.+++..|++.||.+|||+.|+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 237 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000000 00000112367889999999999999999999975
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-42 Score=356.78 Aligned_cols=265 Identities=23% Similarity=0.307 Sum_probs=194.7
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCCC--ChHHHHHHHHHHHhcCCCCccccceeEEeccCC-CCc
Q 046270 263 TNGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDTK--GDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDS-SGK 338 (590)
Q Consensus 263 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~~--~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~-~~~ 338 (590)
.++|...+.||+|+||+||+|++. +|+.||||++...... ..+.+.+|+++|++++|||||++++++...+.. ...
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 467889999999999999999986 4899999998653222 245688999999999999999999999765421 334
Q ss_pred eEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCc
Q 046270 339 RRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLA 418 (590)
Q Consensus 339 ~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla 418 (590)
+.++||||+ +.+|..++ +...+++..++.++.||+.||.||| +.+|+||||||+|||++.++.+||+|||++
T Consensus 97 ~~~lv~e~~-~~~l~~~~----~~~~l~~~~~~~~~~qi~~aL~~LH---~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a 168 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLM----KHEKLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLA 168 (346)
T ss_dssp CCEEEEECC-SEEHHHHH----HHCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecc-cccHHHHH----HhccccHHHHHHHHHHHHHHHHHHH---hCCCcccccCcchhhcccccccccccccce
Confidence 579999999 55666655 3457999999999999999999999 899999999999999999999999999999
Q ss_pred ccccCCCcccccccccCCCccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCc-h
Q 046270 419 KQSLEGHSHLTTRVAGTFGYLAPEYALYG-QLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKV-D 496 (590)
Q Consensus 419 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~-~ 496 (590)
+..... .+...||+.|+|||.+.+. .++.++||||+||+++||++|+.||...... ..+...... .+.. .
T Consensus 169 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~-~~~~~~~~~---~~~~~~ 240 (346)
T d1cm8a_ 169 RQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL-DQLKEIMKV---TGTPPA 240 (346)
T ss_dssp EECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHH---HCCCCH
T ss_pred eccCCc----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChH-HHHHHHHhc---cCCCcH
Confidence 865432 3446789999999998764 5689999999999999999999999754322 111111111 1110 0
Q ss_pred hhhh-----------HHHhh-------hhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH--hccC
Q 046270 497 DIFD-----------EFIRA-------EGARAVMERFVLVGILCAHVMVALRPTITDALKM--LEGD 543 (590)
Q Consensus 497 ~~~d-----------~~l~~-------~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~--L~~~ 543 (590)
+.+. ..+.. .........+.+++..|++.||.+|||+.|++++ ++..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~ 307 (346)
T d1cm8a_ 241 EFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 307 (346)
T ss_dssp HHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred HHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence 0000 00000 0001122356788999999999999999999985 5543
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-42 Score=356.47 Aligned_cols=266 Identities=22% Similarity=0.280 Sum_probs=195.5
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecC--CCCChHHHHHHHHHHHhcCCCCccccceeEEeccC---CCC
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDL--DTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDD---SSG 337 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~--~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~---~~~ 337 (590)
++|...+.||+|+||+||+|++. +|+.||||++... .....+.+.+|+++|++++|+|++++++.+..... ...
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 67889999999999999999985 6899999998543 23345678999999999999999999999865432 123
Q ss_pred ceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCC
Q 046270 338 KRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGL 417 (590)
Q Consensus 338 ~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGl 417 (590)
...++||||++++.+..+. .....++...+..|+.||+.||.||| +.+|+||||||+|||++.++.+||+|||+
T Consensus 90 ~~~~iv~e~~~~~~~~~~~---~~~~~~~~~~~~~i~~qil~~l~~lH---~~~ivHrDlKp~NILl~~~~~~kl~dfg~ 163 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLS---NVLVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGL 163 (318)
T ss_dssp -CEEEEEECCCEEHHHHHT---CTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTT
T ss_pred ceEEEEEeccCCCccchhh---hcccccccHHHHHHHHHHHHHHHHhc---cCCEEecCcCchheeecCCCcEEeeecce
Confidence 4689999999887776544 24457899999999999999999999 89999999999999999999999999999
Q ss_pred cccccCCCcc---cccccccCCCccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcC
Q 046270 418 AKQSLEGHSH---LTTRVAGTFGYLAPEYALYG-QLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSG 493 (590)
Q Consensus 418 a~~~~~~~~~---~~~~~~gt~~Y~APE~~~~~-~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~ 493 (590)
++........ ......||+.|+|||.+.+. .++.++|||||||++|||++|+.||...... ..+...........
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~-~~~~~i~~~~~~~~ 242 (318)
T d3blha1 164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ-HQLALISQLCGSIT 242 (318)
T ss_dssp CEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCCCC
T ss_pred eeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHH-HHHHHHHHhcCCCC
Confidence 9865433221 22335689999999998755 6899999999999999999999999754321 11111111110000
Q ss_pred -Cc-------------------hhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 494 -KV-------------------DDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 494 -~~-------------------~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
.. ...+.+.+. .......+++++..|++.||++|||++|++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLK---AYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp TTTSTTCCCC-------CCSSCCBCHHHHHH---HHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hhhccccchhhhhhhhcccccccccchhhhc---cccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 00 000011110 01112356678899999999999999999974
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2.4e-41 Score=345.30 Aligned_cols=257 Identities=16% Similarity=0.203 Sum_probs=199.4
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCCCChHHHHHHHHHHHhcCC-CCccccceeEEeccCCCCceEE
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDTKGDEDFTNEVEIISKIRH-RNLLSLRGCCVTSDDSSGKRRF 341 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H-~nlv~l~g~~~~~~~~~~~~~~ 341 (590)
++|...+.||+|+||+||+|++. +|+.||||.+.... ..+.+.+|++.++.++| +|++.+++++.. +...+
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~-----~~~~~ 77 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQE-----GLHNV 77 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEE-----TTEEE
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeec-----CCccE
Confidence 57889999999999999999986 58899999875432 23457899999999965 899999988863 45689
Q ss_pred EEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECC-----CCcEEEEeeC
Q 046270 342 LVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDS-----ELNAKVADFG 416 (590)
Q Consensus 342 LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~-----~~~~kL~DFG 416 (590)
+||||+ +++|.+++.. ....+++..+..|+.|++.||+||| +.+|+||||||+|||++. ++.+||+|||
T Consensus 78 ~vme~~-~~~l~~~~~~--~~~~~~~~~~~~i~~q~~~~l~~lH---~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG 151 (293)
T d1csna_ 78 LVIDLL-GPSLEDLLDL--CGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFG 151 (293)
T ss_dssp EEEECC-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCT
T ss_pred EEEEec-CCCHHHHHHh--hccchhhHHHHHHHHHHHHHHHHHH---HCCceeccCCccceeecCcccccCCceEEcccc
Confidence 999998 6899888752 3456999999999999999999999 999999999999999974 5689999999
Q ss_pred CcccccCCCcc------cccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhh-hHHHHHH
Q 046270 417 LAKQSLEGHSH------LTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLI-TDWAWVL 489 (590)
Q Consensus 417 la~~~~~~~~~------~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l-~~~~~~~ 489 (590)
+++........ ......||+.|||||.+.+..++.++|||||||++|||+||+.||.......... .......
T Consensus 152 ~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~ 231 (293)
T d1csna_ 152 MVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEK 231 (293)
T ss_dssp TCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHH
T ss_pred eeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhc
Confidence 99876443221 2334679999999999999999999999999999999999999997544322211 0001000
Q ss_pred HhcCCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHHhcc
Q 046270 490 AKSGKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALKMLEG 542 (590)
Q Consensus 490 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~L~~ 542 (590)
.......+ + ....++.+..++..|++.+|++||+++.+.+.|+.
T Consensus 232 ~~~~~~~~-----l----~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~ 275 (293)
T d1csna_ 232 KQSTPLRE-----L----CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSK 275 (293)
T ss_dssp HHHSCHHH-----H----TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHH
T ss_pred cCCCChHH-----h----cCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHH
Confidence 00011111 1 11123467788889999999999999888777754
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1e-41 Score=353.04 Aligned_cols=258 Identities=18% Similarity=0.263 Sum_probs=197.8
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCCCChHHHHHHHHHHHhcC-CCCccccceeEEeccCCCCceEE
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDTKGDEDFTNEVEIISKIR-HRNLLSLRGCCVTSDDSSGKRRF 341 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~-H~nlv~l~g~~~~~~~~~~~~~~ 341 (590)
++|...++||+|+||+||+|+.. .|+.||||++.. ...+.+.+|+++|++++ ||||+++++++... .....+
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~---~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~---~~~~~~ 108 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP---VKKKKIKREIKILENLRGGPNIITLADIVKDP---VSRTPA 108 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS---SCHHHHHHHHHHHHHHTTSTTBCCEEEEEECT---TTCSEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECH---HHHHHHHHHHHHHHhccCCCCCcEEEEEEEec---CCCcee
Confidence 57899999999999999999985 588999999864 33567899999999995 99999999998753 234689
Q ss_pred EEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCC-cEEEEeeCCccc
Q 046270 342 LVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSEL-NAKVADFGLAKQ 420 (590)
Q Consensus 342 LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~-~~kL~DFGla~~ 420 (590)
+||||+++++|..+. +.+++..++.++.||+.||.||| +.+|+||||||+|||++.++ .+||+|||+++.
T Consensus 109 ~v~e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH---~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~ 179 (328)
T d3bqca1 109 LVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF 179 (328)
T ss_dssp EEEECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCGGGCEE
T ss_pred EEEeecCCCcHHHHh------cCCCHHHHHHHHHHHHHHHHHHh---hcccccccccccceEEcCCCCeeeeccccccee
Confidence 999999999997754 36999999999999999999999 89999999999999998655 689999999987
Q ss_pred ccCCCcccccccccCCCccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHH--------HHHh
Q 046270 421 SLEGHSHLTTRVAGTFGYLAPEYALYG-QLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAW--------VLAK 491 (590)
Q Consensus 421 ~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~--------~~~~ 491 (590)
..... ......||..|+|||.+... .++.++||||+||+++||++|+.||............... ....
T Consensus 180 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~ 257 (328)
T d3bqca1 180 YHPGQ--EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYID 257 (328)
T ss_dssp CCTTC--CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHH
T ss_pred ccCCC--cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhh
Confidence 65433 23445789999999998765 4799999999999999999999999765543321111100 0000
Q ss_pred cC--Cchhhh------------hHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 046270 492 SG--KVDDIF------------DEFIRAEGARAVMERFVLVGILCAHVMVALRPTITDALK 538 (590)
Q Consensus 492 ~~--~~~~~~------------d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~ 538 (590)
.. .....+ ...............+.+++..|++.||++|||++|+++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 258 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp HTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 000000 000001111122346788999999999999999999986
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-42 Score=353.30 Aligned_cols=252 Identities=24% Similarity=0.317 Sum_probs=198.4
Q ss_pred cCCCccceecccCcEEEEEEEEc----CCcEEEEEEeecC----CCCChHHHHHHHHHHHhcCC-CCccccceeEEeccC
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLR----HGNLVAVKQILDL----DTKGDEDFTNEVEIISKIRH-RNLLSLRGCCVTSDD 334 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~----~g~~vAvK~l~~~----~~~~~~~f~~Ev~il~~l~H-~nlv~l~g~~~~~~~ 334 (590)
++|...+.||+|+||+||+|+.. .|+.||||.+... .....+.+.+|++++++++| |||+++++++..
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~--- 100 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT--- 100 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE---
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeecc---
Confidence 56899999999999999999863 3789999998532 22335668899999999976 899999999874
Q ss_pred CCCceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEe
Q 046270 335 SSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVAD 414 (590)
Q Consensus 335 ~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~D 414 (590)
....++||||+.+|+|.+++. ..+.++......++.||+.||+||| +.+|+||||||+||||+.++.+||+|
T Consensus 101 --~~~~~~v~e~~~~~~L~~~i~---~~~~~~e~~~~~~~~Qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~vkL~D 172 (322)
T d1vzoa_ 101 --ETKLHLILDYINGGELFTHLS---QRERFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTD 172 (322)
T ss_dssp --TTEEEEEECCCCSCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESC
T ss_pred --CCceeeeeecccccHHHHHHH---hcccccHHHHHHHHHHHHHHHHHhh---cCCEEeccCCccceeecCCCCEEEee
Confidence 346999999999999999885 3456788999999999999999999 89999999999999999999999999
Q ss_pred eCCcccccCCCcccccccccCCCccCccccccC--CCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhc
Q 046270 415 FGLAKQSLEGHSHLTTRVAGTFGYLAPEYALYG--QLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKS 492 (590)
Q Consensus 415 FGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~--~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~ 492 (590)
||+++..............|++.|++||.+... .++.++|||||||+||||++|+.||........ ...........
T Consensus 173 FG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~-~~~i~~~~~~~ 251 (322)
T d1vzoa_ 173 FGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS-QAEISRRILKS 251 (322)
T ss_dssp SSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC-HHHHHHHHHHC
T ss_pred ccchhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcccC
Confidence 999987655444445556799999999998754 478899999999999999999999976543222 11111111111
Q ss_pred CCchhhhhHHHhhhhHHHHHHHHHHHHHhchhcCCCCCCC-----HHHHHH
Q 046270 493 GKVDDIFDEFIRAEGARAVMERFVLVGILCAHVMVALRPT-----ITDALK 538 (590)
Q Consensus 493 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt-----m~eVl~ 538 (590)
.. ..+.....++.+++..|++.||++||| ++|+++
T Consensus 252 -~~----------~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 252 -EP----------PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp -CC----------CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred -CC----------CCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 10 011123357788889999999999994 788876
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-42 Score=347.41 Aligned_cols=262 Identities=19% Similarity=0.221 Sum_probs=200.6
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCC--CChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCceE
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDT--KGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKRR 340 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~--~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~~ 340 (590)
++|+..+.||+|+||+||+|++. +|+.||||+++.... ...+.+.+|+.++++++||||+++++++.. ....
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~-----~~~~ 76 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS-----DKKL 76 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEC-----SSEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeecccccc-----ccce
Confidence 57889999999999999999985 588999999864432 235678999999999999999999999984 4568
Q ss_pred EEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCccc
Q 046270 341 FLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAKQ 420 (590)
Q Consensus 341 ~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~~ 420 (590)
++|+|++.+++|..++. ..+.+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||.++.
T Consensus 77 ~iv~~~~~~~~l~~~~~---~~~~~~~~~~~~~~~q~~~aL~~lH---~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~ 150 (292)
T d1unla_ 77 TLVFEFCDQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARA 150 (292)
T ss_dssp EEEEECCSEEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred eEEeeeccccccccccc---cccccchhHHHHHHHHHHHHHHHhh---cCCEeeecccCcccccccCCceeeeecchhhc
Confidence 99999999998887764 4567899999999999999999999 89999999999999999999999999999987
Q ss_pred ccCCCcccccccccCCCccCccccccCC-CCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCC---ch
Q 046270 421 SLEGHSHLTTRVAGTFGYLAPEYALYGQ-LTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGK---VD 496 (590)
Q Consensus 421 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~-~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~---~~ 496 (590)
...... ......++..|+|||.+.... ++.++|||||||+++||++|+.||.........+.... ....... ..
T Consensus 151 ~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 228 (292)
T d1unla_ 151 FGIPVR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIF-RLLGTPTEEQWP 228 (292)
T ss_dssp CCSCCS-CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHH-HHHCCCCTTTCT
T ss_pred ccCCCc-cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHH-hhcCCCChhhhh
Confidence 654332 233345678999999887655 69999999999999999999999865444333222111 1111100 00
Q ss_pred ---hhhh--------HHH-hhhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 046270 497 ---DIFD--------EFI-RAEGARAVMERFVLVGILCAHVMVALRPTITDALK 538 (590)
Q Consensus 497 ---~~~d--------~~l-~~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~ 538 (590)
...+ ... ...........+.+++.+|++.||.+|||++|+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 229 SMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp TGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000 000 00001112346677889999999999999999986
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-40 Score=347.47 Aligned_cols=261 Identities=21% Similarity=0.287 Sum_probs=195.1
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCCC--ChHHHHHHHHHHHhcCCCCccccceeEEeccCCCCce
Q 046270 263 TNGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDTK--GDEDFTNEVEIISKIRHRNLLSLRGCCVTSDDSSGKR 339 (590)
Q Consensus 263 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~~--~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~~~~~~ 339 (590)
.++|...+.||+|+||+||+|+.. +|+.||||++...... ..+.+.+|+++|++++|||+|++++++......+...
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 467999999999999999999975 5899999998654322 2356889999999999999999999987654333444
Q ss_pred EEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcc
Q 046270 340 RFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAK 419 (590)
Q Consensus 340 ~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~ 419 (590)
.+++++|+.+|+|.+++. .+.+++.++..|+.||+.||+||| +.+|+||||||+|||++.++.+|++|||++.
T Consensus 97 ~~~i~~~~~gg~L~~~~~----~~~l~e~~~~~i~~qil~aL~~LH---~~giiHrDiKp~NILi~~~~~~kl~dfg~a~ 169 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR 169 (348)
T ss_dssp CCEEEEECCSEEHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCC----
T ss_pred eEEEEEeecCCchhhhcc----cccccHHHHHHHHHHHHHHHHHHH---hCCCcccccCCccccccccccccccccchhc
Confidence 567778888999999884 346999999999999999999999 8999999999999999999999999999987
Q ss_pred cccCCCcccccccccCCCccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHHHHHHhcCCch-h
Q 046270 420 QSLEGHSHLTTRVAGTFGYLAPEYALYG-QLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWAWVLAKSGKVD-D 497 (590)
Q Consensus 420 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~-~ 497 (590)
.... ......||..|+|||...+. .++.++|||||||++|||++|+.||........ ....... .+... +
T Consensus 170 ~~~~----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~-~~~i~~~---~~~~~~~ 241 (348)
T d2gfsa1 170 HTDD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ-LKLILRL---VGTPGAE 241 (348)
T ss_dssp CCTG----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHH---HCCCCHH
T ss_pred ccCc----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHH-HHHHHHh---cCCCChH
Confidence 5432 23345688999999987665 468999999999999999999999975432211 1111000 01100 0
Q ss_pred h--------hhHHHh----------hhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 046270 498 I--------FDEFIR----------AEGARAVMERFVLVGILCAHVMVALRPTITDALK 538 (590)
Q Consensus 498 ~--------~d~~l~----------~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~ 538 (590)
. ...... ..........+.+++..|++.||.+|||+.|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~ 300 (348)
T d2gfsa1 242 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300 (348)
T ss_dssp HHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence 0 000000 0000112346778999999999999999999997
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-41 Score=351.14 Aligned_cols=264 Identities=22% Similarity=0.265 Sum_probs=191.5
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCCC--ChHHHHHHHHHHHhcCCCCccccceeEEeccC-CCCce
Q 046270 264 NGFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDTK--GDEDFTNEVEIISKIRHRNLLSLRGCCVTSDD-SSGKR 339 (590)
Q Consensus 264 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~~--~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~-~~~~~ 339 (590)
++|...++||+|+||+||+|++. .|+.||||++...... ....+.+|++++++++|||||++++++..... .....
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 57889999999999999999987 4899999999754322 23468899999999999999999999875532 24578
Q ss_pred EEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCcEEEEeeCCcc
Q 046270 340 RFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELNAKVADFGLAK 419 (590)
Q Consensus 340 ~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~ 419 (590)
.|+||||+.++.+. .+ ...+++..++.++.||+.||+||| +.+|+||||||+|||++.++..|++|||+++
T Consensus 97 ~~iv~Ey~~~~l~~-~~-----~~~~~~~~i~~~~~qil~gl~~LH---~~giiHrDlKP~Nil~~~~~~~kl~df~~~~ 167 (355)
T d2b1pa1 97 VYLVMELMDANLCQ-VI-----QMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_dssp EEEEEECCSEEHHH-HH-----TSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred eEEEEeccchHHHH-hh-----hcCCCHHHHHHHHHHHHHHHHHhh---hcccccccCCccccccccccceeeechhhhh
Confidence 99999999765544 33 235899999999999999999999 8999999999999999999999999999988
Q ss_pred cccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCchhhhhHHH-------------
Q 046270 420 QSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPFQLITDWA------------- 486 (590)
Q Consensus 420 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~~~l~~~~------------- 486 (590)
..... ...+...||+.|+|||.+.+..++.++||||+||+++||++|+.||....... ......
T Consensus 168 ~~~~~--~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~-~~~~i~~~~~~~~~~~~~~ 244 (355)
T d2b1pa1 168 TAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID-QWNKVIEQLGTPCPEFMKK 244 (355)
T ss_dssp ---------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCCCCHHHHTT
T ss_pred ccccc--cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHH-HHHHHHHhccCCCHHHHHH
Confidence 65433 23445678999999999999999999999999999999999999996543211 111000
Q ss_pred -----HHHHhcC-C-----chhhhhHHHh---hhhHHHHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 046270 487 -----WVLAKSG-K-----VDDIFDEFIR---AEGARAVMERFVLVGILCAHVMVALRPTITDALKM 539 (590)
Q Consensus 487 -----~~~~~~~-~-----~~~~~d~~l~---~~~~~~~~~~l~~l~~~Cl~~dp~~RPtm~eVl~~ 539 (590)
....... . ....+..... ..........+.+++..|++.||++|||++|++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp SCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0000000 0 0011111110 01123345678889999999999999999999864
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=5e-37 Score=321.18 Aligned_cols=262 Identities=18% Similarity=0.194 Sum_probs=193.3
Q ss_pred CCCccceecccCcEEEEEEEEc-CCcEEEEEEeecCCCCChHHHHHHHHHHHhcC-----------CCCccccceeEEec
Q 046270 265 GFSQNNLIGQGASGIVYKGTLR-HGNLVAVKQILDLDTKGDEDFTNEVEIISKIR-----------HRNLLSLRGCCVTS 332 (590)
Q Consensus 265 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~-----------H~nlv~l~g~~~~~ 332 (590)
+|...++||+|+||+||+|+.. +|+.||||+++... ...+.+.+|++++++++ |+||+++++++...
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence 4888999999999999999985 58999999986432 22456789999998886 57899999988654
Q ss_pred cCCCCceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCC----
Q 046270 333 DDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSEL---- 408 (590)
Q Consensus 333 ~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~---- 408 (590)
. ....+++|+++..+..............+++..+..++.||+.||+|||+ ..+|+||||||+||||+.++
T Consensus 93 ~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDlKp~NIll~~~~~~~~ 167 (362)
T d1q8ya_ 93 G---PNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPEN 167 (362)
T ss_dssp E---TTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEEEETTTT
T ss_pred c---ccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhh--hcCcccccCChhHeeeeccCcccc
Confidence 3 23567777777666555444444455678999999999999999999993 37899999999999998664
Q ss_pred --cEEEEeeCCcccccCCCcccccccccCCCccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCch-----hh
Q 046270 409 --NAKVADFGLAKQSLEGHSHLTTRVAGTFGYLAPEYALYGQLTEKSDVYSFGIVILELMSGRKVLDTSTSPF-----QL 481 (590)
Q Consensus 409 --~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVySfGvvLlELltG~~p~~~~~~~~-----~~ 481 (590)
.+|++|||.+...... .....||+.|+|||.+....++.++||||+||+++||++|+.||....... ..
T Consensus 168 ~~~~kl~dfg~s~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~ 243 (362)
T d1q8ya_ 168 LIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 243 (362)
T ss_dssp EEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred cceeeEeecccccccccc----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHH
Confidence 3899999999754332 244578999999999999999999999999999999999999986443211 11
Q ss_pred hhHHHHHHHhcCCc-hhh---------------------------hhHHHh--hhhHHHHHHHHHHHHHhchhcCCCCCC
Q 046270 482 ITDWAWVLAKSGKV-DDI---------------------------FDEFIR--AEGARAVMERFVLVGILCAHVMVALRP 531 (590)
Q Consensus 482 l~~~~~~~~~~~~~-~~~---------------------------~d~~l~--~~~~~~~~~~l~~l~~~Cl~~dp~~RP 531 (590)
+....+.+ |.. .+. ....+. ..........+.+++..|++.||.+||
T Consensus 244 ~~~~~~~l---g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rp 320 (362)
T d1q8ya_ 244 IAQIIELL---GELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA 320 (362)
T ss_dssp HHHHHHHH---CSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred HHHHHHHh---CCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCc
Confidence 21111111 110 000 000010 112234566889999999999999999
Q ss_pred CHHHHHHH
Q 046270 532 TITDALKM 539 (590)
Q Consensus 532 tm~eVl~~ 539 (590)
|++|++++
T Consensus 321 ta~e~L~H 328 (362)
T d1q8ya_ 321 DAGGLVNH 328 (362)
T ss_dssp CHHHHHTC
T ss_pred CHHHHhcC
Confidence 99999874
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.89 E-value=1.1e-23 Score=199.92 Aligned_cols=163 Identities=17% Similarity=0.157 Sum_probs=120.5
Q ss_pred ccceecccCcEEEEEEEEcCCcEEEEEEeecCCCC-------------C-----hHHHHHHHHHHHhcCCCCccccceeE
Q 046270 268 QNNLIGQGASGIVYKGTLRHGNLVAVKQILDLDTK-------------G-----DEDFTNEVEIISKIRHRNLLSLRGCC 329 (590)
Q Consensus 268 ~~~~LG~G~fG~Vykg~~~~g~~vAvK~l~~~~~~-------------~-----~~~f~~Ev~il~~l~H~nlv~l~g~~ 329 (590)
..++||+|+||+||+|++.+|+.||||.++..... . ......|...+.++.|.+++..+++.
T Consensus 4 vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~ 83 (191)
T d1zara2 4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE 83 (191)
T ss_dssp EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE
T ss_pred hCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec
Confidence 46799999999999999999999999987431110 0 12345688899999999998877553
Q ss_pred EeccCCCCceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEECCCCc
Q 046270 330 VTSDDSSGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYGLKPGIYHRDIKSTNILLDSELN 409 (590)
Q Consensus 330 ~~~~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~~~~~ivHrDIKp~NILLd~~~~ 409 (590)
. .+++|||++++.+. .+++.....++.|++++|.||| +.+|+||||||+|||++++ .
T Consensus 84 ~---------~~lvme~~~~~~~~----------~l~~~~~~~i~~ql~~~l~~lH---~~giiHrDiKP~NILv~~~-~ 140 (191)
T d1zara2 84 G---------NAVLMELIDAKELY----------RVRVENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVSEE-G 140 (191)
T ss_dssp T---------TEEEEECCCCEEGG----------GCCCSCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEETT-E
T ss_pred C---------CEEEEEeecccccc----------chhhHHHHHHHHHHHHHHHHHh---hCCEEEccCChhheeeeCC-C
Confidence 1 37999999875432 3566667889999999999999 8999999999999999865 5
Q ss_pred EEEEeeCCcccccCCCcccccccccCCCccC------ccccccCCCCcchhHHHHHHHHH
Q 046270 410 AKVADFGLAKQSLEGHSHLTTRVAGTFGYLA------PEYALYGQLTEKSDVYSFGIVIL 463 (590)
Q Consensus 410 ~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~A------PE~~~~~~~t~ksDVySfGvvLl 463 (590)
++|+|||+++........ .|.. .|+ ....|..++|+||..--++
T Consensus 141 ~~liDFG~a~~~~~~~~~---------~~l~rd~~~~~~~-f~r~y~~~~d~~s~~~~~~ 190 (191)
T d1zara2 141 IWIIDFPQSVEVGEEGWR---------EILERDVRNIITY-FSRTYRTEKDINSAIDRIL 190 (191)
T ss_dssp EEECCCTTCEETTSTTHH---------HHHHHHHHHHHHH-HHHHHCCCCCHHHHHHHHH
T ss_pred EEEEECCCcccCCCCCcH---------HHHHHHHHHHHHH-HcCCCCCcccHHHHHHHHh
Confidence 999999999765322211 0111 122 2356788999999754443
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.44 E-value=4.4e-07 Score=87.51 Aligned_cols=149 Identities=15% Similarity=0.049 Sum_probs=98.3
Q ss_pred HHHHHHhcCCCccceecccCcEEEEEEEEcCCcEEEEEEeecCCCCChHHHHHHHHHHHhcC-CCCccccceeEEeccCC
Q 046270 257 SELEQATNGFSQNNLIGQGASGIVYKGTLRHGNLVAVKQILDLDTKGDEDFTNEVEIISKIR-HRNLLSLRGCCVTSDDS 335 (590)
Q Consensus 257 ~el~~at~~f~~~~~LG~G~fG~Vykg~~~~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~-H~nlv~l~g~~~~~~~~ 335 (590)
.|+.+.-..|...+..+.+....||+...+ ++.+.||+...........+.+|..++..+. +--+.+++.+...
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~~-~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~---- 81 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERH---- 81 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEE----
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEeC-CCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEec----
Confidence 355555566665554443444689998654 5667888876554444556888999988884 3223455555442
Q ss_pred CCceEEEEEeeCCCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHHhc----------------------------
Q 046270 336 SGKRRFLVYDYMPNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLHYG---------------------------- 387 (590)
Q Consensus 336 ~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH~~---------------------------- 387 (590)
++..++||+++++.++.+... +......++.++++.|..||..
T Consensus 82 -~~~~~lv~~~l~G~~~~~~~~--------~~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 152 (263)
T d1j7la_ 82 -DGWSNLLMSEADGVLCSEEYE--------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLAD 152 (263)
T ss_dssp -TTEEEEEEECCSSEEHHHHTT--------TCSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSC
T ss_pred -CCceEEEEEeccccccccccc--------ccccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhh
Confidence 346899999999987754331 1223344566666667777631
Q ss_pred ----------------------------CCCCeEecCCCCCceEECCCCcEEEEeeCCcc
Q 046270 388 ----------------------------LKPGIYHRDIKSTNILLDSELNAKVADFGLAK 419 (590)
Q Consensus 388 ----------------------------~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~ 419 (590)
....++|+|+.|.|||++++...-|.||+.+.
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 153 VDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp CCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred hhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 02237899999999999987667799998775
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.91 E-value=2.1e-05 Score=74.80 Aligned_cols=130 Identities=16% Similarity=0.159 Sum_probs=82.2
Q ss_pred eecccCc-EEEEEEEEcCCcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCc--cccceeEEeccCCCCceEEEEEeeC
Q 046270 271 LIGQGAS-GIVYKGTLRHGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNL--LSLRGCCVTSDDSSGKRRFLVYDYM 347 (590)
Q Consensus 271 ~LG~G~f-G~Vykg~~~~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nl--v~l~g~~~~~~~~~~~~~~LV~E~~ 347 (590)
.+..|.. +.||+...+++..+++|.-.... ...+..|++.++.+....+ .+++++.. .+...++||+++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~-----~~~~~~~v~~~i 88 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVT-----EAGRDWLLLGEV 88 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEE-----CSSCEEEEEECC
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecc-----cccceEEEEEee
Confidence 3444543 68999998888888888754332 3357789999888854443 44555544 234589999999
Q ss_pred CCCCcchhhhhhcccccCChhhHHHHHHHHHHHHHHHH------------------------------------------
Q 046270 348 PNGTLSDNISISHKRKQLTWPQRKKIIVDVAKGIAYLH------------------------------------------ 385 (590)
Q Consensus 348 ~~gsL~~~L~~~~~~~~l~~~~r~~I~~~ia~gL~yLH------------------------------------------ 385 (590)
++.++.+... . ...++.++++.|.-||
T Consensus 89 ~G~~~~~~~~--------~---~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (255)
T d1nd4a_ 89 PGQDLLSSHL--------A---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLA 157 (255)
T ss_dssp SSEETTTSCC--------C---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCC
T ss_pred eccccccccc--------c---HHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhH
Confidence 9876643210 0 0111222222233333
Q ss_pred ---------hc----CCCCeEecCCCCCceEECCCCcEEEEeeCCcc
Q 046270 386 ---------YG----LKPGIYHRDIKSTNILLDSELNAKVADFGLAK 419 (590)
Q Consensus 386 ---------~~----~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~ 419 (590)
.. ....++|+|+.|.|||++++..+-|+||+.+.
T Consensus 158 ~~~~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 158 PAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp HHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 11 12348999999999999987667899998775
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.36 E-value=0.00032 Score=69.53 Aligned_cols=140 Identities=12% Similarity=0.076 Sum_probs=81.2
Q ss_pred EEEEEEEEcCCcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCccccceeEEeccC--CCCceEEEEEeeCCCCCcch-
Q 046270 278 GIVYKGTLRHGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGCCVTSDD--SSGKRRFLVYDYMPNGTLSD- 354 (590)
Q Consensus 278 G~Vykg~~~~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv~l~g~~~~~~~--~~~~~~~LV~E~~~~gsL~~- 354 (590)
-.||+...++|+.+++|..+.. ....+++..|...+..|...++.-.......... ..+...+.++++++|..+..
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~ 114 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD 114 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred ceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence 4899999999999999987543 3356788999999998854333211111110000 13456889999998755421
Q ss_pred ---hh----------hhh------cccccCC-------------------hhhHHHHHHHHHHHHHHHHh----cCCCCe
Q 046270 355 ---NI----------SIS------HKRKQLT-------------------WPQRKKIIVDVAKGIAYLHY----GLKPGI 392 (590)
Q Consensus 355 ---~L----------~~~------~~~~~l~-------------------~~~r~~I~~~ia~gL~yLH~----~~~~~i 392 (590)
.+ +.. ..+..++ ...+..+...+.+.++.+.. ....++
T Consensus 115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l 194 (325)
T d1zyla1 115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR 194 (325)
T ss_dssp CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence 00 000 0011111 11222222223333333332 234678
Q ss_pred EecCCCCCceEECCCCcEEEEeeCCccc
Q 046270 393 YHRDIKSTNILLDSELNAKVADFGLAKQ 420 (590)
Q Consensus 393 vHrDIKp~NILLd~~~~~kL~DFGla~~ 420 (590)
||+|+.+.|||++++ ..++||+-+..
T Consensus 195 iHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 195 LHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred ecCCCCcccEEEeCC--ceEEechhccc
Confidence 999999999999854 46899998764
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.34 E-value=0.0006 Score=69.47 Aligned_cols=76 Identities=12% Similarity=0.092 Sum_probs=46.2
Q ss_pred ceecccCcEEEEEEEEcC-CcEEEEEEeecC---C----CCChHHHHHHHHHHHhcC-C-CC-ccccceeEEeccCCCCc
Q 046270 270 NLIGQGASGIVYKGTLRH-GNLVAVKQILDL---D----TKGDEDFTNEVEIISKIR-H-RN-LLSLRGCCVTSDDSSGK 338 (590)
Q Consensus 270 ~~LG~G~fG~Vykg~~~~-g~~vAvK~l~~~---~----~~~~~~f~~Ev~il~~l~-H-~n-lv~l~g~~~~~~~~~~~ 338 (590)
+.||.|....||+....+ ++.++||.-... . .........|.+.|+.+. + |. +.+++.+ +.+
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~----- 104 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTE----- 104 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETT-----
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCC-----
Confidence 468999999999998765 568999975321 1 112234567888888773 3 23 3334433 221
Q ss_pred eEEEEEeeCCCCCc
Q 046270 339 RRFLVYDYMPNGTL 352 (590)
Q Consensus 339 ~~~LV~E~~~~gsL 352 (590)
..++|||++++..+
T Consensus 105 ~~~lvmE~L~~~~~ 118 (392)
T d2pula1 105 MAVTVMEDLSHLKI 118 (392)
T ss_dssp TTEEEECCCTTSEE
T ss_pred CCEEEEeccCCccc
Confidence 25899999987543
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.69 E-value=0.006 Score=59.33 Aligned_cols=162 Identities=12% Similarity=0.106 Sum_probs=87.2
Q ss_pred ccHHHHHHHhcCCCccceec-----ccCcEEEEEEEEcCCcEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCcccccee
Q 046270 254 FHVSELEQATNGFSQNNLIG-----QGASGIVYKGTLRHGNLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLLSLRGC 328 (590)
Q Consensus 254 f~~~el~~at~~f~~~~~LG-----~G~fG~Vykg~~~~g~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv~l~g~ 328 (590)
.+.+|++....+|...++.. .|---+.|+.+.++|+ +++|+.... ...+++..|++++..|.+.++.-..-.
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~--~~~~~l~~~~~~l~~L~~~g~pvp~pi 79 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPL 79 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCC--CCHHHHHHHHHHHHhhhhccccccccc
Confidence 45677777778887654433 4444678999887665 788887442 234456678888888854332211100
Q ss_pred EEeccC----CCCceEEEEEeeCCCCCcchhh--------------hhh------------------------cccccCC
Q 046270 329 CVTSDD----SSGKRRFLVYDYMPNGTLSDNI--------------SIS------------------------HKRKQLT 366 (590)
Q Consensus 329 ~~~~~~----~~~~~~~LV~E~~~~gsL~~~L--------------~~~------------------------~~~~~l~ 366 (590)
...+. ........++.+..+......- +.. .......
T Consensus 80 -~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (316)
T d2ppqa1 80 -PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV 158 (316)
T ss_dssp -CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred -eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhc
Confidence 00000 0123466777777764442210 000 0000011
Q ss_pred hhhHHHHHHHHHHHHHHHH-hcCCCCeEecCCCCCceEECCCCcEEEEeeCCcc
Q 046270 367 WPQRKKIIVDVAKGIAYLH-YGLKPGIYHRDIKSTNILLDSELNAKVADFGLAK 419 (590)
Q Consensus 367 ~~~r~~I~~~ia~gL~yLH-~~~~~~ivHrDIKp~NILLd~~~~~kL~DFGla~ 419 (590)
.......+..+...+.-.+ .....++||+|+.+.||+++++...-|.||+.+.
T Consensus 159 ~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 159 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred chhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 1122222333333333332 1335789999999999999988777899999875
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.52 E-value=0.0024 Score=64.65 Aligned_cols=73 Identities=22% Similarity=0.311 Sum_probs=49.6
Q ss_pred ceecccCcEEEEEEEEcCC--------cEEEEEEeecCCCCChHHHHHHHHHHHhcCCCCcc-ccceeEEeccCCCCceE
Q 046270 270 NLIGQGASGIVYKGTLRHG--------NLVAVKQILDLDTKGDEDFTNEVEIISKIRHRNLL-SLRGCCVTSDDSSGKRR 340 (590)
Q Consensus 270 ~~LG~G~fG~Vykg~~~~g--------~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H~nlv-~l~g~~~~~~~~~~~~~ 340 (590)
+.|+.|--=.+|+...+++ ..|.++... ......+..+|.++++.+.-.+++ ++++++. -
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g--~~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~---------~ 116 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF--NPETESHLVAESVIFTLLSERHLGPKLYGIFS---------G 116 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC--SCCCHHHHHHHHHHHHHHHHTTSSSCEEEEET---------T
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecC--CcchhhHHHHHHHHHHHHHhCCCCCeEEEEcC---------C
Confidence 4677777789999987643 346665543 233445677899999998545555 6666553 1
Q ss_pred EEEEeeCCCCCcc
Q 046270 341 FLVYDYMPNGTLS 353 (590)
Q Consensus 341 ~LV~E~~~~gsL~ 353 (590)
.+|+||+++..|.
T Consensus 117 g~I~efi~g~~l~ 129 (395)
T d1nw1a_ 117 GRLEEYIPSRPLS 129 (395)
T ss_dssp EEEECCCCEEECC
T ss_pred ceEEEEeccccCC
Confidence 6899999876554
|